data_2lc0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lc0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.48 ' HA ' ' CD ' ' A' ' 37' ' ' GLU . 95.1 mt-30 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 113.572 0.953 . . . . 73.349999999999994 113.572 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -71.33 -23.93 62.02 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.244 -1.021 . . . . 71.510000000000005 108.244 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HA ' ' CE2' ' A' ' 119' ' ' PHE . 98.4 t -69.12 -54.72 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.352 -0.84 . . . . 64.310000000000002 108.844 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' HA ' ' A' ' 34' ' ' GLN . 2.7 mp0 -52.64 -43.9 65.75 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.053 0.454 . . . . 71.040000000000006 110.769 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.72 -54.53 43.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.087 -0.96 . . . . 74.329999999999998 111.399 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.5 tp -74.53 -25.18 59.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.782 -0.367 . . . . 75.310000000000002 110.857 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.17 -47.83 72.69 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.688 0.795 . . . . 73.400000000000006 109.966 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -71.09 -27.95 63.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.152 0.501 . . . . 62.43 110.182 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.16 -42.38 84.43 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.49 -0.777 . . . . 74.329999999999998 109.035 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.18 -32.6 70.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 75.209999999999994 109.434 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.36 95.67 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.923 -0.581 . . . . 74.439999999999998 109.739 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.17 80.19 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.613 0.721 . . . . 63.340000000000003 110.441 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -16.56 60.5 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.339 -0.846 . . . . 74.120000000000005 110.808 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.06 7.9 41.52 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 116.156 -0.475 . . . . 63.32 112.666 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.97 127.51 27.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 120.984 0.421 . . . . 74.230000000000004 110.835 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -105.7 124.43 49.55 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.192 -1.04 . . . . 74.019999999999996 108.192 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -60.9 109.27 1.02 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 124.124 0.89 . . . . 71.310000000000002 109.961 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.528 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.6 tp -122.56 -164.78 1.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.138 -1.801 . . . . 75.340000000000003 106.138 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.528 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.7 mt-30 -46.35 146.17 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.523 0.729 . . . . 75.519999999999996 110.81 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.65 -11.9 38.13 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 114.519 0.568 . . . . 75.140000000000001 114.519 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.34 -47.64 40.74 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.791 0.329 . . . . 73.030000000000001 110.544 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.579 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 24.1 ptt180 -158.88 142.92 15.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.581 0.705 . . . . 75.340000000000003 112.443 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.5 mt -91.26 151.63 20.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 125.223 1.409 . . . . 73.540000000000006 109.933 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 100' ' ' THR . 1.1 tt -90.41 118.28 29.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.045 -1.094 . . . . 73.439999999999998 108.045 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.37 153.78 39.53 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.716 -0.675 . . . . 75.409999999999997 109.714 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 44.8 Cg_exo -60.2 150.07 81.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 112.014 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.82 -36.16 4.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.876 -0.602 . . . . 71.340000000000003 110.959 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -104.24 122.92 46.39 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.062 0.458 . . . . 73.430000000000007 109.853 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.1 m-85 -118.55 118.53 31.96 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.228 -0.897 . . . . 74.439999999999998 109.53 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.6 109.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.477 -1.305 . . . . 73.329999999999998 107.477 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -105.65 107.1 21.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.191 -1.04 . . . . 73.530000000000001 108.191 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 53.2 m -111.08 123.69 50.7 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.43 -0.805 . . . . 75.310000000000002 110.558 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -116.13 175.62 5.47 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.868 -0.606 . . . . 74.239999999999995 109.952 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' N ' HD13 ' A' ' 114' ' ' LEU . . . -71.97 153.84 50.32 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 109.104 -1.598 . . . . 74.329999999999998 109.104 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.67 -42.17 80.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 110.346 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.447 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 5.0 t60 -66.89 -29.9 69.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.272 -0.876 . . . . 71.420000000000002 110.532 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 m-20 -76.27 -46.16 29.28 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.634 -0.506 . . . . 73.430000000000007 109.634 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.4 -42.53 99.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.559 -0.746 . . . . 74.239999999999995 111.877 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HG3' ' HD2' ' A' ' 73' ' ' LYS . 10.1 pt-20 -62.82 -34.33 77.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.929 0.395 . . . . 72.010000000000005 111.581 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.8 mptt -75.47 -27.07 58.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.163 -0.471 . . . . 72.040000000000006 111.201 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 73.5 mt -72.22 -40.3 67.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.517 -0.92 . . . . 74.140000000000001 108.517 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 146.62 6.16 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 109.771 -1.332 . . . . 63.219999999999999 109.771 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.57 -18.9 62.9 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 114.401 1.26 . . . . 71.310000000000002 114.401 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.39 124.04 76.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 119.595 -0.842 . . . . 73.329999999999998 110.472 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -77.39 -35.81 1.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.658 1.572 . . . . 72.420000000000002 110.88 167.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.86 -53.29 33.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.432 2.012 . . . . 73.230000000000004 116.432 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.38 -32.25 66.26 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.492 0.663 . . . . 74.209999999999994 110.389 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.14 -39.16 65.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.909 -1.041 . . . . 71.430000000000007 108.955 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.7 t -62.17 -44.13 97.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.301 -0.863 . . . . 64.049999999999997 109.883 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -59.13 -45.92 89.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.245 -0.434 . . . . 73.200000000000003 110.459 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.93 -48.93 51.6 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.844 -0.616 . . . . 75.219999999999999 112.855 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.25 -39.97 78.14 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.233 0.827 . . . . 74.219999999999999 113.233 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.7 95.23 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 121.085 -0.246 . . . . 75.329999999999998 110.625 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -37.56 87.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 74.019999999999996 110.612 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.77 -44.69 69.64 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.253 -0.431 . . . . 73.450000000000003 110.523 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.07 -37.96 84.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.127 -0.488 . . . . 72.010000000000005 109.844 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.7 71.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.367 0.603 . . . . 74.5 110.485 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 8.2 t70 -68.29 -43.61 77.33 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.148 -1.056 . . . . 74.349999999999994 108.148 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.0 m-85 -57.42 -47.68 81.11 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.323 -0.853 . . . . 74.439999999999998 112.821 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -62.47 -35.42 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.737 -0.785 . . . . 73.099999999999994 111.086 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.76 -45.96 87.46 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.414 -0.587 . . . . 74.409999999999997 109.414 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 32.2 mm-40 -60.44 -31.62 70.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.728 0.811 . . . . 73.540000000000006 113.078 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.2 mm-40 -90.99 -10.95 40.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.319 -0.401 . . . . 74.239999999999995 111.395 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 38.15 35.67 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.702 -0.761 . . . . 65.200000000000003 111.424 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -104.49 158.8 16.23 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.741 -0.466 . . . . 73.150000000000006 109.741 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.579 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -126.9 167.54 15.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.573 -0.528 . . . . 70.420000000000002 109.573 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.446 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.5 t -158.35 179.27 9.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.958 -0.756 . . . . 73.430000000000007 108.958 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -130.81 128.73 41.29 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.588 -0.523 . . . . 72.540000000000006 109.588 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 -149.98 16.9 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 108.313 -1.915 . . . . 63.100000000000001 108.313 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -124.84 141.29 52.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.925 -1.139 . . . . 75.319999999999993 107.925 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.75 112.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 123.53 0.518 . . . . 75.439999999999998 110.02 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.74 125.61 67.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.852 0.834 . . . . 73.099999999999994 111.288 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.02 129.82 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 N-CA-C 108.513 -0.921 . . . . 73.109999999999999 108.513 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -106.0 127.17 52.98 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.939 -0.573 . . . . 75.530000000000001 109.922 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.61 115.43 29.87 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 75.219999999999999 107.877 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.2 pt-20 -145.54 164.02 32.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.992 -0.549 . . . . 74.310000000000002 110.218 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -120.11 154.06 35.24 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.236 0.541 . . . . 74.049999999999997 111.124 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.6 m -137.81 143.47 41.04 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.597 -0.89 . . . . 70.400000000000006 108.597 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -72.5 -20.08 61.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.474 0.654 . . . . 73.310000000000002 111.129 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.01 -11.33 59.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.6 -0.727 . . . . 75.450000000000003 111.025 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.7 OUTLIER -101.39 133.9 45.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 105.808 -1.923 . . . . 74.219999999999999 105.808 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -93.27 170.3 9.73 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 112.88 0.696 . . . . 64.239999999999995 112.88 -173.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -72.59 127.73 33.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.319 -0.855 . . . . 73.329999999999998 111.18 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.02 28.94 24.37 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 110.278 -1.129 . . . . 74.019999999999996 110.278 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -140.64 151.44 44.61 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.144 -1.058 . . . . 70.340000000000003 108.144 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.504 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 p90 -152.77 150.91 29.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.478 -1.304 . . . . 74.239999999999995 107.478 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -141.96 130.3 22.35 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.694 -0.484 . . . . 74.510000000000005 109.694 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.87 121.76 38.78 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.246 -1.39 . . . . 75.430000000000007 107.246 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -121.59 118.33 28.97 Favored 'General case' 0 N--CA 1.398 -3.068 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 109.196 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' N ' ' HD3' ' A' ' 122' ' ' ARG . . . -111.54 138.12 14.75 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 110.312 -1.115 . . . . 75.319999999999993 110.312 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 t -144.85 163.84 32.88 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.369 -0.974 . . . . 74.120000000000005 108.369 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.57 103.77 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 106.943 -1.503 . . . . 72.349999999999994 106.943 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -118.85 106.41 43.84 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.901 -0.591 . . . . 63.340000000000003 110.065 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo . . . . . 0 N--CA 1.451 -0.996 0 C-N-CA 122.053 1.835 . . . . 72.530000000000001 110.949 177.096 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.464 0.913 . . . . 75.120000000000005 113.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.84 -28.87 60.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.225 0.536 . . . . 74.530000000000001 110.296 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 t -71.99 -42.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.646 -0.872 . . . . 71.450000000000003 108.646 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 45.2 mt-10 -58.31 -44.27 88.53 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.97 -0.559 . . . . 75.349999999999994 109.856 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -49.84 72.53 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 124.043 0.839 . . . . 75.150000000000006 111.163 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.16 -37.62 75.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.49 0.552 . . . . 74.140000000000001 112.49 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 mt -64.99 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.39 0.515 . . . . 74.120000000000005 112.39 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 26.3 ptt180 -71.08 -28.01 64.03 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.104 -0.638 . . . . 72.420000000000002 109.808 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -68.9 -40.87 78.92 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 108.526 -0.916 . . . . 73.540000000000006 108.526 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.48 -40.69 92.2 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.91 0.484 . . . . 74.310000000000002 110.248 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.331 -0.85 . . . . 72.519999999999996 110.777 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.11 76.25 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.41 0.624 . . . . 74.299999999999997 111.112 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -71.57 -44.96 63.57 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.508 -0.769 . . . . 72.329999999999998 110.746 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.57 21.69 20.79 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 115.604 -0.726 . . . . 73.519999999999996 113.523 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.406 HD13 ' CD2' ' A' ' 98' ' ' TRP . 11.8 mm -61.97 125.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.255 0.55 . . . . 72.310000000000002 110.346 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -121.17 137.1 54.83 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.986 -1.007 . . . . 75.150000000000006 110.841 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -63.24 118.0 7.37 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.39 -1.277 . . . . 74.230000000000004 112.427 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.5 tp -139.03 -165.88 1.92 Allowed 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.318 -2.475 . . . . 71.329999999999998 104.318 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.531 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.45 140.35 7.98 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.186 0.594 . . . . 72.319999999999993 111.287 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.14 -15.87 57.01 Favored Glycine 0 CA--C 1.505 -0.59 0 CA-C-N 115.896 -0.593 . . . . 74.129999999999995 114.408 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.63 -35.56 67.82 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 111.815 0.302 . . . . 55.130000000000003 111.815 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 4.4 ptm180 -162.28 131.34 4.31 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.647 0.737 . . . . 65.310000000000002 111.083 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.53 152.33 20.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.369 1.467 . . . . 73.329999999999998 110.719 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 100' ' ' THR . 55.7 tp -78.08 126.01 30.19 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.54 -0.754 . . . . 73.099999999999994 109.909 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 158.57 43.28 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 108.316 -0.994 . . . . 73.340000000000003 108.316 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 37.5 Cg_exo -60.66 156.7 41.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.135 2.557 . . . . 72.540000000000006 113.674 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.66 -27.32 3.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.636 -0.711 . . . . 73.340000000000003 110.118 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.41 109.06 21.2 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.804 -0.813 . . . . 71.420000000000002 108.804 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 94.6 m-85 -115.66 115.45 26.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.595 -0.73 . . . . 75.120000000000005 110.656 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.74 119.51 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.191 -1.04 . . . . 74.25 108.191 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 121' ' ' ALA . 15.2 mm -109.48 115.52 49.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.733 -1.21 . . . . 73.219999999999999 107.733 176.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 m -108.8 129.17 55.38 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.947 -0.57 . . . . 71.340000000000003 110.174 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.56 172.72 9.0 Favored 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.939 0.896 . . . . 72.219999999999999 109.587 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.33 179.39 53.2 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.057 -0.817 . . . . 43.100000000000001 111.057 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.45 -41.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.828 0.677 . . . . 72.329999999999998 112.828 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 75.4 t60 -73.04 -28.84 62.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.99 0.9 . . . . 74.129999999999995 109.413 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 1.5 m-20 -69.21 -44.16 72.67 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.999 -1.001 . . . . 74.230000000000004 108.602 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.89 -30.39 66.74 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 111.749 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 13.0 pt-20 -68.55 -29.94 68.61 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.95 -0.7 . . . . 74.530000000000001 110.35 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 14.5 mmmm -68.61 -31.51 70.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.039 -0.982 . . . . 74.219999999999999 109.796 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.74 -30.25 59.15 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.613 0.72 . . . . 74.319999999999993 109.107 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.7 -163.67 15.41 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.158 -0.928 . . . . 71.109999999999999 111.388 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.9 2.33 51.83 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.63 0.729 . . . . 62.130000000000003 109.5 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -111.76 97.87 39.14 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 113.542 0.941 . . . . 72.230000000000004 113.542 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -78.12 -46.85 0.12 Allowed 'Trans proline' 0 N--CA 1.438 -1.74 0 N-CA-C 109.286 -1.082 . . . . 74.299999999999997 109.286 162.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -43.97 -54.3 5.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.558 2.743 . . . . 75.109999999999999 116.994 -167.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.14 -51.37 39.05 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.387 -0.525 . . . . 74.549999999999997 110.216 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -75.42 -27.06 58.85 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.946 1.091 . . . . 71.109999999999999 113.946 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 66.4 p -71.23 -36.25 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.232 -0.587 . . . . 62.329999999999998 110.544 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -73.76 -37.42 65.04 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.09 -0.505 . . . . 75.349999999999994 109.796 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 87' ' ' ARG . . . -66.08 -41.9 94.82 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.832 -0.907 . . . . 73.129999999999995 110.832 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -69.97 -25.14 63.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.194 0.521 . . . . 73.510000000000005 109.832 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.27 78.1 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 75.25 110.251 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 34.6 ttp180 -61.79 -45.57 93.28 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.943 -0.762 . . . . 75.340000000000003 108.943 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 -49.56 76.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.066 -0.97 . . . . 74.239999999999995 110.555 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.62 -35.35 80.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.568 . . . . 72.519999999999996 111.948 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.412 ' HB3' HG12 ' A' ' 104' ' ' VAL . . . -63.9 -36.35 83.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.381 0.61 . . . . 74.209999999999994 109.941 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.66 -39.81 84.51 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.558 -0.746 . . . . 73.299999999999997 109.203 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 21.2 m-85 -57.18 -50.56 72.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.548 -0.751 . . . . 74.030000000000001 112.46 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 pt -65.34 -35.14 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.069 -0.652 . . . . 73.209999999999994 111.284 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -67.46 -37.82 83.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 111.116 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.03 -34.77 76.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.217 -0.447 . . . . 74.049999999999997 112.079 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 66.1 mm-40 -81.78 -13.63 57.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.989 -0.55 . . . . 74.209999999999994 110.986 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 31.12 18.82 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.693 -0.685 . . . . 70.120000000000005 112.254 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.406 ' CD2' HD13 ' A' ' 48' ' ' ILE . 16.5 m0 -104.74 177.21 4.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.859 -0.423 . . . . 74.530000000000001 109.859 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.7 pt20 -147.8 176.58 10.01 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.735 -0.469 . . . . 74.209999999999994 109.735 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.426 ' HA ' HD13 ' A' ' 57' ' ' LEU . 9.8 t -156.29 179.11 9.56 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.911 -1.515 . . . . 74.239999999999995 106.911 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.06 122.22 36.58 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 118.15 0.432 . . . . 74.239999999999995 110.567 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.4 17.15 Favored Glycine 0 N--CA 1.416 -2.656 0 N-CA-C 110.131 -1.187 . . . . 75.0 110.131 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -112.52 149.38 32.76 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.825 -1.176 . . . . 72.329999999999998 107.825 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 90' ' ' ALA . 8.0 p -89.39 134.45 28.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.651 -0.5 . . . . 73.099999999999994 109.651 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.28 120.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.754 0.787 . . . . 74.140000000000001 111.173 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' SER . 98.6 t -105.58 132.35 52.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.375 -1.713 . . . . 64.120000000000005 106.375 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.71 130.96 54.29 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 110.143 -0.317 . . . . 74.5 110.143 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -100.37 114.39 27.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.981 -1.859 . . . . 75.209999999999994 105.981 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -142.93 166.95 23.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.03 164.61 11.62 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.407 1.098 . . . . 74.439999999999998 113.025 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.4 m -151.04 116.17 5.31 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.141 -1.845 . . . . 74.0 106.885 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.4 m -59.35 -21.84 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.692 0.797 . . . . 54.140000000000001 112.43 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.62 -16.11 54.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 110.681 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.2 tp -97.52 140.96 31.17 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.029 -1.471 . . . . 65.430000000000007 107.029 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -121.69 163.14 19.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.298 -0.961 . . . . 72.150000000000006 111.172 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.57 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 44.9 m -45.78 124.32 5.11 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.645 1.978 . . . . 63.009999999999998 115.26 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.1 -27.55 16.92 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.583 -1.189 . . . . 64.150000000000006 110.506 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.13 136.74 35.09 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.317 -0.994 . . . . 63.130000000000003 108.317 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -147.78 160.67 42.49 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.733 -1.58 . . . . 74.400000000000006 106.733 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -141.29 150.3 42.37 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.821 0.344 . . . . 72.329999999999998 110.979 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -118.51 125.77 50.59 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.098 -1.445 . . . . 74.129999999999995 107.098 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.554 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -123.28 115.24 21.37 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 110.138 -0.319 . . . . 73.209999999999994 110.138 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.09 124.34 7.63 Favored Glycine 0 C--N 1.289 -2.078 0 N-CA-C 111.855 -0.498 . . . . 74.049999999999997 111.855 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -140.64 160.19 40.56 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 122.623 0.369 . . . . 73.530000000000001 111.028 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 59' ' ' PRO . 61.8 t -105.95 127.85 60.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.783 0.325 . . . . 72.450000000000003 110.164 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -135.48 101.85 10.81 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 108.189 -1.041 . . . . 74.230000000000004 108.189 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 C-N-CA 122.218 1.945 . . . . 71.409999999999997 111.644 179.383 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 CA--C 1.554 1.12 0 CA-C-O 121.026 0.441 . . . . 70.540000000000006 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.85 -36.93 82.65 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.1 -1.074 . . . . 74.400000000000006 108.1 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -70.22 -44.7 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.11 -0.95 . . . . 75.329999999999998 109.287 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.57 -43.12 75.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.962 0.505 . . . . 72.439999999999998 110.614 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.82 87.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.941 -1.027 . . . . 70.530000000000001 111.0 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.92 -37.52 81.78 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.861 0.689 . . . . 74.219999999999999 112.861 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.19 -46.49 90.24 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.987 -0.285 . . . . 73.329999999999998 111.579 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -73.4 -28.87 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.627 -0.429 . . . . 75.310000000000002 110.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -66.7 -45.86 77.41 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.373 -0.376 . . . . 72.219999999999999 110.706 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.12 -35.3 80.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.749 0.309 . . . . 73.519999999999996 110.332 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.14 77.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 65.549999999999997 110.537 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.99 71.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.647 -0.706 . . . . 74.530000000000001 110.904 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.59 -44.72 73.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.716 -0.674 . . . . 62.009999999999998 110.987 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.84 15.36 37.71 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.99 -0.55 . . . . 74.209999999999994 114.222 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -62.35 123.23 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.388 0.614 . . . . 74.540000000000006 111.504 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -116.4 145.24 43.39 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 115.092 -0.958 . . . . 74.340000000000003 110.704 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -65.46 125.0 23.79 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 75.109999999999999 110.749 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.478 ' HG ' ' OE1' ' A' ' 52' ' ' GLN . 13.9 tp -144.82 -164.34 1.9 Allowed 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 103.65 -2.722 . . . . 73.430000000000007 103.65 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.478 ' OE1' ' HG ' ' A' ' 51' ' ' LEU . 27.2 mp0 -44.64 148.21 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.065 0.848 . . . . 75.510000000000005 111.737 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.68 -20.37 66.05 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.615 -0.326 . . . . 74.310000000000002 112.828 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 -9.37 41.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.079 0.4 . . . . 54.399999999999999 112.079 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.7 ptp180 -157.6 125.3 5.3 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 121.614 0.721 . . . . 73.340000000000003 112.062 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.22 151.54 19.41 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.769 -0.65 . . . . 71.150000000000006 110.063 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.77 127.96 35.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 74.310000000000002 107.18 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.68 158.78 44.54 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 123.448 0.468 . . . . 71.109999999999999 110.479 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.408 ' HA ' HG23 ' A' ' 125' ' ' VAL . 25.9 Cg_exo -65.68 162.76 33.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.936 2.424 . . . . 72.430000000000007 111.912 175.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.07 -26.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.959 -0.564 . . . . 74.340000000000003 111.692 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -100.88 107.2 18.66 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.82 -0.808 . . . . 73.530000000000001 108.82 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 87.3 m-85 -110.37 114.8 28.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.502 -0.772 . . . . 74.349999999999994 110.507 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.69 111.33 34.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.844 -1.169 . . . . 74.200000000000003 107.844 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.29 121.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.193 -1.04 . . . . 71.230000000000004 108.193 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -113.5 124.8 53.25 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.656 -0.418 . . . . 73.439999999999998 110.307 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -108.2 162.83 13.71 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 71.329999999999998 108.905 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.51 150.17 51.72 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 109.625 -1.39 . . . . 63.219999999999999 109.625 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.32 -38.47 69.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 117.575 0.687 . . . . 75.409999999999997 111.741 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.4 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 39.0 t60 -73.44 -25.03 60.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.59 -0.522 . . . . 75.010000000000005 109.59 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.555 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 18.0 m-20 -79.3 -31.73 43.35 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.483 -0.326 . . . . 75.319999999999993 111.457 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.96 -33.75 72.35 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.376 -0.829 . . . . 75.340000000000003 108.916 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.48 -33.56 68.12 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.636 -0.711 . . . . 54.350000000000001 112.683 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' CE ' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -78.4 -30.02 47.55 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.727 -0.608 . . . . 75.439999999999998 110.498 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.16 -36.78 84.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.347 0.594 . . . . 72.310000000000002 110.069 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.62 -163.09 25.52 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 115.483 -0.78 . . . . 72.409999999999997 111.604 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.42 -30.98 14.8 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.287 0.565 . . . . 71.010000000000005 109.918 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.41 128.77 25.3 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.946 -0.57 . . . . 64.200000000000003 109.563 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.14 -27.23 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.213 1.942 . . . . 71.420000000000002 111.287 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.37 -53.74 33.35 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.022 1.729 . . . . 63.329999999999998 115.1 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.11 -31.25 72.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.249 0.547 . . . . 74.239999999999995 110.724 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -77.09 -34.94 56.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.649 -0.705 . . . . 71.109999999999999 109.525 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 42.5 m -65.22 -54.03 35.66 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.403 -0.817 . . . . 75.140000000000001 110.441 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 m -62.01 -38.61 89.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.664 -0.698 . . . . 73.439999999999998 111.166 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 116.024 -0.535 . . . . 71.019999999999996 112.323 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.706 -0.398 . . . . 75.530000000000001 110.03 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.055 -0.52 . . . . 64.209999999999994 110.204 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -56.84 -53.42 58.06 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.186 -0.916 . . . . 73.450000000000003 110.614 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -69.6 -29.59 67.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.018 -0.992 . . . . 74.030000000000001 111.965 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.02 -35.51 61.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.097 -0.705 . . . . 74.109999999999999 109.097 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -62.63 -37.93 88.23 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.741 0.781 . . . . 62.409999999999997 109.58 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.23 -47.6 81.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.728 -1.124 . . . . 64.5 109.608 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.59 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -54.91 -48.47 73.04 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.978 0.733 . . . . 72.319999999999993 112.978 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.07 -31.64 54.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.098 -0.641 . . . . 74.239999999999995 111.737 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 25.9 mt-30 -64.28 -45.42 88.12 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.837 -0.431 . . . . 73.019999999999996 109.837 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -58.04 -41.77 83.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.32 1.013 . . . . 70.540000000000006 111.903 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 75.5 mm-40 -74.74 -14.36 60.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.935 0.346 . . . . 72.299999999999997 111.935 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.95 29.0 48.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.246 -0.502 . . . . 53.130000000000003 112.064 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -104.62 157.31 17.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.201 -0.666 . . . . 74.230000000000004 109.201 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.414 HE21 ' CD2' ' A' ' 51' ' ' LEU . 24.1 pt20 -128.33 166.08 19.34 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.006 -0.678 . . . . 72.140000000000001 110.118 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -155.07 176.57 12.37 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.387 -1.338 . . . . 75.420000000000002 107.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -118.37 120.83 38.78 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.538 -0.542 . . . . 72.540000000000006 109.538 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.68 -151.22 17.09 Favored Glycine 0 C--O 1.253 1.321 0 N-CA-C 108.23 -1.948 . . . . 74.519999999999996 108.23 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -128.06 162.81 25.99 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.986 0.893 . . . . 73.120000000000005 108.646 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.1 t -78.57 121.78 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.094 0.473 . . . . 72.219999999999999 111.184 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.46 120.83 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.366 -0.834 . . . . 74.030000000000001 110.047 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 82' ' ' SER . 59.8 t -116.62 127.77 74.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.068 -1.456 . . . . 74.340000000000003 107.068 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 -121.49 152.49 39.08 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.538 -0.465 . . . . 74.519999999999996 109.747 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.31 114.41 22.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.916 -1.142 . . . . 73.450000000000003 107.916 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.14 170.95 10.71 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.342 -0.543 . . . . 73.120000000000005 112.07 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.47 159.19 17.25 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.401 -0.818 . . . . 73.209999999999994 110.722 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 m -152.24 138.83 18.7 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 123.97 0.908 . . . . 75.230000000000004 109.422 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -81.0 -18.34 47.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.207 -1.035 . . . . 72.049999999999997 108.207 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -65.61 -26.69 67.95 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.318 1.447 . . . . 71.409999999999997 110.035 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.0 mt -101.24 128.31 47.43 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.721 -0.672 . . . . 75.099999999999994 109.832 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -88.1 164.05 15.91 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.468 -0.787 . . . . 72.140000000000001 109.975 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.448 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 16.0 m -55.28 123.13 12.8 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.891 0.744 . . . . 72.049999999999997 111.967 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.16 -20.9 30.06 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.293 -0.723 . . . . 74.239999999999995 111.293 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.22 139.71 35.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.481 0.657 . . . . 73.310000000000002 111.709 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.448 ' HB3' HD13 ' A' ' 66' ' ' LEU . 29.6 p90 -147.7 160.16 43.01 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.715 -1.217 . . . . 74.430000000000007 107.715 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 146.55 43.77 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.176 -1.046 . . . . 75.409999999999997 108.176 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.52 149.45 34.34 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.548 -0.908 . . . . 72.5 108.548 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 64.5 ttt180 -143.26 124.37 14.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.263 -0.273 . . . . 74.299999999999997 110.263 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.15 100.25 0.8 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 110.198 -1.161 . . . . 72.299999999999997 110.198 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -111.67 147.88 34.58 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 109.713 -0.477 . . . . 73.239999999999995 109.713 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 59' ' ' PRO . 62.2 t -87.29 113.98 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 108.152 -1.055 . . . . 72.109999999999999 108.152 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -126.06 99.69 31.23 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 108.344 -0.984 . . . . 70.439999999999998 108.344 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.455 -0.751 0 C-N-CA 121.919 1.746 . . . . 64.019999999999996 111.377 -178.331 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.971 0.415 . . . . 71.030000000000001 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -56.69 -47.67 79.35 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.082 -0.963 . . . . 75.439999999999998 110.37 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.96 -50.9 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.262 -0.881 . . . . 71.450000000000003 110.405 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.9 pp20? -64.4 -38.4 90.91 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.589 0.588 . . . . 72.420000000000002 112.589 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.08 92.48 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.802 0.334 . . . . 70.209999999999994 110.632 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -72.87 -37.58 67.29 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.238 -1.023 . . . . 71.409999999999997 108.238 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.09 -44.79 96.82 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 72.450000000000003 110.582 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.0 ptt85 -73.74 -21.86 60.06 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.96 0.409 . . . . 73.310000000000002 111.635 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.424 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 43.0 tpt85 -73.09 -31.19 64.2 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 52.0 mm-40 -68.21 -38.7 82.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.517 -0.765 . . . . 72.209999999999994 109.835 173.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.62 -46.52 88.74 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.443 -0.799 . . . . 73.310000000000002 109.734 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.29 65.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.788 -0.642 . . . . 64.140000000000001 111.386 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 31.2 t70 -77.77 -41.19 38.34 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.931 0.345 . . . . 71.239999999999995 111.931 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.03 25.89 19.64 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 120.227 -0.987 . . . . 72.209999999999994 113.803 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.77 137.02 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.702 0.401 . . . . 74.129999999999995 111.345 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.1 mt-30 -122.91 143.51 49.84 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.823 -0.626 . . . . 73.409999999999997 110.397 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -79.19 92.32 5.07 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.847 -1.07 . . . . 73.219999999999999 111.687 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD22 ' NE2' ' A' ' 99' ' ' GLN . 11.9 tp -102.38 -165.48 1.19 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.781 -1.933 . . . . 73.299999999999997 105.781 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 54' ' ' ASN . 79.3 mm-40 -48.57 146.89 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.888 0.767 . . . . 72.430000000000007 112.214 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.9 32.89 1.25 Allowed Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.117 -0.947 . . . . 64.319999999999993 113.348 -173.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 52' ' ' GLN . 71.9 m-20 -99.85 -37.01 9.23 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.643 -1.614 . . . . 73.540000000000006 106.643 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -172.97 149.87 1.94 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.491 -1.231 . . . . 71.430000000000007 110.294 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.37 151.79 21.29 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.964 0.506 . . . . 73.349999999999994 110.564 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -87.21 127.7 35.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 -175.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.11 158.17 46.92 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 123.11 0.564 . . . . 61.009999999999998 111.063 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 88.6 Cg_exo -54.86 145.16 63.32 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.948 3.099 . . . . 75.329999999999998 113.997 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -119.96 -22.6 6.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.313 -0.858 . . . . 70.25 110.292 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.69 108.88 20.61 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.412 0.625 . . . . 74.010000000000005 109.684 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.9 m-85 -114.06 117.83 32.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.445 -0.798 . . . . 72.519999999999996 109.423 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.95 116.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.192 -1.04 . . . . 74.329999999999998 108.192 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.1 mt -110.96 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 107.915 -1.143 . . . . 74.030000000000001 107.915 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.7 m -110.33 120.65 43.12 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.866 -0.606 . . . . 74.129999999999995 110.971 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.4 mm? -114.69 163.26 15.71 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.3 -0.864 . . . . 74.239999999999995 108.809 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.17 169.17 51.35 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 109.274 -1.53 . . . . 64.129999999999995 109.274 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.32 -25.7 37.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.595 0.712 . . . . 75.209999999999994 110.936 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -57.95 -55.69 31.64 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.824 -1.08 . . . . 73.209999999999994 110.001 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.84 -29.49 44.69 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.621 -0.718 . . . . 75.530000000000001 111.718 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -63.7 -32.01 73.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.439 -0.346 . . . . 74.200000000000003 110.143 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.17 -35.84 78.2 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 123.25 0.62 . . . . 72.439999999999998 109.954 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.98 -14.64 55.73 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.22 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.21 -25.04 37.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.652 -0.87 . . . . 72.510000000000005 108.652 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.98 -177.26 30.1 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 114.938 -1.028 . . . . 73.299999999999997 111.867 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 1.46 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.831 0.452 . . . . 74.030000000000001 111.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -110.0 92.57 13.16 Favored Pre-proline 0 C--O 1.251 1.178 0 N-CA-C 112.331 0.493 . . . . 54.520000000000003 112.331 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.84 -37.2 1.72 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.686 1.59 . . . . 64.230000000000004 111.096 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.47 -34.33 72.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.26 -0.427 . . . . 72.019999999999996 112.14 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.29 -38.06 85.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.194 0.521 . . . . 73.400000000000006 109.837 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.28 -35.52 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.837 -0.801 . . . . 71.299999999999997 108.837 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 t -58.31 -54.14 50.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.713 -1.131 . . . . 74.400000000000006 110.023 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.1 m -59.15 -42.33 90.44 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.425 0.69 . . . . 74.519999999999996 111.008 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -61.64 6.21 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.011 -0.54 . . . . 55.340000000000003 111.974 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -63.03 -30.78 71.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.304 0.854 . . . . 71.400000000000006 113.304 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.35 -40.43 89.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.896 -0.322 . . . . 72.409999999999997 110.538 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -73.37 -36.88 66.17 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.466 -0.568 . . . . 72.430000000000007 109.466 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.25 -41.06 94.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.573 -0.285 . . . . 63.32 110.73 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -42.27 87.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.447 -0.575 . . . . 75.340000000000003 109.447 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.46 79.67 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 61.439999999999998 109.951 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -64.24 -43.77 93.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.391 -0.822 . . . . 75.400000000000006 109.751 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.544 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.6 m-85 -58.66 -48.42 81.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 112.662 0.615 . . . . 75.409999999999997 112.662 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.99 -29.33 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.733 -0.787 . . . . 75.25 111.247 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.02 -44.24 89.82 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 110.14 -0.318 . . . . 54.420000000000002 110.14 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.6 mt-10 -63.91 -38.38 90.88 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.308 0.575 . . . . 75.230000000000004 110.797 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.2 mm-40 -79.25 -13.9 59.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.971 -0.559 . . . . 64.230000000000004 111.351 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.53 38.37 32.96 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.804 -0.712 . . . . 51.299999999999997 112.2 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -107.11 158.0 17.42 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.765 0.317 . . . . 73.450000000000003 111.093 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.495 ' NE2' HD22 ' A' ' 51' ' ' LEU . 23.2 pt20 -123.01 173.03 8.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.816 0.846 . . . . 73.340000000000003 109.087 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.8 t -159.52 177.61 10.76 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.444 -0.502 . . . . 64.540000000000006 110.432 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.24 120.99 33.85 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.582 -0.896 . . . . 71.319999999999993 108.582 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.24 -164.17 12.48 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.963 -1.655 . . . . 72.530000000000001 108.963 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -104.71 156.86 17.62 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.864 -1.532 . . . . 74.030000000000001 106.864 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.67 104.18 14.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.985 -1.117 . . . . 63.310000000000002 107.985 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.73 120.38 57.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 122.123 0.963 . . . . 74.409999999999997 111.676 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 62' ' ' TYR . 10.1 m -104.86 120.03 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 N-CA-C 105.804 -1.925 . . . . 75.230000000000004 105.804 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.279 0.0 OUTLIER -117.3 125.4 51.01 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 113.638 0.977 . . . . 75.349999999999994 113.638 -174.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -92.47 139.41 30.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.746 -1.57 . . . . 74.329999999999998 108.628 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -156.06 161.1 40.46 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.356 -0.609 . . . . 63.439999999999998 109.356 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.8 pt20 -104.32 157.99 16.76 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.582 0.706 . . . . 75.319999999999993 109.493 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 m -144.2 133.1 22.61 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.909 -1.041 . . . . 74.129999999999995 108.974 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 m -80.9 -11.74 59.53 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.481 0.658 . . . . 53.5 110.098 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -87.99 -5.54 58.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 71.409999999999997 109.918 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.07 120.44 32.04 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.938 -1.875 . . . . 75.129999999999995 105.938 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -88.8 153.22 21.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.325 -0.398 . . . . 73.25 110.405 -174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -64.59 134.16 53.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.51 0.672 . . . . 71.319999999999993 111.234 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.33 -15.46 42.67 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.412 -1.075 . . . . 74.340000000000003 110.412 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -106.08 150.24 25.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.047 -0.723 . . . . 73.420000000000002 109.047 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -149.66 151.25 33.42 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.867 -1.901 . . . . 73.409999999999997 105.867 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -134.99 144.09 47.18 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 112.56 0.578 . . . . 73.420000000000002 112.56 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.79 119.13 10.23 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.701 -1.592 . . . . 64.530000000000001 106.701 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -120.29 120.65 36.67 Favored 'General case' 0 N--CA 1.39 -3.456 0 C-N-CA 123.196 0.598 . . . . 75.120000000000005 109.565 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.53 121.54 7.2 Favored Glycine 0 C--N 1.3 -1.452 0 O-C-N 123.593 0.558 . . . . 64.040000000000006 112.056 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 p -142.21 148.61 38.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.155 -0.683 . . . . 74.200000000000003 109.155 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 5.6 p -95.84 120.54 45.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 119.462 -0.895 . . . . 75.540000000000006 110.006 174.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -125.86 98.62 33.46 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.819 -1.082 . . . . 73.340000000000003 108.167 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.52 -0.221 0 C-N-CA 122.385 2.057 . . . . 75.129999999999995 109.892 177.17 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 . . . . . 0 N--CA 1.434 -1.242 0 CA-C-O 121.219 0.533 . . . . 73.140000000000001 110.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.87 -32.77 73.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.445 -1.317 . . . . 74.129999999999995 107.445 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' O ' HD21 ' A' ' 40' ' ' LEU . 30.7 t -61.3 -49.89 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 114.466 -1.243 . . . . 73.420000000000002 109.619 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 30.6 mt-10 -57.69 -47.11 83.26 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.581 -0.448 . . . . 74.530000000000001 110.734 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.88 35.56 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.69 0.619 . . . . 74.25 111.878 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.74 -29.35 66.68 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.216 0.45 . . . . 74.319999999999993 112.216 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 36' ' ' VAL . 4.0 mm? -70.55 -39.55 73.92 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.176 0.436 . . . . 74.109999999999999 112.176 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 58.7 mtp180 -66.13 -33.42 75.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.977 -1.12 . . . . 74.109999999999999 107.977 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -49.29 62.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.434 -1.257 . . . . 74.519999999999996 108.948 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.54 -37.8 85.11 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.98 0.512 . . . . 72.219999999999999 112.136 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -58.77 -45.82 88.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.998 -0.546 . . . . 63.420000000000002 110.117 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.06 64.66 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.549 0.69 . . . . 75.140000000000001 111.066 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.07 -32.61 73.9 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 72.319999999999993 111.043 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.86 72.61 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.97 -0.633 . . . . 62.240000000000002 113.285 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 98' ' ' TRP . 17.7 mm -64.45 131.31 30.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.547 0.689 . . . . 73.219999999999999 111.949 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 80.5 mt-30 -119.39 144.82 46.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.272 -0.876 . . . . 74.230000000000004 110.535 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.6 m -80.63 98.28 7.6 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.845 -1.07 . . . . 74.299999999999997 109.992 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.591 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.3 tp -101.91 -165.38 1.18 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.935 -1.506 . . . . 75.230000000000004 106.935 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.591 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 48.4 mt-30 -56.19 160.77 2.76 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.493 0.717 . . . . 72.140000000000001 111.395 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 4.75 8.17 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.461 -0.79 . . . . 74.230000000000004 114.397 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.32 -46.57 60.33 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.913 -1.143 . . . . 72.530000000000001 107.913 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -179.51 167.21 1.44 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.002 0.921 . . . . 73.040000000000006 110.716 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.56 151.39 21.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.059 0.457 . . . . 72.030000000000001 111.698 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.4 tm? -90.63 128.3 36.56 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.366 -0.976 . . . . 72.439999999999998 108.366 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.41 158.0 45.98 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 123.58 0.752 . . . . 60.119999999999997 109.433 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.06 157.93 36.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 72.530000000000001 112.628 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -119.8 -33.3 4.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.934 -0.575 . . . . 72.049999999999997 110.695 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -103.66 114.65 29.07 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.651 -0.5 . . . . 74.319999999999993 109.651 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 70.8 m-85 -109.51 119.34 39.12 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.669 -0.696 . . . . 73.349999999999994 109.912 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -109.23 118.5 56.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 115.284 -0.871 . . . . 75.120000000000005 109.545 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.79 119.98 61.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.934 -1.136 . . . . 72.219999999999999 107.934 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -109.57 128.25 55.07 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.98 -0.555 . . . . 75.530000000000001 109.771 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.49 170.58 8.31 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.344 1.058 . . . . 75.450000000000003 109.674 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.99 169.03 54.43 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 109.508 -1.437 . . . . 74.0 109.508 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.86 -48.53 83.62 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 117.472 0.636 . . . . 75.299999999999997 111.681 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -65.03 -40.44 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 75.140000000000001 109.477 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.643 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.0 m-20 -69.48 -34.2 73.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.22 -1.355 . . . . 72.239999999999995 110.698 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.81 -36.92 85.48 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.72 0.771 . . . . 75.0 109.104 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.69 -25.22 64.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.757 -0.656 . . . . 74.310000000000002 111.262 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -77.91 -22.08 50.19 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.387 -0.195 . . . . 75.420000000000002 110.482 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.28 -38.36 71.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.157 -0.683 . . . . 71.129999999999995 109.157 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.31 -171.89 29.43 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.056 -1.068 . . . . 72.140000000000001 111.841 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.57 -31.08 18.81 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.939 -0.763 . . . . 63.119999999999997 108.939 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -131.73 81.81 62.43 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.217 -0.901 . . . . 74.439999999999998 110.548 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.74 -18.7 47.77 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.801 2.334 . . . . 64.120000000000005 112.274 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.01 -22.62 64.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 111.76 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.33 -45.67 92.16 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.88 -0.785 . . . . 63.509999999999998 108.88 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.13 -31.27 65.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.731 -1.122 . . . . 73.109999999999999 110.437 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.7 m -60.42 -43.53 96.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.42 -0.355 . . . . 73.310000000000002 111.224 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.4 m -65.4 -45.44 83.95 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.761 0.315 . . . . 71.439999999999998 111.165 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.87 93.6 Favored Glycine 0 C--O 1.244 0.733 0 C-N-CA 120.715 -0.755 . . . . 72.420000000000002 111.65 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -68.25 -32.59 72.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.279 -0.46 . . . . 74.120000000000005 110.247 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' A' ' 106' ' ' VAL . . . -62.15 -43.1 99.57 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.893 0.378 . . . . 73.25 110.514 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.78 -39.02 92.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 74.319999999999993 109.162 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -71.09 -41.32 70.77 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.305 -0.407 . . . . 73.120000000000005 111.183 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.04 -38.06 85.19 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.555 -0.535 . . . . 70.409999999999997 109.555 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.76 87.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.494 0.664 . . . . 75.109999999999999 109.536 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -37.41 84.38 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.95 -1.023 . . . . 64.439999999999998 110.127 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.588 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.6 m-85 -60.59 -48.02 83.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.192 -0.458 . . . . 74.25 111.903 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -69.69 -31.16 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 119.959 -0.697 . . . . 75.209999999999994 111.544 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.93 -41.14 91.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.808 -0.441 . . . . 72.329999999999998 109.808 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 33.2 tt0 -57.29 -36.85 71.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 125.329 1.452 . . . . 75.230000000000004 110.331 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -85.62 -9.04 57.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 75.409999999999997 111.052 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.29 29.8 57.85 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 116.025 -0.534 . . . . 75.150000000000006 113.016 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.521 ' CD2' HD13 ' A' ' 48' ' ' ILE . 20.0 m0 -96.19 156.9 16.14 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.594 -0.442 . . . . 74.319999999999993 110.457 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.576 ' NE2' HD22 ' A' ' 51' ' ' LEU . 29.9 pt20 -119.07 169.49 9.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.031 -0.359 . . . . 74.109999999999999 110.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -159.83 176.31 12.07 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.935 -0.765 . . . . 75.129999999999995 108.935 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.77 122.04 43.31 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.105 -1.072 . . . . 65.310000000000002 108.105 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.1 17.14 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.863 -1.16 . . . . 75.209999999999994 110.783 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -130.91 151.63 51.12 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.667 -0.864 . . . . 63.420000000000002 108.667 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.51 119.2 18.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.558 0.694 . . . . 71.25 111.335 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.14 131.63 65.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.024 -0.732 . . . . 64.439999999999998 109.024 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 86' ' ' ALA . 7.1 p -137.33 141.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.514 -1.291 . . . . 74.019999999999996 107.514 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -145.06 155.96 43.65 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.455 -0.498 . . . . 73.510000000000005 110.184 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.36 127.9 53.21 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.005 -1.109 . . . . 74.409999999999997 108.005 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.06 167.83 18.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.712 -0.222 . . . . 64.329999999999998 110.46 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -116.47 158.95 22.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.865 0.365 . . . . 75.120000000000005 110.324 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 t -145.01 140.25 28.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.906 -1.146 . . . . 60.32 107.906 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 -10.38 59.74 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.585 -0.524 . . . . 75.5 109.585 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -79.38 -27.25 41.88 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.289 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.24 135.58 33.38 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 115.84 -0.618 . . . . 74.230000000000004 109.919 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -99.33 157.07 16.66 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.952 -0.759 . . . . 72.409999999999997 108.952 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.643 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 57.4 m -53.94 126.62 23.1 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 124.458 1.099 . . . . 73.109999999999999 112.109 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.1 28.94 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-N 115.092 -0.958 . . . . 73.549999999999997 111.675 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -104.36 139.6 39.09 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.82 -0.437 . . . . 71.239999999999995 109.82 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -143.04 157.89 44.11 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.652 -1.24 . . . . 73.549999999999997 107.652 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 134.81 31.39 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.663 -0.866 . . . . 74.439999999999998 108.663 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.32 139.35 48.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.936 -1.505 . . . . 63.240000000000002 106.936 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -139.44 119.13 13.15 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.974 0.416 . . . . 74.209999999999994 110.243 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.4 127.21 8.77 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.263 -1.135 . . . . 74.510000000000005 110.263 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.0 p -127.46 145.31 50.88 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.205 0.526 . . . . 72.200000000000003 111.57 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.09 108.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.433 -0.951 . . . . 75.349999999999994 108.433 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -114.48 97.91 47.66 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 109.262 -0.644 . . . . 73.329999999999998 109.262 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.454 -0.795 0 C-N-CA 121.993 1.796 . . . . 65.150000000000006 111.931 -179.55 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 C--O 1.254 1.31 0 CA-C-O 121.682 0.753 . . . . 71.209999999999994 109.185 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -82.05 -37.11 26.94 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.499 -0.773 . . . . 70.329999999999998 110.639 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 40' ' ' LEU . 97.5 t -61.01 -49.8 83.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 115.868 -0.605 . . . . 73.420000000000002 109.589 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -58.01 -47.8 81.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.528 0.731 . . . . 70.140000000000001 110.887 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.61 82.58 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.17 -0.923 . . . . 74.209999999999994 111.856 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.14 -31.54 58.66 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.399 0.518 . . . . 75.040000000000006 112.399 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 36' ' ' VAL . 5.6 mp -62.52 -42.57 99.6 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.397 0.147 . . . . 71.420000000000002 111.397 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.75 -28.51 62.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.597 -0.841 . . . . 75.420000000000002 110.342 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -63.36 -44.31 95.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.985 -0.552 . . . . 74.329999999999998 109.712 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -71.31 -32.54 68.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 75.010000000000005 111.488 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.15 93.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 75.200000000000003 109.631 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.83 61.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.689 -0.687 . . . . 73.540000000000006 111.074 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.52 -38.13 74.2 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.155 0.982 . . . . 74.230000000000004 110.208 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.72 42.97 1.78 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.568 -0.742 . . . . 70.329999999999998 112.788 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.92 138.08 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.958 0.503 . . . . 73.540000000000006 110.696 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 2.0 mp0 -120.3 146.44 46.11 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 123.066 0.547 . . . . 70.439999999999998 109.697 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.0 m -73.46 120.81 19.58 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 124.175 0.922 . . . . 73.329999999999998 109.407 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.454 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.7 tp -127.19 -170.66 2.26 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 103.733 -2.692 . . . . 73.319999999999993 103.733 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.454 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 62.0 mt-30 -55.54 148.87 14.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.148 0.885 . . . . 74.030000000000001 110.007 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.33 -5.48 8.36 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 115.08 0.792 . . . . 52.049999999999997 115.08 -171.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -66.35 -38.6 88.0 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.391 -0.596 . . . . 74.209999999999994 109.391 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -171.09 152.65 3.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.901 -0.59 . . . . 74.409999999999997 111.266 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -91.94 151.71 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.26 0.624 . . . . 74.109999999999999 111.275 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 41.9 tp -88.98 125.87 35.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.672 -0.695 . . . . 75.129999999999995 109.147 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.05 165.87 12.28 Favored Pre-proline 0 C--N 1.283 -2.288 0 C-N-CA 124.421 1.088 . . . . 65.299999999999997 108.634 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.98 159.08 48.13 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.545 2.164 . . . . 73.120000000000005 111.673 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -115.97 -30.67 5.98 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.71 -0.396 . . . . 74.219999999999999 111.349 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.04 127.71 51.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.353 -0.98 . . . . 72.230000000000004 108.353 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.34 114.83 20.71 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.772 -0.455 . . . . 75.010000000000005 109.772 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -97.9 110.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.755 -0.832 . . . . 65.510000000000005 108.755 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.8 115.57 48.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.6 -0.727 . . . . 72.219999999999999 109.21 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 m -109.53 123.42 49.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.527 -0.306 . . . . 74.340000000000003 110.525 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.22 -176.99 3.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.877 1.271 . . . . 71.5 109.183 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.7 -174.09 42.84 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 108.885 -1.686 . . . . 53.340000000000003 108.885 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.4 p -69.54 -58.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 118.321 1.06 . . . . 74.200000000000003 113.652 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 22.1 t-80 -55.77 -51.56 66.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.866 0.841 . . . . 72.409999999999997 110.068 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -65.19 -31.22 72.29 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.483 -1.235 . . . . 75.129999999999995 113.872 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -68.49 -43.58 76.58 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.409 -0.517 . . . . 71.540000000000006 110.596 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 37.4 mt-10 -62.97 -38.45 91.16 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.837 0.827 . . . . 73.430000000000007 110.092 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 12.4 mptt -80.82 -16.02 54.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.059 -0.973 . . . . 73.430000000000007 112.367 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 65.9 mt -70.61 -45.42 65.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.636 -1.246 . . . . 64.030000000000001 107.636 170.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 121.2 0.8 Allowed Glycine 0 N--CA 1.406 -3.312 0 CA-C-N 114.67 -1.15 . . . . 63.299999999999997 111.648 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.63 -18.73 62.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.995 -1.113 . . . . 74.329999999999998 107.995 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.98 88.89 8.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 104.785 -2.302 . . . . 65.150000000000006 104.785 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.2 -33.13 15.5 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.79 2.326 . . . . 74.5 114.007 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.95 -25.84 60.17 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.943 -0.303 . . . . 74.310000000000002 111.455 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.21 -35.25 80.47 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.571 -0.529 . . . . 73.25 109.571 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -74.23 -34.08 63.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.58 -0.737 . . . . 74.349999999999994 109.505 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.78 -51.31 70.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.497 -0.556 . . . . 64.239999999999995 109.497 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 28.2 m -62.34 -44.02 97.47 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.294 -0.412 . . . . 73.150000000000006 110.484 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.01 -57.94 17.17 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.391 -0.368 . . . . 61.140000000000001 113.051 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -67.87 -28.25 67.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.968 0.729 . . . . 64.150000000000006 112.968 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 104' ' ' VAL . . . -66.6 -46.1 76.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 74.140000000000001 110.637 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.8 mmt85 -67.75 -43.39 80.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.606 . . . . 74.319999999999993 109.883 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.8 t70 -56.69 -56.69 18.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.371 -1.286 . . . . 71.439999999999998 109.583 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.81 -31.11 72.19 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 112.589 0.589 . . . . 65.230000000000004 112.589 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.02 98.63 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.504 0.669 . . . . 72.400000000000006 111.178 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.31 -27.51 27.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.243 -1.391 . . . . 73.540000000000006 107.243 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.586 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 t80 -65.6 -42.78 91.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.723 -1.581 . . . . 64.319999999999993 110.195 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.95 -30.94 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.521 -0.471 . . . . 72.420000000000002 109.787 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -62.71 -42.39 99.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 71.439999999999998 109.964 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' TYR . 11.9 mm-40 -57.72 -38.14 74.77 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.807 0.843 . . . . 71.540000000000006 111.098 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.7 mm-40 -83.43 -14.06 53.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 75.319999999999993 111.623 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.59 38.13 25.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.075 -0.584 . . . . 64.200000000000003 112.1 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -117.74 179.7 4.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.553 -0.906 . . . . 74.409999999999997 108.553 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -160.09 178.94 9.17 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 110.196 -0.298 . . . . 75.319999999999993 110.196 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.426 ' HA ' HD13 ' A' ' 57' ' ' LEU . 14.0 t -153.24 171.97 17.71 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.298 -1.371 . . . . 73.510000000000005 107.298 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.64 118.92 29.62 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.778 -1.564 . . . . 74.329999999999998 106.778 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.83 -149.43 16.59 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 119.277 -1.439 . . . . 63.149999999999999 109.862 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -125.59 152.58 44.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.404 -1.332 . . . . 62.420000000000002 107.404 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.415 ' O ' ' HB1' ' A' ' 86' ' ' ALA . 74.3 t -66.93 125.81 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 O-C-N 123.442 0.463 . . . . 72.230000000000004 111.255 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.86 120.22 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.519 0.676 . . . . 74.150000000000006 109.75 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.1 142.78 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 108.707 -0.849 . . . . 74.120000000000005 108.707 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.56 131.01 23.77 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.356 0.598 . . . . 75.329999999999998 112.028 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.19 151.27 19.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.499 -1.228 . . . . 75.099999999999994 108.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -159.51 170.13 22.36 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.113 0.565 . . . . 74.409999999999997 109.967 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.16 164.82 12.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.939 0.876 . . . . 74.340000000000003 112.941 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 t -142.7 134.91 27.43 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.583 -1.644 . . . . 74.420000000000002 106.885 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.43 -12.02 59.06 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.395 0.616 . . . . 74.299999999999997 110.168 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -85.18 -30.49 23.88 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.948 -0.569 . . . . 74.219999999999999 111.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.7 mt -86.94 149.47 24.77 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.733 -0.667 . . . . 52.439999999999998 111.636 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -126.85 168.78 13.99 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.279 -1.008 . . . . 73.329999999999998 108.279 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -57.49 110.55 0.89 Allowed 'General case' 0 C--O 1.251 1.155 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.65 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.14 -24.82 4.18 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 108.698 -1.761 . . . . 72.109999999999999 108.698 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -92.71 156.02 17.32 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.502 -1.296 . . . . 73.319999999999993 107.502 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -176.11 147.7 0.75 Allowed 'General case' 0 C--N 1.278 -2.539 0 O-C-N 125.077 1.486 . . . . 75.299999999999997 107.643 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -143.25 130.87 21.25 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.368 -0.378 . . . . 75.349999999999994 109.991 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.68 135.92 53.69 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.132 -1.062 . . . . 72.140000000000001 108.132 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -125.32 126.48 45.14 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.953 -0.758 . . . . 74.430000000000007 108.953 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.44 125.13 8.39 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 110.461 -1.055 . . . . 73.409999999999997 110.461 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 p -121.4 140.49 52.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 123.241 0.616 . . . . 71.340000000000003 110.68 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 80.1 t -92.35 103.66 14.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.719 -1.586 . . . . 72.340000000000003 106.719 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -107.35 104.22 51.6 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 108.23 -1.026 . . . . 71.430000000000007 108.23 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.459 -0.504 0 C-N-CA 121.936 1.757 . . . . 74.049999999999997 112.924 -177.473 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 . . . . . 0 C--O 1.21 -1.008 0 N-CA-C 111.781 0.289 . . . . 71.409999999999997 111.781 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.96 -44.85 88.03 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.671 0.748 . . . . 74.299999999999997 109.014 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.48 -38.22 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.196 -0.911 . . . . 74.420000000000002 108.846 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.37 -42.59 91.98 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.67 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.19 -45.82 86.9 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.429 0.692 . . . . 71.540000000000006 110.691 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.59 -45.75 78.2 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.854 -0.612 . . . . 73.430000000000007 109.517 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.59 -40.15 92.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.09 0.774 . . . . 75.340000000000003 113.09 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -72.21 -29.35 63.88 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 64.510000000000005 110.008 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.74 -44.11 97.07 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.17 -1.048 . . . . 74.349999999999994 108.17 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.94 -48.66 65.29 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.92 -1.036 . . . . 64.549999999999997 110.123 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.84 68.32 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.432 -0.349 . . . . 73.140000000000001 111.814 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.64 -23.24 56.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.994 0.368 . . . . 70.200000000000003 111.994 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.02 -34.54 24.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.218 0.533 . . . . 63.229999999999997 110.618 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.75 21.12 15.84 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.54 -0.755 . . . . 73.409999999999997 113.177 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mm -72.57 131.73 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.002 0.43 . . . . 75.129999999999995 110.498 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.7 mt-30 -108.84 133.13 53.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.769 -0.826 . . . . 71.310000000000002 108.769 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -75.32 117.71 17.43 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.949 -1.023 . . . . 71.219999999999999 109.407 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD23 ' NE2' ' A' ' 99' ' ' GLN . 12.9 tp -141.39 -164.34 1.75 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 103.955 -2.609 . . . . 74.140000000000001 103.955 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -42.68 131.74 3.88 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.702 0.626 . . . . 73.010000000000005 111.662 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.38 -18.47 55.69 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 115.062 0.785 . . . . 74.409999999999997 115.062 -170.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.41 -31.9 54.37 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.627 -0.829 . . . . 73.230000000000004 111.422 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 12.4 ptm180 -151.77 114.42 4.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.497 1.141 . . . . 75.530000000000001 111.029 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -91.1 150.71 21.29 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.969 -1.469 . . . . 74.310000000000002 108.322 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -84.25 120.34 26.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.495 -0.558 . . . . 73.140000000000001 109.495 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 157.38 38.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.676 -0.693 . . . . 74.340000000000003 109.672 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.68 147.58 95.01 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.573 2.182 . . . . 72.239999999999995 112.175 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 28.8 p-10 -120.59 -24.44 5.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.966 -0.561 . . . . 73.420000000000002 110.403 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.11 114.8 29.2 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.455 -0.572 . . . . 71.230000000000004 109.455 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -119.56 114.63 22.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.601 -0.727 . . . . 72.319999999999993 109.411 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -109.13 120.27 60.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.616 -0.883 . . . . 75.400000000000006 108.616 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.9 126.71 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 108.556 -0.905 . . . . 74.329999999999998 108.556 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -107.81 130.97 54.94 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.48 -0.782 . . . . 72.510000000000005 109.282 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.35 161.27 22.38 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.68 0.792 . . . . 65.200000000000003 109.244 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.1 157.33 52.55 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.727 -1.349 . . . . 63.509999999999998 109.727 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.4 p -56.76 -39.13 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 117.364 0.582 . . . . 65.439999999999998 112.374 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.95 -44.4 82.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.481 0.658 . . . . 73.25 110.777 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 39.8 m-20 -84.76 -21.67 29.92 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 112.784 0.661 . . . . 75.329999999999998 112.784 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 57.0 t80 -69.3 -26.09 64.55 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.162 -0.681 . . . . 71.349999999999994 109.162 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 46.2 mt-10 -58.67 -38.56 78.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.386 -0.37 . . . . 54.329999999999998 110.784 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' CE ' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -76.55 -32.8 58.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.108 0.48 . . . . 75.219999999999999 109.913 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.08 -29.25 70.11 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.988 -0.551 . . . . 71.129999999999995 109.976 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.03 33.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.672 -0.694 . . . . 54.020000000000003 113.904 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.36 0.58 . . . . 72.230000000000004 109.67 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.35 68.34 2.77 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 122.198 0.999 . . . . 64.209999999999994 109.765 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.76 -51.25 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.199 1.933 . . . . 74.099999999999994 113.685 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.8 -23.16 60.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.439 -0.346 . . . . 73.519999999999996 111.633 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.5 -43.09 81.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.763 -0.458 . . . . 74.310000000000002 109.763 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -63.33 -34.4 77.62 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.739 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.1 m -66.87 -49.03 66.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.785 -0.643 . . . . 70.349999999999994 110.698 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -62.49 -36.27 82.0 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.296 -0.411 . . . . 74.239999999999995 111.141 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.15 40.29 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.424 -0.417 . . . . 62.409999999999997 112.122 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -70.85 -28.04 64.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.324 0.49 . . . . 64.430000000000007 112.324 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.898 -0.408 . . . . 72.040000000000006 109.898 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -59.67 -47.61 84.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.41 -0.813 . . . . 71.239999999999995 109.522 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' O ' ' HD1' ' A' ' 92' ' ' TYR . 59.7 m-20 -69.52 -45.37 69.01 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 113.275 0.843 . . . . 70.200000000000003 113.275 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.137 -0.625 . . . . 70.340000000000003 111.812 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.34 87.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 109.939 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.93 -44.5 72.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.913 -0.585 . . . . 71.109999999999999 109.734 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.623 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.1 m-85 -58.68 -49.62 76.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.485 -0.78 . . . . 65.310000000000002 112.572 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.12 -39.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 119.914 -0.715 . . . . 75.319999999999993 111.363 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.63 -41.58 96.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.61 -0.268 . . . . 73.120000000000005 110.491 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.47 -38.95 75.33 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.693 1.197 . . . . 71.329999999999998 110.723 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 52.2 mm-40 -87.44 -13.35 43.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.782 -0.645 . . . . 75.319999999999993 111.402 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.48 28.74 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.976 -0.85 . . . . 72.540000000000006 110.976 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -105.34 158.71 16.44 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.008 -0.738 . . . . 74.400000000000006 109.008 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.5 pt20 -126.33 171.58 10.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.197 -0.456 . . . . 73.549999999999997 110.175 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.3 t -162.52 158.05 23.05 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.639 -1.245 . . . . 74.239999999999995 107.639 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.51 120.44 40.3 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.265 -1.013 . . . . 75.409999999999997 108.265 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -152.11 16.99 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.154 -1.579 . . . . 71.120000000000005 109.154 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.95 162.58 20.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.217 -0.66 . . . . 72.230000000000004 109.217 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.22 119.83 31.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.58 -0.896 . . . . 75.129999999999995 108.58 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.66 133.1 69.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.451 0.643 . . . . 64.310000000000002 109.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.03 134.37 61.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.377 -0.972 . . . . 72.299999999999997 108.377 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.428 ' HE ' ' HA ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -130.88 142.99 50.41 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.729 -0.841 . . . . 74.340000000000003 108.729 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.98 137.02 52.27 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.765 -0.828 . . . . 73.219999999999999 108.765 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.32 160.8 38.55 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 120.967 0.413 . . . . 73.299999999999997 110.678 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.482 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 26.9 pt20 -103.55 153.89 20.08 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.397 -0.82 . . . . 74.030000000000001 109.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.2 t -144.37 132.22 21.38 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 109.025 -0.732 . . . . 65.299999999999997 109.025 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.05 -15.73 55.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.08 -1.081 . . . . 62.240000000000002 108.08 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.5 -32.89 54.46 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.565 -1.198 . . . . 75.219999999999999 109.769 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -84.44 157.66 21.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.423 -0.954 . . . . 74.409999999999997 108.423 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -98.54 164.53 12.22 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.757 0.651 . . . . 74.140000000000001 112.757 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 m -66.13 134.57 53.07 Favored 'General case' 0 C--O 1.25 1.089 0 C-N-CA 123.995 0.918 . . . . 74.109999999999999 110.802 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.1 86.82 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 112.041 -0.424 . . . . 64.329999999999998 112.041 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -138.49 128.38 25.27 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 107.915 -1.143 . . . . 74.310000000000002 107.915 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -122.59 153.94 38.61 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.776 -0.824 . . . . 74.109999999999999 108.776 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -148.61 153.76 38.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.429 -1.323 . . . . 75.030000000000001 107.429 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.35 34.54 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 120.697 -0.401 . . . . 73.040000000000006 110.966 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -134.42 123.0 23.33 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.5 -0.773 . . . . 72.510000000000005 109.476 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.68 126.17 7.57 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.715 -1.354 . . . . 74.230000000000004 109.715 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.2 m -135.88 150.59 49.42 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 109.402 -0.592 . . . . 73.549999999999997 109.402 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.02 110.97 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 107.179 -1.415 . . . . 74.349999999999994 107.179 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -120.06 86.99 38.23 Favored Pre-proline 0 C--N 1.284 -2.264 0 N-CA-C 107.226 -1.398 . . . . 72.230000000000004 107.226 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.368 2.045 . . . . 70.129999999999995 112.69 -174.54 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.995 0.426 . . . . 74.510000000000005 111.525 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.67 -25.3 67.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.357 -0.608 . . . . 74.109999999999999 109.357 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.99 -49.7 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 109.681 -0.488 . . . . 75.109999999999999 109.681 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.97 -35.8 81.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.366 -0.533 . . . . 75.219999999999999 109.822 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.33 94.15 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.685 -0.688 . . . . 73.319999999999993 110.773 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -44.45 96.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.774 -0.824 . . . . 74.209999999999994 108.774 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.12 -29.18 68.04 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.035 0.754 . . . . 74.409999999999997 113.035 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 11.4 mtm180 -65.52 -36.97 85.41 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.778 -1.194 . . . . 75.510000000000005 107.778 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -46.87 72.26 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.17 -0.923 . . . . 72.439999999999998 110.07 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.21 -41.08 96.22 Favored 'General case' 0 CA--C 1.5 -0.942 0 O-C-N 123.397 0.435 . . . . 74.519999999999996 111.976 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.49 93.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.095 -0.502 . . . . 74.140000000000001 110.583 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.25 -25.36 42.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.089 -0.505 . . . . 71.439999999999998 111.599 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.19 -40.02 28.04 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.04 0.448 . . . . 64.319999999999993 110.167 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.85 17.96 37.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.786 . . . . 64.209999999999994 112.999 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.95 127.03 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-O 121.325 0.583 . . . . 75.329999999999998 110.814 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.2 tt0 -109.59 128.27 55.1 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 106.819 -1.549 . . . . 73.439999999999998 106.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -67.61 116.47 8.36 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.419 0.628 . . . . 75.040000000000006 110.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 18.4 tp -119.62 -165.83 1.21 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.503 -2.036 . . . . 75.530000000000001 105.503 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.547 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 14.1 mm-40 -62.92 166.56 5.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.731 0.696 . . . . 71.230000000000004 110.741 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.4 1.7 18.84 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.416 -0.811 . . . . 70.239999999999995 113.472 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.91 -48.64 57.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.621 -0.881 . . . . 71.430000000000007 108.621 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -173.67 159.8 3.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.869 -0.605 . . . . 74.140000000000001 110.649 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.87 151.68 20.44 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.653 0.781 . . . . 75.420000000000002 109.993 -176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.4 tm? -98.64 126.27 44.19 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.151 -1.796 . . . . 75.310000000000002 106.151 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.47 157.65 33.43 Favored Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 122.899 0.48 . . . . 72.420000000000002 110.305 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.446 ' HG2' ' OH ' ' A' ' 62' ' ' TYR . 23.6 Cg_endo -63.73 148.34 92.12 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.334 2.023 . . . . 75.450000000000003 111.698 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 24.5 p-10 -123.37 -16.33 6.89 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.593 -0.73 . . . . 75.450000000000003 112.175 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.92 109.45 18.15 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 120.365 -0.534 . . . . 74.349999999999994 110.635 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.446 ' OH ' ' HG2' ' A' ' 59' ' ' PRO . 24.9 m-85 -114.44 127.67 55.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.532 -0.758 . . . . 73.420000000000002 110.7 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 64.8 mt -109.28 115.61 50.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.908 -1.145 . . . . 71.310000000000002 107.908 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.99 110.42 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.451 -0.944 . . . . 73.150000000000006 108.451 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -102.27 121.73 42.83 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.189 -0.46 . . . . 70.209999999999994 110.529 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.38 167.89 9.86 Favored 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.698 0.799 . . . . 74.140000000000001 110.168 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 162.38 50.56 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.39 -1.484 . . . . 73.329999999999998 109.39 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 7.9 p -59.71 -42.01 87.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 117.467 0.633 . . . . 74.430000000000007 112.306 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.6 -21.95 60.18 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.494 0.664 . . . . 74.310000000000002 110.17 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -79.26 -36.87 39.19 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.766 -0.584 . . . . 73.409999999999997 110.173 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -31.08 71.56 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.766 -0.652 . . . . 72.349999999999994 109.473 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.6 mm-40 -59.42 -31.43 69.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.713 -0.676 . . . . 75.420000000000002 112.004 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -84.44 -27.82 27.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.085 -0.646 . . . . 62.140000000000001 110.755 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.36 -38.97 92.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.395 -0.366 . . . . 74.420000000000002 110.22 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.51 169.28 11.59 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 111.384 -0.686 . . . . 74.349999999999994 111.384 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.14 -31.41 25.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.0 0.428 . . . . 64.420000000000002 110.417 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 16.3 m-20 -105.8 105.36 52.85 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.51 -0.768 . . . . 71.310000000000002 109.428 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.16 -18.97 17.96 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.08 1.853 . . . . 75.140000000000001 113.783 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.296 0.0 OUTLIER -62.54 -51.91 65.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.789 1.403 . . . . 75.439999999999998 114.789 -174.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -67.35 -36.44 81.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.86 0.3 . . . . 74.010000000000005 111.314 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 72.4 mmtt -64.61 -45.78 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.539 . . . . 65.310000000000002 109.904 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.605 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 43.5 m -71.68 -49.71 37.14 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.378 -0.828 . . . . 72.5 111.11 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 56.1 m -65.63 -35.07 79.73 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.785 0.326 . . . . 74.239999999999995 111.649 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.73 -46.53 74.54 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.336 -0.705 . . . . 55.0 111.336 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.81 -28.28 67.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.274 -0.639 . . . . 74.439999999999998 109.274 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.94 79.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.994 -0.548 . . . . 72.140000000000001 110.25 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 83' ' ' THR . 99.9 mtt180 -66.14 -41.9 89.8 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.104 -0.332 . . . . 75.439999999999998 110.104 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.43 -36.66 83.09 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.927 0.394 . . . . 73.5 110.327 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.39 -39.44 65.1 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.948 -0.569 . . . . 51.109999999999999 110.121 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.44 ' HB1' HG13 ' A' ' 104' ' ' VAL . . . -59.37 -41.44 89.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.65 0.738 . . . . 73.219999999999999 109.026 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 19.2 t70 -58.16 -51.67 68.76 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.265 -1.334 . . . . 75.340000000000003 109.186 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 10.0 m-85 -55.1 -53.72 52.3 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.27 0.841 . . . . 73.239999999999995 113.27 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 pt -61.84 -36.63 74.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 120.774 -0.37 . . . . 75.219999999999999 111.664 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.19 -36.63 82.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.067 -0.515 . . . . 71.439999999999998 111.35 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.9 mt-10 -62.93 -38.84 92.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.381 0.61 . . . . 65.209999999999994 110.844 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 62.3 mm-40 -79.8 -9.45 59.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.377 -0.828 . . . . 75.5 110.905 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.81 56.57 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 112.583 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -101.5 159.76 15.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.488 -0.931 . . . . 65.439999999999998 108.488 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -132.94 171.6 13.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.711 -1.218 . . . . 74.129999999999995 107.711 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.1 t -147.86 166.27 28.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.645 -0.502 . . . . 73.099999999999994 109.645 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -106.51 120.76 42.76 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 109.749 -0.463 . . . . 70.519999999999996 109.749 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.85 -149.79 17.03 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.269 -1.132 . . . . 51.329999999999998 110.269 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -108.8 143.0 38.53 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.885 -1.524 . . . . 73.420000000000002 106.885 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' HB1' ' A' ' 90' ' ' ALA . 14.8 p -81.52 112.99 20.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.128 -1.029 . . . . 71.439999999999998 108.903 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.85 120.15 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-O 122.096 0.95 . . . . 73.209999999999994 110.866 -176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.605 ' O ' ' HB3' ' A' ' 82' ' ' SER . 3.7 m -119.1 139.67 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 N-CA-C 104.025 -2.583 . . . . 74.450000000000003 104.025 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.81 132.88 33.29 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.869 -1.132 . . . . 74.530000000000001 112.119 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -91.35 119.94 31.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.418 -1.265 . . . . 75.540000000000006 108.54 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.89 171.67 9.05 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.81 -0.632 . . . . 74.019999999999996 109.925 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -121.49 157.63 30.22 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.115 -1.069 . . . . 73.549999999999997 108.115 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.7 t -145.76 146.98 31.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.093 -0.706 . . . . 63.149999999999999 109.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.3 m -80.89 -22.74 39.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.433 -0.951 . . . . 75.340000000000003 108.433 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -80.46 -29.7 37.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.251 -0.886 . . . . 73.519999999999996 109.652 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.02 130.78 37.69 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.113 -1.81 . . . . 75.099999999999994 106.113 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 38.1 t-80 -97.74 153.24 18.39 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.499 -0.48 . . . . 73.409999999999997 110.008 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.9 m -60.51 139.59 57.68 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.635 0.774 . . . . 73.129999999999995 110.768 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.18 3.05 57.88 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.211 -1.155 . . . . 52.43 110.211 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 25.3 mt-30 -132.25 154.05 50.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.05 0.94 . . . . 72.439999999999998 109.101 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.11 148.22 26.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.434 -1.321 . . . . 75.109999999999999 107.434 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -137.45 135.94 37.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.802 -0.814 . . . . 74.120000000000005 108.802 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -137.28 120.66 16.98 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 123.527 0.517 . . . . 72.040000000000006 109.78 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 1.5 tpm_? -119.73 137.41 53.94 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.682 -1.229 . . . . 74.409999999999997 107.682 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -120.4 104.34 0.99 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.189 -0.764 . . . . 71.510000000000005 111.189 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.6 m -105.43 151.22 24.5 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 122.43 -0.453 . . . . 74.209999999999994 109.81 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.35 112.48 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.153 -1.054 . . . . 74.430000000000007 108.153 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -115.5 108.02 48.06 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 109.041 -0.726 . . . . 64.239999999999995 109.041 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.455 -0.759 0 C-N-CA 121.92 1.747 . . . . 70.109999999999999 112.236 -179.648 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.666 0 N-CA-C 113.326 0.862 . . . . 75.310000000000002 113.326 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.55 -22.65 43.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.847 -0.741 . . . . 74.519999999999996 109.216 172.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.74 -48.79 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 63.119999999999997 109.074 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.07 -33.24 75.55 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.8 -0.36 . . . . 63.350000000000001 110.654 178.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.19 81.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.585 0.553 . . . . 53.43 109.942 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.74 -45.6 93.65 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 108.765 -0.828 . . . . 74.430000000000007 108.765 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD23 HD11 ' A' ' 64' ' ' ILE . 11.1 mp -64.75 -42.45 95.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.043 1.127 . . . . 75.0 114.043 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.3 ptt180 -71.62 -27.28 63.0 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.205 -0.998 . . . . 74.129999999999995 111.328 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -68.14 -46.26 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.22 -40.42 93.93 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.697 1.199 . . . . 65.219999999999999 109.919 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.33 96.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.729 -0.669 . . . . 74.450000000000003 110.348 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.05 76.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.155 0.502 . . . . 74.310000000000002 111.36 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.91 -28.55 49.81 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.95 0.405 . . . . 72.340000000000003 111.289 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.49 21.6 45.25 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 116.267 -0.424 . . . . 63.32 113.138 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.15 144.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.693 0.797 . . . . 74.319999999999993 111.485 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 9.4 tt0 -120.45 134.66 55.24 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 107.988 -1.116 . . . . 73.319999999999993 107.988 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -64.48 128.94 37.93 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.453 0.644 . . . . 51.420000000000002 109.461 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -135.4 -166.25 1.81 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 105.57 -2.011 . . . . 73.010000000000005 105.57 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.588 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 67.6 mt-30 -59.05 155.68 13.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.611 -0.515 . . . . 72.239999999999995 109.611 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.53 -9.46 37.86 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 116.442 -0.344 . . . . 62.450000000000003 113.494 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -46.73 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.504 -0.184 . . . . 74.120000000000005 110.504 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 99' ' ' GLN . 6.0 ptm180 -172.16 152.92 2.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.4 -0.364 . . . . 75.420000000000002 110.698 -175.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -91.67 152.38 20.25 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.508 1.123 . . . . 73.530000000000001 111.084 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.8 tm? -92.97 133.28 36.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.092 -1.447 . . . . 70.25 107.092 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.61 159.97 41.96 Favored Pre-proline 0 C--N 1.302 -1.461 0 C-N-CA 123.525 0.73 . . . . 64.129999999999995 109.753 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.72 162.1 22.72 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.068 2.512 . . . . 74.209999999999994 113.418 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.409 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 9.8 p30 -134.16 -23.73 1.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.96 -0.563 . . . . 73.430000000000007 112.215 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.05 104.49 14.67 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.117 -1.033 . . . . 74.420000000000002 109.515 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.28 114.62 28.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.313 -0.858 . . . . 73.329999999999998 109.581 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.36 118.03 56.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.722 -1.214 . . . . 70.019999999999996 107.722 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.435 HD11 HD23 ' A' ' 40' ' ' LEU . 41.0 mt -113.31 125.79 70.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.011 -1.107 . . . . 72.150000000000006 108.011 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -116.39 123.32 47.28 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.138 -0.69 . . . . 73.420000000000002 109.138 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 119' ' ' PHE . 4.1 mm? -102.65 159.62 15.29 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.854 0.862 . . . . 72.109999999999999 109.478 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.82 144.68 48.53 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.683 -2.167 . . . . 62.009999999999998 107.683 169.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.59 -36.02 40.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.425 0.898 . . . . 75.310000000000002 113.425 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -69.69 -34.17 73.56 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.762 0.315 . . . . 73.129999999999995 111.227 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.3 m-20 -76.69 -25.82 54.06 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.22 0.533 . . . . 71.549999999999997 110.176 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.97 -31.18 71.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.26 -1.015 . . . . 73.120000000000005 108.26 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.92 -31.7 73.07 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.731 -0.668 . . . . 75.239999999999995 110.532 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -73.23 -27.61 61.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 110.915 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.53 -27.22 66.79 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.167 -0.679 . . . . 73.540000000000006 109.167 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.16 -163.72 12.54 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 114.81 -1.086 . . . . 74.140000000000001 113.389 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.89 -19.35 44.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.34 0.59 . . . . 75.409999999999997 109.672 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.23 67.94 36.29 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.696 -0.684 . . . . 74.349999999999994 112.54 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -72.5 -48.85 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.909 1.739 . . . . 65.230000000000004 110.352 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.578 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 5.4 mm-40 -68.43 -12.84 61.76 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.302 0.853 . . . . 73.109999999999999 113.302 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.22 -38.17 43.69 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.595 -1.261 . . . . 73.219999999999999 107.595 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.54 -25.6 57.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.068 -0.969 . . . . 73.299999999999997 110.407 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 9.3 m -54.65 -42.35 71.19 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 124.126 0.97 . . . . 74.430000000000007 111.28 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 m -60.85 -44.13 97.42 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.537 0.735 . . . . 72.439999999999998 111.275 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.65 -38.11 67.61 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.117 -0.793 . . . . 65.030000000000001 111.117 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -67.37 -36.47 81.41 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.363 0.665 . . . . 74.409999999999997 109.652 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.8 96.17 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.027 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -67.26 -36.29 81.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.316 -0.402 . . . . 74.200000000000003 110.67 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -43.97 96.74 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.638 -0.875 . . . . 75.549999999999997 108.638 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.62 -36.66 81.25 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.462 -0.79 . . . . 73.25 110.818 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.47 ' HB1' HG13 ' A' ' 104' ' ' VAL . . . -61.36 -38.15 85.9 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.401 0.619 . . . . 74.510000000000005 109.6 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 33.1 t70 -66.21 -42.41 88.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.464 -0.789 . . . . 73.219999999999999 109.329 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.8 m-85 -54.82 -47.92 73.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.858 -0.61 . . . . 74.400000000000006 111.936 174.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 pt -68.49 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 119.925 -0.71 . . . . 74.450000000000003 111.19 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -61.04 -41.98 97.62 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.295 0.372 . . . . 72.5 110.275 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 21.7 mm-40 -57.37 -44.15 84.15 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.309 0.644 . . . . 74.340000000000003 111.005 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -79.81 -13.93 59.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.493 -0.776 . . . . 71.010000000000005 110.237 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.83 9.6 63.95 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.852 -0.613 . . . . 70.439999999999998 113.543 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -86.83 152.29 22.61 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.993 -0.71 . . . . 73.310000000000002 110.412 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 55' ' ' ARG . 7.6 pt20 -122.83 168.62 12.03 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.571 -0.529 . . . . 73.439999999999998 109.571 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.0 t -146.78 154.81 41.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.355 -0.609 . . . . 74.409999999999997 109.355 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -97.31 120.82 38.36 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.456 -1.313 . . . . 75.040000000000006 107.456 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.87 -163.98 12.59 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 120.264 -0.969 . . . . 72.140000000000001 110.933 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.47 143.65 40.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.605 0.24 . . . . 73.299999999999997 110.57 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG13 ' HB1' ' A' ' 90' ' ' ALA . 9.6 p -80.94 123.49 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.822 -0.627 . . . . 74.209999999999994 109.799 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.5 129.21 72.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.751 -0.659 . . . . 75.439999999999998 109.939 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 82' ' ' SER . 96.2 t -115.36 119.38 61.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.093 -1.447 . . . . 73.099999999999994 107.093 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 107' ' ' ARG . 1.7 mmp_? -110.47 127.12 54.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.228 -0.442 . . . . 75.019999999999996 110.062 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -99.64 119.73 38.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.21 -0.663 . . . . 74.409999999999997 109.21 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.99 166.7 11.87 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.146 -0.933 . . . . 75.019999999999996 109.767 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.67 156.11 36.52 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.99 -1.115 . . . . 75.409999999999997 107.99 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -144.67 140.13 28.44 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 109.189 -0.671 . . . . 65.230000000000004 109.189 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 m -81.02 -20.36 41.92 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.673 -0.862 . . . . 64.299999999999997 108.673 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -72.01 -40.23 68.63 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.066 -0.97 . . . . 63.240000000000002 108.679 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.92 130.47 34.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.222 -0.899 . . . . 74.540000000000006 110.178 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -95.77 172.76 7.83 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.278 -0.874 . . . . 72.400000000000006 109.284 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.407 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 12.7 t -56.67 138.1 53.1 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.772 0.796 . . . . 74.420000000000002 111.278 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.76 -30.2 9.74 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 115.065 -0.971 . . . . 74.25 111.655 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -84.92 144.0 28.64 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.227 0.537 . . . . 75.040000000000006 111.47 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HB3' HD12 ' A' ' 66' ' ' LEU . 20.0 p90 -156.75 151.93 26.36 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.91 -1.515 . . . . 73.319999999999993 106.91 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -143.72 151.48 40.08 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.183 -1.414 . . . . 72.519999999999996 107.183 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.8 140.12 23.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.089 -0.337 . . . . 75.230000000000004 110.089 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -133.25 137.98 46.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.297 -1.001 . . . . 74.439999999999998 108.297 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.16 117.65 3.97 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.727 -1.349 . . . . 53.340000000000003 109.727 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.7 p -116.49 154.4 30.44 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-O 121.195 0.521 . . . . 74.439999999999998 110.906 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 67.7 t -89.92 103.95 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 108.102 -1.073 . . . . 64.450000000000003 108.102 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -101.85 95.69 5.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 106.397 -1.705 . . . . 65.450000000000003 106.397 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 71.6 Cg_endo . . . . . 0 N--CA 1.445 -1.33 0 C-N-CA 121.709 1.606 . . . . 73.450000000000003 112.429 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 112.888 0.699 . . . . 75.420000000000002 112.888 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.79 -33.98 76.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.918 -0.771 . . . . 72.409999999999997 108.918 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.59 -54.15 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.142 -0.936 . . . . 73.349999999999994 109.964 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -63.86 -29.54 70.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.815 0.34 . . . . 74.420000000000002 111.348 -178.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.539 ' O ' ' HG3' ' A' ' 42' ' ' ARG . . . -60.88 -47.99 83.84 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.107 -0.701 . . . . 72.430000000000007 109.107 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.11 -39.55 90.04 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.393 -0.821 . . . . 75.510000000000005 110.419 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.24 -51.11 67.66 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.137 0.273 . . . . 74.239999999999995 111.687 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.1 ptt180 -70.06 -22.91 63.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.076 0.769 . . . . 74.049999999999997 113.076 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 83.9 mtt180 -70.98 -45.37 64.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.827 -0.435 . . . . 75.129999999999995 109.827 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 121' ' ' ALA . 20.2 mm-40 -68.94 -32.61 72.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.047 -0.524 . . . . 75.409999999999997 110.318 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.05 95.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.451 -0.574 . . . . 71.129999999999995 109.451 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.78 -26.43 66.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.885 -0.598 . . . . 73.120000000000005 111.359 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -78.51 -34.19 47.51 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.316 0.579 . . . . 73.030000000000001 111.172 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.4 9.58 72.67 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.919 -0.658 . . . . 74.219999999999999 112.664 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.8 129.51 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 121.05 0.453 . . . . 74.140000000000001 110.732 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -122.1 141.93 50.9 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.952 -1.022 . . . . 74.239999999999995 110.56 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -75.52 113.44 12.95 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.839 -1.073 . . . . 74.400000000000006 110.782 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.9 tp -116.24 -164.4 0.96 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.428 -2.064 . . . . 52.100000000000001 105.428 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.525 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 mt-30 -48.3 154.89 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.912 0.485 . . . . 75.549999999999997 111.045 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.05 8.97 4.27 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 116.114 -0.494 . . . . 63.439999999999998 114.157 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -78.16 -47.59 17.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.324 -1.361 . . . . 73.219999999999999 107.324 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -173.61 166.08 4.57 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.868 0.692 . . . . 72.150000000000006 112.868 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.0 mt -91.13 151.78 20.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.047 -0.979 . . . . 73.209999999999994 112.298 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.47 129.76 41.12 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.824 -1.176 . . . . 71.219999999999999 107.824 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 158.72 39.14 Favored Pre-proline 0 C--N 1.308 -1.209 0 C-N-CA 123.206 0.602 . . . . 63.409999999999997 109.785 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.73 159.5 41.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.593 2.195 . . . . 73.430000000000007 112.536 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.15 -20.61 4.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.765 -0.652 . . . . 63.109999999999999 110.906 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.52 111.09 23.5 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.714 -1.217 . . . . 64.329999999999998 107.714 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.95 131.03 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.246 0.546 . . . . 74.209999999999994 111.669 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' NH2' ' A' ' 122' ' ' ARG . 52.6 mt -127.6 124.41 63.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.513 -0.767 . . . . 74.340000000000003 109.278 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.27 120.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.022 -1.473 . . . . 72.200000000000003 107.022 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 m -108.81 125.96 52.53 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 115.754 -0.657 . . . . 54.140000000000001 109.719 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.67 -176.78 2.98 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 124.662 1.185 . . . . 74.030000000000001 109.135 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.42 172.15 44.61 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.283 -1.127 . . . . 64.319999999999993 110.283 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 70.2 t -59.23 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.66 0.384 . . . . 72.439999999999998 111.362 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 55.9 t-80 -60.65 -40.94 93.86 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.544 0.688 . . . . 73.340000000000003 110.422 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.96 -40.34 83.2 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.452 -1.249 . . . . 74.420000000000002 110.454 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 88.8 t80 -66.81 -31.74 72.56 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.19 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.6 mm-40 -66.49 -26.2 67.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.993 -0.549 . . . . 72.209999999999994 111.178 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -77.98 -36.12 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.74 -0.837 . . . . 72.319999999999993 108.74 173.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.95 -18.92 65.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.259 -0.882 . . . . 75.400000000000006 110.364 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.45 -5.72 12.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.831 -0.622 . . . . 60.539999999999999 113.394 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.77 70.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.701 -0.481 . . . . 75.540000000000006 109.701 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD1' ' HG3' ' A' ' 81' ' ' LYS . 18.4 t70 -155.71 83.74 3.54 Favored Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 108.568 -0.901 . . . . 74.420000000000002 108.568 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.65 -51.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.995 1.797 . . . . 75.049999999999997 114.417 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -38.93 20.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.273 1.582 . . . . 70.510000000000005 115.273 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.459 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 2.2 tm? -66.2 -52.04 51.82 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.815 -0.439 . . . . 73.109999999999999 109.815 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 30.0 mtpp -58.67 -31.29 68.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.098 0.777 . . . . 74.129999999999995 113.098 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -62.21 -45.09 94.92 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.204 0.526 . . . . 74.310000000000002 110.186 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 m -72.75 -33.72 66.55 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.098 -0.501 . . . . 61.25 110.332 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.05 92.18 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.19 -0.764 . . . . 74.219999999999999 111.19 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -69.67 -36.09 75.71 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 111.674 0.25 . . . . 74.140000000000001 111.674 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.44 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.681 0.277 . . . . 74.109999999999999 110.897 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.29 -41.24 90.07 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.16 -43.94 81.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.868 -0.605 . . . . 73.019999999999996 110.548 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.48 -36.83 76.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.935 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.32 89.21 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.049 -0.723 . . . . 64.439999999999998 109.049 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -41.92 85.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.188 -0.914 . . . . 75.010000000000005 109.788 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 17.4 m-85 -57.91 -50.3 73.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.44 0.533 . . . . 74.140000000000001 112.44 174.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.9 -31.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.049 -0.66 . . . . 73.200000000000003 110.965 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -34.59 76.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.420000000000002 111.205 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.56 -43.34 99.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.138 0.971 . . . . 74.109999999999999 109.436 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.5 mm-40 -73.81 -12.53 60.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.377 -1.283 . . . . 71.209999999999994 110.899 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.12 30.56 46.08 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.009 -0.541 . . . . 64.109999999999999 112.467 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -97.36 172.1 7.99 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 122.521 -0.399 . . . . 74.310000000000002 110.0 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -138.98 169.43 17.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.715 -0.476 . . . . 62.25 109.715 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -159.51 179.3 9.03 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.205 -0.665 . . . . 73.319999999999993 109.205 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.12 120.26 37.79 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.482 -0.562 . . . . 74.319999999999993 109.482 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.37 -149.75 16.71 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.955 -1.117 . . . . 73.019999999999996 110.961 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.3 146.03 45.62 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.222 -1.399 . . . . 71.230000000000004 107.222 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.99 109.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.388 -0.597 . . . . 74.549999999999997 109.388 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.15 122.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.578 0.704 . . . . 74.430000000000007 110.364 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 78.4 t -118.93 123.51 71.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 74.129999999999995 109.106 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -117.33 147.03 42.97 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.191 -0.67 . . . . 74.209999999999994 109.191 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.36 123.61 45.72 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.25 -1.389 . . . . 74.530000000000001 107.25 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.96 176.16 8.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.674 0.273 . . . . 74.310000000000002 110.966 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 25.7 pt20 -113.03 164.72 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.918 -0.583 . . . . 75.140000000000001 111.219 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.3 p -151.01 148.81 28.81 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 107.513 -1.292 . . . . 61.539999999999999 107.513 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -81.02 -24.89 37.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.257 0.551 . . . . 73.530000000000001 109.939 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.66 -21.92 59.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 115.991 -0.549 . . . . 75.450000000000003 112.479 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.36 131.73 41.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 C-N-CA 120.097 -0.641 . . . . 75.530000000000001 109.589 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -114.04 156.42 24.15 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.537 -0.912 . . . . 72.450000000000003 108.537 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.1 m -51.83 110.68 0.5 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.065 0.853 . . . . 73.099999999999994 111.541 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 134.56 -33.96 2.42 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 109.125 -1.59 . . . . 71.209999999999994 109.125 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.17 144.98 31.21 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.783 -0.708 . . . . 75.439999999999998 109.282 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -157.87 160.3 37.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.982 -1.488 . . . . 74.530000000000001 106.982 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -145.43 147.65 32.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.238 -0.653 . . . . 71.340000000000003 109.238 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -122.79 132.74 54.35 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 104.651 -2.352 . . . . 73.019999999999996 104.651 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 4.9 tmm_? -136.5 135.55 38.65 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.31 -1.367 . . . . 75.230000000000004 107.31 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.42 155.48 17.53 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.298 -1.121 . . . . 73.400000000000006 110.298 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.7 t -149.77 161.47 42.17 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.916 -0.772 . . . . 73.200000000000003 108.916 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.9 110.57 20.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.955 -1.498 . . . . 73.099999999999994 106.955 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -125.67 93.56 44.21 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 116.603 -0.271 . . . . 74.420000000000002 110.709 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 C-N-CA 122.31 2.007 . . . . 75.0 110.376 175.068 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.402 . . . . 74.310000000000002 111.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -25.61 66.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.165 0.507 . . . . 73.519999999999996 110.835 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.15 -44.69 49.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.292 -1.003 . . . . 70.329999999999998 108.292 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.59 -34.73 76.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.189 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 42' ' ' ARG . . . -61.61 -57.74 10.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.228 -0.896 . . . . 62.119999999999997 109.638 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -56.94 -44.52 82.6 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.471 -0.566 . . . . 73.409999999999997 109.471 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -58.43 -52.51 65.32 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.488 0.551 . . . . 73.430000000000007 112.488 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 17.9 ptp180 -65.29 -30.22 71.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.929 0.395 . . . . 75.0 110.678 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 35.8 mmt180 -76.38 -37.66 56.86 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.067 -0.515 . . . . 74.510000000000005 110.713 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 122' ' ' ARG . 21.6 tt0 -78.15 -27.48 48.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.827 -0.749 . . . . 71.230000000000004 110.416 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.14 91.87 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.148 -0.686 . . . . 72.329999999999998 109.148 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.38 -32.81 68.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.420000000000002 110.957 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.67 -42.2 78.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.782 -0.644 . . . . 72.329999999999998 111.211 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.95 9.55 59.89 Favored Glycine 0 C--N 1.319 -0.414 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 113.157 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 HD13 ' CD2' ' A' ' 98' ' ' TRP . 14.1 mm -62.1 130.64 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.447 0.641 . . . . 74.140000000000001 111.588 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.7 mt-30 -110.54 134.95 51.91 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 115.517 -0.765 . . . . 72.040000000000006 110.087 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -78.65 91.68 4.66 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.639 -1.164 . . . . 74.120000000000005 108.195 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 24.3 tp -104.4 -165.77 1.18 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.205 -1.405 . . . . 74.420000000000002 107.205 -176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.548 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 54.1 mt-30 -45.15 145.55 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.227 0.611 . . . . 72.099999999999994 110.647 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.35 15.83 1.9 Allowed Glycine 0 C--O 1.218 -0.904 0 CA-C-N 116.003 -0.544 . . . . 73.219999999999999 113.26 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 52' ' ' GLN . 2.4 m-20 -70.17 -44.95 67.71 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.654 -1.61 . . . . 74.439999999999998 106.654 175.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 177.35 166.09 0.6 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-N 113.82 -1.536 . . . . 73.519999999999996 109.045 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -90.64 151.09 21.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 110.914 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 36.6 tp -93.62 131.58 38.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.492 -0.776 . . . . 75.230000000000004 108.985 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.49 162.54 33.7 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.128 -0.693 . . . . 75.439999999999998 109.128 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -66.16 159.33 50.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.752 2.302 . . . . 73.030000000000001 112.602 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 4.8 p-10 -130.23 -19.52 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.328 -0.397 . . . . 71.400000000000006 111.145 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.08 112.46 25.13 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.548 -0.908 . . . . 73.340000000000003 108.548 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 75.8 m-85 -118.54 114.24 22.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.067 0.937 . . . . 64.109999999999999 110.865 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.9 mt -104.93 104.21 16.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.322 -1.308 . . . . 75.349999999999994 108.56 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 106' ' ' VAL . 3.0 mp -96.49 128.53 47.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.9 -0.778 . . . . 63.310000000000002 108.9 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.3 m -121.1 129.02 53.12 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.74 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.81 174.87 6.33 Favored 'General case' 0 C--O 1.255 1.382 0 O-C-N 124.738 1.273 . . . . 71.439999999999998 109.326 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.7 -174.0 41.32 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 110.265 -1.134 . . . . 64.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' HA ' ' NE2' ' A' ' 110' ' ' GLN . 7.6 p -74.68 -51.19 23.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 114.523 1.305 . . . . 72.420000000000002 114.523 -175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.4 -42.07 83.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.547 0.689 . . . . 71.439999999999998 110.358 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.37 -32.27 66.31 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.851 -1.068 . . . . 74.109999999999999 112.759 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.492 ' HB3' HE21 ' A' ' 110' ' ' GLN . 58.7 t80 -66.26 -31.84 72.9 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 119.86 -0.736 . . . . 75.530000000000001 109.302 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.96 -23.15 67.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.387 0.514 . . . . 74.219999999999999 112.387 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -83.21 -28.65 29.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.198 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.8 mt -70.54 -37.94 74.13 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 150.14 8.64 Favored Glycine 0 N--CA 1.411 -2.994 0 CA-C-N 114.816 -1.084 . . . . 75.319999999999993 111.231 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -78.23 1.49 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.173 0.511 . . . . 73.430000000000007 110.992 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.14 92.07 4.29 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 121.934 0.874 . . . . 74.219999999999999 109.688 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.8 Cg_exo -75.51 -30.31 6.59 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.418 1.412 . . . . 71.150000000000006 110.03 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -45.65 -53.43 9.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.699 2.0 . . . . 73.040000000000006 113.078 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.69 -48.34 72.37 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.612 -0.722 . . . . 65.120000000000005 110.245 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -74.58 -38.61 62.62 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.85 1.056 . . . . 75.409999999999997 113.85 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 p -62.87 -51.69 66.02 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.71 0.633 . . . . 74.129999999999995 112.71 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -65.49 -43.13 91.13 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-N 116.244 -0.434 . . . . 73.329999999999998 111.365 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.34 52.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.049 -0.596 . . . . 73.099999999999994 112.239 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -70.65 -23.66 62.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.832 0.349 . . . . 73.25 110.095 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.48 -45.93 81.73 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 109.86 175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.27 -36.72 74.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 109.853 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -62.33 -40.81 97.59 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.275 -0.875 . . . . 74.099999999999994 110.629 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.13 -31.88 66.41 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.06 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.0 85.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.719 0.771 . . . . 65.329999999999998 109.299 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.89 -39.87 91.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.671 -1.15 . . . . 64.129999999999995 109.702 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 12.2 m-85 -57.82 -52.25 66.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.015 -0.539 . . . . 75.25 112.201 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 pt -66.9 -33.42 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.221 -0.591 . . . . 73.439999999999998 111.327 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.94 -31.09 69.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.57 . . . . 70.420000000000002 110.781 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.53 -30.32 69.09 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 111.386 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 54.8 mm-40 -86.74 -10.62 53.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.399 0.618 . . . . 65.200000000000003 109.741 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.57 21.37 58.26 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.709 -0.678 . . . . 73.140000000000001 113.362 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.441 ' CD2' HD13 ' A' ' 48' ' ' ILE . 24.6 m0 -93.67 150.82 20.1 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.085 0.469 . . . . 71.129999999999995 111.488 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -112.47 168.49 9.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.541 -0.754 . . . . 73.549999999999997 110.215 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.7 t -162.72 160.61 25.66 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.704 -0.85 . . . . 74.230000000000004 108.704 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -93.52 119.03 32.09 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.457 -1.312 . . . . 74.329999999999998 107.457 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.84 -150.35 16.75 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.78 -1.328 . . . . 61.140000000000001 109.78 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.75 153.82 47.82 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.517 -0.549 . . . . 75.0 109.517 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.68 123.27 32.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 123.637 0.586 . . . . 74.5 110.731 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.56 130.48 71.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.259 -0.882 . . . . 74.230000000000004 109.128 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 54.9 t -123.97 117.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.07 -1.085 . . . . 72.209999999999994 108.07 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.97 148.49 44.02 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.811 -0.756 . . . . 71.239999999999995 109.887 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.75 129.24 56.18 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.61 158.97 43.24 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.039 0.447 . . . . 64.400000000000006 110.296 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.492 HE21 ' HB3' ' A' ' 71' ' ' PHE . 35.9 tt0 -102.15 143.31 32.12 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.311 -0.859 . . . . 73.439999999999998 109.092 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 133.25 26.95 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 109.572 -0.529 . . . . 43.039999999999999 109.572 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.7 m -69.21 -20.43 63.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.142 0.496 . . . . 75.310000000000002 110.559 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.6 3.19 12.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.481 1.112 . . . . 71.019999999999996 111.408 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 115' ' ' HIS . 2.0 tm? -132.83 149.4 52.27 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.383 -2.08 . . . . 75.219999999999999 105.383 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.489 ' N ' HD13 ' A' ' 114' ' ' LEU . 36.7 t-80 -148.2 159.97 43.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.566 -0.531 . . . . 73.219999999999999 109.566 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 m -43.97 125.24 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.673 1.989 . . . . 73.120000000000005 111.926 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.61 -34.76 4.51 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 108.672 -1.771 . . . . 52.210000000000001 108.672 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 156.82 18.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.177 -1.045 . . . . 71.439999999999998 108.177 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -169.48 151.72 4.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.321 -2.103 . . . . 75.239999999999995 105.321 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -157.11 151.07 24.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.276 -0.969 . . . . 75.510000000000005 109.982 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.9 139.29 51.89 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.597 -1.261 . . . . 74.140000000000001 107.597 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 2.4 tpm_? -111.87 117.79 33.74 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.384 -0.969 . . . . 75.120000000000005 108.384 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.57 109.18 3.04 Favored Glycine 0 C--N 1.291 -1.934 0 O-C-N 123.871 0.732 . . . . 75.0 111.629 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 p -123.64 162.0 23.92 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.33 0.652 . . . . 72.209999999999994 111.138 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.4 131.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 105.069 -2.197 . . . . 73.209999999999994 105.069 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -112.98 130.8 23.19 Favored Pre-proline 0 C--N 1.295 -1.785 0 C-N-CA 118.542 -1.263 . . . . 74.519999999999996 111.375 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 C-N-CA 122.219 1.946 . . . . 74.230000000000004 110.402 175.506 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HA ' ' CG ' ' A' ' 37' ' ' GLU . 20.9 mp0 . . . . . 0 C--O 1.212 -0.911 0 N-CA-C 113.188 0.811 . . . . 75.010000000000005 113.188 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.33 -31.23 43.07 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.177 -1.046 . . . . 74.540000000000006 108.177 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.53 -53.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.089 -0.959 . . . . 73.219999999999999 109.533 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.34 -29.9 71.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.599 -0.273 . . . . 75.239999999999995 111.376 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.49 95.65 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.120000000000005 110.276 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.12 -37.36 58.17 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 120.705 -0.398 . . . . 71.409999999999997 110.461 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 62' ' ' TYR . 4.1 mm? -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.695 -0.402 . . . . 74.109999999999999 112.069 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -69.28 -27.56 65.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.362 -0.607 . . . . 72.030000000000001 109.362 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -70.22 -40.8 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.209 -0.663 . . . . 74.230000000000004 109.209 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -61.13 -43.39 98.96 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 123.446 0.466 . . . . 74.340000000000003 110.677 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.22 86.89 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.613 -0.721 . . . . 54.539999999999999 110.381 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.88 -32.46 72.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 72.120000000000005 111.849 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.88 -32.15 51.74 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.446 0.641 . . . . 72.129999999999995 110.366 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.05 16.22 61.02 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.548 -0.751 . . . . 74.549999999999997 113.418 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 mm -63.04 131.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.14 0.576 . . . . 72.030000000000001 111.932 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.8 mt-30 -117.16 144.15 45.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.214 -0.903 . . . . 72.430000000000007 109.472 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.2 m -71.49 114.73 9.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.053 -0.976 . . . . 64.319999999999993 109.87 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 25.7 tp -122.7 -176.94 3.51 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.068 -1.456 . . . . 74.519999999999996 107.068 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.549 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 78.0 mt-30 -53.69 164.42 0.55 Allowed 'General case' 0 C--O 1.246 0.914 0 C-N-CA 124.601 1.16 . . . . 74.239999999999995 113.525 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.27 -9.46 23.23 Favored Glycine 0 CA--C 1.504 -0.643 0 CA-C-N 114.921 -1.036 . . . . 63.240000000000002 114.734 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -74.7 -43.9 52.76 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.043 -0.663 . . . . 64.430000000000007 111.518 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.4 ptp180 -175.82 167.09 3.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.3 0.482 . . . . 74.439999999999998 112.3 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.82 151.86 20.39 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.438 1.095 . . . . 75.209999999999994 111.403 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.4 tm? -90.73 131.44 36.4 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.07 -1.085 . . . . 71.340000000000003 108.07 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.74 162.65 35.56 Favored Pre-proline 0 C--N 1.311 -1.107 0 C-N-CA 123.559 0.744 . . . . 73.25 110.005 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.446 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.6 Cg_exo -57.42 161.98 10.83 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.38 2.72 . . . . 72.120000000000005 113.958 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -131.36 -32.71 1.53 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.464 -0.789 . . . . 72.340000000000003 111.719 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.56 106.73 18.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.278 -1.379 . . . . 73.340000000000003 107.278 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 96.7 m-85 -112.16 116.15 30.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.216 0.531 . . . . 75.329999999999998 110.463 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.12 114.5 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.258 -0.883 . . . . 75.109999999999999 109.574 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.45 125.98 70.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.999 -0.741 . . . . 75.519999999999996 108.999 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -110.9 126.53 54.81 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.69 160.86 20.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.014 -0.736 . . . . 74.219999999999999 109.014 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.49 145.04 49.22 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 108.625 -1.79 . . . . 75.230000000000004 108.625 172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.8 p -52.57 -37.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 113.01 0.744 . . . . 72.239999999999995 113.01 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.17 -22.67 62.01 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.475 0.655 . . . . 74.340000000000003 111.255 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 29.8 m-20 -85.87 -35.25 20.7 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 121.552 -0.717 . . . . 73.519999999999996 110.279 175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -63.16 -24.86 68.08 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.087 -0.96 . . . . 74.340000000000003 109.444 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 38.2 mt-10 -58.29 -33.6 69.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 111.917 0.34 . . . . 65.430000000000007 111.917 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.463 ' NZ ' ' HA ' ' A' ' 70' ' ' ASP . 4.2 mppt? -81.08 -34.68 32.5 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.327 -0.549 . . . . 72.409999999999997 109.931 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.4 mt -68.58 -35.36 77.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.52 0.676 . . . . 72.439999999999998 110.224 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 6.32 39.2 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.786 -1.097 . . . . 74.239999999999995 113.973 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.29 97.54 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.613 -1.254 . . . . 73.219999999999999 107.613 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -148.25 82.74 7.49 Favored Pre-proline 0 CA--C 1.508 -0.656 0 N-CA-C 106.175 -1.787 . . . . 73.310000000000002 106.175 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.05 -47.64 23.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.511 2.14 . . . . 74.540000000000006 111.694 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -46.66 71.98 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.198 -0.91 . . . . 74.519999999999996 111.046 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.36 -53.7 54.5 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.386 -0.598 . . . . 73.420000000000002 109.386 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.864 -0.607 . . . . 74.030000000000001 111.778 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -67.37 -45.28 76.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.891 -0.324 . . . . 71.040000000000006 110.942 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.4 m -62.42 -44.33 96.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.239 0.216 . . . . 74.439999999999998 111.023 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.17 -46.6 90.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.017 -0.611 . . . . 72.439999999999998 112.059 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.71 -35.87 82.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 110.34 -0.244 . . . . 72.420000000000002 110.34 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.62 86.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.628 0.251 . . . . 74.319999999999993 110.581 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.43 -44.61 90.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.129 -0.487 . . . . 72.150000000000006 111.003 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.4 -34.08 75.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.559 0.578 . . . . 72.409999999999997 112.559 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.34 -35.16 65.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.997 0.427 . . . . 72.040000000000006 110.181 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.78 81.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.799 0.809 . . . . 73.5 109.678 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.57 -38.88 88.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.906 -1.043 . . . . 65.540000000000006 109.022 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -59.36 -49.09 79.15 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 111.918 175.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -66.38 -30.5 50.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 120.32 -0.552 . . . . 75.120000000000005 111.006 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -64.02 -43.3 96.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.433 -0.349 . . . . 63.420000000000002 110.537 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.86 -32.77 72.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.074 0.464 . . . . 71.200000000000003 112.072 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 64.8 mm-40 -81.45 -13.21 58.47 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.197 0.522 . . . . 74.409999999999997 111.452 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 84.55 34.42 16.43 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.764 -0.653 . . . . 61.420000000000002 111.669 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -110.71 173.98 6.08 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.88 -0.415 . . . . 71.0 109.88 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -155.84 174.0 15.96 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.328 -0.99 . . . . 75.349999999999994 108.328 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -147.33 176.4 10.03 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.681 -0.859 . . . . 70.310000000000002 108.681 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -99.06 120.14 38.98 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.277 -1.379 . . . . 75.239999999999995 107.277 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.9 -149.81 16.83 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.999 -1.64 . . . . 61.240000000000002 108.999 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -132.47 144.44 50.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.375 -1.343 . . . . 74.319999999999993 107.375 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.05 124.24 20.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.213 0.53 . . . . 74.230000000000004 112.008 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.93 120.51 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.408 -0.815 . . . . 71.200000000000003 110.045 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 62' ' ' TYR . 14.8 m -106.65 147.5 11.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.774 -1.195 . . . . 73.329999999999998 107.774 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -137.31 142.12 41.88 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.841 -0.8 . . . . 71.129999999999995 108.841 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -114.19 134.75 54.7 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.03 -0.532 . . . . 62.039999999999999 109.655 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.3 159.81 35.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.122 0.487 . . . . 71.310000000000002 110.001 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -107.56 155.1 20.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.51 -0.768 . . . . 74.400000000000006 109.828 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -138.99 140.12 38.1 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.695 -1.224 . . . . 74.400000000000006 107.695 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 m -82.08 -27.43 32.92 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.343 0.592 . . . . 75.310000000000002 110.067 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -80.57 -34.51 35.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.596 -0.729 . . . . 75.219999999999999 109.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 tp -77.45 133.37 38.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.168 -1.789 . . . . 75.310000000000002 106.168 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CG ' ' H ' ' A' ' 116' ' ' THR . 12.5 t-80 -116.5 172.35 7.27 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.848 -1.541 . . . . 65.239999999999995 112.311 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.591 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 21.9 m -50.59 132.02 25.48 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 125.668 1.587 . . . . 73.319999999999993 113.387 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.62 -6.13 83.29 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.634 -1.166 . . . . 74.340000000000003 112.247 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.36 136.17 54.79 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.893 -1.151 . . . . 75.019999999999996 107.893 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.3 159.96 42.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.945 -0.391 . . . . 75.400000000000006 109.945 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 mmp_? -133.17 137.31 46.17 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.811 -0.811 . . . . 74.319999999999993 108.811 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.23 44.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.788 -0.819 . . . . 72.439999999999998 108.788 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -139.7 131.87 28.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.455 -0.572 . . . . 74.530000000000001 109.455 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.82 128.56 8.5 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.825 -0.91 . . . . 71.349999999999994 110.825 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.4 m -123.33 144.76 49.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 109.347 -0.612 . . . . 74.450000000000003 109.347 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 59' ' ' PRO . 89.8 t -93.92 105.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.003 -1.11 . . . . 74.120000000000005 108.003 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.62 110.35 48.68 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.873 -1.158 . . . . 74.430000000000007 107.873 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.454 -0.838 0 C-N-CA 121.613 1.542 . . . . 75.540000000000006 111.608 -179.857 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 . . . . . 0 C--O 1.216 -0.702 0 CA-C-O 120.559 0.219 . . . . 75.0 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -34.46 75.49 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.608 0.595 . . . . 74.409999999999997 112.608 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.42 -51.68 35.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.555 . . . . 74.219999999999999 109.5 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.7 pt-20 -66.79 -30.05 70.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.594 -0.275 . . . . 71.319999999999993 111.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.65 -39.19 93.1 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.149 0.5 . . . . 53.109999999999999 109.873 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -71.11 -45.93 62.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.503 -0.925 . . . . 73.400000000000006 108.503 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.268 3.7 mm? -67.69 -33.69 75.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.586 1.328 . . . . 73.329999999999998 114.586 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 2.5 ptm180 -67.48 -32.47 73.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 119.806 -0.758 . . . . 64.150000000000006 109.085 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -35.8 69.26 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.326 -0.62 . . . . 75.019999999999996 109.326 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.9 -43.91 91.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.469 -0.567 . . . . 75.409999999999997 109.469 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -48.08 82.95 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.632 -0.713 . . . . 75.230000000000004 110.47 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.98 85.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.019 -0.537 . . . . 73.439999999999998 111.732 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -72.51 -39.91 67.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 109.753 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.58 31.36 6.17 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.272 -0.876 . . . . 73.099999999999994 113.311 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.404 HG22 ' HB3' ' A' ' 56' ' ' LEU . 17.7 mm -71.65 130.35 35.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.185 -0.672 . . . . 75.109999999999999 109.185 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 21.0 tt0 -107.74 136.56 47.27 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.667 -0.864 . . . . 74.430000000000007 108.667 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -67.59 107.44 2.51 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.764 0.793 . . . . 72.219999999999999 111.093 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.4 tp -118.12 -166.34 1.2 Allowed 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.065 -2.198 . . . . 72.049999999999997 105.065 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.54 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 52.6 mt-30 -51.77 152.55 2.84 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 111.631 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.45 -3.28 18.85 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-N 116.087 -0.506 . . . . 75.519999999999996 113.453 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -65.23 -46.69 79.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.868 -1.16 . . . . 74.219999999999999 107.868 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -174.68 154.75 2.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.841 -1.072 . . . . 73.040000000000006 110.901 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HB3' HG22 ' A' ' 48' ' ' ILE . 58.3 mt -90.56 151.79 21.18 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.563 -1.199 . . . . 74.310000000000002 109.878 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 40.6 tp -92.92 128.99 38.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.911 -0.586 . . . . 72.439999999999998 109.458 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.54 154.16 42.49 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 109.203 -0.665 . . . . 71.219999999999999 109.203 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.21 155.78 54.48 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.724 2.283 . . . . 63.100000000000001 112.396 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.425 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -127.49 -24.17 3.37 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.707 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.45 112.54 24.53 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.283 -1.006 . . . . 73.310000000000002 108.283 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.4 m-85 -121.93 122.37 39.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.34 0.59 . . . . 74.310000000000002 110.701 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.3 mt -120.08 116.47 50.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.088 -0.708 . . . . 75.549999999999997 109.088 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.09 126.0 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.257 -1.016 . . . . 72.439999999999998 108.257 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.81 117.27 32.36 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.64 -0.709 . . . . 71.109999999999999 109.204 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.5 mm? -100.72 161.69 13.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 122.82 0.448 . . . . 73.430000000000007 109.953 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.02 150.02 51.66 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.324 -1.91 . . . . 71.209999999999994 108.324 170.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.01 -35.01 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 117.325 0.562 . . . . 74.120000000000005 112.389 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.555 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 20.6 t60 -73.12 -28.89 62.52 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 116.021 -0.536 . . . . 74.099999999999994 110.576 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -85.72 -24.21 27.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.545 -0.722 . . . . 70.25 110.462 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.529 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 82.4 t80 -64.74 -41.35 95.99 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.277 0.56 . . . . 75.129999999999995 110.089 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.74 -25.54 65.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.032 -0.531 . . . . 73.0 111.008 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 2.1 mptm? -75.22 -22.57 57.84 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.23 -0.895 . . . . 74.510000000000005 111.763 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.0 -31.13 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.668 -1.234 . . . . 70.140000000000001 107.668 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.96 -162.73 15.62 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.642 -1.163 . . . . 74.239999999999995 111.69 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.14 -37.37 38.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.004 -0.739 . . . . 70.310000000000002 109.004 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -115.71 97.06 48.13 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.522 -0.763 . . . . 75.239999999999995 110.385 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.49 -33.5 22.54 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 121.962 1.775 . . . . 74.329999999999998 109.525 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.96 -22.29 59.89 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.55 -1.204 . . . . 71.420000000000002 111.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.2 tp -54.48 -45.37 73.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.203 -0.665 . . . . 72.450000000000003 109.203 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.54 -26.38 19.76 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 115.698 -0.683 . . . . 73.200000000000003 110.739 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -55.28 -51.14 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.15 0.432 . . . . 61.140000000000001 111.936 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.2 m -56.07 -45.57 79.29 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.127 0.489 . . . . 73.25 111.047 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.81 -43.25 75.6 Favored Glycine 0 C--O 1.206 -1.626 0 C-N-CA 120.907 -0.663 . . . . 74.310000000000002 111.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -61.17 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.168 0.987 . . . . 75.129999999999995 110.152 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB2' HG11 ' A' ' 106' ' ' VAL . . . -60.75 -45.91 92.49 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.546 -0.752 . . . . 74.319999999999993 109.837 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -75.34 -24.71 57.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.617 -0.719 . . . . 73.219999999999999 112.212 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.67 -51.47 59.23 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.092 -1.077 . . . . 73.129999999999995 108.092 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.72 -42.76 99.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.11 -0.95 . . . . 74.129999999999995 109.583 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -60.87 -39.09 87.88 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 111.192 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 23.1 t70 -72.83 -36.39 67.48 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.655 -0.498 . . . . 65.430000000000007 109.655 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.608 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.9 m-85 -59.26 -44.98 92.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.101 -0.5 . . . . 74.409999999999997 111.515 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -70.19 -25.43 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.372 -0.531 . . . . 74.409999999999997 111.293 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 79.5 mt-30 -66.69 -42.54 86.31 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.745 -0.835 . . . . 72.129999999999995 108.745 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 58.4 mt-10 -63.83 -26.68 68.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.458 -0.792 . . . . 72.129999999999995 111.227 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.5 mm-40 -92.95 -13.73 28.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 75.340000000000003 110.794 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.24 28.35 56.1 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.811 -0.632 . . . . 63.520000000000003 113.128 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -97.13 173.45 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.238 -0.653 . . . . 74.219999999999999 109.238 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 26.6 pt20 -132.32 165.75 23.49 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 122.458 -0.151 . . . . 73.310000000000002 110.822 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.8 t -154.15 158.15 39.94 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.449 -1.315 . . . . 74.25 107.449 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.14 120.7 37.89 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.379 -0.529 . . . . 75.310000000000002 110.989 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.04 -169.31 13.81 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.825 -1.31 . . . . 73.540000000000006 109.825 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -92.32 143.96 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.027 -0.731 . . . . 75.420000000000002 109.027 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.85 115.09 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.923 0.868 . . . . 75.329999999999998 109.953 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.44 128.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 115.237 -0.892 . . . . 74.430000000000007 110.092 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 8.6 p -133.81 141.54 43.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.406 -0.961 . . . . 75.340000000000003 108.406 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -137.45 149.9 47.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.129 -0.628 . . . . 73.340000000000003 109.821 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -115.34 114.57 25.3 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.096 -1.446 . . . . 74.230000000000004 107.096 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.09 167.42 11.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.644 -0.502 . . . . 62.329999999999998 109.644 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.529 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.8 pt20 -104.57 160.47 14.92 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.416 0.626 . . . . 72.019999999999996 110.68 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -140.5 130.84 25.17 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.068 -0.969 . . . . 74.019999999999996 108.885 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -81.19 -5.74 58.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.119 -0.492 . . . . 74.129999999999995 110.501 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -88.87 -20.57 24.43 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.055 0.455 . . . . 75.299999999999997 110.758 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.0 mt -94.73 142.96 26.84 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.144 0.497 . . . . 70.450000000000003 110.299 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -98.12 173.07 7.21 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.399 -0.819 . . . . 70.510000000000005 109.787 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 m -53.68 118.38 3.88 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 124.197 0.936 . . . . 73.019999999999996 111.033 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.23 5.3 52.83 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 121.042 -0.599 . . . . 63.210000000000001 113.321 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.04 141.4 48.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.268 0.534 . . . . 71.120000000000005 110.985 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' HB3' HD13 ' A' ' 66' ' ' LEU . 28.8 p90 -152.06 151.02 30.58 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 109.891 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.68 144.87 48.52 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.657 -1.238 . . . . 55.43 107.657 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.44 10.78 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 117.946 0.339 . . . . 71.530000000000001 110.526 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -125.47 135.23 52.11 Favored 'General case' 0 N--CA 1.39 -3.457 0 N-CA-C 109.906 -0.405 . . . . 75.209999999999994 109.906 178.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.6 143.4 17.83 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 109.506 -1.438 . . . . 74.040000000000006 109.506 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.6 m -145.35 150.57 36.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.101 -0.703 . . . . 73.349999999999994 109.101 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 105.99 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.193 -1.039 . . . . 74.299999999999997 108.193 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -122.02 100.13 43.2 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 108.772 -0.825 . . . . 72.019999999999996 108.772 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 C--O 1.245 0.857 0 C-N-CA 122.231 1.954 . . . . 75.450000000000003 112.326 -177.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 . . . . . 0 C--O 1.227 -0.089 0 CA-C-O 120.855 0.36 . . . . 75.230000000000004 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -72.88 -31.38 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 63.43 109.757 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 99.4 t -60.57 -50.96 78.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.22 -0.446 . . . . 73.340000000000003 110.351 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.39 -34.44 77.27 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.043 -0.663 . . . . 75.099999999999994 110.661 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.83 80.8 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 110.582 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.7 tt -66.32 -42.94 87.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.334 -0.848 . . . . 74.120000000000005 109.931 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 93.9 mt -61.28 -39.21 89.59 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.05 0.452 . . . . 71.439999999999998 111.688 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -67.99 -33.46 74.68 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 123.723 0.809 . . . . 73.230000000000004 110.416 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -75.65 -36.16 60.24 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.063 -1.088 . . . . 74.409999999999997 108.063 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 63.2 mm-40 -63.62 -34.59 78.16 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.684 . . . . 73.010000000000005 110.351 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.29 94.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.836 -0.62 . . . . 75.310000000000002 109.727 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.23 -25.23 61.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.342 0.591 . . . . 75.310000000000002 110.89 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.69 -46.11 59.81 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.388 0.675 . . . . 75.310000000000002 111.135 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 26.39 10.12 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 120.698 -0.763 . . . . 53.409999999999997 114.093 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.18 141.61 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 122.65 0.38 . . . . 74.109999999999999 110.544 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.2 mt-30 -120.31 149.13 42.79 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.926 0.393 . . . . 54.240000000000002 110.412 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.5 p -76.56 128.92 35.68 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.72 -1.127 . . . . 62.25 109.446 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 28.4 tp -146.24 -166.35 2.45 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.899 -2.26 . . . . 73.540000000000006 104.899 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.515 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 98.2 mt-30 -43.91 136.52 3.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.743 0.652 . . . . 74.439999999999998 110.357 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.48 -8.23 31.05 Favored Glycine 0 N--CA 1.464 0.503 0 CA-C-N 116.654 -0.248 . . . . 71.0 113.487 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.61 -38.44 90.21 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.085 0.554 . . . . 73.120000000000005 109.801 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -171.59 147.9 2.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 111.213 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -91.08 151.89 20.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.723 0.809 . . . . 74.420000000000002 111.369 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 34.0 tp -84.81 128.88 34.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.74 -0.837 . . . . 75.450000000000003 108.74 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.46 154.31 44.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 122.919 0.487 . . . . 62.299999999999997 111.11 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.405 ' HB3' ' N ' ' A' ' 124' ' ' THR . 78.3 Cg_exo -58.31 145.91 91.55 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.475 2.783 . . . . 74.219999999999999 112.819 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -122.6 -25.37 4.73 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.263 -0.426 . . . . 73.519999999999996 110.137 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.35 113.09 25.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.955 -0.758 . . . . 73.219999999999999 108.955 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 93.9 m-85 -112.67 114.94 27.78 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.363 0.602 . . . . 75.329999999999998 109.49 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.39 120.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 72.439999999999998 108.559 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -115.8 125.74 73.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.967 -1.123 . . . . 73.209999999999994 107.967 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -120.56 120.62 36.35 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 116.4 -0.364 . . . . 72.530000000000001 110.1 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' CB ' ' A' ' 119' ' ' PHE . 4.4 mm? -106.5 170.82 7.7 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 122.905 0.482 . . . . 75.310000000000002 110.736 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.29 167.32 51.96 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.484 -1.446 . . . . 70.430000000000007 109.484 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.97 -40.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 117.492 0.646 . . . . 74.430000000000007 111.936 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -75.77 -28.84 58.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.254 -0.647 . . . . 73.510000000000005 109.254 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 61.1 m-20 -76.16 -29.46 57.75 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 120.791 -0.363 . . . . 63.109999999999999 111.13 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -69.33 -29.46 67.29 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.313 -0.995 . . . . 75.439999999999998 108.313 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.11 -26.46 66.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.777 -0.647 . . . . 75.140000000000001 111.115 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -70.63 -36.29 73.37 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.199 -0.667 . . . . 72.109999999999999 109.199 173.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.77 -30.11 69.48 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.338 -0.986 . . . . 74.200000000000003 108.338 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -138.18 16.03 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 114.13 -1.396 . . . . 35.329999999999998 113.325 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.88 -2.4 56.85 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.123 -0.538 . . . . 73.530000000000001 109.852 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -117.72 100.18 52.36 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 113.27 0.841 . . . . 72.239999999999995 113.27 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.47 -42.57 0.21 Allowed 'Trans proline' 0 CA--C 1.56 1.779 0 C-N-CA 121.656 1.57 . . . . 74.019999999999996 111.589 166.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -84.37 -29.71 26.03 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 118.775 2.88 . . . . 74.329999999999998 118.775 -163.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.74 -44.22 82.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.223 1.374 . . . . 74.319999999999993 108.563 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -65.04 -32.61 74.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.099 -0.955 . . . . 75.200000000000003 111.169 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.2 m -63.34 -43.32 98.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.817 -0.438 . . . . 62.509999999999998 109.817 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 64.3 m -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 116.253 -0.43 . . . . 64.439999999999998 110.817 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -52.11 49.89 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.234 -0.507 . . . . 74.239999999999995 112.036 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -63.16 -39.97 96.21 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.507 0.558 . . . . 72.439999999999998 112.507 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.87 -45.28 95.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.82 0.343 . . . . 73.219999999999999 111.151 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.5 -42.03 87.99 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.759 -0.655 . . . . 72.109999999999999 110.926 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.43 -42.67 82.8 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.48 -0.782 . . . . 75.400000000000006 110.488 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.47 -34.74 78.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.158 0.429 . . . . 73.040000000000006 112.158 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.09 88.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.509 0.671 . . . . 74.239999999999995 110.334 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 24.6 t70 -69.77 -43.95 71.15 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 109.362 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.3 m-85 -55.44 -56.73 16.8 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 113.126 0.787 . . . . 74.349999999999994 113.126 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.8 pt -57.47 -36.66 54.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 123.26 0.35 . . . . 74.150000000000006 111.548 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.17 -37.66 81.24 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.441 -0.345 . . . . 71.409999999999997 111.856 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.7 mt-10 -63.75 -34.75 78.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.304 0.573 . . . . 74.140000000000001 110.682 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 73.5 mm-40 -76.34 -13.72 60.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.508 -0.769 . . . . 75.409999999999997 111.008 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.02 67.46 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.943 -0.572 . . . . 75.430000000000007 112.267 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -81.42 165.01 21.66 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.461 -0.57 . . . . 75.150000000000006 109.461 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -133.8 165.67 24.43 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.257 -0.645 . . . . 75.230000000000004 109.257 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -155.41 170.86 20.94 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.157 -1.053 . . . . 71.340000000000003 108.157 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -106.86 119.18 38.65 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.888 -1.152 . . . . 74.530000000000001 107.888 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.14 -149.33 16.59 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 109.168 -1.573 . . . . 71.540000000000006 109.168 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.95 175.76 7.83 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.762 -1.57 . . . . 72.239999999999995 106.762 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -82.41 127.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.066 0.46 . . . . 75.319999999999993 110.511 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 m -127.54 127.33 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.548 -0.751 . . . . 73.120000000000005 109.083 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -131.62 145.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 107.321 -1.362 . . . . 74.239999999999995 107.321 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.56 139.3 20.75 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.339 0.59 . . . . 74.329999999999998 110.476 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.82 131.8 44.0 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.489 -1.232 . . . . 74.329999999999998 109.432 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -136.89 176.53 8.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.762 -0.829 . . . . 74.540000000000006 108.762 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -127.0 164.58 21.19 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.732 0.777 . . . . 65.120000000000005 111.406 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 m -142.04 127.03 18.34 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.968 -1.123 . . . . 71.209999999999994 107.968 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 t -69.24 -19.16 63.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.271 0.628 . . . . 72.409999999999997 110.283 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -65.79 -30.4 71.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 74.030000000000001 109.765 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.36 131.3 34.71 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.422 0.63 . . . . 74.120000000000005 110.772 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -92.29 162.0 14.46 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.635 -1.246 . . . . 72.049999999999997 107.635 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.9 m -55.93 126.82 27.43 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.431 0.692 . . . . 62.329999999999998 110.972 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.37 -14.53 47.26 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.558 -0.746 . . . . 63.509999999999998 111.616 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.46 131.72 53.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.565 -0.532 . . . . 75.230000000000004 109.565 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.406 ' CB ' HD12 ' A' ' 66' ' ' LEU . 16.4 p90 -145.45 159.37 43.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.093 -0.706 . . . . 73.150000000000006 109.093 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.95 149.81 52.33 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.093 -0.706 . . . . 74.430000000000007 109.093 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.27 134.84 17.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.487 -0.56 . . . . 74.040000000000006 109.487 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -132.39 145.3 51.13 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 121.38 0.609 . . . . 74.209999999999994 111.925 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.81 113.4 1.86 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.989 -1.645 . . . . 73.439999999999998 108.989 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.405 ' N ' ' HB3' ' A' ' 59' ' ' PRO . 61.0 m -143.13 145.45 32.84 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 108.951 -0.759 . . . . 75.299999999999997 108.951 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.91 118.15 32.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.993 -1.114 . . . . 73.329999999999998 107.993 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -126.21 88.78 53.65 Favored Pre-proline 0 C--N 1.29 -2.018 0 CA-C-N 115.626 -0.715 . . . . 62.420000000000002 110.087 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 122.382 2.055 . . . . 71.329999999999998 111.381 178.513 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.279 0.561 . . . . 74.129999999999995 110.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -79.82 -38.58 32.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.187 -0.915 . . . . 61.450000000000003 108.805 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.53 -53.48 46.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 115.532 -0.758 . . . . 74.409999999999997 110.028 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -65.53 -32.42 74.01 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 120.642 -0.423 . . . . 72.340000000000003 111.778 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.05 -53.97 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.062 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.2 mm? -71.59 -34.64 70.07 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.044 -0.525 . . . . 74.530000000000001 111.366 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp -65.85 -41.05 92.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.516 0.198 . . . . 75.450000000000003 111.381 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -73.93 -26.51 60.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.21 -0.596 . . . . 72.120000000000005 109.495 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -71.18 -35.75 71.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.372 -0.603 . . . . 75.340000000000003 109.372 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 78.0 mm-40 -61.09 -37.36 82.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.766 -0.457 . . . . 74.420000000000002 109.766 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.68 82.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 73.409999999999997 109.92 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.42 -33.45 73.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.309 0.576 . . . . 61.219999999999999 112.007 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.05 -37.32 39.28 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.469 0.707 . . . . 72.010000000000005 110.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.54 14.49 63.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.483 -0.78 . . . . 74.200000000000003 113.365 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -54.6 141.6 10.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.005 0.922 . . . . 71.540000000000006 110.96 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.36 126.75 55.62 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 107.02 -1.474 . . . . 74.329999999999998 107.02 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -66.71 102.18 0.9 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.331 0.586 . . . . 74.409999999999997 110.125 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -104.24 -165.97 1.2 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.487 -2.042 . . . . 75.129999999999995 105.487 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.566 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -47.13 144.04 2.85 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.155 -0.683 . . . . 75.129999999999995 109.155 172.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.63 7.49 3.86 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 114.343 0.497 . . . . 53.420000000000002 114.343 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -76.71 -35.6 57.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.536 -0.913 . . . . 54.450000000000003 108.536 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.493 ' HD3' ' OE1' ' A' ' 99' ' ' GLN . 8.2 ptm180 -168.45 157.54 9.0 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.754 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HB2' ' CD1' ' A' ' 98' ' ' TRP . 77.6 mt -91.89 151.37 20.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.258 0.623 . . . . 70.25 110.408 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.24 127.29 47.89 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.619 -1.252 . . . . 75.25 107.619 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.72 158.08 32.45 Favored Pre-proline 0 C--N 1.301 -1.543 0 C-N-CA 122.96 0.504 . . . . 71.430000000000007 110.169 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.424 ' HA ' HG23 ' A' ' 125' ' ' VAL . 73.6 Cg_exo -54.25 161.83 4.91 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.073 2.515 . . . . 73.329999999999998 113.363 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -125.94 -25.54 3.59 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.63 -0.713 . . . . 70.340000000000003 110.421 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -101.2 100.52 11.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.917 -1.142 . . . . 74.25 107.917 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.36 119.24 38.58 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 72.030000000000001 109.898 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.0 mt -116.13 114.09 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.527 -0.761 . . . . 72.409999999999997 109.528 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -104.62 134.15 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 106.641 -1.615 . . . . 74.049999999999997 106.641 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 m -131.6 125.66 32.79 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 120.901 -0.32 . . . . 73.140000000000001 111.329 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.2 mm? -132.44 172.92 11.86 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.341 1.026 . . . . 73.549999999999997 109.543 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.9 51.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.675 -0.97 . . . . 72.140000000000001 110.675 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 88.0 t -60.92 -45.73 97.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.993 0.517 . . . . 74.450000000000003 110.87 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -64.65 -31.47 72.7 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.752 1.221 . . . . 73.519999999999996 110.686 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.51 -37.53 19.57 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.584 0.707 . . . . 74.219999999999999 109.252 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -60.57 -32.02 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.168 -0.924 . . . . 75.439999999999998 111.315 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 54.3 mt-10 -55.61 -38.26 69.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.418 0.627 . . . . 74.409999999999997 110.139 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -83.43 -28.64 28.69 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.006 -0.997 . . . . 65.329999999999998 109.842 -173.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.2 mt -55.78 -45.78 78.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.83 0.707 . . . . 73.540000000000006 109.65 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.68 158.48 21.31 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.614 -0.995 . . . . 72.109999999999999 110.614 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -18.21 60.45 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.491 0.662 . . . . 75.209999999999994 110.202 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.95 138.22 17.85 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 108.459 -0.941 . . . . 72.5 108.459 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.4 -51.45 7.41 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.573 2.182 . . . . 73.409999999999997 112.88 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -64.91 -30.12 71.1 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.326 -0.397 . . . . 74.430000000000007 111.486 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.58 -40.91 53.67 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.329 1.018 . . . . 74.230000000000004 109.514 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 2.1 mmmp? -95.2 -39.23 10.19 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 74.510000000000005 110.688 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.9 m -58.44 -44.82 89.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.72 0.637 . . . . 75.120000000000005 112.72 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -63.04 -54.49 37.37 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 120.926 0.393 . . . . 73.420000000000002 111.558 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.83 -37.71 92.47 Favored Glycine 0 C--O 1.245 0.807 0 C-N-CA 121.406 -0.426 . . . . 75.450000000000003 113.1 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -75.47 -30.0 59.79 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.868 -0.195 . . . . 64.319999999999993 110.684 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.46 90.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.955 -0.387 . . . . 65.549999999999997 109.955 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -60.86 -47.74 85.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.403 -0.817 . . . . 74.349999999999994 111.048 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 11.1 t70 -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.539 0.685 . . . . 74.310000000000002 110.486 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.65 -36.95 70.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 65.519999999999996 109.157 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 104' ' ' VAL . . . -63.45 -36.67 84.53 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 109.298 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 30.1 t70 -59.56 -52.2 66.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.688 -1.142 . . . . 72.310000000000002 109.06 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -52.96 -50.79 63.36 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.403 0.89 . . . . 75.540000000000006 113.403 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.41 -37.26 79.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.193 -0.603 . . . . 73.420000000000002 112.225 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -70.56 -34.83 72.66 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.812 -0.355 . . . . 74.040000000000006 111.281 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 64.7 mm-40 -63.1 -35.26 79.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.156 0.503 . . . . 73.540000000000006 110.636 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -81.79 -12.96 58.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.581 -0.736 . . . . 74.540000000000006 111.204 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 89.85 23.97 31.42 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.903 -0.59 . . . . 41.530000000000001 112.991 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.9 m0 -98.5 149.23 22.94 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.068 0.461 . . . . 75.329999999999998 111.406 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.493 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 13.8 pt20 -124.47 177.46 5.9 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.367 -0.833 . . . . 74.109999999999999 109.14 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -162.13 -179.17 6.88 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.744 -0.836 . . . . 74.030000000000001 108.744 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -112.19 120.53 42.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.099 -0.704 . . . . 64.140000000000001 109.099 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.06 -150.28 16.73 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 119.713 -1.232 . . . . 63.119999999999997 110.451 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.68 144.32 38.22 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.371 -1.344 . . . . 73.129999999999995 107.371 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 90' ' ' ALA . 12.0 p -79.51 141.52 15.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.199 -1.037 . . . . 64.519999999999996 108.199 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.61 124.8 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.309 0.576 . . . . 75.5 109.984 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.63 112.59 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 105.981 -1.859 . . . . 73.5 105.981 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -124.06 140.33 53.08 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.688 -0.687 . . . . 73.219999999999999 111.286 -172.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -109.73 130.77 55.48 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.175 -0.921 . . . . 74.099999999999994 109.972 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.94 166.35 21.86 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.972 0.415 . . . . 72.109999999999999 110.922 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 45.0 mt-30 -106.62 142.8 35.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.233 -0.894 . . . . 73.400000000000006 109.379 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 114' ' ' LEU . 12.5 p -119.88 136.72 54.39 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 112.777 0.658 . . . . 74.129999999999995 112.777 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -82.93 -40.47 20.09 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.582 0.706 . . . . 55.149999999999999 109.7 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.73 -22.43 43.31 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.135 -0.939 . . . . 73.129999999999995 112.194 -174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 111' ' ' SER . 25.7 tp -114.5 137.37 51.93 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.028 -2.582 . . . . 73.209999999999994 104.028 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -139.55 172.61 12.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.325 -1.35 . . . . 71.129999999999995 111.724 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.6 m -35.83 124.64 0.71 Allowed 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.166 2.187 . . . . 75.109999999999999 113.557 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.64 -22.94 27.4 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.217 -1.153 . . . . 75.239999999999995 110.217 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -112.17 128.23 56.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.416 -0.587 . . . . 74.109999999999999 109.416 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -124.69 149.66 46.97 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.27 -1.011 . . . . 60.039999999999999 108.27 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -136.74 143.12 43.13 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.237 -1.023 . . . . 73.340000000000003 108.237 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.74 142.03 40.97 Favored 'General case' 0 C--N 1.257 -3.451 0 N-CA-C 104.302 -2.481 . . . . 75.140000000000001 104.302 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -156.9 162.36 39.66 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.28 -0.568 . . . . 74.319999999999993 110.225 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.03 119.2 1.68 Allowed Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 110.67 -0.972 . . . . 73.340000000000003 110.67 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.7 m -110.23 144.01 39.54 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.017 -0.734 . . . . 73.219999999999999 109.017 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 59' ' ' PRO . 63.0 t -99.35 112.96 33.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.566 -1.272 . . . . 74.099999999999994 107.566 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -88.35 107.5 16.98 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 107.051 -1.462 . . . . 75.0 107.051 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 C-N-CA 122.087 1.858 . . . . 64.340000000000003 113.273 -174.801 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 114.916 1.45 . . . . 74.530000000000001 114.916 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 -27.83 35.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.016 -1.074 . . . . 75.040000000000006 109.949 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.5 -43.23 80.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.026 -1.472 . . . . 74.439999999999998 107.026 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.51 -49.37 72.77 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.104 -0.953 . . . . 71.019999999999996 109.824 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.94 -52.89 22.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.765 0.826 . . . . 72.310000000000002 111.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.65 -42.67 86.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.127 0.417 . . . . 73.200000000000003 112.127 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.24 -39.96 82.12 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.957 0.725 . . . . 75.209999999999994 112.957 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.58 -26.36 62.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.468 0.651 . . . . 75.510000000000005 109.741 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.75 -45.08 60.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.292 -1.003 . . . . 71.140000000000001 108.292 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.047 -0.524 . . . . 72.349999999999994 111.323 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.47 95.33 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.952 -0.567 . . . . 41.450000000000003 111.124 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.69 -22.99 45.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.412 0.625 . . . . 74.340000000000003 111.398 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.28 -40.34 51.98 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.393 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.41 40.8 2.67 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.693 -0.685 . . . . 72.530000000000001 112.559 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mm -79.81 139.41 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.616 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp0 -118.7 144.0 46.51 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.159 0.984 . . . . 73.209999999999994 108.52 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -81.03 100.99 9.27 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.981 0.896 . . . . 64.540000000000006 110.027 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD21 ' NE2' ' A' ' 99' ' ' GLN . 12.3 tp -118.67 -163.92 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 105.596 -2.001 . . . . 74.310000000000002 105.596 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -41.41 126.03 2.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.799 0.687 . . . . 74.140000000000001 109.97 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.3 50.08 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 114.656 0.622 . . . . 74.239999999999995 114.656 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.4 -23.86 62.83 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.526 -0.469 . . . . 73.239999999999995 111.805 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.48 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 13.9 ptm180 -162.18 128.71 3.67 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.532 0.682 . . . . 75.310000000000002 111.808 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.54 151.81 21.18 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 123.848 0.859 . . . . 74.409999999999997 110.985 -170.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.3 tm? -85.75 118.67 25.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.837 -0.801 . . . . 71.340000000000003 108.837 -174.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.44 165.61 12.33 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 124.137 0.975 . . . . 64.200000000000003 110.118 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 50.8 Cg_exo -57.83 160.8 14.09 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.472 2.782 . . . . 70.549999999999997 113.371 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.459 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.9 p-10 -127.28 -31.94 2.51 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.375 -0.829 . . . . 64.219999999999999 111.079 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -109.07 111.5 23.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.026 -0.731 . . . . 74.310000000000002 109.026 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 50.0 m-85 -106.68 120.17 41.26 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.682 -0.858 . . . . 75.420000000000002 108.682 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.72 115.31 43.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.718 -0.475 . . . . 72.540000000000006 109.718 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.7 mp -112.46 109.94 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 107.194 -1.41 . . . . 72.329999999999998 107.194 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -105.86 122.7 46.64 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.539 -0.541 . . . . 74.510000000000005 109.539 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.41 163.64 13.48 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.376 0.67 . . . . 74.209999999999994 109.753 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.13 53.58 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.096 -1.602 . . . . 74.140000000000001 109.096 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 5.8 p -59.73 -37.46 71.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.792 0.796 . . . . 74.299999999999997 111.859 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 56.2 t-80 -58.96 -41.93 88.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 75.230000000000004 109.798 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.405 ' O ' HD23 ' A' ' 74' ' ' LEU . 5.8 m-20 -75.28 -39.62 59.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.535 -0.757 . . . . 70.129999999999995 111.739 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -57.94 -28.28 64.16 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.103 0.477 . . . . 72.409999999999997 111.095 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 94.1 mt-10 -62.77 -35.24 79.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.144 0.497 . . . . 74.510000000000005 110.215 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 69' ' ' HIS . 45.3 mmtt -85.02 -17.47 37.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.034 -0.728 . . . . 74.120000000000005 109.034 -172.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.461 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 4.5 mm? -69.97 -41.49 74.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.882 -1.054 . . . . 71.310000000000002 109.336 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.81 168.7 13.02 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.312 -0.946 . . . . 74.329999999999998 112.167 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.96 53.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.897 0.379 . . . . 64.219999999999999 111.762 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -112.14 96.0 32.68 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.305 -0.628 . . . . 54.420000000000002 109.305 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.1 -31.56 4.79 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 122.042 1.828 . . . . 71.099999999999994 111.038 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -53.15 42.51 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 115.508 1.67 . . . . 75.219999999999999 115.508 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.51 -15.82 61.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.858 0.754 . . . . 64.310000000000002 111.491 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 74' ' ' LEU . 58.4 mttp -90.79 -44.41 9.45 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.561 -0.745 . . . . 73.510000000000005 109.697 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 p -67.43 -51.22 54.29 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.12 0.568 . . . . 62.100000000000001 110.322 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.4 m -59.69 -41.15 90.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.567 -0.531 . . . . 73.439999999999998 109.567 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.58 52.95 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.563 -0.744 . . . . 62.509999999999998 112.634 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.98 -28.12 65.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 70.219999999999999 110.082 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.66 97.02 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.997 -0.547 . . . . 72.530000000000001 110.439 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' THR . 19.0 mmt85 -64.09 -39.59 94.39 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 111.313 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -44.25 87.83 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.332 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.65 -34.98 79.07 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.34 99.05 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.422 0.63 . . . . 72.519999999999996 110.108 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.49 -40.78 80.77 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.107 -0.951 . . . . 54.140000000000001 109.353 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -55.86 -50.75 69.77 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.472 1.109 . . . . 74.230000000000004 111.369 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.45 -35.82 75.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.756 -0.377 . . . . 74.430000000000007 111.142 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.31 -40.93 96.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 75.219999999999999 109.76 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -62.67 -29.54 70.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.333 -0.849 . . . . 44.340000000000003 112.338 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -85.87 1.47 49.72 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.645 -0.707 . . . . 72.340000000000003 111.223 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 27.25 52.65 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 121.07 -0.586 . . . . 45.32 112.261 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.83 167.64 10.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.419 -0.46 . . . . 70.140000000000001 110.065 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.48 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.4 pt20 -143.34 167.24 22.64 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.287 -1.005 . . . . 71.409999999999997 108.287 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.8 t -150.01 -177.33 5.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.718 -0.475 . . . . 73.120000000000005 109.718 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.98 120.09 38.0 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.905 -0.406 . . . . 73.430000000000007 109.905 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -155.33 16.35 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 119.718 -1.23 . . . . 62.310000000000002 111.787 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -103.84 137.1 42.32 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.988 -1.486 . . . . 73.239999999999995 106.988 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.21 124.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.776 -0.824 . . . . 74.420000000000002 108.776 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.05 130.13 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 CA-C-O 121.642 0.734 . . . . 62.32 110.941 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 62' ' ' TYR . 34.7 m -104.43 127.42 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 N-CA-C 106.249 -1.76 . . . . 73.319999999999993 106.249 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -105.78 126.61 52.36 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.838 -0.619 . . . . 74.530000000000001 109.95 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -113.59 114.26 26.21 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.243 -1.392 . . . . 74.439999999999998 107.243 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.87 166.79 23.7 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.377 -0.374 . . . . 75.420000000000002 111.042 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -99.24 160.87 13.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.091 0.948 . . . . 74.450000000000003 112.171 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -149.48 115.67 5.75 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 113.559 -1.655 . . . . 64.030000000000001 107.819 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -81.03 -2.81 49.53 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.881 0.848 . . . . 61.340000000000003 109.559 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.68 -38.47 19.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.631 -1.168 . . . . 74.349999999999994 108.364 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.02 161.8 30.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.542 -0.91 . . . . 73.340000000000003 108.542 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -87.55 154.3 20.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.055 0.455 . . . . 73.209999999999994 110.055 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 m -62.23 132.48 52.87 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 124.354 1.062 . . . . 74.319999999999993 109.489 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 28.96 60.83 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.536 -0.364 . . . . 65.430000000000007 112.417 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -137.07 149.39 47.36 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.024 -1.102 . . . . 75.540000000000006 108.024 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -139.37 156.66 46.86 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.668 -0.413 . . . . 72.420000000000002 110.966 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 36.5 mmt180 -123.63 131.16 53.55 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.384 -0.969 . . . . 72.430000000000007 108.384 174.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.58 120.57 24.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.41 -0.589 . . . . 72.430000000000007 109.41 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -135.38 138.36 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.362 -0.381 . . . . 74.120000000000005 110.4 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -105.44 109.81 3.31 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.79 -0.924 . . . . 73.310000000000002 110.79 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.3 m -109.92 143.16 40.26 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.526 0.679 . . . . 70.540000000000006 110.603 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.54 110.35 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.175 -1.787 . . . . 75.239999999999995 106.175 171.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -102.16 104.42 36.55 Favored Pre-proline 0 C--N 1.281 -2.386 0 N-CA-C 108.087 -1.079 . . . . 74.310000000000002 108.087 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.295 1.996 . . . . 71.409999999999997 110.447 179.586 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--O 1.218 -0.594 0 N-CA-C 112.101 0.408 . . . . 72.340000000000003 112.101 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.34 -55.11 39.17 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.214 -0.661 . . . . 74.219999999999999 109.214 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.67 -42.67 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.113 -0.948 . . . . 75.239999999999995 109.503 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 42.3 mt-10 -56.77 -54.75 42.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 72.5 111.891 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.13 81.75 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.335 0.254 . . . . 65.140000000000001 111.558 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.96 -45.73 92.38 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.994 -0.743 . . . . 75.430000000000007 108.994 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.93 -29.14 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.043 0.757 . . . . 73.409999999999997 113.043 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 67.2 mtt180 -63.92 -41.53 97.62 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.002 -1.11 . . . . 74.400000000000006 108.002 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.32 -47.65 81.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.93 -1.032 . . . . 72.109999999999999 110.931 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -59.43 -42.55 92.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.134 0.574 . . . . 74.319999999999993 110.482 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.17 82.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 72.420000000000002 110.949 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.5 -29.02 63.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 71.450000000000003 111.981 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.49 -36.72 32.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.518 -0.31 . . . . 74.019999999999996 110.567 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.69 18.92 27.49 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.13 -0.487 . . . . 75.120000000000005 113.652 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -68.83 133.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 123.364 0.666 . . . . 74.519999999999996 110.725 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' OE1' HD21 ' A' ' 57' ' ' LEU . 94.3 mt-30 -107.03 147.96 29.3 Favored 'General case' 0 CA--C 1.473 -1.994 0 N-CA-C 109.061 -0.718 . . . . 73.200000000000003 109.061 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -86.38 91.62 8.57 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.011 -1.107 . . . . 72.349999999999994 108.011 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.9 tp -98.9 -165.55 1.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.825 -1.546 . . . . 73.25 106.825 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.586 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.5 mt-30 -44.6 148.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.685 1.194 . . . . 75.319999999999993 111.449 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.87 -15.95 56.04 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.731 -0.668 . . . . 75.409999999999997 113.185 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -61.6 -48.67 79.88 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.791 -0.448 . . . . 75.450000000000003 109.791 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -168.51 149.27 4.73 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.924 -0.58 . . . . 62.450000000000003 111.242 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.04 151.72 20.92 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.047 0.939 . . . . 73.510000000000005 110.594 -173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD21 ' OE1' ' A' ' 49' ' ' GLN . 15.7 tp -89.9 127.68 36.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.844 -0.616 . . . . 75.549999999999997 109.603 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.68 158.0 40.05 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 123.381 0.672 . . . . 61.240000000000002 109.275 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 34.9 Cg_exo -62.93 148.34 93.57 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.62 2.214 . . . . 60.299999999999997 111.611 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 33.9 p-10 -120.77 -28.41 4.87 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.81 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.68 124.61 50.25 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.436 -0.95 . . . . 72.129999999999995 108.436 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 45.3 m-85 -121.38 127.69 51.47 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.873 -0.417 . . . . 74.209999999999994 109.873 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 120.13 63.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.943 -0.762 . . . . 71.340000000000003 108.943 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.54 123.67 68.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.928 -0.767 . . . . 74.230000000000004 108.928 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 m -104.28 124.89 49.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.579 -0.282 . . . . 74.329999999999998 110.39 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.0 165.47 12.85 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.408 0.683 . . . . 73.450000000000003 110.168 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.25 145.23 31.73 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.934 -1.667 . . . . 74.540000000000006 108.934 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.29 -43.04 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 113.937 1.088 . . . . 75.239999999999995 113.937 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -64.73 -36.61 84.84 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.138 0.494 . . . . 75.510000000000005 111.445 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.33 -23.47 26.23 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.639 -0.824 . . . . 64.420000000000002 110.082 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.13 -30.87 71.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.096 -0.705 . . . . 75.230000000000004 109.096 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.46 -33.76 68.3 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.036 -0.529 . . . . 75.010000000000005 110.44 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -74.57 -39.16 62.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.598 -0.89 . . . . 71.319999999999993 108.598 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.41 -37.34 85.43 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.658 0.742 . . . . 72.040000000000006 109.083 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.2 -171.29 13.62 Favored Glycine 0 N--CA 1.414 -2.822 0 CA-C-N 114.615 -1.175 . . . . 73.540000000000006 110.813 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -93.58 -5.81 48.03 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.671 0.272 . . . . 64.310000000000002 110.334 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -89.6 111.18 44.35 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 115.702 -0.681 . . . . 71.450000000000003 112.422 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 5.8 Cg_exo -77.94 -51.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.308 2.005 . . . . 73.409999999999997 113.029 172.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -86.54 -39.36 16.29 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 118.476 2.769 . . . . 75.209999999999994 118.476 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.98 -52.47 65.24 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.419 1.009 . . . . 70.450000000000003 113.057 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -63.91 -32.13 73.56 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 122.692 1.234 . . . . 72.519999999999996 110.742 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -75.8 -17.3 59.91 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.101 -1.409 . . . . 51.219999999999999 112.022 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 m -69.44 -41.87 75.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.372 -0.603 . . . . 71.019999999999996 109.372 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.97 -36.14 61.07 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.9 -0.88 . . . . 74.409999999999997 110.9 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -65.03 -46.51 81.01 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.22 0.533 . . . . 74.329999999999998 109.795 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.85 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.042 -0.526 . . . . 63.32 111.286 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -59.17 -45.02 92.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 75.430000000000007 109.834 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.47 -43.72 89.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.982 -1.008 . . . . 63.039999999999999 110.187 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.82 -39.22 90.66 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 115.718 -0.673 . . . . 74.430000000000007 109.828 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.1 91.41 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.39 0.614 . . . . 73.430000000000007 110.462 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -41.03 83.36 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.473 -0.785 . . . . 73.120000000000005 110.009 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 m-85 -56.31 -53.54 56.1 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.622 -0.717 . . . . 71.340000000000003 112.077 175.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.0 pt -62.88 -35.69 72.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 120.797 -0.361 . . . . 74.120000000000005 111.863 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.73 -37.19 81.85 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 121.135 -0.226 . . . . 75.450000000000003 110.793 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.7 -28.31 69.81 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.41 0.624 . . . . 74.219999999999999 110.483 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 60.2 mm-40 -88.33 -4.68 58.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.985 -0.552 . . . . 74.540000000000006 111.162 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.04 26.94 59.18 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.857 -0.61 . . . . 71.099999999999994 112.416 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -98.44 161.41 13.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.929 -0.767 . . . . 75.230000000000004 108.929 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -129.72 174.61 9.54 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 110.068 -0.345 . . . . 75.439999999999998 110.068 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.5 t -165.15 170.4 14.99 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 105.409 -2.071 . . . . 72.549999999999997 105.409 175.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.08 118.01 33.73 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.092 -1.447 . . . . 72.140000000000001 107.092 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.78 -149.49 16.72 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 119.218 -1.468 . . . . 75.329999999999998 109.885 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -132.28 163.48 28.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.662 -1.236 . . . . 74.129999999999995 107.662 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.66 131.99 33.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.255 0.55 . . . . 74.340000000000003 112.177 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.95 120.52 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-N 115.233 -0.894 . . . . 64.319999999999993 109.294 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 62' ' ' TYR . 4.3 m -112.25 143.36 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 107.071 -1.455 . . . . 75.340000000000003 107.071 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -142.45 150.67 40.87 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.71 0.29 . . . . 74.109999999999999 110.809 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.0 151.14 23.56 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.503 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.71 166.58 24.36 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 63.329999999999998 107.94 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.26 152.57 38.73 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.685 -0.487 . . . . 75.409999999999997 109.685 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.7 m -134.02 138.84 45.64 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 115.902 -0.59 . . . . 65.0 109.669 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 t -80.53 -23.63 39.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.801 -0.814 . . . . 63.439999999999998 108.801 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -82.18 -5.17 58.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.859 -0.61 . . . . 71.299999999999997 111.529 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.3 148.28 29.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.412 -1.329 . . . . 75.150000000000006 107.412 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -119.07 156.7 29.24 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.826 -0.749 . . . . 62.420000000000002 111.055 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 m -49.2 121.14 4.57 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 126.248 1.819 . . . . 73.430000000000007 111.528 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.96 -30.78 6.9 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.832 -0.907 . . . . 71.219999999999999 110.832 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.77 131.1 39.47 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.223 -0.658 . . . . 71.230000000000004 109.223 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 150.75 42.38 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.649 -0.871 . . . . 73.239999999999995 108.649 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -140.65 147.23 38.99 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.24 -0.652 . . . . 72.209999999999994 109.24 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.77 139.84 31.17 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.003 -0.369 . . . . 73.310000000000002 110.003 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -132.66 149.55 52.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.061 -0.518 . . . . 75.120000000000005 109.762 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.29 123.07 5.53 Favored Glycine 0 C--N 1.282 -2.44 0 N-CA-C 109.656 -1.378 . . . . 73.120000000000005 109.656 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.4 m -121.01 150.85 40.51 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.701 -0.852 . . . . 71.329999999999998 108.701 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 59' ' ' PRO . 46.6 t -98.58 118.09 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.411 -0.959 . . . . 73.299999999999997 108.411 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.08 101.97 7.36 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.124 -1.436 . . . . 64.549999999999997 107.124 171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.456 -0.706 0 C-N-CA 122.09 1.86 . . . . 61.43 112.161 -175.875 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 110.53 -0.174 . . . . 73.439999999999998 110.53 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -58.53 -34.74 71.31 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.917 0.389 . . . . 75.319999999999993 111.043 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.57 -56.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.697 -0.683 . . . . 65.299999999999997 110.034 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.45 -25.47 64.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.18 -0.608 . . . . 63.439999999999998 111.901 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.02 94.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.202 0.525 . . . . 73.129999999999995 109.713 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.15 -37.92 66.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 120.045 -0.662 . . . . 64.140000000000001 109.938 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.28 0.474 . . . . 75.319999999999993 112.28 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -63.68 -29.96 71.13 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.961 0.41 . . . . 75.120000000000005 110.341 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 -69.13 -51.76 35.08 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.446 -0.343 . . . . 73.310000000000002 110.512 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -64.76 -30.87 71.89 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.344 0.403 . . . . 71.430000000000007 110.679 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.74 88.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.131 -0.486 . . . . 64.430000000000007 109.887 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.9 61.78 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.818 0.818 . . . . 71.219999999999999 110.787 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.93 -24.91 48.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.268 -0.878 . . . . 74.340000000000003 110.791 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.65 17.01 54.2 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.87 -0.605 . . . . 42.32 112.826 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.2 mm -67.5 131.55 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.059 0.457 . . . . 75.109999999999999 110.943 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -127.91 144.34 51.1 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.654 -0.703 . . . . 64.209999999999994 110.342 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 m -66.76 130.11 42.08 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.512 -1.222 . . . . 74.439999999999998 110.906 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.8 tp -149.12 -166.21 2.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 104.027 -2.583 . . . . 72.319999999999993 104.027 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.447 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 84.6 mm-40 -60.26 155.83 16.83 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.586 0.958 . . . . 71.450000000000003 113.586 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.71 -5.31 44.61 Favored Glycine 0 CA--C 1.507 -0.407 0 CA-C-N 114.991 -1.004 . . . . 64.049999999999997 114.678 -170.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -42.79 51.38 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.29 -0.633 . . . . 74.420000000000002 109.29 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HD3' ' HB3' ' A' ' 99' ' ' GLN . 13.2 ptp180 -165.06 140.69 5.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 112.501 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.89 152.48 20.72 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.117 1.367 . . . . 74.530000000000001 110.282 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.07 127.45 32.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.447 -0.575 . . . . 71.530000000000001 109.447 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -122.26 164.46 25.77 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 123.575 0.75 . . . . 73.519999999999996 109.419 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.04 156.96 46.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.178 2.585 . . . . 73.540000000000006 113.525 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.7 p-10 -128.02 -30.12 2.49 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.342 -0.844 . . . . 63.149999999999999 110.739 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.06 117.55 32.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.165 -1.05 . . . . 71.030000000000001 108.165 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.82 114.14 22.19 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.46 0.648 . . . . 73.239999999999995 110.231 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.11 111.9 37.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.97 -1.014 . . . . 75.030000000000001 108.944 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.97 119.52 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.728 -0.842 . . . . 74.299999999999997 108.728 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 126.58 53.27 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 109.582 -0.525 . . . . 74.109999999999999 109.582 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.45 165.82 16.43 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 122.915 0.486 . . . . 74.510000000000005 110.642 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.08 146.68 50.44 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.734 -1.747 . . . . 62.530000000000001 108.734 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -46.2 -54.96 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.606 0.965 . . . . 75.519999999999996 113.606 -173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -69.06 -29.94 68.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.436 0.532 . . . . 72.25 112.436 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.25 -40.84 62.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.513 -1.291 . . . . 70.209999999999994 107.513 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.03 -34.27 77.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.216 -1.356 . . . . 65.129999999999995 111.891 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -53.79 -37.75 63.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.22 0.533 . . . . 72.239999999999995 111.134 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -85.41 -29.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.664 -0.698 . . . . 73.049999999999997 110.413 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 mt -71.91 -36.79 70.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.367 0.603 . . . . 72.430000000000007 109.962 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.49 12.54 26.74 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.256 -0.884 . . . . 71.019999999999996 112.557 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.32 -10.36 54.61 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.327 -0.62 . . . . 73.319999999999993 109.327 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -139.48 72.48 37.21 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.074 -0.512 . . . . 61.25 111.739 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.69 -28.03 31.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 N-CA-C 108.383 -1.429 . . . . 75.129999999999995 108.383 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.38 -53.67 54.88 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.28 -1.782 . . . . 74.310000000000002 111.343 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.95 -42.88 12.81 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.087 0.773 . . . . 73.349999999999994 113.087 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -76.56 -58.86 3.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.109 0.781 . . . . 73.430000000000007 113.109 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -63.29 -48.52 77.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.854 0.359 . . . . 72.400000000000006 110.998 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -64.87 -44.46 89.62 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 111.256 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -56.49 20.41 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 115.773 -0.649 . . . . 65.129999999999995 112.625 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.27 -32.42 72.24 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 112.301 0.482 . . . . 72.109999999999999 112.301 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.27 86.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 74.319999999999993 111.229 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.564 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -82.1 -25.73 34.22 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.204 0.446 . . . . 75.319999999999993 112.204 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.64 -43.85 65.39 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.486 -0.931 . . . . 65.420000000000002 108.486 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 92' ' ' TYR . 1.2 tm? -67.7 -31.79 71.99 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.769 -0.826 . . . . 74.329999999999998 108.769 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.93 -40.08 94.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 72.120000000000005 110.779 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 29.1 t70 -74.33 -32.87 62.98 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.303 -0.629 . . . . 71.420000000000002 109.303 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.39 -57.6 11.61 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.438 -0.801 . . . . 73.230000000000004 110.191 173.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.3 pt -56.5 -30.08 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 120.995 -0.282 . . . . 72.530000000000001 111.198 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mm-40 -64.75 -45.43 86.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.842 -0.343 . . . . 74.420000000000002 110.926 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 50.3 mt-10 -59.79 -42.55 93.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.711 0.804 . . . . 70.430000000000007 111.895 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -80.64 -13.27 59.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 113.885 1.068 . . . . 74.349999999999994 113.885 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.71 39.41 9.6 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.597 -1.287 . . . . 63.5 112.52 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -112.12 174.45 5.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.519 -0.401 . . . . 73.430000000000007 110.272 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 26.7 pt20 -149.07 171.23 16.74 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.191 0.596 . . . . 72.519999999999996 109.611 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 13.4 t -159.49 178.36 9.97 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.338 -0.986 . . . . 70.420000000000002 108.338 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -101.45 118.62 37.33 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.392 -0.966 . . . . 74.439999999999998 108.392 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.79 -149.46 16.6 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 119.296 -1.431 . . . . 75.310000000000002 111.055 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -118.99 150.57 39.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.878 -1.527 . . . . 74.129999999999995 106.878 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.6 128.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.478 -0.564 . . . . 74.430000000000007 109.478 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.73 149.65 26.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 123.627 0.579 . . . . 74.549999999999997 110.039 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.96 113.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.252 0.549 . . . . 65.219999999999999 110.181 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -119.97 139.66 52.12 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.9 -0.591 . . . . 75.299999999999997 110.285 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.25 143.82 42.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.356 -0.609 . . . . 72.420000000000002 109.356 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.28 171.49 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.886 0.374 . . . . 71.200000000000003 111.653 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.88 159.54 15.56 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.785 -0.643 . . . . 72.239999999999995 110.875 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.2 p -143.74 141.78 30.63 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.496 -0.775 . . . . 75.239999999999995 109.229 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -81.36 -26.77 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.272 0.558 . . . . 75.230000000000004 110.809 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -77.86 -30.39 50.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.655 -0.702 . . . . 72.129999999999995 111.991 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.72 150.7 26.57 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.904 -0.718 . . . . 74.230000000000004 111.518 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 118' ' ' GLN . 84.8 m-70 -97.1 173.54 7.2 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.939 -1.028 . . . . 73.019999999999996 110.606 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 130.58 42.12 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.239 -1.393 . . . . 75.430000000000007 107.239 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.87 -3.87 82.04 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.805 -0.712 . . . . 73.230000000000004 111.903 -174.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 5.2 tp-100 -101.54 119.8 39.32 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.088 -1.449 . . . . 74.510000000000005 107.088 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.9 157.15 46.16 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.69 -0.804 . . . . 75.200000000000003 112.106 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -145.38 143.31 30.04 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.439 -1.255 . . . . 75.349999999999994 107.81 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.56 139.12 45.15 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 105.511 -2.033 . . . . 75.129999999999995 105.511 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -129.25 127.49 41.33 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.99 -0.684 . . . . 73.140000000000001 109.999 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.33 117.47 5.87 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.297 -1.521 . . . . 61.43 109.297 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 90.4 m -121.16 145.82 47.42 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 122.767 0.427 . . . . 74.409999999999997 110.019 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.52 110.07 22.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -108.45 104.12 53.12 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 109.693 -0.484 . . . . 75.120000000000005 109.693 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 C-N-CA 122.38 2.054 . . . . 75.439999999999998 110.893 176.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 120.339 0.114 . . . . 75.5 111.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -60.02 -44.1 94.83 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.98 0.895 . . . . 75.519999999999996 109.198 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.5 t -63.18 -55.87 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.772 -1.558 . . . . 70.200000000000003 110.74 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 pt-20 -64.44 -34.01 77.2 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.391 -0.523 . . . . 75.219999999999999 111.735 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.3 91.01 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.919 -0.401 . . . . 62.520000000000003 109.919 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.96 -38.46 72.8 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.304 -0.407 . . . . 74.409999999999997 110.444 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.9 mt -60.34 -47.65 85.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.908 0.336 . . . . 75.109999999999999 111.908 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.2 ptm180 -71.58 -30.62 66.04 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 120.552 -0.459 . . . . 75.230000000000004 111.034 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -68.13 -41.43 81.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 74.219999999999999 109.269 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -64.51 -43.94 92.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.081 -0.963 . . . . 74.219999999999999 109.024 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.75 76.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 65.340000000000003 110.654 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.42 71.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 62.25 112.64 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.39 -13.54 24.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.969 -1.092 . . . . 74.439999999999998 110.661 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.16 3.42 76.49 Favored Glycine 0 CA--C 1.502 -0.749 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.86 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 56' ' ' LEU . 20.4 mm -55.55 127.67 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 C-N-CA 124.39 1.076 . . . . 73.230000000000004 111.028 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 35.2 tt0 -105.45 135.89 46.01 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.449 -1.315 . . . . 73.329999999999998 107.449 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -70.19 122.25 19.12 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.318 -1.364 . . . . 75.019999999999996 107.318 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.1 tp -127.02 -165.59 1.48 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 105.98 -1.859 . . . . 71.329999999999998 105.98 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.532 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.1 mt-30 -53.29 160.37 1.14 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.056 0.543 . . . . 70.349999999999994 111.733 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.77 -10.91 47.65 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 116.124 -0.489 . . . . 72.140000000000001 113.233 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.45 -44.58 74.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.498 -0.186 . . . . 64.099999999999994 110.498 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -171.89 166.59 6.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 113.066 0.765 . . . . 75.329999999999998 113.066 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HB3' HG23 ' A' ' 48' ' ' ILE . 76.8 mt -93.94 151.92 19.21 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 125.17 1.388 . . . . 73.409999999999997 111.401 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 31.0 tp -98.94 130.96 45.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.554 -0.906 . . . . 74.5 108.554 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 156.28 44.67 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 123.539 0.525 . . . . 74.030000000000001 110.424 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.47 154.87 61.42 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.95 2.434 . . . . 74.409999999999997 112.229 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -128.34 -28.09 2.6 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 112.131 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.7 119.15 35.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 120.067 -0.653 . . . . 73.209999999999994 109.703 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -120.14 114.26 21.69 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.406 0.622 . . . . 71.019999999999996 109.792 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.2 mt -102.2 107.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.985 -1.117 . . . . 73.049999999999997 107.985 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.3 mt -102.02 115.28 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.054 -1.091 . . . . 72.150000000000006 108.054 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 16.9 m -109.06 121.83 45.99 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 115.927 -0.579 . . . . 75.219999999999999 110.152 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.03 174.75 5.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.851 1.26 . . . . 72.109999999999999 109.986 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.67 164.9 50.92 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 108.762 -1.735 . . . . 71.219999999999999 108.762 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.26 -33.12 61.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 118.316 1.058 . . . . 72.329999999999998 111.483 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.547 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 41.9 t60 -75.85 -28.5 58.23 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 120.449 -0.501 . . . . 73.239999999999995 109.729 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 33.0 m-20 -75.29 -31.96 60.86 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.145 -0.687 . . . . 74.219999999999999 109.145 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 78' ' ' PRO . 73.2 t80 -62.25 -44.49 96.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.338 -0.846 . . . . 74.230000000000004 110.734 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.57 -30.58 69.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.316 0.579 . . . . 73.25 110.771 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 74.3 mmtt -73.14 -24.27 60.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.408 -0.814 . . . . 73.530000000000001 110.647 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 98.4 mt -68.26 -31.62 71.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.056 -1.09 . . . . 74.430000000000007 108.056 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.56 179.76 19.65 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.231 -0.895 . . . . 62.200000000000003 111.621 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.32 -17.27 46.35 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.274 -1.009 . . . . 52.420000000000002 108.274 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -128.98 75.16 80.64 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.902 -1.045 . . . . 75.120000000000005 108.399 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.457 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 23.4 Cg_exo -69.15 -36.37 12.55 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.263 1.975 . . . . 73.530000000000001 111.836 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.511 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 2.8 tp10 -69.35 -12.16 61.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.649 -0.705 . . . . 73.230000000000004 110.631 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.56 -36.66 73.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.016 -0.538 . . . . 72.420000000000002 109.839 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -84.89 -13.18 51.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.912 -0.315 . . . . 72.109999999999999 111.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 19.9 m -61.1 -40.96 95.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 65.140000000000001 110.453 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -67.86 -29.09 68.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.785 -0.643 . . . . 73.239999999999995 110.007 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.3 91.89 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.425 -1.07 . . . . 61.439999999999998 110.425 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -68.65 -32.43 72.27 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 111.688 0.255 . . . . 70.129999999999995 111.688 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.69 -44.78 96.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 110.333 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -67.79 -44.15 78.07 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.528 -0.76 . . . . 64.329999999999998 110.625 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.77 -38.07 89.75 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.302 -0.408 . . . . 70.420000000000002 111.237 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.3 -41.79 72.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.439 -0.578 . . . . 75.129999999999995 109.439 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.63 90.68 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.439 0.638 . . . . 73.409999999999997 109.468 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.86 -53.62 55.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.481 -1.236 . . . . 74.219999999999999 108.779 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.627 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.5 m-85 -51.06 -55.37 17.89 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.924 0.713 . . . . 73.430000000000007 112.924 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -62.16 -37.22 77.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 112.618 0.599 . . . . 72.450000000000003 112.618 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -71.74 -35.25 70.08 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.904 -0.319 . . . . 74.409999999999997 111.024 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.87 -31.98 73.46 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.261 0.553 . . . . 74.329999999999998 111.235 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.0 mm-40 -79.45 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.024 -0.534 . . . . 73.319999999999993 110.969 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.46 21.28 32.4 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.218 -0.515 . . . . 72.25 112.033 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -102.99 172.1 7.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.747 -0.834 . . . . 75.019999999999996 108.747 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -140.74 173.91 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.143 -0.688 . . . . 70.439999999999998 109.143 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.403 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 9.3 t -148.98 171.28 16.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.609 -0.886 . . . . 75.230000000000004 108.609 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.43 121.05 42.37 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 109.476 -0.565 . . . . 73.010000000000005 109.476 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -150.06 17.05 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 109.516 -1.434 . . . . 73.230000000000004 109.516 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -119.42 143.48 47.46 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.915 -1.143 . . . . 73.040000000000006 107.915 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.9 t -74.66 118.12 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.173 -0.677 . . . . 75.510000000000005 109.173 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.8 120.23 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-O 122.131 0.967 . . . . 75.340000000000003 110.305 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.9 t -115.33 137.47 48.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 106.297 -1.742 . . . . 74.150000000000006 106.297 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -141.18 139.31 33.84 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.47 0.481 . . . . 74.5 111.859 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -108.72 114.23 27.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 74.129999999999995 108.588 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.1 pt-20 -135.61 165.5 25.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.743 -0.208 . . . . 74.340000000000003 110.793 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.18 165.59 10.93 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 114.612 1.338 . . . . 72.310000000000002 114.612 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -134.22 141.69 47.12 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.541 -1.651 . . . . 71.019999999999996 106.541 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -80.7 -16.66 53.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.516 0.674 . . . . 74.430000000000007 110.295 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -83.49 -30.44 27.17 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 64.319999999999993 110.554 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.22 133.06 37.78 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.915 -0.584 . . . . 73.530000000000001 110.948 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.52 159.52 14.87 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.452 -0.794 . . . . 75.239999999999995 109.012 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.446 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 8.1 m -52.4 117.85 3.14 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 124.409 1.068 . . . . 74.230000000000004 111.863 -176.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.75 -1.84 28.93 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.938 -0.649 . . . . 74.209999999999994 112.842 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.21 123.87 50.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.925 0.393 . . . . 73.219999999999999 111.29 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -131.18 150.75 52.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.861 -0.792 . . . . 70.510000000000005 108.861 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -142.22 132.74 25.22 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.754 -0.832 . . . . 73.340000000000003 108.754 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.04 122.72 41.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.709 -0.848 . . . . 73.219999999999999 108.709 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.8 tpm_? -111.93 121.54 45.3 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.886 -0.783 . . . . 62.32 108.886 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -110.74 130.01 9.59 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 110.98 -0.848 . . . . 64.329999999999998 110.98 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.9 t -135.9 163.29 30.58 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.601 -0.518 . . . . 64.349999999999994 109.601 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.15 107.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.773 -0.825 . . . . 74.129999999999995 108.773 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -116.39 99.68 52.91 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 109.649 -0.501 . . . . 75.310000000000002 109.649 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.699 2.266 . . . . 63.130000000000003 112.429 -178.549 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 C--O 1.217 -0.648 0 CA-C-O 120.371 0.129 . . . . 75.5 111.18 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.24 -34.13 74.32 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.457 -0.942 . . . . 63.350000000000001 108.457 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.8 t -68.06 -48.05 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.623 -1.171 . . . . 75.319999999999993 109.96 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -66.33 -33.79 76.52 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.375 -0.53 . . . . 75.549999999999997 110.934 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.73 82.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.566 -0.531 . . . . 61.0 109.566 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.16 -32.94 74.68 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.31 -0.859 . . . . 74.099999999999994 111.844 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 80.9 mt -69.74 -38.44 76.83 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.06 0.225 . . . . 73.519999999999996 111.19 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 74.9 mtm180 -62.68 -43.23 99.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.538 -0.912 . . . . 73.040000000000006 108.538 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -40.66 90.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.0 -1.0 . . . . 75.409999999999997 111.698 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -60.47 -46.47 89.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.425 0.69 . . . . 61.229999999999997 109.845 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.36 92.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.482 -0.781 . . . . 73.349999999999994 110.83 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.35 68.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 62.219999999999999 111.888 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.03 -35.87 31.32 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.11 -0.369 . . . . 73.219999999999999 111.121 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.99 13.73 52.69 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.814 -0.63 . . . . 62.149999999999999 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 mm -55.88 137.03 17.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 123.43 0.692 . . . . 75.099999999999994 111.978 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.0 tt0 -119.56 132.97 55.86 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.25 -1.389 . . . . 72.030000000000001 107.25 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -66.51 134.89 53.34 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 121.684 0.754 . . . . 74.219999999999999 109.992 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.2 tp -149.7 -165.53 2.3 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 103.096 -2.928 . . . . 75.319999999999993 103.096 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 76.5 mt-30 -54.52 146.36 16.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.083 0.856 . . . . 74.239999999999995 109.506 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.87 -12.92 58.41 Favored Glycine 0 C--O 1.237 0.333 0 CA-C-N 116.773 -0.194 . . . . 72.319999999999993 113.114 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.85 -40.02 93.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.208 -0.664 . . . . 72.310000000000002 109.208 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -167.94 132.83 1.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.416 -0.811 . . . . 73.540000000000006 110.885 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.76 152.17 20.91 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 124.692 1.197 . . . . 73.140000000000001 109.641 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.84 122.14 31.93 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.482 -1.303 . . . . 73.530000000000001 107.482 -174.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.3 160.16 26.98 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.33 -0.619 . . . . 72.430000000000007 109.33 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.66 151.08 72.62 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 111.049 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.45 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 5.3 p-10 -123.24 -27.59 4.12 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.415 -0.514 . . . . 72.319999999999993 111.46 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -106.03 110.91 23.33 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.098 -1.075 . . . . 74.349999999999994 108.098 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.91 131.73 54.8 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.225 -0.443 . . . . 74.099999999999994 109.892 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -121.84 111.73 32.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.613 -0.514 . . . . 74.329999999999998 109.613 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.17 109.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.978 -1.489 . . . . 74.209999999999994 106.978 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -112.94 126.48 55.53 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.088 -0.708 . . . . 73.099999999999994 109.088 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.22 156.14 18.39 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.377 -0.972 . . . . 74.5 108.377 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.64 146.73 50.53 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 109.323 -1.511 . . . . 74.230000000000004 109.323 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.47 HG22 ' NE2' ' A' ' 110' ' ' GLN . 3.3 p -53.83 -40.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 112.516 0.562 . . . . 75.219999999999999 112.516 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.504 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 23.9 t60 -62.17 -33.37 74.38 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 123.336 0.654 . . . . 70.450000000000003 111.004 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.51 -44.33 12.79 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.619 0.247 . . . . 73.439999999999998 111.011 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -66.28 -34.89 79.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 111.957 0.355 . . . . 73.230000000000004 111.957 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.9 pt-20 -63.45 -31.87 73.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.187 0.518 . . . . 74.409999999999997 110.671 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 46.3 mmtm -73.52 -28.1 61.72 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.603 -0.726 . . . . 74.519999999999996 109.869 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.43 -39.11 71.25 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.996 -0.742 . . . . 73.530000000000001 108.996 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.85 175.02 15.59 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.217 -0.753 . . . . 75.219999999999999 111.217 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -94.62 1.25 55.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.712 0.291 . . . . 71.329999999999998 111.236 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.9 95.65 8.07 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.852 1.056 . . . . 71.239999999999995 113.852 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.3 Cg_exo -76.8 -43.78 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.886 2.391 . . . . 64.140000000000001 112.116 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.687 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 44.5 tt0 -63.88 -29.98 71.12 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.016 0.747 . . . . 74.340000000000003 113.016 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.65 -24.23 67.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.974 -0.557 . . . . 73.239999999999995 110.456 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -99.88 -36.75 9.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 111.411 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.687 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 23.2 p -66.32 -45.39 80.44 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.375 0.509 . . . . 75.030000000000001 112.375 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.9 m -67.31 -39.85 85.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.522 -0.471 . . . . 74.019999999999996 110.925 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.0 -51.29 52.49 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.956 -0.566 . . . . 74.319999999999993 111.774 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.92 -30.66 70.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.635 0.605 . . . . 74.109999999999999 112.635 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.447 ' HB3' HG13 ' A' ' 106' ' ' VAL . . . -65.47 -48.05 73.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 120.907 0.384 . . . . 75.219999999999999 110.151 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -67.54 -38.02 83.56 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.56 -0.746 . . . . 72.420000000000002 109.822 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.57 -47.07 80.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.498 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.1 tp -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 65.510000000000005 110.832 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.19 93.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.108 -0.701 . . . . 61.229999999999997 109.108 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.3 t70 -62.59 -44.46 96.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.167 -0.924 . . . . 72.299999999999997 109.636 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.551 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -55.23 -54.25 45.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.786 0.679 . . . . 70.219999999999999 112.42 175.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -62.35 -32.95 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.163 0.506 . . . . 70.409999999999997 111.213 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -64.93 -41.89 95.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.699 -0.682 . . . . 75.340000000000003 110.723 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.0 mt-10 -62.99 -39.19 94.0 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.293 0.568 . . . . 71.150000000000006 111.032 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 76.9 mm-40 -73.57 -14.24 61.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.321 -0.854 . . . . 65.420000000000002 112.336 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 38.21 13.48 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.217 -0.992 . . . . 74.400000000000006 110.972 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -115.18 -178.95 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.271 -0.641 . . . . 74.409999999999997 109.271 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -157.21 178.34 10.45 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.771 -0.825 . . . . 74.420000000000002 108.771 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 11.2 t -156.7 173.57 16.76 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.538 -0.912 . . . . 71.530000000000001 108.538 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.0 m-85 -115.93 124.02 49.54 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 109.306 -0.628 . . . . 74.200000000000003 109.306 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -149.45 18.18 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.115 -1.194 . . . . 71.219999999999999 110.115 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.32 142.74 44.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.749 -0.834 . . . . 74.209999999999994 108.749 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.04 104.0 11.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.296 -1.372 . . . . 74.340000000000003 107.296 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 p -125.84 120.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.733 0.778 . . . . 75.010000000000005 110.434 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 86' ' ' ALA . 7.3 p -110.91 127.87 67.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.108 -1.071 . . . . 64.109999999999999 108.108 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -106.22 132.74 51.92 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.361 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -115.26 114.29 25.0 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.265 -2.124 . . . . 72.140000000000001 105.265 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.02 173.24 12.63 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.239 0.542 . . . . 72.129999999999995 111.893 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.47 ' NE2' HG22 ' A' ' 68' ' ' VAL . 16.1 pt20 -119.86 164.84 15.42 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.903 -1.044 . . . . 73.409999999999997 109.762 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.7 t -143.88 141.42 30.28 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.804 -1.554 . . . . 74.030000000000001 106.804 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -81.01 -16.61 52.91 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.049 -1.093 . . . . 71.129999999999995 108.049 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -82.57 -4.34 57.48 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.049 -0.978 . . . . 74.409999999999997 110.793 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.73 131.05 56.33 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.112 -1.07 . . . . 72.310000000000002 108.112 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 40.2 m80 -100.72 172.35 7.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.587 -0.279 . . . . 64.450000000000003 111.388 -175.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.7 t -68.3 145.31 54.34 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.171 0.51 . . . . 74.239999999999995 110.635 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.65 -4.89 76.56 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.097 -1.201 . . . . 72.400000000000006 110.097 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 52.4 mt-30 -119.74 133.22 55.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.987 0.915 . . . . 72.530000000000001 109.335 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -159.9 157.0 28.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.136 -1.431 . . . . 74.409999999999997 107.136 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -135.84 153.92 51.34 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.581 -0.525 . . . . 72.25 109.581 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.08 118.03 11.15 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.264 -2.124 . . . . 52.439999999999998 105.264 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.99 137.41 21.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.402 -0.962 . . . . 73.439999999999998 108.402 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.65 142.56 17.3 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.501 -1.04 . . . . 65.530000000000001 110.501 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.8 t -136.05 156.7 48.34 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.275 -0.639 . . . . 75.299999999999997 109.275 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.33 110.11 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.564 -0.902 . . . . 73.0 108.564 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -130.91 91.93 35.32 Favored Pre-proline 0 C--N 1.292 -1.895 0 N-CA-C 108.043 -1.095 . . . . 75.430000000000007 108.043 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 51.2 Cg_endo . . . . . 0 N--CA 1.449 -1.108 0 C-N-CA 122.031 1.82 . . . . 72.120000000000005 111.334 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 112.359 0.503 . . . . 72.439999999999998 112.359 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.14 -25.58 68.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.296 -0.411 . . . . 64.219999999999999 110.501 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.16 -47.47 92.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 116.282 -0.417 . . . . 72.329999999999998 110.438 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 48.5 mt-10 -63.47 -48.24 78.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.794 0.331 . . . . 72.099999999999994 110.534 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.17 86.32 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.402 -0.817 . . . . 75.540000000000006 111.865 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.54 -33.68 62.79 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.379 -0.373 . . . . 73.129999999999995 110.539 -178.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -73.57 -36.67 65.62 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.457 -0.497 . . . . 71.400000000000006 111.03 -177.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -71.76 -25.21 61.95 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.377 -0.929 . . . . 74.510000000000005 110.368 175.587 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -68.78 -37.33 79.23 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 107.981 -1.118 . . . . 73.109999999999999 107.981 175.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -68.49 -40.07 81.04 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.37 -0.832 . . . . 75.340000000000003 109.49 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.01 93.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.047 -0.524 . . . . 72.239999999999995 110.834 177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.28 58.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.974 -0.557 . . . . 65.099999999999994 111.189 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.8 -33.69 57.99 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.488 0.661 . . . . 72.430000000000007 109.715 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.33 8.13 59.08 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.202 -0.908 . . . . 74.430000000000007 113.59 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD13 ' CE2' ' A' ' 98' ' ' TRP . 9.5 mm -56.44 135.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 123.434 0.693 . . . . 73.540000000000006 111.537 177.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 19.0 tt0 -124.52 142.86 51.02 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 108.216 -1.031 . . . . 73.439999999999998 108.216 -177.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 m -76.48 131.8 39.23 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.698 -0.683 . . . . 65.340000000000003 110.995 -177.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.2 tp -148.06 -168.99 3.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 105.174 -2.158 . . . . 74.430000000000007 105.174 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.567 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.43 140.43 7.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.439 1.096 . . . . 65.5 110.542 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.2 24.76 0.87 Allowed Glycine 0 C--N 1.316 -0.551 0 C-N-CA 123.457 0.551 . . . . 63.229999999999997 114.465 -173.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 52' ' ' GLN . 91.1 m-20 -85.16 -38.75 18.67 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.638 -1.616 . . . . 72.519999999999996 106.638 173.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.422 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 3.1 ptp180 -174.22 160.24 3.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.407 -1.27 . . . . 74.299999999999997 110.173 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.51 152.38 20.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 123.826 0.851 . . . . 74.209999999999994 111.131 -173.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.437 HD21 HD21 ' A' ' 51' ' ' LEU . 2.0 tm? -92.89 121.79 34.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.608 -1.627 . . . . 74.340000000000003 106.608 -176.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.78 158.24 32.82 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 109.629 -0.508 . . . . 54.420000000000002 109.629 -177.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.35 156.78 58.07 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.427 2.085 . . . . 72.450000000000003 112.266 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -125.18 -22.58 4.37 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.922 -0.581 . . . . 73.420000000000002 110.563 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 11.4 tp10 -94.02 106.36 18.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.644 -1.243 . . . . 72.109999999999999 107.644 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -122.43 114.54 20.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.468 0.651 . . . . 75.450000000000003 111.011 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.52 122.55 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.55 -0.907 . . . . 74.230000000000004 108.55 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -116.25 117.3 55.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.761 -0.829 . . . . 74.439999999999998 108.761 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.3 m -103.47 116.78 33.05 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.775 -0.648 . . . . 75.450000000000003 109.39 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.07 175.04 5.61 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.963 -0.562 . . . . 74.099999999999994 110.027 178.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.18 145.05 32.86 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.11 -0.796 . . . . 75.349999999999994 111.11 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.52 -24.62 36.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.381 0.61 . . . . 75.239999999999995 110.044 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.484 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 52.8 t-80 -55.28 -51.86 65.31 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.051 -0.977 . . . . 74.439999999999998 110.32 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 73' ' ' LYS 0.261 2.6 m-20 -87.23 -20.02 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.938 1.088 . . . . 70.400000000000006 113.938 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 36.6 t80 -61.97 -33.25 73.96 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.43 -0.35 . . . . 74.310000000000002 110.529 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 11.2 pt-20 -66.28 -26.25 67.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 73.510000000000005 111.52 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -70.51 -33.46 71.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.215 -0.902 . . . . 74.340000000000003 109.099 174.471 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.78 -37.01 76.19 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.991 0.901 . . . . 72.409999999999997 108.688 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.19 -157.88 15.56 Favored Glycine 0 N--CA 1.425 -2.089 0 CA-C-N 114.839 -1.073 . . . . 70.109999999999999 111.304 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.79 18.66 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.035 0.445 . . . . 71.0 110.263 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.58 109.81 61.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.963 -0.562 . . . . 71.329999999999998 111.04 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.1 -39.46 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 121.754 1.636 . . . . 63.240000000000002 112.399 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -58.34 -38.94 78.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 116.232 1.938 . . . . 72.129999999999995 116.232 -164.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.65 -37.26 83.38 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.611 0.719 . . . . 72.239999999999995 110.185 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -86.12 -25.02 26.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.785 -0.643 . . . . 72.310000000000002 110.139 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.7 m -65.67 -33.36 75.7 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.603 -0.726 . . . . 72.540000000000006 109.305 175.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -63.08 -44.27 96.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.420000000000002 109.732 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.23 95.29 Favored Glycine 0 C--O 1.243 0.675 0 C-N-CA 120.855 -0.688 . . . . 74.219999999999999 111.798 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.17 -33.03 67.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.327 -0.62 . . . . 74.540000000000006 109.327 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.6 93.47 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.284 -0.416 . . . . 73.540000000000006 110.688 177.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.56 -41.44 94.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.266 0.555 . . . . 75.140000000000001 110.745 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -71.24 -36.61 71.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.734 -0.667 . . . . 71.209999999999994 110.551 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.19 -33.84 75.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.015 0.436 . . . . 74.530000000000001 110.187 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.08 79.19 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.284 -0.635 . . . . 72.230000000000004 109.284 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -46.61 79.21 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.559 -0.746 . . . . 74.040000000000006 109.515 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.611 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 37.1 m-85 -54.57 -49.85 69.36 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 112.581 0.586 . . . . 72.120000000000005 112.581 176.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.9 pt -67.1 -32.51 58.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 C-N-CA 119.818 -0.753 . . . . 74.049999999999997 111.884 -177.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.53 -42.61 95.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.27 0.557 . . . . 74.519999999999996 109.76 174.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -65.93 -31.89 73.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 74.310000000000002 112.315 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 65.2 mm-40 -84.94 -13.28 51.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.315 0.579 . . . . 73.549999999999997 110.512 176.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.16 35.36 53.42 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.239 -0.891 . . . . 72.030000000000001 113.459 176.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.455 ' CE2' HD13 ' A' ' 48' ' ' ILE . 15.6 m0 -97.96 168.26 10.4 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.18 0.49 . . . . 64.239999999999995 110.401 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.451 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.5 pt20 -130.43 167.42 18.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.423 -0.584 . . . . 75.540000000000006 109.423 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -161.61 177.88 9.57 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.005 -0.739 . . . . 72.120000000000005 109.005 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -119.66 120.73 37.49 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.407 -0.59 . . . . 75.010000000000005 109.407 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -158.42 14.7 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.141 -1.584 . . . . 75.409999999999997 109.141 -175.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.27 151.09 37.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.616 -1.253 . . . . 71.099999999999994 107.616 176.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.69 121.62 18.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 120.949 0.404 . . . . 72.219999999999999 110.453 -177.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.34 120.27 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 121.881 0.848 . . . . 43.039999999999999 110.128 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.0 t -119.13 124.01 72.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.84 -1.541 . . . . 74.230000000000004 106.84 177.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -132.79 136.21 46.17 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.05 0.452 . . . . 75.0 110.996 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 94.8 m-85 -104.01 141.26 36.5 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.337 -0.847 . . . . 65.439999999999998 108.854 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.85 162.66 34.26 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.562 -0.29 . . . . 71.299999999999997 110.8 176.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.431 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -100.66 150.38 22.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.729 -0.669 . . . . 73.519999999999996 110.997 -176.026 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 31.6 t -129.95 129.27 43.6 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.525 -1.287 . . . . 73.239999999999995 107.525 174.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 t -81.45 -27.69 34.53 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.704 -0.851 . . . . 71.310000000000002 108.704 176.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -68.85 -46.34 68.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.015 -0.993 . . . . 75.420000000000002 110.434 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 118' ' ' GLN . 6.8 tt -84.41 140.47 31.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.833 -1.076 . . . . 74.140000000000001 110.455 -176.381 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -120.01 156.91 29.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.111 -0.7 . . . . 74.230000000000004 109.111 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -55.8 119.45 5.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.705 1.202 . . . . 74.040000000000006 110.538 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.66 -27.22 3.74 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 106.589 -2.604 . . . . 44.520000000000003 106.589 -174.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.45 ' O ' HD21 ' A' ' 114' ' ' LEU . 29.6 tt0 -116.13 146.95 41.84 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 104.806 -2.294 . . . . 72.099999999999994 104.806 172.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -158.37 157.78 33.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.544 -1.28 . . . . 74.420000000000002 107.544 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -130.13 139.35 50.91 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 110.438 -0.208 . . . . 74.5 110.438 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.03 133.37 29.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.027 -1.472 . . . . 55.43 107.027 177.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -134.72 134.82 41.44 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.607 -0.886 . . . . 74.030000000000001 108.607 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -131.1 125.15 4.38 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.113 -1.195 . . . . 61.210000000000001 110.113 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -142.46 173.0 11.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.899 -0.408 . . . . 71.200000000000003 109.899 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.86 110.37 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.284 -0.636 . . . . 75.109999999999999 109.284 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.4 94.55 40.48 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.828 -0.623 . . . . 73.310000000000002 109.329 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.463 -0.29 0 C-N-CA 122.066 1.844 . . . . 75.030000000000001 110.943 179.448 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.866 1.062 . . . . 63.420000000000002 113.866 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.46 -31.57 71.82 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.822 -0.807 . . . . 74.299999999999997 108.822 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.97 -42.08 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.761 -0.654 . . . . 64.049999999999997 109.282 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.48 -43.14 99.4 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.615 -0.513 . . . . 72.140000000000001 109.615 177.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.9 90.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.299 -0.864 . . . . 60.43 110.97 178.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.85 -44.28 77.52 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.634 -0.427 . . . . 75.010000000000005 110.431 178.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.11 -37.45 87.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.827 0.677 . . . . 72.519999999999996 112.827 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.83 -36.09 82.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 120.036 -0.666 . . . . 75.519999999999996 109.358 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -68.38 -41.89 79.91 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 109.955 176.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.27 -45.02 96.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.734 1.213 . . . . 73.239999999999995 110.14 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.21 97.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.441 -0.799 . . . . 71.400000000000006 110.187 177.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.37 71.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.201 0.524 . . . . 72.430000000000007 111.392 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.13 -21.0 43.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.733 -178.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.56 19.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.975 -0.557 . . . . 53.32 112.139 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.51 134.73 29.72 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-O 121.272 0.558 . . . . 73.530000000000001 111.868 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 5.0 tp-100 -111.6 132.28 54.67 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.36 -1.348 . . . . 74.5 107.36 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -77.06 93.95 3.94 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.796 0.808 . . . . 75.540000000000006 109.883 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.3 tp -103.08 -165.41 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.119 -1.808 . . . . 72.510000000000005 106.119 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.576 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 2.2 mp0 -42.32 139.01 1.56 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.858 0.863 . . . . 63.340000000000003 111.586 175.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.81 -4.45 14.28 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-N 115.492 -0.777 . . . . 72.200000000000003 114.866 -171.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -72.17 -44.93 62.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.043 -0.354 . . . . 74.140000000000001 110.043 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 32.2 ptt180 -163.73 148.05 10.44 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.206 0.527 . . . . 72.230000000000004 111.373 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.12 151.19 21.09 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.017 -0.992 . . . . 75.409999999999997 111.051 -170.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 43.2 tp -86.35 126.6 34.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.443 -0.799 . . . . 71.409999999999997 109.677 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.3 160.38 31.55 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 124.109 0.881 . . . . 74.010000000000005 108.75 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 78.0 Cg_exo -54.56 153.96 21.66 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.213 2.608 . . . . 74.040000000000006 113.253 176.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 30.5 p-10 -120.09 -34.67 3.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.831 -0.622 . . . . 64.430000000000007 111.133 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -107.64 112.81 25.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.338 -0.616 . . . . 74.439999999999998 109.338 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 53.2 m-85 -109.03 132.0 54.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.671 -0.695 . . . . 72.329999999999998 110.279 -177.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 mm -112.93 117.89 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.582 -0.896 . . . . 72.239999999999995 108.582 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.11 125.83 74.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 -179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -126.89 129.0 47.36 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.427 -0.352 . . . . 74.129999999999995 110.309 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -128.6 178.08 6.57 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.864 -0.607 . . . . 73.420000000000002 109.66 172.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -73.66 168.3 54.06 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.982 -0.847 . . . . 43.329999999999998 110.982 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.4 -40.48 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 117.688 0.744 . . . . 70.010000000000005 112.324 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -66.82 -36.01 81.37 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.88 0.848 . . . . 72.109999999999999 109.234 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -65.43 -51.41 60.45 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.498 -1.228 . . . . 75.409999999999997 109.287 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.08 -42.34 98.32 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.251 -1.34 . . . . 74.109999999999999 111.848 -173.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.54 -35.94 78.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.908 0.385 . . . . 74.040000000000006 111.226 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -74.2 -24.98 59.43 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.086 -0.506 . . . . 72.109999999999999 112.208 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 79.1 mt -72.52 -45.2 60.47 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.885 0.374 . . . . 72.420000000000002 111.281 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.13 40.26 56.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 107.912 -2.075 . . . . 63.310000000000002 107.912 -168.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.26 5.54 51.44 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.121 1.768 . . . . 64.209999999999994 112.09 -172.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -43.05 124.19 3.24 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 124.639 1.212 . . . . 72.400000000000006 110.503 -171.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -38.07 -47.8 2.23 Favored 'Trans proline' 0 C--N 1.373 1.836 1 C-N-CA 125.696 4.264 . . . . 73.439999999999998 116.116 -168.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.51 -17.07 52.68 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.863 -0.735 . . . . 70.230000000000004 112.278 -172.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.98 -56.11 3.63 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.395 0.617 . . . . 75.310000000000002 109.38 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -86.54 -5.5 59.13 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 115.16 1.541 . . . . 74.109999999999999 115.16 -174.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 p -64.97 -62.72 1.39 Allowed 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 119.243 0.929 . . . . 73.329999999999998 111.039 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.9 m -59.02 -40.43 84.94 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.155 0.582 . . . . 73.140000000000001 110.955 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.13 -55.46 9.15 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.907 -0.588 . . . . 52.100000000000001 113.495 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.97 -25.97 56.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.083 0.468 . . . . 75.109999999999999 110.448 -173.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.15 63.48 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.285 -0.566 . . . . 71.310000000000002 109.586 175.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -65.46 -40.74 93.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.133 -1.062 . . . . 72.340000000000003 108.133 175.882 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -59.54 -47.45 85.5 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 116.125 -0.488 . . . . 63.030000000000001 109.927 176.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.26 -37.37 77.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 112.034 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -60.56 -43.09 97.65 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.428 0.633 . . . . 61.240000000000002 109.384 178.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.34 -41.68 97.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.875 -1.057 . . . . 74.400000000000006 109.553 177.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.587 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.3 m-85 -61.26 -53.06 61.6 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.918 -0.583 . . . . 64.530000000000001 112.47 175.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 90' ' ' ALA . 37.7 pt -63.91 -31.07 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.742 0.275 . . . . 75.099999999999994 111.742 -176.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 77.3 mm-40 -65.79 -42.93 90.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.45 -0.574 . . . . 72.010000000000005 109.45 174.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.39 -37.33 83.03 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.052 -0.522 . . . . 73.150000000000006 111.202 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 27.3 mm-40 -77.06 -13.51 59.94 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.771 -0.65 . . . . 72.230000000000004 110.603 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 34.05 28.39 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.931 -0.577 . . . . 73.230000000000004 112.629 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -110.77 161.14 16.08 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.577 -0.527 . . . . 75.400000000000006 109.577 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.412 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -130.72 169.55 15.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.461 -0.57 . . . . 73.239999999999995 109.461 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.6 t -158.28 170.55 21.99 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.675 -0.491 . . . . 74.099999999999994 109.675 178.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.32 122.49 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.854 0.359 . . . . 72.319999999999993 111.029 -176.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 -150.01 17.06 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.391 -1.084 . . . . 51.43 110.391 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.1 137.73 46.54 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.667 -0.864 . . . . 75.239999999999995 108.667 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.53 117.68 19.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.09 -1.078 . . . . 75.200000000000003 108.09 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.33 125.76 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-O 121.831 0.824 . . . . 75.439999999999998 112.02 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.87 124.63 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 106.869 -1.53 . . . . 74.540000000000006 106.869 173.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -115.92 130.51 56.86 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.1 -0.704 . . . . 73.239999999999995 109.1 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -104.34 143.9 32.36 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.048 -0.978 . . . . 73.430000000000007 108.859 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.51 168.53 22.47 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.048 -0.524 . . . . 71.219999999999999 110.065 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -114.82 163.52 15.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.287 0.565 . . . . 74.439999999999998 111.051 -176.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.429 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 43.7 t -145.15 133.17 21.37 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.765 -1.198 . . . . 73.540000000000006 107.765 176.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.2 m -80.99 -19.88 43.04 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.43 0.634 . . . . 74.439999999999998 109.498 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -81.01 -32.82 34.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.404 -0.817 . . . . 73.400000000000006 110.854 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.81 148.68 40.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.623 -0.717 . . . . 64.420000000000002 109.79 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -100.48 157.92 16.29 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.859 0.463 . . . . 74.530000000000001 110.229 -171.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.559 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 71.7 m -66.86 120.74 14.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.744 0.783 . . . . 71.019999999999996 112.688 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.1 -5.86 61.53 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.405 -1.27 . . . . 54.43 111.395 -178.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -107.2 104.73 14.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.026 -1.472 . . . . 74.400000000000006 107.026 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -119.62 157.05 29.24 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.084 -0.507 . . . . 74.209999999999994 111.012 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -134.24 137.45 44.35 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.731 -0.84 . . . . 74.450000000000003 108.731 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.15 125.34 10.77 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.251 -0.648 . . . . 65.140000000000001 109.251 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 -131.18 160.43 34.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 109.646 -0.501 . . . . 73.540000000000006 109.646 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.67 135.73 9.65 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 110.429 -1.068 . . . . 34.43 110.429 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 p -126.04 153.69 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.814 -0.439 . . . . 74.219999999999999 109.814 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.508 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 93.0 t -103.87 107.87 23.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.919 -1.141 . . . . 71.5 107.919 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -98.45 96.95 4.13 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.201 -1.407 . . . . 63.219999999999999 107.201 173.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 72.0 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 C-N-CA 121.939 1.759 . . . . 74.510000000000005 112.138 -174.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 109.613 -0.514 . . . . 74.030000000000001 109.613 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -69.3 -42.47 75.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.494 -0.928 . . . . 70.310000000000002 108.494 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.31 -46.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.389 -0.967 . . . . 65.239999999999995 108.389 177.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 23.5 mm-40 -52.02 -52.32 51.57 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.436 -0.802 . . . . 73.319999999999993 111.828 175.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.02 -53.96 49.06 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.8 0.688 . . . . 74.219999999999999 111.355 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.05 -42.18 97.12 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.317 0.488 . . . . 65.109999999999999 112.317 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.3 -47.05 77.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.828 0.677 . . . . 75.409999999999997 112.828 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 7.5 ptp180 -70.82 -32.84 70.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 120.428 -0.509 . . . . 73.209999999999994 110.486 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -67.17 -46.58 73.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.905 -0.406 . . . . 70.439999999999998 109.905 176.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 6.2 tp10 -63.03 -37.43 87.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 73.150000000000006 109.694 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.39 97.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.143 -0.481 . . . . 41.229999999999997 110.943 178.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.07 -34.23 43.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.042 -0.526 . . . . 75.430000000000007 111.566 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.56 -30.82 57.23 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.476 0.655 . . . . 75.5 110.797 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.28 14.0 58.65 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.661 -0.7 . . . . 61.329999999999998 112.607 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.88 131.57 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.306 0.574 . . . . 65.5 111.106 177.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt-30 -119.45 139.64 51.72 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.251 -0.886 . . . . 62.020000000000003 109.772 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -74.56 126.85 31.67 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.352 -1.295 . . . . 71.540000000000006 108.769 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.568 HD21 ' NE2' ' A' ' 99' ' ' GLN . 14.0 tp -141.31 -165.57 2.0 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.186 -2.153 . . . . 73.329999999999998 105.186 -177.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.497 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 25.2 mt-30 -52.52 145.02 12.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.047 0.385 . . . . 73.430000000000007 110.299 176.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.95 -0.95 7.88 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 114.728 0.651 . . . . 75.010000000000005 114.728 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -64.11 -42.81 96.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.851 -0.796 . . . . 74.129999999999995 108.851 177.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -174.87 157.01 2.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.114 -0.948 . . . . 74.349999999999994 110.877 -179.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.15 151.65 20.89 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.495 0.718 . . . . 71.519999999999996 110.858 -173.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.3 tm? -91.74 128.79 37.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.826 -1.176 . . . . 75.430000000000007 107.826 -176.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.66 162.07 36.45 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 122.739 0.415 . . . . 73.239999999999995 109.954 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.43 160.73 30.31 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.244 2.63 . . . . 74.120000000000005 112.941 176.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -132.81 -33.45 1.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.783 -0.644 . . . . 63.119999999999997 112.154 -179.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.04 116.52 32.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 72.200000000000003 108.837 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.44 ' HB2' HG12 ' A' ' 106' ' ' VAL . 35.2 m-85 -118.77 114.81 23.25 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.828 -0.434 . . . . 75.209999999999994 109.828 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.48 110.38 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.68 -0.859 . . . . 74.349999999999994 108.68 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.27 112.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.167 -1.049 . . . . 74.109999999999999 108.167 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -110.79 122.86 48.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.73 -0.668 . . . . 74.409999999999997 109.9 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.65 176.38 5.17 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.385 -0.825 . . . . 74.519999999999996 110.081 177.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.3 165.37 51.77 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.218 -1.553 . . . . 73.209999999999994 109.218 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.515 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 3.1 p -59.27 -48.31 87.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 112.673 0.62 . . . . 72.209999999999994 112.673 -178.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -63.94 -36.46 84.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 74.25 110.249 -178.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -69.02 -41.69 77.4 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.465 0.65 . . . . 74.430000000000007 109.563 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -73.87 -22.74 59.63 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 120.415 -0.514 . . . . 75.049999999999997 111.521 -176.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.8 mt-10 -61.77 -28.5 69.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.345 0.593 . . . . 70.420000000000002 109.66 173.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -84.91 -28.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.76 -0.655 . . . . 71.450000000000003 110.55 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 mt -97.02 -14.16 21.81 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 113.01 0.744 . . . . 73.299999999999997 113.01 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.71 22.13 35.24 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 116.077 1.191 . . . . 75.329999999999998 116.077 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.82 -35.13 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.959 0.88 . . . . 74.049999999999997 108.962 176.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -141.73 77.26 19.2 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 115.537 -0.756 . . . . 64.299999999999997 109.203 175.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.32 -50.37 2.03 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.062 1.841 . . . . 63.100000000000001 112.811 -178.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.01 -37.55 82.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.47 0.176 . . . . 75.319999999999993 111.408 -177.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.84 -55.7 29.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.135 0.493 . . . . 64.019999999999996 110.597 177.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -72.86 -22.64 60.75 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.351 0.871 . . . . 75.340000000000003 113.351 -178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 m -71.48 -36.43 71.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 74.409999999999997 109.131 175.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.3 m -70.89 -40.61 72.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.061 -0.518 . . . . 74.209999999999994 109.765 177.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.638 ' O ' ' HG2' ' A' ' 87' ' ' ARG . . . -57.77 -55.23 31.63 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-N 115.746 -0.661 . . . . 62.350000000000001 112.666 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.402 ' HB2' HG23 ' A' ' 106' ' ' VAL . 62.8 m-85 -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.754 -0.85 . . . . 71.510000000000005 112.824 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.85 53.37 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.223 -0.298 . . . . 71.329999999999998 110.993 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' A' ' 84' ' ' GLY . 35.1 ptt180 -60.68 -41.93 96.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.899 0.857 . . . . 71.129999999999995 110.141 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.474 ' N ' ' HG3' ' A' ' 87' ' ' ARG . 64.5 m-20 -77.74 -34.66 52.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.137 -0.938 . . . . 64.319999999999993 112.69 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.47 -37.99 89.46 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.094 -1.076 . . . . 73.329999999999998 108.094 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -63.12 -35.55 80.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.877 -0.601 . . . . 65.530000000000001 110.386 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.7 t70 -72.39 -42.09 65.57 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.684 -0.406 . . . . 74.340000000000003 110.027 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 13.8 m-85 -53.73 -48.4 69.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 112.074 175.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.4 pt -66.06 -30.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 119.722 -0.791 . . . . 75.540000000000006 111.104 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 78.7 mm-40 -67.61 -37.94 83.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.083 -0.247 . . . . 75.409999999999997 110.598 175.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.1 mt-10 -61.63 -41.04 96.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.883 0.739 . . . . 74.019999999999996 110.884 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 68.2 mm-40 -80.31 -14.22 58.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.191 -0.913 . . . . 63.200000000000003 110.938 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.11 29.11 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.765 -0.652 . . . . 61.43 112.062 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -102.9 174.51 5.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.613 0.72 . . . . 73.25 112.073 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' NE2' HD21 ' A' ' 51' ' ' LEU . 25.4 pt20 -137.18 171.91 13.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.412 -0.813 . . . . 73.140000000000001 109.491 179.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -161.15 153.51 20.26 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.738 -0.467 . . . . 74.030000000000001 109.738 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -109.66 120.04 41.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.652 -1.24 . . . . 75.319999999999993 107.652 175.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.85 -150.27 18.28 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 107.951 -2.06 . . . . 72.400000000000006 107.951 -172.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.93 137.83 35.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.187 0.993 . . . . 65.209999999999994 108.842 177.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.49 103.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.316 0.579 . . . . 75.439999999999998 110.094 -175.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.84 127.43 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.25 -0.887 . . . . 74.530000000000001 109.5 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.9 m -105.55 148.73 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 107.244 -1.391 . . . . 72.140000000000001 107.244 176.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -128.21 137.55 52.09 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.732 -0.84 . . . . 71.450000000000003 108.732 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.11 119.73 38.11 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.95 -0.759 . . . . 74.129999999999995 108.95 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.7 175.75 10.38 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.882 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.25 164.37 18.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.031 -176.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -154.17 117.19 4.48 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 124.058 0.943 . . . . 72.420000000000002 108.848 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 p -67.38 -17.73 64.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.603 0.716 . . . . 73.129999999999995 111.099 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -67.26 -28.18 67.82 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.201 1.0 . . . . 72.109999999999999 109.263 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.53 141.3 51.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.998 -1.001 . . . . 75.239999999999995 109.864 -178.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.55 145.96 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.847 -0.615 . . . . 74.319999999999993 110.16 -172.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 m -68.27 121.59 16.55 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.706 -0.679 . . . . 70.310000000000002 109.764 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.67 -11.09 38.65 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 110.471 -1.052 . . . . 63.149999999999999 110.471 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.69 169.09 9.74 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.207 0.527 . . . . 73.109999999999999 110.585 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -164.08 156.63 17.35 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.015 -2.587 . . . . 75.510000000000005 104.015 173.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -146.14 130.57 17.71 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.215 -0.994 . . . . 75.239999999999995 111.791 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.15 118.71 28.28 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.541 -1.281 . . . . 62.439999999999998 107.541 177.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.473 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 23.8 tpt180 -121.78 125.85 47.49 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.296 -0.631 . . . . 74.450000000000003 109.296 -177.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.09 130.32 9.1 Favored Glycine 0 C--N 1.289 -2.038 0 N-CA-C 110.581 -1.008 . . . . 75.299999999999997 110.581 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.3 t -138.09 167.26 22.17 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.47 -0.567 . . . . 72.540000000000006 109.47 -177.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.4 t -92.59 106.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.526 -1.287 . . . . 65.129999999999995 107.526 175.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.83 102.75 51.12 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.135 -0.691 . . . . 62.409999999999997 109.135 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 C--N 1.323 -0.793 0 C-N-CA 121.84 1.693 . . . . 73.430000000000007 111.13 179.053 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.792 0.329 . . . . 74.430000000000007 110.573 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.87 -32.21 45.84 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.682 -0.488 . . . . 74.430000000000007 109.682 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.7 t -64.47 -49.82 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.781 -0.645 . . . . 73.129999999999995 109.426 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 5.9 pt-20 -66.68 -31.4 72.04 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 119.863 -0.735 . . . . 73.409999999999997 110.284 178.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.93 63.55 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.378 0.424 . . . . 74.430000000000007 110.197 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.68 -40.34 91.77 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 111.191 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 77.8 mt -66.34 -46.78 75.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.554 0.576 . . . . 75.530000000000001 112.554 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.5 ptm180 -72.01 -26.89 62.4 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.277 0.561 . . . . 73.439999999999998 110.134 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -45.65 73.35 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.671 -0.695 . . . . 73.510000000000005 109.679 172.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -62.72 -33.91 76.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 122.837 0.455 . . . . 74.409999999999997 111.174 177.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.07 90.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.012 -0.54 . . . . 73.319999999999993 110.702 177.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.45 53.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.502 0.668 . . . . 73.109999999999999 111.106 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.14 -38.21 61.1 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.717 -0.674 . . . . 72.120000000000005 110.849 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.08 12.81 65.03 Favored Glycine 0 C--N 1.319 -0.396 0 C-N-CA 121.261 -0.495 . . . . 72.540000000000006 113.336 -176.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.72 127.4 19.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.399 0.68 . . . . 74.439999999999998 111.875 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.91 146.15 34.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.705 -0.68 . . . . 75.209999999999994 110.039 177.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.3 m -81.01 103.23 10.69 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.364 -0.834 . . . . 74.329999999999998 109.143 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.7 tp -112.65 -164.21 0.9 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.133 -1.432 . . . . 73.439999999999998 107.133 -177.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.578 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 85.0 mm-40 -49.67 156.99 0.6 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.748 0.819 . . . . 75.019999999999996 112.594 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.72 5.59 22.78 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 114.852 -1.067 . . . . 73.25 114.086 -172.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.45 -43.37 27.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.388 -0.597 . . . . 74.329999999999998 109.388 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -177.69 165.62 2.1 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.682 0.793 . . . . 74.510000000000005 112.016 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.21 151.3 20.99 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.149 0.98 . . . . 74.310000000000002 111.688 -173.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.403 HD22 HD21 ' A' ' 51' ' ' LEU . 1.4 tm? -94.46 125.11 38.9 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.099 -1.075 . . . . 72.129999999999995 108.099 -175.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.56 156.98 40.54 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 123.597 0.759 . . . . 72.310000000000002 109.783 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' HG21 ' A' ' 125' ' ' VAL . 82.1 Cg_exo -51.03 152.15 10.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.983 3.122 . . . . 70.219999999999999 114.307 177.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.6 p-10 -122.69 -33.88 3.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.194 -0.912 . . . . 73.099999999999994 110.605 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.47 100.26 11.27 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.318 0.58 . . . . 71.319999999999993 110.164 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 72.2 m-85 -96.43 114.13 25.77 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.632 0.73 . . . . 74.530000000000001 109.491 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -107.91 117.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.618 -1.174 . . . . 74.340000000000003 109.036 -174.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -118.05 101.74 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.485 -0.932 . . . . 75.0 108.485 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.5 m -95.82 122.93 39.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 109.311 -176.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.59 162.21 14.95 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.419 0.688 . . . . 74.129999999999995 111.056 176.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.16 163.47 50.63 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.889 -1.685 . . . . 74.430000000000007 108.889 173.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.7 p -63.15 -37.89 80.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 117.387 0.593 . . . . 71.5 111.357 -177.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -64.11 -38.04 89.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.634 -0.712 . . . . 74.230000000000004 110.393 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.08 -35.56 28.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.867 -0.606 . . . . 71.430000000000007 111.69 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -65.79 -32.36 73.85 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.744 -0.383 . . . . 74.319999999999993 110.994 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.2 mt-10 -59.57 -29.52 67.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.046 0.45 . . . . 74.530000000000001 111.266 177.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -81.5 -26.33 35.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 111.32 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.73 -34.42 71.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.385 -0.598 . . . . 75.230000000000004 109.385 173.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.37 -165.89 21.86 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 110.877 -0.889 . . . . 64.400000000000006 110.877 177.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.89 1.23 55.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 110.52 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -127.82 135.43 27.47 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.125 -0.489 . . . . 71.450000000000003 110.526 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.86 -34.52 1.75 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.057 1.838 . . . . 75.430000000000007 109.286 163.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -48.02 -52.79 18.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 117.376 2.362 . . . . 74.129999999999995 117.376 -165.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.24 -42.71 77.76 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.662 0.665 . . . . 64.530000000000001 110.606 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -17.95 28.65 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.247 -0.888 . . . . 71.530000000000001 112.152 -177.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 59.6 m -71.18 -44.64 65.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.253 -0.647 . . . . 74.230000000000004 109.253 176.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.0 m -65.48 -43.2 90.98 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 115.87 -0.604 . . . . 65.019999999999996 110.006 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.12 -53.84 41.52 Favored Glycine 0 CA--C 1.504 -0.615 0 CA-C-N 115.492 -0.776 . . . . 72.140000000000001 112.373 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -67.37 -31.0 70.95 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 113.002 0.742 . . . . 60.530000000000001 113.002 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.23 82.69 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.062 0.392 . . . . 74.099999999999994 110.45 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -67.17 -48.08 69.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.798 -0.637 . . . . 73.530000000000001 111.505 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.33 -35.87 78.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.078 -0.51 . . . . 73.310000000000002 111.293 -173.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.22 -35.68 63.9 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.368 -0.605 . . . . 74.349999999999994 109.368 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.36 84.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.773 0.797 . . . . 60.229999999999997 109.438 176.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.89 -41.73 99.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.601 -1.181 . . . . 74.439999999999998 109.445 177.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 16.4 m-85 -59.89 -51.17 70.87 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.876 -0.602 . . . . 74.5 112.085 175.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -65.61 -30.78 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.298 -0.561 . . . . 64.120000000000005 112.101 -175.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.32 -44.93 93.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.701 -0.481 . . . . 75.239999999999995 109.701 175.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.17 -30.09 70.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.702 -0.681 . . . . 74.400000000000006 112.682 177.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 58.4 mm-40 -82.97 -13.62 55.63 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.918 -0.313 . . . . 73.030000000000001 111.222 178.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 27.08 40.6 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.051 -0.522 . . . . 43.32 113.125 176.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -98.68 178.38 5.01 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.888 0.344 . . . . 72.409999999999997 110.163 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -143.03 174.18 10.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.875 -0.787 . . . . 72.129999999999995 108.875 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.9 t -157.19 171.74 19.89 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.612 -0.435 . . . . 63.210000000000001 109.831 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.1 118.93 37.83 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.069 -1.085 . . . . 72.319999999999993 108.069 176.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.39 -149.93 16.74 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.376 -1.392 . . . . 71.109999999999999 110.985 176.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.04 142.49 46.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.765 -1.198 . . . . 72.209999999999994 107.765 176.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.22 118.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.58 -0.896 . . . . 74.349999999999994 108.58 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.21 137.3 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.643 0.735 . . . . 73.310000000000002 110.443 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' SER . 92.4 t -117.92 142.9 30.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 107.023 -1.473 . . . . 71.140000000000001 107.023 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -146.44 146.79 30.71 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.697 0.284 . . . . 73.030000000000001 111.019 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 84.9 m-85 -121.16 125.07 46.26 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.111 -1.441 . . . . 71.319999999999993 107.111 177.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.39 175.61 8.99 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.504 -0.878 . . . . 74.230000000000004 111.597 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.405 ' OE1' HG23 ' A' ' 68' ' ' VAL . 50.2 mt-30 -105.18 149.43 25.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.837 0.827 . . . . 75.340000000000003 112.154 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 m -143.48 118.13 9.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.59 -1.186 . . . . 71.329999999999998 108.961 172.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 m -72.0 -24.22 61.53 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.813 -0.63 . . . . 71.230000000000004 112.574 -175.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -88.7 -0.25 57.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.457 1.122 . . . . 73.140000000000001 109.26 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -83.7 144.49 29.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 108.282 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.02 149.74 35.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.434 -0.803 . . . . 73.540000000000006 110.83 -171.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -66.5 125.1 24.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.075 -0.713 . . . . 72.450000000000003 109.075 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.5 16.64 73.07 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.744 -0.741 . . . . 75.409999999999997 112.206 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -124.52 123.2 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.199 -1.037 . . . . 71.5 108.199 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -116.23 156.66 26.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.389 -0.967 . . . . 63.399999999999999 108.389 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -126.0 130.72 51.76 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.899 -0.778 . . . . 75.239999999999995 108.899 177.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.04 119.75 29.55 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.813 -1.085 . . . . 62.43 108.74 -178.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -135.0 126.5 28.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.094 -178.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.22 98.26 2.3 Favored Glycine 0 N--CA 1.424 -2.149 0 N-CA-C 108.502 -1.839 . . . . 73.549999999999997 108.502 176.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.3 m -93.36 138.94 31.22 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 121.198 0.523 . . . . 75.010000000000005 109.939 -175.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 59' ' ' PRO . 92.5 t -98.36 117.43 43.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.878 -0.786 . . . . 71.219999999999999 108.878 175.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -102.83 94.85 5.65 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.472 -1.677 . . . . 73.310000000000002 106.472 170.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.9 Cg_endo . . . . . 0 N--CA 1.451 -0.995 0 C-N-CA 122.225 1.95 . . . . 74.430000000000007 112.067 -175.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.964 0.411 . . . . 74.140000000000001 110.809 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.03 -48.16 77.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.374 -0.973 . . . . 72.310000000000002 108.374 175.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.94 -45.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.826 -0.624 . . . . 73.030000000000001 109.68 178.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 53.8 mt-10 -53.12 -55.3 25.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.323 -0.399 . . . . 75.209999999999994 111.147 178.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.05 68.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 111.811 -178.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.12 -47.34 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.337 -0.986 . . . . 74.420000000000002 108.337 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD12 ' CD2' ' A' ' 62' ' ' TYR . 3.8 mm? -71.65 -30.7 66.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.852 0.686 . . . . 72.420000000000002 112.852 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtm180 -64.42 -40.09 95.1 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.287 -1.005 . . . . 75.510000000000005 108.287 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -63.9 -44.86 91.7 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 110.333 176.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.59 -39.71 89.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.154 0.502 . . . . 61.219999999999999 110.006 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.22 84.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.786 -0.643 . . . . 72.519999999999996 110.457 177.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.78 64.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 64.200000000000003 111.984 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.52 -37.51 31.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.087 -0.506 . . . . 74.540000000000006 110.267 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 20.56 26.08 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.856 -0.611 . . . . 51.130000000000003 113.03 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -67.12 138.51 22.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 123.28 0.632 . . . . 75.129999999999995 110.657 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -115.87 143.71 45.03 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 176.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 t -76.28 124.67 27.86 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.946 -1.024 . . . . 74.530000000000001 108.705 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.7 tp -140.16 -166.0 2.02 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.073 -2.195 . . . . 73.140000000000001 105.073 -177.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 23.1 mt-30 -51.67 143.53 12.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.674 0.67 . . . . 71.420000000000002 110.259 176.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.88 -18.01 52.41 Favored Glycine 0 C--N 1.322 -0.233 0 CA-C-N 116.087 -0.506 . . . . 71.430000000000007 114.085 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -62.55 -39.1 92.54 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.52 0.328 . . . . 74.010000000000005 111.731 179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -165.8 136.44 3.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.176 -0.465 . . . . 75.200000000000003 111.396 -177.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.87 151.6 21.08 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.934 1.293 . . . . 75.400000000000006 110.353 -176.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -85.71 128.48 34.8 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.446 -0.797 . . . . 74.129999999999995 109.83 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.64 158.57 41.51 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 123.305 0.642 . . . . 74.120000000000005 109.821 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 36.0 Cg_exo -61.26 152.59 71.21 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.019 2.479 . . . . 72.439999999999998 112.7 177.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -130.86 -16.34 3.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.647 -0.706 . . . . 73.109999999999999 111.583 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.59 114.97 27.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.76 -1.2 . . . . 61.420000000000002 107.76 178.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' CD2' HD12 ' A' ' 40' ' ' LEU . 91.7 m-85 -121.18 122.62 40.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.425 -0.352 . . . . 74.040000000000006 110.23 -178.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 63' ' ' ILE . 3.4 mp -106.79 107.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.186 -1.042 . . . . 73.109999999999999 108.186 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 55.9 mt -112.55 103.65 15.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.55 0.691 . . . . 74.099999999999994 109.979 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -103.12 120.01 39.91 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.847 -0.615 . . . . 72.219999999999999 109.779 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -99.38 163.5 12.5 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 123.692 0.797 . . . . 72.430000000000007 111.252 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.25 165.1 49.79 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.31 -1.116 . . . . 64.140000000000001 110.31 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.67 -47.61 92.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 113.674 0.991 . . . . 73.439999999999998 113.674 -175.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.537 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 82.2 t60 -77.35 -24.19 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.477 0.656 . . . . 74.120000000000005 109.857 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.712 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 2.6 m-20 -69.72 -45.79 67.4 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.751 -0.833 . . . . 72.140000000000001 108.751 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 40.8 t80 -71.29 -34.17 70.4 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.564 -0.744 . . . . 74.140000000000001 111.816 -175.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 12.9 pt-20 -65.11 -30.08 70.99 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.103 0.478 . . . . 74.329999999999998 110.936 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 32.1 mmmt -68.94 -35.39 76.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.169 -0.923 . . . . 72.109999999999999 109.703 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.8 -37.33 79.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 110.73 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.49 -167.65 29.72 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 111.525 -0.63 . . . . 52.340000000000003 111.525 -178.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.11 -45.35 7.25 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.089 0.471 . . . . 62.549999999999997 110.475 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 16.1 m-20 -116.43 130.69 24.3 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 75.099999999999994 110.688 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 -20.34 14.48 Favored 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 123.203 2.602 . . . . 72.099999999999994 113.827 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 8.1 pt-20 -58.76 -24.06 61.08 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.323 1.601 . . . . 63.149999999999999 115.323 -171.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.8 tp -78.75 -29.64 45.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.43 0.633 . . . . 74.519999999999996 110.709 175.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.64 -35.17 13.67 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.773 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -60.78 -41.47 95.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.912 0.387 . . . . 73.349999999999994 110.895 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 m -56.91 -48.16 78.88 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.522 -0.763 . . . . 74.319999999999993 110.99 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.35 -46.33 64.36 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.928 -0.653 . . . . 54.340000000000003 112.006 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.62 -39.46 94.42 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.413 0.285 . . . . 72.319999999999993 110.472 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.23 88.65 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.857 0.361 . . . . 71.540000000000006 110.134 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.44 -37.87 86.12 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.193 -0.458 . . . . 75.200000000000003 110.997 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -71.09 -37.1 72.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 111.1 176.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.03 -43.91 90.87 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.008 -0.738 . . . . 73.319999999999993 109.008 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.26 80.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.404 0.621 . . . . 71.049999999999997 110.635 177.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.27 -42.23 79.9 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.153 -0.93 . . . . 75.400000000000006 108.526 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 m-85 -60.72 -56.16 24.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.781 -1.1 . . . . 75.519999999999996 112.403 176.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -59.59 -37.95 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.347 0.499 . . . . 74.319999999999993 112.347 -175.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.88 -37.64 88.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.834 -0.346 . . . . 73.010000000000005 110.733 176.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.5 -21.17 65.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.874 0.694 . . . . 75.439999999999998 112.874 176.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 50.3 mm-40 -92.49 -10.5 37.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.146 0.498 . . . . 71.349999999999994 110.17 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.96 26.55 37.06 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.434 -0.803 . . . . 63.130000000000003 111.851 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -107.22 155.02 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.285 -0.635 . . . . 75.510000000000005 109.285 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -130.87 175.4 9.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.836 -0.431 . . . . 73.409999999999997 109.836 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.1 t -154.39 158.73 40.47 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 108.264 -1.013 . . . . 75.299999999999997 108.264 175.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.18 120.14 39.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.672 -0.492 . . . . 73.25 109.672 -178.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -149.96 16.94 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.601 -1.8 . . . . 61.509999999999998 108.601 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.02 152.26 41.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.349 -0.982 . . . . 75.310000000000002 108.349 177.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.42 122.19 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.626 0.727 . . . . 73.310000000000002 110.721 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.29 120.28 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.065 -0.97 . . . . 74.340000000000003 109.225 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.85 138.9 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 107.506 -1.294 . . . . 71.400000000000006 107.506 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -116.12 150.23 37.72 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 109.742 -0.466 . . . . 75.420000000000002 109.742 176.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 81.3 m-85 -129.57 125.88 37.23 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.543 -2.021 . . . . 75.099999999999994 105.543 172.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.55 174.36 10.62 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.231 -0.655 . . . . 74.319999999999993 109.231 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.1 pt20 -122.27 150.23 42.62 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.367 -0.605 . . . . 72.409999999999997 109.367 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.552 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 75.4 m -119.19 118.67 31.95 Favored 'General case' 0 C--N 1.264 -3.129 0 N-CA-C 107.733 -1.21 . . . . 62.340000000000003 107.733 173.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -59.94 -28.22 67.44 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.818 0.847 . . . . 73.349999999999994 112.073 -176.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.552 ' OD1' ' HB3' ' A' ' 111' ' ' SER . 23.7 p-10 -83.91 -19.87 33.99 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.904 0.881 . . . . 71.430000000000007 111.301 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.1 tp -78.17 135.85 37.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.899 -0.591 . . . . 75.510000000000005 109.915 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -78.78 158.58 28.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.544 -0.753 . . . . 73.25 111.9 -173.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.712 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 30.7 m -70.93 130.72 42.35 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.378 -0.828 . . . . 74.219999999999999 110.082 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 11.42 62.27 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.061 -0.816 . . . . 72.030000000000001 111.061 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -126.49 121.22 31.73 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 108.186 -1.042 . . . . 72.099999999999994 108.186 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 66' ' ' LEU . 31.1 p90 -141.24 154.49 45.81 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.478 -0.564 . . . . 74.109999999999999 109.478 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 3.4 mpt_? -124.17 139.0 54.35 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.183 -0.673 . . . . 74.5 109.183 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.11 118.94 16.19 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.389 -0.967 . . . . 73.209999999999994 108.389 176.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -124.98 119.59 29.16 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.676 -0.41 . . . . 75.0 110.233 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -104.78 124.27 7.94 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.449 -1.06 . . . . 63.100000000000001 110.449 177.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 m -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 108.762 -0.829 . . . . 74.230000000000004 108.762 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.69 119.64 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.84 -1.17 . . . . 64.319999999999993 107.84 175.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -110.93 96.06 27.48 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.317 -1.734 . . . . 73.340000000000003 106.317 171.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.454 -0.845 0 C-N-CA 121.988 1.792 . . . . 73.409999999999997 111.184 -177.68 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.744 0.783 . . . . 72.409999999999997 110.03 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.8 -5.34 42.93 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.825 -0.625 . . . . 74.319999999999993 112.403 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 82.2 t -71.32 -55.51 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.792 -1.188 . . . . 73.0 107.792 174.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.5 pm0 -62.98 -34.93 78.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.88 0.372 . . . . 74.540000000000006 111.538 176.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' A' ' 41' ' ' ARG . . . -62.19 -50.86 70.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.983 -0.553 . . . . 44.119999999999997 111.269 177.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.01 -30.57 67.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.298 0.57 . . . . 63.329999999999998 110.162 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 16.0 tp -66.1 -41.88 90.01 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.687 -0.688 . . . . 74.099999999999994 110.218 -179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.88 -28.96 66.07 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.154 -0.684 . . . . 74.299999999999997 109.154 178.958 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' A' ' 46' ' ' ASP . 6.3 tpt180 -64.62 -52.3 58.14 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-N 115.778 -0.646 . . . . 75.420000000000002 109.614 172.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -60.24 -38.05 82.23 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.856 0.863 . . . . 73.5 110.998 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.28 -46.68 89.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.998 -0.547 . . . . 73.319999999999993 110.88 177.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.8 -22.84 49.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.879 -0.601 . . . . 75.0 111.179 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HB2' ' HE ' ' A' ' 42' ' ' ARG . 28.8 t70 -81.13 -37.33 29.03 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.862 -0.608 . . . . 70.25 110.799 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 19.89 29.59 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 116.1 -0.5 . . . . 73.349999999999994 113.538 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -66.11 139.04 21.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 C-N-CA 123.01 0.524 . . . . 72.219999999999999 110.851 178.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -117.85 143.34 46.38 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.173 0.511 . . . . 74.010000000000005 110.166 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -75.44 111.75 11.05 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.6 -1.182 . . . . 72.409999999999997 109.418 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.9 tp -119.13 -176.0 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.044 -1.835 . . . . 73.140000000000001 106.044 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.479 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 73.6 mt-30 -47.29 141.28 4.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.579 0.751 . . . . 71.120000000000005 110.058 175.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -10.63 7.77 Favored Glycine 0 CA--C 1.5 -0.857 0 N-CA-C 116.012 1.165 . . . . 74.510000000000005 116.012 -167.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -71.64 -35.72 70.5 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.245 -0.582 . . . . 73.5 111.844 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -167.26 148.12 5.58 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 112.07 0.396 . . . . 74.230000000000004 112.07 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.99 151.73 20.96 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.821 0.848 . . . . 73.299999999999997 110.508 -174.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.04 127.92 37.69 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.766 -1.198 . . . . 75.109999999999999 107.766 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.03 46.81 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 109.113 -0.699 . . . . 75.420000000000002 109.113 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.68 149.02 83.9 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.111 1.874 . . . . 63.409999999999997 111.153 177.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -113.23 -26.14 8.55 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.734 -0.386 . . . . 71.430000000000007 110.886 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 35.3 tt0 -113.12 125.18 54.08 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.185 0.517 . . . . 74.120000000000005 110.025 -177.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.428 ' HB2' HG11 ' A' ' 106' ' ' VAL . 39.4 m-85 -121.83 124.87 45.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.578 -0.737 . . . . 72.049999999999997 109.87 -177.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 69.2 mt -98.18 114.86 36.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.133 -1.062 . . . . 74.109999999999999 108.133 -179.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.75 117.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.562 -0.903 . . . . 74.519999999999996 108.562 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.3 m -116.83 121.42 41.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.038 -0.528 . . . . 74.329999999999998 110.078 -178.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.403 HD13 ' CB ' ' A' ' 119' ' ' PHE . 4.4 mm? -106.57 163.05 13.2 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.216 -0.902 . . . . 75.450000000000003 109.555 177.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.43 163.64 54.12 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.261 -1.936 . . . . 73.310000000000002 108.261 171.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.25 -40.32 88.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 118.023 0.912 . . . . 73.230000000000004 112.891 -175.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 53.0 t-80 -68.55 -43.24 77.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.254 -1.017 . . . . 74.430000000000007 108.254 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -65.55 -35.43 80.83 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.356 -1.293 . . . . 73.239999999999995 110.699 -177.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.92 -40.48 91.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 72.420000000000002 109.683 178.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.41 -24.83 60.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.188 0.518 . . . . 73.400000000000006 111.193 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 mmmt -77.52 -17.14 58.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.241 -0.436 . . . . 72.109999999999999 111.848 175.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.5 mt -71.45 -40.44 70.34 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 105.959 -1.867 . . . . 73.400000000000006 105.959 170.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.9 -176.5 18.64 Favored Glycine 0 N--CA 1.414 -2.829 0 CA-C-N 113.776 -1.557 . . . . 72.439999999999998 110.513 176.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.474 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -87.12 1.69 52.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.56 0.695 . . . . 72.230000000000004 109.361 178.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 26.6 p-10 -123.05 49.19 2.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 C-N-CA 124.242 1.017 . . . . 63.229999999999997 112.714 -177.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 5.2 Cg_exo -75.19 -17.16 19.37 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.705 1.604 . . . . 74.200000000000003 110.929 -179.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -26.31 59.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.376 -0.829 . . . . 63.310000000000002 111.982 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.21 -44.94 62.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.645 -1.243 . . . . 72.010000000000005 107.645 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.66 ' HE3' ' CZ ' ' A' ' 85' ' ' PHE . 60.2 tptt -61.3 -33.96 74.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.009 0.924 . . . . 70.329999999999998 109.427 176.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 t -63.05 -49.11 75.84 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.886 -1.052 . . . . 74.430000000000007 110.532 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.5 m -62.04 -34.44 76.24 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-O 120.896 0.379 . . . . 75.120000000000005 110.854 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.73 -52.63 44.1 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.62 -0.992 . . . . 71.219999999999999 110.62 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.66 ' CZ ' ' HE3' ' A' ' 81' ' ' LYS . 8.0 m-30 -58.52 -44.23 89.47 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 112.516 0.562 . . . . 75.450000000000003 112.516 178.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.15 74.65 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.756 0.66 . . . . 70.340000000000003 111.061 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -79.67 -40.28 29.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.372 -0.531 . . . . 72.239999999999995 111.066 -176.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 33.9 t70 -63.9 -38.12 89.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.175 0.512 . . . . 70.230000000000004 111.688 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.55 -29.74 52.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.616 -0.434 . . . . 73.409999999999997 110.08 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.31 -37.28 86.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.566 -0.901 . . . . 74.010000000000005 108.566 173.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 21.4 t70 -60.19 -54.94 39.83 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.593 -1.185 . . . . 72.420000000000002 109.327 176.002 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.4 m-85 -51.71 -49.19 62.94 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 114.005 1.113 . . . . 74.099999999999994 114.005 178.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.9 pt -63.8 -34.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.821 -0.751 . . . . 74.439999999999998 111.12 -177.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 81.1 mm-40 -72.24 -37.37 69.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 121.202 -0.199 . . . . 74.420000000000002 110.697 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 48.3 mm-40 -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.957 -0.565 . . . . 72.129999999999995 110.981 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.4 mm-40 -80.19 -13.3 59.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.727 -0.67 . . . . 74.409999999999997 111.681 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.84 29.81 28.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.756 -0.735 . . . . 60.229999999999997 112.327 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -102.47 162.52 12.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.803 -0.814 . . . . 75.109999999999999 108.803 178.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -133.98 177.17 7.94 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.773 -0.454 . . . . 74.25 109.773 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -160.83 177.33 10.52 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.74 -1.578 . . . . 74.129999999999995 106.74 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.36 119.11 36.53 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.943 -0.762 . . . . 73.219999999999999 108.943 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -150.92 17.05 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 109.387 -1.485 . . . . 73.109999999999999 109.387 -176.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.65 148.11 48.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.834 -1.543 . . . . 75.430000000000007 106.834 177.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.28 122.37 24.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.144 0.497 . . . . 75.129999999999995 110.814 -177.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 7.3 p -138.93 127.73 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.778 0.799 . . . . 74.140000000000001 109.9 -178.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 62' ' ' TYR . 18.8 m -105.17 148.5 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.556 -0.905 . . . . 74.239999999999995 108.556 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -115.52 125.58 53.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.692 -0.855 . . . . 75.310000000000002 108.692 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -101.11 119.79 39.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.265 -0.643 . . . . 75.25 109.265 173.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.9 pt-20 -139.16 164.8 28.85 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 109.377 178.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.66 159.41 29.39 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.558 0.694 . . . . 63.100000000000001 110.928 -177.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -140.21 109.8 6.31 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 114.937 -1.029 . . . . 63.32 109.188 172.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -64.67 -25.83 68.12 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.462 -0.79 . . . . 74.450000000000003 110.054 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -75.84 -14.72 60.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.16 -0.927 . . . . 70.329999999999998 110.438 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -81.98 161.57 22.97 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.211 -1.033 . . . . 74.25 108.211 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -83.15 150.84 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.096 0.474 . . . . 74.129999999999995 110.297 -176.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.0 m -76.31 123.53 26.07 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.59 -0.732 . . . . 75.0 110.602 -178.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.48 8.15 62.79 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.634 -0.986 . . . . 74.420000000000002 110.634 -175.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -114.44 122.02 45.33 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.336 -1.357 . . . . 75.200000000000003 107.336 177.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.403 ' CB ' HD13 ' A' ' 66' ' ' LEU . 43.2 p90 -131.28 154.0 48.96 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.204 -1.035 . . . . 74.549999999999997 108.204 -178.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -141.16 148.42 39.98 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 123.142 0.276 . . . . 75.540000000000006 110.367 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -147.32 121.0 9.19 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.711 -0.848 . . . . 64.25 108.711 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -123.54 140.24 53.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.668 -0.493 . . . . 75.450000000000003 109.668 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.1 136.38 13.34 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 111.555 -0.618 . . . . 72.349999999999994 111.555 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -138.71 158.9 43.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.8 -0.815 . . . . 71.129999999999995 108.8 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.86 106.99 19.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.463 -1.31 . . . . 75.230000000000004 107.463 178.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -124.11 96.83 41.54 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 109.799 -0.445 . . . . 65.310000000000002 109.799 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 N--CA 1.451 -1.021 0 C-N-CA 122.056 1.837 . . . . 73.349999999999994 110.96 178.037 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 34.2 tt0 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.753 -0.462 . . . . 65.349999999999994 109.753 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -65.23 -20.79 66.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.141 0.496 . . . . 74.340000000000003 110.681 179.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 78.8 t -72.34 -48.19 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.221 -0.659 . . . . 71.420000000000002 109.221 177.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -71.5 -26.7 62.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.454 0.645 . . . . 74.0 111.054 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.09 79.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.376 -0.829 . . . . 72.049999999999997 109.665 173.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 6.9 tt -76.74 -34.83 58.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.383 -0.969 . . . . 73.230000000000004 108.383 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 96.9 mt -62.28 -47.21 85.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.291 -0.413 . . . . 71.439999999999998 110.851 177.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -66.4 -30.9 71.37 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.454 -0.573 . . . . 74.049999999999997 109.454 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 39' ' ' LEU . 56.7 ttt180 -63.32 -55.25 26.21 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.146 0.978 . . . . 74.530000000000001 109.82 177.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.45 -23.73 58.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.293 -0.412 . . . . 62.219999999999999 111.423 -175.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.49 98.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.286 -0.635 . . . . 73.430000000000007 109.286 172.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.46 63.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.426 -0.807 . . . . 73.209999999999994 110.85 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.02 -42.42 76.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.784 0.326 . . . . 62.329999999999998 110.937 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.45 9.68 40.69 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.894 -0.593 . . . . 75.409999999999997 114.262 -176.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.0 mm -59.64 135.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.398 0.618 . . . . 75.049999999999997 111.58 177.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.494 ' OE1' HD23 ' A' ' 57' ' ' LEU . 99.5 mt-30 -120.08 150.0 41.29 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.002 -0.999 . . . . 74.510000000000005 110.545 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.1 m -79.78 126.33 30.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.573 -1.194 . . . . 74.439999999999998 109.708 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.5 tp -146.7 -164.07 1.9 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 104.522 -2.399 . . . . 75.099999999999994 104.522 -178.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.556 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 50.7 mt-30 -42.25 133.32 3.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.619 0.768 . . . . 75.510000000000005 110.152 176.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.52 -12.43 46.2 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 114.884 0.714 . . . . 73.010000000000005 114.884 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.55 -34.18 60.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.036 0.384 . . . . 75.120000000000005 112.036 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 29.0 ptt180 -157.05 135.05 11.01 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.307 0.575 . . . . 74.430000000000007 111.943 -177.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.72 151.64 21.15 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.213 -0.903 . . . . 75.409999999999997 110.737 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD23 ' OE1' ' A' ' 49' ' ' GLN . 14.7 tp -84.94 125.0 32.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.744 -0.835 . . . . 73.430000000000007 108.744 -176.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.42 158.31 40.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 115.836 -0.62 . . . . 73.140000000000001 109.73 -178.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.8 148.86 90.75 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.969 2.446 . . . . 75.230000000000004 113.121 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.7 p-10 -125.44 -21.63 4.49 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.234 -0.893 . . . . 61.409999999999997 110.626 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 32.5 tt0 -94.23 107.52 19.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.797 -0.816 . . . . 72.409999999999997 108.797 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 95.3 m-85 -120.52 114.46 21.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.294 0.569 . . . . 74.140000000000001 109.956 177.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.49 122.06 66.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.16 -1.052 . . . . 75.129999999999995 108.16 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.6 mt -115.6 119.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.376 0.607 . . . . 73.299999999999997 109.521 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.1 m -117.45 123.71 47.04 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.721 -0.672 . . . . 50.329999999999998 109.261 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -121.8 171.82 8.61 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 109.949 -0.389 . . . . 74.530000000000001 109.949 175.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.79 147.28 43.11 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.484 -1.046 . . . . 61.299999999999997 110.484 175.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.03 -47.76 65.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 123.099 0.56 . . . . 75.109999999999999 110.666 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 52.7 t-80 -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.506 -0.77 . . . . 65.400000000000006 110.376 -178.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 9.3 t70 -65.2 -43.28 92.11 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.768 0.794 . . . . 73.420000000000002 108.983 -178.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.3 -44.43 92.52 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.82 1.648 . . . . 74.430000000000007 109.8 -178.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -67.25 -37.25 83.2 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.087 -0.506 . . . . 75.409999999999997 110.749 177.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 3.1 mmmp? -68.5 -26.28 65.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.462 -0.336 . . . . 64.040000000000006 110.607 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.65 -45.68 67.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.804 0.811 . . . . 74.400000000000006 109.792 175.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.6 44.87 7.11 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 105.054 -3.218 . . . . 44.219999999999999 105.054 -165.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 6.93 0.05 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 128.624 2.77 . . . . 71.409999999999997 116.851 -171.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -43.45 106.85 0.52 Allowed Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.556 1.142 . . . . 74.400000000000006 108.728 -173.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.65 -52.47 8.79 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.334 3.356 . . . . 74.140000000000001 118.987 -161.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.79 -51.07 7.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.441 1.645 . . . . 73.219999999999999 115.441 -165.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -62.96 -56.48 16.78 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.744 0.646 . . . . 72.049999999999997 112.744 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.435 ' O ' ' HD1' ' A' ' 85' ' ' PHE 0.286 29.1 mmmt -94.8 -8.61 36.98 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 115.55 1.685 . . . . 74.510000000000005 115.55 -177.352 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -69.46 -45.58 68.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.213 -1.773 . . . . 63.240000000000002 106.213 174.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.4 m -69.92 -36.91 75.73 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.059 -0.973 . . . . 65.340000000000003 108.925 175.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.02 -56.22 26.38 Favored Glycine 0 C--O 1.21 -1.345 0 CA-C-N 115.33 -0.85 . . . . 70.109999999999999 113.109 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 32.1 m-85 -60.2 -35.47 75.48 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.449 0.624 . . . . 74.299999999999997 111.492 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.95 94.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.42 . . . . 72.040000000000006 109.99 177.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -68.88 -41.12 78.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.878 -0.601 . . . . 74.510000000000005 110.085 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.67 -50.97 71.43 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.902 -0.407 . . . . 72.049999999999997 109.902 176.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.8 -31.76 70.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.215 0.82 . . . . 72.109999999999999 113.215 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.43 91.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.332 0.587 . . . . 74.319999999999993 109.661 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.0 -41.99 73.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.638 -0.71 . . . . 74.140000000000001 109.655 177.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -56.48 -52.86 63.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 112.565 0.58 . . . . 72.400000000000006 112.565 176.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.32 -37.8 58.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 120.063 -0.655 . . . . 74.239999999999995 111.699 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.28 -50.89 62.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.379 . . . . 73.120000000000005 111.181 175.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -53.31 -51.03 63.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.942 1.297 . . . . 74.420000000000002 110.784 -178.376 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 1.7 mp0 -74.73 -13.44 60.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.086 1.143 . . . . 73.099999999999994 114.086 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.24 38.21 11.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.028 -1.082 . . . . 72.519999999999996 111.796 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -109.42 158.41 17.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.774 -0.825 . . . . 74.200000000000003 108.774 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.4 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 23.6 pt20 -129.11 174.24 9.74 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.923 -0.769 . . . . 73.430000000000007 108.923 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.0 t -162.34 159.29 25.24 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.735 -1.209 . . . . 74.230000000000004 107.735 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.56 118.9 33.11 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.381 -0.97 . . . . 74.25 108.381 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -149.75 16.72 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.567 -1.813 . . . . 75.239999999999995 108.567 -176.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -126.09 164.32 21.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.568 -1.641 . . . . 72.450000000000003 106.568 174.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.37 117.53 28.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.556 -0.905 . . . . 75.530000000000001 108.556 -178.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -118.33 121.03 66.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.607 0.717 . . . . 74.319999999999993 110.643 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.12 113.18 43.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.387 -0.968 . . . . 72.010000000000005 108.387 179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -111.31 134.45 52.89 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.007 -0.542 . . . . 74.510000000000005 109.554 -177.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.4 146.41 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.738 -0.467 . . . . 74.140000000000001 109.738 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.37 168.31 25.2 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.75 -0.833 . . . . 72.030000000000001 108.75 174.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.42 25.77 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.235 0.541 . . . . 73.040000000000006 111.784 178.413 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -135.74 136.87 41.15 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.709 -1.132 . . . . 52.049999999999997 109.146 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 t -80.73 -19.27 45.37 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.8 -0.815 . . . . 64.239999999999995 108.8 176.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -72.79 -36.43 67.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.701 -0.681 . . . . 71.129999999999995 110.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.74 155.22 20.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.176 -0.466 . . . . 73.540000000000006 110.707 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -125.27 173.47 8.78 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.2 0.6 . . . . 72.420000000000002 110.645 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 9.8 m -57.79 125.61 23.77 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.474 0.654 . . . . 75.409999999999997 110.933 -179.139 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.87 54.84 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.318 -0.856 . . . . 74.150000000000006 111.058 -176.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -118.18 118.67 32.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.092 0.472 . . . . 75.310000000000002 110.08 -178.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.457 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 34.0 p90 -139.03 148.45 43.42 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.564 -1.273 . . . . 75.0 107.564 177.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -132.12 130.65 41.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.228 -1.027 . . . . 55.43 108.228 175.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.8 129.48 42.47 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 39.7 mtp180 -119.61 157.8 27.69 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 123.155 0.285 . . . . 71.519999999999996 111.521 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -137.0 109.85 0.74 Allowed Glycine 0 N--CA 1.424 -2.109 0 O-C-N 124.715 1.26 . . . . 60.310000000000002 110.918 176.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.6 m -114.3 150.43 34.48 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.371 -0.603 . . . . 75.530000000000001 109.371 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.24 106.12 16.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 106.49 -1.67 . . . . 75.310000000000002 106.49 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -110.42 102.28 51.07 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 109.962 -0.384 . . . . 75.530000000000001 109.962 -178.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 121.946 1.764 . . . . 74.420000000000002 111.394 178.441 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.445 -0.708 0 N-CA-C 106.271 -1.752 . . . . 74.219999999999999 106.271 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.02 -27.12 33.25 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.443 -1.253 . . . . 72.530000000000001 109.892 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -54.4 33.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.034 0 N-CA-C 107.649 -1.241 . . . . 62.439999999999998 107.649 175.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.78 -46.58 74.45 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.441 1.097 . . . . 71.409999999999997 110.911 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.2 69.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.058 -0.519 . . . . 65.120000000000005 111.655 178.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 119' ' ' PHE . 9.6 tt -70.92 -35.4 72.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.849 0.356 . . . . 74.430000000000007 110.576 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 tp -67.12 -38.65 85.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.938 -0.574 . . . . 73.010000000000005 110.522 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -71.86 -29.06 63.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.407 -0.517 . . . . 73.310000000000002 111.184 177.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.28 -38.02 68.9 Favored 'General case' 0 C--O 1.203 -1.368 0 C-N-CA 119.037 -1.065 . . . . 73.200000000000003 109.075 173.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -64.34 -33.14 75.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.205 -0.665 . . . . 74.219999999999999 109.205 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.52 73.48 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.345 -0.843 . . . . 75.409999999999997 109.613 174.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.98 70.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.563 0.697 . . . . 74.310000000000002 111.477 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.6 -29.92 52.2 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.92 -0.582 . . . . 72.25 109.755 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.51 14.1 65.98 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.824 -0.625 . . . . 75.540000000000006 112.41 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mm -64.0 138.9 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.962 0.905 . . . . 75.230000000000004 111.254 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 76.3 mt-30 -119.25 147.47 44.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.952 -0.567 . . . . 72.109999999999999 110.499 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.5 m -82.95 134.55 35.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 115.029 -0.987 . . . . 55.340000000000003 108.807 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.4 tp -150.69 -165.43 2.27 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.008 -2.219 . . . . 75.019999999999996 105.008 -179.371 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.573 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 80.0 mt-30 -42.2 139.33 1.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.727 0.811 . . . . 74.319999999999993 111.649 176.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.47 20.69 0.97 Allowed Glycine 0 CA--C 1.505 -0.543 0 CA-C-N 115.363 -0.835 . . . . 64.329999999999998 115.032 -170.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 52' ' ' GLN . 20.8 t-20 -86.96 -37.19 17.8 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.316 -1.365 . . . . 71.209999999999994 107.316 175.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -173.92 158.6 3.21 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.195 -0.911 . . . . 73.519999999999996 112.235 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -91.63 151.76 20.55 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.042 -0.981 . . . . 75.430000000000007 111.36 -174.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 22.2 mt -80.88 121.0 25.43 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 115.771 -0.65 . . . . 74.0 110.978 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.13 151.14 37.61 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.731 -1.211 . . . . 61.549999999999997 107.731 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 39.3 Cg_exo -59.44 156.09 37.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.42 2.08 . . . . 72.230000000000004 112.882 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -118.86 -29.41 5.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.572 -0.74 . . . . 72.519999999999996 109.568 176.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -96.52 105.28 17.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.822 -0.626 . . . . 75.439999999999998 109.587 179.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 76.0 m-85 -115.8 114.8 25.25 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.802 -0.444 . . . . 74.120000000000005 109.802 178.24 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.8 119.97 61.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.584 -1.265 . . . . 74.310000000000002 107.584 177.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.42 135.69 41.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.664 -1.236 . . . . 64.299999999999997 107.664 -178.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 27.3 m -124.37 113.36 18.09 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 72.310000000000002 109.685 -177.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.3 -176.89 3.15 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.755 -0.657 . . . . 73.329999999999998 110.26 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.48 173.6 44.17 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.248 -1.141 . . . . 63.340000000000003 110.248 177.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.9 p -65.82 -44.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 117.131 0.466 . . . . 71.209999999999994 111.224 -179.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -56.51 -42.34 78.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.05 0.929 . . . . 74.400000000000006 110.033 177.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 12.6 m-20 -71.94 -37.78 69.93 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.299 -1.318 . . . . 73.430000000000007 110.446 -176.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.7 -37.78 88.77 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.655 -0.498 . . . . 74.329999999999998 109.655 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.5 mt-10 -61.23 -36.96 81.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.693 -0.685 . . . . 75.540000000000006 110.229 177.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.81 -23.88 41.76 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.975 -0.557 . . . . 75.219999999999999 112.362 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 89.5 mt -61.23 -42.29 98.35 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.714 -0.476 . . . . 73.140000000000001 109.714 177.387 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.21 166.65 10.75 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 119.622 -1.275 . . . . 55.240000000000002 113.299 175.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.89 -18.24 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.721 0.408 . . . . 75.299999999999997 111.575 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -115.72 85.4 14.09 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.084 -0.71 . . . . 75.25 109.084 177.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.13 -50.0 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.143 1.895 . . . . 73.129999999999995 112.282 -178.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.27 -49.48 73.89 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.53 0.567 . . . . 74.409999999999997 112.53 -173.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.74 -37.02 82.68 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 112.29 0.478 . . . . 71.239999999999995 112.29 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -77.42 -26.7 51.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.687 -0.405 . . . . 74.310000000000002 111.009 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.1 m -65.57 -40.41 92.75 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.876 -0.416 . . . . 62.210000000000001 109.876 175.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 m -59.79 -39.23 84.24 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.389 0.614 . . . . 73.299999999999997 109.964 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.85 55.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.582 -0.736 . . . . 74.140000000000001 111.976 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -68.95 -28.35 66.55 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.117 0.484 . . . . 74.310000000000002 110.03 -178.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -38.79 86.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 116.147 -0.479 . . . . 74.329999999999998 109.757 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.36 -38.43 89.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 109.564 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -65.31 -42.66 92.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.992 -0.549 . . . . 70.099999999999994 110.344 177.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.15 -33.24 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.373 -0.376 . . . . 74.450000000000003 110.827 178.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.2 98.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.462 -0.569 . . . . 62.229999999999997 109.462 176.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.2 t70 -61.68 -44.18 97.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.304 -0.862 . . . . 73.150000000000006 109.453 177.189 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 m-85 -57.65 -52.96 63.28 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.671 0.619 . . . . 74.129999999999995 112.671 176.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.8 pt -64.59 -30.18 49.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.693 -0.403 . . . . 74.329999999999998 111.705 -176.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -38.31 85.89 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.123 -0.49 . . . . 75.310000000000002 110.366 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 51.3 mt-10 -65.67 -30.55 71.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.951 -0.568 . . . . 75.420000000000002 111.162 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.0 mm-40 -85.52 -11.43 54.18 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.807 -0.633 . . . . 70.340000000000003 110.941 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.66 33.08 60.92 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.764 -0.653 . . . . 65.439999999999998 113.065 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -97.99 161.34 13.77 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.496 -0.482 . . . . 74.540000000000006 110.122 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.95 161.71 18.43 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.021 -0.733 . . . . 74.219999999999999 109.021 178.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -161.1 172.26 17.12 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.576 -1.638 . . . . 74.150000000000006 106.576 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -123.51 120.14 32.03 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 71.450000000000003 110.235 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.74 13.07 Favored Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 109.751 -1.34 . . . . 71.450000000000003 109.751 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.08 141.32 30.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.542 -0.91 . . . . 72.019999999999996 108.542 174.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.37 138.32 21.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.293 -1.002 . . . . 72.329999999999998 108.293 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.19 124.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 121.152 0.501 . . . . 64.310000000000002 111.125 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 15.3 m -108.87 140.54 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 106.643 -1.614 . . . . 74.450000000000003 106.643 172.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.38 144.92 48.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.512 -0.922 . . . . 74.510000000000005 108.512 177.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -111.77 126.93 55.59 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.413 0.445 . . . . 74.349999999999994 110.184 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.5 pt-20 -128.26 168.49 15.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.936 -1.505 . . . . 74.040000000000006 106.936 173.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.35 156.93 34.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 112.004 -177.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 74.5 m -130.48 101.77 5.87 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.171 -1.418 . . . . 74.439999999999998 107.171 169.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -68.14 -9.38 46.17 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 123.948 0.899 . . . . 75.329999999999998 112.941 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.0 -25.66 48.14 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.746 -0.835 . . . . 65.129999999999995 108.746 174.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -104.48 151.45 23.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.66 -1.237 . . . . 75.430000000000007 107.66 -177.235 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -139.65 171.8 13.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 117.563 0.165 . . . . 73.25 111.307 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 m -36.02 112.87 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.28 2.232 . . . . 71.510000000000005 113.057 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.35 -33.07 3.74 Favored Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 107.848 -2.101 . . . . 74.019999999999996 107.848 -175.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -105.73 139.21 40.65 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.908 -1.516 . . . . 74.329999999999998 106.908 174.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CE2' HD11 ' A' ' 39' ' ' LEU . 32.7 p90 -170.45 154.19 4.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.783 -0.821 . . . . 74.230000000000004 108.783 174.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -128.72 157.97 39.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.963 -0.562 . . . . 75.140000000000001 110.261 -177.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.47 144.15 22.62 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.092 -1.818 . . . . 73.209999999999994 106.092 174.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 33.2 ptt-85 -140.41 145.95 37.69 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.436 -0.579 . . . . 72.239999999999995 109.436 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 110.06 0.93 Allowed Glycine 0 C--N 1.284 -2.326 0 O-C-N 124.206 0.942 . . . . 75.219999999999999 111.81 -176.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.6 m -109.25 137.84 46.51 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.65 -0.5 . . . . 73.219999999999999 109.65 -179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.07 109.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.992 -1.855 . . . . 71.400000000000006 105.992 170.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.16 105.88 31.39 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.437 -0.579 . . . . 63.240000000000002 109.437 179.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 C-N-CA 122.165 1.91 . . . . 71.030000000000001 111.689 178.785 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 120.259 0.076 . . . . 73.140000000000001 110.884 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.51 -47.78 69.58 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 123.465 0.706 . . . . 75.099999999999994 109.111 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.36 -44.81 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.272 -0.876 . . . . 74.099999999999994 109.917 -178.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.87 -53.42 56.98 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 116.025 -0.534 . . . . 63.009999999999998 111.352 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.55 86.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.707 -0.679 . . . . 72.329999999999998 111.201 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.36 -41.76 84.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.85 -0.426 . . . . 74.430000000000007 109.85 -178.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.52 -43.4 80.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.581 0.586 . . . . 75.299999999999997 112.581 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -68.65 -29.55 68.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.788 -0.765 . . . . 75.319999999999993 110.78 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -70.06 -38.79 75.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.141 -0.689 . . . . 72.049999999999997 109.141 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.9 -38.15 90.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.962 -0.755 . . . . 74.319999999999993 108.962 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.42 92.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 74.209999999999994 110.421 176.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.91 -31.88 71.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 74.099999999999994 111.468 -178.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.37 -33.55 61.06 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 111.217 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.58 15.53 40.74 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.813 -0.631 . . . . 71.129999999999995 112.94 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.421 HD12 ' CD2' ' A' ' 98' ' ' TRP . 12.2 mm -67.02 130.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 123.332 0.653 . . . . 72.239999999999995 112.132 179.09 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -116.02 147.41 41.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.353 -0.839 . . . . 74.219999999999999 109.622 176.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.6 m -77.55 102.92 7.19 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.163 0.982 . . . . 64.040000000000006 111.484 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.5 tp -105.2 -165.96 1.18 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.246 -2.131 . . . . 75.319999999999993 105.246 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.5 mt-30 -51.06 138.25 20.12 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.348 -0.982 . . . . 72.109999999999999 108.348 171.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.91 22.47 0.57 Allowed Glycine 0 N--CA 1.471 0.982 0 N-CA-C 114.782 0.673 . . . . 52.119999999999997 114.782 -171.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 52' ' ' GLN . 15.9 m120 -104.27 -25.23 12.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.266 -1.013 . . . . 64.319999999999993 108.266 177.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -161.51 134.66 6.31 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.28 -0.873 . . . . 74.400000000000006 110.54 -177.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.0 151.88 19.28 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.783 -0.644 . . . . 75.439999999999998 110.61 -175.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.01 126.6 36.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.159 -1.052 . . . . 74.430000000000007 108.159 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.24 160.41 37.59 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 123.181 0.592 . . . . 70.040000000000006 109.805 -178.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.15 157.99 59.06 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.611 2.208 . . . . 74.540000000000006 111.921 176.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -126.38 -25.12 3.53 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.174 0.435 . . . . 71.430000000000007 112.174 -177.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.48 110.38 21.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.551 -0.537 . . . . 73.319999999999993 109.551 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 55.1 m-85 -116.88 119.16 34.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.434 -0.803 . . . . 73.129999999999995 110.076 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.2 118.99 56.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.669 -0.863 . . . . 73.010000000000005 108.669 177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.1 mp -112.48 124.96 69.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.462 -0.94 . . . . 75.340000000000003 108.462 178.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -119.42 133.64 55.61 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.997 -0.742 . . . . 74.099999999999994 108.997 -178.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.58 173.36 7.23 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.209 0.604 . . . . 75.140000000000001 110.226 175.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.51 166.44 45.57 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 108.846 -1.701 . . . . 72.120000000000005 108.846 172.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 95.1 t -59.07 -59.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 117.666 0.733 . . . . 74.209999999999994 110.885 -178.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.483 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 40.8 t-80 -53.44 -49.17 67.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 75.219999999999999 110.809 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -58.2 -50.38 73.75 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.62 1.168 . . . . 63.130000000000003 111.134 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.24 -40.08 93.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.354 -0.384 . . . . 74.140000000000001 111.24 -176.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 53.5 mt-10 -65.78 -31.27 72.15 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.856 0.36 . . . . 74.329999999999998 111.074 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.6 mptt -79.32 -27.51 42.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 111.266 178.007 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 61.3 mt -75.49 -33.25 60.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.802 . . . . 72.109999999999999 108.833 175.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.01 116.16 1.65 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.833 -1.707 . . . . 72.209999999999994 108.833 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -77.76 1.51 19.89 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.063 0.394 . . . . 62.32 112.063 -176.24 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 25.4 t70 -80.58 101.88 1.07 Allowed Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 124.215 1.006 . . . . 73.299999999999997 109.226 176.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 72.9 Cg_endo -75.92 -33.47 3.7 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.44 2.093 . . . . 72.319999999999993 115.871 -171.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.05 -49.11 71.38 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 112.776 0.658 . . . . 75.140000000000001 112.776 -170.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.96 -15.99 62.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.846 0.355 . . . . 74.450000000000003 111.864 -177.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 75.6 mmtt -81.68 -57.64 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.511 -0.922 . . . . 65.209999999999994 108.511 175.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -53.74 50.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.078 -0.965 . . . . 74.530000000000001 111.308 -173.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.9 m -69.95 -35.5 74.56 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.639 -0.255 . . . . 70.409999999999997 111.195 -177.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.09 -51.05 59.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.284 -0.484 . . . . 75.310000000000002 112.01 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 71.7 m-85 -72.65 -36.03 67.88 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 112.493 0.553 . . . . 73.519999999999996 112.493 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.49 96.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.666 -0.414 . . . . 62.409999999999997 110.739 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -63.83 -49.09 74.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.977 -0.556 . . . . 75.310000000000002 110.559 178.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -67.29 -37.31 83.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 65.230000000000004 111.552 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 tp -74.05 -34.93 64.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 73.239999999999995 111.005 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.11 89.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.814 -0.81 . . . . 63.229999999999997 108.814 175.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.36 -48.83 74.03 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.968 -1.014 . . . . 74.230000000000004 109.736 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.593 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.9 m-85 -52.08 -53.33 43.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.906 0.706 . . . . 71.430000000000007 112.906 176.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.4 pt -62.09 -36.53 74.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 120.594 -0.443 . . . . 73.299999999999997 111.494 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.56 -41.68 79.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.291 . . . . 65.140000000000001 110.861 177.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -59.27 -41.02 87.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.026 0.441 . . . . 63.240000000000002 111.194 177.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 78.6 mm-40 -72.99 -13.37 61.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.009 -0.542 . . . . 73.450000000000003 112.21 -178.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.13 36.07 13.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.37 -0.919 . . . . 63.100000000000001 111.06 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.421 ' CD2' HD12 ' A' ' 48' ' ' ILE . 21.3 m0 -113.21 170.91 7.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.194 -1.039 . . . . 74.200000000000003 108.194 175.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -151.62 178.19 9.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.691 -0.855 . . . . 72.230000000000004 108.691 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -150.52 177.91 9.57 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.518 -0.549 . . . . 75.120000000000005 109.518 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -111.66 121.04 44.05 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 178.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.96 -149.68 17.05 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.222 -1.151 . . . . 64.129999999999995 110.222 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.78 147.19 46.26 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.166 -0.679 . . . . 74.219999999999999 109.166 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.9 125.16 39.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 110.844 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.04 120.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 121.789 0.804 . . . . 74.329999999999998 109.984 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.3 t -117.78 112.43 38.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.212 -1.403 . . . . 74.439999999999998 107.212 179.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -115.97 138.87 50.8 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 111.934 0.346 . . . . 75.030000000000001 111.934 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -119.18 134.9 54.94 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.269 -1.011 . . . . 75.200000000000003 108.269 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -156.17 164.16 38.72 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 123.563 0.539 . . . . 64.409999999999997 111.232 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -95.46 164.91 12.61 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.106 -0.497 . . . . 72.230000000000004 111.241 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 p -150.36 150.21 31.12 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 115.444 -0.798 . . . . 71.420000000000002 109.647 177.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -80.78 -22.83 39.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.607 -0.516 . . . . 73.109999999999999 109.607 176.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.93 -28.1 68.67 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.469 0.707 . . . . 71.510000000000005 110.756 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.3 mt -96.5 135.92 37.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.917 -0.583 . . . . 74.420000000000002 110.716 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -110.66 172.06 7.1 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.638 -1.616 . . . . 74.5 106.638 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.564 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 97.4 m -58.91 126.29 27.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.966 1.469 . . . . 70.310000000000002 114.966 -174.129 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.64 -8.79 47.57 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 114.18 -1.373 . . . . 73.319999999999993 111.443 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -104.53 135.68 45.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.75 0.309 . . . . 74.530000000000001 110.865 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.01 151.04 37.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.24 -1.022 . . . . 74.109999999999999 108.24 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 53.8 mtm180 -124.67 143.21 50.86 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.855 -1.165 . . . . 75.209999999999994 107.855 177.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.85 118.3 10.3 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.292 -1.744 . . . . 71.230000000000004 106.292 173.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 23.1 tpt180 -120.3 121.67 39.17 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 120.05 -0.66 . . . . 74.420000000000002 110.058 -177.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.09 119.25 6.43 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.607 -1.397 . . . . 44.229999999999997 109.607 176.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.3 p -126.06 156.62 39.68 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 110.081 -0.34 . . . . 73.140000000000001 110.081 -178.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.52 110.74 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 107.199 -1.408 . . . . 64.329999999999998 107.199 175.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -117.4 96.29 49.02 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.408 -0.96 . . . . 74.510000000000005 108.408 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 122.333 2.022 . . . . 71.340000000000003 111.848 -177.399 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 . . . . . 0 C--O 1.241 0.616 0 CA-C-O 120.691 0.281 . . . . 72.010000000000005 111.491 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.56 -34.48 74.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.011 -0.366 . . . . 74.140000000000001 110.011 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 59.3 t -56.22 -50.5 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 74.450000000000003 110.111 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.82 -43.31 98.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.547 -178.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.14 89.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.666 -0.697 . . . . 54.219999999999999 110.822 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.6 -23.92 58.8 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.832 0.679 . . . . 72.129999999999995 112.832 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.6 mt -67.26 -37.43 83.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 73.430000000000007 110.294 175.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -65.26 -42.0 93.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.643 0.735 . . . . 75.329999999999998 109.242 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -71.7 -28.68 63.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.415 -0.811 . . . . 75.209999999999994 111.316 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 29.9 tp10 -68.92 -44.67 72.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.192 -0.67 . . . . 71.349999999999994 109.192 176.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -59.99 -41.58 92.33 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.642 -0.708 . . . . 72.219999999999999 109.728 176.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.62 -36.49 80.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.545 -0.752 . . . . 52.329999999999998 111.147 177.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.96 -39.49 83.36 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 64.319999999999993 111.247 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.92 5.96 80.64 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.747 -0.661 . . . . 65.200000000000003 113.697 -178.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 44' ' ' ALA . 10.8 mm -58.91 130.38 22.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.589 0.709 . . . . 75.040000000000006 112.112 178.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -116.19 134.71 54.62 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.356 -0.838 . . . . 74.299999999999997 110.056 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -72.52 106.59 4.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.804 -1.089 . . . . 72.140000000000001 109.694 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.9 tp -109.16 -164.69 0.96 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.796 -1.557 . . . . 61.5 106.796 -177.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 16.1 mm100 -51.52 162.49 0.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.651 0.781 . . . . 73.239999999999995 112.307 176.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -7.48 38.21 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-N 114.946 -1.024 . . . . 74.530000000000001 113.7 -175.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -68.38 -48.63 64.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 71.120000000000005 108.797 177.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -176.27 167.77 2.84 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.774 1.027 . . . . 75.299999999999997 113.774 -177.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.11 151.26 21.06 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.486 -1.234 . . . . 71.120000000000005 111.153 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.95 126.28 43.28 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.664 -1.236 . . . . 74.239999999999995 107.664 -177.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.82 158.06 35.13 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 123.548 0.739 . . . . 54.520000000000003 109.648 -178.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.84 158.27 38.91 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.893 2.396 . . . . 63.450000000000003 113.087 178.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -124.81 -30.16 3.31 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.631 -0.713 . . . . 73.549999999999997 110.448 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.67 107.96 19.62 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.048 0.939 . . . . 64.5 108.596 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -116.22 118.12 31.91 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.885 0.374 . . . . 71.549999999999997 110.353 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.52 114.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.114 -0.698 . . . . 72.120000000000005 109.114 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 2.3 mp -109.27 132.39 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.678 -1.23 . . . . 75.219999999999999 107.678 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.2 m -137.39 135.88 37.36 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.951 -0.389 . . . . 72.329999999999998 109.951 -177.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -130.17 -179.38 5.2 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.303 -0.629 . . . . 74.219999999999999 109.303 175.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.03 53.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.86 -1.296 . . . . 71.400000000000006 109.86 175.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 110' ' ' GLN . 43.4 t -56.25 -56.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 117.443 0.621 . . . . 74.430000000000007 111.83 -175.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.602 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 50.4 t-80 -59.12 -45.14 91.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.462 0.476 . . . . 75.239999999999995 110.555 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.85 -43.19 99.46 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 70.329999999999998 109.753 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.27 -39.44 82.18 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.382 -0.826 . . . . 73.430000000000007 111.12 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 36.5 mt-10 -65.25 -28.58 69.45 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.648 0.261 . . . . 63.329999999999998 111.607 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 0.4 OUTLIER -78.57 -23.33 46.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 120.017 -0.673 . . . . 74.209999999999994 109.686 178.686 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.22 -36.79 74.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 73.299999999999997 109.916 174.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.21 158.32 8.59 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.821 -0.912 . . . . 54.140000000000001 110.821 177.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.8 -6.92 57.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 111.872 0.323 . . . . 74.349999999999994 111.872 -177.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.72 103.31 46.32 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.691 -0.231 . . . . 74.420000000000002 111.594 -179.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.43 -36.55 8.83 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.62 1.547 . . . . 61.219999999999999 109.86 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.52 -29.19 66.75 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.148 0.796 . . . . 73.319999999999993 113.148 -176.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.84 -42.94 94.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.77 -1.567 . . . . 73.109999999999999 106.77 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.69 -38.79 77.12 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.476 -1.238 . . . . 75.420000000000002 109.456 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' HG11 ' A' ' 106' ' ' VAL . 65.2 m -58.22 -48.36 80.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.353 -0.385 . . . . 60.509999999999998 111.02 177.359 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -57.8 -49.01 78.04 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 123.391 0.432 . . . . 70.150000000000006 110.69 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.18 -55.73 19.82 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.719 -0.673 . . . . 74.510000000000005 112.904 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -67.41 -37.12 82.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.741 1.015 . . . . 73.040000000000006 113.741 -175.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -66.6 -45.02 80.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.527 . . . . 75.319999999999993 110.697 -179.314 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.36 -40.01 89.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 74.049999999999997 110.3 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.52 -53.32 53.74 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.166 -0.925 . . . . 74.329999999999998 111.064 178.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.11 -30.34 70.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 75.420000000000002 111.334 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.8 78.55 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.178 0.513 . . . . 63.340000000000003 110.033 176.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.69 -39.7 73.34 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.599 -0.889 . . . . 75.400000000000006 108.599 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 22.0 m-85 -56.83 -52.18 66.08 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.532 -0.758 . . . . 75.340000000000003 112.494 175.346 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.1 pt -61.63 -37.27 77.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.357 -0.537 . . . . 75.219999999999999 111.093 -177.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.32 -38.18 84.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.326 -0.397 . . . . 72.109999999999999 110.567 176.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -60.46 -44.0 96.32 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 64.010000000000005 111.051 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.5 mm-40 -75.91 -13.7 60.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.455 -0.793 . . . . 70.430000000000007 110.837 -178.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.89 35.68 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.928 -0.578 . . . . 75.400000000000006 112.442 177.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.75 172.56 7.18 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.35 173.45 11.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.524 -0.547 . . . . 63.539999999999999 109.524 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 t -157.53 177.84 10.96 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.331 -1.729 . . . . 74.239999999999995 106.331 177.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.07 117.48 34.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.686 -1.227 . . . . 75.340000000000003 107.686 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.82 -149.64 16.75 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.282 -1.927 . . . . 71.420000000000002 108.282 -177.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.68 169.61 15.93 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.387 -1.338 . . . . 74.209999999999994 107.387 171.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 99.7 t -73.01 120.88 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.825 0.345 . . . . 72.019999999999996 111.287 -174.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -115.5 120.0 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.695 -0.854 . . . . 72.129999999999995 108.695 176.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 86' ' ' ALA . 13.9 p -119.69 129.02 75.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.516 0.674 . . . . 74.219999999999999 110.435 -176.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -115.8 138.07 51.49 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.339 -0.846 . . . . 73.319999999999993 109.983 -178.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -121.41 132.69 54.89 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.189 -1.412 . . . . 74.310000000000002 107.189 179.003 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.94 174.79 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.266 0.555 . . . . 74.400000000000006 111.02 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . 17.0 pm0 -110.18 151.94 26.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.063 -0.971 . . . . 73.140000000000001 110.612 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -141.42 132.28 25.91 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 107.24 -1.392 . . . . 71.340000000000003 107.24 176.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -81.6 -22.7 37.53 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.928 -0.767 . . . . 75.030000000000001 108.928 176.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -73.0 -30.21 63.61 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.598 0.714 . . . . 75.209999999999994 109.318 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -81.13 141.7 34.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.68 144.22 28.7 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.894 -0.594 . . . . 73.099999999999994 112.037 -171.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.9 m -64.84 124.54 22.25 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.85 -0.614 . . . . 75.230000000000004 109.567 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.27 -22.89 24.08 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.26 -1.136 . . . . 72.450000000000003 110.26 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -95.04 152.37 18.38 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.254 -1.017 . . . . 74.140000000000001 108.254 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.461 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 31.5 p90 -148.37 146.84 28.68 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.017 -1.475 . . . . 70.340000000000003 107.017 174.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 64.9 mtp180 -126.6 144.64 50.83 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.771 -0.455 . . . . 75.319999999999993 109.771 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.71 122.95 19.32 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.298 -1.371 . . . . 74.019999999999996 107.298 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.483 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 26.1 tpt180 -131.39 130.0 42.04 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.946 -0.702 . . . . 74.109999999999999 111.178 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -102.27 126.43 8.87 Favored Glycine 0 N--CA 1.425 -2.077 0 O-C-N 124.072 0.857 . . . . 72.109999999999999 111.059 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.1 m -122.82 146.57 47.43 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.662 -0.866 . . . . 73.510000000000005 108.662 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.1 t -95.66 105.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.184 -1.413 . . . . 74.329999999999998 107.184 174.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.48 100.14 51.15 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 120.871 -0.332 . . . . 70.200000000000003 110.206 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.442 -1.505 0 C-N-CA 121.994 1.796 . . . . 75.420000000000002 110.901 175.638 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.483 0.183 . . . . 72.150000000000006 111.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.09 85.49 0.14 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.774 -0.93 . . . . 71.310000000000002 110.774 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -63.06 127.33 30.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 109.702 -0.481 . . . . 64.349999999999994 109.702 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.5 165.16 13.51 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.166 -0.679 . . . . 75.340000000000003 109.166 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -90.17 149.36 22.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.841 -1.17 . . . . 72.400000000000006 107.841 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 130' ' ' GLU . 5.3 tpp180 -72.94 99.46 2.71 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.76 0.791 . . . . 74.340000000000003 110.927 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.8 mt -123.97 112.81 17.64 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.764 -1.199 . . . . 74.129999999999995 107.764 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 m -91.62 -7.08 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.564 0.697 . . . . 64.319999999999993 109.23 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.39 93.66 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.768 -1.106 . . . . 71.140000000000001 111.116 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.84 102.55 13.8 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 105.229 -2.138 . . . . 72.409999999999997 105.229 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.5 t -45.12 119.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 124.472 1.107 . . . . 64.209999999999994 111.366 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.4 117.17 19.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 114.153 1.168 . . . . 72.409999999999997 114.153 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -147.31 143.39 28.03 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 104.348 -2.464 . . . . 74.109999999999999 104.348 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -87.26 81.04 8.05 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.561 -0.855 . . . . 75.349999999999994 111.742 -177.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.78 95.35 2.88 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.079 -0.964 . . . . 74.340000000000003 109.55 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.954 -0.758 . . . . 75.510000000000005 108.954 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.84 87.17 4.22 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 106.686 -1.598 . . . . 74.409999999999997 106.686 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 m -99.31 129.82 45.55 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 114.534 -1.212 . . . . 74.329999999999998 108.0 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -119.11 124.91 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.513 0.673 . . . . 73.219999999999999 111.87 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.75 -62.85 0.27 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 111.442 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.94 -4.1 58.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.148 0.499 . . . . 73.420000000000002 110.673 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.69 -36.69 72.3 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.368 -0.833 . . . . 74.420000000000002 111.619 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -61.86 -43.42 98.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.154 -0.475 . . . . 72.340000000000003 111.553 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -46.45 84.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.833 0.349 . . . . 73.329999999999998 111.08 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -71.6 -28.39 63.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.702 -0.681 . . . . 73.439999999999998 112.651 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 22' ' ' ALA . 71.1 mt -67.86 -50.32 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.334 -0.247 . . . . 72.439999999999998 110.334 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -76.14 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.869 0.366 . . . . 73.319999999999993 111.76 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.56 29.24 74.62 Favored Glycine 0 CA--C 1.506 -0.498 0 CA-C-N 115.781 -0.645 . . . . 74.340000000000003 112.897 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.15 83.86 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.484 -0.865 . . . . 74.219999999999999 113.542 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -60.09 -38.22 82.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.482 1.135 . . . . 74.530000000000001 108.204 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.539 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 23.9 pt -130.89 154.99 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 104.063 -2.569 . . . . 74.120000000000005 104.063 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.01 94.37 14.69 Favored Pre-proline 0 C--N 1.289 -2.036 0 C-N-CA 120.265 -0.574 . . . . 74.209999999999994 109.582 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 31' ' ' ILE . 23.3 Cg_exo -67.95 -36.54 17.51 Favored 'Trans proline' 0 C--O 1.2 -1.378 0 C-N-CA 122.277 1.984 . . . . 64.329999999999998 110.722 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.48 ' HA ' ' CD ' ' A' ' 37' ' ' GLU . 95.1 mt-30 -61.74 -11.93 14.39 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.572 0.953 . . . . 73.349999999999994 113.572 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -71.33 -23.93 62.02 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.244 -1.021 . . . . 71.510000000000005 108.244 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HA ' ' CE2' ' A' ' 119' ' ' PHE . 98.4 t -69.12 -54.72 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.352 -0.84 . . . . 64.310000000000002 108.844 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' CD ' ' HA ' ' A' ' 34' ' ' GLN . 2.7 mp0 -52.64 -43.9 65.75 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.053 0.454 . . . . 71.040000000000006 110.769 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.72 -54.53 43.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.087 -0.96 . . . . 74.329999999999998 111.399 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.5 tp -74.53 -25.18 59.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.782 -0.367 . . . . 75.310000000000002 110.857 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.17 -47.83 72.69 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.688 0.795 . . . . 73.400000000000006 109.966 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -71.09 -27.95 63.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.152 0.501 . . . . 62.43 110.182 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.16 -42.38 84.43 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.49 -0.777 . . . . 74.329999999999998 109.035 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.18 -32.6 70.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 75.209999999999994 109.434 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.36 95.67 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.923 -0.581 . . . . 74.439999999999998 109.739 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.17 80.19 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.613 0.721 . . . . 63.340000000000003 110.441 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -16.56 60.5 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.339 -0.846 . . . . 74.120000000000005 110.808 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.06 7.9 41.52 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 116.156 -0.475 . . . . 63.32 112.666 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.97 127.51 27.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 120.984 0.421 . . . . 74.230000000000004 110.835 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -105.7 124.43 49.55 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.192 -1.04 . . . . 74.019999999999996 108.192 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -60.9 109.27 1.02 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 124.124 0.89 . . . . 71.310000000000002 109.961 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.528 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.6 tp -122.56 -164.78 1.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.138 -1.801 . . . . 75.340000000000003 106.138 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.528 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.7 mt-30 -46.35 146.17 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.523 0.729 . . . . 75.519999999999996 110.81 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.65 -11.9 38.13 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 114.519 0.568 . . . . 75.140000000000001 114.519 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.34 -47.64 40.74 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.791 0.329 . . . . 73.030000000000001 110.544 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.579 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 24.1 ptt180 -158.88 142.92 15.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.581 0.705 . . . . 75.340000000000003 112.443 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.5 mt -91.26 151.63 20.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 125.223 1.409 . . . . 73.540000000000006 109.933 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 100' ' ' THR . 1.1 tt -90.41 118.28 29.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.045 -1.094 . . . . 73.439999999999998 108.045 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.37 153.78 39.53 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.716 -0.675 . . . . 75.409999999999997 109.714 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 44.8 Cg_exo -60.2 150.07 81.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 112.014 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.82 -36.16 4.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.876 -0.602 . . . . 71.340000000000003 110.959 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -104.24 122.92 46.39 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.062 0.458 . . . . 73.430000000000007 109.853 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.1 m-85 -118.55 118.53 31.96 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.228 -0.897 . . . . 74.439999999999998 109.53 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.6 109.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.477 -1.305 . . . . 73.329999999999998 107.477 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -105.65 107.1 21.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.191 -1.04 . . . . 73.530000000000001 108.191 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 53.2 m -111.08 123.69 50.7 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.43 -0.805 . . . . 75.310000000000002 110.558 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -116.13 175.62 5.47 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.868 -0.606 . . . . 74.239999999999995 109.952 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' N ' HD13 ' A' ' 114' ' ' LEU . . . -71.97 153.84 50.32 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 109.104 -1.598 . . . . 74.329999999999998 109.104 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.67 -42.17 80.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 110.346 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.447 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 5.0 t60 -66.89 -29.9 69.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.272 -0.876 . . . . 71.420000000000002 110.532 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 m-20 -76.27 -46.16 29.28 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.634 -0.506 . . . . 73.430000000000007 109.634 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.4 -42.53 99.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.559 -0.746 . . . . 74.239999999999995 111.877 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HG3' ' HD2' ' A' ' 73' ' ' LYS . 10.1 pt-20 -62.82 -34.33 77.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.929 0.395 . . . . 72.010000000000005 111.581 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.8 mptt -75.47 -27.07 58.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.163 -0.471 . . . . 72.040000000000006 111.201 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 73.5 mt -72.22 -40.3 67.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.517 -0.92 . . . . 74.140000000000001 108.517 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 146.62 6.16 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 109.771 -1.332 . . . . 63.219999999999999 109.771 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.57 -18.9 62.9 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 114.401 1.26 . . . . 71.310000000000002 114.401 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.39 124.04 76.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 119.595 -0.842 . . . . 73.329999999999998 110.472 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -77.39 -35.81 1.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.658 1.572 . . . . 72.420000000000002 110.88 167.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.86 -53.29 33.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.432 2.012 . . . . 73.230000000000004 116.432 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.38 -32.25 66.26 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.492 0.663 . . . . 74.209999999999994 110.389 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.14 -39.16 65.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.909 -1.041 . . . . 71.430000000000007 108.955 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.7 t -62.17 -44.13 97.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.301 -0.863 . . . . 64.049999999999997 109.883 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -59.13 -45.92 89.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.245 -0.434 . . . . 73.200000000000003 110.459 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.93 -48.93 51.6 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.844 -0.616 . . . . 75.219999999999999 112.855 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.25 -39.97 78.14 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.233 0.827 . . . . 74.219999999999999 113.233 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.7 95.23 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 121.085 -0.246 . . . . 75.329999999999998 110.625 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -37.56 87.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 74.019999999999996 110.612 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.77 -44.69 69.64 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.253 -0.431 . . . . 73.450000000000003 110.523 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.07 -37.96 84.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.127 -0.488 . . . . 72.010000000000005 109.844 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.7 71.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.367 0.603 . . . . 74.5 110.485 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 8.2 t70 -68.29 -43.61 77.33 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.148 -1.056 . . . . 74.349999999999994 108.148 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.0 m-85 -57.42 -47.68 81.11 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.323 -0.853 . . . . 74.439999999999998 112.821 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -62.47 -35.42 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.737 -0.785 . . . . 73.099999999999994 111.086 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.76 -45.96 87.46 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.414 -0.587 . . . . 74.409999999999997 109.414 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 32.2 mm-40 -60.44 -31.62 70.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.728 0.811 . . . . 73.540000000000006 113.078 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.2 mm-40 -90.99 -10.95 40.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.319 -0.401 . . . . 74.239999999999995 111.395 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 38.15 35.67 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.702 -0.761 . . . . 65.200000000000003 111.424 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -104.49 158.8 16.23 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.741 -0.466 . . . . 73.150000000000006 109.741 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.579 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -126.9 167.54 15.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.573 -0.528 . . . . 70.420000000000002 109.573 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.446 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.5 t -158.35 179.27 9.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.958 -0.756 . . . . 73.430000000000007 108.958 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -130.81 128.73 41.29 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.588 -0.523 . . . . 72.540000000000006 109.588 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 -149.98 16.9 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 108.313 -1.915 . . . . 63.100000000000001 108.313 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -124.84 141.29 52.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.925 -1.139 . . . . 75.319999999999993 107.925 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.75 112.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 123.53 0.518 . . . . 75.439999999999998 110.02 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.74 125.61 67.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.852 0.834 . . . . 73.099999999999994 111.288 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.02 129.82 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 N-CA-C 108.513 -0.921 . . . . 73.109999999999999 108.513 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -106.0 127.17 52.98 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.939 -0.573 . . . . 75.530000000000001 109.922 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.61 115.43 29.87 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 75.219999999999999 107.877 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.2 pt-20 -145.54 164.02 32.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.992 -0.549 . . . . 74.310000000000002 110.218 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -120.11 154.06 35.24 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.236 0.541 . . . . 74.049999999999997 111.124 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.6 m -137.81 143.47 41.04 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.597 -0.89 . . . . 70.400000000000006 108.597 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -72.5 -20.08 61.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.474 0.654 . . . . 73.310000000000002 111.129 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.01 -11.33 59.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.6 -0.727 . . . . 75.450000000000003 111.025 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 67' ' ' GLY . 0.7 OUTLIER -101.39 133.9 45.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 105.808 -1.923 . . . . 74.219999999999999 105.808 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -93.27 170.3 9.73 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 112.88 0.696 . . . . 64.239999999999995 112.88 -173.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -72.59 127.73 33.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.319 -0.855 . . . . 73.329999999999998 111.18 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.02 28.94 24.37 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 110.278 -1.129 . . . . 74.019999999999996 110.278 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -140.64 151.44 44.61 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.144 -1.058 . . . . 70.340000000000003 108.144 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.504 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 p90 -152.77 150.91 29.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.478 -1.304 . . . . 74.239999999999995 107.478 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -141.96 130.3 22.35 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.694 -0.484 . . . . 74.510000000000005 109.694 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.87 121.76 38.78 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.246 -1.39 . . . . 75.430000000000007 107.246 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -121.59 118.33 28.97 Favored 'General case' 0 N--CA 1.398 -3.068 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 109.196 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' N ' ' HD3' ' A' ' 122' ' ' ARG . . . -111.54 138.12 14.75 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 110.312 -1.115 . . . . 75.319999999999993 110.312 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 t -144.85 163.84 32.88 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.369 -0.974 . . . . 74.120000000000005 108.369 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.57 103.77 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 106.943 -1.503 . . . . 72.349999999999994 106.943 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -118.85 106.41 43.84 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.901 -0.591 . . . . 63.340000000000003 110.065 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -84.13 -11.15 8.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.053 1.835 . . . . 72.530000000000001 110.949 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 73.510000000000005 111.021 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.52 99.88 8.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.464 -1.31 . . . . 74.230000000000004 107.464 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 6' ' ' ARG . 44.6 mt-10 -75.58 118.79 18.81 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 114.621 -1.172 . . . . 51.409999999999997 111.055 -174.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.07 86.74 2.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 114.263 -1.335 . . . . 75.310000000000002 110.215 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 114.628 -1.169 . . . . 75.319999999999993 109.534 -175.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 CA--C 1.501 -0.929 0 N-CA-C 107.595 -1.261 . . . . 71.200000000000003 107.595 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.02 38.54 63.9 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 110.993 -0.843 . . . . 75.120000000000005 110.993 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.7 t -156.93 157.94 35.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.91 -0.774 . . . . 74.420000000000002 108.91 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -69.61 138.23 52.94 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 123.141 0.577 . . . . 72.430000000000007 112.014 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -94.27 120.86 35.13 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.156 -1.424 . . . . 74.430000000000007 107.156 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -75.81 107.59 8.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.312 -0.625 . . . . 74.299999999999997 109.312 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.17 85.0 6.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.187 0.518 . . . . 74.420000000000002 109.702 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.48 120.92 29.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.249 -0.887 . . . . 71.340000000000003 109.347 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -89.29 98.67 11.9 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.311 -0.625 . . . . 75.450000000000003 109.311 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -89.96 96.22 10.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 75.340000000000003 106.96 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.5 91.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.152 -1.055 . . . . 75.5 108.152 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.19 117.77 26.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.213 -0.903 . . . . 72.400000000000006 109.304 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -68.31 -32.63 72.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 75.519999999999996 111.958 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -97.14 95.36 7.7 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.392 -0.923 . . . . 74.140000000000001 111.196 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -150.31 99.04 2.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 104.135 -2.542 . . . . 71.400000000000006 104.135 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.79 163.36 32.41 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.309 -0.859 . . . . 73.209999999999994 109.811 -172.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -81.25 75.25 8.23 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.174 0.511 . . . . 75.150000000000006 111.972 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.5 m -93.35 101.57 13.81 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 106.13 -1.804 . . . . 65.549999999999997 106.13 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.91 140.25 17.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 114.509 -1.223 . . . . 72.439999999999998 110.189 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.59 159.32 9.56 Favored Glycine 1 N--CA 1.392 -4.254 0 N-CA-C 109.126 -1.59 . . . . 72.230000000000004 109.126 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 7.4 p-10 -72.95 72.35 1.11 Allowed 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 122.587 1.184 . . . . 70.329999999999998 111.627 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -46.91 88.01 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.7 -1.136 . . . . 74.120000000000005 112.641 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -63.03 -35.18 79.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.243 -0.435 . . . . 74.040000000000006 111.284 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.49 -35.96 73.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 72.430000000000007 110.853 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 7.9 mmt180 -77.14 -20.56 55.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 75.030000000000001 110.884 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.2 mt -87.98 -59.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.382 -0.372 . . . . 75.099999999999994 110.85 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' SER . 88.1 m-85 -86.03 -28.31 24.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.289 0.848 . . . . 75.400000000000006 113.289 -173.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.4 -101.83 1.11 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.888 -0.485 . . . . 72.200000000000003 111.888 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.36 31.89 5.81 Favored Glycine 0 C--N 1.294 -1.759 0 N-CA-C 111.476 -0.649 . . . . 71.409999999999997 111.476 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 27' ' ' PHE . 27.4 t -103.14 -150.0 0.41 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.263 -1.755 . . . . 74.010000000000005 106.263 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.429 ' O ' HD13 ' A' ' 31' ' ' ILE 0.267 2.5 pp -55.75 117.97 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.392 1.091 . . . . 75.519999999999996 112.923 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 135.14 19.54 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.525 -1.216 . . . . 73.129999999999995 109.584 -176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 12.4 Cg_endo -55.97 -24.43 48.33 Favored 'Trans proline' 0 C--O 1.21 -0.901 0 C-N-CA 123.624 2.883 . . . . 74.340000000000003 114.82 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.28 -38.99 81.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.464 0.913 . . . . 75.120000000000005 113.464 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.84 -28.87 60.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.225 0.536 . . . . 74.530000000000001 110.296 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 t -71.99 -42.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.646 -0.872 . . . . 71.450000000000003 108.646 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 45.2 mt-10 -58.31 -44.27 88.53 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.97 -0.559 . . . . 75.349999999999994 109.856 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -49.84 72.53 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 124.043 0.839 . . . . 75.150000000000006 111.163 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.16 -37.62 75.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.49 0.552 . . . . 74.140000000000001 112.49 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 mt -64.99 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.39 0.515 . . . . 74.120000000000005 112.39 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 26.3 ptt180 -71.08 -28.01 64.03 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.104 -0.638 . . . . 72.420000000000002 109.808 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -68.9 -40.87 78.92 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 108.526 -0.916 . . . . 73.540000000000006 108.526 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.48 -40.69 92.2 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.91 0.484 . . . . 74.310000000000002 110.248 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.331 -0.85 . . . . 72.519999999999996 110.777 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.11 76.25 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.41 0.624 . . . . 74.299999999999997 111.112 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -71.57 -44.96 63.57 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.508 -0.769 . . . . 72.329999999999998 110.746 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.57 21.69 20.79 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 115.604 -0.726 . . . . 73.519999999999996 113.523 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.406 HD13 ' CD2' ' A' ' 98' ' ' TRP . 11.8 mm -61.97 125.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.255 0.55 . . . . 72.310000000000002 110.346 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -121.17 137.1 54.83 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.986 -1.007 . . . . 75.150000000000006 110.841 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -63.24 118.0 7.37 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.39 -1.277 . . . . 74.230000000000004 112.427 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.5 tp -139.03 -165.88 1.92 Allowed 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.318 -2.475 . . . . 71.329999999999998 104.318 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.531 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.45 140.35 7.98 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.186 0.594 . . . . 72.319999999999993 111.287 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.14 -15.87 57.01 Favored Glycine 0 CA--C 1.505 -0.59 0 CA-C-N 115.896 -0.593 . . . . 74.129999999999995 114.408 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.63 -35.56 67.82 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 111.815 0.302 . . . . 55.130000000000003 111.815 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 4.4 ptm180 -162.28 131.34 4.31 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.647 0.737 . . . . 65.310000000000002 111.083 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.53 152.33 20.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.369 1.467 . . . . 73.329999999999998 110.719 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 100' ' ' THR . 55.7 tp -78.08 126.01 30.19 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.54 -0.754 . . . . 73.099999999999994 109.909 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 158.57 43.28 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 108.316 -0.994 . . . . 73.340000000000003 108.316 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 37.5 Cg_exo -60.66 156.7 41.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.135 2.557 . . . . 72.540000000000006 113.674 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.66 -27.32 3.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.636 -0.711 . . . . 73.340000000000003 110.118 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.41 109.06 21.2 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.804 -0.813 . . . . 71.420000000000002 108.804 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 94.6 m-85 -115.66 115.45 26.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.595 -0.73 . . . . 75.120000000000005 110.656 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.74 119.51 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.191 -1.04 . . . . 74.25 108.191 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 121' ' ' ALA . 15.2 mm -109.48 115.52 49.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.733 -1.21 . . . . 73.219999999999999 107.733 176.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 m -108.8 129.17 55.38 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.947 -0.57 . . . . 71.340000000000003 110.174 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.56 172.72 9.0 Favored 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.939 0.896 . . . . 72.219999999999999 109.587 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.33 179.39 53.2 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.057 -0.817 . . . . 43.100000000000001 111.057 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.45 -41.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.828 0.677 . . . . 72.329999999999998 112.828 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 75.4 t60 -73.04 -28.84 62.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.99 0.9 . . . . 74.129999999999995 109.413 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 1.5 m-20 -69.21 -44.16 72.67 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.999 -1.001 . . . . 74.230000000000004 108.602 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.89 -30.39 66.74 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 111.749 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 13.0 pt-20 -68.55 -29.94 68.61 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.95 -0.7 . . . . 74.530000000000001 110.35 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 14.5 mmmm -68.61 -31.51 70.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.039 -0.982 . . . . 74.219999999999999 109.796 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.74 -30.25 59.15 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.613 0.72 . . . . 74.319999999999993 109.107 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.7 -163.67 15.41 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.158 -0.928 . . . . 71.109999999999999 111.388 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.9 2.33 51.83 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.63 0.729 . . . . 62.130000000000003 109.5 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -111.76 97.87 39.14 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 113.542 0.941 . . . . 72.230000000000004 113.542 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -78.12 -46.85 0.12 Allowed 'Trans proline' 0 N--CA 1.438 -1.74 0 N-CA-C 109.286 -1.082 . . . . 74.299999999999997 109.286 162.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -43.97 -54.3 5.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.558 2.743 . . . . 75.109999999999999 116.994 -167.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.14 -51.37 39.05 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.387 -0.525 . . . . 74.549999999999997 110.216 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -75.42 -27.06 58.85 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.946 1.091 . . . . 71.109999999999999 113.946 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 66.4 p -71.23 -36.25 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.232 -0.587 . . . . 62.329999999999998 110.544 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -73.76 -37.42 65.04 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.09 -0.505 . . . . 75.349999999999994 109.796 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 87' ' ' ARG . . . -66.08 -41.9 94.82 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.832 -0.907 . . . . 73.129999999999995 110.832 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -69.97 -25.14 63.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.194 0.521 . . . . 73.510000000000005 109.832 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.27 78.1 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 75.25 110.251 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 34.6 ttp180 -61.79 -45.57 93.28 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.943 -0.762 . . . . 75.340000000000003 108.943 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 -49.56 76.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.066 -0.97 . . . . 74.239999999999995 110.555 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.4 tp -64.62 -35.35 80.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.568 . . . . 72.519999999999996 111.948 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.412 ' HB3' HG12 ' A' ' 104' ' ' VAL . . . -63.9 -36.35 83.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.381 0.61 . . . . 74.209999999999994 109.941 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.66 -39.81 84.51 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.558 -0.746 . . . . 73.299999999999997 109.203 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 21.2 m-85 -57.18 -50.56 72.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.548 -0.751 . . . . 74.030000000000001 112.46 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 pt -65.34 -35.14 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.069 -0.652 . . . . 73.209999999999994 111.284 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -67.46 -37.82 83.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 111.116 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.03 -34.77 76.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.217 -0.447 . . . . 74.049999999999997 112.079 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 66.1 mm-40 -81.78 -13.63 57.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.989 -0.55 . . . . 74.209999999999994 110.986 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 31.12 18.82 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.693 -0.685 . . . . 70.120000000000005 112.254 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.406 ' CD2' HD13 ' A' ' 48' ' ' ILE . 16.5 m0 -104.74 177.21 4.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.859 -0.423 . . . . 74.530000000000001 109.859 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.7 pt20 -147.8 176.58 10.01 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.735 -0.469 . . . . 74.209999999999994 109.735 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.426 ' HA ' HD13 ' A' ' 57' ' ' LEU . 9.8 t -156.29 179.11 9.56 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.911 -1.515 . . . . 74.239999999999995 106.911 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.06 122.22 36.58 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 118.15 0.432 . . . . 74.239999999999995 110.567 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.4 17.15 Favored Glycine 0 N--CA 1.416 -2.656 0 N-CA-C 110.131 -1.187 . . . . 75.0 110.131 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -112.52 149.38 32.76 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.825 -1.176 . . . . 72.329999999999998 107.825 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 90' ' ' ALA . 8.0 p -89.39 134.45 28.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.651 -0.5 . . . . 73.099999999999994 109.651 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.28 120.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.754 0.787 . . . . 74.140000000000001 111.173 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' SER . 98.6 t -105.58 132.35 52.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.375 -1.713 . . . . 64.120000000000005 106.375 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.71 130.96 54.29 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 110.143 -0.317 . . . . 74.5 110.143 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -100.37 114.39 27.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.981 -1.859 . . . . 75.209999999999994 105.981 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -142.93 166.95 23.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.03 164.61 11.62 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.407 1.098 . . . . 74.439999999999998 113.025 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.4 m -151.04 116.17 5.31 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.141 -1.845 . . . . 74.0 106.885 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.4 m -59.35 -21.84 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.692 0.797 . . . . 54.140000000000001 112.43 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.62 -16.11 54.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 110.681 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.2 tp -97.52 140.96 31.17 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.029 -1.471 . . . . 65.430000000000007 107.029 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -121.69 163.14 19.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.298 -0.961 . . . . 72.150000000000006 111.172 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.57 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 44.9 m -45.78 124.32 5.11 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.645 1.978 . . . . 63.009999999999998 115.26 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.1 -27.55 16.92 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.583 -1.189 . . . . 64.150000000000006 110.506 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.13 136.74 35.09 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.317 -0.994 . . . . 63.130000000000003 108.317 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -147.78 160.67 42.49 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.733 -1.58 . . . . 74.400000000000006 106.733 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -141.29 150.3 42.37 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.821 0.344 . . . . 72.329999999999998 110.979 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HA ' HD11 ' A' ' 64' ' ' ILE . . . -118.51 125.77 50.59 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.098 -1.445 . . . . 74.129999999999995 107.098 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.554 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -123.28 115.24 21.37 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 110.138 -0.319 . . . . 73.209999999999994 110.138 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.09 124.34 7.63 Favored Glycine 0 C--N 1.289 -2.078 0 N-CA-C 111.855 -0.498 . . . . 74.049999999999997 111.855 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -140.64 160.19 40.56 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 122.623 0.369 . . . . 73.530000000000001 111.028 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 59' ' ' PRO . 61.8 t -105.95 127.85 60.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.783 0.325 . . . . 72.450000000000003 110.164 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -135.48 101.85 10.81 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 108.189 -1.041 . . . . 74.230000000000004 108.189 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.52 -2.93 9.25 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.218 1.945 . . . . 71.409999999999997 111.644 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.05 66.86 2.17 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-O 121.678 0.751 . . . . 73.120000000000005 109.523 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 t -135.05 131.52 52.7 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 113.929 -1.487 . . . . 70.319999999999993 107.913 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.72 146.44 53.77 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.851 -0.796 . . . . 74.140000000000001 108.851 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -147.07 144.2 28.9 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.444 -0.902 . . . . 74.420000000000002 112.518 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 106.115 -1.809 . . . . 72.120000000000005 106.115 173.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 120.951 0.405 . . . . 72.340000000000003 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.94 145.76 16.18 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 109.596 -1.402 . . . . 72.400000000000006 109.596 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -91.78 85.08 5.52 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.717 0.77 . . . . 74.099999999999994 110.129 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -101.26 93.59 5.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.606 -1.257 . . . . 75.230000000000004 107.606 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -82.38 113.92 20.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.049 0.452 . . . . 73.430000000000007 110.393 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -134.39 113.15 11.59 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.868 -0.79 . . . . 74.519999999999996 108.868 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 tp -84.73 90.76 7.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.282 -1.007 . . . . 74.329999999999998 108.282 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.64 136.57 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 120.851 -0.339 . . . . 73.129999999999995 110.191 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -94.85 116.32 28.57 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.745 -0.382 . . . . 71.5 110.278 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.499 ' NH1' ' HG2' ' A' ' 94' ' ' GLN . 30.4 mtm105 -137.98 72.69 1.42 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.815 -0.629 . . . . 75.209999999999994 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.42 91.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 122.652 1.215 . . . . 73.439999999999998 109.602 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.84 -173.72 3.45 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.455 -1.248 . . . . 64.049999999999997 108.29 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -89.88 -92.67 0.12 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 114.299 1.222 . . . . 75.430000000000007 114.299 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HD3' ' CG ' ' A' ' 95' ' ' GLU . 23.1 tptm -178.53 141.12 0.21 Allowed 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.325 -0.62 . . . . 75.150000000000006 109.325 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.21 -174.11 2.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.838 -0.801 . . . . 74.340000000000003 108.838 173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.74 135.22 44.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.559 -2.015 . . . . 65.340000000000003 105.559 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.7 151.75 44.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.745 -0.782 . . . . 74.340000000000003 109.39 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -76.79 98.98 4.98 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.448 0.642 . . . . 71.209999999999994 109.467 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -97.6 139.92 18.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 121.871 0.843 . . . . 74.439999999999998 111.797 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.4 170.67 32.86 Favored Glycine 1 N--CA 1.382 -4.911 0 N-CA-C 105.497 -3.041 . . . . 71.030000000000001 105.497 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.9 m-20 -115.27 19.92 15.24 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 110.04 -0.356 . . . . 72.209999999999994 110.04 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -53.36 -60.62 3.07 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.916 0.71 . . . . 64.439999999999998 112.916 -174.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.97 -31.67 69.5 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.191 0.519 . . . . 75.400000000000006 110.276 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.96 -51.34 64.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.326 -0.852 . . . . 74.209999999999994 111.245 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 5.8 ppt_? -71.22 -26.46 62.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.092 0.775 . . . . 75.540000000000006 113.092 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 22' ' ' ALA . 86.5 mt -68.03 -54.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 110.074 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -79.68 -1.58 38.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.637 0.606 . . . . 74.5 112.637 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.35 16.08 68.8 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-O 121.165 0.314 . . . . 70.420000000000002 112.362 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.03 -1.39 87.77 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 121.439 -0.41 . . . . 70.319999999999993 112.862 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.8 m -69.5 -25.03 63.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.554 0.693 . . . . 71.140000000000001 110.367 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.1 mm -124.18 122.68 64.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.439 -1.689 . . . . 63.399999999999999 106.439 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.5 t -85.93 122.3 72.82 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.83 -0.804 . . . . 73.329999999999998 108.83 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.45 -24.57 44.42 Favored 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.376 2.718 . . . . 72.439999999999998 113.091 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -67.99 -11.28 58.56 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.026 0.441 . . . . 70.540000000000006 111.625 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.85 -36.93 82.65 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.1 -1.074 . . . . 74.400000000000006 108.1 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -70.22 -44.7 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.11 -0.95 . . . . 75.329999999999998 109.287 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.57 -43.12 75.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.962 0.505 . . . . 72.439999999999998 110.614 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.82 87.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.941 -1.027 . . . . 70.530000000000001 111.0 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.92 -37.52 81.78 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.861 0.689 . . . . 74.219999999999999 112.861 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.19 -46.49 90.24 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.987 -0.285 . . . . 73.329999999999998 111.579 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -73.4 -28.87 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.627 -0.429 . . . . 75.310000000000002 110.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -66.7 -45.86 77.41 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.373 -0.376 . . . . 72.219999999999999 110.706 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.12 -35.3 80.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.749 0.309 . . . . 73.519999999999996 110.332 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.14 77.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 65.549999999999997 110.537 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.99 71.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.647 -0.706 . . . . 74.530000000000001 110.904 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.59 -44.72 73.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.716 -0.674 . . . . 62.009999999999998 110.987 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.84 15.36 37.71 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.99 -0.55 . . . . 74.209999999999994 114.222 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -62.35 123.23 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.388 0.614 . . . . 74.540000000000006 111.504 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -116.4 145.24 43.39 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 115.092 -0.958 . . . . 74.340000000000003 110.704 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -65.46 125.0 23.79 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 75.109999999999999 110.749 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.478 ' HG ' ' OE1' ' A' ' 52' ' ' GLN . 13.9 tp -144.82 -164.34 1.9 Allowed 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 103.65 -2.722 . . . . 73.430000000000007 103.65 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' OE1' ' HG ' ' A' ' 51' ' ' LEU . 27.2 mp0 -44.64 148.21 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.065 0.848 . . . . 75.510000000000005 111.737 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.68 -20.37 66.05 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.615 -0.326 . . . . 74.310000000000002 112.828 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 -9.37 41.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.079 0.4 . . . . 54.399999999999999 112.079 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.7 ptp180 -157.6 125.3 5.3 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 121.614 0.721 . . . . 73.340000000000003 112.062 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.22 151.54 19.41 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.769 -0.65 . . . . 71.150000000000006 110.063 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.77 127.96 35.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 74.310000000000002 107.18 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.68 158.78 44.54 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 123.448 0.468 . . . . 71.109999999999999 110.479 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.408 ' HA ' HG23 ' A' ' 125' ' ' VAL . 25.9 Cg_exo -65.68 162.76 33.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.936 2.424 . . . . 72.430000000000007 111.912 175.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.07 -26.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.959 -0.564 . . . . 74.340000000000003 111.692 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -100.88 107.2 18.66 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.82 -0.808 . . . . 73.530000000000001 108.82 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 87.3 m-85 -110.37 114.8 28.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.502 -0.772 . . . . 74.349999999999994 110.507 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.69 111.33 34.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.844 -1.169 . . . . 74.200000000000003 107.844 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.29 121.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.193 -1.04 . . . . 71.230000000000004 108.193 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -113.5 124.8 53.25 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.656 -0.418 . . . . 73.439999999999998 110.307 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -108.2 162.83 13.71 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 71.329999999999998 108.905 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.51 150.17 51.72 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 109.625 -1.39 . . . . 63.219999999999999 109.625 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.32 -38.47 69.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 117.575 0.687 . . . . 75.409999999999997 111.741 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.4 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 39.0 t60 -73.44 -25.03 60.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.59 -0.522 . . . . 75.010000000000005 109.59 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.555 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 18.0 m-20 -79.3 -31.73 43.35 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.483 -0.326 . . . . 75.319999999999993 111.457 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.96 -33.75 72.35 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.376 -0.829 . . . . 75.340000000000003 108.916 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.48 -33.56 68.12 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.636 -0.711 . . . . 54.350000000000001 112.683 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' CE ' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -78.4 -30.02 47.55 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.727 -0.608 . . . . 75.439999999999998 110.498 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.16 -36.78 84.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.347 0.594 . . . . 72.310000000000002 110.069 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.62 -163.09 25.52 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 115.483 -0.78 . . . . 72.409999999999997 111.604 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.42 -30.98 14.8 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.287 0.565 . . . . 71.010000000000005 109.918 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.41 128.77 25.3 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.946 -0.57 . . . . 64.200000000000003 109.563 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.14 -27.23 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.213 1.942 . . . . 71.420000000000002 111.287 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.37 -53.74 33.35 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.022 1.729 . . . . 63.329999999999998 115.1 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.11 -31.25 72.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.249 0.547 . . . . 74.239999999999995 110.724 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -77.09 -34.94 56.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.649 -0.705 . . . . 71.109999999999999 109.525 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 42.5 m -65.22 -54.03 35.66 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.403 -0.817 . . . . 75.140000000000001 110.441 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 m -62.01 -38.61 89.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.664 -0.698 . . . . 73.439999999999998 111.166 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 116.024 -0.535 . . . . 71.019999999999996 112.323 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.706 -0.398 . . . . 75.530000000000001 110.03 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.055 -0.52 . . . . 64.209999999999994 110.204 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -56.84 -53.42 58.06 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.186 -0.916 . . . . 73.450000000000003 110.614 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -69.6 -29.59 67.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.018 -0.992 . . . . 74.030000000000001 111.965 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.02 -35.51 61.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.097 -0.705 . . . . 74.109999999999999 109.097 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -62.63 -37.93 88.23 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.741 0.781 . . . . 62.409999999999997 109.58 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.23 -47.6 81.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.728 -1.124 . . . . 64.5 109.608 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.59 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -54.91 -48.47 73.04 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.978 0.733 . . . . 72.319999999999993 112.978 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.07 -31.64 54.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.098 -0.641 . . . . 74.239999999999995 111.737 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 25.9 mt-30 -64.28 -45.42 88.12 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.837 -0.431 . . . . 73.019999999999996 109.837 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' CG ' ' HD3' ' A' ' 14' ' ' LYS . 2.4 mm-40 -58.04 -41.77 83.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.32 1.013 . . . . 70.540000000000006 111.903 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 75.5 mm-40 -74.74 -14.36 60.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.935 0.346 . . . . 72.299999999999997 111.935 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.95 29.0 48.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.246 -0.502 . . . . 53.130000000000003 112.064 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -104.62 157.31 17.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.201 -0.666 . . . . 74.230000000000004 109.201 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' HA ' ' NH2' ' A' ' 10' ' ' ARG . 24.1 pt20 -128.33 166.08 19.34 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.006 -0.678 . . . . 72.140000000000001 110.118 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -155.07 176.57 12.37 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.387 -1.338 . . . . 75.420000000000002 107.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -118.37 120.83 38.78 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.538 -0.542 . . . . 72.540000000000006 109.538 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.68 -151.22 17.09 Favored Glycine 0 C--O 1.253 1.321 0 N-CA-C 108.23 -1.948 . . . . 74.519999999999996 108.23 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -128.06 162.81 25.99 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.986 0.893 . . . . 73.120000000000005 108.646 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.1 t -78.57 121.78 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.094 0.473 . . . . 72.219999999999999 111.184 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.46 120.83 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.366 -0.834 . . . . 74.030000000000001 110.047 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 82' ' ' SER . 59.8 t -116.62 127.77 74.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.068 -1.456 . . . . 74.340000000000003 107.068 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 -121.49 152.49 39.08 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.538 -0.465 . . . . 74.519999999999996 109.747 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.31 114.41 22.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.916 -1.142 . . . . 73.450000000000003 107.916 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.14 170.95 10.71 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.342 -0.543 . . . . 73.120000000000005 112.07 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.47 159.19 17.25 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.401 -0.818 . . . . 73.209999999999994 110.722 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 m -152.24 138.83 18.7 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 123.97 0.908 . . . . 75.230000000000004 109.422 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -81.0 -18.34 47.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.207 -1.035 . . . . 72.049999999999997 108.207 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -65.61 -26.69 67.95 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.318 1.447 . . . . 71.409999999999997 110.035 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.0 mt -101.24 128.31 47.43 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.721 -0.672 . . . . 75.099999999999994 109.832 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -88.1 164.05 15.91 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.468 -0.787 . . . . 72.140000000000001 109.975 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.448 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 16.0 m -55.28 123.13 12.8 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.891 0.744 . . . . 72.049999999999997 111.967 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.16 -20.9 30.06 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.293 -0.723 . . . . 74.239999999999995 111.293 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.22 139.71 35.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.481 0.657 . . . . 73.310000000000002 111.709 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.448 ' HB3' HD13 ' A' ' 66' ' ' LEU . 29.6 p90 -147.7 160.16 43.01 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.715 -1.217 . . . . 74.430000000000007 107.715 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 146.55 43.77 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.176 -1.046 . . . . 75.409999999999997 108.176 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.52 149.45 34.34 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.548 -0.908 . . . . 72.5 108.548 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 64.5 ttt180 -143.26 124.37 14.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.263 -0.273 . . . . 74.299999999999997 110.263 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.15 100.25 0.8 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 110.198 -1.161 . . . . 72.299999999999997 110.198 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -111.67 147.88 34.58 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 109.713 -0.477 . . . . 73.239999999999995 109.713 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 59' ' ' PRO . 62.2 t -87.29 113.98 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 108.152 -1.055 . . . . 72.109999999999999 108.152 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -126.06 99.69 31.23 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 108.344 -0.984 . . . . 70.439999999999998 108.344 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.94 -19.34 23.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.919 1.746 . . . . 64.019999999999996 111.377 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.41 67.17 3.42 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.509 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 110.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-N 114.32 -1.309 . . . . 65.219999999999999 108.129 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -93.33 131.61 38.32 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.44 -0.948 . . . . 75.519999999999996 108.44 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -79.82 179.63 7.45 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.211 -0.904 . . . . 74.400000000000006 110.903 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 . . . . . 0 N--CA 1.419 -1.983 0 N-CA-C 109.762 -0.458 . . . . 74.150000000000006 109.762 178.717 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 108.909 -0.774 . . . . 73.430000000000007 108.909 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.76 147.6 18.74 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 110.608 -0.997 . . . . 73.439999999999998 110.608 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 m -88.84 155.83 19.3 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.866 -0.791 . . . . 75.420000000000002 108.866 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -96.66 -32.1 12.37 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.818 -0.808 . . . . 74.329999999999998 108.818 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -79.6 108.42 13.13 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.792 -1.188 . . . . 71.239999999999995 107.792 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -88.42 107.74 19.01 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.23 0.538 . . . . 73.109999999999999 111.254 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -131.25 118.94 21.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.74 -0.664 . . . . 73.140000000000001 109.408 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.43 131.47 42.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.898 -0.778 . . . . 74.329999999999998 108.898 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -108.6 100.77 9.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.202 -0.453 . . . . 73.120000000000005 110.163 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -83.49 124.57 30.85 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.077 -0.511 . . . . 71.230000000000004 109.848 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.79 136.13 35.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.278 -0.569 . . . . 75.0 110.137 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -94.91 116.45 28.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.864 -1.161 . . . . 74.140000000000001 107.864 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -142.48 141.0 32.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.107 -0.701 . . . . 75.409999999999997 109.107 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.21 127.01 45.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.4 -1.333 . . . . 75.420000000000002 107.4 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -93.71 -76.49 0.47 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.633 -0.427 . . . . 74.519999999999996 111.745 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.64 -179.96 6.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.127 0.571 . . . . 75.299999999999997 109.926 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.21 99.72 10.73 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.837 -1.542 . . . . 73.209999999999994 106.837 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -57.67 124.1 17.92 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.341 -1.3 . . . . 73.299999999999997 113.832 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.0 t -101.67 104.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.51 -1.663 . . . . 72.439999999999998 106.51 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.4 -75.27 1.15 Allowed Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.665 -0.779 . . . . 74.239999999999995 114.503 -172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -44.72 -46.43 10.37 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.003 1.483 . . . . 74.349999999999994 115.003 -173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 -59.22 5.25 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.965 0.791 . . . . 73.439999999999998 111.636 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.91 -36.72 78.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.832 -0.622 . . . . 73.109999999999999 111.044 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 71.239999999999995 111.609 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -74.63 -36.01 62.9 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.812 0.671 . . . . 70.299999999999997 112.812 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.43 -44.25 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.149 0.499 . . . . 73.129999999999995 110.523 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -77.97 -15.57 58.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.564 0.579 . . . . 73.540000000000006 112.564 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.13 45.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.853 -0.689 . . . . 71.319999999999993 111.484 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.16 -29.34 6.08 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.696 -0.252 . . . . 62.5 112.994 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 t -91.61 82.49 5.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.612 0.72 . . . . 71.120000000000005 110.075 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.34 109.87 26.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.665 -1.606 . . . . 71.349999999999994 106.665 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -119.64 88.18 38.67 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 118.941 -1.103 . . . . 74.340000000000003 113.332 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD2' ' OE1' ' A' ' 34' ' ' GLN . 12.2 Cg_exo -76.21 -40.76 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.206 1.937 . . . . 70.140000000000001 110.5 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.453 ' OE1' ' HD2' ' A' ' 33' ' ' PRO . 1.3 mp0 -49.87 -52.23 34.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.444 1.098 . . . . 71.030000000000001 111.302 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -56.69 -47.67 79.35 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.082 -0.963 . . . . 75.439999999999998 110.37 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.96 -50.9 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.262 -0.881 . . . . 71.450000000000003 110.405 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.9 pp20? -64.4 -38.4 90.91 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.589 0.588 . . . . 72.420000000000002 112.589 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.08 92.48 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.802 0.334 . . . . 70.209999999999994 110.632 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -72.87 -37.58 67.29 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.238 -1.023 . . . . 71.409999999999997 108.238 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.09 -44.79 96.82 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 72.450000000000003 110.582 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.0 ptt85 -73.74 -21.86 60.06 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.96 0.409 . . . . 73.310000000000002 111.635 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.424 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 43.0 tpt85 -73.09 -31.19 64.2 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 52.0 mm-40 -68.21 -38.7 82.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.517 -0.765 . . . . 72.209999999999994 109.835 173.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.62 -46.52 88.74 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.443 -0.799 . . . . 73.310000000000002 109.734 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.29 65.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.788 -0.642 . . . . 64.140000000000001 111.386 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 31.2 t70 -77.77 -41.19 38.34 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.931 0.345 . . . . 71.239999999999995 111.931 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.03 25.89 19.64 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 120.227 -0.987 . . . . 72.209999999999994 113.803 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.77 137.02 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.702 0.401 . . . . 74.129999999999995 111.345 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.1 mt-30 -122.91 143.51 49.84 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.823 -0.626 . . . . 73.409999999999997 110.397 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -79.19 92.32 5.07 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.847 -1.07 . . . . 73.219999999999999 111.687 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD22 ' NE2' ' A' ' 99' ' ' GLN . 11.9 tp -102.38 -165.48 1.19 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.781 -1.933 . . . . 73.299999999999997 105.781 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 54' ' ' ASN . 79.3 mm-40 -48.57 146.89 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.888 0.767 . . . . 72.430000000000007 112.214 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.9 32.89 1.25 Allowed Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.117 -0.947 . . . . 64.319999999999993 113.348 -173.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 52' ' ' GLN . 71.9 m-20 -99.85 -37.01 9.23 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.643 -1.614 . . . . 73.540000000000006 106.643 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -172.97 149.87 1.94 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.491 -1.231 . . . . 71.430000000000007 110.294 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.37 151.79 21.29 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.964 0.506 . . . . 73.349999999999994 110.564 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -87.21 127.7 35.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 -175.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.11 158.17 46.92 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 123.11 0.564 . . . . 61.009999999999998 111.063 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 88.6 Cg_exo -54.86 145.16 63.32 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.948 3.099 . . . . 75.329999999999998 113.997 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -119.96 -22.6 6.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.313 -0.858 . . . . 70.25 110.292 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.69 108.88 20.61 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.412 0.625 . . . . 74.010000000000005 109.684 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.9 m-85 -114.06 117.83 32.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.445 -0.798 . . . . 72.519999999999996 109.423 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.95 116.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.192 -1.04 . . . . 74.329999999999998 108.192 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.1 mt -110.96 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 107.915 -1.143 . . . . 74.030000000000001 107.915 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.7 m -110.33 120.65 43.12 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.866 -0.606 . . . . 74.129999999999995 110.971 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.4 mm? -114.69 163.26 15.71 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.3 -0.864 . . . . 74.239999999999995 108.809 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.17 169.17 51.35 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 109.274 -1.53 . . . . 64.129999999999995 109.274 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.32 -25.7 37.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.595 0.712 . . . . 75.209999999999994 110.936 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -57.95 -55.69 31.64 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.824 -1.08 . . . . 73.209999999999994 110.001 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.84 -29.49 44.69 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.621 -0.718 . . . . 75.530000000000001 111.718 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -63.7 -32.01 73.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.439 -0.346 . . . . 74.200000000000003 110.143 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.17 -35.84 78.2 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 123.25 0.62 . . . . 72.439999999999998 109.954 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.98 -14.64 55.73 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.22 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.21 -25.04 37.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.652 -0.87 . . . . 72.510000000000005 108.652 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.98 -177.26 30.1 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 114.938 -1.028 . . . . 73.299999999999997 111.867 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 1.46 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.831 0.452 . . . . 74.030000000000001 111.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -110.0 92.57 13.16 Favored Pre-proline 0 C--O 1.251 1.178 0 N-CA-C 112.331 0.493 . . . . 54.520000000000003 112.331 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.84 -37.2 1.72 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.686 1.59 . . . . 64.230000000000004 111.096 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.47 -34.33 72.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.26 -0.427 . . . . 72.019999999999996 112.14 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.29 -38.06 85.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.194 0.521 . . . . 73.400000000000006 109.837 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.28 -35.52 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.837 -0.801 . . . . 71.299999999999997 108.837 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 t -58.31 -54.14 50.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.713 -1.131 . . . . 74.400000000000006 110.023 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.1 m -59.15 -42.33 90.44 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.425 0.69 . . . . 74.519999999999996 111.008 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -61.64 6.21 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.011 -0.54 . . . . 55.340000000000003 111.974 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -63.03 -30.78 71.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.304 0.854 . . . . 71.400000000000006 113.304 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.35 -40.43 89.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.896 -0.322 . . . . 72.409999999999997 110.538 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -73.37 -36.88 66.17 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.466 -0.568 . . . . 72.430000000000007 109.466 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.25 -41.06 94.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.573 -0.285 . . . . 63.32 110.73 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -42.27 87.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.447 -0.575 . . . . 75.340000000000003 109.447 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.46 79.67 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 61.439999999999998 109.951 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -64.24 -43.77 93.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.391 -0.822 . . . . 75.400000000000006 109.751 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.544 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.6 m-85 -58.66 -48.42 81.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 112.662 0.615 . . . . 75.409999999999997 112.662 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.99 -29.33 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.733 -0.787 . . . . 75.25 111.247 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.02 -44.24 89.82 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 110.14 -0.318 . . . . 54.420000000000002 110.14 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.6 mt-10 -63.91 -38.38 90.88 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.308 0.575 . . . . 75.230000000000004 110.797 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.2 mm-40 -79.25 -13.9 59.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.971 -0.559 . . . . 64.230000000000004 111.351 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.53 38.37 32.96 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.804 -0.712 . . . . 51.299999999999997 112.2 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -107.11 158.0 17.42 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.765 0.317 . . . . 73.450000000000003 111.093 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.495 ' NE2' HD22 ' A' ' 51' ' ' LEU . 23.2 pt20 -123.01 173.03 8.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.816 0.846 . . . . 73.340000000000003 109.087 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.8 t -159.52 177.61 10.76 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.444 -0.502 . . . . 64.540000000000006 110.432 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.24 120.99 33.85 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.582 -0.896 . . . . 71.319999999999993 108.582 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.24 -164.17 12.48 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.963 -1.655 . . . . 72.530000000000001 108.963 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -104.71 156.86 17.62 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.864 -1.532 . . . . 74.030000000000001 106.864 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.67 104.18 14.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.985 -1.117 . . . . 63.310000000000002 107.985 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.73 120.38 57.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 122.123 0.963 . . . . 74.409999999999997 111.676 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 62' ' ' TYR . 10.1 m -104.86 120.03 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 N-CA-C 105.804 -1.925 . . . . 75.230000000000004 105.804 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.279 0.0 OUTLIER -117.3 125.4 51.01 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 113.638 0.977 . . . . 75.349999999999994 113.638 -174.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -92.47 139.41 30.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.746 -1.57 . . . . 74.329999999999998 108.628 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -156.06 161.1 40.46 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.356 -0.609 . . . . 63.439999999999998 109.356 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.8 pt20 -104.32 157.99 16.76 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.582 0.706 . . . . 75.319999999999993 109.493 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.0 m -144.2 133.1 22.61 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.909 -1.041 . . . . 74.129999999999995 108.974 175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 m -80.9 -11.74 59.53 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.481 0.658 . . . . 53.5 110.098 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -87.99 -5.54 58.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 71.409999999999997 109.918 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.07 120.44 32.04 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.938 -1.875 . . . . 75.129999999999995 105.938 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -88.8 153.22 21.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.325 -0.398 . . . . 73.25 110.405 -174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -64.59 134.16 53.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.51 0.672 . . . . 71.319999999999993 111.234 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.33 -15.46 42.67 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.412 -1.075 . . . . 74.340000000000003 110.412 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -106.08 150.24 25.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.047 -0.723 . . . . 73.420000000000002 109.047 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -149.66 151.25 33.42 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.867 -1.901 . . . . 73.409999999999997 105.867 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -134.99 144.09 47.18 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 112.56 0.578 . . . . 73.420000000000002 112.56 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.79 119.13 10.23 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.701 -1.592 . . . . 64.530000000000001 106.701 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -120.29 120.65 36.67 Favored 'General case' 0 N--CA 1.39 -3.456 0 C-N-CA 123.196 0.598 . . . . 75.120000000000005 109.565 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.53 121.54 7.2 Favored Glycine 0 C--N 1.3 -1.452 0 O-C-N 123.593 0.558 . . . . 64.040000000000006 112.056 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 p -142.21 148.61 38.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.155 -0.683 . . . . 74.200000000000003 109.155 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 5.6 p -95.84 120.54 45.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 119.462 -0.895 . . . . 75.540000000000006 110.006 174.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -125.86 98.62 33.46 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.819 -1.082 . . . . 73.340000000000003 108.167 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.33 -15.87 15.68 Favored 'Trans proline' 0 CA--C 1.52 -0.221 0 C-N-CA 122.385 2.057 . . . . 75.129999999999995 109.892 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.49 22.48 2.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.59 -1.186 . . . . 55.009999999999998 109.629 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.32 110.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-O 121.929 0.871 . . . . 74.030000000000001 109.089 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.86 139.7 30.4 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.576 -1.193 . . . . 72.25 109.89 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.7 t -142.89 147.45 35.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.548 -1.279 . . . . 62.420000000000002 107.548 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 t60 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 109.693 -0.484 . . . . 74.310000000000002 109.693 -174.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.742 0.306 . . . . 72.409999999999997 110.189 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.92 173.36 40.68 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 109.731 -1.348 . . . . 71.430000000000007 109.731 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.6 m -82.26 90.44 6.63 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.597 -1.26 . . . . 70.340000000000003 107.597 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -72.11 103.81 3.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.109 -0.95 . . . . 73.209999999999994 110.234 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -109.2 139.51 44.03 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.256 -0.429 . . . . 74.030000000000001 110.14 177.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -134.85 133.61 39.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.257 -1.016 . . . . 74.219999999999999 108.257 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.73 101.41 12.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 O-C-N 123.707 0.63 . . . . 75.209999999999994 109.303 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -89.75 87.88 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.419 1.104 . . . . 74.230000000000004 109.351 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.406 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 10.3 mm-40 -81.78 140.49 34.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.087 -1.415 . . . . 74.439999999999998 110.846 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -136.44 119.88 16.95 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.825 -1.079 . . . . 73.129999999999995 109.987 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -86.41 106.06 15.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.395 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 34' ' ' GLN . 35.4 mm-40 -74.91 96.18 3.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.699 1.237 . . . . 73.209999999999994 113.15 -174.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -100.0 77.77 2.04 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 113.644 -1.617 . . . . 74.239999999999995 108.07 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -85.99 100.77 12.36 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 105.443 -2.058 . . . . 74.409999999999997 105.443 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.97 95.29 2.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 74.239999999999995 109.924 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -162.47 147.76 12.45 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.499 -1.667 . . . . 75.109999999999999 106.499 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.5 84.3 2.01 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.611 -0.885 . . . . 62.399999999999999 108.611 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.8 m -101.52 124.59 47.44 Favored 'General case' 0 N--CA 1.407 -2.616 0 CA-C-N 115.145 -0.934 . . . . 73.239999999999995 109.202 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -85.98 88.28 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.499 -1.297 . . . . 72.519999999999996 107.499 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.94 45.44 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 109.988 -1.245 . . . . 72.230000000000004 109.988 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -74.47 -7.01 51.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.256 0.55 . . . . 72.25 110.549 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 25' ' ' ARG . . . -63.8 -35.65 81.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.951 0.881 . . . . 72.349999999999994 109.708 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.79 -34.19 64.54 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.394 -0.821 . . . . 74.319999999999993 109.315 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -65.0 -41.79 95.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.987 -0.551 . . . . 75.230000000000004 110.745 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 8.6 ptm180 -67.82 -25.58 65.64 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.705 -0.225 . . . . 75.209999999999994 111.279 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.8 mt -86.82 -50.53 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 120.315 -0.554 . . . . 70.329999999999998 111.493 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.09 -28.12 64.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.94 0.719 . . . . 73.420000000000002 112.94 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.77 -73.05 0.27 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.796 -0.716 . . . . 72.510000000000005 112.532 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.19 -35.42 3.4 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.701 -0.761 . . . . 74.409999999999997 111.87 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 36.2 t -79.24 139.17 37.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.276 -0.639 . . . . 74.129999999999995 109.276 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.9 tt -98.84 -33.13 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.369 0.604 . . . . 70.129999999999995 110.309 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.52 118.7 8.25 Favored Pre-proline 0 N--CA 1.428 -1.56 0 N-CA-C 108.89 -0.781 . . . . 75.200000000000003 108.89 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.14 95.74 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.261 1.307 . . . . 71.109999999999999 110.102 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.491 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 49.8 tt0 -91.32 -3.66 56.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.743 -0.662 . . . . 73.140000000000001 110.443 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.87 -32.77 73.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.445 -1.317 . . . . 74.129999999999995 107.445 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' O ' HD21 ' A' ' 40' ' ' LEU . 30.7 t -61.3 -49.89 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 114.466 -1.243 . . . . 73.420000000000002 109.619 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 30.6 mt-10 -57.69 -47.11 83.26 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.581 -0.448 . . . . 74.530000000000001 110.734 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.88 35.56 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.69 0.619 . . . . 74.25 111.878 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.74 -29.35 66.68 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.216 0.45 . . . . 74.319999999999993 112.216 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 36' ' ' VAL . 4.0 mm? -70.55 -39.55 73.92 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.176 0.436 . . . . 74.109999999999999 112.176 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 58.7 mtp180 -66.13 -33.42 75.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.977 -1.12 . . . . 74.109999999999999 107.977 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -49.29 62.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.434 -1.257 . . . . 74.519999999999996 108.948 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.54 -37.8 85.11 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.98 0.512 . . . . 72.219999999999999 112.136 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -58.77 -45.82 88.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.998 -0.546 . . . . 63.420000000000002 110.117 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.06 64.66 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.549 0.69 . . . . 75.140000000000001 111.066 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.07 -32.61 73.9 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 72.319999999999993 111.043 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.86 72.61 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.97 -0.633 . . . . 62.240000000000002 113.285 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 98' ' ' TRP . 17.7 mm -64.45 131.31 30.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.547 0.689 . . . . 73.219999999999999 111.949 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 80.5 mt-30 -119.39 144.82 46.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.272 -0.876 . . . . 74.230000000000004 110.535 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.6 m -80.63 98.28 7.6 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.845 -1.07 . . . . 74.299999999999997 109.992 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.591 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.3 tp -101.91 -165.38 1.18 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.935 -1.506 . . . . 75.230000000000004 106.935 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.591 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 48.4 mt-30 -56.19 160.77 2.76 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.493 0.717 . . . . 72.140000000000001 111.395 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 4.75 8.17 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.461 -0.79 . . . . 74.230000000000004 114.397 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.32 -46.57 60.33 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.913 -1.143 . . . . 72.530000000000001 107.913 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -179.51 167.21 1.44 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.002 0.921 . . . . 73.040000000000006 110.716 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.56 151.39 21.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.059 0.457 . . . . 72.030000000000001 111.698 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.4 tm? -90.63 128.3 36.56 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.366 -0.976 . . . . 72.439999999999998 108.366 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.41 158.0 45.98 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 123.58 0.752 . . . . 60.119999999999997 109.433 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.06 157.93 36.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 72.530000000000001 112.628 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -119.8 -33.3 4.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.934 -0.575 . . . . 72.049999999999997 110.695 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -103.66 114.65 29.07 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.651 -0.5 . . . . 74.319999999999993 109.651 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 70.8 m-85 -109.51 119.34 39.12 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.669 -0.696 . . . . 73.349999999999994 109.912 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -109.23 118.5 56.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 115.284 -0.871 . . . . 75.120000000000005 109.545 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.79 119.98 61.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.934 -1.136 . . . . 72.219999999999999 107.934 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -109.57 128.25 55.07 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.98 -0.555 . . . . 75.530000000000001 109.771 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.49 170.58 8.31 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.344 1.058 . . . . 75.450000000000003 109.674 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.99 169.03 54.43 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 109.508 -1.437 . . . . 74.0 109.508 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.86 -48.53 83.62 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 117.472 0.636 . . . . 75.299999999999997 111.681 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -65.03 -40.44 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 75.140000000000001 109.477 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.643 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.0 m-20 -69.48 -34.2 73.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.22 -1.355 . . . . 72.239999999999995 110.698 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.81 -36.92 85.48 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.72 0.771 . . . . 75.0 109.104 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.69 -25.22 64.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.757 -0.656 . . . . 74.310000000000002 111.262 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -77.91 -22.08 50.19 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.387 -0.195 . . . . 75.420000000000002 110.482 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.28 -38.36 71.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.157 -0.683 . . . . 71.129999999999995 109.157 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.31 -171.89 29.43 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.056 -1.068 . . . . 72.140000000000001 111.841 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.57 -31.08 18.81 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.939 -0.763 . . . . 63.119999999999997 108.939 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -131.73 81.81 62.43 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.217 -0.901 . . . . 74.439999999999998 110.548 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.74 -18.7 47.77 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.801 2.334 . . . . 64.120000000000005 112.274 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.01 -22.62 64.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 111.76 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.33 -45.67 92.16 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.88 -0.785 . . . . 63.509999999999998 108.88 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.13 -31.27 65.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.731 -1.122 . . . . 73.109999999999999 110.437 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.7 m -60.42 -43.53 96.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.42 -0.355 . . . . 73.310000000000002 111.224 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.4 m -65.4 -45.44 83.95 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.761 0.315 . . . . 71.439999999999998 111.165 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.87 93.6 Favored Glycine 0 C--O 1.244 0.733 0 C-N-CA 120.715 -0.755 . . . . 72.420000000000002 111.65 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -68.25 -32.59 72.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.279 -0.46 . . . . 74.120000000000005 110.247 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' A' ' 106' ' ' VAL . . . -62.15 -43.1 99.57 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.893 0.378 . . . . 73.25 110.514 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.78 -39.02 92.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 74.319999999999993 109.162 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -71.09 -41.32 70.77 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.305 -0.407 . . . . 73.120000000000005 111.183 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.04 -38.06 85.19 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.555 -0.535 . . . . 70.409999999999997 109.555 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.76 87.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.494 0.664 . . . . 75.109999999999999 109.536 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -37.41 84.38 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.95 -1.023 . . . . 64.439999999999998 110.127 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.588 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.6 m-85 -60.59 -48.02 83.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.192 -0.458 . . . . 74.25 111.903 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -69.69 -31.16 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 119.959 -0.697 . . . . 75.209999999999994 111.544 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.93 -41.14 91.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.808 -0.441 . . . . 72.329999999999998 109.808 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 33.2 tt0 -57.29 -36.85 71.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 125.329 1.452 . . . . 75.230000000000004 110.331 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -85.62 -9.04 57.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 75.409999999999997 111.052 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.29 29.8 57.85 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 116.025 -0.534 . . . . 75.150000000000006 113.016 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.521 ' CD2' HD13 ' A' ' 48' ' ' ILE . 20.0 m0 -96.19 156.9 16.14 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.594 -0.442 . . . . 74.319999999999993 110.457 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.576 ' NE2' HD22 ' A' ' 51' ' ' LEU . 29.9 pt20 -119.07 169.49 9.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.031 -0.359 . . . . 74.109999999999999 110.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -159.83 176.31 12.07 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.935 -0.765 . . . . 75.129999999999995 108.935 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.77 122.04 43.31 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.105 -1.072 . . . . 65.310000000000002 108.105 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.1 17.14 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.863 -1.16 . . . . 75.209999999999994 110.783 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -130.91 151.63 51.12 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.667 -0.864 . . . . 63.420000000000002 108.667 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.51 119.2 18.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.558 0.694 . . . . 71.25 111.335 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.14 131.63 65.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.024 -0.732 . . . . 64.439999999999998 109.024 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 86' ' ' ALA . 7.1 p -137.33 141.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.514 -1.291 . . . . 74.019999999999996 107.514 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -145.06 155.96 43.65 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.455 -0.498 . . . . 73.510000000000005 110.184 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.36 127.9 53.21 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.005 -1.109 . . . . 74.409999999999997 108.005 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.06 167.83 18.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.712 -0.222 . . . . 64.329999999999998 110.46 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -116.47 158.95 22.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.865 0.365 . . . . 75.120000000000005 110.324 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 t -145.01 140.25 28.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.906 -1.146 . . . . 60.32 107.906 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 -10.38 59.74 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.585 -0.524 . . . . 75.5 109.585 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -79.38 -27.25 41.88 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.289 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.24 135.58 33.38 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 115.84 -0.618 . . . . 74.230000000000004 109.919 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -99.33 157.07 16.66 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.952 -0.759 . . . . 72.409999999999997 108.952 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.643 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 57.4 m -53.94 126.62 23.1 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 124.458 1.099 . . . . 73.109999999999999 112.109 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.1 28.94 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-N 115.092 -0.958 . . . . 73.549999999999997 111.675 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -104.36 139.6 39.09 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.82 -0.437 . . . . 71.239999999999995 109.82 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -143.04 157.89 44.11 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.652 -1.24 . . . . 73.549999999999997 107.652 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 134.81 31.39 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.663 -0.866 . . . . 74.439999999999998 108.663 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.32 139.35 48.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.936 -1.505 . . . . 63.240000000000002 106.936 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -139.44 119.13 13.15 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.974 0.416 . . . . 74.209999999999994 110.243 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.4 127.21 8.77 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.263 -1.135 . . . . 74.510000000000005 110.263 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.0 p -127.46 145.31 50.88 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.205 0.526 . . . . 72.200000000000003 111.57 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.09 108.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.433 -0.951 . . . . 75.349999999999994 108.433 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -114.48 97.91 47.66 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 109.262 -0.644 . . . . 73.329999999999998 109.262 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.04 -8.76 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.993 1.796 . . . . 65.150000000000006 111.931 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -98.61 77.02 2.26 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-O 122.775 1.274 . . . . 73.010000000000005 108.621 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.75 139.93 50.34 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.385 0 CA-C-N 112.662 -2.063 . . . . 74.129999999999995 106.891 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.71 98.85 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.638 1.208 . . . . 63.100000000000001 110.551 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -70.83 116.6 11.33 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.17 -1.377 . . . . 72.409999999999997 110.322 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 C--N 1.295 -1.778 0 CA-C-N 115.314 -0.857 . . . . 74.340000000000003 108.933 -179.761 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 CA--C 1.505 -0.752 0 N-CA-C 108.132 -1.062 . . . . 73.219999999999999 108.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.59 7.3 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.615 -1.394 . . . . 64.230000000000004 109.615 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -82.18 157.99 23.76 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 108.759 -0.83 . . . . 64.200000000000003 108.759 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -143.33 143.05 31.52 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.524 -1.658 . . . . 74.5 106.524 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -78.71 77.26 5.19 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.335 1.541 . . . . 74.420000000000002 111.015 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -84.04 146.72 27.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.781 -2.009 . . . . 74.329999999999998 107.054 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.437 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.27 118.21 11.81 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.801 -0.815 . . . . 75.230000000000004 108.801 172.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 99' ' ' GLN . 24.2 m -119.54 145.79 25.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.068 -0.653 . . . . 73.540000000000006 111.206 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -126.44 177.21 6.61 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.694 -1.224 . . . . 75.519999999999996 107.694 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -134.08 96.91 3.73 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.603 -1.629 . . . . 74.319999999999993 106.603 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -66.34 148.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.836 -0.62 . . . . 75.239999999999995 110.664 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 59.87 76.77 0.35 Allowed 'General case' 0 C--O 1.242 0.689 0 O-C-N 124.496 1.123 . . . . 74.120000000000005 108.887 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -78.5 72.82 5.05 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.887 0.851 . . . . 74.25 113.225 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.22 95.42 5.95 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.125 -1.065 . . . . 74.319999999999993 108.125 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.9 pt? -112.18 94.4 4.92 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.604 -1.258 . . . . 74.319999999999993 107.604 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.76 122.31 30.48 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.735 -1.12 . . . . 74.010000000000005 109.345 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -49.7 117.21 2.13 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.403 -1.271 . . . . 73.400000000000006 113.895 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.8 m -72.31 123.37 22.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.418 -0.956 . . . . 75.400000000000006 108.418 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.58 145.84 19.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.554 -0.906 . . . . 74.120000000000005 108.554 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.42 42.39 1.6 Allowed Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 121.098 -0.572 . . . . 75.420000000000002 112.177 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.44 -38.28 74.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.701 0.763 . . . . 73.340000000000003 110.556 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.54 89.31 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.99 -1.005 . . . . 53.530000000000001 108.472 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HD2' ' A' ' 27' ' ' PHE . 7.4 m-85 -62.68 -44.56 95.94 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.762 -1.108 . . . . 75.340000000000003 109.511 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.85 -49.37 71.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.855 -0.611 . . . . 73.140000000000001 111.723 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -76.51 -33.53 58.62 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 112.723 0.638 . . . . 75.519999999999996 112.723 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -71.29 -44.05 73.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 121.068 -0.253 . . . . 70.430000000000007 111.608 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.444 ' HD2' ' O ' ' A' ' 23' ' ' PHE . 80.6 m-85 -77.02 -29.76 55.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.927 -0.309 . . . . 74.310000000000002 111.19 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.27 -90.13 0.05 OUTLIER Glycine 0 C--O 1.242 0.656 0 O-C-N 123.913 0.758 . . . . 74.25 114.841 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.76 -48.85 32.41 Favored Glycine 0 CA--C 1.495 -1.218 0 CA-C-N 115.344 -0.428 . . . . 71.129999999999995 112.486 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 t -89.39 82.6 6.44 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.43 -1.693 . . . . 74.340000000000003 106.43 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 tp -67.58 105.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.909 -1.496 . . . . 74.409999999999997 113.216 -173.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.23 88.79 53.64 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.811 -0.811 . . . . 73.310000000000002 108.811 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 34' ' ' GLN . 57.9 Cg_endo -103.57 -34.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 122.131 1.887 . . . . 75.030000000000001 115.596 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 25.0 mm-40 -143.02 25.48 1.76 Allowed 'General case' 0 C--O 1.254 1.31 0 CA-C-O 121.682 0.753 . . . . 71.209999999999994 109.185 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -82.05 -37.11 26.94 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.499 -0.773 . . . . 70.329999999999998 110.639 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 40' ' ' LEU . 97.5 t -61.01 -49.8 83.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 115.868 -0.605 . . . . 73.420000000000002 109.589 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -58.01 -47.8 81.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.528 0.731 . . . . 70.140000000000001 110.887 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.61 82.58 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.17 -0.923 . . . . 74.209999999999994 111.856 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.14 -31.54 58.66 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.399 0.518 . . . . 75.040000000000006 112.399 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 36' ' ' VAL . 5.6 mp -62.52 -42.57 99.6 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.397 0.147 . . . . 71.420000000000002 111.397 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.75 -28.51 62.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.597 -0.841 . . . . 75.420000000000002 110.342 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -63.36 -44.31 95.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.985 -0.552 . . . . 74.329999999999998 109.712 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -71.31 -32.54 68.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 75.010000000000005 111.488 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.15 93.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 75.200000000000003 109.631 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.83 61.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.689 -0.687 . . . . 73.540000000000006 111.074 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.52 -38.13 74.2 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.155 0.982 . . . . 74.230000000000004 110.208 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.72 42.97 1.78 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.568 -0.742 . . . . 70.329999999999998 112.788 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.92 138.08 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.958 0.503 . . . . 73.540000000000006 110.696 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 2.0 mp0 -120.3 146.44 46.11 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 123.066 0.547 . . . . 70.439999999999998 109.697 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.0 m -73.46 120.81 19.58 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 124.175 0.922 . . . . 73.329999999999998 109.407 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.454 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.7 tp -127.19 -170.66 2.26 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 103.733 -2.692 . . . . 73.319999999999993 103.733 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.454 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 62.0 mt-30 -55.54 148.87 14.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.148 0.885 . . . . 74.030000000000001 110.007 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.33 -5.48 8.36 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 115.08 0.792 . . . . 52.049999999999997 115.08 -171.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -66.35 -38.6 88.0 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.391 -0.596 . . . . 74.209999999999994 109.391 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -171.09 152.65 3.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.901 -0.59 . . . . 74.409999999999997 111.266 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -91.94 151.71 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.26 0.624 . . . . 74.109999999999999 111.275 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 41.9 tp -88.98 125.87 35.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.672 -0.695 . . . . 75.129999999999995 109.147 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.05 165.87 12.28 Favored Pre-proline 0 C--N 1.283 -2.288 0 C-N-CA 124.421 1.088 . . . . 65.299999999999997 108.634 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -64.98 159.08 48.13 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.545 2.164 . . . . 73.120000000000005 111.673 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -115.97 -30.67 5.98 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.71 -0.396 . . . . 74.219999999999999 111.349 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -104.04 127.71 51.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.353 -0.98 . . . . 72.230000000000004 108.353 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.34 114.83 20.71 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.772 -0.455 . . . . 75.010000000000005 109.772 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -97.9 110.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.755 -0.832 . . . . 65.510000000000005 108.755 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.8 115.57 48.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.6 -0.727 . . . . 72.219999999999999 109.21 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 m -109.53 123.42 49.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.527 -0.306 . . . . 74.340000000000003 110.525 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.22 -176.99 3.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.877 1.271 . . . . 71.5 109.183 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.7 -174.09 42.84 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 108.885 -1.686 . . . . 53.340000000000003 108.885 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.4 p -69.54 -58.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 118.321 1.06 . . . . 74.200000000000003 113.652 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 22.1 t-80 -55.77 -51.56 66.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.866 0.841 . . . . 72.409999999999997 110.068 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -65.19 -31.22 72.29 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.483 -1.235 . . . . 75.129999999999995 113.872 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -68.49 -43.58 76.58 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.409 -0.517 . . . . 71.540000000000006 110.596 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 37.4 mt-10 -62.97 -38.45 91.16 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.837 0.827 . . . . 73.430000000000007 110.092 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 12.4 mptt -80.82 -16.02 54.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.059 -0.973 . . . . 73.430000000000007 112.367 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 65.9 mt -70.61 -45.42 65.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.636 -1.246 . . . . 64.030000000000001 107.636 170.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 121.2 0.8 Allowed Glycine 0 N--CA 1.406 -3.312 0 CA-C-N 114.67 -1.15 . . . . 63.299999999999997 111.648 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.63 -18.73 62.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.995 -1.113 . . . . 74.329999999999998 107.995 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.98 88.89 8.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 104.785 -2.302 . . . . 65.150000000000006 104.785 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.2 -33.13 15.5 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.79 2.326 . . . . 74.5 114.007 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.95 -25.84 60.17 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.943 -0.303 . . . . 74.310000000000002 111.455 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.21 -35.25 80.47 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.571 -0.529 . . . . 73.25 109.571 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -74.23 -34.08 63.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.58 -0.737 . . . . 74.349999999999994 109.505 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.78 -51.31 70.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.497 -0.556 . . . . 64.239999999999995 109.497 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 28.2 m -62.34 -44.02 97.47 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.294 -0.412 . . . . 73.150000000000006 110.484 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.01 -57.94 17.17 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.391 -0.368 . . . . 61.140000000000001 113.051 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -67.87 -28.25 67.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.968 0.729 . . . . 64.150000000000006 112.968 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 104' ' ' VAL . . . -66.6 -46.1 76.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 74.140000000000001 110.637 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.8 mmt85 -67.75 -43.39 80.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.606 . . . . 74.319999999999993 109.883 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.8 t70 -56.69 -56.69 18.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.371 -1.286 . . . . 71.439999999999998 109.583 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.81 -31.11 72.19 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 112.589 0.589 . . . . 65.230000000000004 112.589 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.02 98.63 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.504 0.669 . . . . 72.400000000000006 111.178 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.31 -27.51 27.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.243 -1.391 . . . . 73.540000000000006 107.243 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.586 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 t80 -65.6 -42.78 91.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.723 -1.581 . . . . 64.319999999999993 110.195 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.95 -30.94 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.521 -0.471 . . . . 72.420000000000002 109.787 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -62.71 -42.39 99.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 71.439999999999998 109.964 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' TYR . 11.9 mm-40 -57.72 -38.14 74.77 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.807 0.843 . . . . 71.540000000000006 111.098 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.7 mm-40 -83.43 -14.06 53.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 75.319999999999993 111.623 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.59 38.13 25.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.075 -0.584 . . . . 64.200000000000003 112.1 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -117.74 179.7 4.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.553 -0.906 . . . . 74.409999999999997 108.553 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.433 ' OE1' ' HA ' ' A' ' 7' ' ' LEU . 11.0 pt20 -160.09 178.94 9.17 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 110.196 -0.298 . . . . 75.319999999999993 110.196 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.426 ' HA ' HD13 ' A' ' 57' ' ' LEU . 14.0 t -153.24 171.97 17.71 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.298 -1.371 . . . . 73.510000000000005 107.298 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.64 118.92 29.62 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.778 -1.564 . . . . 74.329999999999998 106.778 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.83 -149.43 16.59 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 119.277 -1.439 . . . . 63.149999999999999 109.862 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -125.59 152.58 44.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.404 -1.332 . . . . 62.420000000000002 107.404 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' O ' ' HB1' ' A' ' 86' ' ' ALA . 74.3 t -66.93 125.81 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 O-C-N 123.442 0.463 . . . . 72.230000000000004 111.255 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.86 120.22 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.519 0.676 . . . . 74.150000000000006 109.75 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.1 142.78 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 108.707 -0.849 . . . . 74.120000000000005 108.707 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.56 131.01 23.77 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.356 0.598 . . . . 75.329999999999998 112.028 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.19 151.27 19.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.499 -1.228 . . . . 75.099999999999994 108.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -159.51 170.13 22.36 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.113 0.565 . . . . 74.409999999999997 109.967 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.16 164.82 12.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.939 0.876 . . . . 74.340000000000003 112.941 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 t -142.7 134.91 27.43 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.583 -1.644 . . . . 74.420000000000002 106.885 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.43 -12.02 59.06 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.395 0.616 . . . . 74.299999999999997 110.168 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -85.18 -30.49 23.88 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.948 -0.569 . . . . 74.219999999999999 111.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.7 mt -86.94 149.47 24.77 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.733 -0.667 . . . . 52.439999999999998 111.636 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -126.85 168.78 13.99 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.279 -1.008 . . . . 73.329999999999998 108.279 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -57.49 110.55 0.89 Allowed 'General case' 0 C--O 1.251 1.155 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.65 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.14 -24.82 4.18 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 108.698 -1.761 . . . . 72.109999999999999 108.698 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -92.71 156.02 17.32 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.502 -1.296 . . . . 73.319999999999993 107.502 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -176.11 147.7 0.75 Allowed 'General case' 0 C--N 1.278 -2.539 0 O-C-N 125.077 1.486 . . . . 75.299999999999997 107.643 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -143.25 130.87 21.25 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.368 -0.378 . . . . 75.349999999999994 109.991 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.68 135.92 53.69 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.132 -1.062 . . . . 72.140000000000001 108.132 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -125.32 126.48 45.14 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.953 -0.758 . . . . 74.430000000000007 108.953 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.44 125.13 8.39 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 110.461 -1.055 . . . . 73.409999999999997 110.461 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 p -121.4 140.49 52.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 123.241 0.616 . . . . 71.340000000000003 110.68 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 80.1 t -92.35 103.66 14.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.719 -1.586 . . . . 72.340000000000003 106.719 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -107.35 104.22 51.6 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 108.23 -1.026 . . . . 71.430000000000007 108.23 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.4 -39.6 6.99 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.936 1.757 . . . . 74.049999999999997 112.924 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.17 69.43 1.15 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.911 1.339 . . . . 71.329999999999998 108.416 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.59 108.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 113.082 -1.872 . . . . 75.109999999999999 109.295 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -85.82 122.15 29.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.769 -1.105 . . . . 73.430000000000007 109.344 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.1 p -70.57 120.09 15.69 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.638 -1.165 . . . . 73.340000000000003 111.718 -173.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 107.314 -1.365 . . . . 74.420000000000002 107.314 175.338 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 121.206 0.527 . . . . 71.420000000000002 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.62 -15.74 13.02 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.939 -1.264 . . . . 70.319999999999993 109.939 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 p -84.56 158.55 20.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 109.551 -0.537 . . . . 72.530000000000001 109.551 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -135.47 108.31 7.56 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.835 0.35 . . . . 71.109999999999999 111.598 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.19 145.63 37.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.929 -0.767 . . . . 70.420000000000002 108.929 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -86.01 8.51 20.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.632 0.729 . . . . 75.140000000000001 111.271 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.6 pp -133.2 96.02 3.66 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 122.229 1.014 . . . . 75.099999999999994 110.485 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.66 108.02 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.209 -0.905 . . . . 73.540000000000006 109.008 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.433 -0.803 . . . . 72.329999999999998 109.733 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -124.48 85.2 2.38 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.112 -0.699 . . . . 72.310000000000002 109.112 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.58 124.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.121 -0.945 . . . . 72.329999999999998 110.103 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.2 148.62 44.0 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.451 -0.795 . . . . 74.439999999999998 109.129 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -89.36 113.68 25.02 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.8 -0.444 . . . . 75.439999999999998 109.8 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -88.69 86.36 6.97 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.916 -1.142 . . . . 74.439999999999998 107.916 172.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.08 113.73 18.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.741 -1.207 . . . . 65.329999999999998 107.741 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.23 145.75 50.27 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.443 -0.947 . . . . 64.310000000000002 108.443 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -134.11 147.62 50.88 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.253 0.549 . . . . 74.519999999999996 110.6 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -148.56 145.38 27.82 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.215 -1.772 . . . . 75.310000000000002 106.215 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.02 100.69 10.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.304 0.573 . . . . 75.310000000000002 109.84 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.11 69.27 0.55 Allowed Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.335 -0.848 . . . . 71.329999999999998 111.876 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 16.5 t70 -151.62 131.26 13.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.788 -1.19 . . . . 73.420000000000002 107.788 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.351 1.032 . . . . 73.109999999999999 113.163 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -76.94 -34.56 57.63 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.541 -0.3 . . . . 62.219999999999999 111.076 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.03 73.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.663 -0.495 . . . . 73.049999999999997 109.663 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 12.8 mmm180 -64.55 -42.41 95.71 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.038 -0.528 . . . . 64.430000000000007 109.714 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -60.92 -39.5 82.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 CA-C-N 115.883 -0.599 . . . . 73.329999999999998 111.147 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' SER . 77.9 m-85 -77.61 -17.38 57.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.342 -0.39 . . . . 74.319999999999993 111.855 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.07 39.69 2.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 61.130000000000003 113.358 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.34 22.7 43.2 Favored Glycine 0 C--N 1.313 -0.722 0 N-CA-C 111.52 -0.632 . . . . 54.399999999999999 111.52 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 33.3 t -142.45 147.97 36.99 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.165 -1.42 . . . . 74.140000000000001 107.165 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.32 88.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.508 1.147 . . . . 73.430000000000007 109.413 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.62 99.31 42.33 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 114.641 -1.163 . . . . 74.430000000000007 109.476 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.37 -24.39 64.53 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 110.299 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -67.09 -14.17 62.65 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 114.6 -1.182 . . . . 71.409999999999997 111.781 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.96 -44.85 88.03 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.671 0.748 . . . . 74.299999999999997 109.014 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.48 -38.22 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.196 -0.911 . . . . 74.420000000000002 108.846 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.37 -42.59 91.98 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.67 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.19 -45.82 86.9 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.429 0.692 . . . . 71.540000000000006 110.691 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -66.59 -45.75 78.2 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.854 -0.612 . . . . 73.430000000000007 109.517 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.59 -40.15 92.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.09 0.774 . . . . 75.340000000000003 113.09 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -72.21 -29.35 63.88 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 64.510000000000005 110.008 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.74 -44.11 97.07 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.17 -1.048 . . . . 74.349999999999994 108.17 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.94 -48.66 65.29 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.92 -1.036 . . . . 64.549999999999997 110.123 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.84 68.32 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.432 -0.349 . . . . 73.140000000000001 111.814 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.64 -23.24 56.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.994 0.368 . . . . 70.200000000000003 111.994 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.02 -34.54 24.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.218 0.533 . . . . 63.229999999999997 110.618 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.75 21.12 15.84 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.54 -0.755 . . . . 73.409999999999997 113.177 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mm -72.57 131.73 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.002 0.43 . . . . 75.129999999999995 110.498 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.7 mt-30 -108.84 133.13 53.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.769 -0.826 . . . . 71.310000000000002 108.769 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -75.32 117.71 17.43 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.949 -1.023 . . . . 71.219999999999999 109.407 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD23 ' NE2' ' A' ' 99' ' ' GLN . 12.9 tp -141.39 -164.34 1.75 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 103.955 -2.609 . . . . 74.140000000000001 103.955 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -42.68 131.74 3.88 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.702 0.626 . . . . 73.010000000000005 111.662 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.38 -18.47 55.69 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 115.062 0.785 . . . . 74.409999999999997 115.062 -170.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.41 -31.9 54.37 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.627 -0.829 . . . . 73.230000000000004 111.422 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 12.4 ptm180 -151.77 114.42 4.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.497 1.141 . . . . 75.530000000000001 111.029 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -91.1 150.71 21.29 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.969 -1.469 . . . . 74.310000000000002 108.322 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -84.25 120.34 26.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.495 -0.558 . . . . 73.140000000000001 109.495 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 157.38 38.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.676 -0.693 . . . . 74.340000000000003 109.672 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.68 147.58 95.01 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.573 2.182 . . . . 72.239999999999995 112.175 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 28.8 p-10 -120.59 -24.44 5.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.966 -0.561 . . . . 73.420000000000002 110.403 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.11 114.8 29.2 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.455 -0.572 . . . . 71.230000000000004 109.455 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -119.56 114.63 22.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.601 -0.727 . . . . 72.319999999999993 109.411 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -109.13 120.27 60.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.616 -0.883 . . . . 75.400000000000006 108.616 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.9 126.71 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 108.556 -0.905 . . . . 74.329999999999998 108.556 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -107.81 130.97 54.94 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.48 -0.782 . . . . 72.510000000000005 109.282 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.35 161.27 22.38 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.68 0.792 . . . . 65.200000000000003 109.244 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.1 157.33 52.55 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.727 -1.349 . . . . 63.509999999999998 109.727 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.4 p -56.76 -39.13 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 117.364 0.582 . . . . 65.439999999999998 112.374 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.95 -44.4 82.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.481 0.658 . . . . 73.25 110.777 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 39.8 m-20 -84.76 -21.67 29.92 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 112.784 0.661 . . . . 75.329999999999998 112.784 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 57.0 t80 -69.3 -26.09 64.55 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.162 -0.681 . . . . 71.349999999999994 109.162 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 46.2 mt-10 -58.67 -38.56 78.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.386 -0.37 . . . . 54.329999999999998 110.784 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' CE ' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -76.55 -32.8 58.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.108 0.48 . . . . 75.219999999999999 109.913 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.08 -29.25 70.11 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.988 -0.551 . . . . 71.129999999999995 109.976 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.03 33.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.672 -0.694 . . . . 54.020000000000003 113.904 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.36 0.58 . . . . 72.230000000000004 109.67 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.35 68.34 2.77 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 122.198 0.999 . . . . 64.209999999999994 109.765 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.76 -51.25 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.199 1.933 . . . . 74.099999999999994 113.685 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.8 -23.16 60.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.439 -0.346 . . . . 73.519999999999996 111.633 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.5 -43.09 81.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.763 -0.458 . . . . 74.310000000000002 109.763 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -63.33 -34.4 77.62 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.739 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.1 m -66.87 -49.03 66.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.785 -0.643 . . . . 70.349999999999994 110.698 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -62.49 -36.27 82.0 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.296 -0.411 . . . . 74.239999999999995 111.141 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.15 40.29 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.424 -0.417 . . . . 62.409999999999997 112.122 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -70.85 -28.04 64.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.324 0.49 . . . . 64.430000000000007 112.324 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.898 -0.408 . . . . 72.040000000000006 109.898 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -59.67 -47.61 84.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.41 -0.813 . . . . 71.239999999999995 109.522 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' O ' ' HD1' ' A' ' 92' ' ' TYR . 59.7 m-20 -69.52 -45.37 69.01 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 113.275 0.843 . . . . 70.200000000000003 113.275 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.137 -0.625 . . . . 70.340000000000003 111.812 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.34 87.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 109.939 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.93 -44.5 72.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.913 -0.585 . . . . 71.109999999999999 109.734 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.623 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.1 m-85 -58.68 -49.62 76.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.485 -0.78 . . . . 65.310000000000002 112.572 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.12 -39.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 119.914 -0.715 . . . . 75.319999999999993 111.363 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.63 -41.58 96.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.61 -0.268 . . . . 73.120000000000005 110.491 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.47 -38.95 75.33 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.693 1.197 . . . . 71.329999999999998 110.723 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 52.2 mm-40 -87.44 -13.35 43.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.782 -0.645 . . . . 75.319999999999993 111.402 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.48 28.74 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.976 -0.85 . . . . 72.540000000000006 110.976 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -105.34 158.71 16.44 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.008 -0.738 . . . . 74.400000000000006 109.008 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.5 pt20 -126.33 171.58 10.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.197 -0.456 . . . . 73.549999999999997 110.175 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.3 t -162.52 158.05 23.05 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.639 -1.245 . . . . 74.239999999999995 107.639 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.51 120.44 40.3 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.265 -1.013 . . . . 75.409999999999997 108.265 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -152.11 16.99 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.154 -1.579 . . . . 71.120000000000005 109.154 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.95 162.58 20.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.217 -0.66 . . . . 72.230000000000004 109.217 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.22 119.83 31.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.58 -0.896 . . . . 75.129999999999995 108.58 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.66 133.1 69.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.451 0.643 . . . . 64.310000000000002 109.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.03 134.37 61.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.377 -0.972 . . . . 72.299999999999997 108.377 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.428 ' HE ' ' HA ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -130.88 142.99 50.41 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.729 -0.841 . . . . 74.340000000000003 108.729 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.98 137.02 52.27 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.765 -0.828 . . . . 73.219999999999999 108.765 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.32 160.8 38.55 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 120.967 0.413 . . . . 73.299999999999997 110.678 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.482 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 26.9 pt20 -103.55 153.89 20.08 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.397 -0.82 . . . . 74.030000000000001 109.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.2 t -144.37 132.22 21.38 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 109.025 -0.732 . . . . 65.299999999999997 109.025 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.05 -15.73 55.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.08 -1.081 . . . . 62.240000000000002 108.08 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.5 -32.89 54.46 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.565 -1.198 . . . . 75.219999999999999 109.769 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -84.44 157.66 21.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.423 -0.954 . . . . 74.409999999999997 108.423 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -98.54 164.53 12.22 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.757 0.651 . . . . 74.140000000000001 112.757 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 m -66.13 134.57 53.07 Favored 'General case' 0 C--O 1.25 1.089 0 C-N-CA 123.995 0.918 . . . . 74.109999999999999 110.802 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.1 86.82 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 112.041 -0.424 . . . . 64.329999999999998 112.041 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -138.49 128.38 25.27 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 107.915 -1.143 . . . . 74.310000000000002 107.915 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -122.59 153.94 38.61 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.776 -0.824 . . . . 74.109999999999999 108.776 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -148.61 153.76 38.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.429 -1.323 . . . . 75.030000000000001 107.429 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.35 34.54 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 120.697 -0.401 . . . . 73.040000000000006 110.966 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -134.42 123.0 23.33 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.5 -0.773 . . . . 72.510000000000005 109.476 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.68 126.17 7.57 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.715 -1.354 . . . . 74.230000000000004 109.715 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.2 m -135.88 150.59 49.42 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 109.402 -0.592 . . . . 73.549999999999997 109.402 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.02 110.97 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 107.179 -1.415 . . . . 74.349999999999994 107.179 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -120.06 86.99 38.23 Favored Pre-proline 0 C--N 1.284 -2.264 0 N-CA-C 107.226 -1.398 . . . . 72.230000000000004 107.226 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.27 -13.68 7.4 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.368 2.045 . . . . 70.129999999999995 112.69 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -87.12 29.32 0.84 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.594 -0.73 . . . . 73.519999999999996 112.71 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.16 98.82 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.17 -0.678 . . . . 75.430000000000007 109.17 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -94.8 121.23 36.17 Favored 'General case' 0 N--CA 1.4 -2.969 0 N-CA-C 106.508 -1.664 . . . . 72.0 106.508 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -123.28 149.39 44.84 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 109.339 -0.615 . . . . 73.409999999999997 109.339 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 106.599 -1.63 . . . . 75.140000000000001 106.599 177.347 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.34 -0.615 . . . . 72.549999999999997 109.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.27 -175.21 34.02 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.869 -1.292 . . . . 71.329999999999998 109.869 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -79.35 92.24 5.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.732 -0.84 . . . . 53.409999999999997 108.732 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -121.94 135.93 54.89 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.588 -0.733 . . . . 73.530000000000001 110.879 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -75.05 83.74 2.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.088 0.947 . . . . 71.540000000000006 108.9 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -84.14 139.9 32.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.593 -1.185 . . . . 73.129999999999995 110.421 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.65 84.21 7.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.205 -1.035 . . . . 70.219999999999999 108.205 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 9' ' ' GLN . 12.2 p -112.35 143.11 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 114.148 -1.387 . . . . 71.209999999999994 109.767 -175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' O ' HG21 ' A' ' 8' ' ' VAL . 17.8 pt20 -90.8 168.25 11.86 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.214 -1.032 . . . . 71.510000000000005 108.214 174.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -76.03 88.39 2.97 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.976 0.893 . . . . 72.230000000000004 111.146 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 13' ' ' ARG . 48.1 t -70.03 145.83 12.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.782 -1.553 . . . . 74.310000000000002 109.229 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -51.61 -45.5 63.25 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.63 0.772 . . . . 71.540000000000006 110.284 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' H ' HG13 ' A' ' 11' ' ' VAL . 22.0 mmt180 -59.43 146.24 40.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.658 -1.155 . . . . 75.239999999999995 110.824 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 117.64 7.69 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.729 -0.841 . . . . 74.140000000000001 108.729 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -91.34 150.37 21.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.263 -0.643 . . . . 75.219999999999999 109.263 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.77 110.8 11.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.324 1.231 . . . . 74.510000000000005 114.324 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -125.38 104.86 8.69 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.103 -1.408 . . . . 72.329999999999998 107.22 171.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.2 m -71.48 112.41 7.58 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.34 -0.846 . . . . 73.329999999999998 110.164 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.65 87.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.058 -0.974 . . . . 74.109999999999999 108.601 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.47 50.47 0.03 OUTLIER Glycine 0 C--N 1.287 -2.176 0 N-CA-C 109.099 -1.601 . . . . 61.200000000000003 109.099 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.89 -39.81 66.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.388 1.075 . . . . 61.43 111.93 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.84 -59.24 5.54 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.17 -0.923 . . . . 61.450000000000003 110.139 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -44.73 86.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.15 -0.932 . . . . 74.420000000000002 110.454 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.57 82.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.341 -0.845 . . . . 72.439999999999998 111.878 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -78.37 -28.88 47.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.412 -0.515 . . . . 72.519999999999996 111.876 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 22' ' ' ALA . 72.1 mt -66.96 -48.05 80.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 O-C-N 123.317 0.386 . . . . 73.540000000000006 110.385 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -84.12 -29.73 26.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.398 -0.921 . . . . 74.200000000000003 110.626 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.39 -86.42 0.61 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 112.004 -0.439 . . . . 54.539999999999999 112.004 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.34 63.54 0.47 Allowed Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.407 -0.677 . . . . 65.340000000000003 111.407 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -147.55 171.4 15.62 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.156 -1.424 . . . . 71.230000000000004 107.156 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.46 147.73 9.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 110.085 -0.339 . . . . 63.43 110.085 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.11 113.74 55.09 Favored Pre-proline 0 N--CA 1.431 -1.405 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -87.49 50.2 1.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 122.484 2.123 . . . . 74.310000000000002 114.406 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -71.02 -12.77 61.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.232 -1.387 . . . . 74.510000000000005 111.525 177.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.67 -25.3 67.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.357 -0.608 . . . . 74.109999999999999 109.357 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.99 -49.7 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 109.681 -0.488 . . . . 75.109999999999999 109.681 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.97 -35.8 81.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.366 -0.533 . . . . 75.219999999999999 109.822 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.33 94.15 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.685 -0.688 . . . . 73.319999999999993 110.773 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -44.45 96.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.774 -0.824 . . . . 74.209999999999994 108.774 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.12 -29.18 68.04 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.035 0.754 . . . . 74.409999999999997 113.035 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 11.4 mtm180 -65.52 -36.97 85.41 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.778 -1.194 . . . . 75.510000000000005 107.778 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -46.87 72.26 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.17 -0.923 . . . . 72.439999999999998 110.07 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.21 -41.08 96.22 Favored 'General case' 0 CA--C 1.5 -0.942 0 O-C-N 123.397 0.435 . . . . 74.519999999999996 111.976 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.49 93.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.095 -0.502 . . . . 74.140000000000001 110.583 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.25 -25.36 42.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.089 -0.505 . . . . 71.439999999999998 111.599 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.19 -40.02 28.04 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.04 0.448 . . . . 64.319999999999993 110.167 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.85 17.96 37.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.786 . . . . 64.209999999999994 112.999 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.95 127.03 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-O 121.325 0.583 . . . . 75.329999999999998 110.814 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.2 tt0 -109.59 128.27 55.1 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 106.819 -1.549 . . . . 73.439999999999998 106.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -67.61 116.47 8.36 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.419 0.628 . . . . 75.040000000000006 110.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 18.4 tp -119.62 -165.83 1.21 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.503 -2.036 . . . . 75.530000000000001 105.503 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.547 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 14.1 mm-40 -62.92 166.56 5.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.731 0.696 . . . . 71.230000000000004 110.741 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.4 1.7 18.84 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.416 -0.811 . . . . 70.239999999999995 113.472 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.91 -48.64 57.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.621 -0.881 . . . . 71.430000000000007 108.621 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -173.67 159.8 3.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.869 -0.605 . . . . 74.140000000000001 110.649 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.87 151.68 20.44 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.653 0.781 . . . . 75.420000000000002 109.993 -176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.4 tm? -98.64 126.27 44.19 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.151 -1.796 . . . . 75.310000000000002 106.151 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.47 157.65 33.43 Favored Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 122.899 0.48 . . . . 72.420000000000002 110.305 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.446 ' HG2' ' OH ' ' A' ' 62' ' ' TYR . 23.6 Cg_endo -63.73 148.34 92.12 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.334 2.023 . . . . 75.450000000000003 111.698 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 24.5 p-10 -123.37 -16.33 6.89 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.593 -0.73 . . . . 75.450000000000003 112.175 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.92 109.45 18.15 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 120.365 -0.534 . . . . 74.349999999999994 110.635 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.446 ' OH ' ' HG2' ' A' ' 59' ' ' PRO . 24.9 m-85 -114.44 127.67 55.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.532 -0.758 . . . . 73.420000000000002 110.7 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 64.8 mt -109.28 115.61 50.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.908 -1.145 . . . . 71.310000000000002 107.908 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.99 110.42 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.451 -0.944 . . . . 73.150000000000006 108.451 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -102.27 121.73 42.83 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.189 -0.46 . . . . 70.209999999999994 110.529 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.38 167.89 9.86 Favored 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.698 0.799 . . . . 74.140000000000001 110.168 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 162.38 50.56 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.39 -1.484 . . . . 73.329999999999998 109.39 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 7.9 p -59.71 -42.01 87.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 117.467 0.633 . . . . 74.430000000000007 112.306 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -73.6 -21.95 60.18 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.494 0.664 . . . . 74.310000000000002 110.17 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -79.26 -36.87 39.19 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.766 -0.584 . . . . 73.409999999999997 110.173 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -31.08 71.56 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.766 -0.652 . . . . 72.349999999999994 109.473 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.6 mm-40 -59.42 -31.43 69.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.713 -0.676 . . . . 75.420000000000002 112.004 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -84.44 -27.82 27.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.085 -0.646 . . . . 62.140000000000001 110.755 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.36 -38.97 92.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.395 -0.366 . . . . 74.420000000000002 110.22 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.51 169.28 11.59 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 111.384 -0.686 . . . . 74.349999999999994 111.384 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.14 -31.41 25.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.0 0.428 . . . . 64.420000000000002 110.417 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 16.3 m-20 -105.8 105.36 52.85 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.51 -0.768 . . . . 71.310000000000002 109.428 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.16 -18.97 17.96 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.08 1.853 . . . . 75.140000000000001 113.783 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.296 0.0 OUTLIER -62.54 -51.91 65.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.789 1.403 . . . . 75.439999999999998 114.789 -174.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -67.35 -36.44 81.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.86 0.3 . . . . 74.010000000000005 111.314 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 72.4 mmtt -64.61 -45.78 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.539 . . . . 65.310000000000002 109.904 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.605 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 43.5 m -71.68 -49.71 37.14 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.378 -0.828 . . . . 72.5 111.11 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 56.1 m -65.63 -35.07 79.73 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.785 0.326 . . . . 74.239999999999995 111.649 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.73 -46.53 74.54 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.336 -0.705 . . . . 55.0 111.336 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.81 -28.28 67.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.274 -0.639 . . . . 74.439999999999998 109.274 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.94 79.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.994 -0.548 . . . . 72.140000000000001 110.25 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 83' ' ' THR . 99.9 mtt180 -66.14 -41.9 89.8 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.104 -0.332 . . . . 75.439999999999998 110.104 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.43 -36.66 83.09 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.927 0.394 . . . . 73.5 110.327 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.39 -39.44 65.1 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.948 -0.569 . . . . 51.109999999999999 110.121 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.44 ' HB1' HG13 ' A' ' 104' ' ' VAL . . . -59.37 -41.44 89.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.65 0.738 . . . . 73.219999999999999 109.026 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 19.2 t70 -58.16 -51.67 68.76 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.265 -1.334 . . . . 75.340000000000003 109.186 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 10.0 m-85 -55.1 -53.72 52.3 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.27 0.841 . . . . 73.239999999999995 113.27 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 pt -61.84 -36.63 74.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 120.774 -0.37 . . . . 75.219999999999999 111.664 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.19 -36.63 82.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.067 -0.515 . . . . 71.439999999999998 111.35 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.9 mt-10 -62.93 -38.84 92.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.381 0.61 . . . . 65.209999999999994 110.844 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 62.3 mm-40 -79.8 -9.45 59.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.377 -0.828 . . . . 75.5 110.905 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.81 56.57 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 112.583 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -101.5 159.76 15.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.488 -0.931 . . . . 65.439999999999998 108.488 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -132.94 171.6 13.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.711 -1.218 . . . . 74.129999999999995 107.711 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.1 t -147.86 166.27 28.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.645 -0.502 . . . . 73.099999999999994 109.645 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -106.51 120.76 42.76 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 109.749 -0.463 . . . . 70.519999999999996 109.749 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.85 -149.79 17.03 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.269 -1.132 . . . . 51.329999999999998 110.269 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -108.8 143.0 38.53 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.885 -1.524 . . . . 73.420000000000002 106.885 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 HG13 ' HB1' ' A' ' 90' ' ' ALA . 14.8 p -81.52 112.99 20.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.128 -1.029 . . . . 71.439999999999998 108.903 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.85 120.15 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-O 122.096 0.95 . . . . 73.209999999999994 110.866 -176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.605 ' O ' ' HB3' ' A' ' 82' ' ' SER . 3.7 m -119.1 139.67 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 N-CA-C 104.025 -2.583 . . . . 74.450000000000003 104.025 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.81 132.88 33.29 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.869 -1.132 . . . . 74.530000000000001 112.119 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -91.35 119.94 31.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.418 -1.265 . . . . 75.540000000000006 108.54 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.89 171.67 9.05 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.81 -0.632 . . . . 74.019999999999996 109.925 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -121.49 157.63 30.22 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.115 -1.069 . . . . 73.549999999999997 108.115 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.7 t -145.76 146.98 31.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.093 -0.706 . . . . 63.149999999999999 109.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.3 m -80.89 -22.74 39.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.433 -0.951 . . . . 75.340000000000003 108.433 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -80.46 -29.7 37.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.251 -0.886 . . . . 73.519999999999996 109.652 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.02 130.78 37.69 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.113 -1.81 . . . . 75.099999999999994 106.113 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 38.1 t-80 -97.74 153.24 18.39 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.499 -0.48 . . . . 73.409999999999997 110.008 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.9 m -60.51 139.59 57.68 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.635 0.774 . . . . 73.129999999999995 110.768 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.18 3.05 57.88 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.211 -1.155 . . . . 52.43 110.211 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 25.3 mt-30 -132.25 154.05 50.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.05 0.94 . . . . 72.439999999999998 109.101 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.11 148.22 26.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.434 -1.321 . . . . 75.109999999999999 107.434 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -137.45 135.94 37.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.802 -0.814 . . . . 74.120000000000005 108.802 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -137.28 120.66 16.98 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 123.527 0.517 . . . . 72.040000000000006 109.78 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 1.5 tpm_? -119.73 137.41 53.94 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.682 -1.229 . . . . 74.409999999999997 107.682 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -120.4 104.34 0.99 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.189 -0.764 . . . . 71.510000000000005 111.189 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.6 m -105.43 151.22 24.5 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 122.43 -0.453 . . . . 74.209999999999994 109.81 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.35 112.48 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.153 -1.054 . . . . 74.430000000000007 108.153 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -115.5 108.02 48.06 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 109.041 -0.726 . . . . 64.239999999999995 109.041 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.53 -23.98 19.4 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.92 1.747 . . . . 70.109999999999999 112.236 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.07 77.26 1.81 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.507 1.146 . . . . 70.409999999999997 110.471 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.88 131.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.773 0 CA-C-N 113.171 -1.831 . . . . 73.519999999999996 107.546 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -76.97 143.35 39.52 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 110.388 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -131.58 140.08 49.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.849 -1.537 . . . . 72.019999999999996 106.849 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.4 m80 . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 118.755 -0.641 . . . . 74.239999999999995 109.965 -175.788 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 CA--C 1.516 -0.365 0 N-CA-C 110.233 -0.284 . . . . 75.329999999999998 110.233 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.09 110.78 3.15 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.426 -1.47 . . . . 75.340000000000003 109.426 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -72.91 151.01 42.1 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 122.535 0.334 . . . . 62.399999999999999 111.025 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -78.04 24.85 0.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.624 0.602 . . . . 75.299999999999997 112.624 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -169.43 146.83 3.51 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 123.048 0.539 . . . . 73.310000000000002 109.941 177.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -108.64 153.49 23.34 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.374 -1.343 . . . . 73.400000000000006 107.374 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.71 101.26 8.31 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.917 -0.771 . . . . 73.549999999999997 108.917 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.73 -79.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.962 -0.563 . . . . 63.109999999999999 109.539 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -154.74 -178.83 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.691 -1.966 . . . . 73.140000000000001 105.691 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -63.85 116.73 6.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.668 0.747 . . . . 72.010000000000005 110.675 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.401 ' HA ' ' NE2' ' A' ' 17' ' ' GLN . 36.0 t -79.6 81.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 107.423 -1.325 . . . . 64.140000000000001 107.423 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.62 113.61 25.37 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.219 -1.355 . . . . 75.409999999999997 113.08 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 57.76 33.24 22.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.685 1.194 . . . . 73.530000000000001 112.48 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -171.42 140.21 1.38 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.611 -1.996 . . . . 75.040000000000006 105.611 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.82 -9.25 58.03 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.702 1.001 . . . . 73.439999999999998 113.702 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.14 168.81 20.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.846 -1.538 . . . . 74.120000000000005 106.846 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' NE2' ' HA ' ' A' ' 11' ' ' VAL . 92.8 mm-40 -106.32 -0.6 24.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.208 1.004 . . . . 75.030000000000001 112.172 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 p -95.93 177.34 5.79 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.179 -1.373 . . . . 75.530000000000001 107.755 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.88 81.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.833 -0.802 . . . . 73.340000000000003 108.833 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.46 9.26 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 110.534 -1.026 . . . . 63.240000000000002 110.534 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -42.5 -54.86 3.71 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 114.636 1.347 . . . . 73.430000000000007 114.636 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -59.3 -59.51 5.35 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 123.972 0.795 . . . . 73.439999999999998 111.753 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -63.25 -38.38 90.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.189 0.44 . . . . 73.409999999999997 112.189 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -60.51 -43.7 96.79 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.284 0.365 . . . . 73.5 111.055 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -78.09 -19.81 53.44 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 120.801 0.334 . . . . 71.120000000000005 111.415 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.4 mt -74.07 -56.47 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.834 -0.432 . . . . 74.340000000000003 109.834 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -69.59 -28.32 65.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 111.401 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.59 -49.5 0.94 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.988 -0.845 . . . . 55.409999999999997 110.988 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.52 47.06 0.69 Allowed Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.514 -0.85 . . . . 53.140000000000001 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 21.1 t -167.72 136.58 2.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.868 -0.79 . . . . 73.319999999999993 108.868 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tt -93.3 -43.69 13.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.194 -1.039 . . . . 72.430000000000007 108.194 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.16 123.49 10.38 Favored Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 105.599 -2.001 . . . . 75.010000000000005 105.599 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.46 87.57 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.088 1.859 . . . . 73.519999999999996 111.78 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.68 -5.95 59.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 113.326 0.862 . . . . 75.310000000000002 113.326 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.55 -22.65 43.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.847 -0.741 . . . . 74.519999999999996 109.216 172.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.74 -48.79 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 63.119999999999997 109.074 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.07 -33.24 75.55 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.8 -0.36 . . . . 63.350000000000001 110.654 178.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.19 81.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.585 0.553 . . . . 53.43 109.942 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.74 -45.6 93.65 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 108.765 -0.828 . . . . 74.430000000000007 108.765 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD23 HD11 ' A' ' 64' ' ' ILE . 11.1 mp -64.75 -42.45 95.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.043 1.127 . . . . 75.0 114.043 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.3 ptt180 -71.62 -27.28 63.0 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.205 -0.998 . . . . 74.129999999999995 111.328 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -68.14 -46.26 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.22 -40.42 93.93 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.697 1.199 . . . . 65.219999999999999 109.919 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.33 96.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.729 -0.669 . . . . 74.450000000000003 110.348 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.05 76.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.155 0.502 . . . . 74.310000000000002 111.36 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.91 -28.55 49.81 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.95 0.405 . . . . 72.340000000000003 111.289 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.49 21.6 45.25 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 116.267 -0.424 . . . . 63.32 113.138 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.15 144.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.693 0.797 . . . . 74.319999999999993 111.485 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 9.4 tt0 -120.45 134.66 55.24 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 107.988 -1.116 . . . . 73.319999999999993 107.988 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -64.48 128.94 37.93 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.453 0.644 . . . . 51.420000000000002 109.461 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -135.4 -166.25 1.81 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 105.57 -2.011 . . . . 73.010000000000005 105.57 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.588 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 67.6 mt-30 -59.05 155.68 13.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.611 -0.515 . . . . 72.239999999999995 109.611 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.53 -9.46 37.86 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 116.442 -0.344 . . . . 62.450000000000003 113.494 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -46.73 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.504 -0.184 . . . . 74.120000000000005 110.504 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 99' ' ' GLN . 6.0 ptm180 -172.16 152.92 2.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.4 -0.364 . . . . 75.420000000000002 110.698 -175.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -91.67 152.38 20.25 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.508 1.123 . . . . 73.530000000000001 111.084 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.8 tm? -92.97 133.28 36.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.092 -1.447 . . . . 70.25 107.092 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.61 159.97 41.96 Favored Pre-proline 0 C--N 1.302 -1.461 0 C-N-CA 123.525 0.73 . . . . 64.129999999999995 109.753 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.72 162.1 22.72 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.068 2.512 . . . . 74.209999999999994 113.418 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.409 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 9.8 p30 -134.16 -23.73 1.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.96 -0.563 . . . . 73.430000000000007 112.215 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.05 104.49 14.67 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.117 -1.033 . . . . 74.420000000000002 109.515 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.28 114.62 28.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.313 -0.858 . . . . 73.329999999999998 109.581 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.36 118.03 56.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.722 -1.214 . . . . 70.019999999999996 107.722 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.435 HD11 HD23 ' A' ' 40' ' ' LEU . 41.0 mt -113.31 125.79 70.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.011 -1.107 . . . . 72.150000000000006 108.011 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -116.39 123.32 47.28 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.138 -0.69 . . . . 73.420000000000002 109.138 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 119' ' ' PHE . 4.1 mm? -102.65 159.62 15.29 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.854 0.862 . . . . 72.109999999999999 109.478 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.82 144.68 48.53 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.683 -2.167 . . . . 62.009999999999998 107.683 169.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -55.59 -36.02 40.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.425 0.898 . . . . 75.310000000000002 113.425 -173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -69.69 -34.17 73.56 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.762 0.315 . . . . 73.129999999999995 111.227 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.3 m-20 -76.69 -25.82 54.06 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.22 0.533 . . . . 71.549999999999997 110.176 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.97 -31.18 71.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.26 -1.015 . . . . 73.120000000000005 108.26 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.92 -31.7 73.07 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.731 -0.668 . . . . 75.239999999999995 110.532 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -73.23 -27.61 61.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 110.915 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.53 -27.22 66.79 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.167 -0.679 . . . . 73.540000000000006 109.167 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.16 -163.72 12.54 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 114.81 -1.086 . . . . 74.140000000000001 113.389 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.89 -19.35 44.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.34 0.59 . . . . 75.409999999999997 109.672 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.23 67.94 36.29 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.696 -0.684 . . . . 74.349999999999994 112.54 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -72.5 -48.85 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.909 1.739 . . . . 65.230000000000004 110.352 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.578 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 5.4 mm-40 -68.43 -12.84 61.76 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.302 0.853 . . . . 73.109999999999999 113.302 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.22 -38.17 43.69 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.595 -1.261 . . . . 73.219999999999999 107.595 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.54 -25.6 57.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.068 -0.969 . . . . 73.299999999999997 110.407 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 9.3 m -54.65 -42.35 71.19 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 124.126 0.97 . . . . 74.430000000000007 111.28 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 m -60.85 -44.13 97.42 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.537 0.735 . . . . 72.439999999999998 111.275 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.65 -38.11 67.61 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.117 -0.793 . . . . 65.030000000000001 111.117 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -67.37 -36.47 81.41 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.363 0.665 . . . . 74.409999999999997 109.652 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.8 96.17 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.027 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -67.26 -36.29 81.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.316 -0.402 . . . . 74.200000000000003 110.67 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -43.97 96.74 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.638 -0.875 . . . . 75.549999999999997 108.638 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.62 -36.66 81.25 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.462 -0.79 . . . . 73.25 110.818 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.47 ' HB1' HG13 ' A' ' 104' ' ' VAL . . . -61.36 -38.15 85.9 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.401 0.619 . . . . 74.510000000000005 109.6 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 33.1 t70 -66.21 -42.41 88.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.464 -0.789 . . . . 73.219999999999999 109.329 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.56 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.8 m-85 -54.82 -47.92 73.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.858 -0.61 . . . . 74.400000000000006 111.936 174.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 pt -68.49 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 119.925 -0.71 . . . . 74.450000000000003 111.19 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -61.04 -41.98 97.62 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.295 0.372 . . . . 72.5 110.275 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 21.7 mm-40 -57.37 -44.15 84.15 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.309 0.644 . . . . 74.340000000000003 111.005 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -79.81 -13.93 59.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.493 -0.776 . . . . 71.010000000000005 110.237 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.83 9.6 63.95 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.852 -0.613 . . . . 70.439999999999998 113.543 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -86.83 152.29 22.61 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.993 -0.71 . . . . 73.310000000000002 110.412 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 55' ' ' ARG . 7.6 pt20 -122.83 168.62 12.03 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.571 -0.529 . . . . 73.439999999999998 109.571 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.0 t -146.78 154.81 41.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.355 -0.609 . . . . 74.409999999999997 109.355 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -97.31 120.82 38.36 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.456 -1.313 . . . . 75.040000000000006 107.456 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.87 -163.98 12.59 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 120.264 -0.969 . . . . 72.140000000000001 110.933 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.47 143.65 40.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.605 0.24 . . . . 73.299999999999997 110.57 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG13 ' HB1' ' A' ' 90' ' ' ALA . 9.6 p -80.94 123.49 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.822 -0.627 . . . . 74.209999999999994 109.799 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.5 129.21 72.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.751 -0.659 . . . . 75.439999999999998 109.939 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 82' ' ' SER . 96.2 t -115.36 119.38 61.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.093 -1.447 . . . . 73.099999999999994 107.093 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 107' ' ' ARG . 1.7 mmp_? -110.47 127.12 54.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.228 -0.442 . . . . 75.019999999999996 110.062 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -99.64 119.73 38.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.21 -0.663 . . . . 74.409999999999997 109.21 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.99 166.7 11.87 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.146 -0.933 . . . . 75.019999999999996 109.767 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.67 156.11 36.52 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.99 -1.115 . . . . 75.409999999999997 107.99 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -144.67 140.13 28.44 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 109.189 -0.671 . . . . 65.230000000000004 109.189 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 m -81.02 -20.36 41.92 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.673 -0.862 . . . . 64.299999999999997 108.673 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -72.01 -40.23 68.63 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.066 -0.97 . . . . 63.240000000000002 108.679 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.92 130.47 34.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.222 -0.899 . . . . 74.540000000000006 110.178 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -95.77 172.76 7.83 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.278 -0.874 . . . . 72.400000000000006 109.284 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.407 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 12.7 t -56.67 138.1 53.1 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.772 0.796 . . . . 74.420000000000002 111.278 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.76 -30.2 9.74 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 115.065 -0.971 . . . . 74.25 111.655 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -84.92 144.0 28.64 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.227 0.537 . . . . 75.040000000000006 111.47 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HB3' HD12 ' A' ' 66' ' ' LEU . 20.0 p90 -156.75 151.93 26.36 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.91 -1.515 . . . . 73.319999999999993 106.91 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -143.72 151.48 40.08 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.183 -1.414 . . . . 72.519999999999996 107.183 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.8 140.12 23.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.089 -0.337 . . . . 75.230000000000004 110.089 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -133.25 137.98 46.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.297 -1.001 . . . . 74.439999999999998 108.297 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.16 117.65 3.97 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.727 -1.349 . . . . 53.340000000000003 109.727 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.7 p -116.49 154.4 30.44 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-O 121.195 0.521 . . . . 74.439999999999998 110.906 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.431 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 67.7 t -89.92 103.95 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 108.102 -1.073 . . . . 64.450000000000003 108.102 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -101.85 95.69 5.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 106.397 -1.705 . . . . 65.450000000000003 106.397 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 71.6 Cg_endo -84.53 -14.46 6.68 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.709 1.606 . . . . 73.450000000000003 112.429 -176.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -95.42 66.42 2.83 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.147 0.975 . . . . 71.200000000000003 109.869 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.4 114.58 47.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 114.221 -1.354 . . . . 74.319999999999993 108.006 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -78.12 146.54 35.09 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.633 -0.712 . . . . 74.0 110.203 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -137.23 165.69 25.53 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 108.809 -0.811 . . . . 74.400000000000006 108.809 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 N--CA 1.42 -1.934 0 N-CA-C 106.468 -1.679 . . . . 74.239999999999995 106.468 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 C--O 1.24 0.571 0 N-CA-C 108.718 -0.845 . . . . 74.040000000000006 108.718 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.5 40.71 0.33 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.508 -1.037 . . . . 52.039999999999999 110.508 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -79.22 95.47 5.64 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.672 -0.862 . . . . 74.349999999999994 108.672 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -150.82 160.98 43.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.451 -0.944 . . . . 65.209999999999994 108.451 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 122.22 13.52 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.365 -0.606 . . . . 74.140000000000001 109.365 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -93.25 118.47 31.3 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.892 -0.781 . . . . 74.239999999999995 108.892 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.09 102.71 8.32 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.542 -0.754 . . . . 72.409999999999997 111.322 -173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.67 110.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.122 -1.436 . . . . 63.350000000000001 107.122 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.53 91.68 3.97 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.711 0.767 . . . . 71.409999999999997 111.611 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.65 150.85 29.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.917 -1.038 . . . . 73.400000000000006 108.262 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.79 131.26 72.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.192 -0.603 . . . . 74.409999999999997 110.115 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -71.88 -28.49 63.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.489 0.661 . . . . 71.120000000000005 109.288 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -94.12 64.87 3.34 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.624 -0.88 . . . . 75.219999999999999 108.624 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -93.36 85.17 4.9 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.909 0.862 . . . . 74.239999999999995 109.167 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -94.48 84.03 4.25 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.246 -0.888 . . . . 75.129999999999995 111.273 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -178.57 94.69 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.851 -1.537 . . . . 74.409999999999997 106.851 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' HG3' ' CG2' ' A' ' 32' ' ' VAL . 17.1 mp0 -112.82 132.47 55.26 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.135 -0.939 . . . . 75.200000000000003 110.148 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 p -74.14 94.59 2.45 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.921 -0.77 . . . . 71.0 108.921 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.38 94.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.839 0.828 . . . . 75.329999999999998 112.001 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.46 73.16 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.089 -0.96 . . . . 71.109999999999999 112.28 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.21 129.22 12.61 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.42 -0.956 . . . . 64.349999999999994 108.42 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -61.45 -41.08 96.67 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.941 0.719 . . . . 74.430000000000007 112.941 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -80.51 -31.26 37.17 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 116.069 -0.514 . . . . 75.430000000000007 110.486 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 31' ' ' ILE . . . -60.9 -39.06 87.88 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.537 0.684 . . . . 75.349999999999994 109.254 172.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -69.59 -24.14 63.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.476 -0.784 . . . . 75.420000000000002 111.404 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 22' ' ' ALA . 47.3 mm -70.01 -34.84 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 109.513 -0.551 . . . . 65.239999999999995 109.513 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -79.2 -29.91 43.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.836 0.35 . . . . 73.129999999999995 111.35 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.35 -90.14 0.65 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 116.087 -0.506 . . . . 70.519999999999996 112.711 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.53 -13.89 39.74 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.616 -0.802 . . . . 71.230000000000004 112.708 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -79.45 97.65 6.48 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 107.006 -1.479 . . . . 73.310000000000002 107.006 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 19.6 tt -128.54 20.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.088 0.947 . . . . 64.219999999999999 112.055 -169.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' CG2' ' HG3' ' A' ' 17' ' ' GLN . 20.3 t -113.81 88.96 14.95 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.16 -1.052 . . . . 74.219999999999999 108.16 172.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -73.0 -20.03 22.4 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.361 2.041 . . . . 73.450000000000003 112.266 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -73.04 -8.09 54.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.888 0.699 . . . . 75.420000000000002 112.888 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.79 -33.98 76.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.918 -0.771 . . . . 72.409999999999997 108.918 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.59 -54.15 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.142 -0.936 . . . . 73.349999999999994 109.964 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -63.86 -29.54 70.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.815 0.34 . . . . 74.420000000000002 111.348 -178.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.539 ' O ' ' HG3' ' A' ' 42' ' ' ARG . . . -60.88 -47.99 83.84 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.107 -0.701 . . . . 72.430000000000007 109.107 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.11 -39.55 90.04 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.393 -0.821 . . . . 75.510000000000005 110.419 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.24 -51.11 67.66 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.137 0.273 . . . . 74.239999999999995 111.687 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.1 ptt180 -70.06 -22.91 63.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.076 0.769 . . . . 74.049999999999997 113.076 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 83.9 mtt180 -70.98 -45.37 64.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.827 -0.435 . . . . 75.129999999999995 109.827 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 121' ' ' ALA . 20.2 mm-40 -68.94 -32.61 72.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.047 -0.524 . . . . 75.409999999999997 110.318 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.05 95.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.451 -0.574 . . . . 71.129999999999995 109.451 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.78 -26.43 66.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.885 -0.598 . . . . 73.120000000000005 111.359 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -78.51 -34.19 47.51 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.316 0.579 . . . . 73.030000000000001 111.172 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.4 9.58 72.67 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.919 -0.658 . . . . 74.219999999999999 112.664 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.8 129.51 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 121.05 0.453 . . . . 74.140000000000001 110.732 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -122.1 141.93 50.9 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.952 -1.022 . . . . 74.239999999999995 110.56 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -75.52 113.44 12.95 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.839 -1.073 . . . . 74.400000000000006 110.782 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.9 tp -116.24 -164.4 0.96 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.428 -2.064 . . . . 52.100000000000001 105.428 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.525 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 mt-30 -48.3 154.89 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.912 0.485 . . . . 75.549999999999997 111.045 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.05 8.97 4.27 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 116.114 -0.494 . . . . 63.439999999999998 114.157 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -78.16 -47.59 17.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.324 -1.361 . . . . 73.219999999999999 107.324 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -173.61 166.08 4.57 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.868 0.692 . . . . 72.150000000000006 112.868 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.0 mt -91.13 151.78 20.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.047 -0.979 . . . . 73.209999999999994 112.298 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.47 129.76 41.12 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.824 -1.176 . . . . 71.219999999999999 107.824 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 158.72 39.14 Favored Pre-proline 0 C--N 1.308 -1.209 0 C-N-CA 123.206 0.602 . . . . 63.409999999999997 109.785 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.73 159.5 41.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.593 2.195 . . . . 73.430000000000007 112.536 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.15 -20.61 4.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.765 -0.652 . . . . 63.109999999999999 110.906 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.52 111.09 23.5 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.714 -1.217 . . . . 64.329999999999998 107.714 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.95 131.03 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.246 0.546 . . . . 74.209999999999994 111.669 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' NH2' ' A' ' 122' ' ' ARG . 52.6 mt -127.6 124.41 63.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.513 -0.767 . . . . 74.340000000000003 109.278 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.27 120.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.022 -1.473 . . . . 72.200000000000003 107.022 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 m -108.81 125.96 52.53 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 115.754 -0.657 . . . . 54.140000000000001 109.719 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.67 -176.78 2.98 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 124.662 1.185 . . . . 74.030000000000001 109.135 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.42 172.15 44.61 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.283 -1.127 . . . . 64.319999999999993 110.283 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 70.2 t -59.23 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.66 0.384 . . . . 72.439999999999998 111.362 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 55.9 t-80 -60.65 -40.94 93.86 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.544 0.688 . . . . 73.340000000000003 110.422 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.96 -40.34 83.2 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.452 -1.249 . . . . 74.420000000000002 110.454 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 88.8 t80 -66.81 -31.74 72.56 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.19 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.6 mm-40 -66.49 -26.2 67.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.993 -0.549 . . . . 72.209999999999994 111.178 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -77.98 -36.12 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.74 -0.837 . . . . 72.319999999999993 108.74 173.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.95 -18.92 65.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.259 -0.882 . . . . 75.400000000000006 110.364 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.45 -5.72 12.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.831 -0.622 . . . . 60.539999999999999 113.394 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.77 70.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.701 -0.481 . . . . 75.540000000000006 109.701 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD1' ' HG3' ' A' ' 81' ' ' LYS . 18.4 t70 -155.71 83.74 3.54 Favored Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 108.568 -0.901 . . . . 74.420000000000002 108.568 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.65 -51.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.995 1.797 . . . . 75.049999999999997 114.417 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -38.93 20.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.273 1.582 . . . . 70.510000000000005 115.273 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.459 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 2.2 tm? -66.2 -52.04 51.82 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.815 -0.439 . . . . 73.109999999999999 109.815 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 30.0 mtpp -58.67 -31.29 68.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.098 0.777 . . . . 74.129999999999995 113.098 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -62.21 -45.09 94.92 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.204 0.526 . . . . 74.310000000000002 110.186 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 m -72.75 -33.72 66.55 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.098 -0.501 . . . . 61.25 110.332 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.05 92.18 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.19 -0.764 . . . . 74.219999999999999 111.19 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -69.67 -36.09 75.71 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 111.674 0.25 . . . . 74.140000000000001 111.674 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.44 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.681 0.277 . . . . 74.109999999999999 110.897 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.29 -41.24 90.07 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.16 -43.94 81.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.868 -0.605 . . . . 73.019999999999996 110.548 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.48 -36.83 76.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.935 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.32 89.21 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.049 -0.723 . . . . 64.439999999999998 109.049 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -41.92 85.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.188 -0.914 . . . . 75.010000000000005 109.788 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 17.4 m-85 -57.91 -50.3 73.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.44 0.533 . . . . 74.140000000000001 112.44 174.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.9 -31.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.049 -0.66 . . . . 73.200000000000003 110.965 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -34.59 76.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.420000000000002 111.205 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.56 -43.34 99.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.138 0.971 . . . . 74.109999999999999 109.436 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.5 mm-40 -73.81 -12.53 60.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.377 -1.283 . . . . 71.209999999999994 110.899 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.12 30.56 46.08 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.009 -0.541 . . . . 64.109999999999999 112.467 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -97.36 172.1 7.99 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 122.521 -0.399 . . . . 74.310000000000002 110.0 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -138.98 169.43 17.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.715 -0.476 . . . . 62.25 109.715 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -159.51 179.3 9.03 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.205 -0.665 . . . . 73.319999999999993 109.205 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.12 120.26 37.79 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.482 -0.562 . . . . 74.319999999999993 109.482 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.37 -149.75 16.71 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.955 -1.117 . . . . 73.019999999999996 110.961 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.3 146.03 45.62 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.222 -1.399 . . . . 71.230000000000004 107.222 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.99 109.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.388 -0.597 . . . . 74.549999999999997 109.388 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.15 122.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.578 0.704 . . . . 74.430000000000007 110.364 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 78.4 t -118.93 123.51 71.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 74.129999999999995 109.106 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -117.33 147.03 42.97 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.191 -0.67 . . . . 74.209999999999994 109.191 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.36 123.61 45.72 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.25 -1.389 . . . . 74.530000000000001 107.25 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.96 176.16 8.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.674 0.273 . . . . 74.310000000000002 110.966 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 25.7 pt20 -113.03 164.72 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.918 -0.583 . . . . 75.140000000000001 111.219 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.3 p -151.01 148.81 28.81 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 107.513 -1.292 . . . . 61.539999999999999 107.513 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -81.02 -24.89 37.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.257 0.551 . . . . 73.530000000000001 109.939 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.66 -21.92 59.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 115.991 -0.549 . . . . 75.450000000000003 112.479 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.36 131.73 41.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 C-N-CA 120.097 -0.641 . . . . 75.530000000000001 109.589 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -114.04 156.42 24.15 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.537 -0.912 . . . . 72.450000000000003 108.537 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.1 m -51.83 110.68 0.5 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.065 0.853 . . . . 73.099999999999994 111.541 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 134.56 -33.96 2.42 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 109.125 -1.59 . . . . 71.209999999999994 109.125 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.17 144.98 31.21 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.783 -0.708 . . . . 75.439999999999998 109.282 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -157.87 160.3 37.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.982 -1.488 . . . . 74.530000000000001 106.982 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -145.43 147.65 32.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.238 -0.653 . . . . 71.340000000000003 109.238 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -122.79 132.74 54.35 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 104.651 -2.352 . . . . 73.019999999999996 104.651 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 4.9 tmm_? -136.5 135.55 38.65 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.31 -1.367 . . . . 75.230000000000004 107.31 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.42 155.48 17.53 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.298 -1.121 . . . . 73.400000000000006 110.298 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.7 t -149.77 161.47 42.17 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.916 -0.772 . . . . 73.200000000000003 108.916 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.9 110.57 20.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.955 -1.498 . . . . 73.099999999999994 106.955 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' ND2' ' HB ' ' A' ' 129' ' ' VAL . 44.8 t30 -125.67 93.56 44.21 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 116.603 -0.271 . . . . 74.420000000000002 110.709 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -89.87 -6.23 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.31 2.007 . . . . 75.0 110.376 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.96 27.58 1.79 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.228 1.011 . . . . 74.140000000000001 109.494 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.431 ' HB ' ' ND2' ' A' ' 126' ' ' ASN . 8.2 p -99.73 126.79 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 107.95 -1.13 . . . . 73.310000000000002 107.95 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -69.26 161.35 29.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 73.319999999999993 111.649 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 t -149.86 164.12 36.21 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.258 -1.386 . . . . 71.239999999999995 107.258 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 117.946 -1.026 . . . . 65.329999999999998 108.802 176.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.564 -0.532 . . . . 71.230000000000004 109.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.51 12.22 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 108.318 -1.913 . . . . 75.150000000000006 108.318 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -91.38 15.84 11.36 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.449 -0.876 . . . . 63.229999999999997 113.273 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -83.06 71.82 10.12 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.015 0.912 . . . . 75.129999999999995 110.346 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -117.3 97.87 6.13 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 114.512 -1.222 . . . . 74.549999999999997 107.849 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -84.87 80.67 9.2 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.04 0.924 . . . . 74.439999999999998 110.084 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.5 tp -150.56 92.13 1.82 Allowed 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.666 -1.606 . . . . 75.219999999999999 109.267 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.13 144.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.229 -1.397 . . . . 75.409999999999997 107.229 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -78.71 70.66 5.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.445 0.64 . . . . 64.200000000000003 112.4 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -99.52 83.89 2.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.21 1.005 . . . . 64.140000000000001 109.616 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.86 149.25 27.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 106.907 -1.516 . . . . 75.340000000000003 106.907 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -117.7 147.32 43.04 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.801 -0.76 . . . . 62.549999999999997 111.429 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -145.57 126.86 14.85 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 105.74 -1.948 . . . . 64.329999999999998 105.74 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -84.34 122.46 28.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.533 -1.654 . . . . 75.319999999999993 106.533 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.79 65.95 7.15 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.164 0.983 . . . . 70.0 110.616 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.08 82.55 8.38 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.463 -1.31 . . . . 64.040000000000006 107.463 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 12.2 mm-40 -94.1 105.87 17.85 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.961 -1.018 . . . . 73.319999999999993 108.77 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -149.78 144.02 25.76 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 115.209 -0.905 . . . . 73.129999999999995 111.235 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.56 9.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.552 -1.204 . . . . 75.239999999999995 108.306 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 -70.67 0.21 Allowed Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.704 -0.958 . . . . 72.450000000000003 110.704 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 5.2 p-10 -83.12 9.27 10.81 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.468 -0.43 . . . . 74.430000000000007 111.738 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.55 97.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.831 0.452 . . . . 64.439999999999998 111.893 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HA ' HG12 ' A' ' 26' ' ' ILE . 81.2 m-85 -68.75 -32.09 71.62 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.479 -0.782 . . . . 74.019999999999996 111.024 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.36 71.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.4 0.619 . . . . 75.409999999999997 109.741 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 28.1 mmt180 -71.65 -34.52 69.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.892 -0.595 . . . . 72.230000000000004 110.255 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 23' ' ' PHE . 45.3 pt -87.99 -47.77 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 74.319999999999993 113.656 -176.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -30.19 29.82 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.188 -0.605 . . . . 75.010000000000005 111.405 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.94 -49.96 0.91 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.022 -1.085 . . . . 71.140000000000001 111.502 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.32 -34.03 0.03 OUTLIER Glycine 0 C--N 1.31 -0.864 0 C-N-CA 119.912 -1.137 . . . . 74.109999999999999 114.022 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 144.95 34.49 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.771 0.656 . . . . 74.230000000000004 112.771 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.7 pt -95.81 -11.48 8.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.881 0.848 . . . . 63.340000000000003 110.375 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.54 170.01 6.74 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 106.827 -1.545 . . . . 73.319999999999993 106.827 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 16.7 Cg_exo -70.56 30.55 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.879 2.386 . . . . 72.530000000000001 114.531 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.47 -48.73 79.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.323 0.649 . . . . 74.310000000000002 111.491 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -25.61 66.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.165 0.507 . . . . 73.519999999999996 110.835 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.15 -44.69 49.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.292 -1.003 . . . . 70.329999999999998 108.292 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 45.7 mt-10 -61.59 -34.73 76.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.189 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 42' ' ' ARG . . . -61.61 -57.74 10.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.228 -0.896 . . . . 62.119999999999997 109.638 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -56.94 -44.52 82.6 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.471 -0.566 . . . . 73.409999999999997 109.471 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -58.43 -52.51 65.32 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.488 0.551 . . . . 73.430000000000007 112.488 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 17.9 ptp180 -65.29 -30.22 71.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.929 0.395 . . . . 75.0 110.678 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 35.8 mmt180 -76.38 -37.66 56.86 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.067 -0.515 . . . . 74.510000000000005 110.713 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' A' ' 122' ' ' ARG . 21.6 tt0 -78.15 -27.48 48.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.827 -0.749 . . . . 71.230000000000004 110.416 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.14 91.87 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.148 -0.686 . . . . 72.329999999999998 109.148 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.38 -32.81 68.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.420000000000002 110.957 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.67 -42.2 78.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.782 -0.644 . . . . 72.329999999999998 111.211 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.95 9.55 59.89 Favored Glycine 0 C--N 1.319 -0.414 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 113.157 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 HD13 ' CD2' ' A' ' 98' ' ' TRP . 14.1 mm -62.1 130.64 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.447 0.641 . . . . 74.140000000000001 111.588 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.7 mt-30 -110.54 134.95 51.91 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 115.517 -0.765 . . . . 72.040000000000006 110.087 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -78.65 91.68 4.66 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.639 -1.164 . . . . 74.120000000000005 108.195 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 24.3 tp -104.4 -165.77 1.18 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.205 -1.405 . . . . 74.420000000000002 107.205 -176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.548 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 54.1 mt-30 -45.15 145.55 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.227 0.611 . . . . 72.099999999999994 110.647 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.35 15.83 1.9 Allowed Glycine 0 C--O 1.218 -0.904 0 CA-C-N 116.003 -0.544 . . . . 73.219999999999999 113.26 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 52' ' ' GLN . 2.4 m-20 -70.17 -44.95 67.71 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.654 -1.61 . . . . 74.439999999999998 106.654 175.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 177.35 166.09 0.6 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-N 113.82 -1.536 . . . . 73.519999999999996 109.045 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -90.64 151.09 21.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 110.914 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 36.6 tp -93.62 131.58 38.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.492 -0.776 . . . . 75.230000000000004 108.985 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.49 162.54 33.7 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.128 -0.693 . . . . 75.439999999999998 109.128 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -66.16 159.33 50.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.752 2.302 . . . . 73.030000000000001 112.602 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 4.8 p-10 -130.23 -19.52 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.328 -0.397 . . . . 71.400000000000006 111.145 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.08 112.46 25.13 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.548 -0.908 . . . . 73.340000000000003 108.548 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 75.8 m-85 -118.54 114.24 22.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.067 0.937 . . . . 64.109999999999999 110.865 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.9 mt -104.93 104.21 16.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.322 -1.308 . . . . 75.349999999999994 108.56 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 106' ' ' VAL . 3.0 mp -96.49 128.53 47.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.9 -0.778 . . . . 63.310000000000002 108.9 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.3 m -121.1 129.02 53.12 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.74 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.81 174.87 6.33 Favored 'General case' 0 C--O 1.255 1.382 0 O-C-N 124.738 1.273 . . . . 71.439999999999998 109.326 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.7 -174.0 41.32 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 110.265 -1.134 . . . . 64.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' HA ' ' NE2' ' A' ' 110' ' ' GLN . 7.6 p -74.68 -51.19 23.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 114.523 1.305 . . . . 72.420000000000002 114.523 -175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.4 -42.07 83.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.547 0.689 . . . . 71.439999999999998 110.358 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.37 -32.27 66.31 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.851 -1.068 . . . . 74.109999999999999 112.759 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' HB3' HE21 ' A' ' 110' ' ' GLN . 58.7 t80 -66.26 -31.84 72.9 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 119.86 -0.736 . . . . 75.530000000000001 109.302 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.96 -23.15 67.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.387 0.514 . . . . 74.219999999999999 112.387 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -83.21 -28.65 29.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.198 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.8 mt -70.54 -37.94 74.13 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 150.14 8.64 Favored Glycine 0 N--CA 1.411 -2.994 0 CA-C-N 114.816 -1.084 . . . . 75.319999999999993 111.231 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -78.23 1.49 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.173 0.511 . . . . 73.430000000000007 110.992 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.14 92.07 4.29 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 121.934 0.874 . . . . 74.219999999999999 109.688 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.8 Cg_exo -75.51 -30.31 6.59 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.418 1.412 . . . . 71.150000000000006 110.03 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -45.65 -53.43 9.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.699 2.0 . . . . 73.040000000000006 113.078 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.69 -48.34 72.37 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.612 -0.722 . . . . 65.120000000000005 110.245 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -74.58 -38.61 62.62 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.85 1.056 . . . . 75.409999999999997 113.85 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 p -62.87 -51.69 66.02 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.71 0.633 . . . . 74.129999999999995 112.71 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -65.49 -43.13 91.13 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-N 116.244 -0.434 . . . . 73.329999999999998 111.365 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.34 52.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.049 -0.596 . . . . 73.099999999999994 112.239 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -70.65 -23.66 62.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.832 0.349 . . . . 73.25 110.095 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.48 -45.93 81.73 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 109.86 175.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.27 -36.72 74.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 109.853 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -62.33 -40.81 97.59 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.275 -0.875 . . . . 74.099999999999994 110.629 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.7 tp -72.13 -31.88 66.41 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.06 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.0 85.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.719 0.771 . . . . 65.329999999999998 109.299 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.89 -39.87 91.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.671 -1.15 . . . . 64.129999999999995 109.702 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 12.2 m-85 -57.82 -52.25 66.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.015 -0.539 . . . . 75.25 112.201 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 pt -66.9 -33.42 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.221 -0.591 . . . . 73.439999999999998 111.327 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.94 -31.09 69.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.57 . . . . 70.420000000000002 110.781 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.53 -30.32 69.09 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 111.386 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 54.8 mm-40 -86.74 -10.62 53.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.399 0.618 . . . . 65.200000000000003 109.741 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.57 21.37 58.26 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.709 -0.678 . . . . 73.140000000000001 113.362 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.441 ' CD2' HD13 ' A' ' 48' ' ' ILE . 24.6 m0 -93.67 150.82 20.1 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.085 0.469 . . . . 71.129999999999995 111.488 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -112.47 168.49 9.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.541 -0.754 . . . . 73.549999999999997 110.215 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.7 t -162.72 160.61 25.66 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.704 -0.85 . . . . 74.230000000000004 108.704 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -93.52 119.03 32.09 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.457 -1.312 . . . . 74.329999999999998 107.457 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.84 -150.35 16.75 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.78 -1.328 . . . . 61.140000000000001 109.78 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.75 153.82 47.82 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.517 -0.549 . . . . 75.0 109.517 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.68 123.27 32.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 123.637 0.586 . . . . 74.5 110.731 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.56 130.48 71.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.259 -0.882 . . . . 74.230000000000004 109.128 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 54.9 t -123.97 117.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.07 -1.085 . . . . 72.209999999999994 108.07 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.97 148.49 44.02 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.811 -0.756 . . . . 71.239999999999995 109.887 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.75 129.24 56.18 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.61 158.97 43.24 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.039 0.447 . . . . 64.400000000000006 110.296 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.492 HE21 ' HB3' ' A' ' 71' ' ' PHE . 35.9 tt0 -102.15 143.31 32.12 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.311 -0.859 . . . . 73.439999999999998 109.092 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 133.25 26.95 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 109.572 -0.529 . . . . 43.039999999999999 109.572 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.7 m -69.21 -20.43 63.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.142 0.496 . . . . 75.310000000000002 110.559 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.6 3.19 12.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.481 1.112 . . . . 71.019999999999996 111.408 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 115' ' ' HIS . 2.0 tm? -132.83 149.4 52.27 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.383 -2.08 . . . . 75.219999999999999 105.383 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.489 ' N ' HD13 ' A' ' 114' ' ' LEU . 36.7 t-80 -148.2 159.97 43.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.566 -0.531 . . . . 73.219999999999999 109.566 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 m -43.97 125.24 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.673 1.989 . . . . 73.120000000000005 111.926 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.61 -34.76 4.51 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 108.672 -1.771 . . . . 52.210000000000001 108.672 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 156.82 18.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.177 -1.045 . . . . 71.439999999999998 108.177 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -169.48 151.72 4.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.321 -2.103 . . . . 75.239999999999995 105.321 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -157.11 151.07 24.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.276 -0.969 . . . . 75.510000000000005 109.982 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -118.9 139.29 51.89 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.597 -1.261 . . . . 74.140000000000001 107.597 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 2.4 tpm_? -111.87 117.79 33.74 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.384 -0.969 . . . . 75.120000000000005 108.384 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.57 109.18 3.04 Favored Glycine 0 C--N 1.291 -1.934 0 O-C-N 123.871 0.732 . . . . 75.0 111.629 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 p -123.64 162.0 23.92 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.33 0.652 . . . . 72.209999999999994 111.138 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.4 131.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 105.069 -2.197 . . . . 73.209999999999994 105.069 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -112.98 130.8 23.19 Favored Pre-proline 0 C--N 1.295 -1.785 0 C-N-CA 118.542 -1.263 . . . . 74.519999999999996 111.375 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.24 -4.79 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.219 1.946 . . . . 74.230000000000004 110.402 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -97.96 64.77 1.73 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.538 0.685 . . . . 55.329999999999998 111.7 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.79 104.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.824 -1.08 . . . . 75.340000000000003 108.319 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.65 156.1 27.77 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.372 0.606 . . . . 75.409999999999997 111.864 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.2 t -129.32 108.75 10.55 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.227 1.013 . . . . 72.430000000000007 109.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.2 m80 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.848 -1.168 . . . . 73.109999999999999 107.848 -179.613 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 75.099999999999994 110.368 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.9 152.13 52.02 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.819 -0.913 . . . . 75.310000000000002 110.819 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 p -88.5 120.12 29.58 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.147 -0.686 . . . . 72.5 109.147 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.3 109.05 2.96 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.202 -1.036 . . . . 73.239999999999995 108.202 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -78.02 78.62 4.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.417 -0.957 . . . . 73.340000000000003 108.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.19 94.96 1.61 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 122.26 1.029 . . . . 74.099999999999994 111.095 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -116.38 80.96 1.54 Allowed 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 106.117 -1.808 . . . . 63.549999999999997 106.117 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -111.32 95.83 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.384 -1.28 . . . . 64.140000000000001 107.612 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -88.12 110.44 20.67 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.159 -0.928 . . . . 73.209999999999994 110.449 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -118.83 78.93 1.32 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.07 -1.085 . . . . 74.030000000000001 108.07 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.88 87.71 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.78 -1.563 . . . . 75.310000000000002 106.78 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.48 141.95 36.28 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.258 -1.015 . . . . 70.219999999999999 108.258 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -84.97 92.88 8.43 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.768 -0.827 . . . . 73.540000000000006 108.768 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 108.0 8.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.679 0.752 . . . . 75.319999999999993 109.865 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 mt -117.09 77.34 1.11 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.252 -1.018 . . . . 74.019999999999996 108.252 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.04 100.68 12.33 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.363 -0.835 . . . . 70.420000000000002 110.421 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.27 6.55 44.67 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.135 -0.939 . . . . 73.420000000000002 110.157 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -64.71 125.4 24.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.335 -1.357 . . . . 70.409999999999997 107.335 172.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 p -154.38 133.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.335 0.588 . . . . 73.129999999999995 111.512 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 68.94 2.6 Favored Glycine 0 N--CA 1.431 -1.672 0 CA-C-N 115.723 -0.672 . . . . 70.230000000000004 112.537 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.96 -23.78 66.6 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 111.68 0.252 . . . . 64.510000000000005 111.68 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.39 73.24 Favored 'General case' 0 C--O 1.213 -0.826 0 O-C-N 123.573 0.545 . . . . 75.120000000000005 110.093 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -60.11 -39.89 87.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.001 -0.545 . . . . 74.420000000000002 110.62 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.32 83.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.834 -0.621 . . . . 73.430000000000007 111.262 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -81.74 -20.36 39.48 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.88 -0.512 . . . . 72.439999999999998 112.098 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.6 -49.23 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.343 -0.223 . . . . 74.439999999999998 111.504 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -101.76 -25.45 13.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.089 0.403 . . . . 73.450000000000003 112.089 -175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.39 -79.24 1.85 Allowed Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.494 -0.86 . . . . 63.210000000000001 111.493 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.41 65.29 0.27 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.673 -0.571 . . . . 50.549999999999997 111.673 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -103.97 161.63 13.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.96 -0.755 . . . . 73.219999999999999 108.96 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.6 tt -66.0 138.44 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 109.013 -0.736 . . . . 71.049999999999997 109.013 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.2 113.91 15.99 Favored Pre-proline 0 C--O 1.243 0.76 0 CA-C-N 116.156 -0.474 . . . . 75.25 110.205 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.36 -26.49 76.97 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.82 2.347 . . . . 73.219999999999999 111.872 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HA ' ' CG ' ' A' ' 37' ' ' GLU . 20.9 mp0 -65.17 -28.3 69.31 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 113.188 0.811 . . . . 75.010000000000005 113.188 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.33 -31.23 43.07 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.177 -1.046 . . . . 74.540000000000006 108.177 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.53 -53.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.089 -0.959 . . . . 73.219999999999999 109.533 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.34 -29.9 71.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.599 -0.273 . . . . 75.239999999999995 111.376 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.49 95.65 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.120000000000005 110.276 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.12 -37.36 58.17 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 120.705 -0.398 . . . . 71.409999999999997 110.461 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 62' ' ' TYR . 4.1 mm? -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.695 -0.402 . . . . 74.109999999999999 112.069 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -69.28 -27.56 65.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.362 -0.607 . . . . 72.030000000000001 109.362 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -70.22 -40.8 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.209 -0.663 . . . . 74.230000000000004 109.209 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -61.13 -43.39 98.96 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 123.446 0.466 . . . . 74.340000000000003 110.677 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.21 -47.22 86.89 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.613 -0.721 . . . . 54.539999999999999 110.381 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.88 -32.46 72.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 72.120000000000005 111.849 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.88 -32.15 51.74 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.446 0.641 . . . . 72.129999999999995 110.366 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.05 16.22 61.02 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.548 -0.751 . . . . 74.549999999999997 113.418 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 mm -63.04 131.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.14 0.576 . . . . 72.030000000000001 111.932 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.8 mt-30 -117.16 144.15 45.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.214 -0.903 . . . . 72.430000000000007 109.472 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.2 m -71.49 114.73 9.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.053 -0.976 . . . . 64.319999999999993 109.87 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 25.7 tp -122.7 -176.94 3.51 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.068 -1.456 . . . . 74.519999999999996 107.068 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.549 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 78.0 mt-30 -53.69 164.42 0.55 Allowed 'General case' 0 C--O 1.246 0.914 0 C-N-CA 124.601 1.16 . . . . 74.239999999999995 113.525 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.27 -9.46 23.23 Favored Glycine 0 CA--C 1.504 -0.643 0 CA-C-N 114.921 -1.036 . . . . 63.240000000000002 114.734 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -74.7 -43.9 52.76 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.043 -0.663 . . . . 64.430000000000007 111.518 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.4 ptp180 -175.82 167.09 3.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.3 0.482 . . . . 74.439999999999998 112.3 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.82 151.86 20.39 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.438 1.095 . . . . 75.209999999999994 111.403 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.4 tm? -90.73 131.44 36.4 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.07 -1.085 . . . . 71.340000000000003 108.07 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.74 162.65 35.56 Favored Pre-proline 0 C--N 1.311 -1.107 0 C-N-CA 123.559 0.744 . . . . 73.25 110.005 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.446 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.6 Cg_exo -57.42 161.98 10.83 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.38 2.72 . . . . 72.120000000000005 113.958 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -131.36 -32.71 1.53 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.464 -0.789 . . . . 72.340000000000003 111.719 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.56 106.73 18.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.278 -1.379 . . . . 73.340000000000003 107.278 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 96.7 m-85 -112.16 116.15 30.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.216 0.531 . . . . 75.329999999999998 110.463 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.12 114.5 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.258 -0.883 . . . . 75.109999999999999 109.574 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.45 125.98 70.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.999 -0.741 . . . . 75.519999999999996 108.999 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -110.9 126.53 54.81 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.69 160.86 20.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.014 -0.736 . . . . 74.219999999999999 109.014 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.49 145.04 49.22 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 108.625 -1.79 . . . . 75.230000000000004 108.625 172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.8 p -52.57 -37.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 113.01 0.744 . . . . 72.239999999999995 113.01 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.17 -22.67 62.01 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.475 0.655 . . . . 74.340000000000003 111.255 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 29.8 m-20 -85.87 -35.25 20.7 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 121.552 -0.717 . . . . 73.519999999999996 110.279 175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -63.16 -24.86 68.08 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.087 -0.96 . . . . 74.340000000000003 109.444 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 38.2 mt-10 -58.29 -33.6 69.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 111.917 0.34 . . . . 65.430000000000007 111.917 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.463 ' NZ ' ' HA ' ' A' ' 70' ' ' ASP . 4.2 mppt? -81.08 -34.68 32.5 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.327 -0.549 . . . . 72.409999999999997 109.931 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.4 mt -68.58 -35.36 77.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.52 0.676 . . . . 72.439999999999998 110.224 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 6.32 39.2 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.786 -1.097 . . . . 74.239999999999995 113.973 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.29 97.54 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.613 -1.254 . . . . 73.219999999999999 107.613 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -148.25 82.74 7.49 Favored Pre-proline 0 CA--C 1.508 -0.656 0 N-CA-C 106.175 -1.787 . . . . 73.310000000000002 106.175 173.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.05 -47.64 23.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.511 2.14 . . . . 74.540000000000006 111.694 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -46.66 71.98 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.198 -0.91 . . . . 74.519999999999996 111.046 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.36 -53.7 54.5 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.386 -0.598 . . . . 73.420000000000002 109.386 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.864 -0.607 . . . . 74.030000000000001 111.778 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -67.37 -45.28 76.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.891 -0.324 . . . . 71.040000000000006 110.942 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.4 m -62.42 -44.33 96.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.239 0.216 . . . . 74.439999999999998 111.023 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.17 -46.6 90.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.017 -0.611 . . . . 72.439999999999998 112.059 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.71 -35.87 82.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 110.34 -0.244 . . . . 72.420000000000002 110.34 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.19 -46.62 86.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.628 0.251 . . . . 74.319999999999993 110.581 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.43 -44.61 90.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.129 -0.487 . . . . 72.150000000000006 111.003 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.4 -34.08 75.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.559 0.578 . . . . 72.409999999999997 112.559 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.34 -35.16 65.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.997 0.427 . . . . 72.040000000000006 110.181 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.78 81.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.799 0.809 . . . . 73.5 109.678 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.57 -38.88 88.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.906 -1.043 . . . . 65.540000000000006 109.022 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -59.36 -49.09 79.15 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 111.918 175.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -66.38 -30.5 50.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 120.32 -0.552 . . . . 75.120000000000005 111.006 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -64.02 -43.3 96.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.433 -0.349 . . . . 63.420000000000002 110.537 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.86 -32.77 72.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.074 0.464 . . . . 71.200000000000003 112.072 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 64.8 mm-40 -81.45 -13.21 58.47 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.197 0.522 . . . . 74.409999999999997 111.452 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 84.55 34.42 16.43 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.764 -0.653 . . . . 61.420000000000002 111.669 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -110.71 173.98 6.08 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.88 -0.415 . . . . 71.0 109.88 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -155.84 174.0 15.96 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.328 -0.99 . . . . 75.349999999999994 108.328 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -147.33 176.4 10.03 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.681 -0.859 . . . . 70.310000000000002 108.681 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -99.06 120.14 38.98 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.277 -1.379 . . . . 75.239999999999995 107.277 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.9 -149.81 16.83 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.999 -1.64 . . . . 61.240000000000002 108.999 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -132.47 144.44 50.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.375 -1.343 . . . . 74.319999999999993 107.375 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.05 124.24 20.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.213 0.53 . . . . 74.230000000000004 112.008 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.93 120.51 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.408 -0.815 . . . . 71.200000000000003 110.045 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 62' ' ' TYR . 14.8 m -106.65 147.5 11.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.774 -1.195 . . . . 73.329999999999998 107.774 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -137.31 142.12 41.88 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.841 -0.8 . . . . 71.129999999999995 108.841 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -114.19 134.75 54.7 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.03 -0.532 . . . . 62.039999999999999 109.655 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.3 159.81 35.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.122 0.487 . . . . 71.310000000000002 110.001 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -107.56 155.1 20.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.51 -0.768 . . . . 74.400000000000006 109.828 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -138.99 140.12 38.1 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.695 -1.224 . . . . 74.400000000000006 107.695 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 m -82.08 -27.43 32.92 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.343 0.592 . . . . 75.310000000000002 110.067 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -80.57 -34.51 35.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.596 -0.729 . . . . 75.219999999999999 109.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 tp -77.45 133.37 38.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.168 -1.789 . . . . 75.310000000000002 106.168 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.419 ' CG ' ' H ' ' A' ' 116' ' ' THR . 12.5 t-80 -116.5 172.35 7.27 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.848 -1.541 . . . . 65.239999999999995 112.311 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.591 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 21.9 m -50.59 132.02 25.48 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 125.668 1.587 . . . . 73.319999999999993 113.387 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.62 -6.13 83.29 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.634 -1.166 . . . . 74.340000000000003 112.247 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.36 136.17 54.79 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.893 -1.151 . . . . 75.019999999999996 107.893 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.3 159.96 42.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.945 -0.391 . . . . 75.400000000000006 109.945 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 mmp_? -133.17 137.31 46.17 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.811 -0.811 . . . . 74.319999999999993 108.811 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.23 44.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.788 -0.819 . . . . 72.439999999999998 108.788 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -139.7 131.87 28.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.455 -0.572 . . . . 74.530000000000001 109.455 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.82 128.56 8.5 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.825 -0.91 . . . . 71.349999999999994 110.825 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.4 m -123.33 144.76 49.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 109.347 -0.612 . . . . 74.450000000000003 109.347 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 59' ' ' PRO . 89.8 t -93.92 105.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.003 -1.11 . . . . 74.120000000000005 108.003 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.62 110.35 48.68 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.873 -1.158 . . . . 74.430000000000007 107.873 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.77 -20.9 7.45 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.613 1.542 . . . . 75.540000000000006 111.608 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.97 72.42 2.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.473 1.13 . . . . 71.239999999999995 109.275 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.43 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 113.374 -1.739 . . . . 72.299999999999997 107.156 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.48 116.24 8.0 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.88 -1.896 . . . . 62.210000000000001 105.88 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 t -156.11 165.08 37.49 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.934 -0.765 . . . . 74.400000000000006 108.934 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 N--CA 1.422 -1.827 0 N-CA-C 107.046 -1.465 . . . . 75.519999999999996 107.046 179.866 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.561 -0.533 . . . . 74.219999999999999 109.561 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.74 -128.1 20.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.954 -0.641 . . . . 63.329999999999998 111.98 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -80.98 0.18 36.7 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.485 0.714 . . . . 74.329999999999998 112.139 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -74.24 75.16 1.82 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.239 0.542 . . . . 74.120000000000005 111.33 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -133.1 160.2 37.89 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.004 -1.11 . . . . 72.430000000000007 108.004 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.37 119.8 33.2 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.075 -0.713 . . . . 72.329999999999998 109.075 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pp -69.89 138.14 52.23 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.93 -0.577 . . . . 74.430000000000007 110.789 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.39 71.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.843 0.83 . . . . 73.230000000000004 110.413 -174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -174.73 104.13 0.09 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.544 -1.207 . . . . 75.040000000000006 108.003 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -139.58 -159.74 0.99 Allowed 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.065 -1.087 . . . . 75.430000000000007 108.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.85 90.67 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 119.699 -0.8 . . . . 74.099999999999994 110.732 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -77.15 7.2 5.32 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.766 -0.584 . . . . 74.109999999999999 111.197 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.42 -13.48 62.06 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.714 0.635 . . . . 72.430000000000007 112.714 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 15.89 19.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.483 0.659 . . . . 75.329999999999998 109.918 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.16 108.31 15.02 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.644 -0.707 . . . . 72.209999999999994 110.088 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.01 -5.37 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.617 0.723 . . . . 74.540000000000006 109.31 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -88.57 151.44 22.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.357 -1.292 . . . . 71.209999999999994 108.875 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -90.09 134.97 33.94 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.979 -0.748 . . . . 70.409999999999997 108.979 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.15 93.12 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 122.629 1.204 . . . . 75.420000000000002 109.197 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.07 54.02 4.51 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 114.714 -1.13 . . . . 75.239999999999995 113.164 -174.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.5 -42.87 93.16 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 123.135 0.574 . . . . 70.219999999999999 111.413 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -67.51 -52.74 35.5 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.106 -0.952 . . . . 74.340000000000003 109.494 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -54.73 -44.75 73.82 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.356 -0.838 . . . . 75.329999999999998 112.064 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.4 92.63 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 120.757 0.313 . . . . 72.439999999999998 111.019 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -77.17 -30.89 55.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.372 -0.376 . . . . 72.150000000000006 111.767 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.2 mt -65.82 -57.13 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.659 -0.497 . . . . 75.140000000000001 109.659 176.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' CB ' ' HB ' ' A' ' 31' ' ' ILE . 35.7 m-85 -68.79 -29.0 67.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 64.319999999999993 111.82 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.65 -92.95 1.81 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 111.675 -0.57 . . . . 73.430000000000007 111.675 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 -44.26 0.95 Allowed Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.257 -0.973 . . . . 60.310000000000002 112.863 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -87.77 97.33 10.84 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.968 0.413 . . . . 63.140000000000001 110.721 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.478 ' HB ' ' CB ' ' A' ' 27' ' ' PHE . 6.8 tt -154.98 101.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.73 0.776 . . . . 72.239999999999995 112.151 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.71 94.49 47.48 Favored Pre-proline 0 C--N 1.296 -1.727 0 N-CA-C 108.742 -0.836 . . . . 75.420000000000002 108.742 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.31 -17.79 39.45 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.718 2.279 . . . . 75.420000000000002 112.563 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.96 -25.92 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.368 -0.833 . . . . 75.0 110.494 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -34.46 75.49 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.608 0.595 . . . . 74.409999999999997 112.608 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.42 -51.68 35.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.555 . . . . 74.219999999999999 109.5 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.7 pt-20 -66.79 -30.05 70.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.594 -0.275 . . . . 71.319999999999993 111.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.65 -39.19 93.1 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.149 0.5 . . . . 53.109999999999999 109.873 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -71.11 -45.93 62.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.503 -0.925 . . . . 73.400000000000006 108.503 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.268 3.7 mm? -67.69 -33.69 75.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.586 1.328 . . . . 73.329999999999998 114.586 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 2.5 ptm180 -67.48 -32.47 73.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 119.806 -0.758 . . . . 64.150000000000006 109.085 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -35.8 69.26 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.326 -0.62 . . . . 75.019999999999996 109.326 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.9 -43.91 91.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.469 -0.567 . . . . 75.409999999999997 109.469 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -48.08 82.95 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.632 -0.713 . . . . 75.230000000000004 110.47 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.98 85.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.019 -0.537 . . . . 73.439999999999998 111.732 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -72.51 -39.91 67.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 109.753 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.58 31.36 6.17 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.272 -0.876 . . . . 73.099999999999994 113.311 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.404 HG22 ' HB3' ' A' ' 56' ' ' LEU . 17.7 mm -71.65 130.35 35.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.185 -0.672 . . . . 75.109999999999999 109.185 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 21.0 tt0 -107.74 136.56 47.27 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.667 -0.864 . . . . 74.430000000000007 108.667 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -67.59 107.44 2.51 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.764 0.793 . . . . 72.219999999999999 111.093 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.4 tp -118.12 -166.34 1.2 Allowed 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.065 -2.198 . . . . 72.049999999999997 105.065 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.54 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 52.6 mt-30 -51.77 152.55 2.84 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 111.631 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.45 -3.28 18.85 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-N 116.087 -0.506 . . . . 75.519999999999996 113.453 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -65.23 -46.69 79.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.868 -1.16 . . . . 74.219999999999999 107.868 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -174.68 154.75 2.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.841 -1.072 . . . . 73.040000000000006 110.901 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HB3' HG22 ' A' ' 48' ' ' ILE . 58.3 mt -90.56 151.79 21.18 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.563 -1.199 . . . . 74.310000000000002 109.878 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 40.6 tp -92.92 128.99 38.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.911 -0.586 . . . . 72.439999999999998 109.458 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.54 154.16 42.49 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 109.203 -0.665 . . . . 71.219999999999999 109.203 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.21 155.78 54.48 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.724 2.283 . . . . 63.100000000000001 112.396 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.425 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -127.49 -24.17 3.37 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.707 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.45 112.54 24.53 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.283 -1.006 . . . . 73.310000000000002 108.283 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.4 m-85 -121.93 122.37 39.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.34 0.59 . . . . 74.310000000000002 110.701 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.3 mt -120.08 116.47 50.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.088 -0.708 . . . . 75.549999999999997 109.088 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.09 126.0 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.257 -1.016 . . . . 72.439999999999998 108.257 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.81 117.27 32.36 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.64 -0.709 . . . . 71.109999999999999 109.204 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.5 mm? -100.72 161.69 13.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 122.82 0.448 . . . . 73.430000000000007 109.953 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.02 150.02 51.66 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.324 -1.91 . . . . 71.209999999999994 108.324 170.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.01 -35.01 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 117.325 0.562 . . . . 74.120000000000005 112.389 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.555 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 20.6 t60 -73.12 -28.89 62.52 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 116.021 -0.536 . . . . 74.099999999999994 110.576 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -85.72 -24.21 27.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.545 -0.722 . . . . 70.25 110.462 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.529 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 82.4 t80 -64.74 -41.35 95.99 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.277 0.56 . . . . 75.129999999999995 110.089 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.74 -25.54 65.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.032 -0.531 . . . . 73.0 111.008 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 2.1 mptm? -75.22 -22.57 57.84 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.23 -0.895 . . . . 74.510000000000005 111.763 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.0 -31.13 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.668 -1.234 . . . . 70.140000000000001 107.668 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.96 -162.73 15.62 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.642 -1.163 . . . . 74.239999999999995 111.69 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.14 -37.37 38.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.004 -0.739 . . . . 70.310000000000002 109.004 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -115.71 97.06 48.13 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.522 -0.763 . . . . 75.239999999999995 110.385 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.49 -33.5 22.54 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 121.962 1.775 . . . . 74.329999999999998 109.525 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.96 -22.29 59.89 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.55 -1.204 . . . . 71.420000000000002 111.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.2 tp -54.48 -45.37 73.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.203 -0.665 . . . . 72.450000000000003 109.203 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.54 -26.38 19.76 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 115.698 -0.683 . . . . 73.200000000000003 110.739 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -55.28 -51.14 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.15 0.432 . . . . 61.140000000000001 111.936 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.2 m -56.07 -45.57 79.29 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.127 0.489 . . . . 73.25 111.047 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.81 -43.25 75.6 Favored Glycine 0 C--O 1.206 -1.626 0 C-N-CA 120.907 -0.663 . . . . 74.310000000000002 111.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -61.17 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.168 0.987 . . . . 75.129999999999995 110.152 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB2' HG11 ' A' ' 106' ' ' VAL . . . -60.75 -45.91 92.49 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.546 -0.752 . . . . 74.319999999999993 109.837 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -75.34 -24.71 57.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.617 -0.719 . . . . 73.219999999999999 112.212 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.67 -51.47 59.23 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.092 -1.077 . . . . 73.129999999999995 108.092 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.72 -42.76 99.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.11 -0.95 . . . . 74.129999999999995 109.583 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -60.87 -39.09 87.88 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 111.192 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 23.1 t70 -72.83 -36.39 67.48 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.655 -0.498 . . . . 65.430000000000007 109.655 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.608 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.9 m-85 -59.26 -44.98 92.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.101 -0.5 . . . . 74.409999999999997 111.515 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -70.19 -25.43 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.372 -0.531 . . . . 74.409999999999997 111.293 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 79.5 mt-30 -66.69 -42.54 86.31 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.745 -0.835 . . . . 72.129999999999995 108.745 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 58.4 mt-10 -63.83 -26.68 68.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.458 -0.792 . . . . 72.129999999999995 111.227 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.5 mm-40 -92.95 -13.73 28.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 75.340000000000003 110.794 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.24 28.35 56.1 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.811 -0.632 . . . . 63.520000000000003 113.128 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -97.13 173.45 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.238 -0.653 . . . . 74.219999999999999 109.238 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 26.6 pt20 -132.32 165.75 23.49 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 122.458 -0.151 . . . . 73.310000000000002 110.822 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.8 t -154.15 158.15 39.94 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.449 -1.315 . . . . 74.25 107.449 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.14 120.7 37.89 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.379 -0.529 . . . . 75.310000000000002 110.989 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.04 -169.31 13.81 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.825 -1.31 . . . . 73.540000000000006 109.825 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -92.32 143.96 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.027 -0.731 . . . . 75.420000000000002 109.027 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.85 115.09 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.923 0.868 . . . . 75.329999999999998 109.953 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.44 128.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 115.237 -0.892 . . . . 74.430000000000007 110.092 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 8.6 p -133.81 141.54 43.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.406 -0.961 . . . . 75.340000000000003 108.406 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -137.45 149.9 47.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.129 -0.628 . . . . 73.340000000000003 109.821 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -115.34 114.57 25.3 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.096 -1.446 . . . . 74.230000000000004 107.096 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.09 167.42 11.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.644 -0.502 . . . . 62.329999999999998 109.644 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.529 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.8 pt20 -104.57 160.47 14.92 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.416 0.626 . . . . 72.019999999999996 110.68 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -140.5 130.84 25.17 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.068 -0.969 . . . . 74.019999999999996 108.885 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -81.19 -5.74 58.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.119 -0.492 . . . . 74.129999999999995 110.501 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -88.87 -20.57 24.43 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.055 0.455 . . . . 75.299999999999997 110.758 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.0 mt -94.73 142.96 26.84 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.144 0.497 . . . . 70.450000000000003 110.299 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -98.12 173.07 7.21 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.399 -0.819 . . . . 70.510000000000005 109.787 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 m -53.68 118.38 3.88 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 124.197 0.936 . . . . 73.019999999999996 111.033 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.23 5.3 52.83 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 121.042 -0.599 . . . . 63.210000000000001 113.321 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.04 141.4 48.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.268 0.534 . . . . 71.120000000000005 110.985 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' HB3' HD13 ' A' ' 66' ' ' LEU . 28.8 p90 -152.06 151.02 30.58 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 109.891 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.68 144.87 48.52 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.657 -1.238 . . . . 55.43 107.657 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.44 10.78 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 117.946 0.339 . . . . 71.530000000000001 110.526 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -125.47 135.23 52.11 Favored 'General case' 0 N--CA 1.39 -3.457 0 N-CA-C 109.906 -0.405 . . . . 75.209999999999994 109.906 178.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.6 143.4 17.83 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 109.506 -1.438 . . . . 74.040000000000006 109.506 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.6 m -145.35 150.57 36.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.101 -0.703 . . . . 73.349999999999994 109.101 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 105.99 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.193 -1.039 . . . . 74.299999999999997 108.193 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -122.02 100.13 43.2 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 108.772 -0.825 . . . . 72.019999999999996 108.772 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.46 -24.21 31.29 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.231 1.954 . . . . 75.450000000000003 112.326 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.38 77.08 3.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.211 1.482 . . . . 74.209999999999994 109.431 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.87 135.96 61.6 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.345 0 CA-C-N 111.737 -2.483 . . . . 62.530000000000001 104.909 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -54.68 128.66 33.56 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.811 0.815 . . . . 73.340000000000003 112.838 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -81.8 137.75 35.24 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.64 -1.244 . . . . 74.329999999999998 107.64 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.7 t60 . . . . . 0 C--N 1.286 -2.155 0 N-CA-C 107.172 -1.418 . . . . 75.010000000000005 107.172 179.669 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 CA--C 1.503 -0.83 0 N-CA-C 108.508 -0.923 . . . . 71.049999999999997 108.508 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.94 -133.11 11.33 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.536 -0.84 . . . . 43.450000000000003 111.766 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -120.95 134.16 55.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.388 -0.597 . . . . 75.409999999999997 109.388 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -137.55 130.02 29.65 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.398 -0.593 . . . . 74.129999999999995 109.398 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -78.48 94.74 4.99 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.554 -0.536 . . . . 72.219999999999999 109.554 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -88.45 84.85 6.79 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.871 -1.159 . . . . 73.019999999999996 107.871 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.1 87.98 5.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.61 -1.177 . . . . 73.319999999999993 110.795 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.9 m -87.43 110.15 20.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 114.531 -1.213 . . . . 61.140000000000001 109.412 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -90.12 103.5 16.16 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.433 -0.803 . . . . 75.319999999999993 108.851 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -137.74 106.98 6.06 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.901 -1.045 . . . . 73.120000000000005 109.767 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.08 136.32 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.887 -0.783 . . . . 71.299999999999997 108.887 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -87.24 88.44 7.69 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.844 -0.428 . . . . 75.25 109.844 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -85.51 102.27 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.955 -1.498 . . . . 75.450000000000003 106.955 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.6 166.73 27.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.418 0.525 . . . . 74.430000000000007 112.418 -175.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 pp -162.29 170.22 19.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.808 -1.553 . . . . 73.219999999999999 106.808 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -105.52 149.02 26.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.908 -1.117 . . . . 75.510000000000005 109.594 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -103.52 111.23 23.58 Favored 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 104.401 -2.444 . . . . 74.030000000000001 104.401 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.8 m -74.42 95.44 2.72 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.271 1.034 . . . . 52.240000000000002 110.12 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 m -95.13 122.64 46.77 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 113.794 -1.548 . . . . 73.450000000000003 109.701 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.89 42.9 0.56 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.508 -1.037 . . . . 64.030000000000001 110.508 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 6.2 p-10 -77.99 9.82 3.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.529 -0.335 . . . . 72.209999999999994 111.413 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -54.47 -36.97 64.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.923 0.889 . . . . 71.319999999999993 110.456 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -63.48 -40.4 96.99 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.656 -0.702 . . . . 75.129999999999995 110.585 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.49 70.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.146 0.498 . . . . 73.310000000000002 109.888 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 27.3 mmm180 -69.05 -32.53 72.08 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.02 -0.733 . . . . 74.209999999999994 109.02 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 22' ' ' ALA . 73.4 mt -73.57 -43.21 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.577 -0.738 . . . . 75.109999999999999 110.178 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -65.71 -29.27 69.77 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 111.796 0.295 . . . . 75.409999999999997 111.796 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.32 -91.84 0.21 Allowed Glycine 0 N--CA 1.445 -0.745 0 O-C-N 123.743 0.652 . . . . 74.319999999999993 112.386 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.32 -6.41 41.84 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.934 -0.466 . . . . 74.439999999999998 111.934 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.8 m -82.55 173.41 11.99 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.454 0.169 . . . . 73.409999999999997 110.925 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.98 136.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 123.998 0.919 . . . . 72.219999999999999 112.476 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.34 152.34 60.93 Favored Pre-proline 0 C--O 1.246 0.899 0 CA-C-N 115.234 -0.894 . . . . 71.209999999999994 112.136 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.73 -17.17 53.3 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 123.734 2.956 . . . . 65.430000000000007 113.949 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -61.15 -43.61 98.62 Favored 'General case' 0 C--O 1.227 -0.089 0 CA-C-O 120.855 0.36 . . . . 75.230000000000004 110.124 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -72.88 -31.38 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 63.43 109.757 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 99.4 t -60.57 -50.96 78.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.22 -0.446 . . . . 73.340000000000003 110.351 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.39 -34.44 77.27 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.043 -0.663 . . . . 75.099999999999994 110.661 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.83 80.8 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 110.582 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.7 tt -66.32 -42.94 87.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.334 -0.848 . . . . 74.120000000000005 109.931 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 93.9 mt -61.28 -39.21 89.59 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.05 0.452 . . . . 71.439999999999998 111.688 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -67.99 -33.46 74.68 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 123.723 0.809 . . . . 73.230000000000004 110.416 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -75.65 -36.16 60.24 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.063 -1.088 . . . . 74.409999999999997 108.063 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 63.2 mm-40 -63.62 -34.59 78.16 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.684 . . . . 73.010000000000005 110.351 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.29 94.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.836 -0.62 . . . . 75.310000000000002 109.727 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.23 -25.23 61.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.342 0.591 . . . . 75.310000000000002 110.89 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.69 -46.11 59.81 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.388 0.675 . . . . 75.310000000000002 111.135 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 26.39 10.12 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 120.698 -0.763 . . . . 53.409999999999997 114.093 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.18 141.61 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 122.65 0.38 . . . . 74.109999999999999 110.544 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.2 mt-30 -120.31 149.13 42.79 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.926 0.393 . . . . 54.240000000000002 110.412 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.5 p -76.56 128.92 35.68 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.72 -1.127 . . . . 62.25 109.446 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 28.4 tp -146.24 -166.35 2.45 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.899 -2.26 . . . . 73.540000000000006 104.899 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.515 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 98.2 mt-30 -43.91 136.52 3.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.743 0.652 . . . . 74.439999999999998 110.357 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.48 -8.23 31.05 Favored Glycine 0 N--CA 1.464 0.503 0 CA-C-N 116.654 -0.248 . . . . 71.0 113.487 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.61 -38.44 90.21 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.085 0.554 . . . . 73.120000000000005 109.801 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -171.59 147.9 2.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 111.213 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -91.08 151.89 20.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.723 0.809 . . . . 74.420000000000002 111.369 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 34.0 tp -84.81 128.88 34.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.74 -0.837 . . . . 75.450000000000003 108.74 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.46 154.31 44.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 122.919 0.487 . . . . 62.299999999999997 111.11 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.405 ' HB3' ' N ' ' A' ' 124' ' ' THR . 78.3 Cg_exo -58.31 145.91 91.55 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.475 2.783 . . . . 74.219999999999999 112.819 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -122.6 -25.37 4.73 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.263 -0.426 . . . . 73.519999999999996 110.137 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.35 113.09 25.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.955 -0.758 . . . . 73.219999999999999 108.955 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 93.9 m-85 -112.67 114.94 27.78 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.363 0.602 . . . . 75.329999999999998 109.49 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.39 120.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 72.439999999999998 108.559 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -115.8 125.74 73.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.967 -1.123 . . . . 73.209999999999994 107.967 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.9 m -120.56 120.62 36.35 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 116.4 -0.364 . . . . 72.530000000000001 110.1 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD12 ' CB ' ' A' ' 119' ' ' PHE . 4.4 mm? -106.5 170.82 7.7 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 122.905 0.482 . . . . 75.310000000000002 110.736 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.29 167.32 51.96 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.484 -1.446 . . . . 70.430000000000007 109.484 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.97 -40.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 117.492 0.646 . . . . 74.430000000000007 111.936 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -75.77 -28.84 58.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.254 -0.647 . . . . 73.510000000000005 109.254 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 61.1 m-20 -76.16 -29.46 57.75 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 120.791 -0.363 . . . . 63.109999999999999 111.13 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -69.33 -29.46 67.29 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.313 -0.995 . . . . 75.439999999999998 108.313 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.11 -26.46 66.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.777 -0.647 . . . . 75.140000000000001 111.115 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -70.63 -36.29 73.37 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.199 -0.667 . . . . 72.109999999999999 109.199 173.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.77 -30.11 69.48 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.338 -0.986 . . . . 74.200000000000003 108.338 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -138.18 16.03 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 114.13 -1.396 . . . . 35.329999999999998 113.325 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.88 -2.4 56.85 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.123 -0.538 . . . . 73.530000000000001 109.852 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -117.72 100.18 52.36 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 113.27 0.841 . . . . 72.239999999999995 113.27 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.47 -42.57 0.21 Allowed 'Trans proline' 0 CA--C 1.56 1.779 0 C-N-CA 121.656 1.57 . . . . 74.019999999999996 111.589 166.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -84.37 -29.71 26.03 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 118.775 2.88 . . . . 74.329999999999998 118.775 -163.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.74 -44.22 82.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.223 1.374 . . . . 74.319999999999993 108.563 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -65.04 -32.61 74.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.099 -0.955 . . . . 75.200000000000003 111.169 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.2 m -63.34 -43.32 98.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.817 -0.438 . . . . 62.509999999999998 109.817 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 64.3 m -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 116.253 -0.43 . . . . 64.439999999999998 110.817 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -52.11 49.89 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.234 -0.507 . . . . 74.239999999999995 112.036 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -63.16 -39.97 96.21 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.507 0.558 . . . . 72.439999999999998 112.507 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.87 -45.28 95.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.82 0.343 . . . . 73.219999999999999 111.151 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.5 -42.03 87.99 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.759 -0.655 . . . . 72.109999999999999 110.926 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.43 -42.67 82.8 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.48 -0.782 . . . . 75.400000000000006 110.488 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.47 -34.74 78.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.158 0.429 . . . . 73.040000000000006 112.158 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.09 88.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.509 0.671 . . . . 74.239999999999995 110.334 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 24.6 t70 -69.77 -43.95 71.15 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 109.362 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.529 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.3 m-85 -55.44 -56.73 16.8 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 113.126 0.787 . . . . 74.349999999999994 113.126 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.8 pt -57.47 -36.66 54.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 123.26 0.35 . . . . 74.150000000000006 111.548 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.17 -37.66 81.24 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.441 -0.345 . . . . 71.409999999999997 111.856 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.7 mt-10 -63.75 -34.75 78.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.304 0.573 . . . . 74.140000000000001 110.682 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 73.5 mm-40 -76.34 -13.72 60.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.508 -0.769 . . . . 75.409999999999997 111.008 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.02 67.46 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.943 -0.572 . . . . 75.430000000000007 112.267 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -81.42 165.01 21.66 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.461 -0.57 . . . . 75.150000000000006 109.461 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -133.8 165.67 24.43 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.257 -0.645 . . . . 75.230000000000004 109.257 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -155.41 170.86 20.94 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.157 -1.053 . . . . 71.340000000000003 108.157 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -106.86 119.18 38.65 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.888 -1.152 . . . . 74.530000000000001 107.888 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.14 -149.33 16.59 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 109.168 -1.573 . . . . 71.540000000000006 109.168 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.95 175.76 7.83 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.762 -1.57 . . . . 72.239999999999995 106.762 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -82.41 127.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.066 0.46 . . . . 75.319999999999993 110.511 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 m -127.54 127.33 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.548 -0.751 . . . . 73.120000000000005 109.083 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -131.62 145.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 107.321 -1.362 . . . . 74.239999999999995 107.321 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.56 139.3 20.75 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.339 0.59 . . . . 74.329999999999998 110.476 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.82 131.8 44.0 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.489 -1.232 . . . . 74.329999999999998 109.432 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -136.89 176.53 8.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.762 -0.829 . . . . 74.540000000000006 108.762 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -127.0 164.58 21.19 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.732 0.777 . . . . 65.120000000000005 111.406 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 m -142.04 127.03 18.34 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.968 -1.123 . . . . 71.209999999999994 107.968 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 t -69.24 -19.16 63.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.271 0.628 . . . . 72.409999999999997 110.283 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -65.79 -30.4 71.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 74.030000000000001 109.765 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.36 131.3 34.71 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.422 0.63 . . . . 74.120000000000005 110.772 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -92.29 162.0 14.46 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.635 -1.246 . . . . 72.049999999999997 107.635 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.9 m -55.93 126.82 27.43 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.431 0.692 . . . . 62.329999999999998 110.972 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.37 -14.53 47.26 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.558 -0.746 . . . . 63.509999999999998 111.616 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.46 131.72 53.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.565 -0.532 . . . . 75.230000000000004 109.565 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.406 ' CB ' HD12 ' A' ' 66' ' ' LEU . 16.4 p90 -145.45 159.37 43.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.093 -0.706 . . . . 73.150000000000006 109.093 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.95 149.81 52.33 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.093 -0.706 . . . . 74.430000000000007 109.093 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.27 134.84 17.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.487 -0.56 . . . . 74.040000000000006 109.487 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -132.39 145.3 51.13 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 121.38 0.609 . . . . 74.209999999999994 111.925 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.81 113.4 1.86 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.989 -1.645 . . . . 73.439999999999998 108.989 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.405 ' N ' ' HB3' ' A' ' 59' ' ' PRO . 61.0 m -143.13 145.45 32.84 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 108.951 -0.759 . . . . 75.299999999999997 108.951 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.91 118.15 32.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.993 -1.114 . . . . 73.329999999999998 107.993 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.413 ' ND2' ' HB ' ' A' ' 129' ' ' VAL . 46.2 t30 -126.21 88.78 53.65 Favored Pre-proline 0 C--N 1.29 -2.018 0 CA-C-N 115.626 -0.715 . . . . 62.420000000000002 110.087 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -83.89 -18.32 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.382 2.055 . . . . 71.329999999999998 111.381 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -98.75 70.32 1.88 Allowed 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.479 1.133 . . . . 74.219999999999999 108.126 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.413 ' HB ' ' ND2' ' A' ' 126' ' ' ASN . 6.9 p -125.71 120.99 58.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.133 -1.394 . . . . 73.540000000000006 111.95 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.56 111.08 23.06 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.828 -1.175 . . . . 73.019999999999996 107.828 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -151.79 158.59 43.52 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.595 -1.632 . . . . 74.420000000000002 106.595 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--N 1.295 -1.798 0 N-CA-C 108.111 -1.07 . . . . 74.129999999999995 108.111 179.389 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 107.986 -1.116 . . . . 74.329999999999998 107.986 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.4 -128.66 24.89 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.821 -0.704 . . . . 64.450000000000003 111.577 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 m 60.95 25.06 15.08 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.074 0.95 . . . . 75.310000000000002 111.445 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 136.75 45.18 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.521 0.676 . . . . 73.329999999999998 112.154 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -97.12 92.01 5.84 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.425 0.631 . . . . 75.219999999999999 109.601 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -88.07 88.34 7.61 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.582 -0.895 . . . . 74.310000000000002 108.582 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 tt -92.45 108.34 19.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.303 -1.369 . . . . 73.329999999999998 107.303 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.38 106.16 20.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.171 -1.048 . . . . 62.32 108.171 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -73.13 100.1 2.97 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.89 0.853 . . . . 72.019999999999996 109.794 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -85.84 72.04 10.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.265 1.031 . . . . 74.120000000000005 111.494 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -130.74 92.29 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 113.724 -1.58 . . . . 74.219999999999999 109.593 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.88 -24.54 61.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.945 0.879 . . . . 72.200000000000003 109.272 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -141.75 128.05 19.88 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 102.79 -3.041 . . . . 73.25 102.79 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -73.31 -27.3 61.45 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.609 -0.836 . . . . 74.409999999999997 110.647 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 15' ' ' LEU . 3.7 pp -168.35 141.64 3.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 108.405 -0.961 . . . . 75.019999999999996 108.405 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.9 124.72 16.04 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.3 -0.63 . . . . 75.140000000000001 109.3 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.45 5.66 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.757 1.265 . . . . 75.230000000000004 111.182 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 32' ' ' VAL . 1.3 m -85.89 96.95 9.95 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.368 -1.287 . . . . 71.030000000000001 108.128 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.1 23.04 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.569 0.699 . . . . 65.0 111.644 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.99 41.26 2.28 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.653 -0.979 . . . . 72.120000000000005 110.653 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 t70 -150.02 136.26 18.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.121 -1.807 . . . . 74.530000000000001 106.121 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.42 -55.69 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.264 1.026 . . . . 73.310000000000002 113.295 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.06 -29.57 66.61 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 75.040000000000006 111.373 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.95 85.63 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.728 -0.669 . . . . 74.319999999999993 110.38 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 63.6 mtp180 -77.42 -19.93 55.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.859 -0.609 . . . . 75.25 110.513 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -69.04 -38.92 79.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.484 -0.932 . . . . 72.200000000000003 108.484 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 73' ' ' LYS . 58.7 m-85 -75.34 -29.3 59.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.857 -0.61 . . . . 75.519999999999996 110.927 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.74 -76.61 2.16 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 110.747 -0.941 . . . . 61.100000000000001 110.747 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.3 19.53 1.19 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 121.233 -0.508 . . . . 53.539999999999999 112.469 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -69.46 -74.44 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.577 -0.527 . . . . 74.230000000000004 109.577 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.81 159.37 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 N-CA-C 104.839 -2.282 . . . . 75.209999999999994 104.839 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 35' ' ' GLU . 29.1 m -125.98 148.73 63.91 Favored Pre-proline 0 C--N 1.292 -1.892 0 C-N-CA 118.888 -1.125 . . . . 73.099999999999994 111.043 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.72 -34.91 76.44 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.067 2.511 . . . . 75.239999999999995 112.121 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.507 -0.769 . . . . 74.129999999999995 110.481 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 32' ' ' VAL . 41.4 tt0 -79.82 -38.58 32.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.187 -0.915 . . . . 61.450000000000003 108.805 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.53 -53.48 46.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 115.532 -0.758 . . . . 74.409999999999997 110.028 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -65.53 -32.42 74.01 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 120.642 -0.423 . . . . 72.340000000000003 111.778 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.05 -53.97 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.062 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.2 mm? -71.59 -34.64 70.07 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.044 -0.525 . . . . 74.530000000000001 111.366 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp -65.85 -41.05 92.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.516 0.198 . . . . 75.450000000000003 111.381 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -73.93 -26.51 60.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.21 -0.596 . . . . 72.120000000000005 109.495 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -71.18 -35.75 71.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.372 -0.603 . . . . 75.340000000000003 109.372 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 78.0 mm-40 -61.09 -37.36 82.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.766 -0.457 . . . . 74.420000000000002 109.766 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.68 82.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 73.409999999999997 109.92 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.42 -33.45 73.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.309 0.576 . . . . 61.219999999999999 112.007 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.05 -37.32 39.28 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.469 0.707 . . . . 72.010000000000005 110.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.54 14.49 63.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.483 -0.78 . . . . 74.200000000000003 113.365 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -54.6 141.6 10.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.005 0.922 . . . . 71.540000000000006 110.96 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.36 126.75 55.62 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 107.02 -1.474 . . . . 74.329999999999998 107.02 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -66.71 102.18 0.9 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.331 0.586 . . . . 74.409999999999997 110.125 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -104.24 -165.97 1.2 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.487 -2.042 . . . . 75.129999999999995 105.487 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.566 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -47.13 144.04 2.85 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.155 -0.683 . . . . 75.129999999999995 109.155 172.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.63 7.49 3.86 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 114.343 0.497 . . . . 53.420000000000002 114.343 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -76.71 -35.6 57.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.536 -0.913 . . . . 54.450000000000003 108.536 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.493 ' HD3' ' OE1' ' A' ' 99' ' ' GLN . 8.2 ptm180 -168.45 157.54 9.0 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.754 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' HB2' ' CD1' ' A' ' 98' ' ' TRP . 77.6 mt -91.89 151.37 20.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.258 0.623 . . . . 70.25 110.408 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 tt -101.24 127.29 47.89 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.619 -1.252 . . . . 75.25 107.619 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.72 158.08 32.45 Favored Pre-proline 0 C--N 1.301 -1.543 0 C-N-CA 122.96 0.504 . . . . 71.430000000000007 110.169 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.424 ' HA ' HG23 ' A' ' 125' ' ' VAL . 73.6 Cg_exo -54.25 161.83 4.91 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.073 2.515 . . . . 73.329999999999998 113.363 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -125.94 -25.54 3.59 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.63 -0.713 . . . . 70.340000000000003 110.421 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -101.2 100.52 11.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.917 -1.142 . . . . 74.25 107.917 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.36 119.24 38.58 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 72.030000000000001 109.898 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.0 mt -116.13 114.09 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.527 -0.761 . . . . 72.409999999999997 109.528 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -104.62 134.15 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 106.641 -1.615 . . . . 74.049999999999997 106.641 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 m -131.6 125.66 32.79 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 120.901 -0.32 . . . . 73.140000000000001 111.329 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.2 mm? -132.44 172.92 11.86 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.341 1.026 . . . . 73.549999999999997 109.543 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.9 51.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.675 -0.97 . . . . 72.140000000000001 110.675 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 88.0 t -60.92 -45.73 97.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.993 0.517 . . . . 74.450000000000003 110.87 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -64.65 -31.47 72.7 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.752 1.221 . . . . 73.519999999999996 110.686 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.51 -37.53 19.57 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.584 0.707 . . . . 74.219999999999999 109.252 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -60.57 -32.02 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.168 -0.924 . . . . 75.439999999999998 111.315 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 54.3 mt-10 -55.61 -38.26 69.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.418 0.627 . . . . 74.409999999999997 110.139 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 39.0 mmtm -83.43 -28.64 28.69 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.006 -0.997 . . . . 65.329999999999998 109.842 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.2 mt -55.78 -45.78 78.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.83 0.707 . . . . 73.540000000000006 109.65 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.68 158.48 21.31 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.614 -0.995 . . . . 72.109999999999999 110.614 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -18.21 60.45 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.491 0.662 . . . . 75.209999999999994 110.202 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.95 138.22 17.85 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 108.459 -0.941 . . . . 72.5 108.459 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.4 -51.45 7.41 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.573 2.182 . . . . 73.409999999999997 112.88 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -64.91 -30.12 71.1 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.326 -0.397 . . . . 74.430000000000007 111.486 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.58 -40.91 53.67 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.329 1.018 . . . . 74.230000000000004 109.514 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 2.1 mmmp? -95.2 -39.23 10.19 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 74.510000000000005 110.688 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.9 m -58.44 -44.82 89.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.72 0.637 . . . . 75.120000000000005 112.72 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -63.04 -54.49 37.37 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 120.926 0.393 . . . . 73.420000000000002 111.558 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.83 -37.71 92.47 Favored Glycine 0 C--O 1.245 0.807 0 C-N-CA 121.406 -0.426 . . . . 75.450000000000003 113.1 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -75.47 -30.0 59.79 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.868 -0.195 . . . . 64.319999999999993 110.684 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.46 90.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.955 -0.387 . . . . 65.549999999999997 109.955 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -60.86 -47.74 85.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.403 -0.817 . . . . 74.349999999999994 111.048 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 11.1 t70 -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.539 0.685 . . . . 74.310000000000002 110.486 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.65 -36.95 70.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 65.519999999999996 109.157 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 104' ' ' VAL . . . -63.45 -36.67 84.53 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 109.298 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 30.1 t70 -59.56 -52.2 66.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.688 -1.142 . . . . 72.310000000000002 109.06 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -52.96 -50.79 63.36 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.403 0.89 . . . . 75.540000000000006 113.403 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.41 -37.26 79.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.193 -0.603 . . . . 73.420000000000002 112.225 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -70.56 -34.83 72.66 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.812 -0.355 . . . . 74.040000000000006 111.281 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 64.7 mm-40 -63.1 -35.26 79.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.156 0.503 . . . . 73.540000000000006 110.636 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -81.79 -12.96 58.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.581 -0.736 . . . . 74.540000000000006 111.204 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 89.85 23.97 31.42 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.903 -0.59 . . . . 41.530000000000001 112.991 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.9 m0 -98.5 149.23 22.94 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.068 0.461 . . . . 75.329999999999998 111.406 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.493 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 13.8 pt20 -124.47 177.46 5.9 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.367 -0.833 . . . . 74.109999999999999 109.14 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -162.13 -179.17 6.88 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.744 -0.836 . . . . 74.030000000000001 108.744 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -112.19 120.53 42.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.099 -0.704 . . . . 64.140000000000001 109.099 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.06 -150.28 16.73 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 119.713 -1.232 . . . . 63.119999999999997 110.451 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.68 144.32 38.22 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.371 -1.344 . . . . 73.129999999999995 107.371 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 90' ' ' ALA . 12.0 p -79.51 141.52 15.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.199 -1.037 . . . . 64.519999999999996 108.199 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.61 124.8 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.309 0.576 . . . . 75.5 109.984 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.63 112.59 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 105.981 -1.859 . . . . 73.5 105.981 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -124.06 140.33 53.08 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.688 -0.687 . . . . 73.219999999999999 111.286 -172.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -109.73 130.77 55.48 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.175 -0.921 . . . . 74.099999999999994 109.972 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.94 166.35 21.86 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.972 0.415 . . . . 72.109999999999999 110.922 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 45.0 mt-30 -106.62 142.8 35.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.233 -0.894 . . . . 73.400000000000006 109.379 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 114' ' ' LEU . 12.5 p -119.88 136.72 54.39 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 112.777 0.658 . . . . 74.129999999999995 112.777 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -82.93 -40.47 20.09 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.582 0.706 . . . . 55.149999999999999 109.7 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.73 -22.43 43.31 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.135 -0.939 . . . . 73.129999999999995 112.194 -174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.448 ' HB3' ' OG ' ' A' ' 111' ' ' SER . 25.7 tp -114.5 137.37 51.93 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.028 -2.582 . . . . 73.209999999999994 104.028 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -139.55 172.61 12.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.325 -1.35 . . . . 71.129999999999995 111.724 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.6 m -35.83 124.64 0.71 Allowed 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.166 2.187 . . . . 75.109999999999999 113.557 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.64 -22.94 27.4 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.217 -1.153 . . . . 75.239999999999995 110.217 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -112.17 128.23 56.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.416 -0.587 . . . . 74.109999999999999 109.416 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -124.69 149.66 46.97 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.27 -1.011 . . . . 60.039999999999999 108.27 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -136.74 143.12 43.13 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.237 -1.023 . . . . 73.340000000000003 108.237 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.74 142.03 40.97 Favored 'General case' 0 C--N 1.257 -3.451 0 N-CA-C 104.302 -2.481 . . . . 75.140000000000001 104.302 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -156.9 162.36 39.66 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.28 -0.568 . . . . 74.319999999999993 110.225 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.03 119.2 1.68 Allowed Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 110.67 -0.972 . . . . 73.340000000000003 110.67 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.7 m -110.23 144.01 39.54 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.017 -0.734 . . . . 73.219999999999999 109.017 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 59' ' ' PRO . 63.0 t -99.35 112.96 33.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.566 -1.272 . . . . 74.099999999999994 107.566 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -88.35 107.5 16.98 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 107.051 -1.462 . . . . 75.0 107.051 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.27 -36.01 4.52 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.087 1.858 . . . . 64.340000000000003 113.273 -174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.87 73.12 1.97 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.204 1.002 . . . . 72.140000000000001 110.453 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.71 99.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 114.024 -1.444 . . . . 70.120000000000005 109.673 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.07 147.04 30.31 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.805 -1.088 . . . . 74.200000000000003 109.106 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -86.08 104.6 15.82 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 122.348 1.071 . . . . 73.010000000000005 108.323 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.9 p80 . . . . . 0 C--N 1.282 -2.338 0 CA-C-N 114.195 -1.366 . . . . 73.049999999999997 107.657 179.788 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.242 0.669 0 N-CA-C 109.298 -0.63 . . . . 75.549999999999997 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.19 117.08 1.51 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.484 -0.646 . . . . 72.109999999999999 111.484 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -68.85 145.21 53.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 122.683 0.393 . . . . 74.430000000000007 110.861 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.38 125.13 30.68 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.128 0.489 . . . . 64.420000000000002 110.795 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.92 145.68 33.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.131 -1.803 . . . . 71.200000000000003 106.131 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.7 139.87 35.78 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.138 -0.625 . . . . 74.519999999999996 109.356 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -102.46 85.68 2.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.201 -1.037 . . . . 74.200000000000003 108.201 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -171.6 153.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.317 -2.105 . . . . 74.140000000000001 105.317 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -85.89 -168.03 2.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.655 -0.868 . . . . 73.540000000000006 108.655 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -73.68 78.62 1.53 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.744 0.783 . . . . 73.530000000000001 109.262 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -124.78 107.49 18.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.428 -1.323 . . . . 73.400000000000006 107.428 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -95.32 -43.93 7.81 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.243 -0.651 . . . . 63.299999999999997 109.243 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 57.17 66.42 1.16 Allowed 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.331 -0.989 . . . . 75.510000000000005 108.331 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -94.23 80.71 4.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.729 -0.669 . . . . 74.109999999999999 109.428 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.83 -22.96 19.84 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.226 -0.897 . . . . 75.140000000000001 109.637 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.36 97.44 10.43 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.049 -1.463 . . . . 74.140000000000001 107.049 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -134.19 137.29 44.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.888 -0.596 . . . . 73.439999999999998 109.766 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.556 ' HB ' ' OH ' ' A' ' 92' ' ' TYR . 63.2 m -145.5 151.64 38.5 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.761 -1.94 . . . . 54.299999999999997 105.761 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -99.69 125.27 53.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.423 -0.911 . . . . 75.5 113.038 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.63 20.06 6.16 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.16 -1.976 . . . . 62.219999999999999 108.16 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 23.6 m-20 -73.0 -2.67 22.03 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 124.743 1.217 . . . . 72.109999999999999 112.519 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.18 -39.39 66.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.604 0.716 . . . . 73.549999999999997 110.294 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -71.29 -26.46 62.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.773 -0.648 . . . . 74.439999999999998 112.04 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.63 60.26 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.03 -0.73 . . . . 62.549999999999997 109.03 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 17.1 mmm180 -72.3 -44.19 63.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.578 -0.737 . . . . 73.400000000000006 109.145 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.55 -49.01 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.949 -0.569 . . . . 73.209999999999994 112.197 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -78.08 -23.7 47.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.61 0.596 . . . . 75.340000000000003 112.61 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.72 -65.93 4.02 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 109.631 -1.388 . . . . 74.099999999999994 109.631 -174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.4 27.06 0.15 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 121.106 -0.569 . . . . 64.319999999999993 113.215 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -62.46 -42.91 99.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.454 0.627 . . . . 73.310000000000002 109.587 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.95 151.84 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 107.472 -1.307 . . . . 74.319999999999993 107.472 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.76 106.31 32.79 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 109.125 -0.694 . . . . 74.129999999999995 109.125 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -47.46 -50.65 10.96 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.26 3.307 . . . . 74.150000000000006 114.395 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -65.39 -25.29 67.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 114.916 1.45 . . . . 74.530000000000001 114.916 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 -27.83 35.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.016 -1.074 . . . . 75.040000000000006 109.949 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.5 -43.23 80.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.026 -1.472 . . . . 74.439999999999998 107.026 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.51 -49.37 72.77 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.104 -0.953 . . . . 71.019999999999996 109.824 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.94 -52.89 22.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.765 0.826 . . . . 72.310000000000002 111.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.65 -42.67 86.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.127 0.417 . . . . 73.200000000000003 112.127 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.24 -39.96 82.12 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.957 0.725 . . . . 75.209999999999994 112.957 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.58 -26.36 62.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.468 0.651 . . . . 75.510000000000005 109.741 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.75 -45.08 60.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.292 -1.003 . . . . 71.140000000000001 108.292 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.047 -0.524 . . . . 72.349999999999994 111.323 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.47 95.33 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.952 -0.567 . . . . 41.450000000000003 111.124 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.69 -22.99 45.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.412 0.625 . . . . 74.340000000000003 111.398 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.28 -40.34 51.98 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.393 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.41 40.8 2.67 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.693 -0.685 . . . . 72.530000000000001 112.559 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mm -79.81 139.41 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.616 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp0 -118.7 144.0 46.51 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.159 0.984 . . . . 73.209999999999994 108.52 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -81.03 100.99 9.27 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.981 0.896 . . . . 64.540000000000006 110.027 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD21 ' NE2' ' A' ' 99' ' ' GLN . 12.3 tp -118.67 -163.92 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 105.596 -2.001 . . . . 74.310000000000002 105.596 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -41.41 126.03 2.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.799 0.687 . . . . 74.140000000000001 109.97 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.3 50.08 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 114.656 0.622 . . . . 74.239999999999995 114.656 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.4 -23.86 62.83 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.526 -0.469 . . . . 73.239999999999995 111.805 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 13.9 ptm180 -162.18 128.71 3.67 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.532 0.682 . . . . 75.310000000000002 111.808 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.54 151.81 21.18 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 123.848 0.859 . . . . 74.409999999999997 110.985 -170.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.3 tm? -85.75 118.67 25.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.837 -0.801 . . . . 71.340000000000003 108.837 -174.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.44 165.61 12.33 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 124.137 0.975 . . . . 64.200000000000003 110.118 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 50.8 Cg_exo -57.83 160.8 14.09 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.472 2.782 . . . . 70.549999999999997 113.371 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.459 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.9 p-10 -127.28 -31.94 2.51 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.375 -0.829 . . . . 64.219999999999999 111.079 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -109.07 111.5 23.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.026 -0.731 . . . . 74.310000000000002 109.026 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 50.0 m-85 -106.68 120.17 41.26 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.682 -0.858 . . . . 75.420000000000002 108.682 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.72 115.31 43.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.718 -0.475 . . . . 72.540000000000006 109.718 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.7 mp -112.46 109.94 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 107.194 -1.41 . . . . 72.329999999999998 107.194 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -105.86 122.7 46.64 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.539 -0.541 . . . . 74.510000000000005 109.539 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.41 163.64 13.48 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.376 0.67 . . . . 74.209999999999994 109.753 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.13 53.58 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.096 -1.602 . . . . 74.140000000000001 109.096 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 5.8 p -59.73 -37.46 71.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.792 0.796 . . . . 74.299999999999997 111.859 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 56.2 t-80 -58.96 -41.93 88.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 75.230000000000004 109.798 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.405 ' O ' HD23 ' A' ' 74' ' ' LEU . 5.8 m-20 -75.28 -39.62 59.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.535 -0.757 . . . . 70.129999999999995 111.739 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -57.94 -28.28 64.16 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.103 0.477 . . . . 72.409999999999997 111.095 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 94.1 mt-10 -62.77 -35.24 79.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.144 0.497 . . . . 74.510000000000005 110.215 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 69' ' ' HIS . 45.3 mmtt -85.02 -17.47 37.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.034 -0.728 . . . . 74.120000000000005 109.034 -172.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.461 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 4.5 mm? -69.97 -41.49 74.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.882 -1.054 . . . . 71.310000000000002 109.336 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.81 168.7 13.02 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.312 -0.946 . . . . 74.329999999999998 112.167 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.96 53.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.897 0.379 . . . . 64.219999999999999 111.762 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -112.14 96.0 32.68 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.305 -0.628 . . . . 54.420000000000002 109.305 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.1 -31.56 4.79 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 122.042 1.828 . . . . 71.099999999999994 111.038 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -53.15 42.51 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 115.508 1.67 . . . . 75.219999999999999 115.508 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.51 -15.82 61.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.858 0.754 . . . . 64.310000000000002 111.491 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 74' ' ' LEU . 58.4 mttp -90.79 -44.41 9.45 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.561 -0.745 . . . . 73.510000000000005 109.697 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 p -67.43 -51.22 54.29 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.12 0.568 . . . . 62.100000000000001 110.322 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.4 m -59.69 -41.15 90.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.567 -0.531 . . . . 73.439999999999998 109.567 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.58 52.95 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.563 -0.744 . . . . 62.509999999999998 112.634 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.98 -28.12 65.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 70.219999999999999 110.082 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.66 97.02 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.997 -0.547 . . . . 72.530000000000001 110.439 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' THR . 19.0 mmt85 -64.09 -39.59 94.39 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 111.313 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -44.25 87.83 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.332 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.65 -34.98 79.07 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.34 99.05 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.422 0.63 . . . . 72.519999999999996 110.108 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.49 -40.78 80.77 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.107 -0.951 . . . . 54.140000000000001 109.353 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -55.86 -50.75 69.77 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.472 1.109 . . . . 74.230000000000004 111.369 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.45 -35.82 75.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.756 -0.377 . . . . 74.430000000000007 111.142 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.31 -40.93 96.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 75.219999999999999 109.76 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -62.67 -29.54 70.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.333 -0.849 . . . . 44.340000000000003 112.338 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -85.87 1.47 49.72 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.645 -0.707 . . . . 72.340000000000003 111.223 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 27.25 52.65 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 121.07 -0.586 . . . . 45.32 112.261 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.83 167.64 10.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.419 -0.46 . . . . 70.140000000000001 110.065 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.48 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.4 pt20 -143.34 167.24 22.64 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.287 -1.005 . . . . 71.409999999999997 108.287 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.8 t -150.01 -177.33 5.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.718 -0.475 . . . . 73.120000000000005 109.718 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.98 120.09 38.0 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.905 -0.406 . . . . 73.430000000000007 109.905 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -155.33 16.35 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 119.718 -1.23 . . . . 62.310000000000002 111.787 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -103.84 137.1 42.32 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.988 -1.486 . . . . 73.239999999999995 106.988 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.21 124.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.776 -0.824 . . . . 74.420000000000002 108.776 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.05 130.13 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 CA-C-O 121.642 0.734 . . . . 62.32 110.941 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 62' ' ' TYR . 34.7 m -104.43 127.42 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 N-CA-C 106.249 -1.76 . . . . 73.319999999999993 106.249 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -105.78 126.61 52.36 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.838 -0.619 . . . . 74.530000000000001 109.95 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -113.59 114.26 26.21 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.243 -1.392 . . . . 74.439999999999998 107.243 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.87 166.79 23.7 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.377 -0.374 . . . . 75.420000000000002 111.042 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -99.24 160.87 13.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.091 0.948 . . . . 74.450000000000003 112.171 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -149.48 115.67 5.75 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 113.559 -1.655 . . . . 64.030000000000001 107.819 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -81.03 -2.81 49.53 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.881 0.848 . . . . 61.340000000000003 109.559 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.68 -38.47 19.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.631 -1.168 . . . . 74.349999999999994 108.364 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.02 161.8 30.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.542 -0.91 . . . . 73.340000000000003 108.542 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -87.55 154.3 20.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.055 0.455 . . . . 73.209999999999994 110.055 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 m -62.23 132.48 52.87 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 124.354 1.062 . . . . 74.319999999999993 109.489 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 28.96 60.83 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.536 -0.364 . . . . 65.430000000000007 112.417 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -137.07 149.39 47.36 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.024 -1.102 . . . . 75.540000000000006 108.024 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -139.37 156.66 46.86 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.668 -0.413 . . . . 72.420000000000002 110.966 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 36.5 mmt180 -123.63 131.16 53.55 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.384 -0.969 . . . . 72.430000000000007 108.384 174.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.58 120.57 24.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.41 -0.589 . . . . 72.430000000000007 109.41 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -135.38 138.36 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.362 -0.381 . . . . 74.120000000000005 110.4 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -105.44 109.81 3.31 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.79 -0.924 . . . . 73.310000000000002 110.79 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.3 m -109.92 143.16 40.26 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.526 0.679 . . . . 70.540000000000006 110.603 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.9 t -90.54 110.35 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.175 -1.787 . . . . 75.239999999999995 106.175 171.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -102.16 104.42 36.55 Favored Pre-proline 0 C--N 1.281 -2.386 0 N-CA-C 108.087 -1.079 . . . . 74.310000000000002 108.087 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.66 -21.04 13.19 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.295 1.996 . . . . 71.409999999999997 110.447 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.23 42.58 1.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.23 -0.896 . . . . 63.130000000000003 109.295 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.2 109.94 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 108.268 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.89 123.35 29.31 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.943 0.878 . . . . 73.420000000000002 112.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.8 m -80.9 136.46 36.06 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.965 -1.47 . . . . 75.019999999999996 109.303 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 p80 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 108.637 -0.875 . . . . 74.510000000000005 108.637 175.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 109.141 -0.689 . . . . 71.420000000000002 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.0 -67.23 0.41 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.619 -0.801 . . . . 62.229999999999997 111.58 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 t 62.08 73.99 0.45 Allowed 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.555 -0.906 . . . . 75.040000000000006 108.555 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -86.46 84.75 7.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.405 -0.816 . . . . 74.319999999999993 112.813 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 155.91 38.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.136 -2.172 . . . . 74.239999999999995 105.136 171.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -157.36 155.67 30.99 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.568 -0.853 . . . . 64.420000000000002 111.829 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.53 85.93 2.86 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.855 -1.906 . . . . 64.400000000000006 105.855 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.57 148.55 11.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.745 -0.661 . . . . 75.230000000000004 109.925 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.03 109.99 10.14 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.066 -1.087 . . . . 73.340000000000003 108.066 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.18 115.23 27.48 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.887 -1.051 . . . . 74.549999999999997 109.792 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.8 73.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 123.338 1.542 . . . . 74.040000000000006 110.506 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.93 -166.0 1.16 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.505 -1.68 . . . . 73.099999999999994 107.694 178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -117.08 148.54 41.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.148 -1.021 . . . . 74.129999999999995 110.382 -174.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -74.35 -40.81 61.91 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.451 -2.055 . . . . 73.239999999999995 105.451 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.92 149.23 33.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.791 -0.818 . . . . 75.209999999999994 108.791 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -105.28 150.26 25.31 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.166 -1.42 . . . . 75.140000000000001 107.166 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -83.65 69.85 10.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.62 0.724 . . . . 74.219999999999999 109.541 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 m -83.04 95.47 8.05 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 115.098 -0.955 . . . . 75.140000000000001 108.743 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.6 t -94.68 98.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.121 -1.066 . . . . 61.399999999999999 108.121 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 116.39 0.85 Allowed Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.271 -0.732 . . . . 70.140000000000001 111.271 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 15.6 t70 -171.42 158.16 5.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.489 -2.041 . . . . 74.140000000000001 105.489 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.4 86.78 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 123.874 0.734 . . . . 74.109999999999999 111.439 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HA ' HG13 ' A' ' 26' ' ' ILE . 82.8 m-85 -70.39 -32.57 70.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.261 -0.427 . . . . 75.439999999999998 110.375 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -65.69 -34.86 79.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.2 -0.667 . . . . 72.230000000000004 109.2 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 24.3 mmt180 -67.57 -52.26 40.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.711 -0.677 . . . . 72.540000000000006 110.21 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG13 ' HA ' ' A' ' 23' ' ' PHE 0.311 2.7 pp -67.71 -31.69 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 115.25 1.574 . . . . 72.439999999999998 115.25 -176.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 30' ' ' SER . 30.6 m-85 -81.58 -28.15 33.94 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.221 -0.992 . . . . 72.140000000000001 111.109 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.89 59.52 0.74 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.302 -0.951 . . . . 51.439999999999998 112.993 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.6 20.37 56.48 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 121.359 -0.448 . . . . 75.409999999999997 112.638 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 50.2 m -151.98 153.64 34.46 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 122.248 -0.56 . . . . 62.43 109.707 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 tt -155.05 131.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.645 -0.872 . . . . 72.239999999999995 108.645 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.15 89.4 52.68 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 121.328 0.585 . . . . 74.200000000000003 110.747 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.8 Cg_exo -80.38 -54.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.307 2.004 . . . . 71.239999999999995 111.573 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -62.18 -24.45 67.21 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.242 -0.89 . . . . 72.340000000000003 112.101 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.34 -55.11 39.17 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.214 -0.661 . . . . 74.219999999999999 109.214 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.67 -42.67 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.113 -0.948 . . . . 75.239999999999995 109.503 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 42.3 mt-10 -56.77 -54.75 42.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 72.5 111.891 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.13 81.75 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.335 0.254 . . . . 65.140000000000001 111.558 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.96 -45.73 92.38 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.994 -0.743 . . . . 75.430000000000007 108.994 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.93 -29.14 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.043 0.757 . . . . 73.409999999999997 113.043 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 67.2 mtt180 -63.92 -41.53 97.62 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.002 -1.11 . . . . 74.400000000000006 108.002 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.32 -47.65 81.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.93 -1.032 . . . . 72.109999999999999 110.931 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -59.43 -42.55 92.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.134 0.574 . . . . 74.319999999999993 110.482 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.17 82.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 72.420000000000002 110.949 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.5 -29.02 63.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 71.450000000000003 111.981 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.49 -36.72 32.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.518 -0.31 . . . . 74.019999999999996 110.567 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.69 18.92 27.49 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.13 -0.487 . . . . 75.120000000000005 113.652 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -68.83 133.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 123.364 0.666 . . . . 74.519999999999996 110.725 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' OE1' HD21 ' A' ' 57' ' ' LEU . 94.3 mt-30 -107.03 147.96 29.3 Favored 'General case' 0 CA--C 1.473 -1.994 0 N-CA-C 109.061 -0.718 . . . . 73.200000000000003 109.061 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -86.38 91.62 8.57 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.011 -1.107 . . . . 72.349999999999994 108.011 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.9 tp -98.9 -165.55 1.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.825 -1.546 . . . . 73.25 106.825 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.586 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.5 mt-30 -44.6 148.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.685 1.194 . . . . 75.319999999999993 111.449 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.87 -15.95 56.04 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.731 -0.668 . . . . 75.409999999999997 113.185 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -61.6 -48.67 79.88 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.791 -0.448 . . . . 75.450000000000003 109.791 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -168.51 149.27 4.73 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.924 -0.58 . . . . 62.450000000000003 111.242 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.04 151.72 20.92 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.047 0.939 . . . . 73.510000000000005 110.594 -173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD21 ' OE1' ' A' ' 49' ' ' GLN . 15.7 tp -89.9 127.68 36.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.844 -0.616 . . . . 75.549999999999997 109.603 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.68 158.0 40.05 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 123.381 0.672 . . . . 61.240000000000002 109.275 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 34.9 Cg_exo -62.93 148.34 93.57 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.62 2.214 . . . . 60.299999999999997 111.611 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 33.9 p-10 -120.77 -28.41 4.87 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.81 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.68 124.61 50.25 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.436 -0.95 . . . . 72.129999999999995 108.436 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 45.3 m-85 -121.38 127.69 51.47 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.873 -0.417 . . . . 74.209999999999994 109.873 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 120.13 63.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.943 -0.762 . . . . 71.340000000000003 108.943 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.54 123.67 68.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.928 -0.767 . . . . 74.230000000000004 108.928 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 m -104.28 124.89 49.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.579 -0.282 . . . . 74.329999999999998 110.39 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.0 165.47 12.85 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.408 0.683 . . . . 73.450000000000003 110.168 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.25 145.23 31.73 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.934 -1.667 . . . . 74.540000000000006 108.934 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.29 -43.04 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 113.937 1.088 . . . . 75.239999999999995 113.937 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -64.73 -36.61 84.84 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.138 0.494 . . . . 75.510000000000005 111.445 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.33 -23.47 26.23 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.639 -0.824 . . . . 64.420000000000002 110.082 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.13 -30.87 71.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.096 -0.705 . . . . 75.230000000000004 109.096 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.46 -33.76 68.3 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.036 -0.529 . . . . 75.010000000000005 110.44 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -74.57 -39.16 62.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.598 -0.89 . . . . 71.319999999999993 108.598 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.41 -37.34 85.43 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.658 0.742 . . . . 72.040000000000006 109.083 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.2 -171.29 13.62 Favored Glycine 0 N--CA 1.414 -2.822 0 CA-C-N 114.615 -1.175 . . . . 73.540000000000006 110.813 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -93.58 -5.81 48.03 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.671 0.272 . . . . 64.310000000000002 110.334 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -89.6 111.18 44.35 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 115.702 -0.681 . . . . 71.450000000000003 112.422 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 5.8 Cg_exo -77.94 -51.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.308 2.005 . . . . 73.409999999999997 113.029 172.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -86.54 -39.36 16.29 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 118.476 2.769 . . . . 75.209999999999994 118.476 -169.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.98 -52.47 65.24 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.419 1.009 . . . . 70.450000000000003 113.057 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -63.91 -32.13 73.56 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 122.692 1.234 . . . . 72.519999999999996 110.742 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -75.8 -17.3 59.91 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.101 -1.409 . . . . 51.219999999999999 112.022 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 m -69.44 -41.87 75.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.372 -0.603 . . . . 71.019999999999996 109.372 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.97 -36.14 61.07 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.9 -0.88 . . . . 74.409999999999997 110.9 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -65.03 -46.51 81.01 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.22 0.533 . . . . 74.329999999999998 109.795 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.85 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.042 -0.526 . . . . 63.32 111.286 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -59.17 -45.02 92.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 75.430000000000007 109.834 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.47 -43.72 89.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.982 -1.008 . . . . 63.039999999999999 110.187 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.82 -39.22 90.66 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 115.718 -0.673 . . . . 74.430000000000007 109.828 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.1 91.41 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.39 0.614 . . . . 73.430000000000007 110.462 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -41.03 83.36 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.473 -0.785 . . . . 73.120000000000005 110.009 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 m-85 -56.31 -53.54 56.1 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.622 -0.717 . . . . 71.340000000000003 112.077 175.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.0 pt -62.88 -35.69 72.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 120.797 -0.361 . . . . 74.120000000000005 111.863 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.73 -37.19 81.85 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 121.135 -0.226 . . . . 75.450000000000003 110.793 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.7 -28.31 69.81 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.41 0.624 . . . . 74.219999999999999 110.483 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 60.2 mm-40 -88.33 -4.68 58.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.985 -0.552 . . . . 74.540000000000006 111.162 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.04 26.94 59.18 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.857 -0.61 . . . . 71.099999999999994 112.416 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -98.44 161.41 13.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.929 -0.767 . . . . 75.230000000000004 108.929 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -129.72 174.61 9.54 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 110.068 -0.345 . . . . 75.439999999999998 110.068 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.5 t -165.15 170.4 14.99 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 105.409 -2.071 . . . . 72.549999999999997 105.409 175.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.08 118.01 33.73 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.092 -1.447 . . . . 72.140000000000001 107.092 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.78 -149.49 16.72 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 119.218 -1.468 . . . . 75.329999999999998 109.885 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -132.28 163.48 28.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.662 -1.236 . . . . 74.129999999999995 107.662 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.66 131.99 33.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.255 0.55 . . . . 74.340000000000003 112.177 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.95 120.52 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-N 115.233 -0.894 . . . . 64.319999999999993 109.294 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 62' ' ' TYR . 4.3 m -112.25 143.36 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 107.071 -1.455 . . . . 75.340000000000003 107.071 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -142.45 150.67 40.87 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.71 0.29 . . . . 74.109999999999999 110.809 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.0 151.14 23.56 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.503 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.71 166.58 24.36 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 63.329999999999998 107.94 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.26 152.57 38.73 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.685 -0.487 . . . . 75.409999999999997 109.685 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.7 m -134.02 138.84 45.64 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 115.902 -0.59 . . . . 65.0 109.669 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 t -80.53 -23.63 39.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.801 -0.814 . . . . 63.439999999999998 108.801 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -82.18 -5.17 58.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.859 -0.61 . . . . 71.299999999999997 111.529 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.3 148.28 29.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.412 -1.329 . . . . 75.150000000000006 107.412 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -119.07 156.7 29.24 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.826 -0.749 . . . . 62.420000000000002 111.055 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 m -49.2 121.14 4.57 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 126.248 1.819 . . . . 73.430000000000007 111.528 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.96 -30.78 6.9 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.832 -0.907 . . . . 71.219999999999999 110.832 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.77 131.1 39.47 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.223 -0.658 . . . . 71.230000000000004 109.223 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 150.75 42.38 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.649 -0.871 . . . . 73.239999999999995 108.649 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -140.65 147.23 38.99 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.24 -0.652 . . . . 72.209999999999994 109.24 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.77 139.84 31.17 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.003 -0.369 . . . . 73.310000000000002 110.003 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -132.66 149.55 52.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.061 -0.518 . . . . 75.120000000000005 109.762 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.29 123.07 5.53 Favored Glycine 0 C--N 1.282 -2.44 0 N-CA-C 109.656 -1.378 . . . . 73.120000000000005 109.656 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.4 m -121.01 150.85 40.51 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.701 -0.852 . . . . 71.329999999999998 108.701 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 59' ' ' PRO . 46.6 t -98.58 118.09 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.411 -0.959 . . . . 73.299999999999997 108.411 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.08 101.97 7.36 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.124 -1.436 . . . . 64.549999999999997 107.124 171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.44 -9.31 12.51 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.09 1.86 . . . . 61.43 112.161 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -86.84 26.92 1.05 Allowed 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.772 -0.649 . . . . 63.240000000000002 112.053 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.49 101.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.091 -1.448 . . . . 73.219999999999999 107.091 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.79 156.36 19.01 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.074 -0.512 . . . . 75.420000000000002 109.982 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -80.37 123.36 27.95 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.492 0.663 . . . . 75.219999999999999 109.54 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.9 m80 . . . . . 0 C--N 1.292 -1.91 0 N-CA-C 107.566 -1.272 . . . . 74.540000000000006 107.566 -179.665 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm . . . . . 0 CA--C 1.5 -0.979 0 N-CA-C 108.923 -0.769 . . . . 74.099999999999994 108.923 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.0 -104.25 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 119.952 -1.118 . . . . 74.109999999999999 111.719 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -118.26 106.43 12.79 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 109.54 -0.541 . . . . 63.420000000000002 109.54 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -139.08 107.33 5.77 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.048 -1.093 . . . . 73.420000000000002 108.048 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 -162.19 0.8 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.793 -1.188 . . . . 73.319999999999993 107.793 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -77.28 91.89 3.84 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.342 -0.614 . . . . 75.109999999999999 109.342 174.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.99 106.84 2.9 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.387 -1.338 . . . . 72.540000000000006 107.387 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -73.83 144.2 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.281 -1.007 . . . . 73.239999999999995 108.281 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -42.75 111.62 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.426 1.491 . . . . 75.319999999999993 112.402 -174.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -95.21 177.32 5.9 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.522 -0.763 . . . . 72.409999999999997 111.978 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.55 144.97 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.468 -0.787 . . . . 75.510000000000005 110.702 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.23 114.55 8.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.028 -0.73 . . . . 74.420000000000002 109.028 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -137.7 155.62 48.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.727 -0.842 . . . . 74.420000000000002 108.727 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.07 134.37 40.51 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.914 -1.143 . . . . 71.230000000000004 107.914 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -74.61 156.61 36.57 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.386 0.429 . . . . 74.230000000000004 110.436 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.75 124.93 24.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.433 0.635 . . . . 72.340000000000003 110.627 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -101.32 142.18 33.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.43 -0.805 . . . . 74.209999999999994 109.356 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 m -64.9 147.14 53.9 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 107.575 -1.268 . . . . 75.129999999999995 107.575 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 m -76.05 84.59 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 122.823 1.297 . . . . 74.409999999999997 111.153 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 67.67 2.07 Favored Glycine 0 N--CA 1.42 -2.371 0 CA-C-N 114.648 -1.16 . . . . 75.150000000000006 112.081 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.69 -40.35 83.36 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.115 0.483 . . . . 73.430000000000007 110.151 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.23 -51.21 68.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.107 -0.952 . . . . 54.399999999999999 110.102 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -56.54 -48.48 77.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.33 -0.85 . . . . 72.140000000000001 110.682 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.22 -49.41 74.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 74.319999999999993 111.576 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -72.24 -28.08 62.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.439 0.533 . . . . 72.230000000000004 112.439 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.8 mt -77.24 -55.89 9.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.899 0.38 . . . . 72.450000000000003 111.523 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -84.89 -13.55 50.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.623 0.601 . . . . 75.310000000000002 112.623 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.79 3.79 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.041 -0.823 . . . . 62.119999999999997 111.041 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.01 -73.61 0.46 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.955 -0.858 . . . . 74.120000000000005 110.955 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 t 57.38 32.19 21.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.16 0.984 . . . . 74.310000000000002 110.44 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.45 -44.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.646 -1.242 . . . . 74.5 107.646 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -140.24 119.86 8.81 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 114.63 -1.168 . . . . 53.109999999999999 108.923 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.34 74.23 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.783 1.655 . . . . 74.450000000000003 110.544 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -71.31 -42.0 69.19 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.84 -1.073 . . . . 73.439999999999998 110.53 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -58.53 -34.74 71.31 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.917 0.389 . . . . 75.319999999999993 111.043 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.57 -56.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.697 -0.683 . . . . 65.299999999999997 110.034 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.45 -25.47 64.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.18 -0.608 . . . . 63.439999999999998 111.901 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.02 94.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.202 0.525 . . . . 73.129999999999995 109.713 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.15 -37.92 66.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 120.045 -0.662 . . . . 64.140000000000001 109.938 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.28 0.474 . . . . 75.319999999999993 112.28 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -63.68 -29.96 71.13 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.961 0.41 . . . . 75.120000000000005 110.341 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 -69.13 -51.76 35.08 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.446 -0.343 . . . . 73.310000000000002 110.512 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -64.76 -30.87 71.89 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.344 0.403 . . . . 71.430000000000007 110.679 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.74 88.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.131 -0.486 . . . . 64.430000000000007 109.887 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.27 -25.9 61.78 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.818 0.818 . . . . 71.219999999999999 110.787 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.93 -24.91 48.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.268 -0.878 . . . . 74.340000000000003 110.791 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.65 17.01 54.2 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.87 -0.605 . . . . 42.32 112.826 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.2 mm -67.5 131.55 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.059 0.457 . . . . 75.109999999999999 110.943 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -127.91 144.34 51.1 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.654 -0.703 . . . . 64.209999999999994 110.342 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 m -66.76 130.11 42.08 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.512 -1.222 . . . . 74.439999999999998 110.906 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.8 tp -149.12 -166.21 2.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 104.027 -2.583 . . . . 72.319999999999993 104.027 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.447 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 84.6 mm-40 -60.26 155.83 16.83 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.586 0.958 . . . . 71.450000000000003 113.586 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.71 -5.31 44.61 Favored Glycine 0 CA--C 1.507 -0.407 0 CA-C-N 114.991 -1.004 . . . . 64.049999999999997 114.678 -170.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -42.79 51.38 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.29 -0.633 . . . . 74.420000000000002 109.29 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HD3' ' HB3' ' A' ' 99' ' ' GLN . 13.2 ptp180 -165.06 140.69 5.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 112.501 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.89 152.48 20.72 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.117 1.367 . . . . 74.530000000000001 110.282 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 44.9 tp -79.07 127.45 32.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.447 -0.575 . . . . 71.530000000000001 109.447 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -122.26 164.46 25.77 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 123.575 0.75 . . . . 73.519999999999996 109.419 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -62.04 156.96 46.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.178 2.585 . . . . 73.540000000000006 113.525 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.7 p-10 -128.02 -30.12 2.49 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.342 -0.844 . . . . 63.149999999999999 110.739 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.06 117.55 32.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.165 -1.05 . . . . 71.030000000000001 108.165 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.82 114.14 22.19 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.46 0.648 . . . . 73.239999999999995 110.231 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.11 111.9 37.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.97 -1.014 . . . . 75.030000000000001 108.944 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.97 119.52 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.728 -0.842 . . . . 74.299999999999997 108.728 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 126.58 53.27 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 109.582 -0.525 . . . . 74.109999999999999 109.582 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.45 165.82 16.43 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 122.915 0.486 . . . . 74.510000000000005 110.642 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.08 146.68 50.44 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.734 -1.747 . . . . 62.530000000000001 108.734 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -46.2 -54.96 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.606 0.965 . . . . 75.519999999999996 113.606 -173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -69.06 -29.94 68.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.436 0.532 . . . . 72.25 112.436 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.25 -40.84 62.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.513 -1.291 . . . . 70.209999999999994 107.513 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.03 -34.27 77.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.216 -1.356 . . . . 65.129999999999995 111.891 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -53.79 -37.75 63.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.22 0.533 . . . . 72.239999999999995 111.134 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -85.41 -29.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.664 -0.698 . . . . 73.049999999999997 110.413 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 mt -71.91 -36.79 70.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.367 0.603 . . . . 72.430000000000007 109.962 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.49 12.54 26.74 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.256 -0.884 . . . . 71.019999999999996 112.557 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.32 -10.36 54.61 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.327 -0.62 . . . . 73.319999999999993 109.327 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -139.48 72.48 37.21 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.074 -0.512 . . . . 61.25 111.739 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.69 -28.03 31.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 N-CA-C 108.383 -1.429 . . . . 75.129999999999995 108.383 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.38 -53.67 54.88 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.28 -1.782 . . . . 74.310000000000002 111.343 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.95 -42.88 12.81 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.087 0.773 . . . . 73.349999999999994 113.087 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -76.56 -58.86 3.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.109 0.781 . . . . 73.430000000000007 113.109 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -63.29 -48.52 77.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.854 0.359 . . . . 72.400000000000006 110.998 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -64.87 -44.46 89.62 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 111.256 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -56.49 20.41 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 115.773 -0.649 . . . . 65.129999999999995 112.625 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.27 -32.42 72.24 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 112.301 0.482 . . . . 72.109999999999999 112.301 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.27 86.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 74.319999999999993 111.229 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.564 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -82.1 -25.73 34.22 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.204 0.446 . . . . 75.319999999999993 112.204 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.64 -43.85 65.39 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.486 -0.931 . . . . 65.420000000000002 108.486 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 92' ' ' TYR . 1.2 tm? -67.7 -31.79 71.99 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.769 -0.826 . . . . 74.329999999999998 108.769 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.93 -40.08 94.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 72.120000000000005 110.779 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 29.1 t70 -74.33 -32.87 62.98 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.303 -0.629 . . . . 71.420000000000002 109.303 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.39 -57.6 11.61 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.438 -0.801 . . . . 73.230000000000004 110.191 173.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.3 pt -56.5 -30.08 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 120.995 -0.282 . . . . 72.530000000000001 111.198 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mm-40 -64.75 -45.43 86.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.842 -0.343 . . . . 74.420000000000002 110.926 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 50.3 mt-10 -59.79 -42.55 93.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.711 0.804 . . . . 70.430000000000007 111.895 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -80.64 -13.27 59.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 113.885 1.068 . . . . 74.349999999999994 113.885 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.71 39.41 9.6 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.597 -1.287 . . . . 63.5 112.52 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -112.12 174.45 5.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.519 -0.401 . . . . 73.430000000000007 110.272 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 26.7 pt20 -149.07 171.23 16.74 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.191 0.596 . . . . 72.519999999999996 109.611 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 13.4 t -159.49 178.36 9.97 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.338 -0.986 . . . . 70.420000000000002 108.338 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -101.45 118.62 37.33 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.392 -0.966 . . . . 74.439999999999998 108.392 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.79 -149.46 16.6 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 119.296 -1.431 . . . . 75.310000000000002 111.055 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -118.99 150.57 39.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.878 -1.527 . . . . 74.129999999999995 106.878 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.6 128.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.478 -0.564 . . . . 74.430000000000007 109.478 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.73 149.65 26.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 123.627 0.579 . . . . 74.549999999999997 110.039 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.96 113.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.252 0.549 . . . . 65.219999999999999 110.181 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -119.97 139.66 52.12 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.9 -0.591 . . . . 75.299999999999997 110.285 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.25 143.82 42.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.356 -0.609 . . . . 72.420000000000002 109.356 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.28 171.49 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.886 0.374 . . . . 71.200000000000003 111.653 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.88 159.54 15.56 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.785 -0.643 . . . . 72.239999999999995 110.875 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.2 p -143.74 141.78 30.63 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.496 -0.775 . . . . 75.239999999999995 109.229 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -81.36 -26.77 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.272 0.558 . . . . 75.230000000000004 110.809 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -77.86 -30.39 50.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.655 -0.702 . . . . 72.129999999999995 111.991 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.72 150.7 26.57 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.904 -0.718 . . . . 74.230000000000004 111.518 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 118' ' ' GLN . 84.8 m-70 -97.1 173.54 7.2 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.939 -1.028 . . . . 73.019999999999996 110.606 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 130.58 42.12 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.239 -1.393 . . . . 75.430000000000007 107.239 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.87 -3.87 82.04 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.805 -0.712 . . . . 73.230000000000004 111.903 -174.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 5.2 tp-100 -101.54 119.8 39.32 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.088 -1.449 . . . . 74.510000000000005 107.088 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.9 157.15 46.16 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.69 -0.804 . . . . 75.200000000000003 112.106 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -145.38 143.31 30.04 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.439 -1.255 . . . . 75.349999999999994 107.81 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.56 139.12 45.15 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 105.511 -2.033 . . . . 75.129999999999995 105.511 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -129.25 127.49 41.33 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.99 -0.684 . . . . 73.140000000000001 109.999 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.33 117.47 5.87 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.297 -1.521 . . . . 61.43 109.297 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 90.4 m -121.16 145.82 47.42 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 122.767 0.427 . . . . 74.409999999999997 110.019 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.52 110.07 22.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -108.45 104.12 53.12 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 109.693 -0.484 . . . . 75.120000000000005 109.693 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.51 3.43 5.35 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.38 2.054 . . . . 75.439999999999998 110.893 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -96.59 71.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.398 1.094 . . . . 74.019999999999996 109.834 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.99 121.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.482 -1.69 . . . . 74.329999999999998 106.548 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -73.31 143.88 46.79 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.242 -0.651 . . . . 75.430000000000007 109.242 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -88.46 116.3 26.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.976 -1.12 . . . . 73.510000000000005 107.976 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 107.19 -1.411 . . . . 73.420000000000002 107.19 -177.023 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.634 0.254 . . . . 72.319999999999993 110.651 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.19 166.38 40.38 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.872 -1.291 . . . . 72.219999999999999 109.872 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -79.93 -68.52 0.66 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.936 -0.705 . . . . 74.239999999999995 109.183 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 61.81 -0.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.046 1.339 . . . . 75.219999999999999 114.204 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -71.84 129.97 39.93 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.448 0.642 . . . . 72.0 110.991 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -84.7 88.64 7.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.529 -0.759 . . . . 74.140000000000001 110.537 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.76 92.87 9.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.334 -0.987 . . . . 74.25 108.334 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 m -80.73 81.63 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 122.425 1.107 . . . . 74.519999999999996 110.434 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.88 140.58 45.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.815 -1.084 . . . . 75.109999999999999 110.165 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -84.15 89.63 7.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.72 -0.844 . . . . 74.140000000000001 108.72 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 p -130.93 117.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.356 -0.838 . . . . 74.430000000000007 109.084 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.27 146.27 24.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.938 -0.574 . . . . 73.319999999999993 112.229 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -159.38 173.19 16.63 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.742 -0.836 . . . . 72.409999999999997 108.742 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.12 174.72 10.26 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.323 -0.991 . . . . 74.319999999999993 108.323 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 tp -86.13 -43.25 13.2 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.147 -1.797 . . . . 75.209999999999994 106.147 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 81.03 2.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.142 -1.39 . . . . 74.200000000000003 109.493 177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -89.78 -32.02 17.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.134 -0.626 . . . . 74.140000000000001 109.98 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.6 m -86.2 123.68 31.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.248 -0.887 . . . . 74.239999999999995 109.286 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.63 101.11 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 116.186 -0.461 . . . . 63.119999999999997 109.878 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.79 97.37 0.18 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.653 -0.703 . . . . 71.239999999999995 111.983 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -162.38 151.95 15.92 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.298 -1.371 . . . . 73.120000000000005 107.298 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -58.72 -59.86 4.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 124.107 0.879 . . . . 74.239999999999995 111.581 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.41 -35.8 78.17 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.644 -0.253 . . . . 75.510000000000005 111.345 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.41 79.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.129999999999995 111.643 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 10.4 ptp180 -81.1 -28.41 35.22 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 121.001 -0.28 . . . . 74.310000000000002 111.064 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 22' ' ' ALA . 80.1 mt -63.23 -50.21 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 110.013 -0.366 . . . . 74.140000000000001 110.013 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -81.3 -28.24 34.71 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.125 0.488 . . . . 73.319999999999993 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.86 -48.94 3.3 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 111.184 -0.767 . . . . 75.420000000000002 111.184 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.22 24.35 3.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 115.042 0.777 . . . . 70.209999999999994 115.042 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t 67.58 27.36 7.81 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.47 0.635 . . . . 74.230000000000004 111.418 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.16 121.06 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.553 -0.906 . . . . 75.230000000000004 108.553 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 m -125.64 162.26 45.91 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.051 -0.722 . . . . 75.209999999999994 109.051 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.3 -21.51 52.94 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.003 2.468 . . . . 65.200000000000003 112.02 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -62.84 -34.34 77.13 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.606 -0.725 . . . . 75.5 111.071 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -60.02 -44.1 94.83 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.98 0.895 . . . . 75.519999999999996 109.198 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.5 t -63.18 -55.87 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.772 -1.558 . . . . 70.200000000000003 110.74 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 pt-20 -64.44 -34.01 77.2 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.391 -0.523 . . . . 75.219999999999999 111.735 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.3 91.01 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.919 -0.401 . . . . 62.520000000000003 109.919 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.96 -38.46 72.8 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.304 -0.407 . . . . 74.409999999999997 110.444 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.9 mt -60.34 -47.65 85.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.908 0.336 . . . . 75.109999999999999 111.908 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.2 ptm180 -71.58 -30.62 66.04 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 120.552 -0.459 . . . . 75.230000000000004 111.034 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -68.13 -41.43 81.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 74.219999999999999 109.269 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -64.51 -43.94 92.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.081 -0.963 . . . . 74.219999999999999 109.024 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.75 76.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 65.340000000000003 110.654 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.42 71.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 62.25 112.64 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.39 -13.54 24.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.969 -1.092 . . . . 74.439999999999998 110.661 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.16 3.42 76.49 Favored Glycine 0 CA--C 1.502 -0.749 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.86 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 56' ' ' LEU . 20.4 mm -55.55 127.67 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 C-N-CA 124.39 1.076 . . . . 73.230000000000004 111.028 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 35.2 tt0 -105.45 135.89 46.01 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.449 -1.315 . . . . 73.329999999999998 107.449 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -70.19 122.25 19.12 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.318 -1.364 . . . . 75.019999999999996 107.318 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.1 tp -127.02 -165.59 1.48 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 105.98 -1.859 . . . . 71.329999999999998 105.98 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.532 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.1 mt-30 -53.29 160.37 1.14 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.056 0.543 . . . . 70.349999999999994 111.733 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.77 -10.91 47.65 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 116.124 -0.489 . . . . 72.140000000000001 113.233 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.45 -44.58 74.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.498 -0.186 . . . . 64.099999999999994 110.498 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -171.89 166.59 6.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 113.066 0.765 . . . . 75.329999999999998 113.066 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HB3' HG23 ' A' ' 48' ' ' ILE . 76.8 mt -93.94 151.92 19.21 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 125.17 1.388 . . . . 73.409999999999997 111.401 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 31.0 tp -98.94 130.96 45.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.554 -0.906 . . . . 74.5 108.554 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 156.28 44.67 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 123.539 0.525 . . . . 74.030000000000001 110.424 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.47 154.87 61.42 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.95 2.434 . . . . 74.409999999999997 112.229 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -128.34 -28.09 2.6 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 112.131 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.7 119.15 35.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 120.067 -0.653 . . . . 73.209999999999994 109.703 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -120.14 114.26 21.69 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.406 0.622 . . . . 71.019999999999996 109.792 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.2 mt -102.2 107.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.985 -1.117 . . . . 73.049999999999997 107.985 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.3 mt -102.02 115.28 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.054 -1.091 . . . . 72.150000000000006 108.054 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 16.9 m -109.06 121.83 45.99 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 115.927 -0.579 . . . . 75.219999999999999 110.152 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.03 174.75 5.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.851 1.26 . . . . 72.109999999999999 109.986 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.67 164.9 50.92 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 108.762 -1.735 . . . . 71.219999999999999 108.762 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.26 -33.12 61.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 118.316 1.058 . . . . 72.329999999999998 111.483 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.547 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 41.9 t60 -75.85 -28.5 58.23 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 120.449 -0.501 . . . . 73.239999999999995 109.729 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 33.0 m-20 -75.29 -31.96 60.86 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.145 -0.687 . . . . 74.219999999999999 109.145 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 78' ' ' PRO . 73.2 t80 -62.25 -44.49 96.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.338 -0.846 . . . . 74.230000000000004 110.734 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.57 -30.58 69.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.316 0.579 . . . . 73.25 110.771 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 74.3 mmtt -73.14 -24.27 60.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.408 -0.814 . . . . 73.530000000000001 110.647 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 98.4 mt -68.26 -31.62 71.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.056 -1.09 . . . . 74.430000000000007 108.056 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.56 179.76 19.65 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.231 -0.895 . . . . 62.200000000000003 111.621 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.32 -17.27 46.35 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.274 -1.009 . . . . 52.420000000000002 108.274 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -128.98 75.16 80.64 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.902 -1.045 . . . . 75.120000000000005 108.399 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.457 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 23.4 Cg_exo -69.15 -36.37 12.55 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.263 1.975 . . . . 73.530000000000001 111.836 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.511 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 2.8 tp10 -69.35 -12.16 61.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.649 -0.705 . . . . 73.230000000000004 110.631 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.56 -36.66 73.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.016 -0.538 . . . . 72.420000000000002 109.839 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -84.89 -13.18 51.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.912 -0.315 . . . . 72.109999999999999 111.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 19.9 m -61.1 -40.96 95.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 65.140000000000001 110.453 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -67.86 -29.09 68.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.785 -0.643 . . . . 73.239999999999995 110.007 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.3 91.89 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.425 -1.07 . . . . 61.439999999999998 110.425 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -68.65 -32.43 72.27 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 111.688 0.255 . . . . 70.129999999999995 111.688 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.69 -44.78 96.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 110.333 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -67.79 -44.15 78.07 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.528 -0.76 . . . . 64.329999999999998 110.625 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.77 -38.07 89.75 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.302 -0.408 . . . . 70.420000000000002 111.237 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.3 -41.79 72.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.439 -0.578 . . . . 75.129999999999995 109.439 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.63 90.68 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.439 0.638 . . . . 73.409999999999997 109.468 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.86 -53.62 55.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.481 -1.236 . . . . 74.219999999999999 108.779 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.627 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.5 m-85 -51.06 -55.37 17.89 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.924 0.713 . . . . 73.430000000000007 112.924 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -62.16 -37.22 77.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 112.618 0.599 . . . . 72.450000000000003 112.618 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -71.74 -35.25 70.08 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.904 -0.319 . . . . 74.409999999999997 111.024 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.87 -31.98 73.46 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.261 0.553 . . . . 74.329999999999998 111.235 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.0 mm-40 -79.45 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.024 -0.534 . . . . 73.319999999999993 110.969 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.46 21.28 32.4 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.218 -0.515 . . . . 72.25 112.033 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -102.99 172.1 7.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.747 -0.834 . . . . 75.019999999999996 108.747 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -140.74 173.91 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.143 -0.688 . . . . 70.439999999999998 109.143 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.403 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 9.3 t -148.98 171.28 16.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.609 -0.886 . . . . 75.230000000000004 108.609 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.43 121.05 42.37 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 109.476 -0.565 . . . . 73.010000000000005 109.476 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -150.06 17.05 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 109.516 -1.434 . . . . 73.230000000000004 109.516 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -119.42 143.48 47.46 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.915 -1.143 . . . . 73.040000000000006 107.915 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.9 t -74.66 118.12 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.173 -0.677 . . . . 75.510000000000005 109.173 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.8 120.23 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-O 122.131 0.967 . . . . 75.340000000000003 110.305 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.9 t -115.33 137.47 48.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 106.297 -1.742 . . . . 74.150000000000006 106.297 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -141.18 139.31 33.84 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.47 0.481 . . . . 74.5 111.859 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -108.72 114.23 27.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 74.129999999999995 108.588 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.1 pt-20 -135.61 165.5 25.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.743 -0.208 . . . . 74.340000000000003 110.793 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.18 165.59 10.93 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 114.612 1.338 . . . . 72.310000000000002 114.612 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -134.22 141.69 47.12 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.541 -1.651 . . . . 71.019999999999996 106.541 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -80.7 -16.66 53.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.516 0.674 . . . . 74.430000000000007 110.295 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -83.49 -30.44 27.17 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 64.319999999999993 110.554 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.22 133.06 37.78 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.915 -0.584 . . . . 73.530000000000001 110.948 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.52 159.52 14.87 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.452 -0.794 . . . . 75.239999999999995 109.012 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.446 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 8.1 m -52.4 117.85 3.14 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 124.409 1.068 . . . . 74.230000000000004 111.863 -176.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.75 -1.84 28.93 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.938 -0.649 . . . . 74.209999999999994 112.842 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.21 123.87 50.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.925 0.393 . . . . 73.219999999999999 111.29 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -131.18 150.75 52.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.861 -0.792 . . . . 70.510000000000005 108.861 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -142.22 132.74 25.22 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.754 -0.832 . . . . 73.340000000000003 108.754 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.04 122.72 41.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.709 -0.848 . . . . 73.219999999999999 108.709 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.8 tpm_? -111.93 121.54 45.3 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.886 -0.783 . . . . 62.32 108.886 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -110.74 130.01 9.59 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 110.98 -0.848 . . . . 64.329999999999998 110.98 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.9 t -135.9 163.29 30.58 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.601 -0.518 . . . . 64.349999999999994 109.601 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.15 107.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.773 -0.825 . . . . 74.129999999999995 108.773 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -116.39 99.68 52.91 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 109.649 -0.501 . . . . 75.310000000000002 109.649 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.61 -23.97 16.47 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.699 2.266 . . . . 63.130000000000003 112.429 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -86.73 66.85 9.65 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.123 0.963 . . . . 73.219999999999999 112.479 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.83 98.0 6.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.586 -2.005 . . . . 74.430000000000007 105.586 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.31 96.49 2.83 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.009 -0.996 . . . . 72.25 110.512 -175.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -91.15 163.05 14.41 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.582 -1.19 . . . . 73.239999999999995 110.033 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.8 t60 . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 106.955 -1.498 . . . . 72.310000000000002 106.955 176.183 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.674 -0.491 . . . . 75.439999999999998 109.674 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.52 54.96 0.19 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.794 -0.923 . . . . 63.130000000000003 110.794 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 m -108.51 82.75 1.66 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.602 0.715 . . . . 63.43 110.534 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -108.69 103.01 12.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.13 -0.941 . . . . 74.439999999999998 108.757 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 147.12 48.65 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.164 -0.615 . . . . 70.299999999999997 110.422 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -125.45 96.13 4.7 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.084 -1.821 . . . . 74.239999999999995 106.084 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.24 97.27 2.41 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.195 0.521 . . . . 74.239999999999995 111.965 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.26 127.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 107.103 -1.443 . . . . 74.5 107.103 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -92.98 -2.68 55.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.229 0.538 . . . . 73.209999999999994 111.498 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -95.84 138.41 33.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.196 -1.409 . . . . 75.239999999999995 107.196 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -82.63 89.69 2.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.47 -1.307 . . . . 74.420000000000002 107.47 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -50.62 110.42 0.41 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.116 -1.402 . . . . 71.450000000000003 111.94 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 118.82 4.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.395 -1.275 . . . . 74.5 110.665 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -88.65 109.29 19.99 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.749 -0.834 . . . . 71.329999999999998 108.749 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 tp -72.63 121.61 20.03 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.358 -0.837 . . . . 62.119999999999997 109.091 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.68 101.56 1.69 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.748 -1.575 . . . . 74.430000000000007 106.748 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -67.72 166.19 15.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.336 -0.847 . . . . 74.219999999999999 110.696 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -56.3 107.26 0.35 Allowed 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.73 0.644 . . . . 75.420000000000002 110.407 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.81 106.81 3.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.78 -0.822 . . . . 75.329999999999998 108.78 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 45.87 1.83 Allowed Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.475 -1.05 . . . . 73.109999999999999 110.475 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 11.2 t70 -135.36 120.87 19.28 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.861 -1.163 . . . . 73.299999999999997 107.861 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.13 92.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.079 0.862 . . . . 62.130000000000003 112.844 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -65.65 -42.64 91.16 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.325 -0.398 . . . . 65.109999999999999 110.184 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.07 72.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 62.130000000000003 111.018 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 25.2 mmm180 -71.65 -47.61 53.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.367 0.603 . . . . 75.420000000000002 109.596 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -53.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.877 -1.056 . . . . 75.400000000000006 112.111 -176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -78.01 -28.98 49.32 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.909 -0.716 . . . . 55.32 111.68 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.04 -14.19 28.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.412 -0.675 . . . . 74.239999999999995 111.412 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.77 99.5 0.19 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 108.033 -2.027 . . . . 71.530000000000001 108.033 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.9 m -43.37 125.81 3.99 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 125.689 1.595 . . . . 54.229999999999997 114.108 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.13 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.395 -1.335 . . . . 70.420000000000002 107.395 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.35 155.21 43.15 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.031 -0.531 . . . . 72.409999999999997 110.587 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.97 -18.41 9.43 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.974 3.116 . . . . 71.549999999999997 113.705 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.85 -30.93 71.62 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.551 -0.295 . . . . 75.5 111.18 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.24 -34.13 74.32 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.457 -0.942 . . . . 63.350000000000001 108.457 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.8 t -68.06 -48.05 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.623 -1.171 . . . . 75.319999999999993 109.96 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -66.33 -33.79 76.52 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.375 -0.53 . . . . 75.549999999999997 110.934 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.73 82.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.566 -0.531 . . . . 61.0 109.566 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.16 -32.94 74.68 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.31 -0.859 . . . . 74.099999999999994 111.844 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 80.9 mt -69.74 -38.44 76.83 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.06 0.225 . . . . 73.519999999999996 111.19 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 74.9 mtm180 -62.68 -43.23 99.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.538 -0.912 . . . . 73.040000000000006 108.538 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -40.66 90.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.0 -1.0 . . . . 75.409999999999997 111.698 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -60.47 -46.47 89.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.425 0.69 . . . . 61.229999999999997 109.845 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.36 92.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.482 -0.781 . . . . 73.349999999999994 110.83 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.35 68.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 62.219999999999999 111.888 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.03 -35.87 31.32 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.11 -0.369 . . . . 73.219999999999999 111.121 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.99 13.73 52.69 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.814 -0.63 . . . . 62.149999999999999 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.6 mm -55.88 137.03 17.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 123.43 0.692 . . . . 75.099999999999994 111.978 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.0 tt0 -119.56 132.97 55.86 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.25 -1.389 . . . . 72.030000000000001 107.25 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -66.51 134.89 53.34 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 121.684 0.754 . . . . 74.219999999999999 109.992 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.2 tp -149.7 -165.53 2.3 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 103.096 -2.928 . . . . 75.319999999999993 103.096 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 76.5 mt-30 -54.52 146.36 16.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.083 0.856 . . . . 74.239999999999995 109.506 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.87 -12.92 58.41 Favored Glycine 0 C--O 1.237 0.333 0 CA-C-N 116.773 -0.194 . . . . 72.319999999999993 113.114 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.85 -40.02 93.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.208 -0.664 . . . . 72.310000000000002 109.208 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -167.94 132.83 1.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.416 -0.811 . . . . 73.540000000000006 110.885 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.76 152.17 20.91 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 124.692 1.197 . . . . 73.140000000000001 109.641 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.84 122.14 31.93 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.482 -1.303 . . . . 73.530000000000001 107.482 -174.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.3 160.16 26.98 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.33 -0.619 . . . . 72.430000000000007 109.33 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.66 151.08 72.62 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 111.049 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 5.3 p-10 -123.24 -27.59 4.12 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.415 -0.514 . . . . 72.319999999999993 111.46 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -106.03 110.91 23.33 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.098 -1.075 . . . . 74.349999999999994 108.098 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.91 131.73 54.8 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.225 -0.443 . . . . 74.099999999999994 109.892 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -121.84 111.73 32.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.613 -0.514 . . . . 74.329999999999998 109.613 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.17 109.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.978 -1.489 . . . . 74.209999999999994 106.978 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -112.94 126.48 55.53 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.088 -0.708 . . . . 73.099999999999994 109.088 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.22 156.14 18.39 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.377 -0.972 . . . . 74.5 108.377 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.64 146.73 50.53 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 109.323 -1.511 . . . . 74.230000000000004 109.323 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.47 HG22 ' NE2' ' A' ' 110' ' ' GLN . 3.3 p -53.83 -40.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 112.516 0.562 . . . . 75.219999999999999 112.516 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.504 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 23.9 t60 -62.17 -33.37 74.38 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 123.336 0.654 . . . . 70.450000000000003 111.004 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.51 -44.33 12.79 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.619 0.247 . . . . 73.439999999999998 111.011 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -66.28 -34.89 79.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 111.957 0.355 . . . . 73.230000000000004 111.957 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.9 pt-20 -63.45 -31.87 73.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.187 0.518 . . . . 74.409999999999997 110.671 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 46.3 mmtm -73.52 -28.1 61.72 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.603 -0.726 . . . . 74.519999999999996 109.869 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.43 -39.11 71.25 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.996 -0.742 . . . . 73.530000000000001 108.996 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.85 175.02 15.59 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.217 -0.753 . . . . 75.219999999999999 111.217 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -94.62 1.25 55.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.712 0.291 . . . . 71.329999999999998 111.236 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.9 95.65 8.07 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.852 1.056 . . . . 71.239999999999995 113.852 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.3 Cg_exo -76.8 -43.78 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.886 2.391 . . . . 64.140000000000001 112.116 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.687 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 44.5 tt0 -63.88 -29.98 71.12 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.016 0.747 . . . . 74.340000000000003 113.016 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.65 -24.23 67.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.974 -0.557 . . . . 73.239999999999995 110.456 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -99.88 -36.75 9.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 111.411 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.687 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 23.2 p -66.32 -45.39 80.44 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.375 0.509 . . . . 75.030000000000001 112.375 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.9 m -67.31 -39.85 85.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.522 -0.471 . . . . 74.019999999999996 110.925 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.0 -51.29 52.49 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.956 -0.566 . . . . 74.319999999999993 111.774 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.92 -30.66 70.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.635 0.605 . . . . 74.109999999999999 112.635 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.447 ' HB3' HG13 ' A' ' 106' ' ' VAL . . . -65.47 -48.05 73.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 120.907 0.384 . . . . 75.219999999999999 110.151 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -67.54 -38.02 83.56 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.56 -0.746 . . . . 72.420000000000002 109.822 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.57 -47.07 80.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.498 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.1 tp -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 65.510000000000005 110.832 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.19 93.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.108 -0.701 . . . . 61.229999999999997 109.108 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.3 t70 -62.59 -44.46 96.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.167 -0.924 . . . . 72.299999999999997 109.636 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.551 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -55.23 -54.25 45.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.786 0.679 . . . . 70.219999999999999 112.42 175.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -62.35 -32.95 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.163 0.506 . . . . 70.409999999999997 111.213 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -64.93 -41.89 95.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.699 -0.682 . . . . 75.340000000000003 110.723 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.0 mt-10 -62.99 -39.19 94.0 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.293 0.568 . . . . 71.150000000000006 111.032 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 76.9 mm-40 -73.57 -14.24 61.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.321 -0.854 . . . . 65.420000000000002 112.336 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 38.21 13.48 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.217 -0.992 . . . . 74.400000000000006 110.972 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -115.18 -178.95 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.271 -0.641 . . . . 74.409999999999997 109.271 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -157.21 178.34 10.45 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.771 -0.825 . . . . 74.420000000000002 108.771 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 11.2 t -156.7 173.57 16.76 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.538 -0.912 . . . . 71.530000000000001 108.538 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.0 m-85 -115.93 124.02 49.54 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 109.306 -0.628 . . . . 74.200000000000003 109.306 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -149.45 18.18 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.115 -1.194 . . . . 71.219999999999999 110.115 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.32 142.74 44.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.749 -0.834 . . . . 74.209999999999994 108.749 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.04 104.0 11.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.296 -1.372 . . . . 74.340000000000003 107.296 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 p -125.84 120.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.733 0.778 . . . . 75.010000000000005 110.434 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 86' ' ' ALA . 7.3 p -110.91 127.87 67.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.108 -1.071 . . . . 64.109999999999999 108.108 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -106.22 132.74 51.92 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.361 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -115.26 114.29 25.0 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.265 -2.124 . . . . 72.140000000000001 105.265 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.02 173.24 12.63 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.239 0.542 . . . . 72.129999999999995 111.893 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.47 ' NE2' HG22 ' A' ' 68' ' ' VAL . 16.1 pt20 -119.86 164.84 15.42 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.903 -1.044 . . . . 73.409999999999997 109.762 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.7 t -143.88 141.42 30.28 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.804 -1.554 . . . . 74.030000000000001 106.804 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -81.01 -16.61 52.91 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.049 -1.093 . . . . 71.129999999999995 108.049 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -82.57 -4.34 57.48 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.049 -0.978 . . . . 74.409999999999997 110.793 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.73 131.05 56.33 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.112 -1.07 . . . . 72.310000000000002 108.112 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 40.2 m80 -100.72 172.35 7.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.587 -0.279 . . . . 64.450000000000003 111.388 -175.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.7 t -68.3 145.31 54.34 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.171 0.51 . . . . 74.239999999999995 110.635 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.65 -4.89 76.56 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.097 -1.201 . . . . 72.400000000000006 110.097 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 52.4 mt-30 -119.74 133.22 55.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.987 0.915 . . . . 72.530000000000001 109.335 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -159.9 157.0 28.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.136 -1.431 . . . . 74.409999999999997 107.136 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -135.84 153.92 51.34 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.581 -0.525 . . . . 72.25 109.581 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.08 118.03 11.15 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.264 -2.124 . . . . 52.439999999999998 105.264 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.99 137.41 21.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.402 -0.962 . . . . 73.439999999999998 108.402 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.65 142.56 17.3 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.501 -1.04 . . . . 65.530000000000001 110.501 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.8 t -136.05 156.7 48.34 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.275 -0.639 . . . . 75.299999999999997 109.275 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.33 110.11 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.564 -0.902 . . . . 73.0 108.564 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -130.91 91.93 35.32 Favored Pre-proline 0 C--N 1.292 -1.895 0 N-CA-C 108.043 -1.095 . . . . 75.430000000000007 108.043 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 51.2 Cg_endo -72.18 -15.13 28.79 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.031 1.82 . . . . 72.120000000000005 111.334 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.62 65.16 9.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.599 1.19 . . . . 72.239999999999995 111.533 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 p -136.29 127.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-N 113.11 -1.859 . . . . 75.349999999999994 106.288 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.73 118.17 11.38 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 110.268 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 131' ' ' THR . 9.0 t -122.4 88.4 2.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.882 1.325 . . . . 71.010000000000005 111.992 -173.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 106.935 -1.505 . . . . 73.430000000000007 106.935 176.926 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.503 -0.861 0 N-CA-C 110.224 -0.287 . . . . 75.109999999999999 110.224 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.97 149.02 5.47 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.994 -1.642 . . . . 74.049999999999997 108.994 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 m -85.06 89.5 7.63 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.812 0.815 . . . . 75.310000000000002 110.1 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -103.24 123.6 47.05 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.191 -0.913 . . . . 74.019999999999996 109.598 -178.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -171.59 159.07 5.32 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.976 -1.49 . . . . 75.530000000000001 106.976 175.724 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -101.44 109.75 21.63 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.92 -1.141 . . . . 74.120000000000005 107.92 176.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -81.76 87.86 6.31 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.791 -2.3 . . . . 70.340000000000003 104.791 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG21 ' HG3' ' A' ' 10' ' ' ARG . 10.7 p -92.53 129.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 114.74 -1.118 . . . . 64.349999999999994 109.954 -174.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -110.49 24.96 12.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.748 -0.66 . . . . 72.239999999999995 112.277 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 10' ' ' ARG 0.321 0.0 OUTLIER -83.63 105.31 14.44 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 118.616 -1.233 . . . . 71.510000000000005 111.076 173.61 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.61 127.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.445 -0.798 . . . . 72.030000000000001 110.14 -178.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.39 150.31 29.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 109.018 -0.734 . . . . 73.120000000000005 109.018 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 150.25 50.0 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.12 -0.491 . . . . 74.109999999999999 109.996 -178.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -166.22 152.59 9.12 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 106.244 -1.761 . . . . 72.430000000000007 106.244 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.85 74.94 8.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.349 -1.352 . . . . 74.319999999999993 107.349 171.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.511 ' OE1' ' HG2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -105.59 163.03 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.15 -1.387 . . . . 74.010000000000005 109.163 -174.273 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.511 ' HG2' ' OE1' ' A' ' 16' ' ' GLU . 12.7 pt20 -79.72 147.12 32.05 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.031 -0.531 . . . . 75.019999999999996 110.562 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -77.79 106.07 9.38 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.104 -0.498 . . . . 71.25 110.754 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t -85.34 123.9 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 107.041 -1.466 . . . . 73.530000000000001 107.041 178.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 33' ' ' PRO . . . 83.35 36.31 14.93 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 108.5 -1.84 . . . . 73.030000000000001 108.5 -172.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 18.5 t70 -54.64 -37.67 65.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.059 0.944 . . . . 64.420000000000002 111.76 -176.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -60.58 -44.87 95.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 110.395 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -65.83 -41.2 92.07 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.751 -0.659 . . . . 74.430000000000007 110.293 178.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -48.13 77.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 75.239999999999995 111.195 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 20.6 ptt85 -74.03 -26.03 60.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.177 0.806 . . . . 75.409999999999997 113.177 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.7 mt -71.36 -37.69 66.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 109.305 -0.628 . . . . 72.430000000000007 109.305 173.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.47 -28.62 59.31 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.053 -0.522 . . . . 64.200000000000003 109.82 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.18 -86.14 0.77 Allowed Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 121.132 -0.556 . . . . 72.209999999999994 112.472 175.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.17 -21.76 40.6 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 121.126 -0.559 . . . . 63.409999999999997 113.511 -176.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 m -74.44 107.86 6.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.345 0.593 . . . . 63.32 110.48 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.1 pt -84.16 -25.92 7.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 114.914 1.45 . . . . 72.510000000000005 114.914 -173.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.46 96.39 49.81 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 120.062 -0.655 . . . . 75.049999999999997 111.827 -177.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HG2' ' O ' ' A' ' 20' ' ' GLY . 5.3 Cg_exo -87.08 -23.3 1.56 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.762 2.308 . . . . 74.209999999999994 111.708 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.4 -17.41 64.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.728 -0.669 . . . . 72.439999999999998 112.359 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.14 -25.58 68.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.296 -0.411 . . . . 64.219999999999999 110.501 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.16 -47.47 92.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 116.282 -0.417 . . . . 72.329999999999998 110.438 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 48.5 mt-10 -63.47 -48.24 78.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.794 0.331 . . . . 72.099999999999994 110.534 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.17 86.32 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.402 -0.817 . . . . 75.540000000000006 111.865 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.54 -33.68 62.79 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.379 -0.373 . . . . 73.129999999999995 110.539 -178.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -73.57 -36.67 65.62 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.457 -0.497 . . . . 71.400000000000006 111.03 -177.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -71.76 -25.21 61.95 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.377 -0.929 . . . . 74.510000000000005 110.368 175.587 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -68.78 -37.33 79.23 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 107.981 -1.118 . . . . 73.109999999999999 107.981 175.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -68.49 -40.07 81.04 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.37 -0.832 . . . . 75.340000000000003 109.49 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.01 93.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.047 -0.524 . . . . 72.239999999999995 110.834 177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.28 58.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.974 -0.557 . . . . 65.099999999999994 111.189 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.8 -33.69 57.99 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.488 0.661 . . . . 72.430000000000007 109.715 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.33 8.13 59.08 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.202 -0.908 . . . . 74.430000000000007 113.59 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD13 ' CE2' ' A' ' 98' ' ' TRP . 9.5 mm -56.44 135.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 123.434 0.693 . . . . 73.540000000000006 111.537 177.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 19.0 tt0 -124.52 142.86 51.02 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 108.216 -1.031 . . . . 73.439999999999998 108.216 -177.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 m -76.48 131.8 39.23 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.698 -0.683 . . . . 65.340000000000003 110.995 -177.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.2 tp -148.06 -168.99 3.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 105.174 -2.158 . . . . 74.430000000000007 105.174 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.567 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.43 140.43 7.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.439 1.096 . . . . 65.5 110.542 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.2 24.76 0.87 Allowed Glycine 0 C--N 1.316 -0.551 0 C-N-CA 123.457 0.551 . . . . 63.229999999999997 114.465 -173.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 52' ' ' GLN . 91.1 m-20 -85.16 -38.75 18.67 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.638 -1.616 . . . . 72.519999999999996 106.638 173.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 3.1 ptp180 -174.22 160.24 3.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.407 -1.27 . . . . 74.299999999999997 110.173 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.51 152.38 20.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 123.826 0.851 . . . . 74.209999999999994 111.131 -173.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.437 HD21 HD21 ' A' ' 51' ' ' LEU . 2.0 tm? -92.89 121.79 34.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.608 -1.627 . . . . 74.340000000000003 106.608 -176.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.78 158.24 32.82 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 109.629 -0.508 . . . . 54.420000000000002 109.629 -177.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.35 156.78 58.07 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.427 2.085 . . . . 72.450000000000003 112.266 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -125.18 -22.58 4.37 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.922 -0.581 . . . . 73.420000000000002 110.563 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 11.4 tp10 -94.02 106.36 18.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.644 -1.243 . . . . 72.109999999999999 107.644 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -122.43 114.54 20.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.468 0.651 . . . . 75.450000000000003 111.011 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.52 122.55 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.55 -0.907 . . . . 74.230000000000004 108.55 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -116.25 117.3 55.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.761 -0.829 . . . . 74.439999999999998 108.761 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.3 m -103.47 116.78 33.05 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.775 -0.648 . . . . 75.450000000000003 109.39 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.07 175.04 5.61 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.963 -0.562 . . . . 74.099999999999994 110.027 178.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.18 145.05 32.86 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.11 -0.796 . . . . 75.349999999999994 111.11 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.52 -24.62 36.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.381 0.61 . . . . 75.239999999999995 110.044 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.484 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 52.8 t-80 -55.28 -51.86 65.31 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.051 -0.977 . . . . 74.439999999999998 110.32 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 73' ' ' LYS 0.261 2.6 m-20 -87.23 -20.02 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.938 1.088 . . . . 70.400000000000006 113.938 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.431 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 36.6 t80 -61.97 -33.25 73.96 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.43 -0.35 . . . . 74.310000000000002 110.529 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 11.2 pt-20 -66.28 -26.25 67.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 73.510000000000005 111.52 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -70.51 -33.46 71.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.215 -0.902 . . . . 74.340000000000003 109.099 174.471 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.78 -37.01 76.19 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.991 0.901 . . . . 72.409999999999997 108.688 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.19 -157.88 15.56 Favored Glycine 0 N--CA 1.425 -2.089 0 CA-C-N 114.839 -1.073 . . . . 70.109999999999999 111.304 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.79 18.66 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.035 0.445 . . . . 71.0 110.263 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.58 109.81 61.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.963 -0.562 . . . . 71.329999999999998 111.04 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.1 -39.46 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 121.754 1.636 . . . . 63.240000000000002 112.399 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -58.34 -38.94 78.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 116.232 1.938 . . . . 72.129999999999995 116.232 -164.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.65 -37.26 83.38 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.611 0.719 . . . . 72.239999999999995 110.185 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -86.12 -25.02 26.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.785 -0.643 . . . . 72.310000000000002 110.139 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.7 m -65.67 -33.36 75.7 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.603 -0.726 . . . . 72.540000000000006 109.305 175.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -63.08 -44.27 96.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.420000000000002 109.732 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.23 95.29 Favored Glycine 0 C--O 1.243 0.675 0 C-N-CA 120.855 -0.688 . . . . 74.219999999999999 111.798 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.17 -33.03 67.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.327 -0.62 . . . . 74.540000000000006 109.327 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.6 93.47 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.284 -0.416 . . . . 73.540000000000006 110.688 177.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.56 -41.44 94.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.266 0.555 . . . . 75.140000000000001 110.745 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -71.24 -36.61 71.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.734 -0.667 . . . . 71.209999999999994 110.551 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.19 -33.84 75.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.015 0.436 . . . . 74.530000000000001 110.187 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.08 79.19 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.284 -0.635 . . . . 72.230000000000004 109.284 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.45 -46.61 79.21 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.559 -0.746 . . . . 74.040000000000006 109.515 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.611 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 37.1 m-85 -54.57 -49.85 69.36 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 112.581 0.586 . . . . 72.120000000000005 112.581 176.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.9 pt -67.1 -32.51 58.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 C-N-CA 119.818 -0.753 . . . . 74.049999999999997 111.884 -177.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.53 -42.61 95.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.27 0.557 . . . . 74.519999999999996 109.76 174.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -65.93 -31.89 73.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 74.310000000000002 112.315 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 65.2 mm-40 -84.94 -13.28 51.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.315 0.579 . . . . 73.549999999999997 110.512 176.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.16 35.36 53.42 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.239 -0.891 . . . . 72.030000000000001 113.459 176.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.455 ' CE2' HD13 ' A' ' 48' ' ' ILE . 15.6 m0 -97.96 168.26 10.4 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.18 0.49 . . . . 64.239999999999995 110.401 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.451 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.5 pt20 -130.43 167.42 18.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.423 -0.584 . . . . 75.540000000000006 109.423 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -161.61 177.88 9.57 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.005 -0.739 . . . . 72.120000000000005 109.005 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -119.66 120.73 37.49 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.407 -0.59 . . . . 75.010000000000005 109.407 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -158.42 14.7 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.141 -1.584 . . . . 75.409999999999997 109.141 -175.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.27 151.09 37.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.616 -1.253 . . . . 71.099999999999994 107.616 176.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.69 121.62 18.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 120.949 0.404 . . . . 72.219999999999999 110.453 -177.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.34 120.27 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 121.881 0.848 . . . . 43.039999999999999 110.128 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.0 t -119.13 124.01 72.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.84 -1.541 . . . . 74.230000000000004 106.84 177.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -132.79 136.21 46.17 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.05 0.452 . . . . 75.0 110.996 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 94.8 m-85 -104.01 141.26 36.5 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.337 -0.847 . . . . 65.439999999999998 108.854 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.85 162.66 34.26 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.562 -0.29 . . . . 71.299999999999997 110.8 176.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.431 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -100.66 150.38 22.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.729 -0.669 . . . . 73.519999999999996 110.997 -176.026 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 31.6 t -129.95 129.27 43.6 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.525 -1.287 . . . . 73.239999999999995 107.525 174.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 t -81.45 -27.69 34.53 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.704 -0.851 . . . . 71.310000000000002 108.704 176.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -68.85 -46.34 68.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.015 -0.993 . . . . 75.420000000000002 110.434 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 118' ' ' GLN . 6.8 tt -84.41 140.47 31.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.833 -1.076 . . . . 74.140000000000001 110.455 -176.381 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -120.01 156.91 29.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.111 -0.7 . . . . 74.230000000000004 109.111 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -55.8 119.45 5.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.705 1.202 . . . . 74.040000000000006 110.538 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.66 -27.22 3.74 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 106.589 -2.604 . . . . 44.520000000000003 106.589 -174.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.45 ' O ' HD21 ' A' ' 114' ' ' LEU . 29.6 tt0 -116.13 146.95 41.84 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 104.806 -2.294 . . . . 72.099999999999994 104.806 172.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -158.37 157.78 33.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.544 -1.28 . . . . 74.420000000000002 107.544 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -130.13 139.35 50.91 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 110.438 -0.208 . . . . 74.5 110.438 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.03 133.37 29.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.027 -1.472 . . . . 55.43 107.027 177.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -134.72 134.82 41.44 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.607 -0.886 . . . . 74.030000000000001 108.607 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -131.1 125.15 4.38 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.113 -1.195 . . . . 61.210000000000001 110.113 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -142.46 173.0 11.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.899 -0.408 . . . . 71.200000000000003 109.899 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.86 110.37 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.284 -0.636 . . . . 75.109999999999999 109.284 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.4 94.55 40.48 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.828 -0.623 . . . . 73.310000000000002 109.329 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.57 -19.27 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.066 1.844 . . . . 75.030000000000001 110.943 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.18 20.37 2.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.319 -0.855 . . . . 72.019999999999996 110.662 -176.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.96 108.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-O 122.265 1.031 . . . . 74.310000000000002 110.44 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.91 143.51 37.65 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 114.614 -1.176 . . . . 74.299999999999997 109.05 177.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 t -126.23 149.35 49.12 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.826 0.346 . . . . 72.349999999999994 111.227 -174.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 . . . . . 0 C--N 1.304 -1.407 0 N-CA-C 106.273 -1.751 . . . . 72.040000000000006 106.273 172.649 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.501 -0.909 0 N-CA-C 108.859 -0.793 . . . . 72.310000000000002 108.859 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.91 55.24 0.55 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 108.938 -1.665 . . . . 70.319999999999993 108.938 178.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -59.94 -44.42 94.39 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.775 0.83 . . . . 74.430000000000007 112.138 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.84 110.23 20.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.536 -0.542 . . . . 70.340000000000003 109.536 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.3 125.77 51.41 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.122 -0.696 . . . . 74.319999999999993 109.122 178.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -94.97 157.16 16.02 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.888 -0.597 . . . . 72.329999999999998 109.916 -174.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 mp 61.56 72.32 0.52 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.996 0.81 . . . . 74.349999999999994 110.907 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.26 83.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.400000000000006 110.24 -176.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.0 126.16 9.23 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.295 -0.866 . . . . 74.340000000000003 108.747 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -92.31 88.1 6.31 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.502 -0.925 . . . . 75.049999999999997 108.502 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -84.65 95.87 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.983 0.897 . . . . 74.409999999999997 111.611 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.93 90.23 3.25 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.513 -1.662 . . . . 73.129999999999995 106.513 175.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -88.73 150.04 23.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.202 -1.363 . . . . 74.310000000000002 111.99 -169.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -110.97 115.86 30.2 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 74.430000000000007 111.213 176.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.44 65.02 0.88 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.345 -1.724 . . . . 75.150000000000006 106.345 173.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.93 145.99 27.94 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.311 -1.313 . . . . 75.420000000000002 110.065 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -122.0 115.63 22.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.652 -0.704 . . . . 72.310000000000002 109.514 179.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.6 m -111.86 128.78 56.23 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.462 -0.94 . . . . 71.439999999999998 108.462 177.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.74 162.94 7.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.06 0.457 . . . . 73.549999999999997 110.902 -178.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.77 29.86 2.32 Favored Glycine 0 C--N 1.299 -1.474 0 N-CA-C 109.285 -1.526 . . . . 62.100000000000001 109.285 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 4.6 p-10 -62.6 -29.65 70.76 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.889 -0.655 . . . . 74.329999999999998 111.141 -176.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.32 93.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.088 0.47 . . . . 74.450000000000003 110.122 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.4 -43.12 91.6 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.463 -0.79 . . . . 74.329999999999998 109.332 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.71 -47.07 87.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.46 -0.791 . . . . 71.510000000000005 111.469 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 37.4 mmt180 -66.66 -37.85 85.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 75.200000000000003 111.643 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.37 -49.82 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 111.946 0.35 . . . . 73.409999999999997 111.946 -178.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.426 ' O ' ' HA3' ' A' ' 117' ' ' GLY . 98.9 m-85 -91.73 -28.58 17.33 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.236 0.828 . . . . 64.010000000000005 113.236 -172.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.59 -69.3 3.04 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 120.395 -0.907 . . . . 72.010000000000005 112.172 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.72 -49.23 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.675 -0.57 . . . . 60.219999999999999 111.675 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 m -79.05 88.95 4.78 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.596 -0.52 . . . . 75.219999999999999 109.596 178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -85.19 -27.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.84 -0.618 . . . . 70.329999999999998 111.237 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.27 136.46 24.53 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 116.235 -0.439 . . . . 62.420000000000002 110.188 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.26 -36.47 46.92 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.528 2.818 . . . . 73.219999999999999 112.21 175.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.32 -9.91 14.01 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.866 1.062 . . . . 63.420000000000002 113.866 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.46 -31.57 71.82 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.822 -0.807 . . . . 74.299999999999997 108.822 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.97 -42.08 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.761 -0.654 . . . . 64.049999999999997 109.282 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.48 -43.14 99.4 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.615 -0.513 . . . . 72.140000000000001 109.615 177.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.9 90.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.299 -0.864 . . . . 60.43 110.97 178.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.85 -44.28 77.52 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.634 -0.427 . . . . 75.010000000000005 110.431 178.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.11 -37.45 87.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.827 0.677 . . . . 72.519999999999996 112.827 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.83 -36.09 82.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 120.036 -0.666 . . . . 75.519999999999996 109.358 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -68.38 -41.89 79.91 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 109.955 176.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.27 -45.02 96.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.734 1.213 . . . . 73.239999999999995 110.14 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.21 97.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.441 -0.799 . . . . 71.400000000000006 110.187 177.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.37 71.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.201 0.524 . . . . 72.430000000000007 111.392 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.13 -21.0 43.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.789 -0.641 . . . . 74.219999999999999 110.733 -178.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.56 19.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.975 -0.557 . . . . 53.32 112.139 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.51 134.73 29.72 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-O 121.272 0.558 . . . . 73.530000000000001 111.868 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 5.0 tp-100 -111.6 132.28 54.67 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.36 -1.348 . . . . 74.5 107.36 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -77.06 93.95 3.94 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.796 0.808 . . . . 75.540000000000006 109.883 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.3 tp -103.08 -165.41 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.119 -1.808 . . . . 72.510000000000005 106.119 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.576 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 2.2 mp0 -42.32 139.01 1.56 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.858 0.863 . . . . 63.340000000000003 111.586 175.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.81 -4.45 14.28 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-N 115.492 -0.777 . . . . 72.200000000000003 114.866 -171.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -72.17 -44.93 62.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.043 -0.354 . . . . 74.140000000000001 110.043 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 32.2 ptt180 -163.73 148.05 10.44 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.206 0.527 . . . . 72.230000000000004 111.373 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.12 151.19 21.09 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.017 -0.992 . . . . 75.409999999999997 111.051 -170.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 43.2 tp -86.35 126.6 34.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.443 -0.799 . . . . 71.409999999999997 109.677 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.3 160.38 31.55 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 124.109 0.881 . . . . 74.010000000000005 108.75 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 78.0 Cg_exo -54.56 153.96 21.66 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.213 2.608 . . . . 74.040000000000006 113.253 176.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 30.5 p-10 -120.09 -34.67 3.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.831 -0.622 . . . . 64.430000000000007 111.133 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -107.64 112.81 25.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.338 -0.616 . . . . 74.439999999999998 109.338 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 53.2 m-85 -109.03 132.0 54.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.671 -0.695 . . . . 72.329999999999998 110.279 -177.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 mm -112.93 117.89 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.582 -0.896 . . . . 72.239999999999995 108.582 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.11 125.83 74.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 -179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -126.89 129.0 47.36 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.427 -0.352 . . . . 74.129999999999995 110.309 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -128.6 178.08 6.57 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.864 -0.607 . . . . 73.420000000000002 109.66 172.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -73.66 168.3 54.06 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.982 -0.847 . . . . 43.329999999999998 110.982 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.4 -40.48 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 117.688 0.744 . . . . 70.010000000000005 112.324 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -66.82 -36.01 81.37 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.88 0.848 . . . . 72.109999999999999 109.234 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -65.43 -51.41 60.45 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.498 -1.228 . . . . 75.409999999999997 109.287 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.08 -42.34 98.32 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.251 -1.34 . . . . 74.109999999999999 111.848 -173.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.54 -35.94 78.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.908 0.385 . . . . 74.040000000000006 111.226 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -74.2 -24.98 59.43 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.086 -0.506 . . . . 72.109999999999999 112.208 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 79.1 mt -72.52 -45.2 60.47 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.885 0.374 . . . . 72.420000000000002 111.281 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.13 40.26 56.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 107.912 -2.075 . . . . 63.310000000000002 107.912 -168.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.26 5.54 51.44 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.121 1.768 . . . . 64.209999999999994 112.09 -172.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -43.05 124.19 3.24 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 124.639 1.212 . . . . 72.400000000000006 110.503 -171.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -38.07 -47.8 2.23 Favored 'Trans proline' 0 C--N 1.373 1.836 1 C-N-CA 125.696 4.264 . . . . 73.439999999999998 116.116 -168.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.51 -17.07 52.68 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.863 -0.735 . . . . 70.230000000000004 112.278 -172.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.98 -56.11 3.63 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.395 0.617 . . . . 75.310000000000002 109.38 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -86.54 -5.5 59.13 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 115.16 1.541 . . . . 74.109999999999999 115.16 -174.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 p -64.97 -62.72 1.39 Allowed 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 119.243 0.929 . . . . 73.329999999999998 111.039 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.9 m -59.02 -40.43 84.94 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.155 0.582 . . . . 73.140000000000001 110.955 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.13 -55.46 9.15 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.907 -0.588 . . . . 52.100000000000001 113.495 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.97 -25.97 56.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.083 0.468 . . . . 75.109999999999999 110.448 -173.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.15 63.48 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.285 -0.566 . . . . 71.310000000000002 109.586 175.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -65.46 -40.74 93.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.133 -1.062 . . . . 72.340000000000003 108.133 175.882 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -59.54 -47.45 85.5 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 116.125 -0.488 . . . . 63.030000000000001 109.927 176.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.26 -37.37 77.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 112.034 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -60.56 -43.09 97.65 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.428 0.633 . . . . 61.240000000000002 109.384 178.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.34 -41.68 97.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.875 -1.057 . . . . 74.400000000000006 109.553 177.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.587 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.3 m-85 -61.26 -53.06 61.6 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.918 -0.583 . . . . 64.530000000000001 112.47 175.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 90' ' ' ALA . 37.7 pt -63.91 -31.07 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.742 0.275 . . . . 75.099999999999994 111.742 -176.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 77.3 mm-40 -65.79 -42.93 90.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.45 -0.574 . . . . 72.010000000000005 109.45 174.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.39 -37.33 83.03 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.052 -0.522 . . . . 73.150000000000006 111.202 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 27.3 mm-40 -77.06 -13.51 59.94 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.771 -0.65 . . . . 72.230000000000004 110.603 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 34.05 28.39 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.931 -0.577 . . . . 73.230000000000004 112.629 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -110.77 161.14 16.08 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.577 -0.527 . . . . 75.400000000000006 109.577 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.412 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -130.72 169.55 15.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.461 -0.57 . . . . 73.239999999999995 109.461 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.6 t -158.28 170.55 21.99 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.675 -0.491 . . . . 74.099999999999994 109.675 178.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.32 122.49 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.854 0.359 . . . . 72.319999999999993 111.029 -176.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 -150.01 17.06 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.391 -1.084 . . . . 51.43 110.391 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.1 137.73 46.54 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.667 -0.864 . . . . 75.239999999999995 108.667 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.53 117.68 19.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.09 -1.078 . . . . 75.200000000000003 108.09 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.33 125.76 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-O 121.831 0.824 . . . . 75.439999999999998 112.02 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.87 124.63 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 106.869 -1.53 . . . . 74.540000000000006 106.869 173.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -115.92 130.51 56.86 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.1 -0.704 . . . . 73.239999999999995 109.1 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -104.34 143.9 32.36 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.048 -0.978 . . . . 73.430000000000007 108.859 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.51 168.53 22.47 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.048 -0.524 . . . . 71.219999999999999 110.065 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -114.82 163.52 15.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.287 0.565 . . . . 74.439999999999998 111.051 -176.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.429 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 43.7 t -145.15 133.17 21.37 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.765 -1.198 . . . . 73.540000000000006 107.765 176.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.2 m -80.99 -19.88 43.04 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.43 0.634 . . . . 74.439999999999998 109.498 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -81.01 -32.82 34.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.404 -0.817 . . . . 73.400000000000006 110.854 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.81 148.68 40.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.623 -0.717 . . . . 64.420000000000002 109.79 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -100.48 157.92 16.29 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.859 0.463 . . . . 74.530000000000001 110.229 -171.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.559 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 71.7 m -66.86 120.74 14.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.744 0.783 . . . . 71.019999999999996 112.688 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 27' ' ' PHE . . . 98.1 -5.86 61.53 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.405 -1.27 . . . . 54.43 111.395 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -107.2 104.73 14.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.026 -1.472 . . . . 74.400000000000006 107.026 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -119.62 157.05 29.24 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.084 -0.507 . . . . 74.209999999999994 111.012 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -134.24 137.45 44.35 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.731 -0.84 . . . . 74.450000000000003 108.731 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.15 125.34 10.77 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.251 -0.648 . . . . 65.140000000000001 109.251 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 -131.18 160.43 34.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 109.646 -0.501 . . . . 73.540000000000006 109.646 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.67 135.73 9.65 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 110.429 -1.068 . . . . 34.43 110.429 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 p -126.04 153.69 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.814 -0.439 . . . . 74.219999999999999 109.814 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.508 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 93.0 t -103.87 107.87 23.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.919 -1.141 . . . . 71.5 107.919 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -98.45 96.95 4.13 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.201 -1.407 . . . . 63.219999999999999 107.201 173.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 72.0 Cg_endo -82.43 -21.66 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.939 1.759 . . . . 74.510000000000005 112.138 -174.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -100.28 70.58 1.53 Allowed 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 122.778 1.275 . . . . 64.200000000000003 107.853 -176.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 p -118.36 129.06 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.84 0 CA-C-N 113.11 -1.859 . . . . 72.329999999999998 107.137 179.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -64.16 142.69 58.32 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.345 -0.843 . . . . 72.329999999999998 111.238 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -121.39 164.92 16.32 Favored 'General case' 0 N--CA 1.417 -2.125 0 N-CA-C 109.041 -0.725 . . . . 72.319999999999993 109.041 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 106.965 -1.495 . . . . 73.099999999999994 106.965 179.876 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 109.121 -0.696 . . . . 72.230000000000004 109.121 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.89 63.29 0.5 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.709 -1.356 . . . . 72.239999999999995 109.709 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 m -78.69 82.69 4.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.319 0.581 . . . . 65.030000000000001 112.479 -175.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -102.96 91.6 4.2 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.244 -2.132 . . . . 72.409999999999997 105.244 171.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.1 169.59 18.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.545 0.943 . . . . 75.310000000000002 113.545 -169.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 177.44 171.1 0.59 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.028 -2.212 . . . . 75.030000000000001 105.028 173.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.31 126.29 30.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.226 -1.398 . . . . 73.540000000000006 107.226 172.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.37 -24.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 120.793 0.33 . . . . 73.400000000000006 110.747 -177.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -77.24 132.68 38.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.74 -0.664 . . . . 72.209999999999994 109.575 178.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -89.97 129.91 36.24 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.33 -2.1 . . . . 73.340000000000003 105.33 174.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.73 109.54 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.037 0.922 . . . . 73.030000000000001 111.826 -174.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -119.34 90.58 3.36 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.065 -0.971 . . . . 73.230000000000004 109.924 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 5.3 ppt_? -97.04 105.05 17.13 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 105.426 -2.064 . . . . 73.329999999999998 105.426 168.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -109.42 116.14 31.26 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.984 -1.007 . . . . 73.409999999999997 112.927 -165.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt 65.22 20.04 11.84 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.778 1.299 . . . . 74.5 110.78 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -94.84 126.81 40.42 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.111 -0.95 . . . . 74.109999999999999 110.792 -175.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -154.9 110.99 3.19 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.59 -1.263 . . . . 75.400000000000006 107.59 174.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 5.0 t -101.53 140.85 35.26 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.33 -1.359 . . . . 71.040000000000006 107.33 176.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 18' ' ' THR . 13.6 p 172.15 169.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 105.318 -2.105 . . . . 71.530000000000001 105.318 -177.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.5 51.65 2.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.522 0.601 . . . . 74.450000000000003 112.612 177.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 24.7 t70 -67.17 -35.17 79.11 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.419 0.687 . . . . 64.420000000000002 109.395 -178.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.44 -46.29 83.76 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.813 -1.085 . . . . 63.32 110.272 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -67.25 -35.11 78.85 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 110.636 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.73 76.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.791 0.329 . . . . 74.209999999999994 110.456 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.573 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 31.9 mtm-85 -74.44 -32.52 62.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.253 -0.431 . . . . 74.430000000000007 110.382 178.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.4 mt -73.37 -54.73 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.107 -0.497 . . . . 73.329999999999998 110.71 178.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.59 -27.78 62.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.966 0.728 . . . . 75.049999999999997 112.966 -175.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 -96.35 0.18 Allowed Glycine 0 N--CA 1.441 -1.027 0 O-C-N 123.785 0.678 . . . . 74.349999999999994 112.814 177.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.45 9.22 5.31 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.116 -0.542 . . . . 63.229999999999997 112.449 -178.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.6 t -80.32 -86.13 0.08 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.484 0.642 . . . . 65.150000000000006 109.398 179.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.93 93.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 106.224 -1.769 . . . . 74.209999999999994 106.224 175.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.37 121.67 85.33 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 116.188 -0.46 . . . . 64.049999999999997 111.228 -173.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 -2.48 8.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.216 2.61 . . . . 73.140000000000001 114.082 -176.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -67.61 -23.25 65.35 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.613 -0.514 . . . . 74.030000000000001 109.613 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -69.3 -42.47 75.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.494 -0.928 . . . . 70.310000000000002 108.494 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.31 -46.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.389 -0.967 . . . . 65.239999999999995 108.389 177.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 23.5 mm-40 -52.02 -52.32 51.57 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.436 -0.802 . . . . 73.319999999999993 111.828 175.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.02 -53.96 49.06 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.8 0.688 . . . . 74.219999999999999 111.355 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.05 -42.18 97.12 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.317 0.488 . . . . 65.109999999999999 112.317 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.3 -47.05 77.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.828 0.677 . . . . 75.409999999999997 112.828 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 7.5 ptp180 -70.82 -32.84 70.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 120.428 -0.509 . . . . 73.209999999999994 110.486 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -67.17 -46.58 73.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.905 -0.406 . . . . 70.439999999999998 109.905 176.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 6.2 tp10 -63.03 -37.43 87.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 73.150000000000006 109.694 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.39 97.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.143 -0.481 . . . . 41.229999999999997 110.943 178.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.07 -34.23 43.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.042 -0.526 . . . . 75.430000000000007 111.566 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.56 -30.82 57.23 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.476 0.655 . . . . 75.5 110.797 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.28 14.0 58.65 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.661 -0.7 . . . . 61.329999999999998 112.607 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.88 131.57 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.306 0.574 . . . . 65.5 111.106 177.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt-30 -119.45 139.64 51.72 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.251 -0.886 . . . . 62.020000000000003 109.772 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -74.56 126.85 31.67 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.352 -1.295 . . . . 71.540000000000006 108.769 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.568 HD21 ' NE2' ' A' ' 99' ' ' GLN . 14.0 tp -141.31 -165.57 2.0 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.186 -2.153 . . . . 73.329999999999998 105.186 -177.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.497 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 25.2 mt-30 -52.52 145.02 12.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.047 0.385 . . . . 73.430000000000007 110.299 176.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.95 -0.95 7.88 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 114.728 0.651 . . . . 75.010000000000005 114.728 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -64.11 -42.81 96.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.851 -0.796 . . . . 74.129999999999995 108.851 177.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -174.87 157.01 2.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.114 -0.948 . . . . 74.349999999999994 110.877 -179.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.15 151.65 20.89 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.495 0.718 . . . . 71.519999999999996 110.858 -173.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.3 tm? -91.74 128.79 37.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.826 -1.176 . . . . 75.430000000000007 107.826 -176.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.66 162.07 36.45 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 122.739 0.415 . . . . 73.239999999999995 109.954 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.43 160.73 30.31 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.244 2.63 . . . . 74.120000000000005 112.941 176.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -132.81 -33.45 1.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.783 -0.644 . . . . 63.119999999999997 112.154 -179.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.04 116.52 32.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 72.200000000000003 108.837 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.44 ' HB2' HG12 ' A' ' 106' ' ' VAL . 35.2 m-85 -118.77 114.81 23.25 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.828 -0.434 . . . . 75.209999999999994 109.828 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.48 110.38 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.68 -0.859 . . . . 74.349999999999994 108.68 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.27 112.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.167 -1.049 . . . . 74.109999999999999 108.167 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -110.79 122.86 48.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.73 -0.668 . . . . 74.409999999999997 109.9 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.65 176.38 5.17 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.385 -0.825 . . . . 74.519999999999996 110.081 177.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.3 165.37 51.77 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.218 -1.553 . . . . 73.209999999999994 109.218 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.515 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 3.1 p -59.27 -48.31 87.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 112.673 0.62 . . . . 72.209999999999994 112.673 -178.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -63.94 -36.46 84.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 74.25 110.249 -178.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -69.02 -41.69 77.4 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.465 0.65 . . . . 74.430000000000007 109.563 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -73.87 -22.74 59.63 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 120.415 -0.514 . . . . 75.049999999999997 111.521 -176.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.8 mt-10 -61.77 -28.5 69.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.345 0.593 . . . . 70.420000000000002 109.66 173.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -84.91 -28.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.76 -0.655 . . . . 71.450000000000003 110.55 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 mt -97.02 -14.16 21.81 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 113.01 0.744 . . . . 73.299999999999997 113.01 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.71 22.13 35.24 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 116.077 1.191 . . . . 75.329999999999998 116.077 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.82 -35.13 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.959 0.88 . . . . 74.049999999999997 108.962 176.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -141.73 77.26 19.2 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 115.537 -0.756 . . . . 64.299999999999997 109.203 175.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.32 -50.37 2.03 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.062 1.841 . . . . 63.100000000000001 112.811 -178.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.01 -37.55 82.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.47 0.176 . . . . 75.319999999999993 111.408 -177.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.84 -55.7 29.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.135 0.493 . . . . 64.019999999999996 110.597 177.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -72.86 -22.64 60.75 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.351 0.871 . . . . 75.340000000000003 113.351 -178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 m -71.48 -36.43 71.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 74.409999999999997 109.131 175.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.3 m -70.89 -40.61 72.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.061 -0.518 . . . . 74.209999999999994 109.765 177.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.638 ' O ' ' HG2' ' A' ' 87' ' ' ARG . . . -57.77 -55.23 31.63 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-N 115.746 -0.661 . . . . 62.350000000000001 112.666 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.402 ' HB2' HG23 ' A' ' 106' ' ' VAL . 62.8 m-85 -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.754 -0.85 . . . . 71.510000000000005 112.824 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.85 53.37 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.223 -0.298 . . . . 71.329999999999998 110.993 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' A' ' 84' ' ' GLY . 35.1 ptt180 -60.68 -41.93 96.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.899 0.857 . . . . 71.129999999999995 110.141 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.474 ' N ' ' HG3' ' A' ' 87' ' ' ARG . 64.5 m-20 -77.74 -34.66 52.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.137 -0.938 . . . . 64.319999999999993 112.69 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.47 -37.99 89.46 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.094 -1.076 . . . . 73.329999999999998 108.094 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -63.12 -35.55 80.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.877 -0.601 . . . . 65.530000000000001 110.386 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.7 t70 -72.39 -42.09 65.57 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.684 -0.406 . . . . 74.340000000000003 110.027 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 13.8 m-85 -53.73 -48.4 69.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 112.074 175.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.4 pt -66.06 -30.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 119.722 -0.791 . . . . 75.540000000000006 111.104 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 78.7 mm-40 -67.61 -37.94 83.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.083 -0.247 . . . . 75.409999999999997 110.598 175.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.1 mt-10 -61.63 -41.04 96.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.883 0.739 . . . . 74.019999999999996 110.884 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 68.2 mm-40 -80.31 -14.22 58.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.191 -0.913 . . . . 63.200000000000003 110.938 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.11 29.11 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.765 -0.652 . . . . 61.43 112.062 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -102.9 174.51 5.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.613 0.72 . . . . 73.25 112.073 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' NE2' HD21 ' A' ' 51' ' ' LEU . 25.4 pt20 -137.18 171.91 13.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.412 -0.813 . . . . 73.140000000000001 109.491 179.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -161.15 153.51 20.26 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.738 -0.467 . . . . 74.030000000000001 109.738 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -109.66 120.04 41.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.652 -1.24 . . . . 75.319999999999993 107.652 175.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.85 -150.27 18.28 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 107.951 -2.06 . . . . 72.400000000000006 107.951 -172.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.93 137.83 35.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.187 0.993 . . . . 65.209999999999994 108.842 177.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.49 103.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.316 0.579 . . . . 75.439999999999998 110.094 -175.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.84 127.43 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.25 -0.887 . . . . 74.530000000000001 109.5 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.9 m -105.55 148.73 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 107.244 -1.391 . . . . 72.140000000000001 107.244 176.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -128.21 137.55 52.09 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.732 -0.84 . . . . 71.450000000000003 108.732 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.11 119.73 38.11 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.95 -0.759 . . . . 74.129999999999995 108.95 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.7 175.75 10.38 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.882 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.25 164.37 18.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.031 -176.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -154.17 117.19 4.48 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 124.058 0.943 . . . . 72.420000000000002 108.848 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 p -67.38 -17.73 64.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.603 0.716 . . . . 73.129999999999995 111.099 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -67.26 -28.18 67.82 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.201 1.0 . . . . 72.109999999999999 109.263 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.53 141.3 51.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.998 -1.001 . . . . 75.239999999999995 109.864 -178.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.55 145.96 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.847 -0.615 . . . . 74.319999999999993 110.16 -172.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 m -68.27 121.59 16.55 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.706 -0.679 . . . . 70.310000000000002 109.764 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.67 -11.09 38.65 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 110.471 -1.052 . . . . 63.149999999999999 110.471 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.69 169.09 9.74 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.207 0.527 . . . . 73.109999999999999 110.585 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -164.08 156.63 17.35 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.015 -2.587 . . . . 75.510000000000005 104.015 173.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -146.14 130.57 17.71 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.215 -0.994 . . . . 75.239999999999995 111.791 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.15 118.71 28.28 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.541 -1.281 . . . . 62.439999999999998 107.541 177.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.473 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 23.8 tpt180 -121.78 125.85 47.49 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.296 -0.631 . . . . 74.450000000000003 109.296 -177.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.09 130.32 9.1 Favored Glycine 0 C--N 1.289 -2.038 0 N-CA-C 110.581 -1.008 . . . . 75.299999999999997 110.581 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.3 t -138.09 167.26 22.17 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.47 -0.567 . . . . 72.540000000000006 109.47 -177.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.4 t -92.59 106.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.526 -1.287 . . . . 65.129999999999995 107.526 175.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.571 ' O ' HG21 ' A' ' 129' ' ' VAL . 43.6 t30 -117.83 102.75 51.12 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.135 -0.691 . . . . 62.409999999999997 109.135 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.4 -25.01 15.84 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.84 1.693 . . . . 73.430000000000007 111.13 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -91.24 32.08 1.07 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.297 -0.865 . . . . 64.310000000000002 111.492 -174.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 126' ' ' ASN . 79.2 t -66.92 117.12 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.14 -1.059 . . . . 72.219999999999999 108.14 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.92 138.95 58.7 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.567 -1.197 . . . . 73.310000000000002 109.8 177.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 t -133.03 162.17 32.4 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.274 -1.01 . . . . 74.019999999999996 108.274 -174.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 C--N 1.297 -1.686 0 N-CA-C 108.772 -0.825 . . . . 75.349999999999994 108.772 -179.615 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.568 -0.531 . . . . 74.530000000000001 109.568 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.17 116.23 0.62 Allowed Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.802 -0.919 . . . . 71.430000000000007 110.802 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 m -73.96 134.52 43.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.893 -0.41 . . . . 60.140000000000001 109.893 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -74.67 146.33 42.44 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.519 -0.919 . . . . 71.030000000000001 108.519 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -72.03 82.81 0.96 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.514 0.673 . . . . 75.319999999999993 111.33 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -152.46 172.96 15.72 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.272 1.429 . . . . 74.540000000000006 107.481 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.28 138.89 29.89 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.662 -0.866 . . . . 71.439999999999998 108.662 175.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.14 82.98 2.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.378 1.085 . . . . 75.239999999999995 110.146 176.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -79.62 77.43 6.22 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.533 -1.212 . . . . 73.439999999999998 110.677 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 59.51 61.7 1.94 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 113.392 -1.731 . . . . 74.340000000000003 111.599 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.7 t -131.74 90.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.823 -1.177 . . . . 74.530000000000001 107.823 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -79.89 98.11 6.98 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.463 0.649 . . . . 62.219999999999999 109.347 178.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -57.6 -42.01 82.36 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.521 -1.218 . . . . 75.439999999999998 112.808 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -94.3 73.41 3.91 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.65 -0.82 . . . . 74.150000000000006 109.395 177.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -114.29 104.55 12.19 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.842 -1.17 . . . . 75.439999999999998 107.842 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.68 -161.74 1.3 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.486 -0.779 . . . . 73.319999999999993 109.253 -178.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -50.67 118.1 2.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.094 0.957 . . . . 75.310000000000002 112.826 -176.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -178.37 145.07 0.32 Allowed 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.361 -1.718 . . . . 72.340000000000003 106.361 175.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.93 107.84 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.321 -0.551 . . . . 74.109999999999999 111.256 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.93 22.21 12.79 Favored Glycine 0 C--N 1.308 -1.017 0 N-CA-C 109.058 -1.617 . . . . 74.230000000000004 109.058 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 22.8 t70 -64.39 -41.42 96.68 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.391 -0.905 . . . . 75.400000000000006 111.674 -174.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.96 -37.99 87.43 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.86 -0.609 . . . . 73.409999999999997 110.597 -178.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -64.64 -40.24 95.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.576 -0.738 . . . . 74.329999999999998 109.654 177.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.01 -33.4 75.49 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.669 -0.696 . . . . 72.219999999999999 110.415 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 15.5 mmm180 -72.61 -28.07 62.55 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.176 0.512 . . . . 74.519999999999996 110.918 177.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -86.56 -50.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 112.251 0.463 . . . . 74.109999999999999 112.251 -178.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.25 -28.52 12.23 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 113.006 0.743 . . . . 73.219999999999999 113.006 -175.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.0 -104.5 0.68 Allowed Glycine 0 CA--C 1.496 -1.155 0 O-C-N 123.429 0.456 . . . . 71.439999999999998 112.01 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.16 12.88 8.49 Favored Glycine 0 C--N 1.286 -2.203 0 CA-C-N 114.516 -0.842 . . . . 72.319999999999993 111.583 -178.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -72.56 -33.64 66.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.525 -0.917 . . . . 73.439999999999998 108.525 178.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 tp -163.7 133.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.404 -1.702 . . . . 72.219999999999999 106.404 176.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.48 153.29 53.85 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 110.511 -0.181 . . . . 71.340000000000003 110.511 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.76 -26.5 66.42 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.351 2.701 . . . . 74.019999999999996 111.915 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.6 -33.74 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.282 -0.872 . . . . 74.430000000000007 110.573 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.87 -32.21 45.84 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.682 -0.488 . . . . 74.430000000000007 109.682 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.7 t -64.47 -49.82 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.781 -0.645 . . . . 73.129999999999995 109.426 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 5.9 pt-20 -66.68 -31.4 72.04 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 119.863 -0.735 . . . . 73.409999999999997 110.284 178.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.93 63.55 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.378 0.424 . . . . 74.430000000000007 110.197 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.68 -40.34 91.77 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 111.191 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 77.8 mt -66.34 -46.78 75.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.554 0.576 . . . . 75.530000000000001 112.554 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.5 ptm180 -72.01 -26.89 62.4 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.277 0.561 . . . . 73.439999999999998 110.134 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -45.65 73.35 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.671 -0.695 . . . . 73.510000000000005 109.679 172.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -62.72 -33.91 76.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 122.837 0.455 . . . . 74.409999999999997 111.174 177.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.07 90.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.012 -0.54 . . . . 73.319999999999993 110.702 177.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.45 53.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.502 0.668 . . . . 73.109999999999999 111.106 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.14 -38.21 61.1 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.717 -0.674 . . . . 72.120000000000005 110.849 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.08 12.81 65.03 Favored Glycine 0 C--N 1.319 -0.396 0 C-N-CA 121.261 -0.495 . . . . 72.540000000000006 113.336 -176.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.72 127.4 19.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.399 0.68 . . . . 74.439999999999998 111.875 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -108.91 146.15 34.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.705 -0.68 . . . . 75.209999999999994 110.039 177.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.3 m -81.01 103.23 10.69 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.364 -0.834 . . . . 74.329999999999998 109.143 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.7 tp -112.65 -164.21 0.9 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.133 -1.432 . . . . 73.439999999999998 107.133 -177.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.578 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 85.0 mm-40 -49.67 156.99 0.6 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.748 0.819 . . . . 75.019999999999996 112.594 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.72 5.59 22.78 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 114.852 -1.067 . . . . 73.25 114.086 -172.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.45 -43.37 27.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.388 -0.597 . . . . 74.329999999999998 109.388 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -177.69 165.62 2.1 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.682 0.793 . . . . 74.510000000000005 112.016 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.21 151.3 20.99 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.149 0.98 . . . . 74.310000000000002 111.688 -173.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.403 HD22 HD21 ' A' ' 51' ' ' LEU . 1.4 tm? -94.46 125.11 38.9 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.099 -1.075 . . . . 72.129999999999995 108.099 -175.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.56 156.98 40.54 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 123.597 0.759 . . . . 72.310000000000002 109.783 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' HG21 ' A' ' 125' ' ' VAL . 82.1 Cg_exo -51.03 152.15 10.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.983 3.122 . . . . 70.219999999999999 114.307 177.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.6 p-10 -122.69 -33.88 3.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.194 -0.912 . . . . 73.099999999999994 110.605 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.47 100.26 11.27 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.318 0.58 . . . . 71.319999999999993 110.164 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 72.2 m-85 -96.43 114.13 25.77 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.632 0.73 . . . . 74.530000000000001 109.491 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -107.91 117.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.618 -1.174 . . . . 74.340000000000003 109.036 -174.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -118.05 101.74 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.485 -0.932 . . . . 75.0 108.485 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.5 m -95.82 122.93 39.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 109.311 -176.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.59 162.21 14.95 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.419 0.688 . . . . 74.129999999999995 111.056 176.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.16 163.47 50.63 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.889 -1.685 . . . . 74.430000000000007 108.889 173.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.7 p -63.15 -37.89 80.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 117.387 0.593 . . . . 71.5 111.357 -177.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -64.11 -38.04 89.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.634 -0.712 . . . . 74.230000000000004 110.393 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.08 -35.56 28.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.867 -0.606 . . . . 71.430000000000007 111.69 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -65.79 -32.36 73.85 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.744 -0.383 . . . . 74.319999999999993 110.994 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.2 mt-10 -59.57 -29.52 67.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.046 0.45 . . . . 74.530000000000001 111.266 177.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -81.5 -26.33 35.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 111.32 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.73 -34.42 71.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.385 -0.598 . . . . 75.230000000000004 109.385 173.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.37 -165.89 21.86 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 110.877 -0.889 . . . . 64.400000000000006 110.877 177.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.89 1.23 55.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 110.52 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -127.82 135.43 27.47 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.125 -0.489 . . . . 71.450000000000003 110.526 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.86 -34.52 1.75 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.057 1.838 . . . . 75.430000000000007 109.286 163.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -48.02 -52.79 18.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 117.376 2.362 . . . . 74.129999999999995 117.376 -165.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.24 -42.71 77.76 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.662 0.665 . . . . 64.530000000000001 110.606 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.84 -17.95 28.65 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.247 -0.888 . . . . 71.530000000000001 112.152 -177.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 59.6 m -71.18 -44.64 65.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.253 -0.647 . . . . 74.230000000000004 109.253 176.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.0 m -65.48 -43.2 90.98 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 115.87 -0.604 . . . . 65.019999999999996 110.006 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.12 -53.84 41.52 Favored Glycine 0 CA--C 1.504 -0.615 0 CA-C-N 115.492 -0.776 . . . . 72.140000000000001 112.373 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -67.37 -31.0 70.95 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 113.002 0.742 . . . . 60.530000000000001 113.002 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.23 82.69 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.062 0.392 . . . . 74.099999999999994 110.45 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -67.17 -48.08 69.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.798 -0.637 . . . . 73.530000000000001 111.505 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.33 -35.87 78.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.078 -0.51 . . . . 73.310000000000002 111.293 -173.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.22 -35.68 63.9 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.368 -0.605 . . . . 74.349999999999994 109.368 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.36 84.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.773 0.797 . . . . 60.229999999999997 109.438 176.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.89 -41.73 99.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.601 -1.181 . . . . 74.439999999999998 109.445 177.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 16.4 m-85 -59.89 -51.17 70.87 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.876 -0.602 . . . . 74.5 112.085 175.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -65.61 -30.78 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.298 -0.561 . . . . 64.120000000000005 112.101 -175.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.32 -44.93 93.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.701 -0.481 . . . . 75.239999999999995 109.701 175.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.17 -30.09 70.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.702 -0.681 . . . . 74.400000000000006 112.682 177.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 58.4 mm-40 -82.97 -13.62 55.63 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.918 -0.313 . . . . 73.030000000000001 111.222 178.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 27.08 40.6 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.051 -0.522 . . . . 43.32 113.125 176.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -98.68 178.38 5.01 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.888 0.344 . . . . 72.409999999999997 110.163 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -143.03 174.18 10.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.875 -0.787 . . . . 72.129999999999995 108.875 178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.9 t -157.19 171.74 19.89 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.612 -0.435 . . . . 63.210000000000001 109.831 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.1 118.93 37.83 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.069 -1.085 . . . . 72.319999999999993 108.069 176.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.39 -149.93 16.74 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.376 -1.392 . . . . 71.109999999999999 110.985 176.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.04 142.49 46.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.765 -1.198 . . . . 72.209999999999994 107.765 176.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.22 118.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.58 -0.896 . . . . 74.349999999999994 108.58 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.21 137.3 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.643 0.735 . . . . 73.310000000000002 110.443 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' SER . 92.4 t -117.92 142.9 30.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 107.023 -1.473 . . . . 71.140000000000001 107.023 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -146.44 146.79 30.71 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.697 0.284 . . . . 73.030000000000001 111.019 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 84.9 m-85 -121.16 125.07 46.26 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.111 -1.441 . . . . 71.319999999999993 107.111 177.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.39 175.61 8.99 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.504 -0.878 . . . . 74.230000000000004 111.597 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.405 ' OE1' HG23 ' A' ' 68' ' ' VAL . 50.2 mt-30 -105.18 149.43 25.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.837 0.827 . . . . 75.340000000000003 112.154 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 m -143.48 118.13 9.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.59 -1.186 . . . . 71.329999999999998 108.961 172.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 m -72.0 -24.22 61.53 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.813 -0.63 . . . . 71.230000000000004 112.574 -175.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -88.7 -0.25 57.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.457 1.122 . . . . 73.140000000000001 109.26 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -83.7 144.49 29.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 108.282 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.02 149.74 35.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.434 -0.803 . . . . 73.540000000000006 110.83 -171.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -66.5 125.1 24.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.075 -0.713 . . . . 72.450000000000003 109.075 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.5 16.64 73.07 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.744 -0.741 . . . . 75.409999999999997 112.206 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -124.52 123.2 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.199 -1.037 . . . . 71.5 108.199 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -116.23 156.66 26.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.389 -0.967 . . . . 63.399999999999999 108.389 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -126.0 130.72 51.76 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.899 -0.778 . . . . 75.239999999999995 108.899 177.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.04 119.75 29.55 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.813 -1.085 . . . . 62.43 108.74 -178.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -135.0 126.5 28.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.094 -178.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.22 98.26 2.3 Favored Glycine 0 N--CA 1.424 -2.149 0 N-CA-C 108.502 -1.839 . . . . 73.549999999999997 108.502 176.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.3 m -93.36 138.94 31.22 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 121.198 0.523 . . . . 75.010000000000005 109.939 -175.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 59' ' ' PRO . 92.5 t -98.36 117.43 43.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.878 -0.786 . . . . 71.219999999999999 108.878 175.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -102.83 94.85 5.65 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.472 -1.677 . . . . 73.310000000000002 106.472 170.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.9 Cg_endo -88.73 -3.56 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.225 1.95 . . . . 74.430000000000007 112.067 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -91.34 33.14 1.0 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.494 -0.775 . . . . 61.130000000000003 110.716 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -75.76 97.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.113 -1.069 . . . . 74.519999999999996 108.113 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.79 91.69 8.72 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.7 1.238 . . . . 75.140000000000001 110.466 -176.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -81.8 90.54 6.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 123.628 1.68 . . . . 71.040000000000006 110.215 -178.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--N 1.284 -2.28 0 CA-C-N 112.963 -1.926 . . . . 73.310000000000002 108.063 179.808 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tmm? . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 106.884 -1.524 . . . . 72.319999999999993 106.884 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.73 83.24 0.13 Allowed Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 119.709 -1.234 . . . . 72.310000000000002 112.417 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -65.13 -57.31 8.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.561 -0.533 . . . . 74.409999999999997 109.561 175.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 67.93 -43.54 0.47 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.358 1.463 . . . . 63.520000000000003 114.467 170.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -66.04 122.4 17.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 123.884 0.874 . . . . 75.120000000000005 110.532 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -107.8 115.75 30.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.419 -0.956 . . . . 75.439999999999998 108.419 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.6 104.13 16.45 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.591 -0.522 . . . . 71.109999999999999 109.591 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.28 98.95 6.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.034 -1.098 . . . . 75.120000000000005 108.034 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -88.93 113.63 24.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.814 -0.63 . . . . 70.340000000000003 109.587 -176.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -119.31 122.07 41.04 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.253 0.549 . . . . 75.219999999999999 109.825 178.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -80.09 79.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 122.391 1.091 . . . . 72.25 110.872 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.94 -31.17 71.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.22 -1.355 . . . . 71.530000000000001 110.273 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -72.11 97.09 1.86 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.139 -0.937 . . . . 72.299999999999997 108.829 174.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -91.96 -69.75 0.72 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.919 -0.582 . . . . 61.32 110.311 -176.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.55 85.58 2.36 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.017 -0.673 . . . . 75.120000000000005 111.095 178.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.77 129.24 50.75 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.228 -1.026 . . . . 72.129999999999995 108.228 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.87 132.99 34.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.947 0.403 . . . . 75.420000000000002 110.505 -177.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.8 p -91.84 97.07 10.76 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 106.335 -1.728 . . . . 70.239999999999995 106.335 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.89 117.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 115.187 -0.915 . . . . 75.209999999999994 110.704 -171.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.94 29.7 11.94 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 111.163 -0.775 . . . . 73.209999999999994 111.163 179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.53 -34.63 76.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.231 0.538 . . . . 74.319999999999993 110.549 -177.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -59.68 -45.52 91.84 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.157 -0.929 . . . . 65.109999999999999 109.639 176.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -67.48 -27.95 67.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.147 -0.933 . . . . 63.530000000000001 111.497 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.75 87.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 73.450000000000003 109.915 177.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -80.41 -19.92 45.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.975 -0.557 . . . . 70.239999999999995 110.054 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 22' ' ' ALA . 41.1 mm -67.47 -57.13 10.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.656 -0.498 . . . . 73.430000000000007 109.656 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.82 -30.17 56.27 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.657 0.614 . . . . 75.310000000000002 112.657 -176.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.94 -67.39 1.72 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.373 0.509 . . . . 54.219999999999999 114.373 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.39 -61.7 0.92 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.462 -0.399 . . . . 73.519999999999996 112.705 -176.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -96.59 89.55 5.02 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.46 -0.57 . . . . 73.319999999999993 109.46 -179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.85 88.19 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 120.439 -0.504 . . . . 74.120000000000005 110.145 -177.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 35' ' ' GLU . 6.2 m -128.45 86.46 57.7 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-O 121.784 0.802 . . . . 74.430000000000007 111.802 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -88.8 -46.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.938 2.425 . . . . 64.109999999999999 111.447 174.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -71.47 -16.52 62.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.751 -0.658 . . . . 74.140000000000001 110.809 -178.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' CB ' ' HB ' ' A' ' 32' ' ' VAL . 8.8 tp10 -64.03 -48.16 77.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.374 -0.973 . . . . 72.310000000000002 108.374 175.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.94 -45.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.826 -0.624 . . . . 73.030000000000001 109.68 178.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 53.8 mt-10 -53.12 -55.3 25.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.323 -0.399 . . . . 75.209999999999994 111.147 178.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.05 68.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 111.811 -178.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.12 -47.34 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.337 -0.986 . . . . 74.420000000000002 108.337 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD12 ' CD2' ' A' ' 62' ' ' TYR . 3.8 mm? -71.65 -30.7 66.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.852 0.686 . . . . 72.420000000000002 112.852 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtm180 -64.42 -40.09 95.1 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.287 -1.005 . . . . 75.510000000000005 108.287 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -63.9 -44.86 91.7 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 110.333 176.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.59 -39.71 89.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.154 0.502 . . . . 61.219999999999999 110.006 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.22 84.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.786 -0.643 . . . . 72.519999999999996 110.457 177.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.78 64.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 64.200000000000003 111.984 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.52 -37.51 31.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.087 -0.506 . . . . 74.540000000000006 110.267 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 20.56 26.08 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.856 -0.611 . . . . 51.130000000000003 113.03 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -67.12 138.51 22.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 123.28 0.632 . . . . 75.129999999999995 110.657 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -115.87 143.71 45.03 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 176.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 t -76.28 124.67 27.86 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.946 -1.024 . . . . 74.530000000000001 108.705 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.7 tp -140.16 -166.0 2.02 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.073 -2.195 . . . . 73.140000000000001 105.073 -177.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 23.1 mt-30 -51.67 143.53 12.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.674 0.67 . . . . 71.420000000000002 110.259 176.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.88 -18.01 52.41 Favored Glycine 0 C--N 1.322 -0.233 0 CA-C-N 116.087 -0.506 . . . . 71.430000000000007 114.085 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -62.55 -39.1 92.54 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.52 0.328 . . . . 74.010000000000005 111.731 179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -165.8 136.44 3.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.176 -0.465 . . . . 75.200000000000003 111.396 -177.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.87 151.6 21.08 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.934 1.293 . . . . 75.400000000000006 110.353 -176.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -85.71 128.48 34.8 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.446 -0.797 . . . . 74.129999999999995 109.83 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.64 158.57 41.51 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 123.305 0.642 . . . . 74.120000000000005 109.821 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 36.0 Cg_exo -61.26 152.59 71.21 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.019 2.479 . . . . 72.439999999999998 112.7 177.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -130.86 -16.34 3.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.647 -0.706 . . . . 73.109999999999999 111.583 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.59 114.97 27.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.76 -1.2 . . . . 61.420000000000002 107.76 178.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' CD2' HD12 ' A' ' 40' ' ' LEU . 91.7 m-85 -121.18 122.62 40.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.425 -0.352 . . . . 74.040000000000006 110.23 -178.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 63' ' ' ILE . 3.4 mp -106.79 107.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.186 -1.042 . . . . 73.109999999999999 108.186 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 55.9 mt -112.55 103.65 15.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.55 0.691 . . . . 74.099999999999994 109.979 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -103.12 120.01 39.91 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.847 -0.615 . . . . 72.219999999999999 109.779 -177.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -99.38 163.5 12.5 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 123.692 0.797 . . . . 72.430000000000007 111.252 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.25 165.1 49.79 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.31 -1.116 . . . . 64.140000000000001 110.31 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.67 -47.61 92.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 113.674 0.991 . . . . 73.439999999999998 113.674 -175.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.537 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 82.2 t60 -77.35 -24.19 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.477 0.656 . . . . 74.120000000000005 109.857 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.712 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 2.6 m-20 -69.72 -45.79 67.4 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.751 -0.833 . . . . 72.140000000000001 108.751 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 40.8 t80 -71.29 -34.17 70.4 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.564 -0.744 . . . . 74.140000000000001 111.816 -175.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 12.9 pt-20 -65.11 -30.08 70.99 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.103 0.478 . . . . 74.329999999999998 110.936 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 32.1 mmmt -68.94 -35.39 76.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.169 -0.923 . . . . 72.109999999999999 109.703 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.8 -37.33 79.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 110.73 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.49 -167.65 29.72 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 111.525 -0.63 . . . . 52.340000000000003 111.525 -178.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.11 -45.35 7.25 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.089 0.471 . . . . 62.549999999999997 110.475 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 16.1 m-20 -116.43 130.69 24.3 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 75.099999999999994 110.688 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 -20.34 14.48 Favored 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 123.203 2.602 . . . . 72.099999999999994 113.827 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 8.1 pt-20 -58.76 -24.06 61.08 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.323 1.601 . . . . 63.149999999999999 115.323 -171.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.8 tp -78.75 -29.64 45.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.43 0.633 . . . . 74.519999999999996 110.709 175.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.64 -35.17 13.67 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.773 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -60.78 -41.47 95.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.912 0.387 . . . . 73.349999999999994 110.895 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 m -56.91 -48.16 78.88 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.522 -0.763 . . . . 74.319999999999993 110.99 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.35 -46.33 64.36 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.928 -0.653 . . . . 54.340000000000003 112.006 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.62 -39.46 94.42 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.413 0.285 . . . . 72.319999999999993 110.472 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.23 88.65 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.857 0.361 . . . . 71.540000000000006 110.134 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.44 -37.87 86.12 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.193 -0.458 . . . . 75.200000000000003 110.997 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -71.09 -37.1 72.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 111.1 176.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.03 -43.91 90.87 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.008 -0.738 . . . . 73.319999999999993 109.008 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.26 80.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.404 0.621 . . . . 71.049999999999997 110.635 177.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.27 -42.23 79.9 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.153 -0.93 . . . . 75.400000000000006 108.526 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 m-85 -60.72 -56.16 24.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.781 -1.1 . . . . 75.519999999999996 112.403 176.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -59.59 -37.95 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.347 0.499 . . . . 74.319999999999993 112.347 -175.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.88 -37.64 88.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.834 -0.346 . . . . 73.010000000000005 110.733 176.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.5 -21.17 65.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.874 0.694 . . . . 75.439999999999998 112.874 176.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 50.3 mm-40 -92.49 -10.5 37.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.146 0.498 . . . . 71.349999999999994 110.17 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.96 26.55 37.06 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.434 -0.803 . . . . 63.130000000000003 111.851 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -107.22 155.02 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.285 -0.635 . . . . 75.510000000000005 109.285 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -130.87 175.4 9.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.836 -0.431 . . . . 73.409999999999997 109.836 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.1 t -154.39 158.73 40.47 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 108.264 -1.013 . . . . 75.299999999999997 108.264 175.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.18 120.14 39.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.672 -0.492 . . . . 73.25 109.672 -178.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -149.96 16.94 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.601 -1.8 . . . . 61.509999999999998 108.601 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.02 152.26 41.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.349 -0.982 . . . . 75.310000000000002 108.349 177.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.42 122.19 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.626 0.727 . . . . 73.310000000000002 110.721 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.29 120.28 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.065 -0.97 . . . . 74.340000000000003 109.225 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.85 138.9 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 107.506 -1.294 . . . . 71.400000000000006 107.506 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -116.12 150.23 37.72 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 109.742 -0.466 . . . . 75.420000000000002 109.742 176.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 81.3 m-85 -129.57 125.88 37.23 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.543 -2.021 . . . . 75.099999999999994 105.543 172.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.55 174.36 10.62 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.231 -0.655 . . . . 74.319999999999993 109.231 174.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.1 pt20 -122.27 150.23 42.62 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.367 -0.605 . . . . 72.409999999999997 109.367 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.552 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 75.4 m -119.19 118.67 31.95 Favored 'General case' 0 C--N 1.264 -3.129 0 N-CA-C 107.733 -1.21 . . . . 62.340000000000003 107.733 173.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -59.94 -28.22 67.44 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.818 0.847 . . . . 73.349999999999994 112.073 -176.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.552 ' OD1' ' HB3' ' A' ' 111' ' ' SER . 23.7 p-10 -83.91 -19.87 33.99 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.904 0.881 . . . . 71.430000000000007 111.301 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 22.1 tp -78.17 135.85 37.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.899 -0.591 . . . . 75.510000000000005 109.915 -175.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -78.78 158.58 28.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.544 -0.753 . . . . 73.25 111.9 -173.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.712 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 30.7 m -70.93 130.72 42.35 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.378 -0.828 . . . . 74.219999999999999 110.082 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 11.42 62.27 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.061 -0.816 . . . . 72.030000000000001 111.061 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -126.49 121.22 31.73 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 108.186 -1.042 . . . . 72.099999999999994 108.186 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.472 ' HB3' HD12 ' A' ' 66' ' ' LEU . 31.1 p90 -141.24 154.49 45.81 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.478 -0.564 . . . . 74.109999999999999 109.478 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 3.4 mpt_? -124.17 139.0 54.35 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.183 -0.673 . . . . 74.5 109.183 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.11 118.94 16.19 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.389 -0.967 . . . . 73.209999999999994 108.389 176.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -124.98 119.59 29.16 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.676 -0.41 . . . . 75.0 110.233 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -104.78 124.27 7.94 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.449 -1.06 . . . . 63.100000000000001 110.449 177.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 m -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 108.762 -0.829 . . . . 74.230000000000004 108.762 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.69 119.64 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.84 -1.17 . . . . 64.319999999999993 107.84 175.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -110.93 96.06 27.48 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.317 -1.734 . . . . 73.340000000000003 106.317 171.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.36 -25.92 17.84 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.988 1.792 . . . . 73.409999999999997 111.184 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -95.52 70.7 3.1 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.99 1.376 . . . . 53.439999999999998 111.035 -177.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.76 127.19 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 N-CA-C 103.559 -2.756 . . . . 74.540000000000006 103.559 171.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -69.47 95.0 0.79 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.938 0.875 . . . . 74.109999999999999 110.089 -178.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -76.91 120.47 22.09 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.047 -1.433 . . . . 73.299999999999997 108.33 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 C--N 1.293 -1.86 0 CA-C-N 114.656 -1.157 . . . . 73.140000000000001 108.528 -171.096 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.555 0.217 . . . . 75.25 110.938 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.71 33.16 22.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.305 -1.918 . . . . 52.109999999999999 108.305 -172.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -109.16 135.86 49.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.084 -1.058 . . . . 70.239999999999995 110.611 -176.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.85 -178.37 4.49 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.662 0.385 . . . . 73.549999999999997 110.668 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.72 112.9 22.88 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.504 -0.924 . . . . 71.420000000000002 108.504 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -89.01 93.86 9.75 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.421 -0.912 . . . . 75.239999999999995 110.875 179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.53 95.66 10.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.261 -1.385 . . . . 74.030000000000001 107.261 176.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -156.35 109.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.73 0.776 . . . . 72.450000000000003 112.125 -176.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -116.72 119.86 36.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.402 -1.703 . . . . 73.099999999999994 106.402 171.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -79.03 100.83 7.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.269 -1.011 . . . . 74.230000000000004 108.269 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -74.27 95.9 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.285 -1.006 . . . . 71.409999999999997 108.285 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.134 -0.939 . . . . 74.519999999999996 109.782 -176.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -87.09 76.96 9.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.99 -1.856 . . . . 74.120000000000005 105.99 172.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.51 94.04 1.25 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.054 -0.975 . . . . 72.420000000000002 112.058 -171.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.79 151.48 49.54 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.384 -1.71 . . . . 74.209999999999994 106.384 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.56 97.6 11.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.927 -1.508 . . . . 73.120000000000005 106.927 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.83 102.36 11.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.98 0.895 . . . . 65.340000000000003 112.509 -176.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -131.89 90.49 2.83 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.508 -1.664 . . . . 64.450000000000003 106.508 172.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 p -95.21 112.86 28.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 114.497 -1.229 . . . . 75.340000000000003 110.662 -177.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.9 133.71 5.95 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.72 -0.952 . . . . 64.310000000000002 110.72 -179.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -90.45 105.36 17.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.414 -1.328 . . . . 73.25 107.414 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -43.95 -56.55 3.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.477 -1.238 . . . . 74.140000000000001 112.932 -177.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -65.81 -29.76 70.29 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.0 0.741 . . . . 74.129999999999995 113.0 -177.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.4 79.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.835 -0.802 . . . . 55.399999999999999 108.835 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -67.6 -21.83 65.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.739 -0.664 . . . . 71.439999999999998 111.753 178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 22' ' ' ALA . 73.5 mt -78.28 -59.32 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.046 0.451 . . . . 73.129999999999995 110.261 177.812 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -83.98 -17.02 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.121 1.156 . . . . 74.439999999999998 114.121 -173.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.4 38.46 3.49 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 119.918 -1.134 . . . . 75.019999999999996 112.088 179.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.5 45.63 95.91 Favored Glycine 0 CA--C 1.509 -0.3 0 CA-C-N 115.548 -0.326 . . . . 63.329999999999998 112.585 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -165.87 164.8 18.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.889 -1.523 . . . . 71.319999999999993 106.889 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 pt 42.63 37.66 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 125.952 1.701 . . . . 75.549999999999997 114.705 176.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.1 m -73.75 128.76 86.31 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.064 -0.516 . . . . 75.349999999999994 110.906 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 3.4 Cg_exo -75.31 71.64 5.12 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.736 2.291 . . . . 70.120000000000005 111.536 177.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -89.15 -2.65 58.61 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.744 0.783 . . . . 72.409999999999997 110.03 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -74.8 -5.34 42.93 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.825 -0.625 . . . . 74.319999999999993 112.403 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 82.2 t -71.32 -55.51 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.792 -1.188 . . . . 73.0 107.792 174.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.5 pm0 -62.98 -34.93 78.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.88 0.372 . . . . 74.540000000000006 111.538 176.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' A' ' 41' ' ' ARG . . . -62.19 -50.86 70.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.983 -0.553 . . . . 44.119999999999997 111.269 177.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.01 -30.57 67.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.298 0.57 . . . . 63.329999999999998 110.162 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 16.0 tp -66.1 -41.88 90.01 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.687 -0.688 . . . . 74.099999999999994 110.218 -179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.88 -28.96 66.07 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.154 -0.684 . . . . 74.299999999999997 109.154 178.958 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' A' ' 46' ' ' ASP . 6.3 tpt180 -64.62 -52.3 58.14 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-N 115.778 -0.646 . . . . 75.420000000000002 109.614 172.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -60.24 -38.05 82.23 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.856 0.863 . . . . 73.5 110.998 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.28 -46.68 89.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.998 -0.547 . . . . 73.319999999999993 110.88 177.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.8 -22.84 49.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.879 -0.601 . . . . 75.0 111.179 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HB2' ' HE ' ' A' ' 42' ' ' ARG . 28.8 t70 -81.13 -37.33 29.03 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.862 -0.608 . . . . 70.25 110.799 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 19.89 29.59 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 116.1 -0.5 . . . . 73.349999999999994 113.538 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -66.11 139.04 21.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 C-N-CA 123.01 0.524 . . . . 72.219999999999999 110.851 178.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -117.85 143.34 46.38 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.173 0.511 . . . . 74.010000000000005 110.166 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -75.44 111.75 11.05 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.6 -1.182 . . . . 72.409999999999997 109.418 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.9 tp -119.13 -176.0 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.044 -1.835 . . . . 73.140000000000001 106.044 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 73.6 mt-30 -47.29 141.28 4.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.579 0.751 . . . . 71.120000000000005 110.058 175.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -10.63 7.77 Favored Glycine 0 CA--C 1.5 -0.857 0 N-CA-C 116.012 1.165 . . . . 74.510000000000005 116.012 -167.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -71.64 -35.72 70.5 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.245 -0.582 . . . . 73.5 111.844 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -167.26 148.12 5.58 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 112.07 0.396 . . . . 74.230000000000004 112.07 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.99 151.73 20.96 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.821 0.848 . . . . 73.299999999999997 110.508 -174.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.04 127.92 37.69 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.766 -1.198 . . . . 75.109999999999999 107.766 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.03 46.81 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 109.113 -0.699 . . . . 75.420000000000002 109.113 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.68 149.02 83.9 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.111 1.874 . . . . 63.409999999999997 111.153 177.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -113.23 -26.14 8.55 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.734 -0.386 . . . . 71.430000000000007 110.886 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 35.3 tt0 -113.12 125.18 54.08 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.185 0.517 . . . . 74.120000000000005 110.025 -177.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.428 ' HB2' HG11 ' A' ' 106' ' ' VAL . 39.4 m-85 -121.83 124.87 45.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.578 -0.737 . . . . 72.049999999999997 109.87 -177.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 69.2 mt -98.18 114.86 36.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.133 -1.062 . . . . 74.109999999999999 108.133 -179.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.75 117.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.562 -0.903 . . . . 74.519999999999996 108.562 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.3 m -116.83 121.42 41.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.038 -0.528 . . . . 74.329999999999998 110.078 -178.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.403 HD13 ' CB ' ' A' ' 119' ' ' PHE . 4.4 mm? -106.57 163.05 13.2 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.216 -0.902 . . . . 75.450000000000003 109.555 177.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.43 163.64 54.12 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.261 -1.936 . . . . 73.310000000000002 108.261 171.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.25 -40.32 88.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 118.023 0.912 . . . . 73.230000000000004 112.891 -175.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 53.0 t-80 -68.55 -43.24 77.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.254 -1.017 . . . . 74.430000000000007 108.254 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -65.55 -35.43 80.83 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.356 -1.293 . . . . 73.239999999999995 110.699 -177.283 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.92 -40.48 91.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 72.420000000000002 109.683 178.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.41 -24.83 60.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.188 0.518 . . . . 73.400000000000006 111.193 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 mmmt -77.52 -17.14 58.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.241 -0.436 . . . . 72.109999999999999 111.848 175.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.5 mt -71.45 -40.44 70.34 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 105.959 -1.867 . . . . 73.400000000000006 105.959 170.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.9 -176.5 18.64 Favored Glycine 0 N--CA 1.414 -2.829 0 CA-C-N 113.776 -1.557 . . . . 72.439999999999998 110.513 176.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.474 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -87.12 1.69 52.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.56 0.695 . . . . 72.230000000000004 109.361 178.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 26.6 p-10 -123.05 49.19 2.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 C-N-CA 124.242 1.017 . . . . 63.229999999999997 112.714 -177.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 5.2 Cg_exo -75.19 -17.16 19.37 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.705 1.604 . . . . 74.200000000000003 110.929 -179.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -26.31 59.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.376 -0.829 . . . . 63.310000000000002 111.982 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.21 -44.94 62.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.645 -1.243 . . . . 72.010000000000005 107.645 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.66 ' HE3' ' CZ ' ' A' ' 85' ' ' PHE . 60.2 tptt -61.3 -33.96 74.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.009 0.924 . . . . 70.329999999999998 109.427 176.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 t -63.05 -49.11 75.84 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.886 -1.052 . . . . 74.430000000000007 110.532 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.5 m -62.04 -34.44 76.24 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-O 120.896 0.379 . . . . 75.120000000000005 110.854 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.73 -52.63 44.1 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.62 -0.992 . . . . 71.219999999999999 110.62 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.66 ' CZ ' ' HE3' ' A' ' 81' ' ' LYS . 8.0 m-30 -58.52 -44.23 89.47 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 112.516 0.562 . . . . 75.450000000000003 112.516 178.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.15 74.65 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.756 0.66 . . . . 70.340000000000003 111.061 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -79.67 -40.28 29.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.372 -0.531 . . . . 72.239999999999995 111.066 -176.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 33.9 t70 -63.9 -38.12 89.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.175 0.512 . . . . 70.230000000000004 111.688 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.55 -29.74 52.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.616 -0.434 . . . . 73.409999999999997 110.08 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.31 -37.28 86.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.566 -0.901 . . . . 74.010000000000005 108.566 173.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 21.4 t70 -60.19 -54.94 39.83 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.593 -1.185 . . . . 72.420000000000002 109.327 176.002 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.4 m-85 -51.71 -49.19 62.94 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 114.005 1.113 . . . . 74.099999999999994 114.005 178.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.9 pt -63.8 -34.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.821 -0.751 . . . . 74.439999999999998 111.12 -177.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 81.1 mm-40 -72.24 -37.37 69.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 121.202 -0.199 . . . . 74.420000000000002 110.697 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 48.3 mm-40 -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.957 -0.565 . . . . 72.129999999999995 110.981 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.4 mm-40 -80.19 -13.3 59.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.727 -0.67 . . . . 74.409999999999997 111.681 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.84 29.81 28.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.756 -0.735 . . . . 60.229999999999997 112.327 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -102.47 162.52 12.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.803 -0.814 . . . . 75.109999999999999 108.803 178.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -133.98 177.17 7.94 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.773 -0.454 . . . . 74.25 109.773 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -160.83 177.33 10.52 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.74 -1.578 . . . . 74.129999999999995 106.74 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.36 119.11 36.53 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.943 -0.762 . . . . 73.219999999999999 108.943 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -150.92 17.05 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 109.387 -1.485 . . . . 73.109999999999999 109.387 -176.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.65 148.11 48.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.834 -1.543 . . . . 75.430000000000007 106.834 177.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.28 122.37 24.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.144 0.497 . . . . 75.129999999999995 110.814 -177.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 7.3 p -138.93 127.73 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.778 0.799 . . . . 74.140000000000001 109.9 -178.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 62' ' ' TYR . 18.8 m -105.17 148.5 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.556 -0.905 . . . . 74.239999999999995 108.556 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -115.52 125.58 53.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.692 -0.855 . . . . 75.310000000000002 108.692 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -101.11 119.79 39.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.265 -0.643 . . . . 75.25 109.265 173.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.9 pt-20 -139.16 164.8 28.85 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 109.377 178.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.66 159.41 29.39 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.558 0.694 . . . . 63.100000000000001 110.928 -177.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -140.21 109.8 6.31 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 114.937 -1.029 . . . . 63.32 109.188 172.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -64.67 -25.83 68.12 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.462 -0.79 . . . . 74.450000000000003 110.054 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -75.84 -14.72 60.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.16 -0.927 . . . . 70.329999999999998 110.438 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -81.98 161.57 22.97 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.211 -1.033 . . . . 74.25 108.211 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -83.15 150.84 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.096 0.474 . . . . 74.129999999999995 110.297 -176.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.0 m -76.31 123.53 26.07 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.59 -0.732 . . . . 75.0 110.602 -178.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.48 8.15 62.79 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.634 -0.986 . . . . 74.420000000000002 110.634 -175.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -114.44 122.02 45.33 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.336 -1.357 . . . . 75.200000000000003 107.336 177.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.403 ' CB ' HD13 ' A' ' 66' ' ' LEU . 43.2 p90 -131.28 154.0 48.96 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.204 -1.035 . . . . 74.549999999999997 108.204 -178.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -141.16 148.42 39.98 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 123.142 0.276 . . . . 75.540000000000006 110.367 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -147.32 121.0 9.19 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.711 -0.848 . . . . 64.25 108.711 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -123.54 140.24 53.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.668 -0.493 . . . . 75.450000000000003 109.668 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.1 136.38 13.34 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 111.555 -0.618 . . . . 72.349999999999994 111.555 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -138.71 158.9 43.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.8 -0.815 . . . . 71.129999999999995 108.8 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.86 106.99 19.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.463 -1.31 . . . . 75.230000000000004 107.463 178.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -124.11 96.83 41.54 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 109.799 -0.445 . . . . 65.310000000000002 109.799 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.76 -6.86 12.48 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.056 1.837 . . . . 73.349999999999994 110.96 178.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.25 73.9 3.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.604 1.193 . . . . 60.25 108.981 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.88 114.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 113.122 -1.854 . . . . 72.340000000000003 108.422 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.22 125.56 42.61 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.417 0.627 . . . . 72.420000000000002 111.094 -179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.7 m -81.64 133.06 35.32 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.801 -1.555 . . . . 74.510000000000005 106.801 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.8 m170 . . . . . 0 C--O 1.263 1.767 0 CA-C-O 118.15 -0.929 . . . . 72.040000000000006 109.038 -178.692 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtm . . . . . 0 C--O 1.249 1.038 0 N-CA-C 108.732 -0.84 . . . . 73.140000000000001 108.732 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.46 -118.23 9.78 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.991 -0.843 . . . . 51.409999999999997 110.991 -178.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -154.43 144.13 21.6 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 122.614 0.366 . . . . 73.129999999999995 110.626 176.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -88.69 93.84 9.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.741 -1.948 . . . . 74.200000000000003 105.741 170.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 1.2 pptp? -54.77 121.23 8.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 114.667 1.358 . . . . 73.329999999999998 114.667 -172.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.47 122.11 37.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.134 -1.432 . . . . 75.340000000000003 107.134 175.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.56 121.29 23.71 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.148 0.499 . . . . 74.439999999999998 110.525 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -111.77 23.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.906 1.336 . . . . 72.409999999999997 107.465 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -77.75 -45.49 24.5 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.682 -1.144 . . . . 75.340000000000003 111.676 -177.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -87.01 71.97 10.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.209 1.004 . . . . 74.049999999999997 111.125 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.4 73.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 104.938 -2.245 . . . . 74.329999999999998 104.938 170.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.41 30.4 0.71 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.257 -1.792 . . . . 73.439999999999998 110.246 -174.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 70.16 13.19 7.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.221 1.01 . . . . 75.319999999999993 111.002 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -120.12 92.8 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.384 -1.28 . . . . 75.109999999999999 107.923 173.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 tp -152.07 -66.68 0.17 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.544 -1.28 . . . . 72.409999999999997 107.544 179.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 94.74 9.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.232 -1.766 . . . . 75.099999999999994 106.232 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -102.02 -20.12 14.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.214 -0.903 . . . . 63.340000000000003 109.908 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -145.55 118.47 8.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.771 -1.196 . . . . 74.349999999999994 107.771 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.87 86.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 122.385 1.088 . . . . 72.019999999999996 111.652 -178.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.13 175.11 15.9 Favored Glycine 1 N--CA 1.379 -5.117 0 N-CA-C 110.532 -1.027 . . . . 74.230000000000004 110.532 178.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 9.0 m-20 56.25 31.29 18.19 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 125.83 1.652 . . . . 74.129999999999995 112.647 177.052 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.51 -60.2 4.22 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.271 0.629 . . . . 71.200000000000003 112.326 -176.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -70.14 -28.93 65.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.649 -0.705 . . . . 75.219999999999999 109.733 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.07 65.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.075 -0.966 . . . . 60.020000000000003 110.926 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 10.4 ptp180 -74.88 -33.2 62.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.164 0.431 . . . . 72.140000000000001 112.164 -178.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.8 mt -78.88 -55.01 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.751 0.31 . . . . 75.25 111.767 -177.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 94.9 m-85 -93.48 -11.27 32.42 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.899 0.703 . . . . 74.530000000000001 112.899 -173.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.35 -1.6 80.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.217 -0.992 . . . . 75.239999999999995 113.804 176.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.59 13.09 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 119.888 -1.148 . . . . 71.329999999999998 112.978 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -75.45 -63.57 1.26 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.996 0.427 . . . . 74.140000000000001 110.73 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HB ' ' CG ' ' A' ' 27' ' ' PHE . 47.2 mm -91.47 79.26 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.955 0.883 . . . . 73.0 108.72 176.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.9 t -134.0 120.23 15.09 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.589 -1.263 . . . . 63.310000000000002 107.589 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.26 58.03 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.136 2.557 . . . . 75.299999999999997 112.718 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 34.2 tt0 -71.8 -33.84 68.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.753 -0.462 . . . . 65.349999999999994 109.753 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -65.23 -20.79 66.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.141 0.496 . . . . 74.340000000000003 110.681 179.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 78.8 t -72.34 -48.19 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.221 -0.659 . . . . 71.420000000000002 109.221 177.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -71.5 -26.7 62.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.454 0.645 . . . . 74.0 111.054 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.09 79.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.376 -0.829 . . . . 72.049999999999997 109.665 173.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 6.9 tt -76.74 -34.83 58.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.383 -0.969 . . . . 73.230000000000004 108.383 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 96.9 mt -62.28 -47.21 85.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.291 -0.413 . . . . 71.439999999999998 110.851 177.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -66.4 -30.9 71.37 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.454 -0.573 . . . . 74.049999999999997 109.454 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 39' ' ' LEU . 56.7 ttt180 -63.32 -55.25 26.21 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.146 0.978 . . . . 74.530000000000001 109.82 177.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.45 -23.73 58.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.293 -0.412 . . . . 62.219999999999999 111.423 -175.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.49 98.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.286 -0.635 . . . . 73.430000000000007 109.286 172.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.46 63.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.426 -0.807 . . . . 73.209999999999994 110.85 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.02 -42.42 76.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.784 0.326 . . . . 62.329999999999998 110.937 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.45 9.68 40.69 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.894 -0.593 . . . . 75.409999999999997 114.262 -176.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.0 mm -59.64 135.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.398 0.618 . . . . 75.049999999999997 111.58 177.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' OE1' HD23 ' A' ' 57' ' ' LEU . 99.5 mt-30 -120.08 150.0 41.29 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.002 -0.999 . . . . 74.510000000000005 110.545 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.1 m -79.78 126.33 30.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.573 -1.194 . . . . 74.439999999999998 109.708 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.5 tp -146.7 -164.07 1.9 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 104.522 -2.399 . . . . 75.099999999999994 104.522 -178.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.556 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 50.7 mt-30 -42.25 133.32 3.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.619 0.768 . . . . 75.510000000000005 110.152 176.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.52 -12.43 46.2 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 114.884 0.714 . . . . 73.010000000000005 114.884 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.55 -34.18 60.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.036 0.384 . . . . 75.120000000000005 112.036 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 29.0 ptt180 -157.05 135.05 11.01 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.307 0.575 . . . . 74.430000000000007 111.943 -177.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.72 151.64 21.15 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.213 -0.903 . . . . 75.409999999999997 110.737 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD23 ' OE1' ' A' ' 49' ' ' GLN . 14.7 tp -84.94 125.0 32.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.744 -0.835 . . . . 73.430000000000007 108.744 -176.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.42 158.31 40.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 115.836 -0.62 . . . . 73.140000000000001 109.73 -178.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.8 148.86 90.75 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.969 2.446 . . . . 75.230000000000004 113.121 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.7 p-10 -125.44 -21.63 4.49 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.234 -0.893 . . . . 61.409999999999997 110.626 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 32.5 tt0 -94.23 107.52 19.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.797 -0.816 . . . . 72.409999999999997 108.797 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 95.3 m-85 -120.52 114.46 21.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.294 0.569 . . . . 74.140000000000001 109.956 177.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.49 122.06 66.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.16 -1.052 . . . . 75.129999999999995 108.16 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.6 mt -115.6 119.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.376 0.607 . . . . 73.299999999999997 109.521 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.1 m -117.45 123.71 47.04 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.721 -0.672 . . . . 50.329999999999998 109.261 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -121.8 171.82 8.61 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 109.949 -0.389 . . . . 74.530000000000001 109.949 175.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.79 147.28 43.11 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.484 -1.046 . . . . 61.299999999999997 110.484 175.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.03 -47.76 65.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 123.099 0.56 . . . . 75.109999999999999 110.666 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 52.7 t-80 -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.506 -0.77 . . . . 65.400000000000006 110.376 -178.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 9.3 t70 -65.2 -43.28 92.11 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.768 0.794 . . . . 73.420000000000002 108.983 -178.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.3 -44.43 92.52 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.82 1.648 . . . . 74.430000000000007 109.8 -178.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -67.25 -37.25 83.2 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.087 -0.506 . . . . 75.409999999999997 110.749 177.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 3.1 mmmp? -68.5 -26.28 65.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.462 -0.336 . . . . 64.040000000000006 110.607 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.65 -45.68 67.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.804 0.811 . . . . 74.400000000000006 109.792 175.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.6 44.87 7.11 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 105.054 -3.218 . . . . 44.219999999999999 105.054 -165.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 6.93 0.05 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 128.624 2.77 . . . . 71.409999999999997 116.851 -171.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -43.45 106.85 0.52 Allowed Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.556 1.142 . . . . 74.400000000000006 108.728 -173.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.65 -52.47 8.79 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.334 3.356 . . . . 74.140000000000001 118.987 -161.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.79 -51.07 7.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.441 1.645 . . . . 73.219999999999999 115.441 -165.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -62.96 -56.48 16.78 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.744 0.646 . . . . 72.049999999999997 112.744 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.435 ' O ' ' HD1' ' A' ' 85' ' ' PHE 0.286 29.1 mmmt -94.8 -8.61 36.98 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 115.55 1.685 . . . . 74.510000000000005 115.55 -177.352 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -69.46 -45.58 68.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.213 -1.773 . . . . 63.240000000000002 106.213 174.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.4 m -69.92 -36.91 75.73 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.059 -0.973 . . . . 65.340000000000003 108.925 175.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.02 -56.22 26.38 Favored Glycine 0 C--O 1.21 -1.345 0 CA-C-N 115.33 -0.85 . . . . 70.109999999999999 113.109 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 32.1 m-85 -60.2 -35.47 75.48 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.449 0.624 . . . . 74.299999999999997 111.492 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.95 94.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.42 . . . . 72.040000000000006 109.99 177.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -68.88 -41.12 78.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.878 -0.601 . . . . 74.510000000000005 110.085 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.67 -50.97 71.43 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.902 -0.407 . . . . 72.049999999999997 109.902 176.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.8 -31.76 70.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.215 0.82 . . . . 72.109999999999999 113.215 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.43 91.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.332 0.587 . . . . 74.319999999999993 109.661 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.0 -41.99 73.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.638 -0.71 . . . . 74.140000000000001 109.655 177.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -56.48 -52.86 63.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 112.565 0.58 . . . . 72.400000000000006 112.565 176.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.32 -37.8 58.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 120.063 -0.655 . . . . 74.239999999999995 111.699 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.28 -50.89 62.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.379 . . . . 73.120000000000005 111.181 175.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -53.31 -51.03 63.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.942 1.297 . . . . 74.420000000000002 110.784 -178.376 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 1.7 mp0 -74.73 -13.44 60.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.086 1.143 . . . . 73.099999999999994 114.086 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.24 38.21 11.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.028 -1.082 . . . . 72.519999999999996 111.796 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -109.42 158.41 17.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.774 -0.825 . . . . 74.200000000000003 108.774 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.4 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 23.6 pt20 -129.11 174.24 9.74 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.923 -0.769 . . . . 73.430000000000007 108.923 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.0 t -162.34 159.29 25.24 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.735 -1.209 . . . . 74.230000000000004 107.735 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.56 118.9 33.11 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.381 -0.97 . . . . 74.25 108.381 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -149.75 16.72 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.567 -1.813 . . . . 75.239999999999995 108.567 -176.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -126.09 164.32 21.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.568 -1.641 . . . . 72.450000000000003 106.568 174.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.37 117.53 28.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.556 -0.905 . . . . 75.530000000000001 108.556 -178.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -118.33 121.03 66.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.607 0.717 . . . . 74.319999999999993 110.643 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.12 113.18 43.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.387 -0.968 . . . . 72.010000000000005 108.387 179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -111.31 134.45 52.89 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.007 -0.542 . . . . 74.510000000000005 109.554 -177.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.4 146.41 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.738 -0.467 . . . . 74.140000000000001 109.738 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.37 168.31 25.2 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.75 -0.833 . . . . 72.030000000000001 108.75 174.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.42 25.77 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.235 0.541 . . . . 73.040000000000006 111.784 178.413 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -135.74 136.87 41.15 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.709 -1.132 . . . . 52.049999999999997 109.146 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 t -80.73 -19.27 45.37 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.8 -0.815 . . . . 64.239999999999995 108.8 176.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -72.79 -36.43 67.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.701 -0.681 . . . . 71.129999999999995 110.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.74 155.22 20.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.176 -0.466 . . . . 73.540000000000006 110.707 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -125.27 173.47 8.78 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.2 0.6 . . . . 72.420000000000002 110.645 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 9.8 m -57.79 125.61 23.77 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.474 0.654 . . . . 75.409999999999997 110.933 -179.139 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.87 54.84 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.318 -0.856 . . . . 74.150000000000006 111.058 -176.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -118.18 118.67 32.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.092 0.472 . . . . 75.310000000000002 110.08 -178.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.457 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 34.0 p90 -139.03 148.45 43.42 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.564 -1.273 . . . . 75.0 107.564 177.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -132.12 130.65 41.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.228 -1.027 . . . . 55.43 108.228 175.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.8 129.48 42.47 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 39.7 mtp180 -119.61 157.8 27.69 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 123.155 0.285 . . . . 71.519999999999996 111.521 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -137.0 109.85 0.74 Allowed Glycine 0 N--CA 1.424 -2.109 0 O-C-N 124.715 1.26 . . . . 60.310000000000002 110.918 176.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.6 m -114.3 150.43 34.48 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.371 -0.603 . . . . 75.530000000000001 109.371 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.24 106.12 16.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 106.49 -1.67 . . . . 75.310000000000002 106.49 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -110.42 102.28 51.07 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 109.962 -0.384 . . . . 75.530000000000001 109.962 -178.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.9 -14.17 12.55 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.946 1.764 . . . . 74.420000000000002 111.394 178.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.12 70.53 3.27 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 123.2 1.476 . . . . 74.200000000000003 109.111 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.76 131.36 64.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 112.479 -2.146 . . . . 72.420000000000002 107.451 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -76.62 124.52 27.75 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.166 -1.049 . . . . 74.209999999999994 108.166 178.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -130.77 157.63 42.31 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.391 -0.822 . . . . 74.040000000000006 109.362 -177.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--N 1.291 -1.977 0 CA-C-O 118.366 -0.826 . . . . 72.200000000000003 109.028 -178.453 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 108.597 -0.89 . . . . 63.350000000000001 108.597 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.39 8.63 68.01 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.819 -0.705 . . . . 71.319999999999993 112.899 177.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -102.54 23.71 11.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.213 0.53 . . . . 72.140000000000001 109.666 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -102.18 164.1 11.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.997 -0.547 . . . . 75.200000000000003 110.293 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -126.03 103.98 8.03 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.536 -1.283 . . . . 73.010000000000005 107.536 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -83.67 104.31 13.69 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.223 0.535 . . . . 74.310000000000002 110.151 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.2 149.6 52.35 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.057 -0.974 . . . . 75.030000000000001 109.104 177.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.16 125.48 33.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.201 -0.666 . . . . 75.420000000000002 109.201 178.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -117.75 130.61 56.42 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.691 -0.485 . . . . 70.510000000000005 109.691 -178.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -94.48 102.41 14.36 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.034 -0.728 . . . . 75.400000000000006 109.034 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.75 -5.43 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.519 1.152 . . . . 74.540000000000006 108.272 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -68.59 141.77 55.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.994 -1.457 . . . . 71.230000000000004 109.833 176.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 68.4 21.14 8.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.797 1.239 . . . . 74.420000000000002 112.729 173.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.77 -35.11 57.93 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.135 -1.802 . . . . 75.099999999999994 106.135 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.92 98.09 8.36 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 104.982 -2.229 . . . . 64.219999999999999 104.982 171.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.15 88.01 6.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 C-N-CA 120.235 -0.586 . . . . 75.430000000000007 110.983 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -73.28 129.75 38.71 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.278 -1.749 . . . . 75.450000000000003 106.278 172.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -79.56 159.65 26.77 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.062 -0.517 . . . . 72.519999999999996 111.223 -176.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.01 91.63 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.932 -1.136 . . . . 61.219999999999999 107.932 177.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.8 -68.58 0.14 Allowed Glycine 0 C--N 1.3 -1.471 0 N-CA-C 110.074 -1.21 . . . . 73.109999999999999 110.074 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -103.28 15.26 29.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.57 0.7 . . . . 75.120000000000005 109.946 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -59.7 -44.86 93.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.622 -1.172 . . . . 72.349999999999994 111.857 -177.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' HA ' HG12 ' A' ' 26' ' ' ILE . 63.3 m-85 -63.93 -34.54 78.2 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.36 0.412 . . . . 71.439999999999998 111.87 -177.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.09 82.06 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.438 0.637 . . . . 74.340000000000003 109.86 177.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -71.84 -30.86 65.91 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.367 -0.833 . . . . 73.340000000000003 112.248 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 22' ' ' ALA . 24.0 pt -85.23 -16.24 10.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 112.766 0.654 . . . . 73.319999999999993 112.766 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -92.4 -29.45 16.3 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.282 -0.567 . . . . 73.109999999999999 111.204 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.79 -94.62 0.03 OUTLIER Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.928 0.767 . . . . 51.200000000000003 114.522 174.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.02 71.43 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.164 -0.518 . . . . 73.430000000000007 112.443 -177.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 m -91.37 172.94 8.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.847 -0.427 . . . . 73.530000000000001 109.847 174.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.77 121.66 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.722 -1.584 . . . . 74.230000000000004 106.722 176.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.419 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 21.6 m -85.01 142.02 38.27 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.28 -0.418 . . . . 74.219999999999999 111.951 -173.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -53.56 115.46 2.33 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.965 2.443 . . . . 71.099999999999994 112.171 175.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 32' ' ' VAL . 13.1 pt20 176.46 -41.67 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 127.036 2.134 . . . . 74.219999999999999 106.271 -178.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.02 -27.12 33.25 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.443 -1.253 . . . . 72.530000000000001 109.892 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -54.4 33.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.034 0 N-CA-C 107.649 -1.241 . . . . 62.439999999999998 107.649 175.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.78 -46.58 74.45 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.441 1.097 . . . . 71.409999999999997 110.911 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.2 69.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.058 -0.519 . . . . 65.120000000000005 111.655 178.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 119' ' ' PHE . 9.6 tt -70.92 -35.4 72.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.849 0.356 . . . . 74.430000000000007 110.576 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 tp -67.12 -38.65 85.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.938 -0.574 . . . . 73.010000000000005 110.522 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -71.86 -29.06 63.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.407 -0.517 . . . . 73.310000000000002 111.184 177.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.28 -38.02 68.9 Favored 'General case' 0 C--O 1.203 -1.368 0 C-N-CA 119.037 -1.065 . . . . 73.200000000000003 109.075 173.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -64.34 -33.14 75.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.205 -0.665 . . . . 74.219999999999999 109.205 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.52 73.48 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.345 -0.843 . . . . 75.409999999999997 109.613 174.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.98 70.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.563 0.697 . . . . 74.310000000000002 111.477 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.6 -29.92 52.2 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.92 -0.582 . . . . 72.25 109.755 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.51 14.1 65.98 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.824 -0.625 . . . . 75.540000000000006 112.41 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mm -64.0 138.9 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.962 0.905 . . . . 75.230000000000004 111.254 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 76.3 mt-30 -119.25 147.47 44.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.952 -0.567 . . . . 72.109999999999999 110.499 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.5 m -82.95 134.55 35.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 115.029 -0.987 . . . . 55.340000000000003 108.807 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.4 tp -150.69 -165.43 2.27 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.008 -2.219 . . . . 75.019999999999996 105.008 -179.371 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.573 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 80.0 mt-30 -42.2 139.33 1.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.727 0.811 . . . . 74.319999999999993 111.649 176.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.47 20.69 0.97 Allowed Glycine 0 CA--C 1.505 -0.543 0 CA-C-N 115.363 -0.835 . . . . 64.329999999999998 115.032 -170.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 52' ' ' GLN . 20.8 t-20 -86.96 -37.19 17.8 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.316 -1.365 . . . . 71.209999999999994 107.316 175.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -173.92 158.6 3.21 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.195 -0.911 . . . . 73.519999999999996 112.235 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -91.63 151.76 20.55 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.042 -0.981 . . . . 75.430000000000007 111.36 -174.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 22.2 mt -80.88 121.0 25.43 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 115.771 -0.65 . . . . 74.0 110.978 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.13 151.14 37.61 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.731 -1.211 . . . . 61.549999999999997 107.731 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 39.3 Cg_exo -59.44 156.09 37.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.42 2.08 . . . . 72.230000000000004 112.882 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -118.86 -29.41 5.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.572 -0.74 . . . . 72.519999999999996 109.568 176.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -96.52 105.28 17.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.822 -0.626 . . . . 75.439999999999998 109.587 179.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 76.0 m-85 -115.8 114.8 25.25 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.802 -0.444 . . . . 74.120000000000005 109.802 178.24 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.8 119.97 61.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.584 -1.265 . . . . 74.310000000000002 107.584 177.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.42 135.69 41.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.664 -1.236 . . . . 64.299999999999997 107.664 -178.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 27.3 m -124.37 113.36 18.09 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 72.310000000000002 109.685 -177.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.3 -176.89 3.15 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.755 -0.657 . . . . 73.329999999999998 110.26 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.48 173.6 44.17 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.248 -1.141 . . . . 63.340000000000003 110.248 177.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.9 p -65.82 -44.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 117.131 0.466 . . . . 71.209999999999994 111.224 -179.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -56.51 -42.34 78.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.05 0.929 . . . . 74.400000000000006 110.033 177.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 12.6 m-20 -71.94 -37.78 69.93 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.299 -1.318 . . . . 73.430000000000007 110.446 -176.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.7 -37.78 88.77 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.655 -0.498 . . . . 74.329999999999998 109.655 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.5 mt-10 -61.23 -36.96 81.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.693 -0.685 . . . . 75.540000000000006 110.229 177.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.81 -23.88 41.76 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.975 -0.557 . . . . 75.219999999999999 112.362 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 89.5 mt -61.23 -42.29 98.35 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.714 -0.476 . . . . 73.140000000000001 109.714 177.387 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.21 166.65 10.75 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 119.622 -1.275 . . . . 55.240000000000002 113.299 175.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.89 -18.24 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.721 0.408 . . . . 75.299999999999997 111.575 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -115.72 85.4 14.09 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.084 -0.71 . . . . 75.25 109.084 177.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.13 -50.0 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.143 1.895 . . . . 73.129999999999995 112.282 -178.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.27 -49.48 73.89 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.53 0.567 . . . . 74.409999999999997 112.53 -173.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.74 -37.02 82.68 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 112.29 0.478 . . . . 71.239999999999995 112.29 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -77.42 -26.7 51.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.687 -0.405 . . . . 74.310000000000002 111.009 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.1 m -65.57 -40.41 92.75 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.876 -0.416 . . . . 62.210000000000001 109.876 175.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 m -59.79 -39.23 84.24 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.389 0.614 . . . . 73.299999999999997 109.964 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.85 55.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.582 -0.736 . . . . 74.140000000000001 111.976 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -68.95 -28.35 66.55 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.117 0.484 . . . . 74.310000000000002 110.03 -178.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.9 -38.79 86.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 116.147 -0.479 . . . . 74.329999999999998 109.757 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.36 -38.43 89.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 109.564 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -65.31 -42.66 92.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.992 -0.549 . . . . 70.099999999999994 110.344 177.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.15 -33.24 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.373 -0.376 . . . . 74.450000000000003 110.827 178.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.2 98.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.462 -0.569 . . . . 62.229999999999997 109.462 176.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.2 t70 -61.68 -44.18 97.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.304 -0.862 . . . . 73.150000000000006 109.453 177.189 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 m-85 -57.65 -52.96 63.28 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.671 0.619 . . . . 74.129999999999995 112.671 176.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.8 pt -64.59 -30.18 49.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.693 -0.403 . . . . 74.329999999999998 111.705 -176.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -38.31 85.89 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.123 -0.49 . . . . 75.310000000000002 110.366 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 51.3 mt-10 -65.67 -30.55 71.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.951 -0.568 . . . . 75.420000000000002 111.162 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.0 mm-40 -85.52 -11.43 54.18 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.807 -0.633 . . . . 70.340000000000003 110.941 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.66 33.08 60.92 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.764 -0.653 . . . . 65.439999999999998 113.065 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -97.99 161.34 13.77 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.496 -0.482 . . . . 74.540000000000006 110.122 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.95 161.71 18.43 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.021 -0.733 . . . . 74.219999999999999 109.021 178.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -161.1 172.26 17.12 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.576 -1.638 . . . . 74.150000000000006 106.576 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -123.51 120.14 32.03 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 71.450000000000003 110.235 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.74 13.07 Favored Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 109.751 -1.34 . . . . 71.450000000000003 109.751 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.08 141.32 30.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.542 -0.91 . . . . 72.019999999999996 108.542 174.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.37 138.32 21.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.293 -1.002 . . . . 72.329999999999998 108.293 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.19 124.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 121.152 0.501 . . . . 64.310000000000002 111.125 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 15.3 m -108.87 140.54 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 106.643 -1.614 . . . . 74.450000000000003 106.643 172.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.38 144.92 48.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.512 -0.922 . . . . 74.510000000000005 108.512 177.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -111.77 126.93 55.59 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.413 0.445 . . . . 74.349999999999994 110.184 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.5 pt-20 -128.26 168.49 15.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.936 -1.505 . . . . 74.040000000000006 106.936 173.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.35 156.93 34.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 112.004 -177.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 74.5 m -130.48 101.77 5.87 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.171 -1.418 . . . . 74.439999999999998 107.171 169.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -68.14 -9.38 46.17 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 123.948 0.899 . . . . 75.329999999999998 112.941 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.0 -25.66 48.14 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.746 -0.835 . . . . 65.129999999999995 108.746 174.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -104.48 151.45 23.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.66 -1.237 . . . . 75.430000000000007 107.66 -177.235 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -139.65 171.8 13.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 117.563 0.165 . . . . 73.25 111.307 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 m -36.02 112.87 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.28 2.232 . . . . 71.510000000000005 113.057 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.35 -33.07 3.74 Favored Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 107.848 -2.101 . . . . 74.019999999999996 107.848 -175.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -105.73 139.21 40.65 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.908 -1.516 . . . . 74.329999999999998 106.908 174.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' CE2' HD11 ' A' ' 39' ' ' LEU . 32.7 p90 -170.45 154.19 4.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.783 -0.821 . . . . 74.230000000000004 108.783 174.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -128.72 157.97 39.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.963 -0.562 . . . . 75.140000000000001 110.261 -177.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.47 144.15 22.62 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.092 -1.818 . . . . 73.209999999999994 106.092 174.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 33.2 ptt-85 -140.41 145.95 37.69 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.436 -0.579 . . . . 72.239999999999995 109.436 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 110.06 0.93 Allowed Glycine 0 C--N 1.284 -2.326 0 O-C-N 124.206 0.942 . . . . 75.219999999999999 111.81 -176.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.6 m -109.25 137.84 46.51 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.65 -0.5 . . . . 73.219999999999999 109.65 -179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.07 109.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.992 -1.855 . . . . 71.400000000000006 105.992 170.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.16 105.88 31.39 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.437 -0.579 . . . . 63.240000000000002 109.437 179.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.5 -11.37 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.165 1.91 . . . . 71.030000000000001 111.689 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -93.72 72.19 4.23 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-O 123.297 1.522 . . . . 74.310000000000002 109.057 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.9 p -142.21 143.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 104.614 -2.365 . . . . 73.239999999999995 104.614 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.21 134.95 44.51 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.694 0.759 . . . . 70.420000000000002 111.109 -179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -147.12 136.61 22.8 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.527 -1.215 . . . . 75.129999999999995 108.002 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.023 -1.103 . . . . 75.219999999999999 108.023 -178.633 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 73.140000000000001 109.14 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.37 9.78 10.11 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.667 -0.778 . . . . 73.400000000000006 111.437 -178.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -79.2 84.67 5.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.536 0.684 . . . . 74.140000000000001 109.722 178.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -113.39 163.69 14.54 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.078 -0.965 . . . . 72.120000000000005 110.976 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.2 150.21 24.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.197 -0.91 . . . . 72.540000000000006 108.903 -178.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -93.09 93.96 8.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 105.408 -2.071 . . . . 75.510000000000005 105.408 170.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.82 -40.32 94.85 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 74.530000000000001 112.247 -173.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t 65.44 91.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 124.18 0.925 . . . . 74.150000000000006 110.263 -176.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -156.9 123.55 5.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.444 -1.317 . . . . 74.430000000000007 107.444 178.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -83.79 134.49 34.72 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.213 -1.032 . . . . 74.420000000000002 108.213 178.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.81 98.38 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.397 -0.964 . . . . 63.310000000000002 108.397 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.12 152.76 43.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.366 -1.288 . . . . 65.450000000000003 112.104 -176.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -119.66 79.15 1.39 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.477 -0.783 . . . . 74.219999999999999 109.129 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 14' ' ' LYS . 3.9 ttpm? -109.17 84.67 1.96 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.891 -1.151 . . . . 75.430000000000007 107.891 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -77.72 -40.62 40.62 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.333 -1.358 . . . . 65.430000000000007 107.333 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -138.92 154.62 48.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.525 -1.287 . . . . 74.310000000000002 107.525 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.64 152.16 24.93 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 123.322 0.389 . . . . 73.340000000000003 110.092 -178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 m -69.07 109.53 4.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.319 -0.993 . . . . 64.25 108.319 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.44 145.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 109.105 -0.702 . . . . 75.329999999999998 109.105 -175.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.06 22.98 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 109.762 -1.335 . . . . 70.230000000000004 109.762 -175.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.85 111.77 9.52 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.482 -1.303 . . . . 73.120000000000005 107.482 -178.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.49 -56.92 9.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.652 0.982 . . . . 63.210000000000001 113.652 -174.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.06 -42.61 96.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.69 0.626 . . . . 72.420000000000002 112.69 -175.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.27 96.7 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.801 0.334 . . . . 75.310000000000002 111.193 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -69.59 -41.57 75.58 Favored 'General case' 0 N--CA 1.393 -3.306 0 C-N-CA 124.275 1.03 . . . . 73.109999999999999 111.464 -178.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.54 -55.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.024 0.379 . . . . 74.310000000000002 112.024 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.52 -29.79 17.67 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.939 1.089 . . . . 75.239999999999995 113.939 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.95 -67.74 1.36 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.759 -0.734 . . . . 70.430000000000007 113.588 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.55 -79.44 1.2 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.711 -0.28 . . . . 71.450000000000003 112.87 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -81.3 91.72 6.27 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 74.329999999999998 109.027 -179.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.3 pt -108.41 19.42 5.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.32 -0.855 . . . . 73.519999999999996 110.728 -175.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.17 123.73 47.74 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 113.222 0.823 . . . . 71.430000000000007 113.222 -173.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.67 -12.63 22.26 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.261 1.974 . . . . 74.409999999999997 109.388 174.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -61.9 -20.84 64.19 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 113.43 -1.714 . . . . 73.140000000000001 110.884 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.51 -47.78 69.58 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 123.465 0.706 . . . . 75.099999999999994 109.111 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.36 -44.81 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.272 -0.876 . . . . 74.099999999999994 109.917 -178.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.87 -53.42 56.98 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 116.025 -0.534 . . . . 63.009999999999998 111.352 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.55 86.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.707 -0.679 . . . . 72.329999999999998 111.201 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.36 -41.76 84.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.85 -0.426 . . . . 74.430000000000007 109.85 -178.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.52 -43.4 80.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.581 0.586 . . . . 75.299999999999997 112.581 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -68.65 -29.55 68.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.788 -0.765 . . . . 75.319999999999993 110.78 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -70.06 -38.79 75.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.141 -0.689 . . . . 72.049999999999997 109.141 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.9 -38.15 90.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.962 -0.755 . . . . 74.319999999999993 108.962 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.42 92.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 74.209999999999994 110.421 176.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.91 -31.88 71.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 74.099999999999994 111.468 -178.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.37 -33.55 61.06 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 111.217 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.58 15.53 40.74 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.813 -0.631 . . . . 71.129999999999995 112.94 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.421 HD12 ' CD2' ' A' ' 98' ' ' TRP . 12.2 mm -67.02 130.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 123.332 0.653 . . . . 72.239999999999995 112.132 179.09 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -116.02 147.41 41.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.353 -0.839 . . . . 74.219999999999999 109.622 176.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.6 m -77.55 102.92 7.19 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.163 0.982 . . . . 64.040000000000006 111.484 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.5 tp -105.2 -165.96 1.18 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.246 -2.131 . . . . 75.319999999999993 105.246 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.5 mt-30 -51.06 138.25 20.12 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.348 -0.982 . . . . 72.109999999999999 108.348 171.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.91 22.47 0.57 Allowed Glycine 0 N--CA 1.471 0.982 0 N-CA-C 114.782 0.673 . . . . 52.119999999999997 114.782 -171.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 52' ' ' GLN . 15.9 m120 -104.27 -25.23 12.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.266 -1.013 . . . . 64.319999999999993 108.266 177.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -161.51 134.66 6.31 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.28 -0.873 . . . . 74.400000000000006 110.54 -177.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.0 151.88 19.28 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.783 -0.644 . . . . 75.439999999999998 110.61 -175.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.01 126.6 36.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.159 -1.052 . . . . 74.430000000000007 108.159 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.24 160.41 37.59 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 123.181 0.592 . . . . 70.040000000000006 109.805 -178.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.15 157.99 59.06 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.611 2.208 . . . . 74.540000000000006 111.921 176.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -126.38 -25.12 3.53 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.174 0.435 . . . . 71.430000000000007 112.174 -177.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.48 110.38 21.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.551 -0.537 . . . . 73.319999999999993 109.551 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 55.1 m-85 -116.88 119.16 34.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.434 -0.803 . . . . 73.129999999999995 110.076 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.2 118.99 56.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.669 -0.863 . . . . 73.010000000000005 108.669 177.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.1 mp -112.48 124.96 69.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.462 -0.94 . . . . 75.340000000000003 108.462 178.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -119.42 133.64 55.61 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.997 -0.742 . . . . 74.099999999999994 108.997 -178.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.58 173.36 7.23 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.209 0.604 . . . . 75.140000000000001 110.226 175.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.51 166.44 45.57 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 108.846 -1.701 . . . . 72.120000000000005 108.846 172.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 95.1 t -59.07 -59.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 117.666 0.733 . . . . 74.209999999999994 110.885 -178.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.483 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 40.8 t-80 -53.44 -49.17 67.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 75.219999999999999 110.809 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -58.2 -50.38 73.75 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.62 1.168 . . . . 63.130000000000003 111.134 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.24 -40.08 93.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.354 -0.384 . . . . 74.140000000000001 111.24 -176.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 53.5 mt-10 -65.78 -31.27 72.15 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.856 0.36 . . . . 74.329999999999998 111.074 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.6 mptt -79.32 -27.51 42.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 111.266 178.007 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 61.3 mt -75.49 -33.25 60.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.802 . . . . 72.109999999999999 108.833 175.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.01 116.16 1.65 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.833 -1.707 . . . . 72.209999999999994 108.833 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -77.76 1.51 19.89 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.063 0.394 . . . . 62.32 112.063 -176.24 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 25.4 t70 -80.58 101.88 1.07 Allowed Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 124.215 1.006 . . . . 73.299999999999997 109.226 176.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 72.9 Cg_endo -75.92 -33.47 3.7 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.44 2.093 . . . . 72.319999999999993 115.871 -171.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.05 -49.11 71.38 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 112.776 0.658 . . . . 75.140000000000001 112.776 -170.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.96 -15.99 62.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.846 0.355 . . . . 74.450000000000003 111.864 -177.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 75.6 mmtt -81.68 -57.64 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.511 -0.922 . . . . 65.209999999999994 108.511 175.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -53.74 50.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.078 -0.965 . . . . 74.530000000000001 111.308 -173.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.9 m -69.95 -35.5 74.56 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.639 -0.255 . . . . 70.409999999999997 111.195 -177.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.09 -51.05 59.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.284 -0.484 . . . . 75.310000000000002 112.01 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 71.7 m-85 -72.65 -36.03 67.88 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 112.493 0.553 . . . . 73.519999999999996 112.493 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.49 96.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.666 -0.414 . . . . 62.409999999999997 110.739 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -63.83 -49.09 74.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.977 -0.556 . . . . 75.310000000000002 110.559 178.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -67.29 -37.31 83.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 65.230000000000004 111.552 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 tp -74.05 -34.93 64.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 73.239999999999995 111.005 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.11 89.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.814 -0.81 . . . . 63.229999999999997 108.814 175.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.36 -48.83 74.03 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.968 -1.014 . . . . 74.230000000000004 109.736 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.593 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.9 m-85 -52.08 -53.33 43.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.906 0.706 . . . . 71.430000000000007 112.906 176.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.4 pt -62.09 -36.53 74.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 120.594 -0.443 . . . . 73.299999999999997 111.494 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.56 -41.68 79.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.291 . . . . 65.140000000000001 110.861 177.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -59.27 -41.02 87.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.026 0.441 . . . . 63.240000000000002 111.194 177.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 78.6 mm-40 -72.99 -13.37 61.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.009 -0.542 . . . . 73.450000000000003 112.21 -178.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.13 36.07 13.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.37 -0.919 . . . . 63.100000000000001 111.06 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.421 ' CD2' HD12 ' A' ' 48' ' ' ILE . 21.3 m0 -113.21 170.91 7.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.194 -1.039 . . . . 74.200000000000003 108.194 175.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -151.62 178.19 9.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.691 -0.855 . . . . 72.230000000000004 108.691 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -150.52 177.91 9.57 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.518 -0.549 . . . . 75.120000000000005 109.518 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -111.66 121.04 44.05 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 178.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.96 -149.68 17.05 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.222 -1.151 . . . . 64.129999999999995 110.222 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' H ' ' HB ' ' A' ' 129' ' ' VAL . 32.2 t70 -121.78 147.19 46.26 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.166 -0.679 . . . . 74.219999999999999 109.166 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.9 125.16 39.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 110.844 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.04 120.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 121.789 0.804 . . . . 74.329999999999998 109.984 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.3 t -117.78 112.43 38.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.212 -1.403 . . . . 74.439999999999998 107.212 179.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -115.97 138.87 50.8 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 111.934 0.346 . . . . 75.030000000000001 111.934 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -119.18 134.9 54.94 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.269 -1.011 . . . . 75.200000000000003 108.269 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -156.17 164.16 38.72 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 123.563 0.539 . . . . 64.409999999999997 111.232 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -95.46 164.91 12.61 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.106 -0.497 . . . . 72.230000000000004 111.241 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 p -150.36 150.21 31.12 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 115.444 -0.798 . . . . 71.420000000000002 109.647 177.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -80.78 -22.83 39.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.607 -0.516 . . . . 73.109999999999999 109.607 176.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.93 -28.1 68.67 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.469 0.707 . . . . 71.510000000000005 110.756 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.3 mt -96.5 135.92 37.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.917 -0.583 . . . . 74.420000000000002 110.716 -178.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -110.66 172.06 7.1 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.638 -1.616 . . . . 74.5 106.638 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.564 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 97.4 m -58.91 126.29 27.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.966 1.469 . . . . 70.310000000000002 114.966 -174.129 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.64 -8.79 47.57 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 114.18 -1.373 . . . . 73.319999999999993 111.443 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -104.53 135.68 45.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.75 0.309 . . . . 74.530000000000001 110.865 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.01 151.04 37.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.24 -1.022 . . . . 74.109999999999999 108.24 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 53.8 mtm180 -124.67 143.21 50.86 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.855 -1.165 . . . . 75.209999999999994 107.855 177.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.85 118.3 10.3 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.292 -1.744 . . . . 71.230000000000004 106.292 173.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 23.1 tpt180 -120.3 121.67 39.17 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 120.05 -0.66 . . . . 74.420000000000002 110.058 -177.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.09 119.25 6.43 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.607 -1.397 . . . . 44.229999999999997 109.607 176.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.3 p -126.06 156.62 39.68 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 110.081 -0.34 . . . . 73.140000000000001 110.081 -178.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.52 110.74 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 107.199 -1.408 . . . . 64.329999999999998 107.199 175.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -117.4 96.29 49.02 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.408 -0.96 . . . . 74.510000000000005 108.408 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.28 -23.75 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.333 2.022 . . . . 71.340000000000003 111.848 -177.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.37 69.95 4.31 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.404 1.097 . . . . 72.430000000000007 111.223 -176.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 103' ' ' ASP . 44.0 t -123.85 97.81 4.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.469 -2.048 . . . . 73.140000000000001 105.469 171.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.08 98.9 10.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.816 -0.629 . . . . 64.519999999999996 111.161 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 t -103.77 123.65 47.45 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 107.621 -1.252 . . . . 64.129999999999995 107.621 177.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--N 1.311 -1.084 0 N-CA-C 108.53 -0.915 . . . . 74.299999999999997 108.53 -176.345 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 108.707 -0.849 . . . . 74.420000000000002 108.707 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.95 89.19 0.51 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.004 -1.238 . . . . 74.420000000000002 110.004 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -150.85 119.35 6.46 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.91 -0.774 . . . . 74.120000000000005 108.91 -176.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -169.6 131.19 1.1 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.34 -0.615 . . . . 71.0 109.34 177.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 162.53 35.25 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.778 -0.823 . . . . 70.430000000000007 108.778 178.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -148.24 79.19 1.45 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.905 0.859 . . . . 74.310000000000002 110.308 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -114.62 96.14 5.6 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 104.756 -2.312 . . . . 74.420000000000002 104.756 175.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.0 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.622 -0.717 . . . . 75.299999999999997 109.797 -175.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -80.31 105.05 11.27 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.501 -1.666 . . . . 72.25 106.501 174.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -75.87 81.49 2.78 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.031 0.919 . . . . 75.430000000000007 111.687 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.2 126.35 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 113.851 -1.522 . . . . 73.439999999999998 107.86 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -65.86 136.0 55.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.47 -0.786 . . . . 74.439999999999998 110.934 -178.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.24 143.8 40.76 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.272 -1.01 . . . . 73.219999999999999 108.272 178.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -80.6 87.76 5.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.497 -1.297 . . . . 75.439999999999998 107.497 175.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.43 140.77 58.07 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.168 -1.378 . . . . 74.340000000000003 109.758 -177.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -98.42 136.61 38.32 Favored 'General case' 0 N--CA 1.402 -2.842 0 C-N-CA 119.408 -0.917 . . . . 75.310000000000002 110.298 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -83.92 86.99 7.1 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.981 -1.859 . . . . 71.030000000000001 105.981 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -72.3 92.14 1.38 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.051 -0.977 . . . . 75.409999999999997 112.514 -174.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -73.8 128.38 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 CA-C-N 114.866 -1.061 . . . . 74.310000000000002 108.906 178.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.91 -4.48 61.14 Favored Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.62 -0.8 . . . . 73.109999999999999 111.654 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.56 86.18 6.4 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.682 0.754 . . . . 74.019999999999996 110.3 177.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.52 -59.13 4.67 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.013 -1.449 . . . . 72.129999999999995 110.838 -176.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -51.78 -49.71 62.16 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.426 0.691 . . . . 75.230000000000004 112.12 -176.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.21 -43.11 87.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.105 -0.498 . . . . 73.319999999999993 111.027 178.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -81.77 -19.47 41.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.496 1.295 . . . . 74.519999999999996 114.496 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.87 -41.74 92.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.89 -0.781 . . . . 64.109999999999999 108.89 171.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 50.9 m-85 -84.62 -17.16 39.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.842 -0.617 . . . . 74.409999999999997 110.439 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -65.37 4.08 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.596 -0.602 . . . . 63.210000000000001 111.596 178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 25.79 2.61 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.143 0.417 . . . . 72.439999999999998 114.143 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.1 p 51.78 75.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.161 1.385 . . . . 74.329999999999998 113.876 178.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.513 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 68.6 mt -94.9 100.7 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 107.323 -1.362 . . . . 75.409999999999997 107.323 175.629 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.79 132.25 58.13 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.416 -0.957 . . . . 72.120000000000005 108.416 -177.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -65.65 29.21 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.916 3.077 . . . . 71.349999999999994 114.731 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.46 -21.11 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.719 -0.613 . . . . 72.010000000000005 111.491 -177.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.56 -34.48 74.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.011 -0.366 . . . . 74.140000000000001 110.011 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 59.3 t -56.22 -50.5 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 74.450000000000003 110.111 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.82 -43.31 98.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.547 -178.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.14 89.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.666 -0.697 . . . . 54.219999999999999 110.822 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.6 -23.92 58.8 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.832 0.679 . . . . 72.129999999999995 112.832 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.6 mt -67.26 -37.43 83.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 73.430000000000007 110.294 175.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -65.26 -42.0 93.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.643 0.735 . . . . 75.329999999999998 109.242 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -71.7 -28.68 63.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.415 -0.811 . . . . 75.209999999999994 111.316 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 29.9 tp10 -68.92 -44.67 72.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.192 -0.67 . . . . 71.349999999999994 109.192 176.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -59.99 -41.58 92.33 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.642 -0.708 . . . . 72.219999999999999 109.728 176.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.62 -36.49 80.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.545 -0.752 . . . . 52.329999999999998 111.147 177.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.96 -39.49 83.36 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 64.319999999999993 111.247 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.92 5.96 80.64 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.747 -0.661 . . . . 65.200000000000003 113.697 -178.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 44' ' ' ALA . 10.8 mm -58.91 130.38 22.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.589 0.709 . . . . 75.040000000000006 112.112 178.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -116.19 134.71 54.62 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.356 -0.838 . . . . 74.299999999999997 110.056 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -72.52 106.59 4.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.804 -1.089 . . . . 72.140000000000001 109.694 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.9 tp -109.16 -164.69 0.96 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.796 -1.557 . . . . 61.5 106.796 -177.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 16.1 mm100 -51.52 162.49 0.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.651 0.781 . . . . 73.239999999999995 112.307 176.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -7.48 38.21 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-N 114.946 -1.024 . . . . 74.530000000000001 113.7 -175.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -68.38 -48.63 64.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 71.120000000000005 108.797 177.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -176.27 167.77 2.84 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.774 1.027 . . . . 75.299999999999997 113.774 -177.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.11 151.26 21.06 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.486 -1.234 . . . . 71.120000000000005 111.153 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.95 126.28 43.28 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.664 -1.236 . . . . 74.239999999999995 107.664 -177.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.82 158.06 35.13 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 123.548 0.739 . . . . 54.520000000000003 109.648 -178.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.84 158.27 38.91 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.893 2.396 . . . . 63.450000000000003 113.087 178.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -124.81 -30.16 3.31 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.631 -0.713 . . . . 73.549999999999997 110.448 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.67 107.96 19.62 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.048 0.939 . . . . 64.5 108.596 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -116.22 118.12 31.91 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.885 0.374 . . . . 71.549999999999997 110.353 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.52 114.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.114 -0.698 . . . . 72.120000000000005 109.114 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 2.3 mp -109.27 132.39 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.678 -1.23 . . . . 75.219999999999999 107.678 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.2 m -137.39 135.88 37.36 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.951 -0.389 . . . . 72.329999999999998 109.951 -177.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -130.17 -179.38 5.2 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.303 -0.629 . . . . 74.219999999999999 109.303 175.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.03 53.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.86 -1.296 . . . . 71.400000000000006 109.86 175.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 110' ' ' GLN . 43.4 t -56.25 -56.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 117.443 0.621 . . . . 74.430000000000007 111.83 -175.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.602 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 50.4 t-80 -59.12 -45.14 91.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.462 0.476 . . . . 75.239999999999995 110.555 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.85 -43.19 99.46 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 70.329999999999998 109.753 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.27 -39.44 82.18 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.382 -0.826 . . . . 73.430000000000007 111.12 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 36.5 mt-10 -65.25 -28.58 69.45 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.648 0.261 . . . . 63.329999999999998 111.607 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 0.4 OUTLIER -78.57 -23.33 46.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 120.017 -0.673 . . . . 74.209999999999994 109.686 178.686 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.22 -36.79 74.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 73.299999999999997 109.916 174.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.21 158.32 8.59 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.821 -0.912 . . . . 54.140000000000001 110.821 177.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.8 -6.92 57.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 111.872 0.323 . . . . 74.349999999999994 111.872 -177.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.72 103.31 46.32 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.691 -0.231 . . . . 74.420000000000002 111.594 -179.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.43 -36.55 8.83 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.62 1.547 . . . . 61.219999999999999 109.86 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.52 -29.19 66.75 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.148 0.796 . . . . 73.319999999999993 113.148 -176.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.84 -42.94 94.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.77 -1.567 . . . . 73.109999999999999 106.77 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.69 -38.79 77.12 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.476 -1.238 . . . . 75.420000000000002 109.456 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' HG11 ' A' ' 106' ' ' VAL . 65.2 m -58.22 -48.36 80.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.353 -0.385 . . . . 60.509999999999998 111.02 177.359 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -57.8 -49.01 78.04 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 123.391 0.432 . . . . 70.150000000000006 110.69 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.18 -55.73 19.82 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.719 -0.673 . . . . 74.510000000000005 112.904 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -67.41 -37.12 82.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.741 1.015 . . . . 73.040000000000006 113.741 -175.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -66.6 -45.02 80.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.527 . . . . 75.319999999999993 110.697 -179.314 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.36 -40.01 89.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 74.049999999999997 110.3 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.52 -53.32 53.74 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.166 -0.925 . . . . 74.329999999999998 111.064 178.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.11 -30.34 70.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 75.420000000000002 111.334 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.8 78.55 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.178 0.513 . . . . 63.340000000000003 110.033 176.516 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.69 -39.7 73.34 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.599 -0.889 . . . . 75.400000000000006 108.599 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 22.0 m-85 -56.83 -52.18 66.08 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.532 -0.758 . . . . 75.340000000000003 112.494 175.346 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.1 pt -61.63 -37.27 77.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.357 -0.537 . . . . 75.219999999999999 111.093 -177.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.32 -38.18 84.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.326 -0.397 . . . . 72.109999999999999 110.567 176.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -60.46 -44.0 96.32 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 64.010000000000005 111.051 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.5 mm-40 -75.91 -13.7 60.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.455 -0.793 . . . . 70.430000000000007 110.837 -178.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.89 35.68 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.928 -0.578 . . . . 75.400000000000006 112.442 177.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.75 172.56 7.18 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.891 -0.781 . . . . 74.340000000000003 108.891 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.35 173.45 11.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.524 -0.547 . . . . 63.539999999999999 109.524 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 t -157.53 177.84 10.96 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.331 -1.729 . . . . 74.239999999999995 106.331 177.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.07 117.48 34.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.686 -1.227 . . . . 75.340000000000003 107.686 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.82 -149.64 16.75 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.282 -1.927 . . . . 71.420000000000002 108.282 -177.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.68 169.61 15.93 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.387 -1.338 . . . . 74.209999999999994 107.387 171.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 99.7 t -73.01 120.88 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.825 0.345 . . . . 72.019999999999996 111.287 -174.32 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -115.5 120.0 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.695 -0.854 . . . . 72.129999999999995 108.695 176.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 86' ' ' ALA . 13.9 p -119.69 129.02 75.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.516 0.674 . . . . 74.219999999999999 110.435 -176.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -115.8 138.07 51.49 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.339 -0.846 . . . . 73.319999999999993 109.983 -178.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -121.41 132.69 54.89 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.189 -1.412 . . . . 74.310000000000002 107.189 179.003 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.94 174.79 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.266 0.555 . . . . 74.400000000000006 111.02 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . 17.0 pm0 -110.18 151.94 26.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.063 -0.971 . . . . 73.140000000000001 110.612 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -141.42 132.28 25.91 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 107.24 -1.392 . . . . 71.340000000000003 107.24 176.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -81.6 -22.7 37.53 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.928 -0.767 . . . . 75.030000000000001 108.928 176.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -73.0 -30.21 63.61 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.598 0.714 . . . . 75.209999999999994 109.318 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -81.13 141.7 34.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.68 144.22 28.7 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.894 -0.594 . . . . 73.099999999999994 112.037 -171.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.9 m -64.84 124.54 22.25 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.85 -0.614 . . . . 75.230000000000004 109.567 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.27 -22.89 24.08 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.26 -1.136 . . . . 72.450000000000003 110.26 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -95.04 152.37 18.38 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.254 -1.017 . . . . 74.140000000000001 108.254 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.461 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 31.5 p90 -148.37 146.84 28.68 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.017 -1.475 . . . . 70.340000000000003 107.017 174.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 64.9 mtp180 -126.6 144.64 50.83 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.771 -0.455 . . . . 75.319999999999993 109.771 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.71 122.95 19.32 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.298 -1.371 . . . . 74.019999999999996 107.298 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.483 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 26.1 tpt180 -131.39 130.0 42.04 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.946 -0.702 . . . . 74.109999999999999 111.178 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -102.27 126.43 8.87 Favored Glycine 0 N--CA 1.425 -2.077 0 O-C-N 124.072 0.857 . . . . 72.109999999999999 111.059 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.1 m -122.82 146.57 47.43 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.662 -0.866 . . . . 73.510000000000005 108.662 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.1 t -95.66 105.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.184 -1.413 . . . . 74.329999999999998 107.184 174.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.48 100.14 51.15 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 120.871 -0.332 . . . . 70.200000000000003 110.206 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.21 -3.71 4.49 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 121.994 1.796 . . . . 75.420000000000002 110.901 175.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -92.59 29.14 1.81 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 64.129999999999995 109.708 -175.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.4 123.81 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 CA-C-O 121.702 0.763 . . . . 64.120000000000005 110.621 -178.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.81 147.02 24.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.626 -1.99 . . . . 74.049999999999997 105.626 168.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 m -30.41 115.51 0.13 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.112 1.765 . . . . 75.319999999999993 114.446 -174.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 107.188 -1.412 . . . . 74.409999999999997 107.188 177.56 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' CD ' ' A' ' 37' ' ' GLU . 95.1 mt-30 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 113.572 0.953 . . . . 73.35 113.572 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -71.33 -23.93 62.02 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.244 -1.021 . . . . 71.51 108.244 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 119' ' ' PHE . 98.4 t -69.12 -54.72 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.352 -0.84 . . . . 54.13 108.844 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 34' ' ' GLN . 2.7 mp0 -52.64 -43.9 65.75 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.053 0.454 . . . . 71.04 110.769 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.72 -54.53 43.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.087 -0.96 . . . . 74.33 111.399 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.5 tp -74.53 -25.18 59.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.782 -0.367 . . . . 51.02 110.857 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.17 -47.83 72.69 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.688 0.795 . . . . 73.34 109.966 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -71.09 -27.95 63.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.152 0.501 . . . . 62.43 110.182 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.16 -42.38 84.43 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.49 -0.777 . . . . 74.33 109.035 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.18 -32.6 70.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 72.55 109.434 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.36 95.67 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.923 -0.581 . . . . 74.01 109.739 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -65.31 -35.17 80.19 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.613 0.721 . . . . 54.14 110.441 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -16.56 60.5 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.339 -0.846 . . . . 74.12 110.808 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.06 7.9 41.52 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 116.156 -0.475 . . . . 63.32 112.666 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 45' ' ' ALA . 29.2 mm -65.97 127.51 27.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 120.984 0.421 . . . . 74.23 110.835 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 62.5 tt0 -105.7 124.43 49.55 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.192 -1.04 . . . . 74.02 108.192 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -60.9 109.27 1.02 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 124.124 0.89 . . . . 31.2 109.961 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.6 tp -122.56 -164.78 1.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.138 -1.801 . . . . 75.34 106.138 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.7 mt-30 -46.35 146.17 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.523 0.729 . . . . 73.33 110.81 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.65 -11.9 38.13 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 114.519 0.568 . . . . 52.41 114.519 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.34 -47.64 40.74 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.791 0.329 . . . . 73.03 110.544 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.442 ' HG3' ' OE1' ' A' ' 99' ' ' GLN . 24.1 ptt180 -158.88 142.92 15.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.581 0.705 . . . . 75.31 112.443 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.5 mt -91.26 151.63 20.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 125.223 1.409 . . . . 64.44 109.933 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 100' ' ' THR . 1.1 tt -90.41 118.28 29.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.045 -1.094 . . . . 73.44 108.045 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.37 153.78 39.53 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.716 -0.675 . . . . 74.0 109.714 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 44.8 Cg_exo -60.2 150.07 81.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.563 2.175 . . . . 75.31 112.014 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.82 -36.16 4.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.876 -0.602 . . . . 71.34 110.959 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -104.24 122.92 46.39 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.062 0.458 . . . . 73.41 109.853 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.1 m-85 -118.55 118.53 31.96 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.228 -0.897 . . . . 74.44 109.53 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.6 109.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.477 -1.305 . . . . 55.34 107.477 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -105.65 107.1 21.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.191 -1.04 . . . . 73.53 108.191 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 53.2 m -111.08 123.69 50.7 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.43 -0.805 . . . . 62.12 110.558 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -116.13 175.62 5.47 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.868 -0.606 . . . . 74.14 109.952 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -71.97 153.84 50.32 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 109.104 -1.598 . . . . 54.54 109.104 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.67 -42.17 80.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 120.81 0.338 . . . . 72.42 110.346 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 5.0 t60 -66.89 -29.9 69.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.272 -0.876 . . . . 71.42 110.532 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 m-20 -76.27 -46.16 29.28 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.634 -0.506 . . . . 73.43 109.634 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.4 -42.53 99.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.559 -0.746 . . . . 74.24 111.877 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 73' ' ' LYS . 10.1 pt-20 -62.82 -34.33 77.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.929 0.395 . . . . 72.01 111.581 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 13.8 mptt -75.47 -27.07 58.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.163 -0.471 . . . . 72.04 111.201 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 66' ' ' LEU . 73.5 mt -72.22 -40.3 67.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.517 -0.92 . . . . 74.14 108.517 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 146.62 6.16 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 109.771 -1.332 . . . . 62.11 109.771 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.57 -18.9 62.9 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 114.401 1.26 . . . . 64.25 114.401 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.39 124.04 76.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 119.595 -0.842 . . . . 72.13 110.472 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -77.39 -35.81 1.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.658 1.572 . . . . 72.42 110.88 167.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.86 -53.29 33.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.432 2.012 . . . . 65.31 116.432 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.38 -32.25 66.26 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.492 0.663 . . . . 72.42 110.389 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.14 -39.16 65.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.909 -1.041 . . . . 71.43 108.955 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.7 t -62.17 -44.13 97.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.301 -0.863 . . . . 63.04 109.883 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -59.13 -45.92 89.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.245 -0.434 . . . . 52.13 110.459 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.93 -48.93 51.6 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.844 -0.616 . . . . 75.22 112.855 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.25 -39.97 78.14 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.233 0.827 . . . . 74.22 113.233 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.7 95.23 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 121.085 -0.246 . . . . 75.33 110.625 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -37.56 87.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 72.04 110.612 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.77 -44.69 69.64 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.253 -0.431 . . . . 71.44 110.523 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.07 -37.96 84.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.127 -0.488 . . . . 71.1 109.844 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.7 71.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.367 0.603 . . . . 61.22 110.485 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 8.2 t70 -68.29 -43.61 77.33 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.148 -1.056 . . . . 72.33 108.148 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.0 m-85 -57.42 -47.68 81.11 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.323 -0.853 . . . . 74.42 112.821 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -62.47 -35.42 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.737 -0.785 . . . . 44.44 111.086 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.76 -45.96 87.46 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.414 -0.587 . . . . 74.41 109.414 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 32.2 mm-40 -60.44 -31.62 70.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.728 0.811 . . . . 61.35 113.078 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.2 mm-40 -90.99 -10.95 40.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.319 -0.401 . . . . 65.04 111.395 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 38.15 35.67 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.702 -0.761 . . . . 65.2 111.424 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -104.49 158.8 16.23 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.741 -0.466 . . . . 73.15 109.741 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.442 ' OE1' ' HG3' ' A' ' 55' ' ' ARG . 4.7 pt20 -126.9 167.54 15.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.573 -0.528 . . . . 64.03 109.573 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.5 t -158.35 179.27 9.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.958 -0.756 . . . . 52.4 108.958 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -130.81 128.73 41.29 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.588 -0.523 . . . . 70.31 109.588 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 -149.98 16.9 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 108.313 -1.915 . . . . 15.3 108.313 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -124.84 141.29 52.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.925 -1.139 . . . . 63.13 107.925 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.75 112.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 123.53 0.518 . . . . 71.41 110.02 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.74 125.61 67.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.852 0.834 . . . . 70.44 111.288 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.2 m -105.02 129.82 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 N-CA-C 108.513 -0.921 . . . . 73.11 108.513 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -106.0 127.17 52.98 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.939 -0.573 . . . . 74.12 109.922 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.61 115.43 29.87 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 75.22 107.877 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.2 pt-20 -145.54 164.02 32.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.992 -0.549 . . . . 62.2 110.218 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -120.11 154.06 35.24 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.236 0.541 . . . . 74.03 111.124 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.6 m -137.81 143.47 41.04 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.597 -0.89 . . . . 55.12 108.597 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -72.5 -20.08 61.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.474 0.654 . . . . 73.31 111.129 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.01 -11.33 59.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.6 -0.727 . . . . 75.45 111.025 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 67' ' ' GLY . 0.7 OUTLIER -101.39 133.9 45.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 105.808 -1.923 . . . . 74.11 105.808 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -93.27 170.3 9.73 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 112.88 0.696 . . . . 64.24 112.88 -173.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -72.59 127.73 33.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.319 -0.855 . . . . 72.33 111.18 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.02 28.94 24.37 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 110.278 -1.129 . . . . 52.23 110.278 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -140.64 151.44 44.61 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.144 -1.058 . . . . 64.44 108.144 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 p90 -152.77 150.91 29.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.478 -1.304 . . . . 74.24 107.478 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -141.96 130.3 22.35 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.694 -0.484 . . . . 53.12 109.694 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.87 121.76 38.78 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.246 -1.39 . . . . 75.43 107.246 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.419 ' HD3' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -121.59 118.33 28.97 Favored 'General case' 0 N--CA 1.398 -3.068 0 C-N-CA 123.408 0.683 . . . . 75.13 109.196 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 122' ' ' ARG . . . -111.54 138.12 14.75 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 110.312 -1.115 . . . . 75.32 110.312 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 t -144.85 163.84 32.88 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.57 103.77 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 106.943 -1.503 . . . . 44.54 106.943 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -118.85 106.41 43.84 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.901 -0.591 . . . . 60.33 110.065 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo . . . . . 0 N--CA 1.451 -0.996 0 C-N-CA 122.053 1.835 . . . . 61.23 110.949 177.096 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.464 0.913 . . . . 75.12 113.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.84 -28.87 60.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.225 0.536 . . . . 71.21 110.296 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 t -71.99 -42.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.646 -0.872 . . . . 71.45 108.646 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 45.2 mt-10 -58.31 -44.27 88.53 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.97 -0.559 . . . . 75.35 109.856 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -49.84 72.53 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 124.043 0.839 . . . . 55.23 111.163 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.16 -37.62 75.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.49 0.552 . . . . 55.01 112.49 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 64' ' ' ILE . 54.7 mt -64.99 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.39 0.515 . . . . 74.12 112.39 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 26.3 ptt180 -71.08 -28.01 64.03 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.104 -0.638 . . . . 72.42 109.808 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -68.9 -40.87 78.92 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 108.526 -0.916 . . . . 73.54 108.526 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.48 -40.69 92.2 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.91 0.484 . . . . 35.54 110.248 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.331 -0.85 . . . . 72.52 110.777 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.11 76.25 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.41 0.624 . . . . 74.3 111.112 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -71.57 -44.96 63.57 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.508 -0.769 . . . . 72.33 110.746 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.57 21.69 20.79 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 115.604 -0.726 . . . . 50.33 113.523 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 48' ' ' ILE . 11.8 mm -61.97 125.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.255 0.55 . . . . 72.31 110.346 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -121.17 137.1 54.83 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.986 -1.007 . . . . 74.51 110.841 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -63.24 118.0 7.37 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.39 -1.277 . . . . 74.23 112.427 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.5 tp -139.03 -165.88 1.92 Allowed 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.318 -2.475 . . . . 71.33 104.318 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.564 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.45 140.35 7.98 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.186 0.594 . . . . 72.32 111.287 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.14 -15.87 57.01 Favored Glycine 0 CA--C 1.505 -0.59 0 CA-C-N 115.896 -0.593 . . . . 74.13 114.408 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.63 -35.56 67.82 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 111.815 0.302 . . . . 55.13 111.815 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 4.4 ptm180 -162.28 131.34 4.31 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.647 0.737 . . . . 65.31 111.083 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.53 152.33 20.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.369 1.467 . . . . 73.33 110.719 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 100' ' ' THR . 55.7 tp -78.08 126.01 30.19 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.54 -0.754 . . . . 63.1 109.909 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 158.57 43.28 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 108.316 -0.994 . . . . 73.34 108.316 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.592 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.5 Cg_exo -60.66 156.7 41.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.135 2.557 . . . . 71.42 113.674 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.66 -27.32 3.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.636 -0.711 . . . . 52.42 110.118 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.41 109.06 21.2 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.804 -0.813 . . . . 71.1 108.804 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 94.6 m-85 -115.66 115.45 26.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.595 -0.73 . . . . 75.12 110.656 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.74 119.51 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.191 -1.04 . . . . 71.53 108.191 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.462 HD11 HD21 ' A' ' 40' ' ' LEU . 15.2 mm -109.48 115.52 49.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.733 -1.21 . . . . 62.52 107.733 176.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 m -108.8 129.17 55.38 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.947 -0.57 . . . . 60.33 110.174 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.1 mm? -124.56 172.72 9.0 Favored 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.939 0.896 . . . . 60.25 109.587 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.33 179.39 53.2 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.057 -0.817 . . . . 41.43 111.057 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.45 -41.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.828 0.677 . . . . 61.44 112.828 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 75.4 t60 -73.04 -28.84 62.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.99 0.9 . . . . 73.22 109.413 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.579 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.5 m-20 -69.21 -44.16 72.67 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.999 -1.001 . . . . 74.23 108.602 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.89 -30.39 66.74 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.386 -0.825 . . . . 61.31 111.749 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 13.0 pt-20 -68.55 -29.94 68.61 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.95 -0.7 . . . . 74.53 110.35 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 14.5 mmmm -68.61 -31.51 70.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.039 -0.982 . . . . 74.21 109.796 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.74 -30.25 59.15 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.613 0.72 . . . . 61.44 109.107 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.7 -163.67 15.41 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.158 -0.928 . . . . 65.25 111.388 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.9 2.33 51.83 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.63 0.729 . . . . 51.3 109.5 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -111.76 97.87 39.14 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 113.542 0.941 . . . . 72.23 113.542 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -78.12 -46.85 0.12 Allowed 'Trans proline' 0 N--CA 1.438 -1.74 0 N-CA-C 109.286 -1.082 . . . . 70.21 109.286 162.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -43.97 -54.3 5.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.558 2.743 . . . . 71.43 116.994 -167.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.14 -51.37 39.05 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.387 -0.525 . . . . 74.1 110.216 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -75.42 -27.06 58.85 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.946 1.091 . . . . 64.13 113.946 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 66.4 p -71.23 -36.25 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.232 -0.587 . . . . 62.33 110.544 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -73.76 -37.42 65.04 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.09 -0.505 . . . . 74.15 109.796 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 87' ' ' ARG . . . -66.08 -41.9 94.82 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.832 -0.907 . . . . 73.13 110.832 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -69.97 -25.14 63.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.194 0.521 . . . . 73.51 109.832 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.27 78.1 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 75.25 110.251 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 34.6 ttp180 -61.79 -45.57 93.28 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.943 -0.762 . . . . 75.34 108.943 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 -49.56 76.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.066 -0.97 . . . . 74.24 110.555 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 40' ' ' LEU . 46.4 tp -64.62 -35.35 80.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.568 . . . . 71.34 111.948 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.9 -36.35 83.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.381 0.61 . . . . 70.22 109.941 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.66 -39.81 84.51 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.558 -0.746 . . . . 73.3 109.203 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 21.2 m-85 -57.18 -50.56 72.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.548 -0.751 . . . . 72.4 112.46 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 pt -65.34 -35.14 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.069 -0.652 . . . . 73.21 111.284 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -67.46 -37.82 83.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.831 0.348 . . . . 55.44 111.116 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.03 -34.77 76.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.217 -0.447 . . . . 64.33 112.079 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 66.1 mm-40 -81.78 -13.63 57.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.989 -0.55 . . . . 73.02 110.986 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 31.12 18.82 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.693 -0.685 . . . . 70.12 112.254 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -104.74 177.21 4.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.859 -0.423 . . . . 74.53 109.859 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.536 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.7 pt20 -147.8 176.58 10.01 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.735 -0.469 . . . . 72.3 109.735 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.463 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.8 t -156.29 179.11 9.56 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.911 -1.515 . . . . 71.33 106.911 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.06 122.22 36.58 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 118.15 0.432 . . . . 74.24 110.567 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.4 17.15 Favored Glycine 0 N--CA 1.416 -2.656 0 N-CA-C 110.131 -1.187 . . . . 75.0 110.131 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -112.52 149.38 32.76 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.825 -1.176 . . . . 72.33 107.825 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 90' ' ' ALA . 8.0 p -89.39 134.45 28.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.651 -0.5 . . . . 73.1 109.651 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.28 120.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.754 0.787 . . . . 51.15 111.173 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' SER . 98.6 t -105.58 132.35 52.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.375 -1.713 . . . . 64.12 106.375 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.71 130.96 54.29 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 110.143 -0.317 . . . . 74.5 110.143 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -100.37 114.39 27.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.981 -1.859 . . . . 75.21 105.981 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -142.93 166.95 23.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 112.113 0.412 . . . . 72.34 112.113 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -102.03 164.61 11.62 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.407 1.098 . . . . 65.22 113.025 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.4 m -151.04 116.17 5.31 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.141 -1.845 . . . . 70.34 106.885 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.4 m -59.35 -21.84 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.692 0.797 . . . . 54.14 112.43 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.62 -16.11 54.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.695 0.76 . . . . 75.42 110.681 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.2 tp -97.52 140.96 31.17 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.029 -1.471 . . . . 65.43 107.029 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -121.69 163.14 19.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.298 -0.961 . . . . 71.15 111.172 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.579 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 44.9 m -45.78 124.32 5.11 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.645 1.978 . . . . 61.53 115.26 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.1 -27.55 16.92 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.583 -1.189 . . . . 62.02 110.506 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.13 136.74 35.09 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.317 -0.994 . . . . 63.13 108.317 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -147.78 160.67 42.49 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.733 -1.58 . . . . 74.4 106.733 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -141.29 150.3 42.37 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.821 0.344 . . . . 65.31 110.979 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.461 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.51 125.77 50.59 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.098 -1.445 . . . . 61.35 107.098 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.623 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -123.28 115.24 21.37 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 110.138 -0.319 . . . . 73.21 110.138 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.09 124.34 7.63 Favored Glycine 0 C--N 1.289 -2.078 0 N-CA-C 111.855 -0.498 . . . . 64.21 111.855 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -140.64 160.19 40.56 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 122.623 0.369 . . . . 54.15 111.028 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 59' ' ' PRO . 61.8 t -105.95 127.85 60.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.783 0.325 . . . . 62.54 110.164 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -135.48 101.85 10.81 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 108.189 -1.041 . . . . 74.23 108.189 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 C-N-CA 122.218 1.945 . . . . 71.41 111.644 179.383 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 CA--C 1.554 1.12 0 CA-C-O 121.026 0.441 . . . . 63.32 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.85 -36.93 82.65 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.1 -1.074 . . . . 74.4 108.1 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -70.22 -44.7 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.11 -0.95 . . . . 75.33 109.287 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.57 -43.12 75.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.962 0.505 . . . . 72.44 110.614 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.82 87.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.941 -1.027 . . . . 70.53 111.0 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.92 -37.52 81.78 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.861 0.689 . . . . 74.22 112.861 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.19 -46.49 90.24 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.987 -0.285 . . . . 73.33 111.579 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -73.4 -28.87 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.627 -0.429 . . . . 61.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -66.7 -45.86 77.41 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.373 -0.376 . . . . 64.14 110.706 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.12 -35.3 80.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.749 0.309 . . . . 73.52 110.332 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.14 77.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 54.33 110.537 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.99 71.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.647 -0.706 . . . . 73.02 110.904 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.59 -44.72 73.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.716 -0.674 . . . . 62.01 110.987 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.84 15.36 37.71 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.99 -0.55 . . . . 52.15 114.222 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 48' ' ' ILE . 11.4 mm -62.35 123.23 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.388 0.614 . . . . 74.54 111.504 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 57.2 mt-30 -116.4 145.24 43.39 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 115.092 -0.958 . . . . 62.45 110.704 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -65.46 125.0 23.79 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 75.11 110.749 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' OE1' ' A' ' 52' ' ' GLN . 13.9 tp -144.82 -164.34 1.9 Allowed 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 103.65 -2.722 . . . . 71.04 103.65 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' OE1' ' HG ' ' A' ' 51' ' ' LEU . 27.2 mp0 -44.64 148.21 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.065 0.848 . . . . 71.42 111.737 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.68 -20.37 66.05 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.615 -0.326 . . . . 74.31 112.828 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 -9.37 41.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.079 0.4 . . . . 54.4 112.079 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.7 ptp180 -157.6 125.3 5.3 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 121.614 0.721 . . . . 72.41 112.062 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.22 151.54 19.41 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.769 -0.65 . . . . 53.42 110.063 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 tm? -86.77 127.96 35.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 61.12 107.18 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.68 158.78 44.54 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 123.448 0.468 . . . . 71.11 110.479 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HA ' HG22 ' A' ' 125' ' ' VAL . 25.9 Cg_exo -65.68 162.76 33.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.936 2.424 . . . . 72.42 111.912 175.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.07 -26.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.959 -0.564 . . . . 74.34 111.692 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -100.88 107.2 18.66 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.82 -0.808 . . . . 73.53 108.82 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 87.3 m-85 -110.37 114.8 28.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.502 -0.772 . . . . 74.35 110.507 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.69 111.33 34.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.844 -1.169 . . . . 74.2 107.844 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.29 121.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.193 -1.04 . . . . 53.14 108.193 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -113.5 124.8 53.25 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.656 -0.418 . . . . 64.43 110.307 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -108.2 162.83 13.71 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 62.05 108.905 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.51 150.17 51.72 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 109.625 -1.39 . . . . 23.54 109.625 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.32 -38.47 69.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 117.575 0.687 . . . . 70.32 111.741 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 39.0 t60 -73.44 -25.03 60.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.59 -0.522 . . . . 74.12 109.59 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.581 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 18.0 m-20 -79.3 -31.73 43.35 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.483 -0.326 . . . . 75.32 111.457 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.96 -33.75 72.35 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.376 -0.829 . . . . 75.34 108.916 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.48 -33.56 68.12 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.636 -0.711 . . . . 54.35 112.683 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -78.4 -30.02 47.55 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.727 -0.608 . . . . 72.33 110.498 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 66' ' ' LEU . 75.1 mt -63.16 -36.78 84.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.347 0.594 . . . . 72.31 110.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.62 -163.09 25.52 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 115.483 -0.78 . . . . 45.21 111.604 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.42 -30.98 14.8 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.287 0.565 . . . . 71.01 109.918 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.41 128.77 25.3 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.946 -0.57 . . . . 64.2 109.563 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.14 -27.23 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.213 1.942 . . . . 63.12 111.287 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.37 -53.74 33.35 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.022 1.729 . . . . 63.33 115.1 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.11 -31.25 72.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.249 0.547 . . . . 74.24 110.724 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -77.09 -34.94 56.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.649 -0.705 . . . . 71.11 109.525 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 42.5 m -65.22 -54.03 35.66 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.403 -0.817 . . . . 75.14 110.441 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 m -62.01 -38.61 89.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.664 -0.698 . . . . 73.44 111.166 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 116.024 -0.535 . . . . 71.02 112.323 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.706 -0.398 . . . . 75.53 110.03 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.055 -0.52 . . . . 61.12 110.204 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -56.84 -53.42 58.06 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.186 -0.916 . . . . 72.51 110.614 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -69.6 -29.59 67.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.018 -0.992 . . . . 74.03 111.965 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.02 -35.51 61.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -62.63 -37.93 88.23 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.741 0.781 . . . . 44.04 109.58 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.23 -47.6 81.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.728 -1.124 . . . . 63.53 109.608 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.6 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -54.91 -48.47 73.04 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.978 0.733 . . . . 65.12 112.978 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.07 -31.64 54.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.098 -0.641 . . . . 74.24 111.737 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 25.9 mt-30 -64.28 -45.42 88.12 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.837 -0.431 . . . . 65.43 109.837 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -58.04 -41.77 83.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.32 1.013 . . . . 70.54 111.903 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 75.5 mm-40 -74.74 -14.36 60.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.935 0.346 . . . . 72.3 111.935 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.95 29.0 48.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.246 -0.502 . . . . 53.13 112.064 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -104.62 157.31 17.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.201 -0.666 . . . . 63.44 109.201 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -128.33 166.08 19.34 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.006 -0.678 . . . . 72.14 110.118 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -155.07 176.57 12.37 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.387 -1.338 . . . . 75.42 107.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 46.2 m-85 -118.37 120.83 38.78 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.538 -0.542 . . . . 72.54 109.538 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.68 -151.22 17.09 Favored Glycine 0 C--O 1.253 1.321 0 N-CA-C 108.23 -1.948 . . . . 74.52 108.23 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -128.06 162.81 25.99 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.986 0.893 . . . . 73.12 108.646 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.1 t -78.57 121.78 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.094 0.473 . . . . 71.33 111.184 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.46 120.83 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.366 -0.834 . . . . 33.12 110.047 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 82' ' ' SER . 59.8 t -116.62 127.77 74.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.068 -1.456 . . . . 72.14 107.068 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 -121.49 152.49 39.08 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.538 -0.465 . . . . 74.52 109.747 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.31 114.41 22.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.916 -1.142 . . . . 73.45 107.916 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.14 170.95 10.71 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.342 -0.543 . . . . 73.12 112.07 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.47 159.19 17.25 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.401 -0.818 . . . . 73.21 110.722 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 m -152.24 138.83 18.7 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 123.97 0.908 . . . . 72.24 109.422 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -81.0 -18.34 47.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.207 -1.035 . . . . 72.05 108.207 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -65.61 -26.69 67.95 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.318 1.447 . . . . 71.41 110.035 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.0 mt -101.24 128.31 47.43 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.721 -0.672 . . . . 71.22 109.832 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -88.1 164.05 15.91 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.468 -0.787 . . . . 72.14 109.975 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.475 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 16.0 m -55.28 123.13 12.8 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.891 0.744 . . . . 72.05 111.967 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.16 -20.9 30.06 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.293 -0.723 . . . . 44.41 111.293 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.22 139.71 35.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.481 0.657 . . . . 73.31 111.709 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 66' ' ' LEU . 29.6 p90 -147.7 160.16 43.01 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.715 -1.217 . . . . 74.43 107.715 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 146.55 43.77 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.176 -1.046 . . . . 75.41 108.176 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.52 149.45 34.34 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.548 -0.908 . . . . 72.5 108.548 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 64.5 ttt180 -143.26 124.37 14.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.263 -0.273 . . . . 74.13 110.263 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.15 100.25 0.8 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 110.198 -1.161 . . . . 34.14 110.198 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -111.67 147.88 34.58 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 109.713 -0.477 . . . . 73.24 109.713 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.2 t -87.29 113.98 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 108.152 -1.055 . . . . 63.32 108.152 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -126.06 99.69 31.23 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 108.344 -0.984 . . . . 70.13 108.344 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 57.8 Cg_endo . . . . . 0 N--CA 1.455 -0.751 0 C-N-CA 121.919 1.746 . . . . 51.34 111.377 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.971 0.415 . . . . 63.1 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -56.69 -47.67 79.35 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.082 -0.963 . . . . 75.44 110.37 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.96 -50.9 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.262 -0.881 . . . . 63.03 110.405 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.9 pp20? -64.4 -38.4 90.91 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.589 0.588 . . . . 72.42 112.589 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.08 92.48 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.802 0.334 . . . . 32.21 110.632 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -72.87 -37.58 67.29 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.238 -1.023 . . . . 64.41 108.238 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.09 -44.79 96.82 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 72.45 110.582 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.0 ptt85 -73.74 -21.86 60.06 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.96 0.409 . . . . 73.31 111.635 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 43.0 tpt85 -73.09 -31.19 64.2 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.171 -0.677 . . . . 74.43 109.171 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 52.0 mm-40 -68.21 -38.7 82.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.517 -0.765 . . . . 72.21 109.835 173.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.62 -46.52 88.74 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.443 -0.799 . . . . 60.23 109.734 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.29 65.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.788 -0.642 . . . . 62.11 111.386 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 31.2 t70 -77.77 -41.19 38.34 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.931 0.345 . . . . 71.24 111.931 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.03 25.89 19.64 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 120.227 -0.987 . . . . 70.24 113.803 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.77 137.02 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.702 0.401 . . . . 52.1 111.345 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.1 mt-30 -122.91 143.51 49.84 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.823 -0.626 . . . . 61.25 110.397 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -79.19 92.32 5.07 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.847 -1.07 . . . . 73.22 111.687 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 HD23 ' A' ' 57' ' ' LEU . 11.9 tp -102.38 -165.48 1.19 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.781 -1.933 . . . . 64.41 105.781 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.3 mm-40 -48.57 146.89 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.888 0.767 . . . . 72.14 112.214 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.9 32.89 1.25 Allowed Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.117 -0.947 . . . . 41.4 113.348 -173.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 52' ' ' GLN . 71.9 m-20 -99.85 -37.01 9.23 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.643 -1.614 . . . . 71.03 106.643 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -172.97 149.87 1.94 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.491 -1.231 . . . . 71.43 110.294 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.37 151.79 21.29 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.964 0.506 . . . . 73.35 110.564 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.572 HD23 HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -87.21 127.7 35.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 -175.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.11 158.17 46.92 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 123.11 0.564 . . . . 61.01 111.063 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.621 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 88.6 Cg_exo -54.86 145.16 63.32 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.948 3.099 . . . . 75.33 113.997 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -119.96 -22.6 6.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.313 -0.858 . . . . 61.13 110.292 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.69 108.88 20.61 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.412 0.625 . . . . 74.01 109.684 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.9 m-85 -114.06 117.83 32.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.445 -0.798 . . . . 72.52 109.423 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.95 116.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.192 -1.04 . . . . 74.33 108.192 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.1 mt -110.96 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 107.915 -1.143 . . . . 74.03 107.915 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.7 m -110.33 120.65 43.12 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.866 -0.606 . . . . 74.13 110.971 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.4 mm? -114.69 163.26 15.71 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.3 -0.864 . . . . 74.24 108.809 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.17 169.17 51.35 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 109.274 -1.53 . . . . 62.3 109.274 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.32 -25.7 37.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.595 0.712 . . . . 64.02 110.936 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -57.95 -55.69 31.64 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.824 -1.08 . . . . 73.21 110.001 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.84 -29.49 44.69 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.621 -0.718 . . . . 75.53 111.718 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -63.7 -32.01 73.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.439 -0.346 . . . . 74.2 110.143 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.17 -35.84 78.2 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 123.25 0.62 . . . . 55.15 109.954 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.98 -14.64 55.73 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.235 -0.438 . . . . 75.21 111.22 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.21 -25.04 37.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.652 -0.87 . . . . 54.5 108.652 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.98 -177.26 30.1 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 114.938 -1.028 . . . . 54.23 111.867 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 1.46 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.831 0.452 . . . . 54.42 111.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.7 m-20 -110.0 92.57 13.16 Favored Pre-proline 0 C--O 1.251 1.178 0 N-CA-C 112.331 0.493 . . . . 53.41 112.331 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.84 -37.2 1.72 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.686 1.59 . . . . 64.23 111.096 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.47 -34.33 72.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.26 -0.427 . . . . 55.11 112.14 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.29 -38.06 85.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.194 0.521 . . . . 73.4 109.837 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 43.4 mmtm -77.28 -35.52 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.837 -0.801 . . . . 71.3 108.837 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 t -58.31 -54.14 50.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.713 -1.131 . . . . 65.01 110.023 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.1 m -59.15 -42.33 90.44 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.425 0.69 . . . . 73.32 111.008 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -61.64 6.21 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.011 -0.54 . . . . 52.45 111.974 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -63.03 -30.78 71.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.304 0.854 . . . . 63.12 113.304 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.35 -40.43 89.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.896 -0.322 . . . . 72.41 110.538 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -73.37 -36.88 66.17 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.466 -0.568 . . . . 72.43 109.466 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.25 -41.06 94.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.573 -0.285 . . . . 63.32 110.73 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -42.27 87.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.447 -0.575 . . . . 75.12 109.447 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.46 79.67 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 61.44 109.951 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -64.24 -43.77 93.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.391 -0.822 . . . . 73.25 109.751 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.6 m-85 -58.66 -48.42 81.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 112.662 0.615 . . . . 75.41 112.662 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.99 -29.33 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.733 -0.787 . . . . 74.34 111.247 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.02 -44.24 89.82 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 110.14 -0.318 . . . . 42.22 110.14 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.6 mt-10 -63.91 -38.38 90.88 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.308 0.575 . . . . 74.42 110.797 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.2 mm-40 -79.25 -13.9 59.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.971 -0.559 . . . . 64.23 111.351 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.53 38.37 32.96 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.804 -0.712 . . . . 51.3 112.2 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -107.11 158.0 17.42 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.765 0.317 . . . . 73.12 111.093 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD23 ' A' ' 51' ' ' LEU . 23.2 pt20 -123.01 173.03 8.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.816 0.846 . . . . 73.15 109.087 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.8 t -159.52 177.61 10.76 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.444 -0.502 . . . . 64.52 110.432 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.24 120.99 33.85 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.582 -0.896 . . . . 71.32 108.582 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.24 -164.17 12.48 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.963 -1.655 . . . . 53.42 108.963 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -104.71 156.86 17.62 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.864 -1.532 . . . . 72.12 106.864 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.67 104.18 14.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.985 -1.117 . . . . 63.31 107.985 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.73 120.38 57.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 122.123 0.963 . . . . 74.41 111.676 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 62' ' ' TYR . 10.1 m -104.86 120.03 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 N-CA-C 105.804 -1.925 . . . . 75.23 105.804 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.279 0.0 OUTLIER -117.3 125.4 51.01 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 113.638 0.977 . . . . 72.54 113.638 -174.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -92.47 139.41 30.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.746 -1.57 . . . . 74.33 108.628 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -156.06 161.1 40.46 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.356 -0.609 . . . . 63.44 109.356 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.8 pt20 -104.32 157.99 16.76 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.582 0.706 . . . . 54.45 109.493 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 62.0 m -144.2 133.1 22.61 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.909 -1.041 . . . . 74.13 108.974 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 m -80.9 -11.74 59.53 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.481 0.658 . . . . 53.23 110.098 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -87.99 -5.54 58.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 71.41 109.918 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 1.4 tm? -91.07 120.44 32.04 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.938 -1.875 . . . . 65.33 105.938 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -88.8 153.22 21.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.325 -0.398 . . . . 73.25 110.405 -174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -64.59 134.16 53.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.51 0.672 . . . . 71.32 111.234 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.33 -15.46 42.67 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.412 -1.075 . . . . 74.34 110.412 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -106.08 150.24 25.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.047 -0.723 . . . . 72.44 109.047 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -149.66 151.25 33.42 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.867 -1.901 . . . . 73.41 105.867 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -134.99 144.09 47.18 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 112.56 0.578 . . . . 73.42 112.56 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.79 119.13 10.23 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.701 -1.592 . . . . 64.53 106.701 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.613 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -120.29 120.65 36.67 Favored 'General case' 0 N--CA 1.39 -3.456 0 C-N-CA 123.196 0.598 . . . . 71.35 109.565 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.53 121.54 7.2 Favored Glycine 0 C--N 1.3 -1.452 0 O-C-N 123.593 0.558 . . . . 64.04 112.056 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 p -142.21 148.61 38.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.155 -0.683 . . . . 73.53 109.155 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 5.6 p -95.84 120.54 45.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 119.462 -0.895 . . . . 63.45 110.006 174.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -125.86 98.62 33.46 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.819 -1.082 . . . . 64.24 108.167 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.52 -0.221 0 C-N-CA 122.385 2.057 . . . . 75.13 109.892 177.17 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 . . . . . 0 N--CA 1.434 -1.242 0 CA-C-O 121.219 0.533 . . . . 53.34 110.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.87 -32.77 73.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.445 -1.317 . . . . 74.13 107.445 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' HD23 ' A' ' 40' ' ' LEU . 30.7 t -61.3 -49.89 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 114.466 -1.243 . . . . 73.31 109.619 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 30.6 mt-10 -57.69 -47.11 83.26 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.581 -0.448 . . . . 74.53 110.734 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.88 35.56 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.69 0.619 . . . . 65.32 111.878 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.74 -29.35 66.68 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.216 0.45 . . . . 73.21 112.216 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 36' ' ' VAL . 4.0 mm? -70.55 -39.55 73.92 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.176 0.436 . . . . 70.43 112.176 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 58.7 mtp180 -66.13 -33.42 75.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.977 -1.12 . . . . 72.25 107.977 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -49.29 62.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.434 -1.257 . . . . 73.44 108.948 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.54 -37.8 85.11 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.98 0.512 . . . . 72.22 112.136 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -58.77 -45.82 88.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.998 -0.546 . . . . 41.1 110.117 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.06 64.66 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.549 0.69 . . . . 75.14 111.066 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.07 -32.61 73.9 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 63.53 111.043 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.86 72.61 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.97 -0.633 . . . . 62.24 113.285 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 98' ' ' TRP . 17.7 mm -64.45 131.31 30.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.547 0.689 . . . . 54.11 111.949 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 80.5 mt-30 -119.39 144.82 46.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.272 -0.876 . . . . 74.23 110.535 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.6 m -80.63 98.28 7.6 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.845 -1.07 . . . . 73.44 109.992 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.645 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.3 tp -101.91 -165.38 1.18 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.935 -1.506 . . . . 75.23 106.935 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.645 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 48.4 mt-30 -56.19 160.77 2.76 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.493 0.717 . . . . 72.14 111.395 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 4.75 8.17 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.461 -0.79 . . . . 61.51 114.397 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.32 -46.57 60.33 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.913 -1.143 . . . . 72.53 107.913 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -179.51 167.21 1.44 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.002 0.921 . . . . 73.04 110.716 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.56 151.39 21.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.059 0.457 . . . . 71.44 111.698 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.4 tm? -90.63 128.3 36.56 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.366 -0.976 . . . . 44.53 108.366 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.41 158.0 45.98 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 123.58 0.752 . . . . 45.53 109.433 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.8 Cg_exo -61.06 157.93 36.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 72.53 112.628 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -119.8 -33.3 4.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.934 -0.575 . . . . 71.1 110.695 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -103.66 114.65 29.07 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.651 -0.5 . . . . 74.32 109.651 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 70.8 m-85 -109.51 119.34 39.12 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.669 -0.696 . . . . 72.53 109.912 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -109.23 118.5 56.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 115.284 -0.871 . . . . 75.12 109.545 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.79 119.98 61.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.934 -1.136 . . . . 71.22 107.934 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -109.57 128.25 55.07 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.98 -0.555 . . . . 74.1 109.771 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.6 mm? -115.49 170.58 8.31 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.344 1.058 . . . . 71.2 109.674 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.99 169.03 54.43 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 109.508 -1.437 . . . . 74.0 109.508 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.86 -48.53 83.62 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 117.472 0.636 . . . . 75.3 111.681 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -65.03 -40.44 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 72.14 109.477 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.628 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.0 m-20 -69.48 -34.2 73.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.22 -1.355 . . . . 64.44 110.698 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.81 -36.92 85.48 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.72 0.771 . . . . 75.0 109.104 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.69 -25.22 64.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.757 -0.656 . . . . 73.2 111.262 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -77.91 -22.08 50.19 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.387 -0.195 . . . . 75.42 110.482 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.28 -38.36 71.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.157 -0.683 . . . . 71.13 109.157 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.31 -171.89 29.43 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.056 -1.068 . . . . 64.41 111.841 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.57 -31.08 18.81 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.939 -0.763 . . . . 62.33 108.939 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -131.73 81.81 62.43 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.217 -0.901 . . . . 74.44 110.548 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.74 -18.7 47.77 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.801 2.334 . . . . 51.15 112.274 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.01 -22.62 64.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.76 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.33 -45.67 92.16 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.88 -0.785 . . . . 55.03 108.88 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.13 -31.27 65.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.731 -1.122 . . . . 64.13 110.437 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.7 m -60.42 -43.53 96.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.42 -0.355 . . . . 73.31 111.224 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.4 m -65.4 -45.44 83.95 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.761 0.315 . . . . 71.44 111.165 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.87 93.6 Favored Glycine 0 C--O 1.244 0.733 0 C-N-CA 120.715 -0.755 . . . . 52.25 111.65 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -68.25 -32.59 72.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.279 -0.46 . . . . 63.33 110.247 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -62.15 -43.1 99.57 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.893 0.378 . . . . 73.25 110.514 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.78 -39.02 92.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 74.32 109.162 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -71.09 -41.32 70.77 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.305 -0.407 . . . . 65.13 111.183 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.04 -38.06 85.19 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.555 -0.535 . . . . 70.41 109.555 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.76 87.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.494 0.664 . . . . 75.11 109.536 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -37.41 84.38 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.95 -1.023 . . . . 62.54 110.127 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.6 m-85 -60.59 -48.02 83.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.192 -0.458 . . . . 71.33 111.903 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -69.69 -31.16 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 119.959 -0.697 . . . . 75.21 111.544 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.93 -41.14 91.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.808 -0.441 . . . . 72.33 109.808 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 33.2 tt0 -57.29 -36.85 71.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 125.329 1.452 . . . . 65.01 110.331 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -85.62 -9.04 57.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 75.41 111.052 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.29 29.8 57.85 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 116.025 -0.534 . . . . 75.15 113.016 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.473 ' CD2' HD11 ' A' ' 48' ' ' ILE . 20.0 m0 -96.19 156.9 16.14 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.594 -0.442 . . . . 64.34 110.457 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.429 ' OE1' HD23 ' A' ' 51' ' ' LEU . 5.0 pt20 -119.07 169.49 9.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.031 -0.359 . . . . 61.52 110.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -159.83 176.31 12.07 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.935 -0.765 . . . . 75.13 108.935 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.77 122.04 43.31 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.105 -1.072 . . . . 64.32 108.105 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.1 17.14 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.863 -1.16 . . . . 75.21 110.783 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -130.91 151.63 51.12 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.667 -0.864 . . . . 63.42 108.667 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.51 119.2 18.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.558 0.694 . . . . 71.11 111.335 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.14 131.63 65.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.024 -0.732 . . . . 64.11 109.024 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.1 p -137.33 141.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.514 -1.291 . . . . 74.02 107.514 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -145.06 155.96 43.65 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.455 -0.498 . . . . 73.51 110.184 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.36 127.9 53.21 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.005 -1.109 . . . . 74.41 108.005 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.06 167.83 18.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.712 -0.222 . . . . 64.33 110.46 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -116.47 158.95 22.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.865 0.365 . . . . 63.21 110.324 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 t -145.01 140.25 28.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.906 -1.146 . . . . 53.33 107.906 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 -10.38 59.74 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.585 -0.524 . . . . 70.33 109.585 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -79.38 -27.25 41.88 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.176 -0.465 . . . . 63.3 110.289 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.24 135.58 33.38 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 115.84 -0.618 . . . . 72.11 109.919 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -99.33 157.07 16.66 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.952 -0.759 . . . . 72.41 108.952 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.628 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 57.4 m -53.94 126.62 23.1 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 124.458 1.099 . . . . 73.11 112.109 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.1 28.94 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-N 115.092 -0.958 . . . . 73.55 111.675 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -104.36 139.6 39.09 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.82 -0.437 . . . . 70.01 109.82 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' HD13 ' A' ' 66' ' ' LEU . 42.9 p90 -143.04 157.89 44.11 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.652 -1.24 . . . . 71.4 107.652 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 134.81 31.39 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.663 -0.866 . . . . 73.24 108.663 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.32 139.35 48.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.936 -1.505 . . . . 63.24 106.936 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -139.44 119.13 13.15 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.974 0.416 . . . . 71.13 110.243 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.4 127.21 8.77 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.263 -1.135 . . . . 71.42 110.263 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.0 p -127.46 145.31 50.88 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.205 0.526 . . . . 72.2 111.57 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.5 t -98.09 108.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.433 -0.951 . . . . 63.44 108.433 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -114.48 97.91 47.66 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 109.262 -0.644 . . . . 73.33 109.262 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.454 -0.795 0 C-N-CA 121.993 1.796 . . . . 64.03 111.931 -179.55 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 C--O 1.254 1.31 0 CA-C-O 121.682 0.753 . . . . 71.21 109.185 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -82.05 -37.11 26.94 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.499 -0.773 . . . . 70.11 110.639 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 40' ' ' LEU . 97.5 t -61.01 -49.8 83.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 115.868 -0.605 . . . . 71.22 109.589 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -58.01 -47.8 81.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.528 0.731 . . . . 64.53 110.887 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.61 82.58 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.17 -0.923 . . . . 73.43 111.856 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.14 -31.54 58.66 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.399 0.518 . . . . 64.14 112.399 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 36' ' ' VAL . 5.6 mp -62.52 -42.57 99.6 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.397 0.147 . . . . 61.22 111.397 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.75 -28.51 62.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.597 -0.841 . . . . 75.42 110.342 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -63.36 -44.31 95.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.985 -0.552 . . . . 64.24 109.712 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -71.31 -32.54 68.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 75.01 111.488 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.15 93.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 63.23 109.631 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.61 -24.83 61.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.689 -0.687 . . . . 73.54 111.074 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.52 -38.13 74.2 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.155 0.982 . . . . 62.13 110.208 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.72 42.97 1.78 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.568 -0.742 . . . . 70.33 112.788 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 45' ' ' ALA . 19.6 mm -81.92 138.08 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.958 0.503 . . . . 64.1 110.696 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 2.0 mp0 -120.3 146.44 46.11 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 123.066 0.547 . . . . 70.44 109.697 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.0 m -73.46 120.81 19.58 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 124.175 0.922 . . . . 73.33 109.407 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.7 tp -127.19 -170.66 2.26 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 103.733 -2.692 . . . . 64.35 103.733 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.479 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 62.0 mt-30 -55.54 148.87 14.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.148 0.885 . . . . 63.04 110.007 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.33 -5.48 8.36 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 115.08 0.792 . . . . 52.05 115.08 -171.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -66.35 -38.6 88.0 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.391 -0.596 . . . . 74.21 109.391 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -171.09 152.65 3.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.901 -0.59 . . . . 74.11 111.266 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -91.94 151.71 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.26 0.624 . . . . 74.11 111.275 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 100' ' ' THR . 41.9 tp -88.98 125.87 35.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.672 -0.695 . . . . 42.1 109.147 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.05 165.87 12.28 Favored Pre-proline 0 C--N 1.283 -2.288 0 C-N-CA 124.421 1.088 . . . . 65.3 108.634 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 125' ' ' VAL . 28.7 Cg_exo -64.98 159.08 48.13 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.545 2.164 . . . . 73.12 111.673 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -115.97 -30.67 5.98 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.71 -0.396 . . . . 74.22 111.349 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 46.4 tt0 -104.04 127.71 51.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.353 -0.98 . . . . 71.51 108.353 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 106' ' ' VAL . 64.4 m-85 -123.34 114.83 20.71 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.772 -0.455 . . . . 72.0 109.772 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -97.9 110.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.755 -0.832 . . . . 65.51 108.755 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.8 115.57 48.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.6 -0.727 . . . . 72.22 109.21 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 m -109.53 123.42 49.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.527 -0.306 . . . . 72.22 110.525 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -117.22 -176.99 3.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.877 1.271 . . . . 71.5 109.183 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.7 -174.09 42.84 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 108.885 -1.686 . . . . 42.31 108.885 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.583 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.4 p -69.54 -58.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 118.321 1.06 . . . . 72.1 113.652 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.627 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 22.1 t-80 -55.77 -51.56 66.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.866 0.841 . . . . 72.41 110.068 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -65.19 -31.22 72.29 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.483 -1.235 . . . . 75.13 113.872 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -68.49 -43.58 76.58 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.409 -0.517 . . . . 71.54 110.596 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 37.4 mt-10 -62.97 -38.45 91.16 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.837 0.827 . . . . 73.43 110.092 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 12.4 mptt -80.82 -16.02 54.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.059 -0.973 . . . . 73.43 112.367 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 65.9 mt -70.61 -45.42 65.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.636 -1.246 . . . . 54.34 107.636 170.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 121.2 0.8 Allowed Glycine 0 N--CA 1.406 -3.312 0 CA-C-N 114.67 -1.15 . . . . 63.3 111.648 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.63 -18.73 62.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.995 -1.113 . . . . 74.33 107.995 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.98 88.89 8.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 104.785 -2.302 . . . . 61.31 104.785 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.2 -33.13 15.5 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.79 2.326 . . . . 74.5 114.007 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.95 -25.84 60.17 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.943 -0.303 . . . . 74.31 111.455 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.21 -35.25 80.47 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.571 -0.529 . . . . 73.25 109.571 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -74.23 -34.08 63.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.58 -0.737 . . . . 74.35 109.505 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.78 -51.31 70.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.497 -0.556 . . . . 64.24 109.497 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 28.2 m -62.34 -44.02 97.47 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.294 -0.412 . . . . 73.15 110.484 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.01 -57.94 17.17 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.391 -0.368 . . . . 61.14 113.051 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -67.87 -28.25 67.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.968 0.729 . . . . 64.15 112.968 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.1 76.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 74.14 110.637 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.8 mmt85 -67.75 -43.39 80.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.606 . . . . 64.32 109.883 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.8 t70 -56.69 -56.69 18.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.371 -1.286 . . . . 71.14 109.583 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.81 -31.11 72.19 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 112.589 0.589 . . . . 55.42 112.589 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.02 98.63 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.504 0.669 . . . . 62.53 111.178 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.31 -27.51 27.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.243 -1.391 . . . . 73.54 107.243 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 3.3 t80 -65.6 -42.78 91.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.723 -1.581 . . . . 64.32 110.195 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.95 -30.94 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.521 -0.471 . . . . 72.42 109.787 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -62.71 -42.39 99.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 71.44 109.964 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 92' ' ' TYR . 11.9 mm-40 -57.72 -38.14 74.77 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.807 0.843 . . . . 71.54 111.098 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.7 mm-40 -83.43 -14.06 53.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 63.41 111.623 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.59 38.13 25.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.075 -0.584 . . . . 41.34 112.1 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -117.74 179.7 4.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -160.09 178.94 9.17 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 110.196 -0.298 . . . . 55.51 110.196 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.515 ' HA ' HD12 ' A' ' 57' ' ' LEU . 14.0 t -153.24 171.97 17.71 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.298 -1.371 . . . . 72.23 107.298 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.64 118.92 29.62 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.778 -1.564 . . . . 74.33 106.778 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.83 -149.43 16.59 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 119.277 -1.439 . . . . 63.15 109.862 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -125.59 152.58 44.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.404 -1.332 . . . . 62.42 107.404 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.93 125.81 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 O-C-N 123.442 0.463 . . . . 72.23 111.255 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 19.7 m -123.86 120.22 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.519 0.676 . . . . 74.15 109.75 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 62' ' ' TYR . 15.1 m -116.1 142.78 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 108.707 -0.849 . . . . 65.24 108.707 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.56 131.01 23.77 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.356 0.598 . . . . 73.52 112.028 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.19 151.27 19.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.499 -1.228 . . . . 63.44 108.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -159.51 170.13 22.36 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.113 0.565 . . . . 74.11 109.967 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.16 164.82 12.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.939 0.876 . . . . 63.15 112.941 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 t -142.7 134.91 27.43 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.583 -1.644 . . . . 70.13 106.885 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.43 -12.02 59.06 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.395 0.616 . . . . 74.3 110.168 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -85.18 -30.49 23.88 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.948 -0.569 . . . . 74.22 111.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 118' ' ' GLN . 57.7 mt -86.94 149.47 24.77 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.733 -0.667 . . . . 52.44 111.636 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -126.85 168.78 13.99 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.279 -1.008 . . . . 73.33 108.279 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -57.49 110.55 0.89 Allowed 'General case' 0 C--O 1.251 1.155 0 CA-C-O 121.646 0.736 . . . . 74.13 110.65 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.14 -24.82 4.18 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 108.698 -1.761 . . . . 72.11 108.698 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 29.0 mm-40 -92.71 156.02 17.32 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.502 -1.296 . . . . 41.33 107.502 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -176.11 147.7 0.75 Allowed 'General case' 0 C--N 1.278 -2.539 0 O-C-N 125.077 1.486 . . . . 75.3 107.643 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -143.25 130.87 21.25 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.368 -0.378 . . . . 75.35 109.991 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.68 135.92 53.69 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.132 -1.062 . . . . 42.4 108.132 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -125.32 126.48 45.14 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.953 -0.758 . . . . 72.15 108.953 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.44 125.13 8.39 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 110.461 -1.055 . . . . 54.24 110.461 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 p -121.4 140.49 52.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 123.241 0.616 . . . . 71.34 110.68 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 59' ' ' PRO . 80.1 t -92.35 103.66 14.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.719 -1.586 . . . . 62.23 106.719 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -107.35 104.22 51.6 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 108.23 -1.026 . . . . 71.43 108.23 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.459 -0.504 0 C-N-CA 121.936 1.757 . . . . 73.12 112.924 -177.473 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 . . . . . 0 C--O 1.21 -1.008 0 N-CA-C 111.781 0.289 . . . . 55.0 111.781 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.96 -44.85 88.03 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.671 0.748 . . . . 64.55 109.014 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG12 HD23 ' A' ' 40' ' ' LEU . 47.2 t -72.48 -38.22 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.196 -0.911 . . . . 73.33 108.846 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.37 -42.59 91.98 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.203 -0.453 . . . . 63.13 110.67 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.19 -45.82 86.9 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.429 0.692 . . . . 55.41 110.691 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 121' ' ' ALA . 1.6 tm? -66.59 -45.75 78.2 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.854 -0.612 . . . . 54.53 109.517 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 36' ' ' VAL . 4.6 mm? -65.59 -40.15 92.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.09 0.774 . . . . 75.34 113.09 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -72.21 -29.35 63.88 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 63.04 110.008 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.74 -44.11 97.07 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.17 -1.048 . . . . 74.35 108.17 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.94 -48.66 65.29 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.92 -1.036 . . . . 64.55 110.123 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.84 68.32 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.432 -0.349 . . . . 73.14 111.814 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.64 -23.24 56.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.994 0.368 . . . . 63.33 111.994 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.02 -34.54 24.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.218 0.533 . . . . 63.23 110.618 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.75 21.12 15.84 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.54 -0.755 . . . . 73.41 113.177 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mm -72.57 131.73 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.002 0.43 . . . . 75.13 110.498 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.7 mt-30 -108.84 133.13 53.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.769 -0.826 . . . . 71.31 108.769 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -75.32 117.71 17.43 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.949 -1.023 . . . . 71.22 109.407 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.455 HD23 ' NE2' ' A' ' 99' ' ' GLN . 12.9 tp -141.39 -164.34 1.75 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 103.955 -2.609 . . . . 74.14 103.955 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 97.9 mt-30 -42.68 131.74 3.88 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.702 0.626 . . . . 72.12 111.662 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.38 -18.47 55.69 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 115.062 0.785 . . . . 74.41 115.062 -170.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.41 -31.9 54.37 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.627 -0.829 . . . . 73.23 111.422 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 12.4 ptm180 -151.77 114.42 4.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.497 1.141 . . . . 75.53 111.029 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -91.1 150.71 21.29 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.969 -1.469 . . . . 74.31 108.322 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -84.25 120.34 26.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.495 -0.558 . . . . 71.42 109.495 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 157.38 38.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.676 -0.693 . . . . 74.34 109.672 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -61.68 147.58 95.01 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.573 2.182 . . . . 71.14 112.175 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.403 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 28.8 p-10 -120.59 -24.44 5.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.966 -0.561 . . . . 73.42 110.403 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.11 114.8 29.2 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.455 -0.572 . . . . 71.23 109.455 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -119.56 114.63 22.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.601 -0.727 . . . . 52.23 109.411 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -109.13 120.27 60.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.616 -0.883 . . . . 72.23 108.616 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.9 126.71 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 108.556 -0.905 . . . . 64.41 108.556 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -107.81 130.97 54.94 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.48 -0.782 . . . . 72.34 109.282 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.35 161.27 22.38 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.68 0.792 . . . . 44.23 109.244 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.1 157.33 52.55 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.727 -1.349 . . . . 63.51 109.727 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.4 p -56.76 -39.13 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 117.364 0.582 . . . . 64.41 112.374 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.95 -44.4 82.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.481 0.658 . . . . 73.25 110.777 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.57 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 39.8 m-20 -84.76 -21.67 29.92 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 112.784 0.661 . . . . 75.33 112.784 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 57.0 t80 -69.3 -26.09 64.55 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.162 -0.681 . . . . 70.55 109.162 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 46.2 mt-10 -58.67 -38.56 78.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.386 -0.37 . . . . 54.33 110.784 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -76.55 -32.8 58.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.108 0.48 . . . . 73.41 109.913 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.08 -29.25 70.11 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.988 -0.551 . . . . 63.33 109.976 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.03 33.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.672 -0.694 . . . . 53.15 113.904 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.36 0.58 . . . . 72.23 109.67 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.35 68.34 2.77 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 122.198 0.999 . . . . 64.21 109.765 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.76 -51.25 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.199 1.933 . . . . 74.1 113.685 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.8 -23.16 60.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.439 -0.346 . . . . 73.52 111.633 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.5 -43.09 81.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.763 -0.458 . . . . 74.31 109.763 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -63.33 -34.4 77.62 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.231 -0.44 . . . . 74.24 110.739 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.1 m -66.87 -49.03 66.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.785 -0.643 . . . . 61.32 110.698 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -62.49 -36.27 82.0 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.296 -0.411 . . . . 72.43 111.141 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.15 40.29 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.424 -0.417 . . . . 62.41 112.122 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -70.85 -28.04 64.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.324 0.49 . . . . 64.31 112.324 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.898 -0.408 . . . . 72.04 109.898 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -59.67 -47.61 84.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.41 -0.813 . . . . 71.24 109.522 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' HD1' ' A' ' 92' ' ' TYR . 59.7 m-20 -69.52 -45.37 69.01 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 113.275 0.843 . . . . 61.05 113.275 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.137 -0.625 . . . . 63.34 111.812 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.34 87.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 72.33 109.939 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.93 -44.5 72.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.913 -0.585 . . . . 71.11 109.734 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.626 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.1 m-85 -58.68 -49.62 76.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.485 -0.78 . . . . 65.31 112.572 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.12 -39.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 119.914 -0.715 . . . . 75.32 111.363 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.63 -41.58 96.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.61 -0.268 . . . . 73.12 110.491 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.47 -38.95 75.33 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.693 1.197 . . . . 71.33 110.723 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 52.2 mm-40 -87.44 -13.35 43.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.782 -0.645 . . . . 54.54 111.402 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.48 28.74 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.976 -0.85 . . . . 72.54 110.976 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -105.34 158.71 16.44 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.008 -0.738 . . . . 74.4 109.008 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.5 pt20 -126.33 171.58 10.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.197 -0.456 . . . . 62.01 110.175 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 57' ' ' LEU . 6.3 t -162.52 158.05 23.05 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.639 -1.245 . . . . 73.05 107.639 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.51 120.44 40.3 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.265 -1.013 . . . . 75.41 108.265 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -152.11 16.99 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.154 -1.579 . . . . 23.33 109.154 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.95 162.58 20.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.217 -0.66 . . . . 72.23 109.217 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.22 119.83 31.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.58 -0.896 . . . . 75.13 108.58 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.66 133.1 69.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.451 0.643 . . . . 64.31 109.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.03 134.37 61.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.377 -0.972 . . . . 72.3 108.377 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -130.88 142.99 50.41 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.729 -0.841 . . . . 73.22 108.729 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.98 137.02 52.27 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.765 -0.828 . . . . 63.13 108.765 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.32 160.8 38.55 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 120.967 0.413 . . . . 73.3 110.678 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 26.9 pt20 -103.55 153.89 20.08 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.397 -0.82 . . . . 70.35 109.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.2 t -144.37 132.22 21.38 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 109.025 -0.732 . . . . 65.3 109.025 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.05 -15.73 55.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.08 -1.081 . . . . 53.22 108.08 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.5 -32.89 54.46 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.565 -1.198 . . . . 72.25 109.769 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -84.44 157.66 21.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.423 -0.954 . . . . 63.12 108.423 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -98.54 164.53 12.22 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.757 0.651 . . . . 74.14 112.757 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 m -66.13 134.57 53.07 Favored 'General case' 0 C--O 1.25 1.089 0 C-N-CA 123.995 0.918 . . . . 73.51 110.802 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.1 86.82 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 112.041 -0.424 . . . . 62.34 112.041 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -138.49 128.38 25.27 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 107.915 -1.143 . . . . 60.21 107.915 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -122.59 153.94 38.61 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.776 -0.824 . . . . 65.31 108.776 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -148.61 153.76 38.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.429 -1.323 . . . . 75.03 107.429 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -145.44 149.35 34.54 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 120.697 -0.401 . . . . 72.2 110.966 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -134.42 123.0 23.33 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.5 -0.773 . . . . 72.01 109.476 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.68 126.17 7.57 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.715 -1.354 . . . . 74.23 109.715 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.2 m -135.88 150.59 49.42 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 109.402 -0.592 . . . . 54.52 109.402 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 59' ' ' PRO . 40.2 t -88.02 110.97 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 107.179 -1.415 . . . . 74.35 107.179 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -120.06 86.99 38.23 Favored Pre-proline 0 C--N 1.284 -2.264 0 N-CA-C 107.226 -1.398 . . . . 72.23 107.226 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.368 2.045 . . . . 70.13 112.69 -174.54 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.995 0.426 . . . . 74.01 111.525 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.67 -25.3 67.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.357 -0.608 . . . . 73.01 109.357 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.99 -49.7 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 109.681 -0.488 . . . . 75.11 109.681 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.97 -35.8 81.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.366 -0.533 . . . . 61.44 109.822 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.33 94.15 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.685 -0.688 . . . . 73.32 110.773 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -44.45 96.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.774 -0.824 . . . . 74.21 108.774 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.12 -29.18 68.04 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.035 0.754 . . . . 71.12 113.035 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 11.4 mtm180 -65.52 -36.97 85.41 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.778 -1.194 . . . . 73.3 107.778 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -46.87 72.26 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.17 -0.923 . . . . 72.44 110.07 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.21 -41.08 96.22 Favored 'General case' 0 CA--C 1.5 -0.942 0 O-C-N 123.397 0.435 . . . . 74.52 111.976 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.49 93.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.095 -0.502 . . . . 63.21 110.583 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.25 -25.36 42.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.089 -0.505 . . . . 71.33 111.599 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.19 -40.02 28.04 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.04 0.448 . . . . 64.32 110.167 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.85 17.96 37.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.786 . . . . 64.21 112.999 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 48' ' ' ILE . 13.8 mm -59.95 127.03 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-O 121.325 0.583 . . . . 75.33 110.814 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.2 tt0 -109.59 128.27 55.1 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 106.819 -1.549 . . . . 64.22 106.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -67.61 116.47 8.36 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.419 0.628 . . . . 61.43 110.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 18.4 tp -119.62 -165.83 1.21 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.503 -2.036 . . . . 75.53 105.503 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.577 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 14.1 mm-40 -62.92 166.56 5.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.731 0.696 . . . . 71.23 110.741 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.4 1.7 18.84 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.416 -0.811 . . . . 61.01 113.472 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.91 -48.64 57.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.621 -0.881 . . . . 71.43 108.621 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -173.67 159.8 3.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.869 -0.605 . . . . 74.13 110.649 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.87 151.68 20.44 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.653 0.781 . . . . 72.55 109.993 -176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.4 tm? -98.64 126.27 44.19 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.151 -1.796 . . . . 71.15 106.151 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.47 157.65 33.43 Favored Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 122.899 0.48 . . . . 53.43 110.305 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HG2' ' OH ' ' A' ' 62' ' ' TYR . 23.6 Cg_endo -63.73 148.34 92.12 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.334 2.023 . . . . 51.1 111.698 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 24.5 p-10 -123.37 -16.33 6.89 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.593 -0.73 . . . . 74.13 112.175 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.92 109.45 18.15 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 120.365 -0.534 . . . . 74.35 110.635 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.451 ' OH ' ' HG2' ' A' ' 59' ' ' PRO . 24.9 m-85 -114.44 127.67 55.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.532 -0.758 . . . . 73.42 110.7 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 64.8 mt -109.28 115.61 50.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.908 -1.145 . . . . 61.32 107.908 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.99 110.42 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.451 -0.944 . . . . 73.15 108.451 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -102.27 121.73 42.83 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.189 -0.46 . . . . 70.21 110.529 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.38 167.89 9.86 Favored 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.698 0.799 . . . . 71.4 110.168 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 162.38 50.56 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.39 -1.484 . . . . 73.33 109.39 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 7.9 p -59.71 -42.01 87.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 117.467 0.633 . . . . 74.43 112.306 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.476 ' HB3' HG21 ' A' ' 116' ' ' THR . 15.3 t-80 -73.6 -21.95 60.18 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.494 0.664 . . . . 74.31 110.17 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -79.26 -36.87 39.19 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.766 -0.584 . . . . 73.41 110.173 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -31.08 71.56 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.766 -0.652 . . . . 64.3 109.473 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.6 mm-40 -59.42 -31.43 69.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.713 -0.676 . . . . 75.42 112.004 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -84.44 -27.82 27.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.085 -0.646 . . . . 62.14 110.755 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.412 HD11 ' HG ' ' A' ' 66' ' ' LEU . 88.2 mt -64.36 -38.97 92.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.395 -0.366 . . . . 63.11 110.22 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.51 169.28 11.59 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 111.384 -0.686 . . . . 74.35 111.384 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.14 -31.41 25.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.0 0.428 . . . . 64.42 110.417 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 16.3 m-20 -105.8 105.36 52.85 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.51 -0.768 . . . . 71.31 109.428 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.16 -18.97 17.96 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.08 1.853 . . . . 71.31 113.783 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.296 0.0 OUTLIER -62.54 -51.91 65.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.789 1.403 . . . . 71.32 114.789 -174.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -67.35 -36.44 81.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.86 0.3 . . . . 64.42 111.314 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 72.4 mmtt -64.61 -45.78 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.539 . . . . 64.22 109.904 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.615 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 43.5 m -71.68 -49.71 37.14 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.378 -0.828 . . . . 72.5 111.11 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 56.1 m -65.63 -35.07 79.73 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.785 0.326 . . . . 74.24 111.649 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.73 -46.53 74.54 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.336 -0.705 . . . . 43.43 111.336 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.81 -28.28 67.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.274 -0.639 . . . . 73.44 109.274 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.94 79.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.994 -0.548 . . . . 72.14 110.25 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 83' ' ' THR . 99.9 mtt180 -66.14 -41.9 89.8 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.104 -0.332 . . . . 75.44 110.104 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.43 -36.66 83.09 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.927 0.394 . . . . 73.5 110.327 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 104' ' ' VAL . 2.7 tm? -73.39 -39.44 65.1 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.948 -0.569 . . . . 51.11 110.121 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -59.37 -41.44 89.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.65 0.738 . . . . 72.45 109.026 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 19.2 t70 -58.16 -51.67 68.76 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.265 -1.334 . . . . 73.3 109.186 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.614 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 10.0 m-85 -55.1 -53.72 52.3 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.27 0.841 . . . . 70.21 113.27 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 pt -61.84 -36.63 74.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 120.774 -0.37 . . . . 75.22 111.664 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.19 -36.63 82.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.067 -0.515 . . . . 65.24 111.35 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.9 mt-10 -62.93 -38.84 92.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.381 0.61 . . . . 65.21 110.844 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 62.3 mm-40 -79.8 -9.45 59.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.377 -0.828 . . . . 73.45 110.905 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.81 56.57 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 116.051 -0.522 . . . . 71.3 112.583 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -101.5 159.76 15.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.488 -0.931 . . . . 65.44 108.488 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -132.94 171.6 13.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.711 -1.218 . . . . 74.13 107.711 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.1 t -147.86 166.27 28.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.645 -0.502 . . . . 60.41 109.645 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -106.51 120.76 42.76 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 109.749 -0.463 . . . . 61.22 109.749 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.85 -149.79 17.03 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.269 -1.132 . . . . 51.33 110.269 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -108.8 143.0 38.53 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.885 -1.524 . . . . 73.42 106.885 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 90' ' ' ALA . 14.8 p -81.52 112.99 20.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.128 -1.029 . . . . 61.35 108.903 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.85 120.15 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-O 122.096 0.95 . . . . 73.21 110.866 -176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 82' ' ' SER . 3.7 m -119.1 139.67 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 N-CA-C 104.025 -2.583 . . . . 74.2 104.025 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -137.81 132.88 33.29 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.869 -1.132 . . . . 74.53 112.119 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -91.35 119.94 31.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.418 -1.265 . . . . 61.21 108.54 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.89 171.67 9.05 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.81 -0.632 . . . . 74.02 109.925 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -121.49 157.63 30.22 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.115 -1.069 . . . . 73.55 108.115 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.7 t -145.76 146.98 31.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.093 -0.706 . . . . 60.22 109.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.3 m -80.89 -22.74 39.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.433 -0.951 . . . . 75.34 108.433 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -80.46 -29.7 37.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.251 -0.886 . . . . 73.52 109.652 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.02 130.78 37.69 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.113 -1.81 . . . . 72.5 106.113 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 38.1 t-80 -97.74 153.24 18.39 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.499 -0.48 . . . . 73.41 110.008 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 69' ' ' HIS . 97.9 m -60.51 139.59 57.68 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.635 0.774 . . . . 64.01 110.768 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.18 3.05 57.88 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.211 -1.155 . . . . 52.43 110.211 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 99.5 mt-30 -132.25 154.05 50.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.05 0.94 . . . . 64.34 109.101 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.11 148.22 26.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.434 -1.321 . . . . 61.3 107.434 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -137.45 135.94 37.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.802 -0.814 . . . . 72.21 108.802 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -137.28 120.66 16.98 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 123.527 0.517 . . . . 72.04 109.78 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 1.5 tpm_? -119.73 137.41 53.94 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.682 -1.229 . . . . 74.41 107.682 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -120.4 104.34 0.99 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.189 -0.764 . . . . 62.22 111.189 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.6 m -105.43 151.22 24.5 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 122.43 -0.453 . . . . 64.52 109.81 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.35 112.48 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.153 -1.054 . . . . 74.43 108.153 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -115.5 108.02 48.06 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 109.041 -0.726 . . . . 64.24 109.041 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.455 -0.759 0 C-N-CA 121.92 1.747 . . . . 70.11 112.236 -179.648 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.666 0 N-CA-C 113.326 0.862 . . . . 72.42 113.326 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.55 -22.65 43.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.847 -0.741 . . . . 74.21 109.216 172.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.74 -48.79 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 63.12 109.074 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.07 -33.24 75.55 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.8 -0.36 . . . . 63.35 110.654 178.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.19 81.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.585 0.553 . . . . 21.33 109.942 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.74 -45.6 93.65 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 108.765 -0.828 . . . . 71.42 108.765 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD21 HD11 ' A' ' 64' ' ' ILE . 11.1 mp -64.75 -42.45 95.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.043 1.127 . . . . 75.0 114.043 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.3 ptt180 -71.62 -27.28 63.0 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.205 -0.998 . . . . 70.44 111.328 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -68.14 -46.26 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.22 -40.42 93.93 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.697 1.199 . . . . 65.22 109.919 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.33 96.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.729 -0.669 . . . . 74.02 110.348 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.05 76.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.155 0.502 . . . . 63.22 111.36 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.91 -28.55 49.81 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.95 0.405 . . . . 72.34 111.289 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.49 21.6 45.25 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 116.267 -0.424 . . . . 51.13 113.138 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 56' ' ' LEU . 9.0 mm -62.15 144.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.693 0.797 . . . . 74.32 111.485 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 9.4 tt0 -120.45 134.66 55.24 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 107.988 -1.116 . . . . 73.25 107.988 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -64.48 128.94 37.93 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.453 0.644 . . . . 40.44 109.461 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -135.4 -166.25 1.81 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 105.57 -2.011 . . . . 45.25 105.57 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.638 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 67.6 mt-30 -59.05 155.68 13.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.611 -0.515 . . . . 64.13 109.611 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.53 -9.46 37.86 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 116.442 -0.344 . . . . 32.13 113.494 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -46.73 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.504 -0.184 . . . . 72.11 110.504 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 99' ' ' GLN . 6.0 ptm180 -172.16 152.92 2.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.4 -0.364 . . . . 75.42 110.698 -175.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 48' ' ' ILE . 81.5 mt -91.67 152.38 20.25 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.508 1.123 . . . . 73.53 111.084 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.8 tm? -92.97 133.28 36.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.092 -1.447 . . . . 70.12 107.092 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.61 159.97 41.96 Favored Pre-proline 0 C--N 1.302 -1.461 0 C-N-CA 123.525 0.73 . . . . 40.35 109.753 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.427 ' HA ' HG22 ' A' ' 125' ' ' VAL . 32.1 Cg_exo -61.72 162.1 22.72 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.068 2.512 . . . . 72.5 113.418 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 9.8 p30 -134.16 -23.73 1.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.96 -0.563 . . . . 53.3 112.215 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.05 104.49 14.67 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.117 -1.033 . . . . 74.42 109.515 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.28 114.62 28.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.313 -0.858 . . . . 73.33 109.581 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.36 118.03 56.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.722 -1.214 . . . . 70.02 107.722 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 40' ' ' LEU . 41.0 mt -113.31 125.79 70.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.011 -1.107 . . . . 72.15 108.011 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -116.39 123.32 47.28 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.138 -0.69 . . . . 73.42 109.138 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.1 mm? -102.65 159.62 15.29 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.854 0.862 . . . . 72.11 109.478 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.82 144.68 48.53 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.683 -2.167 . . . . 62.01 107.683 169.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.3 p -55.59 -36.02 40.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.425 0.898 . . . . 75.24 113.425 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -69.69 -34.17 73.56 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.762 0.315 . . . . 62.42 111.227 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.3 m-20 -76.69 -25.82 54.06 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.22 0.533 . . . . 71.55 110.176 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.97 -31.18 71.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.26 -1.015 . . . . 73.12 108.26 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 41.6 mt-10 -64.92 -31.7 73.07 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.731 -0.668 . . . . 75.24 110.532 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -73.23 -27.61 61.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.199 -0.455 . . . . 71.13 110.915 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.53 -27.22 66.79 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.167 -0.679 . . . . 73.54 109.167 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.16 -163.72 12.54 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 114.81 -1.086 . . . . 44.34 113.389 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -80.89 -19.35 44.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.34 0.59 . . . . 75.41 109.672 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.23 67.94 36.29 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.696 -0.684 . . . . 74.35 112.54 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 17.1 Cg_exo -72.5 -48.85 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.909 1.739 . . . . 65.23 110.352 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.599 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 5.4 mm-40 -68.43 -12.84 61.76 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.302 0.853 . . . . 72.23 113.302 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.22 -38.17 43.69 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.595 -1.261 . . . . 73.22 107.595 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.54 -25.6 57.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.068 -0.969 . . . . 73.3 110.407 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 9.3 m -54.65 -42.35 71.19 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 124.126 0.97 . . . . 74.43 111.28 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 m -60.85 -44.13 97.42 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.537 0.735 . . . . 72.44 111.275 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.65 -38.11 67.61 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.117 -0.793 . . . . 40.34 111.117 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -67.37 -36.47 81.41 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.363 0.665 . . . . 73.32 109.652 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.8 96.17 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.214 -0.448 . . . . 64.41 110.027 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -67.26 -36.29 81.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.316 -0.402 . . . . 74.14 110.67 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -43.97 96.74 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.638 -0.875 . . . . 75.55 108.638 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD22 HD23 ' A' ' 40' ' ' LEU . 53.7 tp -67.62 -36.66 81.25 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.462 -0.79 . . . . 73.25 110.818 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.36 -38.15 85.9 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.401 0.619 . . . . 72.34 109.6 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 33.1 t70 -66.21 -42.41 88.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.464 -0.789 . . . . 65.15 109.329 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.575 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.8 m-85 -54.82 -47.92 73.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.858 -0.61 . . . . 74.4 111.936 174.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 pt -68.49 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 119.925 -0.71 . . . . 74.45 111.19 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -61.04 -41.98 97.62 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.295 0.372 . . . . 71.43 110.275 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 21.7 mm-40 -57.37 -44.15 84.15 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.309 0.644 . . . . 74.34 111.005 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -79.81 -13.93 59.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.493 -0.776 . . . . 71.01 110.237 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 90.83 9.6 63.95 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.852 -0.613 . . . . 63.55 113.543 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -86.83 152.29 22.61 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.993 -0.71 . . . . 73.31 110.412 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 55' ' ' ARG . 9.8 pt20 -122.83 168.62 12.03 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.571 -0.529 . . . . 73.44 109.571 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.0 t -146.78 154.81 41.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.355 -0.609 . . . . 71.12 109.355 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -97.31 120.82 38.36 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.456 -1.313 . . . . 75.04 107.456 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.87 -163.98 12.59 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 120.264 -0.969 . . . . 72.14 110.933 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.47 143.65 40.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.605 0.24 . . . . 62.3 110.57 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 90' ' ' ALA . 9.6 p -80.94 123.49 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.822 -0.627 . . . . 63.43 109.799 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.5 129.21 72.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.751 -0.659 . . . . 72.11 109.939 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' SER . 96.2 t -115.36 119.38 61.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.093 -1.447 . . . . 62.1 107.093 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -110.47 127.12 54.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.062 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -99.64 119.73 38.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.21 -0.663 . . . . 74.41 109.21 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.99 166.7 11.87 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.146 -0.933 . . . . 75.02 109.767 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.67 156.11 36.52 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.99 -1.115 . . . . 75.41 107.99 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -144.67 140.13 28.44 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 109.189 -0.671 . . . . 65.23 109.189 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 m -81.02 -20.36 41.92 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.673 -0.862 . . . . 53.53 108.673 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -72.01 -40.23 68.63 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.066 -0.97 . . . . 63.24 108.679 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.92 130.47 34.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.222 -0.899 . . . . 62.44 110.178 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -95.77 172.76 7.83 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.278 -0.874 . . . . 72.4 109.284 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.431 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 12.7 t -56.67 138.1 53.1 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.772 0.796 . . . . 74.42 111.278 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.76 -30.2 9.74 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 115.065 -0.971 . . . . 74.25 111.655 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -84.92 144.0 28.64 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.227 0.537 . . . . 75.04 111.47 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HB3' HD13 ' A' ' 66' ' ' LEU . 20.0 p90 -156.75 151.93 26.36 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.91 -1.515 . . . . 73.32 106.91 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -143.72 151.48 40.08 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.183 -1.414 . . . . 72.52 107.183 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.8 140.12 23.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.089 -0.337 . . . . 75.23 110.089 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -133.25 137.98 46.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.297 -1.001 . . . . 70.41 108.297 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.16 117.65 3.97 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.727 -1.349 . . . . 51.22 109.727 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.7 p -116.49 154.4 30.44 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-O 121.195 0.521 . . . . 73.32 110.906 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 67.7 t -89.92 103.95 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 108.102 -1.073 . . . . 53.14 108.102 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -101.85 95.69 5.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 106.397 -1.705 . . . . 65.45 106.397 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 71.6 Cg_endo . . . . . 0 N--CA 1.445 -1.33 0 C-N-CA 121.709 1.606 . . . . 61.11 112.429 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 112.888 0.699 . . . . 74.34 112.888 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.79 -33.98 76.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.918 -0.771 . . . . 72.41 108.918 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.59 -54.15 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.142 -0.936 . . . . 73.35 109.964 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -63.86 -29.54 70.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.815 0.34 . . . . 74.41 111.348 -178.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' ARG . . . -60.88 -47.99 83.84 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.107 -0.701 . . . . 72.43 109.107 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 26.7 tp -66.11 -39.55 90.04 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.393 -0.821 . . . . 64.53 110.419 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.24 -51.11 67.66 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.137 0.273 . . . . 72.53 111.687 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.1 ptt180 -70.06 -22.91 63.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.076 0.769 . . . . 72.24 113.076 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 83.9 mtt180 -70.98 -45.37 64.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.827 -0.435 . . . . 65.43 109.827 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' ALA . 20.2 mm-40 -68.94 -32.61 72.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.047 -0.524 . . . . 75.41 110.318 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.05 95.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.451 -0.574 . . . . 62.15 109.451 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.78 -26.43 66.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.885 -0.598 . . . . 73.12 111.359 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -78.51 -34.19 47.51 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.316 0.579 . . . . 73.03 111.172 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.4 9.58 72.67 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.919 -0.658 . . . . 60.12 112.664 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.8 129.51 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 121.05 0.453 . . . . 74.14 110.732 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -122.1 141.93 50.9 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.952 -1.022 . . . . 74.24 110.56 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -75.52 113.44 12.95 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.839 -1.073 . . . . 74.4 110.782 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.9 tp -116.24 -164.4 0.96 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.428 -2.064 . . . . 51.02 105.428 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.576 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 mt-30 -48.3 154.89 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.912 0.485 . . . . 72.33 111.045 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.05 8.97 4.27 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 116.114 -0.494 . . . . 63.44 114.157 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -78.16 -47.59 17.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.324 -1.361 . . . . 73.22 107.324 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -173.61 166.08 4.57 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.868 0.692 . . . . 72.15 112.868 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.0 mt -91.13 151.78 20.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.047 -0.979 . . . . 72.31 112.298 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.47 129.76 41.12 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.824 -1.176 . . . . 60.01 107.824 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 158.72 39.14 Favored Pre-proline 0 C--N 1.308 -1.209 0 C-N-CA 123.206 0.602 . . . . 63.31 109.785 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.73 159.5 41.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.593 2.195 . . . . 73.14 112.536 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.15 -20.61 4.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.765 -0.652 . . . . 63.11 110.906 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.52 111.09 23.5 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.714 -1.217 . . . . 64.33 107.714 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB2' HG22 ' A' ' 106' ' ' VAL . 91.8 m-85 -124.95 131.03 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.246 0.546 . . . . 74.21 111.669 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' NH2' ' A' ' 122' ' ' ARG . 52.6 mt -127.6 124.41 63.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.513 -0.767 . . . . 62.33 109.278 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.27 120.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.022 -1.473 . . . . 72.2 107.022 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 m -108.81 125.96 52.53 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 115.754 -0.657 . . . . 54.14 109.719 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.67 -176.78 2.98 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 124.662 1.185 . . . . 72.23 109.135 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.42 172.15 44.61 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.283 -1.127 . . . . 64.32 110.283 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 70.2 t -59.23 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.66 0.384 . . . . 70.31 111.362 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 55.9 t-80 -60.65 -40.94 93.86 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.544 0.688 . . . . 73.34 110.422 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.96 -40.34 83.2 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.452 -1.249 . . . . 74.42 110.454 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.444 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 88.8 t80 -66.81 -31.74 72.56 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.142 -0.481 . . . . 73.1 110.19 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.6 mm-40 -66.49 -26.2 67.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.993 -0.549 . . . . 72.21 111.178 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -77.98 -36.12 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.74 -0.837 . . . . 72.32 108.74 173.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.95 -18.92 65.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.259 -0.882 . . . . 75.4 110.364 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.45 -5.72 12.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.831 -0.622 . . . . 31.31 113.394 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.77 70.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.701 -0.481 . . . . 75.54 109.701 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 81' ' ' LYS . 18.4 t70 -155.71 83.74 3.54 Favored Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 108.568 -0.901 . . . . 71.31 108.568 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.65 -51.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.995 1.797 . . . . 60.24 114.417 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -38.93 20.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.273 1.582 . . . . 70.51 115.273 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 2.2 tm? -66.2 -52.04 51.82 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.815 -0.439 . . . . 62.22 109.815 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 30.0 mtpp -58.67 -31.29 68.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.098 0.777 . . . . 63.22 113.098 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -62.21 -45.09 94.92 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.204 0.526 . . . . 33.25 110.186 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 m -72.75 -33.72 66.55 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.098 -0.501 . . . . 61.25 110.332 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.05 92.18 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.19 -0.764 . . . . 71.3 111.19 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -69.67 -36.09 75.71 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 111.674 0.25 . . . . 73.24 111.674 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.44 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.681 0.277 . . . . 53.42 110.897 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.29 -41.24 90.07 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.342 -0.614 . . . . 73.14 109.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.16 -43.94 81.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.868 -0.605 . . . . 72.43 110.548 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.48 -36.83 76.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.172 -0.467 . . . . 45.5 110.935 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.32 89.21 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.049 -0.723 . . . . 62.45 109.049 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -41.92 85.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.188 -0.914 . . . . 75.01 109.788 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.573 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 17.4 m-85 -57.91 -50.3 73.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.44 0.533 . . . . 74.14 112.44 174.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.9 -31.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.049 -0.66 . . . . 73.2 110.965 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -34.59 76.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.42 111.205 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.56 -43.34 99.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.138 0.971 . . . . 74.11 109.436 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.5 mm-40 -73.81 -12.53 60.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.377 -1.283 . . . . 71.21 110.899 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.12 30.56 46.08 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.009 -0.541 . . . . 54.45 112.467 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -97.36 172.1 7.99 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 122.521 -0.399 . . . . 74.31 110.0 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.98 169.43 17.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.715 -0.476 . . . . 62.25 109.715 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -159.51 179.3 9.03 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.205 -0.665 . . . . 64.24 109.205 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.12 120.26 37.79 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.482 -0.562 . . . . 72.41 109.482 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.37 -149.75 16.71 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.955 -1.117 . . . . 73.02 110.961 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.3 146.03 45.62 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.222 -1.399 . . . . 64.01 107.222 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.99 109.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.388 -0.597 . . . . 73.23 109.388 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.15 122.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.578 0.704 . . . . 74.43 110.364 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' TYR . 78.4 t -118.93 123.51 71.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 74.13 109.106 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -117.33 147.03 42.97 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.191 -0.67 . . . . 74.21 109.191 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.36 123.61 45.72 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.25 -1.389 . . . . 74.03 107.25 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.96 176.16 8.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.674 0.273 . . . . 64.34 110.966 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 25.7 pt20 -113.03 164.72 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.918 -0.583 . . . . 64.51 111.219 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.3 p -151.01 148.81 28.81 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 107.513 -1.292 . . . . 52.42 107.513 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -81.02 -24.89 37.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.257 0.551 . . . . 61.32 109.939 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.66 -21.92 59.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 115.991 -0.549 . . . . 75.45 112.479 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.36 131.73 41.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 C-N-CA 120.097 -0.641 . . . . 75.53 109.589 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -114.04 156.42 24.15 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.537 -0.912 . . . . 71.15 108.537 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.1 m -51.83 110.68 0.5 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.065 0.853 . . . . 73.1 111.541 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 134.56 -33.96 2.42 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 109.125 -1.59 . . . . 71.21 109.125 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.17 144.98 31.21 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.783 -0.708 . . . . 74.11 109.282 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -157.87 160.3 37.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.982 -1.488 . . . . 74.53 106.982 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -145.43 147.65 32.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.238 -0.653 . . . . 70.52 109.238 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -122.79 132.74 54.35 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 104.651 -2.352 . . . . 52.11 104.651 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' A' ' 122' ' ' ARG . 4.9 tmm_? -136.5 135.55 38.65 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.31 -1.367 . . . . 43.14 107.31 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.42 155.48 17.53 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.298 -1.121 . . . . 73.4 110.298 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.7 t -149.77 161.47 42.17 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.916 -0.772 . . . . 73.2 108.916 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.9 110.57 20.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.955 -1.498 . . . . 52.51 106.955 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -125.67 93.56 44.21 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 116.603 -0.271 . . . . 74.42 110.709 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 C-N-CA 122.31 2.007 . . . . 71.23 110.376 175.068 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.402 . . . . 74.31 111.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -25.61 66.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.165 0.507 . . . . 73.41 110.835 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.15 -44.69 49.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.292 -1.003 . . . . 54.24 108.292 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' HH21 ' A' ' 41' ' ' ARG . 45.7 mt-10 -61.59 -34.73 76.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.189 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 42' ' ' ARG . . . -61.61 -57.74 10.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.228 -0.896 . . . . 62.12 109.638 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.4 tm? -56.94 -44.52 82.6 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.471 -0.566 . . . . 73.41 109.471 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 HD22 ' A' ' 89' ' ' LEU . 92.5 mt -58.43 -52.51 65.32 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.488 0.551 . . . . 72.35 112.488 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 17.9 ptp180 -65.29 -30.22 71.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.929 0.395 . . . . 71.11 110.678 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 35.8 mmt180 -76.38 -37.66 56.86 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.067 -0.515 . . . . 71.41 110.713 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 122' ' ' ARG . 21.6 tt0 -78.15 -27.48 48.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.827 -0.749 . . . . 71.23 110.416 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.14 91.87 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.148 -0.686 . . . . 65.43 109.148 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.38 -32.81 68.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.42 110.957 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.67 -42.2 78.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.782 -0.644 . . . . 72.33 111.211 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.95 9.55 59.89 Favored Glycine 0 C--N 1.319 -0.414 0 CA-C-N 116.134 -0.484 . . . . 72.22 113.157 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 14.1 mm -62.1 130.64 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.447 0.641 . . . . 74.14 111.588 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.7 mt-30 -110.54 134.95 51.91 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 115.517 -0.765 . . . . 71.33 110.087 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -78.65 91.68 4.66 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.639 -1.164 . . . . 64.33 108.195 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 24.3 tp -104.4 -165.77 1.18 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.205 -1.405 . . . . 74.42 107.205 -176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 54.1 mt-30 -45.15 145.55 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.227 0.611 . . . . 72.1 110.647 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.35 15.83 1.9 Allowed Glycine 0 C--O 1.218 -0.904 0 CA-C-N 116.003 -0.544 . . . . 73.22 113.26 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 52' ' ' GLN . 2.4 m-20 -70.17 -44.95 67.71 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.654 -1.61 . . . . 74.41 106.654 175.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 177.35 166.09 0.6 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-N 113.82 -1.536 . . . . 64.43 109.045 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -90.64 151.09 21.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 120.89 0.376 . . . . 74.32 110.914 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 36.6 tp -93.62 131.58 38.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.492 -0.776 . . . . 74.41 108.985 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.49 162.54 33.7 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.128 -0.693 . . . . 75.44 109.128 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 125' ' ' VAL . 30.4 Cg_exo -66.16 159.33 50.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.752 2.302 . . . . 73.03 112.602 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 4.8 p-10 -130.23 -19.52 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.328 -0.397 . . . . 71.4 111.145 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.08 112.46 25.13 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.548 -0.908 . . . . 63.03 108.548 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 75.8 m-85 -118.54 114.24 22.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.067 0.937 . . . . 64.11 110.865 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.9 mt -104.93 104.21 16.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.322 -1.308 . . . . 71.41 108.56 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 HG13 ' A' ' 106' ' ' VAL . 3.0 mp -96.49 128.53 47.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.9 -0.778 . . . . 63.31 108.9 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.3 m -121.1 129.02 53.12 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 116.119 -0.491 . . . . 73.33 111.74 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -120.81 174.87 6.33 Favored 'General case' 0 C--O 1.255 1.382 0 O-C-N 124.738 1.273 . . . . 71.24 109.326 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.7 -174.0 41.32 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 110.265 -1.134 . . . . 31.45 110.265 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.68 -51.19 23.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 114.523 1.305 . . . . 63.13 114.523 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.4 -42.07 83.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.547 0.689 . . . . 71.44 110.358 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.37 -32.27 66.31 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.851 -1.068 . . . . 74.11 112.759 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -66.26 -31.84 72.9 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 119.86 -0.736 . . . . 70.12 109.302 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.96 -23.15 67.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.387 0.514 . . . . 74.22 112.387 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -83.21 -28.65 29.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.8 0.333 . . . . 74.24 110.198 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.497 HD11 ' HG ' ' A' ' 66' ' ' LEU . 57.8 mt -70.54 -37.94 74.13 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 109.011 -0.737 . . . . 72.53 109.011 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 150.14 8.64 Favored Glycine 0 N--CA 1.411 -2.994 0 CA-C-N 114.816 -1.084 . . . . 75.32 111.231 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -78.23 1.49 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.173 0.511 . . . . 73.43 110.992 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.14 92.07 4.29 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 121.934 0.874 . . . . 74.22 109.688 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.8 Cg_exo -75.51 -30.31 6.59 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.418 1.412 . . . . 62.53 110.03 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -45.65 -53.43 9.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.699 2.0 . . . . 72.13 113.078 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.69 -48.34 72.37 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.612 -0.722 . . . . 53.55 110.245 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -74.58 -38.61 62.62 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.85 1.056 . . . . 75.41 113.85 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 p -62.87 -51.69 66.02 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.71 0.633 . . . . 74.04 112.71 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -65.49 -43.13 91.13 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-N 116.244 -0.434 . . . . 73.33 111.365 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.34 52.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.049 -0.596 . . . . 73.1 112.239 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -70.65 -23.66 62.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.832 0.349 . . . . 73.25 110.095 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.48 -45.93 81.73 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.024 0.44 . . . . 74.22 109.86 175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.27 -36.72 74.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.779 -0.646 . . . . 73.53 109.853 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -62.33 -40.81 97.59 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.275 -0.875 . . . . 73.31 110.629 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 40' ' ' LEU . 54.7 tp -72.13 -31.88 66.41 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.759 0.314 . . . . 73.24 111.06 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.0 85.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.719 0.771 . . . . 63.23 109.299 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.89 -39.87 91.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.671 -1.15 . . . . 64.13 109.702 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 12.2 m-85 -57.82 -52.25 66.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.015 -0.539 . . . . 75.14 112.201 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 pt -66.9 -33.42 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.221 -0.591 . . . . 73.44 111.327 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.94 -31.09 69.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.57 . . . . 62.32 110.781 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.53 -30.32 69.09 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.244 0.545 . . . . 72.33 111.386 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 54.8 mm-40 -86.74 -10.62 53.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.399 0.618 . . . . 65.2 109.741 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.57 21.37 58.26 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.709 -0.678 . . . . 73.14 113.362 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.419 ' CD2' HD11 ' A' ' 48' ' ' ILE . 24.6 m0 -93.67 150.82 20.1 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.085 0.469 . . . . 70.21 111.488 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -112.47 168.49 9.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.541 -0.754 . . . . 73.55 110.215 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.7 t -162.72 160.61 25.66 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.704 -0.85 . . . . 65.44 108.704 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -93.52 119.03 32.09 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.457 -1.312 . . . . 74.33 107.457 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.84 -150.35 16.75 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.78 -1.328 . . . . 61.14 109.78 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.75 153.82 47.82 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.517 -0.549 . . . . 71.21 109.517 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.68 123.27 32.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 123.637 0.586 . . . . 63.44 110.731 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.56 130.48 71.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.259 -0.882 . . . . 63.41 109.128 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 64' ' ' ILE . 54.9 t -123.97 117.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.07 -1.085 . . . . 54.11 108.07 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.97 148.49 44.02 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.811 -0.756 . . . . 71.24 109.887 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.75 129.24 56.18 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.381 -1.34 . . . . 73.23 107.381 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.61 158.97 43.24 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.039 0.447 . . . . 64.4 110.296 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.15 143.31 32.12 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.311 -0.859 . . . . 73.44 109.092 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 133.25 26.95 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 109.572 -0.529 . . . . 41.44 109.572 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.7 m -69.21 -20.43 63.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.142 0.496 . . . . 74.42 110.559 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.6 3.19 12.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.481 1.112 . . . . 71.02 111.408 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 115' ' ' HIS . 2.0 tm? -132.83 149.4 52.27 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.383 -2.08 . . . . 75.22 105.383 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.494 ' N ' HD13 ' A' ' 114' ' ' LEU . 36.7 t-80 -148.2 159.97 43.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.566 -0.531 . . . . 71.01 109.566 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 m -43.97 125.24 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.673 1.989 . . . . 71.31 111.926 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.61 -34.76 4.51 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 108.672 -1.771 . . . . 31.32 108.672 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.94 156.82 18.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.177 -1.045 . . . . 71.35 108.177 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -169.48 151.72 4.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.321 -2.103 . . . . 75.24 105.321 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -157.11 151.07 24.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.276 -0.969 . . . . 75.51 109.982 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -118.9 139.29 51.89 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.597 -1.261 . . . . 43.14 107.597 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 2.4 tpm_? -111.87 117.79 33.74 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.384 -0.969 . . . . 74.14 108.384 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.57 109.18 3.04 Favored Glycine 0 C--N 1.291 -1.934 0 O-C-N 123.871 0.732 . . . . 75.0 111.629 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 p -123.64 162.0 23.92 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.33 0.652 . . . . 72.21 111.138 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.1 t -101.4 131.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 105.069 -2.197 . . . . 73.21 105.069 173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -112.98 130.8 23.19 Favored Pre-proline 0 C--N 1.295 -1.785 0 C-N-CA 118.542 -1.263 . . . . 74.52 111.375 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 C-N-CA 122.219 1.946 . . . . 74.23 110.402 175.506 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' CG ' ' A' ' 37' ' ' GLU . 20.9 mp0 . . . . . 0 C--O 1.212 -0.911 0 N-CA-C 113.188 0.811 . . . . 75.01 113.188 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.33 -31.23 43.07 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.177 -1.046 . . . . 71.45 108.177 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.53 -53.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.089 -0.959 . . . . 61.0 109.533 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.34 -29.9 71.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.599 -0.273 . . . . 71.13 111.376 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.49 95.65 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.276 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.12 -37.36 58.17 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 120.705 -0.398 . . . . 63.12 110.461 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 62' ' ' TYR . 4.1 mm? -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.695 -0.402 . . . . 64.14 112.069 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -69.28 -27.56 65.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.362 -0.607 . . . . 72.03 109.362 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -70.22 -40.8 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.209 -0.663 . . . . 71.33 109.209 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -61.13 -43.39 98.96 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 123.446 0.466 . . . . 74.34 110.677 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -60.21 -47.22 86.89 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.613 -0.721 . . . . 54.54 110.381 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.88 -32.46 72.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 63.11 111.849 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.88 -32.15 51.74 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.446 0.641 . . . . 72.13 110.366 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.05 16.22 61.02 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.548 -0.751 . . . . 74.55 113.418 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 mm -63.04 131.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.14 0.576 . . . . 72.03 111.932 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.8 mt-30 -117.16 144.15 45.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.214 -0.903 . . . . 72.13 109.472 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.2 m -71.49 114.73 9.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.053 -0.976 . . . . 64.32 109.87 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 25.7 tp -122.7 -176.94 3.51 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.068 -1.456 . . . . 74.52 107.068 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 78.0 mt-30 -53.69 164.42 0.55 Allowed 'General case' 0 C--O 1.246 0.914 0 C-N-CA 124.601 1.16 . . . . 74.24 113.525 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.27 -9.46 23.23 Favored Glycine 0 CA--C 1.504 -0.643 0 CA-C-N 114.921 -1.036 . . . . 63.24 114.734 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -74.7 -43.9 52.76 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.043 -0.663 . . . . 64.43 111.518 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.4 ptp180 -175.82 167.09 3.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.3 0.482 . . . . 73.02 112.3 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.82 151.86 20.39 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.438 1.095 . . . . 71.51 111.403 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.4 tm? -90.73 131.44 36.4 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.07 -1.085 . . . . 62.34 108.07 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.74 162.65 35.56 Favored Pre-proline 0 C--N 1.311 -1.107 0 C-N-CA 123.559 0.744 . . . . 52.42 110.005 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.6 Cg_exo -57.42 161.98 10.83 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.38 2.72 . . . . 72.12 113.958 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -131.36 -32.71 1.53 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.464 -0.789 . . . . 72.34 111.719 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.56 106.73 18.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.278 -1.379 . . . . 73.22 107.278 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.46 ' HB2' HG12 ' A' ' 106' ' ' VAL . 96.7 m-85 -112.16 116.15 30.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.216 0.531 . . . . 75.33 110.463 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.12 114.5 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.258 -0.883 . . . . 73.15 109.574 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.45 125.98 70.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.999 -0.741 . . . . 61.34 108.999 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -110.9 126.53 54.81 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.902 -0.777 . . . . 73.41 108.902 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.69 160.86 20.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.014 -0.736 . . . . 74.22 109.014 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.49 145.04 49.22 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 108.625 -1.79 . . . . 55.25 108.625 172.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.8 p -52.57 -37.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 113.01 0.744 . . . . 62.14 113.01 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.17 -22.67 62.01 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.475 0.655 . . . . 74.34 111.255 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 29.8 m-20 -85.87 -35.25 20.7 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 121.552 -0.717 . . . . 73.52 110.279 175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -63.16 -24.86 68.08 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.087 -0.96 . . . . 74.34 109.444 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 38.2 mt-10 -58.29 -33.6 69.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 111.917 0.34 . . . . 65.43 111.917 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 70' ' ' ASP . 4.2 mppt? -81.08 -34.68 32.5 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.327 -0.549 . . . . 71.54 109.931 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.4 mt -68.58 -35.36 77.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.52 0.676 . . . . 72.44 110.224 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 6.32 39.2 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.786 -1.097 . . . . 43.54 113.973 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.29 97.54 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.613 -1.254 . . . . 73.22 107.613 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 9.3 m-20 -148.25 82.74 7.49 Favored Pre-proline 0 CA--C 1.508 -0.656 0 N-CA-C 106.175 -1.787 . . . . 73.31 106.175 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.05 -47.64 23.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.511 2.14 . . . . 72.03 111.694 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -46.66 71.98 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.198 -0.91 . . . . 74.52 111.046 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.36 -53.7 54.5 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.386 -0.598 . . . . 73.42 109.386 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 77' ' ' ASP . 14.1 mptt -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.864 -0.607 . . . . 74.03 111.778 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -67.37 -45.28 76.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.891 -0.324 . . . . 71.04 110.942 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.4 m -62.42 -44.33 96.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.239 0.216 . . . . 74.44 111.023 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.17 -46.6 90.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.017 -0.611 . . . . 72.2 112.059 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.71 -35.87 82.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 110.34 -0.244 . . . . 72.42 110.34 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -63.19 -46.62 86.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.628 0.251 . . . . 74.32 110.581 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.43 -44.61 90.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.129 -0.487 . . . . 65.53 111.003 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.4 -34.08 75.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.559 0.578 . . . . 72.41 112.559 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.34 -35.16 65.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.997 0.427 . . . . 55.33 110.181 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.78 81.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.799 0.809 . . . . 73.5 109.678 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.57 -38.88 88.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.906 -1.043 . . . . 65.54 109.022 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -59.36 -49.09 79.15 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.41 -0.814 . . . . 63.33 111.918 175.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -66.38 -30.5 50.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 120.32 -0.552 . . . . 70.23 111.006 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -64.02 -43.3 96.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.433 -0.349 . . . . 63.42 110.537 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.86 -32.77 72.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.074 0.464 . . . . 71.2 112.072 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 64.8 mm-40 -81.45 -13.21 58.47 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.197 0.522 . . . . 55.3 111.452 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 84.55 34.42 16.43 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.764 -0.653 . . . . 50.31 111.669 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -110.71 173.98 6.08 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.88 -0.415 . . . . 64.43 109.88 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -155.84 174.0 15.96 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.328 -0.99 . . . . 44.11 108.328 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -147.33 176.4 10.03 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.681 -0.859 . . . . 53.42 108.681 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -99.06 120.14 38.98 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.277 -1.379 . . . . 72.33 107.277 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.9 -149.81 16.83 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.999 -1.64 . . . . 61.24 108.999 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -132.47 144.44 50.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.375 -1.343 . . . . 74.32 107.375 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.05 124.24 20.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.213 0.53 . . . . 74.23 112.008 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.93 120.51 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.408 -0.815 . . . . 64.33 110.045 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 62' ' ' TYR . 14.8 m -106.65 147.5 11.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.774 -1.195 . . . . 35.23 107.774 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -137.31 142.12 41.88 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.841 -0.8 . . . . 71.13 108.841 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -114.19 134.75 54.7 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.03 -0.532 . . . . 62.04 109.655 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.3 159.81 35.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.122 0.487 . . . . 71.23 110.001 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -107.56 155.1 20.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.51 -0.768 . . . . 72.51 109.828 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -138.99 140.12 38.1 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.695 -1.224 . . . . 74.4 107.695 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 m -82.08 -27.43 32.92 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.343 0.592 . . . . 71.11 110.067 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -80.57 -34.51 35.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.596 -0.729 . . . . 75.22 109.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 tp -77.45 133.37 38.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.168 -1.789 . . . . 73.11 106.168 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.4 ' CG ' ' H ' ' A' ' 116' ' ' THR . 12.5 t-80 -116.5 172.35 7.27 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.848 -1.541 . . . . 65.24 112.311 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.612 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 21.9 m -50.59 132.02 25.48 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 125.668 1.587 . . . . 73.32 113.387 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.62 -6.13 83.29 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.634 -1.166 . . . . 72.44 112.247 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.36 136.17 54.79 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.893 -1.151 . . . . 75.02 107.893 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.3 159.96 42.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.945 -0.391 . . . . 75.4 109.945 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 mmp_? -133.17 137.31 46.17 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.811 -0.811 . . . . 74.32 108.811 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.23 44.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.788 -0.819 . . . . 72.44 108.788 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -139.7 131.87 28.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.455 -0.572 . . . . 74.53 109.455 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.82 128.56 8.5 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.825 -0.91 . . . . 62.41 110.825 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.4 m -123.33 144.76 49.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 109.347 -0.612 . . . . 74.45 109.347 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 59' ' ' PRO . 89.8 t -93.92 105.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.003 -1.11 . . . . 74.12 108.003 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.62 110.35 48.68 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.873 -1.158 . . . . 73.41 107.873 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.454 -0.838 0 C-N-CA 121.613 1.542 . . . . 73.2 111.608 -179.857 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 . . . . . 0 C--O 1.216 -0.702 0 CA-C-O 120.559 0.219 . . . . 74.2 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -34.46 75.49 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.608 0.595 . . . . 72.02 112.608 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.42 -51.68 35.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.555 . . . . 74.22 109.5 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.7 pt-20 -66.79 -30.05 70.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.594 -0.275 . . . . 61.45 111.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.65 -39.19 93.1 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.149 0.5 . . . . 53.11 109.873 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -71.11 -45.93 62.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.503 -0.925 . . . . 71.41 108.503 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 40' ' ' LEU 0.268 3.7 mm? -67.69 -33.69 75.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.586 1.328 . . . . 72.11 114.586 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 2.5 ptm180 -67.48 -32.47 73.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 119.806 -0.758 . . . . 54.43 109.085 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -35.8 69.26 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.326 -0.62 . . . . 71.43 109.326 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.9 -43.91 91.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.469 -0.567 . . . . 75.41 109.469 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -48.08 82.95 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.632 -0.713 . . . . 75.1 110.47 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.98 85.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.019 -0.537 . . . . 71.22 111.732 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -72.51 -39.91 67.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.137 0.494 . . . . 72.23 109.753 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.58 31.36 6.17 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.272 -0.876 . . . . 73.1 113.311 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 56' ' ' LEU . 17.7 mm -71.65 130.35 35.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.185 -0.672 . . . . 55.01 109.185 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 31.8 tt0 -107.74 136.56 47.27 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.667 -0.864 . . . . 74.43 108.667 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -67.59 107.44 2.51 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.764 0.793 . . . . 72.22 111.093 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.4 tp -118.12 -166.34 1.2 Allowed 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.065 -2.198 . . . . 70.02 105.065 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.605 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 52.6 mt-30 -51.77 152.55 2.84 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 123.245 0.618 . . . . 74.23 111.631 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.45 -3.28 18.85 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-N 116.087 -0.506 . . . . 74.22 113.453 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -65.23 -46.69 79.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.868 -1.16 . . . . 74.22 107.868 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -174.68 154.75 2.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.841 -1.072 . . . . 73.04 110.901 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.3 mt -90.56 151.79 21.18 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.563 -1.199 . . . . 65.43 109.878 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 40.6 tp -92.92 128.99 38.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.911 -0.586 . . . . 72.44 109.458 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.54 154.16 42.49 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 109.203 -0.665 . . . . 64.53 109.203 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 125' ' ' VAL . 38.8 Cg_exo -62.21 155.78 54.48 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.724 2.283 . . . . 63.1 112.396 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -127.49 -24.17 3.37 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.959 -0.564 . . . . 73.22 110.707 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.45 112.54 24.53 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.283 -1.006 . . . . 73.31 108.283 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.4 m-85 -121.93 122.37 39.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.34 0.59 . . . . 74.31 110.701 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.3 mt -120.08 116.47 50.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.088 -0.708 . . . . 75.55 109.088 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.09 126.0 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.257 -1.016 . . . . 70.43 108.257 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.81 117.27 32.36 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.64 -0.709 . . . . 71.11 109.204 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.5 mm? -100.72 161.69 13.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 122.82 0.448 . . . . 73.43 109.953 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.02 150.02 51.66 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.324 -1.91 . . . . 71.21 108.324 170.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.01 -35.01 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 117.325 0.562 . . . . 74.12 112.389 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.57 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 20.6 t60 -73.12 -28.89 62.52 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 116.021 -0.536 . . . . 63.52 110.576 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -85.72 -24.21 27.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.545 -0.722 . . . . 70.25 110.462 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.54 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 82.4 t80 -64.74 -41.35 95.99 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.277 0.56 . . . . 75.13 110.089 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.74 -25.54 65.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.032 -0.531 . . . . 73.0 111.008 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 2.1 mptm? -75.22 -22.57 57.84 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.23 -0.895 . . . . 74.51 111.763 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.0 -31.13 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.668 -1.234 . . . . 70.14 107.668 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.96 -162.73 15.62 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.642 -1.163 . . . . 71.31 111.69 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.14 -37.37 38.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.004 -0.739 . . . . 64.5 109.004 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -115.71 97.06 48.13 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.522 -0.763 . . . . 64.44 110.385 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.49 -33.5 22.54 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 121.962 1.775 . . . . 74.33 109.525 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.96 -22.29 59.89 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.55 -1.204 . . . . 63.33 111.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.2 tp -54.48 -45.37 73.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.203 -0.665 . . . . 63.23 109.203 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.54 -26.38 19.76 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 115.698 -0.683 . . . . 61.21 110.739 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -55.28 -51.14 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.15 0.432 . . . . 52.2 111.936 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.2 m -56.07 -45.57 79.29 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.127 0.489 . . . . 65.45 111.047 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.81 -43.25 75.6 Favored Glycine 0 C--O 1.206 -1.626 0 C-N-CA 120.907 -0.663 . . . . 25.3 111.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -61.17 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.168 0.987 . . . . 74.44 110.152 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.75 -45.91 92.49 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.546 -0.752 . . . . 63.32 109.837 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -75.34 -24.71 57.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.617 -0.719 . . . . 71.33 112.212 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.67 -51.47 59.23 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.092 -1.077 . . . . 73.13 108.092 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.72 -42.76 99.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.11 -0.95 . . . . 71.55 109.583 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -60.87 -39.09 87.88 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.157 -0.474 . . . . 72.41 111.192 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 23.1 t70 -72.83 -36.39 67.48 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.655 -0.498 . . . . 60.14 109.655 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.9 m-85 -59.26 -44.98 92.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.101 -0.5 . . . . 74.41 111.515 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -70.19 -25.43 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.372 -0.531 . . . . 45.33 111.293 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 79.5 mt-30 -66.69 -42.54 86.31 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.745 -0.835 . . . . 72.13 108.745 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 58.4 mt-10 -63.83 -26.68 68.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.458 -0.792 . . . . 72.13 111.227 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.5 mm-40 -92.95 -13.73 28.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 75.34 110.794 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.24 28.35 56.1 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.811 -0.632 . . . . 63.52 113.128 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -97.13 173.45 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.238 -0.653 . . . . 72.45 109.238 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.442 ' NE2' HD23 ' A' ' 51' ' ' LEU . 26.6 pt20 -132.32 165.75 23.49 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 122.458 -0.151 . . . . 72.23 110.822 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.8 t -154.15 158.15 39.94 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.449 -1.315 . . . . 74.25 107.449 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.14 120.7 37.89 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.379 -0.529 . . . . 71.13 110.989 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.04 -169.31 13.81 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.825 -1.31 . . . . 73.54 109.825 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -92.32 143.96 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.027 -0.731 . . . . 75.42 109.027 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 90' ' ' ALA . 6.1 p -80.85 115.09 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.923 0.868 . . . . 75.33 109.953 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.44 128.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 115.237 -0.892 . . . . 64.35 110.092 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 8.6 p -133.81 141.54 43.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.406 -0.961 . . . . 75.34 108.406 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -137.45 149.9 47.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.129 -0.628 . . . . 62.02 109.821 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -115.34 114.57 25.3 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.096 -1.446 . . . . 63.11 107.096 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.09 167.42 11.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.644 -0.502 . . . . 33.43 109.644 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.8 pt20 -104.57 160.47 14.92 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.416 0.626 . . . . 53.23 110.68 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -140.5 130.84 25.17 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.068 -0.969 . . . . 72.13 108.885 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -81.19 -5.74 58.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.501 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -88.87 -20.57 24.43 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.055 0.455 . . . . 75.25 110.758 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.0 mt -94.73 142.96 26.84 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.144 0.497 . . . . 61.04 110.299 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -98.12 173.07 7.21 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.399 -0.819 . . . . 64.33 109.787 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 m -53.68 118.38 3.88 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 124.197 0.936 . . . . 73.02 111.033 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.23 5.3 52.83 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 121.042 -0.599 . . . . 63.21 113.321 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.04 141.4 48.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.268 0.534 . . . . 71.12 110.985 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.641 ' HB3' HD13 ' A' ' 66' ' ' LEU . 28.8 p90 -152.06 151.02 30.58 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.066 0.46 . . . . 73.24 109.891 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.68 144.87 48.52 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.657 -1.238 . . . . 55.43 107.657 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.44 10.78 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 117.946 0.339 . . . . 64.32 110.526 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.51 ' NE ' ' HA ' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -125.47 135.23 52.11 Favored 'General case' 0 N--CA 1.39 -3.457 0 N-CA-C 109.906 -0.405 . . . . 75.21 109.906 178.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.6 143.4 17.83 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 109.506 -1.438 . . . . 72.04 109.506 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.6 m -145.35 150.57 36.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.101 -0.703 . . . . 73.35 109.101 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 59' ' ' PRO . 48.7 t -86.38 105.99 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.193 -1.039 . . . . 72.23 108.193 177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -122.02 100.13 43.2 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 108.772 -0.825 . . . . 72.02 108.772 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 C--O 1.245 0.857 0 C-N-CA 122.231 1.954 . . . . 75.45 112.326 -177.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 . . . . . 0 C--O 1.227 -0.089 0 CA-C-O 120.855 0.36 . . . . 75.23 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -72.88 -31.38 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 43.1 109.757 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 99.4 t -60.57 -50.96 78.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.351 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.39 -34.44 77.27 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.043 -0.663 . . . . 74.24 110.661 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.83 80.8 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.068 0.461 . . . . 75.23 110.582 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.7 tt -66.32 -42.94 87.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.334 -0.848 . . . . 70.12 109.931 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 93.9 mt -61.28 -39.21 89.59 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.05 0.452 . . . . 71.1 111.688 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -67.99 -33.46 74.68 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 123.723 0.809 . . . . 71.24 110.416 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -75.65 -36.16 60.24 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.063 -1.088 . . . . 74.41 108.063 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 63.2 mm-40 -63.62 -34.59 78.16 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.684 . . . . 73.01 110.351 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.29 94.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.836 -0.62 . . . . 74.14 109.727 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.23 -25.23 61.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.342 0.591 . . . . 72.14 110.89 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.69 -46.11 59.81 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.388 0.675 . . . . 75.31 111.135 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 26.39 10.12 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 120.698 -0.763 . . . . 53.41 114.093 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.18 141.61 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 122.65 0.38 . . . . 74.11 110.544 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.2 mt-30 -120.31 149.13 42.79 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.926 0.393 . . . . 54.24 110.412 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.5 p -76.56 128.92 35.68 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.72 -1.127 . . . . 52.21 109.446 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 28.4 tp -146.24 -166.35 2.45 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.899 -2.26 . . . . 73.32 104.899 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.568 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 98.2 mt-30 -43.91 136.52 3.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.743 0.652 . . . . 64.15 110.357 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.48 -8.23 31.05 Favored Glycine 0 N--CA 1.464 0.503 0 CA-C-N 116.654 -0.248 . . . . 40.21 113.487 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.61 -38.44 90.21 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.085 0.554 . . . . 73.12 109.801 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -171.59 147.9 2.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.025 -0.534 . . . . 72.23 111.213 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -91.08 151.89 20.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.723 0.809 . . . . 74.42 111.369 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 34.0 tp -84.81 128.88 34.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.74 -0.837 . . . . 65.3 108.74 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 98' ' ' TRP . . . -112.46 154.31 44.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 122.919 0.487 . . . . 62.3 111.11 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HB3' ' N ' ' A' ' 124' ' ' THR . 78.3 Cg_exo -58.31 145.91 91.55 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.475 2.783 . . . . 63.31 112.819 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 125' ' ' VAL . 24.6 p-10 -122.6 -25.37 4.73 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.263 -0.426 . . . . 73.52 110.137 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.35 113.09 25.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.955 -0.758 . . . . 65.44 108.955 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 93.9 m-85 -112.67 114.94 27.78 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.363 0.602 . . . . 70.23 109.49 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.39 120.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 71.22 108.559 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 40' ' ' LEU . 63.6 mt -115.8 125.74 73.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.967 -1.123 . . . . 64.14 107.967 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.9 m -120.56 120.62 36.35 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 116.4 -0.364 . . . . 72.53 110.1 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.4 mm? -106.5 170.82 7.7 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 122.905 0.482 . . . . 65.23 110.736 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.29 167.32 51.96 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.484 -1.446 . . . . 70.43 109.484 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.97 -40.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 117.492 0.646 . . . . 74.43 111.936 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -75.77 -28.84 58.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.254 -0.647 . . . . 73.51 109.254 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 61.1 m-20 -76.16 -29.46 57.75 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 120.791 -0.363 . . . . 63.11 111.13 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -69.33 -29.46 67.29 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.313 -0.995 . . . . 75.44 108.313 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.11 -26.46 66.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.777 -0.647 . . . . 75.14 111.115 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -70.63 -36.29 73.37 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.199 -0.667 . . . . 71.34 109.199 173.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.77 -30.11 69.48 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.338 -0.986 . . . . 74.2 108.338 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -138.18 16.03 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 114.13 -1.396 . . . . 23.43 113.325 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.88 -2.4 56.85 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.123 -0.538 . . . . 53.43 109.852 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -117.72 100.18 52.36 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 113.27 0.841 . . . . 53.45 113.27 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.47 -42.57 0.21 Allowed 'Trans proline' 0 CA--C 1.56 1.779 0 C-N-CA 121.656 1.57 . . . . 74.02 111.589 166.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -84.37 -29.71 26.03 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 118.775 2.88 . . . . 74.33 118.775 -163.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.74 -44.22 82.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.223 1.374 . . . . 64.44 108.563 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -65.04 -32.61 74.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.099 -0.955 . . . . 74.23 111.169 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.2 m -63.34 -43.32 98.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.817 -0.438 . . . . 53.13 109.817 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 64.3 m -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 116.253 -0.43 . . . . 64.44 110.817 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -52.11 49.89 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.234 -0.507 . . . . 24.4 112.036 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -63.16 -39.97 96.21 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.507 0.558 . . . . 62.04 112.507 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.571 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.87 -45.28 95.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.82 0.343 . . . . 61.44 111.151 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.5 -42.03 87.99 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.759 -0.655 . . . . 72.11 110.926 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.43 -42.67 82.8 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.48 -0.782 . . . . 75.4 110.488 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.47 -34.74 78.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.158 0.429 . . . . 64.4 112.158 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.09 88.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.509 0.671 . . . . 74.24 110.334 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 24.6 t70 -69.77 -43.95 71.15 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.806 -0.634 . . . . 74.22 109.362 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.3 m-85 -55.44 -56.73 16.8 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 113.126 0.787 . . . . 74.35 113.126 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.8 pt -57.47 -36.66 54.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 123.26 0.35 . . . . 74.15 111.548 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.17 -37.66 81.24 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.441 -0.345 . . . . 65.41 111.856 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.7 mt-10 -63.75 -34.75 78.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.304 0.573 . . . . 71.43 110.682 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 73.5 mm-40 -76.34 -13.72 60.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.508 -0.769 . . . . 62.31 111.008 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.02 67.46 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.943 -0.572 . . . . 75.15 112.267 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 14.8 m0 -81.42 165.01 21.66 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.461 -0.57 . . . . 72.45 109.461 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -133.8 165.67 24.43 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.257 -0.645 . . . . 75.23 109.257 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -155.41 170.86 20.94 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.157 -1.053 . . . . 65.43 108.157 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -106.86 119.18 38.65 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.888 -1.152 . . . . 74.53 107.888 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.14 -149.33 16.59 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 109.168 -1.573 . . . . 71.54 109.168 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.95 175.76 7.83 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.762 -1.57 . . . . 71.52 106.762 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -82.41 127.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.066 0.46 . . . . 74.34 110.511 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 m -127.54 127.33 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.548 -0.751 . . . . 71.5 109.083 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -131.62 145.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 107.321 -1.362 . . . . 74.24 107.321 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.56 139.3 20.75 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.339 0.59 . . . . 73.41 110.476 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.82 131.8 44.0 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.489 -1.232 . . . . 74.01 109.432 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.2 pt-20 -136.89 176.53 8.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.762 -0.829 . . . . 71.14 108.762 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -127.0 164.58 21.19 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.732 0.777 . . . . 65.12 111.406 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 m -142.04 127.03 18.34 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.968 -1.123 . . . . 63.34 107.968 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 t -69.24 -19.16 63.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.271 0.628 . . . . 71.33 110.283 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -65.79 -30.4 71.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 74.03 109.765 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.36 131.3 34.71 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.422 0.63 . . . . 74.12 110.772 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -92.29 162.0 14.46 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.635 -1.246 . . . . 72.02 107.635 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.9 m -55.93 126.82 27.43 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.431 0.692 . . . . 62.33 110.972 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.37 -14.53 47.26 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.558 -0.746 . . . . 63.51 111.616 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -106.46 131.72 53.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.565 -0.532 . . . . 63.53 109.565 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.448 ' HB3' HD13 ' A' ' 66' ' ' LEU . 16.4 p90 -145.45 159.37 43.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.093 -0.706 . . . . 73.15 109.093 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.95 149.81 52.33 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.093 -0.706 . . . . 74.43 109.093 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.27 134.84 17.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.487 -0.56 . . . . 55.02 109.487 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -132.39 145.3 51.13 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 121.38 0.609 . . . . 64.13 111.925 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.81 113.4 1.86 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.989 -1.645 . . . . 73.44 108.989 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 59' ' ' PRO . 61.0 m -143.13 145.45 32.84 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 108.951 -0.759 . . . . 75.3 108.951 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.44 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 6.0 p -86.91 118.15 32.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.993 -1.114 . . . . 71.42 107.993 174.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -126.21 88.78 53.65 Favored Pre-proline 0 C--N 1.29 -2.018 0 CA-C-N 115.626 -0.715 . . . . 62.42 110.087 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 122.382 2.055 . . . . 64.14 111.381 178.513 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.279 0.561 . . . . 73.2 110.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -79.82 -38.58 32.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.187 -0.915 . . . . 61.45 108.805 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.53 -53.48 46.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 115.532 -0.758 . . . . 63.51 110.028 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -65.53 -32.42 74.01 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 120.642 -0.423 . . . . 72.34 111.778 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.05 -53.97 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.0 0.429 . . . . 74.35 110.062 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.2 mm? -71.59 -34.64 70.07 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.044 -0.525 . . . . 74.53 111.366 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp -65.85 -41.05 92.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.516 0.198 . . . . 70.1 111.381 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -73.93 -26.51 60.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.21 -0.596 . . . . 72.12 109.495 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -71.18 -35.75 71.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.372 -0.603 . . . . 73.24 109.372 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 78.0 mm-40 -61.09 -37.36 82.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.766 -0.457 . . . . 73.24 109.766 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.68 82.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 73.41 109.92 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.42 -33.45 73.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.309 0.576 . . . . 45.24 112.007 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.05 -37.32 39.28 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.469 0.707 . . . . 61.51 110.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.54 14.49 63.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.483 -0.78 . . . . 41.52 113.365 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG23 ' HB3' ' A' ' 56' ' ' LEU . 9.0 mm -54.6 141.6 10.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.005 0.922 . . . . 61.45 110.96 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -112.36 126.75 55.62 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 107.02 -1.474 . . . . 74.33 107.02 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -66.71 102.18 0.9 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.331 0.586 . . . . 51.51 110.125 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -104.24 -165.97 1.2 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.487 -2.042 . . . . 71.23 105.487 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.619 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -47.13 144.04 2.85 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.155 -0.683 . . . . 62.22 109.155 172.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.63 7.49 3.86 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 114.343 0.497 . . . . 51.31 114.343 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -76.71 -35.6 57.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.536 -0.913 . . . . 44.25 108.536 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HD3' ' OE1' ' A' ' 99' ' ' GLN . 8.2 ptm180 -168.45 157.54 9.0 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.754 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 98' ' ' TRP . 77.6 mt -91.89 151.37 20.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.258 0.623 . . . . 70.25 110.408 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 HD22 ' A' ' 51' ' ' LEU . 5.6 tt -101.24 127.29 47.89 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.619 -1.252 . . . . 74.11 107.619 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.72 158.08 32.45 Favored Pre-proline 0 C--N 1.301 -1.543 0 C-N-CA 122.96 0.504 . . . . 71.43 110.169 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 125' ' ' VAL . 73.6 Cg_exo -54.25 161.83 4.91 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.073 2.515 . . . . 73.33 113.363 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -125.94 -25.54 3.59 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.63 -0.713 . . . . 70.34 110.421 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -101.2 100.52 11.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.917 -1.142 . . . . 53.44 107.917 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.36 119.24 38.58 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 72.03 109.898 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.0 mt -116.13 114.09 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.527 -0.761 . . . . 71.45 109.528 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -104.62 134.15 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 106.641 -1.615 . . . . 74.05 106.641 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 m -131.6 125.66 32.79 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 120.901 -0.32 . . . . 73.14 111.329 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.2 mm? -132.44 172.92 11.86 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.341 1.026 . . . . 73.55 109.543 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.9 51.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.675 -0.97 . . . . 72.14 110.675 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 88.0 t -60.92 -45.73 97.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.993 0.517 . . . . 74.45 110.87 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -64.65 -31.47 72.7 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.752 1.221 . . . . 73.52 110.686 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.51 -37.53 19.57 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.584 0.707 . . . . 64.23 109.252 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 74' ' ' LEU . 40.1 t80 -60.57 -32.02 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.168 -0.924 . . . . 75.44 111.315 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 54.3 mt-10 -55.61 -38.26 69.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.418 0.627 . . . . 74.41 110.139 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -83.43 -28.64 28.69 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.006 -0.997 . . . . 54.44 109.842 -173.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 71' ' ' PHE . 67.2 mt -55.78 -45.78 78.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.83 0.707 . . . . 73.54 109.65 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.68 158.48 21.31 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.614 -0.995 . . . . 72.11 110.614 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -18.21 60.45 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.491 0.662 . . . . 75.21 110.202 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.95 138.22 17.85 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 108.459 -0.941 . . . . 72.15 108.459 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.4 -51.45 7.41 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.573 2.182 . . . . 73.41 112.88 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -64.91 -30.12 71.1 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.326 -0.397 . . . . 74.43 111.486 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.58 -40.91 53.67 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.329 1.018 . . . . 74.23 109.514 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -95.2 -39.23 10.19 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 74.51 110.688 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.9 m -58.44 -44.82 89.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.72 0.637 . . . . 75.12 112.72 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -63.04 -54.49 37.37 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 120.926 0.393 . . . . 64.13 111.558 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.83 -37.71 92.47 Favored Glycine 0 C--O 1.245 0.807 0 C-N-CA 121.406 -0.426 . . . . 74.22 113.1 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -75.47 -30.0 59.79 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.868 -0.195 . . . . 64.32 110.684 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.03 -38.46 90.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.955 -0.387 . . . . 62.31 109.955 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -60.86 -47.74 85.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.403 -0.817 . . . . 71.01 111.048 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 11.1 t70 -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.539 0.685 . . . . 74.31 110.486 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.65 -36.95 70.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 65.52 109.157 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.45 -36.67 84.53 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.577 0.703 . . . . 73.23 109.298 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 30.1 t70 -59.56 -52.2 66.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.688 -1.142 . . . . 52.41 109.06 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -52.96 -50.79 63.36 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.403 0.89 . . . . 75.54 113.403 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.41 -37.26 79.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.193 -0.603 . . . . 71.0 112.225 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -70.56 -34.83 72.66 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.812 -0.355 . . . . 74.04 111.281 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 64.7 mm-40 -63.1 -35.26 79.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.156 0.503 . . . . 73.54 110.636 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -81.79 -12.96 58.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.581 -0.736 . . . . 71.03 111.204 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 89.85 23.97 31.42 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.903 -0.59 . . . . 41.53 112.991 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.9 m0 -98.5 149.23 22.94 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.068 0.461 . . . . 75.33 111.406 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.488 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 13.8 pt20 -124.47 177.46 5.9 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.367 -0.833 . . . . 74.11 109.14 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -162.13 -179.17 6.88 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.744 -0.836 . . . . 60.14 108.744 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -112.19 120.53 42.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.099 -0.704 . . . . 61.11 109.099 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.06 -150.28 16.73 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 119.713 -1.232 . . . . 63.12 110.451 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.68 144.32 38.22 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.371 -1.344 . . . . 73.13 107.371 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 90' ' ' ALA . 12.0 p -79.51 141.52 15.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.199 -1.037 . . . . 64.52 108.199 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.61 124.8 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.309 0.576 . . . . 54.44 109.984 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 72.7 t -108.63 112.59 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 105.981 -1.859 . . . . 73.5 105.981 175.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -124.06 140.33 53.08 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.688 -0.687 . . . . 73.21 111.286 -172.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -109.73 130.77 55.48 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.175 -0.921 . . . . 74.1 109.972 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.94 166.35 21.86 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.972 0.415 . . . . 72.11 110.922 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 45.0 mt-30 -106.62 142.8 35.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.233 -0.894 . . . . 71.4 109.379 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 114' ' ' LEU . 12.5 p -119.88 136.72 54.39 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 112.777 0.658 . . . . 73.14 112.777 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -82.93 -40.47 20.09 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.582 0.706 . . . . 50.12 109.7 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.73 -22.43 43.31 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.135 -0.939 . . . . 72.42 112.194 -174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.453 ' HB3' ' OG ' ' A' ' 111' ' ' SER . 25.7 tp -114.5 137.37 51.93 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.028 -2.582 . . . . 73.14 104.028 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -139.55 172.61 12.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.325 -1.35 . . . . 65.41 111.724 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.6 m -35.83 124.64 0.71 Allowed 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.166 2.187 . . . . 74.12 113.557 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.64 -22.94 27.4 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.217 -1.153 . . . . 75.24 110.217 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -112.17 128.23 56.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.416 -0.587 . . . . 61.14 109.416 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -124.69 149.66 46.97 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.27 -1.011 . . . . 60.04 108.27 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -136.74 143.12 43.13 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.237 -1.023 . . . . 73.34 108.237 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.74 142.03 40.97 Favored 'General case' 0 C--N 1.257 -3.451 0 N-CA-C 104.302 -2.481 . . . . 73.55 104.302 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -156.9 162.36 39.66 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.28 -0.568 . . . . 74.32 110.225 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.03 119.2 1.68 Allowed Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 110.67 -0.972 . . . . 73.34 110.67 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.7 m -110.23 144.01 39.54 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.017 -0.734 . . . . 73.22 109.017 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 59' ' ' PRO . 63.0 t -99.35 112.96 33.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.566 -1.272 . . . . 71.45 107.566 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -88.35 107.5 16.98 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 107.051 -1.462 . . . . 75.0 107.051 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 C-N-CA 122.087 1.858 . . . . 63.32 113.273 -174.801 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 114.916 1.45 . . . . 74.53 114.916 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 -27.83 35.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.016 -1.074 . . . . 75.04 109.949 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.5 -43.23 80.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.026 -1.472 . . . . 74.44 107.026 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.51 -49.37 72.77 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.104 -0.953 . . . . 62.44 109.824 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.94 -52.89 22.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.765 0.826 . . . . 71.43 111.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.65 -42.67 86.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.127 0.417 . . . . 62.44 112.127 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.24 -39.96 82.12 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.957 0.725 . . . . 72.23 112.957 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.58 -26.36 62.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.468 0.651 . . . . 75.51 109.741 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.75 -45.08 60.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.292 -1.003 . . . . 64.04 108.292 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.047 -0.524 . . . . 72.35 111.323 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.47 95.33 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.952 -0.567 . . . . 30.13 111.124 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.69 -22.99 45.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.412 0.625 . . . . 74.34 111.398 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.28 -40.34 51.98 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.783 -0.644 . . . . 72.15 110.393 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.41 40.8 2.67 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.693 -0.685 . . . . 72.53 112.559 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mm -79.81 139.41 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.21 0.529 . . . . 72.41 111.616 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 19.4 mp0 -118.7 144.0 46.51 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.159 0.984 . . . . 73.21 108.52 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -81.03 100.99 9.27 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.981 0.896 . . . . 53.3 110.027 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.3 tp -118.67 -163.92 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 105.596 -2.001 . . . . 74.31 105.596 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -41.41 126.03 2.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.799 0.687 . . . . 63.4 109.97 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.3 50.08 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 114.656 0.622 . . . . 74.24 114.656 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.4 -23.86 62.83 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.526 -0.469 . . . . 73.24 111.805 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 13.9 ptm180 -162.18 128.71 3.67 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.532 0.682 . . . . 72.12 111.808 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.54 151.81 21.18 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 123.848 0.859 . . . . 60.51 110.985 -170.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.3 tm? -85.75 118.67 25.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.837 -0.801 . . . . 71.34 108.837 -174.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.44 165.61 12.33 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 124.137 0.975 . . . . 64.2 110.118 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.8 Cg_exo -57.83 160.8 14.09 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.472 2.782 . . . . 54.13 113.371 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.9 p-10 -127.28 -31.94 2.51 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.375 -0.829 . . . . 62.24 111.079 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -109.07 111.5 23.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' HB2' HG12 ' A' ' 106' ' ' VAL . 50.0 m-85 -106.68 120.17 41.26 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.682 -0.858 . . . . 75.42 108.682 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.72 115.31 43.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.718 -0.475 . . . . 72.54 109.718 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.7 mp -112.46 109.94 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 107.194 -1.41 . . . . 72.33 107.194 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -105.86 122.7 46.64 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.539 -0.541 . . . . 74.51 109.539 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.3 mm? -110.41 163.64 13.48 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.376 0.67 . . . . 61.52 109.753 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.13 53.58 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.096 -1.602 . . . . 74.14 109.096 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 5.8 p -59.73 -37.46 71.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.792 0.796 . . . . 72.12 111.859 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 56.2 t-80 -58.96 -41.93 88.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 75.23 109.798 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.409 ' O ' HD23 ' A' ' 74' ' ' LEU . 5.8 m-20 -75.28 -39.62 59.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.535 -0.757 . . . . 61.42 111.739 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -57.94 -28.28 64.16 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.103 0.477 . . . . 72.41 111.095 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 94.1 mt-10 -62.77 -35.24 79.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.144 0.497 . . . . 74.51 110.215 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 69' ' ' HIS . 45.3 mmtt -85.02 -17.47 37.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.034 -0.728 . . . . 74.12 109.034 -172.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 4.5 mm? -69.97 -41.49 74.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.882 -1.054 . . . . 63.34 109.336 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.81 168.7 13.02 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.312 -0.946 . . . . 74.23 112.167 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.96 53.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.897 0.379 . . . . 52.54 111.762 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -112.14 96.0 32.68 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.305 -0.628 . . . . 54.42 109.305 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.1 -31.56 4.79 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 122.042 1.828 . . . . 60.21 111.038 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -53.15 42.51 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 115.508 1.67 . . . . 75.22 115.508 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.51 -15.82 61.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.858 0.754 . . . . 63.44 111.491 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 74' ' ' LEU . 58.4 mttp -90.79 -44.41 9.45 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.561 -0.745 . . . . 71.34 109.697 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 p -67.43 -51.22 54.29 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.12 0.568 . . . . 62.1 110.322 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.4 m -59.69 -41.15 90.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.567 -0.531 . . . . 73.44 109.567 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.58 52.95 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.563 -0.744 . . . . 62.51 112.634 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.98 -28.12 65.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 61.45 110.082 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 104' ' ' VAL . . . -64.03 -42.66 97.02 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.997 -0.547 . . . . 50.53 110.439 176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 19.0 mmt85 -64.09 -39.59 94.39 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.233 -0.44 . . . . 74.14 111.313 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -44.25 87.83 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.085 -0.507 . . . . 74.32 111.332 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.65 -34.98 79.07 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 109.304 -0.628 . . . . 74.13 109.304 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.34 99.05 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.422 0.63 . . . . 72.52 110.108 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.49 -40.78 80.77 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.107 -0.951 . . . . 54.14 109.353 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -55.86 -50.75 69.77 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.472 1.109 . . . . 74.23 111.369 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.45 -35.82 75.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.756 -0.377 . . . . 72.21 111.142 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.31 -40.93 96.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 75.11 109.76 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -62.67 -29.54 70.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.333 -0.849 . . . . 41.2 112.338 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -85.87 1.47 49.72 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.645 -0.707 . . . . 72.34 111.223 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 27.25 52.65 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 121.07 -0.586 . . . . 45.32 112.261 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.83 167.64 10.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.419 -0.46 . . . . 70.14 110.065 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.504 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.4 pt20 -143.34 167.24 22.64 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.287 -1.005 . . . . 71.41 108.287 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.572 ' HA ' HD22 ' A' ' 57' ' ' LEU . 10.8 t -150.01 -177.33 5.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.718 -0.475 . . . . 73.01 109.718 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.98 120.09 38.0 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.905 -0.406 . . . . 72.44 109.905 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -155.33 16.35 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 119.718 -1.23 . . . . 62.31 111.787 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -103.84 137.1 42.32 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.988 -1.486 . . . . 73.24 106.988 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.409 ' O ' ' HB1' ' A' ' 86' ' ' ALA . 66.6 t -83.21 124.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.776 -0.824 . . . . 60.32 108.776 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.05 130.13 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 CA-C-O 121.642 0.734 . . . . 62.32 110.941 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 62' ' ' TYR . 34.7 m -104.43 127.42 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 N-CA-C 106.249 -1.76 . . . . 73.32 106.249 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -105.78 126.61 52.36 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.838 -0.619 . . . . 74.53 109.95 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -113.59 114.26 26.21 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.243 -1.392 . . . . 74.44 107.243 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.87 166.79 23.7 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.377 -0.374 . . . . 75.42 111.042 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -99.24 160.87 13.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.091 0.948 . . . . 74.45 112.171 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -149.48 115.67 5.75 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 113.559 -1.655 . . . . 51.0 107.819 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -81.03 -2.81 49.53 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.881 0.848 . . . . 61.34 109.559 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.68 -38.47 19.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.631 -1.168 . . . . 74.35 108.364 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.02 161.8 30.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.542 -0.91 . . . . 73.34 108.542 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -87.55 154.3 20.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.055 0.455 . . . . 63.31 110.055 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 m -62.23 132.48 52.87 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 124.354 1.062 . . . . 71.43 109.489 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 28.96 60.83 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.536 -0.364 . . . . 64.1 112.417 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -137.07 149.39 47.36 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.024 -1.102 . . . . 71.31 108.024 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.429 ' HB3' HD13 ' A' ' 66' ' ' LEU . 41.8 p90 -139.37 156.66 46.86 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.668 -0.413 . . . . 72.42 110.966 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 36.5 mmt180 -123.63 131.16 53.55 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.384 -0.969 . . . . 72.43 108.384 174.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.58 120.57 24.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.41 -0.589 . . . . 54.02 109.41 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -135.38 138.36 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.362 -0.381 . . . . 74.12 110.4 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -105.44 109.81 3.31 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.79 -0.924 . . . . 62.43 110.79 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.3 m -109.92 143.16 40.26 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.526 0.679 . . . . 70.54 110.603 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.9 t -90.54 110.35 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.175 -1.787 . . . . 75.24 106.175 171.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -102.16 104.42 36.55 Favored Pre-proline 0 C--N 1.281 -2.386 0 N-CA-C 108.087 -1.079 . . . . 74.31 108.087 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.295 1.996 . . . . 71.41 110.447 179.586 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--O 1.218 -0.594 0 N-CA-C 112.101 0.408 . . . . 55.22 112.101 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.34 -55.11 39.17 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.214 -0.661 . . . . 74.22 109.214 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.67 -42.67 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.113 -0.948 . . . . 71.23 109.503 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 42.3 mt-10 -56.77 -54.75 42.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 72.5 111.891 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.13 81.75 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.335 0.254 . . . . 65.14 111.558 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.6 tm? -61.96 -45.73 92.38 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.994 -0.743 . . . . 74.1 108.994 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.93 -29.14 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.043 0.757 . . . . 73.41 113.043 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 67.2 mtt180 -63.92 -41.53 97.62 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.002 -1.11 . . . . 74.4 108.002 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.32 -47.65 81.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.93 -1.032 . . . . 72.11 110.931 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -59.43 -42.55 92.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.134 0.574 . . . . 64.42 110.482 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.17 82.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 72.42 110.949 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.5 -29.02 63.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 71.45 111.981 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.49 -36.72 32.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.518 -0.31 . . . . 54.32 110.567 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.69 18.92 27.49 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.13 -0.487 . . . . 75.12 113.652 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -68.83 133.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 123.364 0.666 . . . . 74.52 110.725 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' HD23 ' A' ' 57' ' ' LEU . 94.3 mt-30 -107.03 147.96 29.3 Favored 'General case' 0 CA--C 1.473 -1.994 0 N-CA-C 109.061 -0.718 . . . . 73.2 109.061 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -86.38 91.62 8.57 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.011 -1.107 . . . . 72.35 108.011 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.9 tp -98.9 -165.55 1.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.825 -1.546 . . . . 73.25 106.825 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.661 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.5 mt-30 -44.6 148.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.685 1.194 . . . . 65.54 111.449 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.87 -15.95 56.04 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.731 -0.668 . . . . 75.41 113.185 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -61.6 -48.67 79.88 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.791 -0.448 . . . . 74.33 109.791 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -168.51 149.27 4.73 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.924 -0.58 . . . . 61.45 111.242 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.04 151.72 20.92 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.047 0.939 . . . . 63.15 110.594 -173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD23 ' OE1' ' A' ' 49' ' ' GLN . 15.7 tp -89.9 127.68 36.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.844 -0.616 . . . . 75.55 109.603 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.68 158.0 40.05 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 123.381 0.672 . . . . 61.24 109.275 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.573 ' HA ' HG22 ' A' ' 125' ' ' VAL . 34.9 Cg_exo -62.93 148.34 93.57 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.62 2.214 . . . . 60.3 111.611 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 33.9 p-10 -120.77 -28.41 4.87 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.81 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.68 124.61 50.25 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.436 -0.95 . . . . 72.13 108.436 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 106' ' ' VAL . 45.3 m-85 -121.38 127.69 51.47 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.873 -0.417 . . . . 74.21 109.873 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 120.13 63.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.943 -0.762 . . . . 71.34 108.943 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.54 123.67 68.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.928 -0.767 . . . . 74.23 108.928 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 m -104.28 124.89 49.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.579 -0.282 . . . . 72.01 110.39 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -115.0 165.47 12.85 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.408 0.683 . . . . 61.14 110.168 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.25 145.23 31.73 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.934 -1.667 . . . . 64.51 108.934 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.4 p -50.29 -43.04 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 113.937 1.088 . . . . 75.24 113.937 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -64.73 -36.61 84.84 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.138 0.494 . . . . 75.51 111.445 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 116' ' ' THR . 13.0 t70 -86.33 -23.47 26.23 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.639 -0.824 . . . . 64.42 110.082 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.13 -30.87 71.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.096 -0.705 . . . . 62.14 109.096 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.6 mt-10 -57.46 -33.76 68.3 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.036 -0.529 . . . . 75.01 110.44 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -74.57 -39.16 62.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.598 -0.89 . . . . 63.33 108.598 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.481 HD11 ' HG ' ' A' ' 66' ' ' LEU . 89.5 mt -62.41 -37.34 85.43 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.658 0.742 . . . . 72.04 109.083 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.2 -171.29 13.62 Favored Glycine 0 N--CA 1.414 -2.822 0 CA-C-N 114.615 -1.175 . . . . 55.13 110.813 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -93.58 -5.81 48.03 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.671 0.272 . . . . 55.51 110.334 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -89.6 111.18 44.35 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 115.702 -0.681 . . . . 71.41 112.422 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 5.8 Cg_exo -77.94 -51.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.308 2.005 . . . . 73.41 113.029 172.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 107' ' ' ARG . 48.9 mt-10 -86.54 -39.36 16.29 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 118.476 2.769 . . . . 75.21 118.476 -169.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.98 -52.47 65.24 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.419 1.009 . . . . 70.45 113.057 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -63.91 -32.13 73.56 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 122.692 1.234 . . . . 65.21 110.742 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 106' ' ' VAL . 37.9 m -75.8 -17.3 59.91 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.101 -1.409 . . . . 51.22 112.022 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 m -69.44 -41.87 75.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.372 -0.603 . . . . 71.02 109.372 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.97 -36.14 61.07 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.9 -0.88 . . . . 42.33 110.9 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -65.03 -46.51 81.01 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.22 0.533 . . . . 74.33 109.795 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.85 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.042 -0.526 . . . . 55.1 111.286 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -59.17 -45.02 92.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 75.43 109.834 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.47 -43.72 89.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.982 -1.008 . . . . 62.2 110.187 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.82 -39.22 90.66 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 115.718 -0.673 . . . . 74.43 109.828 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.1 91.41 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.39 0.614 . . . . 63.1 110.462 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -41.03 83.36 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.473 -0.785 . . . . 72.34 110.009 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 m-85 -56.31 -53.54 56.1 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.622 -0.717 . . . . 71.34 112.077 175.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.0 pt -62.88 -35.69 72.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 120.797 -0.361 . . . . 74.12 111.863 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.73 -37.19 81.85 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 121.135 -0.226 . . . . 52.25 110.793 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.7 -28.31 69.81 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.41 0.624 . . . . 72.12 110.483 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 60.2 mm-40 -88.33 -4.68 58.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.985 -0.552 . . . . 60.44 111.162 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.04 26.94 59.18 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.857 -0.61 . . . . 65.14 112.416 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -98.44 161.41 13.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.929 -0.767 . . . . 75.23 108.929 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -129.72 174.61 9.54 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 110.068 -0.345 . . . . 75.44 110.068 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.5 t -165.15 170.4 14.99 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 105.409 -2.071 . . . . 72.55 105.409 175.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.08 118.01 33.73 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.092 -1.447 . . . . 64.21 107.092 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.78 -149.49 16.72 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 119.218 -1.468 . . . . 75.33 109.885 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -132.28 163.48 28.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.662 -1.236 . . . . 65.32 107.662 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.66 131.99 33.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.255 0.55 . . . . 73.33 112.177 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.95 120.52 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-N 115.233 -0.894 . . . . 64.32 109.294 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.3 m -112.25 143.36 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 107.071 -1.455 . . . . 75.12 107.071 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.3 mtt180 -142.45 150.67 40.87 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.71 0.29 . . . . 74.11 110.809 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.0 151.14 23.56 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.878 -0.601 . . . . 72.14 109.503 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.71 166.58 24.36 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 53.3 107.94 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.26 152.57 38.73 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.685 -0.487 . . . . 74.22 109.685 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.7 m -134.02 138.84 45.64 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 115.902 -0.59 . . . . 62.51 109.669 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 t -80.53 -23.63 39.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.801 -0.814 . . . . 63.44 108.801 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -82.18 -5.17 58.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.859 -0.61 . . . . 71.3 111.529 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.3 148.28 29.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.412 -1.329 . . . . 73.12 107.412 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -119.07 156.7 29.24 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.826 -0.749 . . . . 62.42 111.055 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 70' ' ' ASP . 4.7 m -49.2 121.14 4.57 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 126.248 1.819 . . . . 60.14 111.528 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.96 -30.78 6.9 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.832 -0.907 . . . . 70.04 110.832 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.77 131.1 39.47 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.223 -0.658 . . . . 71.23 109.223 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 150.75 42.38 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.649 -0.871 . . . . 73.24 108.649 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -140.65 147.23 38.99 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.24 -0.652 . . . . 72.21 109.24 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -142.77 139.84 31.17 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.003 -0.369 . . . . 73.31 110.003 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -132.66 149.55 52.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.061 -0.518 . . . . 75.12 109.762 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.29 123.07 5.53 Favored Glycine 0 C--N 1.282 -2.44 0 N-CA-C 109.656 -1.378 . . . . 73.12 109.656 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.4 m -121.01 150.85 40.51 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.701 -0.852 . . . . 71.33 108.701 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 59' ' ' PRO . 46.6 t -98.58 118.09 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.411 -0.959 . . . . 73.3 108.411 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.08 101.97 7.36 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.124 -1.436 . . . . 63.31 107.124 171.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.5 Cg_endo . . . . . 0 N--CA 1.456 -0.706 0 C-N-CA 122.09 1.86 . . . . 54.44 112.161 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 110.53 -0.174 . . . . 73.41 110.53 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -58.53 -34.74 71.31 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.917 0.389 . . . . 53.01 111.043 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.57 -56.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.697 -0.683 . . . . 44.31 110.034 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.45 -25.47 64.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.18 -0.608 . . . . 63.44 111.901 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.02 94.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.202 0.525 . . . . 65.15 109.713 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.15 -37.92 66.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 120.045 -0.662 . . . . 62.51 109.938 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.28 0.474 . . . . 64.3 112.28 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -63.68 -29.96 71.13 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.961 0.41 . . . . 75.12 110.341 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 -69.13 -51.76 35.08 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.446 -0.343 . . . . 73.23 110.512 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -64.76 -30.87 71.89 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.344 0.403 . . . . 71.22 110.679 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.74 88.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.131 -0.486 . . . . 41.45 109.887 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.27 -25.9 61.78 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.818 0.818 . . . . 71.22 110.787 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.93 -24.91 48.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.268 -0.878 . . . . 70.15 110.791 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.65 17.01 54.2 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.87 -0.605 . . . . 34.24 112.826 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 45' ' ' ALA . 22.2 mm -67.5 131.55 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.059 0.457 . . . . 74.35 110.943 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -127.91 144.34 51.1 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.654 -0.703 . . . . 64.21 110.342 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 m -66.76 130.11 42.08 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.512 -1.222 . . . . 74.44 110.906 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.8 tp -149.12 -166.21 2.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 104.027 -2.583 . . . . 63.15 104.027 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 84.6 mm-40 -60.26 155.83 16.83 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.586 0.958 . . . . 64.41 113.586 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.71 -5.31 44.61 Favored Glycine 0 CA--C 1.507 -0.407 0 CA-C-N 114.991 -1.004 . . . . 64.05 114.678 -170.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.56 -42.79 51.38 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.29 -0.633 . . . . 74.42 109.29 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 99' ' ' GLN . 13.2 ptp180 -165.06 140.69 5.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.636 -0.711 . . . . 73.22 112.501 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.89 152.48 20.72 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.117 1.367 . . . . 74.53 110.282 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 100' ' ' THR . 44.9 tp -79.07 127.45 32.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.447 -0.575 . . . . 71.53 109.447 -176.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -122.26 164.46 25.77 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 123.575 0.75 . . . . 73.52 109.419 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 125' ' ' VAL . 44.9 Cg_exo -62.04 156.96 46.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.178 2.585 . . . . 71.51 113.525 176.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.7 p-10 -128.02 -30.12 2.49 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.342 -0.844 . . . . 63.15 110.739 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.06 117.55 32.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.165 -1.05 . . . . 71.03 108.165 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.82 114.14 22.19 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.46 0.648 . . . . 73.24 110.231 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.11 111.9 37.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.97 -1.014 . . . . 64.42 108.944 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 3.0 mp -102.97 119.52 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.728 -0.842 . . . . 74.22 108.728 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 126.58 53.27 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 109.582 -0.525 . . . . 72.2 109.582 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.45 165.82 16.43 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 122.915 0.486 . . . . 64.02 110.642 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.08 146.68 50.44 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.734 -1.747 . . . . 43.44 108.734 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -46.2 -54.96 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.606 0.965 . . . . 75.52 113.606 -173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -69.06 -29.94 68.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.436 0.532 . . . . 72.25 112.436 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.25 -40.84 62.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.513 -1.291 . . . . 70.21 107.513 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.03 -34.27 77.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.216 -1.356 . . . . 63.42 111.891 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -53.79 -37.75 63.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.22 0.533 . . . . 62.31 111.134 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -85.41 -29.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.664 -0.698 . . . . 73.05 110.413 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 mt -71.91 -36.79 70.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.367 0.603 . . . . 63.24 109.962 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.49 12.54 26.74 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.256 -0.884 . . . . 62.14 112.557 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.32 -10.36 54.61 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.327 -0.62 . . . . 73.32 109.327 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -139.48 72.48 37.21 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.074 -0.512 . . . . 61.25 111.739 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.69 -28.03 31.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 N-CA-C 108.383 -1.429 . . . . 75.13 108.383 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.38 -53.67 54.88 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.28 -1.782 . . . . 74.31 111.343 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.95 -42.88 12.81 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.087 0.773 . . . . 63.11 113.087 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -76.56 -58.86 3.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.109 0.781 . . . . 72.12 113.109 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -63.29 -48.52 77.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.854 0.359 . . . . 72.4 110.998 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -64.87 -44.46 89.62 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.248 -0.433 . . . . 75.44 111.256 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -56.49 20.41 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 115.773 -0.649 . . . . 63.03 112.625 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.27 -32.42 72.24 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 112.301 0.482 . . . . 72.1 112.301 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.27 86.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 71.21 111.229 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.565 ' HD2' ' N ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -82.1 -25.73 34.22 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.204 0.446 . . . . 75.32 112.204 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.64 -43.85 65.39 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.486 -0.931 . . . . 65.42 108.486 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 92' ' ' TYR . 1.2 tm? -67.7 -31.79 71.99 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.769 -0.826 . . . . 73.31 108.769 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.93 -40.08 94.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 72.12 110.779 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 29.1 t70 -74.33 -32.87 62.98 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.303 -0.629 . . . . 62.43 109.303 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.39 -57.6 11.61 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.438 -0.801 . . . . 73.23 110.191 173.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.3 pt -56.5 -30.08 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 120.995 -0.282 . . . . 64.42 111.198 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mm-40 -64.75 -45.43 86.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.842 -0.343 . . . . 72.23 110.926 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 50.3 mt-10 -59.79 -42.55 93.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.711 0.804 . . . . 63.42 111.895 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -80.64 -13.27 59.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 113.885 1.068 . . . . 74.35 113.885 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.71 39.41 9.6 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.597 -1.287 . . . . 50.33 112.52 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -112.12 174.45 5.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.519 -0.401 . . . . 73.43 110.272 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 26.7 pt20 -149.07 171.23 16.74 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.191 0.596 . . . . 72.52 109.611 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 57' ' ' LEU . 13.4 t -159.49 178.36 9.97 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.338 -0.986 . . . . 44.42 108.338 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -101.45 118.62 37.33 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.392 -0.966 . . . . 74.44 108.392 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.79 -149.46 16.6 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 119.296 -1.431 . . . . 75.31 111.055 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -118.99 150.57 39.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.878 -1.527 . . . . 74.13 106.878 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.6 128.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.478 -0.564 . . . . 54.41 109.478 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.73 149.65 26.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 123.627 0.579 . . . . 74.55 110.039 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.96 113.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.252 0.549 . . . . 50.3 110.181 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -119.97 139.66 52.12 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.9 -0.591 . . . . 72.23 110.285 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.25 143.82 42.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.356 -0.609 . . . . 72.34 109.356 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.28 171.49 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.886 0.374 . . . . 70.25 111.653 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.88 159.54 15.56 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.785 -0.643 . . . . 61.34 110.875 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.2 p -143.74 141.78 30.63 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.496 -0.775 . . . . 54.13 109.229 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -81.36 -26.77 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.272 0.558 . . . . 71.44 110.809 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -77.86 -30.39 50.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.655 -0.702 . . . . 72.13 111.991 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.72 150.7 26.57 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.904 -0.718 . . . . 61.13 111.518 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' GLN . 84.8 m-70 -97.1 173.54 7.2 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.939 -1.028 . . . . 73.02 110.606 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 130.58 42.12 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.239 -1.393 . . . . 75.43 107.239 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.87 -3.87 82.04 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.805 -0.712 . . . . 51.02 111.903 -174.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 5.2 tp-100 -101.54 119.8 39.32 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.088 -1.449 . . . . 74.51 107.088 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.9 157.15 46.16 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.69 -0.804 . . . . 75.01 112.106 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -145.38 143.31 30.04 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.439 -1.255 . . . . 75.35 107.81 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . . . -134.56 139.12 45.15 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 105.511 -2.033 . . . . 75.13 105.511 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -129.25 127.49 41.33 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.99 -0.684 . . . . 70.14 109.999 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.33 117.47 5.87 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.297 -1.521 . . . . 61.43 109.297 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 90.4 m -121.16 145.82 47.42 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 122.767 0.427 . . . . 52.32 110.019 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 59' ' ' PRO . 47.1 t -93.52 110.07 22.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.24 -1.022 . . . . 74.53 108.24 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -108.45 104.12 53.12 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 109.693 -0.484 . . . . 73.23 109.693 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 C-N-CA 122.38 2.054 . . . . 73.43 110.893 176.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 120.339 0.114 . . . . 75.34 111.071 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -60.02 -44.1 94.83 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.98 0.895 . . . . 62.43 109.198 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.5 t -63.18 -55.87 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.772 -1.558 . . . . 43.54 110.74 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 pt-20 -64.44 -34.01 77.2 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.391 -0.523 . . . . 75.22 111.735 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.3 91.01 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.919 -0.401 . . . . 62.52 109.919 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.96 -38.46 72.8 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.304 -0.407 . . . . 72.34 110.444 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.9 mt -60.34 -47.65 85.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.908 0.336 . . . . 74.55 111.908 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.2 ptm180 -71.58 -30.62 66.04 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 120.552 -0.459 . . . . 75.23 111.034 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -68.13 -41.43 81.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 72.54 109.269 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 122' ' ' ARG . 4.9 tp10 -64.51 -43.94 92.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.081 -0.963 . . . . 73.13 109.024 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.75 76.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 65.34 110.654 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.42 71.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 60.22 112.64 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.39 -13.54 24.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.969 -1.092 . . . . 74.44 110.661 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.16 3.42 76.49 Favored Glycine 0 CA--C 1.502 -0.749 0 CA-C-N 115.806 -0.634 . . . . 72.14 111.86 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 56' ' ' LEU . 20.4 mm -55.55 127.67 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 C-N-CA 124.39 1.076 . . . . 73.23 111.028 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 35.2 tt0 -105.45 135.89 46.01 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.449 -1.315 . . . . 65.05 107.449 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -70.19 122.25 19.12 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.318 -1.364 . . . . 60.45 107.318 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.1 tp -127.02 -165.59 1.48 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 105.98 -1.859 . . . . 71.33 105.98 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.582 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.1 mt-30 -53.29 160.37 1.14 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.056 0.543 . . . . 70.35 111.733 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.77 -10.91 47.65 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 116.124 -0.489 . . . . 60.41 113.233 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.45 -44.58 74.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.498 -0.186 . . . . 55.24 110.498 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -171.89 166.59 6.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 113.066 0.765 . . . . 71.41 113.066 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB3' HG23 ' A' ' 48' ' ' ILE . 76.8 mt -93.94 151.92 19.21 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 125.17 1.388 . . . . 73.41 111.401 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 31.0 tp -98.94 130.96 45.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.554 -0.906 . . . . 74.5 108.554 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 156.28 44.67 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 123.539 0.525 . . . . 74.03 110.424 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -62.47 154.87 61.42 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.95 2.434 . . . . 72.42 112.229 176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 29.0 p-10 -128.34 -28.09 2.6 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.04 -0.527 . . . . 62.02 112.131 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.7 119.15 35.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 120.067 -0.653 . . . . 73.21 109.703 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' HB2' HG22 ' A' ' 106' ' ' VAL . 68.7 m-85 -120.14 114.26 21.69 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.406 0.622 . . . . 71.02 109.792 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.2 mt -102.2 107.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.985 -1.117 . . . . 73.05 107.985 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.3 mt -102.02 115.28 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.054 -1.091 . . . . 72.15 108.054 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 16.9 m -109.06 121.83 45.99 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 115.927 -0.579 . . . . 75.22 110.152 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.6 mm? -110.03 174.75 5.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.851 1.26 . . . . 72.11 109.986 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.67 164.9 50.92 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 108.762 -1.735 . . . . 71.22 108.762 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.26 -33.12 61.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 118.316 1.058 . . . . 63.22 111.483 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.562 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 41.9 t60 -75.85 -28.5 58.23 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 120.449 -0.501 . . . . 73.24 109.729 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 33.0 m-20 -75.29 -31.96 60.86 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.145 -0.687 . . . . 74.22 109.145 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 78' ' ' PRO . 73.2 t80 -62.25 -44.49 96.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.338 -0.846 . . . . 74.23 110.734 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.57 -30.58 69.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.316 0.579 . . . . 73.25 110.771 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 74.3 mmtt -73.14 -24.27 60.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.408 -0.814 . . . . 73.53 110.647 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 98.4 mt -68.26 -31.62 71.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.056 -1.09 . . . . 71.4 108.056 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.56 179.76 19.65 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.231 -0.895 . . . . 52.15 111.621 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.32 -17.27 46.35 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.274 -1.009 . . . . 44.45 108.274 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -128.98 75.16 80.64 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.902 -1.045 . . . . 75.12 108.399 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 23.4 Cg_exo -69.15 -36.37 12.55 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.263 1.975 . . . . 73.53 111.836 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.52 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 2.8 tp10 -69.35 -12.16 61.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.649 -0.705 . . . . 73.23 110.631 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.56 -36.66 73.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.016 -0.538 . . . . 63.22 109.839 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -84.89 -13.18 51.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.912 -0.315 . . . . 72.11 111.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 19.9 m -61.1 -40.96 95.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 64.01 110.453 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -67.86 -29.09 68.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.785 -0.643 . . . . 73.24 110.007 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.3 91.89 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.425 -1.07 . . . . 44.25 110.425 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -68.65 -32.43 72.27 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 111.688 0.255 . . . . 70.13 111.688 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.69 -44.78 96.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.144 0.497 . . . . 73.04 110.333 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -67.79 -44.15 78.07 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.528 -0.76 . . . . 64.33 110.625 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.77 -38.07 89.75 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.302 -0.408 . . . . 64.42 111.237 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.3 -41.79 72.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.439 -0.578 . . . . 74.43 109.439 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.63 90.68 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.439 0.638 . . . . 71.5 109.468 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.86 -53.62 55.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.481 -1.236 . . . . 74.22 108.779 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.632 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.5 m-85 -51.06 -55.37 17.89 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.924 0.713 . . . . 72.15 112.924 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -62.16 -37.22 77.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 112.618 0.599 . . . . 72.45 112.618 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -71.74 -35.25 70.08 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.904 -0.319 . . . . 74.41 111.024 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.87 -31.98 73.46 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.261 0.553 . . . . 74.33 111.235 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.0 mm-40 -79.45 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.024 -0.534 . . . . 70.24 110.969 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.46 21.28 32.4 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.218 -0.515 . . . . 72.25 112.033 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -102.99 172.1 7.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.747 -0.834 . . . . 75.02 108.747 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -140.74 173.91 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.143 -0.688 . . . . 70.44 109.143 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.3 t -148.98 171.28 16.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.609 -0.886 . . . . 64.11 108.609 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 73.8 m-85 -114.43 121.05 42.37 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 109.476 -0.565 . . . . 62.13 109.476 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -150.06 17.05 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 109.516 -1.434 . . . . 73.23 109.516 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -119.42 143.48 47.46 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.915 -1.143 . . . . 62.21 107.915 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 69.9 t -74.66 118.12 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.173 -0.677 . . . . 75.51 109.173 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.8 120.23 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-O 122.131 0.967 . . . . 64.22 110.305 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.9 t -115.33 137.47 48.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 106.297 -1.742 . . . . 73.42 106.297 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -141.18 139.31 33.84 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.47 0.481 . . . . 74.5 111.859 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -108.72 114.23 27.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 64.2 108.588 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.1 pt-20 -135.61 165.5 25.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.743 -0.208 . . . . 71.12 110.793 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.18 165.59 10.93 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 114.612 1.338 . . . . 62.33 114.612 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -134.22 141.69 47.12 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.541 -1.651 . . . . 42.13 106.541 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -80.7 -16.66 53.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.516 0.674 . . . . 74.43 110.295 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -83.49 -30.44 27.17 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 53.1 110.554 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.22 133.06 37.78 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.915 -0.584 . . . . 71.21 110.948 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.52 159.52 14.87 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.452 -0.794 . . . . 32.22 109.012 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 8.1 m -52.4 117.85 3.14 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 124.409 1.068 . . . . 74.15 111.863 -176.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.75 -1.84 28.93 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.938 -0.649 . . . . 64.21 112.842 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.21 123.87 50.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.925 0.393 . . . . 73.05 111.29 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.0 p90 -131.18 150.75 52.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.861 -0.792 . . . . 70.51 108.861 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -142.22 132.74 25.22 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.754 -0.832 . . . . 73.34 108.754 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.04 122.72 41.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.709 -0.848 . . . . 73.22 108.709 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.453 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.8 tpm_? -111.93 121.54 45.3 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.886 -0.783 . . . . 61.21 108.886 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -110.74 130.01 9.59 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 110.98 -0.848 . . . . 45.31 110.98 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.9 t -135.9 163.29 30.58 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.601 -0.518 . . . . 64.35 109.601 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 59' ' ' PRO . 45.1 t -99.15 107.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.773 -0.825 . . . . 63.14 108.773 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -116.39 99.68 52.91 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 109.649 -0.501 . . . . 64.52 109.649 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 6.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.699 2.266 . . . . 63.13 112.429 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 77.4 mt-30 . . . . . 0 C--O 1.217 -0.648 0 CA-C-O 120.371 0.129 . . . . 73.21 111.18 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.24 -34.13 74.32 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.457 -0.942 . . . . 62.31 108.457 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.8 t -68.06 -48.05 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.623 -1.171 . . . . 22.42 109.96 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -66.33 -33.79 76.52 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.375 -0.53 . . . . 75.55 110.934 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.73 82.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.566 -0.531 . . . . 53.14 109.566 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.16 -32.94 74.68 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.31 -0.859 . . . . 74.1 111.844 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 80.9 mt -69.74 -38.44 76.83 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.06 0.225 . . . . 64.45 111.19 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 74.9 mtm180 -62.68 -43.23 99.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.538 -0.912 . . . . 72.54 108.538 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -40.66 90.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.0 -1.0 . . . . 75.41 111.698 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -60.47 -46.47 89.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.425 0.69 . . . . 61.23 109.845 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.36 92.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.482 -0.781 . . . . 52.45 110.83 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.35 68.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 62.22 111.888 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.03 -35.87 31.32 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.11 -0.369 . . . . 73.22 111.121 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.99 13.73 52.69 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.814 -0.63 . . . . 62.15 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 48' ' ' ILE . 15.6 mm -55.88 137.03 17.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 123.43 0.692 . . . . 75.1 111.978 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.0 tt0 -119.56 132.97 55.86 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.25 -1.389 . . . . 64.31 107.25 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -66.51 134.89 53.34 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 121.684 0.754 . . . . 65.0 109.992 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.2 tp -149.7 -165.53 2.3 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 103.096 -2.928 . . . . 75.32 103.096 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.509 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 76.5 mt-30 -54.52 146.36 16.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.083 0.856 . . . . 72.04 109.506 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.87 -12.92 58.41 Favored Glycine 0 C--O 1.237 0.333 0 CA-C-N 116.773 -0.194 . . . . 72.32 113.114 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.85 -40.02 93.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.208 -0.664 . . . . 71.43 109.208 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -167.94 132.83 1.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.416 -0.811 . . . . 73.31 110.885 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.76 152.17 20.91 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 124.692 1.197 . . . . 73.11 109.641 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.84 122.14 31.93 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.482 -1.303 . . . . 73.53 107.482 -174.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.3 160.16 26.98 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.33 -0.619 . . . . 64.44 109.33 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.66 151.08 72.62 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.125 1.883 . . . . 63.14 111.049 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 5.3 p-10 -123.24 -27.59 4.12 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.415 -0.514 . . . . 54.24 111.46 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -106.03 110.91 23.33 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.098 -1.075 . . . . 74.35 108.098 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.91 131.73 54.8 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.225 -0.443 . . . . 73.11 109.892 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -121.84 111.73 32.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.613 -0.514 . . . . 63.21 109.613 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.17 109.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.978 -1.489 . . . . 64.21 106.978 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.425 ' HB ' ' HG2' ' A' ' 120' ' ' ARG . 8.7 m -112.94 126.48 55.53 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.088 -0.708 . . . . 64.14 109.088 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.2 mm? -105.22 156.14 18.39 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.377 -0.972 . . . . 74.5 108.377 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.64 146.73 50.53 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 109.323 -1.511 . . . . 74.23 109.323 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.477 HG23 ' NE2' ' A' ' 110' ' ' GLN . 3.3 p -53.83 -40.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 112.516 0.562 . . . . 52.51 112.516 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 23.9 t60 -62.17 -33.37 74.38 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 123.336 0.654 . . . . 70.45 111.004 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.51 -44.33 12.79 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.619 0.247 . . . . 73.44 111.011 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 35.6 t80 -66.28 -34.89 79.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 111.957 0.355 . . . . 73.14 111.957 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.9 pt-20 -63.45 -31.87 73.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.187 0.518 . . . . 74.24 110.671 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 46.3 mmtm -73.52 -28.1 61.72 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.603 -0.726 . . . . 74.01 109.869 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.43 -39.11 71.25 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.996 -0.742 . . . . 54.43 108.996 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.85 175.02 15.59 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.217 -0.753 . . . . 75.22 111.217 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.625 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -94.62 1.25 55.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.712 0.291 . . . . 71.33 111.236 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.9 95.65 8.07 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.852 1.056 . . . . 64.14 113.852 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.3 Cg_exo -76.8 -43.78 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.886 2.391 . . . . 64.14 112.116 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.699 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 44.5 tt0 -63.88 -29.98 71.12 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.016 0.747 . . . . 74.34 113.016 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.65 -24.23 67.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.974 -0.557 . . . . 73.0 110.456 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -99.88 -36.75 9.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.096 -0.502 . . . . 74.23 111.411 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.699 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 23.2 p -66.32 -45.39 80.44 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.375 0.509 . . . . 75.03 112.375 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.9 m -67.31 -39.85 85.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.522 -0.471 . . . . 53.15 110.925 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.0 -51.29 52.49 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.956 -0.566 . . . . 61.42 111.774 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.92 -30.66 70.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.635 0.605 . . . . 73.2 112.635 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -65.47 -48.05 73.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 120.907 0.384 . . . . 64.51 110.151 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -67.54 -38.02 83.56 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.56 -0.746 . . . . 72.42 109.822 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.57 -47.07 80.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.363 -0.835 . . . . 73.12 110.498 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.1 tp -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 65.51 110.832 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.19 93.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.108 -0.701 . . . . 44.13 109.108 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.3 t70 -62.59 -44.46 96.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.167 -0.924 . . . . 72.21 109.636 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -55.23 -54.25 45.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.786 0.679 . . . . 52.32 112.42 175.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -62.35 -32.95 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.163 0.506 . . . . 70.41 111.213 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -64.93 -41.89 95.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.699 -0.682 . . . . 75.01 110.723 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.0 mt-10 -62.99 -39.19 94.0 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.293 0.568 . . . . 71.15 111.032 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 76.9 mm-40 -73.57 -14.24 61.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.321 -0.854 . . . . 65.42 112.336 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 38.21 13.48 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.217 -0.992 . . . . 64.21 110.972 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -115.18 -178.95 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.271 -0.641 . . . . 73.44 109.271 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -157.21 178.34 10.45 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.771 -0.825 . . . . 73.12 108.771 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 11.2 t -156.7 173.57 16.76 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.538 -0.912 . . . . 71.53 108.538 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.0 m-85 -115.93 124.02 49.54 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 109.306 -0.628 . . . . 74.2 109.306 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -149.45 18.18 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.115 -1.194 . . . . 71.22 110.115 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.32 142.74 44.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.749 -0.834 . . . . 44.13 108.749 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.04 104.0 11.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.296 -1.372 . . . . 74.34 107.296 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 p -125.84 120.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.733 0.778 . . . . 65.21 110.434 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -110.91 127.87 67.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.108 -1.071 . . . . 64.11 108.108 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -106.22 132.74 51.92 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.361 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -115.26 114.29 25.0 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.265 -2.124 . . . . 70.25 105.265 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.02 173.24 12.63 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.239 0.542 . . . . 62.23 111.893 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.477 ' NE2' HG23 ' A' ' 68' ' ' VAL . 16.1 pt20 -119.86 164.84 15.42 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.903 -1.044 . . . . 72.44 109.762 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.7 t -143.88 141.42 30.28 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.804 -1.554 . . . . 71.34 106.804 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -81.01 -16.61 52.91 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.049 -1.093 . . . . 53.03 108.049 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -82.57 -4.34 57.48 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.049 -0.978 . . . . 74.41 110.793 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.73 131.05 56.33 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.112 -1.07 . . . . 72.31 108.112 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 40.2 m80 -100.72 172.35 7.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.587 -0.279 . . . . 64.45 111.388 -175.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.7 t -68.3 145.31 54.34 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.171 0.51 . . . . 71.15 110.635 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.65 -4.89 76.56 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.097 -1.201 . . . . 72.4 110.097 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 52.4 mt-30 -119.74 133.22 55.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.987 0.915 . . . . 64.25 109.335 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.472 ' HB3' HD13 ' A' ' 66' ' ' LEU . 50.5 p90 -159.9 157.0 28.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.136 -1.431 . . . . 74.41 107.136 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 9.1 ptp85 -135.84 153.92 51.34 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.581 -0.525 . . . . 62.32 109.581 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.08 118.03 11.15 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.264 -2.124 . . . . 51.22 105.264 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.99 137.41 21.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.402 -0.962 . . . . 73.44 108.402 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.65 142.56 17.3 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.501 -1.04 . . . . 65.53 110.501 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.8 t -136.05 156.7 48.34 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.275 -0.639 . . . . 73.34 109.275 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.33 110.11 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.564 -0.902 . . . . 72.42 108.564 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -130.91 91.93 35.32 Favored Pre-proline 0 C--N 1.292 -1.895 0 N-CA-C 108.043 -1.095 . . . . 74.12 108.043 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 51.2 Cg_endo . . . . . 0 N--CA 1.449 -1.108 0 C-N-CA 122.031 1.82 . . . . 61.04 111.334 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 112.359 0.503 . . . . 63.21 112.359 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.14 -25.58 68.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.296 -0.411 . . . . 64.22 110.501 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.16 -47.47 92.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 116.282 -0.417 . . . . 60.5 110.438 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 48.5 mt-10 -63.47 -48.24 78.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.794 0.331 . . . . 72.1 110.534 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.17 86.32 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.402 -0.817 . . . . 74.11 111.865 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.54 -33.68 62.79 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.379 -0.373 . . . . 65.13 110.539 -178.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -73.57 -36.67 65.62 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.457 -0.497 . . . . 44.12 111.03 -177.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -71.76 -25.21 61.95 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.377 -0.929 . . . . 74.51 110.368 175.587 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -68.78 -37.33 79.23 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 107.981 -1.118 . . . . 73.11 107.981 175.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -68.49 -40.07 81.04 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.37 -0.832 . . . . 73.24 109.49 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.01 93.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.047 -0.524 . . . . 72.24 110.834 177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.28 58.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.974 -0.557 . . . . 42.53 111.189 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.8 -33.69 57.99 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.488 0.661 . . . . 72.43 109.715 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.33 8.13 59.08 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.202 -0.908 . . . . 74.43 113.59 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 56' ' ' LEU . 9.5 mm -56.44 135.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 123.434 0.693 . . . . 73.54 111.537 177.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 19.0 tt0 -124.52 142.86 51.02 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 108.216 -1.031 . . . . 73.24 108.216 -177.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 m -76.48 131.8 39.23 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.698 -0.683 . . . . 54.41 110.995 -177.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.2 tp -148.06 -168.99 3.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 105.174 -2.158 . . . . 71.45 105.174 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.637 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.43 140.43 7.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.439 1.096 . . . . 65.5 110.542 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.2 24.76 0.87 Allowed Glycine 0 C--N 1.316 -0.551 0 C-N-CA 123.457 0.551 . . . . 52.2 114.465 -173.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -85.16 -38.75 18.67 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.638 -1.616 . . . . 72.52 106.638 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -174.22 160.24 3.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.407 -1.27 . . . . 74.3 110.173 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 48' ' ' ILE . 65.3 mt -90.51 152.38 20.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 123.826 0.851 . . . . 74.21 111.131 -173.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.488 HD23 HD22 ' A' ' 51' ' ' LEU . 2.0 tm? -92.89 121.79 34.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.608 -1.627 . . . . 74.34 106.608 -176.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.78 158.24 32.82 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 109.629 -0.508 . . . . 54.42 109.629 -177.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.35 156.78 58.07 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.427 2.085 . . . . 71.43 112.266 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -125.18 -22.58 4.37 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.922 -0.581 . . . . 23.31 110.563 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 11.4 tp10 -94.02 106.36 18.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.644 -1.243 . . . . 72.11 107.644 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -122.43 114.54 20.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.468 0.651 . . . . 75.45 111.011 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.52 122.55 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.55 -0.907 . . . . 61.34 108.55 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -116.25 117.3 55.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.761 -0.829 . . . . 71.14 108.761 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.3 m -103.47 116.78 33.05 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.775 -0.648 . . . . 75.45 109.39 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.07 175.04 5.61 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.963 -0.562 . . . . 70.11 110.027 178.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.18 145.05 32.86 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.11 -0.796 . . . . 75.35 111.11 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.52 -24.62 36.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.381 0.61 . . . . 73.32 110.044 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 52.8 t-80 -55.28 -51.86 65.31 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.051 -0.977 . . . . 61.21 110.32 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 73' ' ' LYS 0.261 2.6 m-20 -87.23 -20.02 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.938 1.088 . . . . 70.4 113.938 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.442 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 36.6 t80 -61.97 -33.25 73.96 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.43 -0.35 . . . . 61.32 110.529 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 11.2 pt-20 -66.28 -26.25 67.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 73.51 111.52 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -70.51 -33.46 71.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.215 -0.902 . . . . 51.24 109.099 174.471 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.78 -37.01 76.19 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.991 0.901 . . . . 72.41 108.688 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.19 -157.88 15.56 Favored Glycine 0 N--CA 1.425 -2.089 0 CA-C-N 114.839 -1.073 . . . . 70.11 111.304 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.79 18.66 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.035 0.445 . . . . 71.0 110.263 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.58 109.81 61.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.963 -0.562 . . . . 71.33 111.04 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.1 -39.46 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 121.754 1.636 . . . . 63.24 112.399 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -58.34 -38.94 78.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 116.232 1.938 . . . . 72.13 116.232 -164.123 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.65 -37.26 83.38 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.611 0.719 . . . . 72.24 110.185 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -86.12 -25.02 26.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.785 -0.643 . . . . 63.13 110.139 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.587 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.7 m -65.67 -33.36 75.7 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.603 -0.726 . . . . 72.54 109.305 175.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -63.08 -44.27 96.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.42 109.732 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.23 95.29 Favored Glycine 0 C--O 1.243 0.675 0 C-N-CA 120.855 -0.688 . . . . 55.32 111.798 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.17 -33.03 67.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.327 -0.62 . . . . 42.11 109.327 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.6 93.47 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.284 -0.416 . . . . 63.13 110.688 177.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.56 -41.44 94.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.266 0.555 . . . . 74.24 110.745 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 38.9 t70 -71.24 -36.61 71.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.734 -0.667 . . . . 71.21 110.551 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.19 -33.84 75.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.015 0.436 . . . . 74.34 110.187 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.08 79.19 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.284 -0.635 . . . . 55.53 109.284 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 29.7 t70 -65.45 -46.61 79.21 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.559 -0.746 . . . . 74.04 109.515 176.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 37.1 m-85 -54.57 -49.85 69.36 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 112.581 0.586 . . . . 72.12 112.581 176.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.9 pt -67.1 -32.51 58.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 C-N-CA 119.818 -0.753 . . . . 74.05 111.884 -177.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.53 -42.61 95.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.27 0.557 . . . . 74.52 109.76 174.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -65.93 -31.89 73.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 74.31 112.315 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 65.2 mm-40 -84.94 -13.28 51.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.315 0.579 . . . . 73.55 110.512 176.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.16 35.36 53.42 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.239 -0.891 . . . . 72.03 113.459 176.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.416 ' CE2' HD11 ' A' ' 48' ' ' ILE . 15.6 m0 -97.96 168.26 10.4 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.18 0.49 . . . . 64.24 110.401 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -130.43 167.42 18.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.423 -0.584 . . . . 64.11 109.423 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -161.61 177.88 9.57 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.005 -0.739 . . . . 72.12 109.005 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -119.66 120.73 37.49 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.407 -0.59 . . . . 75.01 109.407 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -158.42 14.7 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.141 -1.584 . . . . 75.41 109.141 -175.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.27 151.09 37.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.616 -1.253 . . . . 64.11 107.616 176.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.69 121.62 18.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 120.949 0.404 . . . . 65.04 110.453 -177.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.34 120.27 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 121.881 0.848 . . . . 41.54 110.128 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.0 t -119.13 124.01 72.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.84 -1.541 . . . . 74.23 106.84 177.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -132.79 136.21 46.17 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.05 0.452 . . . . 72.43 110.996 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 94.8 m-85 -104.01 141.26 36.5 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.337 -0.847 . . . . 65.44 108.854 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.85 162.66 34.26 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.562 -0.29 . . . . 71.3 110.8 176.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -100.66 150.38 22.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.729 -0.669 . . . . 73.44 110.997 -176.026 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 31.6 t -129.95 129.27 43.6 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.525 -1.287 . . . . 73.24 107.525 174.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 t -81.45 -27.69 34.53 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.704 -0.851 . . . . 55.1 108.704 176.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -68.85 -46.34 68.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.015 -0.993 . . . . 70.11 110.434 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 118' ' ' GLN . 6.8 tt -84.41 140.47 31.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.833 -1.076 . . . . 74.14 110.455 -176.381 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -120.01 156.91 29.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.111 -0.7 . . . . 74.23 109.111 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -55.8 119.45 5.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.705 1.202 . . . . 74.04 110.538 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.66 -27.22 3.74 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 106.589 -2.604 . . . . 32.14 106.589 -174.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.444 ' O ' HD21 ' A' ' 114' ' ' LEU . 34.5 tt0 -116.13 146.95 41.84 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 104.806 -2.294 . . . . 70.21 104.806 172.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -158.37 157.78 33.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.544 -1.28 . . . . 74.42 107.544 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -130.13 139.35 50.91 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 110.438 -0.208 . . . . 72.32 110.438 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.03 133.37 29.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.027 -1.472 . . . . 55.43 107.027 177.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -134.72 134.82 41.44 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.607 -0.886 . . . . 71.23 108.607 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -131.1 125.15 4.38 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.113 -1.195 . . . . 61.21 110.113 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -142.46 173.0 11.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.899 -0.408 . . . . 71.2 109.899 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.86 110.37 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.284 -0.636 . . . . 75.11 109.284 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.4 94.55 40.48 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.828 -0.623 . . . . 73.23 109.329 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.463 -0.29 0 C-N-CA 122.066 1.844 . . . . 61.42 110.943 179.448 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.866 1.062 . . . . 62.25 113.866 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.46 -31.57 71.82 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.97 -42.08 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.761 -0.654 . . . . 64.05 109.282 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.48 -43.14 99.4 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.615 -0.513 . . . . 64.33 109.615 177.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.9 90.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.299 -0.864 . . . . 52.23 110.97 178.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.85 -44.28 77.52 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.634 -0.427 . . . . 74.24 110.431 178.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.11 -37.45 87.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.827 0.677 . . . . 71.03 112.827 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.83 -36.09 82.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 120.036 -0.666 . . . . 75.52 109.358 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -68.38 -41.89 79.91 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.254 -0.43 . . . . 71.42 109.955 176.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.27 -45.02 96.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.734 1.213 . . . . 73.24 110.14 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.21 97.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.441 -0.799 . . . . 71.4 110.187 177.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.37 71.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.201 0.524 . . . . 65.14 111.392 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.13 -21.0 43.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.789 -0.641 . . . . 73.24 110.733 -178.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.56 19.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.975 -0.557 . . . . 53.32 112.139 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.51 134.73 29.72 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-O 121.272 0.558 . . . . 73.53 111.868 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 5.0 tp-100 -111.6 132.28 54.67 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.36 -1.348 . . . . 74.5 107.36 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -77.06 93.95 3.94 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.796 0.808 . . . . 71.23 109.883 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.628 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.3 tp -103.08 -165.41 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.119 -1.808 . . . . 72.51 106.119 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.628 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 2.2 mp0 -42.32 139.01 1.56 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.858 0.863 . . . . 63.34 111.586 175.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.81 -4.45 14.28 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-N 115.492 -0.777 . . . . 72.2 114.866 -171.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -72.17 -44.93 62.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.043 -0.354 . . . . 74.14 110.043 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 32.2 ptt180 -163.73 148.05 10.44 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.206 0.527 . . . . 72.14 111.373 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.12 151.19 21.09 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.017 -0.992 . . . . 74.11 111.051 -170.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 43.2 tp -86.35 126.6 34.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.443 -0.799 . . . . 64.31 109.677 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.3 160.38 31.55 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 124.109 0.881 . . . . 72.31 108.75 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HA ' HG22 ' A' ' 125' ' ' VAL . 78.0 Cg_exo -54.56 153.96 21.66 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.213 2.608 . . . . 64.43 113.253 176.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 30.5 p-10 -120.09 -34.67 3.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.831 -0.622 . . . . 64.42 111.133 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -107.64 112.81 25.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.338 -0.616 . . . . 74.44 109.338 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 53.2 m-85 -109.03 132.0 54.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.671 -0.695 . . . . 65.14 110.279 -177.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 mm -112.93 117.89 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.582 -0.896 . . . . 65.21 108.582 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.11 125.83 74.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 -179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -126.89 129.0 47.36 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.427 -0.352 . . . . 72.3 110.309 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 74' ' ' LEU . 6.2 mp -128.6 178.08 6.57 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.864 -0.607 . . . . 73.42 109.66 172.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -73.66 168.3 54.06 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.982 -0.847 . . . . 33.43 110.982 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.4 -40.48 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 117.688 0.744 . . . . 70.01 112.324 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -66.82 -36.01 81.37 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.88 0.848 . . . . 34.13 109.234 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -65.43 -51.41 60.45 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.498 -1.228 . . . . 75.41 109.287 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.08 -42.34 98.32 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.251 -1.34 . . . . 74.11 111.848 -173.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.54 -35.94 78.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.908 0.385 . . . . 64.43 111.226 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -74.2 -24.98 59.43 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.086 -0.506 . . . . 72.11 112.208 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 79.1 mt -72.52 -45.2 60.47 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.885 0.374 . . . . 72.41 111.281 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.13 40.26 56.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 107.912 -2.075 . . . . 43.32 107.912 -168.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.26 5.54 51.44 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.121 1.768 . . . . 60.43 112.09 -172.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -43.05 124.19 3.24 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 124.639 1.212 . . . . 72.4 110.503 -171.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -38.07 -47.8 2.23 Favored 'Trans proline' 0 C--N 1.373 1.836 1 C-N-CA 125.696 4.264 . . . . 73.44 116.116 -168.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.51 -17.07 52.68 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.863 -0.735 . . . . 70.23 112.278 -172.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.98 -56.11 3.63 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.395 0.617 . . . . 75.31 109.38 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -86.54 -5.5 59.13 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 115.16 1.541 . . . . 71.24 115.16 -174.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 p -64.97 -62.72 1.39 Allowed 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 119.243 0.929 . . . . 73.33 111.039 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.9 m -59.02 -40.43 84.94 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.155 0.582 . . . . 62.14 110.955 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.13 -55.46 9.15 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.907 -0.588 . . . . 40.31 113.495 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.97 -25.97 56.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.083 0.468 . . . . 73.31 110.448 -173.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.15 63.48 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.285 -0.566 . . . . 71.31 109.586 175.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -65.46 -40.74 93.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.133 -1.062 . . . . 60.13 108.133 175.882 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -59.54 -47.45 85.5 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 116.125 -0.488 . . . . 63.03 109.927 176.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.26 -37.37 77.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.584 -0.735 . . . . 73.41 112.034 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -60.56 -43.09 97.65 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.428 0.633 . . . . 52.11 109.384 178.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.34 -41.68 97.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.875 -1.057 . . . . 71.01 109.553 177.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.3 m-85 -61.26 -53.06 61.6 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.918 -0.583 . . . . 63.13 112.47 175.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 90' ' ' ALA . 37.7 pt -63.91 -31.07 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.742 0.275 . . . . 75.1 111.742 -176.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 77.3 mm-40 -65.79 -42.93 90.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.45 -0.574 . . . . 71.3 109.45 174.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.39 -37.33 83.03 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.052 -0.522 . . . . 73.15 111.202 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 27.3 mm-40 -77.06 -13.51 59.94 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.771 -0.65 . . . . 72.23 110.603 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 34.05 28.39 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.931 -0.577 . . . . 73.23 112.629 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -110.77 161.14 16.08 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.577 -0.527 . . . . 75.4 109.577 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.426 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -130.72 169.55 15.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.461 -0.57 . . . . 71.22 109.461 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 6.6 t -158.28 170.55 21.99 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.675 -0.491 . . . . 65.01 109.675 178.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.32 122.49 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.854 0.359 . . . . 71.52 111.029 -176.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 -150.01 17.06 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.391 -1.084 . . . . 43.52 110.391 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.1 137.73 46.54 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.667 -0.864 . . . . 60.42 108.667 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.53 117.68 19.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.09 -1.078 . . . . 72.14 108.09 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.33 125.76 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-O 121.831 0.824 . . . . 75.44 112.02 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.0 m -104.87 124.63 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 106.869 -1.53 . . . . 60.04 106.869 173.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -115.92 130.51 56.86 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.1 -0.704 . . . . 73.24 109.1 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -104.34 143.9 32.36 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.048 -0.978 . . . . 73.43 108.859 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.51 168.53 22.47 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.048 -0.524 . . . . 61.41 110.065 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -114.82 163.52 15.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.287 0.565 . . . . 64.31 111.051 -176.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.44 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 43.7 t -145.15 133.17 21.37 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.765 -1.198 . . . . 61.4 107.765 176.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.2 m -80.99 -19.88 43.04 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.43 0.634 . . . . 53.1 109.498 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -81.01 -32.82 34.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.404 -0.817 . . . . 73.4 110.854 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.81 148.68 40.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.623 -0.717 . . . . 61.12 109.79 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -100.48 157.92 16.29 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.859 0.463 . . . . 74.53 110.229 -171.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.578 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 71.7 m -66.86 120.74 14.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.744 0.783 . . . . 71.02 112.688 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.1 -5.86 61.53 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.405 -1.27 . . . . 53.33 111.395 -178.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -107.2 104.73 14.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.026 -1.472 . . . . 63.54 107.026 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -119.62 157.05 29.24 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.084 -0.507 . . . . 74.21 111.012 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -134.24 137.45 44.35 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.731 -0.84 . . . . 74.42 108.731 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.15 125.34 10.77 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.251 -0.648 . . . . 44.1 109.251 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 -131.18 160.43 34.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 109.646 -0.501 . . . . 73.54 109.646 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.67 135.73 9.65 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 110.429 -1.068 . . . . 34.43 110.429 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 p -126.04 153.69 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.814 -0.439 . . . . 74.21 109.814 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.0 t -103.87 107.87 23.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.919 -1.141 . . . . 54.14 107.919 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -98.45 96.95 4.13 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.201 -1.407 . . . . 53.13 107.201 173.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 72.0 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 C-N-CA 121.939 1.759 . . . . 64.34 112.138 -174.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 109.613 -0.514 . . . . 74.03 109.613 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -69.3 -42.47 75.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.494 -0.928 . . . . 70.31 108.494 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.31 -46.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.389 -0.967 . . . . 52.34 108.389 177.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 23.5 mm-40 -52.02 -52.32 51.57 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.436 -0.802 . . . . 73.32 111.828 175.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.02 -53.96 49.06 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.8 0.688 . . . . 71.02 111.355 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.05 -42.18 97.12 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.317 0.488 . . . . 65.11 112.317 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.3 -47.05 77.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.828 0.677 . . . . 72.3 112.828 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 7.5 ptp180 -70.82 -32.84 70.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 120.428 -0.509 . . . . 73.21 110.486 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -67.17 -46.58 73.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.905 -0.406 . . . . 60.41 109.905 176.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 6.2 tp10 -63.03 -37.43 87.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 73.15 109.694 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -61.57 -41.39 97.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.143 -0.481 . . . . 32.13 110.943 178.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.07 -34.23 43.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.042 -0.526 . . . . 43.52 111.566 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.56 -30.82 57.23 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.476 0.655 . . . . 75.5 110.797 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.28 14.0 58.65 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.661 -0.7 . . . . 61.33 112.607 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.88 131.57 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.306 0.574 . . . . 62.44 111.106 177.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt-30 -119.45 139.64 51.72 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.251 -0.886 . . . . 62.02 109.772 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -74.56 126.85 31.67 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.352 -1.295 . . . . 71.54 108.769 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.574 HD23 ' NE2' ' A' ' 99' ' ' GLN . 14.0 tp -141.31 -165.57 2.0 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.186 -2.153 . . . . 72.43 105.186 -177.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.525 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.9 mt-30 -52.52 145.02 12.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.047 0.385 . . . . 73.43 110.299 176.567 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.95 -0.95 7.88 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 114.728 0.651 . . . . 52.11 114.728 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -64.11 -42.81 96.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.851 -0.796 . . . . 74.13 108.851 177.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -174.87 157.01 2.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.114 -0.948 . . . . 74.35 110.877 -179.125 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.15 151.65 20.89 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.495 0.718 . . . . 71.52 110.858 -173.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.3 tm? -91.74 128.79 37.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.826 -1.176 . . . . 71.23 107.826 -176.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.66 162.07 36.45 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 122.739 0.415 . . . . 73.24 109.954 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.8 Cg_exo -62.43 160.73 30.31 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.244 2.63 . . . . 70.41 112.941 176.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -132.81 -33.45 1.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.783 -0.644 . . . . 63.12 112.154 -179.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.04 116.52 32.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 72.2 108.837 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.516 ' HB2' HG12 ' A' ' 106' ' ' VAL . 35.2 m-85 -118.77 114.81 23.25 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.828 -0.434 . . . . 75.21 109.828 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.48 110.38 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.68 -0.859 . . . . 53.13 108.68 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.27 112.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.167 -1.049 . . . . 70.43 108.167 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -110.79 122.86 48.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.73 -0.668 . . . . 74.41 109.9 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.65 176.38 5.17 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.385 -0.825 . . . . 74.52 110.081 177.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.3 165.37 51.77 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.218 -1.553 . . . . 73.21 109.218 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 3.1 p -59.27 -48.31 87.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 112.673 0.62 . . . . 72.21 112.673 -178.038 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -63.94 -36.46 84.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 74.25 110.249 -178.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -69.02 -41.69 77.4 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.465 0.65 . . . . 74.43 109.563 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -73.87 -22.74 59.63 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 120.415 -0.514 . . . . 72.34 111.521 -176.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.8 mt-10 -61.77 -28.5 69.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.345 0.593 . . . . 65.13 109.66 173.264 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -84.91 -28.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.76 -0.655 . . . . 71.45 110.55 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 mt -97.02 -14.16 21.81 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 113.01 0.744 . . . . 73.3 113.01 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.71 22.13 35.24 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 116.077 1.191 . . . . 75.33 116.077 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.82 -35.13 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.959 0.88 . . . . 74.05 108.962 176.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -141.73 77.26 19.2 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 115.537 -0.756 . . . . 64.3 109.203 175.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.32 -50.37 2.03 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.062 1.841 . . . . 42.04 112.811 -178.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.01 -37.55 82.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.47 0.176 . . . . 74.44 111.408 -177.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.84 -55.7 29.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.135 0.493 . . . . 52.41 110.597 177.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 14.3 ptpt -72.86 -22.64 60.75 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.351 0.871 . . . . 75.34 113.351 -178.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 m -71.48 -36.43 71.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 74.41 109.131 175.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.3 m -70.89 -40.61 72.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.061 -0.518 . . . . 74.21 109.765 177.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.664 ' O ' ' HG2' ' A' ' 87' ' ' ARG . . . -57.77 -55.23 31.63 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-N 115.746 -0.661 . . . . 62.35 112.666 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 106' ' ' VAL . 62.8 m-85 -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.754 -0.85 . . . . 71.51 112.824 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.85 53.37 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.223 -0.298 . . . . 71.33 110.993 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 84' ' ' GLY . 35.1 ptt180 -60.68 -41.93 96.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.899 0.857 . . . . 71.13 110.141 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 87' ' ' ARG . 64.5 m-20 -77.74 -34.66 52.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.137 -0.938 . . . . 51.44 112.69 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.47 -37.99 89.46 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.094 -1.076 . . . . 71.21 108.094 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -63.12 -35.55 80.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.877 -0.601 . . . . 65.53 110.386 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.7 t70 -72.39 -42.09 65.57 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.684 -0.406 . . . . 74.34 110.027 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 13.8 m-85 -53.73 -48.4 69.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.224 -0.444 . . . . 74.52 112.074 175.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.4 pt -66.06 -30.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 119.722 -0.791 . . . . 63.34 111.104 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 78.7 mm-40 -67.61 -37.94 83.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.083 -0.247 . . . . 75.14 110.598 175.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.1 mt-10 -61.63 -41.04 96.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.883 0.739 . . . . 63.0 110.884 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 68.2 mm-40 -80.31 -14.22 58.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.938 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.11 29.11 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.765 -0.652 . . . . 61.43 112.062 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -102.9 174.51 5.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.613 0.72 . . . . 73.25 112.073 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' HD23 ' A' ' 51' ' ' LEU . 25.4 pt20 -137.18 171.91 13.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.412 -0.813 . . . . 72.21 109.491 179.184 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -161.15 153.51 20.26 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.738 -0.467 . . . . 44.33 109.738 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -109.66 120.04 41.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.652 -1.24 . . . . 75.32 107.652 175.03 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.85 -150.27 18.28 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 107.951 -2.06 . . . . 71.34 107.951 -172.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.93 137.83 35.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.187 0.993 . . . . 63.03 108.842 177.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.49 103.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.316 0.579 . . . . 75.44 110.094 -175.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.84 127.43 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.25 -0.887 . . . . 74.53 109.5 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.9 m -105.55 148.73 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 107.244 -1.391 . . . . 72.14 107.244 176.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -128.21 137.55 52.09 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.732 -0.84 . . . . 71.45 108.732 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.11 119.73 38.11 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.95 -0.759 . . . . 74.13 108.95 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.7 175.75 10.38 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.882 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.25 164.37 18.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 74.33 111.031 -176.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -154.17 117.19 4.48 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 124.058 0.943 . . . . 63.22 108.848 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 p -67.38 -17.73 64.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.603 0.716 . . . . 73.13 111.099 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -67.26 -28.18 67.82 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.201 1.0 . . . . 72.11 109.263 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.53 141.3 51.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.998 -1.001 . . . . 75.24 109.864 -178.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.55 145.96 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.847 -0.615 . . . . 73.45 110.16 -172.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 m -68.27 121.59 16.55 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.706 -0.679 . . . . 63.12 109.764 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.67 -11.09 38.65 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 110.471 -1.052 . . . . 63.15 110.471 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.69 169.09 9.74 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.207 0.527 . . . . 72.42 110.585 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -164.08 156.63 17.35 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.015 -2.587 . . . . 61.42 104.015 173.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -146.14 130.57 17.71 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.215 -0.994 . . . . 73.02 111.791 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.15 118.71 28.28 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.541 -1.281 . . . . 60.4 107.541 177.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 23.8 tpt180 -121.78 125.85 47.49 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.296 -0.631 . . . . 73.43 109.296 -177.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.09 130.32 9.1 Favored Glycine 0 C--N 1.289 -2.038 0 N-CA-C 110.581 -1.008 . . . . 72.45 110.581 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.3 t -138.09 167.26 22.17 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.47 -0.567 . . . . 65.53 109.47 -177.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 59' ' ' PRO . 50.4 t -92.59 106.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.526 -1.287 . . . . 55.25 107.526 175.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.83 102.75 51.12 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.135 -0.691 . . . . 62.41 109.135 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 C--N 1.323 -0.793 0 C-N-CA 121.84 1.693 . . . . 73.42 111.13 179.053 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.792 0.329 . . . . 74.43 110.573 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.87 -32.21 45.84 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.682 -0.488 . . . . 74.43 109.682 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.7 t -64.47 -49.82 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.781 -0.645 . . . . 60.3 109.426 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -66.68 -31.4 72.04 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 119.863 -0.735 . . . . 73.41 110.284 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.93 63.55 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.378 0.424 . . . . 73.14 110.197 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.68 -40.34 91.77 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.191 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 77.8 mt -66.34 -46.78 75.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.554 0.576 . . . . 73.41 112.554 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.01 -26.89 62.4 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.277 0.561 . . . . 73.44 110.134 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -45.65 73.35 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.671 -0.695 . . . . 73.51 109.679 172.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -62.72 -33.91 76.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 122.837 0.455 . . . . 74.41 111.174 177.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -62.12 -46.07 90.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.012 -0.54 . . . . 73.21 110.702 177.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.45 53.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.502 0.668 . . . . 65.42 111.106 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.14 -38.21 61.1 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.717 -0.674 . . . . 43.11 110.849 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.08 12.81 65.03 Favored Glycine 0 C--N 1.319 -0.396 0 C-N-CA 121.261 -0.495 . . . . 72.54 113.336 -176.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.72 127.4 19.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.399 0.68 . . . . 74.44 111.875 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -108.91 146.15 34.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.705 -0.68 . . . . 75.21 110.039 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.3 m -81.01 103.23 10.69 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.364 -0.834 . . . . 74.33 109.143 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.7 tp -112.65 -164.21 0.9 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.133 -1.432 . . . . 73.41 107.133 -177.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.626 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 85.0 mm-40 -49.67 156.99 0.6 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.748 0.819 . . . . 75.02 112.594 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.72 5.59 22.78 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 114.852 -1.067 . . . . 72.44 114.086 -172.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.45 -43.37 27.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.388 -0.597 . . . . 53.13 109.388 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -177.69 165.62 2.1 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.682 0.793 . . . . 72.15 112.016 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.21 151.3 20.99 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.149 0.98 . . . . 72.31 111.688 -173.31 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 51' ' ' LEU . 1.4 tm? -94.46 125.11 38.9 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.099 -1.075 . . . . 54.53 108.099 -175.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.56 156.98 40.54 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 123.597 0.759 . . . . 72.31 109.783 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 125' ' ' VAL . 82.1 Cg_exo -51.03 152.15 10.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.983 3.122 . . . . 70.22 114.307 177.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.6 p-10 -122.69 -33.88 3.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.194 -0.912 . . . . 63.4 110.605 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.47 100.26 11.27 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.318 0.58 . . . . 64.24 110.164 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 72.2 m-85 -96.43 114.13 25.77 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.632 0.73 . . . . 74.53 109.491 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -107.91 117.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.618 -1.174 . . . . 74.34 109.036 -174.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -118.05 101.74 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.485 -0.932 . . . . 71.44 108.485 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.5 m -95.82 122.93 39.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.184 -0.916 . . . . 74.42 109.311 -176.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.59 162.21 14.95 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.419 0.688 . . . . 73.11 111.056 176.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.16 163.47 50.63 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.889 -1.685 . . . . 74.43 108.889 173.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.7 p -63.15 -37.89 80.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 117.387 0.593 . . . . 61.51 111.357 -177.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -64.11 -38.04 89.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.634 -0.712 . . . . 73.51 110.393 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.08 -35.56 28.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.867 -0.606 . . . . 71.43 111.69 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -65.79 -32.36 73.85 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.744 -0.383 . . . . 74.32 110.994 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.2 mt-10 -59.57 -29.52 67.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.046 0.45 . . . . 74.53 111.266 177.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -81.5 -26.33 35.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.189 -0.46 . . . . 72.33 111.32 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.451 HD11 ' HG ' ' A' ' 66' ' ' LEU . 86.9 mt -70.73 -34.42 71.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.385 -0.598 . . . . 73.11 109.385 173.334 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.37 -165.89 21.86 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 110.877 -0.889 . . . . 64.4 110.877 177.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.89 1.23 55.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.017 0.437 . . . . 71.43 110.52 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -127.82 135.43 27.47 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.125 -0.489 . . . . 71.45 110.526 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.86 -34.52 1.75 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.057 1.838 . . . . 75.43 109.286 163.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -48.02 -52.79 18.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 117.376 2.362 . . . . 72.21 117.376 -165.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.24 -42.71 77.76 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.662 0.665 . . . . 54.14 110.606 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -88.84 -17.95 28.65 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.247 -0.888 . . . . 71.1 112.152 -177.803 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 59.6 m -71.18 -44.64 65.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.253 -0.647 . . . . 73.41 109.253 176.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.0 m -65.48 -43.2 90.98 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 115.87 -0.604 . . . . 64.3 110.006 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.12 -53.84 41.52 Favored Glycine 0 CA--C 1.504 -0.615 0 CA-C-N 115.492 -0.776 . . . . 53.13 112.373 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -67.37 -31.0 70.95 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 113.002 0.742 . . . . 45.11 113.002 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.23 82.69 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.062 0.392 . . . . 71.21 110.45 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -67.17 -48.08 69.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.798 -0.637 . . . . 73.53 111.505 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.33 -35.87 78.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.078 -0.51 . . . . 73.31 111.293 -173.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.22 -35.68 63.9 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.368 -0.605 . . . . 74.35 109.368 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.36 84.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.773 0.797 . . . . 54.35 109.438 176.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.89 -41.73 99.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.601 -1.181 . . . . 72.14 109.445 177.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 16.4 m-85 -59.89 -51.17 70.87 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.876 -0.602 . . . . 74.5 112.085 175.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -65.61 -30.78 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.298 -0.561 . . . . 64.12 112.101 -175.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.32 -44.93 93.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.701 -0.481 . . . . 75.24 109.701 175.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.17 -30.09 70.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.702 -0.681 . . . . 62.32 112.682 177.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 58.4 mm-40 -82.97 -13.62 55.63 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.918 -0.313 . . . . 73.03 111.222 178.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 27.08 40.6 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.051 -0.522 . . . . 43.13 113.125 176.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -98.68 178.38 5.01 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.888 0.344 . . . . 70.31 110.163 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.7 pt20 -143.03 174.18 10.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.875 -0.787 . . . . 72.13 108.875 178.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.9 t -157.19 171.74 19.89 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.612 -0.435 . . . . 61.0 109.831 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.1 118.93 37.83 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.069 -1.085 . . . . 72.32 108.069 176.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.39 -149.93 16.74 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.376 -1.392 . . . . 71.11 110.985 176.326 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.04 142.49 46.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.765 -1.198 . . . . 72.21 107.765 176.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.22 118.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.58 -0.896 . . . . 63.21 108.58 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.21 137.3 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.643 0.735 . . . . 73.31 110.443 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 82' ' ' SER . 92.4 t -117.92 142.9 30.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 107.023 -1.473 . . . . 64.12 107.023 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -146.44 146.79 30.71 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.697 0.284 . . . . 52.03 111.019 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 84.9 m-85 -121.16 125.07 46.26 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.111 -1.441 . . . . 71.32 107.111 177.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.39 175.61 8.99 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.504 -0.878 . . . . 65.11 111.597 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.412 ' OE1' HG23 ' A' ' 68' ' ' VAL . 50.2 mt-30 -105.18 149.43 25.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.837 0.827 . . . . 75.34 112.154 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 m -143.48 118.13 9.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.59 -1.186 . . . . 63.3 108.961 172.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 m -72.0 -24.22 61.53 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.813 -0.63 . . . . 65.41 112.574 -175.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -88.7 -0.25 57.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.457 1.122 . . . . 71.33 109.26 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -83.7 144.49 29.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.902 -1.045 . . . . 74.2 108.282 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.02 149.74 35.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.434 -0.803 . . . . 73.54 110.83 -171.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -66.5 125.1 24.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.075 -0.713 . . . . 72.45 109.075 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.5 16.64 73.07 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.744 -0.741 . . . . 75.41 112.206 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -124.52 123.2 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.199 -1.037 . . . . 71.5 108.199 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -116.23 156.66 26.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.389 -0.967 . . . . 63.4 108.389 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -126.0 130.72 51.76 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.899 -0.778 . . . . 63.21 108.899 177.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.04 119.75 29.55 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.813 -1.085 . . . . 53.51 108.74 -178.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -135.0 126.5 28.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.853 0.359 . . . . 74.01 110.094 -178.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.22 98.26 2.3 Favored Glycine 0 N--CA 1.424 -2.149 0 N-CA-C 108.502 -1.839 . . . . 55.31 108.502 176.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.3 m -93.36 138.94 31.22 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 121.198 0.523 . . . . 74.24 109.939 -175.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 59' ' ' PRO . 92.5 t -98.36 117.43 43.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.878 -0.786 . . . . 71.22 108.878 175.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -102.83 94.85 5.65 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.472 -1.677 . . . . 34.44 106.472 170.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.9 Cg_endo . . . . . 0 N--CA 1.451 -0.995 0 C-N-CA 122.225 1.95 . . . . 52.1 112.067 -175.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.964 0.411 . . . . 74.14 110.809 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.03 -48.16 77.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.374 -0.973 . . . . 72.31 108.374 175.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.94 -45.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.826 -0.624 . . . . 73.03 109.68 178.059 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.619 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 53.8 mt-10 -53.12 -55.3 25.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.323 -0.399 . . . . 75.21 111.147 178.28 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.05 68.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 71.34 111.811 -178.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.12 -47.34 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.337 -0.986 . . . . 63.24 108.337 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 62' ' ' TYR . 3.8 mm? -71.65 -30.7 66.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.852 0.686 . . . . 72.42 112.852 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtm180 -64.42 -40.09 95.1 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.287 -1.005 . . . . 75.51 108.287 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -63.9 -44.86 91.7 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 115.554 -0.748 . . . . 74.22 110.333 176.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.59 -39.71 89.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.154 0.502 . . . . 61.22 110.006 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.22 84.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.786 -0.643 . . . . 60.2 110.457 177.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.78 64.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 64.2 111.984 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.52 -37.51 31.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.087 -0.506 . . . . 74.44 110.267 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 20.56 26.08 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.856 -0.611 . . . . 42.42 113.03 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -67.12 138.51 22.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 123.28 0.632 . . . . 41.14 110.657 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -115.87 143.71 45.03 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 176.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 t -76.28 124.67 27.86 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.946 -1.024 . . . . 73.43 108.705 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.7 tp -140.16 -166.0 2.02 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.073 -2.195 . . . . 73.14 105.073 -177.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 97.0 mt-30 -51.67 143.53 12.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.674 0.67 . . . . 71.42 110.259 176.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.88 -18.01 52.41 Favored Glycine 0 C--N 1.322 -0.233 0 CA-C-N 116.087 -0.506 . . . . 71.43 114.085 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -62.55 -39.1 92.54 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.52 0.328 . . . . 73.21 111.731 179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -165.8 136.44 3.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.176 -0.465 . . . . 73.45 111.396 -177.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.87 151.6 21.08 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.934 1.293 . . . . 75.11 110.353 -176.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -85.71 128.48 34.8 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.446 -0.797 . . . . 73.24 109.83 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.64 158.57 41.51 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 123.305 0.642 . . . . 73.44 109.821 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 125' ' ' VAL . 36.0 Cg_exo -61.26 152.59 71.21 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.019 2.479 . . . . 72.44 112.7 177.326 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -130.86 -16.34 3.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.647 -0.706 . . . . 63.35 111.583 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.59 114.97 27.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.76 -1.2 . . . . 61.42 107.76 178.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.488 ' CD2' HD12 ' A' ' 40' ' ' LEU . 91.7 m-85 -121.18 122.62 40.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.425 -0.352 . . . . 74.04 110.23 -178.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 63' ' ' ILE . 3.4 mp -106.79 107.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.186 -1.042 . . . . 73.11 108.186 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 55.9 mt -112.55 103.65 15.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.55 0.691 . . . . 62.03 109.979 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 109' ' ' GLU . 26.2 m -103.12 120.01 39.91 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.847 -0.615 . . . . 72.11 109.779 -177.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -99.38 163.5 12.5 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 123.692 0.797 . . . . 71.41 111.252 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.25 165.1 49.79 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.31 -1.116 . . . . 41.25 110.31 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 112' ' ' SER . 7.4 p -62.67 -47.61 92.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 113.674 0.991 . . . . 72.31 113.674 -175.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 82.2 t60 -77.35 -24.19 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.477 0.656 . . . . 55.04 109.857 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.726 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 2.6 m-20 -69.72 -45.79 67.4 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.751 -0.833 . . . . 72.14 108.751 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 40.8 t80 -71.29 -34.17 70.4 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.564 -0.744 . . . . 74.14 111.816 -175.336 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 12.9 pt-20 -65.11 -30.08 70.99 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.103 0.478 . . . . 74.33 110.936 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 32.1 mmmt -68.94 -35.39 76.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.169 -0.923 . . . . 50.14 109.703 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.8 -37.33 79.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 73.24 110.73 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.49 -167.65 29.72 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 111.525 -0.63 . . . . 51.14 111.525 -178.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.11 -45.35 7.25 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.089 0.471 . . . . 52.01 110.475 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 16.1 m-20 -116.43 130.69 24.3 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 75.1 110.688 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 -20.34 14.48 Favored 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 123.203 2.602 . . . . 65.33 113.827 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 8.1 pt-20 -58.76 -24.06 61.08 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.323 1.601 . . . . 54.02 115.323 -171.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.8 tp -78.75 -29.64 45.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.43 0.633 . . . . 73.22 110.709 175.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.64 -35.17 13.67 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.217 -0.447 . . . . 70.13 111.773 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -60.78 -41.47 95.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.912 0.387 . . . . 63.44 110.895 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 m -56.91 -48.16 78.88 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.522 -0.763 . . . . 62.44 110.99 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.35 -46.33 64.36 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.928 -0.653 . . . . 53.14 112.006 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.62 -39.46 94.42 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.413 0.285 . . . . 54.11 110.472 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.23 88.65 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.857 0.361 . . . . 61.55 110.134 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.44 -37.87 86.12 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.193 -0.458 . . . . 72.03 110.997 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -71.09 -37.1 72.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.248 -0.433 . . . . 74.43 111.1 176.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.03 -43.91 90.87 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.008 -0.738 . . . . 72.0 109.008 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.79 -36.26 80.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.404 0.621 . . . . 65.45 110.635 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.27 -42.23 79.9 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.153 -0.93 . . . . 72.13 108.526 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 m-85 -60.72 -56.16 24.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.781 -1.1 . . . . 75.52 112.403 176.349 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -59.59 -37.95 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.347 0.499 . . . . 74.14 112.347 -175.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.88 -37.64 88.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.834 -0.346 . . . . 71.32 110.733 176.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.5 -21.17 65.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.874 0.694 . . . . 75.44 112.874 176.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 50.3 mm-40 -92.49 -10.5 37.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.146 0.498 . . . . 71.35 110.17 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.96 26.55 37.06 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.434 -0.803 . . . . 63.13 111.851 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -107.22 155.02 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.285 -0.635 . . . . 75.51 109.285 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -130.87 175.4 9.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.836 -0.431 . . . . 73.41 109.836 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 t -154.39 158.73 40.47 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 108.264 -1.013 . . . . 52.11 108.264 175.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.18 120.14 39.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.672 -0.492 . . . . 73.25 109.672 -178.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -149.96 16.94 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.601 -1.8 . . . . 61.51 108.601 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.02 152.26 41.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 177.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 p -81.42 122.19 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.626 0.727 . . . . 73.31 110.721 -179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.29 120.28 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.065 -0.97 . . . . 74.34 109.225 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.85 138.9 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 107.506 -1.294 . . . . 71.4 107.506 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -116.12 150.23 37.72 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 109.742 -0.466 . . . . 75.42 109.742 176.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 81.3 m-85 -129.57 125.88 37.23 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.543 -2.021 . . . . 75.1 105.543 172.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -138.55 174.36 10.62 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.231 -0.655 . . . . 74.32 109.231 174.608 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.1 pt20 -122.27 150.23 42.62 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.367 -0.605 . . . . 63.4 109.367 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.564 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 75.4 m -119.19 118.67 31.95 Favored 'General case' 0 C--N 1.264 -3.129 0 N-CA-C 107.733 -1.21 . . . . 61.22 107.733 173.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' A' ' 68' ' ' VAL . 10.5 m -59.94 -28.22 67.44 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.818 0.847 . . . . 62.15 112.073 -176.131 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' A' ' 111' ' ' SER . 23.7 p-10 -83.91 -19.87 33.99 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.904 0.881 . . . . 62.1 111.301 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 22.1 tp -78.17 135.85 37.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.899 -0.591 . . . . 73.31 109.915 -175.138 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -78.78 158.58 28.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.544 -0.753 . . . . 73.25 111.9 -173.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.726 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 30.7 m -70.93 130.72 42.35 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.378 -0.828 . . . . 73.52 110.082 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 11.42 62.27 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.061 -0.816 . . . . 72.03 111.061 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -126.49 121.22 31.73 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 108.186 -1.042 . . . . 72.1 108.186 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 66' ' ' LEU . 31.1 p90 -141.24 154.49 45.81 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.478 -0.564 . . . . 64.13 109.478 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 3.4 mpt_? -124.17 139.0 54.35 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.183 -0.673 . . . . 74.5 109.183 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.11 118.94 16.19 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.389 -0.967 . . . . 72.2 108.389 176.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -124.98 119.59 29.16 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.676 -0.41 . . . . 75.0 110.233 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -104.78 124.27 7.94 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.449 -1.06 . . . . 63.1 110.449 177.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 m -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 108.762 -0.829 . . . . 74.23 108.762 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.7 t -87.69 119.64 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.84 -1.17 . . . . 64.32 107.84 175.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -110.93 96.06 27.48 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.317 -1.734 . . . . 73.34 106.317 171.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.454 -0.845 0 C-N-CA 121.988 1.792 . . . . 52.41 111.184 -177.68 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.744 0.783 . . . . 72.41 110.03 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 37.5 mt-10 -74.8 -5.34 42.93 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.825 -0.625 . . . . 74.32 112.403 178.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 82.2 t -71.32 -55.51 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.792 -1.188 . . . . 72.35 107.792 174.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.5 pm0 -62.98 -34.93 78.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.88 0.372 . . . . 70.41 111.538 176.444 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . . . -62.19 -50.86 70.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.983 -0.553 . . . . 42.41 111.269 177.177 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.01 -30.57 67.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.298 0.57 . . . . 63.33 110.162 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 16.0 tp -66.1 -41.88 90.01 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.687 -0.688 . . . . 51.13 110.218 -179.03 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.88 -28.96 66.07 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.154 -0.684 . . . . 73.03 109.154 178.958 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HE ' ' HB2' ' A' ' 46' ' ' ASP . 6.3 tpt180 -64.62 -52.3 58.14 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-N 115.778 -0.646 . . . . 75.42 109.614 172.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -60.24 -38.05 82.23 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.856 0.863 . . . . 62.41 110.998 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.28 -46.68 89.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.998 -0.547 . . . . 70.02 110.88 177.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.8 -22.84 49.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.879 -0.601 . . . . 75.0 111.179 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' HE ' ' A' ' 42' ' ' ARG . 28.8 t70 -81.13 -37.33 29.03 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.862 -0.608 . . . . 70.25 110.799 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 19.89 29.59 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 116.1 -0.5 . . . . 73.35 113.538 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -66.11 139.04 21.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 C-N-CA 123.01 0.524 . . . . 70.24 110.851 178.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -117.85 143.34 46.38 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.173 0.511 . . . . 74.01 110.166 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -75.44 111.75 11.05 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.6 -1.182 . . . . 64.3 109.418 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.9 tp -119.13 -176.0 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.044 -1.835 . . . . 73.14 106.044 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 73.6 mt-30 -47.29 141.28 4.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.579 0.751 . . . . 64.13 110.058 175.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -10.63 7.77 Favored Glycine 0 CA--C 1.5 -0.857 0 N-CA-C 116.012 1.165 . . . . 74.51 116.012 -167.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -71.64 -35.72 70.5 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.245 -0.582 . . . . 61.45 111.844 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -167.26 148.12 5.58 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 112.07 0.396 . . . . 74.23 112.07 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.99 151.73 20.96 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.821 0.848 . . . . 73.3 110.508 -174.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.04 127.92 37.69 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.766 -1.198 . . . . 75.11 107.766 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.03 46.81 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 109.113 -0.699 . . . . 75.42 109.113 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.68 149.02 83.9 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.111 1.874 . . . . 63.41 111.153 177.177 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -113.23 -26.14 8.55 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.734 -0.386 . . . . 71.43 110.886 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 35.3 tt0 -113.12 125.18 54.08 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.185 0.517 . . . . 74.12 110.025 -177.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB2' HG12 ' A' ' 106' ' ' VAL . 39.4 m-85 -121.83 124.87 45.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.578 -0.737 . . . . 60.22 109.87 -177.452 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 69.2 mt -98.18 114.86 36.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.133 -1.062 . . . . 74.11 108.133 -179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.75 117.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.3 m -116.83 121.42 41.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.038 -0.528 . . . . 74.33 110.078 -178.437 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.4 mm? -106.57 163.05 13.2 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.216 -0.902 . . . . 70.2 109.555 177.02 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.43 163.64 54.12 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.261 -1.936 . . . . 73.31 108.261 171.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.25 -40.32 88.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 118.023 0.912 . . . . 63.14 112.891 -175.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 53.0 t-80 -68.55 -43.24 77.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.254 -1.017 . . . . 74.43 108.254 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -65.55 -35.43 80.83 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.356 -1.293 . . . . 73.24 110.699 -177.283 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.92 -40.48 91.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 70.23 109.683 178.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.41 -24.83 60.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.188 0.518 . . . . 62.14 111.193 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 mmmt -77.52 -17.14 58.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.241 -0.436 . . . . 55.33 111.848 175.299 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 66' ' ' LEU . 77.5 mt -71.45 -40.44 70.34 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 105.959 -1.867 . . . . 73.21 105.959 170.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.9 -176.5 18.64 Favored Glycine 0 N--CA 1.414 -2.829 0 CA-C-N 113.776 -1.557 . . . . 72.44 110.513 176.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -87.12 1.69 52.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.56 0.695 . . . . 72.23 109.361 178.008 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 26.6 p-10 -123.05 49.19 2.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 C-N-CA 124.242 1.017 . . . . 63.23 112.714 -177.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 5.2 Cg_exo -75.19 -17.16 19.37 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.705 1.604 . . . . 53.13 110.929 -179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -26.31 59.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.376 -0.829 . . . . 63.31 111.982 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.21 -44.94 62.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.645 -1.243 . . . . 71.15 107.645 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HE3' ' CZ ' ' A' ' 85' ' ' PHE . 60.2 tptt -61.3 -33.96 74.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.009 0.924 . . . . 61.3 109.427 176.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 t -63.05 -49.11 75.84 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.886 -1.052 . . . . 65.34 110.532 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.5 m -62.04 -34.44 76.24 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-O 120.896 0.379 . . . . 75.12 110.854 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.73 -52.63 44.1 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.62 -0.992 . . . . 60.45 110.62 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.671 ' CZ ' ' HE3' ' A' ' 81' ' ' LYS . 8.0 m-30 -58.52 -44.23 89.47 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 112.516 0.562 . . . . 75.45 112.516 178.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.15 74.65 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.756 0.66 . . . . 70.34 111.061 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -79.67 -40.28 29.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.372 -0.531 . . . . 54.23 111.066 -176.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 33.9 t70 -63.9 -38.12 89.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.175 0.512 . . . . 70.23 111.688 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.55 -29.74 52.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.616 -0.434 . . . . 73.41 110.08 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.31 -37.28 86.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.566 -0.901 . . . . 70.04 108.566 173.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 21.4 t70 -60.19 -54.94 39.83 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.593 -1.185 . . . . 72.42 109.327 176.002 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.4 m-85 -51.71 -49.19 62.94 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 114.005 1.113 . . . . 73.31 114.005 178.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.9 pt -63.8 -34.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.821 -0.751 . . . . 74.44 111.12 -177.087 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 81.1 mm-40 -72.24 -37.37 69.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 121.202 -0.199 . . . . 74.42 110.697 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 48.3 mm-40 -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.957 -0.565 . . . . 72.13 110.981 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.4 mm-40 -80.19 -13.3 59.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.727 -0.67 . . . . 74.41 111.681 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.84 29.81 28.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.756 -0.735 . . . . 60.23 112.327 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -102.47 162.52 12.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.803 -0.814 . . . . 74.41 108.803 178.202 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -133.98 177.17 7.94 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.773 -0.454 . . . . 73.12 109.773 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -160.83 177.33 10.52 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.74 -1.578 . . . . 74.13 106.74 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.36 119.11 36.53 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.943 -0.762 . . . . 65.43 108.943 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -150.92 17.05 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 109.387 -1.485 . . . . 62.3 109.387 -176.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.65 148.11 48.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.834 -1.543 . . . . 75.43 106.834 177.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.28 122.37 24.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.144 0.497 . . . . 75.13 110.814 -177.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 7.3 p -138.93 127.73 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.778 0.799 . . . . 71.22 109.9 -178.588 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 62' ' ' TYR . 18.8 m -105.17 148.5 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.556 -0.905 . . . . 74.2 108.556 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -115.52 125.58 53.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.692 -0.855 . . . . 75.31 108.692 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -101.11 119.79 39.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.265 -0.643 . . . . 75.25 109.265 173.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.9 pt-20 -139.16 164.8 28.85 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.844 -0.616 . . . . 74.31 109.377 178.465 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.66 159.41 29.39 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.558 0.694 . . . . 61.21 110.928 -177.007 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -140.21 109.8 6.31 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 114.937 -1.029 . . . . 63.32 109.188 172.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -64.67 -25.83 68.12 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.462 -0.79 . . . . 74.45 110.054 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -75.84 -14.72 60.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.16 -0.927 . . . . 70.33 110.438 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -81.98 161.57 22.97 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.211 -1.033 . . . . 65.35 108.211 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -83.15 150.84 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.096 0.474 . . . . 63.24 110.297 -176.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.0 m -76.31 123.53 26.07 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.59 -0.732 . . . . 75.0 110.602 -178.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.48 8.15 62.79 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.634 -0.986 . . . . 74.42 110.634 -175.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -114.44 122.02 45.33 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.336 -1.357 . . . . 75.2 107.336 177.537 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.447 ' HB3' HD13 ' A' ' 66' ' ' LEU . 43.2 p90 -131.28 154.0 48.96 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.204 -1.035 . . . . 73.34 108.204 -178.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -141.16 148.42 39.98 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 123.142 0.276 . . . . 75.54 110.367 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -147.32 121.0 9.19 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.711 -0.848 . . . . 64.25 108.711 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -123.54 140.24 53.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.668 -0.493 . . . . 73.12 109.668 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.1 136.38 13.34 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 111.555 -0.618 . . . . 72.15 111.555 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -138.71 158.9 43.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.8 -0.815 . . . . 71.13 108.8 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.86 106.99 19.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.463 -1.31 . . . . 75.23 107.463 178.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -124.11 96.83 41.54 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 109.799 -0.445 . . . . 65.02 109.799 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 N--CA 1.451 -1.021 0 C-N-CA 122.056 1.837 . . . . 73.35 110.96 178.037 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 34.2 tt0 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.753 -0.462 . . . . 65.35 109.753 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -65.23 -20.79 66.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.141 0.496 . . . . 74.34 110.681 179.112 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 78.8 t -72.34 -48.19 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.221 -0.659 . . . . 64.43 109.221 177.681 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -71.5 -26.7 62.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.454 0.645 . . . . 74.0 111.054 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.09 79.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.376 -0.829 . . . . 50.13 109.665 173.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 6.9 tt -76.74 -34.83 58.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.383 -0.969 . . . . 73.23 108.383 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 96.9 mt -62.28 -47.21 85.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.291 -0.413 . . . . 71.44 110.851 177.249 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -66.4 -30.9 71.37 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.454 -0.573 . . . . 72.41 109.454 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' LEU . 56.7 ttt180 -63.32 -55.25 26.21 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.146 0.978 . . . . 72.4 109.82 177.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.45 -23.73 58.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.293 -0.412 . . . . 62.22 111.423 -175.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.49 98.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.286 -0.635 . . . . 63.41 109.286 172.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.46 63.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.426 -0.807 . . . . 72.23 110.85 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.02 -42.42 76.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.784 0.326 . . . . 54.12 110.937 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.45 9.68 40.69 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.894 -0.593 . . . . 75.41 114.262 -176.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 48' ' ' ILE . 16.0 mm -59.64 135.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.398 0.618 . . . . 75.05 111.58 177.419 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 99.5 mt-30 -120.08 150.0 41.29 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.002 -0.999 . . . . 74.43 110.545 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.1 m -79.78 126.33 30.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.573 -1.194 . . . . 72.45 109.708 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.5 tp -146.7 -164.07 1.9 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 104.522 -2.399 . . . . 64.53 104.522 -178.238 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.608 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 50.7 mt-30 -42.25 133.32 3.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.619 0.768 . . . . 74.02 110.152 176.564 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.52 -12.43 46.2 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 114.884 0.714 . . . . 70.41 114.884 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.55 -34.18 60.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.036 0.384 . . . . 75.12 112.036 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 29.0 ptt180 -157.05 135.05 11.01 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.307 0.575 . . . . 74.41 111.943 -177.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.72 151.64 21.15 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.213 -0.903 . . . . 75.11 110.737 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 14.7 tp -84.94 125.0 32.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.744 -0.835 . . . . 72.41 108.744 -176.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.42 158.31 40.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 115.836 -0.62 . . . . 73.14 109.73 -178.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 39.1 Cg_exo -60.8 148.86 90.75 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.969 2.446 . . . . 75.23 113.121 177.759 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.7 p-10 -125.44 -21.63 4.49 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.234 -0.893 . . . . 35.33 110.626 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 32.5 tt0 -94.23 107.52 19.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.797 -0.816 . . . . 61.25 108.797 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 95.3 m-85 -120.52 114.46 21.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.294 0.569 . . . . 70.22 109.956 177.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.49 122.06 66.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.16 -1.052 . . . . 71.54 108.16 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.6 mt -115.6 119.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.376 0.607 . . . . 73.3 109.521 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 109' ' ' GLU . 15.1 m -117.45 123.71 47.04 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.721 -0.672 . . . . 43.45 109.261 -177.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 74' ' ' LEU . 6.4 mp -121.8 171.82 8.61 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 109.949 -0.389 . . . . 73.53 109.949 175.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.79 147.28 43.11 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.484 -1.046 . . . . 61.3 110.484 175.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.03 -47.76 65.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 123.099 0.56 . . . . 63.04 110.666 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.592 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 52.7 t-80 -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.506 -0.77 . . . . 65.4 110.376 -178.358 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 9.3 t70 -65.2 -43.28 92.11 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.768 0.794 . . . . 73.42 108.983 -178.337 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.3 -44.43 92.52 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.82 1.648 . . . . 74.43 109.8 -178.227 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -67.25 -37.25 83.2 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.087 -0.506 . . . . 73.31 110.749 177.366 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 3.1 mmmp? -68.5 -26.28 65.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.462 -0.336 . . . . 61.3 110.607 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 66' ' ' LEU . 78.8 mt -69.65 -45.68 67.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.804 0.811 . . . . 74.4 109.792 175.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.6 44.87 7.11 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 105.054 -3.218 . . . . 44.22 105.054 -165.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -61.53 6.93 0.05 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 128.624 2.77 . . . . 71.13 116.851 -171.53 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.4 t70 -43.45 106.85 0.52 Allowed Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.556 1.142 . . . . 71.11 108.728 -173.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 52.9 Cg_exo -52.65 -52.47 8.79 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.334 3.356 . . . . 74.14 118.987 -161.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.79 -51.07 7.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.441 1.645 . . . . 72.12 115.441 -165.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -62.96 -56.48 16.78 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.744 0.646 . . . . 63.41 112.744 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 85' ' ' PHE 0.286 29.1 mmmt -94.8 -8.61 36.98 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 115.55 1.685 . . . . 64.24 115.55 -177.352 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -69.46 -45.58 68.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.213 -1.773 . . . . 63.24 106.213 174.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.4 m -69.92 -36.91 75.73 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.059 -0.973 . . . . 65.34 108.925 175.097 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.02 -56.22 26.38 Favored Glycine 0 C--O 1.21 -1.345 0 CA-C-N 115.33 -0.85 . . . . 61.41 113.109 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 32.1 m-85 -60.2 -35.47 75.48 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.449 0.624 . . . . 70.54 111.492 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.95 94.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.42 . . . . 52.01 109.99 177.15 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -68.88 -41.12 78.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.878 -0.601 . . . . 74.51 110.085 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.67 -50.97 71.43 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.902 -0.407 . . . . 72.05 109.902 176.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.8 -31.76 70.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.215 0.82 . . . . 72.11 113.215 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.43 91.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.332 0.587 . . . . 74.23 109.661 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.0 -41.99 73.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.638 -0.71 . . . . 61.41 109.655 177.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -56.48 -52.86 63.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 112.565 0.58 . . . . 72.4 112.565 176.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.32 -37.8 58.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 120.063 -0.655 . . . . 74.24 111.699 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.28 -50.89 62.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.379 . . . . 71.51 111.181 175.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -53.31 -51.03 63.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.942 1.297 . . . . 74.42 110.784 -178.376 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 1.7 mp0 -74.73 -13.44 60.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.086 1.143 . . . . 72.11 114.086 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.24 38.21 11.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.028 -1.082 . . . . 72.52 111.796 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -109.42 158.41 17.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.774 -0.825 . . . . 72.24 108.774 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 23.6 pt20 -129.11 174.24 9.74 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.923 -0.769 . . . . 73.43 108.923 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.0 t -162.34 159.29 25.24 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.735 -1.209 . . . . 74.23 107.735 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.56 118.9 33.11 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.381 -0.97 . . . . 74.25 108.381 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -149.75 16.72 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.567 -1.813 . . . . 54.51 108.567 -176.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -126.09 164.32 21.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.568 -1.641 . . . . 63.14 106.568 174.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.37 117.53 28.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.556 -0.905 . . . . 54.4 108.556 -178.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -118.33 121.03 66.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.607 0.717 . . . . 74.32 110.643 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 62' ' ' TYR . 79.5 t -111.12 113.18 43.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.387 -0.968 . . . . 72.01 108.387 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -111.31 134.45 52.89 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.007 -0.542 . . . . 72.53 109.554 -177.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.4 146.41 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.738 -0.467 . . . . 73.35 109.738 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 65' ' ' THR . 9.2 pt-20 -151.37 168.31 25.2 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.75 -0.833 . . . . 62.12 108.75 174.857 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.95 158.42 25.77 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.235 0.541 . . . . 51.11 111.784 178.413 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -135.74 136.87 41.15 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.709 -1.132 . . . . 52.05 109.146 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 t -80.73 -19.27 45.37 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.8 -0.815 . . . . 54.34 108.8 176.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -72.79 -36.43 67.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.701 -0.681 . . . . 71.13 110.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.74 155.22 20.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.176 -0.466 . . . . 73.54 110.707 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -125.27 173.47 8.78 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.2 0.6 . . . . 72.42 110.645 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 9.8 m -57.79 125.61 23.77 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.474 0.654 . . . . 75.41 110.933 -179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.87 54.84 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.318 -0.856 . . . . 74.15 111.058 -176.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -118.18 118.67 32.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.092 0.472 . . . . 73.12 110.08 -178.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 34.0 p90 -139.03 148.45 43.42 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.564 -1.273 . . . . 74.32 107.564 177.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -132.12 130.65 41.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.228 -1.027 . . . . 55.43 108.228 175.41 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . -130.8 129.48 42.47 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.83 -1.174 . . . . 53.12 107.83 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 39.7 mtp180 -119.61 157.8 27.69 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 123.155 0.285 . . . . 71.52 111.521 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -137.0 109.85 0.74 Allowed Glycine 0 N--CA 1.424 -2.109 0 O-C-N 124.715 1.26 . . . . 60.31 110.918 176.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.6 m -114.3 150.43 34.48 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.371 -0.603 . . . . 73.44 109.371 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.24 106.12 16.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 106.49 -1.67 . . . . 75.31 106.49 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -110.42 102.28 51.07 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 109.962 -0.384 . . . . 71.24 109.962 -178.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 121.946 1.764 . . . . 54.5 111.394 178.441 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.445 -0.708 0 N-CA-C 106.271 -1.752 . . . . 74.22 106.271 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.02 -27.12 33.25 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.443 -1.253 . . . . 72.53 109.892 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -54.4 33.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.034 0 N-CA-C 107.649 -1.241 . . . . 61.14 107.649 175.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.78 -46.58 74.45 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.441 1.097 . . . . 71.41 110.911 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.2 69.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.058 -0.519 . . . . 65.12 111.655 178.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' CE2' ' A' ' 119' ' ' PHE . 9.6 tt -70.92 -35.4 72.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.849 0.356 . . . . 74.43 110.576 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 tp -67.12 -38.65 85.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.938 -0.574 . . . . 73.01 110.522 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -71.86 -29.06 63.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.407 -0.517 . . . . 61.25 111.184 177.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.28 -38.02 68.9 Favored 'General case' 0 C--O 1.203 -1.368 0 C-N-CA 119.037 -1.065 . . . . 61.13 109.075 173.465 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -64.34 -33.14 75.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.205 -0.665 . . . . 74.22 109.205 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.52 73.48 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.345 -0.843 . . . . 74.22 109.613 174.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -67.98 -30.98 70.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.563 0.697 . . . . 72.24 111.477 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.6 -29.92 52.2 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.92 -0.582 . . . . 72.25 109.755 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.51 14.1 65.98 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.824 -0.625 . . . . 75.54 112.41 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 45' ' ' ALA . 8.7 mm -64.0 138.9 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.962 0.905 . . . . 64.44 111.254 177.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 76.3 mt-30 -119.25 147.47 44.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.952 -0.567 . . . . 72.11 110.499 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.5 m -82.95 134.55 35.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 115.029 -0.987 . . . . 55.34 108.807 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.4 tp -150.69 -165.43 2.27 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.008 -2.219 . . . . 64.34 105.008 -179.371 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.623 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 80.0 mt-30 -42.2 139.33 1.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.727 0.811 . . . . 72.53 111.649 176.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.47 20.69 0.97 Allowed Glycine 0 CA--C 1.505 -0.543 0 CA-C-N 115.363 -0.835 . . . . 53.21 115.032 -170.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -86.96 -37.19 17.8 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.316 -1.365 . . . . 53.21 107.316 175.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -173.92 158.6 3.21 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.195 -0.911 . . . . 63.41 112.235 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB3' HG23 ' A' ' 48' ' ' ILE . 57.5 mt -91.63 151.76 20.55 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.042 -0.981 . . . . 74.23 111.36 -174.477 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 22.2 mt -80.88 121.0 25.43 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 115.771 -0.65 . . . . 70.13 110.978 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.13 151.14 37.61 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.731 -1.211 . . . . 53.33 107.731 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' HG22 ' A' ' 125' ' ' VAL . 39.3 Cg_exo -59.44 156.09 37.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.42 2.08 . . . . 43.52 112.882 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -118.86 -29.41 5.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.572 -0.74 . . . . 72.52 109.568 176.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -96.52 105.28 17.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.822 -0.626 . . . . 75.44 109.587 179.075 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 76.0 m-85 -115.8 114.8 25.25 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.802 -0.444 . . . . 74.12 109.802 178.24 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.8 119.97 61.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.584 -1.265 . . . . 64.2 107.584 177.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.42 135.69 41.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.664 -1.236 . . . . 63.21 107.664 -178.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 27.3 m -124.37 113.36 18.09 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 72.31 109.685 -177.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 3.5 mm? -109.3 -176.89 3.15 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.755 -0.657 . . . . 43.02 110.26 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.48 173.6 44.17 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.248 -1.141 . . . . 63.34 110.248 177.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.9 p -65.82 -44.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 117.131 0.466 . . . . 54.52 111.224 -179.099 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -56.51 -42.34 78.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.05 0.929 . . . . 74.4 110.033 177.468 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 12.6 m-20 -71.94 -37.78 69.93 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.299 -1.318 . . . . 72.02 110.446 -176.102 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.7 -37.78 88.77 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.655 -0.498 . . . . 74.33 109.655 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.5 mt-10 -61.23 -36.96 81.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.693 -0.685 . . . . 65.14 110.229 177.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.81 -23.88 41.76 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.975 -0.557 . . . . 75.12 112.362 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 89.5 mt -61.23 -42.29 98.35 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.714 -0.476 . . . . 64.14 109.714 177.387 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.21 166.65 10.75 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 119.622 -1.275 . . . . 43.44 113.299 175.252 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.89 -18.24 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.721 0.408 . . . . 75.3 111.575 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -115.72 85.4 14.09 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.084 -0.71 . . . . 54.32 109.084 177.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.13 -50.0 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.143 1.895 . . . . 73.13 112.282 -178.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.27 -49.48 73.89 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.53 0.567 . . . . 74.41 112.53 -173.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.74 -37.02 82.68 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 112.29 0.478 . . . . 70.03 112.29 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -77.42 -26.7 51.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.687 -0.405 . . . . 74.31 111.009 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 60.1 m -65.57 -40.41 92.75 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.876 -0.416 . . . . 52.12 109.876 175.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 m -59.79 -39.23 84.24 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.389 0.614 . . . . 72.32 109.964 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.85 55.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.582 -0.736 . . . . 54.44 111.976 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -68.95 -28.35 66.55 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.117 0.484 . . . . 74.1 110.03 -178.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -66.9 -38.79 86.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 116.147 -0.479 . . . . 72.53 109.757 176.243 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.36 -38.43 89.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 73.41 109.564 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -65.31 -42.66 92.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.992 -0.549 . . . . 70.1 110.344 177.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.15 -33.24 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.373 -0.376 . . . . 74.45 110.827 178.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.2 98.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.462 -0.569 . . . . 61.01 109.462 176.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.2 t70 -61.68 -44.18 97.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.304 -0.862 . . . . 73.15 109.453 177.189 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 m-85 -57.65 -52.96 63.28 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.671 0.619 . . . . 72.51 112.671 176.047 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.8 pt -64.59 -30.18 49.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.693 -0.403 . . . . 63.25 111.705 -176.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -38.31 85.89 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.123 -0.49 . . . . 72.45 110.366 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 51.3 mt-10 -65.67 -30.55 71.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.951 -0.568 . . . . 72.13 111.162 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.0 mm-40 -85.52 -11.43 54.18 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.807 -0.633 . . . . 70.34 110.941 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.66 33.08 60.92 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.764 -0.653 . . . . 51.1 113.065 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -97.99 161.34 13.77 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.496 -0.482 . . . . 74.54 110.122 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.95 161.71 18.43 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.021 -0.733 . . . . 71.54 109.021 178.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -161.1 172.26 17.12 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.576 -1.638 . . . . 54.34 106.576 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -123.51 120.14 32.03 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 71.45 110.235 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.74 13.07 Favored Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 109.751 -1.34 . . . . 53.14 109.751 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.08 141.32 30.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.542 -0.91 . . . . 64.11 108.542 174.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.37 138.32 21.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.293 -1.002 . . . . 65.04 108.293 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.19 124.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 121.152 0.501 . . . . 43.42 111.125 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 15.3 m -108.87 140.54 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 106.643 -1.614 . . . . 52.21 106.643 172.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.38 144.92 48.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.512 -0.922 . . . . 74.51 108.512 177.018 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -111.77 126.93 55.59 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.413 0.445 . . . . 53.0 110.184 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.5 pt-20 -128.26 168.49 15.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.936 -1.505 . . . . 74.04 106.936 173.272 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.35 156.93 34.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.805 0.812 . . . . 73.32 112.004 -177.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 74.5 m -130.48 101.77 5.87 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.171 -1.418 . . . . 61.42 107.171 169.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -68.14 -9.38 46.17 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 123.948 0.899 . . . . 72.34 112.941 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.0 -25.66 48.14 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.746 -0.835 . . . . 60.51 108.746 174.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -104.48 151.45 23.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.66 -1.237 . . . . 72.31 107.66 -177.235 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -139.65 171.8 13.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 117.563 0.165 . . . . 72.44 111.307 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 m -36.02 112.87 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.28 2.232 . . . . 53.03 113.057 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.35 -33.07 3.74 Favored Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 107.848 -2.101 . . . . 74.02 107.848 -175.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -105.73 139.21 40.65 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.908 -1.516 . . . . 74.33 106.908 174.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CE2' HD13 ' A' ' 39' ' ' LEU . 32.7 p90 -170.45 154.19 4.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.783 -0.821 . . . . 74.03 108.783 174.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -128.72 157.97 39.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.963 -0.562 . . . . 72.04 110.261 -177.385 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.47 144.15 22.62 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.092 -1.818 . . . . 72.42 106.092 174.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 33.2 ptt-85 -140.41 145.95 37.69 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.436 -0.579 . . . . 64.44 109.436 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 110.06 0.93 Allowed Glycine 0 C--N 1.284 -2.326 0 O-C-N 124.206 0.942 . . . . 75.22 111.81 -176.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.6 m -109.25 137.84 46.51 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.65 -0.5 . . . . 71.34 109.65 -179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.0 t -89.07 109.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.992 -1.855 . . . . 71.4 105.992 170.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.16 105.88 31.39 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.437 -0.579 . . . . 44.5 109.437 179.272 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 C-N-CA 122.165 1.91 . . . . 71.03 111.689 178.785 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 120.259 0.076 . . . . 60.24 110.884 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.51 -47.78 69.58 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 123.465 0.706 . . . . 73.22 109.111 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.36 -44.81 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.272 -0.876 . . . . 74.1 109.917 -178.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.87 -53.42 56.98 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 116.025 -0.534 . . . . 63.01 111.352 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.55 86.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.707 -0.679 . . . . 72.33 111.201 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.36 -41.76 84.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.85 -0.426 . . . . 73.15 109.85 -178.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.52 -43.4 80.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.581 0.586 . . . . 75.3 112.581 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -68.65 -29.55 68.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.788 -0.765 . . . . 73.13 110.78 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -70.06 -38.79 75.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.141 -0.689 . . . . 72.05 109.141 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.9 -38.15 90.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.962 -0.755 . . . . 74.32 108.962 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.42 92.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 74.21 110.421 176.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.91 -31.88 71.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 74.1 111.468 -178.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.37 -33.55 61.06 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.165 -0.47 . . . . 61.24 111.217 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.58 15.53 40.74 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.813 -0.631 . . . . 35.11 112.94 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 48' ' ' ILE . 12.2 mm -67.02 130.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 123.332 0.653 . . . . 72.24 112.132 179.09 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -116.02 147.41 41.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.353 -0.839 . . . . 74.22 109.622 176.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.6 m -77.55 102.92 7.19 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.163 0.982 . . . . 64.04 111.484 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.5 tp -105.2 -165.96 1.18 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.246 -2.131 . . . . 60.13 105.246 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.5 mt-30 -51.06 138.25 20.12 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.348 -0.982 . . . . 72.03 108.348 171.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.91 22.47 0.57 Allowed Glycine 0 N--CA 1.471 0.982 0 N-CA-C 114.782 0.673 . . . . 32.32 114.782 -171.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -104.27 -25.23 12.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.266 -1.013 . . . . 64.32 108.266 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -161.51 134.66 6.31 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.28 -0.873 . . . . 73.13 110.54 -177.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.0 151.88 19.28 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.783 -0.644 . . . . 75.44 110.61 -175.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.01 126.6 36.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.159 -1.052 . . . . 74.43 108.159 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.24 160.41 37.59 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 123.181 0.592 . . . . 53.54 109.805 -178.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.15 157.99 59.06 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.611 2.208 . . . . 74.51 111.921 176.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB3' HG21 ' A' ' 100' ' ' THR . 25.3 p-10 -126.38 -25.12 3.53 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.174 0.435 . . . . 63.34 112.174 -177.75 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.48 110.38 21.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.551 -0.537 . . . . 72.1 109.551 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 55.1 m-85 -116.88 119.16 34.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.434 -0.803 . . . . 62.54 110.076 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.2 118.99 56.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.669 -0.863 . . . . 73.01 108.669 177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.1 mp -112.48 124.96 69.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.462 -0.94 . . . . 71.21 108.462 178.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -119.42 133.64 55.61 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.997 -0.742 . . . . 54.44 108.997 -178.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.58 173.36 7.23 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.209 0.604 . . . . 71.01 110.226 175.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.51 166.44 45.57 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 108.846 -1.701 . . . . 72.12 108.846 172.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 95.1 t -59.07 -59.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 117.666 0.733 . . . . 54.44 110.885 -178.599 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.499 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 40.8 t-80 -53.44 -49.17 67.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 65.51 110.809 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.8 m-20 -58.2 -50.38 73.75 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.62 1.168 . . . . 63.13 111.134 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.24 -40.08 93.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.354 -0.384 . . . . 71.02 111.24 -176.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 53.5 mt-10 -65.78 -31.27 72.15 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.856 0.36 . . . . 62.34 111.074 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.6 mptt -79.32 -27.51 42.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 73.31 111.266 178.007 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 61.3 mt -75.49 -33.25 60.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.802 . . . . 72.11 108.833 175.411 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.01 116.16 1.65 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.833 -1.707 . . . . 72.21 108.833 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -77.76 1.51 19.89 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.063 0.394 . . . . 61.32 112.063 -176.24 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 25.4 t70 -80.58 101.88 1.07 Allowed Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 124.215 1.006 . . . . 72.11 109.226 176.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 72.9 Cg_endo -75.92 -33.47 3.7 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.44 2.093 . . . . 72.32 115.871 -171.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.05 -49.11 71.38 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 112.776 0.658 . . . . 74.15 112.776 -170.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.96 -15.99 62.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.846 0.355 . . . . 74.45 111.864 -177.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 75.6 mmtt -81.68 -57.64 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.511 -0.922 . . . . 65.21 108.511 175.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -53.74 50.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.078 -0.965 . . . . 74.53 111.308 -173.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.9 m -69.95 -35.5 74.56 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.639 -0.255 . . . . 32.45 111.195 -177.266 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.09 -51.05 59.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.284 -0.484 . . . . 75.31 112.01 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 71.7 m-85 -72.65 -36.03 67.88 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 112.493 0.553 . . . . 73.52 112.493 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.49 96.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.666 -0.414 . . . . 62.41 110.739 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -63.83 -49.09 74.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.977 -0.556 . . . . 75.31 110.559 178.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -67.29 -37.31 83.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 64.2 111.552 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 tp -74.05 -34.93 64.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 63.0 111.005 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.11 89.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.814 -0.81 . . . . 63.23 108.814 175.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.36 -48.83 74.03 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.968 -1.014 . . . . 74.23 109.736 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.606 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.9 m-85 -52.08 -53.33 43.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.906 0.706 . . . . 71.43 112.906 176.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.4 pt -62.09 -36.53 74.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 120.594 -0.443 . . . . 73.3 111.494 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.56 -41.68 79.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.291 . . . . 64.53 110.861 177.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -59.27 -41.02 87.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.026 0.441 . . . . 61.43 111.194 177.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 78.6 mm-40 -72.99 -13.37 61.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.009 -0.542 . . . . 63.35 112.21 -178.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.13 36.07 13.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.37 -0.919 . . . . 63.1 111.06 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -113.21 170.91 7.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.194 -1.039 . . . . 73.02 108.194 175.944 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -151.62 178.19 9.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.691 -0.855 . . . . 72.23 108.691 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 60' ' ' ASN . 14.6 t -150.52 177.91 9.57 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.518 -0.549 . . . . 74.11 109.518 -179.314 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.7 m-85 -111.66 121.04 44.05 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.202 -1.036 . . . . 74.21 108.202 178.052 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.96 -149.68 17.05 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.222 -1.151 . . . . 64.13 110.222 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.78 147.19 46.26 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.166 -0.679 . . . . 62.51 109.166 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.9 125.16 39.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.118 0.485 . . . . 73.24 110.844 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.04 120.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 121.789 0.804 . . . . 74.33 109.984 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.3 t -117.78 112.43 38.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.212 -1.403 . . . . 74.44 107.212 179.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -115.97 138.87 50.8 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 111.934 0.346 . . . . 75.03 111.934 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -119.18 134.9 54.94 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.269 -1.011 . . . . 60.31 108.269 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -156.17 164.16 38.72 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 123.563 0.539 . . . . 64.41 111.232 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -95.46 164.91 12.61 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.106 -0.497 . . . . 50.1 111.241 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 p -150.36 150.21 31.12 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 115.444 -0.798 . . . . 71.42 109.647 177.425 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -80.78 -22.83 39.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.607 -0.516 . . . . 73.11 109.607 176.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.93 -28.1 68.67 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.469 0.707 . . . . 71.51 110.756 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 120' ' ' ARG . 77.3 mt -96.5 135.92 37.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.917 -0.583 . . . . 72.41 110.716 -178.66 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -110.66 172.06 7.1 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.638 -1.616 . . . . 74.5 106.638 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 97.4 m -58.91 126.29 27.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.966 1.469 . . . . 62.53 114.966 -174.129 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.64 -8.79 47.57 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 114.18 -1.373 . . . . 64.12 111.443 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -104.53 135.68 45.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.75 0.309 . . . . 64.11 110.865 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.01 151.04 37.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.24 -1.022 . . . . 74.11 108.24 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 114' ' ' LEU . 53.8 mtm180 -124.67 143.21 50.86 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.855 -1.165 . . . . 75.21 107.855 177.35 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.85 118.3 10.3 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.292 -1.744 . . . . 71.23 106.292 173.723 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 23.1 tpt180 -120.3 121.67 39.17 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 120.05 -0.66 . . . . 74.13 110.058 -177.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.09 119.25 6.43 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.607 -1.397 . . . . 42.42 109.607 176.311 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.3 p -126.06 156.62 39.68 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 110.081 -0.34 . . . . 73.14 110.081 -178.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.52 110.74 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 107.199 -1.408 . . . . 62.22 107.199 175.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -117.4 96.29 49.02 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.408 -0.96 . . . . 74.51 108.408 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 9.9 Cg_exo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 122.333 2.022 . . . . 71.34 111.848 -177.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 . . . . . 0 C--O 1.241 0.616 0 CA-C-O 120.691 0.281 . . . . 72.01 111.491 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.56 -34.48 74.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.011 -0.366 . . . . 74.14 110.011 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 59.3 t -56.22 -50.5 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 74.45 110.111 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.82 -43.31 98.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.105 -0.498 . . . . 74.35 110.547 -178.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.14 89.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.666 -0.697 . . . . 54.22 110.822 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.6 -23.92 58.8 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.832 0.679 . . . . 70.5 112.832 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.6 mt -67.26 -37.43 83.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 65.14 110.294 175.518 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -65.26 -42.0 93.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.643 0.735 . . . . 73.04 109.242 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' ARG . 29.8 mmt180 -71.7 -28.68 63.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.415 -0.811 . . . . 75.21 111.316 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 29.9 tp10 -68.92 -44.67 72.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.192 -0.67 . . . . 71.35 109.192 176.09 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -59.99 -41.58 92.33 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.642 -0.708 . . . . 34.35 109.728 176.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.62 -36.49 80.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.545 -0.752 . . . . 22.12 111.147 177.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.96 -39.49 83.36 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 63.42 111.247 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.92 5.96 80.64 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.747 -0.661 . . . . 62.12 113.697 -178.04 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ALA . 10.8 mm -58.91 130.38 22.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.589 0.709 . . . . 73.31 112.112 178.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -116.19 134.71 54.62 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.356 -0.838 . . . . 70.22 110.056 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -72.52 106.59 4.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.804 -1.089 . . . . 72.14 109.694 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.9 tp -109.16 -164.69 0.96 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.796 -1.557 . . . . 61.5 106.796 -177.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.639 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 16.1 mm100 -51.52 162.49 0.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.651 0.781 . . . . 70.31 112.307 176.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -7.48 38.21 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-N 114.946 -1.024 . . . . 74.53 113.7 -175.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -68.38 -48.63 64.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 64.32 108.797 177.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -176.27 167.77 2.84 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.774 1.027 . . . . 73.44 113.774 -177.42 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.11 151.26 21.06 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.486 -1.234 . . . . 71.12 111.153 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.95 126.28 43.28 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.664 -1.236 . . . . 74.24 107.664 -177.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.82 158.06 35.13 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 123.548 0.739 . . . . 54.22 109.648 -178.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.9 Cg_exo -61.84 158.27 38.91 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.893 2.396 . . . . 50.44 113.087 178.206 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -124.81 -30.16 3.31 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.631 -0.713 . . . . 73.55 110.448 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.67 107.96 19.62 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.048 0.939 . . . . 64.5 108.596 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -116.22 118.12 31.91 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.885 0.374 . . . . 71.1 110.353 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.52 114.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.114 -0.698 . . . . 65.04 109.114 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 2.3 mp -109.27 132.39 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.678 -1.23 . . . . 72.4 107.678 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.2 m -137.39 135.88 37.36 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.951 -0.389 . . . . 72.33 109.951 -177.552 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -130.17 -179.38 5.2 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.303 -0.629 . . . . 74.22 109.303 175.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -69.77 156.03 53.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.86 -1.296 . . . . 71.4 109.86 175.659 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLN . 43.4 t -56.25 -56.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 117.443 0.621 . . . . 45.22 111.83 -175.23 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.606 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 50.4 t-80 -59.12 -45.14 91.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.462 0.476 . . . . 74.01 110.555 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.85 -43.19 99.46 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 70.33 109.753 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.27 -39.44 82.18 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.382 -0.826 . . . . 73.43 111.12 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 36.5 mt-10 -65.25 -28.58 69.45 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.648 0.261 . . . . 63.33 111.607 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 0.4 OUTLIER -78.57 -23.33 46.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 120.017 -0.673 . . . . 73.24 109.686 178.686 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.22 -36.79 74.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 72.11 109.916 174.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.21 158.32 8.59 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.821 -0.912 . . . . 51.3 110.821 177.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.8 -6.92 57.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 111.872 0.323 . . . . 61.42 111.872 -177.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.72 103.31 46.32 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.691 -0.231 . . . . 74.24 111.594 -179.05 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.43 -36.55 8.83 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.62 1.547 . . . . 61.22 109.86 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.52 -29.19 66.75 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.148 0.796 . . . . 73.32 113.148 -176.441 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.84 -42.94 94.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.77 -1.567 . . . . 61.32 106.77 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.69 -38.79 77.12 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.476 -1.238 . . . . 75.42 109.456 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 106' ' ' VAL . 65.2 m -58.22 -48.36 80.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.353 -0.385 . . . . 54.42 111.02 177.359 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -57.8 -49.01 78.04 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 123.391 0.432 . . . . 70.15 110.69 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.18 -55.73 19.82 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.719 -0.673 . . . . 74.51 112.904 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -67.41 -37.12 82.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.741 1.015 . . . . 73.04 113.741 -175.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -66.6 -45.02 80.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.527 . . . . 75.32 110.697 -179.314 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.36 -40.01 89.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 71.54 110.3 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.52 -53.32 53.74 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.166 -0.925 . . . . 74.33 111.064 178.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.11 -30.34 70.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 75.42 111.334 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.8 78.55 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.178 0.513 . . . . 63.34 110.033 176.516 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.69 -39.7 73.34 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.599 -0.889 . . . . 64.24 108.599 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 22.0 m-85 -56.83 -52.18 66.08 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.532 -0.758 . . . . 63.21 112.494 175.346 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.1 pt -61.63 -37.27 77.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.357 -0.537 . . . . 73.41 111.093 -177.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.32 -38.18 84.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.326 -0.397 . . . . 72.11 110.567 176.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -60.46 -44.0 96.32 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 63.25 111.051 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.5 mm-40 -75.91 -13.7 60.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.455 -0.793 . . . . 65.43 110.837 -178.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.89 35.68 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.928 -0.578 . . . . 75.4 112.442 177.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.75 172.56 7.18 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.891 -0.781 . . . . 73.02 108.891 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.35 173.45 11.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.524 -0.547 . . . . 61.45 109.524 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 t -157.53 177.84 10.96 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.331 -1.729 . . . . 63.21 106.331 177.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.07 117.48 34.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.686 -1.227 . . . . 75.34 107.686 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.82 -149.64 16.75 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.282 -1.927 . . . . 71.42 108.282 -177.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.68 169.61 15.93 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.387 -1.338 . . . . 74.21 107.387 171.46 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.01 120.88 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.825 0.345 . . . . 65.3 111.287 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -115.5 120.0 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.695 -0.854 . . . . 31.14 108.695 176.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 86' ' ' ALA . 13.9 p -119.69 129.02 75.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.516 0.674 . . . . 74.22 110.435 -176.323 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -115.8 138.07 51.49 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.339 -0.846 . . . . 72.13 109.983 -178.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -121.41 132.69 54.89 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.189 -1.412 . . . . 64.11 107.189 179.003 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.94 174.79 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.266 0.555 . . . . 65.25 111.02 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . 17.0 pm0 -110.18 151.94 26.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.063 -0.971 . . . . 73.14 110.612 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.404 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 37.8 t -141.42 132.28 25.91 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 107.24 -1.392 . . . . 71.34 107.24 176.063 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -81.6 -22.7 37.53 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.928 -0.767 . . . . 63.11 108.928 176.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -73.0 -30.21 63.61 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.598 0.714 . . . . 75.21 109.318 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -81.13 141.7 34.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.156 -1.053 . . . . 75.15 108.156 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.68 144.22 28.7 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.894 -0.594 . . . . 61.04 112.037 -171.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.9 m -64.84 124.54 22.25 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.85 -0.614 . . . . 63.3 109.567 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.27 -22.89 24.08 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.26 -1.136 . . . . 55.33 110.26 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -95.04 152.37 18.38 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.254 -1.017 . . . . 74.14 108.254 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 31.5 p90 -148.37 146.84 28.68 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.017 -1.475 . . . . 62.24 107.017 174.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 64.9 mtp180 -126.6 144.64 50.83 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.771 -0.455 . . . . 70.35 109.771 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.71 122.95 19.32 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.298 -1.371 . . . . 74.02 107.298 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.493 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 26.1 tpt180 -131.39 130.0 42.04 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.946 -0.702 . . . . 74.11 111.178 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -102.27 126.43 8.87 Favored Glycine 0 N--CA 1.425 -2.077 0 O-C-N 124.072 0.857 . . . . 72.11 111.059 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.1 m -122.82 146.57 47.43 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.662 -0.866 . . . . 72.23 108.662 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.1 t -95.66 105.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.184 -1.413 . . . . 74.33 107.184 174.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.48 100.14 51.15 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 120.871 -0.332 . . . . 63.55 110.206 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.442 -1.505 0 C-N-CA 121.994 1.796 . . . . 72.51 110.901 175.638 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.483 0.183 . . . . 72.15 111.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.09 85.49 0.14 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.774 -0.93 . . . . 71.31 110.774 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -63.06 127.33 30.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 109.702 -0.481 . . . . 64.01 109.702 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.5 165.16 13.51 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.166 -0.679 . . . . 62.54 109.166 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -90.17 149.36 22.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.841 -1.17 . . . . 72.05 107.841 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HD2' ' OE1' ' A' ' 130' ' ' GLU . 5.3 tpp180 -72.94 99.46 2.71 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.76 0.791 . . . . 53.13 110.927 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.8 mt -123.97 112.81 17.64 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.764 -1.199 . . . . 74.13 107.764 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 m -91.62 -7.08 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.564 0.697 . . . . 54.33 109.23 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.39 93.66 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.768 -1.106 . . . . 71.14 111.116 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.84 102.55 13.8 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 105.229 -2.138 . . . . 70.34 105.229 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.5 t -45.12 119.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 124.472 1.107 . . . . 43.24 111.366 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.4 117.17 19.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 114.153 1.168 . . . . 72.41 114.153 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -147.31 143.39 28.03 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 104.348 -2.464 . . . . 70.14 104.348 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.568 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -87.26 81.04 8.05 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.561 -0.855 . . . . 71.42 111.742 -177.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.78 95.35 2.88 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.079 -0.964 . . . . 74.34 109.55 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.954 -0.758 . . . . 75.51 108.954 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.84 87.17 4.22 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 106.686 -1.598 . . . . 74.41 106.686 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 m -99.31 129.82 45.55 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 114.534 -1.212 . . . . 74.33 108.0 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 31.4 m -119.11 124.91 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.513 0.673 . . . . 61.41 111.87 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.75 -62.85 0.27 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.356 -0.838 . . . . 74.34 111.442 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.94 -4.1 58.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.148 0.499 . . . . 73.42 110.673 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.69 -36.69 72.3 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.368 -0.833 . . . . 74.42 111.619 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -61.86 -43.42 98.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.154 -0.475 . . . . 72.11 111.553 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -46.45 84.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.833 0.349 . . . . 43.35 111.08 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -71.6 -28.39 63.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.702 -0.681 . . . . 55.32 112.651 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 22' ' ' ALA . 71.1 mt -67.86 -50.32 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.334 -0.247 . . . . 72.44 110.334 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -76.14 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.869 0.366 . . . . 73.01 111.76 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.56 29.24 74.62 Favored Glycine 0 CA--C 1.506 -0.498 0 CA-C-N 115.781 -0.645 . . . . 74.34 112.897 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.15 83.86 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.484 -0.865 . . . . 74.22 113.542 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -60.09 -38.22 82.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.482 1.135 . . . . 55.52 108.204 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.556 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 23.9 pt -130.89 154.99 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 104.063 -2.569 . . . . 62.33 104.063 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.01 94.37 14.69 Favored Pre-proline 0 C--N 1.289 -2.036 0 C-N-CA 120.265 -0.574 . . . . 74.21 109.582 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 31' ' ' ILE . 23.3 Cg_exo -67.95 -36.54 17.51 Favored 'Trans proline' 0 C--O 1.2 -1.378 0 C-N-CA 122.277 1.984 . . . . 64.33 110.722 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' CD ' ' A' ' 37' ' ' GLU . 95.1 mt-30 -61.74 -11.93 14.39 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.572 0.953 . . . . 73.35 113.572 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -71.33 -23.93 62.02 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.244 -1.021 . . . . 71.51 108.244 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 119' ' ' PHE . 98.4 t -69.12 -54.72 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.352 -0.84 . . . . 54.13 108.844 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 34' ' ' GLN . 2.7 mp0 -52.64 -43.9 65.75 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.053 0.454 . . . . 71.04 110.769 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.72 -54.53 43.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.087 -0.96 . . . . 74.33 111.399 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.5 tp -74.53 -25.18 59.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.782 -0.367 . . . . 51.02 110.857 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.17 -47.83 72.69 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.688 0.795 . . . . 73.34 109.966 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -71.09 -27.95 63.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.152 0.501 . . . . 62.43 110.182 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.16 -42.38 84.43 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.49 -0.777 . . . . 74.33 109.035 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.18 -32.6 70.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 72.55 109.434 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.36 95.67 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.923 -0.581 . . . . 74.01 109.739 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -65.31 -35.17 80.19 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.613 0.721 . . . . 54.14 110.441 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -16.56 60.5 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.339 -0.846 . . . . 74.12 110.808 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.06 7.9 41.52 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 116.156 -0.475 . . . . 63.32 112.666 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 45' ' ' ALA . 29.2 mm -65.97 127.51 27.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 120.984 0.421 . . . . 74.23 110.835 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 62.5 tt0 -105.7 124.43 49.55 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.192 -1.04 . . . . 74.02 108.192 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -60.9 109.27 1.02 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 124.124 0.89 . . . . 31.2 109.961 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.6 tp -122.56 -164.78 1.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.138 -1.801 . . . . 75.34 106.138 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.7 mt-30 -46.35 146.17 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.523 0.729 . . . . 73.33 110.81 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.65 -11.9 38.13 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 114.519 0.568 . . . . 52.41 114.519 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.34 -47.64 40.74 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.791 0.329 . . . . 73.03 110.544 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.442 ' HG3' ' OE1' ' A' ' 99' ' ' GLN . 24.1 ptt180 -158.88 142.92 15.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.581 0.705 . . . . 75.31 112.443 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.5 mt -91.26 151.63 20.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 125.223 1.409 . . . . 64.44 109.933 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 100' ' ' THR . 1.1 tt -90.41 118.28 29.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.045 -1.094 . . . . 73.44 108.045 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.37 153.78 39.53 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.716 -0.675 . . . . 74.0 109.714 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 44.8 Cg_exo -60.2 150.07 81.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.563 2.175 . . . . 75.31 112.014 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.82 -36.16 4.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.876 -0.602 . . . . 71.34 110.959 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -104.24 122.92 46.39 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.062 0.458 . . . . 73.41 109.853 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.1 m-85 -118.55 118.53 31.96 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.228 -0.897 . . . . 74.44 109.53 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.6 109.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.477 -1.305 . . . . 55.34 107.477 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -105.65 107.1 21.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.191 -1.04 . . . . 73.53 108.191 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 53.2 m -111.08 123.69 50.7 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.43 -0.805 . . . . 62.12 110.558 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -116.13 175.62 5.47 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.868 -0.606 . . . . 74.14 109.952 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -71.97 153.84 50.32 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 109.104 -1.598 . . . . 54.54 109.104 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.67 -42.17 80.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 120.81 0.338 . . . . 72.42 110.346 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 5.0 t60 -66.89 -29.9 69.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.272 -0.876 . . . . 71.42 110.532 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 m-20 -76.27 -46.16 29.28 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.634 -0.506 . . . . 73.43 109.634 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.4 -42.53 99.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.559 -0.746 . . . . 74.24 111.877 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 73' ' ' LYS . 10.1 pt-20 -62.82 -34.33 77.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.929 0.395 . . . . 72.01 111.581 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 13.8 mptt -75.47 -27.07 58.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.163 -0.471 . . . . 72.04 111.201 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 66' ' ' LEU . 73.5 mt -72.22 -40.3 67.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.517 -0.92 . . . . 74.14 108.517 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 146.62 6.16 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 109.771 -1.332 . . . . 62.11 109.771 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.57 -18.9 62.9 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 114.401 1.26 . . . . 64.25 114.401 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.39 124.04 76.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 119.595 -0.842 . . . . 72.13 110.472 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -77.39 -35.81 1.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.658 1.572 . . . . 72.42 110.88 167.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.86 -53.29 33.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.432 2.012 . . . . 65.31 116.432 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.38 -32.25 66.26 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.492 0.663 . . . . 72.42 110.389 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.14 -39.16 65.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.909 -1.041 . . . . 71.43 108.955 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.7 t -62.17 -44.13 97.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.301 -0.863 . . . . 63.04 109.883 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -59.13 -45.92 89.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.245 -0.434 . . . . 52.13 110.459 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.93 -48.93 51.6 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.844 -0.616 . . . . 75.22 112.855 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.25 -39.97 78.14 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.233 0.827 . . . . 74.22 113.233 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.7 95.23 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 121.085 -0.246 . . . . 75.33 110.625 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -37.56 87.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 72.04 110.612 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.77 -44.69 69.64 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.253 -0.431 . . . . 71.44 110.523 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.07 -37.96 84.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.127 -0.488 . . . . 71.1 109.844 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.7 71.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.367 0.603 . . . . 61.22 110.485 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 8.2 t70 -68.29 -43.61 77.33 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.148 -1.056 . . . . 72.33 108.148 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.0 m-85 -57.42 -47.68 81.11 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.323 -0.853 . . . . 74.42 112.821 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -62.47 -35.42 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.737 -0.785 . . . . 44.44 111.086 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.76 -45.96 87.46 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.414 -0.587 . . . . 74.41 109.414 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 32.2 mm-40 -60.44 -31.62 70.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.728 0.811 . . . . 61.35 113.078 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.2 mm-40 -90.99 -10.95 40.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.319 -0.401 . . . . 65.04 111.395 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 38.15 35.67 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.702 -0.761 . . . . 65.2 111.424 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -104.49 158.8 16.23 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.741 -0.466 . . . . 73.15 109.741 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.442 ' OE1' ' HG3' ' A' ' 55' ' ' ARG . 4.7 pt20 -126.9 167.54 15.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.573 -0.528 . . . . 64.03 109.573 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.5 t -158.35 179.27 9.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.958 -0.756 . . . . 52.4 108.958 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -130.81 128.73 41.29 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.588 -0.523 . . . . 70.31 109.588 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 -149.98 16.9 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 108.313 -1.915 . . . . 15.3 108.313 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -124.84 141.29 52.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.925 -1.139 . . . . 63.13 107.925 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.75 112.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 123.53 0.518 . . . . 71.41 110.02 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.74 125.61 67.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.852 0.834 . . . . 70.44 111.288 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.2 m -105.02 129.82 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 N-CA-C 108.513 -0.921 . . . . 73.11 108.513 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -106.0 127.17 52.98 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.939 -0.573 . . . . 74.12 109.922 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.61 115.43 29.87 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 75.22 107.877 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.2 pt-20 -145.54 164.02 32.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.992 -0.549 . . . . 62.2 110.218 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -120.11 154.06 35.24 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.236 0.541 . . . . 74.03 111.124 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.6 m -137.81 143.47 41.04 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.597 -0.89 . . . . 55.12 108.597 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -72.5 -20.08 61.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.474 0.654 . . . . 73.31 111.129 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.01 -11.33 59.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.6 -0.727 . . . . 75.45 111.025 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 67' ' ' GLY . 0.7 OUTLIER -101.39 133.9 45.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 105.808 -1.923 . . . . 74.11 105.808 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -93.27 170.3 9.73 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 112.88 0.696 . . . . 64.24 112.88 -173.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -72.59 127.73 33.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.319 -0.855 . . . . 72.33 111.18 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.02 28.94 24.37 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 110.278 -1.129 . . . . 52.23 110.278 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -140.64 151.44 44.61 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.144 -1.058 . . . . 64.44 108.144 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 p90 -152.77 150.91 29.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.478 -1.304 . . . . 74.24 107.478 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -141.96 130.3 22.35 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.694 -0.484 . . . . 53.12 109.694 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.87 121.76 38.78 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.246 -1.39 . . . . 75.43 107.246 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.419 ' HD3' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -121.59 118.33 28.97 Favored 'General case' 0 N--CA 1.398 -3.068 0 C-N-CA 123.408 0.683 . . . . 75.13 109.196 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 122' ' ' ARG . . . -111.54 138.12 14.75 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 110.312 -1.115 . . . . 75.32 110.312 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 t -144.85 163.84 32.88 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.57 103.77 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 106.943 -1.503 . . . . 44.54 106.943 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -118.85 106.41 43.84 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.901 -0.591 . . . . 60.33 110.065 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -84.13 -11.15 8.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.053 1.835 . . . . 61.23 110.949 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 73.51 111.021 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.52 99.88 8.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.464 -1.31 . . . . 74.23 107.464 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.483 ' OE1' ' HD2' ' A' ' 6' ' ' ARG . 44.6 mt-10 -75.58 118.79 18.81 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 114.621 -1.172 . . . . 51.41 111.055 -174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.07 86.74 2.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 114.263 -1.335 . . . . 75.31 110.215 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 114.628 -1.169 . . . . 75.32 109.534 -175.852 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 CA--C 1.501 -0.929 0 N-CA-C 107.595 -1.261 . . . . 71.2 107.595 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.02 38.54 63.9 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 110.993 -0.843 . . . . 74.44 110.993 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.7 t -156.93 157.94 35.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.91 -0.774 . . . . 50.13 108.91 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -69.61 138.23 52.94 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 123.141 0.577 . . . . 72.43 112.014 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -94.27 120.86 35.13 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.156 -1.424 . . . . 74.43 107.156 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -75.81 107.59 8.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.312 -0.625 . . . . 70.41 109.312 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.17 85.0 6.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.187 0.518 . . . . 74.42 109.702 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.48 120.92 29.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.249 -0.887 . . . . 71.22 109.347 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -89.29 98.67 11.9 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.311 -0.625 . . . . 75.45 109.311 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -89.96 96.22 10.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 75.34 106.96 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.5 91.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.152 -1.055 . . . . 71.33 108.152 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.19 117.77 26.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.213 -0.903 . . . . 64.14 109.304 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -68.31 -32.63 72.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 75.52 111.958 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -97.14 95.36 7.7 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.392 -0.923 . . . . 74.14 111.196 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -150.31 99.04 2.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 104.135 -2.542 . . . . 71.4 104.135 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.79 163.36 32.41 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.309 -0.859 . . . . 73.21 109.811 -172.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -81.25 75.25 8.23 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.174 0.511 . . . . 75.15 111.972 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.5 m -93.35 101.57 13.81 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 106.13 -1.804 . . . . 51.42 106.13 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.91 140.25 17.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 114.509 -1.223 . . . . 72.44 110.189 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.59 159.32 9.56 Favored Glycine 1 N--CA 1.392 -4.254 0 N-CA-C 109.126 -1.59 . . . . 62.13 109.126 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 7.4 p-10 -72.95 72.35 1.11 Allowed 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 122.587 1.184 . . . . 70.33 111.627 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -46.91 88.01 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.7 -1.136 . . . . 74.12 112.641 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -63.03 -35.18 79.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.243 -0.435 . . . . 74.04 111.284 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.49 -35.96 73.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 70.12 110.853 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 7.9 mmt180 -77.14 -20.56 55.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 74.03 110.884 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.2 mt -87.98 -59.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.382 -0.372 . . . . 70.22 110.85 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 30' ' ' SER . 88.1 m-85 -86.03 -28.31 24.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.289 0.848 . . . . 72.14 113.289 -173.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.4 -101.83 1.11 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.888 -0.485 . . . . 72.2 111.888 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.36 31.89 5.81 Favored Glycine 0 C--N 1.294 -1.759 0 N-CA-C 111.476 -0.649 . . . . 71.41 111.476 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' PHE . 27.4 t -103.14 -150.0 0.41 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.263 -1.755 . . . . 44.54 106.263 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 31' ' ' ILE 0.267 2.5 pp -55.75 117.97 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.392 1.091 . . . . 72.22 112.923 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 135.14 19.54 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.525 -1.216 . . . . 62.21 109.584 -176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 12.4 Cg_endo -55.97 -24.43 48.33 Favored 'Trans proline' 0 C--O 1.21 -0.901 0 C-N-CA 123.624 2.883 . . . . 73.2 114.82 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.28 -38.99 81.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.464 0.913 . . . . 75.12 113.464 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.84 -28.87 60.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.225 0.536 . . . . 71.21 110.296 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 t -71.99 -42.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.646 -0.872 . . . . 71.45 108.646 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 45.2 mt-10 -58.31 -44.27 88.53 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.97 -0.559 . . . . 75.35 109.856 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -49.84 72.53 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 124.043 0.839 . . . . 55.23 111.163 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.16 -37.62 75.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.49 0.552 . . . . 55.01 112.49 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 64' ' ' ILE . 54.7 mt -64.99 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.39 0.515 . . . . 74.12 112.39 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 26.3 ptt180 -71.08 -28.01 64.03 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.104 -0.638 . . . . 72.42 109.808 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -68.9 -40.87 78.92 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 108.526 -0.916 . . . . 73.54 108.526 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.48 -40.69 92.2 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.91 0.484 . . . . 35.54 110.248 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.331 -0.85 . . . . 72.52 110.777 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.11 76.25 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.41 0.624 . . . . 74.3 111.112 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -71.57 -44.96 63.57 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.508 -0.769 . . . . 72.33 110.746 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.57 21.69 20.79 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 115.604 -0.726 . . . . 50.33 113.523 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 48' ' ' ILE . 11.8 mm -61.97 125.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.255 0.55 . . . . 72.31 110.346 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -121.17 137.1 54.83 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.986 -1.007 . . . . 74.51 110.841 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -63.24 118.0 7.37 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.39 -1.277 . . . . 74.23 112.427 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.5 tp -139.03 -165.88 1.92 Allowed 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.318 -2.475 . . . . 71.33 104.318 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.45 140.35 7.98 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.186 0.594 . . . . 72.32 111.287 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.14 -15.87 57.01 Favored Glycine 0 CA--C 1.505 -0.59 0 CA-C-N 115.896 -0.593 . . . . 74.13 114.408 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.63 -35.56 67.82 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 111.815 0.302 . . . . 55.13 111.815 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 4.4 ptm180 -162.28 131.34 4.31 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.647 0.737 . . . . 65.31 111.083 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.53 152.33 20.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.369 1.467 . . . . 73.33 110.719 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 100' ' ' THR . 55.7 tp -78.08 126.01 30.19 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.54 -0.754 . . . . 63.1 109.909 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 158.57 43.28 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 108.316 -0.994 . . . . 73.34 108.316 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.592 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.5 Cg_exo -60.66 156.7 41.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.135 2.557 . . . . 71.42 113.674 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.66 -27.32 3.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.636 -0.711 . . . . 52.42 110.118 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.41 109.06 21.2 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.804 -0.813 . . . . 71.1 108.804 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 94.6 m-85 -115.66 115.45 26.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.595 -0.73 . . . . 75.12 110.656 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.74 119.51 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.191 -1.04 . . . . 71.53 108.191 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.462 HD11 HD21 ' A' ' 40' ' ' LEU . 15.2 mm -109.48 115.52 49.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.733 -1.21 . . . . 62.52 107.733 176.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 m -108.8 129.17 55.38 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.947 -0.57 . . . . 60.33 110.174 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.1 mm? -124.56 172.72 9.0 Favored 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.939 0.896 . . . . 60.25 109.587 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.33 179.39 53.2 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.057 -0.817 . . . . 41.43 111.057 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.45 -41.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.828 0.677 . . . . 61.44 112.828 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 75.4 t60 -73.04 -28.84 62.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.99 0.9 . . . . 73.22 109.413 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.579 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.5 m-20 -69.21 -44.16 72.67 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.999 -1.001 . . . . 74.23 108.602 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.89 -30.39 66.74 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.386 -0.825 . . . . 61.31 111.749 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 13.0 pt-20 -68.55 -29.94 68.61 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.95 -0.7 . . . . 74.53 110.35 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 14.5 mmmm -68.61 -31.51 70.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.039 -0.982 . . . . 74.21 109.796 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.74 -30.25 59.15 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.613 0.72 . . . . 61.44 109.107 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.7 -163.67 15.41 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.158 -0.928 . . . . 65.25 111.388 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.9 2.33 51.83 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.63 0.729 . . . . 51.3 109.5 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -111.76 97.87 39.14 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 113.542 0.941 . . . . 72.23 113.542 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -78.12 -46.85 0.12 Allowed 'Trans proline' 0 N--CA 1.438 -1.74 0 N-CA-C 109.286 -1.082 . . . . 70.21 109.286 162.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -43.97 -54.3 5.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.558 2.743 . . . . 71.43 116.994 -167.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.14 -51.37 39.05 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.387 -0.525 . . . . 74.1 110.216 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -75.42 -27.06 58.85 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.946 1.091 . . . . 64.13 113.946 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 66.4 p -71.23 -36.25 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.232 -0.587 . . . . 62.33 110.544 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -73.76 -37.42 65.04 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.09 -0.505 . . . . 74.15 109.796 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 87' ' ' ARG . . . -66.08 -41.9 94.82 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.832 -0.907 . . . . 73.13 110.832 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -69.97 -25.14 63.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.194 0.521 . . . . 73.51 109.832 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.27 78.1 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 75.25 110.251 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 34.6 ttp180 -61.79 -45.57 93.28 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.943 -0.762 . . . . 75.34 108.943 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 -49.56 76.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.066 -0.97 . . . . 74.24 110.555 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 40' ' ' LEU . 46.4 tp -64.62 -35.35 80.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.568 . . . . 71.34 111.948 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.9 -36.35 83.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.381 0.61 . . . . 70.22 109.941 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.66 -39.81 84.51 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.558 -0.746 . . . . 73.3 109.203 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 21.2 m-85 -57.18 -50.56 72.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.548 -0.751 . . . . 72.4 112.46 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 pt -65.34 -35.14 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.069 -0.652 . . . . 73.21 111.284 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -67.46 -37.82 83.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.831 0.348 . . . . 55.44 111.116 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.03 -34.77 76.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.217 -0.447 . . . . 64.33 112.079 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 66.1 mm-40 -81.78 -13.63 57.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.989 -0.55 . . . . 73.02 110.986 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 31.12 18.82 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.693 -0.685 . . . . 70.12 112.254 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -104.74 177.21 4.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.859 -0.423 . . . . 74.53 109.859 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.536 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.7 pt20 -147.8 176.58 10.01 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.735 -0.469 . . . . 72.3 109.735 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.463 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.8 t -156.29 179.11 9.56 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.911 -1.515 . . . . 71.33 106.911 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.06 122.22 36.58 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 118.15 0.432 . . . . 74.24 110.567 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.4 17.15 Favored Glycine 0 N--CA 1.416 -2.656 0 N-CA-C 110.131 -1.187 . . . . 75.0 110.131 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -112.52 149.38 32.76 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.825 -1.176 . . . . 72.33 107.825 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 90' ' ' ALA . 8.0 p -89.39 134.45 28.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.651 -0.5 . . . . 73.1 109.651 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.28 120.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.754 0.787 . . . . 51.15 111.173 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' SER . 98.6 t -105.58 132.35 52.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.375 -1.713 . . . . 64.12 106.375 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.71 130.96 54.29 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 110.143 -0.317 . . . . 74.5 110.143 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -100.37 114.39 27.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.981 -1.859 . . . . 75.21 105.981 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -142.93 166.95 23.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 112.113 0.412 . . . . 72.34 112.113 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -102.03 164.61 11.62 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.407 1.098 . . . . 65.22 113.025 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.4 m -151.04 116.17 5.31 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.141 -1.845 . . . . 70.34 106.885 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.4 m -59.35 -21.84 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.692 0.797 . . . . 54.14 112.43 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.62 -16.11 54.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.695 0.76 . . . . 75.42 110.681 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.2 tp -97.52 140.96 31.17 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.029 -1.471 . . . . 65.43 107.029 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -121.69 163.14 19.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.298 -0.961 . . . . 71.15 111.172 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.579 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 44.9 m -45.78 124.32 5.11 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.645 1.978 . . . . 61.53 115.26 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.1 -27.55 16.92 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.583 -1.189 . . . . 62.02 110.506 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.13 136.74 35.09 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.317 -0.994 . . . . 63.13 108.317 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -147.78 160.67 42.49 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.733 -1.58 . . . . 74.4 106.733 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -141.29 150.3 42.37 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.821 0.344 . . . . 65.31 110.979 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.461 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.51 125.77 50.59 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.098 -1.445 . . . . 61.35 107.098 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.623 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -123.28 115.24 21.37 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 110.138 -0.319 . . . . 73.21 110.138 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.09 124.34 7.63 Favored Glycine 0 C--N 1.289 -2.078 0 N-CA-C 111.855 -0.498 . . . . 64.21 111.855 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -140.64 160.19 40.56 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 122.623 0.369 . . . . 54.15 111.028 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 59' ' ' PRO . 61.8 t -105.95 127.85 60.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.783 0.325 . . . . 62.54 110.164 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -135.48 101.85 10.81 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 108.189 -1.041 . . . . 74.23 108.189 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.52 -2.93 9.25 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.218 1.945 . . . . 71.41 111.644 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.05 66.86 2.17 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-O 121.678 0.751 . . . . 73.12 109.523 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 t -135.05 131.52 52.7 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 113.929 -1.487 . . . . 64.33 107.913 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.72 146.44 53.77 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.851 -0.796 . . . . 74.14 108.851 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -147.07 144.2 28.9 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.444 -0.902 . . . . 74.42 112.518 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 106.115 -1.809 . . . . 70.32 106.115 173.27 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 120.951 0.405 . . . . 72.34 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.94 145.76 16.18 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 109.596 -1.402 . . . . 52.45 109.596 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -91.78 85.08 5.52 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.717 0.77 . . . . 74.1 110.129 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -101.26 93.59 5.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.606 -1.257 . . . . 75.23 107.606 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -82.38 113.92 20.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.049 0.452 . . . . 71.53 110.393 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -134.39 113.15 11.59 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.868 -0.79 . . . . 55.22 108.868 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 tp -84.73 90.76 7.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.282 -1.007 . . . . 74.33 108.282 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.64 136.57 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 120.851 -0.339 . . . . 73.02 110.191 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -94.85 116.32 28.57 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.745 -0.382 . . . . 71.5 110.278 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 99' ' ' GLN . 30.4 mtm105 -137.98 72.69 1.42 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.815 -0.629 . . . . 72.55 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.42 91.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 122.652 1.215 . . . . 70.24 109.602 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.84 -173.72 3.45 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.455 -1.248 . . . . 64.05 108.29 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -89.88 -92.67 0.12 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 114.299 1.222 . . . . 74.22 114.299 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HD3' ' CG ' ' A' ' 95' ' ' GLU . 23.1 tptm -178.53 141.12 0.21 Allowed 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.325 -0.62 . . . . 71.31 109.325 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.21 -174.11 2.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.838 -0.801 . . . . 74.34 108.838 173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.74 135.22 44.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.559 -2.015 . . . . 65.34 105.559 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.7 151.75 44.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.745 -0.782 . . . . 74.34 109.39 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -76.79 98.98 4.98 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.448 0.642 . . . . 70.44 109.467 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -97.6 139.92 18.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 121.871 0.843 . . . . 43.43 111.797 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.4 170.67 32.86 Favored Glycine 1 N--CA 1.382 -4.911 0 N-CA-C 105.497 -3.041 . . . . 71.03 105.497 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.9 m-20 -115.27 19.92 15.24 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 110.04 -0.356 . . . . 72.21 110.04 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -53.36 -60.62 3.07 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.916 0.71 . . . . 45.44 112.916 -174.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.97 -31.67 69.5 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.191 0.519 . . . . 75.4 110.276 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.96 -51.34 64.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.326 -0.852 . . . . 72.13 111.245 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 5.8 ppt_? -71.22 -26.46 62.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.092 0.775 . . . . 73.22 113.092 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 22' ' ' ALA . 86.5 mt -68.03 -54.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.365 . . . . 71.13 110.074 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -79.68 -1.58 38.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.637 0.606 . . . . 74.24 112.637 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.35 16.08 68.8 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-O 121.165 0.314 . . . . 70.42 112.362 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.03 -1.39 87.77 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 121.439 -0.41 . . . . 70.32 112.862 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.8 m -69.5 -25.03 63.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.554 0.693 . . . . 71.14 110.367 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.1 mm -124.18 122.68 64.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.439 -1.689 . . . . 63.1 106.439 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 34' ' ' GLN . 55.5 t -85.93 122.3 72.82 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.83 -0.804 . . . . 73.33 108.83 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.45 -24.57 44.42 Favored 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.376 2.718 . . . . 72.44 113.091 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.473 ' H ' HG12 ' A' ' 32' ' ' VAL . 35.1 tt0 -67.99 -11.28 58.56 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.026 0.441 . . . . 63.32 111.625 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.85 -36.93 82.65 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.1 -1.074 . . . . 74.4 108.1 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -70.22 -44.7 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.11 -0.95 . . . . 75.33 109.287 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.57 -43.12 75.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.962 0.505 . . . . 72.44 110.614 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.82 87.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.941 -1.027 . . . . 70.53 111.0 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.92 -37.52 81.78 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.861 0.689 . . . . 74.22 112.861 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.19 -46.49 90.24 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.987 -0.285 . . . . 73.33 111.579 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -73.4 -28.87 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.627 -0.429 . . . . 61.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -66.7 -45.86 77.41 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.373 -0.376 . . . . 64.14 110.706 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.12 -35.3 80.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.749 0.309 . . . . 73.52 110.332 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.14 77.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 54.33 110.537 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.99 71.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.647 -0.706 . . . . 73.02 110.904 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.59 -44.72 73.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.716 -0.674 . . . . 62.01 110.987 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.84 15.36 37.71 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.99 -0.55 . . . . 52.15 114.222 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 48' ' ' ILE . 11.4 mm -62.35 123.23 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.388 0.614 . . . . 74.54 111.504 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 57.2 mt-30 -116.4 145.24 43.39 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 115.092 -0.958 . . . . 62.45 110.704 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -65.46 125.0 23.79 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 75.11 110.749 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' OE1' ' A' ' 52' ' ' GLN . 13.9 tp -144.82 -164.34 1.9 Allowed 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 103.65 -2.722 . . . . 71.04 103.65 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' OE1' ' HG ' ' A' ' 51' ' ' LEU . 27.2 mp0 -44.64 148.21 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.065 0.848 . . . . 71.42 111.737 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.68 -20.37 66.05 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.615 -0.326 . . . . 74.31 112.828 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 -9.37 41.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.079 0.4 . . . . 54.4 112.079 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.7 ptp180 -157.6 125.3 5.3 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 121.614 0.721 . . . . 72.41 112.062 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.22 151.54 19.41 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.769 -0.65 . . . . 53.42 110.063 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 tm? -86.77 127.96 35.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 61.12 107.18 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.68 158.78 44.54 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 123.448 0.468 . . . . 71.11 110.479 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HA ' HG22 ' A' ' 125' ' ' VAL . 25.9 Cg_exo -65.68 162.76 33.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.936 2.424 . . . . 72.42 111.912 175.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.07 -26.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.959 -0.564 . . . . 74.34 111.692 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -100.88 107.2 18.66 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.82 -0.808 . . . . 73.53 108.82 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 87.3 m-85 -110.37 114.8 28.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.502 -0.772 . . . . 74.35 110.507 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.69 111.33 34.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.844 -1.169 . . . . 74.2 107.844 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.29 121.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.193 -1.04 . . . . 53.14 108.193 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -113.5 124.8 53.25 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.656 -0.418 . . . . 64.43 110.307 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -108.2 162.83 13.71 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 62.05 108.905 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.51 150.17 51.72 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 109.625 -1.39 . . . . 23.54 109.625 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.32 -38.47 69.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 117.575 0.687 . . . . 70.32 111.741 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 39.0 t60 -73.44 -25.03 60.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.59 -0.522 . . . . 74.12 109.59 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.581 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 18.0 m-20 -79.3 -31.73 43.35 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.483 -0.326 . . . . 75.32 111.457 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.96 -33.75 72.35 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.376 -0.829 . . . . 75.34 108.916 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.48 -33.56 68.12 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.636 -0.711 . . . . 54.35 112.683 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -78.4 -30.02 47.55 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.727 -0.608 . . . . 72.33 110.498 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 66' ' ' LEU . 75.1 mt -63.16 -36.78 84.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.347 0.594 . . . . 72.31 110.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.62 -163.09 25.52 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 115.483 -0.78 . . . . 45.21 111.604 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.42 -30.98 14.8 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.287 0.565 . . . . 71.01 109.918 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.41 128.77 25.3 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.946 -0.57 . . . . 64.2 109.563 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.14 -27.23 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.213 1.942 . . . . 63.12 111.287 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.37 -53.74 33.35 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.022 1.729 . . . . 63.33 115.1 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.11 -31.25 72.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.249 0.547 . . . . 74.24 110.724 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -77.09 -34.94 56.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.649 -0.705 . . . . 71.11 109.525 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 42.5 m -65.22 -54.03 35.66 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.403 -0.817 . . . . 75.14 110.441 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 m -62.01 -38.61 89.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.664 -0.698 . . . . 73.44 111.166 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 116.024 -0.535 . . . . 71.02 112.323 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.706 -0.398 . . . . 75.53 110.03 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.055 -0.52 . . . . 61.12 110.204 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -56.84 -53.42 58.06 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.186 -0.916 . . . . 72.51 110.614 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -69.6 -29.59 67.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.018 -0.992 . . . . 74.03 111.965 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.02 -35.51 61.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -62.63 -37.93 88.23 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.741 0.781 . . . . 44.04 109.58 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.23 -47.6 81.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.728 -1.124 . . . . 63.53 109.608 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.6 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -54.91 -48.47 73.04 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.978 0.733 . . . . 65.12 112.978 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.07 -31.64 54.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.098 -0.641 . . . . 74.24 111.737 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 25.9 mt-30 -64.28 -45.42 88.12 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.837 -0.431 . . . . 65.43 109.837 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' CG ' ' HD3' ' A' ' 14' ' ' LYS . 2.4 mm-40 -58.04 -41.77 83.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.32 1.013 . . . . 70.54 111.903 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 75.5 mm-40 -74.74 -14.36 60.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.935 0.346 . . . . 72.3 111.935 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.95 29.0 48.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.246 -0.502 . . . . 53.13 112.064 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -104.62 157.31 17.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.201 -0.666 . . . . 63.44 109.201 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.516 ' HA ' ' NH2' ' A' ' 10' ' ' ARG . 24.1 pt20 -128.33 166.08 19.34 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.006 -0.678 . . . . 72.14 110.118 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -155.07 176.57 12.37 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.387 -1.338 . . . . 75.42 107.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 46.2 m-85 -118.37 120.83 38.78 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.538 -0.542 . . . . 72.54 109.538 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.68 -151.22 17.09 Favored Glycine 0 C--O 1.253 1.321 0 N-CA-C 108.23 -1.948 . . . . 74.52 108.23 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -128.06 162.81 25.99 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.986 0.893 . . . . 73.12 108.646 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.1 t -78.57 121.78 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.094 0.473 . . . . 71.33 111.184 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.46 120.83 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.366 -0.834 . . . . 33.12 110.047 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 82' ' ' SER . 59.8 t -116.62 127.77 74.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.068 -1.456 . . . . 72.14 107.068 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 -121.49 152.49 39.08 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.538 -0.465 . . . . 74.52 109.747 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.31 114.41 22.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.916 -1.142 . . . . 73.45 107.916 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.14 170.95 10.71 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.342 -0.543 . . . . 73.12 112.07 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.47 159.19 17.25 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.401 -0.818 . . . . 73.21 110.722 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 m -152.24 138.83 18.7 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 123.97 0.908 . . . . 72.24 109.422 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -81.0 -18.34 47.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.207 -1.035 . . . . 72.05 108.207 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -65.61 -26.69 67.95 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.318 1.447 . . . . 71.41 110.035 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.0 mt -101.24 128.31 47.43 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.721 -0.672 . . . . 71.22 109.832 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -88.1 164.05 15.91 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.468 -0.787 . . . . 72.14 109.975 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.475 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 16.0 m -55.28 123.13 12.8 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.891 0.744 . . . . 72.05 111.967 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.16 -20.9 30.06 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.293 -0.723 . . . . 44.41 111.293 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.22 139.71 35.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.481 0.657 . . . . 73.31 111.709 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 66' ' ' LEU . 29.6 p90 -147.7 160.16 43.01 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.715 -1.217 . . . . 74.43 107.715 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 146.55 43.77 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.176 -1.046 . . . . 75.41 108.176 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.52 149.45 34.34 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.548 -0.908 . . . . 72.5 108.548 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 64.5 ttt180 -143.26 124.37 14.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.263 -0.273 . . . . 74.13 110.263 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.15 100.25 0.8 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 110.198 -1.161 . . . . 34.14 110.198 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -111.67 147.88 34.58 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 109.713 -0.477 . . . . 73.24 109.713 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.2 t -87.29 113.98 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 108.152 -1.055 . . . . 63.32 108.152 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -126.06 99.69 31.23 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 108.344 -0.984 . . . . 70.13 108.344 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 57.8 Cg_endo -72.94 -19.34 23.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.919 1.746 . . . . 51.34 111.377 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.41 67.17 3.42 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.711 0.767 . . . . 73.43 110.509 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 110.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-N 114.32 -1.309 . . . . 65.22 108.129 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -93.33 131.61 38.32 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.44 -0.948 . . . . 75.52 108.44 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -79.82 179.63 7.45 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.211 -0.904 . . . . 72.54 110.903 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 . . . . . 0 N--CA 1.419 -1.983 0 N-CA-C 109.762 -0.458 . . . . 74.15 109.762 178.717 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 108.909 -0.774 . . . . 73.43 108.909 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.76 147.6 18.74 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 110.608 -0.997 . . . . 73.44 110.608 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 m -88.84 155.83 19.3 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.866 -0.791 . . . . 53.31 108.866 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -96.66 -32.1 12.37 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.818 -0.808 . . . . 62.35 108.818 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -79.6 108.42 13.13 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.792 -1.188 . . . . 62.1 107.792 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -88.42 107.74 19.01 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.23 0.538 . . . . 73.11 111.254 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -131.25 118.94 21.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.74 -0.664 . . . . 73.14 109.408 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.43 131.47 42.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.898 -0.778 . . . . 70.03 108.898 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -108.6 100.77 9.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.202 -0.453 . . . . 73.12 110.163 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -83.49 124.57 30.85 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.077 -0.511 . . . . 71.23 109.848 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.79 136.13 35.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.278 -0.569 . . . . 60.25 110.137 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -94.91 116.45 28.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.864 -1.161 . . . . 73.43 107.864 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -142.48 141.0 32.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.107 -0.701 . . . . 75.41 109.107 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.21 127.01 45.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.4 -1.333 . . . . 72.03 107.4 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -93.71 -76.49 0.47 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.633 -0.427 . . . . 54.14 111.745 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.64 -179.96 6.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.127 0.571 . . . . 64.11 109.926 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.21 99.72 10.73 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.837 -1.542 . . . . 60.14 106.837 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -57.67 124.1 17.92 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.341 -1.3 . . . . 54.41 113.832 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.0 t -101.67 104.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.51 -1.663 . . . . 65.53 106.51 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.4 -75.27 1.15 Allowed Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.665 -0.779 . . . . 74.24 114.503 -172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -44.72 -46.43 10.37 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.003 1.483 . . . . 74.35 115.003 -173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 -59.22 5.25 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.965 0.791 . . . . 73.44 111.636 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.91 -36.72 78.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.832 -0.622 . . . . 71.41 111.044 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 71.24 111.609 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -74.63 -36.01 62.9 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.812 0.671 . . . . 54.43 112.812 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.43 -44.25 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.149 0.499 . . . . 71.33 110.523 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -77.97 -15.57 58.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.564 0.579 . . . . 73.54 112.564 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.13 45.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.853 -0.689 . . . . 25.44 111.484 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.16 -29.34 6.08 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.696 -0.252 . . . . 62.5 112.994 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 t -91.61 82.49 5.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.612 0.72 . . . . 71.11 110.075 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.34 109.87 26.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.665 -1.606 . . . . 71.22 106.665 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -119.64 88.18 38.67 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 118.941 -1.103 . . . . 74.34 113.332 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' OE1' ' A' ' 34' ' ' GLN . 12.2 Cg_exo -76.21 -40.76 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.206 1.937 . . . . 52.43 110.5 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' OE1' ' HD2' ' A' ' 33' ' ' PRO . 1.3 mp0 -49.87 -52.23 34.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.444 1.098 . . . . 63.1 111.302 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -56.69 -47.67 79.35 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.082 -0.963 . . . . 75.44 110.37 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.96 -50.9 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.262 -0.881 . . . . 63.03 110.405 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.9 pp20? -64.4 -38.4 90.91 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.589 0.588 . . . . 72.42 112.589 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.08 92.48 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.802 0.334 . . . . 32.21 110.632 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -72.87 -37.58 67.29 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.238 -1.023 . . . . 64.41 108.238 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.09 -44.79 96.82 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 72.45 110.582 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.0 ptt85 -73.74 -21.86 60.06 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.96 0.409 . . . . 73.31 111.635 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 43.0 tpt85 -73.09 -31.19 64.2 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.171 -0.677 . . . . 74.43 109.171 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 52.0 mm-40 -68.21 -38.7 82.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.517 -0.765 . . . . 72.21 109.835 173.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.62 -46.52 88.74 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.443 -0.799 . . . . 60.23 109.734 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.29 65.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.788 -0.642 . . . . 62.11 111.386 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 31.2 t70 -77.77 -41.19 38.34 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.931 0.345 . . . . 71.24 111.931 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.03 25.89 19.64 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 120.227 -0.987 . . . . 70.24 113.803 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.77 137.02 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.702 0.401 . . . . 52.1 111.345 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.1 mt-30 -122.91 143.51 49.84 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.823 -0.626 . . . . 61.25 110.397 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -79.19 92.32 5.07 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.847 -1.07 . . . . 73.22 111.687 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 HD23 ' A' ' 57' ' ' LEU . 11.9 tp -102.38 -165.48 1.19 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.781 -1.933 . . . . 64.41 105.781 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.3 mm-40 -48.57 146.89 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.888 0.767 . . . . 72.14 112.214 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.9 32.89 1.25 Allowed Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.117 -0.947 . . . . 41.4 113.348 -173.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 52' ' ' GLN . 71.9 m-20 -99.85 -37.01 9.23 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.643 -1.614 . . . . 71.03 106.643 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -172.97 149.87 1.94 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.491 -1.231 . . . . 71.43 110.294 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.37 151.79 21.29 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.964 0.506 . . . . 73.35 110.564 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.572 HD23 HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -87.21 127.7 35.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 -175.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.11 158.17 46.92 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 123.11 0.564 . . . . 61.01 111.063 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.621 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 88.6 Cg_exo -54.86 145.16 63.32 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.948 3.099 . . . . 75.33 113.997 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -119.96 -22.6 6.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.313 -0.858 . . . . 61.13 110.292 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.69 108.88 20.61 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.412 0.625 . . . . 74.01 109.684 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.9 m-85 -114.06 117.83 32.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.445 -0.798 . . . . 72.52 109.423 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.95 116.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.192 -1.04 . . . . 74.33 108.192 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.1 mt -110.96 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 107.915 -1.143 . . . . 74.03 107.915 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.7 m -110.33 120.65 43.12 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.866 -0.606 . . . . 74.13 110.971 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.4 mm? -114.69 163.26 15.71 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.3 -0.864 . . . . 74.24 108.809 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.17 169.17 51.35 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 109.274 -1.53 . . . . 62.3 109.274 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.32 -25.7 37.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.595 0.712 . . . . 64.02 110.936 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -57.95 -55.69 31.64 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.824 -1.08 . . . . 73.21 110.001 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.84 -29.49 44.69 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.621 -0.718 . . . . 75.53 111.718 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -63.7 -32.01 73.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.439 -0.346 . . . . 74.2 110.143 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.17 -35.84 78.2 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 123.25 0.62 . . . . 55.15 109.954 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.98 -14.64 55.73 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.235 -0.438 . . . . 75.21 111.22 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.21 -25.04 37.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.652 -0.87 . . . . 54.5 108.652 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.98 -177.26 30.1 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 114.938 -1.028 . . . . 54.23 111.867 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 1.46 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.831 0.452 . . . . 54.42 111.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.7 m-20 -110.0 92.57 13.16 Favored Pre-proline 0 C--O 1.251 1.178 0 N-CA-C 112.331 0.493 . . . . 53.41 112.331 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.84 -37.2 1.72 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.686 1.59 . . . . 64.23 111.096 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.47 -34.33 72.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.26 -0.427 . . . . 55.11 112.14 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.29 -38.06 85.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.194 0.521 . . . . 73.4 109.837 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 43.4 mmtm -77.28 -35.52 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.837 -0.801 . . . . 71.3 108.837 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 t -58.31 -54.14 50.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.713 -1.131 . . . . 65.01 110.023 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.1 m -59.15 -42.33 90.44 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.425 0.69 . . . . 73.32 111.008 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -61.64 6.21 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.011 -0.54 . . . . 52.45 111.974 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -63.03 -30.78 71.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.304 0.854 . . . . 63.12 113.304 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.35 -40.43 89.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.896 -0.322 . . . . 72.41 110.538 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.538 ' O ' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -73.37 -36.88 66.17 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.466 -0.568 . . . . 72.43 109.466 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.25 -41.06 94.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.573 -0.285 . . . . 63.32 110.73 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -42.27 87.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.447 -0.575 . . . . 75.12 109.447 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.46 79.67 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 61.44 109.951 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -64.24 -43.77 93.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.391 -0.822 . . . . 73.25 109.751 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.6 m-85 -58.66 -48.42 81.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 112.662 0.615 . . . . 75.41 112.662 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.99 -29.33 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.733 -0.787 . . . . 74.34 111.247 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.02 -44.24 89.82 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 110.14 -0.318 . . . . 42.22 110.14 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.6 mt-10 -63.91 -38.38 90.88 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.308 0.575 . . . . 74.42 110.797 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.2 mm-40 -79.25 -13.9 59.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.971 -0.559 . . . . 64.23 111.351 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.53 38.37 32.96 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.804 -0.712 . . . . 51.3 112.2 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -107.11 158.0 17.42 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.765 0.317 . . . . 73.12 111.093 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD23 ' A' ' 51' ' ' LEU . 23.2 pt20 -123.01 173.03 8.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.816 0.846 . . . . 73.15 109.087 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.8 t -159.52 177.61 10.76 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.444 -0.502 . . . . 64.52 110.432 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.24 120.99 33.85 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.582 -0.896 . . . . 71.32 108.582 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.24 -164.17 12.48 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.963 -1.655 . . . . 53.42 108.963 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -104.71 156.86 17.62 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.864 -1.532 . . . . 72.12 106.864 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.67 104.18 14.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.985 -1.117 . . . . 63.31 107.985 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.73 120.38 57.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 122.123 0.963 . . . . 74.41 111.676 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 62' ' ' TYR . 10.1 m -104.86 120.03 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 N-CA-C 105.804 -1.925 . . . . 75.23 105.804 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.279 0.0 OUTLIER -117.3 125.4 51.01 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 113.638 0.977 . . . . 72.54 113.638 -174.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -92.47 139.41 30.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.746 -1.57 . . . . 74.33 108.628 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -156.06 161.1 40.46 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.356 -0.609 . . . . 63.44 109.356 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.8 pt20 -104.32 157.99 16.76 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.582 0.706 . . . . 54.45 109.493 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 62.0 m -144.2 133.1 22.61 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.909 -1.041 . . . . 74.13 108.974 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 m -80.9 -11.74 59.53 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.481 0.658 . . . . 53.23 110.098 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -87.99 -5.54 58.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 71.41 109.918 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 1.4 tm? -91.07 120.44 32.04 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.938 -1.875 . . . . 65.33 105.938 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -88.8 153.22 21.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.325 -0.398 . . . . 73.25 110.405 -174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -64.59 134.16 53.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.51 0.672 . . . . 71.32 111.234 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.33 -15.46 42.67 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.412 -1.075 . . . . 74.34 110.412 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -106.08 150.24 25.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.047 -0.723 . . . . 72.44 109.047 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -149.66 151.25 33.42 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.867 -1.901 . . . . 73.41 105.867 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -134.99 144.09 47.18 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 112.56 0.578 . . . . 73.42 112.56 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.79 119.13 10.23 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.701 -1.592 . . . . 64.53 106.701 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.613 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -120.29 120.65 36.67 Favored 'General case' 0 N--CA 1.39 -3.456 0 C-N-CA 123.196 0.598 . . . . 71.35 109.565 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.53 121.54 7.2 Favored Glycine 0 C--N 1.3 -1.452 0 O-C-N 123.593 0.558 . . . . 64.04 112.056 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 p -142.21 148.61 38.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.155 -0.683 . . . . 73.53 109.155 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 5.6 p -95.84 120.54 45.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 119.462 -0.895 . . . . 63.45 110.006 174.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -125.86 98.62 33.46 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.819 -1.082 . . . . 64.24 108.167 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.33 -15.87 15.68 Favored 'Trans proline' 0 CA--C 1.52 -0.221 0 C-N-CA 122.385 2.057 . . . . 75.13 109.892 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.49 22.48 2.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.59 -1.186 . . . . 55.01 109.629 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.32 110.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-O 121.929 0.871 . . . . 71.23 109.089 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.86 139.7 30.4 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.576 -1.193 . . . . 72.25 109.89 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.7 t -142.89 147.45 35.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.548 -1.279 . . . . 60.14 107.548 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 t60 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 109.693 -0.484 . . . . 72.22 109.693 -174.789 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.742 0.306 . . . . 70.44 110.189 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.92 173.36 40.68 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 109.731 -1.348 . . . . 71.43 109.731 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.6 m -82.26 90.44 6.63 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.597 -1.26 . . . . 70.34 107.597 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -72.11 103.81 3.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.109 -0.95 . . . . 73.21 110.234 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -109.2 139.51 44.03 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.256 -0.429 . . . . 73.14 110.14 177.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -134.85 133.61 39.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.257 -1.016 . . . . 74.22 108.257 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.73 101.41 12.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 O-C-N 123.707 0.63 . . . . 63.12 109.303 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -89.75 87.88 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.419 1.104 . . . . 72.12 109.351 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 10.3 mm-40 -81.78 140.49 34.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.087 -1.415 . . . . 74.44 110.846 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -136.44 119.88 16.95 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.825 -1.079 . . . . 62.21 109.987 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -86.41 106.06 15.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.395 0 N-CA-C 108.528 -0.916 . . . . 74.1 108.528 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.619 ' HG3' ' H ' ' A' ' 34' ' ' GLN . 35.4 mm-40 -74.91 96.18 3.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.699 1.237 . . . . 73.21 113.15 -174.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -100.0 77.77 2.04 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 113.644 -1.617 . . . . 72.44 108.07 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -85.99 100.77 12.36 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 105.443 -2.058 . . . . 71.32 105.443 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.97 95.29 2.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 71.53 109.924 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -162.47 147.76 12.45 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.499 -1.667 . . . . 75.11 106.499 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.5 84.3 2.01 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.611 -0.885 . . . . 53.32 108.611 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.8 m -101.52 124.59 47.44 Favored 'General case' 0 N--CA 1.407 -2.616 0 CA-C-N 115.145 -0.934 . . . . 73.24 109.202 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -85.98 88.28 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.499 -1.297 . . . . 71.45 107.499 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.94 45.44 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 109.988 -1.245 . . . . 72.23 109.988 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -74.47 -7.01 51.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.256 0.55 . . . . 72.25 110.549 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.57 ' O ' ' HG2' ' A' ' 25' ' ' ARG . . . -63.8 -35.65 81.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.951 0.881 . . . . 55.33 109.708 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 98.9 m-85 -73.79 -34.19 64.54 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.394 -0.821 . . . . 70.34 109.315 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -65.0 -41.79 95.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.987 -0.551 . . . . 52.3 110.745 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 8.6 ptm180 -67.82 -25.58 65.64 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.705 -0.225 . . . . 75.21 111.279 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.8 mt -86.82 -50.53 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 120.315 -0.554 . . . . 70.33 111.493 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.09 -28.12 64.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.94 0.719 . . . . 72.25 112.94 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.77 -73.05 0.27 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.796 -0.716 . . . . 51.2 112.532 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.19 -35.42 3.4 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.701 -0.761 . . . . 64.24 111.87 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 36.2 t -79.24 139.17 37.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.276 -0.639 . . . . 60.42 109.276 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.9 tt -98.84 -33.13 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.369 0.604 . . . . 43.4 110.309 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.52 118.7 8.25 Favored Pre-proline 0 N--CA 1.428 -1.56 0 N-CA-C 108.89 -0.781 . . . . 54.22 108.89 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.14 95.74 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.261 1.307 . . . . 64.35 110.102 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.619 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 49.8 tt0 -91.32 -3.66 56.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.743 -0.662 . . . . 53.34 110.443 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.87 -32.77 73.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.445 -1.317 . . . . 74.13 107.445 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' HD23 ' A' ' 40' ' ' LEU . 30.7 t -61.3 -49.89 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 114.466 -1.243 . . . . 73.31 109.619 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 30.6 mt-10 -57.69 -47.11 83.26 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.581 -0.448 . . . . 74.53 110.734 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.88 35.56 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.69 0.619 . . . . 65.32 111.878 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.74 -29.35 66.68 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.216 0.45 . . . . 73.21 112.216 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 36' ' ' VAL . 4.0 mm? -70.55 -39.55 73.92 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.176 0.436 . . . . 70.43 112.176 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 58.7 mtp180 -66.13 -33.42 75.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.977 -1.12 . . . . 72.25 107.977 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -49.29 62.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.434 -1.257 . . . . 73.44 108.948 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.54 -37.8 85.11 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.98 0.512 . . . . 72.22 112.136 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -58.77 -45.82 88.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.998 -0.546 . . . . 41.1 110.117 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.06 64.66 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.549 0.69 . . . . 75.14 111.066 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.07 -32.61 73.9 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 63.53 111.043 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.86 72.61 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.97 -0.633 . . . . 62.24 113.285 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 98' ' ' TRP . 17.7 mm -64.45 131.31 30.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.547 0.689 . . . . 54.11 111.949 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 80.5 mt-30 -119.39 144.82 46.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.272 -0.876 . . . . 74.23 110.535 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.6 m -80.63 98.28 7.6 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.845 -1.07 . . . . 73.44 109.992 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.645 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.3 tp -101.91 -165.38 1.18 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.935 -1.506 . . . . 75.23 106.935 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.645 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 48.4 mt-30 -56.19 160.77 2.76 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.493 0.717 . . . . 72.14 111.395 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 4.75 8.17 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.461 -0.79 . . . . 61.51 114.397 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.32 -46.57 60.33 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.913 -1.143 . . . . 72.53 107.913 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -179.51 167.21 1.44 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.002 0.921 . . . . 73.04 110.716 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.56 151.39 21.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.059 0.457 . . . . 71.44 111.698 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.4 tm? -90.63 128.3 36.56 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.366 -0.976 . . . . 44.53 108.366 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.41 158.0 45.98 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 123.58 0.752 . . . . 45.53 109.433 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.8 Cg_exo -61.06 157.93 36.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 72.53 112.628 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -119.8 -33.3 4.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.934 -0.575 . . . . 71.1 110.695 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -103.66 114.65 29.07 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.651 -0.5 . . . . 74.32 109.651 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 70.8 m-85 -109.51 119.34 39.12 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.669 -0.696 . . . . 72.53 109.912 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -109.23 118.5 56.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 115.284 -0.871 . . . . 75.12 109.545 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.79 119.98 61.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.934 -1.136 . . . . 71.22 107.934 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -109.57 128.25 55.07 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.98 -0.555 . . . . 74.1 109.771 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.6 mm? -115.49 170.58 8.31 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.344 1.058 . . . . 71.2 109.674 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.99 169.03 54.43 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 109.508 -1.437 . . . . 74.0 109.508 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.86 -48.53 83.62 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 117.472 0.636 . . . . 75.3 111.681 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -65.03 -40.44 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 72.14 109.477 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.628 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.0 m-20 -69.48 -34.2 73.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.22 -1.355 . . . . 64.44 110.698 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.81 -36.92 85.48 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.72 0.771 . . . . 75.0 109.104 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.69 -25.22 64.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.757 -0.656 . . . . 73.2 111.262 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -77.91 -22.08 50.19 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.387 -0.195 . . . . 75.42 110.482 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.28 -38.36 71.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.157 -0.683 . . . . 71.13 109.157 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.31 -171.89 29.43 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.056 -1.068 . . . . 64.41 111.841 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.57 -31.08 18.81 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.939 -0.763 . . . . 62.33 108.939 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -131.73 81.81 62.43 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.217 -0.901 . . . . 74.44 110.548 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.74 -18.7 47.77 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.801 2.334 . . . . 51.15 112.274 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.01 -22.62 64.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.76 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.33 -45.67 92.16 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.88 -0.785 . . . . 55.03 108.88 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HD2' ' CE1' ' A' ' 23' ' ' PHE . 63.3 tttp -72.13 -31.27 65.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.731 -1.122 . . . . 64.13 110.437 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.7 m -60.42 -43.53 96.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.42 -0.355 . . . . 73.31 111.224 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.4 m -65.4 -45.44 83.95 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.761 0.315 . . . . 71.44 111.165 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.87 93.6 Favored Glycine 0 C--O 1.244 0.733 0 C-N-CA 120.715 -0.755 . . . . 52.25 111.65 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -68.25 -32.59 72.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.279 -0.46 . . . . 63.33 110.247 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -62.15 -43.1 99.57 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.893 0.378 . . . . 73.25 110.514 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.78 -39.02 92.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 74.32 109.162 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -71.09 -41.32 70.77 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.305 -0.407 . . . . 65.13 111.183 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.04 -38.06 85.19 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.555 -0.535 . . . . 70.41 109.555 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.76 87.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.494 0.664 . . . . 75.11 109.536 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -37.41 84.38 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.95 -1.023 . . . . 62.54 110.127 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.6 m-85 -60.59 -48.02 83.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.192 -0.458 . . . . 71.33 111.903 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -69.69 -31.16 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 119.959 -0.697 . . . . 75.21 111.544 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.93 -41.14 91.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.808 -0.441 . . . . 72.33 109.808 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 33.2 tt0 -57.29 -36.85 71.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 125.329 1.452 . . . . 65.01 110.331 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -85.62 -9.04 57.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 75.41 111.052 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.29 29.8 57.85 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 116.025 -0.534 . . . . 75.15 113.016 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.473 ' CD2' HD11 ' A' ' 48' ' ' ILE . 20.0 m0 -96.19 156.9 16.14 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.594 -0.442 . . . . 64.34 110.457 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' OE1' HD23 ' A' ' 51' ' ' LEU . 5.0 pt20 -119.07 169.49 9.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.031 -0.359 . . . . 61.52 110.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -159.83 176.31 12.07 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.935 -0.765 . . . . 75.13 108.935 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.77 122.04 43.31 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.105 -1.072 . . . . 64.32 108.105 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.1 17.14 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.863 -1.16 . . . . 75.21 110.783 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -130.91 151.63 51.12 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.667 -0.864 . . . . 63.42 108.667 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.51 119.2 18.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.558 0.694 . . . . 71.11 111.335 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.14 131.63 65.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.024 -0.732 . . . . 64.11 109.024 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.1 p -137.33 141.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.514 -1.291 . . . . 74.02 107.514 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -145.06 155.96 43.65 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.455 -0.498 . . . . 73.51 110.184 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.36 127.9 53.21 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.005 -1.109 . . . . 74.41 108.005 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.06 167.83 18.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.712 -0.222 . . . . 64.33 110.46 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -116.47 158.95 22.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.865 0.365 . . . . 63.21 110.324 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 t -145.01 140.25 28.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.906 -1.146 . . . . 53.33 107.906 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 -10.38 59.74 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.585 -0.524 . . . . 70.33 109.585 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -79.38 -27.25 41.88 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.176 -0.465 . . . . 63.3 110.289 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.24 135.58 33.38 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 115.84 -0.618 . . . . 72.11 109.919 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -99.33 157.07 16.66 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.952 -0.759 . . . . 72.41 108.952 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.628 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 57.4 m -53.94 126.62 23.1 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 124.458 1.099 . . . . 73.11 112.109 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.1 28.94 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-N 115.092 -0.958 . . . . 73.55 111.675 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -104.36 139.6 39.09 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.82 -0.437 . . . . 70.01 109.82 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' HD13 ' A' ' 66' ' ' LEU . 42.9 p90 -143.04 157.89 44.11 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.652 -1.24 . . . . 71.4 107.652 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 134.81 31.39 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.663 -0.866 . . . . 73.24 108.663 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.32 139.35 48.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.936 -1.505 . . . . 63.24 106.936 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -139.44 119.13 13.15 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.974 0.416 . . . . 71.13 110.243 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.4 127.21 8.77 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.263 -1.135 . . . . 71.42 110.263 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.0 p -127.46 145.31 50.88 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.205 0.526 . . . . 72.2 111.57 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.5 t -98.09 108.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.433 -0.951 . . . . 63.44 108.433 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -114.48 97.91 47.66 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 109.262 -0.644 . . . . 73.33 109.262 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.04 -8.76 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.993 1.796 . . . . 64.03 111.931 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -98.61 77.02 2.26 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-O 122.775 1.274 . . . . 72.54 108.621 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.75 139.93 50.34 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.385 0 CA-C-N 112.662 -2.063 . . . . 74.13 106.891 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.71 98.85 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.638 1.208 . . . . 63.1 110.551 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -70.83 116.6 11.33 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.17 -1.377 . . . . 72.22 110.322 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 C--N 1.295 -1.778 0 CA-C-N 115.314 -0.857 . . . . 64.41 108.933 -179.761 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 CA--C 1.505 -0.752 0 N-CA-C 108.132 -1.062 . . . . 64.11 108.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.59 7.3 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.615 -1.394 . . . . 53.2 109.615 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -82.18 157.99 23.76 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 108.759 -0.83 . . . . 63.13 108.759 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -143.33 143.05 31.52 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.524 -1.658 . . . . 74.5 106.524 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -78.71 77.26 5.19 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.335 1.541 . . . . 65.23 111.015 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -84.04 146.72 27.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.781 -2.009 . . . . 71.33 107.054 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.27 118.21 11.81 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.801 -0.815 . . . . 55.13 108.801 172.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 99' ' ' GLN . 24.2 m -119.54 145.79 25.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.068 -0.653 . . . . 73.54 111.206 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -126.44 177.21 6.61 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.694 -1.224 . . . . 75.52 107.694 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -134.08 96.91 3.73 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.603 -1.629 . . . . 74.21 106.603 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -66.34 148.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.836 -0.62 . . . . 73.5 110.664 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 59.87 76.77 0.35 Allowed 'General case' 0 C--O 1.242 0.689 0 O-C-N 124.496 1.123 . . . . 65.1 108.887 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -78.5 72.82 5.05 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.887 0.851 . . . . 73.11 113.225 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.22 95.42 5.95 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.125 -1.065 . . . . 74.32 108.125 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' H ' HD23 ' A' ' 15' ' ' LEU . 1.9 pt? -112.18 94.4 4.92 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.604 -1.258 . . . . 74.32 107.604 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.76 122.31 30.48 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.735 -1.12 . . . . 74.01 109.345 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -49.7 117.21 2.13 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.403 -1.271 . . . . 71.13 113.895 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.8 m -72.31 123.37 22.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.418 -0.956 . . . . 75.4 108.418 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.58 145.84 19.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.554 -0.906 . . . . 64.34 108.554 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.42 42.39 1.6 Allowed Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 121.098 -0.572 . . . . 53.34 112.177 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.44 -38.28 74.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.701 0.763 . . . . 73.34 110.556 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.54 89.31 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.99 -1.005 . . . . 53.53 108.472 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' PHE . 7.4 m-85 -62.68 -44.56 95.94 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.762 -1.108 . . . . 75.34 109.511 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.85 -49.37 71.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.855 -0.611 . . . . 73.14 111.723 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -76.51 -33.53 58.62 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 112.723 0.638 . . . . 75.52 112.723 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -71.29 -44.05 73.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 121.068 -0.253 . . . . 63.33 111.608 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' HD2' ' O ' ' A' ' 23' ' ' PHE . 80.6 m-85 -77.02 -29.76 55.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.927 -0.309 . . . . 74.31 111.19 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.27 -90.13 0.05 OUTLIER Glycine 0 C--O 1.242 0.656 0 O-C-N 123.913 0.758 . . . . 74.25 114.841 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.76 -48.85 32.41 Favored Glycine 0 CA--C 1.495 -1.218 0 CA-C-N 115.344 -0.428 . . . . 63.14 112.486 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 t -89.39 82.6 6.44 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.43 -1.693 . . . . 74.34 106.43 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 tp -67.58 105.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.909 -1.496 . . . . 72.22 113.216 -173.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 35' ' ' GLU . 58.7 t -126.23 88.79 53.64 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.811 -0.811 . . . . 71.25 108.811 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 34' ' ' GLN . 57.9 Cg_endo -103.57 -34.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 122.131 1.887 . . . . 63.4 115.596 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 25.0 mm-40 -143.02 25.48 1.76 Allowed 'General case' 0 C--O 1.254 1.31 0 CA-C-O 121.682 0.753 . . . . 71.21 109.185 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' HB2' HG13 ' A' ' 32' ' ' VAL . 13.4 mm-40 -82.05 -37.11 26.94 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.499 -0.773 . . . . 70.11 110.639 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 40' ' ' LEU . 97.5 t -61.01 -49.8 83.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 115.868 -0.605 . . . . 71.22 109.589 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -58.01 -47.8 81.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.528 0.731 . . . . 64.53 110.887 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.61 82.58 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.17 -0.923 . . . . 73.43 111.856 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.14 -31.54 58.66 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.399 0.518 . . . . 64.14 112.399 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 36' ' ' VAL . 5.6 mp -62.52 -42.57 99.6 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.397 0.147 . . . . 61.22 111.397 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.75 -28.51 62.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.597 -0.841 . . . . 75.42 110.342 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -63.36 -44.31 95.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.985 -0.552 . . . . 64.24 109.712 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -71.31 -32.54 68.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 75.01 111.488 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.15 93.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 63.23 109.631 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.61 -24.83 61.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.689 -0.687 . . . . 73.54 111.074 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.52 -38.13 74.2 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.155 0.982 . . . . 62.13 110.208 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.72 42.97 1.78 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.568 -0.742 . . . . 70.33 112.788 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 45' ' ' ALA . 19.6 mm -81.92 138.08 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.958 0.503 . . . . 64.1 110.696 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 2.0 mp0 -120.3 146.44 46.11 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 123.066 0.547 . . . . 70.44 109.697 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.0 m -73.46 120.81 19.58 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 124.175 0.922 . . . . 73.33 109.407 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.7 tp -127.19 -170.66 2.26 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 103.733 -2.692 . . . . 64.35 103.733 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 62.0 mt-30 -55.54 148.87 14.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.148 0.885 . . . . 63.04 110.007 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.33 -5.48 8.36 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 115.08 0.792 . . . . 52.05 115.08 -171.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -66.35 -38.6 88.0 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.391 -0.596 . . . . 74.21 109.391 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -171.09 152.65 3.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.901 -0.59 . . . . 74.11 111.266 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -91.94 151.71 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.26 0.624 . . . . 74.11 111.275 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 100' ' ' THR . 41.9 tp -88.98 125.87 35.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.672 -0.695 . . . . 42.1 109.147 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.05 165.87 12.28 Favored Pre-proline 0 C--N 1.283 -2.288 0 C-N-CA 124.421 1.088 . . . . 65.3 108.634 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 125' ' ' VAL . 28.7 Cg_exo -64.98 159.08 48.13 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.545 2.164 . . . . 73.12 111.673 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -115.97 -30.67 5.98 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.71 -0.396 . . . . 74.22 111.349 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 46.4 tt0 -104.04 127.71 51.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.353 -0.98 . . . . 71.51 108.353 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 106' ' ' VAL . 64.4 m-85 -123.34 114.83 20.71 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.772 -0.455 . . . . 72.0 109.772 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -97.9 110.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.755 -0.832 . . . . 65.51 108.755 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.8 115.57 48.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.6 -0.727 . . . . 72.22 109.21 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 m -109.53 123.42 49.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.527 -0.306 . . . . 72.22 110.525 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -117.22 -176.99 3.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.877 1.271 . . . . 71.5 109.183 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.7 -174.09 42.84 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 108.885 -1.686 . . . . 42.31 108.885 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.583 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.4 p -69.54 -58.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 118.321 1.06 . . . . 72.1 113.652 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.627 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 22.1 t-80 -55.77 -51.56 66.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.866 0.841 . . . . 72.41 110.068 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -65.19 -31.22 72.29 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.483 -1.235 . . . . 75.13 113.872 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -68.49 -43.58 76.58 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.409 -0.517 . . . . 71.54 110.596 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 37.4 mt-10 -62.97 -38.45 91.16 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.837 0.827 . . . . 73.43 110.092 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 12.4 mptt -80.82 -16.02 54.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.059 -0.973 . . . . 73.43 112.367 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 65.9 mt -70.61 -45.42 65.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.636 -1.246 . . . . 54.34 107.636 170.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 121.2 0.8 Allowed Glycine 0 N--CA 1.406 -3.312 0 CA-C-N 114.67 -1.15 . . . . 63.3 111.648 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.63 -18.73 62.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.995 -1.113 . . . . 74.33 107.995 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.98 88.89 8.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 104.785 -2.302 . . . . 61.31 104.785 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.2 -33.13 15.5 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.79 2.326 . . . . 74.5 114.007 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.95 -25.84 60.17 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.943 -0.303 . . . . 74.31 111.455 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.21 -35.25 80.47 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.571 -0.529 . . . . 73.25 109.571 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -74.23 -34.08 63.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.58 -0.737 . . . . 74.35 109.505 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.78 -51.31 70.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.497 -0.556 . . . . 64.24 109.497 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 28.2 m -62.34 -44.02 97.47 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.294 -0.412 . . . . 73.15 110.484 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.01 -57.94 17.17 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.391 -0.368 . . . . 61.14 113.051 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -67.87 -28.25 67.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.968 0.729 . . . . 64.15 112.968 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.1 76.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 74.14 110.637 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.8 mmt85 -67.75 -43.39 80.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.606 . . . . 64.32 109.883 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.8 t70 -56.69 -56.69 18.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.371 -1.286 . . . . 71.14 109.583 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.81 -31.11 72.19 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 112.589 0.589 . . . . 55.42 112.589 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.02 98.63 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.504 0.669 . . . . 62.53 111.178 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.31 -27.51 27.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.243 -1.391 . . . . 73.54 107.243 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 3.3 t80 -65.6 -42.78 91.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.723 -1.581 . . . . 64.32 110.195 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.95 -30.94 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.521 -0.471 . . . . 72.42 109.787 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -62.71 -42.39 99.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 71.44 109.964 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 92' ' ' TYR . 11.9 mm-40 -57.72 -38.14 74.77 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.807 0.843 . . . . 71.54 111.098 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.7 mm-40 -83.43 -14.06 53.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 63.41 111.623 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.59 38.13 25.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.075 -0.584 . . . . 41.34 112.1 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -117.74 179.7 4.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.553 -0.906 . . . . 74.41 108.553 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.53 ' HB2' HG22 ' A' ' 8' ' ' VAL . 11.0 pt20 -160.09 178.94 9.17 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 110.196 -0.298 . . . . 55.51 110.196 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.515 ' HA ' HD12 ' A' ' 57' ' ' LEU . 14.0 t -153.24 171.97 17.71 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.298 -1.371 . . . . 72.23 107.298 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.64 118.92 29.62 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.778 -1.564 . . . . 74.33 106.778 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.83 -149.43 16.59 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 119.277 -1.439 . . . . 63.15 109.862 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -125.59 152.58 44.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.404 -1.332 . . . . 62.42 107.404 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.93 125.81 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 O-C-N 123.442 0.463 . . . . 72.23 111.255 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 19.7 m -123.86 120.22 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.519 0.676 . . . . 74.15 109.75 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 62' ' ' TYR . 15.1 m -116.1 142.78 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 108.707 -0.849 . . . . 65.24 108.707 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.56 131.01 23.77 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.356 0.598 . . . . 73.52 112.028 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.19 151.27 19.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.499 -1.228 . . . . 63.44 108.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -159.51 170.13 22.36 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.113 0.565 . . . . 74.11 109.967 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.16 164.82 12.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.939 0.876 . . . . 63.15 112.941 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 t -142.7 134.91 27.43 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.583 -1.644 . . . . 70.13 106.885 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.43 -12.02 59.06 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.395 0.616 . . . . 74.3 110.168 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -85.18 -30.49 23.88 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.948 -0.569 . . . . 74.22 111.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 118' ' ' GLN . 57.7 mt -86.94 149.47 24.77 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.733 -0.667 . . . . 52.44 111.636 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -126.85 168.78 13.99 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.279 -1.008 . . . . 73.33 108.279 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -57.49 110.55 0.89 Allowed 'General case' 0 C--O 1.251 1.155 0 CA-C-O 121.646 0.736 . . . . 74.13 110.65 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.14 -24.82 4.18 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 108.698 -1.761 . . . . 72.11 108.698 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 29.0 mm-40 -92.71 156.02 17.32 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.502 -1.296 . . . . 41.33 107.502 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -176.11 147.7 0.75 Allowed 'General case' 0 C--N 1.278 -2.539 0 O-C-N 125.077 1.486 . . . . 75.3 107.643 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -143.25 130.87 21.25 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.368 -0.378 . . . . 75.35 109.991 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.68 135.92 53.69 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.132 -1.062 . . . . 42.4 108.132 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -125.32 126.48 45.14 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.953 -0.758 . . . . 72.15 108.953 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.44 125.13 8.39 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 110.461 -1.055 . . . . 54.24 110.461 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 p -121.4 140.49 52.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 123.241 0.616 . . . . 71.34 110.68 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 59' ' ' PRO . 80.1 t -92.35 103.66 14.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.719 -1.586 . . . . 62.23 106.719 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -107.35 104.22 51.6 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 108.23 -1.026 . . . . 71.43 108.23 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.4 -39.6 6.99 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.936 1.757 . . . . 73.12 112.924 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.17 69.43 1.15 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.911 1.339 . . . . 62.01 108.416 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.59 108.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 113.082 -1.872 . . . . 75.11 109.295 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -85.82 122.15 29.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.769 -1.105 . . . . 71.5 109.344 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.1 p -70.57 120.09 15.69 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.638 -1.165 . . . . 73.13 111.718 -173.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 107.314 -1.365 . . . . 71.43 107.314 175.338 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 121.206 0.527 . . . . 61.54 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.62 -15.74 13.02 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.939 -1.264 . . . . 70.32 109.939 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 p -84.56 158.55 20.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 109.551 -0.537 . . . . 72.45 109.551 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -135.47 108.31 7.56 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.835 0.35 . . . . 71.11 111.598 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.19 145.63 37.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.929 -0.767 . . . . 70.42 108.929 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -86.01 8.51 20.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.632 0.729 . . . . 74.44 111.271 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.6 pp -133.2 96.02 3.66 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 122.229 1.014 . . . . 75.1 110.485 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.66 108.02 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.209 -0.905 . . . . 64.44 109.008 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.433 -0.803 . . . . 72.33 109.733 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -124.48 85.2 2.38 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.112 -0.699 . . . . 64.15 109.112 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.58 124.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.121 -0.945 . . . . 72.33 110.103 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.2 148.62 44.0 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.451 -0.795 . . . . 63.12 109.129 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -89.36 113.68 25.02 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.8 -0.444 . . . . 74.14 109.8 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -88.69 86.36 6.97 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.916 -1.142 . . . . 74.41 107.916 172.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.08 113.73 18.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.741 -1.207 . . . . 64.23 107.741 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.23 145.75 50.27 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.443 -0.947 . . . . 62.14 108.443 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -134.11 147.62 50.88 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.253 0.549 . . . . 74.52 110.6 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -148.56 145.38 27.82 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.215 -1.772 . . . . 65.12 106.215 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.02 100.69 10.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.304 0.573 . . . . 73.4 109.84 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.11 69.27 0.55 Allowed Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.335 -0.848 . . . . 51.01 111.876 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 16.5 t70 -151.62 131.26 13.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.788 -1.19 . . . . 73.42 107.788 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.351 1.032 . . . . 55.21 113.163 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -76.94 -34.56 57.63 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.541 -0.3 . . . . 62.22 111.076 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -58.89 -36.03 73.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.663 -0.495 . . . . 61.21 109.663 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 12.8 mmm180 -64.55 -42.41 95.71 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.038 -0.528 . . . . 64.43 109.714 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 22' ' ' ALA . 51.3 mm -60.92 -39.5 82.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 CA-C-N 115.883 -0.599 . . . . 73.33 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' SER . 77.9 m-85 -77.61 -17.38 57.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.342 -0.39 . . . . 65.45 111.855 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.07 39.69 2.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 61.13 113.358 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.34 22.7 43.2 Favored Glycine 0 C--N 1.313 -0.722 0 N-CA-C 111.52 -0.632 . . . . 54.4 111.52 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 33.3 t -142.45 147.97 36.99 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.165 -1.42 . . . . 74.14 107.165 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.32 88.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.508 1.147 . . . . 64.4 109.413 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.62 99.31 42.33 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 114.641 -1.163 . . . . 53.34 109.476 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.37 -24.39 64.53 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.463 2.109 . . . . 61.14 110.299 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -67.09 -14.17 62.65 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 114.6 -1.182 . . . . 55.0 111.781 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.96 -44.85 88.03 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.671 0.748 . . . . 64.55 109.014 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG12 HD23 ' A' ' 40' ' ' LEU . 47.2 t -72.48 -38.22 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.196 -0.911 . . . . 73.33 108.846 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.37 -42.59 91.98 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.203 -0.453 . . . . 63.13 110.67 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.19 -45.82 86.9 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.429 0.692 . . . . 55.41 110.691 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 121' ' ' ALA . 1.6 tm? -66.59 -45.75 78.2 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.854 -0.612 . . . . 54.53 109.517 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 36' ' ' VAL . 4.6 mm? -65.59 -40.15 92.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.09 0.774 . . . . 75.34 113.09 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -72.21 -29.35 63.88 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 63.04 110.008 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.74 -44.11 97.07 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.17 -1.048 . . . . 74.35 108.17 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.94 -48.66 65.29 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.92 -1.036 . . . . 64.55 110.123 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.84 68.32 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.432 -0.349 . . . . 73.14 111.814 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.64 -23.24 56.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.994 0.368 . . . . 63.33 111.994 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.02 -34.54 24.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.218 0.533 . . . . 63.23 110.618 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.75 21.12 15.84 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.54 -0.755 . . . . 73.41 113.177 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mm -72.57 131.73 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.002 0.43 . . . . 75.13 110.498 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.7 mt-30 -108.84 133.13 53.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.769 -0.826 . . . . 71.31 108.769 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -75.32 117.71 17.43 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.949 -1.023 . . . . 71.22 109.407 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD23 ' NE2' ' A' ' 99' ' ' GLN . 12.9 tp -141.39 -164.34 1.75 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 103.955 -2.609 . . . . 74.14 103.955 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 97.9 mt-30 -42.68 131.74 3.88 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.702 0.626 . . . . 72.12 111.662 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.38 -18.47 55.69 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 115.062 0.785 . . . . 74.41 115.062 -170.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.41 -31.9 54.37 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.627 -0.829 . . . . 73.23 111.422 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 12.4 ptm180 -151.77 114.42 4.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.497 1.141 . . . . 75.53 111.029 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -91.1 150.71 21.29 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.969 -1.469 . . . . 74.31 108.322 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -84.25 120.34 26.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.495 -0.558 . . . . 71.42 109.495 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 157.38 38.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.676 -0.693 . . . . 74.34 109.672 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -61.68 147.58 95.01 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.573 2.182 . . . . 71.14 112.175 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.403 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 28.8 p-10 -120.59 -24.44 5.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.966 -0.561 . . . . 73.42 110.403 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.11 114.8 29.2 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.455 -0.572 . . . . 71.23 109.455 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -119.56 114.63 22.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.601 -0.727 . . . . 52.23 109.411 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -109.13 120.27 60.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.616 -0.883 . . . . 72.23 108.616 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.9 126.71 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 108.556 -0.905 . . . . 64.41 108.556 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -107.81 130.97 54.94 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.48 -0.782 . . . . 72.34 109.282 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.35 161.27 22.38 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.68 0.792 . . . . 44.23 109.244 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.1 157.33 52.55 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.727 -1.349 . . . . 63.51 109.727 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.4 p -56.76 -39.13 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 117.364 0.582 . . . . 64.41 112.374 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.95 -44.4 82.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.481 0.658 . . . . 73.25 110.777 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.57 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 39.8 m-20 -84.76 -21.67 29.92 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 112.784 0.661 . . . . 75.33 112.784 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 57.0 t80 -69.3 -26.09 64.55 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.162 -0.681 . . . . 70.55 109.162 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 46.2 mt-10 -58.67 -38.56 78.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.386 -0.37 . . . . 54.33 110.784 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -76.55 -32.8 58.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.108 0.48 . . . . 73.41 109.913 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.08 -29.25 70.11 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.988 -0.551 . . . . 63.33 109.976 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.03 33.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.672 -0.694 . . . . 53.15 113.904 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.36 0.58 . . . . 72.23 109.67 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.35 68.34 2.77 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 122.198 0.999 . . . . 64.21 109.765 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.76 -51.25 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.199 1.933 . . . . 74.1 113.685 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.8 -23.16 60.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.439 -0.346 . . . . 73.52 111.633 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.5 -43.09 81.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.763 -0.458 . . . . 74.31 109.763 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -63.33 -34.4 77.62 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.231 -0.44 . . . . 74.24 110.739 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.1 m -66.87 -49.03 66.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.785 -0.643 . . . . 61.32 110.698 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -62.49 -36.27 82.0 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.296 -0.411 . . . . 72.43 111.141 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.15 40.29 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.424 -0.417 . . . . 62.41 112.122 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -70.85 -28.04 64.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.324 0.49 . . . . 64.31 112.324 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.898 -0.408 . . . . 72.04 109.898 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -59.67 -47.61 84.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.41 -0.813 . . . . 71.24 109.522 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' HD1' ' A' ' 92' ' ' TYR . 59.7 m-20 -69.52 -45.37 69.01 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 113.275 0.843 . . . . 61.05 113.275 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.137 -0.625 . . . . 63.34 111.812 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.34 87.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 72.33 109.939 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.93 -44.5 72.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.913 -0.585 . . . . 71.11 109.734 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.626 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.1 m-85 -58.68 -49.62 76.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.485 -0.78 . . . . 65.31 112.572 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.12 -39.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 119.914 -0.715 . . . . 75.32 111.363 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.63 -41.58 96.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.61 -0.268 . . . . 73.12 110.491 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.47 -38.95 75.33 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.693 1.197 . . . . 71.33 110.723 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 52.2 mm-40 -87.44 -13.35 43.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.782 -0.645 . . . . 54.54 111.402 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.48 28.74 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.976 -0.85 . . . . 72.54 110.976 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -105.34 158.71 16.44 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.008 -0.738 . . . . 74.4 109.008 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.5 pt20 -126.33 171.58 10.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.197 -0.456 . . . . 62.01 110.175 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 57' ' ' LEU . 6.3 t -162.52 158.05 23.05 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.639 -1.245 . . . . 73.05 107.639 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.51 120.44 40.3 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.265 -1.013 . . . . 75.41 108.265 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -152.11 16.99 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.154 -1.579 . . . . 23.33 109.154 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.95 162.58 20.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.217 -0.66 . . . . 72.23 109.217 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.22 119.83 31.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.58 -0.896 . . . . 75.13 108.58 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.66 133.1 69.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.451 0.643 . . . . 64.31 109.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.03 134.37 61.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.377 -0.972 . . . . 72.3 108.377 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -130.88 142.99 50.41 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.729 -0.841 . . . . 73.22 108.729 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.98 137.02 52.27 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.765 -0.828 . . . . 63.13 108.765 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.32 160.8 38.55 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 120.967 0.413 . . . . 73.3 110.678 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 26.9 pt20 -103.55 153.89 20.08 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.397 -0.82 . . . . 70.35 109.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.2 t -144.37 132.22 21.38 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 109.025 -0.732 . . . . 65.3 109.025 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.05 -15.73 55.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.08 -1.081 . . . . 53.22 108.08 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.5 -32.89 54.46 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.565 -1.198 . . . . 72.25 109.769 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -84.44 157.66 21.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.423 -0.954 . . . . 63.12 108.423 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -98.54 164.53 12.22 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.757 0.651 . . . . 74.14 112.757 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 m -66.13 134.57 53.07 Favored 'General case' 0 C--O 1.25 1.089 0 C-N-CA 123.995 0.918 . . . . 73.51 110.802 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.1 86.82 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 112.041 -0.424 . . . . 62.34 112.041 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -138.49 128.38 25.27 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 107.915 -1.143 . . . . 60.21 107.915 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -122.59 153.94 38.61 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.776 -0.824 . . . . 65.31 108.776 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -148.61 153.76 38.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.429 -1.323 . . . . 75.03 107.429 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -145.44 149.35 34.54 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 120.697 -0.401 . . . . 72.2 110.966 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -134.42 123.0 23.33 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.5 -0.773 . . . . 72.01 109.476 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.68 126.17 7.57 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.715 -1.354 . . . . 74.23 109.715 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.2 m -135.88 150.59 49.42 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 109.402 -0.592 . . . . 54.52 109.402 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 59' ' ' PRO . 40.2 t -88.02 110.97 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 107.179 -1.415 . . . . 74.35 107.179 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -120.06 86.99 38.23 Favored Pre-proline 0 C--N 1.284 -2.264 0 N-CA-C 107.226 -1.398 . . . . 72.23 107.226 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.27 -13.68 7.4 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.368 2.045 . . . . 70.13 112.69 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -87.12 29.32 0.84 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.594 -0.73 . . . . 64.24 112.71 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.16 98.82 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.17 -0.678 . . . . 75.43 109.17 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -94.8 121.23 36.17 Favored 'General case' 0 N--CA 1.4 -2.969 0 N-CA-C 106.508 -1.664 . . . . 64.5 106.508 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -123.28 149.39 44.84 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 109.339 -0.615 . . . . 73.41 109.339 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 106.599 -1.63 . . . . 75.14 106.599 177.347 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.34 -0.615 . . . . 64.14 109.34 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.27 -175.21 34.02 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.869 -1.292 . . . . 71.33 109.869 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -79.35 92.24 5.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.732 -0.84 . . . . 53.41 108.732 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -121.94 135.93 54.89 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.588 -0.733 . . . . 71.35 110.879 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -75.05 83.74 2.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.088 0.947 . . . . 65.13 108.9 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -84.14 139.9 32.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.593 -1.185 . . . . 63.22 110.421 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.65 84.21 7.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.205 -1.035 . . . . 61.42 108.205 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 9' ' ' GLN . 12.2 p -112.35 143.11 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 114.148 -1.387 . . . . 71.21 109.767 -175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 8' ' ' VAL . 17.8 pt20 -90.8 168.25 11.86 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.214 -1.032 . . . . 71.51 108.214 174.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -76.03 88.39 2.97 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.976 0.893 . . . . 71.2 111.146 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 13' ' ' ARG . 48.1 t -70.03 145.83 12.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.782 -1.553 . . . . 74.31 109.229 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -51.61 -45.5 63.25 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.63 0.772 . . . . 71.54 110.284 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' H ' HG12 ' A' ' 11' ' ' VAL . 22.0 mmt180 -59.43 146.24 40.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.658 -1.155 . . . . 75.24 110.824 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 117.64 7.69 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.729 -0.841 . . . . 74.01 108.729 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -91.34 150.37 21.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.263 -0.643 . . . . 65.33 109.263 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.77 110.8 11.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.324 1.231 . . . . 74.51 114.324 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.448 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 11.1 mm-40 -125.38 104.86 8.69 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.103 -1.408 . . . . 63.51 107.22 171.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.2 m -71.48 112.41 7.58 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.34 -0.846 . . . . 73.33 110.164 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.65 87.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.058 -0.974 . . . . 74.11 108.601 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.47 50.47 0.03 OUTLIER Glycine 0 C--N 1.287 -2.176 0 N-CA-C 109.099 -1.601 . . . . 61.2 109.099 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.89 -39.81 66.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.388 1.075 . . . . 61.43 111.93 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.503 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.84 -59.24 5.54 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.17 -0.923 . . . . 61.45 110.139 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -44.73 86.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.15 -0.932 . . . . 72.55 110.454 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.57 82.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.341 -0.845 . . . . 72.44 111.878 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -78.37 -28.88 47.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.412 -0.515 . . . . 55.02 111.876 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 22' ' ' ALA . 72.1 mt -66.96 -48.05 80.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 O-C-N 123.317 0.386 . . . . 73.54 110.385 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.401 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 24.8 m-85 -84.12 -29.73 26.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.398 -0.921 . . . . 74.2 110.626 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.39 -86.42 0.61 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 112.004 -0.439 . . . . 54.54 112.004 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.34 63.54 0.47 Allowed Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.407 -0.677 . . . . 62.03 111.407 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 27' ' ' PHE . 23.0 m -147.55 171.4 15.62 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.156 -1.424 . . . . 71.23 107.156 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.46 147.73 9.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 110.085 -0.339 . . . . 54.41 110.085 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.11 113.74 55.09 Favored Pre-proline 0 N--CA 1.431 -1.405 0 N-CA-C 107.036 -1.468 . . . . 71.52 107.036 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -87.49 50.2 1.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 122.484 2.123 . . . . 73.22 114.406 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -71.02 -12.77 61.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.232 -1.387 . . . . 74.01 111.525 177.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.67 -25.3 67.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.357 -0.608 . . . . 73.01 109.357 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.99 -49.7 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 109.681 -0.488 . . . . 75.11 109.681 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.97 -35.8 81.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.366 -0.533 . . . . 61.44 109.822 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.33 94.15 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.685 -0.688 . . . . 73.32 110.773 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -44.45 96.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.774 -0.824 . . . . 74.21 108.774 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.12 -29.18 68.04 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.035 0.754 . . . . 71.12 113.035 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 11.4 mtm180 -65.52 -36.97 85.41 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.778 -1.194 . . . . 73.3 107.778 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -46.87 72.26 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.17 -0.923 . . . . 72.44 110.07 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.21 -41.08 96.22 Favored 'General case' 0 CA--C 1.5 -0.942 0 O-C-N 123.397 0.435 . . . . 74.52 111.976 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.49 93.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.095 -0.502 . . . . 63.21 110.583 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.25 -25.36 42.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.089 -0.505 . . . . 71.33 111.599 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.19 -40.02 28.04 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.04 0.448 . . . . 64.32 110.167 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.85 17.96 37.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.786 . . . . 64.21 112.999 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 48' ' ' ILE . 13.8 mm -59.95 127.03 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-O 121.325 0.583 . . . . 75.33 110.814 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.2 tt0 -109.59 128.27 55.1 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 106.819 -1.549 . . . . 64.22 106.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -67.61 116.47 8.36 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.419 0.628 . . . . 61.43 110.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 18.4 tp -119.62 -165.83 1.21 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.503 -2.036 . . . . 75.53 105.503 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.577 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 14.1 mm-40 -62.92 166.56 5.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.731 0.696 . . . . 71.23 110.741 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.4 1.7 18.84 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.416 -0.811 . . . . 61.01 113.472 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.91 -48.64 57.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.621 -0.881 . . . . 71.43 108.621 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -173.67 159.8 3.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.869 -0.605 . . . . 74.13 110.649 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.87 151.68 20.44 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.653 0.781 . . . . 72.55 109.993 -176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.4 tm? -98.64 126.27 44.19 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.151 -1.796 . . . . 71.15 106.151 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.47 157.65 33.43 Favored Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 122.899 0.48 . . . . 53.43 110.305 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HG2' ' OH ' ' A' ' 62' ' ' TYR . 23.6 Cg_endo -63.73 148.34 92.12 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.334 2.023 . . . . 51.1 111.698 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 24.5 p-10 -123.37 -16.33 6.89 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.593 -0.73 . . . . 74.13 112.175 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.92 109.45 18.15 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 120.365 -0.534 . . . . 74.35 110.635 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.451 ' OH ' ' HG2' ' A' ' 59' ' ' PRO . 24.9 m-85 -114.44 127.67 55.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.532 -0.758 . . . . 73.42 110.7 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 64.8 mt -109.28 115.61 50.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.908 -1.145 . . . . 61.32 107.908 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.99 110.42 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.451 -0.944 . . . . 73.15 108.451 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -102.27 121.73 42.83 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.189 -0.46 . . . . 70.21 110.529 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.38 167.89 9.86 Favored 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.698 0.799 . . . . 71.4 110.168 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 162.38 50.56 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.39 -1.484 . . . . 73.33 109.39 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 7.9 p -59.71 -42.01 87.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 117.467 0.633 . . . . 74.43 112.306 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.476 ' HB3' HG21 ' A' ' 116' ' ' THR . 15.3 t-80 -73.6 -21.95 60.18 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.494 0.664 . . . . 74.31 110.17 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -79.26 -36.87 39.19 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.766 -0.584 . . . . 73.41 110.173 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -31.08 71.56 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.766 -0.652 . . . . 64.3 109.473 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.6 mm-40 -59.42 -31.43 69.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.713 -0.676 . . . . 75.42 112.004 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -84.44 -27.82 27.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.085 -0.646 . . . . 62.14 110.755 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD11 ' HG ' ' A' ' 66' ' ' LEU . 88.2 mt -64.36 -38.97 92.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.395 -0.366 . . . . 63.11 110.22 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.51 169.28 11.59 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 111.384 -0.686 . . . . 74.35 111.384 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.14 -31.41 25.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.0 0.428 . . . . 64.42 110.417 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 16.3 m-20 -105.8 105.36 52.85 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.51 -0.768 . . . . 71.31 109.428 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.16 -18.97 17.96 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.08 1.853 . . . . 71.31 113.783 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.296 0.0 OUTLIER -62.54 -51.91 65.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.789 1.403 . . . . 71.32 114.789 -174.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -67.35 -36.44 81.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.86 0.3 . . . . 64.42 111.314 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 72.4 mmtt -64.61 -45.78 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.539 . . . . 64.22 109.904 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.615 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 43.5 m -71.68 -49.71 37.14 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.378 -0.828 . . . . 72.5 111.11 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 56.1 m -65.63 -35.07 79.73 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.785 0.326 . . . . 74.24 111.649 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.73 -46.53 74.54 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.336 -0.705 . . . . 43.43 111.336 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.81 -28.28 67.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.274 -0.639 . . . . 73.44 109.274 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.94 79.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.994 -0.548 . . . . 72.14 110.25 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 83' ' ' THR . 99.9 mtt180 -66.14 -41.9 89.8 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.104 -0.332 . . . . 75.44 110.104 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.43 -36.66 83.09 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.927 0.394 . . . . 73.5 110.327 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 104' ' ' VAL . 2.7 tm? -73.39 -39.44 65.1 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.948 -0.569 . . . . 51.11 110.121 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -59.37 -41.44 89.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.65 0.738 . . . . 72.45 109.026 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 19.2 t70 -58.16 -51.67 68.76 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.265 -1.334 . . . . 73.3 109.186 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.614 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 10.0 m-85 -55.1 -53.72 52.3 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.27 0.841 . . . . 70.21 113.27 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 pt -61.84 -36.63 74.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 120.774 -0.37 . . . . 75.22 111.664 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.19 -36.63 82.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.067 -0.515 . . . . 65.24 111.35 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.9 mt-10 -62.93 -38.84 92.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.381 0.61 . . . . 65.21 110.844 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 62.3 mm-40 -79.8 -9.45 59.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.377 -0.828 . . . . 73.45 110.905 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.81 56.57 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 116.051 -0.522 . . . . 71.3 112.583 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -101.5 159.76 15.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.488 -0.931 . . . . 65.44 108.488 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -132.94 171.6 13.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.711 -1.218 . . . . 74.13 107.711 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.1 t -147.86 166.27 28.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.645 -0.502 . . . . 60.41 109.645 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -106.51 120.76 42.76 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 109.749 -0.463 . . . . 61.22 109.749 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.85 -149.79 17.03 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.269 -1.132 . . . . 51.33 110.269 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -108.8 143.0 38.53 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.885 -1.524 . . . . 73.42 106.885 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 90' ' ' ALA . 14.8 p -81.52 112.99 20.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.128 -1.029 . . . . 61.35 108.903 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.85 120.15 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-O 122.096 0.95 . . . . 73.21 110.866 -176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 82' ' ' SER . 3.7 m -119.1 139.67 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 N-CA-C 104.025 -2.583 . . . . 74.2 104.025 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -137.81 132.88 33.29 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.869 -1.132 . . . . 74.53 112.119 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -91.35 119.94 31.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.418 -1.265 . . . . 61.21 108.54 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.89 171.67 9.05 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.81 -0.632 . . . . 74.02 109.925 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -121.49 157.63 30.22 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.115 -1.069 . . . . 73.55 108.115 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.7 t -145.76 146.98 31.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.093 -0.706 . . . . 60.22 109.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.3 m -80.89 -22.74 39.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.433 -0.951 . . . . 75.34 108.433 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -80.46 -29.7 37.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.251 -0.886 . . . . 73.52 109.652 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.02 130.78 37.69 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.113 -1.81 . . . . 72.5 106.113 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 38.1 t-80 -97.74 153.24 18.39 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.499 -0.48 . . . . 73.41 110.008 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 69' ' ' HIS . 97.9 m -60.51 139.59 57.68 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.635 0.774 . . . . 64.01 110.768 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.18 3.05 57.88 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.211 -1.155 . . . . 52.43 110.211 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 99.5 mt-30 -132.25 154.05 50.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.05 0.94 . . . . 64.34 109.101 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.11 148.22 26.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.434 -1.321 . . . . 61.3 107.434 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -137.45 135.94 37.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.802 -0.814 . . . . 72.21 108.802 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -137.28 120.66 16.98 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 123.527 0.517 . . . . 72.04 109.78 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 1.5 tpm_? -119.73 137.41 53.94 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.682 -1.229 . . . . 74.41 107.682 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -120.4 104.34 0.99 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.189 -0.764 . . . . 62.22 111.189 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.6 m -105.43 151.22 24.5 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 122.43 -0.453 . . . . 64.52 109.81 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.35 112.48 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.153 -1.054 . . . . 74.43 108.153 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -115.5 108.02 48.06 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 109.041 -0.726 . . . . 64.24 109.041 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.53 -23.98 19.4 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.92 1.747 . . . . 70.11 112.236 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.07 77.26 1.81 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.507 1.146 . . . . 70.41 110.471 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.88 131.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.773 0 CA-C-N 113.171 -1.831 . . . . 60.11 107.546 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -76.97 143.35 39.52 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.119 -0.491 . . . . 74.21 110.388 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -131.58 140.08 49.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.849 -1.537 . . . . 61.34 106.849 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.4 m80 . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 118.755 -0.641 . . . . 74.24 109.965 -175.788 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 CA--C 1.516 -0.365 0 N-CA-C 110.233 -0.284 . . . . 75.33 110.233 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.09 110.78 3.15 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.426 -1.47 . . . . 71.42 109.426 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -72.91 151.01 42.1 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 122.535 0.334 . . . . 62.4 111.025 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -78.04 24.85 0.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.624 0.602 . . . . 73.0 112.624 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -169.43 146.83 3.51 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 123.048 0.539 . . . . 73.31 109.941 177.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -108.64 153.49 23.34 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.374 -1.343 . . . . 73.4 107.374 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.71 101.26 8.31 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.917 -0.771 . . . . 73.22 108.917 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.73 -79.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.962 -0.563 . . . . 63.11 109.539 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -154.74 -178.83 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.691 -1.966 . . . . 60.24 105.691 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -63.85 116.73 6.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.668 0.747 . . . . 72.01 110.675 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -79.6 81.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 107.423 -1.325 . . . . 63.23 107.423 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.62 113.61 25.37 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.219 -1.355 . . . . 75.41 113.08 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 57.76 33.24 22.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.685 1.194 . . . . 52.43 112.48 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.42 140.21 1.38 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.611 -1.996 . . . . 74.44 105.611 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.82 -9.25 58.03 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.702 1.001 . . . . 72.23 113.702 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.14 168.81 20.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.846 -1.538 . . . . 74.12 106.846 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -106.32 -0.6 24.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.208 1.004 . . . . 75.03 112.172 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 p -95.93 177.34 5.79 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.179 -1.373 . . . . 74.12 107.755 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.88 81.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.833 -0.802 . . . . 73.34 108.833 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.46 9.26 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 110.534 -1.026 . . . . 30.0 110.534 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -42.5 -54.86 3.71 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 114.636 1.347 . . . . 61.21 114.636 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.521 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -59.3 -59.51 5.35 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 123.972 0.795 . . . . 72.51 111.753 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -63.25 -38.38 90.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.189 0.44 . . . . 73.41 112.189 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -60.51 -43.7 96.79 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.284 0.365 . . . . 73.5 111.055 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -78.09 -19.81 53.44 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 120.801 0.334 . . . . 71.12 111.415 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.4 mt -74.07 -56.47 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.834 -0.432 . . . . 74.34 109.834 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -69.59 -28.32 65.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.864 0.364 . . . . 71.53 111.401 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.59 -49.5 0.94 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.988 -0.845 . . . . 51.22 110.988 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.52 47.06 0.69 Allowed Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.514 -0.85 . . . . 53.14 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 21.1 t -167.72 136.58 2.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.868 -0.79 . . . . 73.32 108.868 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tt -93.3 -43.69 13.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.194 -1.039 . . . . 72.43 108.194 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.16 123.49 10.38 Favored Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 105.599 -2.001 . . . . 75.01 105.599 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.46 87.57 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.088 1.859 . . . . 61.32 111.78 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.68 -5.95 59.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 113.326 0.862 . . . . 72.42 113.326 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.55 -22.65 43.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.847 -0.741 . . . . 74.21 109.216 172.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.74 -48.79 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 63.12 109.074 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.07 -33.24 75.55 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.8 -0.36 . . . . 63.35 110.654 178.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.19 81.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.585 0.553 . . . . 21.33 109.942 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.74 -45.6 93.65 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 108.765 -0.828 . . . . 71.42 108.765 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD21 HD11 ' A' ' 64' ' ' ILE . 11.1 mp -64.75 -42.45 95.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.043 1.127 . . . . 75.0 114.043 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.3 ptt180 -71.62 -27.28 63.0 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.205 -0.998 . . . . 70.44 111.328 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -68.14 -46.26 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.22 -40.42 93.93 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.697 1.199 . . . . 65.22 109.919 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.33 96.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.729 -0.669 . . . . 74.02 110.348 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.05 76.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.155 0.502 . . . . 63.22 111.36 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.91 -28.55 49.81 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.95 0.405 . . . . 72.34 111.289 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.49 21.6 45.25 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 116.267 -0.424 . . . . 51.13 113.138 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 56' ' ' LEU . 9.0 mm -62.15 144.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.693 0.797 . . . . 74.32 111.485 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 9.4 tt0 -120.45 134.66 55.24 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 107.988 -1.116 . . . . 73.25 107.988 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -64.48 128.94 37.93 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.453 0.644 . . . . 40.44 109.461 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -135.4 -166.25 1.81 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 105.57 -2.011 . . . . 45.25 105.57 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.638 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 67.6 mt-30 -59.05 155.68 13.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.611 -0.515 . . . . 64.13 109.611 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.53 -9.46 37.86 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 116.442 -0.344 . . . . 32.13 113.494 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -46.73 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.504 -0.184 . . . . 72.11 110.504 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 99' ' ' GLN . 6.0 ptm180 -172.16 152.92 2.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.4 -0.364 . . . . 75.42 110.698 -175.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 48' ' ' ILE . 81.5 mt -91.67 152.38 20.25 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.508 1.123 . . . . 73.53 111.084 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.8 tm? -92.97 133.28 36.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.092 -1.447 . . . . 70.12 107.092 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.61 159.97 41.96 Favored Pre-proline 0 C--N 1.302 -1.461 0 C-N-CA 123.525 0.73 . . . . 40.35 109.753 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.427 ' HA ' HG22 ' A' ' 125' ' ' VAL . 32.1 Cg_exo -61.72 162.1 22.72 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.068 2.512 . . . . 72.5 113.418 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 9.8 p30 -134.16 -23.73 1.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.96 -0.563 . . . . 53.3 112.215 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.05 104.49 14.67 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.117 -1.033 . . . . 74.42 109.515 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.28 114.62 28.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.313 -0.858 . . . . 73.33 109.581 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.36 118.03 56.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.722 -1.214 . . . . 70.02 107.722 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 40' ' ' LEU . 41.0 mt -113.31 125.79 70.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.011 -1.107 . . . . 72.15 108.011 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -116.39 123.32 47.28 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.138 -0.69 . . . . 73.42 109.138 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.1 mm? -102.65 159.62 15.29 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.854 0.862 . . . . 72.11 109.478 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.82 144.68 48.53 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.683 -2.167 . . . . 62.01 107.683 169.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.3 p -55.59 -36.02 40.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.425 0.898 . . . . 75.24 113.425 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -69.69 -34.17 73.56 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.762 0.315 . . . . 62.42 111.227 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.3 m-20 -76.69 -25.82 54.06 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.22 0.533 . . . . 71.55 110.176 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.97 -31.18 71.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.26 -1.015 . . . . 73.12 108.26 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 41.6 mt-10 -64.92 -31.7 73.07 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.731 -0.668 . . . . 75.24 110.532 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -73.23 -27.61 61.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.199 -0.455 . . . . 71.13 110.915 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.53 -27.22 66.79 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.167 -0.679 . . . . 73.54 109.167 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.16 -163.72 12.54 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 114.81 -1.086 . . . . 44.34 113.389 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -80.89 -19.35 44.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.34 0.59 . . . . 75.41 109.672 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.23 67.94 36.29 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.696 -0.684 . . . . 74.35 112.54 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 17.1 Cg_exo -72.5 -48.85 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.909 1.739 . . . . 65.23 110.352 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.599 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 5.4 mm-40 -68.43 -12.84 61.76 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.302 0.853 . . . . 72.23 113.302 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.22 -38.17 43.69 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.595 -1.261 . . . . 73.22 107.595 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.54 -25.6 57.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.068 -0.969 . . . . 73.3 110.407 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 9.3 m -54.65 -42.35 71.19 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 124.126 0.97 . . . . 74.43 111.28 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 m -60.85 -44.13 97.42 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.537 0.735 . . . . 72.44 111.275 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.65 -38.11 67.61 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.117 -0.793 . . . . 40.34 111.117 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -67.37 -36.47 81.41 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.363 0.665 . . . . 73.32 109.652 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.8 96.17 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.214 -0.448 . . . . 64.41 110.027 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -67.26 -36.29 81.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.316 -0.402 . . . . 74.14 110.67 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -43.97 96.74 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.638 -0.875 . . . . 75.55 108.638 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD22 HD23 ' A' ' 40' ' ' LEU . 53.7 tp -67.62 -36.66 81.25 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.462 -0.79 . . . . 73.25 110.818 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.36 -38.15 85.9 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.401 0.619 . . . . 72.34 109.6 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 33.1 t70 -66.21 -42.41 88.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.464 -0.789 . . . . 65.15 109.329 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.575 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.8 m-85 -54.82 -47.92 73.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.858 -0.61 . . . . 74.4 111.936 174.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 pt -68.49 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 119.925 -0.71 . . . . 74.45 111.19 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -61.04 -41.98 97.62 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.295 0.372 . . . . 71.43 110.275 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 21.7 mm-40 -57.37 -44.15 84.15 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.309 0.644 . . . . 74.34 111.005 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -79.81 -13.93 59.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.493 -0.776 . . . . 71.01 110.237 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 90.83 9.6 63.95 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.852 -0.613 . . . . 63.55 113.543 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -86.83 152.29 22.61 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.993 -0.71 . . . . 73.31 110.412 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 55' ' ' ARG . 9.8 pt20 -122.83 168.62 12.03 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.571 -0.529 . . . . 73.44 109.571 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.0 t -146.78 154.81 41.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.355 -0.609 . . . . 71.12 109.355 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -97.31 120.82 38.36 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.456 -1.313 . . . . 75.04 107.456 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.87 -163.98 12.59 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 120.264 -0.969 . . . . 72.14 110.933 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.47 143.65 40.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.605 0.24 . . . . 62.3 110.57 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 90' ' ' ALA . 9.6 p -80.94 123.49 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.822 -0.627 . . . . 63.43 109.799 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.5 129.21 72.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.751 -0.659 . . . . 72.11 109.939 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' SER . 96.2 t -115.36 119.38 61.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.093 -1.447 . . . . 62.1 107.093 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -110.47 127.12 54.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.062 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -99.64 119.73 38.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.21 -0.663 . . . . 74.41 109.21 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.99 166.7 11.87 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.146 -0.933 . . . . 75.02 109.767 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.67 156.11 36.52 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.99 -1.115 . . . . 75.41 107.99 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -144.67 140.13 28.44 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 109.189 -0.671 . . . . 65.23 109.189 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 m -81.02 -20.36 41.92 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.673 -0.862 . . . . 53.53 108.673 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -72.01 -40.23 68.63 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.066 -0.97 . . . . 63.24 108.679 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.92 130.47 34.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.222 -0.899 . . . . 62.44 110.178 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -95.77 172.76 7.83 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.278 -0.874 . . . . 72.4 109.284 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.431 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 12.7 t -56.67 138.1 53.1 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.772 0.796 . . . . 74.42 111.278 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.76 -30.2 9.74 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 115.065 -0.971 . . . . 74.25 111.655 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -84.92 144.0 28.64 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.227 0.537 . . . . 75.04 111.47 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HB3' HD13 ' A' ' 66' ' ' LEU . 20.0 p90 -156.75 151.93 26.36 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.91 -1.515 . . . . 73.32 106.91 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -143.72 151.48 40.08 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.183 -1.414 . . . . 72.52 107.183 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.8 140.12 23.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.089 -0.337 . . . . 75.23 110.089 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -133.25 137.98 46.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.297 -1.001 . . . . 70.41 108.297 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.16 117.65 3.97 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.727 -1.349 . . . . 51.22 109.727 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.7 p -116.49 154.4 30.44 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-O 121.195 0.521 . . . . 73.32 110.906 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 67.7 t -89.92 103.95 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 108.102 -1.073 . . . . 53.14 108.102 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -101.85 95.69 5.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 106.397 -1.705 . . . . 65.45 106.397 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 71.6 Cg_endo -84.53 -14.46 6.68 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.709 1.606 . . . . 61.11 112.429 -176.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -95.42 66.42 2.83 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.147 0.975 . . . . 71.2 109.869 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.4 114.58 47.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 114.221 -1.354 . . . . 71.2 108.006 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -78.12 146.54 35.09 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.633 -0.712 . . . . 74.0 110.203 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -137.23 165.69 25.53 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 108.809 -0.811 . . . . 74.4 108.809 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 N--CA 1.42 -1.934 0 N-CA-C 106.468 -1.679 . . . . 42.14 106.468 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 C--O 1.24 0.571 0 N-CA-C 108.718 -0.845 . . . . 74.04 108.718 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.5 40.71 0.33 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.508 -1.037 . . . . 52.04 110.508 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -79.22 95.47 5.64 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.672 -0.862 . . . . 74.35 108.672 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -150.82 160.98 43.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.451 -0.944 . . . . 65.21 108.451 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 122.22 13.52 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.365 -0.606 . . . . 74.14 109.365 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -93.25 118.47 31.3 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.892 -0.781 . . . . 74.24 108.892 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.09 102.71 8.32 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.542 -0.754 . . . . 64.14 111.322 -173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.67 110.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.122 -1.436 . . . . 63.35 107.122 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.53 91.68 3.97 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.711 0.767 . . . . 71.04 111.611 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.65 150.85 29.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.917 -1.038 . . . . 73.14 108.262 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 14' ' ' LYS . 16.1 m -119.79 131.26 72.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.192 -0.603 . . . . 74.41 110.115 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -71.88 -28.49 63.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.489 0.661 . . . . 71.12 109.288 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -94.12 64.87 3.34 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.624 -0.88 . . . . 71.52 108.624 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HB3' HG23 ' A' ' 11' ' ' VAL . 50.0 pttt -93.36 85.17 4.9 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.909 0.862 . . . . 65.43 109.167 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -94.48 84.03 4.25 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.246 -0.888 . . . . 71.34 111.273 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -178.57 94.69 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.851 -1.537 . . . . 74.41 106.851 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 32' ' ' VAL . 17.1 mp0 -112.82 132.47 55.26 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.135 -0.939 . . . . 75.2 110.148 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 p -74.14 94.59 2.45 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.921 -0.77 . . . . 51.44 108.921 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.43 ' HA ' HD11 ' A' ' 31' ' ' ILE . 5.0 p -81.38 94.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.839 0.828 . . . . 62.02 112.001 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.46 73.16 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.089 -0.96 . . . . 62.41 112.28 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.21 129.22 12.61 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.42 -0.956 . . . . 45.22 108.42 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -61.45 -41.08 96.67 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.941 0.719 . . . . 74.14 112.941 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -80.51 -31.26 37.17 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 116.069 -0.514 . . . . 75.43 110.486 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 31' ' ' ILE . . . -60.9 -39.06 87.88 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.537 0.684 . . . . 72.44 109.254 172.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -69.59 -24.14 63.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.476 -0.784 . . . . 65.11 111.404 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 22' ' ' ALA . 47.3 mm -70.01 -34.84 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 109.513 -0.551 . . . . 65.24 109.513 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -79.2 -29.91 43.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.836 0.35 . . . . 73.13 111.35 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.35 -90.14 0.65 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 116.087 -0.506 . . . . 70.52 112.711 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.53 -13.89 39.74 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.616 -0.802 . . . . 71.23 112.708 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -79.45 97.65 6.48 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 107.006 -1.479 . . . . 73.31 107.006 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.625 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 19.6 tt -128.54 20.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.088 0.947 . . . . 61.42 112.055 -169.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' CG2' ' HG3' ' A' ' 17' ' ' GLN . 20.3 t -113.81 88.96 14.95 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.16 -1.052 . . . . 74.22 108.16 172.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 31' ' ' ILE . 16.4 Cg_exo -73.0 -20.03 22.4 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.361 2.041 . . . . 73.45 112.266 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -73.04 -8.09 54.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.888 0.699 . . . . 74.34 112.888 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.79 -33.98 76.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.918 -0.771 . . . . 72.41 108.918 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.59 -54.15 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.142 -0.936 . . . . 73.35 109.964 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -63.86 -29.54 70.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.815 0.34 . . . . 74.41 111.348 -178.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' ARG . . . -60.88 -47.99 83.84 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.107 -0.701 . . . . 72.43 109.107 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 26.7 tp -66.11 -39.55 90.04 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.393 -0.821 . . . . 64.53 110.419 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.24 -51.11 67.66 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.137 0.273 . . . . 72.53 111.687 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.1 ptt180 -70.06 -22.91 63.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.076 0.769 . . . . 72.24 113.076 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 83.9 mtt180 -70.98 -45.37 64.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.827 -0.435 . . . . 65.43 109.827 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' ALA . 20.2 mm-40 -68.94 -32.61 72.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.047 -0.524 . . . . 75.41 110.318 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.05 95.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.451 -0.574 . . . . 62.15 109.451 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.78 -26.43 66.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.885 -0.598 . . . . 73.12 111.359 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -78.51 -34.19 47.51 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.316 0.579 . . . . 73.03 111.172 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.4 9.58 72.67 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.919 -0.658 . . . . 60.12 112.664 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.8 129.51 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 121.05 0.453 . . . . 74.14 110.732 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -122.1 141.93 50.9 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.952 -1.022 . . . . 74.24 110.56 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -75.52 113.44 12.95 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.839 -1.073 . . . . 74.4 110.782 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.9 tp -116.24 -164.4 0.96 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.428 -2.064 . . . . 51.02 105.428 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.576 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 mt-30 -48.3 154.89 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.912 0.485 . . . . 72.33 111.045 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.05 8.97 4.27 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 116.114 -0.494 . . . . 63.44 114.157 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -78.16 -47.59 17.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.324 -1.361 . . . . 73.22 107.324 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -173.61 166.08 4.57 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.868 0.692 . . . . 72.15 112.868 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.0 mt -91.13 151.78 20.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.047 -0.979 . . . . 72.31 112.298 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.47 129.76 41.12 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.824 -1.176 . . . . 60.01 107.824 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 158.72 39.14 Favored Pre-proline 0 C--N 1.308 -1.209 0 C-N-CA 123.206 0.602 . . . . 63.31 109.785 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.73 159.5 41.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.593 2.195 . . . . 73.14 112.536 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.15 -20.61 4.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.765 -0.652 . . . . 63.11 110.906 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.52 111.09 23.5 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.714 -1.217 . . . . 64.33 107.714 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB2' HG22 ' A' ' 106' ' ' VAL . 91.8 m-85 -124.95 131.03 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.246 0.546 . . . . 74.21 111.669 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' NH2' ' A' ' 122' ' ' ARG . 52.6 mt -127.6 124.41 63.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.513 -0.767 . . . . 62.33 109.278 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.27 120.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.022 -1.473 . . . . 72.2 107.022 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 m -108.81 125.96 52.53 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 115.754 -0.657 . . . . 54.14 109.719 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.67 -176.78 2.98 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 124.662 1.185 . . . . 72.23 109.135 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.42 172.15 44.61 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.283 -1.127 . . . . 64.32 110.283 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 70.2 t -59.23 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.66 0.384 . . . . 70.31 111.362 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 55.9 t-80 -60.65 -40.94 93.86 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.544 0.688 . . . . 73.34 110.422 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.96 -40.34 83.2 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.452 -1.249 . . . . 74.42 110.454 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.444 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 88.8 t80 -66.81 -31.74 72.56 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.142 -0.481 . . . . 73.1 110.19 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.6 mm-40 -66.49 -26.2 67.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.993 -0.549 . . . . 72.21 111.178 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -77.98 -36.12 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.74 -0.837 . . . . 72.32 108.74 173.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.95 -18.92 65.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.259 -0.882 . . . . 75.4 110.364 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.45 -5.72 12.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.831 -0.622 . . . . 31.31 113.394 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.77 70.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.701 -0.481 . . . . 75.54 109.701 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 81' ' ' LYS . 18.4 t70 -155.71 83.74 3.54 Favored Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 108.568 -0.901 . . . . 71.31 108.568 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.65 -51.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.995 1.797 . . . . 60.24 114.417 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -38.93 20.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.273 1.582 . . . . 70.51 115.273 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 2.2 tm? -66.2 -52.04 51.82 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.815 -0.439 . . . . 62.22 109.815 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 30.0 mtpp -58.67 -31.29 68.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.098 0.777 . . . . 63.22 113.098 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -62.21 -45.09 94.92 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.204 0.526 . . . . 33.25 110.186 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 m -72.75 -33.72 66.55 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.098 -0.501 . . . . 61.25 110.332 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.05 92.18 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.19 -0.764 . . . . 71.3 111.19 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -69.67 -36.09 75.71 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 111.674 0.25 . . . . 73.24 111.674 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.44 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.681 0.277 . . . . 53.42 110.897 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.29 -41.24 90.07 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.342 -0.614 . . . . 73.14 109.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.16 -43.94 81.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.868 -0.605 . . . . 72.43 110.548 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.48 -36.83 76.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.172 -0.467 . . . . 45.5 110.935 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.32 89.21 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.049 -0.723 . . . . 62.45 109.049 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -41.92 85.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.188 -0.914 . . . . 75.01 109.788 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.573 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 17.4 m-85 -57.91 -50.3 73.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.44 0.533 . . . . 74.14 112.44 174.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.9 -31.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.049 -0.66 . . . . 73.2 110.965 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -34.59 76.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.42 111.205 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.56 -43.34 99.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.138 0.971 . . . . 74.11 109.436 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.5 mm-40 -73.81 -12.53 60.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.377 -1.283 . . . . 71.21 110.899 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.12 30.56 46.08 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.009 -0.541 . . . . 54.45 112.467 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -97.36 172.1 7.99 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 122.521 -0.399 . . . . 74.31 110.0 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.98 169.43 17.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.715 -0.476 . . . . 62.25 109.715 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -159.51 179.3 9.03 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.205 -0.665 . . . . 64.24 109.205 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.12 120.26 37.79 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.482 -0.562 . . . . 72.41 109.482 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.37 -149.75 16.71 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.955 -1.117 . . . . 73.02 110.961 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.3 146.03 45.62 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.222 -1.399 . . . . 64.01 107.222 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.99 109.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.388 -0.597 . . . . 73.23 109.388 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.15 122.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.578 0.704 . . . . 74.43 110.364 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' TYR . 78.4 t -118.93 123.51 71.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 74.13 109.106 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -117.33 147.03 42.97 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.191 -0.67 . . . . 74.21 109.191 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.36 123.61 45.72 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.25 -1.389 . . . . 74.03 107.25 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.96 176.16 8.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.674 0.273 . . . . 64.34 110.966 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 25.7 pt20 -113.03 164.72 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.918 -0.583 . . . . 64.51 111.219 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.3 p -151.01 148.81 28.81 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 107.513 -1.292 . . . . 52.42 107.513 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -81.02 -24.89 37.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.257 0.551 . . . . 61.32 109.939 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.66 -21.92 59.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 115.991 -0.549 . . . . 75.45 112.479 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.36 131.73 41.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 C-N-CA 120.097 -0.641 . . . . 75.53 109.589 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -114.04 156.42 24.15 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.537 -0.912 . . . . 71.15 108.537 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.1 m -51.83 110.68 0.5 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.065 0.853 . . . . 73.1 111.541 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 134.56 -33.96 2.42 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 109.125 -1.59 . . . . 71.21 109.125 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.17 144.98 31.21 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.783 -0.708 . . . . 74.11 109.282 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -157.87 160.3 37.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.982 -1.488 . . . . 74.53 106.982 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -145.43 147.65 32.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.238 -0.653 . . . . 70.52 109.238 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -122.79 132.74 54.35 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 104.651 -2.352 . . . . 52.11 104.651 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' A' ' 122' ' ' ARG . 4.9 tmm_? -136.5 135.55 38.65 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.31 -1.367 . . . . 43.14 107.31 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.42 155.48 17.53 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.298 -1.121 . . . . 73.4 110.298 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.7 t -149.77 161.47 42.17 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.916 -0.772 . . . . 73.2 108.916 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.9 110.57 20.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.955 -1.498 . . . . 52.51 106.955 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.441 ' ND2' ' HB ' ' A' ' 129' ' ' VAL . 44.8 t30 -125.67 93.56 44.21 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 116.603 -0.271 . . . . 74.42 110.709 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -89.87 -6.23 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.31 2.007 . . . . 71.23 110.376 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.96 27.58 1.79 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.228 1.011 . . . . 74.14 109.494 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.441 ' HB ' ' ND2' ' A' ' 126' ' ' ASN . 8.2 p -99.73 126.79 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 107.95 -1.13 . . . . 72.05 107.95 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -69.26 161.35 29.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 53.43 111.649 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 t -149.86 164.12 36.21 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.258 -1.386 . . . . 71.24 107.258 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 117.946 -1.026 . . . . 63.31 108.802 176.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.564 -0.532 . . . . 71.23 109.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.51 12.22 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 108.318 -1.913 . . . . 75.15 108.318 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -91.38 15.84 11.36 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.449 -0.876 . . . . 63.23 113.273 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -83.06 71.82 10.12 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.015 0.912 . . . . 71.02 110.346 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -117.3 97.87 6.13 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 114.512 -1.222 . . . . 70.03 107.849 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -84.87 80.67 9.2 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.04 0.924 . . . . 64.2 110.084 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.5 tp -150.56 92.13 1.82 Allowed 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.666 -1.606 . . . . 73.1 109.267 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.13 144.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.229 -1.397 . . . . 75.41 107.229 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -78.71 70.66 5.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.445 0.64 . . . . 64.12 112.4 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -99.52 83.89 2.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.21 1.005 . . . . 64.14 109.616 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.86 149.25 27.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 106.907 -1.516 . . . . 75.12 106.907 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -117.7 147.32 43.04 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.801 -0.76 . . . . 62.55 111.429 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -145.57 126.86 14.85 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 105.74 -1.948 . . . . 63.02 105.74 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -84.34 122.46 28.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.533 -1.654 . . . . 63.4 106.533 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.79 65.95 7.15 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.164 0.983 . . . . 55.41 110.616 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.08 82.55 8.38 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.463 -1.31 . . . . 54.03 107.463 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 12.2 mm-40 -94.1 105.87 17.85 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.961 -1.018 . . . . 73.32 108.77 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -149.78 144.02 25.76 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 115.209 -0.905 . . . . 64.52 111.235 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.56 9.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.552 -1.204 . . . . 65.22 108.306 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 -70.67 0.21 Allowed Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.704 -0.958 . . . . 72.45 110.704 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 5.2 p-10 -83.12 9.27 10.81 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.468 -0.43 . . . . 72.54 111.738 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.55 97.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.831 0.452 . . . . 64.44 111.893 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' HA ' HG12 ' A' ' 26' ' ' ILE . 81.2 m-85 -68.75 -32.09 71.62 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.479 -0.782 . . . . 74.02 111.024 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.36 71.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.4 0.619 . . . . 75.41 109.741 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 28.1 mmt180 -71.65 -34.52 69.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.892 -0.595 . . . . 70.41 110.255 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 23' ' ' PHE . 45.3 pt -87.99 -47.77 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 65.43 113.656 -176.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -30.19 29.82 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.188 -0.605 . . . . 73.32 111.405 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.94 -49.96 0.91 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.022 -1.085 . . . . 34.22 111.502 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.32 -34.03 0.03 OUTLIER Glycine 0 C--N 1.31 -0.864 0 C-N-CA 119.912 -1.137 . . . . 74.11 114.022 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 144.95 34.49 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.771 0.656 . . . . 64.11 112.771 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HA ' ' HB2' ' A' ' 23' ' ' PHE . 35.7 pt -95.81 -11.48 8.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.881 0.848 . . . . 54.42 110.375 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.54 170.01 6.74 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 106.827 -1.545 . . . . 73.32 106.827 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 16.7 Cg_exo -70.56 30.55 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.879 2.386 . . . . 65.31 114.531 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.47 -48.73 79.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.323 0.649 . . . . 74.31 111.491 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -25.61 66.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.165 0.507 . . . . 73.41 110.835 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.15 -44.69 49.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.292 -1.003 . . . . 54.24 108.292 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 45.7 mt-10 -61.59 -34.73 76.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.189 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 42' ' ' ARG . . . -61.61 -57.74 10.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.228 -0.896 . . . . 62.12 109.638 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.4 tm? -56.94 -44.52 82.6 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.471 -0.566 . . . . 73.41 109.471 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 HD22 ' A' ' 89' ' ' LEU . 92.5 mt -58.43 -52.51 65.32 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.488 0.551 . . . . 72.35 112.488 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 17.9 ptp180 -65.29 -30.22 71.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.929 0.395 . . . . 71.11 110.678 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 35.8 mmt180 -76.38 -37.66 56.86 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.067 -0.515 . . . . 71.41 110.713 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 122' ' ' ARG . 21.6 tt0 -78.15 -27.48 48.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.827 -0.749 . . . . 71.23 110.416 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.14 91.87 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.148 -0.686 . . . . 65.43 109.148 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.38 -32.81 68.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.42 110.957 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.67 -42.2 78.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.782 -0.644 . . . . 72.33 111.211 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.95 9.55 59.89 Favored Glycine 0 C--N 1.319 -0.414 0 CA-C-N 116.134 -0.484 . . . . 72.22 113.157 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 14.1 mm -62.1 130.64 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.447 0.641 . . . . 74.14 111.588 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.7 mt-30 -110.54 134.95 51.91 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 115.517 -0.765 . . . . 71.33 110.087 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -78.65 91.68 4.66 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.639 -1.164 . . . . 64.33 108.195 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 24.3 tp -104.4 -165.77 1.18 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.205 -1.405 . . . . 74.42 107.205 -176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 54.1 mt-30 -45.15 145.55 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.227 0.611 . . . . 72.1 110.647 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.35 15.83 1.9 Allowed Glycine 0 C--O 1.218 -0.904 0 CA-C-N 116.003 -0.544 . . . . 73.22 113.26 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 52' ' ' GLN . 2.4 m-20 -70.17 -44.95 67.71 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.654 -1.61 . . . . 74.41 106.654 175.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 177.35 166.09 0.6 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-N 113.82 -1.536 . . . . 64.43 109.045 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -90.64 151.09 21.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 120.89 0.376 . . . . 74.32 110.914 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 36.6 tp -93.62 131.58 38.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.492 -0.776 . . . . 74.41 108.985 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.49 162.54 33.7 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.128 -0.693 . . . . 75.44 109.128 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 125' ' ' VAL . 30.4 Cg_exo -66.16 159.33 50.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.752 2.302 . . . . 73.03 112.602 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 4.8 p-10 -130.23 -19.52 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.328 -0.397 . . . . 71.4 111.145 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.08 112.46 25.13 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.548 -0.908 . . . . 63.03 108.548 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 75.8 m-85 -118.54 114.24 22.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.067 0.937 . . . . 64.11 110.865 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.9 mt -104.93 104.21 16.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.322 -1.308 . . . . 71.41 108.56 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 HG13 ' A' ' 106' ' ' VAL . 3.0 mp -96.49 128.53 47.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.9 -0.778 . . . . 63.31 108.9 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.3 m -121.1 129.02 53.12 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 116.119 -0.491 . . . . 73.33 111.74 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -120.81 174.87 6.33 Favored 'General case' 0 C--O 1.255 1.382 0 O-C-N 124.738 1.273 . . . . 71.24 109.326 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.7 -174.0 41.32 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 110.265 -1.134 . . . . 31.45 110.265 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.68 -51.19 23.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 114.523 1.305 . . . . 63.13 114.523 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.4 -42.07 83.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.547 0.689 . . . . 71.44 110.358 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.37 -32.27 66.31 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.851 -1.068 . . . . 74.11 112.759 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -66.26 -31.84 72.9 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 119.86 -0.736 . . . . 70.12 109.302 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.96 -23.15 67.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.387 0.514 . . . . 74.22 112.387 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -83.21 -28.65 29.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.8 0.333 . . . . 74.24 110.198 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.497 HD11 ' HG ' ' A' ' 66' ' ' LEU . 57.8 mt -70.54 -37.94 74.13 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 109.011 -0.737 . . . . 72.53 109.011 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 150.14 8.64 Favored Glycine 0 N--CA 1.411 -2.994 0 CA-C-N 114.816 -1.084 . . . . 75.32 111.231 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -78.23 1.49 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.173 0.511 . . . . 73.43 110.992 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.14 92.07 4.29 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 121.934 0.874 . . . . 74.22 109.688 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.8 Cg_exo -75.51 -30.31 6.59 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.418 1.412 . . . . 62.53 110.03 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -45.65 -53.43 9.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.699 2.0 . . . . 72.13 113.078 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.69 -48.34 72.37 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.612 -0.722 . . . . 53.55 110.245 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -74.58 -38.61 62.62 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.85 1.056 . . . . 75.41 113.85 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 p -62.87 -51.69 66.02 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.71 0.633 . . . . 74.04 112.71 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -65.49 -43.13 91.13 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-N 116.244 -0.434 . . . . 73.33 111.365 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.34 52.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.049 -0.596 . . . . 73.1 112.239 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -70.65 -23.66 62.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.832 0.349 . . . . 73.25 110.095 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.48 -45.93 81.73 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.024 0.44 . . . . 74.22 109.86 175.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.27 -36.72 74.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.779 -0.646 . . . . 73.53 109.853 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -62.33 -40.81 97.59 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.275 -0.875 . . . . 73.31 110.629 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 40' ' ' LEU . 54.7 tp -72.13 -31.88 66.41 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.759 0.314 . . . . 73.24 111.06 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.0 85.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.719 0.771 . . . . 63.23 109.299 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.89 -39.87 91.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.671 -1.15 . . . . 64.13 109.702 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 12.2 m-85 -57.82 -52.25 66.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.015 -0.539 . . . . 75.14 112.201 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 pt -66.9 -33.42 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.221 -0.591 . . . . 73.44 111.327 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.94 -31.09 69.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.57 . . . . 62.32 110.781 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.53 -30.32 69.09 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.244 0.545 . . . . 72.33 111.386 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 54.8 mm-40 -86.74 -10.62 53.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.399 0.618 . . . . 65.2 109.741 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.57 21.37 58.26 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.709 -0.678 . . . . 73.14 113.362 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.419 ' CD2' HD11 ' A' ' 48' ' ' ILE . 24.6 m0 -93.67 150.82 20.1 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.085 0.469 . . . . 70.21 111.488 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -112.47 168.49 9.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.541 -0.754 . . . . 73.55 110.215 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.7 t -162.72 160.61 25.66 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.704 -0.85 . . . . 65.44 108.704 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -93.52 119.03 32.09 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.457 -1.312 . . . . 74.33 107.457 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.84 -150.35 16.75 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.78 -1.328 . . . . 61.14 109.78 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.75 153.82 47.82 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.517 -0.549 . . . . 71.21 109.517 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.68 123.27 32.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 123.637 0.586 . . . . 63.44 110.731 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.56 130.48 71.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.259 -0.882 . . . . 63.41 109.128 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 64' ' ' ILE . 54.9 t -123.97 117.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.07 -1.085 . . . . 54.11 108.07 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.97 148.49 44.02 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.811 -0.756 . . . . 71.24 109.887 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.75 129.24 56.18 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.381 -1.34 . . . . 73.23 107.381 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.61 158.97 43.24 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.039 0.447 . . . . 64.4 110.296 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -102.15 143.31 32.12 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.311 -0.859 . . . . 73.44 109.092 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 133.25 26.95 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 109.572 -0.529 . . . . 41.44 109.572 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.7 m -69.21 -20.43 63.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.142 0.496 . . . . 74.42 110.559 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.6 3.19 12.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.481 1.112 . . . . 71.02 111.408 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 115' ' ' HIS . 2.0 tm? -132.83 149.4 52.27 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.383 -2.08 . . . . 75.22 105.383 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.494 ' N ' HD13 ' A' ' 114' ' ' LEU . 36.7 t-80 -148.2 159.97 43.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.566 -0.531 . . . . 71.01 109.566 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 m -43.97 125.24 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.673 1.989 . . . . 71.31 111.926 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.61 -34.76 4.51 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 108.672 -1.771 . . . . 31.32 108.672 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -106.94 156.82 18.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.177 -1.045 . . . . 71.35 108.177 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -169.48 151.72 4.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.321 -2.103 . . . . 75.24 105.321 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -157.11 151.07 24.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.276 -0.969 . . . . 75.51 109.982 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -118.9 139.29 51.89 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.597 -1.261 . . . . 43.14 107.597 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 2.4 tpm_? -111.87 117.79 33.74 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.384 -0.969 . . . . 74.14 108.384 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.57 109.18 3.04 Favored Glycine 0 C--N 1.291 -1.934 0 O-C-N 123.871 0.732 . . . . 75.0 111.629 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 p -123.64 162.0 23.92 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.33 0.652 . . . . 72.21 111.138 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.1 t -101.4 131.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 105.069 -2.197 . . . . 73.21 105.069 173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -112.98 130.8 23.19 Favored Pre-proline 0 C--N 1.295 -1.785 0 C-N-CA 118.542 -1.263 . . . . 74.52 111.375 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.24 -4.79 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.219 1.946 . . . . 74.23 110.402 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -97.96 64.77 1.73 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.538 0.685 . . . . 55.33 111.7 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.79 104.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.824 -1.08 . . . . 63.14 108.319 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.65 156.1 27.77 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.372 0.606 . . . . 74.01 111.864 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.2 t -129.32 108.75 10.55 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.227 1.013 . . . . 72.24 109.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.2 m80 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.848 -1.168 . . . . 73.11 107.848 -179.613 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 75.1 110.368 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.9 152.13 52.02 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.819 -0.913 . . . . 64.21 110.819 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 p -88.5 120.12 29.58 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.147 -0.686 . . . . 72.5 109.147 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.3 109.05 2.96 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.202 -1.036 . . . . 54.13 108.202 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -78.02 78.62 4.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.417 -0.957 . . . . 73.34 108.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.19 94.96 1.61 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 122.26 1.029 . . . . 74.1 111.095 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -116.38 80.96 1.54 Allowed 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 106.117 -1.808 . . . . 63.55 106.117 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -111.32 95.83 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.384 -1.28 . . . . 64.14 107.612 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -88.12 110.44 20.67 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.159 -0.928 . . . . 51.42 110.449 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -118.83 78.93 1.32 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.07 -1.085 . . . . 74.03 108.07 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.88 87.71 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.78 -1.563 . . . . 75.31 106.78 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.48 141.95 36.28 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.258 -1.015 . . . . 53.51 108.258 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -84.97 92.88 8.43 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.768 -0.827 . . . . 73.54 108.768 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.54 108.0 8.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.679 0.752 . . . . 74.2 109.865 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 mt -117.09 77.34 1.11 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.252 -1.018 . . . . 63.25 108.252 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.04 100.68 12.33 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.363 -0.835 . . . . 70.42 110.421 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.27 6.55 44.67 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.135 -0.939 . . . . 63.55 110.157 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -64.71 125.4 24.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.335 -1.357 . . . . 70.41 107.335 172.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 p -154.38 133.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.335 0.588 . . . . 53.12 111.512 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 68.94 2.6 Favored Glycine 0 N--CA 1.431 -1.672 0 CA-C-N 115.723 -0.672 . . . . 43.23 112.537 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.96 -23.78 66.6 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 111.68 0.252 . . . . 64.51 111.68 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.39 73.24 Favored 'General case' 0 C--O 1.213 -0.826 0 O-C-N 123.573 0.545 . . . . 62.1 110.093 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -60.11 -39.89 87.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.001 -0.545 . . . . 74.42 110.62 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.32 83.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.834 -0.621 . . . . 73.13 111.262 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -81.74 -20.36 39.48 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.88 -0.512 . . . . 72.44 112.098 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.6 -49.23 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.343 -0.223 . . . . 70.04 111.504 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 80.2 m-85 -101.76 -25.45 13.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.089 0.403 . . . . 73.45 112.089 -175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.39 -79.24 1.85 Allowed Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.494 -0.86 . . . . 60.33 111.493 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.41 65.29 0.27 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.673 -0.571 . . . . 50.55 111.673 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 32.6 t -103.97 161.63 13.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.96 -0.755 . . . . 73.22 108.96 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.6 tt -66.0 138.44 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 109.013 -0.736 . . . . 71.05 109.013 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.2 113.91 15.99 Favored Pre-proline 0 C--O 1.243 0.76 0 CA-C-N 116.156 -0.474 . . . . 71.14 110.205 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.36 -26.49 76.97 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.82 2.347 . . . . 73.22 111.872 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' CG ' ' A' ' 37' ' ' GLU . 20.9 mp0 -65.17 -28.3 69.31 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 113.188 0.811 . . . . 75.01 113.188 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.33 -31.23 43.07 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.177 -1.046 . . . . 71.45 108.177 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.53 -53.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.089 -0.959 . . . . 61.0 109.533 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.34 -29.9 71.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.599 -0.273 . . . . 71.13 111.376 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.49 95.65 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.276 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.12 -37.36 58.17 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 120.705 -0.398 . . . . 63.12 110.461 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 62' ' ' TYR . 4.1 mm? -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.695 -0.402 . . . . 64.14 112.069 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -69.28 -27.56 65.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.362 -0.607 . . . . 72.03 109.362 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -70.22 -40.8 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.209 -0.663 . . . . 71.33 109.209 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -61.13 -43.39 98.96 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 123.446 0.466 . . . . 74.34 110.677 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -60.21 -47.22 86.89 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.613 -0.721 . . . . 54.54 110.381 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.88 -32.46 72.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 63.11 111.849 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.88 -32.15 51.74 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.446 0.641 . . . . 72.13 110.366 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.05 16.22 61.02 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.548 -0.751 . . . . 74.55 113.418 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 mm -63.04 131.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.14 0.576 . . . . 72.03 111.932 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.8 mt-30 -117.16 144.15 45.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.214 -0.903 . . . . 72.13 109.472 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.2 m -71.49 114.73 9.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.053 -0.976 . . . . 64.32 109.87 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 25.7 tp -122.7 -176.94 3.51 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.068 -1.456 . . . . 74.52 107.068 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 78.0 mt-30 -53.69 164.42 0.55 Allowed 'General case' 0 C--O 1.246 0.914 0 C-N-CA 124.601 1.16 . . . . 74.24 113.525 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.27 -9.46 23.23 Favored Glycine 0 CA--C 1.504 -0.643 0 CA-C-N 114.921 -1.036 . . . . 63.24 114.734 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -74.7 -43.9 52.76 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.043 -0.663 . . . . 64.43 111.518 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.4 ptp180 -175.82 167.09 3.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.3 0.482 . . . . 73.02 112.3 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.82 151.86 20.39 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.438 1.095 . . . . 71.51 111.403 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.4 tm? -90.73 131.44 36.4 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.07 -1.085 . . . . 62.34 108.07 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.74 162.65 35.56 Favored Pre-proline 0 C--N 1.311 -1.107 0 C-N-CA 123.559 0.744 . . . . 52.42 110.005 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.6 Cg_exo -57.42 161.98 10.83 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.38 2.72 . . . . 72.12 113.958 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -131.36 -32.71 1.53 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.464 -0.789 . . . . 72.34 111.719 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.56 106.73 18.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.278 -1.379 . . . . 73.22 107.278 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.46 ' HB2' HG12 ' A' ' 106' ' ' VAL . 96.7 m-85 -112.16 116.15 30.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.216 0.531 . . . . 75.33 110.463 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.12 114.5 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.258 -0.883 . . . . 73.15 109.574 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.45 125.98 70.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.999 -0.741 . . . . 61.34 108.999 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -110.9 126.53 54.81 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.902 -0.777 . . . . 73.41 108.902 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.69 160.86 20.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.014 -0.736 . . . . 74.22 109.014 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.49 145.04 49.22 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 108.625 -1.79 . . . . 55.25 108.625 172.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.8 p -52.57 -37.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 113.01 0.744 . . . . 62.14 113.01 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.17 -22.67 62.01 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.475 0.655 . . . . 74.34 111.255 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 29.8 m-20 -85.87 -35.25 20.7 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 121.552 -0.717 . . . . 73.52 110.279 175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -63.16 -24.86 68.08 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.087 -0.96 . . . . 74.34 109.444 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 38.2 mt-10 -58.29 -33.6 69.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 111.917 0.34 . . . . 65.43 111.917 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 70' ' ' ASP . 4.2 mppt? -81.08 -34.68 32.5 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.327 -0.549 . . . . 71.54 109.931 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.4 mt -68.58 -35.36 77.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.52 0.676 . . . . 72.44 110.224 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 6.32 39.2 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.786 -1.097 . . . . 43.54 113.973 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.29 97.54 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.613 -1.254 . . . . 73.22 107.613 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 9.3 m-20 -148.25 82.74 7.49 Favored Pre-proline 0 CA--C 1.508 -0.656 0 N-CA-C 106.175 -1.787 . . . . 73.31 106.175 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.05 -47.64 23.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.511 2.14 . . . . 72.03 111.694 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -46.66 71.98 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.198 -0.91 . . . . 74.52 111.046 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.36 -53.7 54.5 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.386 -0.598 . . . . 73.42 109.386 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 77' ' ' ASP . 14.1 mptt -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.864 -0.607 . . . . 74.03 111.778 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -67.37 -45.28 76.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.891 -0.324 . . . . 71.04 110.942 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.4 m -62.42 -44.33 96.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.239 0.216 . . . . 74.44 111.023 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.17 -46.6 90.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.017 -0.611 . . . . 72.2 112.059 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.71 -35.87 82.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 110.34 -0.244 . . . . 72.42 110.34 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -63.19 -46.62 86.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.628 0.251 . . . . 74.32 110.581 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.43 -44.61 90.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.129 -0.487 . . . . 65.53 111.003 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.4 -34.08 75.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.559 0.578 . . . . 72.41 112.559 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.34 -35.16 65.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.997 0.427 . . . . 55.33 110.181 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.78 81.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.799 0.809 . . . . 73.5 109.678 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.57 -38.88 88.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.906 -1.043 . . . . 65.54 109.022 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -59.36 -49.09 79.15 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.41 -0.814 . . . . 63.33 111.918 175.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -66.38 -30.5 50.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 120.32 -0.552 . . . . 70.23 111.006 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -64.02 -43.3 96.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.433 -0.349 . . . . 63.42 110.537 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.86 -32.77 72.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.074 0.464 . . . . 71.2 112.072 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 64.8 mm-40 -81.45 -13.21 58.47 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.197 0.522 . . . . 55.3 111.452 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 84.55 34.42 16.43 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.764 -0.653 . . . . 50.31 111.669 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -110.71 173.98 6.08 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.88 -0.415 . . . . 64.43 109.88 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -155.84 174.0 15.96 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.328 -0.99 . . . . 44.11 108.328 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -147.33 176.4 10.03 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.681 -0.859 . . . . 53.42 108.681 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -99.06 120.14 38.98 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.277 -1.379 . . . . 72.33 107.277 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.9 -149.81 16.83 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.999 -1.64 . . . . 61.24 108.999 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -132.47 144.44 50.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.375 -1.343 . . . . 74.32 107.375 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.05 124.24 20.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.213 0.53 . . . . 74.23 112.008 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.93 120.51 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.408 -0.815 . . . . 64.33 110.045 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 62' ' ' TYR . 14.8 m -106.65 147.5 11.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.774 -1.195 . . . . 35.23 107.774 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -137.31 142.12 41.88 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.841 -0.8 . . . . 71.13 108.841 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -114.19 134.75 54.7 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.03 -0.532 . . . . 62.04 109.655 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.3 159.81 35.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.122 0.487 . . . . 71.23 110.001 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -107.56 155.1 20.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.51 -0.768 . . . . 72.51 109.828 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -138.99 140.12 38.1 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.695 -1.224 . . . . 74.4 107.695 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 m -82.08 -27.43 32.92 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.343 0.592 . . . . 71.11 110.067 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -80.57 -34.51 35.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.596 -0.729 . . . . 75.22 109.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 tp -77.45 133.37 38.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.168 -1.789 . . . . 73.11 106.168 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' CG ' ' H ' ' A' ' 116' ' ' THR . 12.5 t-80 -116.5 172.35 7.27 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.848 -1.541 . . . . 65.24 112.311 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.612 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 21.9 m -50.59 132.02 25.48 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 125.668 1.587 . . . . 73.32 113.387 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.62 -6.13 83.29 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.634 -1.166 . . . . 72.44 112.247 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.36 136.17 54.79 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.893 -1.151 . . . . 75.02 107.893 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.3 159.96 42.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.945 -0.391 . . . . 75.4 109.945 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 mmp_? -133.17 137.31 46.17 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.811 -0.811 . . . . 74.32 108.811 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.23 44.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.788 -0.819 . . . . 72.44 108.788 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -139.7 131.87 28.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.455 -0.572 . . . . 74.53 109.455 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.82 128.56 8.5 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.825 -0.91 . . . . 62.41 110.825 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.4 m -123.33 144.76 49.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 109.347 -0.612 . . . . 74.45 109.347 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 59' ' ' PRO . 89.8 t -93.92 105.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.003 -1.11 . . . . 74.12 108.003 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.62 110.35 48.68 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.873 -1.158 . . . . 73.41 107.873 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.77 -20.9 7.45 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.613 1.542 . . . . 73.2 111.608 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.97 72.42 2.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.473 1.13 . . . . 71.24 109.275 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.43 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 113.374 -1.739 . . . . 72.3 107.156 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.48 116.24 8.0 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.88 -1.896 . . . . 62.21 105.88 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 t -156.11 165.08 37.49 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.934 -0.765 . . . . 74.4 108.934 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 N--CA 1.422 -1.827 0 N-CA-C 107.046 -1.465 . . . . 64.54 107.046 179.866 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.561 -0.533 . . . . 74.22 109.561 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.74 -128.1 20.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.954 -0.641 . . . . 30.5 111.98 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -80.98 0.18 36.7 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.485 0.714 . . . . 74.33 112.139 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -74.24 75.16 1.82 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.239 0.542 . . . . 74.12 111.33 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -133.1 160.2 37.89 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.004 -1.11 . . . . 72.43 108.004 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.37 119.8 33.2 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.075 -0.713 . . . . 72.33 109.075 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pp -69.89 138.14 52.23 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.93 -0.577 . . . . 64.31 110.789 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.39 71.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.843 0.83 . . . . 73.23 110.413 -174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -174.73 104.13 0.09 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.544 -1.207 . . . . 75.04 108.003 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -139.58 -159.74 0.99 Allowed 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.065 -1.087 . . . . 71.21 108.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.85 90.67 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 119.699 -0.8 . . . . 55.33 110.732 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -77.15 7.2 5.32 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.766 -0.584 . . . . 74.11 111.197 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.42 -13.48 62.06 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.714 0.635 . . . . 62.44 112.714 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -112.52 15.89 19.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.483 0.659 . . . . 75.33 109.918 174.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' HG2' ' A' ' 14' ' ' LYS . 8.7 mp -118.16 108.31 15.02 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.644 -0.707 . . . . 71.32 110.088 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.01 -5.37 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.617 0.723 . . . . 74.54 109.31 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -88.57 151.44 22.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.357 -1.292 . . . . 44.42 108.875 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -90.09 134.97 33.94 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.979 -0.748 . . . . 50.23 108.979 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.15 93.12 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 122.629 1.204 . . . . 73.12 109.197 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.07 54.02 4.51 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 114.714 -1.13 . . . . 75.24 113.164 -174.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.5 -42.87 93.16 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 123.135 0.574 . . . . 70.22 111.413 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -67.51 -52.74 35.5 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.106 -0.952 . . . . 64.52 109.494 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -54.73 -44.75 73.82 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.356 -0.838 . . . . 75.33 112.064 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.4 92.63 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 120.757 0.313 . . . . 65.42 111.019 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -77.17 -30.89 55.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.372 -0.376 . . . . 72.15 111.767 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.2 mt -65.82 -57.13 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.659 -0.497 . . . . 74.13 109.659 176.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CB ' ' HB ' ' A' ' 31' ' ' ILE . 35.7 m-85 -68.79 -29.0 67.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 64.25 111.82 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.65 -92.95 1.81 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 111.675 -0.57 . . . . 73.43 111.675 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 -44.26 0.95 Allowed Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.257 -0.973 . . . . 60.31 112.863 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -87.77 97.33 10.84 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.968 0.413 . . . . 63.14 110.721 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.492 ' HB ' ' CB ' ' A' ' 27' ' ' PHE . 6.8 tt -154.98 101.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.73 0.776 . . . . 72.24 112.151 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.71 94.49 47.48 Favored Pre-proline 0 C--N 1.296 -1.727 0 N-CA-C 108.742 -0.836 . . . . 75.42 108.742 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.31 -17.79 39.45 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.718 2.279 . . . . 75.42 112.563 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.96 -25.92 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.368 -0.833 . . . . 74.2 110.494 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -34.46 75.49 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.608 0.595 . . . . 72.02 112.608 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.42 -51.68 35.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.555 . . . . 74.22 109.5 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.7 pt-20 -66.79 -30.05 70.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.594 -0.275 . . . . 61.45 111.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.65 -39.19 93.1 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.149 0.5 . . . . 53.11 109.873 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -71.11 -45.93 62.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.503 -0.925 . . . . 71.41 108.503 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 40' ' ' LEU 0.268 3.7 mm? -67.69 -33.69 75.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.586 1.328 . . . . 72.11 114.586 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 2.5 ptm180 -67.48 -32.47 73.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 119.806 -0.758 . . . . 54.43 109.085 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -35.8 69.26 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.326 -0.62 . . . . 71.43 109.326 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.9 -43.91 91.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.469 -0.567 . . . . 75.41 109.469 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -48.08 82.95 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.632 -0.713 . . . . 75.1 110.47 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.98 85.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.019 -0.537 . . . . 71.22 111.732 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -72.51 -39.91 67.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.137 0.494 . . . . 72.23 109.753 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.58 31.36 6.17 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.272 -0.876 . . . . 73.1 113.311 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 56' ' ' LEU . 17.7 mm -71.65 130.35 35.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.185 -0.672 . . . . 55.01 109.185 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 31.8 tt0 -107.74 136.56 47.27 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.667 -0.864 . . . . 74.43 108.667 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -67.59 107.44 2.51 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.764 0.793 . . . . 72.22 111.093 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.4 tp -118.12 -166.34 1.2 Allowed 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.065 -2.198 . . . . 70.02 105.065 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.605 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 52.6 mt-30 -51.77 152.55 2.84 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 123.245 0.618 . . . . 74.23 111.631 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.45 -3.28 18.85 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-N 116.087 -0.506 . . . . 74.22 113.453 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -65.23 -46.69 79.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.868 -1.16 . . . . 74.22 107.868 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -174.68 154.75 2.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.841 -1.072 . . . . 73.04 110.901 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.3 mt -90.56 151.79 21.18 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.563 -1.199 . . . . 65.43 109.878 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 40.6 tp -92.92 128.99 38.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.911 -0.586 . . . . 72.44 109.458 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.54 154.16 42.49 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 109.203 -0.665 . . . . 64.53 109.203 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 125' ' ' VAL . 38.8 Cg_exo -62.21 155.78 54.48 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.724 2.283 . . . . 63.1 112.396 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -127.49 -24.17 3.37 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.959 -0.564 . . . . 73.22 110.707 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.45 112.54 24.53 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.283 -1.006 . . . . 73.31 108.283 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.4 m-85 -121.93 122.37 39.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.34 0.59 . . . . 74.31 110.701 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.3 mt -120.08 116.47 50.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.088 -0.708 . . . . 75.55 109.088 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.09 126.0 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.257 -1.016 . . . . 70.43 108.257 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.81 117.27 32.36 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.64 -0.709 . . . . 71.11 109.204 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.5 mm? -100.72 161.69 13.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 122.82 0.448 . . . . 73.43 109.953 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.02 150.02 51.66 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.324 -1.91 . . . . 71.21 108.324 170.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.01 -35.01 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 117.325 0.562 . . . . 74.12 112.389 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.57 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 20.6 t60 -73.12 -28.89 62.52 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 116.021 -0.536 . . . . 63.52 110.576 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -85.72 -24.21 27.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.545 -0.722 . . . . 70.25 110.462 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.54 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 82.4 t80 -64.74 -41.35 95.99 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.277 0.56 . . . . 75.13 110.089 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.74 -25.54 65.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.032 -0.531 . . . . 73.0 111.008 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 2.1 mptm? -75.22 -22.57 57.84 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.23 -0.895 . . . . 74.51 111.763 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.0 -31.13 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.668 -1.234 . . . . 70.14 107.668 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.96 -162.73 15.62 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.642 -1.163 . . . . 71.31 111.69 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.14 -37.37 38.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.004 -0.739 . . . . 64.5 109.004 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -115.71 97.06 48.13 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.522 -0.763 . . . . 64.44 110.385 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.49 -33.5 22.54 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 121.962 1.775 . . . . 74.33 109.525 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.96 -22.29 59.89 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.55 -1.204 . . . . 63.33 111.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.2 tp -54.48 -45.37 73.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.203 -0.665 . . . . 63.23 109.203 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.54 -26.38 19.76 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 115.698 -0.683 . . . . 61.21 110.739 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -55.28 -51.14 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.15 0.432 . . . . 52.2 111.936 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.2 m -56.07 -45.57 79.29 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.127 0.489 . . . . 65.45 111.047 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.81 -43.25 75.6 Favored Glycine 0 C--O 1.206 -1.626 0 C-N-CA 120.907 -0.663 . . . . 25.3 111.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -61.17 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.168 0.987 . . . . 74.44 110.152 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.75 -45.91 92.49 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.546 -0.752 . . . . 63.32 109.837 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -75.34 -24.71 57.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.617 -0.719 . . . . 71.33 112.212 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.67 -51.47 59.23 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.092 -1.077 . . . . 73.13 108.092 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.72 -42.76 99.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.11 -0.95 . . . . 71.55 109.583 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -60.87 -39.09 87.88 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.157 -0.474 . . . . 72.41 111.192 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 23.1 t70 -72.83 -36.39 67.48 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.655 -0.498 . . . . 60.14 109.655 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.9 m-85 -59.26 -44.98 92.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.101 -0.5 . . . . 74.41 111.515 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -70.19 -25.43 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.372 -0.531 . . . . 45.33 111.293 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 79.5 mt-30 -66.69 -42.54 86.31 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.745 -0.835 . . . . 72.13 108.745 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 58.4 mt-10 -63.83 -26.68 68.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.458 -0.792 . . . . 72.13 111.227 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.5 mm-40 -92.95 -13.73 28.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 75.34 110.794 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.24 28.35 56.1 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.811 -0.632 . . . . 63.52 113.128 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -97.13 173.45 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.238 -0.653 . . . . 72.45 109.238 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.442 ' NE2' HD23 ' A' ' 51' ' ' LEU . 26.6 pt20 -132.32 165.75 23.49 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 122.458 -0.151 . . . . 72.23 110.822 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.8 t -154.15 158.15 39.94 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.449 -1.315 . . . . 74.25 107.449 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.14 120.7 37.89 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.379 -0.529 . . . . 71.13 110.989 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.04 -169.31 13.81 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.825 -1.31 . . . . 73.54 109.825 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -92.32 143.96 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.027 -0.731 . . . . 75.42 109.027 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 90' ' ' ALA . 6.1 p -80.85 115.09 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.923 0.868 . . . . 75.33 109.953 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.44 128.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 115.237 -0.892 . . . . 64.35 110.092 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 8.6 p -133.81 141.54 43.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.406 -0.961 . . . . 75.34 108.406 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -137.45 149.9 47.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.129 -0.628 . . . . 62.02 109.821 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -115.34 114.57 25.3 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.096 -1.446 . . . . 63.11 107.096 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.09 167.42 11.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.644 -0.502 . . . . 33.43 109.644 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.8 pt20 -104.57 160.47 14.92 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.416 0.626 . . . . 53.23 110.68 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -140.5 130.84 25.17 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.068 -0.969 . . . . 72.13 108.885 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -81.19 -5.74 58.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.501 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -88.87 -20.57 24.43 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.055 0.455 . . . . 75.25 110.758 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.0 mt -94.73 142.96 26.84 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.144 0.497 . . . . 61.04 110.299 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -98.12 173.07 7.21 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.399 -0.819 . . . . 64.33 109.787 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 m -53.68 118.38 3.88 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 124.197 0.936 . . . . 73.02 111.033 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.23 5.3 52.83 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 121.042 -0.599 . . . . 63.21 113.321 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.04 141.4 48.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.268 0.534 . . . . 71.12 110.985 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.641 ' HB3' HD13 ' A' ' 66' ' ' LEU . 28.8 p90 -152.06 151.02 30.58 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.066 0.46 . . . . 73.24 109.891 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.68 144.87 48.52 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.657 -1.238 . . . . 55.43 107.657 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.44 10.78 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 117.946 0.339 . . . . 64.32 110.526 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.51 ' NE ' ' HA ' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -125.47 135.23 52.11 Favored 'General case' 0 N--CA 1.39 -3.457 0 N-CA-C 109.906 -0.405 . . . . 75.21 109.906 178.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.6 143.4 17.83 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 109.506 -1.438 . . . . 72.04 109.506 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.6 m -145.35 150.57 36.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.101 -0.703 . . . . 73.35 109.101 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 59' ' ' PRO . 48.7 t -86.38 105.99 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.193 -1.039 . . . . 72.23 108.193 177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -122.02 100.13 43.2 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 108.772 -0.825 . . . . 72.02 108.772 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.46 -24.21 31.29 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.231 1.954 . . . . 75.45 112.326 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.38 77.08 3.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.211 1.482 . . . . 63.53 109.431 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.87 135.96 61.6 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.345 0 CA-C-N 111.737 -2.483 . . . . 61.31 104.909 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -54.68 128.66 33.56 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.811 0.815 . . . . 73.34 112.838 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -81.8 137.75 35.24 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.64 -1.244 . . . . 74.33 107.64 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.7 t60 . . . . . 0 C--N 1.286 -2.155 0 N-CA-C 107.172 -1.418 . . . . 75.01 107.172 179.669 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 CA--C 1.503 -0.83 0 N-CA-C 108.508 -0.923 . . . . 61.32 108.508 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.94 -133.11 11.33 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.536 -0.84 . . . . 33.41 111.766 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -120.95 134.16 55.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.388 -0.597 . . . . 73.54 109.388 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -137.55 130.02 29.65 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.398 -0.593 . . . . 74.13 109.398 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -78.48 94.74 4.99 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.554 -0.536 . . . . 61.11 109.554 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -88.45 84.85 6.79 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.871 -1.159 . . . . 73.02 107.871 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.1 87.98 5.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.61 -1.177 . . . . 73.32 110.795 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.9 m -87.43 110.15 20.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 114.531 -1.213 . . . . 60.2 109.412 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -90.12 103.5 16.16 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.433 -0.803 . . . . 74.34 108.851 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -137.74 106.98 6.06 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.901 -1.045 . . . . 71.31 109.767 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.08 136.32 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.887 -0.783 . . . . 64.21 108.887 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -87.24 88.44 7.69 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.844 -0.428 . . . . 75.25 109.844 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -85.51 102.27 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.955 -1.498 . . . . 62.55 106.955 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.6 166.73 27.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.418 0.525 . . . . 74.43 112.418 -175.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 pp -162.29 170.22 19.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.808 -1.553 . . . . 72.32 106.808 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -105.52 149.02 26.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.908 -1.117 . . . . 72.51 109.594 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -103.52 111.23 23.58 Favored 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 104.401 -2.444 . . . . 74.03 104.401 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.8 m -74.42 95.44 2.72 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.271 1.034 . . . . 45.45 110.12 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 m -95.13 122.64 46.77 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 113.794 -1.548 . . . . 61.55 109.701 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.89 42.9 0.56 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.508 -1.037 . . . . 64.03 110.508 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 6.2 p-10 -77.99 9.82 3.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.529 -0.335 . . . . 72.21 111.413 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -54.47 -36.97 64.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.923 0.889 . . . . 63.13 110.456 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HB2' ' HG3' ' A' ' 33' ' ' PRO . 61.6 m-85 -63.48 -40.4 96.99 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.656 -0.702 . . . . 61.14 110.585 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.49 70.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.146 0.498 . . . . 73.31 109.888 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 27.3 mmm180 -69.05 -32.53 72.08 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.02 -0.733 . . . . 63.5 109.02 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 22' ' ' ALA . 73.4 mt -73.57 -43.21 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.577 -0.738 . . . . 63.34 110.178 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -65.71 -29.27 69.77 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 111.796 0.295 . . . . 75.41 111.796 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.32 -91.84 0.21 Allowed Glycine 0 N--CA 1.445 -0.745 0 O-C-N 123.743 0.652 . . . . 40.13 112.386 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.32 -6.41 41.84 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.934 -0.466 . . . . 73.2 111.934 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.8 m -82.55 173.41 11.99 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.454 0.169 . . . . 73.41 110.925 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.98 136.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 123.998 0.919 . . . . 72.22 112.476 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.34 152.34 60.93 Favored Pre-proline 0 C--O 1.246 0.899 0 CA-C-N 115.234 -0.894 . . . . 63.11 112.136 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HG3' ' HB2' ' A' ' 23' ' ' PHE . 33.7 Cg_endo -61.73 -17.17 53.3 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 123.734 2.956 . . . . 65.43 113.949 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -61.15 -43.61 98.62 Favored 'General case' 0 C--O 1.227 -0.089 0 CA-C-O 120.855 0.36 . . . . 75.23 110.124 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -72.88 -31.38 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 43.1 109.757 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 99.4 t -60.57 -50.96 78.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.351 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.39 -34.44 77.27 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.043 -0.663 . . . . 74.24 110.661 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.83 80.8 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.068 0.461 . . . . 75.23 110.582 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.7 tt -66.32 -42.94 87.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.334 -0.848 . . . . 70.12 109.931 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 93.9 mt -61.28 -39.21 89.59 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.05 0.452 . . . . 71.1 111.688 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -67.99 -33.46 74.68 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 123.723 0.809 . . . . 71.24 110.416 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -75.65 -36.16 60.24 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.063 -1.088 . . . . 74.41 108.063 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 63.2 mm-40 -63.62 -34.59 78.16 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.684 . . . . 73.01 110.351 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.29 94.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.836 -0.62 . . . . 74.14 109.727 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.23 -25.23 61.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.342 0.591 . . . . 72.14 110.89 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.69 -46.11 59.81 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.388 0.675 . . . . 75.31 111.135 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 26.39 10.12 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 120.698 -0.763 . . . . 53.41 114.093 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.18 141.61 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 122.65 0.38 . . . . 74.11 110.544 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.2 mt-30 -120.31 149.13 42.79 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.926 0.393 . . . . 54.24 110.412 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.5 p -76.56 128.92 35.68 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.72 -1.127 . . . . 52.21 109.446 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 28.4 tp -146.24 -166.35 2.45 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.899 -2.26 . . . . 73.32 104.899 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.568 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 98.2 mt-30 -43.91 136.52 3.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.743 0.652 . . . . 64.15 110.357 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.48 -8.23 31.05 Favored Glycine 0 N--CA 1.464 0.503 0 CA-C-N 116.654 -0.248 . . . . 40.21 113.487 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.61 -38.44 90.21 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.085 0.554 . . . . 73.12 109.801 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -171.59 147.9 2.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.025 -0.534 . . . . 72.23 111.213 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -91.08 151.89 20.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.723 0.809 . . . . 74.42 111.369 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 34.0 tp -84.81 128.88 34.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.74 -0.837 . . . . 65.3 108.74 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 98' ' ' TRP . . . -112.46 154.31 44.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 122.919 0.487 . . . . 62.3 111.11 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HB3' ' N ' ' A' ' 124' ' ' THR . 78.3 Cg_exo -58.31 145.91 91.55 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.475 2.783 . . . . 63.31 112.819 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 125' ' ' VAL . 24.6 p-10 -122.6 -25.37 4.73 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.263 -0.426 . . . . 73.52 110.137 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.35 113.09 25.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.955 -0.758 . . . . 65.44 108.955 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 93.9 m-85 -112.67 114.94 27.78 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.363 0.602 . . . . 70.23 109.49 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.39 120.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 71.22 108.559 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 40' ' ' LEU . 63.6 mt -115.8 125.74 73.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.967 -1.123 . . . . 64.14 107.967 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.9 m -120.56 120.62 36.35 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 116.4 -0.364 . . . . 72.53 110.1 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.4 mm? -106.5 170.82 7.7 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 122.905 0.482 . . . . 65.23 110.736 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.29 167.32 51.96 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.484 -1.446 . . . . 70.43 109.484 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.97 -40.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 117.492 0.646 . . . . 74.43 111.936 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -75.77 -28.84 58.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.254 -0.647 . . . . 73.51 109.254 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 61.1 m-20 -76.16 -29.46 57.75 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 120.791 -0.363 . . . . 63.11 111.13 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -69.33 -29.46 67.29 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.313 -0.995 . . . . 75.44 108.313 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.11 -26.46 66.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.777 -0.647 . . . . 75.14 111.115 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -70.63 -36.29 73.37 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.199 -0.667 . . . . 71.34 109.199 173.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.77 -30.11 69.48 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.338 -0.986 . . . . 74.2 108.338 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -138.18 16.03 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 114.13 -1.396 . . . . 23.43 113.325 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.88 -2.4 56.85 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.123 -0.538 . . . . 53.43 109.852 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -117.72 100.18 52.36 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 113.27 0.841 . . . . 53.45 113.27 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.47 -42.57 0.21 Allowed 'Trans proline' 0 CA--C 1.56 1.779 0 C-N-CA 121.656 1.57 . . . . 74.02 111.589 166.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -84.37 -29.71 26.03 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 118.775 2.88 . . . . 74.33 118.775 -163.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.74 -44.22 82.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.223 1.374 . . . . 64.44 108.563 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -65.04 -32.61 74.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.099 -0.955 . . . . 74.23 111.169 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.2 m -63.34 -43.32 98.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.817 -0.438 . . . . 53.13 109.817 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 64.3 m -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 116.253 -0.43 . . . . 64.44 110.817 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -52.11 49.89 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.234 -0.507 . . . . 24.4 112.036 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -63.16 -39.97 96.21 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.507 0.558 . . . . 62.04 112.507 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.571 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.87 -45.28 95.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.82 0.343 . . . . 61.44 111.151 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.5 -42.03 87.99 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.759 -0.655 . . . . 72.11 110.926 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.43 -42.67 82.8 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.48 -0.782 . . . . 75.4 110.488 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.47 -34.74 78.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.158 0.429 . . . . 64.4 112.158 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.09 88.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.509 0.671 . . . . 74.24 110.334 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 24.6 t70 -69.77 -43.95 71.15 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.806 -0.634 . . . . 74.22 109.362 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.3 m-85 -55.44 -56.73 16.8 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 113.126 0.787 . . . . 74.35 113.126 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.8 pt -57.47 -36.66 54.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 123.26 0.35 . . . . 74.15 111.548 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.17 -37.66 81.24 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.441 -0.345 . . . . 65.41 111.856 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.7 mt-10 -63.75 -34.75 78.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.304 0.573 . . . . 71.43 110.682 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 73.5 mm-40 -76.34 -13.72 60.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.508 -0.769 . . . . 62.31 111.008 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.02 67.46 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.943 -0.572 . . . . 75.15 112.267 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 14.8 m0 -81.42 165.01 21.66 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.461 -0.57 . . . . 72.45 109.461 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -133.8 165.67 24.43 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.257 -0.645 . . . . 75.23 109.257 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -155.41 170.86 20.94 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.157 -1.053 . . . . 65.43 108.157 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -106.86 119.18 38.65 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.888 -1.152 . . . . 74.53 107.888 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.14 -149.33 16.59 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 109.168 -1.573 . . . . 71.54 109.168 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.95 175.76 7.83 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.762 -1.57 . . . . 71.52 106.762 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -82.41 127.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.066 0.46 . . . . 74.34 110.511 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 m -127.54 127.33 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.548 -0.751 . . . . 71.5 109.083 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -131.62 145.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 107.321 -1.362 . . . . 74.24 107.321 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.56 139.3 20.75 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.339 0.59 . . . . 73.41 110.476 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.82 131.8 44.0 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.489 -1.232 . . . . 74.01 109.432 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.2 pt-20 -136.89 176.53 8.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.762 -0.829 . . . . 71.14 108.762 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -127.0 164.58 21.19 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.732 0.777 . . . . 65.12 111.406 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 m -142.04 127.03 18.34 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.968 -1.123 . . . . 63.34 107.968 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 t -69.24 -19.16 63.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.271 0.628 . . . . 71.33 110.283 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -65.79 -30.4 71.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 74.03 109.765 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.36 131.3 34.71 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.422 0.63 . . . . 74.12 110.772 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -92.29 162.0 14.46 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.635 -1.246 . . . . 72.02 107.635 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.9 m -55.93 126.82 27.43 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.431 0.692 . . . . 62.33 110.972 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.37 -14.53 47.26 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.558 -0.746 . . . . 63.51 111.616 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -106.46 131.72 53.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.565 -0.532 . . . . 63.53 109.565 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.448 ' HB3' HD13 ' A' ' 66' ' ' LEU . 16.4 p90 -145.45 159.37 43.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.093 -0.706 . . . . 73.15 109.093 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.95 149.81 52.33 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.093 -0.706 . . . . 74.43 109.093 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.27 134.84 17.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.487 -0.56 . . . . 55.02 109.487 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -132.39 145.3 51.13 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 121.38 0.609 . . . . 64.13 111.925 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.81 113.4 1.86 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.989 -1.645 . . . . 73.44 108.989 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 59' ' ' PRO . 61.0 m -143.13 145.45 32.84 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 108.951 -0.759 . . . . 75.3 108.951 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.44 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 6.0 p -86.91 118.15 32.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.993 -1.114 . . . . 71.42 107.993 174.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' ND2' ' HB ' ' A' ' 129' ' ' VAL . 46.2 t30 -126.21 88.78 53.65 Favored Pre-proline 0 C--N 1.29 -2.018 0 CA-C-N 115.626 -0.715 . . . . 62.42 110.087 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -83.89 -18.32 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.382 2.055 . . . . 64.14 111.381 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -98.75 70.32 1.88 Allowed 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.479 1.133 . . . . 72.5 108.126 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.421 ' HB ' ' ND2' ' A' ' 126' ' ' ASN . 6.9 p -125.71 120.99 58.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.133 -1.394 . . . . 73.54 111.95 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.56 111.08 23.06 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.828 -1.175 . . . . 73.02 107.828 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -151.79 158.59 43.52 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.595 -1.632 . . . . 64.44 106.595 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--N 1.295 -1.798 0 N-CA-C 108.111 -1.07 . . . . 74.13 108.111 179.389 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 107.986 -1.116 . . . . 62.52 107.986 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.4 -128.66 24.89 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.821 -0.704 . . . . 42.01 111.577 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 m 60.95 25.06 15.08 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.074 0.95 . . . . 75.31 111.445 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 136.75 45.18 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.521 0.676 . . . . 73.33 112.154 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -97.12 92.01 5.84 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.425 0.631 . . . . 50.1 109.601 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -88.07 88.34 7.61 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.582 -0.895 . . . . 70.43 108.582 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 tt -92.45 108.34 19.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.303 -1.369 . . . . 73.33 107.303 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.38 106.16 20.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.171 -1.048 . . . . 62.32 108.171 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -73.13 100.1 2.97 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.89 0.853 . . . . 72.02 109.794 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -85.84 72.04 10.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.265 1.031 . . . . 74.12 111.494 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -130.74 92.29 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 113.724 -1.58 . . . . 72.24 109.593 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.88 -24.54 61.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.945 0.879 . . . . 72.2 109.272 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -141.75 128.05 19.88 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 102.79 -3.041 . . . . 73.25 102.79 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -73.31 -27.3 61.45 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.609 -0.836 . . . . 74.24 110.647 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 15' ' ' LEU . 3.7 pp -168.35 141.64 3.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 108.405 -0.961 . . . . 72.23 108.405 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.9 124.72 16.04 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.3 -0.63 . . . . 75.14 109.3 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.45 5.66 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.757 1.265 . . . . 64.31 111.182 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.512 ' H ' HG21 ' A' ' 32' ' ' VAL . 1.3 m -85.89 96.95 9.95 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.368 -1.287 . . . . 71.03 108.128 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.1 23.04 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.569 0.699 . . . . 54.04 111.644 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.99 41.26 2.28 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.653 -0.979 . . . . 72.12 110.653 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 t70 -150.02 136.26 18.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.121 -1.807 . . . . 74.53 106.121 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.42 -55.69 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.264 1.026 . . . . 73.31 113.295 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.06 -29.57 66.61 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 75.04 111.373 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.95 85.63 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.728 -0.669 . . . . 74.32 110.38 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 63.6 mtp180 -77.42 -19.93 55.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.859 -0.609 . . . . 61.35 110.513 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -69.04 -38.92 79.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.484 -0.932 . . . . 71.11 108.484 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 73' ' ' LYS . 58.7 m-85 -75.34 -29.3 59.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.857 -0.61 . . . . 73.44 110.927 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.74 -76.61 2.16 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 110.747 -0.941 . . . . 55.33 110.747 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.3 19.53 1.19 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 121.233 -0.508 . . . . 53.54 112.469 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -69.46 -74.44 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.577 -0.527 . . . . 74.23 109.577 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.81 159.37 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 N-CA-C 104.839 -2.282 . . . . 74.33 104.839 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.512 HG21 ' H ' ' A' ' 18' ' ' THR . 29.1 m -125.98 148.73 63.91 Favored Pre-proline 0 C--N 1.292 -1.892 0 C-N-CA 118.888 -1.125 . . . . 73.1 111.043 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.72 -34.91 76.44 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.067 2.511 . . . . 71.45 112.121 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.507 -0.769 . . . . 73.2 110.481 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' H ' HG23 ' A' ' 32' ' ' VAL . 41.4 tt0 -79.82 -38.58 32.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.187 -0.915 . . . . 61.45 108.805 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.53 -53.48 46.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 115.532 -0.758 . . . . 63.51 110.028 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -65.53 -32.42 74.01 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 120.642 -0.423 . . . . 72.34 111.778 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.05 -53.97 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.0 0.429 . . . . 74.35 110.062 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.2 mm? -71.59 -34.64 70.07 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.044 -0.525 . . . . 74.53 111.366 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp -65.85 -41.05 92.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.516 0.198 . . . . 70.1 111.381 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -73.93 -26.51 60.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.21 -0.596 . . . . 72.12 109.495 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -71.18 -35.75 71.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.372 -0.603 . . . . 73.24 109.372 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 78.0 mm-40 -61.09 -37.36 82.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.766 -0.457 . . . . 73.24 109.766 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.68 82.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 73.41 109.92 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.42 -33.45 73.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.309 0.576 . . . . 45.24 112.007 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.05 -37.32 39.28 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.469 0.707 . . . . 61.51 110.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.54 14.49 63.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.483 -0.78 . . . . 41.52 113.365 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG23 ' HB3' ' A' ' 56' ' ' LEU . 9.0 mm -54.6 141.6 10.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.005 0.922 . . . . 61.45 110.96 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -112.36 126.75 55.62 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 107.02 -1.474 . . . . 74.33 107.02 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -66.71 102.18 0.9 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.331 0.586 . . . . 51.51 110.125 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -104.24 -165.97 1.2 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.487 -2.042 . . . . 71.23 105.487 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.619 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -47.13 144.04 2.85 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.155 -0.683 . . . . 62.22 109.155 172.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.63 7.49 3.86 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 114.343 0.497 . . . . 51.31 114.343 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -76.71 -35.6 57.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.536 -0.913 . . . . 44.25 108.536 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HD3' ' OE1' ' A' ' 99' ' ' GLN . 8.2 ptm180 -168.45 157.54 9.0 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.754 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 98' ' ' TRP . 77.6 mt -91.89 151.37 20.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.258 0.623 . . . . 70.25 110.408 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 HD22 ' A' ' 51' ' ' LEU . 5.6 tt -101.24 127.29 47.89 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.619 -1.252 . . . . 74.11 107.619 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.72 158.08 32.45 Favored Pre-proline 0 C--N 1.301 -1.543 0 C-N-CA 122.96 0.504 . . . . 71.43 110.169 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 125' ' ' VAL . 73.6 Cg_exo -54.25 161.83 4.91 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.073 2.515 . . . . 73.33 113.363 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -125.94 -25.54 3.59 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.63 -0.713 . . . . 70.34 110.421 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -101.2 100.52 11.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.917 -1.142 . . . . 53.44 107.917 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.36 119.24 38.58 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 72.03 109.898 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.0 mt -116.13 114.09 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.527 -0.761 . . . . 71.45 109.528 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -104.62 134.15 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 106.641 -1.615 . . . . 74.05 106.641 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 m -131.6 125.66 32.79 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 120.901 -0.32 . . . . 73.14 111.329 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.2 mm? -132.44 172.92 11.86 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.341 1.026 . . . . 73.55 109.543 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.9 51.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.675 -0.97 . . . . 72.14 110.675 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 88.0 t -60.92 -45.73 97.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.993 0.517 . . . . 74.45 110.87 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -64.65 -31.47 72.7 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.752 1.221 . . . . 73.52 110.686 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.51 -37.53 19.57 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.584 0.707 . . . . 64.23 109.252 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 74' ' ' LEU . 40.1 t80 -60.57 -32.02 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.168 -0.924 . . . . 75.44 111.315 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 54.3 mt-10 -55.61 -38.26 69.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.418 0.627 . . . . 74.41 110.139 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 39.0 mmtm -83.43 -28.64 28.69 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.006 -0.997 . . . . 54.44 109.842 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 71' ' ' PHE . 67.2 mt -55.78 -45.78 78.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.83 0.707 . . . . 73.54 109.65 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.68 158.48 21.31 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.614 -0.995 . . . . 72.11 110.614 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -18.21 60.45 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.491 0.662 . . . . 75.21 110.202 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.95 138.22 17.85 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 108.459 -0.941 . . . . 72.15 108.459 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.4 -51.45 7.41 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.573 2.182 . . . . 73.41 112.88 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -64.91 -30.12 71.1 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.326 -0.397 . . . . 74.43 111.486 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.58 -40.91 53.67 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.329 1.018 . . . . 74.23 109.514 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -95.2 -39.23 10.19 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 74.51 110.688 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.9 m -58.44 -44.82 89.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.72 0.637 . . . . 75.12 112.72 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -63.04 -54.49 37.37 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 120.926 0.393 . . . . 64.13 111.558 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.83 -37.71 92.47 Favored Glycine 0 C--O 1.245 0.807 0 C-N-CA 121.406 -0.426 . . . . 74.22 113.1 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -75.47 -30.0 59.79 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.868 -0.195 . . . . 64.32 110.684 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.03 -38.46 90.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.955 -0.387 . . . . 62.31 109.955 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -60.86 -47.74 85.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.403 -0.817 . . . . 71.01 111.048 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 11.1 t70 -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.539 0.685 . . . . 74.31 110.486 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.65 -36.95 70.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 65.52 109.157 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.45 -36.67 84.53 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.577 0.703 . . . . 73.23 109.298 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 30.1 t70 -59.56 -52.2 66.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.688 -1.142 . . . . 52.41 109.06 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -52.96 -50.79 63.36 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.403 0.89 . . . . 75.54 113.403 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.41 -37.26 79.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.193 -0.603 . . . . 71.0 112.225 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -70.56 -34.83 72.66 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.812 -0.355 . . . . 74.04 111.281 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 64.7 mm-40 -63.1 -35.26 79.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.156 0.503 . . . . 73.54 110.636 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -81.79 -12.96 58.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.581 -0.736 . . . . 71.03 111.204 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 89.85 23.97 31.42 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.903 -0.59 . . . . 41.53 112.991 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.9 m0 -98.5 149.23 22.94 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.068 0.461 . . . . 75.33 111.406 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.488 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 13.8 pt20 -124.47 177.46 5.9 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.367 -0.833 . . . . 74.11 109.14 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -162.13 -179.17 6.88 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.744 -0.836 . . . . 60.14 108.744 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -112.19 120.53 42.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.099 -0.704 . . . . 61.11 109.099 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.06 -150.28 16.73 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 119.713 -1.232 . . . . 63.12 110.451 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.68 144.32 38.22 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.371 -1.344 . . . . 73.13 107.371 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 90' ' ' ALA . 12.0 p -79.51 141.52 15.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.199 -1.037 . . . . 64.52 108.199 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.61 124.8 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.309 0.576 . . . . 54.44 109.984 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 72.7 t -108.63 112.59 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 105.981 -1.859 . . . . 73.5 105.981 175.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -124.06 140.33 53.08 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.688 -0.687 . . . . 73.21 111.286 -172.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -109.73 130.77 55.48 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.175 -0.921 . . . . 74.1 109.972 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.94 166.35 21.86 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.972 0.415 . . . . 72.11 110.922 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 45.0 mt-30 -106.62 142.8 35.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.233 -0.894 . . . . 71.4 109.379 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 114' ' ' LEU . 12.5 p -119.88 136.72 54.39 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 112.777 0.658 . . . . 73.14 112.777 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -82.93 -40.47 20.09 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.582 0.706 . . . . 50.12 109.7 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.73 -22.43 43.31 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.135 -0.939 . . . . 72.42 112.194 -174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.453 ' HB3' ' OG ' ' A' ' 111' ' ' SER . 25.7 tp -114.5 137.37 51.93 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.028 -2.582 . . . . 73.14 104.028 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -139.55 172.61 12.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.325 -1.35 . . . . 65.41 111.724 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.6 m -35.83 124.64 0.71 Allowed 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.166 2.187 . . . . 74.12 113.557 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.64 -22.94 27.4 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.217 -1.153 . . . . 75.24 110.217 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -112.17 128.23 56.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.416 -0.587 . . . . 61.14 109.416 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -124.69 149.66 46.97 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.27 -1.011 . . . . 60.04 108.27 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -136.74 143.12 43.13 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.237 -1.023 . . . . 73.34 108.237 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.74 142.03 40.97 Favored 'General case' 0 C--N 1.257 -3.451 0 N-CA-C 104.302 -2.481 . . . . 73.55 104.302 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -156.9 162.36 39.66 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.28 -0.568 . . . . 74.32 110.225 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.03 119.2 1.68 Allowed Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 110.67 -0.972 . . . . 73.34 110.67 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.7 m -110.23 144.01 39.54 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.017 -0.734 . . . . 73.22 109.017 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 59' ' ' PRO . 63.0 t -99.35 112.96 33.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.566 -1.272 . . . . 71.45 107.566 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' O ' HG12 ' A' ' 129' ' ' VAL . 54.0 t30 -88.35 107.5 16.98 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 107.051 -1.462 . . . . 75.0 107.051 174.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.27 -36.01 4.52 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.087 1.858 . . . . 63.32 113.273 -174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.87 73.12 1.97 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.204 1.002 . . . . 72.14 110.453 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 126' ' ' ASN . 7.1 p -144.71 99.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 114.024 -1.444 . . . . 70.12 109.673 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.07 147.04 30.31 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.805 -1.088 . . . . 74.2 109.106 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -86.08 104.6 15.82 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 122.348 1.071 . . . . 70.55 108.323 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 . . . . . 0 C--N 1.282 -2.338 0 CA-C-N 114.195 -1.366 . . . . 73.05 107.657 179.788 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.242 0.669 0 N-CA-C 109.298 -0.63 . . . . 64.14 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.19 117.08 1.51 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.484 -0.646 . . . . 72.11 111.484 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -68.85 145.21 53.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 122.683 0.393 . . . . 74.43 110.861 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.38 125.13 30.68 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.128 0.489 . . . . 54.21 110.795 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.92 145.68 33.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.131 -1.803 . . . . 71.2 106.131 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.7 139.87 35.78 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.138 -0.625 . . . . 73.43 109.356 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -102.46 85.68 2.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.201 -1.037 . . . . 74.2 108.201 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -171.6 153.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.317 -2.105 . . . . 72.15 105.317 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -85.89 -168.03 2.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.655 -0.868 . . . . 73.54 108.655 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -73.68 78.62 1.53 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.744 0.783 . . . . 73.53 109.262 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -124.78 107.49 18.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.428 -1.323 . . . . 73.4 107.428 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -95.32 -43.93 7.81 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.243 -0.651 . . . . 63.23 109.243 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 57.17 66.42 1.16 Allowed 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.331 -0.989 . . . . 75.51 108.331 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -94.23 80.71 4.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.729 -0.669 . . . . 74.11 109.428 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.83 -22.96 19.84 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.226 -0.897 . . . . 75.14 109.637 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.36 97.44 10.43 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.049 -1.463 . . . . 64.33 107.049 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -134.19 137.29 44.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.888 -0.596 . . . . 73.44 109.766 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.565 ' HB ' ' OH ' ' A' ' 92' ' ' TYR . 63.2 m -145.5 151.64 38.5 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.761 -1.94 . . . . 54.3 105.761 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -99.69 125.27 53.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.423 -0.911 . . . . 75.5 113.038 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.63 20.06 6.16 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.16 -1.976 . . . . 62.22 108.16 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 23.6 m-20 -73.0 -2.67 22.03 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 124.743 1.217 . . . . 72.11 112.519 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.18 -39.39 66.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.604 0.716 . . . . 73.55 110.294 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -71.29 -26.46 62.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.773 -0.648 . . . . 70.51 112.04 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.63 60.26 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.03 -0.73 . . . . 62.55 109.03 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 17.1 mmm180 -72.3 -44.19 63.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.578 -0.737 . . . . 73.25 109.145 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.55 -49.01 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.949 -0.569 . . . . 73.21 112.197 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -78.08 -23.7 47.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.61 0.596 . . . . 63.51 112.61 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.72 -65.93 4.02 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 109.631 -1.388 . . . . 40.32 109.631 -174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.4 27.06 0.15 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 121.106 -0.569 . . . . 64.02 113.215 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -62.46 -42.91 99.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.454 0.627 . . . . 73.31 109.587 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.95 151.84 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 107.472 -1.307 . . . . 51.25 107.472 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 35' ' ' GLU . 2.7 p -97.76 106.31 32.79 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 109.125 -0.694 . . . . 72.22 109.125 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -47.46 -50.65 10.96 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.26 3.307 . . . . 65.43 114.395 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -65.39 -25.29 67.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 114.916 1.45 . . . . 74.53 114.916 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HB2' HG13 ' A' ' 32' ' ' VAL . 43.3 mt-10 -81.11 -27.83 35.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.016 -1.074 . . . . 75.04 109.949 176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.5 -43.23 80.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.026 -1.472 . . . . 74.44 107.026 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.51 -49.37 72.77 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.104 -0.953 . . . . 62.44 109.824 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.94 -52.89 22.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.765 0.826 . . . . 71.43 111.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.65 -42.67 86.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.127 0.417 . . . . 62.44 112.127 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.24 -39.96 82.12 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.957 0.725 . . . . 72.23 112.957 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.58 -26.36 62.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.468 0.651 . . . . 75.51 109.741 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.75 -45.08 60.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.292 -1.003 . . . . 64.04 108.292 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.047 -0.524 . . . . 72.35 111.323 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.47 95.33 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.952 -0.567 . . . . 30.13 111.124 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.69 -22.99 45.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.412 0.625 . . . . 74.34 111.398 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.28 -40.34 51.98 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.783 -0.644 . . . . 72.15 110.393 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.41 40.8 2.67 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.693 -0.685 . . . . 72.53 112.559 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mm -79.81 139.41 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.21 0.529 . . . . 72.41 111.616 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 19.4 mp0 -118.7 144.0 46.51 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.159 0.984 . . . . 73.21 108.52 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -81.03 100.99 9.27 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.981 0.896 . . . . 53.3 110.027 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.3 tp -118.67 -163.92 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 105.596 -2.001 . . . . 74.31 105.596 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -41.41 126.03 2.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.799 0.687 . . . . 63.4 109.97 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.3 50.08 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 114.656 0.622 . . . . 74.24 114.656 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.4 -23.86 62.83 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.526 -0.469 . . . . 73.24 111.805 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 13.9 ptm180 -162.18 128.71 3.67 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.532 0.682 . . . . 72.12 111.808 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.54 151.81 21.18 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 123.848 0.859 . . . . 60.51 110.985 -170.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.3 tm? -85.75 118.67 25.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.837 -0.801 . . . . 71.34 108.837 -174.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.44 165.61 12.33 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 124.137 0.975 . . . . 64.2 110.118 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.8 Cg_exo -57.83 160.8 14.09 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.472 2.782 . . . . 54.13 113.371 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.9 p-10 -127.28 -31.94 2.51 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.375 -0.829 . . . . 62.24 111.079 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -109.07 111.5 23.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' HB2' HG12 ' A' ' 106' ' ' VAL . 50.0 m-85 -106.68 120.17 41.26 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.682 -0.858 . . . . 75.42 108.682 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.72 115.31 43.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.718 -0.475 . . . . 72.54 109.718 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.7 mp -112.46 109.94 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 107.194 -1.41 . . . . 72.33 107.194 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -105.86 122.7 46.64 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.539 -0.541 . . . . 74.51 109.539 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.3 mm? -110.41 163.64 13.48 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.376 0.67 . . . . 61.52 109.753 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.13 53.58 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.096 -1.602 . . . . 74.14 109.096 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 5.8 p -59.73 -37.46 71.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.792 0.796 . . . . 72.12 111.859 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 56.2 t-80 -58.96 -41.93 88.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 75.23 109.798 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.409 ' O ' HD23 ' A' ' 74' ' ' LEU . 5.8 m-20 -75.28 -39.62 59.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.535 -0.757 . . . . 61.42 111.739 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -57.94 -28.28 64.16 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.103 0.477 . . . . 72.41 111.095 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 94.1 mt-10 -62.77 -35.24 79.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.144 0.497 . . . . 74.51 110.215 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 69' ' ' HIS . 45.3 mmtt -85.02 -17.47 37.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.034 -0.728 . . . . 74.12 109.034 -172.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 4.5 mm? -69.97 -41.49 74.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.882 -1.054 . . . . 63.34 109.336 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.81 168.7 13.02 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.312 -0.946 . . . . 74.23 112.167 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.96 53.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.897 0.379 . . . . 52.54 111.762 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -112.14 96.0 32.68 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.305 -0.628 . . . . 54.42 109.305 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.1 -31.56 4.79 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 122.042 1.828 . . . . 60.21 111.038 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -53.15 42.51 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 115.508 1.67 . . . . 75.22 115.508 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.51 -15.82 61.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.858 0.754 . . . . 63.44 111.491 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 74' ' ' LEU . 58.4 mttp -90.79 -44.41 9.45 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.561 -0.745 . . . . 71.34 109.697 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 p -67.43 -51.22 54.29 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.12 0.568 . . . . 62.1 110.322 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.4 m -59.69 -41.15 90.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.567 -0.531 . . . . 73.44 109.567 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.58 52.95 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.563 -0.744 . . . . 62.51 112.634 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.98 -28.12 65.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 61.45 110.082 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 104' ' ' VAL . . . -64.03 -42.66 97.02 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.997 -0.547 . . . . 50.53 110.439 176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 19.0 mmt85 -64.09 -39.59 94.39 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.233 -0.44 . . . . 74.14 111.313 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -44.25 87.83 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.085 -0.507 . . . . 74.32 111.332 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.65 -34.98 79.07 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 109.304 -0.628 . . . . 74.13 109.304 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.34 99.05 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.422 0.63 . . . . 72.52 110.108 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.49 -40.78 80.77 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.107 -0.951 . . . . 54.14 109.353 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -55.86 -50.75 69.77 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.472 1.109 . . . . 74.23 111.369 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.45 -35.82 75.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.756 -0.377 . . . . 72.21 111.142 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.31 -40.93 96.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 75.11 109.76 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -62.67 -29.54 70.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.333 -0.849 . . . . 41.2 112.338 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -85.87 1.47 49.72 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.645 -0.707 . . . . 72.34 111.223 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 27.25 52.65 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 121.07 -0.586 . . . . 45.32 112.261 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.83 167.64 10.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.419 -0.46 . . . . 70.14 110.065 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.504 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.4 pt20 -143.34 167.24 22.64 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.287 -1.005 . . . . 71.41 108.287 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.572 ' HA ' HD22 ' A' ' 57' ' ' LEU . 10.8 t -150.01 -177.33 5.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.718 -0.475 . . . . 73.01 109.718 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.98 120.09 38.0 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.905 -0.406 . . . . 72.44 109.905 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -155.33 16.35 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 119.718 -1.23 . . . . 62.31 111.787 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -103.84 137.1 42.32 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.988 -1.486 . . . . 73.24 106.988 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.409 ' O ' ' HB1' ' A' ' 86' ' ' ALA . 66.6 t -83.21 124.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.776 -0.824 . . . . 60.32 108.776 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.05 130.13 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 CA-C-O 121.642 0.734 . . . . 62.32 110.941 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 62' ' ' TYR . 34.7 m -104.43 127.42 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 N-CA-C 106.249 -1.76 . . . . 73.32 106.249 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -105.78 126.61 52.36 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.838 -0.619 . . . . 74.53 109.95 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -113.59 114.26 26.21 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.243 -1.392 . . . . 74.44 107.243 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.87 166.79 23.7 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.377 -0.374 . . . . 75.42 111.042 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -99.24 160.87 13.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.091 0.948 . . . . 74.45 112.171 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -149.48 115.67 5.75 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 113.559 -1.655 . . . . 51.0 107.819 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -81.03 -2.81 49.53 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.881 0.848 . . . . 61.34 109.559 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.68 -38.47 19.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.631 -1.168 . . . . 74.35 108.364 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.02 161.8 30.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.542 -0.91 . . . . 73.34 108.542 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -87.55 154.3 20.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.055 0.455 . . . . 63.31 110.055 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 m -62.23 132.48 52.87 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 124.354 1.062 . . . . 71.43 109.489 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 28.96 60.83 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.536 -0.364 . . . . 64.1 112.417 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -137.07 149.39 47.36 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.024 -1.102 . . . . 71.31 108.024 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.429 ' HB3' HD13 ' A' ' 66' ' ' LEU . 41.8 p90 -139.37 156.66 46.86 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.668 -0.413 . . . . 72.42 110.966 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 36.5 mmt180 -123.63 131.16 53.55 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.384 -0.969 . . . . 72.43 108.384 174.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.58 120.57 24.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.41 -0.589 . . . . 54.02 109.41 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -135.38 138.36 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.362 -0.381 . . . . 74.12 110.4 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -105.44 109.81 3.31 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.79 -0.924 . . . . 62.43 110.79 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.3 m -109.92 143.16 40.26 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.526 0.679 . . . . 70.54 110.603 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.9 t -90.54 110.35 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.175 -1.787 . . . . 75.24 106.175 171.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -102.16 104.42 36.55 Favored Pre-proline 0 C--N 1.281 -2.386 0 N-CA-C 108.087 -1.079 . . . . 74.31 108.087 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.66 -21.04 13.19 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.295 1.996 . . . . 71.41 110.447 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.23 42.58 1.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.23 -0.896 . . . . 63.13 109.295 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.2 109.94 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-N 114.949 -1.023 . . . . 71.11 108.268 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.89 123.35 29.31 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.943 0.878 . . . . 73.42 112.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.8 m -80.9 136.46 36.06 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.965 -1.47 . . . . 75.02 109.303 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 p80 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 108.637 -0.875 . . . . 73.01 108.637 175.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 109.141 -0.689 . . . . 63.52 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.0 -67.23 0.41 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.619 -0.801 . . . . 43.32 111.58 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 t 62.08 73.99 0.45 Allowed 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.555 -0.906 . . . . 75.04 108.555 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -86.46 84.75 7.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.405 -0.816 . . . . 74.32 112.813 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -124.58 155.91 38.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.136 -2.172 . . . . 74.0 105.136 171.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -157.36 155.67 30.99 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.568 -0.853 . . . . 54.51 111.829 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.53 85.93 2.86 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.855 -1.906 . . . . 52.31 105.855 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.57 148.55 11.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.745 -0.661 . . . . 75.15 109.925 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -76.03 109.99 10.14 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.066 -1.087 . . . . 73.34 108.066 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.18 115.23 27.48 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.887 -1.051 . . . . 74.4 109.792 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.8 73.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 123.338 1.542 . . . . 74.04 110.506 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.93 -166.0 1.16 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.505 -1.68 . . . . 73.1 107.694 178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -117.08 148.54 41.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.148 -1.021 . . . . 74.13 110.382 -174.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -74.35 -40.81 61.91 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.451 -2.055 . . . . 73.24 105.451 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.92 149.23 33.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.791 -0.818 . . . . 71.13 108.791 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -105.28 150.26 25.31 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.166 -1.42 . . . . 62.51 107.166 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -83.65 69.85 10.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.62 0.724 . . . . 74.22 109.541 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 m -83.04 95.47 8.05 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 115.098 -0.955 . . . . 75.14 108.743 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.6 t -94.68 98.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.121 -1.066 . . . . 52.13 108.121 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 116.39 0.85 Allowed Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.271 -0.732 . . . . 70.14 111.271 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 15.6 t70 -171.42 158.16 5.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.489 -2.041 . . . . 74.14 105.489 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.4 86.78 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 123.874 0.734 . . . . 64.03 111.439 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HA ' HG13 ' A' ' 26' ' ' ILE . 82.8 m-85 -70.39 -32.57 70.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.261 -0.427 . . . . 70.35 110.375 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -65.69 -34.86 79.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.2 -0.667 . . . . 72.23 109.2 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 24.3 mmt180 -67.57 -52.26 40.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.711 -0.677 . . . . 72.54 110.21 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.429 HG13 ' HA ' ' A' ' 23' ' ' PHE 0.311 2.7 pp -67.71 -31.69 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 115.25 1.574 . . . . 72.44 115.25 -176.31 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 30' ' ' SER . 30.6 m-85 -81.58 -28.15 33.94 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.221 -0.992 . . . . 72.14 111.109 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.89 59.52 0.74 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.302 -0.951 . . . . 51.44 112.993 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.6 20.37 56.48 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 121.359 -0.448 . . . . 75.41 112.638 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 50.2 m -151.98 153.64 34.46 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 122.248 -0.56 . . . . 62.43 109.707 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 23' ' ' PHE . 4.6 tt -155.05 131.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.645 -0.872 . . . . 72.24 108.645 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.15 89.4 52.68 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 121.328 0.585 . . . . 72.3 110.747 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.8 Cg_exo -80.38 -54.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.307 2.004 . . . . 71.24 111.573 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -62.18 -24.45 67.21 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.242 -0.89 . . . . 55.22 112.101 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.34 -55.11 39.17 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.214 -0.661 . . . . 74.22 109.214 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.67 -42.67 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.113 -0.948 . . . . 71.23 109.503 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 42.3 mt-10 -56.77 -54.75 42.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 72.5 111.891 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.13 81.75 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.335 0.254 . . . . 65.14 111.558 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.6 tm? -61.96 -45.73 92.38 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.994 -0.743 . . . . 74.1 108.994 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.93 -29.14 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.043 0.757 . . . . 73.41 113.043 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 67.2 mtt180 -63.92 -41.53 97.62 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.002 -1.11 . . . . 74.4 108.002 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.32 -47.65 81.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.93 -1.032 . . . . 72.11 110.931 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -59.43 -42.55 92.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.134 0.574 . . . . 64.42 110.482 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.17 82.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 72.42 110.949 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.5 -29.02 63.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 71.45 111.981 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.49 -36.72 32.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.518 -0.31 . . . . 54.32 110.567 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.69 18.92 27.49 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.13 -0.487 . . . . 75.12 113.652 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -68.83 133.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 123.364 0.666 . . . . 74.52 110.725 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' HD23 ' A' ' 57' ' ' LEU . 94.3 mt-30 -107.03 147.96 29.3 Favored 'General case' 0 CA--C 1.473 -1.994 0 N-CA-C 109.061 -0.718 . . . . 73.2 109.061 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -86.38 91.62 8.57 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.011 -1.107 . . . . 72.35 108.011 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.9 tp -98.9 -165.55 1.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.825 -1.546 . . . . 73.25 106.825 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.661 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.5 mt-30 -44.6 148.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.685 1.194 . . . . 65.54 111.449 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.87 -15.95 56.04 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.731 -0.668 . . . . 75.41 113.185 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -61.6 -48.67 79.88 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.791 -0.448 . . . . 74.33 109.791 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -168.51 149.27 4.73 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.924 -0.58 . . . . 61.45 111.242 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.04 151.72 20.92 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.047 0.939 . . . . 63.15 110.594 -173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD23 ' OE1' ' A' ' 49' ' ' GLN . 15.7 tp -89.9 127.68 36.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.844 -0.616 . . . . 75.55 109.603 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.68 158.0 40.05 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 123.381 0.672 . . . . 61.24 109.275 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.573 ' HA ' HG22 ' A' ' 125' ' ' VAL . 34.9 Cg_exo -62.93 148.34 93.57 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.62 2.214 . . . . 60.3 111.611 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 33.9 p-10 -120.77 -28.41 4.87 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.81 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.68 124.61 50.25 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.436 -0.95 . . . . 72.13 108.436 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 106' ' ' VAL . 45.3 m-85 -121.38 127.69 51.47 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.873 -0.417 . . . . 74.21 109.873 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 120.13 63.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.943 -0.762 . . . . 71.34 108.943 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.54 123.67 68.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.928 -0.767 . . . . 74.23 108.928 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 m -104.28 124.89 49.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.579 -0.282 . . . . 72.01 110.39 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -115.0 165.47 12.85 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.408 0.683 . . . . 61.14 110.168 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.25 145.23 31.73 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.934 -1.667 . . . . 64.51 108.934 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.4 p -50.29 -43.04 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 113.937 1.088 . . . . 75.24 113.937 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -64.73 -36.61 84.84 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.138 0.494 . . . . 75.51 111.445 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 116' ' ' THR . 13.0 t70 -86.33 -23.47 26.23 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.639 -0.824 . . . . 64.42 110.082 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.13 -30.87 71.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.096 -0.705 . . . . 62.14 109.096 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.6 mt-10 -57.46 -33.76 68.3 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.036 -0.529 . . . . 75.01 110.44 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -74.57 -39.16 62.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.598 -0.89 . . . . 63.33 108.598 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.481 HD11 ' HG ' ' A' ' 66' ' ' LEU . 89.5 mt -62.41 -37.34 85.43 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.658 0.742 . . . . 72.04 109.083 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.2 -171.29 13.62 Favored Glycine 0 N--CA 1.414 -2.822 0 CA-C-N 114.615 -1.175 . . . . 55.13 110.813 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -93.58 -5.81 48.03 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.671 0.272 . . . . 55.51 110.334 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -89.6 111.18 44.35 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 115.702 -0.681 . . . . 71.41 112.422 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 5.8 Cg_exo -77.94 -51.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.308 2.005 . . . . 73.41 113.029 172.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 107' ' ' ARG . 48.9 mt-10 -86.54 -39.36 16.29 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 118.476 2.769 . . . . 75.21 118.476 -169.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.98 -52.47 65.24 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.419 1.009 . . . . 70.45 113.057 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -63.91 -32.13 73.56 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 122.692 1.234 . . . . 65.21 110.742 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 106' ' ' VAL . 37.9 m -75.8 -17.3 59.91 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.101 -1.409 . . . . 51.22 112.022 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 m -69.44 -41.87 75.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.372 -0.603 . . . . 71.02 109.372 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.97 -36.14 61.07 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.9 -0.88 . . . . 42.33 110.9 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -65.03 -46.51 81.01 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.22 0.533 . . . . 74.33 109.795 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.85 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.042 -0.526 . . . . 55.1 111.286 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -59.17 -45.02 92.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 75.43 109.834 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.47 -43.72 89.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.982 -1.008 . . . . 62.2 110.187 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.82 -39.22 90.66 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 115.718 -0.673 . . . . 74.43 109.828 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.1 91.41 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.39 0.614 . . . . 63.1 110.462 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -41.03 83.36 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.473 -0.785 . . . . 72.34 110.009 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 m-85 -56.31 -53.54 56.1 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.622 -0.717 . . . . 71.34 112.077 175.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.0 pt -62.88 -35.69 72.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 120.797 -0.361 . . . . 74.12 111.863 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.73 -37.19 81.85 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 121.135 -0.226 . . . . 52.25 110.793 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.7 -28.31 69.81 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.41 0.624 . . . . 72.12 110.483 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 60.2 mm-40 -88.33 -4.68 58.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.985 -0.552 . . . . 60.44 111.162 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.04 26.94 59.18 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.857 -0.61 . . . . 65.14 112.416 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -98.44 161.41 13.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.929 -0.767 . . . . 75.23 108.929 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -129.72 174.61 9.54 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 110.068 -0.345 . . . . 75.44 110.068 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.5 t -165.15 170.4 14.99 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 105.409 -2.071 . . . . 72.55 105.409 175.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.08 118.01 33.73 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.092 -1.447 . . . . 64.21 107.092 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.78 -149.49 16.72 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 119.218 -1.468 . . . . 75.33 109.885 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -132.28 163.48 28.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.662 -1.236 . . . . 65.32 107.662 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.66 131.99 33.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.255 0.55 . . . . 73.33 112.177 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.95 120.52 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-N 115.233 -0.894 . . . . 64.32 109.294 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.3 m -112.25 143.36 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 107.071 -1.455 . . . . 75.12 107.071 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.3 mtt180 -142.45 150.67 40.87 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.71 0.29 . . . . 74.11 110.809 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.0 151.14 23.56 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.878 -0.601 . . . . 72.14 109.503 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.71 166.58 24.36 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 53.3 107.94 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.26 152.57 38.73 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.685 -0.487 . . . . 74.22 109.685 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.7 m -134.02 138.84 45.64 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 115.902 -0.59 . . . . 62.51 109.669 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 t -80.53 -23.63 39.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.801 -0.814 . . . . 63.44 108.801 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -82.18 -5.17 58.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.859 -0.61 . . . . 71.3 111.529 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.3 148.28 29.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.412 -1.329 . . . . 73.12 107.412 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -119.07 156.7 29.24 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.826 -0.749 . . . . 62.42 111.055 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 70' ' ' ASP . 4.7 m -49.2 121.14 4.57 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 126.248 1.819 . . . . 60.14 111.528 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.96 -30.78 6.9 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.832 -0.907 . . . . 70.04 110.832 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.77 131.1 39.47 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.223 -0.658 . . . . 71.23 109.223 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 150.75 42.38 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.649 -0.871 . . . . 73.24 108.649 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -140.65 147.23 38.99 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.24 -0.652 . . . . 72.21 109.24 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -142.77 139.84 31.17 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.003 -0.369 . . . . 73.31 110.003 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -132.66 149.55 52.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.061 -0.518 . . . . 75.12 109.762 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.29 123.07 5.53 Favored Glycine 0 C--N 1.282 -2.44 0 N-CA-C 109.656 -1.378 . . . . 73.12 109.656 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.4 m -121.01 150.85 40.51 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.701 -0.852 . . . . 71.33 108.701 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 59' ' ' PRO . 46.6 t -98.58 118.09 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.411 -0.959 . . . . 73.3 108.411 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.08 101.97 7.36 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.124 -1.436 . . . . 63.31 107.124 171.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.5 Cg_endo -81.44 -9.31 12.51 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.09 1.86 . . . . 54.44 112.161 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -86.84 26.92 1.05 Allowed 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.772 -0.649 . . . . 63.24 112.053 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.49 101.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.091 -1.448 . . . . 73.22 107.091 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.79 156.36 19.01 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.074 -0.512 . . . . 61.51 109.982 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -80.37 123.36 27.95 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.492 0.663 . . . . 75.22 109.54 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.9 m80 . . . . . 0 C--N 1.292 -1.91 0 N-CA-C 107.566 -1.272 . . . . 74.54 107.566 -179.665 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm . . . . . 0 CA--C 1.5 -0.979 0 N-CA-C 108.923 -0.769 . . . . 54.33 108.923 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.0 -104.25 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 119.952 -1.118 . . . . 65.24 111.719 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -118.26 106.43 12.79 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 109.54 -0.541 . . . . 52.21 109.54 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -139.08 107.33 5.77 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.048 -1.093 . . . . 64.01 108.048 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 -162.19 0.8 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.793 -1.188 . . . . 73.32 107.793 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 23.2 mmt180 -77.28 91.89 3.84 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.342 -0.614 . . . . 74.2 109.342 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.99 106.84 2.9 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.387 -1.338 . . . . 72.54 107.387 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -73.83 144.2 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.281 -1.007 . . . . 73.24 108.281 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -42.75 111.62 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.426 1.491 . . . . 75.32 112.402 -174.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -95.21 177.32 5.9 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.522 -0.763 . . . . 72.41 111.978 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.55 144.97 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.468 -0.787 . . . . 72.13 110.702 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.23 114.55 8.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.028 -0.73 . . . . 73.54 109.028 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -137.7 155.62 48.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.07 134.37 40.51 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.914 -1.143 . . . . 63.44 107.914 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -74.61 156.61 36.57 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.386 0.429 . . . . 74.23 110.436 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.75 124.93 24.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.433 0.635 . . . . 72.34 110.627 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -101.32 142.18 33.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.43 -0.805 . . . . 74.21 109.356 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 m -64.9 147.14 53.9 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 107.575 -1.268 . . . . 75.13 107.575 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 m -76.05 84.59 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 122.823 1.297 . . . . 74.41 111.153 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 67.67 2.07 Favored Glycine 0 N--CA 1.42 -2.371 0 CA-C-N 114.648 -1.16 . . . . 75.15 112.081 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.69 -40.35 83.36 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.115 0.483 . . . . 61.4 110.151 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.23 -51.21 68.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.107 -0.952 . . . . 25.22 110.102 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -56.54 -48.48 77.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.33 -0.85 . . . . 53.43 110.682 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.22 -49.41 74.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 74.32 111.576 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -72.24 -28.08 62.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.439 0.533 . . . . 72.23 112.439 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.8 mt -77.24 -55.89 9.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.899 0.38 . . . . 72.45 111.523 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -84.89 -13.55 50.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.623 0.601 . . . . 75.31 112.623 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.79 3.79 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.041 -0.823 . . . . 42.52 111.041 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.01 -73.61 0.46 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.955 -0.858 . . . . 65.41 110.955 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 t 57.38 32.19 21.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.16 0.984 . . . . 74.31 110.44 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.45 -44.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.646 -1.242 . . . . 74.5 107.646 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -140.24 119.86 8.81 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 114.63 -1.168 . . . . 41.21 108.923 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.34 74.23 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.783 1.655 . . . . 74.45 110.544 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -71.31 -42.0 69.19 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.84 -1.073 . . . . 73.41 110.53 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -58.53 -34.74 71.31 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.917 0.389 . . . . 53.01 111.043 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.57 -56.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.697 -0.683 . . . . 44.31 110.034 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.45 -25.47 64.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.18 -0.608 . . . . 63.44 111.901 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.02 94.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.202 0.525 . . . . 65.15 109.713 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.15 -37.92 66.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 120.045 -0.662 . . . . 62.51 109.938 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.28 0.474 . . . . 64.3 112.28 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -63.68 -29.96 71.13 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.961 0.41 . . . . 75.12 110.341 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 -69.13 -51.76 35.08 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.446 -0.343 . . . . 73.23 110.512 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -64.76 -30.87 71.89 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.344 0.403 . . . . 71.22 110.679 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.74 88.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.131 -0.486 . . . . 41.45 109.887 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.27 -25.9 61.78 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.818 0.818 . . . . 71.22 110.787 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.93 -24.91 48.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.268 -0.878 . . . . 70.15 110.791 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.65 17.01 54.2 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.87 -0.605 . . . . 34.24 112.826 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 45' ' ' ALA . 22.2 mm -67.5 131.55 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.059 0.457 . . . . 74.35 110.943 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -127.91 144.34 51.1 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.654 -0.703 . . . . 64.21 110.342 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 m -66.76 130.11 42.08 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.512 -1.222 . . . . 74.44 110.906 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.8 tp -149.12 -166.21 2.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 104.027 -2.583 . . . . 63.15 104.027 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 84.6 mm-40 -60.26 155.83 16.83 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.586 0.958 . . . . 64.41 113.586 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.71 -5.31 44.61 Favored Glycine 0 CA--C 1.507 -0.407 0 CA-C-N 114.991 -1.004 . . . . 64.05 114.678 -170.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.56 -42.79 51.38 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.29 -0.633 . . . . 74.42 109.29 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 99' ' ' GLN . 13.2 ptp180 -165.06 140.69 5.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.636 -0.711 . . . . 73.22 112.501 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.89 152.48 20.72 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.117 1.367 . . . . 74.53 110.282 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 100' ' ' THR . 44.9 tp -79.07 127.45 32.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.447 -0.575 . . . . 71.53 109.447 -176.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -122.26 164.46 25.77 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 123.575 0.75 . . . . 73.52 109.419 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 125' ' ' VAL . 44.9 Cg_exo -62.04 156.96 46.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.178 2.585 . . . . 71.51 113.525 176.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.7 p-10 -128.02 -30.12 2.49 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.342 -0.844 . . . . 63.15 110.739 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.06 117.55 32.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.165 -1.05 . . . . 71.03 108.165 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.82 114.14 22.19 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.46 0.648 . . . . 73.24 110.231 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.11 111.9 37.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.97 -1.014 . . . . 64.42 108.944 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 3.0 mp -102.97 119.52 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.728 -0.842 . . . . 74.22 108.728 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 126.58 53.27 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 109.582 -0.525 . . . . 72.2 109.582 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.45 165.82 16.43 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 122.915 0.486 . . . . 64.02 110.642 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.08 146.68 50.44 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.734 -1.747 . . . . 43.44 108.734 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -46.2 -54.96 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.606 0.965 . . . . 75.52 113.606 -173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -69.06 -29.94 68.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.436 0.532 . . . . 72.25 112.436 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.25 -40.84 62.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.513 -1.291 . . . . 70.21 107.513 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.03 -34.27 77.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.216 -1.356 . . . . 63.42 111.891 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -53.79 -37.75 63.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.22 0.533 . . . . 62.31 111.134 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -85.41 -29.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.664 -0.698 . . . . 73.05 110.413 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 mt -71.91 -36.79 70.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.367 0.603 . . . . 63.24 109.962 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.49 12.54 26.74 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.256 -0.884 . . . . 62.14 112.557 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.32 -10.36 54.61 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.327 -0.62 . . . . 73.32 109.327 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -139.48 72.48 37.21 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.074 -0.512 . . . . 61.25 111.739 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.69 -28.03 31.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 N-CA-C 108.383 -1.429 . . . . 75.13 108.383 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.38 -53.67 54.88 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.28 -1.782 . . . . 74.31 111.343 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.95 -42.88 12.81 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.087 0.773 . . . . 63.11 113.087 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -76.56 -58.86 3.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.109 0.781 . . . . 72.12 113.109 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -63.29 -48.52 77.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.854 0.359 . . . . 72.4 110.998 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -64.87 -44.46 89.62 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.248 -0.433 . . . . 75.44 111.256 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -56.49 20.41 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 115.773 -0.649 . . . . 63.03 112.625 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.27 -32.42 72.24 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 112.301 0.482 . . . . 72.1 112.301 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.27 86.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 71.21 111.229 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' HD2' ' N ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -82.1 -25.73 34.22 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.204 0.446 . . . . 75.32 112.204 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.64 -43.85 65.39 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.486 -0.931 . . . . 65.42 108.486 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 92' ' ' TYR . 1.2 tm? -67.7 -31.79 71.99 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.769 -0.826 . . . . 73.31 108.769 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.93 -40.08 94.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 72.12 110.779 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 29.1 t70 -74.33 -32.87 62.98 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.303 -0.629 . . . . 62.43 109.303 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.39 -57.6 11.61 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.438 -0.801 . . . . 73.23 110.191 173.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.3 pt -56.5 -30.08 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 120.995 -0.282 . . . . 64.42 111.198 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mm-40 -64.75 -45.43 86.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.842 -0.343 . . . . 72.23 110.926 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 50.3 mt-10 -59.79 -42.55 93.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.711 0.804 . . . . 63.42 111.895 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -80.64 -13.27 59.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 113.885 1.068 . . . . 74.35 113.885 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.71 39.41 9.6 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.597 -1.287 . . . . 50.33 112.52 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -112.12 174.45 5.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.519 -0.401 . . . . 73.43 110.272 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 26.7 pt20 -149.07 171.23 16.74 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.191 0.596 . . . . 72.52 109.611 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 57' ' ' LEU . 13.4 t -159.49 178.36 9.97 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.338 -0.986 . . . . 44.42 108.338 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -101.45 118.62 37.33 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.392 -0.966 . . . . 74.44 108.392 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.79 -149.46 16.6 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 119.296 -1.431 . . . . 75.31 111.055 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -118.99 150.57 39.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.878 -1.527 . . . . 74.13 106.878 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.6 128.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.478 -0.564 . . . . 54.41 109.478 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.73 149.65 26.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 123.627 0.579 . . . . 74.55 110.039 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.96 113.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.252 0.549 . . . . 50.3 110.181 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -119.97 139.66 52.12 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.9 -0.591 . . . . 72.23 110.285 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.25 143.82 42.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.356 -0.609 . . . . 72.34 109.356 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.28 171.49 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.886 0.374 . . . . 70.25 111.653 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.88 159.54 15.56 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.785 -0.643 . . . . 61.34 110.875 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.2 p -143.74 141.78 30.63 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.496 -0.775 . . . . 54.13 109.229 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -81.36 -26.77 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.272 0.558 . . . . 71.44 110.809 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -77.86 -30.39 50.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.655 -0.702 . . . . 72.13 111.991 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.72 150.7 26.57 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.904 -0.718 . . . . 61.13 111.518 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' GLN . 84.8 m-70 -97.1 173.54 7.2 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.939 -1.028 . . . . 73.02 110.606 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 130.58 42.12 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.239 -1.393 . . . . 75.43 107.239 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.87 -3.87 82.04 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.805 -0.712 . . . . 51.02 111.903 -174.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 5.2 tp-100 -101.54 119.8 39.32 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.088 -1.449 . . . . 74.51 107.088 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.9 157.15 46.16 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.69 -0.804 . . . . 75.01 112.106 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -145.38 143.31 30.04 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.439 -1.255 . . . . 75.35 107.81 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . . . -134.56 139.12 45.15 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 105.511 -2.033 . . . . 75.13 105.511 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -129.25 127.49 41.33 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.99 -0.684 . . . . 70.14 109.999 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.33 117.47 5.87 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.297 -1.521 . . . . 61.43 109.297 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 90.4 m -121.16 145.82 47.42 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 122.767 0.427 . . . . 52.32 110.019 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 59' ' ' PRO . 47.1 t -93.52 110.07 22.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.24 -1.022 . . . . 74.53 108.24 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -108.45 104.12 53.12 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 109.693 -0.484 . . . . 73.23 109.693 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.51 3.43 5.35 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.38 2.054 . . . . 73.43 110.893 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -96.59 71.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.398 1.094 . . . . 74.02 109.834 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.99 121.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.482 -1.69 . . . . 73.52 106.548 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -73.31 143.88 46.79 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.242 -0.651 . . . . 75.43 109.242 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -88.46 116.3 26.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.976 -1.12 . . . . 73.51 107.976 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 107.19 -1.411 . . . . 64.33 107.19 -177.023 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.634 0.254 . . . . 72.32 110.651 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.19 166.38 40.38 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.872 -1.291 . . . . 63.53 109.872 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -79.93 -68.52 0.66 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.936 -0.705 . . . . 74.24 109.183 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 61.81 -0.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.046 1.339 . . . . 72.51 114.204 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -71.84 129.97 39.93 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.448 0.642 . . . . 71.44 110.991 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -84.7 88.64 7.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.529 -0.759 . . . . 73.34 110.537 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.76 92.87 9.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.334 -0.987 . . . . 74.25 108.334 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 m -80.73 81.63 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 122.425 1.107 . . . . 74.52 110.434 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.88 140.58 45.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.815 -1.084 . . . . 75.11 110.165 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -84.15 89.63 7.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.72 -0.844 . . . . 62.33 108.72 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 p -130.93 117.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.356 -0.838 . . . . 30.04 109.084 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.27 146.27 24.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.938 -0.574 . . . . 73.32 112.229 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -159.38 173.19 16.63 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.742 -0.836 . . . . 35.32 108.742 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.12 174.72 10.26 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.323 -0.991 . . . . 74.32 108.323 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 tp -86.13 -43.25 13.2 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.147 -1.797 . . . . 75.21 106.147 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 81.03 2.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.142 -1.39 . . . . 71.52 109.493 177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -89.78 -32.02 17.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.134 -0.626 . . . . 74.14 109.98 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.6 m -86.2 123.68 31.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.248 -0.887 . . . . 74.24 109.286 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.63 101.11 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 116.186 -0.461 . . . . 63.12 109.878 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.79 97.37 0.18 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.653 -0.703 . . . . 54.13 111.983 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -162.38 151.95 15.92 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.298 -1.371 . . . . 62.24 107.298 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -58.72 -59.86 4.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 124.107 0.879 . . . . 70.52 111.581 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.41 -35.8 78.17 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.644 -0.253 . . . . 74.42 111.345 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.41 79.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.13 111.643 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 10.4 ptp180 -81.1 -28.41 35.22 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 121.001 -0.28 . . . . 74.31 111.064 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 22' ' ' ALA . 80.1 mt -63.23 -50.21 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 110.013 -0.366 . . . . 73.15 110.013 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -81.3 -28.24 34.71 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.125 0.488 . . . . 73.32 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.86 -48.94 3.3 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 111.184 -0.767 . . . . 75.42 111.184 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.22 24.35 3.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 115.042 0.777 . . . . 70.21 115.042 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t 67.58 27.36 7.81 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.47 0.635 . . . . 52.44 111.418 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.16 121.06 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.553 -0.906 . . . . 72.52 108.553 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 m -125.64 162.26 45.91 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.051 -0.722 . . . . 70.23 109.051 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.3 -21.51 52.94 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.003 2.468 . . . . 63.02 112.02 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -62.84 -34.34 77.13 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.606 -0.725 . . . . 75.34 111.071 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -60.02 -44.1 94.83 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.98 0.895 . . . . 62.43 109.198 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.5 t -63.18 -55.87 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.772 -1.558 . . . . 43.54 110.74 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 pt-20 -64.44 -34.01 77.2 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.391 -0.523 . . . . 75.22 111.735 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.3 91.01 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.919 -0.401 . . . . 62.52 109.919 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.96 -38.46 72.8 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.304 -0.407 . . . . 72.34 110.444 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.9 mt -60.34 -47.65 85.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.908 0.336 . . . . 74.55 111.908 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.2 ptm180 -71.58 -30.62 66.04 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 120.552 -0.459 . . . . 75.23 111.034 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -68.13 -41.43 81.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 72.54 109.269 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 122' ' ' ARG . 4.9 tp10 -64.51 -43.94 92.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.081 -0.963 . . . . 73.13 109.024 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.75 76.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 65.34 110.654 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.42 71.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 60.22 112.64 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.39 -13.54 24.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.969 -1.092 . . . . 74.44 110.661 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.16 3.42 76.49 Favored Glycine 0 CA--C 1.502 -0.749 0 CA-C-N 115.806 -0.634 . . . . 72.14 111.86 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 56' ' ' LEU . 20.4 mm -55.55 127.67 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 C-N-CA 124.39 1.076 . . . . 73.23 111.028 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 35.2 tt0 -105.45 135.89 46.01 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.449 -1.315 . . . . 65.05 107.449 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -70.19 122.25 19.12 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.318 -1.364 . . . . 60.45 107.318 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.1 tp -127.02 -165.59 1.48 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 105.98 -1.859 . . . . 71.33 105.98 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.582 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.1 mt-30 -53.29 160.37 1.14 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.056 0.543 . . . . 70.35 111.733 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.77 -10.91 47.65 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 116.124 -0.489 . . . . 60.41 113.233 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.45 -44.58 74.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.498 -0.186 . . . . 55.24 110.498 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -171.89 166.59 6.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 113.066 0.765 . . . . 71.41 113.066 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB3' HG23 ' A' ' 48' ' ' ILE . 76.8 mt -93.94 151.92 19.21 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 125.17 1.388 . . . . 73.41 111.401 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 31.0 tp -98.94 130.96 45.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.554 -0.906 . . . . 74.5 108.554 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 156.28 44.67 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 123.539 0.525 . . . . 74.03 110.424 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -62.47 154.87 61.42 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.95 2.434 . . . . 72.42 112.229 176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 29.0 p-10 -128.34 -28.09 2.6 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.04 -0.527 . . . . 62.02 112.131 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.7 119.15 35.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 120.067 -0.653 . . . . 73.21 109.703 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' HB2' HG22 ' A' ' 106' ' ' VAL . 68.7 m-85 -120.14 114.26 21.69 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.406 0.622 . . . . 71.02 109.792 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.2 mt -102.2 107.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.985 -1.117 . . . . 73.05 107.985 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.3 mt -102.02 115.28 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.054 -1.091 . . . . 72.15 108.054 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 16.9 m -109.06 121.83 45.99 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 115.927 -0.579 . . . . 75.22 110.152 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.6 mm? -110.03 174.75 5.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.851 1.26 . . . . 72.11 109.986 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.67 164.9 50.92 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 108.762 -1.735 . . . . 71.22 108.762 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.26 -33.12 61.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 118.316 1.058 . . . . 63.22 111.483 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.562 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 41.9 t60 -75.85 -28.5 58.23 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 120.449 -0.501 . . . . 73.24 109.729 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 33.0 m-20 -75.29 -31.96 60.86 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.145 -0.687 . . . . 74.22 109.145 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 78' ' ' PRO . 73.2 t80 -62.25 -44.49 96.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.338 -0.846 . . . . 74.23 110.734 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.57 -30.58 69.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.316 0.579 . . . . 73.25 110.771 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 74.3 mmtt -73.14 -24.27 60.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.408 -0.814 . . . . 73.53 110.647 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 98.4 mt -68.26 -31.62 71.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.056 -1.09 . . . . 71.4 108.056 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.56 179.76 19.65 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.231 -0.895 . . . . 52.15 111.621 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.32 -17.27 46.35 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.274 -1.009 . . . . 44.45 108.274 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -128.98 75.16 80.64 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.902 -1.045 . . . . 75.12 108.399 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 23.4 Cg_exo -69.15 -36.37 12.55 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.263 1.975 . . . . 73.53 111.836 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.52 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 2.8 tp10 -69.35 -12.16 61.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.649 -0.705 . . . . 73.23 110.631 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.56 -36.66 73.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.016 -0.538 . . . . 63.22 109.839 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -84.89 -13.18 51.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.912 -0.315 . . . . 72.11 111.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 19.9 m -61.1 -40.96 95.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 64.01 110.453 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -67.86 -29.09 68.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.785 -0.643 . . . . 73.24 110.007 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.3 91.89 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.425 -1.07 . . . . 44.25 110.425 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -68.65 -32.43 72.27 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 111.688 0.255 . . . . 70.13 111.688 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.69 -44.78 96.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.144 0.497 . . . . 73.04 110.333 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -67.79 -44.15 78.07 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.528 -0.76 . . . . 64.33 110.625 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.77 -38.07 89.75 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.302 -0.408 . . . . 64.42 111.237 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.3 -41.79 72.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.439 -0.578 . . . . 74.43 109.439 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.63 90.68 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.439 0.638 . . . . 71.5 109.468 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.86 -53.62 55.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.481 -1.236 . . . . 74.22 108.779 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.632 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.5 m-85 -51.06 -55.37 17.89 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.924 0.713 . . . . 72.15 112.924 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -62.16 -37.22 77.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 112.618 0.599 . . . . 72.45 112.618 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -71.74 -35.25 70.08 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.904 -0.319 . . . . 74.41 111.024 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.87 -31.98 73.46 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.261 0.553 . . . . 74.33 111.235 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.0 mm-40 -79.45 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.024 -0.534 . . . . 70.24 110.969 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.46 21.28 32.4 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.218 -0.515 . . . . 72.25 112.033 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -102.99 172.1 7.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.747 -0.834 . . . . 75.02 108.747 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -140.74 173.91 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.143 -0.688 . . . . 70.44 109.143 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.3 t -148.98 171.28 16.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.609 -0.886 . . . . 64.11 108.609 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 73.8 m-85 -114.43 121.05 42.37 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 109.476 -0.565 . . . . 62.13 109.476 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -150.06 17.05 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 109.516 -1.434 . . . . 73.23 109.516 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -119.42 143.48 47.46 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.915 -1.143 . . . . 62.21 107.915 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 69.9 t -74.66 118.12 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.173 -0.677 . . . . 75.51 109.173 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.8 120.23 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-O 122.131 0.967 . . . . 64.22 110.305 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.9 t -115.33 137.47 48.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 106.297 -1.742 . . . . 73.42 106.297 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -141.18 139.31 33.84 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.47 0.481 . . . . 74.5 111.859 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -108.72 114.23 27.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 64.2 108.588 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.1 pt-20 -135.61 165.5 25.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.743 -0.208 . . . . 71.12 110.793 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.18 165.59 10.93 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 114.612 1.338 . . . . 62.33 114.612 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -134.22 141.69 47.12 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.541 -1.651 . . . . 42.13 106.541 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -80.7 -16.66 53.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.516 0.674 . . . . 74.43 110.295 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -83.49 -30.44 27.17 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 53.1 110.554 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.22 133.06 37.78 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.915 -0.584 . . . . 71.21 110.948 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.52 159.52 14.87 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.452 -0.794 . . . . 32.22 109.012 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 8.1 m -52.4 117.85 3.14 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 124.409 1.068 . . . . 74.15 111.863 -176.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.75 -1.84 28.93 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.938 -0.649 . . . . 64.21 112.842 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.21 123.87 50.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.925 0.393 . . . . 73.05 111.29 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.0 p90 -131.18 150.75 52.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.861 -0.792 . . . . 70.51 108.861 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -142.22 132.74 25.22 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.754 -0.832 . . . . 73.34 108.754 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.04 122.72 41.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.709 -0.848 . . . . 73.22 108.709 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.453 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.8 tpm_? -111.93 121.54 45.3 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.886 -0.783 . . . . 61.21 108.886 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -110.74 130.01 9.59 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 110.98 -0.848 . . . . 45.31 110.98 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.9 t -135.9 163.29 30.58 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.601 -0.518 . . . . 64.35 109.601 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 59' ' ' PRO . 45.1 t -99.15 107.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.773 -0.825 . . . . 63.14 108.773 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -116.39 99.68 52.91 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 109.649 -0.501 . . . . 64.52 109.649 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 6.8 Cg_exo -73.61 -23.97 16.47 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.699 2.266 . . . . 63.13 112.429 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -86.73 66.85 9.65 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.123 0.963 . . . . 73.22 112.479 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.83 98.0 6.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.586 -2.005 . . . . 74.43 105.586 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.31 96.49 2.83 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.009 -0.996 . . . . 61.2 110.512 -175.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -91.15 163.05 14.41 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.582 -1.19 . . . . 44.24 110.033 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.8 t60 . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 106.955 -1.498 . . . . 72.31 106.955 176.183 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.674 -0.491 . . . . 75.44 109.674 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.52 54.96 0.19 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.794 -0.923 . . . . 52.33 110.794 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 m -108.51 82.75 1.66 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.602 0.715 . . . . 54.52 110.534 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -108.69 103.01 12.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.13 -0.941 . . . . 74.44 108.757 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 147.12 48.65 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.164 -0.615 . . . . 70.3 110.422 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -125.45 96.13 4.7 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.084 -1.821 . . . . 72.24 106.084 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.24 97.27 2.41 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.195 0.521 . . . . 74.24 111.965 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.26 127.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 107.103 -1.443 . . . . 70.11 107.103 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -92.98 -2.68 55.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.229 0.538 . . . . 73.21 111.498 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -95.84 138.41 33.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.196 -1.409 . . . . 73.52 107.196 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -82.63 89.69 2.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.47 -1.307 . . . . 74.42 107.47 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -50.62 110.42 0.41 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.116 -1.402 . . . . 53.44 111.94 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 118.82 4.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.395 -1.275 . . . . 71.51 110.665 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -88.65 109.29 19.99 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.749 -0.834 . . . . 62.01 108.749 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 tp -72.63 121.61 20.03 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.358 -0.837 . . . . 62.12 109.091 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.68 101.56 1.69 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.748 -1.575 . . . . 74.43 106.748 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -67.72 166.19 15.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.336 -0.847 . . . . 74.22 110.696 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -56.3 107.26 0.35 Allowed 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.73 0.644 . . . . 75.42 110.407 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.81 106.81 3.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.78 -0.822 . . . . 75.33 108.78 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 45.87 1.83 Allowed Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.475 -1.05 . . . . 62.25 110.475 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 11.2 t70 -135.36 120.87 19.28 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.861 -1.163 . . . . 72.11 107.861 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.13 92.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.079 0.862 . . . . 61.25 112.844 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -65.65 -42.64 91.16 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.325 -0.398 . . . . 62.33 110.184 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.07 72.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 62.13 111.018 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 25.2 mmm180 -71.65 -47.61 53.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.367 0.603 . . . . 74.35 109.596 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -53.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.877 -1.056 . . . . 72.22 112.111 -176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -78.01 -28.98 49.32 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.909 -0.716 . . . . 55.32 111.68 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.04 -14.19 28.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.412 -0.675 . . . . 74.24 111.412 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.77 99.5 0.19 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 108.033 -2.027 . . . . 71.53 108.033 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.9 m -43.37 125.81 3.99 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 125.689 1.595 . . . . 43.23 114.108 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.13 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.395 -1.335 . . . . 70.22 107.395 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.35 155.21 43.15 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.031 -0.531 . . . . 72.41 110.587 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.97 -18.41 9.43 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.974 3.116 . . . . 52.03 113.705 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 77.4 mt-30 -65.85 -30.93 71.62 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.551 -0.295 . . . . 73.21 111.18 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.24 -34.13 74.32 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.457 -0.942 . . . . 62.31 108.457 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.8 t -68.06 -48.05 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.623 -1.171 . . . . 22.42 109.96 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -66.33 -33.79 76.52 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.375 -0.53 . . . . 75.55 110.934 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.73 82.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.566 -0.531 . . . . 53.14 109.566 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.16 -32.94 74.68 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.31 -0.859 . . . . 74.1 111.844 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 80.9 mt -69.74 -38.44 76.83 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.06 0.225 . . . . 64.45 111.19 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 74.9 mtm180 -62.68 -43.23 99.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.538 -0.912 . . . . 72.54 108.538 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -40.66 90.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.0 -1.0 . . . . 75.41 111.698 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -60.47 -46.47 89.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.425 0.69 . . . . 61.23 109.845 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.36 92.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.482 -0.781 . . . . 52.45 110.83 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.35 68.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 62.22 111.888 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.03 -35.87 31.32 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.11 -0.369 . . . . 73.22 111.121 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.99 13.73 52.69 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.814 -0.63 . . . . 62.15 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 48' ' ' ILE . 15.6 mm -55.88 137.03 17.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 123.43 0.692 . . . . 75.1 111.978 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.0 tt0 -119.56 132.97 55.86 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.25 -1.389 . . . . 64.31 107.25 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -66.51 134.89 53.34 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 121.684 0.754 . . . . 65.0 109.992 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.2 tp -149.7 -165.53 2.3 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 103.096 -2.928 . . . . 75.32 103.096 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.509 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 76.5 mt-30 -54.52 146.36 16.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.083 0.856 . . . . 72.04 109.506 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.87 -12.92 58.41 Favored Glycine 0 C--O 1.237 0.333 0 CA-C-N 116.773 -0.194 . . . . 72.32 113.114 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.85 -40.02 93.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.208 -0.664 . . . . 71.43 109.208 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -167.94 132.83 1.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.416 -0.811 . . . . 73.31 110.885 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.76 152.17 20.91 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 124.692 1.197 . . . . 73.11 109.641 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.84 122.14 31.93 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.482 -1.303 . . . . 73.53 107.482 -174.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.3 160.16 26.98 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.33 -0.619 . . . . 64.44 109.33 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.66 151.08 72.62 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.125 1.883 . . . . 63.14 111.049 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 5.3 p-10 -123.24 -27.59 4.12 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.415 -0.514 . . . . 54.24 111.46 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -106.03 110.91 23.33 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.098 -1.075 . . . . 74.35 108.098 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.91 131.73 54.8 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.225 -0.443 . . . . 73.11 109.892 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -121.84 111.73 32.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.613 -0.514 . . . . 63.21 109.613 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.17 109.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.978 -1.489 . . . . 64.21 106.978 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.425 ' HB ' ' HG2' ' A' ' 120' ' ' ARG . 8.7 m -112.94 126.48 55.53 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.088 -0.708 . . . . 64.14 109.088 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.2 mm? -105.22 156.14 18.39 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.377 -0.972 . . . . 74.5 108.377 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.64 146.73 50.53 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 109.323 -1.511 . . . . 74.23 109.323 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.477 HG23 ' NE2' ' A' ' 110' ' ' GLN . 3.3 p -53.83 -40.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 112.516 0.562 . . . . 52.51 112.516 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 23.9 t60 -62.17 -33.37 74.38 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 123.336 0.654 . . . . 70.45 111.004 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.51 -44.33 12.79 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.619 0.247 . . . . 73.44 111.011 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 35.6 t80 -66.28 -34.89 79.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 111.957 0.355 . . . . 73.14 111.957 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.9 pt-20 -63.45 -31.87 73.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.187 0.518 . . . . 74.24 110.671 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 46.3 mmtm -73.52 -28.1 61.72 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.603 -0.726 . . . . 74.01 109.869 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.43 -39.11 71.25 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.996 -0.742 . . . . 54.43 108.996 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.85 175.02 15.59 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.217 -0.753 . . . . 75.22 111.217 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.625 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -94.62 1.25 55.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.712 0.291 . . . . 71.33 111.236 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.9 95.65 8.07 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.852 1.056 . . . . 64.14 113.852 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.3 Cg_exo -76.8 -43.78 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.886 2.391 . . . . 64.14 112.116 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.699 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 44.5 tt0 -63.88 -29.98 71.12 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.016 0.747 . . . . 74.34 113.016 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.65 -24.23 67.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.974 -0.557 . . . . 73.0 110.456 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -99.88 -36.75 9.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.096 -0.502 . . . . 74.23 111.411 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.699 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 23.2 p -66.32 -45.39 80.44 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.375 0.509 . . . . 75.03 112.375 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.9 m -67.31 -39.85 85.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.522 -0.471 . . . . 53.15 110.925 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.0 -51.29 52.49 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.956 -0.566 . . . . 61.42 111.774 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.92 -30.66 70.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.635 0.605 . . . . 73.2 112.635 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -65.47 -48.05 73.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 120.907 0.384 . . . . 64.51 110.151 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -67.54 -38.02 83.56 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.56 -0.746 . . . . 72.42 109.822 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.57 -47.07 80.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.363 -0.835 . . . . 73.12 110.498 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.1 tp -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 65.51 110.832 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.19 93.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.108 -0.701 . . . . 44.13 109.108 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.3 t70 -62.59 -44.46 96.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.167 -0.924 . . . . 72.21 109.636 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -55.23 -54.25 45.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.786 0.679 . . . . 52.32 112.42 175.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -62.35 -32.95 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.163 0.506 . . . . 70.41 111.213 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -64.93 -41.89 95.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.699 -0.682 . . . . 75.01 110.723 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.0 mt-10 -62.99 -39.19 94.0 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.293 0.568 . . . . 71.15 111.032 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 76.9 mm-40 -73.57 -14.24 61.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.321 -0.854 . . . . 65.42 112.336 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 38.21 13.48 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.217 -0.992 . . . . 64.21 110.972 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -115.18 -178.95 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.271 -0.641 . . . . 73.44 109.271 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -157.21 178.34 10.45 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.771 -0.825 . . . . 73.12 108.771 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 11.2 t -156.7 173.57 16.76 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.538 -0.912 . . . . 71.53 108.538 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.0 m-85 -115.93 124.02 49.54 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 109.306 -0.628 . . . . 74.2 109.306 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -149.45 18.18 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.115 -1.194 . . . . 71.22 110.115 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.32 142.74 44.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.749 -0.834 . . . . 44.13 108.749 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.04 104.0 11.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.296 -1.372 . . . . 74.34 107.296 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 p -125.84 120.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.733 0.778 . . . . 65.21 110.434 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -110.91 127.87 67.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.108 -1.071 . . . . 64.11 108.108 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -106.22 132.74 51.92 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.361 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -115.26 114.29 25.0 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.265 -2.124 . . . . 70.25 105.265 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.02 173.24 12.63 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.239 0.542 . . . . 62.23 111.893 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.477 ' NE2' HG23 ' A' ' 68' ' ' VAL . 16.1 pt20 -119.86 164.84 15.42 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.903 -1.044 . . . . 72.44 109.762 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.7 t -143.88 141.42 30.28 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.804 -1.554 . . . . 71.34 106.804 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -81.01 -16.61 52.91 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.049 -1.093 . . . . 53.03 108.049 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -82.57 -4.34 57.48 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.049 -0.978 . . . . 74.41 110.793 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.73 131.05 56.33 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.112 -1.07 . . . . 72.31 108.112 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 40.2 m80 -100.72 172.35 7.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.587 -0.279 . . . . 64.45 111.388 -175.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.7 t -68.3 145.31 54.34 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.171 0.51 . . . . 71.15 110.635 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.65 -4.89 76.56 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.097 -1.201 . . . . 72.4 110.097 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 52.4 mt-30 -119.74 133.22 55.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.987 0.915 . . . . 64.25 109.335 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.472 ' HB3' HD13 ' A' ' 66' ' ' LEU . 50.5 p90 -159.9 157.0 28.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.136 -1.431 . . . . 74.41 107.136 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 9.1 ptp85 -135.84 153.92 51.34 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.581 -0.525 . . . . 62.32 109.581 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.08 118.03 11.15 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.264 -2.124 . . . . 51.22 105.264 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.99 137.41 21.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.402 -0.962 . . . . 73.44 108.402 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.65 142.56 17.3 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.501 -1.04 . . . . 65.53 110.501 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.8 t -136.05 156.7 48.34 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.275 -0.639 . . . . 73.34 109.275 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.33 110.11 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.564 -0.902 . . . . 72.42 108.564 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -130.91 91.93 35.32 Favored Pre-proline 0 C--N 1.292 -1.895 0 N-CA-C 108.043 -1.095 . . . . 74.12 108.043 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 51.2 Cg_endo -72.18 -15.13 28.79 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.031 1.82 . . . . 61.04 111.334 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.62 65.16 9.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.599 1.19 . . . . 72.24 111.533 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 p -136.29 127.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-N 113.11 -1.859 . . . . 74.42 106.288 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.73 118.17 11.38 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.282 0.563 . . . . 74.13 110.268 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 t -122.4 88.4 2.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.882 1.325 . . . . 65.2 111.992 -173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 106.935 -1.505 . . . . 71.3 106.935 176.926 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.503 -0.861 0 N-CA-C 110.224 -0.287 . . . . 75.11 110.224 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.97 149.02 5.47 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.994 -1.642 . . . . 64.24 108.994 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.414 ' HB3' ' HE2' ' A' ' 5' ' ' LYS . 63.6 m -85.06 89.5 7.63 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.812 0.815 . . . . 75.31 110.1 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -103.24 123.6 47.05 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.191 -0.913 . . . . 73.44 109.598 -178.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -171.59 159.07 5.32 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.976 -1.49 . . . . 54.3 106.976 175.724 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -101.44 109.75 21.63 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.92 -1.141 . . . . 65.44 107.92 176.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -81.76 87.86 6.31 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.791 -2.3 . . . . 70.34 104.791 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 10' ' ' ARG . 10.7 p -92.53 129.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 114.74 -1.118 . . . . 54.11 109.954 -174.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -110.49 24.96 12.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.748 -0.66 . . . . 72.24 112.277 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HD3' ' O ' ' A' ' 10' ' ' ARG 0.321 0.0 OUTLIER -83.63 105.31 14.44 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 118.616 -1.233 . . . . 71.51 111.076 173.61 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.61 127.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.445 -0.798 . . . . 64.43 110.14 -178.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.39 150.31 29.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 109.018 -0.734 . . . . 73.12 109.018 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 150.25 50.0 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.12 -0.491 . . . . 73.35 109.996 -178.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -166.22 152.59 9.12 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 106.244 -1.761 . . . . 72.43 106.244 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.85 74.94 8.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.349 -1.352 . . . . 74.32 107.349 171.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.522 ' OE1' ' HG2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -105.59 163.03 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.15 -1.387 . . . . 74.01 109.163 -174.273 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' HG2' ' OE1' ' A' ' 16' ' ' GLU . 12.7 pt20 -79.72 147.12 32.05 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.031 -0.531 . . . . 72.34 110.562 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -77.79 106.07 9.38 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.104 -0.498 . . . . 63.41 110.754 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t -85.34 123.9 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 107.041 -1.466 . . . . 53.23 107.041 178.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 33' ' ' PRO . . . 83.35 36.31 14.93 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 108.5 -1.84 . . . . 51.25 108.5 -172.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.611 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 18.5 t70 -54.64 -37.67 65.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.059 0.944 . . . . 64.42 111.76 -176.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -60.58 -44.87 95.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.416 -0.811 . . . . 72.23 110.395 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -65.83 -41.2 92.07 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.751 -0.659 . . . . 62.11 110.293 178.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -48.13 77.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 75.24 111.195 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 20.6 ptt85 -74.03 -26.03 60.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.177 0.806 . . . . 54.12 113.177 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.7 mt -71.36 -37.69 66.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 109.305 -0.628 . . . . 72.42 109.305 173.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.47 -28.62 59.31 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.053 -0.522 . . . . 64.2 109.82 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.18 -86.14 0.77 Allowed Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 121.132 -0.556 . . . . 72.21 112.472 175.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.17 -21.76 40.6 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 121.126 -0.559 . . . . 61.13 113.511 -176.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 m -74.44 107.86 6.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.345 0.593 . . . . 63.32 110.48 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.1 pt -84.16 -25.92 7.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 114.914 1.45 . . . . 62.54 114.914 -173.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.46 96.39 49.81 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 120.062 -0.655 . . . . 62.03 111.827 -177.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' HG2' ' O ' ' A' ' 20' ' ' GLY . 5.3 Cg_exo -87.08 -23.3 1.56 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.762 2.308 . . . . 64.31 111.708 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.4 -17.41 64.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.728 -0.669 . . . . 63.21 112.359 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.14 -25.58 68.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.296 -0.411 . . . . 64.22 110.501 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.16 -47.47 92.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 116.282 -0.417 . . . . 60.5 110.438 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 48.5 mt-10 -63.47 -48.24 78.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.794 0.331 . . . . 72.1 110.534 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.17 86.32 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.402 -0.817 . . . . 74.11 111.865 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.54 -33.68 62.79 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.379 -0.373 . . . . 65.13 110.539 -178.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -73.57 -36.67 65.62 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.457 -0.497 . . . . 44.12 111.03 -177.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -71.76 -25.21 61.95 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.377 -0.929 . . . . 74.51 110.368 175.587 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -68.78 -37.33 79.23 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 107.981 -1.118 . . . . 73.11 107.981 175.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -68.49 -40.07 81.04 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.37 -0.832 . . . . 73.24 109.49 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.01 93.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.047 -0.524 . . . . 72.24 110.834 177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.28 58.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.974 -0.557 . . . . 42.53 111.189 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.8 -33.69 57.99 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.488 0.661 . . . . 72.43 109.715 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.33 8.13 59.08 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.202 -0.908 . . . . 74.43 113.59 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 56' ' ' LEU . 9.5 mm -56.44 135.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 123.434 0.693 . . . . 73.54 111.537 177.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 19.0 tt0 -124.52 142.86 51.02 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 108.216 -1.031 . . . . 73.24 108.216 -177.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 m -76.48 131.8 39.23 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.698 -0.683 . . . . 54.41 110.995 -177.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.2 tp -148.06 -168.99 3.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 105.174 -2.158 . . . . 71.45 105.174 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.637 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.43 140.43 7.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.439 1.096 . . . . 65.5 110.542 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.2 24.76 0.87 Allowed Glycine 0 C--N 1.316 -0.551 0 C-N-CA 123.457 0.551 . . . . 52.2 114.465 -173.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -85.16 -38.75 18.67 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.638 -1.616 . . . . 72.52 106.638 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -174.22 160.24 3.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.407 -1.27 . . . . 74.3 110.173 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 48' ' ' ILE . 65.3 mt -90.51 152.38 20.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 123.826 0.851 . . . . 74.21 111.131 -173.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD23 HD22 ' A' ' 51' ' ' LEU . 2.0 tm? -92.89 121.79 34.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.608 -1.627 . . . . 74.34 106.608 -176.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.78 158.24 32.82 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 109.629 -0.508 . . . . 54.42 109.629 -177.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.35 156.78 58.07 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.427 2.085 . . . . 71.43 112.266 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -125.18 -22.58 4.37 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.922 -0.581 . . . . 23.31 110.563 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 11.4 tp10 -94.02 106.36 18.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.644 -1.243 . . . . 72.11 107.644 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -122.43 114.54 20.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.468 0.651 . . . . 75.45 111.011 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.52 122.55 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.55 -0.907 . . . . 61.34 108.55 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -116.25 117.3 55.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.761 -0.829 . . . . 71.14 108.761 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.3 m -103.47 116.78 33.05 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.775 -0.648 . . . . 75.45 109.39 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.07 175.04 5.61 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.963 -0.562 . . . . 70.11 110.027 178.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.18 145.05 32.86 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.11 -0.796 . . . . 75.35 111.11 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.52 -24.62 36.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.381 0.61 . . . . 73.32 110.044 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 52.8 t-80 -55.28 -51.86 65.31 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.051 -0.977 . . . . 61.21 110.32 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 73' ' ' LYS 0.261 2.6 m-20 -87.23 -20.02 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.938 1.088 . . . . 70.4 113.938 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.442 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 36.6 t80 -61.97 -33.25 73.96 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.43 -0.35 . . . . 61.32 110.529 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 11.2 pt-20 -66.28 -26.25 67.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 73.51 111.52 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -70.51 -33.46 71.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.215 -0.902 . . . . 51.24 109.099 174.471 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.78 -37.01 76.19 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.991 0.901 . . . . 72.41 108.688 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.19 -157.88 15.56 Favored Glycine 0 N--CA 1.425 -2.089 0 CA-C-N 114.839 -1.073 . . . . 70.11 111.304 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.79 18.66 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.035 0.445 . . . . 71.0 110.263 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.58 109.81 61.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.963 -0.562 . . . . 71.33 111.04 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.1 -39.46 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 121.754 1.636 . . . . 63.24 112.399 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -58.34 -38.94 78.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 116.232 1.938 . . . . 72.13 116.232 -164.123 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.65 -37.26 83.38 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.611 0.719 . . . . 72.24 110.185 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -86.12 -25.02 26.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.785 -0.643 . . . . 63.13 110.139 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.587 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.7 m -65.67 -33.36 75.7 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.603 -0.726 . . . . 72.54 109.305 175.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -63.08 -44.27 96.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.42 109.732 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.23 95.29 Favored Glycine 0 C--O 1.243 0.675 0 C-N-CA 120.855 -0.688 . . . . 55.32 111.798 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.17 -33.03 67.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.327 -0.62 . . . . 42.11 109.327 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.6 93.47 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.284 -0.416 . . . . 63.13 110.688 177.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.56 -41.44 94.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.266 0.555 . . . . 74.24 110.745 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 38.9 t70 -71.24 -36.61 71.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.734 -0.667 . . . . 71.21 110.551 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.19 -33.84 75.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.015 0.436 . . . . 74.34 110.187 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.08 79.19 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.284 -0.635 . . . . 55.53 109.284 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 29.7 t70 -65.45 -46.61 79.21 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.559 -0.746 . . . . 74.04 109.515 176.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 37.1 m-85 -54.57 -49.85 69.36 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 112.581 0.586 . . . . 72.12 112.581 176.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.9 pt -67.1 -32.51 58.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 C-N-CA 119.818 -0.753 . . . . 74.05 111.884 -177.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.53 -42.61 95.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.27 0.557 . . . . 74.52 109.76 174.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -65.93 -31.89 73.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 74.31 112.315 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 65.2 mm-40 -84.94 -13.28 51.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.315 0.579 . . . . 73.55 110.512 176.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.16 35.36 53.42 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.239 -0.891 . . . . 72.03 113.459 176.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.416 ' CE2' HD11 ' A' ' 48' ' ' ILE . 15.6 m0 -97.96 168.26 10.4 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.18 0.49 . . . . 64.24 110.401 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -130.43 167.42 18.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.423 -0.584 . . . . 64.11 109.423 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -161.61 177.88 9.57 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.005 -0.739 . . . . 72.12 109.005 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -119.66 120.73 37.49 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.407 -0.59 . . . . 75.01 109.407 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -158.42 14.7 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.141 -1.584 . . . . 75.41 109.141 -175.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.27 151.09 37.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.616 -1.253 . . . . 64.11 107.616 176.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.69 121.62 18.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 120.949 0.404 . . . . 65.04 110.453 -177.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.34 120.27 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 121.881 0.848 . . . . 41.54 110.128 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.0 t -119.13 124.01 72.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.84 -1.541 . . . . 74.23 106.84 177.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -132.79 136.21 46.17 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.05 0.452 . . . . 72.43 110.996 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 94.8 m-85 -104.01 141.26 36.5 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.337 -0.847 . . . . 65.44 108.854 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.85 162.66 34.26 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.562 -0.29 . . . . 71.3 110.8 176.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -100.66 150.38 22.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.729 -0.669 . . . . 73.44 110.997 -176.026 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 31.6 t -129.95 129.27 43.6 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.525 -1.287 . . . . 73.24 107.525 174.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 t -81.45 -27.69 34.53 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.704 -0.851 . . . . 55.1 108.704 176.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -68.85 -46.34 68.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.015 -0.993 . . . . 70.11 110.434 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.444 HD21 ' O ' ' A' ' 118' ' ' GLN . 6.8 tt -84.41 140.47 31.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.833 -1.076 . . . . 74.14 110.455 -176.381 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -120.01 156.91 29.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.111 -0.7 . . . . 74.23 109.111 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -55.8 119.45 5.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.705 1.202 . . . . 74.04 110.538 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.66 -27.22 3.74 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 106.589 -2.604 . . . . 32.14 106.589 -174.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.444 ' O ' HD21 ' A' ' 114' ' ' LEU . 34.5 tt0 -116.13 146.95 41.84 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 104.806 -2.294 . . . . 70.21 104.806 172.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -158.37 157.78 33.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.544 -1.28 . . . . 74.42 107.544 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -130.13 139.35 50.91 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 110.438 -0.208 . . . . 72.32 110.438 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.03 133.37 29.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.027 -1.472 . . . . 55.43 107.027 177.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -134.72 134.82 41.44 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.607 -0.886 . . . . 71.23 108.607 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -131.1 125.15 4.38 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.113 -1.195 . . . . 61.21 110.113 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -142.46 173.0 11.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.899 -0.408 . . . . 71.2 109.899 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.86 110.37 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.284 -0.636 . . . . 75.11 109.284 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.4 94.55 40.48 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.828 -0.623 . . . . 73.23 109.329 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.57 -19.27 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.066 1.844 . . . . 61.42 110.943 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.18 20.37 2.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.319 -0.855 . . . . 72.02 110.662 -176.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.96 108.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-O 122.265 1.031 . . . . 73.34 110.44 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -77.91 143.51 37.65 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 114.614 -1.176 . . . . 74.3 109.05 177.261 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 t -126.23 149.35 49.12 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.826 0.346 . . . . 72.35 111.227 -174.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 . . . . . 0 C--N 1.304 -1.407 0 N-CA-C 106.273 -1.751 . . . . 72.04 106.273 172.649 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.501 -0.909 0 N-CA-C 108.859 -0.793 . . . . 72.31 108.859 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.91 55.24 0.55 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 108.938 -1.665 . . . . 70.32 108.938 178.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -59.94 -44.42 94.39 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.775 0.83 . . . . 65.25 112.138 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.84 110.23 20.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.536 -0.542 . . . . 70.34 109.536 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -106.3 125.77 51.41 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.122 -0.696 . . . . 73.21 109.122 178.442 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -94.97 157.16 16.02 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.888 -0.597 . . . . 63.44 109.916 -174.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 mp 61.56 72.32 0.52 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.996 0.81 . . . . 65.31 110.907 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.26 83.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.4 110.24 -176.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.0 126.16 9.23 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.295 -0.866 . . . . 65.31 108.747 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -92.31 88.1 6.31 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.502 -0.925 . . . . 71.52 108.502 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -84.65 95.87 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.983 0.897 . . . . 74.41 111.611 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.93 90.23 3.25 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.513 -1.662 . . . . 73.13 106.513 175.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -88.73 150.04 23.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.202 -1.363 . . . . 73.03 111.99 -169.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -110.97 115.86 30.2 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 72.23 111.213 176.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.44 65.02 0.88 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.345 -1.724 . . . . 74.14 106.345 173.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.93 145.99 27.94 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.311 -1.313 . . . . 75.42 110.065 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -122.0 115.63 22.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.652 -0.704 . . . . 72.31 109.514 179.199 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.6 m -111.86 128.78 56.23 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.462 -0.94 . . . . 71.43 108.462 177.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.74 162.94 7.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.06 0.457 . . . . 64.21 110.902 -178.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.77 29.86 2.32 Favored Glycine 0 C--N 1.299 -1.474 0 N-CA-C 109.285 -1.526 . . . . 52.34 109.285 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 4.6 p-10 -62.6 -29.65 70.76 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.889 -0.655 . . . . 73.01 111.141 -176.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.32 93.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.088 0.47 . . . . 74.45 110.122 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.4 -43.12 91.6 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.463 -0.79 . . . . 71.25 109.332 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.71 -47.07 87.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.46 -0.791 . . . . 71.51 111.469 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 37.4 mmt180 -66.66 -37.85 85.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 73.44 111.643 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.37 -49.82 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 111.946 0.35 . . . . 54.24 111.946 -178.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' O ' ' HA3' ' A' ' 117' ' ' GLY . 98.9 m-85 -91.73 -28.58 17.33 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.236 0.828 . . . . 55.43 113.236 -172.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.59 -69.3 3.04 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 120.395 -0.907 . . . . 43.23 112.172 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.72 -49.23 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.675 -0.57 . . . . 60.22 111.675 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 m -79.05 88.95 4.78 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.596 -0.52 . . . . 74.43 109.596 178.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -85.19 -27.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.84 -0.618 . . . . 70.33 111.237 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.27 136.46 24.53 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 116.235 -0.439 . . . . 62.42 110.188 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.26 -36.47 46.92 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.528 2.818 . . . . 71.23 112.21 175.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.32 -9.91 14.01 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.866 1.062 . . . . 62.25 113.866 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.46 -31.57 71.82 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.97 -42.08 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.761 -0.654 . . . . 64.05 109.282 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.48 -43.14 99.4 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.615 -0.513 . . . . 64.33 109.615 177.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.9 90.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.299 -0.864 . . . . 52.23 110.97 178.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.85 -44.28 77.52 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.634 -0.427 . . . . 74.24 110.431 178.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.11 -37.45 87.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.827 0.677 . . . . 71.03 112.827 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.83 -36.09 82.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 120.036 -0.666 . . . . 75.52 109.358 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -68.38 -41.89 79.91 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.254 -0.43 . . . . 71.42 109.955 176.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.27 -45.02 96.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.734 1.213 . . . . 73.24 110.14 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.21 97.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.441 -0.799 . . . . 71.4 110.187 177.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.37 71.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.201 0.524 . . . . 65.14 111.392 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.13 -21.0 43.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.789 -0.641 . . . . 73.24 110.733 -178.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.56 19.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.975 -0.557 . . . . 53.32 112.139 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.51 134.73 29.72 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-O 121.272 0.558 . . . . 73.53 111.868 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 5.0 tp-100 -111.6 132.28 54.67 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.36 -1.348 . . . . 74.5 107.36 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -77.06 93.95 3.94 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.796 0.808 . . . . 71.23 109.883 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.628 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.3 tp -103.08 -165.41 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.119 -1.808 . . . . 72.51 106.119 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.628 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 2.2 mp0 -42.32 139.01 1.56 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.858 0.863 . . . . 63.34 111.586 175.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.81 -4.45 14.28 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-N 115.492 -0.777 . . . . 72.2 114.866 -171.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -72.17 -44.93 62.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.043 -0.354 . . . . 74.14 110.043 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 32.2 ptt180 -163.73 148.05 10.44 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.206 0.527 . . . . 72.14 111.373 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.12 151.19 21.09 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.017 -0.992 . . . . 74.11 111.051 -170.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 43.2 tp -86.35 126.6 34.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.443 -0.799 . . . . 64.31 109.677 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.3 160.38 31.55 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 124.109 0.881 . . . . 72.31 108.75 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HA ' HG22 ' A' ' 125' ' ' VAL . 78.0 Cg_exo -54.56 153.96 21.66 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.213 2.608 . . . . 64.43 113.253 176.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 30.5 p-10 -120.09 -34.67 3.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.831 -0.622 . . . . 64.42 111.133 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -107.64 112.81 25.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.338 -0.616 . . . . 74.44 109.338 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 53.2 m-85 -109.03 132.0 54.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.671 -0.695 . . . . 65.14 110.279 -177.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 mm -112.93 117.89 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.582 -0.896 . . . . 65.21 108.582 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.11 125.83 74.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 -179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -126.89 129.0 47.36 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.427 -0.352 . . . . 72.3 110.309 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 74' ' ' LEU . 6.2 mp -128.6 178.08 6.57 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.864 -0.607 . . . . 73.42 109.66 172.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -73.66 168.3 54.06 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.982 -0.847 . . . . 33.43 110.982 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.4 -40.48 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 117.688 0.744 . . . . 70.01 112.324 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -66.82 -36.01 81.37 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.88 0.848 . . . . 34.13 109.234 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -65.43 -51.41 60.45 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.498 -1.228 . . . . 75.41 109.287 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.08 -42.34 98.32 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.251 -1.34 . . . . 74.11 111.848 -173.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.54 -35.94 78.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.908 0.385 . . . . 64.43 111.226 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -74.2 -24.98 59.43 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.086 -0.506 . . . . 72.11 112.208 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 79.1 mt -72.52 -45.2 60.47 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.885 0.374 . . . . 72.41 111.281 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.13 40.26 56.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 107.912 -2.075 . . . . 43.32 107.912 -168.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.26 5.54 51.44 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.121 1.768 . . . . 60.43 112.09 -172.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -43.05 124.19 3.24 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 124.639 1.212 . . . . 72.4 110.503 -171.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -38.07 -47.8 2.23 Favored 'Trans proline' 0 C--N 1.373 1.836 1 C-N-CA 125.696 4.264 . . . . 73.44 116.116 -168.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.51 -17.07 52.68 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.863 -0.735 . . . . 70.23 112.278 -172.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.98 -56.11 3.63 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.395 0.617 . . . . 75.31 109.38 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -86.54 -5.5 59.13 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 115.16 1.541 . . . . 71.24 115.16 -174.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 p -64.97 -62.72 1.39 Allowed 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 119.243 0.929 . . . . 73.33 111.039 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.9 m -59.02 -40.43 84.94 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.155 0.582 . . . . 62.14 110.955 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.13 -55.46 9.15 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.907 -0.588 . . . . 40.31 113.495 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.97 -25.97 56.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.083 0.468 . . . . 73.31 110.448 -173.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.15 63.48 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.285 -0.566 . . . . 71.31 109.586 175.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -65.46 -40.74 93.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.133 -1.062 . . . . 60.13 108.133 175.882 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -59.54 -47.45 85.5 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 116.125 -0.488 . . . . 63.03 109.927 176.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.26 -37.37 77.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.584 -0.735 . . . . 73.41 112.034 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -60.56 -43.09 97.65 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.428 0.633 . . . . 52.11 109.384 178.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.34 -41.68 97.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.875 -1.057 . . . . 71.01 109.553 177.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.3 m-85 -61.26 -53.06 61.6 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.918 -0.583 . . . . 63.13 112.47 175.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 90' ' ' ALA . 37.7 pt -63.91 -31.07 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.742 0.275 . . . . 75.1 111.742 -176.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 77.3 mm-40 -65.79 -42.93 90.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.45 -0.574 . . . . 71.3 109.45 174.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.39 -37.33 83.03 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.052 -0.522 . . . . 73.15 111.202 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 27.3 mm-40 -77.06 -13.51 59.94 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.771 -0.65 . . . . 72.23 110.603 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 34.05 28.39 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.931 -0.577 . . . . 73.23 112.629 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -110.77 161.14 16.08 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.577 -0.527 . . . . 75.4 109.577 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.426 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -130.72 169.55 15.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.461 -0.57 . . . . 71.22 109.461 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 6.6 t -158.28 170.55 21.99 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.675 -0.491 . . . . 65.01 109.675 178.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.32 122.49 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.854 0.359 . . . . 71.52 111.029 -176.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 -150.01 17.06 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.391 -1.084 . . . . 43.52 110.391 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.1 137.73 46.54 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.667 -0.864 . . . . 60.42 108.667 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.53 117.68 19.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.09 -1.078 . . . . 72.14 108.09 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.33 125.76 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-O 121.831 0.824 . . . . 75.44 112.02 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.0 m -104.87 124.63 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 106.869 -1.53 . . . . 60.04 106.869 173.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -115.92 130.51 56.86 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.1 -0.704 . . . . 73.24 109.1 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -104.34 143.9 32.36 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.048 -0.978 . . . . 73.43 108.859 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.51 168.53 22.47 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.048 -0.524 . . . . 61.41 110.065 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -114.82 163.52 15.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.287 0.565 . . . . 64.31 111.051 -176.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.44 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 43.7 t -145.15 133.17 21.37 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.765 -1.198 . . . . 61.4 107.765 176.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.2 m -80.99 -19.88 43.04 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.43 0.634 . . . . 53.1 109.498 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -81.01 -32.82 34.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.404 -0.817 . . . . 73.4 110.854 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.81 148.68 40.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.623 -0.717 . . . . 61.12 109.79 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -100.48 157.92 16.29 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.859 0.463 . . . . 74.53 110.229 -171.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.578 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 71.7 m -66.86 120.74 14.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.744 0.783 . . . . 71.02 112.688 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 27' ' ' PHE . . . 98.1 -5.86 61.53 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.405 -1.27 . . . . 53.33 111.395 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -107.2 104.73 14.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.026 -1.472 . . . . 63.54 107.026 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -119.62 157.05 29.24 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.084 -0.507 . . . . 74.21 111.012 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -134.24 137.45 44.35 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.731 -0.84 . . . . 74.42 108.731 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.15 125.34 10.77 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.251 -0.648 . . . . 44.1 109.251 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 -131.18 160.43 34.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 109.646 -0.501 . . . . 73.54 109.646 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.67 135.73 9.65 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 110.429 -1.068 . . . . 34.43 110.429 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 p -126.04 153.69 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.814 -0.439 . . . . 74.21 109.814 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.0 t -103.87 107.87 23.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.919 -1.141 . . . . 54.14 107.919 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -98.45 96.95 4.13 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.201 -1.407 . . . . 53.13 107.201 173.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 72.0 Cg_endo -82.43 -21.66 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.939 1.759 . . . . 64.34 112.138 -174.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -100.28 70.58 1.53 Allowed 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 122.778 1.275 . . . . 64.2 107.853 -176.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 p -118.36 129.06 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.84 0 CA-C-N 113.11 -1.859 . . . . 72.33 107.137 179.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -64.16 142.69 58.32 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.345 -0.843 . . . . 72.33 111.238 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -121.39 164.92 16.32 Favored 'General case' 0 N--CA 1.417 -2.125 0 N-CA-C 109.041 -0.725 . . . . 72.32 109.041 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 106.965 -1.495 . . . . 64.51 106.965 179.876 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 109.121 -0.696 . . . . 72.23 109.121 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.89 63.29 0.5 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.709 -1.356 . . . . 71.05 109.709 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 m -78.69 82.69 4.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.319 0.581 . . . . 30.24 112.479 -175.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -102.96 91.6 4.2 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.244 -2.132 . . . . 72.41 105.244 171.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.1 169.59 18.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.545 0.943 . . . . 72.33 113.545 -169.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 177.44 171.1 0.59 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.028 -2.212 . . . . 75.03 105.028 173.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.31 126.29 30.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.226 -1.398 . . . . 73.54 107.226 172.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.37 -24.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 120.793 0.33 . . . . 62.24 110.747 -177.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -77.24 132.68 38.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.74 -0.664 . . . . 70.1 109.575 178.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 10' ' ' ARG . 19.5 mtp180 -89.97 129.91 36.24 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.33 -2.1 . . . . 64.33 105.33 174.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.73 109.54 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.037 0.922 . . . . 63.42 111.826 -174.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -119.34 90.58 3.36 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.065 -0.971 . . . . 73.23 109.924 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 5.3 ppt_? -97.04 105.05 17.13 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 105.426 -2.064 . . . . 64.43 105.426 168.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -109.42 116.14 31.26 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.984 -1.007 . . . . 73.41 112.927 -165.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt 65.22 20.04 11.84 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.778 1.299 . . . . 74.13 110.78 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -94.84 126.81 40.42 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.111 -0.95 . . . . 74.11 110.792 -175.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -154.9 110.99 3.19 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.59 -1.263 . . . . 73.15 107.59 174.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 5.0 t -101.53 140.85 35.26 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.33 -1.359 . . . . 64.35 107.33 176.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 18' ' ' THR . 13.6 p 172.15 169.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 105.318 -2.105 . . . . 71.53 105.318 -177.067 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.5 51.65 2.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.522 0.601 . . . . 74.45 112.612 177.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 24.7 t70 -67.17 -35.17 79.11 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.419 0.687 . . . . 44.1 109.395 -178.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.44 -46.29 83.76 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.813 -1.085 . . . . 51.31 110.272 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -67.25 -35.11 78.85 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.315 -0.857 . . . . 72.22 110.636 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.73 76.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.791 0.329 . . . . 73.01 110.456 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 31.9 mtm-85 -74.44 -32.52 62.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.253 -0.431 . . . . 74.43 110.382 178.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.4 mt -73.37 -54.73 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.107 -0.497 . . . . 65.22 110.71 178.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.59 -27.78 62.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.966 0.728 . . . . 75.05 112.966 -175.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 -96.35 0.18 Allowed Glycine 0 N--CA 1.441 -1.027 0 O-C-N 123.785 0.678 . . . . 63.14 112.814 177.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.45 9.22 5.31 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.116 -0.542 . . . . 63.23 112.449 -178.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.6 t -80.32 -86.13 0.08 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.484 0.642 . . . . 64.24 109.398 179.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.93 93.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 106.224 -1.769 . . . . 71.04 106.224 175.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 34' ' ' GLN . 21.3 t -76.37 121.67 85.33 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 116.188 -0.46 . . . . 64.05 111.228 -173.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 -2.48 8.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.216 2.61 . . . . 61.24 114.082 -176.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.462 ' H ' HG12 ' A' ' 32' ' ' VAL . 9.4 pt20 -67.61 -23.25 65.35 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.613 -0.514 . . . . 74.03 109.613 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -69.3 -42.47 75.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.494 -0.928 . . . . 70.31 108.494 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.31 -46.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.389 -0.967 . . . . 52.34 108.389 177.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 23.5 mm-40 -52.02 -52.32 51.57 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.436 -0.802 . . . . 73.32 111.828 175.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.02 -53.96 49.06 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.8 0.688 . . . . 71.02 111.355 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.05 -42.18 97.12 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.317 0.488 . . . . 65.11 112.317 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.3 -47.05 77.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.828 0.677 . . . . 72.3 112.828 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 7.5 ptp180 -70.82 -32.84 70.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 120.428 -0.509 . . . . 73.21 110.486 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -67.17 -46.58 73.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.905 -0.406 . . . . 60.41 109.905 176.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 6.2 tp10 -63.03 -37.43 87.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 73.15 109.694 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -61.57 -41.39 97.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.143 -0.481 . . . . 32.13 110.943 178.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.07 -34.23 43.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.042 -0.526 . . . . 43.52 111.566 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.56 -30.82 57.23 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.476 0.655 . . . . 75.5 110.797 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.28 14.0 58.65 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.661 -0.7 . . . . 61.33 112.607 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.88 131.57 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.306 0.574 . . . . 62.44 111.106 177.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt-30 -119.45 139.64 51.72 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.251 -0.886 . . . . 62.02 109.772 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -74.56 126.85 31.67 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.352 -1.295 . . . . 71.54 108.769 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.574 HD23 ' NE2' ' A' ' 99' ' ' GLN . 14.0 tp -141.31 -165.57 2.0 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.186 -2.153 . . . . 72.43 105.186 -177.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.525 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.9 mt-30 -52.52 145.02 12.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.047 0.385 . . . . 73.43 110.299 176.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.95 -0.95 7.88 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 114.728 0.651 . . . . 52.11 114.728 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -64.11 -42.81 96.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.851 -0.796 . . . . 74.13 108.851 177.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -174.87 157.01 2.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.114 -0.948 . . . . 74.35 110.877 -179.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.15 151.65 20.89 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.495 0.718 . . . . 71.52 110.858 -173.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.3 tm? -91.74 128.79 37.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.826 -1.176 . . . . 71.23 107.826 -176.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.66 162.07 36.45 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 122.739 0.415 . . . . 73.24 109.954 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.8 Cg_exo -62.43 160.73 30.31 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.244 2.63 . . . . 70.41 112.941 176.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -132.81 -33.45 1.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.783 -0.644 . . . . 63.12 112.154 -179.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.04 116.52 32.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 72.2 108.837 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.516 ' HB2' HG12 ' A' ' 106' ' ' VAL . 35.2 m-85 -118.77 114.81 23.25 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.828 -0.434 . . . . 75.21 109.828 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.48 110.38 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.68 -0.859 . . . . 53.13 108.68 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.27 112.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.167 -1.049 . . . . 70.43 108.167 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -110.79 122.86 48.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.73 -0.668 . . . . 74.41 109.9 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.65 176.38 5.17 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.385 -0.825 . . . . 74.52 110.081 177.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.3 165.37 51.77 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.218 -1.553 . . . . 73.21 109.218 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 3.1 p -59.27 -48.31 87.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 112.673 0.62 . . . . 72.21 112.673 -178.038 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -63.94 -36.46 84.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 74.25 110.249 -178.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -69.02 -41.69 77.4 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.465 0.65 . . . . 74.43 109.563 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -73.87 -22.74 59.63 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 120.415 -0.514 . . . . 72.34 111.521 -176.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.8 mt-10 -61.77 -28.5 69.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.345 0.593 . . . . 65.13 109.66 173.264 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -84.91 -28.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.76 -0.655 . . . . 71.45 110.55 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 mt -97.02 -14.16 21.81 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 113.01 0.744 . . . . 73.3 113.01 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.71 22.13 35.24 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 116.077 1.191 . . . . 75.33 116.077 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.82 -35.13 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.959 0.88 . . . . 74.05 108.962 176.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -141.73 77.26 19.2 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 115.537 -0.756 . . . . 64.3 109.203 175.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.32 -50.37 2.03 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.062 1.841 . . . . 42.04 112.811 -178.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.01 -37.55 82.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.47 0.176 . . . . 74.44 111.408 -177.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.84 -55.7 29.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.135 0.493 . . . . 52.41 110.597 177.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 14.3 ptpt -72.86 -22.64 60.75 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.351 0.871 . . . . 75.34 113.351 -178.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 m -71.48 -36.43 71.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 74.41 109.131 175.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.3 m -70.89 -40.61 72.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.061 -0.518 . . . . 74.21 109.765 177.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.664 ' O ' ' HG2' ' A' ' 87' ' ' ARG . . . -57.77 -55.23 31.63 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-N 115.746 -0.661 . . . . 62.35 112.666 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 106' ' ' VAL . 62.8 m-85 -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.754 -0.85 . . . . 71.51 112.824 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.85 53.37 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.223 -0.298 . . . . 71.33 110.993 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 84' ' ' GLY . 35.1 ptt180 -60.68 -41.93 96.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.899 0.857 . . . . 71.13 110.141 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 87' ' ' ARG . 64.5 m-20 -77.74 -34.66 52.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.137 -0.938 . . . . 51.44 112.69 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.47 -37.99 89.46 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.094 -1.076 . . . . 71.21 108.094 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -63.12 -35.55 80.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.877 -0.601 . . . . 65.53 110.386 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.7 t70 -72.39 -42.09 65.57 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.684 -0.406 . . . . 74.34 110.027 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 13.8 m-85 -53.73 -48.4 69.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.224 -0.444 . . . . 74.52 112.074 175.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.4 pt -66.06 -30.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 119.722 -0.791 . . . . 63.34 111.104 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 78.7 mm-40 -67.61 -37.94 83.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.083 -0.247 . . . . 75.14 110.598 175.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.1 mt-10 -61.63 -41.04 96.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.883 0.739 . . . . 63.0 110.884 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 68.2 mm-40 -80.31 -14.22 58.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.191 -0.913 . . . . 63.2 110.938 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.11 29.11 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.765 -0.652 . . . . 61.43 112.062 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -102.9 174.51 5.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.613 0.72 . . . . 73.25 112.073 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' HD23 ' A' ' 51' ' ' LEU . 25.4 pt20 -137.18 171.91 13.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.412 -0.813 . . . . 72.21 109.491 179.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -161.15 153.51 20.26 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.738 -0.467 . . . . 44.33 109.738 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -109.66 120.04 41.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.652 -1.24 . . . . 75.32 107.652 175.03 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.85 -150.27 18.28 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 107.951 -2.06 . . . . 71.34 107.951 -172.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.93 137.83 35.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.187 0.993 . . . . 63.03 108.842 177.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.49 103.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.316 0.579 . . . . 75.44 110.094 -175.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.84 127.43 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.25 -0.887 . . . . 74.53 109.5 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.9 m -105.55 148.73 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 107.244 -1.391 . . . . 72.14 107.244 176.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -128.21 137.55 52.09 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.732 -0.84 . . . . 71.45 108.732 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.11 119.73 38.11 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.95 -0.759 . . . . 74.13 108.95 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.7 175.75 10.38 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.882 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.25 164.37 18.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 74.33 111.031 -176.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -154.17 117.19 4.48 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 124.058 0.943 . . . . 63.22 108.848 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 p -67.38 -17.73 64.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.603 0.716 . . . . 73.13 111.099 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -67.26 -28.18 67.82 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.201 1.0 . . . . 72.11 109.263 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.53 141.3 51.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.998 -1.001 . . . . 75.24 109.864 -178.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.55 145.96 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.847 -0.615 . . . . 73.45 110.16 -172.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 m -68.27 121.59 16.55 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.706 -0.679 . . . . 63.12 109.764 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.67 -11.09 38.65 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 110.471 -1.052 . . . . 63.15 110.471 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.69 169.09 9.74 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.207 0.527 . . . . 72.42 110.585 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -164.08 156.63 17.35 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.015 -2.587 . . . . 61.42 104.015 173.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -146.14 130.57 17.71 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.215 -0.994 . . . . 73.02 111.791 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.15 118.71 28.28 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.541 -1.281 . . . . 60.4 107.541 177.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 23.8 tpt180 -121.78 125.85 47.49 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.296 -0.631 . . . . 73.43 109.296 -177.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.09 130.32 9.1 Favored Glycine 0 C--N 1.289 -2.038 0 N-CA-C 110.581 -1.008 . . . . 72.45 110.581 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.3 t -138.09 167.26 22.17 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.47 -0.567 . . . . 65.53 109.47 -177.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 59' ' ' PRO . 50.4 t -92.59 106.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.526 -1.287 . . . . 55.25 107.526 175.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.581 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.6 t30 -117.83 102.75 51.12 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.135 -0.691 . . . . 62.41 109.135 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.4 -25.01 15.84 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.84 1.693 . . . . 73.42 111.13 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -91.24 32.08 1.07 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.297 -0.865 . . . . 54.33 111.492 -174.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 126' ' ' ASN . 79.2 t -66.92 117.12 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.14 -1.059 . . . . 72.22 108.14 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -63.92 138.95 58.7 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.567 -1.197 . . . . 73.31 109.8 177.531 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 t -133.03 162.17 32.4 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.274 -1.01 . . . . 73.44 108.274 -174.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 C--N 1.297 -1.686 0 N-CA-C 108.772 -0.825 . . . . 75.35 108.772 -179.615 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.568 -0.531 . . . . 74.53 109.568 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.17 116.23 0.62 Allowed Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.802 -0.919 . . . . 71.43 110.802 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 m -73.96 134.52 43.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.893 -0.41 . . . . 44.43 109.893 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -74.67 146.33 42.44 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.519 -0.919 . . . . 62.43 108.519 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -72.03 82.81 0.96 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.514 0.673 . . . . 75.32 111.33 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -152.46 172.96 15.72 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.272 1.429 . . . . 74.54 107.481 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.28 138.89 29.89 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.662 -0.866 . . . . 71.44 108.662 175.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.14 82.98 2.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.378 1.085 . . . . 75.24 110.146 176.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -79.62 77.43 6.22 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.533 -1.212 . . . . 73.44 110.677 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 59.51 61.7 1.94 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 113.392 -1.731 . . . . 73.22 111.599 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.7 t -131.74 90.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.823 -1.177 . . . . 74.53 107.823 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -79.89 98.11 6.98 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.463 0.649 . . . . 62.22 109.347 178.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -57.6 -42.01 82.36 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.521 -1.218 . . . . 63.13 112.808 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -94.3 73.41 3.91 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.65 -0.82 . . . . 63.4 109.395 177.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -114.29 104.55 12.19 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.842 -1.17 . . . . 75.44 107.842 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.68 -161.74 1.3 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.486 -0.779 . . . . 54.55 109.253 -178.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -50.67 118.1 2.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.094 0.957 . . . . 65.23 112.826 -176.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -178.37 145.07 0.32 Allowed 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.361 -1.718 . . . . 72.33 106.361 175.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.93 107.84 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.321 -0.551 . . . . 50.0 111.256 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.93 22.21 12.79 Favored Glycine 0 C--N 1.308 -1.017 0 N-CA-C 109.058 -1.617 . . . . 74.23 109.058 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 22.8 t70 -64.39 -41.42 96.68 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.391 -0.905 . . . . 75.4 111.674 -174.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.96 -37.99 87.43 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.86 -0.609 . . . . 62.15 110.597 -178.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -64.64 -40.24 95.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.576 -0.738 . . . . 74.33 109.654 177.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.01 -33.4 75.49 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.669 -0.696 . . . . 72.22 110.415 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 15.5 mmm180 -72.61 -28.07 62.55 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.176 0.512 . . . . 74.0 110.918 177.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -86.56 -50.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 112.251 0.463 . . . . 42.34 112.251 -178.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.25 -28.52 12.23 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 113.006 0.743 . . . . 73.22 113.006 -175.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.0 -104.5 0.68 Allowed Glycine 0 CA--C 1.496 -1.155 0 O-C-N 123.429 0.456 . . . . 71.44 112.01 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.16 12.88 8.49 Favored Glycine 0 C--N 1.286 -2.203 0 CA-C-N 114.516 -0.842 . . . . 71.43 111.583 -178.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -72.56 -33.64 66.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.525 -0.917 . . . . 73.02 108.525 178.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 tp -163.7 133.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.404 -1.702 . . . . 72.22 106.404 176.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.48 153.29 53.85 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 110.511 -0.181 . . . . 71.34 110.511 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.76 -26.5 66.42 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.351 2.701 . . . . 73.52 111.915 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.6 -33.74 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.282 -0.872 . . . . 74.43 110.573 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.87 -32.21 45.84 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.682 -0.488 . . . . 74.43 109.682 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.7 t -64.47 -49.82 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.781 -0.645 . . . . 60.3 109.426 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -66.68 -31.4 72.04 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 119.863 -0.735 . . . . 73.41 110.284 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.93 63.55 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.378 0.424 . . . . 73.14 110.197 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.68 -40.34 91.77 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.191 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 77.8 mt -66.34 -46.78 75.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.554 0.576 . . . . 73.41 112.554 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.01 -26.89 62.4 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.277 0.561 . . . . 73.44 110.134 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -45.65 73.35 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.671 -0.695 . . . . 73.51 109.679 172.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -62.72 -33.91 76.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 122.837 0.455 . . . . 74.41 111.174 177.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -62.12 -46.07 90.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.012 -0.54 . . . . 73.21 110.702 177.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.45 53.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.502 0.668 . . . . 65.42 111.106 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.14 -38.21 61.1 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.717 -0.674 . . . . 43.11 110.849 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.08 12.81 65.03 Favored Glycine 0 C--N 1.319 -0.396 0 C-N-CA 121.261 -0.495 . . . . 72.54 113.336 -176.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.72 127.4 19.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.399 0.68 . . . . 74.44 111.875 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -108.91 146.15 34.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.705 -0.68 . . . . 75.21 110.039 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.3 m -81.01 103.23 10.69 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.364 -0.834 . . . . 74.33 109.143 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.7 tp -112.65 -164.21 0.9 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.133 -1.432 . . . . 73.41 107.133 -177.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.626 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 85.0 mm-40 -49.67 156.99 0.6 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.748 0.819 . . . . 75.02 112.594 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.72 5.59 22.78 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 114.852 -1.067 . . . . 72.44 114.086 -172.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.45 -43.37 27.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.388 -0.597 . . . . 53.13 109.388 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -177.69 165.62 2.1 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.682 0.793 . . . . 72.15 112.016 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.21 151.3 20.99 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.149 0.98 . . . . 72.31 111.688 -173.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 51' ' ' LEU . 1.4 tm? -94.46 125.11 38.9 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.099 -1.075 . . . . 54.53 108.099 -175.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.56 156.98 40.54 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 123.597 0.759 . . . . 72.31 109.783 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 125' ' ' VAL . 82.1 Cg_exo -51.03 152.15 10.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.983 3.122 . . . . 70.22 114.307 177.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.6 p-10 -122.69 -33.88 3.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.194 -0.912 . . . . 63.4 110.605 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.47 100.26 11.27 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.318 0.58 . . . . 64.24 110.164 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 72.2 m-85 -96.43 114.13 25.77 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.632 0.73 . . . . 74.53 109.491 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -107.91 117.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.618 -1.174 . . . . 74.34 109.036 -174.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -118.05 101.74 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.485 -0.932 . . . . 71.44 108.485 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.5 m -95.82 122.93 39.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.184 -0.916 . . . . 74.42 109.311 -176.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.59 162.21 14.95 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.419 0.688 . . . . 73.11 111.056 176.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.16 163.47 50.63 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.889 -1.685 . . . . 74.43 108.889 173.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.7 p -63.15 -37.89 80.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 117.387 0.593 . . . . 61.51 111.357 -177.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -64.11 -38.04 89.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.634 -0.712 . . . . 73.51 110.393 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.08 -35.56 28.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.867 -0.606 . . . . 71.43 111.69 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -65.79 -32.36 73.85 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.744 -0.383 . . . . 74.32 110.994 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.2 mt-10 -59.57 -29.52 67.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.046 0.45 . . . . 74.53 111.266 177.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -81.5 -26.33 35.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.189 -0.46 . . . . 72.33 111.32 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.451 HD11 ' HG ' ' A' ' 66' ' ' LEU . 86.9 mt -70.73 -34.42 71.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.385 -0.598 . . . . 73.11 109.385 173.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.37 -165.89 21.86 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 110.877 -0.889 . . . . 64.4 110.877 177.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.89 1.23 55.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.017 0.437 . . . . 71.43 110.52 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -127.82 135.43 27.47 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.125 -0.489 . . . . 71.45 110.526 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.86 -34.52 1.75 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.057 1.838 . . . . 75.43 109.286 163.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -48.02 -52.79 18.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 117.376 2.362 . . . . 72.21 117.376 -165.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.24 -42.71 77.76 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.662 0.665 . . . . 54.14 110.606 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -88.84 -17.95 28.65 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.247 -0.888 . . . . 71.1 112.152 -177.803 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 59.6 m -71.18 -44.64 65.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.253 -0.647 . . . . 73.41 109.253 176.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.0 m -65.48 -43.2 90.98 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 115.87 -0.604 . . . . 64.3 110.006 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.12 -53.84 41.52 Favored Glycine 0 CA--C 1.504 -0.615 0 CA-C-N 115.492 -0.776 . . . . 53.13 112.373 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -67.37 -31.0 70.95 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 113.002 0.742 . . . . 45.11 113.002 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.23 82.69 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.062 0.392 . . . . 71.21 110.45 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -67.17 -48.08 69.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.798 -0.637 . . . . 73.53 111.505 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.33 -35.87 78.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.078 -0.51 . . . . 73.31 111.293 -173.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.22 -35.68 63.9 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.368 -0.605 . . . . 74.35 109.368 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.36 84.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.773 0.797 . . . . 54.35 109.438 176.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.89 -41.73 99.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.601 -1.181 . . . . 72.14 109.445 177.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 16.4 m-85 -59.89 -51.17 70.87 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.876 -0.602 . . . . 74.5 112.085 175.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -65.61 -30.78 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.298 -0.561 . . . . 64.12 112.101 -175.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.32 -44.93 93.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.701 -0.481 . . . . 75.24 109.701 175.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.17 -30.09 70.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.702 -0.681 . . . . 62.32 112.682 177.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 58.4 mm-40 -82.97 -13.62 55.63 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.918 -0.313 . . . . 73.03 111.222 178.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 27.08 40.6 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.051 -0.522 . . . . 43.13 113.125 176.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -98.68 178.38 5.01 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.888 0.344 . . . . 70.31 110.163 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.7 pt20 -143.03 174.18 10.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.875 -0.787 . . . . 72.13 108.875 178.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.9 t -157.19 171.74 19.89 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.612 -0.435 . . . . 61.0 109.831 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.1 118.93 37.83 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.069 -1.085 . . . . 72.32 108.069 176.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.39 -149.93 16.74 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.376 -1.392 . . . . 71.11 110.985 176.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.04 142.49 46.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.765 -1.198 . . . . 72.21 107.765 176.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.22 118.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.58 -0.896 . . . . 63.21 108.58 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.21 137.3 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.643 0.735 . . . . 73.31 110.443 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 82' ' ' SER . 92.4 t -117.92 142.9 30.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 107.023 -1.473 . . . . 64.12 107.023 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -146.44 146.79 30.71 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.697 0.284 . . . . 52.03 111.019 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 84.9 m-85 -121.16 125.07 46.26 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.111 -1.441 . . . . 71.32 107.111 177.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.39 175.61 8.99 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.504 -0.878 . . . . 65.11 111.597 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' OE1' HG23 ' A' ' 68' ' ' VAL . 50.2 mt-30 -105.18 149.43 25.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.837 0.827 . . . . 75.34 112.154 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 m -143.48 118.13 9.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.59 -1.186 . . . . 63.3 108.961 172.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 m -72.0 -24.22 61.53 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.813 -0.63 . . . . 65.41 112.574 -175.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -88.7 -0.25 57.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.457 1.122 . . . . 71.33 109.26 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -83.7 144.49 29.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.902 -1.045 . . . . 74.2 108.282 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.02 149.74 35.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.434 -0.803 . . . . 73.54 110.83 -171.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -66.5 125.1 24.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.075 -0.713 . . . . 72.45 109.075 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.5 16.64 73.07 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.744 -0.741 . . . . 75.41 112.206 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -124.52 123.2 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.199 -1.037 . . . . 71.5 108.199 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -116.23 156.66 26.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.389 -0.967 . . . . 63.4 108.389 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -126.0 130.72 51.76 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.899 -0.778 . . . . 63.21 108.899 177.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.04 119.75 29.55 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.813 -1.085 . . . . 53.51 108.74 -178.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -135.0 126.5 28.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.853 0.359 . . . . 74.01 110.094 -178.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.22 98.26 2.3 Favored Glycine 0 N--CA 1.424 -2.149 0 N-CA-C 108.502 -1.839 . . . . 55.31 108.502 176.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.3 m -93.36 138.94 31.22 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 121.198 0.523 . . . . 74.24 109.939 -175.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 59' ' ' PRO . 92.5 t -98.36 117.43 43.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.878 -0.786 . . . . 71.22 108.878 175.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -102.83 94.85 5.65 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.472 -1.677 . . . . 34.44 106.472 170.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.9 Cg_endo -88.73 -3.56 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.225 1.95 . . . . 52.1 112.067 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -91.34 33.14 1.0 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.494 -0.775 . . . . 61.13 110.716 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -75.76 97.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.113 -1.069 . . . . 71.32 108.113 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.79 91.69 8.72 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.7 1.238 . . . . 75.14 110.466 -176.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -81.8 90.54 6.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 123.628 1.68 . . . . 64.42 110.215 -178.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 C--N 1.284 -2.28 0 CA-C-N 112.963 -1.926 . . . . 65.15 108.063 179.808 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tmm? . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 106.884 -1.524 . . . . 72.32 106.884 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.73 83.24 0.13 Allowed Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 119.709 -1.234 . . . . 72.31 112.417 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -65.13 -57.31 8.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.561 -0.533 . . . . 74.41 109.561 175.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 67.93 -43.54 0.47 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.358 1.463 . . . . 42.1 114.467 170.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -66.04 122.4 17.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 123.884 0.874 . . . . 75.12 110.532 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -107.8 115.75 30.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.419 -0.956 . . . . 74.41 108.419 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.6 104.13 16.45 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.591 -0.522 . . . . 32.12 109.591 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.28 98.95 6.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.034 -1.098 . . . . 75.12 108.034 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -88.93 113.63 24.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.814 -0.63 . . . . 70.34 109.587 -176.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -119.31 122.07 41.04 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.253 0.549 . . . . 75.22 109.825 178.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -80.09 79.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 122.391 1.091 . . . . 65.44 110.872 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.94 -31.17 71.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.22 -1.355 . . . . 63.32 110.273 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -72.11 97.09 1.86 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.139 -0.937 . . . . 52.03 108.829 174.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' ' 15' ' ' LEU . 79.8 tttt -91.96 -69.75 0.72 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.919 -0.582 . . . . 61.32 110.311 -176.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD12 ' HG2' ' A' ' 14' ' ' LYS . 6.9 mp -104.55 85.58 2.36 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.017 -0.673 . . . . 75.12 111.095 178.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.77 129.24 50.75 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.228 -1.026 . . . . 64.0 108.228 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.87 132.99 34.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.947 0.403 . . . . 75.42 110.505 -177.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.8 p -91.84 97.07 10.76 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 106.335 -1.728 . . . . 70.24 106.335 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 21' ' ' ASP . 17.9 t -76.89 117.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 115.187 -0.915 . . . . 45.33 110.704 -171.141 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.94 29.7 11.94 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 111.163 -0.775 . . . . 71.14 111.163 179.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' H ' HG12 ' A' ' 19' ' ' VAL . 19.5 t70 -68.53 -34.63 76.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.231 0.538 . . . . 74.32 110.549 -177.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -59.68 -45.52 91.84 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.157 -0.929 . . . . 65.11 109.639 176.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -67.48 -27.95 67.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.147 -0.933 . . . . 63.53 111.497 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.75 87.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 70.32 109.915 177.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -80.41 -19.92 45.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.975 -0.557 . . . . 70.24 110.054 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 22' ' ' ALA . 41.1 mm -67.47 -57.13 10.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.656 -0.498 . . . . 71.11 109.656 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.82 -30.17 56.27 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.657 0.614 . . . . 74.33 112.657 -176.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.94 -67.39 1.72 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.373 0.509 . . . . 54.22 114.373 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.39 -61.7 0.92 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.462 -0.399 . . . . 72.22 112.705 -176.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -96.59 89.55 5.02 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.46 -0.57 . . . . 73.32 109.46 -179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.85 88.19 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 120.439 -0.504 . . . . 71.11 110.145 -177.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.488 ' HB ' ' CB ' ' A' ' 35' ' ' GLU . 6.2 m -128.45 86.46 57.7 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-O 121.784 0.802 . . . . 74.43 111.802 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -88.8 -46.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.938 2.425 . . . . 64.11 111.447 174.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -71.47 -16.52 62.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.751 -0.658 . . . . 74.14 110.809 -178.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' CB ' ' HB ' ' A' ' 32' ' ' VAL . 8.8 tp10 -64.03 -48.16 77.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.374 -0.973 . . . . 72.31 108.374 175.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.94 -45.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.826 -0.624 . . . . 73.03 109.68 178.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.619 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 53.8 mt-10 -53.12 -55.3 25.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.323 -0.399 . . . . 75.21 111.147 178.28 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.05 68.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 71.34 111.811 -178.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.12 -47.34 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.337 -0.986 . . . . 63.24 108.337 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 62' ' ' TYR . 3.8 mm? -71.65 -30.7 66.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.852 0.686 . . . . 72.42 112.852 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtm180 -64.42 -40.09 95.1 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.287 -1.005 . . . . 75.51 108.287 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -63.9 -44.86 91.7 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 115.554 -0.748 . . . . 74.22 110.333 176.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.59 -39.71 89.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.154 0.502 . . . . 61.22 110.006 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.22 84.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.786 -0.643 . . . . 60.2 110.457 177.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.78 64.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 64.2 111.984 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.52 -37.51 31.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.087 -0.506 . . . . 74.44 110.267 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 20.56 26.08 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.856 -0.611 . . . . 42.42 113.03 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -67.12 138.51 22.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 123.28 0.632 . . . . 41.14 110.657 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -115.87 143.71 45.03 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 176.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 t -76.28 124.67 27.86 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.946 -1.024 . . . . 73.43 108.705 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.7 tp -140.16 -166.0 2.02 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.073 -2.195 . . . . 73.14 105.073 -177.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 97.0 mt-30 -51.67 143.53 12.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.674 0.67 . . . . 71.42 110.259 176.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.88 -18.01 52.41 Favored Glycine 0 C--N 1.322 -0.233 0 CA-C-N 116.087 -0.506 . . . . 71.43 114.085 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -62.55 -39.1 92.54 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.52 0.328 . . . . 73.21 111.731 179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -165.8 136.44 3.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.176 -0.465 . . . . 73.45 111.396 -177.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.87 151.6 21.08 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.934 1.293 . . . . 75.11 110.353 -176.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -85.71 128.48 34.8 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.446 -0.797 . . . . 73.24 109.83 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.64 158.57 41.51 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 123.305 0.642 . . . . 73.44 109.821 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 125' ' ' VAL . 36.0 Cg_exo -61.26 152.59 71.21 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.019 2.479 . . . . 72.44 112.7 177.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -130.86 -16.34 3.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.647 -0.706 . . . . 63.35 111.583 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.59 114.97 27.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.76 -1.2 . . . . 61.42 107.76 178.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.488 ' CD2' HD12 ' A' ' 40' ' ' LEU . 91.7 m-85 -121.18 122.62 40.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.425 -0.352 . . . . 74.04 110.23 -178.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 63' ' ' ILE . 3.4 mp -106.79 107.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.186 -1.042 . . . . 73.11 108.186 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 55.9 mt -112.55 103.65 15.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.55 0.691 . . . . 62.03 109.979 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 109' ' ' GLU . 26.2 m -103.12 120.01 39.91 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.847 -0.615 . . . . 72.11 109.779 -177.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -99.38 163.5 12.5 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 123.692 0.797 . . . . 71.41 111.252 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.25 165.1 49.79 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.31 -1.116 . . . . 41.25 110.31 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 112' ' ' SER . 7.4 p -62.67 -47.61 92.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 113.674 0.991 . . . . 72.31 113.674 -175.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 82.2 t60 -77.35 -24.19 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.477 0.656 . . . . 55.04 109.857 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.726 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 2.6 m-20 -69.72 -45.79 67.4 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.751 -0.833 . . . . 72.14 108.751 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 40.8 t80 -71.29 -34.17 70.4 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.564 -0.744 . . . . 74.14 111.816 -175.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 12.9 pt-20 -65.11 -30.08 70.99 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.103 0.478 . . . . 74.33 110.936 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 32.1 mmmt -68.94 -35.39 76.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.169 -0.923 . . . . 50.14 109.703 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.8 -37.33 79.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 73.24 110.73 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.49 -167.65 29.72 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 111.525 -0.63 . . . . 51.14 111.525 -178.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.11 -45.35 7.25 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.089 0.471 . . . . 52.01 110.475 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 16.1 m-20 -116.43 130.69 24.3 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 75.1 110.688 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 -20.34 14.48 Favored 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 123.203 2.602 . . . . 65.33 113.827 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 8.1 pt-20 -58.76 -24.06 61.08 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.323 1.601 . . . . 54.02 115.323 -171.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.8 tp -78.75 -29.64 45.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.43 0.633 . . . . 73.22 110.709 175.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.64 -35.17 13.67 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.217 -0.447 . . . . 70.13 111.773 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -60.78 -41.47 95.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.912 0.387 . . . . 63.44 110.895 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 m -56.91 -48.16 78.88 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.522 -0.763 . . . . 62.44 110.99 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.35 -46.33 64.36 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.928 -0.653 . . . . 53.14 112.006 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.62 -39.46 94.42 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.413 0.285 . . . . 54.11 110.472 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.23 88.65 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.857 0.361 . . . . 61.55 110.134 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.44 -37.87 86.12 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.193 -0.458 . . . . 72.03 110.997 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -71.09 -37.1 72.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.248 -0.433 . . . . 74.43 111.1 176.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.03 -43.91 90.87 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.008 -0.738 . . . . 72.0 109.008 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.79 -36.26 80.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.404 0.621 . . . . 65.45 110.635 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.27 -42.23 79.9 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.153 -0.93 . . . . 72.13 108.526 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 m-85 -60.72 -56.16 24.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.781 -1.1 . . . . 75.52 112.403 176.349 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -59.59 -37.95 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.347 0.499 . . . . 74.14 112.347 -175.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.88 -37.64 88.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.834 -0.346 . . . . 71.32 110.733 176.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.5 -21.17 65.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.874 0.694 . . . . 75.44 112.874 176.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 50.3 mm-40 -92.49 -10.5 37.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.146 0.498 . . . . 71.35 110.17 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.96 26.55 37.06 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.434 -0.803 . . . . 63.13 111.851 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -107.22 155.02 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.285 -0.635 . . . . 75.51 109.285 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -130.87 175.4 9.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.836 -0.431 . . . . 73.41 109.836 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 t -154.39 158.73 40.47 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 108.264 -1.013 . . . . 52.11 108.264 175.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.18 120.14 39.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.672 -0.492 . . . . 73.25 109.672 -178.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -149.96 16.94 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.601 -1.8 . . . . 61.51 108.601 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.02 152.26 41.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 177.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 p -81.42 122.19 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.626 0.727 . . . . 73.31 110.721 -179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.29 120.28 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.065 -0.97 . . . . 74.34 109.225 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.85 138.9 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 107.506 -1.294 . . . . 71.4 107.506 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -116.12 150.23 37.72 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 109.742 -0.466 . . . . 75.42 109.742 176.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 81.3 m-85 -129.57 125.88 37.23 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.543 -2.021 . . . . 75.1 105.543 172.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -138.55 174.36 10.62 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.231 -0.655 . . . . 74.32 109.231 174.608 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.1 pt20 -122.27 150.23 42.62 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.367 -0.605 . . . . 63.4 109.367 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.564 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 75.4 m -119.19 118.67 31.95 Favored 'General case' 0 C--N 1.264 -3.129 0 N-CA-C 107.733 -1.21 . . . . 61.22 107.733 173.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' A' ' 68' ' ' VAL . 10.5 m -59.94 -28.22 67.44 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.818 0.847 . . . . 62.15 112.073 -176.131 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' A' ' 111' ' ' SER . 23.7 p-10 -83.91 -19.87 33.99 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.904 0.881 . . . . 62.1 111.301 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 22.1 tp -78.17 135.85 37.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.899 -0.591 . . . . 73.31 109.915 -175.138 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -78.78 158.58 28.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.544 -0.753 . . . . 73.25 111.9 -173.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.726 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 30.7 m -70.93 130.72 42.35 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.378 -0.828 . . . . 73.52 110.082 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 11.42 62.27 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.061 -0.816 . . . . 72.03 111.061 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -126.49 121.22 31.73 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 108.186 -1.042 . . . . 72.1 108.186 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 66' ' ' LEU . 31.1 p90 -141.24 154.49 45.81 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.478 -0.564 . . . . 64.13 109.478 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 3.4 mpt_? -124.17 139.0 54.35 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.183 -0.673 . . . . 74.5 109.183 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.11 118.94 16.19 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.389 -0.967 . . . . 72.2 108.389 176.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -124.98 119.59 29.16 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.676 -0.41 . . . . 75.0 110.233 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -104.78 124.27 7.94 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.449 -1.06 . . . . 63.1 110.449 177.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 m -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 108.762 -0.829 . . . . 74.23 108.762 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.7 t -87.69 119.64 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.84 -1.17 . . . . 64.32 107.84 175.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -110.93 96.06 27.48 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.317 -1.734 . . . . 73.34 106.317 171.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.36 -25.92 17.84 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.988 1.792 . . . . 52.41 111.184 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -95.52 70.7 3.1 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.99 1.376 . . . . 53.44 111.035 -177.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.76 127.19 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 N-CA-C 103.559 -2.756 . . . . 74.54 103.559 171.416 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -69.47 95.0 0.79 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.938 0.875 . . . . 74.11 110.089 -178.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -76.91 120.47 22.09 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.047 -1.433 . . . . 73.3 108.33 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 C--N 1.293 -1.86 0 CA-C-N 114.656 -1.157 . . . . 73.14 108.528 -171.096 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.555 0.217 . . . . 60.51 110.938 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.71 33.16 22.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.305 -1.918 . . . . 52.11 108.305 -172.427 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -109.16 135.86 49.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.084 -1.058 . . . . 70.24 110.611 -176.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.85 -178.37 4.49 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.662 0.385 . . . . 73.41 110.668 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.72 112.9 22.88 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.504 -0.924 . . . . 70.55 108.504 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -89.01 93.86 9.75 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.421 -0.912 . . . . 72.44 110.875 179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.53 95.66 10.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.261 -1.385 . . . . 74.03 107.261 176.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -156.35 109.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.73 0.776 . . . . 72.45 112.125 -176.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -116.72 119.86 36.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.402 -1.703 . . . . 73.1 106.402 171.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -79.03 100.83 7.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.269 -1.011 . . . . 73.11 108.269 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -74.27 95.9 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.285 -1.006 . . . . 71.41 108.285 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.134 -0.939 . . . . 74.52 109.782 -176.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -87.09 76.96 9.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.99 -1.856 . . . . 73.32 105.99 172.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.51 94.04 1.25 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.054 -0.975 . . . . 71.32 112.058 -171.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.79 151.48 49.54 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.384 -1.71 . . . . 65.15 106.384 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.56 97.6 11.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.927 -1.508 . . . . 73.12 106.927 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.83 102.36 11.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.98 0.895 . . . . 61.32 112.509 -176.224 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -131.89 90.49 2.83 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.508 -1.664 . . . . 64.45 106.508 172.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 p -95.21 112.86 28.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 114.497 -1.229 . . . . 73.53 110.662 -177.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.9 133.71 5.95 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.72 -0.952 . . . . 64.31 110.72 -179.334 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -90.45 105.36 17.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.414 -1.328 . . . . 73.25 107.414 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -43.95 -56.55 3.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.477 -1.238 . . . . 74.14 112.932 -177.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -65.81 -29.76 70.29 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.0 0.741 . . . . 74.13 113.0 -177.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.4 79.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.835 -0.802 . . . . 55.4 108.835 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -67.6 -21.83 65.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.739 -0.664 . . . . 71.44 111.753 178.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 22' ' ' ALA . 73.5 mt -78.28 -59.32 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.046 0.451 . . . . 72.33 110.261 177.812 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -83.98 -17.02 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.121 1.156 . . . . 74.44 114.121 -173.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.4 38.46 3.49 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 119.918 -1.134 . . . . 74.24 112.088 179.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.5 45.63 95.91 Favored Glycine 0 CA--C 1.509 -0.3 0 CA-C-N 115.548 -0.326 . . . . 63.33 112.585 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -165.87 164.8 18.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.889 -1.523 . . . . 70.45 106.889 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 pt 42.63 37.66 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 125.952 1.701 . . . . 75.12 114.705 176.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.1 m -73.75 128.76 86.31 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.064 -0.516 . . . . 74.12 110.906 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 3.4 Cg_exo -75.31 71.64 5.12 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.736 2.291 . . . . 34.33 111.536 177.135 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -89.15 -2.65 58.61 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.744 0.783 . . . . 72.41 110.03 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 37.5 mt-10 -74.8 -5.34 42.93 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.825 -0.625 . . . . 74.32 112.403 178.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 82.2 t -71.32 -55.51 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.792 -1.188 . . . . 72.35 107.792 174.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.5 pm0 -62.98 -34.93 78.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.88 0.372 . . . . 70.41 111.538 176.444 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . . . -62.19 -50.86 70.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.983 -0.553 . . . . 42.41 111.269 177.177 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.01 -30.57 67.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.298 0.57 . . . . 63.33 110.162 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 16.0 tp -66.1 -41.88 90.01 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.687 -0.688 . . . . 51.13 110.218 -179.03 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.88 -28.96 66.07 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.154 -0.684 . . . . 73.03 109.154 178.958 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HE ' ' HB2' ' A' ' 46' ' ' ASP . 6.3 tpt180 -64.62 -52.3 58.14 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-N 115.778 -0.646 . . . . 75.42 109.614 172.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -60.24 -38.05 82.23 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.856 0.863 . . . . 62.41 110.998 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.28 -46.68 89.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.998 -0.547 . . . . 70.02 110.88 177.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.8 -22.84 49.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.879 -0.601 . . . . 75.0 111.179 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' HE ' ' A' ' 42' ' ' ARG . 28.8 t70 -81.13 -37.33 29.03 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.862 -0.608 . . . . 70.25 110.799 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 19.89 29.59 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 116.1 -0.5 . . . . 73.35 113.538 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -66.11 139.04 21.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 C-N-CA 123.01 0.524 . . . . 70.24 110.851 178.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -117.85 143.34 46.38 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.173 0.511 . . . . 74.01 110.166 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -75.44 111.75 11.05 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.6 -1.182 . . . . 64.3 109.418 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.9 tp -119.13 -176.0 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.044 -1.835 . . . . 73.14 106.044 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 73.6 mt-30 -47.29 141.28 4.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.579 0.751 . . . . 64.13 110.058 175.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -10.63 7.77 Favored Glycine 0 CA--C 1.5 -0.857 0 N-CA-C 116.012 1.165 . . . . 74.51 116.012 -167.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -71.64 -35.72 70.5 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.245 -0.582 . . . . 61.45 111.844 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -167.26 148.12 5.58 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 112.07 0.396 . . . . 74.23 112.07 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.99 151.73 20.96 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.821 0.848 . . . . 73.3 110.508 -174.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.04 127.92 37.69 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.766 -1.198 . . . . 75.11 107.766 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.03 46.81 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 109.113 -0.699 . . . . 75.42 109.113 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.68 149.02 83.9 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.111 1.874 . . . . 63.41 111.153 177.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -113.23 -26.14 8.55 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.734 -0.386 . . . . 71.43 110.886 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 35.3 tt0 -113.12 125.18 54.08 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.185 0.517 . . . . 74.12 110.025 -177.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB2' HG12 ' A' ' 106' ' ' VAL . 39.4 m-85 -121.83 124.87 45.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.578 -0.737 . . . . 60.22 109.87 -177.452 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 69.2 mt -98.18 114.86 36.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.133 -1.062 . . . . 74.11 108.133 -179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.75 117.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.3 m -116.83 121.42 41.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.038 -0.528 . . . . 74.33 110.078 -178.437 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.4 mm? -106.57 163.05 13.2 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.216 -0.902 . . . . 70.2 109.555 177.02 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.43 163.64 54.12 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.261 -1.936 . . . . 73.31 108.261 171.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.25 -40.32 88.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 118.023 0.912 . . . . 63.14 112.891 -175.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 53.0 t-80 -68.55 -43.24 77.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.254 -1.017 . . . . 74.43 108.254 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -65.55 -35.43 80.83 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.356 -1.293 . . . . 73.24 110.699 -177.283 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.92 -40.48 91.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 70.23 109.683 178.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.41 -24.83 60.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.188 0.518 . . . . 62.14 111.193 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 mmmt -77.52 -17.14 58.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.241 -0.436 . . . . 55.33 111.848 175.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 66' ' ' LEU . 77.5 mt -71.45 -40.44 70.34 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 105.959 -1.867 . . . . 73.21 105.959 170.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.9 -176.5 18.64 Favored Glycine 0 N--CA 1.414 -2.829 0 CA-C-N 113.776 -1.557 . . . . 72.44 110.513 176.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -87.12 1.69 52.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.56 0.695 . . . . 72.23 109.361 178.008 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 26.6 p-10 -123.05 49.19 2.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 C-N-CA 124.242 1.017 . . . . 63.23 112.714 -177.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 5.2 Cg_exo -75.19 -17.16 19.37 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.705 1.604 . . . . 53.13 110.929 -179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -26.31 59.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.376 -0.829 . . . . 63.31 111.982 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.21 -44.94 62.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.645 -1.243 . . . . 71.15 107.645 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HE3' ' CZ ' ' A' ' 85' ' ' PHE . 60.2 tptt -61.3 -33.96 74.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.009 0.924 . . . . 61.3 109.427 176.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 t -63.05 -49.11 75.84 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.886 -1.052 . . . . 65.34 110.532 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.5 m -62.04 -34.44 76.24 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-O 120.896 0.379 . . . . 75.12 110.854 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.73 -52.63 44.1 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.62 -0.992 . . . . 60.45 110.62 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.671 ' CZ ' ' HE3' ' A' ' 81' ' ' LYS . 8.0 m-30 -58.52 -44.23 89.47 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 112.516 0.562 . . . . 75.45 112.516 178.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.15 74.65 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.756 0.66 . . . . 70.34 111.061 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -79.67 -40.28 29.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.372 -0.531 . . . . 54.23 111.066 -176.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 33.9 t70 -63.9 -38.12 89.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.175 0.512 . . . . 70.23 111.688 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.55 -29.74 52.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.616 -0.434 . . . . 73.41 110.08 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.31 -37.28 86.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.566 -0.901 . . . . 70.04 108.566 173.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 21.4 t70 -60.19 -54.94 39.83 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.593 -1.185 . . . . 72.42 109.327 176.002 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.4 m-85 -51.71 -49.19 62.94 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 114.005 1.113 . . . . 73.31 114.005 178.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.9 pt -63.8 -34.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.821 -0.751 . . . . 74.44 111.12 -177.087 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 81.1 mm-40 -72.24 -37.37 69.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 121.202 -0.199 . . . . 74.42 110.697 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 48.3 mm-40 -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.957 -0.565 . . . . 72.13 110.981 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.4 mm-40 -80.19 -13.3 59.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.727 -0.67 . . . . 74.41 111.681 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.84 29.81 28.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.756 -0.735 . . . . 60.23 112.327 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -102.47 162.52 12.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.803 -0.814 . . . . 74.41 108.803 178.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -133.98 177.17 7.94 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.773 -0.454 . . . . 73.12 109.773 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -160.83 177.33 10.52 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.74 -1.578 . . . . 74.13 106.74 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.36 119.11 36.53 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.943 -0.762 . . . . 65.43 108.943 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -150.92 17.05 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 109.387 -1.485 . . . . 62.3 109.387 -176.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.65 148.11 48.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.834 -1.543 . . . . 75.43 106.834 177.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.28 122.37 24.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.144 0.497 . . . . 75.13 110.814 -177.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 7.3 p -138.93 127.73 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.778 0.799 . . . . 71.22 109.9 -178.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 62' ' ' TYR . 18.8 m -105.17 148.5 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.556 -0.905 . . . . 74.2 108.556 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -115.52 125.58 53.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.692 -0.855 . . . . 75.31 108.692 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -101.11 119.79 39.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.265 -0.643 . . . . 75.25 109.265 173.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.9 pt-20 -139.16 164.8 28.85 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.844 -0.616 . . . . 74.31 109.377 178.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.66 159.41 29.39 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.558 0.694 . . . . 61.21 110.928 -177.007 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -140.21 109.8 6.31 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 114.937 -1.029 . . . . 63.32 109.188 172.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -64.67 -25.83 68.12 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.462 -0.79 . . . . 74.45 110.054 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -75.84 -14.72 60.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.16 -0.927 . . . . 70.33 110.438 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -81.98 161.57 22.97 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.211 -1.033 . . . . 65.35 108.211 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -83.15 150.84 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.096 0.474 . . . . 63.24 110.297 -176.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.0 m -76.31 123.53 26.07 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.59 -0.732 . . . . 75.0 110.602 -178.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.48 8.15 62.79 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.634 -0.986 . . . . 74.42 110.634 -175.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -114.44 122.02 45.33 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.336 -1.357 . . . . 75.2 107.336 177.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.447 ' HB3' HD13 ' A' ' 66' ' ' LEU . 43.2 p90 -131.28 154.0 48.96 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.204 -1.035 . . . . 73.34 108.204 -178.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -141.16 148.42 39.98 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 123.142 0.276 . . . . 75.54 110.367 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -147.32 121.0 9.19 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.711 -0.848 . . . . 64.25 108.711 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -123.54 140.24 53.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.668 -0.493 . . . . 73.12 109.668 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.1 136.38 13.34 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 111.555 -0.618 . . . . 72.15 111.555 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -138.71 158.9 43.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.8 -0.815 . . . . 71.13 108.8 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.86 106.99 19.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.463 -1.31 . . . . 75.23 107.463 178.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -124.11 96.83 41.54 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 109.799 -0.445 . . . . 65.02 109.799 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.76 -6.86 12.48 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.056 1.837 . . . . 73.35 110.96 178.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.25 73.9 3.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.604 1.193 . . . . 50.45 108.981 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.88 114.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 113.122 -1.854 . . . . 72.34 108.422 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.22 125.56 42.61 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.417 0.627 . . . . 72.42 111.094 -179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.7 m -81.64 133.06 35.32 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.801 -1.555 . . . . 74.51 106.801 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.8 m170 . . . . . 0 C--O 1.263 1.767 0 CA-C-O 118.15 -0.929 . . . . 72.04 109.038 -178.692 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtm . . . . . 0 C--O 1.249 1.038 0 N-CA-C 108.732 -0.84 . . . . 73.14 108.732 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.46 -118.23 9.78 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.991 -0.843 . . . . 51.41 110.991 -178.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -154.43 144.13 21.6 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 122.614 0.366 . . . . 62.02 110.626 176.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -88.69 93.84 9.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.741 -1.948 . . . . 64.02 105.741 170.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.556 ' HD2' ' O ' ' A' ' 5' ' ' LYS . 1.2 pptp? -54.77 121.23 8.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 114.667 1.358 . . . . 72.23 114.667 -172.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.47 122.11 37.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.134 -1.432 . . . . 75.34 107.134 175.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.56 121.29 23.71 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.148 0.499 . . . . 74.44 110.525 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -111.77 23.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.906 1.336 . . . . 72.41 107.465 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -77.75 -45.49 24.5 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.682 -1.144 . . . . 75.34 111.676 -177.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -87.01 71.97 10.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.209 1.004 . . . . 72.24 111.125 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.4 73.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 104.938 -2.245 . . . . 74.33 104.938 170.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.41 30.4 0.71 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.257 -1.792 . . . . 73.44 110.246 -174.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 70.16 13.19 7.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.221 1.01 . . . . 74.43 111.002 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -120.12 92.8 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.384 -1.28 . . . . 75.11 107.923 173.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 tp -152.07 -66.68 0.17 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.544 -1.28 . . . . 72.41 107.544 179.395 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 94.74 9.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.232 -1.766 . . . . 75.1 106.232 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -102.02 -20.12 14.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.214 -0.903 . . . . 63.34 109.908 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -145.55 118.47 8.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.771 -1.196 . . . . 74.21 107.771 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.87 86.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 122.385 1.088 . . . . 34.33 111.652 -178.142 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.13 175.11 15.9 Favored Glycine 1 N--CA 1.379 -5.117 0 N-CA-C 110.532 -1.027 . . . . 74.23 110.532 178.036 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 9.0 m-20 56.25 31.29 18.19 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 125.83 1.652 . . . . 74.13 112.647 177.052 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.51 -60.2 4.22 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.271 0.629 . . . . 70.21 112.326 -176.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -70.14 -28.93 65.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.649 -0.705 . . . . 75.22 109.733 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.07 65.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.075 -0.966 . . . . 60.02 110.926 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 10.4 ptp180 -74.88 -33.2 62.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.164 0.431 . . . . 72.14 112.164 -178.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.8 mt -78.88 -55.01 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.751 0.31 . . . . 75.25 111.767 -177.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 94.9 m-85 -93.48 -11.27 32.42 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.899 0.703 . . . . 74.53 112.899 -173.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.35 -1.6 80.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.217 -0.992 . . . . 75.24 113.804 176.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.59 13.09 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 119.888 -1.148 . . . . 71.24 112.978 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -75.45 -63.57 1.26 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.996 0.427 . . . . 74.14 110.73 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HB ' ' CG ' ' A' ' 27' ' ' PHE . 47.2 mm -91.47 79.26 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.955 0.883 . . . . 73.0 108.72 176.691 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.9 t -134.0 120.23 15.09 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.589 -1.263 . . . . 63.2 107.589 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.26 58.03 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.136 2.557 . . . . 75.3 112.718 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 34.2 tt0 -71.8 -33.84 68.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.753 -0.462 . . . . 65.35 109.753 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -65.23 -20.79 66.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.141 0.496 . . . . 74.34 110.681 179.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 78.8 t -72.34 -48.19 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.221 -0.659 . . . . 64.43 109.221 177.681 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -71.5 -26.7 62.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.454 0.645 . . . . 74.0 111.054 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.09 79.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.376 -0.829 . . . . 50.13 109.665 173.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 6.9 tt -76.74 -34.83 58.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.383 -0.969 . . . . 73.23 108.383 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 96.9 mt -62.28 -47.21 85.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.291 -0.413 . . . . 71.44 110.851 177.249 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -66.4 -30.9 71.37 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.454 -0.573 . . . . 72.41 109.454 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' LEU . 56.7 ttt180 -63.32 -55.25 26.21 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.146 0.978 . . . . 72.4 109.82 177.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.45 -23.73 58.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.293 -0.412 . . . . 62.22 111.423 -175.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.49 98.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.286 -0.635 . . . . 63.41 109.286 172.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.46 63.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.426 -0.807 . . . . 72.23 110.85 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.02 -42.42 76.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.784 0.326 . . . . 54.12 110.937 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.45 9.68 40.69 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.894 -0.593 . . . . 75.41 114.262 -176.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 48' ' ' ILE . 16.0 mm -59.64 135.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.398 0.618 . . . . 75.05 111.58 177.419 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 99.5 mt-30 -120.08 150.0 41.29 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.002 -0.999 . . . . 74.43 110.545 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.1 m -79.78 126.33 30.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.573 -1.194 . . . . 72.45 109.708 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.5 tp -146.7 -164.07 1.9 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 104.522 -2.399 . . . . 64.53 104.522 -178.238 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.608 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 50.7 mt-30 -42.25 133.32 3.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.619 0.768 . . . . 74.02 110.152 176.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.52 -12.43 46.2 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 114.884 0.714 . . . . 70.41 114.884 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.55 -34.18 60.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.036 0.384 . . . . 75.12 112.036 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 29.0 ptt180 -157.05 135.05 11.01 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.307 0.575 . . . . 74.41 111.943 -177.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.72 151.64 21.15 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.213 -0.903 . . . . 75.11 110.737 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 14.7 tp -84.94 125.0 32.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.744 -0.835 . . . . 72.41 108.744 -176.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.42 158.31 40.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 115.836 -0.62 . . . . 73.14 109.73 -178.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 39.1 Cg_exo -60.8 148.86 90.75 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.969 2.446 . . . . 75.23 113.121 177.759 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.7 p-10 -125.44 -21.63 4.49 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.234 -0.893 . . . . 35.33 110.626 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 32.5 tt0 -94.23 107.52 19.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.797 -0.816 . . . . 61.25 108.797 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 95.3 m-85 -120.52 114.46 21.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.294 0.569 . . . . 70.22 109.956 177.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.49 122.06 66.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.16 -1.052 . . . . 71.54 108.16 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.6 mt -115.6 119.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.376 0.607 . . . . 73.3 109.521 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 109' ' ' GLU . 15.1 m -117.45 123.71 47.04 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.721 -0.672 . . . . 43.45 109.261 -177.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 74' ' ' LEU . 6.4 mp -121.8 171.82 8.61 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 109.949 -0.389 . . . . 73.53 109.949 175.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.79 147.28 43.11 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.484 -1.046 . . . . 61.3 110.484 175.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.03 -47.76 65.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 123.099 0.56 . . . . 63.04 110.666 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.592 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 52.7 t-80 -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.506 -0.77 . . . . 65.4 110.376 -178.358 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 9.3 t70 -65.2 -43.28 92.11 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.768 0.794 . . . . 73.42 108.983 -178.337 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.3 -44.43 92.52 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.82 1.648 . . . . 74.43 109.8 -178.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -67.25 -37.25 83.2 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.087 -0.506 . . . . 73.31 110.749 177.366 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 3.1 mmmp? -68.5 -26.28 65.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.462 -0.336 . . . . 61.3 110.607 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 66' ' ' LEU . 78.8 mt -69.65 -45.68 67.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.804 0.811 . . . . 74.4 109.792 175.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.6 44.87 7.11 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 105.054 -3.218 . . . . 44.22 105.054 -165.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -61.53 6.93 0.05 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 128.624 2.77 . . . . 71.13 116.851 -171.53 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.4 t70 -43.45 106.85 0.52 Allowed Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.556 1.142 . . . . 71.11 108.728 -173.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 52.9 Cg_exo -52.65 -52.47 8.79 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.334 3.356 . . . . 74.14 118.987 -161.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.79 -51.07 7.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.441 1.645 . . . . 72.12 115.441 -165.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -62.96 -56.48 16.78 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.744 0.646 . . . . 63.41 112.744 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 85' ' ' PHE 0.286 29.1 mmmt -94.8 -8.61 36.98 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 115.55 1.685 . . . . 64.24 115.55 -177.352 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -69.46 -45.58 68.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.213 -1.773 . . . . 63.24 106.213 174.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.4 m -69.92 -36.91 75.73 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.059 -0.973 . . . . 65.34 108.925 175.097 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.02 -56.22 26.38 Favored Glycine 0 C--O 1.21 -1.345 0 CA-C-N 115.33 -0.85 . . . . 61.41 113.109 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 32.1 m-85 -60.2 -35.47 75.48 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.449 0.624 . . . . 70.54 111.492 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.95 94.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.42 . . . . 52.01 109.99 177.15 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -68.88 -41.12 78.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.878 -0.601 . . . . 74.51 110.085 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.67 -50.97 71.43 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.902 -0.407 . . . . 72.05 109.902 176.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.8 -31.76 70.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.215 0.82 . . . . 72.11 113.215 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.43 91.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.332 0.587 . . . . 74.23 109.661 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.0 -41.99 73.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.638 -0.71 . . . . 61.41 109.655 177.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -56.48 -52.86 63.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 112.565 0.58 . . . . 72.4 112.565 176.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.32 -37.8 58.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 120.063 -0.655 . . . . 74.24 111.699 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.28 -50.89 62.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.379 . . . . 71.51 111.181 175.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -53.31 -51.03 63.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.942 1.297 . . . . 74.42 110.784 -178.376 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 1.7 mp0 -74.73 -13.44 60.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.086 1.143 . . . . 72.11 114.086 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.24 38.21 11.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.028 -1.082 . . . . 72.52 111.796 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -109.42 158.41 17.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.774 -0.825 . . . . 72.24 108.774 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 23.6 pt20 -129.11 174.24 9.74 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.923 -0.769 . . . . 73.43 108.923 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.0 t -162.34 159.29 25.24 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.735 -1.209 . . . . 74.23 107.735 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.56 118.9 33.11 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.381 -0.97 . . . . 74.25 108.381 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -149.75 16.72 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.567 -1.813 . . . . 54.51 108.567 -176.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -126.09 164.32 21.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.568 -1.641 . . . . 63.14 106.568 174.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.37 117.53 28.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.556 -0.905 . . . . 54.4 108.556 -178.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -118.33 121.03 66.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.607 0.717 . . . . 74.32 110.643 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 62' ' ' TYR . 79.5 t -111.12 113.18 43.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.387 -0.968 . . . . 72.01 108.387 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -111.31 134.45 52.89 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.007 -0.542 . . . . 72.53 109.554 -177.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.4 146.41 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.738 -0.467 . . . . 73.35 109.738 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 65' ' ' THR . 9.2 pt-20 -151.37 168.31 25.2 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.75 -0.833 . . . . 62.12 108.75 174.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.95 158.42 25.77 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.235 0.541 . . . . 51.11 111.784 178.413 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -135.74 136.87 41.15 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.709 -1.132 . . . . 52.05 109.146 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 t -80.73 -19.27 45.37 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.8 -0.815 . . . . 54.34 108.8 176.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -72.79 -36.43 67.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.701 -0.681 . . . . 71.13 110.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.74 155.22 20.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.176 -0.466 . . . . 73.54 110.707 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -125.27 173.47 8.78 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.2 0.6 . . . . 72.42 110.645 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 9.8 m -57.79 125.61 23.77 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.474 0.654 . . . . 75.41 110.933 -179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.87 54.84 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.318 -0.856 . . . . 74.15 111.058 -176.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -118.18 118.67 32.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.092 0.472 . . . . 73.12 110.08 -178.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 34.0 p90 -139.03 148.45 43.42 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.564 -1.273 . . . . 74.32 107.564 177.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -132.12 130.65 41.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.228 -1.027 . . . . 55.43 108.228 175.41 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . -130.8 129.48 42.47 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.83 -1.174 . . . . 53.12 107.83 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 39.7 mtp180 -119.61 157.8 27.69 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 123.155 0.285 . . . . 71.52 111.521 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -137.0 109.85 0.74 Allowed Glycine 0 N--CA 1.424 -2.109 0 O-C-N 124.715 1.26 . . . . 60.31 110.918 176.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.6 m -114.3 150.43 34.48 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.371 -0.603 . . . . 73.44 109.371 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.24 106.12 16.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 106.49 -1.67 . . . . 75.31 106.49 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -110.42 102.28 51.07 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 109.962 -0.384 . . . . 71.24 109.962 -178.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.9 -14.17 12.55 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.946 1.764 . . . . 54.5 111.394 178.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.12 70.53 3.27 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 123.2 1.476 . . . . 42.41 109.111 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.76 131.36 64.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 112.479 -2.146 . . . . 72.42 107.451 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -76.62 124.52 27.75 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.166 -1.049 . . . . 74.21 108.166 178.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -130.77 157.63 42.31 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.391 -0.822 . . . . 74.04 109.362 -177.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--N 1.291 -1.977 0 CA-C-O 118.366 -0.826 . . . . 72.2 109.028 -178.453 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 108.597 -0.89 . . . . 61.22 108.597 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.39 8.63 68.01 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.819 -0.705 . . . . 71.32 112.899 177.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -102.54 23.71 11.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.213 0.53 . . . . 71.45 109.666 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -102.18 164.1 11.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.997 -0.547 . . . . 75.2 110.293 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -126.03 103.98 8.03 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.536 -1.283 . . . . 65.21 107.536 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -83.67 104.31 13.69 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.223 0.535 . . . . 62.32 110.151 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.2 149.6 52.35 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.057 -0.974 . . . . 64.12 109.104 177.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.16 125.48 33.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.201 -0.666 . . . . 75.42 109.201 178.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -117.75 130.61 56.42 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.691 -0.485 . . . . 70.44 109.691 -178.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -94.48 102.41 14.36 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.034 -0.728 . . . . 75.4 109.034 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.75 -5.43 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.519 1.152 . . . . 74.54 108.272 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -68.59 141.77 55.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.994 -1.457 . . . . 64.23 109.833 176.016 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 68.4 21.14 8.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.797 1.239 . . . . 73.41 112.729 173.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.77 -35.11 57.93 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.135 -1.802 . . . . 75.1 106.135 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.92 98.09 8.36 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 104.982 -2.229 . . . . 64.14 104.982 171.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.15 88.01 6.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 C-N-CA 120.235 -0.586 . . . . 75.43 110.983 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -73.28 129.75 38.71 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.278 -1.749 . . . . 75.45 106.278 172.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -79.56 159.65 26.77 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.062 -0.517 . . . . 72.52 111.223 -176.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.01 91.63 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.932 -1.136 . . . . 53.43 107.932 177.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.8 -68.58 0.14 Allowed Glycine 0 C--N 1.3 -1.471 0 N-CA-C 110.074 -1.21 . . . . 73.11 110.074 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -103.28 15.26 29.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.57 0.7 . . . . 75.12 109.946 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.479 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -59.7 -44.86 93.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.622 -1.172 . . . . 44.4 111.857 -177.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' HA ' HG12 ' A' ' 26' ' ' ILE . 63.3 m-85 -63.93 -34.54 78.2 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.36 0.412 . . . . 71.44 111.87 -177.338 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.09 82.06 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.438 0.637 . . . . 74.34 109.86 177.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -71.84 -30.86 65.91 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.367 -0.833 . . . . 73.34 112.248 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 23' ' ' PHE . 24.0 pt -85.23 -16.24 10.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 112.766 0.654 . . . . 71.4 112.766 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -92.4 -29.45 16.3 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.282 -0.567 . . . . 60.2 111.204 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.79 -94.62 0.03 OUTLIER Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.928 0.767 . . . . 51.2 114.522 174.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.02 71.43 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.164 -0.518 . . . . 73.42 112.443 -177.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 m -91.37 172.94 8.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.847 -0.427 . . . . 71.35 109.847 174.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.77 121.66 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.722 -1.584 . . . . 74.23 106.722 176.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 21.6 m -85.01 142.02 38.27 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.28 -0.418 . . . . 72.51 111.951 -173.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -53.56 115.46 2.33 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.965 2.443 . . . . 65.43 112.171 175.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 32' ' ' VAL . 13.1 pt20 176.46 -41.67 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 127.036 2.134 . . . . 74.22 106.271 -178.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.02 -27.12 33.25 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.443 -1.253 . . . . 72.53 109.892 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -54.4 33.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.034 0 N-CA-C 107.649 -1.241 . . . . 61.14 107.649 175.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.78 -46.58 74.45 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.441 1.097 . . . . 71.41 110.911 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.2 69.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.058 -0.519 . . . . 65.12 111.655 178.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' CE2' ' A' ' 119' ' ' PHE . 9.6 tt -70.92 -35.4 72.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.849 0.356 . . . . 74.43 110.576 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 tp -67.12 -38.65 85.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.938 -0.574 . . . . 73.01 110.522 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -71.86 -29.06 63.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.407 -0.517 . . . . 61.25 111.184 177.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.28 -38.02 68.9 Favored 'General case' 0 C--O 1.203 -1.368 0 C-N-CA 119.037 -1.065 . . . . 61.13 109.075 173.465 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -64.34 -33.14 75.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.205 -0.665 . . . . 74.22 109.205 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.52 73.48 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.345 -0.843 . . . . 74.22 109.613 174.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -67.98 -30.98 70.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.563 0.697 . . . . 72.24 111.477 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.6 -29.92 52.2 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.92 -0.582 . . . . 72.25 109.755 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.51 14.1 65.98 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.824 -0.625 . . . . 75.54 112.41 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 45' ' ' ALA . 8.7 mm -64.0 138.9 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.962 0.905 . . . . 64.44 111.254 177.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 76.3 mt-30 -119.25 147.47 44.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.952 -0.567 . . . . 72.11 110.499 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.5 m -82.95 134.55 35.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 115.029 -0.987 . . . . 55.34 108.807 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.4 tp -150.69 -165.43 2.27 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.008 -2.219 . . . . 64.34 105.008 -179.371 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.623 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 80.0 mt-30 -42.2 139.33 1.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.727 0.811 . . . . 72.53 111.649 176.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.47 20.69 0.97 Allowed Glycine 0 CA--C 1.505 -0.543 0 CA-C-N 115.363 -0.835 . . . . 53.21 115.032 -170.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -86.96 -37.19 17.8 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.316 -1.365 . . . . 53.21 107.316 175.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -173.92 158.6 3.21 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.195 -0.911 . . . . 63.41 112.235 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB3' HG23 ' A' ' 48' ' ' ILE . 57.5 mt -91.63 151.76 20.55 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.042 -0.981 . . . . 74.23 111.36 -174.477 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 22.2 mt -80.88 121.0 25.43 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 115.771 -0.65 . . . . 70.13 110.978 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.13 151.14 37.61 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.731 -1.211 . . . . 53.33 107.731 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' HG22 ' A' ' 125' ' ' VAL . 39.3 Cg_exo -59.44 156.09 37.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.42 2.08 . . . . 43.52 112.882 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -118.86 -29.41 5.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.572 -0.74 . . . . 72.52 109.568 176.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -96.52 105.28 17.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.822 -0.626 . . . . 75.44 109.587 179.075 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 76.0 m-85 -115.8 114.8 25.25 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.802 -0.444 . . . . 74.12 109.802 178.24 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.8 119.97 61.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.584 -1.265 . . . . 64.2 107.584 177.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.42 135.69 41.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.664 -1.236 . . . . 63.21 107.664 -178.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 27.3 m -124.37 113.36 18.09 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 72.31 109.685 -177.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 3.5 mm? -109.3 -176.89 3.15 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.755 -0.657 . . . . 43.02 110.26 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.48 173.6 44.17 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.248 -1.141 . . . . 63.34 110.248 177.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.9 p -65.82 -44.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 117.131 0.466 . . . . 54.52 111.224 -179.099 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -56.51 -42.34 78.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.05 0.929 . . . . 74.4 110.033 177.468 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 12.6 m-20 -71.94 -37.78 69.93 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.299 -1.318 . . . . 72.02 110.446 -176.102 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.7 -37.78 88.77 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.655 -0.498 . . . . 74.33 109.655 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.5 mt-10 -61.23 -36.96 81.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.693 -0.685 . . . . 65.14 110.229 177.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.81 -23.88 41.76 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.975 -0.557 . . . . 75.12 112.362 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 89.5 mt -61.23 -42.29 98.35 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.714 -0.476 . . . . 64.14 109.714 177.387 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.21 166.65 10.75 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 119.622 -1.275 . . . . 43.44 113.299 175.252 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.89 -18.24 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.721 0.408 . . . . 75.3 111.575 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -115.72 85.4 14.09 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.084 -0.71 . . . . 54.32 109.084 177.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.13 -50.0 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.143 1.895 . . . . 73.13 112.282 -178.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.27 -49.48 73.89 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.53 0.567 . . . . 74.41 112.53 -173.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.74 -37.02 82.68 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 112.29 0.478 . . . . 70.03 112.29 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -77.42 -26.7 51.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.687 -0.405 . . . . 74.31 111.009 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 60.1 m -65.57 -40.41 92.75 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.876 -0.416 . . . . 52.12 109.876 175.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 m -59.79 -39.23 84.24 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.389 0.614 . . . . 72.32 109.964 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.85 55.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.582 -0.736 . . . . 54.44 111.976 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -68.95 -28.35 66.55 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.117 0.484 . . . . 74.1 110.03 -178.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -66.9 -38.79 86.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 116.147 -0.479 . . . . 72.53 109.757 176.243 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.36 -38.43 89.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 73.41 109.564 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -65.31 -42.66 92.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.992 -0.549 . . . . 70.1 110.344 177.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.15 -33.24 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.373 -0.376 . . . . 74.45 110.827 178.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.2 98.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.462 -0.569 . . . . 61.01 109.462 176.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.2 t70 -61.68 -44.18 97.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.304 -0.862 . . . . 73.15 109.453 177.189 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 m-85 -57.65 -52.96 63.28 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.671 0.619 . . . . 72.51 112.671 176.047 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.8 pt -64.59 -30.18 49.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.693 -0.403 . . . . 63.25 111.705 -176.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -38.31 85.89 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.123 -0.49 . . . . 72.45 110.366 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 51.3 mt-10 -65.67 -30.55 71.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.951 -0.568 . . . . 72.13 111.162 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.0 mm-40 -85.52 -11.43 54.18 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.807 -0.633 . . . . 70.34 110.941 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.66 33.08 60.92 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.764 -0.653 . . . . 51.1 113.065 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -97.99 161.34 13.77 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.496 -0.482 . . . . 74.54 110.122 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.95 161.71 18.43 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.021 -0.733 . . . . 71.54 109.021 178.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -161.1 172.26 17.12 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.576 -1.638 . . . . 54.34 106.576 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -123.51 120.14 32.03 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 71.45 110.235 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.74 13.07 Favored Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 109.751 -1.34 . . . . 53.14 109.751 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.08 141.32 30.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.542 -0.91 . . . . 64.11 108.542 174.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.37 138.32 21.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.293 -1.002 . . . . 65.04 108.293 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.19 124.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 121.152 0.501 . . . . 43.42 111.125 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 15.3 m -108.87 140.54 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 106.643 -1.614 . . . . 52.21 106.643 172.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.38 144.92 48.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.512 -0.922 . . . . 74.51 108.512 177.018 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -111.77 126.93 55.59 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.413 0.445 . . . . 53.0 110.184 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.5 pt-20 -128.26 168.49 15.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.936 -1.505 . . . . 74.04 106.936 173.272 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.35 156.93 34.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.805 0.812 . . . . 73.32 112.004 -177.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 74.5 m -130.48 101.77 5.87 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.171 -1.418 . . . . 61.42 107.171 169.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -68.14 -9.38 46.17 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 123.948 0.899 . . . . 72.34 112.941 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.0 -25.66 48.14 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.746 -0.835 . . . . 60.51 108.746 174.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -104.48 151.45 23.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.66 -1.237 . . . . 72.31 107.66 -177.235 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -139.65 171.8 13.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 117.563 0.165 . . . . 72.44 111.307 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 m -36.02 112.87 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.28 2.232 . . . . 53.03 113.057 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.35 -33.07 3.74 Favored Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 107.848 -2.101 . . . . 74.02 107.848 -175.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -105.73 139.21 40.65 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.908 -1.516 . . . . 74.33 106.908 174.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CE2' HD13 ' A' ' 39' ' ' LEU . 32.7 p90 -170.45 154.19 4.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.783 -0.821 . . . . 74.03 108.783 174.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -128.72 157.97 39.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.963 -0.562 . . . . 72.04 110.261 -177.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.47 144.15 22.62 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.092 -1.818 . . . . 72.42 106.092 174.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 33.2 ptt-85 -140.41 145.95 37.69 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.436 -0.579 . . . . 64.44 109.436 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 110.06 0.93 Allowed Glycine 0 C--N 1.284 -2.326 0 O-C-N 124.206 0.942 . . . . 75.22 111.81 -176.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.6 m -109.25 137.84 46.51 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.65 -0.5 . . . . 71.34 109.65 -179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.0 t -89.07 109.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.992 -1.855 . . . . 71.4 105.992 170.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.16 105.88 31.39 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.437 -0.579 . . . . 44.5 109.437 179.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.5 -11.37 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.165 1.91 . . . . 71.03 111.689 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -93.72 72.19 4.23 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-O 123.297 1.522 . . . . 74.31 109.057 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.9 p -142.21 143.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 104.614 -2.365 . . . . 62.21 104.614 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 0.8 OUTLIER -73.21 134.95 44.51 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.694 0.759 . . . . 70.42 111.109 -179.102 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -147.12 136.61 22.8 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.527 -1.215 . . . . 75.13 108.002 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.023 -1.103 . . . . 75.22 108.023 -178.633 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 73.14 109.14 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.37 9.78 10.11 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.667 -0.778 . . . . 50.22 111.437 -178.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -79.2 84.67 5.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.536 0.684 . . . . 41.13 109.722 178.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -113.39 163.69 14.54 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.078 -0.965 . . . . 44.32 110.976 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.2 150.21 24.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.197 -0.91 . . . . 64.04 108.903 -178.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -93.09 93.96 8.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 105.408 -2.071 . . . . 75.51 105.408 170.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.82 -40.32 94.85 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 74.53 112.247 -173.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t 65.44 91.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 124.18 0.925 . . . . 71.15 110.263 -176.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -156.9 123.55 5.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.444 -1.317 . . . . 65.51 107.444 178.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -83.79 134.49 34.72 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.213 -1.032 . . . . 65.52 108.213 178.141 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.81 98.38 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.397 -0.964 . . . . 63.31 108.397 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.12 152.76 43.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.366 -1.288 . . . . 54.34 112.104 -176.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -119.66 79.15 1.39 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.477 -0.783 . . . . 55.43 109.129 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 3.9 ttpm? -109.17 84.67 1.96 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.891 -1.151 . . . . 63.24 107.891 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -77.72 -40.62 40.62 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.333 -1.358 . . . . 65.43 107.333 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -138.92 154.62 48.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.525 -1.287 . . . . 74.31 107.525 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.64 152.16 24.93 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 123.322 0.389 . . . . 73.34 110.092 -178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 m -69.07 109.53 4.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.319 -0.993 . . . . 64.25 108.319 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.44 145.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 109.105 -0.702 . . . . 75.33 109.105 -175.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.06 22.98 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 109.762 -1.335 . . . . 70.23 109.762 -175.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.85 111.77 9.52 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.482 -1.303 . . . . 71.14 107.482 -178.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.49 -56.92 9.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.652 0.982 . . . . 63.21 113.652 -174.336 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.06 -42.61 96.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.69 0.626 . . . . 63.24 112.69 -175.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' HG21 ' A' ' 31' ' ' ILE . . . -63.44 -40.27 96.7 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.801 0.334 . . . . 75.31 111.193 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -69.59 -41.57 75.58 Favored 'General case' 0 N--CA 1.393 -3.306 0 C-N-CA 124.275 1.03 . . . . 73.11 111.464 -178.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.54 -55.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.024 0.379 . . . . 73.14 112.024 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.52 -29.79 17.67 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.939 1.089 . . . . 75.24 113.939 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.95 -67.74 1.36 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.759 -0.734 . . . . 70.43 113.588 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.55 -79.44 1.2 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.711 -0.28 . . . . 71.45 112.87 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -81.3 91.72 6.27 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 65.13 109.027 -179.022 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.499 HG21 ' HA ' ' A' ' 24' ' ' ALA . 36.3 pt -108.41 19.42 5.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.32 -0.855 . . . . 73.52 110.728 -175.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.17 123.73 47.74 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 113.222 0.823 . . . . 71.2 113.222 -173.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.67 -12.63 22.26 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.261 1.974 . . . . 74.41 109.388 174.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -61.9 -20.84 64.19 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 113.43 -1.714 . . . . 60.24 110.884 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.51 -47.78 69.58 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 123.465 0.706 . . . . 73.22 109.111 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.36 -44.81 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.272 -0.876 . . . . 74.1 109.917 -178.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.87 -53.42 56.98 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 116.025 -0.534 . . . . 63.01 111.352 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.55 86.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.707 -0.679 . . . . 72.33 111.201 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.36 -41.76 84.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.85 -0.426 . . . . 73.15 109.85 -178.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.52 -43.4 80.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.581 0.586 . . . . 75.3 112.581 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -68.65 -29.55 68.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.788 -0.765 . . . . 73.13 110.78 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -70.06 -38.79 75.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.141 -0.689 . . . . 72.05 109.141 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.9 -38.15 90.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.962 -0.755 . . . . 74.32 108.962 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.42 92.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 74.21 110.421 176.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.91 -31.88 71.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 74.1 111.468 -178.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.37 -33.55 61.06 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.165 -0.47 . . . . 61.24 111.217 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.58 15.53 40.74 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.813 -0.631 . . . . 35.11 112.94 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 48' ' ' ILE . 12.2 mm -67.02 130.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 123.332 0.653 . . . . 72.24 112.132 179.09 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -116.02 147.41 41.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.353 -0.839 . . . . 74.22 109.622 176.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.6 m -77.55 102.92 7.19 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.163 0.982 . . . . 64.04 111.484 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.5 tp -105.2 -165.96 1.18 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.246 -2.131 . . . . 60.13 105.246 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.5 mt-30 -51.06 138.25 20.12 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.348 -0.982 . . . . 72.03 108.348 171.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.91 22.47 0.57 Allowed Glycine 0 N--CA 1.471 0.982 0 N-CA-C 114.782 0.673 . . . . 32.32 114.782 -171.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -104.27 -25.23 12.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.266 -1.013 . . . . 64.32 108.266 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -161.51 134.66 6.31 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.28 -0.873 . . . . 73.13 110.54 -177.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.0 151.88 19.28 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.783 -0.644 . . . . 75.44 110.61 -175.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.01 126.6 36.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.159 -1.052 . . . . 74.43 108.159 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.24 160.41 37.59 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 123.181 0.592 . . . . 53.54 109.805 -178.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.15 157.99 59.06 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.611 2.208 . . . . 74.51 111.921 176.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB3' HG21 ' A' ' 100' ' ' THR . 25.3 p-10 -126.38 -25.12 3.53 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.174 0.435 . . . . 63.34 112.174 -177.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.48 110.38 21.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.551 -0.537 . . . . 72.1 109.551 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 55.1 m-85 -116.88 119.16 34.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.434 -0.803 . . . . 62.54 110.076 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.2 118.99 56.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.669 -0.863 . . . . 73.01 108.669 177.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.1 mp -112.48 124.96 69.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.462 -0.94 . . . . 71.21 108.462 178.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -119.42 133.64 55.61 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.997 -0.742 . . . . 54.44 108.997 -178.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.58 173.36 7.23 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.209 0.604 . . . . 71.01 110.226 175.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.51 166.44 45.57 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 108.846 -1.701 . . . . 72.12 108.846 172.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 95.1 t -59.07 -59.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 117.666 0.733 . . . . 54.44 110.885 -178.599 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.499 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 40.8 t-80 -53.44 -49.17 67.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 65.51 110.809 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.552 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.8 m-20 -58.2 -50.38 73.75 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.62 1.168 . . . . 63.13 111.134 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.24 -40.08 93.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.354 -0.384 . . . . 71.02 111.24 -176.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 53.5 mt-10 -65.78 -31.27 72.15 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.856 0.36 . . . . 62.34 111.074 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.6 mptt -79.32 -27.51 42.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 73.31 111.266 178.007 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 61.3 mt -75.49 -33.25 60.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.802 . . . . 72.11 108.833 175.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.01 116.16 1.65 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.833 -1.707 . . . . 72.21 108.833 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -77.76 1.51 19.89 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.063 0.394 . . . . 61.32 112.063 -176.24 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 25.4 t70 -80.58 101.88 1.07 Allowed Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 124.215 1.006 . . . . 72.11 109.226 176.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 72.9 Cg_endo -75.92 -33.47 3.7 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.44 2.093 . . . . 72.32 115.871 -171.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.05 -49.11 71.38 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 112.776 0.658 . . . . 74.15 112.776 -170.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.96 -15.99 62.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.846 0.355 . . . . 74.45 111.864 -177.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 75.6 mmtt -81.68 -57.64 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.511 -0.922 . . . . 65.21 108.511 175.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -53.74 50.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.078 -0.965 . . . . 74.53 111.308 -173.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.9 m -69.95 -35.5 74.56 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.639 -0.255 . . . . 32.45 111.195 -177.266 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.09 -51.05 59.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.284 -0.484 . . . . 75.31 112.01 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 71.7 m-85 -72.65 -36.03 67.88 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 112.493 0.553 . . . . 73.52 112.493 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.49 96.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.666 -0.414 . . . . 62.41 110.739 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -63.83 -49.09 74.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.977 -0.556 . . . . 75.31 110.559 178.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -67.29 -37.31 83.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 64.2 111.552 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 tp -74.05 -34.93 64.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 63.0 111.005 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.11 89.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.814 -0.81 . . . . 63.23 108.814 175.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.36 -48.83 74.03 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.968 -1.014 . . . . 74.23 109.736 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.606 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.9 m-85 -52.08 -53.33 43.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.906 0.706 . . . . 71.43 112.906 176.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.4 pt -62.09 -36.53 74.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 120.594 -0.443 . . . . 73.3 111.494 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.56 -41.68 79.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.291 . . . . 64.53 110.861 177.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -59.27 -41.02 87.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.026 0.441 . . . . 61.43 111.194 177.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 78.6 mm-40 -72.99 -13.37 61.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.009 -0.542 . . . . 63.35 112.21 -178.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.13 36.07 13.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.37 -0.919 . . . . 63.1 111.06 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -113.21 170.91 7.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.194 -1.039 . . . . 73.02 108.194 175.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -151.62 178.19 9.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.691 -0.855 . . . . 72.23 108.691 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 60' ' ' ASN . 14.6 t -150.52 177.91 9.57 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.518 -0.549 . . . . 74.11 109.518 -179.314 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.7 m-85 -111.66 121.04 44.05 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.202 -1.036 . . . . 74.21 108.202 178.052 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.96 -149.68 17.05 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.222 -1.151 . . . . 64.13 110.222 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.481 ' H ' ' HB ' ' A' ' 129' ' ' VAL . 32.2 t70 -121.78 147.19 46.26 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.166 -0.679 . . . . 62.51 109.166 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.9 125.16 39.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.118 0.485 . . . . 73.24 110.844 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.04 120.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 121.789 0.804 . . . . 74.33 109.984 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.3 t -117.78 112.43 38.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.212 -1.403 . . . . 74.44 107.212 179.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -115.97 138.87 50.8 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 111.934 0.346 . . . . 75.03 111.934 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -119.18 134.9 54.94 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.269 -1.011 . . . . 60.31 108.269 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -156.17 164.16 38.72 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 123.563 0.539 . . . . 64.41 111.232 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -95.46 164.91 12.61 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.106 -0.497 . . . . 50.1 111.241 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 p -150.36 150.21 31.12 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 115.444 -0.798 . . . . 71.42 109.647 177.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -80.78 -22.83 39.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.607 -0.516 . . . . 73.11 109.607 176.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.93 -28.1 68.67 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.469 0.707 . . . . 71.51 110.756 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 120' ' ' ARG . 77.3 mt -96.5 135.92 37.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.917 -0.583 . . . . 72.41 110.716 -178.66 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -110.66 172.06 7.1 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.638 -1.616 . . . . 74.5 106.638 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 97.4 m -58.91 126.29 27.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.966 1.469 . . . . 62.53 114.966 -174.129 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.64 -8.79 47.57 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 114.18 -1.373 . . . . 64.12 111.443 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -104.53 135.68 45.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.75 0.309 . . . . 64.11 110.865 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.01 151.04 37.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.24 -1.022 . . . . 74.11 108.24 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 114' ' ' LEU . 53.8 mtm180 -124.67 143.21 50.86 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.855 -1.165 . . . . 75.21 107.855 177.35 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.85 118.3 10.3 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.292 -1.744 . . . . 71.23 106.292 173.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 23.1 tpt180 -120.3 121.67 39.17 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 120.05 -0.66 . . . . 74.13 110.058 -177.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.09 119.25 6.43 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.607 -1.397 . . . . 42.42 109.607 176.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.3 p -126.06 156.62 39.68 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 110.081 -0.34 . . . . 73.14 110.081 -178.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.52 110.74 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 107.199 -1.408 . . . . 62.22 107.199 175.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -117.4 96.29 49.02 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.408 -0.96 . . . . 74.51 108.408 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 9.9 Cg_exo -69.28 -23.75 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.333 2.022 . . . . 71.34 111.848 -177.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.37 69.95 4.31 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.404 1.097 . . . . 72.43 111.223 -176.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 103' ' ' ASP . 44.0 t -123.85 97.81 4.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.469 -2.048 . . . . 73.14 105.469 171.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.08 98.9 10.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.816 -0.629 . . . . 63.14 111.161 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 t -103.77 123.65 47.45 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 107.621 -1.252 . . . . 61.44 107.621 177.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--N 1.311 -1.084 0 N-CA-C 108.53 -0.915 . . . . 74.13 108.53 -176.345 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 108.707 -0.849 . . . . 71.13 108.707 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.95 89.19 0.51 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.004 -1.238 . . . . 62.35 110.004 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -150.85 119.35 6.46 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.91 -0.774 . . . . 74.12 108.91 -176.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -169.6 131.19 1.1 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.34 -0.615 . . . . 71.0 109.34 177.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 162.53 35.25 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.778 -0.823 . . . . 53.42 108.778 178.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -148.24 79.19 1.45 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.905 0.859 . . . . 74.31 110.308 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -114.62 96.14 5.6 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 104.756 -2.312 . . . . 74.42 104.756 175.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.0 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.622 -0.717 . . . . 75.3 109.797 -175.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -80.31 105.05 11.27 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.501 -1.666 . . . . 72.25 106.501 174.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -75.87 81.49 2.78 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.031 0.919 . . . . 71.45 111.687 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.2 126.35 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 113.851 -1.522 . . . . 71.2 107.86 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -65.86 136.0 55.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.47 -0.786 . . . . 74.44 110.934 -178.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.24 143.8 40.76 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.272 -1.01 . . . . 73.22 108.272 178.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -80.6 87.76 5.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.497 -1.297 . . . . 75.44 107.497 175.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.43 140.77 58.07 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.168 -1.378 . . . . 62.51 109.758 -177.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -98.42 136.61 38.32 Favored 'General case' 0 N--CA 1.402 -2.842 0 C-N-CA 119.408 -0.917 . . . . 75.31 110.298 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -83.92 86.99 7.1 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.981 -1.859 . . . . 71.03 105.981 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -72.3 92.14 1.38 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.051 -0.977 . . . . 74.42 112.514 -174.04 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -73.8 128.38 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 CA-C-N 114.866 -1.061 . . . . 60.24 108.906 178.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.91 -4.48 61.14 Favored Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.62 -0.8 . . . . 73.11 111.654 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.56 86.18 6.4 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.682 0.754 . . . . 74.02 110.3 177.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.52 -59.13 4.67 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.013 -1.449 . . . . 72.13 110.838 -176.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -51.78 -49.71 62.16 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.426 0.691 . . . . 75.23 112.12 -176.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.21 -43.11 87.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.105 -0.498 . . . . 71.31 111.027 178.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -81.77 -19.47 41.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.496 1.295 . . . . 72.14 114.496 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 73' ' ' LYS . 1.4 mp -64.87 -41.74 92.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.89 -0.781 . . . . 62.4 108.89 171.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.523 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 50.9 m-85 -84.62 -17.16 39.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.842 -0.617 . . . . 74.41 110.439 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -65.37 4.08 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.596 -0.602 . . . . 52.43 111.596 178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 25.79 2.61 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.143 0.417 . . . . 72.44 114.143 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.1 p 51.78 75.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.161 1.385 . . . . 74.33 113.876 178.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.523 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 68.6 mt -94.9 100.7 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 107.323 -1.362 . . . . 75.41 107.323 175.629 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 40.1 t -80.79 132.25 58.13 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.416 -0.957 . . . . 65.5 108.416 -177.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 36.6 Cg_exo -65.65 29.21 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.916 3.077 . . . . 71.35 114.731 -178.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.46 -21.11 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.719 -0.613 . . . . 72.01 111.491 -177.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.56 -34.48 74.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.011 -0.366 . . . . 74.14 110.011 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 59.3 t -56.22 -50.5 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 74.45 110.111 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.82 -43.31 98.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.105 -0.498 . . . . 74.35 110.547 -178.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.14 89.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.666 -0.697 . . . . 54.22 110.822 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.6 -23.92 58.8 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.832 0.679 . . . . 70.5 112.832 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.6 mt -67.26 -37.43 83.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 65.14 110.294 175.518 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -65.26 -42.0 93.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.643 0.735 . . . . 73.04 109.242 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' ARG . 29.8 mmt180 -71.7 -28.68 63.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.415 -0.811 . . . . 75.21 111.316 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 29.9 tp10 -68.92 -44.67 72.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.192 -0.67 . . . . 71.35 109.192 176.09 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -59.99 -41.58 92.33 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.642 -0.708 . . . . 34.35 109.728 176.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.62 -36.49 80.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.545 -0.752 . . . . 22.12 111.147 177.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.96 -39.49 83.36 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 63.42 111.247 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.92 5.96 80.64 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.747 -0.661 . . . . 62.12 113.697 -178.04 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ALA . 10.8 mm -58.91 130.38 22.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.589 0.709 . . . . 73.31 112.112 178.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -116.19 134.71 54.62 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.356 -0.838 . . . . 70.22 110.056 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -72.52 106.59 4.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.804 -1.089 . . . . 72.14 109.694 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.9 tp -109.16 -164.69 0.96 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.796 -1.557 . . . . 61.5 106.796 -177.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.639 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 16.1 mm100 -51.52 162.49 0.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.651 0.781 . . . . 70.31 112.307 176.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -7.48 38.21 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-N 114.946 -1.024 . . . . 74.53 113.7 -175.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -68.38 -48.63 64.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 64.32 108.797 177.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -176.27 167.77 2.84 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.774 1.027 . . . . 73.44 113.774 -177.42 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.11 151.26 21.06 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.486 -1.234 . . . . 71.12 111.153 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.95 126.28 43.28 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.664 -1.236 . . . . 74.24 107.664 -177.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.82 158.06 35.13 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 123.548 0.739 . . . . 54.22 109.648 -178.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.9 Cg_exo -61.84 158.27 38.91 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.893 2.396 . . . . 50.44 113.087 178.206 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -124.81 -30.16 3.31 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.631 -0.713 . . . . 73.55 110.448 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.67 107.96 19.62 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.048 0.939 . . . . 64.5 108.596 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -116.22 118.12 31.91 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.885 0.374 . . . . 71.1 110.353 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.52 114.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.114 -0.698 . . . . 65.04 109.114 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 2.3 mp -109.27 132.39 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.678 -1.23 . . . . 72.4 107.678 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.2 m -137.39 135.88 37.36 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.951 -0.389 . . . . 72.33 109.951 -177.552 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -130.17 -179.38 5.2 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.303 -0.629 . . . . 74.22 109.303 175.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -69.77 156.03 53.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.86 -1.296 . . . . 71.4 109.86 175.659 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLN . 43.4 t -56.25 -56.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 117.443 0.621 . . . . 45.22 111.83 -175.23 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.606 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 50.4 t-80 -59.12 -45.14 91.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.462 0.476 . . . . 74.01 110.555 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.85 -43.19 99.46 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 70.33 109.753 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.27 -39.44 82.18 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.382 -0.826 . . . . 73.43 111.12 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 36.5 mt-10 -65.25 -28.58 69.45 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.648 0.261 . . . . 63.33 111.607 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 0.4 OUTLIER -78.57 -23.33 46.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 120.017 -0.673 . . . . 73.24 109.686 178.686 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.22 -36.79 74.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 72.11 109.916 174.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.21 158.32 8.59 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.821 -0.912 . . . . 51.3 110.821 177.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.8 -6.92 57.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 111.872 0.323 . . . . 61.42 111.872 -177.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.72 103.31 46.32 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.691 -0.231 . . . . 74.24 111.594 -179.05 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.43 -36.55 8.83 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.62 1.547 . . . . 61.22 109.86 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.52 -29.19 66.75 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.148 0.796 . . . . 73.32 113.148 -176.441 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.84 -42.94 94.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.77 -1.567 . . . . 61.32 106.77 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.69 -38.79 77.12 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.476 -1.238 . . . . 75.42 109.456 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 106' ' ' VAL . 65.2 m -58.22 -48.36 80.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.353 -0.385 . . . . 54.42 111.02 177.359 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -57.8 -49.01 78.04 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 123.391 0.432 . . . . 70.15 110.69 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.18 -55.73 19.82 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.719 -0.673 . . . . 74.51 112.904 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -67.41 -37.12 82.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.741 1.015 . . . . 73.04 113.741 -175.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -66.6 -45.02 80.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.527 . . . . 75.32 110.697 -179.314 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.36 -40.01 89.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 71.54 110.3 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.52 -53.32 53.74 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.166 -0.925 . . . . 74.33 111.064 178.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.11 -30.34 70.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 75.42 111.334 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.8 78.55 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.178 0.513 . . . . 63.34 110.033 176.516 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.69 -39.7 73.34 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.599 -0.889 . . . . 64.24 108.599 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 22.0 m-85 -56.83 -52.18 66.08 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.532 -0.758 . . . . 63.21 112.494 175.346 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.1 pt -61.63 -37.27 77.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.357 -0.537 . . . . 73.41 111.093 -177.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.32 -38.18 84.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.326 -0.397 . . . . 72.11 110.567 176.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -60.46 -44.0 96.32 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 63.25 111.051 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.5 mm-40 -75.91 -13.7 60.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.455 -0.793 . . . . 65.43 110.837 -178.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.89 35.68 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.928 -0.578 . . . . 75.4 112.442 177.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.75 172.56 7.18 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.891 -0.781 . . . . 73.02 108.891 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.35 173.45 11.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.524 -0.547 . . . . 61.45 109.524 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 t -157.53 177.84 10.96 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.331 -1.729 . . . . 63.21 106.331 177.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.07 117.48 34.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.686 -1.227 . . . . 75.34 107.686 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.82 -149.64 16.75 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.282 -1.927 . . . . 71.42 108.282 -177.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.68 169.61 15.93 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.387 -1.338 . . . . 74.21 107.387 171.46 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.01 120.88 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.825 0.345 . . . . 65.3 111.287 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -115.5 120.0 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.695 -0.854 . . . . 31.14 108.695 176.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 86' ' ' ALA . 13.9 p -119.69 129.02 75.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.516 0.674 . . . . 74.22 110.435 -176.323 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -115.8 138.07 51.49 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.339 -0.846 . . . . 72.13 109.983 -178.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -121.41 132.69 54.89 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.189 -1.412 . . . . 64.11 107.189 179.003 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.94 174.79 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.266 0.555 . . . . 65.25 111.02 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . 17.0 pm0 -110.18 151.94 26.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.063 -0.971 . . . . 73.14 110.612 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.404 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 37.8 t -141.42 132.28 25.91 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 107.24 -1.392 . . . . 71.34 107.24 176.063 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -81.6 -22.7 37.53 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.928 -0.767 . . . . 63.11 108.928 176.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -73.0 -30.21 63.61 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.598 0.714 . . . . 75.21 109.318 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -81.13 141.7 34.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.156 -1.053 . . . . 75.15 108.156 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.68 144.22 28.7 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.894 -0.594 . . . . 61.04 112.037 -171.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.9 m -64.84 124.54 22.25 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.85 -0.614 . . . . 63.3 109.567 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.27 -22.89 24.08 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.26 -1.136 . . . . 55.33 110.26 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -95.04 152.37 18.38 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.254 -1.017 . . . . 74.14 108.254 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 31.5 p90 -148.37 146.84 28.68 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.017 -1.475 . . . . 62.24 107.017 174.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 64.9 mtp180 -126.6 144.64 50.83 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.771 -0.455 . . . . 70.35 109.771 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.71 122.95 19.32 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.298 -1.371 . . . . 74.02 107.298 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.493 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 26.1 tpt180 -131.39 130.0 42.04 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.946 -0.702 . . . . 74.11 111.178 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -102.27 126.43 8.87 Favored Glycine 0 N--CA 1.425 -2.077 0 O-C-N 124.072 0.857 . . . . 72.11 111.059 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.1 m -122.82 146.57 47.43 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.662 -0.866 . . . . 72.23 108.662 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.1 t -95.66 105.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.184 -1.413 . . . . 74.33 107.184 174.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.48 100.14 51.15 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 120.871 -0.332 . . . . 63.55 110.206 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.21 -3.71 4.49 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 121.994 1.796 . . . . 72.51 110.901 175.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -92.59 29.14 1.81 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 64.13 109.708 -175.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.4 123.81 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 CA-C-O 121.702 0.763 . . . . 61.51 110.621 -178.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -96.81 147.02 24.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.626 -1.99 . . . . 74.05 105.626 168.448 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 m -30.41 115.51 0.13 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.112 1.765 . . . . 75.32 114.446 -174.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 107.188 -1.412 . . . . 74.41 107.188 177.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' CD ' ' A' ' 37' ' ' GLU . 95.1 mt-30 . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 113.572 0.953 . . . . 73.349999999999994 113.572 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -71.33 -23.93 62.02 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.244 -1.021 . . . . 71.510000000000005 108.244 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 119' ' ' PHE . 98.4 t -69.12 -54.72 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.352 -0.84 . . . . 54.130000000000003 108.844 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 34' ' ' GLN . 2.7 mp0 -52.64 -43.9 65.75 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.053 0.454 . . . . 71.040000000000006 110.769 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.72 -54.53 43.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.087 -0.96 . . . . 74.329999999999998 111.399 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.5 tp -74.53 -25.18 59.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.782 -0.367 . . . . 51.020000000000003 110.857 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.17 -47.83 72.69 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.688 0.795 . . . . 73.340000000000003 109.966 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -71.09 -27.95 63.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.152 0.501 . . . . 62.43 110.182 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.16 -42.38 84.43 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.49 -0.777 . . . . 74.329999999999998 109.035 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.18 -32.6 70.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 72.549999999999997 109.434 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.36 95.67 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.923 -0.581 . . . . 74.010000000000005 109.739 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -65.31 -35.17 80.19 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.613 0.721 . . . . 54.140000000000001 110.441 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -16.56 60.5 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.339 -0.846 . . . . 74.120000000000005 110.808 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.06 7.9 41.52 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 116.156 -0.475 . . . . 63.32 112.666 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 45' ' ' ALA . 29.2 mm -65.97 127.51 27.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 120.984 0.421 . . . . 74.230000000000004 110.835 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 10.3 tt0 -105.7 124.43 49.55 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.192 -1.04 . . . . 74.019999999999996 108.192 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -60.9 109.27 1.02 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 124.124 0.89 . . . . 31.199999999999999 109.961 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.6 tp -122.56 -164.78 1.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.138 -1.801 . . . . 75.340000000000003 106.138 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.7 mt-30 -46.35 146.17 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.523 0.729 . . . . 73.329999999999998 110.81 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.65 -11.9 38.13 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 114.519 0.568 . . . . 52.409999999999997 114.519 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.34 -47.64 40.74 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.791 0.329 . . . . 73.030000000000001 110.544 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.592 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 24.1 ptt180 -158.88 142.92 15.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.581 0.705 . . . . 75.310000000000002 112.443 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.5 mt -91.26 151.63 20.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 125.223 1.409 . . . . 64.439999999999998 109.933 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 100' ' ' THR . 1.1 tt -90.41 118.28 29.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.045 -1.094 . . . . 73.439999999999998 108.045 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.37 153.78 39.53 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.716 -0.675 . . . . 74.0 109.714 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 44.8 Cg_exo -60.2 150.07 81.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 112.014 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.82 -36.16 4.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.876 -0.602 . . . . 71.340000000000003 110.959 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -104.24 122.92 46.39 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 109.853 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.1 m-85 -118.55 118.53 31.96 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.228 -0.897 . . . . 74.439999999999998 109.53 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.6 109.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.477 -1.305 . . . . 55.340000000000003 107.477 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -105.65 107.1 21.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.191 -1.04 . . . . 73.530000000000001 108.191 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 53.2 m -111.08 123.69 50.7 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.43 -0.805 . . . . 62.119999999999997 110.558 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -116.13 175.62 5.47 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.868 -0.606 . . . . 74.140000000000001 109.952 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -71.97 153.84 50.32 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 109.104 -1.598 . . . . 54.539999999999999 109.104 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.67 -42.17 80.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 110.346 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 5.0 t60 -66.89 -29.9 69.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.272 -0.876 . . . . 71.420000000000002 110.532 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 m-20 -76.27 -46.16 29.28 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.634 -0.506 . . . . 73.430000000000007 109.634 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.4 -42.53 99.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.559 -0.746 . . . . 74.239999999999995 111.877 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 73' ' ' LYS . 10.1 pt-20 -62.82 -34.33 77.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.929 0.395 . . . . 72.010000000000005 111.581 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 13.8 mptt -75.47 -27.07 58.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.163 -0.471 . . . . 72.040000000000006 111.201 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 66' ' ' LEU . 73.5 mt -72.22 -40.3 67.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.517 -0.92 . . . . 74.140000000000001 108.517 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 146.62 6.16 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 109.771 -1.332 . . . . 62.109999999999999 109.771 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.57 -18.9 62.9 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 114.401 1.26 . . . . 64.25 114.401 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.39 124.04 76.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 119.595 -0.842 . . . . 72.129999999999995 110.472 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -77.39 -35.81 1.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.658 1.572 . . . . 72.420000000000002 110.88 167.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.86 -53.29 33.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.432 2.012 . . . . 65.310000000000002 116.432 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.38 -32.25 66.26 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.492 0.663 . . . . 72.420000000000002 110.389 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.14 -39.16 65.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.909 -1.041 . . . . 71.430000000000007 108.955 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.7 t -62.17 -44.13 97.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.301 -0.863 . . . . 63.039999999999999 109.883 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -59.13 -45.92 89.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.245 -0.434 . . . . 52.130000000000003 110.459 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.93 -48.93 51.6 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.844 -0.616 . . . . 75.219999999999999 112.855 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.25 -39.97 78.14 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.233 0.827 . . . . 74.219999999999999 113.233 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.7 95.23 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 121.085 -0.246 . . . . 75.329999999999998 110.625 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -37.56 87.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 72.040000000000006 110.612 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.77 -44.69 69.64 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.253 -0.431 . . . . 71.439999999999998 110.523 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.07 -37.96 84.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.127 -0.488 . . . . 71.099999999999994 109.844 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.7 71.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.367 0.603 . . . . 61.219999999999999 110.485 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 8.2 t70 -68.29 -43.61 77.33 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.148 -1.056 . . . . 72.329999999999998 108.148 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.0 m-85 -57.42 -47.68 81.11 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.323 -0.853 . . . . 74.420000000000002 112.821 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -62.47 -35.42 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.737 -0.785 . . . . 44.439999999999998 111.086 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.76 -45.96 87.46 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.414 -0.587 . . . . 74.409999999999997 109.414 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 32.2 mm-40 -60.44 -31.62 70.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.728 0.811 . . . . 61.350000000000001 113.078 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.2 mm-40 -90.99 -10.95 40.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.319 -0.401 . . . . 65.040000000000006 111.395 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 38.15 35.67 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.702 -0.761 . . . . 65.200000000000003 111.424 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -104.49 158.8 16.23 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.741 -0.466 . . . . 73.150000000000006 109.741 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.592 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -126.9 167.54 15.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.573 -0.528 . . . . 64.030000000000001 109.573 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.5 t -158.35 179.27 9.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.958 -0.756 . . . . 52.399999999999999 108.958 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -130.81 128.73 41.29 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.588 -0.523 . . . . 70.310000000000002 109.588 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 -149.98 16.9 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 108.313 -1.915 . . . . 15.300000000000001 108.313 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -124.84 141.29 52.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.925 -1.139 . . . . 63.130000000000003 107.925 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.75 112.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 123.53 0.518 . . . . 71.409999999999997 110.02 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.74 125.61 67.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.852 0.834 . . . . 70.439999999999998 111.288 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.2 m -105.02 129.82 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 N-CA-C 108.513 -0.921 . . . . 73.109999999999999 108.513 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -106.0 127.17 52.98 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.939 -0.573 . . . . 74.120000000000005 109.922 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.61 115.43 29.87 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 75.219999999999999 107.877 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.2 pt-20 -145.54 164.02 32.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.992 -0.549 . . . . 62.200000000000003 110.218 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -120.11 154.06 35.24 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.236 0.541 . . . . 74.030000000000001 111.124 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.6 m -137.81 143.47 41.04 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.597 -0.89 . . . . 55.119999999999997 108.597 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -72.5 -20.08 61.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.474 0.654 . . . . 73.310000000000002 111.129 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.01 -11.33 59.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.6 -0.727 . . . . 75.450000000000003 111.025 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 67' ' ' GLY . 0.7 OUTLIER -101.39 133.9 45.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 105.808 -1.923 . . . . 74.109999999999999 105.808 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -93.27 170.3 9.73 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 112.88 0.696 . . . . 64.239999999999995 112.88 -173.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -72.59 127.73 33.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.319 -0.855 . . . . 72.329999999999998 111.18 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.02 28.94 24.37 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 110.278 -1.129 . . . . 52.229999999999997 110.278 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -140.64 151.44 44.61 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.144 -1.058 . . . . 64.439999999999998 108.144 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 p90 -152.77 150.91 29.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.478 -1.304 . . . . 74.239999999999995 107.478 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -141.96 130.3 22.35 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.694 -0.484 . . . . 53.119999999999997 109.694 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.87 121.76 38.78 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.246 -1.39 . . . . 75.430000000000007 107.246 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.419 ' HD3' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -121.59 118.33 28.97 Favored 'General case' 0 N--CA 1.398 -3.068 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 109.196 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 122' ' ' ARG . . . -111.54 138.12 14.75 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 110.312 -1.115 . . . . 75.319999999999993 110.312 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 t -144.85 163.84 32.88 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.369 -0.974 . . . . 74.120000000000005 108.369 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.57 103.77 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 106.943 -1.503 . . . . 44.539999999999999 106.943 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -118.85 106.41 43.84 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.901 -0.591 . . . . 60.329999999999998 110.065 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo . . . . . 0 N--CA 1.451 -0.996 0 C-N-CA 122.053 1.835 . . . . 61.229999999999997 110.949 177.096 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 113.464 0.913 . . . . 75.120000000000005 113.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.84 -28.87 60.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.225 0.536 . . . . 71.209999999999994 110.296 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 t -71.99 -42.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.646 -0.872 . . . . 71.450000000000003 108.646 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 45.2 mt-10 -58.31 -44.27 88.53 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.97 -0.559 . . . . 75.349999999999994 109.856 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -49.84 72.53 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 124.043 0.839 . . . . 55.229999999999997 111.163 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.16 -37.62 75.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.49 0.552 . . . . 55.009999999999998 112.49 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 64' ' ' ILE . 54.7 mt -64.99 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.39 0.515 . . . . 74.120000000000005 112.39 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 26.3 ptt180 -71.08 -28.01 64.03 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.104 -0.638 . . . . 72.420000000000002 109.808 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -68.9 -40.87 78.92 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 108.526 -0.916 . . . . 73.540000000000006 108.526 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.48 -40.69 92.2 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.91 0.484 . . . . 35.539999999999999 110.248 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.331 -0.85 . . . . 72.519999999999996 110.777 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.11 76.25 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.41 0.624 . . . . 74.299999999999997 111.112 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -71.57 -44.96 63.57 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.508 -0.769 . . . . 72.329999999999998 110.746 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.57 21.69 20.79 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 115.604 -0.726 . . . . 50.329999999999998 113.523 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 48' ' ' ILE . 11.8 mm -61.97 125.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.255 0.55 . . . . 72.310000000000002 110.346 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -121.17 137.1 54.83 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.986 -1.007 . . . . 74.510000000000005 110.841 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -63.24 118.0 7.37 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.39 -1.277 . . . . 74.230000000000004 112.427 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.5 tp -139.03 -165.88 1.92 Allowed 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.318 -2.475 . . . . 71.329999999999998 104.318 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.564 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.45 140.35 7.98 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.186 0.594 . . . . 72.319999999999993 111.287 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.14 -15.87 57.01 Favored Glycine 0 CA--C 1.505 -0.59 0 CA-C-N 115.896 -0.593 . . . . 74.129999999999995 114.408 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.63 -35.56 67.82 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 111.815 0.302 . . . . 55.130000000000003 111.815 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 4.4 ptm180 -162.28 131.34 4.31 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.647 0.737 . . . . 65.310000000000002 111.083 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.53 152.33 20.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.369 1.467 . . . . 73.329999999999998 110.719 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 100' ' ' THR . 55.7 tp -78.08 126.01 30.19 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.54 -0.754 . . . . 63.100000000000001 109.909 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 158.57 43.28 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 108.316 -0.994 . . . . 73.340000000000003 108.316 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.592 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.5 Cg_exo -60.66 156.7 41.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.135 2.557 . . . . 71.420000000000002 113.674 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.66 -27.32 3.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.636 -0.711 . . . . 52.420000000000002 110.118 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.41 109.06 21.2 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.804 -0.813 . . . . 71.099999999999994 108.804 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 94.6 m-85 -115.66 115.45 26.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.595 -0.73 . . . . 75.120000000000005 110.656 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.74 119.51 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.191 -1.04 . . . . 71.530000000000001 108.191 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.462 HD11 HD21 ' A' ' 40' ' ' LEU . 15.2 mm -109.48 115.52 49.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.733 -1.21 . . . . 62.520000000000003 107.733 176.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 m -108.8 129.17 55.38 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.947 -0.57 . . . . 60.329999999999998 110.174 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.1 mm? -124.56 172.72 9.0 Favored 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.939 0.896 . . . . 60.25 109.587 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.33 179.39 53.2 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.057 -0.817 . . . . 41.43 111.057 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.45 -41.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.828 0.677 . . . . 61.439999999999998 112.828 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 75.4 t60 -73.04 -28.84 62.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.99 0.9 . . . . 73.219999999999999 109.413 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.579 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.5 m-20 -69.21 -44.16 72.67 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.999 -1.001 . . . . 74.230000000000004 108.602 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.89 -30.39 66.74 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.386 -0.825 . . . . 61.310000000000002 111.749 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 13.0 pt-20 -68.55 -29.94 68.61 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.95 -0.7 . . . . 74.530000000000001 110.35 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 14.5 mmmm -68.61 -31.51 70.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.039 -0.982 . . . . 74.209999999999994 109.796 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.74 -30.25 59.15 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.613 0.72 . . . . 61.439999999999998 109.107 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.7 -163.67 15.41 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.158 -0.928 . . . . 65.25 111.388 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.9 2.33 51.83 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.63 0.729 . . . . 51.299999999999997 109.5 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -111.76 97.87 39.14 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 113.542 0.941 . . . . 72.230000000000004 113.542 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -78.12 -46.85 0.12 Allowed 'Trans proline' 0 N--CA 1.438 -1.74 0 N-CA-C 109.286 -1.082 . . . . 70.209999999999994 109.286 162.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -43.97 -54.3 5.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.558 2.743 . . . . 71.430000000000007 116.994 -167.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.14 -51.37 39.05 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.387 -0.525 . . . . 74.099999999999994 110.216 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -75.42 -27.06 58.85 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.946 1.091 . . . . 64.129999999999995 113.946 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 66.4 p -71.23 -36.25 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.232 -0.587 . . . . 62.329999999999998 110.544 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -73.76 -37.42 65.04 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.09 -0.505 . . . . 74.150000000000006 109.796 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 87' ' ' ARG . . . -66.08 -41.9 94.82 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.832 -0.907 . . . . 73.129999999999995 110.832 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -69.97 -25.14 63.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.194 0.521 . . . . 73.510000000000005 109.832 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.27 78.1 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 75.25 110.251 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 34.6 ttp180 -61.79 -45.57 93.28 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.943 -0.762 . . . . 75.340000000000003 108.943 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 -49.56 76.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.066 -0.97 . . . . 74.239999999999995 110.555 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 40' ' ' LEU . 46.4 tp -64.62 -35.35 80.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.568 . . . . 71.340000000000003 111.948 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.9 -36.35 83.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.381 0.61 . . . . 70.219999999999999 109.941 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.66 -39.81 84.51 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.558 -0.746 . . . . 73.299999999999997 109.203 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 21.2 m-85 -57.18 -50.56 72.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.548 -0.751 . . . . 72.400000000000006 112.46 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 pt -65.34 -35.14 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.069 -0.652 . . . . 73.209999999999994 111.284 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -67.46 -37.82 83.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.831 0.348 . . . . 55.439999999999998 111.116 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.03 -34.77 76.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.217 -0.447 . . . . 64.329999999999998 112.079 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 66.1 mm-40 -81.78 -13.63 57.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.989 -0.55 . . . . 73.019999999999996 110.986 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 31.12 18.82 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.693 -0.685 . . . . 70.120000000000005 112.254 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -104.74 177.21 4.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.859 -0.423 . . . . 74.530000000000001 109.859 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.536 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.7 pt20 -147.8 176.58 10.01 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.735 -0.469 . . . . 72.299999999999997 109.735 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.463 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.8 t -156.29 179.11 9.56 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.911 -1.515 . . . . 71.329999999999998 106.911 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.06 122.22 36.58 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 118.15 0.432 . . . . 74.239999999999995 110.567 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.4 17.15 Favored Glycine 0 N--CA 1.416 -2.656 0 N-CA-C 110.131 -1.187 . . . . 75.0 110.131 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -112.52 149.38 32.76 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.825 -1.176 . . . . 72.329999999999998 107.825 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 90' ' ' ALA . 8.0 p -89.39 134.45 28.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.651 -0.5 . . . . 73.099999999999994 109.651 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.28 120.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.754 0.787 . . . . 51.149999999999999 111.173 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' SER . 98.6 t -105.58 132.35 52.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.375 -1.713 . . . . 64.120000000000005 106.375 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.71 130.96 54.29 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 110.143 -0.317 . . . . 74.5 110.143 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -100.37 114.39 27.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.981 -1.859 . . . . 75.209999999999994 105.981 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -142.93 166.95 23.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.03 164.61 11.62 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.407 1.098 . . . . 65.219999999999999 113.025 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.4 m -151.04 116.17 5.31 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.141 -1.845 . . . . 70.340000000000003 106.885 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.4 m -59.35 -21.84 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.692 0.797 . . . . 54.140000000000001 112.43 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.62 -16.11 54.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 110.681 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.2 tp -97.52 140.96 31.17 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.029 -1.471 . . . . 65.430000000000007 107.029 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -121.69 163.14 19.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.298 -0.961 . . . . 71.150000000000006 111.172 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.579 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 44.9 m -45.78 124.32 5.11 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.645 1.978 . . . . 61.530000000000001 115.26 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.1 -27.55 16.92 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.583 -1.189 . . . . 62.020000000000003 110.506 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.13 136.74 35.09 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.317 -0.994 . . . . 63.130000000000003 108.317 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -147.78 160.67 42.49 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.733 -1.58 . . . . 74.400000000000006 106.733 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -141.29 150.3 42.37 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.821 0.344 . . . . 65.310000000000002 110.979 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.461 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.51 125.77 50.59 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.098 -1.445 . . . . 61.350000000000001 107.098 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.623 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -123.28 115.24 21.37 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 110.138 -0.319 . . . . 73.209999999999994 110.138 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.09 124.34 7.63 Favored Glycine 0 C--N 1.289 -2.078 0 N-CA-C 111.855 -0.498 . . . . 64.209999999999994 111.855 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -140.64 160.19 40.56 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 122.623 0.369 . . . . 54.149999999999999 111.028 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 59' ' ' PRO . 61.8 t -105.95 127.85 60.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.783 0.325 . . . . 62.539999999999999 110.164 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -135.48 101.85 10.81 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 108.189 -1.041 . . . . 74.230000000000004 108.189 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 C-N-CA 122.218 1.945 . . . . 71.409999999999997 111.644 179.383 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 CA--C 1.554 1.12 0 CA-C-O 121.026 0.441 . . . . 63.32 111.625 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.85 -36.93 82.65 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.1 -1.074 . . . . 74.400000000000006 108.1 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -70.22 -44.7 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.11 -0.95 . . . . 75.329999999999998 109.287 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.57 -43.12 75.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.962 0.505 . . . . 72.439999999999998 110.614 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.82 87.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.941 -1.027 . . . . 70.530000000000001 111.0 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.92 -37.52 81.78 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.861 0.689 . . . . 74.219999999999999 112.861 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.19 -46.49 90.24 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.987 -0.285 . . . . 73.329999999999998 111.579 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -73.4 -28.87 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.627 -0.429 . . . . 61.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -66.7 -45.86 77.41 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.373 -0.376 . . . . 64.140000000000001 110.706 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.12 -35.3 80.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.749 0.309 . . . . 73.519999999999996 110.332 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.14 77.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 54.329999999999998 110.537 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.99 71.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.647 -0.706 . . . . 73.019999999999996 110.904 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.59 -44.72 73.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.716 -0.674 . . . . 62.009999999999998 110.987 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.84 15.36 37.71 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.99 -0.55 . . . . 52.149999999999999 114.222 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 48' ' ' ILE . 11.4 mm -62.35 123.23 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.388 0.614 . . . . 74.540000000000006 111.504 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 48.5 mt-30 -116.4 145.24 43.39 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 115.092 -0.958 . . . . 62.450000000000003 110.704 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -65.46 125.0 23.79 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 75.109999999999999 110.749 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' OE1' ' A' ' 52' ' ' GLN . 13.9 tp -144.82 -164.34 1.9 Allowed 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 103.65 -2.722 . . . . 71.040000000000006 103.65 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' OE1' ' HG ' ' A' ' 51' ' ' LEU . 27.2 mp0 -44.64 148.21 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.065 0.848 . . . . 71.420000000000002 111.737 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.68 -20.37 66.05 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.615 -0.326 . . . . 74.310000000000002 112.828 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 -9.37 41.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.079 0.4 . . . . 54.399999999999999 112.079 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.7 ptp180 -157.6 125.3 5.3 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 121.614 0.721 . . . . 72.409999999999997 112.062 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.22 151.54 19.41 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.769 -0.65 . . . . 53.420000000000002 110.063 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 tm? -86.77 127.96 35.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 61.119999999999997 107.18 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.68 158.78 44.54 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 123.448 0.468 . . . . 71.109999999999999 110.479 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HA ' HG22 ' A' ' 125' ' ' VAL . 25.9 Cg_exo -65.68 162.76 33.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.936 2.424 . . . . 72.420000000000002 111.912 175.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.07 -26.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.959 -0.564 . . . . 74.340000000000003 111.692 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -100.88 107.2 18.66 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.82 -0.808 . . . . 73.530000000000001 108.82 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 87.3 m-85 -110.37 114.8 28.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.502 -0.772 . . . . 74.349999999999994 110.507 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.69 111.33 34.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.844 -1.169 . . . . 74.200000000000003 107.844 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.29 121.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.193 -1.04 . . . . 53.140000000000001 108.193 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -113.5 124.8 53.25 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.656 -0.418 . . . . 64.430000000000007 110.307 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -108.2 162.83 13.71 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 62.049999999999997 108.905 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.51 150.17 51.72 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 109.625 -1.39 . . . . 23.539999999999999 109.625 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.32 -38.47 69.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 117.575 0.687 . . . . 70.319999999999993 111.741 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 39.0 t60 -73.44 -25.03 60.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.59 -0.522 . . . . 74.120000000000005 109.59 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.581 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 18.0 m-20 -79.3 -31.73 43.35 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.483 -0.326 . . . . 75.319999999999993 111.457 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.96 -33.75 72.35 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.376 -0.829 . . . . 75.340000000000003 108.916 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.48 -33.56 68.12 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.636 -0.711 . . . . 54.350000000000001 112.683 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -78.4 -30.02 47.55 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.727 -0.608 . . . . 72.329999999999998 110.498 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 66' ' ' LEU . 75.1 mt -63.16 -36.78 84.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.347 0.594 . . . . 72.310000000000002 110.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.62 -163.09 25.52 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 115.483 -0.78 . . . . 45.210000000000001 111.604 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.42 -30.98 14.8 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.287 0.565 . . . . 71.010000000000005 109.918 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.41 128.77 25.3 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.946 -0.57 . . . . 64.200000000000003 109.563 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.14 -27.23 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.213 1.942 . . . . 63.119999999999997 111.287 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.37 -53.74 33.35 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.022 1.729 . . . . 63.329999999999998 115.1 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.11 -31.25 72.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.249 0.547 . . . . 74.239999999999995 110.724 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -77.09 -34.94 56.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.649 -0.705 . . . . 71.109999999999999 109.525 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 42.5 m -65.22 -54.03 35.66 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.403 -0.817 . . . . 75.140000000000001 110.441 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 m -62.01 -38.61 89.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.664 -0.698 . . . . 73.439999999999998 111.166 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 116.024 -0.535 . . . . 71.019999999999996 112.323 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.706 -0.398 . . . . 75.530000000000001 110.03 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.055 -0.52 . . . . 61.119999999999997 110.204 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -56.84 -53.42 58.06 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.186 -0.916 . . . . 72.510000000000005 110.614 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -69.6 -29.59 67.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.018 -0.992 . . . . 74.030000000000001 111.965 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.02 -35.51 61.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.097 -0.705 . . . . 72.150000000000006 109.097 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -62.63 -37.93 88.23 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.741 0.781 . . . . 44.039999999999999 109.58 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.23 -47.6 81.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.728 -1.124 . . . . 63.530000000000001 109.608 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.6 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -54.91 -48.47 73.04 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.978 0.733 . . . . 65.120000000000005 112.978 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.07 -31.64 54.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.098 -0.641 . . . . 74.239999999999995 111.737 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 25.9 mt-30 -64.28 -45.42 88.12 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.837 -0.431 . . . . 65.430000000000007 109.837 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -58.04 -41.77 83.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.32 1.013 . . . . 70.540000000000006 111.903 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 75.5 mm-40 -74.74 -14.36 60.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.935 0.346 . . . . 72.299999999999997 111.935 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.95 29.0 48.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.246 -0.502 . . . . 53.130000000000003 112.064 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -104.62 157.31 17.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.201 -0.666 . . . . 63.439999999999998 109.201 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.472 HE21 HD21 ' A' ' 51' ' ' LEU . 24.1 pt20 -128.33 166.08 19.34 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.006 -0.678 . . . . 72.140000000000001 110.118 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -155.07 176.57 12.37 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.387 -1.338 . . . . 75.420000000000002 107.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 46.2 m-85 -118.37 120.83 38.78 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.538 -0.542 . . . . 72.540000000000006 109.538 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.68 -151.22 17.09 Favored Glycine 0 C--O 1.253 1.321 0 N-CA-C 108.23 -1.948 . . . . 74.519999999999996 108.23 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -128.06 162.81 25.99 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.986 0.893 . . . . 73.120000000000005 108.646 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.1 t -78.57 121.78 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.094 0.473 . . . . 71.329999999999998 111.184 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.46 120.83 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.366 -0.834 . . . . 33.119999999999997 110.047 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 82' ' ' SER . 59.8 t -116.62 127.77 74.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.068 -1.456 . . . . 72.140000000000001 107.068 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 -121.49 152.49 39.08 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.538 -0.465 . . . . 74.519999999999996 109.747 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.31 114.41 22.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.916 -1.142 . . . . 73.450000000000003 107.916 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.14 170.95 10.71 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.342 -0.543 . . . . 73.120000000000005 112.07 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.47 159.19 17.25 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.401 -0.818 . . . . 73.209999999999994 110.722 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 m -152.24 138.83 18.7 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 123.97 0.908 . . . . 72.239999999999995 109.422 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -81.0 -18.34 47.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.207 -1.035 . . . . 72.049999999999997 108.207 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -65.61 -26.69 67.95 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.318 1.447 . . . . 71.409999999999997 110.035 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.0 mt -101.24 128.31 47.43 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.721 -0.672 . . . . 71.219999999999999 109.832 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -88.1 164.05 15.91 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.468 -0.787 . . . . 72.140000000000001 109.975 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.475 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 16.0 m -55.28 123.13 12.8 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.891 0.744 . . . . 72.049999999999997 111.967 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.16 -20.9 30.06 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.293 -0.723 . . . . 44.409999999999997 111.293 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.22 139.71 35.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.481 0.657 . . . . 73.310000000000002 111.709 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 66' ' ' LEU . 29.6 p90 -147.7 160.16 43.01 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.715 -1.217 . . . . 74.430000000000007 107.715 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 146.55 43.77 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.176 -1.046 . . . . 75.409999999999997 108.176 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.52 149.45 34.34 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.548 -0.908 . . . . 72.5 108.548 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 64.5 ttt180 -143.26 124.37 14.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.263 -0.273 . . . . 74.129999999999995 110.263 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.15 100.25 0.8 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 110.198 -1.161 . . . . 34.140000000000001 110.198 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -111.67 147.88 34.58 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 109.713 -0.477 . . . . 73.239999999999995 109.713 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.2 t -87.29 113.98 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 108.152 -1.055 . . . . 63.32 108.152 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -126.06 99.69 31.23 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 108.344 -0.984 . . . . 70.129999999999995 108.344 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 57.8 Cg_endo . . . . . 0 N--CA 1.455 -0.751 0 C-N-CA 121.919 1.746 . . . . 51.340000000000003 111.377 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.971 0.415 . . . . 63.100000000000001 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -56.69 -47.67 79.35 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.082 -0.963 . . . . 75.439999999999998 110.37 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.96 -50.9 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.262 -0.881 . . . . 63.030000000000001 110.405 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.9 pp20? -64.4 -38.4 90.91 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.589 0.588 . . . . 72.420000000000002 112.589 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.08 92.48 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.802 0.334 . . . . 32.210000000000001 110.632 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -72.87 -37.58 67.29 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.238 -1.023 . . . . 64.409999999999997 108.238 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.09 -44.79 96.82 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 72.450000000000003 110.582 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.0 ptt85 -73.74 -21.86 60.06 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.96 0.409 . . . . 73.310000000000002 111.635 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 43.0 tpt85 -73.09 -31.19 64.2 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 52.0 mm-40 -68.21 -38.7 82.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.517 -0.765 . . . . 72.209999999999994 109.835 173.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.62 -46.52 88.74 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.443 -0.799 . . . . 60.229999999999997 109.734 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.29 65.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.788 -0.642 . . . . 62.109999999999999 111.386 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 31.2 t70 -77.77 -41.19 38.34 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.931 0.345 . . . . 71.239999999999995 111.931 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.03 25.89 19.64 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 120.227 -0.987 . . . . 70.239999999999995 113.803 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.77 137.02 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.702 0.401 . . . . 52.100000000000001 111.345 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.1 mt-30 -122.91 143.51 49.84 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.823 -0.626 . . . . 61.25 110.397 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -79.19 92.32 5.07 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.847 -1.07 . . . . 73.219999999999999 111.687 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 HD23 ' A' ' 57' ' ' LEU . 11.9 tp -102.38 -165.48 1.19 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.781 -1.933 . . . . 64.409999999999997 105.781 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.3 mm-40 -48.57 146.89 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.888 0.767 . . . . 72.140000000000001 112.214 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.9 32.89 1.25 Allowed Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.117 -0.947 . . . . 41.399999999999999 113.348 -173.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 52' ' ' GLN . 71.9 m-20 -99.85 -37.01 9.23 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.643 -1.614 . . . . 71.030000000000001 106.643 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -172.97 149.87 1.94 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.491 -1.231 . . . . 71.430000000000007 110.294 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.37 151.79 21.29 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.964 0.506 . . . . 73.349999999999994 110.564 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.572 HD23 HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -87.21 127.7 35.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 -175.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.11 158.17 46.92 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 123.11 0.564 . . . . 61.009999999999998 111.063 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.621 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 88.6 Cg_exo -54.86 145.16 63.32 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.948 3.099 . . . . 75.329999999999998 113.997 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -119.96 -22.6 6.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.313 -0.858 . . . . 61.130000000000003 110.292 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.69 108.88 20.61 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.412 0.625 . . . . 74.010000000000005 109.684 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.9 m-85 -114.06 117.83 32.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.445 -0.798 . . . . 72.519999999999996 109.423 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.95 116.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.192 -1.04 . . . . 74.329999999999998 108.192 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.1 mt -110.96 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 107.915 -1.143 . . . . 74.030000000000001 107.915 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.7 m -110.33 120.65 43.12 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.866 -0.606 . . . . 74.129999999999995 110.971 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.4 mm? -114.69 163.26 15.71 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.3 -0.864 . . . . 74.239999999999995 108.809 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.17 169.17 51.35 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 109.274 -1.53 . . . . 62.299999999999997 109.274 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.32 -25.7 37.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.595 0.712 . . . . 64.019999999999996 110.936 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -57.95 -55.69 31.64 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.824 -1.08 . . . . 73.209999999999994 110.001 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.84 -29.49 44.69 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.621 -0.718 . . . . 75.530000000000001 111.718 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -63.7 -32.01 73.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.439 -0.346 . . . . 74.200000000000003 110.143 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.17 -35.84 78.2 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 123.25 0.62 . . . . 55.149999999999999 109.954 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.98 -14.64 55.73 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.22 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.21 -25.04 37.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.652 -0.87 . . . . 54.5 108.652 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.98 -177.26 30.1 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 114.938 -1.028 . . . . 54.229999999999997 111.867 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 1.46 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.831 0.452 . . . . 54.420000000000002 111.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.7 m-20 -110.0 92.57 13.16 Favored Pre-proline 0 C--O 1.251 1.178 0 N-CA-C 112.331 0.493 . . . . 53.409999999999997 112.331 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.84 -37.2 1.72 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.686 1.59 . . . . 64.230000000000004 111.096 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.47 -34.33 72.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.26 -0.427 . . . . 55.109999999999999 112.14 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.29 -38.06 85.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.194 0.521 . . . . 73.400000000000006 109.837 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 43.4 mmtm -77.28 -35.52 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.837 -0.801 . . . . 71.299999999999997 108.837 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 t -58.31 -54.14 50.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.713 -1.131 . . . . 65.010000000000005 110.023 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.1 m -59.15 -42.33 90.44 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.425 0.69 . . . . 73.319999999999993 111.008 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -61.64 6.21 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.011 -0.54 . . . . 52.450000000000003 111.974 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -63.03 -30.78 71.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.304 0.854 . . . . 63.119999999999997 113.304 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.35 -40.43 89.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.896 -0.322 . . . . 72.409999999999997 110.538 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.538 ' O ' ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -73.37 -36.88 66.17 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.466 -0.568 . . . . 72.430000000000007 109.466 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.25 -41.06 94.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.573 -0.285 . . . . 63.32 110.73 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -42.27 87.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.447 -0.575 . . . . 75.120000000000005 109.447 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.46 79.67 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 61.439999999999998 109.951 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -64.24 -43.77 93.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.391 -0.822 . . . . 73.25 109.751 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.6 m-85 -58.66 -48.42 81.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 112.662 0.615 . . . . 75.409999999999997 112.662 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.99 -29.33 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.733 -0.787 . . . . 74.340000000000003 111.247 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.02 -44.24 89.82 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 110.14 -0.318 . . . . 42.219999999999999 110.14 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.6 mt-10 -63.91 -38.38 90.88 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.308 0.575 . . . . 74.420000000000002 110.797 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.2 mm-40 -79.25 -13.9 59.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.971 -0.559 . . . . 64.230000000000004 111.351 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.53 38.37 32.96 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.804 -0.712 . . . . 51.299999999999997 112.2 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -107.11 158.0 17.42 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.765 0.317 . . . . 73.120000000000005 111.093 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD23 ' A' ' 51' ' ' LEU . 23.2 pt20 -123.01 173.03 8.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.816 0.846 . . . . 73.150000000000006 109.087 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.8 t -159.52 177.61 10.76 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.444 -0.502 . . . . 64.519999999999996 110.432 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.24 120.99 33.85 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.582 -0.896 . . . . 71.319999999999993 108.582 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.24 -164.17 12.48 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.963 -1.655 . . . . 53.420000000000002 108.963 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -104.71 156.86 17.62 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.864 -1.532 . . . . 72.120000000000005 106.864 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.67 104.18 14.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.985 -1.117 . . . . 63.310000000000002 107.985 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.73 120.38 57.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 122.123 0.963 . . . . 74.409999999999997 111.676 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 62' ' ' TYR . 10.1 m -104.86 120.03 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 N-CA-C 105.804 -1.925 . . . . 75.230000000000004 105.804 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.279 0.0 OUTLIER -117.3 125.4 51.01 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 113.638 0.977 . . . . 72.540000000000006 113.638 -174.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -92.47 139.41 30.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.746 -1.57 . . . . 74.329999999999998 108.628 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -156.06 161.1 40.46 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.356 -0.609 . . . . 63.439999999999998 109.356 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.8 pt20 -104.32 157.99 16.76 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.582 0.706 . . . . 54.450000000000003 109.493 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 62.0 m -144.2 133.1 22.61 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.909 -1.041 . . . . 74.129999999999995 108.974 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 m -80.9 -11.74 59.53 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.481 0.658 . . . . 53.229999999999997 110.098 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -87.99 -5.54 58.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 71.409999999999997 109.918 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 1.4 tm? -91.07 120.44 32.04 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.938 -1.875 . . . . 65.329999999999998 105.938 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -88.8 153.22 21.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.325 -0.398 . . . . 73.25 110.405 -174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -64.59 134.16 53.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.51 0.672 . . . . 71.319999999999993 111.234 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.33 -15.46 42.67 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.412 -1.075 . . . . 74.340000000000003 110.412 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -106.08 150.24 25.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.047 -0.723 . . . . 72.439999999999998 109.047 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -149.66 151.25 33.42 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.867 -1.901 . . . . 73.409999999999997 105.867 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -134.99 144.09 47.18 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 112.56 0.578 . . . . 73.420000000000002 112.56 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.79 119.13 10.23 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.701 -1.592 . . . . 64.530000000000001 106.701 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.613 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -120.29 120.65 36.67 Favored 'General case' 0 N--CA 1.39 -3.456 0 C-N-CA 123.196 0.598 . . . . 71.349999999999994 109.565 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.53 121.54 7.2 Favored Glycine 0 C--N 1.3 -1.452 0 O-C-N 123.593 0.558 . . . . 64.040000000000006 112.056 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 p -142.21 148.61 38.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.155 -0.683 . . . . 73.530000000000001 109.155 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 5.6 p -95.84 120.54 45.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 119.462 -0.895 . . . . 63.450000000000003 110.006 174.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -125.86 98.62 33.46 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.819 -1.082 . . . . 64.239999999999995 108.167 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.52 -0.221 0 C-N-CA 122.385 2.057 . . . . 75.129999999999995 109.892 177.17 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 . . . . . 0 N--CA 1.434 -1.242 0 CA-C-O 121.219 0.533 . . . . 53.340000000000003 110.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.87 -32.77 73.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.445 -1.317 . . . . 74.129999999999995 107.445 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' HD23 ' A' ' 40' ' ' LEU . 30.7 t -61.3 -49.89 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 114.466 -1.243 . . . . 73.310000000000002 109.619 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 30.6 mt-10 -57.69 -47.11 83.26 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.581 -0.448 . . . . 74.530000000000001 110.734 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.88 35.56 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.69 0.619 . . . . 65.319999999999993 111.878 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.74 -29.35 66.68 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.216 0.45 . . . . 73.209999999999994 112.216 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 36' ' ' VAL . 4.0 mm? -70.55 -39.55 73.92 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.176 0.436 . . . . 70.430000000000007 112.176 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 58.7 mtp180 -66.13 -33.42 75.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.977 -1.12 . . . . 72.25 107.977 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -49.29 62.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.434 -1.257 . . . . 73.439999999999998 108.948 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.54 -37.8 85.11 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.98 0.512 . . . . 72.219999999999999 112.136 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -58.77 -45.82 88.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.998 -0.546 . . . . 41.100000000000001 110.117 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.06 64.66 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.549 0.69 . . . . 75.140000000000001 111.066 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.07 -32.61 73.9 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 63.530000000000001 111.043 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.86 72.61 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.97 -0.633 . . . . 62.240000000000002 113.285 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 98' ' ' TRP . 17.7 mm -64.45 131.31 30.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.547 0.689 . . . . 54.109999999999999 111.949 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 80.5 mt-30 -119.39 144.82 46.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.272 -0.876 . . . . 74.230000000000004 110.535 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.6 m -80.63 98.28 7.6 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.845 -1.07 . . . . 73.439999999999998 109.992 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.645 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.3 tp -101.91 -165.38 1.18 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.935 -1.506 . . . . 75.230000000000004 106.935 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.645 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 48.4 mt-30 -56.19 160.77 2.76 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.493 0.717 . . . . 72.140000000000001 111.395 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 4.75 8.17 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.461 -0.79 . . . . 61.509999999999998 114.397 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.32 -46.57 60.33 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.913 -1.143 . . . . 72.530000000000001 107.913 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -179.51 167.21 1.44 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.002 0.921 . . . . 73.040000000000006 110.716 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.56 151.39 21.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.059 0.457 . . . . 71.439999999999998 111.698 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.4 tm? -90.63 128.3 36.56 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.366 -0.976 . . . . 44.530000000000001 108.366 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.41 158.0 45.98 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 123.58 0.752 . . . . 45.530000000000001 109.433 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.8 Cg_exo -61.06 157.93 36.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 72.530000000000001 112.628 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -119.8 -33.3 4.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.934 -0.575 . . . . 71.099999999999994 110.695 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -103.66 114.65 29.07 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.651 -0.5 . . . . 74.319999999999993 109.651 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 70.8 m-85 -109.51 119.34 39.12 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.669 -0.696 . . . . 72.530000000000001 109.912 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -109.23 118.5 56.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 115.284 -0.871 . . . . 75.120000000000005 109.545 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.79 119.98 61.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.934 -1.136 . . . . 71.219999999999999 107.934 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -109.57 128.25 55.07 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.98 -0.555 . . . . 74.099999999999994 109.771 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.6 mm? -115.49 170.58 8.31 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.344 1.058 . . . . 71.200000000000003 109.674 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.99 169.03 54.43 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 109.508 -1.437 . . . . 74.0 109.508 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.86 -48.53 83.62 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 117.472 0.636 . . . . 75.299999999999997 111.681 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -65.03 -40.44 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 72.140000000000001 109.477 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.628 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.0 m-20 -69.48 -34.2 73.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.22 -1.355 . . . . 64.439999999999998 110.698 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.81 -36.92 85.48 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.72 0.771 . . . . 75.0 109.104 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.69 -25.22 64.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.757 -0.656 . . . . 73.200000000000003 111.262 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -77.91 -22.08 50.19 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.387 -0.195 . . . . 75.420000000000002 110.482 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.28 -38.36 71.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.157 -0.683 . . . . 71.129999999999995 109.157 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.31 -171.89 29.43 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.056 -1.068 . . . . 64.409999999999997 111.841 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.57 -31.08 18.81 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.939 -0.763 . . . . 62.329999999999998 108.939 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -131.73 81.81 62.43 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.217 -0.901 . . . . 74.439999999999998 110.548 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.74 -18.7 47.77 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.801 2.334 . . . . 51.149999999999999 112.274 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.01 -22.62 64.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 111.76 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.33 -45.67 92.16 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.88 -0.785 . . . . 55.030000000000001 108.88 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.13 -31.27 65.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.731 -1.122 . . . . 64.129999999999995 110.437 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.7 m -60.42 -43.53 96.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.42 -0.355 . . . . 73.310000000000002 111.224 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.4 m -65.4 -45.44 83.95 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.761 0.315 . . . . 71.439999999999998 111.165 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.87 93.6 Favored Glycine 0 C--O 1.244 0.733 0 C-N-CA 120.715 -0.755 . . . . 52.25 111.65 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -68.25 -32.59 72.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.279 -0.46 . . . . 63.329999999999998 110.247 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -62.15 -43.1 99.57 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.893 0.378 . . . . 73.25 110.514 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.78 -39.02 92.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 74.319999999999993 109.162 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -71.09 -41.32 70.77 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.305 -0.407 . . . . 65.129999999999995 111.183 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.04 -38.06 85.19 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.555 -0.535 . . . . 70.409999999999997 109.555 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.76 87.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.494 0.664 . . . . 75.109999999999999 109.536 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -37.41 84.38 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.95 -1.023 . . . . 62.539999999999999 110.127 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.6 m-85 -60.59 -48.02 83.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 111.903 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -69.69 -31.16 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 119.959 -0.697 . . . . 75.209999999999994 111.544 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.93 -41.14 91.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.808 -0.441 . . . . 72.329999999999998 109.808 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 33.2 tt0 -57.29 -36.85 71.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 125.329 1.452 . . . . 65.010000000000005 110.331 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -85.62 -9.04 57.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 75.409999999999997 111.052 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.29 29.8 57.85 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 116.025 -0.534 . . . . 75.150000000000006 113.016 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.473 ' CD2' HD11 ' A' ' 48' ' ' ILE . 20.0 m0 -96.19 156.9 16.14 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.594 -0.442 . . . . 64.340000000000003 110.457 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.584 ' NE2' HD23 ' A' ' 51' ' ' LEU . 29.9 pt20 -119.07 169.49 9.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.031 -0.359 . . . . 61.520000000000003 110.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -159.83 176.31 12.07 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.935 -0.765 . . . . 75.129999999999995 108.935 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.77 122.04 43.31 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.105 -1.072 . . . . 64.319999999999993 108.105 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.1 17.14 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.863 -1.16 . . . . 75.209999999999994 110.783 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -130.91 151.63 51.12 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.667 -0.864 . . . . 63.420000000000002 108.667 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.51 119.2 18.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.558 0.694 . . . . 71.109999999999999 111.335 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.14 131.63 65.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.024 -0.732 . . . . 64.109999999999999 109.024 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.1 p -137.33 141.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.514 -1.291 . . . . 74.019999999999996 107.514 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -145.06 155.96 43.65 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.455 -0.498 . . . . 73.510000000000005 110.184 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.36 127.9 53.21 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.005 -1.109 . . . . 74.409999999999997 108.005 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.06 167.83 18.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.712 -0.222 . . . . 64.329999999999998 110.46 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -116.47 158.95 22.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.865 0.365 . . . . 63.210000000000001 110.324 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 t -145.01 140.25 28.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.906 -1.146 . . . . 53.329999999999998 107.906 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 -10.38 59.74 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.585 -0.524 . . . . 70.329999999999998 109.585 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -79.38 -27.25 41.88 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.176 -0.465 . . . . 63.299999999999997 110.289 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.24 135.58 33.38 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 115.84 -0.618 . . . . 72.109999999999999 109.919 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -99.33 157.07 16.66 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.952 -0.759 . . . . 72.409999999999997 108.952 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.628 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 57.4 m -53.94 126.62 23.1 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 124.458 1.099 . . . . 73.109999999999999 112.109 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.1 28.94 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-N 115.092 -0.958 . . . . 73.549999999999997 111.675 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -104.36 139.6 39.09 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.82 -0.437 . . . . 70.010000000000005 109.82 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' HD13 ' A' ' 66' ' ' LEU . 42.9 p90 -143.04 157.89 44.11 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.652 -1.24 . . . . 71.400000000000006 107.652 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 134.81 31.39 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.663 -0.866 . . . . 73.239999999999995 108.663 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.32 139.35 48.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.936 -1.505 . . . . 63.240000000000002 106.936 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -139.44 119.13 13.15 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.974 0.416 . . . . 71.129999999999995 110.243 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.4 127.21 8.77 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.263 -1.135 . . . . 71.420000000000002 110.263 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.0 p -127.46 145.31 50.88 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.205 0.526 . . . . 72.200000000000003 111.57 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.5 t -98.09 108.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.433 -0.951 . . . . 63.439999999999998 108.433 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -114.48 97.91 47.66 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 109.262 -0.644 . . . . 73.329999999999998 109.262 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.454 -0.795 0 C-N-CA 121.993 1.796 . . . . 64.030000000000001 111.931 -179.55 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 . . . . . 0 C--O 1.254 1.31 0 CA-C-O 121.682 0.753 . . . . 71.209999999999994 109.185 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -82.05 -37.11 26.94 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.499 -0.773 . . . . 70.109999999999999 110.639 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 40' ' ' LEU . 97.5 t -61.01 -49.8 83.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 115.868 -0.605 . . . . 71.219999999999999 109.589 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -58.01 -47.8 81.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.528 0.731 . . . . 64.530000000000001 110.887 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.61 82.58 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.17 -0.923 . . . . 73.430000000000007 111.856 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.14 -31.54 58.66 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.399 0.518 . . . . 64.140000000000001 112.399 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 36' ' ' VAL . 5.6 mp -62.52 -42.57 99.6 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.397 0.147 . . . . 61.219999999999999 111.397 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.75 -28.51 62.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.597 -0.841 . . . . 75.420000000000002 110.342 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -63.36 -44.31 95.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.985 -0.552 . . . . 64.239999999999995 109.712 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -71.31 -32.54 68.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 75.010000000000005 111.488 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.15 93.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 63.229999999999997 109.631 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.61 -24.83 61.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.689 -0.687 . . . . 73.540000000000006 111.074 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.52 -38.13 74.2 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.155 0.982 . . . . 62.130000000000003 110.208 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.72 42.97 1.78 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.568 -0.742 . . . . 70.329999999999998 112.788 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 45' ' ' ALA . 19.6 mm -81.92 138.08 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.958 0.503 . . . . 64.099999999999994 110.696 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 2.0 mp0 -120.3 146.44 46.11 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 123.066 0.547 . . . . 70.439999999999998 109.697 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.0 m -73.46 120.81 19.58 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 124.175 0.922 . . . . 73.329999999999998 109.407 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.7 tp -127.19 -170.66 2.26 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 103.733 -2.692 . . . . 64.349999999999994 103.733 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.479 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 62.0 mt-30 -55.54 148.87 14.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.148 0.885 . . . . 63.039999999999999 110.007 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.33 -5.48 8.36 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 115.08 0.792 . . . . 52.049999999999997 115.08 -171.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -66.35 -38.6 88.0 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.391 -0.596 . . . . 74.209999999999994 109.391 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -171.09 152.65 3.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.901 -0.59 . . . . 74.109999999999999 111.266 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -91.94 151.71 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.26 0.624 . . . . 74.109999999999999 111.275 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 100' ' ' THR . 41.9 tp -88.98 125.87 35.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.672 -0.695 . . . . 42.100000000000001 109.147 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.05 165.87 12.28 Favored Pre-proline 0 C--N 1.283 -2.288 0 C-N-CA 124.421 1.088 . . . . 65.299999999999997 108.634 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 125' ' ' VAL . 28.7 Cg_exo -64.98 159.08 48.13 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.545 2.164 . . . . 73.120000000000005 111.673 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -115.97 -30.67 5.98 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.71 -0.396 . . . . 74.219999999999999 111.349 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 46.4 tt0 -104.04 127.71 51.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.353 -0.98 . . . . 71.510000000000005 108.353 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 106' ' ' VAL . 64.4 m-85 -123.34 114.83 20.71 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.772 -0.455 . . . . 72.0 109.772 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -97.9 110.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.755 -0.832 . . . . 65.510000000000005 108.755 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.8 115.57 48.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.6 -0.727 . . . . 72.219999999999999 109.21 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 m -109.53 123.42 49.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.527 -0.306 . . . . 72.219999999999999 110.525 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -117.22 -176.99 3.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.877 1.271 . . . . 71.5 109.183 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.7 -174.09 42.84 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 108.885 -1.686 . . . . 42.310000000000002 108.885 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.583 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.4 p -69.54 -58.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 118.321 1.06 . . . . 72.099999999999994 113.652 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.627 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 22.1 t-80 -55.77 -51.56 66.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.866 0.841 . . . . 72.409999999999997 110.068 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -65.19 -31.22 72.29 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.483 -1.235 . . . . 75.129999999999995 113.872 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -68.49 -43.58 76.58 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.409 -0.517 . . . . 71.540000000000006 110.596 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 37.4 mt-10 -62.97 -38.45 91.16 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.837 0.827 . . . . 73.430000000000007 110.092 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 12.4 mptt -80.82 -16.02 54.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.059 -0.973 . . . . 73.430000000000007 112.367 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 65.9 mt -70.61 -45.42 65.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.636 -1.246 . . . . 54.340000000000003 107.636 170.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 121.2 0.8 Allowed Glycine 0 N--CA 1.406 -3.312 0 CA-C-N 114.67 -1.15 . . . . 63.299999999999997 111.648 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.63 -18.73 62.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.995 -1.113 . . . . 74.329999999999998 107.995 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.98 88.89 8.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 104.785 -2.302 . . . . 61.310000000000002 104.785 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.2 -33.13 15.5 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.79 2.326 . . . . 74.5 114.007 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.95 -25.84 60.17 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.943 -0.303 . . . . 74.310000000000002 111.455 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.21 -35.25 80.47 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.571 -0.529 . . . . 73.25 109.571 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -74.23 -34.08 63.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.58 -0.737 . . . . 74.349999999999994 109.505 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.78 -51.31 70.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.497 -0.556 . . . . 64.239999999999995 109.497 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 28.2 m -62.34 -44.02 97.47 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.294 -0.412 . . . . 73.150000000000006 110.484 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.01 -57.94 17.17 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.391 -0.368 . . . . 61.140000000000001 113.051 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -67.87 -28.25 67.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.968 0.729 . . . . 64.150000000000006 112.968 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.1 76.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 74.140000000000001 110.637 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.8 mmt85 -67.75 -43.39 80.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.606 . . . . 64.319999999999993 109.883 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.8 t70 -56.69 -56.69 18.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.371 -1.286 . . . . 71.140000000000001 109.583 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.81 -31.11 72.19 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 112.589 0.589 . . . . 55.420000000000002 112.589 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.02 98.63 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.504 0.669 . . . . 62.530000000000001 111.178 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.31 -27.51 27.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.243 -1.391 . . . . 73.540000000000006 107.243 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 3.3 t80 -65.6 -42.78 91.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.723 -1.581 . . . . 64.319999999999993 110.195 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.95 -30.94 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.521 -0.471 . . . . 72.420000000000002 109.787 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -62.71 -42.39 99.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 71.439999999999998 109.964 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 92' ' ' TYR . 11.9 mm-40 -57.72 -38.14 74.77 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.807 0.843 . . . . 71.540000000000006 111.098 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.7 mm-40 -83.43 -14.06 53.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 63.409999999999997 111.623 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.59 38.13 25.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.075 -0.584 . . . . 41.340000000000003 112.1 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -117.74 179.7 4.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.553 -0.906 . . . . 74.409999999999997 108.553 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -160.09 178.94 9.17 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 110.196 -0.298 . . . . 55.509999999999998 110.196 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.515 ' HA ' HD12 ' A' ' 57' ' ' LEU . 14.0 t -153.24 171.97 17.71 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.298 -1.371 . . . . 72.230000000000004 107.298 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.64 118.92 29.62 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.778 -1.564 . . . . 74.329999999999998 106.778 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.83 -149.43 16.59 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 119.277 -1.439 . . . . 63.149999999999999 109.862 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -125.59 152.58 44.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.404 -1.332 . . . . 62.420000000000002 107.404 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.93 125.81 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 O-C-N 123.442 0.463 . . . . 72.230000000000004 111.255 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 19.7 m -123.86 120.22 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.519 0.676 . . . . 74.150000000000006 109.75 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 62' ' ' TYR . 15.1 m -116.1 142.78 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 108.707 -0.849 . . . . 65.239999999999995 108.707 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.56 131.01 23.77 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.356 0.598 . . . . 73.519999999999996 112.028 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.19 151.27 19.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.499 -1.228 . . . . 63.439999999999998 108.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -159.51 170.13 22.36 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.113 0.565 . . . . 74.109999999999999 109.967 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.16 164.82 12.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.939 0.876 . . . . 63.149999999999999 112.941 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 t -142.7 134.91 27.43 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.583 -1.644 . . . . 70.129999999999995 106.885 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.43 -12.02 59.06 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.395 0.616 . . . . 74.299999999999997 110.168 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -85.18 -30.49 23.88 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.948 -0.569 . . . . 74.219999999999999 111.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 118' ' ' GLN . 57.7 mt -86.94 149.47 24.77 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.733 -0.667 . . . . 52.439999999999998 111.636 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -126.85 168.78 13.99 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.279 -1.008 . . . . 73.329999999999998 108.279 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -57.49 110.55 0.89 Allowed 'General case' 0 C--O 1.251 1.155 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.65 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.14 -24.82 4.18 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 108.698 -1.761 . . . . 72.109999999999999 108.698 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 29.0 mm-40 -92.71 156.02 17.32 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.502 -1.296 . . . . 41.329999999999998 107.502 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -176.11 147.7 0.75 Allowed 'General case' 0 C--N 1.278 -2.539 0 O-C-N 125.077 1.486 . . . . 75.299999999999997 107.643 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -143.25 130.87 21.25 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.368 -0.378 . . . . 75.349999999999994 109.991 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.68 135.92 53.69 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.132 -1.062 . . . . 42.399999999999999 108.132 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -125.32 126.48 45.14 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.953 -0.758 . . . . 72.150000000000006 108.953 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.44 125.13 8.39 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 110.461 -1.055 . . . . 54.240000000000002 110.461 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 p -121.4 140.49 52.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 123.241 0.616 . . . . 71.340000000000003 110.68 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 59' ' ' PRO . 80.1 t -92.35 103.66 14.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.719 -1.586 . . . . 62.229999999999997 106.719 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -107.35 104.22 51.6 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 108.23 -1.026 . . . . 71.430000000000007 108.23 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.459 -0.504 0 C-N-CA 121.936 1.757 . . . . 73.120000000000005 112.924 -177.473 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 . . . . . 0 C--O 1.21 -1.008 0 N-CA-C 111.781 0.289 . . . . 55.0 111.781 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.96 -44.85 88.03 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.671 0.748 . . . . 64.549999999999997 109.014 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG12 HD23 ' A' ' 40' ' ' LEU . 47.2 t -72.48 -38.22 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.196 -0.911 . . . . 73.329999999999998 108.846 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.37 -42.59 91.98 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.203 -0.453 . . . . 63.130000000000003 110.67 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.19 -45.82 86.9 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.429 0.692 . . . . 55.409999999999997 110.691 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 121' ' ' ALA . 1.6 tm? -66.59 -45.75 78.2 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.854 -0.612 . . . . 54.530000000000001 109.517 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 36' ' ' VAL . 4.6 mm? -65.59 -40.15 92.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.09 0.774 . . . . 75.340000000000003 113.09 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -72.21 -29.35 63.88 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 63.039999999999999 110.008 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.74 -44.11 97.07 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.17 -1.048 . . . . 74.349999999999994 108.17 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.94 -48.66 65.29 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.92 -1.036 . . . . 64.549999999999997 110.123 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.84 68.32 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.432 -0.349 . . . . 73.140000000000001 111.814 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.64 -23.24 56.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.994 0.368 . . . . 63.329999999999998 111.994 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.02 -34.54 24.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.218 0.533 . . . . 63.229999999999997 110.618 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.75 21.12 15.84 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.54 -0.755 . . . . 73.409999999999997 113.177 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mm -72.57 131.73 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.002 0.43 . . . . 75.129999999999995 110.498 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.7 mt-30 -108.84 133.13 53.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.769 -0.826 . . . . 71.310000000000002 108.769 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -75.32 117.71 17.43 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.949 -1.023 . . . . 71.219999999999999 109.407 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.455 HD23 ' NE2' ' A' ' 99' ' ' GLN . 12.9 tp -141.39 -164.34 1.75 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 103.955 -2.609 . . . . 74.140000000000001 103.955 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.411 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 97.9 mt-30 -42.68 131.74 3.88 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.702 0.626 . . . . 72.120000000000005 111.662 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.38 -18.47 55.69 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 115.062 0.785 . . . . 74.409999999999997 115.062 -170.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.41 -31.9 54.37 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.627 -0.829 . . . . 73.230000000000004 111.422 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 12.4 ptm180 -151.77 114.42 4.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.497 1.141 . . . . 75.530000000000001 111.029 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -91.1 150.71 21.29 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.969 -1.469 . . . . 74.310000000000002 108.322 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -84.25 120.34 26.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.495 -0.558 . . . . 71.420000000000002 109.495 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 157.38 38.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.676 -0.693 . . . . 74.340000000000003 109.672 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -61.68 147.58 95.01 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.573 2.182 . . . . 71.140000000000001 112.175 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.403 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 28.8 p-10 -120.59 -24.44 5.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.966 -0.561 . . . . 73.420000000000002 110.403 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.11 114.8 29.2 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.455 -0.572 . . . . 71.230000000000004 109.455 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -119.56 114.63 22.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.601 -0.727 . . . . 52.229999999999997 109.411 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -109.13 120.27 60.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.616 -0.883 . . . . 72.230000000000004 108.616 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.9 126.71 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 108.556 -0.905 . . . . 64.409999999999997 108.556 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -107.81 130.97 54.94 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.48 -0.782 . . . . 72.340000000000003 109.282 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.35 161.27 22.38 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.68 0.792 . . . . 44.229999999999997 109.244 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.1 157.33 52.55 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.727 -1.349 . . . . 63.509999999999998 109.727 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.4 p -56.76 -39.13 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 117.364 0.582 . . . . 64.409999999999997 112.374 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.95 -44.4 82.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.481 0.658 . . . . 73.25 110.777 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.57 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 39.8 m-20 -84.76 -21.67 29.92 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 112.784 0.661 . . . . 75.329999999999998 112.784 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 57.0 t80 -69.3 -26.09 64.55 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.162 -0.681 . . . . 70.549999999999997 109.162 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 46.2 mt-10 -58.67 -38.56 78.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.386 -0.37 . . . . 54.329999999999998 110.784 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -76.55 -32.8 58.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.108 0.48 . . . . 73.409999999999997 109.913 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.08 -29.25 70.11 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.988 -0.551 . . . . 63.329999999999998 109.976 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.03 33.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.672 -0.694 . . . . 53.149999999999999 113.904 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.36 0.58 . . . . 72.230000000000004 109.67 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.35 68.34 2.77 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 122.198 0.999 . . . . 64.209999999999994 109.765 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.76 -51.25 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.199 1.933 . . . . 74.099999999999994 113.685 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.8 -23.16 60.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.439 -0.346 . . . . 73.519999999999996 111.633 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.5 -43.09 81.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.763 -0.458 . . . . 74.310000000000002 109.763 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -63.33 -34.4 77.62 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.739 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.1 m -66.87 -49.03 66.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.785 -0.643 . . . . 61.32 110.698 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -62.49 -36.27 82.0 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.141 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.15 40.29 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.424 -0.417 . . . . 62.409999999999997 112.122 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -70.85 -28.04 64.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.324 0.49 . . . . 64.310000000000002 112.324 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.898 -0.408 . . . . 72.040000000000006 109.898 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -59.67 -47.61 84.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.41 -0.813 . . . . 71.239999999999995 109.522 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' HD1' ' A' ' 92' ' ' TYR . 59.7 m-20 -69.52 -45.37 69.01 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 113.275 0.843 . . . . 61.049999999999997 113.275 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.137 -0.625 . . . . 63.340000000000003 111.812 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.34 87.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 109.939 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.93 -44.5 72.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.913 -0.585 . . . . 71.109999999999999 109.734 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.626 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.1 m-85 -58.68 -49.62 76.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.485 -0.78 . . . . 65.310000000000002 112.572 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.12 -39.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 119.914 -0.715 . . . . 75.319999999999993 111.363 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.63 -41.58 96.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.61 -0.268 . . . . 73.120000000000005 110.491 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.47 -38.95 75.33 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.693 1.197 . . . . 71.329999999999998 110.723 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 52.2 mm-40 -87.44 -13.35 43.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.782 -0.645 . . . . 54.539999999999999 111.402 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.48 28.74 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.976 -0.85 . . . . 72.540000000000006 110.976 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -105.34 158.71 16.44 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.008 -0.738 . . . . 74.400000000000006 109.008 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.5 pt20 -126.33 171.58 10.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.197 -0.456 . . . . 62.009999999999998 110.175 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 57' ' ' LEU . 6.3 t -162.52 158.05 23.05 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.639 -1.245 . . . . 73.049999999999997 107.639 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.51 120.44 40.3 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.265 -1.013 . . . . 75.409999999999997 108.265 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -152.11 16.99 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.154 -1.579 . . . . 23.329999999999998 109.154 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.95 162.58 20.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.217 -0.66 . . . . 72.230000000000004 109.217 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.22 119.83 31.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.58 -0.896 . . . . 75.129999999999995 108.58 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.66 133.1 69.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.451 0.643 . . . . 64.310000000000002 109.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.03 134.37 61.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.377 -0.972 . . . . 72.299999999999997 108.377 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -130.88 142.99 50.41 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.729 -0.841 . . . . 73.219999999999999 108.729 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.98 137.02 52.27 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.765 -0.828 . . . . 63.130000000000003 108.765 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.32 160.8 38.55 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 120.967 0.413 . . . . 73.299999999999997 110.678 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 26.9 pt20 -103.55 153.89 20.08 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.397 -0.82 . . . . 70.349999999999994 109.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.2 t -144.37 132.22 21.38 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 109.025 -0.732 . . . . 65.299999999999997 109.025 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.05 -15.73 55.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.08 -1.081 . . . . 53.219999999999999 108.08 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.5 -32.89 54.46 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.565 -1.198 . . . . 72.25 109.769 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -84.44 157.66 21.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.423 -0.954 . . . . 63.119999999999997 108.423 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -98.54 164.53 12.22 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.757 0.651 . . . . 74.140000000000001 112.757 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 m -66.13 134.57 53.07 Favored 'General case' 0 C--O 1.25 1.089 0 C-N-CA 123.995 0.918 . . . . 73.510000000000005 110.802 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.1 86.82 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 112.041 -0.424 . . . . 62.340000000000003 112.041 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -138.49 128.38 25.27 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 107.915 -1.143 . . . . 60.210000000000001 107.915 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -122.59 153.94 38.61 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.776 -0.824 . . . . 65.310000000000002 108.776 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -148.61 153.76 38.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.429 -1.323 . . . . 75.030000000000001 107.429 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -145.44 149.35 34.54 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 120.697 -0.401 . . . . 72.200000000000003 110.966 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -134.42 123.0 23.33 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.5 -0.773 . . . . 72.010000000000005 109.476 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.68 126.17 7.57 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.715 -1.354 . . . . 74.230000000000004 109.715 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.2 m -135.88 150.59 49.42 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 109.402 -0.592 . . . . 54.520000000000003 109.402 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 59' ' ' PRO . 40.2 t -88.02 110.97 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 107.179 -1.415 . . . . 74.349999999999994 107.179 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -120.06 86.99 38.23 Favored Pre-proline 0 C--N 1.284 -2.264 0 N-CA-C 107.226 -1.398 . . . . 72.230000000000004 107.226 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 122.368 2.045 . . . . 70.129999999999995 112.69 -174.54 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.995 0.426 . . . . 74.010000000000005 111.525 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.67 -25.3 67.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.357 -0.608 . . . . 73.010000000000005 109.357 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.99 -49.7 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 109.681 -0.488 . . . . 75.109999999999999 109.681 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.97 -35.8 81.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.366 -0.533 . . . . 61.439999999999998 109.822 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.33 94.15 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.685 -0.688 . . . . 73.319999999999993 110.773 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -44.45 96.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.774 -0.824 . . . . 74.209999999999994 108.774 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.12 -29.18 68.04 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.035 0.754 . . . . 71.120000000000005 113.035 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 11.4 mtm180 -65.52 -36.97 85.41 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.778 -1.194 . . . . 73.299999999999997 107.778 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -46.87 72.26 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.17 -0.923 . . . . 72.439999999999998 110.07 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.21 -41.08 96.22 Favored 'General case' 0 CA--C 1.5 -0.942 0 O-C-N 123.397 0.435 . . . . 74.519999999999996 111.976 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.49 93.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.095 -0.502 . . . . 63.210000000000001 110.583 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.25 -25.36 42.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.089 -0.505 . . . . 71.329999999999998 111.599 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.19 -40.02 28.04 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.04 0.448 . . . . 64.319999999999993 110.167 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.85 17.96 37.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.786 . . . . 64.209999999999994 112.999 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 48' ' ' ILE . 13.8 mm -59.95 127.03 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-O 121.325 0.583 . . . . 75.329999999999998 110.814 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.2 tt0 -109.59 128.27 55.1 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 106.819 -1.549 . . . . 64.219999999999999 106.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -67.61 116.47 8.36 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.419 0.628 . . . . 61.43 110.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 18.4 tp -119.62 -165.83 1.21 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.503 -2.036 . . . . 75.530000000000001 105.503 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.577 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 14.1 mm-40 -62.92 166.56 5.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.731 0.696 . . . . 71.230000000000004 110.741 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.4 1.7 18.84 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.416 -0.811 . . . . 61.009999999999998 113.472 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.91 -48.64 57.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.621 -0.881 . . . . 71.430000000000007 108.621 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -173.67 159.8 3.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.869 -0.605 . . . . 74.129999999999995 110.649 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.87 151.68 20.44 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.653 0.781 . . . . 72.549999999999997 109.993 -176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.4 tm? -98.64 126.27 44.19 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.151 -1.796 . . . . 71.150000000000006 106.151 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.47 157.65 33.43 Favored Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 122.899 0.48 . . . . 53.43 110.305 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HG2' ' OH ' ' A' ' 62' ' ' TYR . 23.6 Cg_endo -63.73 148.34 92.12 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.334 2.023 . . . . 51.100000000000001 111.698 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 24.5 p-10 -123.37 -16.33 6.89 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.593 -0.73 . . . . 74.129999999999995 112.175 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.92 109.45 18.15 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 120.365 -0.534 . . . . 74.349999999999994 110.635 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.451 ' OH ' ' HG2' ' A' ' 59' ' ' PRO . 24.9 m-85 -114.44 127.67 55.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.532 -0.758 . . . . 73.420000000000002 110.7 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 64.8 mt -109.28 115.61 50.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.908 -1.145 . . . . 61.32 107.908 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.99 110.42 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.451 -0.944 . . . . 73.150000000000006 108.451 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -102.27 121.73 42.83 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.189 -0.46 . . . . 70.209999999999994 110.529 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.38 167.89 9.86 Favored 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.698 0.799 . . . . 71.400000000000006 110.168 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 162.38 50.56 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.39 -1.484 . . . . 73.329999999999998 109.39 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 7.9 p -59.71 -42.01 87.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 117.467 0.633 . . . . 74.430000000000007 112.306 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.476 ' HB3' HG21 ' A' ' 116' ' ' THR . 15.3 t-80 -73.6 -21.95 60.18 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.494 0.664 . . . . 74.310000000000002 110.17 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -79.26 -36.87 39.19 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.766 -0.584 . . . . 73.409999999999997 110.173 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -31.08 71.56 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.766 -0.652 . . . . 64.299999999999997 109.473 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.6 mm-40 -59.42 -31.43 69.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.713 -0.676 . . . . 75.420000000000002 112.004 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -84.44 -27.82 27.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.085 -0.646 . . . . 62.140000000000001 110.755 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.412 HD11 ' HG ' ' A' ' 66' ' ' LEU . 88.2 mt -64.36 -38.97 92.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.395 -0.366 . . . . 63.109999999999999 110.22 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.51 169.28 11.59 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 111.384 -0.686 . . . . 74.349999999999994 111.384 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.14 -31.41 25.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.0 0.428 . . . . 64.420000000000002 110.417 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 16.3 m-20 -105.8 105.36 52.85 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.51 -0.768 . . . . 71.310000000000002 109.428 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.16 -18.97 17.96 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.08 1.853 . . . . 71.310000000000002 113.783 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.296 0.0 OUTLIER -62.54 -51.91 65.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.789 1.403 . . . . 71.319999999999993 114.789 -174.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -67.35 -36.44 81.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.86 0.3 . . . . 64.420000000000002 111.314 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 72.4 mmtt -64.61 -45.78 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.539 . . . . 64.219999999999999 109.904 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.615 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 43.5 m -71.68 -49.71 37.14 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.378 -0.828 . . . . 72.5 111.11 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 56.1 m -65.63 -35.07 79.73 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.785 0.326 . . . . 74.239999999999995 111.649 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.73 -46.53 74.54 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.336 -0.705 . . . . 43.43 111.336 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.81 -28.28 67.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.274 -0.639 . . . . 73.439999999999998 109.274 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.94 79.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.994 -0.548 . . . . 72.140000000000001 110.25 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 83' ' ' THR . 99.9 mtt180 -66.14 -41.9 89.8 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.104 -0.332 . . . . 75.439999999999998 110.104 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.43 -36.66 83.09 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.927 0.394 . . . . 73.5 110.327 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 104' ' ' VAL . 2.7 tm? -73.39 -39.44 65.1 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.948 -0.569 . . . . 51.109999999999999 110.121 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -59.37 -41.44 89.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.65 0.738 . . . . 72.450000000000003 109.026 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 19.2 t70 -58.16 -51.67 68.76 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.265 -1.334 . . . . 73.299999999999997 109.186 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.614 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 10.0 m-85 -55.1 -53.72 52.3 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.27 0.841 . . . . 70.209999999999994 113.27 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 pt -61.84 -36.63 74.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 120.774 -0.37 . . . . 75.219999999999999 111.664 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.19 -36.63 82.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.067 -0.515 . . . . 65.239999999999995 111.35 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.9 mt-10 -62.93 -38.84 92.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.381 0.61 . . . . 65.209999999999994 110.844 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 62.3 mm-40 -79.8 -9.45 59.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.377 -0.828 . . . . 73.450000000000003 110.905 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.81 56.57 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 112.583 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -101.5 159.76 15.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.488 -0.931 . . . . 65.439999999999998 108.488 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -132.94 171.6 13.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.711 -1.218 . . . . 74.129999999999995 107.711 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.1 t -147.86 166.27 28.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.645 -0.502 . . . . 60.409999999999997 109.645 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -106.51 120.76 42.76 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 109.749 -0.463 . . . . 61.219999999999999 109.749 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.85 -149.79 17.03 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.269 -1.132 . . . . 51.329999999999998 110.269 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -108.8 143.0 38.53 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.885 -1.524 . . . . 73.420000000000002 106.885 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 90' ' ' ALA . 14.8 p -81.52 112.99 20.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.128 -1.029 . . . . 61.350000000000001 108.903 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.85 120.15 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-O 122.096 0.95 . . . . 73.209999999999994 110.866 -176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 82' ' ' SER . 3.7 m -119.1 139.67 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 N-CA-C 104.025 -2.583 . . . . 74.200000000000003 104.025 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -137.81 132.88 33.29 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.869 -1.132 . . . . 74.530000000000001 112.119 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -91.35 119.94 31.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.418 -1.265 . . . . 61.210000000000001 108.54 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.89 171.67 9.05 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.81 -0.632 . . . . 74.019999999999996 109.925 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -121.49 157.63 30.22 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.115 -1.069 . . . . 73.549999999999997 108.115 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.7 t -145.76 146.98 31.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.093 -0.706 . . . . 60.219999999999999 109.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.3 m -80.89 -22.74 39.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.433 -0.951 . . . . 75.340000000000003 108.433 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -80.46 -29.7 37.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.251 -0.886 . . . . 73.519999999999996 109.652 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.02 130.78 37.69 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.113 -1.81 . . . . 72.5 106.113 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 38.1 t-80 -97.74 153.24 18.39 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.499 -0.48 . . . . 73.409999999999997 110.008 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 69' ' ' HIS . 97.9 m -60.51 139.59 57.68 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.635 0.774 . . . . 64.010000000000005 110.768 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.18 3.05 57.88 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.211 -1.155 . . . . 52.43 110.211 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 25.3 mt-30 -132.25 154.05 50.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.05 0.94 . . . . 64.340000000000003 109.101 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.11 148.22 26.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.434 -1.321 . . . . 61.299999999999997 107.434 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -137.45 135.94 37.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.802 -0.814 . . . . 72.209999999999994 108.802 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -137.28 120.66 16.98 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 123.527 0.517 . . . . 72.040000000000006 109.78 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 1.5 tpm_? -119.73 137.41 53.94 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.682 -1.229 . . . . 74.409999999999997 107.682 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -120.4 104.34 0.99 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.189 -0.764 . . . . 62.219999999999999 111.189 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.6 m -105.43 151.22 24.5 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 122.43 -0.453 . . . . 64.519999999999996 109.81 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.35 112.48 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.153 -1.054 . . . . 74.430000000000007 108.153 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -115.5 108.02 48.06 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 109.041 -0.726 . . . . 64.239999999999995 109.041 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.455 -0.759 0 C-N-CA 121.92 1.747 . . . . 70.109999999999999 112.236 -179.648 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . 0.272 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.666 0 N-CA-C 113.326 0.862 . . . . 72.420000000000002 113.326 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.55 -22.65 43.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.847 -0.741 . . . . 74.209999999999994 109.216 172.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.74 -48.79 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 63.119999999999997 109.074 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.07 -33.24 75.55 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.8 -0.36 . . . . 63.350000000000001 110.654 178.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.19 81.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.585 0.553 . . . . 21.329999999999998 109.942 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.74 -45.6 93.65 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 108.765 -0.828 . . . . 71.420000000000002 108.765 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.515 HD21 HD11 ' A' ' 64' ' ' ILE . 11.1 mp -64.75 -42.45 95.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.043 1.127 . . . . 75.0 114.043 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.3 ptt180 -71.62 -27.28 63.0 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.205 -0.998 . . . . 70.439999999999998 111.328 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -68.14 -46.26 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.22 -40.42 93.93 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.697 1.199 . . . . 65.219999999999999 109.919 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.33 96.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.729 -0.669 . . . . 74.019999999999996 110.348 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.05 76.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.155 0.502 . . . . 63.219999999999999 111.36 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.91 -28.55 49.81 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.95 0.405 . . . . 72.340000000000003 111.289 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.49 21.6 45.25 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 116.267 -0.424 . . . . 51.130000000000003 113.138 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 56' ' ' LEU . 9.0 mm -62.15 144.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.693 0.797 . . . . 74.319999999999993 111.485 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 9.4 tt0 -120.45 134.66 55.24 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 107.988 -1.116 . . . . 73.25 107.988 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -64.48 128.94 37.93 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.453 0.644 . . . . 40.439999999999998 109.461 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -135.4 -166.25 1.81 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 105.57 -2.011 . . . . 45.25 105.57 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.638 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 67.6 mt-30 -59.05 155.68 13.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.611 -0.515 . . . . 64.129999999999995 109.611 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.53 -9.46 37.86 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 116.442 -0.344 . . . . 32.130000000000003 113.494 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -46.73 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.504 -0.184 . . . . 72.109999999999999 110.504 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 99' ' ' GLN . 6.0 ptm180 -172.16 152.92 2.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.4 -0.364 . . . . 75.420000000000002 110.698 -175.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 48' ' ' ILE . 81.5 mt -91.67 152.38 20.25 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.508 1.123 . . . . 73.530000000000001 111.084 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.8 tm? -92.97 133.28 36.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.092 -1.447 . . . . 70.120000000000005 107.092 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.61 159.97 41.96 Favored Pre-proline 0 C--N 1.302 -1.461 0 C-N-CA 123.525 0.73 . . . . 40.350000000000001 109.753 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.427 ' HA ' HG22 ' A' ' 125' ' ' VAL . 32.1 Cg_exo -61.72 162.1 22.72 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.068 2.512 . . . . 72.5 113.418 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 9.8 p30 -134.16 -23.73 1.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.96 -0.563 . . . . 53.299999999999997 112.215 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.05 104.49 14.67 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.117 -1.033 . . . . 74.420000000000002 109.515 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.28 114.62 28.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.313 -0.858 . . . . 73.329999999999998 109.581 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.36 118.03 56.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.722 -1.214 . . . . 70.019999999999996 107.722 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 40' ' ' LEU . 41.0 mt -113.31 125.79 70.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.011 -1.107 . . . . 72.150000000000006 108.011 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -116.39 123.32 47.28 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.138 -0.69 . . . . 73.420000000000002 109.138 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.578 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.1 mm? -102.65 159.62 15.29 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.854 0.862 . . . . 72.109999999999999 109.478 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.82 144.68 48.53 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.683 -2.167 . . . . 62.009999999999998 107.683 169.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.3 p -55.59 -36.02 40.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.425 0.898 . . . . 75.239999999999995 113.425 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -69.69 -34.17 73.56 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.762 0.315 . . . . 62.420000000000002 111.227 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.3 m-20 -76.69 -25.82 54.06 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.22 0.533 . . . . 71.549999999999997 110.176 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.97 -31.18 71.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.26 -1.015 . . . . 73.120000000000005 108.26 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 41.6 mt-10 -64.92 -31.7 73.07 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.731 -0.668 . . . . 75.239999999999995 110.532 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -73.23 -27.61 61.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 110.915 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.53 -27.22 66.79 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.167 -0.679 . . . . 73.540000000000006 109.167 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.16 -163.72 12.54 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 114.81 -1.086 . . . . 44.340000000000003 113.389 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -80.89 -19.35 44.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.34 0.59 . . . . 75.409999999999997 109.672 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.23 67.94 36.29 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.696 -0.684 . . . . 74.349999999999994 112.54 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 17.1 Cg_exo -72.5 -48.85 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.909 1.739 . . . . 65.230000000000004 110.352 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.599 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 5.4 mm-40 -68.43 -12.84 61.76 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.302 0.853 . . . . 72.230000000000004 113.302 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.22 -38.17 43.69 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.595 -1.261 . . . . 73.219999999999999 107.595 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.54 -25.6 57.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.068 -0.969 . . . . 73.299999999999997 110.407 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 9.3 m -54.65 -42.35 71.19 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 124.126 0.97 . . . . 74.430000000000007 111.28 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 m -60.85 -44.13 97.42 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.537 0.735 . . . . 72.439999999999998 111.275 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.65 -38.11 67.61 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.117 -0.793 . . . . 40.340000000000003 111.117 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -67.37 -36.47 81.41 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.363 0.665 . . . . 73.319999999999993 109.652 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.8 96.17 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 110.027 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -67.26 -36.29 81.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.316 -0.402 . . . . 74.140000000000001 110.67 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -43.97 96.74 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.638 -0.875 . . . . 75.549999999999997 108.638 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD22 HD23 ' A' ' 40' ' ' LEU . 53.7 tp -67.62 -36.66 81.25 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.462 -0.79 . . . . 73.25 110.818 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.36 -38.15 85.9 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.401 0.619 . . . . 72.340000000000003 109.6 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 33.1 t70 -66.21 -42.41 88.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.464 -0.789 . . . . 65.150000000000006 109.329 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.575 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.8 m-85 -54.82 -47.92 73.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.858 -0.61 . . . . 74.400000000000006 111.936 174.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 pt -68.49 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 119.925 -0.71 . . . . 74.450000000000003 111.19 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -61.04 -41.98 97.62 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.295 0.372 . . . . 71.430000000000007 110.275 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 21.7 mm-40 -57.37 -44.15 84.15 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.309 0.644 . . . . 74.340000000000003 111.005 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -79.81 -13.93 59.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.493 -0.776 . . . . 71.010000000000005 110.237 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 90.83 9.6 63.95 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.852 -0.613 . . . . 63.549999999999997 113.543 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -86.83 152.29 22.61 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.993 -0.71 . . . . 73.310000000000002 110.412 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 55' ' ' ARG . 7.6 pt20 -122.83 168.62 12.03 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.571 -0.529 . . . . 73.439999999999998 109.571 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.0 t -146.78 154.81 41.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.355 -0.609 . . . . 71.120000000000005 109.355 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -97.31 120.82 38.36 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.456 -1.313 . . . . 75.040000000000006 107.456 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.87 -163.98 12.59 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 120.264 -0.969 . . . . 72.140000000000001 110.933 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.47 143.65 40.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.605 0.24 . . . . 62.299999999999997 110.57 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 90' ' ' ALA . 9.6 p -80.94 123.49 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.822 -0.627 . . . . 63.43 109.799 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.5 129.21 72.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.751 -0.659 . . . . 72.109999999999999 109.939 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' SER . 96.2 t -115.36 119.38 61.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.093 -1.447 . . . . 62.100000000000001 107.093 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -110.47 127.12 54.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.228 -0.442 . . . . 75.019999999999996 110.062 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -99.64 119.73 38.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.21 -0.663 . . . . 74.409999999999997 109.21 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.99 166.7 11.87 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.146 -0.933 . . . . 75.019999999999996 109.767 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.67 156.11 36.52 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.99 -1.115 . . . . 75.409999999999997 107.99 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -144.67 140.13 28.44 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 109.189 -0.671 . . . . 65.230000000000004 109.189 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 m -81.02 -20.36 41.92 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.673 -0.862 . . . . 53.530000000000001 108.673 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -72.01 -40.23 68.63 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.066 -0.97 . . . . 63.240000000000002 108.679 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.92 130.47 34.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.222 -0.899 . . . . 62.439999999999998 110.178 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -95.77 172.76 7.83 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.278 -0.874 . . . . 72.400000000000006 109.284 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.431 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 12.7 t -56.67 138.1 53.1 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.772 0.796 . . . . 74.420000000000002 111.278 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.76 -30.2 9.74 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 115.065 -0.971 . . . . 74.25 111.655 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -84.92 144.0 28.64 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.227 0.537 . . . . 75.040000000000006 111.47 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HB3' HD13 ' A' ' 66' ' ' LEU . 20.0 p90 -156.75 151.93 26.36 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.91 -1.515 . . . . 73.319999999999993 106.91 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -143.72 151.48 40.08 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.183 -1.414 . . . . 72.519999999999996 107.183 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.8 140.12 23.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.089 -0.337 . . . . 75.230000000000004 110.089 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -133.25 137.98 46.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.297 -1.001 . . . . 70.409999999999997 108.297 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.16 117.65 3.97 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.727 -1.349 . . . . 51.219999999999999 109.727 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.7 p -116.49 154.4 30.44 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-O 121.195 0.521 . . . . 73.319999999999993 110.906 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 67.7 t -89.92 103.95 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 108.102 -1.073 . . . . 53.140000000000001 108.102 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -101.85 95.69 5.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 106.397 -1.705 . . . . 65.450000000000003 106.397 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 71.6 Cg_endo . . . . . 0 N--CA 1.445 -1.33 0 C-N-CA 121.709 1.606 . . . . 61.109999999999999 112.429 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 112.888 0.699 . . . . 74.340000000000003 112.888 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.79 -33.98 76.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.918 -0.771 . . . . 72.409999999999997 108.918 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.59 -54.15 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.142 -0.936 . . . . 73.349999999999994 109.964 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -63.86 -29.54 70.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.815 0.34 . . . . 74.409999999999997 111.348 -178.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' ARG . . . -60.88 -47.99 83.84 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.107 -0.701 . . . . 72.430000000000007 109.107 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 26.7 tp -66.11 -39.55 90.04 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.393 -0.821 . . . . 64.530000000000001 110.419 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.24 -51.11 67.66 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.137 0.273 . . . . 72.530000000000001 111.687 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.1 ptt180 -70.06 -22.91 63.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.076 0.769 . . . . 72.239999999999995 113.076 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 83.9 mtt180 -70.98 -45.37 64.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.827 -0.435 . . . . 65.430000000000007 109.827 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' ALA . 20.2 mm-40 -68.94 -32.61 72.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.047 -0.524 . . . . 75.409999999999997 110.318 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.05 95.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.451 -0.574 . . . . 62.149999999999999 109.451 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.78 -26.43 66.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.885 -0.598 . . . . 73.120000000000005 111.359 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -78.51 -34.19 47.51 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.316 0.579 . . . . 73.030000000000001 111.172 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.4 9.58 72.67 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.919 -0.658 . . . . 60.119999999999997 112.664 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.8 129.51 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 121.05 0.453 . . . . 74.140000000000001 110.732 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -122.1 141.93 50.9 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.952 -1.022 . . . . 74.239999999999995 110.56 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -75.52 113.44 12.95 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.839 -1.073 . . . . 74.400000000000006 110.782 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.9 tp -116.24 -164.4 0.96 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.428 -2.064 . . . . 51.020000000000003 105.428 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.576 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 mt-30 -48.3 154.89 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.912 0.485 . . . . 72.329999999999998 111.045 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.05 8.97 4.27 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 116.114 -0.494 . . . . 63.439999999999998 114.157 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -78.16 -47.59 17.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.324 -1.361 . . . . 73.219999999999999 107.324 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -173.61 166.08 4.57 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.868 0.692 . . . . 72.150000000000006 112.868 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.0 mt -91.13 151.78 20.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.047 -0.979 . . . . 72.310000000000002 112.298 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.47 129.76 41.12 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.824 -1.176 . . . . 60.009999999999998 107.824 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 158.72 39.14 Favored Pre-proline 0 C--N 1.308 -1.209 0 C-N-CA 123.206 0.602 . . . . 63.310000000000002 109.785 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.73 159.5 41.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.593 2.195 . . . . 73.140000000000001 112.536 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.15 -20.61 4.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.765 -0.652 . . . . 63.109999999999999 110.906 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.52 111.09 23.5 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.714 -1.217 . . . . 64.329999999999998 107.714 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB2' HG22 ' A' ' 106' ' ' VAL . 91.8 m-85 -124.95 131.03 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.246 0.546 . . . . 74.209999999999994 111.669 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' NH2' ' A' ' 122' ' ' ARG . 52.6 mt -127.6 124.41 63.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.513 -0.767 . . . . 62.329999999999998 109.278 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.27 120.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.022 -1.473 . . . . 72.200000000000003 107.022 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 m -108.81 125.96 52.53 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 115.754 -0.657 . . . . 54.140000000000001 109.719 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.67 -176.78 2.98 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 124.662 1.185 . . . . 72.230000000000004 109.135 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.42 172.15 44.61 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.283 -1.127 . . . . 64.319999999999993 110.283 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 70.2 t -59.23 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.66 0.384 . . . . 70.310000000000002 111.362 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 55.9 t-80 -60.65 -40.94 93.86 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.544 0.688 . . . . 73.340000000000003 110.422 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.96 -40.34 83.2 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.452 -1.249 . . . . 74.420000000000002 110.454 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.444 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 88.8 t80 -66.81 -31.74 72.56 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.19 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.6 mm-40 -66.49 -26.2 67.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.993 -0.549 . . . . 72.209999999999994 111.178 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -77.98 -36.12 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.74 -0.837 . . . . 72.319999999999993 108.74 173.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.95 -18.92 65.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.259 -0.882 . . . . 75.400000000000006 110.364 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.45 -5.72 12.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.831 -0.622 . . . . 31.309999999999999 113.394 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.77 70.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.701 -0.481 . . . . 75.540000000000006 109.701 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 81' ' ' LYS . 18.4 t70 -155.71 83.74 3.54 Favored Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 108.568 -0.901 . . . . 71.310000000000002 108.568 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.65 -51.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.995 1.797 . . . . 60.240000000000002 114.417 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -38.93 20.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.273 1.582 . . . . 70.510000000000005 115.273 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 2.2 tm? -66.2 -52.04 51.82 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.815 -0.439 . . . . 62.219999999999999 109.815 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 30.0 mtpp -58.67 -31.29 68.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.098 0.777 . . . . 63.219999999999999 113.098 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -62.21 -45.09 94.92 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.204 0.526 . . . . 33.25 110.186 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 m -72.75 -33.72 66.55 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.098 -0.501 . . . . 61.25 110.332 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.05 92.18 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.19 -0.764 . . . . 71.299999999999997 111.19 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -69.67 -36.09 75.71 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 111.674 0.25 . . . . 73.239999999999995 111.674 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.44 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.681 0.277 . . . . 53.420000000000002 110.897 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.29 -41.24 90.07 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.342 -0.614 . . . . 73.140000000000001 109.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.16 -43.94 81.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.868 -0.605 . . . . 72.430000000000007 110.548 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.48 -36.83 76.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.172 -0.467 . . . . 45.5 110.935 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.32 89.21 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.049 -0.723 . . . . 62.450000000000003 109.049 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -41.92 85.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.188 -0.914 . . . . 75.010000000000005 109.788 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.573 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 17.4 m-85 -57.91 -50.3 73.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.44 0.533 . . . . 74.140000000000001 112.44 174.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.9 -31.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.049 -0.66 . . . . 73.200000000000003 110.965 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -34.59 76.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.420000000000002 111.205 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.56 -43.34 99.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.138 0.971 . . . . 74.109999999999999 109.436 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.5 mm-40 -73.81 -12.53 60.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.377 -1.283 . . . . 71.209999999999994 110.899 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.12 30.56 46.08 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.009 -0.541 . . . . 54.450000000000003 112.467 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -97.36 172.1 7.99 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 122.521 -0.399 . . . . 74.310000000000002 110.0 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HD23 ' A' ' 51' ' ' LEU . 27.9 pt20 -138.98 169.43 17.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.715 -0.476 . . . . 62.25 109.715 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -159.51 179.3 9.03 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.205 -0.665 . . . . 64.239999999999995 109.205 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.12 120.26 37.79 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.482 -0.562 . . . . 72.409999999999997 109.482 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.37 -149.75 16.71 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.955 -1.117 . . . . 73.019999999999996 110.961 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.3 146.03 45.62 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.222 -1.399 . . . . 64.010000000000005 107.222 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.99 109.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.388 -0.597 . . . . 73.230000000000004 109.388 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.15 122.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.578 0.704 . . . . 74.430000000000007 110.364 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' TYR . 78.4 t -118.93 123.51 71.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 74.129999999999995 109.106 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -117.33 147.03 42.97 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.191 -0.67 . . . . 74.209999999999994 109.191 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.36 123.61 45.72 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.25 -1.389 . . . . 74.030000000000001 107.25 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.96 176.16 8.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.674 0.273 . . . . 64.340000000000003 110.966 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 25.7 pt20 -113.03 164.72 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.918 -0.583 . . . . 64.510000000000005 111.219 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.3 p -151.01 148.81 28.81 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 107.513 -1.292 . . . . 52.420000000000002 107.513 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -81.02 -24.89 37.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.257 0.551 . . . . 61.32 109.939 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.66 -21.92 59.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 115.991 -0.549 . . . . 75.450000000000003 112.479 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.36 131.73 41.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 C-N-CA 120.097 -0.641 . . . . 75.530000000000001 109.589 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -114.04 156.42 24.15 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.537 -0.912 . . . . 71.150000000000006 108.537 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.1 m -51.83 110.68 0.5 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.065 0.853 . . . . 73.099999999999994 111.541 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 134.56 -33.96 2.42 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 109.125 -1.59 . . . . 71.209999999999994 109.125 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.17 144.98 31.21 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.783 -0.708 . . . . 74.109999999999999 109.282 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -157.87 160.3 37.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.982 -1.488 . . . . 74.530000000000001 106.982 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -145.43 147.65 32.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.238 -0.653 . . . . 70.519999999999996 109.238 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -122.79 132.74 54.35 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 104.651 -2.352 . . . . 52.109999999999999 104.651 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.445 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 4.9 tmm_? -136.5 135.55 38.65 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.31 -1.367 . . . . 43.140000000000001 107.31 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.42 155.48 17.53 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.298 -1.121 . . . . 73.400000000000006 110.298 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.7 t -149.77 161.47 42.17 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.916 -0.772 . . . . 73.200000000000003 108.916 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.9 110.57 20.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.955 -1.498 . . . . 52.509999999999998 106.955 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -125.67 93.56 44.21 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 116.603 -0.271 . . . . 74.420000000000002 110.709 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 C-N-CA 122.31 2.007 . . . . 71.230000000000004 110.376 175.068 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.945 0.402 . . . . 74.310000000000002 111.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -25.61 66.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.165 0.507 . . . . 73.409999999999997 110.835 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.15 -44.69 49.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.292 -1.003 . . . . 54.240000000000002 108.292 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' HH21 ' A' ' 41' ' ' ARG . 45.7 mt-10 -61.59 -34.73 76.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.189 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 42' ' ' ARG . . . -61.61 -57.74 10.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.228 -0.896 . . . . 62.119999999999997 109.638 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.4 tm? -56.94 -44.52 82.6 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.471 -0.566 . . . . 73.409999999999997 109.471 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 HD22 ' A' ' 89' ' ' LEU . 92.5 mt -58.43 -52.51 65.32 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.488 0.551 . . . . 72.349999999999994 112.488 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 17.9 ptp180 -65.29 -30.22 71.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.929 0.395 . . . . 71.109999999999999 110.678 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 35.8 mmt180 -76.38 -37.66 56.86 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.067 -0.515 . . . . 71.409999999999997 110.713 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 122' ' ' ARG . 21.6 tt0 -78.15 -27.48 48.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.827 -0.749 . . . . 71.230000000000004 110.416 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.14 91.87 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.148 -0.686 . . . . 65.430000000000007 109.148 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.38 -32.81 68.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.420000000000002 110.957 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.67 -42.2 78.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.782 -0.644 . . . . 72.329999999999998 111.211 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.95 9.55 59.89 Favored Glycine 0 C--N 1.319 -0.414 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 113.157 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 14.1 mm -62.1 130.64 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.447 0.641 . . . . 74.140000000000001 111.588 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.7 mt-30 -110.54 134.95 51.91 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 115.517 -0.765 . . . . 71.329999999999998 110.087 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -78.65 91.68 4.66 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.639 -1.164 . . . . 64.329999999999998 108.195 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 24.3 tp -104.4 -165.77 1.18 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.205 -1.405 . . . . 74.420000000000002 107.205 -176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 54.1 mt-30 -45.15 145.55 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.227 0.611 . . . . 72.099999999999994 110.647 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.35 15.83 1.9 Allowed Glycine 0 C--O 1.218 -0.904 0 CA-C-N 116.003 -0.544 . . . . 73.219999999999999 113.26 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 52' ' ' GLN . 2.4 m-20 -70.17 -44.95 67.71 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.654 -1.61 . . . . 74.409999999999997 106.654 175.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 177.35 166.09 0.6 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-N 113.82 -1.536 . . . . 64.430000000000007 109.045 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -90.64 151.09 21.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 110.914 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 36.6 tp -93.62 131.58 38.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.492 -0.776 . . . . 74.409999999999997 108.985 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.49 162.54 33.7 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.128 -0.693 . . . . 75.439999999999998 109.128 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 125' ' ' VAL . 30.4 Cg_exo -66.16 159.33 50.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.752 2.302 . . . . 73.030000000000001 112.602 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 4.8 p-10 -130.23 -19.52 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.328 -0.397 . . . . 71.400000000000006 111.145 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.08 112.46 25.13 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.548 -0.908 . . . . 63.030000000000001 108.548 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 75.8 m-85 -118.54 114.24 22.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.067 0.937 . . . . 64.109999999999999 110.865 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.9 mt -104.93 104.21 16.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.322 -1.308 . . . . 71.409999999999997 108.56 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 HG13 ' A' ' 106' ' ' VAL . 3.0 mp -96.49 128.53 47.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.9 -0.778 . . . . 63.310000000000002 108.9 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.3 m -121.1 129.02 53.12 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.74 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -120.81 174.87 6.33 Favored 'General case' 0 C--O 1.255 1.382 0 O-C-N 124.738 1.273 . . . . 71.239999999999995 109.326 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.7 -174.0 41.32 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 110.265 -1.134 . . . . 31.449999999999999 110.265 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.469 ' HA ' ' NE2' ' A' ' 110' ' ' GLN . 7.6 p -74.68 -51.19 23.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 114.523 1.305 . . . . 63.130000000000003 114.523 -175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.4 -42.07 83.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.547 0.689 . . . . 71.439999999999998 110.358 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.37 -32.27 66.31 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.851 -1.068 . . . . 74.109999999999999 112.759 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.576 ' HB3' HE21 ' A' ' 110' ' ' GLN . 58.7 t80 -66.26 -31.84 72.9 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 119.86 -0.736 . . . . 70.120000000000005 109.302 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.96 -23.15 67.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.387 0.514 . . . . 74.219999999999999 112.387 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -83.21 -28.65 29.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.198 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.497 HD11 ' HG ' ' A' ' 66' ' ' LEU . 57.8 mt -70.54 -37.94 74.13 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 150.14 8.64 Favored Glycine 0 N--CA 1.411 -2.994 0 CA-C-N 114.816 -1.084 . . . . 75.319999999999993 111.231 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -78.23 1.49 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.173 0.511 . . . . 73.430000000000007 110.992 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.14 92.07 4.29 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 121.934 0.874 . . . . 74.219999999999999 109.688 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.8 Cg_exo -75.51 -30.31 6.59 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.418 1.412 . . . . 62.530000000000001 110.03 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -45.65 -53.43 9.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.699 2.0 . . . . 72.129999999999995 113.078 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.69 -48.34 72.37 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.612 -0.722 . . . . 53.549999999999997 110.245 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -74.58 -38.61 62.62 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.85 1.056 . . . . 75.409999999999997 113.85 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 p -62.87 -51.69 66.02 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.71 0.633 . . . . 74.040000000000006 112.71 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -65.49 -43.13 91.13 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-N 116.244 -0.434 . . . . 73.329999999999998 111.365 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.34 52.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.049 -0.596 . . . . 73.099999999999994 112.239 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -70.65 -23.66 62.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.832 0.349 . . . . 73.25 110.095 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.48 -45.93 81.73 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.024 0.44 . . . . 74.219999999999999 109.86 175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.27 -36.72 74.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 109.853 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -62.33 -40.81 97.59 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.275 -0.875 . . . . 73.310000000000002 110.629 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 40' ' ' LEU . 54.7 tp -72.13 -31.88 66.41 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.06 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.0 85.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.719 0.771 . . . . 63.229999999999997 109.299 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.89 -39.87 91.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.671 -1.15 . . . . 64.129999999999995 109.702 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 12.2 m-85 -57.82 -52.25 66.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.015 -0.539 . . . . 75.140000000000001 112.201 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 pt -66.9 -33.42 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.221 -0.591 . . . . 73.439999999999998 111.327 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.94 -31.09 69.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.57 . . . . 62.32 110.781 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.53 -30.32 69.09 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 111.386 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 54.8 mm-40 -86.74 -10.62 53.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.399 0.618 . . . . 65.200000000000003 109.741 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.57 21.37 58.26 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.709 -0.678 . . . . 73.140000000000001 113.362 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.419 ' CD2' HD11 ' A' ' 48' ' ' ILE . 24.6 m0 -93.67 150.82 20.1 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.085 0.469 . . . . 70.209999999999994 111.488 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -112.47 168.49 9.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.541 -0.754 . . . . 73.549999999999997 110.215 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.7 t -162.72 160.61 25.66 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.704 -0.85 . . . . 65.439999999999998 108.704 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -93.52 119.03 32.09 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.457 -1.312 . . . . 74.329999999999998 107.457 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.84 -150.35 16.75 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.78 -1.328 . . . . 61.140000000000001 109.78 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.75 153.82 47.82 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.517 -0.549 . . . . 71.209999999999994 109.517 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.68 123.27 32.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 123.637 0.586 . . . . 63.439999999999998 110.731 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.56 130.48 71.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.259 -0.882 . . . . 63.409999999999997 109.128 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 64' ' ' ILE . 54.9 t -123.97 117.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.07 -1.085 . . . . 54.109999999999999 108.07 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.97 148.49 44.02 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.811 -0.756 . . . . 71.239999999999995 109.887 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.75 129.24 56.18 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.381 -1.34 . . . . 73.230000000000004 107.381 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.61 158.97 43.24 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.039 0.447 . . . . 64.400000000000006 110.296 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.576 HE21 ' HB3' ' A' ' 71' ' ' PHE . 35.9 tt0 -102.15 143.31 32.12 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.311 -0.859 . . . . 73.439999999999998 109.092 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 133.25 26.95 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 109.572 -0.529 . . . . 41.439999999999998 109.572 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.7 m -69.21 -20.43 63.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.142 0.496 . . . . 74.420000000000002 110.559 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.6 3.19 12.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.481 1.112 . . . . 71.019999999999996 111.408 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 115' ' ' HIS . 2.0 tm? -132.83 149.4 52.27 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.383 -2.08 . . . . 75.219999999999999 105.383 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.494 ' N ' HD13 ' A' ' 114' ' ' LEU . 36.7 t-80 -148.2 159.97 43.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.566 -0.531 . . . . 71.010000000000005 109.566 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 m -43.97 125.24 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.673 1.989 . . . . 71.310000000000002 111.926 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.61 -34.76 4.51 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 108.672 -1.771 . . . . 31.32 108.672 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 156.82 18.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.177 -1.045 . . . . 71.349999999999994 108.177 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -169.48 151.72 4.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.321 -2.103 . . . . 75.239999999999995 105.321 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -157.11 151.07 24.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.276 -0.969 . . . . 75.510000000000005 109.982 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -118.9 139.29 51.89 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.597 -1.261 . . . . 43.140000000000001 107.597 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 2.4 tpm_? -111.87 117.79 33.74 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.384 -0.969 . . . . 74.140000000000001 108.384 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.57 109.18 3.04 Favored Glycine 0 C--N 1.291 -1.934 0 O-C-N 123.871 0.732 . . . . 75.0 111.629 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 p -123.64 162.0 23.92 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.33 0.652 . . . . 72.209999999999994 111.138 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.1 t -101.4 131.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 105.069 -2.197 . . . . 73.209999999999994 105.069 173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -112.98 130.8 23.19 Favored Pre-proline 0 C--N 1.295 -1.785 0 C-N-CA 118.542 -1.263 . . . . 74.519999999999996 111.375 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 C-N-CA 122.219 1.946 . . . . 74.230000000000004 110.402 175.506 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' CG ' ' A' ' 37' ' ' GLU . 20.9 mp0 . . . . . 0 C--O 1.212 -0.911 0 N-CA-C 113.188 0.811 . . . . 75.010000000000005 113.188 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.33 -31.23 43.07 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.177 -1.046 . . . . 71.450000000000003 108.177 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.53 -53.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.089 -0.959 . . . . 61.0 109.533 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.34 -29.9 71.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.599 -0.273 . . . . 71.129999999999995 111.376 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.49 95.65 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.329999999999998 110.276 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.12 -37.36 58.17 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 120.705 -0.398 . . . . 63.119999999999997 110.461 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 62' ' ' TYR . 4.1 mm? -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.695 -0.402 . . . . 64.140000000000001 112.069 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -69.28 -27.56 65.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.362 -0.607 . . . . 72.030000000000001 109.362 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -70.22 -40.8 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.209 -0.663 . . . . 71.329999999999998 109.209 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -61.13 -43.39 98.96 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 123.446 0.466 . . . . 74.340000000000003 110.677 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -60.21 -47.22 86.89 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.613 -0.721 . . . . 54.539999999999999 110.381 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.88 -32.46 72.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 63.109999999999999 111.849 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.88 -32.15 51.74 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.446 0.641 . . . . 72.129999999999995 110.366 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.05 16.22 61.02 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.548 -0.751 . . . . 74.549999999999997 113.418 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 mm -63.04 131.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.14 0.576 . . . . 72.030000000000001 111.932 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.8 mt-30 -117.16 144.15 45.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.214 -0.903 . . . . 72.129999999999995 109.472 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.2 m -71.49 114.73 9.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.053 -0.976 . . . . 64.319999999999993 109.87 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 25.7 tp -122.7 -176.94 3.51 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.068 -1.456 . . . . 74.519999999999996 107.068 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 78.0 mt-30 -53.69 164.42 0.55 Allowed 'General case' 0 C--O 1.246 0.914 0 C-N-CA 124.601 1.16 . . . . 74.239999999999995 113.525 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.27 -9.46 23.23 Favored Glycine 0 CA--C 1.504 -0.643 0 CA-C-N 114.921 -1.036 . . . . 63.240000000000002 114.734 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -74.7 -43.9 52.76 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.043 -0.663 . . . . 64.430000000000007 111.518 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.4 ptp180 -175.82 167.09 3.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.3 0.482 . . . . 73.019999999999996 112.3 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.82 151.86 20.39 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.438 1.095 . . . . 71.510000000000005 111.403 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.4 tm? -90.73 131.44 36.4 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.07 -1.085 . . . . 62.340000000000003 108.07 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.74 162.65 35.56 Favored Pre-proline 0 C--N 1.311 -1.107 0 C-N-CA 123.559 0.744 . . . . 52.420000000000002 110.005 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.6 Cg_exo -57.42 161.98 10.83 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.38 2.72 . . . . 72.120000000000005 113.958 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -131.36 -32.71 1.53 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.464 -0.789 . . . . 72.340000000000003 111.719 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.56 106.73 18.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.278 -1.379 . . . . 73.219999999999999 107.278 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.46 ' HB2' HG12 ' A' ' 106' ' ' VAL . 96.7 m-85 -112.16 116.15 30.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.216 0.531 . . . . 75.329999999999998 110.463 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.12 114.5 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.258 -0.883 . . . . 73.150000000000006 109.574 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.45 125.98 70.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.999 -0.741 . . . . 61.340000000000003 108.999 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -110.9 126.53 54.81 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.69 160.86 20.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.014 -0.736 . . . . 74.219999999999999 109.014 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.49 145.04 49.22 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 108.625 -1.79 . . . . 55.25 108.625 172.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.8 p -52.57 -37.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 113.01 0.744 . . . . 62.140000000000001 113.01 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.17 -22.67 62.01 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.475 0.655 . . . . 74.340000000000003 111.255 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 29.8 m-20 -85.87 -35.25 20.7 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 121.552 -0.717 . . . . 73.519999999999996 110.279 175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -63.16 -24.86 68.08 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.087 -0.96 . . . . 74.340000000000003 109.444 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 38.2 mt-10 -58.29 -33.6 69.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 111.917 0.34 . . . . 65.430000000000007 111.917 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 70' ' ' ASP . 4.2 mppt? -81.08 -34.68 32.5 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.327 -0.549 . . . . 71.540000000000006 109.931 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.4 mt -68.58 -35.36 77.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.52 0.676 . . . . 72.439999999999998 110.224 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 6.32 39.2 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.786 -1.097 . . . . 43.539999999999999 113.973 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.29 97.54 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.613 -1.254 . . . . 73.219999999999999 107.613 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 9.3 m-20 -148.25 82.74 7.49 Favored Pre-proline 0 CA--C 1.508 -0.656 0 N-CA-C 106.175 -1.787 . . . . 73.310000000000002 106.175 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.05 -47.64 23.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.511 2.14 . . . . 72.030000000000001 111.694 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -46.66 71.98 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.198 -0.91 . . . . 74.519999999999996 111.046 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.36 -53.7 54.5 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.386 -0.598 . . . . 73.420000000000002 109.386 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 77' ' ' ASP . 14.1 mptt -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.864 -0.607 . . . . 74.030000000000001 111.778 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -67.37 -45.28 76.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.891 -0.324 . . . . 71.040000000000006 110.942 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.4 m -62.42 -44.33 96.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.239 0.216 . . . . 74.439999999999998 111.023 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.17 -46.6 90.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.017 -0.611 . . . . 72.200000000000003 112.059 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.71 -35.87 82.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 110.34 -0.244 . . . . 72.420000000000002 110.34 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -63.19 -46.62 86.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.628 0.251 . . . . 74.319999999999993 110.581 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.43 -44.61 90.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.129 -0.487 . . . . 65.530000000000001 111.003 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.4 -34.08 75.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.559 0.578 . . . . 72.409999999999997 112.559 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.34 -35.16 65.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.997 0.427 . . . . 55.329999999999998 110.181 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.78 81.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.799 0.809 . . . . 73.5 109.678 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.57 -38.88 88.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.906 -1.043 . . . . 65.540000000000006 109.022 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -59.36 -49.09 79.15 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.41 -0.814 . . . . 63.329999999999998 111.918 175.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -66.38 -30.5 50.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 120.32 -0.552 . . . . 70.230000000000004 111.006 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -64.02 -43.3 96.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.433 -0.349 . . . . 63.420000000000002 110.537 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.86 -32.77 72.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.074 0.464 . . . . 71.200000000000003 112.072 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 64.8 mm-40 -81.45 -13.21 58.47 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.197 0.522 . . . . 55.299999999999997 111.452 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 84.55 34.42 16.43 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.764 -0.653 . . . . 50.310000000000002 111.669 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -110.71 173.98 6.08 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.88 -0.415 . . . . 64.430000000000007 109.88 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -155.84 174.0 15.96 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.328 -0.99 . . . . 44.109999999999999 108.328 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -147.33 176.4 10.03 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.681 -0.859 . . . . 53.420000000000002 108.681 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -99.06 120.14 38.98 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.277 -1.379 . . . . 72.329999999999998 107.277 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.9 -149.81 16.83 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.999 -1.64 . . . . 61.240000000000002 108.999 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -132.47 144.44 50.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.375 -1.343 . . . . 74.319999999999993 107.375 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.05 124.24 20.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.213 0.53 . . . . 74.230000000000004 112.008 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.93 120.51 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.408 -0.815 . . . . 64.329999999999998 110.045 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 62' ' ' TYR . 14.8 m -106.65 147.5 11.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.774 -1.195 . . . . 35.229999999999997 107.774 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -137.31 142.12 41.88 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.841 -0.8 . . . . 71.129999999999995 108.841 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -114.19 134.75 54.7 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.03 -0.532 . . . . 62.039999999999999 109.655 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.3 159.81 35.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.122 0.487 . . . . 71.230000000000004 110.001 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -107.56 155.1 20.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.51 -0.768 . . . . 72.510000000000005 109.828 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -138.99 140.12 38.1 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.695 -1.224 . . . . 74.400000000000006 107.695 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 m -82.08 -27.43 32.92 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.343 0.592 . . . . 71.109999999999999 110.067 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -80.57 -34.51 35.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.596 -0.729 . . . . 75.219999999999999 109.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 tp -77.45 133.37 38.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.168 -1.789 . . . . 73.109999999999999 106.168 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.4 ' CG ' ' H ' ' A' ' 116' ' ' THR . 12.5 t-80 -116.5 172.35 7.27 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.848 -1.541 . . . . 65.239999999999995 112.311 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.612 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 21.9 m -50.59 132.02 25.48 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 125.668 1.587 . . . . 73.319999999999993 113.387 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.62 -6.13 83.29 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.634 -1.166 . . . . 72.439999999999998 112.247 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.36 136.17 54.79 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.893 -1.151 . . . . 75.019999999999996 107.893 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.3 159.96 42.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.945 -0.391 . . . . 75.400000000000006 109.945 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 mmp_? -133.17 137.31 46.17 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.811 -0.811 . . . . 74.319999999999993 108.811 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.23 44.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.788 -0.819 . . . . 72.439999999999998 108.788 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -139.7 131.87 28.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.455 -0.572 . . . . 74.530000000000001 109.455 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.82 128.56 8.5 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.825 -0.91 . . . . 62.409999999999997 110.825 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.4 m -123.33 144.76 49.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 109.347 -0.612 . . . . 74.450000000000003 109.347 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 59' ' ' PRO . 89.8 t -93.92 105.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.003 -1.11 . . . . 74.120000000000005 108.003 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.62 110.35 48.68 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.873 -1.158 . . . . 73.409999999999997 107.873 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.454 -0.838 0 C-N-CA 121.613 1.542 . . . . 73.200000000000003 111.608 -179.857 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 . . . . . 0 C--O 1.216 -0.702 0 CA-C-O 120.559 0.219 . . . . 74.200000000000003 110.494 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -34.46 75.49 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.608 0.595 . . . . 72.019999999999996 112.608 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.42 -51.68 35.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.555 . . . . 74.219999999999999 109.5 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.7 pt-20 -66.79 -30.05 70.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.594 -0.275 . . . . 61.450000000000003 111.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.65 -39.19 93.1 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.149 0.5 . . . . 53.109999999999999 109.873 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -71.11 -45.93 62.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.503 -0.925 . . . . 71.409999999999997 108.503 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 40' ' ' LEU 0.268 3.7 mm? -67.69 -33.69 75.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.586 1.328 . . . . 72.109999999999999 114.586 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 2.5 ptm180 -67.48 -32.47 73.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 119.806 -0.758 . . . . 54.43 109.085 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -35.8 69.26 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.326 -0.62 . . . . 71.430000000000007 109.326 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.9 -43.91 91.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.469 -0.567 . . . . 75.409999999999997 109.469 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -48.08 82.95 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.632 -0.713 . . . . 75.099999999999994 110.47 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.98 85.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.019 -0.537 . . . . 71.219999999999999 111.732 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -72.51 -39.91 67.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 109.753 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.58 31.36 6.17 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.272 -0.876 . . . . 73.099999999999994 113.311 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 56' ' ' LEU . 17.7 mm -71.65 130.35 35.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.185 -0.672 . . . . 55.009999999999998 109.185 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 21.0 tt0 -107.74 136.56 47.27 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.667 -0.864 . . . . 74.430000000000007 108.667 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -67.59 107.44 2.51 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.764 0.793 . . . . 72.219999999999999 111.093 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.4 tp -118.12 -166.34 1.2 Allowed 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.065 -2.198 . . . . 70.019999999999996 105.065 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.605 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 52.6 mt-30 -51.77 152.55 2.84 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 111.631 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.45 -3.28 18.85 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-N 116.087 -0.506 . . . . 74.219999999999999 113.453 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -65.23 -46.69 79.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.868 -1.16 . . . . 74.219999999999999 107.868 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -174.68 154.75 2.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.841 -1.072 . . . . 73.040000000000006 110.901 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.3 mt -90.56 151.79 21.18 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.563 -1.199 . . . . 65.430000000000007 109.878 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 40.6 tp -92.92 128.99 38.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.911 -0.586 . . . . 72.439999999999998 109.458 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.54 154.16 42.49 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 109.203 -0.665 . . . . 64.530000000000001 109.203 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 125' ' ' VAL . 38.8 Cg_exo -62.21 155.78 54.48 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.724 2.283 . . . . 63.100000000000001 112.396 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -127.49 -24.17 3.37 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.707 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.45 112.54 24.53 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.283 -1.006 . . . . 73.310000000000002 108.283 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.4 m-85 -121.93 122.37 39.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.34 0.59 . . . . 74.310000000000002 110.701 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.3 mt -120.08 116.47 50.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.088 -0.708 . . . . 75.549999999999997 109.088 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.09 126.0 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.257 -1.016 . . . . 70.430000000000007 108.257 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.81 117.27 32.36 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.64 -0.709 . . . . 71.109999999999999 109.204 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.5 mm? -100.72 161.69 13.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 122.82 0.448 . . . . 73.430000000000007 109.953 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.02 150.02 51.66 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.324 -1.91 . . . . 71.209999999999994 108.324 170.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.01 -35.01 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 117.325 0.562 . . . . 74.120000000000005 112.389 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.57 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 20.6 t60 -73.12 -28.89 62.52 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 116.021 -0.536 . . . . 63.520000000000003 110.576 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -85.72 -24.21 27.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.545 -0.722 . . . . 70.25 110.462 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.54 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 82.4 t80 -64.74 -41.35 95.99 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.277 0.56 . . . . 75.129999999999995 110.089 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.74 -25.54 65.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.032 -0.531 . . . . 73.0 111.008 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 2.1 mptm? -75.22 -22.57 57.84 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.23 -0.895 . . . . 74.510000000000005 111.763 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.0 -31.13 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.668 -1.234 . . . . 70.140000000000001 107.668 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.96 -162.73 15.62 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.642 -1.163 . . . . 71.310000000000002 111.69 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.14 -37.37 38.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.004 -0.739 . . . . 64.5 109.004 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -115.71 97.06 48.13 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.522 -0.763 . . . . 64.439999999999998 110.385 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.49 -33.5 22.54 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 121.962 1.775 . . . . 74.329999999999998 109.525 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.96 -22.29 59.89 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.55 -1.204 . . . . 63.329999999999998 111.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.2 tp -54.48 -45.37 73.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.203 -0.665 . . . . 63.229999999999997 109.203 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.54 -26.38 19.76 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 115.698 -0.683 . . . . 61.210000000000001 110.739 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -55.28 -51.14 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.15 0.432 . . . . 52.200000000000003 111.936 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.2 m -56.07 -45.57 79.29 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.127 0.489 . . . . 65.450000000000003 111.047 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.81 -43.25 75.6 Favored Glycine 0 C--O 1.206 -1.626 0 C-N-CA 120.907 -0.663 . . . . 25.300000000000001 111.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -61.17 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.168 0.987 . . . . 74.439999999999998 110.152 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.75 -45.91 92.49 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.546 -0.752 . . . . 63.32 109.837 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -75.34 -24.71 57.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.617 -0.719 . . . . 71.329999999999998 112.212 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.67 -51.47 59.23 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.092 -1.077 . . . . 73.129999999999995 108.092 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.72 -42.76 99.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.11 -0.95 . . . . 71.549999999999997 109.583 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -60.87 -39.09 87.88 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.192 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 23.1 t70 -72.83 -36.39 67.48 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.655 -0.498 . . . . 60.140000000000001 109.655 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.9 m-85 -59.26 -44.98 92.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.101 -0.5 . . . . 74.409999999999997 111.515 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -70.19 -25.43 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.372 -0.531 . . . . 45.329999999999998 111.293 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 79.5 mt-30 -66.69 -42.54 86.31 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.745 -0.835 . . . . 72.129999999999995 108.745 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 58.4 mt-10 -63.83 -26.68 68.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.458 -0.792 . . . . 72.129999999999995 111.227 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.5 mm-40 -92.95 -13.73 28.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 75.340000000000003 110.794 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.24 28.35 56.1 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.811 -0.632 . . . . 63.520000000000003 113.128 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -97.13 173.45 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.238 -0.653 . . . . 72.450000000000003 109.238 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.442 ' NE2' HD23 ' A' ' 51' ' ' LEU . 26.6 pt20 -132.32 165.75 23.49 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 122.458 -0.151 . . . . 72.230000000000004 110.822 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.8 t -154.15 158.15 39.94 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.449 -1.315 . . . . 74.25 107.449 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.14 120.7 37.89 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.379 -0.529 . . . . 71.129999999999995 110.989 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.04 -169.31 13.81 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.825 -1.31 . . . . 73.540000000000006 109.825 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -92.32 143.96 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.027 -0.731 . . . . 75.420000000000002 109.027 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 90' ' ' ALA . 6.1 p -80.85 115.09 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.923 0.868 . . . . 75.329999999999998 109.953 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.44 128.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 115.237 -0.892 . . . . 64.349999999999994 110.092 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 8.6 p -133.81 141.54 43.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.406 -0.961 . . . . 75.340000000000003 108.406 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -137.45 149.9 47.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.129 -0.628 . . . . 62.020000000000003 109.821 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -115.34 114.57 25.3 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.096 -1.446 . . . . 63.109999999999999 107.096 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.09 167.42 11.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.644 -0.502 . . . . 33.43 109.644 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.8 pt20 -104.57 160.47 14.92 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.416 0.626 . . . . 53.229999999999997 110.68 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -140.5 130.84 25.17 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.068 -0.969 . . . . 72.129999999999995 108.885 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -81.19 -5.74 58.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.119 -0.492 . . . . 74.129999999999995 110.501 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -88.87 -20.57 24.43 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.055 0.455 . . . . 75.25 110.758 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.0 mt -94.73 142.96 26.84 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.144 0.497 . . . . 61.039999999999999 110.299 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -98.12 173.07 7.21 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.399 -0.819 . . . . 64.329999999999998 109.787 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 m -53.68 118.38 3.88 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 124.197 0.936 . . . . 73.019999999999996 111.033 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.23 5.3 52.83 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 121.042 -0.599 . . . . 63.210000000000001 113.321 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.04 141.4 48.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.268 0.534 . . . . 71.120000000000005 110.985 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.641 ' HB3' HD13 ' A' ' 66' ' ' LEU . 28.8 p90 -152.06 151.02 30.58 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 109.891 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.68 144.87 48.52 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.657 -1.238 . . . . 55.43 107.657 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.44 10.78 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 117.946 0.339 . . . . 64.319999999999993 110.526 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.51 ' HA ' ' NE ' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -125.47 135.23 52.11 Favored 'General case' 0 N--CA 1.39 -3.457 0 N-CA-C 109.906 -0.405 . . . . 75.209999999999994 109.906 178.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.6 143.4 17.83 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 109.506 -1.438 . . . . 72.040000000000006 109.506 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.6 m -145.35 150.57 36.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.101 -0.703 . . . . 73.349999999999994 109.101 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 59' ' ' PRO . 48.7 t -86.38 105.99 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.193 -1.039 . . . . 72.230000000000004 108.193 177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -122.02 100.13 43.2 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 108.772 -0.825 . . . . 72.019999999999996 108.772 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 C--O 1.245 0.857 0 C-N-CA 122.231 1.954 . . . . 75.450000000000003 112.326 -177.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 . . . . . 0 C--O 1.227 -0.089 0 CA-C-O 120.855 0.36 . . . . 75.230000000000004 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -72.88 -31.38 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 43.100000000000001 109.757 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 99.4 t -60.57 -50.96 78.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.22 -0.446 . . . . 73.340000000000003 110.351 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.39 -34.44 77.27 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.043 -0.663 . . . . 74.239999999999995 110.661 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.83 80.8 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 110.582 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.7 tt -66.32 -42.94 87.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.334 -0.848 . . . . 70.120000000000005 109.931 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 93.9 mt -61.28 -39.21 89.59 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.05 0.452 . . . . 71.099999999999994 111.688 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -67.99 -33.46 74.68 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 123.723 0.809 . . . . 71.239999999999995 110.416 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -75.65 -36.16 60.24 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.063 -1.088 . . . . 74.409999999999997 108.063 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 63.2 mm-40 -63.62 -34.59 78.16 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.684 . . . . 73.010000000000005 110.351 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.29 94.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.836 -0.62 . . . . 74.140000000000001 109.727 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.23 -25.23 61.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.342 0.591 . . . . 72.140000000000001 110.89 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.69 -46.11 59.81 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.388 0.675 . . . . 75.310000000000002 111.135 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 26.39 10.12 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 120.698 -0.763 . . . . 53.409999999999997 114.093 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.18 141.61 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 122.65 0.38 . . . . 74.109999999999999 110.544 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.2 mt-30 -120.31 149.13 42.79 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.926 0.393 . . . . 54.240000000000002 110.412 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.5 p -76.56 128.92 35.68 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.72 -1.127 . . . . 52.210000000000001 109.446 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 28.4 tp -146.24 -166.35 2.45 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.899 -2.26 . . . . 73.319999999999993 104.899 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.568 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 98.2 mt-30 -43.91 136.52 3.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.743 0.652 . . . . 64.150000000000006 110.357 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.48 -8.23 31.05 Favored Glycine 0 N--CA 1.464 0.503 0 CA-C-N 116.654 -0.248 . . . . 40.210000000000001 113.487 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.61 -38.44 90.21 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.085 0.554 . . . . 73.120000000000005 109.801 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -171.59 147.9 2.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.025 -0.534 . . . . 72.230000000000004 111.213 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -91.08 151.89 20.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.723 0.809 . . . . 74.420000000000002 111.369 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 34.0 tp -84.81 128.88 34.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.74 -0.837 . . . . 65.299999999999997 108.74 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 98' ' ' TRP . . . -112.46 154.31 44.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 122.919 0.487 . . . . 62.299999999999997 111.11 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HB3' ' N ' ' A' ' 124' ' ' THR . 78.3 Cg_exo -58.31 145.91 91.55 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.475 2.783 . . . . 63.310000000000002 112.819 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 125' ' ' VAL . 24.6 p-10 -122.6 -25.37 4.73 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.263 -0.426 . . . . 73.519999999999996 110.137 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.35 113.09 25.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.955 -0.758 . . . . 65.439999999999998 108.955 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 93.9 m-85 -112.67 114.94 27.78 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.363 0.602 . . . . 70.230000000000004 109.49 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.39 120.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 71.219999999999999 108.559 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 40' ' ' LEU . 63.6 mt -115.8 125.74 73.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.967 -1.123 . . . . 64.140000000000001 107.967 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.9 m -120.56 120.62 36.35 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 116.4 -0.364 . . . . 72.530000000000001 110.1 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.4 mm? -106.5 170.82 7.7 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 122.905 0.482 . . . . 65.230000000000004 110.736 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.29 167.32 51.96 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.484 -1.446 . . . . 70.430000000000007 109.484 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.97 -40.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 117.492 0.646 . . . . 74.430000000000007 111.936 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.419 ' CD2' ' HE2' ' A' ' 73' ' ' LYS . 58.3 t60 -75.77 -28.84 58.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.254 -0.647 . . . . 73.510000000000005 109.254 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 61.1 m-20 -76.16 -29.46 57.75 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 120.791 -0.363 . . . . 63.109999999999999 111.13 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -69.33 -29.46 67.29 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.313 -0.995 . . . . 75.439999999999998 108.313 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.11 -26.46 66.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.777 -0.647 . . . . 75.140000000000001 111.115 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -70.63 -36.29 73.37 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.199 -0.667 . . . . 71.340000000000003 109.199 173.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.77 -30.11 69.48 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.338 -0.986 . . . . 74.200000000000003 108.338 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -138.18 16.03 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 114.13 -1.396 . . . . 23.43 113.325 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.88 -2.4 56.85 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.123 -0.538 . . . . 53.43 109.852 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -117.72 100.18 52.36 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 113.27 0.841 . . . . 53.450000000000003 113.27 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.47 -42.57 0.21 Allowed 'Trans proline' 0 CA--C 1.56 1.779 0 C-N-CA 121.656 1.57 . . . . 74.019999999999996 111.589 166.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -84.37 -29.71 26.03 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 118.775 2.88 . . . . 74.329999999999998 118.775 -163.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.74 -44.22 82.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.223 1.374 . . . . 64.439999999999998 108.563 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -65.04 -32.61 74.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.099 -0.955 . . . . 74.230000000000004 111.169 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.2 m -63.34 -43.32 98.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.817 -0.438 . . . . 53.130000000000003 109.817 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 64.3 m -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 116.253 -0.43 . . . . 64.439999999999998 110.817 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -52.11 49.89 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.234 -0.507 . . . . 24.399999999999999 112.036 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -63.16 -39.97 96.21 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.507 0.558 . . . . 62.039999999999999 112.507 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.571 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.87 -45.28 95.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.82 0.343 . . . . 61.439999999999998 111.151 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.5 -42.03 87.99 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.759 -0.655 . . . . 72.109999999999999 110.926 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.43 -42.67 82.8 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.48 -0.782 . . . . 75.400000000000006 110.488 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.47 -34.74 78.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.158 0.429 . . . . 64.400000000000006 112.158 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.09 88.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.509 0.671 . . . . 74.239999999999995 110.334 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 24.6 t70 -69.77 -43.95 71.15 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 109.362 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.3 m-85 -55.44 -56.73 16.8 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 113.126 0.787 . . . . 74.349999999999994 113.126 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.8 pt -57.47 -36.66 54.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 123.26 0.35 . . . . 74.150000000000006 111.548 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.17 -37.66 81.24 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.441 -0.345 . . . . 65.409999999999997 111.856 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.7 mt-10 -63.75 -34.75 78.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.304 0.573 . . . . 71.430000000000007 110.682 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 73.5 mm-40 -76.34 -13.72 60.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.508 -0.769 . . . . 62.310000000000002 111.008 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.02 67.46 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.943 -0.572 . . . . 75.150000000000006 112.267 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 14.8 m0 -81.42 165.01 21.66 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.461 -0.57 . . . . 72.450000000000003 109.461 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -133.8 165.67 24.43 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.257 -0.645 . . . . 75.230000000000004 109.257 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -155.41 170.86 20.94 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.157 -1.053 . . . . 65.430000000000007 108.157 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -106.86 119.18 38.65 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.888 -1.152 . . . . 74.530000000000001 107.888 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.14 -149.33 16.59 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 109.168 -1.573 . . . . 71.540000000000006 109.168 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.95 175.76 7.83 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.762 -1.57 . . . . 71.519999999999996 106.762 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -82.41 127.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.066 0.46 . . . . 74.340000000000003 110.511 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 m -127.54 127.33 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.548 -0.751 . . . . 71.5 109.083 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -131.62 145.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 107.321 -1.362 . . . . 74.239999999999995 107.321 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.56 139.3 20.75 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.339 0.59 . . . . 73.409999999999997 110.476 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.82 131.8 44.0 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.489 -1.232 . . . . 74.010000000000005 109.432 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.2 pt-20 -136.89 176.53 8.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.762 -0.829 . . . . 71.140000000000001 108.762 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -127.0 164.58 21.19 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.732 0.777 . . . . 65.120000000000005 111.406 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 m -142.04 127.03 18.34 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.968 -1.123 . . . . 63.340000000000003 107.968 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 t -69.24 -19.16 63.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.271 0.628 . . . . 71.329999999999998 110.283 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -65.79 -30.4 71.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 74.030000000000001 109.765 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.36 131.3 34.71 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.422 0.63 . . . . 74.120000000000005 110.772 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.405 ' HB3' HE21 ' A' ' 118' ' ' GLN . 47.5 t60 -92.29 162.0 14.46 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.635 -1.246 . . . . 72.019999999999996 107.635 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.9 m -55.93 126.82 27.43 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.431 0.692 . . . . 62.329999999999998 110.972 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.37 -14.53 47.26 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.558 -0.746 . . . . 63.509999999999998 111.616 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 115' ' ' HIS . 2.2 mp0 -106.46 131.72 53.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.565 -0.532 . . . . 63.530000000000001 109.565 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.448 ' HB3' HD13 ' A' ' 66' ' ' LEU . 16.4 p90 -145.45 159.37 43.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.093 -0.706 . . . . 73.150000000000006 109.093 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.95 149.81 52.33 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.093 -0.706 . . . . 74.430000000000007 109.093 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.27 134.84 17.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.487 -0.56 . . . . 55.020000000000003 109.487 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -132.39 145.3 51.13 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 121.38 0.609 . . . . 64.129999999999995 111.925 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.81 113.4 1.86 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.989 -1.645 . . . . 73.439999999999998 108.989 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 59' ' ' PRO . 61.0 m -143.13 145.45 32.84 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 108.951 -0.759 . . . . 75.299999999999997 108.951 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.44 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 6.0 p -86.91 118.15 32.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.993 -1.114 . . . . 71.420000000000002 107.993 174.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -126.21 88.78 53.65 Favored Pre-proline 0 C--N 1.29 -2.018 0 CA-C-N 115.626 -0.715 . . . . 62.420000000000002 110.087 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 122.382 2.055 . . . . 64.140000000000001 111.381 178.513 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.279 0.561 . . . . 73.200000000000003 110.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -79.82 -38.58 32.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.187 -0.915 . . . . 61.450000000000003 108.805 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.53 -53.48 46.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 115.532 -0.758 . . . . 63.509999999999998 110.028 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -65.53 -32.42 74.01 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 120.642 -0.423 . . . . 72.340000000000003 111.778 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.05 -53.97 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.062 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.2 mm? -71.59 -34.64 70.07 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.044 -0.525 . . . . 74.530000000000001 111.366 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp -65.85 -41.05 92.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.516 0.198 . . . . 70.099999999999994 111.381 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -73.93 -26.51 60.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.21 -0.596 . . . . 72.120000000000005 109.495 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -71.18 -35.75 71.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.372 -0.603 . . . . 73.239999999999995 109.372 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 78.0 mm-40 -61.09 -37.36 82.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.766 -0.457 . . . . 73.239999999999995 109.766 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.68 82.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 73.409999999999997 109.92 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.42 -33.45 73.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.309 0.576 . . . . 45.240000000000002 112.007 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.05 -37.32 39.28 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.469 0.707 . . . . 61.509999999999998 110.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.54 14.49 63.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.483 -0.78 . . . . 41.520000000000003 113.365 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG23 ' HB3' ' A' ' 56' ' ' LEU . 9.0 mm -54.6 141.6 10.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.005 0.922 . . . . 61.450000000000003 110.96 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.36 126.75 55.62 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 107.02 -1.474 . . . . 74.329999999999998 107.02 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -66.71 102.18 0.9 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.331 0.586 . . . . 51.509999999999998 110.125 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -104.24 -165.97 1.2 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.487 -2.042 . . . . 71.230000000000004 105.487 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.619 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -47.13 144.04 2.85 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.155 -0.683 . . . . 62.219999999999999 109.155 172.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.63 7.49 3.86 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 114.343 0.497 . . . . 51.310000000000002 114.343 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -76.71 -35.6 57.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.536 -0.913 . . . . 44.25 108.536 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HD3' ' OE1' ' A' ' 99' ' ' GLN . 8.2 ptm180 -168.45 157.54 9.0 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.137 -0.483 . . . . 73.219999999999999 110.754 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 98' ' ' TRP . 77.6 mt -91.89 151.37 20.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.258 0.623 . . . . 70.25 110.408 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 HD22 ' A' ' 51' ' ' LEU . 5.6 tt -101.24 127.29 47.89 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.619 -1.252 . . . . 74.109999999999999 107.619 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.72 158.08 32.45 Favored Pre-proline 0 C--N 1.301 -1.543 0 C-N-CA 122.96 0.504 . . . . 71.430000000000007 110.169 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 125' ' ' VAL . 73.6 Cg_exo -54.25 161.83 4.91 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.073 2.515 . . . . 73.329999999999998 113.363 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -125.94 -25.54 3.59 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.63 -0.713 . . . . 70.340000000000003 110.421 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -101.2 100.52 11.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.917 -1.142 . . . . 53.439999999999998 107.917 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.36 119.24 38.58 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 72.030000000000001 109.898 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.0 mt -116.13 114.09 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.527 -0.761 . . . . 71.450000000000003 109.528 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -104.62 134.15 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 106.641 -1.615 . . . . 74.049999999999997 106.641 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 m -131.6 125.66 32.79 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 120.901 -0.32 . . . . 73.140000000000001 111.329 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.2 mm? -132.44 172.92 11.86 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.341 1.026 . . . . 73.549999999999997 109.543 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.9 51.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.675 -0.97 . . . . 72.140000000000001 110.675 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 88.0 t -60.92 -45.73 97.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.993 0.517 . . . . 74.450000000000003 110.87 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -64.65 -31.47 72.7 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.752 1.221 . . . . 73.519999999999996 110.686 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.51 -37.53 19.57 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.584 0.707 . . . . 64.230000000000004 109.252 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 74' ' ' LEU . 40.1 t80 -60.57 -32.02 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.168 -0.924 . . . . 75.439999999999998 111.315 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 54.3 mt-10 -55.61 -38.26 69.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.418 0.627 . . . . 74.409999999999997 110.139 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -83.43 -28.64 28.69 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.006 -0.997 . . . . 54.439999999999998 109.842 -173.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 71' ' ' PHE . 67.2 mt -55.78 -45.78 78.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.83 0.707 . . . . 73.540000000000006 109.65 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.68 158.48 21.31 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.614 -0.995 . . . . 72.109999999999999 110.614 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -18.21 60.45 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.491 0.662 . . . . 75.209999999999994 110.202 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.95 138.22 17.85 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 108.459 -0.941 . . . . 72.150000000000006 108.459 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.4 -51.45 7.41 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.573 2.182 . . . . 73.409999999999997 112.88 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -64.91 -30.12 71.1 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.326 -0.397 . . . . 74.430000000000007 111.486 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.58 -40.91 53.67 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.329 1.018 . . . . 74.230000000000004 109.514 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -95.2 -39.23 10.19 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 74.510000000000005 110.688 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.9 m -58.44 -44.82 89.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.72 0.637 . . . . 75.120000000000005 112.72 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -63.04 -54.49 37.37 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 120.926 0.393 . . . . 64.129999999999995 111.558 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.83 -37.71 92.47 Favored Glycine 0 C--O 1.245 0.807 0 C-N-CA 121.406 -0.426 . . . . 74.219999999999999 113.1 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -75.47 -30.0 59.79 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.868 -0.195 . . . . 64.319999999999993 110.684 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.03 -38.46 90.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.955 -0.387 . . . . 62.310000000000002 109.955 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -60.86 -47.74 85.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.403 -0.817 . . . . 71.010000000000005 111.048 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 11.1 t70 -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.539 0.685 . . . . 74.310000000000002 110.486 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.65 -36.95 70.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 65.519999999999996 109.157 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.45 -36.67 84.53 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 109.298 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 30.1 t70 -59.56 -52.2 66.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.688 -1.142 . . . . 52.409999999999997 109.06 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -52.96 -50.79 63.36 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.403 0.89 . . . . 75.540000000000006 113.403 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.41 -37.26 79.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.193 -0.603 . . . . 71.0 112.225 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -70.56 -34.83 72.66 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.812 -0.355 . . . . 74.040000000000006 111.281 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 64.7 mm-40 -63.1 -35.26 79.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.156 0.503 . . . . 73.540000000000006 110.636 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -81.79 -12.96 58.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.581 -0.736 . . . . 71.030000000000001 111.204 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 89.85 23.97 31.42 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.903 -0.59 . . . . 41.530000000000001 112.991 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.9 m0 -98.5 149.23 22.94 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.068 0.461 . . . . 75.329999999999998 111.406 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.488 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 13.8 pt20 -124.47 177.46 5.9 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.367 -0.833 . . . . 74.109999999999999 109.14 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -162.13 -179.17 6.88 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.744 -0.836 . . . . 60.140000000000001 108.744 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -112.19 120.53 42.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.099 -0.704 . . . . 61.109999999999999 109.099 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.06 -150.28 16.73 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 119.713 -1.232 . . . . 63.119999999999997 110.451 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.68 144.32 38.22 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.371 -1.344 . . . . 73.129999999999995 107.371 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 90' ' ' ALA . 12.0 p -79.51 141.52 15.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.199 -1.037 . . . . 64.519999999999996 108.199 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.61 124.8 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.309 0.576 . . . . 54.439999999999998 109.984 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 72.7 t -108.63 112.59 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 105.981 -1.859 . . . . 73.5 105.981 175.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -124.06 140.33 53.08 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.688 -0.687 . . . . 73.209999999999994 111.286 -172.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -109.73 130.77 55.48 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.175 -0.921 . . . . 74.099999999999994 109.972 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.94 166.35 21.86 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.972 0.415 . . . . 72.109999999999999 110.922 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 45.0 mt-30 -106.62 142.8 35.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.233 -0.894 . . . . 71.400000000000006 109.379 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 114' ' ' LEU . 12.5 p -119.88 136.72 54.39 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 112.777 0.658 . . . . 73.140000000000001 112.777 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -82.93 -40.47 20.09 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.582 0.706 . . . . 50.119999999999997 109.7 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.73 -22.43 43.31 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.135 -0.939 . . . . 72.420000000000002 112.194 -174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.453 ' HB3' ' OG ' ' A' ' 111' ' ' SER . 25.7 tp -114.5 137.37 51.93 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.028 -2.582 . . . . 73.140000000000001 104.028 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -139.55 172.61 12.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.325 -1.35 . . . . 65.409999999999997 111.724 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.6 m -35.83 124.64 0.71 Allowed 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.166 2.187 . . . . 74.120000000000005 113.557 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.64 -22.94 27.4 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.217 -1.153 . . . . 75.239999999999995 110.217 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -112.17 128.23 56.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.416 -0.587 . . . . 61.140000000000001 109.416 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -124.69 149.66 46.97 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.27 -1.011 . . . . 60.039999999999999 108.27 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -136.74 143.12 43.13 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.237 -1.023 . . . . 73.340000000000003 108.237 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.74 142.03 40.97 Favored 'General case' 0 C--N 1.257 -3.451 0 N-CA-C 104.302 -2.481 . . . . 73.549999999999997 104.302 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -156.9 162.36 39.66 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.28 -0.568 . . . . 74.319999999999993 110.225 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.03 119.2 1.68 Allowed Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 110.67 -0.972 . . . . 73.340000000000003 110.67 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.7 m -110.23 144.01 39.54 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.017 -0.734 . . . . 73.219999999999999 109.017 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 59' ' ' PRO . 63.0 t -99.35 112.96 33.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.566 -1.272 . . . . 71.450000000000003 107.566 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -88.35 107.5 16.98 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 107.051 -1.462 . . . . 75.0 107.051 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 C-N-CA 122.087 1.858 . . . . 63.32 113.273 -174.801 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 114.916 1.45 . . . . 74.530000000000001 114.916 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 -27.83 35.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.016 -1.074 . . . . 75.040000000000006 109.949 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.5 -43.23 80.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.026 -1.472 . . . . 74.439999999999998 107.026 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.51 -49.37 72.77 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.104 -0.953 . . . . 62.439999999999998 109.824 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.94 -52.89 22.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.765 0.826 . . . . 71.430000000000007 111.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.65 -42.67 86.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.127 0.417 . . . . 62.439999999999998 112.127 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.24 -39.96 82.12 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.957 0.725 . . . . 72.230000000000004 112.957 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.58 -26.36 62.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.468 0.651 . . . . 75.510000000000005 109.741 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.75 -45.08 60.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.292 -1.003 . . . . 64.040000000000006 108.292 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.047 -0.524 . . . . 72.349999999999994 111.323 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.47 95.33 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.952 -0.567 . . . . 30.129999999999999 111.124 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.69 -22.99 45.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.412 0.625 . . . . 74.340000000000003 111.398 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.28 -40.34 51.98 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.393 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.41 40.8 2.67 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.693 -0.685 . . . . 72.530000000000001 112.559 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mm -79.81 139.41 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.616 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp0 -118.7 144.0 46.51 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.159 0.984 . . . . 73.209999999999994 108.52 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -81.03 100.99 9.27 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.981 0.896 . . . . 53.299999999999997 110.027 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.3 tp -118.67 -163.92 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 105.596 -2.001 . . . . 74.310000000000002 105.596 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -41.41 126.03 2.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.799 0.687 . . . . 63.399999999999999 109.97 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.3 50.08 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 114.656 0.622 . . . . 74.239999999999995 114.656 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.4 -23.86 62.83 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.526 -0.469 . . . . 73.239999999999995 111.805 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 13.9 ptm180 -162.18 128.71 3.67 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.532 0.682 . . . . 72.120000000000005 111.808 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.54 151.81 21.18 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 123.848 0.859 . . . . 60.509999999999998 110.985 -170.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.3 tm? -85.75 118.67 25.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.837 -0.801 . . . . 71.340000000000003 108.837 -174.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.44 165.61 12.33 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 124.137 0.975 . . . . 64.200000000000003 110.118 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.8 Cg_exo -57.83 160.8 14.09 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.472 2.782 . . . . 54.130000000000003 113.371 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.9 p-10 -127.28 -31.94 2.51 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.375 -0.829 . . . . 62.240000000000002 111.079 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -109.07 111.5 23.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.026 -0.731 . . . . 74.219999999999999 109.026 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' HB2' HG12 ' A' ' 106' ' ' VAL . 50.0 m-85 -106.68 120.17 41.26 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.682 -0.858 . . . . 75.420000000000002 108.682 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.72 115.31 43.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.718 -0.475 . . . . 72.540000000000006 109.718 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.7 mp -112.46 109.94 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 107.194 -1.41 . . . . 72.329999999999998 107.194 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -105.86 122.7 46.64 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.539 -0.541 . . . . 74.510000000000005 109.539 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.3 mm? -110.41 163.64 13.48 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.376 0.67 . . . . 61.520000000000003 109.753 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.13 53.58 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.096 -1.602 . . . . 74.140000000000001 109.096 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 5.8 p -59.73 -37.46 71.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.792 0.796 . . . . 72.120000000000005 111.859 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 56.2 t-80 -58.96 -41.93 88.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 75.230000000000004 109.798 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.409 ' O ' HD23 ' A' ' 74' ' ' LEU . 5.8 m-20 -75.28 -39.62 59.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.535 -0.757 . . . . 61.420000000000002 111.739 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -57.94 -28.28 64.16 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.103 0.477 . . . . 72.409999999999997 111.095 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 94.1 mt-10 -62.77 -35.24 79.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.144 0.497 . . . . 74.510000000000005 110.215 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 69' ' ' HIS . 45.3 mmtt -85.02 -17.47 37.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.034 -0.728 . . . . 74.120000000000005 109.034 -172.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 4.5 mm? -69.97 -41.49 74.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.882 -1.054 . . . . 63.340000000000003 109.336 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.81 168.7 13.02 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.312 -0.946 . . . . 74.230000000000004 112.167 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.96 53.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.897 0.379 . . . . 52.539999999999999 111.762 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -112.14 96.0 32.68 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.305 -0.628 . . . . 54.420000000000002 109.305 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.1 -31.56 4.79 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 122.042 1.828 . . . . 60.210000000000001 111.038 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -53.15 42.51 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 115.508 1.67 . . . . 75.219999999999999 115.508 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.51 -15.82 61.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.858 0.754 . . . . 63.439999999999998 111.491 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 74' ' ' LEU . 58.4 mttp -90.79 -44.41 9.45 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.561 -0.745 . . . . 71.340000000000003 109.697 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 p -67.43 -51.22 54.29 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.12 0.568 . . . . 62.100000000000001 110.322 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.4 m -59.69 -41.15 90.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.567 -0.531 . . . . 73.439999999999998 109.567 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.58 52.95 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.563 -0.744 . . . . 62.509999999999998 112.634 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.98 -28.12 65.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 61.450000000000003 110.082 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 104' ' ' VAL . . . -64.03 -42.66 97.02 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.997 -0.547 . . . . 50.530000000000001 110.439 176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 19.0 mmt85 -64.09 -39.59 94.39 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 111.313 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -44.25 87.83 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.332 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.65 -34.98 79.07 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.34 99.05 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.422 0.63 . . . . 72.519999999999996 110.108 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.49 -40.78 80.77 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.107 -0.951 . . . . 54.140000000000001 109.353 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -55.86 -50.75 69.77 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.472 1.109 . . . . 74.230000000000004 111.369 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.45 -35.82 75.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.756 -0.377 . . . . 72.209999999999994 111.142 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.31 -40.93 96.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 75.109999999999999 109.76 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -62.67 -29.54 70.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.333 -0.849 . . . . 41.200000000000003 112.338 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -85.87 1.47 49.72 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.645 -0.707 . . . . 72.340000000000003 111.223 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 27.25 52.65 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 121.07 -0.586 . . . . 45.32 112.261 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.83 167.64 10.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.419 -0.46 . . . . 70.140000000000001 110.065 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.504 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.4 pt20 -143.34 167.24 22.64 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.287 -1.005 . . . . 71.409999999999997 108.287 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.572 ' HA ' HD22 ' A' ' 57' ' ' LEU . 10.8 t -150.01 -177.33 5.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.718 -0.475 . . . . 73.010000000000005 109.718 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.98 120.09 38.0 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.905 -0.406 . . . . 72.439999999999998 109.905 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -155.33 16.35 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 119.718 -1.23 . . . . 62.310000000000002 111.787 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -103.84 137.1 42.32 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.988 -1.486 . . . . 73.239999999999995 106.988 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.409 ' O ' ' HB1' ' A' ' 86' ' ' ALA . 66.6 t -83.21 124.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.776 -0.824 . . . . 60.32 108.776 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.05 130.13 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 CA-C-O 121.642 0.734 . . . . 62.32 110.941 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 62' ' ' TYR . 34.7 m -104.43 127.42 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 N-CA-C 106.249 -1.76 . . . . 73.319999999999993 106.249 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -105.78 126.61 52.36 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.838 -0.619 . . . . 74.530000000000001 109.95 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -113.59 114.26 26.21 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.243 -1.392 . . . . 74.439999999999998 107.243 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.87 166.79 23.7 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.377 -0.374 . . . . 75.420000000000002 111.042 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -99.24 160.87 13.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.091 0.948 . . . . 74.450000000000003 112.171 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -149.48 115.67 5.75 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 113.559 -1.655 . . . . 51.0 107.819 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -81.03 -2.81 49.53 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.881 0.848 . . . . 61.340000000000003 109.559 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.68 -38.47 19.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.631 -1.168 . . . . 74.349999999999994 108.364 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.02 161.8 30.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.542 -0.91 . . . . 73.340000000000003 108.542 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -87.55 154.3 20.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.055 0.455 . . . . 63.310000000000002 110.055 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 m -62.23 132.48 52.87 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 124.354 1.062 . . . . 71.430000000000007 109.489 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 28.96 60.83 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.536 -0.364 . . . . 64.099999999999994 112.417 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -137.07 149.39 47.36 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.024 -1.102 . . . . 71.310000000000002 108.024 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.429 ' HB3' HD13 ' A' ' 66' ' ' LEU . 41.8 p90 -139.37 156.66 46.86 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.668 -0.413 . . . . 72.420000000000002 110.966 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 36.5 mmt180 -123.63 131.16 53.55 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.384 -0.969 . . . . 72.430000000000007 108.384 174.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.58 120.57 24.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.41 -0.589 . . . . 54.020000000000003 109.41 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -135.38 138.36 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.362 -0.381 . . . . 74.120000000000005 110.4 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -105.44 109.81 3.31 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.79 -0.924 . . . . 62.43 110.79 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.3 m -109.92 143.16 40.26 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.526 0.679 . . . . 70.540000000000006 110.603 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.9 t -90.54 110.35 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.175 -1.787 . . . . 75.239999999999995 106.175 171.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -102.16 104.42 36.55 Favored Pre-proline 0 C--N 1.281 -2.386 0 N-CA-C 108.087 -1.079 . . . . 74.310000000000002 108.087 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.295 1.996 . . . . 71.409999999999997 110.447 179.586 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--O 1.218 -0.594 0 N-CA-C 112.101 0.408 . . . . 55.219999999999999 112.101 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.34 -55.11 39.17 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.214 -0.661 . . . . 74.219999999999999 109.214 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.67 -42.67 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.113 -0.948 . . . . 71.230000000000004 109.503 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 42.3 mt-10 -56.77 -54.75 42.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 72.5 111.891 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.13 81.75 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.335 0.254 . . . . 65.140000000000001 111.558 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.6 tm? -61.96 -45.73 92.38 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.994 -0.743 . . . . 74.099999999999994 108.994 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.93 -29.14 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.043 0.757 . . . . 73.409999999999997 113.043 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 67.2 mtt180 -63.92 -41.53 97.62 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.002 -1.11 . . . . 74.400000000000006 108.002 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.32 -47.65 81.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.93 -1.032 . . . . 72.109999999999999 110.931 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -59.43 -42.55 92.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.134 0.574 . . . . 64.420000000000002 110.482 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.17 82.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 72.420000000000002 110.949 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.5 -29.02 63.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 71.450000000000003 111.981 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.49 -36.72 32.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.518 -0.31 . . . . 54.32 110.567 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.69 18.92 27.49 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.13 -0.487 . . . . 75.120000000000005 113.652 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -68.83 133.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 123.364 0.666 . . . . 74.519999999999996 110.725 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' HD23 ' A' ' 57' ' ' LEU . 94.3 mt-30 -107.03 147.96 29.3 Favored 'General case' 0 CA--C 1.473 -1.994 0 N-CA-C 109.061 -0.718 . . . . 73.200000000000003 109.061 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -86.38 91.62 8.57 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.011 -1.107 . . . . 72.349999999999994 108.011 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.9 tp -98.9 -165.55 1.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.825 -1.546 . . . . 73.25 106.825 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.661 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.5 mt-30 -44.6 148.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.685 1.194 . . . . 65.540000000000006 111.449 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.87 -15.95 56.04 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.731 -0.668 . . . . 75.409999999999997 113.185 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -61.6 -48.67 79.88 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.791 -0.448 . . . . 74.329999999999998 109.791 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -168.51 149.27 4.73 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.924 -0.58 . . . . 61.450000000000003 111.242 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.04 151.72 20.92 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.047 0.939 . . . . 63.149999999999999 110.594 -173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD23 ' OE1' ' A' ' 49' ' ' GLN . 15.7 tp -89.9 127.68 36.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.844 -0.616 . . . . 75.549999999999997 109.603 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.68 158.0 40.05 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 123.381 0.672 . . . . 61.240000000000002 109.275 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.573 ' HA ' HG22 ' A' ' 125' ' ' VAL . 34.9 Cg_exo -62.93 148.34 93.57 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.62 2.214 . . . . 60.299999999999997 111.611 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 33.9 p-10 -120.77 -28.41 4.87 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.81 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.68 124.61 50.25 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.436 -0.95 . . . . 72.129999999999995 108.436 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 106' ' ' VAL . 45.3 m-85 -121.38 127.69 51.47 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.873 -0.417 . . . . 74.209999999999994 109.873 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 120.13 63.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.943 -0.762 . . . . 71.340000000000003 108.943 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.54 123.67 68.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.928 -0.767 . . . . 74.230000000000004 108.928 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 m -104.28 124.89 49.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.579 -0.282 . . . . 72.010000000000005 110.39 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -115.0 165.47 12.85 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.408 0.683 . . . . 61.140000000000001 110.168 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.25 145.23 31.73 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.934 -1.667 . . . . 64.510000000000005 108.934 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.4 p -50.29 -43.04 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 113.937 1.088 . . . . 75.239999999999995 113.937 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -64.73 -36.61 84.84 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.138 0.494 . . . . 75.510000000000005 111.445 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 116' ' ' THR . 13.0 t70 -86.33 -23.47 26.23 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.639 -0.824 . . . . 64.420000000000002 110.082 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.13 -30.87 71.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.096 -0.705 . . . . 62.140000000000001 109.096 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.6 mt-10 -57.46 -33.76 68.3 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.036 -0.529 . . . . 75.010000000000005 110.44 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -74.57 -39.16 62.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.598 -0.89 . . . . 63.329999999999998 108.598 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.481 HD11 ' HG ' ' A' ' 66' ' ' LEU . 89.5 mt -62.41 -37.34 85.43 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.658 0.742 . . . . 72.040000000000006 109.083 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.2 -171.29 13.62 Favored Glycine 0 N--CA 1.414 -2.822 0 CA-C-N 114.615 -1.175 . . . . 55.130000000000003 110.813 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -93.58 -5.81 48.03 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.671 0.272 . . . . 55.509999999999998 110.334 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -89.6 111.18 44.35 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 115.702 -0.681 . . . . 71.409999999999997 112.422 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 5.8 Cg_exo -77.94 -51.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.308 2.005 . . . . 73.409999999999997 113.029 172.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 107' ' ' ARG . 48.9 mt-10 -86.54 -39.36 16.29 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 118.476 2.769 . . . . 75.209999999999994 118.476 -169.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.98 -52.47 65.24 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.419 1.009 . . . . 70.450000000000003 113.057 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -63.91 -32.13 73.56 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 122.692 1.234 . . . . 65.209999999999994 110.742 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 106' ' ' VAL . 37.9 m -75.8 -17.3 59.91 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.101 -1.409 . . . . 51.219999999999999 112.022 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 m -69.44 -41.87 75.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.372 -0.603 . . . . 71.019999999999996 109.372 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.97 -36.14 61.07 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.9 -0.88 . . . . 42.329999999999998 110.9 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -65.03 -46.51 81.01 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.22 0.533 . . . . 74.329999999999998 109.795 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.85 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.042 -0.526 . . . . 55.100000000000001 111.286 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -59.17 -45.02 92.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 75.430000000000007 109.834 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.47 -43.72 89.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.982 -1.008 . . . . 62.200000000000003 110.187 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.82 -39.22 90.66 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 115.718 -0.673 . . . . 74.430000000000007 109.828 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.1 91.41 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.39 0.614 . . . . 63.100000000000001 110.462 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -41.03 83.36 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.473 -0.785 . . . . 72.340000000000003 110.009 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 m-85 -56.31 -53.54 56.1 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.622 -0.717 . . . . 71.340000000000003 112.077 175.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.0 pt -62.88 -35.69 72.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 120.797 -0.361 . . . . 74.120000000000005 111.863 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.73 -37.19 81.85 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 121.135 -0.226 . . . . 52.25 110.793 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.7 -28.31 69.81 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.41 0.624 . . . . 72.120000000000005 110.483 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 60.2 mm-40 -88.33 -4.68 58.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.985 -0.552 . . . . 60.439999999999998 111.162 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.04 26.94 59.18 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.857 -0.61 . . . . 65.140000000000001 112.416 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -98.44 161.41 13.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.929 -0.767 . . . . 75.230000000000004 108.929 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -129.72 174.61 9.54 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 110.068 -0.345 . . . . 75.439999999999998 110.068 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.5 t -165.15 170.4 14.99 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 105.409 -2.071 . . . . 72.549999999999997 105.409 175.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.08 118.01 33.73 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.092 -1.447 . . . . 64.209999999999994 107.092 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.78 -149.49 16.72 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 119.218 -1.468 . . . . 75.329999999999998 109.885 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -132.28 163.48 28.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.662 -1.236 . . . . 65.319999999999993 107.662 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.66 131.99 33.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.255 0.55 . . . . 73.329999999999998 112.177 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.95 120.52 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-N 115.233 -0.894 . . . . 64.319999999999993 109.294 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.3 m -112.25 143.36 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 107.071 -1.455 . . . . 75.120000000000005 107.071 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.3 mtt180 -142.45 150.67 40.87 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.71 0.29 . . . . 74.109999999999999 110.809 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.0 151.14 23.56 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.503 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.71 166.58 24.36 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 53.299999999999997 107.94 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.26 152.57 38.73 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.685 -0.487 . . . . 74.219999999999999 109.685 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.7 m -134.02 138.84 45.64 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 115.902 -0.59 . . . . 62.509999999999998 109.669 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 t -80.53 -23.63 39.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.801 -0.814 . . . . 63.439999999999998 108.801 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -82.18 -5.17 58.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.859 -0.61 . . . . 71.299999999999997 111.529 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.3 148.28 29.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.412 -1.329 . . . . 73.120000000000005 107.412 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -119.07 156.7 29.24 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.826 -0.749 . . . . 62.420000000000002 111.055 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 70' ' ' ASP . 4.7 m -49.2 121.14 4.57 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 126.248 1.819 . . . . 60.140000000000001 111.528 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.96 -30.78 6.9 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.832 -0.907 . . . . 70.040000000000006 110.832 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.77 131.1 39.47 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.223 -0.658 . . . . 71.230000000000004 109.223 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 150.75 42.38 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.649 -0.871 . . . . 73.239999999999995 108.649 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -140.65 147.23 38.99 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.24 -0.652 . . . . 72.209999999999994 109.24 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -142.77 139.84 31.17 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.003 -0.369 . . . . 73.310000000000002 110.003 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -132.66 149.55 52.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.061 -0.518 . . . . 75.120000000000005 109.762 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.29 123.07 5.53 Favored Glycine 0 C--N 1.282 -2.44 0 N-CA-C 109.656 -1.378 . . . . 73.120000000000005 109.656 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.4 m -121.01 150.85 40.51 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.701 -0.852 . . . . 71.329999999999998 108.701 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 59' ' ' PRO . 46.6 t -98.58 118.09 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.411 -0.959 . . . . 73.299999999999997 108.411 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.08 101.97 7.36 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.124 -1.436 . . . . 63.310000000000002 107.124 171.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.5 Cg_endo . . . . . 0 N--CA 1.456 -0.706 0 C-N-CA 122.09 1.86 . . . . 54.439999999999998 112.161 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 110.53 -0.174 . . . . 73.409999999999997 110.53 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -58.53 -34.74 71.31 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.917 0.389 . . . . 53.009999999999998 111.043 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.57 -56.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.697 -0.683 . . . . 44.310000000000002 110.034 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.45 -25.47 64.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.18 -0.608 . . . . 63.439999999999998 111.901 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.02 94.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.202 0.525 . . . . 65.150000000000006 109.713 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.15 -37.92 66.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 120.045 -0.662 . . . . 62.509999999999998 109.938 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.28 0.474 . . . . 64.299999999999997 112.28 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -63.68 -29.96 71.13 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.961 0.41 . . . . 75.120000000000005 110.341 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 -69.13 -51.76 35.08 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.446 -0.343 . . . . 73.230000000000004 110.512 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -64.76 -30.87 71.89 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.344 0.403 . . . . 71.219999999999999 110.679 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.74 88.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.131 -0.486 . . . . 41.450000000000003 109.887 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.27 -25.9 61.78 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.818 0.818 . . . . 71.219999999999999 110.787 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.93 -24.91 48.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.268 -0.878 . . . . 70.150000000000006 110.791 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.65 17.01 54.2 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.87 -0.605 . . . . 34.240000000000002 112.826 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 45' ' ' ALA . 22.2 mm -67.5 131.55 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.059 0.457 . . . . 74.349999999999994 110.943 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 HE21 HD23 ' A' ' 57' ' ' LEU . 26.3 mt-30 -127.91 144.34 51.1 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.654 -0.703 . . . . 64.209999999999994 110.342 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 m -66.76 130.11 42.08 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.512 -1.222 . . . . 74.439999999999998 110.906 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.8 tp -149.12 -166.21 2.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 104.027 -2.583 . . . . 63.149999999999999 104.027 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 84.6 mm-40 -60.26 155.83 16.83 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.586 0.958 . . . . 64.409999999999997 113.586 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.71 -5.31 44.61 Favored Glycine 0 CA--C 1.507 -0.407 0 CA-C-N 114.991 -1.004 . . . . 64.049999999999997 114.678 -170.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -42.79 51.38 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.29 -0.633 . . . . 74.420000000000002 109.29 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 99' ' ' GLN . 13.2 ptp180 -165.06 140.69 5.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 112.501 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.89 152.48 20.72 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.117 1.367 . . . . 74.530000000000001 110.282 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 100' ' ' THR . 44.9 tp -79.07 127.45 32.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.447 -0.575 . . . . 71.530000000000001 109.447 -176.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -122.26 164.46 25.77 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 123.575 0.75 . . . . 73.519999999999996 109.419 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 125' ' ' VAL . 44.9 Cg_exo -62.04 156.96 46.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.178 2.585 . . . . 71.510000000000005 113.525 176.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.7 p-10 -128.02 -30.12 2.49 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.342 -0.844 . . . . 63.149999999999999 110.739 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.06 117.55 32.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.165 -1.05 . . . . 71.030000000000001 108.165 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.82 114.14 22.19 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.46 0.648 . . . . 73.239999999999995 110.231 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.11 111.9 37.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.97 -1.014 . . . . 64.420000000000002 108.944 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 3.0 mp -102.97 119.52 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.728 -0.842 . . . . 74.219999999999999 108.728 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 126.58 53.27 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 109.582 -0.525 . . . . 72.200000000000003 109.582 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.45 165.82 16.43 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 122.915 0.486 . . . . 64.019999999999996 110.642 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.08 146.68 50.44 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.734 -1.747 . . . . 43.439999999999998 108.734 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -46.2 -54.96 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.606 0.965 . . . . 75.519999999999996 113.606 -173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -69.06 -29.94 68.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.436 0.532 . . . . 72.25 112.436 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.25 -40.84 62.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.513 -1.291 . . . . 70.209999999999994 107.513 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.03 -34.27 77.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.216 -1.356 . . . . 63.420000000000002 111.891 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -53.79 -37.75 63.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.22 0.533 . . . . 62.310000000000002 111.134 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -85.41 -29.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.664 -0.698 . . . . 73.049999999999997 110.413 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 mt -71.91 -36.79 70.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.367 0.603 . . . . 63.240000000000002 109.962 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.49 12.54 26.74 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.256 -0.884 . . . . 62.140000000000001 112.557 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.32 -10.36 54.61 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.327 -0.62 . . . . 73.319999999999993 109.327 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -139.48 72.48 37.21 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.074 -0.512 . . . . 61.25 111.739 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.69 -28.03 31.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 N-CA-C 108.383 -1.429 . . . . 75.129999999999995 108.383 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.38 -53.67 54.88 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.28 -1.782 . . . . 74.310000000000002 111.343 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.95 -42.88 12.81 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.087 0.773 . . . . 63.109999999999999 113.087 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -76.56 -58.86 3.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.109 0.781 . . . . 72.120000000000005 113.109 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -63.29 -48.52 77.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.854 0.359 . . . . 72.400000000000006 110.998 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -64.87 -44.46 89.62 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 111.256 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -56.49 20.41 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 115.773 -0.649 . . . . 63.030000000000001 112.625 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.27 -32.42 72.24 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 112.301 0.482 . . . . 72.099999999999994 112.301 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.27 86.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 71.209999999999994 111.229 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.565 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -82.1 -25.73 34.22 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.204 0.446 . . . . 75.319999999999993 112.204 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.64 -43.85 65.39 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.486 -0.931 . . . . 65.420000000000002 108.486 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 92' ' ' TYR . 1.2 tm? -67.7 -31.79 71.99 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.769 -0.826 . . . . 73.310000000000002 108.769 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.93 -40.08 94.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 72.120000000000005 110.779 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 29.1 t70 -74.33 -32.87 62.98 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.303 -0.629 . . . . 62.43 109.303 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.39 -57.6 11.61 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.438 -0.801 . . . . 73.230000000000004 110.191 173.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.3 pt -56.5 -30.08 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 120.995 -0.282 . . . . 64.420000000000002 111.198 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mm-40 -64.75 -45.43 86.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.842 -0.343 . . . . 72.230000000000004 110.926 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 50.3 mt-10 -59.79 -42.55 93.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.711 0.804 . . . . 63.420000000000002 111.895 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -80.64 -13.27 59.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 113.885 1.068 . . . . 74.349999999999994 113.885 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.71 39.41 9.6 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.597 -1.287 . . . . 50.329999999999998 112.52 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -112.12 174.45 5.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.519 -0.401 . . . . 73.430000000000007 110.272 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 26.7 pt20 -149.07 171.23 16.74 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.191 0.596 . . . . 72.519999999999996 109.611 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 57' ' ' LEU . 13.4 t -159.49 178.36 9.97 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.338 -0.986 . . . . 44.420000000000002 108.338 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -101.45 118.62 37.33 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.392 -0.966 . . . . 74.439999999999998 108.392 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.79 -149.46 16.6 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 119.296 -1.431 . . . . 75.310000000000002 111.055 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -118.99 150.57 39.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.878 -1.527 . . . . 74.129999999999995 106.878 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.6 128.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.478 -0.564 . . . . 54.409999999999997 109.478 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.73 149.65 26.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 123.627 0.579 . . . . 74.549999999999997 110.039 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.96 113.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.252 0.549 . . . . 50.299999999999997 110.181 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -119.97 139.66 52.12 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.9 -0.591 . . . . 72.230000000000004 110.285 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.25 143.82 42.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.356 -0.609 . . . . 72.340000000000003 109.356 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.28 171.49 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.886 0.374 . . . . 70.25 111.653 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.88 159.54 15.56 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.785 -0.643 . . . . 61.340000000000003 110.875 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.2 p -143.74 141.78 30.63 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.496 -0.775 . . . . 54.130000000000003 109.229 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -81.36 -26.77 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.272 0.558 . . . . 71.439999999999998 110.809 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -77.86 -30.39 50.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.655 -0.702 . . . . 72.129999999999995 111.991 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.72 150.7 26.57 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.904 -0.718 . . . . 61.130000000000003 111.518 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' GLN . 84.8 m-70 -97.1 173.54 7.2 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.939 -1.028 . . . . 73.019999999999996 110.606 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 130.58 42.12 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.239 -1.393 . . . . 75.430000000000007 107.239 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.87 -3.87 82.04 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.805 -0.712 . . . . 51.020000000000003 111.903 -174.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 5.2 tp-100 -101.54 119.8 39.32 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.088 -1.449 . . . . 74.510000000000005 107.088 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.9 157.15 46.16 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.69 -0.804 . . . . 75.010000000000005 112.106 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -145.38 143.31 30.04 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.439 -1.255 . . . . 75.349999999999994 107.81 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . . . -134.56 139.12 45.15 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 105.511 -2.033 . . . . 75.129999999999995 105.511 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -129.25 127.49 41.33 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.99 -0.684 . . . . 70.140000000000001 109.999 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.33 117.47 5.87 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.297 -1.521 . . . . 61.43 109.297 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 90.4 m -121.16 145.82 47.42 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 122.767 0.427 . . . . 52.32 110.019 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 59' ' ' PRO . 47.1 t -93.52 110.07 22.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -108.45 104.12 53.12 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 109.693 -0.484 . . . . 73.230000000000004 109.693 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 C-N-CA 122.38 2.054 . . . . 73.430000000000007 110.893 176.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 120.339 0.114 . . . . 75.340000000000003 111.071 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -60.02 -44.1 94.83 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.98 0.895 . . . . 62.43 109.198 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.5 t -63.18 -55.87 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.772 -1.558 . . . . 43.539999999999999 110.74 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 pt-20 -64.44 -34.01 77.2 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.391 -0.523 . . . . 75.219999999999999 111.735 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.3 91.01 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.919 -0.401 . . . . 62.520000000000003 109.919 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.96 -38.46 72.8 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.304 -0.407 . . . . 72.340000000000003 110.444 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.9 mt -60.34 -47.65 85.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.908 0.336 . . . . 74.549999999999997 111.908 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.2 ptm180 -71.58 -30.62 66.04 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 120.552 -0.459 . . . . 75.230000000000004 111.034 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -68.13 -41.43 81.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 72.540000000000006 109.269 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 122' ' ' ARG . 4.9 tp10 -64.51 -43.94 92.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.081 -0.963 . . . . 73.129999999999995 109.024 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.75 76.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 65.340000000000003 110.654 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.42 71.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 60.219999999999999 112.64 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.39 -13.54 24.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.969 -1.092 . . . . 74.439999999999998 110.661 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.16 3.42 76.49 Favored Glycine 0 CA--C 1.502 -0.749 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.86 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 56' ' ' LEU . 20.4 mm -55.55 127.67 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 C-N-CA 124.39 1.076 . . . . 73.230000000000004 111.028 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 35.2 tt0 -105.45 135.89 46.01 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.449 -1.315 . . . . 65.049999999999997 107.449 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -70.19 122.25 19.12 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.318 -1.364 . . . . 60.450000000000003 107.318 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.1 tp -127.02 -165.59 1.48 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 105.98 -1.859 . . . . 71.329999999999998 105.98 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.582 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.1 mt-30 -53.29 160.37 1.14 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.056 0.543 . . . . 70.349999999999994 111.733 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.77 -10.91 47.65 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 116.124 -0.489 . . . . 60.409999999999997 113.233 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.45 -44.58 74.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.498 -0.186 . . . . 55.240000000000002 110.498 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -171.89 166.59 6.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 113.066 0.765 . . . . 71.409999999999997 113.066 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB3' HG23 ' A' ' 48' ' ' ILE . 76.8 mt -93.94 151.92 19.21 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 125.17 1.388 . . . . 73.409999999999997 111.401 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 31.0 tp -98.94 130.96 45.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.554 -0.906 . . . . 74.5 108.554 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 156.28 44.67 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 123.539 0.525 . . . . 74.030000000000001 110.424 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -62.47 154.87 61.42 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.95 2.434 . . . . 72.420000000000002 112.229 176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 29.0 p-10 -128.34 -28.09 2.6 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.04 -0.527 . . . . 62.020000000000003 112.131 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.7 119.15 35.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 120.067 -0.653 . . . . 73.209999999999994 109.703 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' HB2' HG22 ' A' ' 106' ' ' VAL . 68.7 m-85 -120.14 114.26 21.69 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.406 0.622 . . . . 71.019999999999996 109.792 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.2 mt -102.2 107.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.985 -1.117 . . . . 73.049999999999997 107.985 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.3 mt -102.02 115.28 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.054 -1.091 . . . . 72.150000000000006 108.054 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 16.9 m -109.06 121.83 45.99 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 115.927 -0.579 . . . . 75.219999999999999 110.152 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.6 mm? -110.03 174.75 5.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.851 1.26 . . . . 72.109999999999999 109.986 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.67 164.9 50.92 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 108.762 -1.735 . . . . 71.219999999999999 108.762 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.26 -33.12 61.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 118.316 1.058 . . . . 63.219999999999999 111.483 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.562 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 41.9 t60 -75.85 -28.5 58.23 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 120.449 -0.501 . . . . 73.239999999999995 109.729 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 33.0 m-20 -75.29 -31.96 60.86 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.145 -0.687 . . . . 74.219999999999999 109.145 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 78' ' ' PRO . 73.2 t80 -62.25 -44.49 96.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.338 -0.846 . . . . 74.230000000000004 110.734 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.57 -30.58 69.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.316 0.579 . . . . 73.25 110.771 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 74.3 mmtt -73.14 -24.27 60.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.408 -0.814 . . . . 73.530000000000001 110.647 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 98.4 mt -68.26 -31.62 71.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.056 -1.09 . . . . 71.400000000000006 108.056 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.56 179.76 19.65 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.231 -0.895 . . . . 52.149999999999999 111.621 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.32 -17.27 46.35 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.274 -1.009 . . . . 44.450000000000003 108.274 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -128.98 75.16 80.64 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.902 -1.045 . . . . 75.120000000000005 108.399 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 23.4 Cg_exo -69.15 -36.37 12.55 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.263 1.975 . . . . 73.530000000000001 111.836 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.52 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 2.8 tp10 -69.35 -12.16 61.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.649 -0.705 . . . . 73.230000000000004 110.631 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.56 -36.66 73.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.016 -0.538 . . . . 63.219999999999999 109.839 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -84.89 -13.18 51.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.912 -0.315 . . . . 72.109999999999999 111.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 19.9 m -61.1 -40.96 95.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 64.010000000000005 110.453 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -67.86 -29.09 68.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.785 -0.643 . . . . 73.239999999999995 110.007 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.3 91.89 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.425 -1.07 . . . . 44.25 110.425 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -68.65 -32.43 72.27 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 111.688 0.255 . . . . 70.129999999999995 111.688 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.69 -44.78 96.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 110.333 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -67.79 -44.15 78.07 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.528 -0.76 . . . . 64.329999999999998 110.625 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.77 -38.07 89.75 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.302 -0.408 . . . . 64.420000000000002 111.237 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.3 -41.79 72.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.439 -0.578 . . . . 74.430000000000007 109.439 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.63 90.68 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.439 0.638 . . . . 71.5 109.468 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.86 -53.62 55.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.481 -1.236 . . . . 74.219999999999999 108.779 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.632 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.5 m-85 -51.06 -55.37 17.89 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.924 0.713 . . . . 72.150000000000006 112.924 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -62.16 -37.22 77.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 112.618 0.599 . . . . 72.450000000000003 112.618 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -71.74 -35.25 70.08 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.904 -0.319 . . . . 74.409999999999997 111.024 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.87 -31.98 73.46 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.261 0.553 . . . . 74.329999999999998 111.235 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.0 mm-40 -79.45 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.024 -0.534 . . . . 70.239999999999995 110.969 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.46 21.28 32.4 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.218 -0.515 . . . . 72.25 112.033 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -102.99 172.1 7.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.747 -0.834 . . . . 75.019999999999996 108.747 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -140.74 173.91 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.143 -0.688 . . . . 70.439999999999998 109.143 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.3 t -148.98 171.28 16.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.609 -0.886 . . . . 64.109999999999999 108.609 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 73.8 m-85 -114.43 121.05 42.37 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 109.476 -0.565 . . . . 62.130000000000003 109.476 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -150.06 17.05 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 109.516 -1.434 . . . . 73.230000000000004 109.516 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -119.42 143.48 47.46 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.915 -1.143 . . . . 62.210000000000001 107.915 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 69.9 t -74.66 118.12 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.173 -0.677 . . . . 75.510000000000005 109.173 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.8 120.23 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-O 122.131 0.967 . . . . 64.219999999999999 110.305 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.9 t -115.33 137.47 48.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 106.297 -1.742 . . . . 73.420000000000002 106.297 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -141.18 139.31 33.84 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.47 0.481 . . . . 74.5 111.859 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -108.72 114.23 27.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 64.200000000000003 108.588 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.1 pt-20 -135.61 165.5 25.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.743 -0.208 . . . . 71.120000000000005 110.793 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.18 165.59 10.93 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 114.612 1.338 . . . . 62.329999999999998 114.612 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -134.22 141.69 47.12 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.541 -1.651 . . . . 42.130000000000003 106.541 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -80.7 -16.66 53.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.516 0.674 . . . . 74.430000000000007 110.295 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -83.49 -30.44 27.17 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 53.100000000000001 110.554 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.22 133.06 37.78 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.915 -0.584 . . . . 71.209999999999994 110.948 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.52 159.52 14.87 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.452 -0.794 . . . . 32.219999999999999 109.012 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 8.1 m -52.4 117.85 3.14 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 124.409 1.068 . . . . 74.150000000000006 111.863 -176.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.75 -1.84 28.93 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.938 -0.649 . . . . 64.209999999999994 112.842 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.21 123.87 50.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.925 0.393 . . . . 73.049999999999997 111.29 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.0 p90 -131.18 150.75 52.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.861 -0.792 . . . . 70.510000000000005 108.861 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -142.22 132.74 25.22 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.754 -0.832 . . . . 73.340000000000003 108.754 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.04 122.72 41.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.709 -0.848 . . . . 73.219999999999999 108.709 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.453 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.8 tpm_? -111.93 121.54 45.3 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.886 -0.783 . . . . 61.210000000000001 108.886 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -110.74 130.01 9.59 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 110.98 -0.848 . . . . 45.310000000000002 110.98 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.9 t -135.9 163.29 30.58 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.601 -0.518 . . . . 64.349999999999994 109.601 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 59' ' ' PRO . 45.1 t -99.15 107.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.773 -0.825 . . . . 63.140000000000001 108.773 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -116.39 99.68 52.91 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 109.649 -0.501 . . . . 64.519999999999996 109.649 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 6.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.699 2.266 . . . . 63.130000000000003 112.429 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 27.2 mt-30 . . . . . 0 C--O 1.217 -0.648 0 CA-C-O 120.371 0.129 . . . . 73.209999999999994 111.18 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.24 -34.13 74.32 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.457 -0.942 . . . . 62.310000000000002 108.457 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.8 t -68.06 -48.05 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.623 -1.171 . . . . 22.420000000000002 109.96 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -66.33 -33.79 76.52 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.375 -0.53 . . . . 75.549999999999997 110.934 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.73 82.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.566 -0.531 . . . . 53.140000000000001 109.566 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.16 -32.94 74.68 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.31 -0.859 . . . . 74.099999999999994 111.844 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 80.9 mt -69.74 -38.44 76.83 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.06 0.225 . . . . 64.450000000000003 111.19 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 74.9 mtm180 -62.68 -43.23 99.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.538 -0.912 . . . . 72.540000000000006 108.538 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -40.66 90.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.0 -1.0 . . . . 75.409999999999997 111.698 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -60.47 -46.47 89.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.425 0.69 . . . . 61.229999999999997 109.845 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.36 92.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.482 -0.781 . . . . 52.450000000000003 110.83 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.35 68.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 62.219999999999999 111.888 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.03 -35.87 31.32 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.11 -0.369 . . . . 73.219999999999999 111.121 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.99 13.73 52.69 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.814 -0.63 . . . . 62.149999999999999 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 48' ' ' ILE . 15.6 mm -55.88 137.03 17.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 123.43 0.692 . . . . 75.099999999999994 111.978 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.0 tt0 -119.56 132.97 55.86 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.25 -1.389 . . . . 64.310000000000002 107.25 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -66.51 134.89 53.34 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 121.684 0.754 . . . . 65.0 109.992 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.2 tp -149.7 -165.53 2.3 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 103.096 -2.928 . . . . 75.319999999999993 103.096 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.509 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 76.5 mt-30 -54.52 146.36 16.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.083 0.856 . . . . 72.040000000000006 109.506 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.87 -12.92 58.41 Favored Glycine 0 C--O 1.237 0.333 0 CA-C-N 116.773 -0.194 . . . . 72.319999999999993 113.114 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.85 -40.02 93.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.208 -0.664 . . . . 71.430000000000007 109.208 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -167.94 132.83 1.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.416 -0.811 . . . . 73.310000000000002 110.885 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.76 152.17 20.91 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 124.692 1.197 . . . . 73.109999999999999 109.641 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.84 122.14 31.93 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.482 -1.303 . . . . 73.530000000000001 107.482 -174.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.3 160.16 26.98 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.33 -0.619 . . . . 64.439999999999998 109.33 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.66 151.08 72.62 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 111.049 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 5.3 p-10 -123.24 -27.59 4.12 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.415 -0.514 . . . . 54.240000000000002 111.46 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -106.03 110.91 23.33 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.098 -1.075 . . . . 74.349999999999994 108.098 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.91 131.73 54.8 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 109.892 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -121.84 111.73 32.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.613 -0.514 . . . . 63.210000000000001 109.613 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.17 109.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.978 -1.489 . . . . 64.209999999999994 106.978 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.425 ' HB ' ' HG2' ' A' ' 120' ' ' ARG . 8.7 m -112.94 126.48 55.53 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.088 -0.708 . . . . 64.140000000000001 109.088 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.2 mm? -105.22 156.14 18.39 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.377 -0.972 . . . . 74.5 108.377 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.64 146.73 50.53 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 109.323 -1.511 . . . . 74.230000000000004 109.323 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.477 HG23 ' NE2' ' A' ' 110' ' ' GLN . 3.3 p -53.83 -40.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 112.516 0.562 . . . . 52.509999999999998 112.516 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 23.9 t60 -62.17 -33.37 74.38 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 123.336 0.654 . . . . 70.450000000000003 111.004 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.51 -44.33 12.79 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.619 0.247 . . . . 73.439999999999998 111.011 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 35.6 t80 -66.28 -34.89 79.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 111.957 0.355 . . . . 73.140000000000001 111.957 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.9 pt-20 -63.45 -31.87 73.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.187 0.518 . . . . 74.239999999999995 110.671 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 46.3 mmtm -73.52 -28.1 61.72 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.603 -0.726 . . . . 74.010000000000005 109.869 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.43 -39.11 71.25 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.996 -0.742 . . . . 54.43 108.996 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.85 175.02 15.59 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.217 -0.753 . . . . 75.219999999999999 111.217 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.625 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -94.62 1.25 55.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.712 0.291 . . . . 71.329999999999998 111.236 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.9 95.65 8.07 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.852 1.056 . . . . 64.140000000000001 113.852 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.3 Cg_exo -76.8 -43.78 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.886 2.391 . . . . 64.140000000000001 112.116 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.699 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 44.5 tt0 -63.88 -29.98 71.12 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.016 0.747 . . . . 74.340000000000003 113.016 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.65 -24.23 67.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.974 -0.557 . . . . 73.0 110.456 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -99.88 -36.75 9.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 111.411 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.699 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 23.2 p -66.32 -45.39 80.44 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.375 0.509 . . . . 75.030000000000001 112.375 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.9 m -67.31 -39.85 85.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.522 -0.471 . . . . 53.149999999999999 110.925 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.0 -51.29 52.49 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.956 -0.566 . . . . 61.420000000000002 111.774 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.92 -30.66 70.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.635 0.605 . . . . 73.200000000000003 112.635 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -65.47 -48.05 73.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 120.907 0.384 . . . . 64.510000000000005 110.151 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -67.54 -38.02 83.56 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.56 -0.746 . . . . 72.420000000000002 109.822 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.57 -47.07 80.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.498 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.1 tp -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 65.510000000000005 110.832 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.19 93.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.108 -0.701 . . . . 44.130000000000003 109.108 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.3 t70 -62.59 -44.46 96.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.167 -0.924 . . . . 72.209999999999994 109.636 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -55.23 -54.25 45.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.786 0.679 . . . . 52.32 112.42 175.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -62.35 -32.95 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.163 0.506 . . . . 70.409999999999997 111.213 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -64.93 -41.89 95.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.699 -0.682 . . . . 75.010000000000005 110.723 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.0 mt-10 -62.99 -39.19 94.0 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.293 0.568 . . . . 71.150000000000006 111.032 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 76.9 mm-40 -73.57 -14.24 61.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.321 -0.854 . . . . 65.420000000000002 112.336 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 38.21 13.48 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.217 -0.992 . . . . 64.209999999999994 110.972 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -115.18 -178.95 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.271 -0.641 . . . . 73.439999999999998 109.271 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -157.21 178.34 10.45 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.771 -0.825 . . . . 73.120000000000005 108.771 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 11.2 t -156.7 173.57 16.76 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.538 -0.912 . . . . 71.530000000000001 108.538 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.0 m-85 -115.93 124.02 49.54 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 109.306 -0.628 . . . . 74.200000000000003 109.306 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -149.45 18.18 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.115 -1.194 . . . . 71.219999999999999 110.115 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.32 142.74 44.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.749 -0.834 . . . . 44.130000000000003 108.749 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.04 104.0 11.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.296 -1.372 . . . . 74.340000000000003 107.296 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 p -125.84 120.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.733 0.778 . . . . 65.209999999999994 110.434 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -110.91 127.87 67.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.108 -1.071 . . . . 64.109999999999999 108.108 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -106.22 132.74 51.92 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.361 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -115.26 114.29 25.0 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.265 -2.124 . . . . 70.25 105.265 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.02 173.24 12.63 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.239 0.542 . . . . 62.229999999999997 111.893 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.477 ' NE2' HG23 ' A' ' 68' ' ' VAL . 16.1 pt20 -119.86 164.84 15.42 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.903 -1.044 . . . . 72.439999999999998 109.762 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.7 t -143.88 141.42 30.28 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.804 -1.554 . . . . 71.340000000000003 106.804 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -81.01 -16.61 52.91 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.049 -1.093 . . . . 53.030000000000001 108.049 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -82.57 -4.34 57.48 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.049 -0.978 . . . . 74.409999999999997 110.793 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.73 131.05 56.33 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.112 -1.07 . . . . 72.310000000000002 108.112 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 40.2 m80 -100.72 172.35 7.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.587 -0.279 . . . . 64.450000000000003 111.388 -175.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.7 t -68.3 145.31 54.34 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.171 0.51 . . . . 71.150000000000006 110.635 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.65 -4.89 76.56 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.097 -1.201 . . . . 72.400000000000006 110.097 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 52.4 mt-30 -119.74 133.22 55.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.987 0.915 . . . . 64.25 109.335 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.472 ' HB3' HD13 ' A' ' 66' ' ' LEU . 50.5 p90 -159.9 157.0 28.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.136 -1.431 . . . . 74.409999999999997 107.136 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 9.1 ptp85 -135.84 153.92 51.34 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.581 -0.525 . . . . 62.32 109.581 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.08 118.03 11.15 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.264 -2.124 . . . . 51.219999999999999 105.264 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.99 137.41 21.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.402 -0.962 . . . . 73.439999999999998 108.402 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.65 142.56 17.3 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.501 -1.04 . . . . 65.530000000000001 110.501 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.8 t -136.05 156.7 48.34 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.275 -0.639 . . . . 73.340000000000003 109.275 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.33 110.11 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.564 -0.902 . . . . 72.420000000000002 108.564 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -130.91 91.93 35.32 Favored Pre-proline 0 C--N 1.292 -1.895 0 N-CA-C 108.043 -1.095 . . . . 74.120000000000005 108.043 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 51.2 Cg_endo . . . . . 0 N--CA 1.449 -1.108 0 C-N-CA 122.031 1.82 . . . . 61.039999999999999 111.334 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 112.359 0.503 . . . . 63.210000000000001 112.359 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.14 -25.58 68.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.296 -0.411 . . . . 64.219999999999999 110.501 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.16 -47.47 92.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 116.282 -0.417 . . . . 60.5 110.438 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 48.5 mt-10 -63.47 -48.24 78.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.794 0.331 . . . . 72.099999999999994 110.534 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.17 86.32 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.402 -0.817 . . . . 74.109999999999999 111.865 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.54 -33.68 62.79 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.379 -0.373 . . . . 65.129999999999995 110.539 -178.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -73.57 -36.67 65.62 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.457 -0.497 . . . . 44.119999999999997 111.03 -177.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -71.76 -25.21 61.95 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.377 -0.929 . . . . 74.510000000000005 110.368 175.587 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -68.78 -37.33 79.23 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 107.981 -1.118 . . . . 73.109999999999999 107.981 175.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -68.49 -40.07 81.04 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.37 -0.832 . . . . 73.239999999999995 109.49 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.01 93.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.047 -0.524 . . . . 72.239999999999995 110.834 177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.28 58.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.974 -0.557 . . . . 42.530000000000001 111.189 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.8 -33.69 57.99 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.488 0.661 . . . . 72.430000000000007 109.715 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.33 8.13 59.08 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.202 -0.908 . . . . 74.430000000000007 113.59 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 56' ' ' LEU . 9.5 mm -56.44 135.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 123.434 0.693 . . . . 73.540000000000006 111.537 177.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 19.0 tt0 -124.52 142.86 51.02 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 108.216 -1.031 . . . . 73.239999999999995 108.216 -177.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 m -76.48 131.8 39.23 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.698 -0.683 . . . . 54.409999999999997 110.995 -177.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.2 tp -148.06 -168.99 3.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 105.174 -2.158 . . . . 71.450000000000003 105.174 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.637 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.43 140.43 7.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.439 1.096 . . . . 65.5 110.542 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.2 24.76 0.87 Allowed Glycine 0 C--N 1.316 -0.551 0 C-N-CA 123.457 0.551 . . . . 52.200000000000003 114.465 -173.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -85.16 -38.75 18.67 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.638 -1.616 . . . . 72.519999999999996 106.638 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 3.1 ptp180 -174.22 160.24 3.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.407 -1.27 . . . . 74.299999999999997 110.173 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 48' ' ' ILE . 65.3 mt -90.51 152.38 20.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 123.826 0.851 . . . . 74.209999999999994 111.131 -173.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.488 HD23 HD22 ' A' ' 51' ' ' LEU . 2.0 tm? -92.89 121.79 34.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.608 -1.627 . . . . 74.340000000000003 106.608 -176.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.78 158.24 32.82 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 109.629 -0.508 . . . . 54.420000000000002 109.629 -177.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.35 156.78 58.07 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.427 2.085 . . . . 71.430000000000007 112.266 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -125.18 -22.58 4.37 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.922 -0.581 . . . . 23.309999999999999 110.563 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 11.4 tp10 -94.02 106.36 18.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.644 -1.243 . . . . 72.109999999999999 107.644 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -122.43 114.54 20.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.468 0.651 . . . . 75.450000000000003 111.011 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.52 122.55 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.55 -0.907 . . . . 61.340000000000003 108.55 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -116.25 117.3 55.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.761 -0.829 . . . . 71.140000000000001 108.761 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.3 m -103.47 116.78 33.05 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.775 -0.648 . . . . 75.450000000000003 109.39 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.07 175.04 5.61 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.963 -0.562 . . . . 70.109999999999999 110.027 178.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.18 145.05 32.86 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.11 -0.796 . . . . 75.349999999999994 111.11 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.52 -24.62 36.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.381 0.61 . . . . 73.319999999999993 110.044 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 52.8 t-80 -55.28 -51.86 65.31 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.051 -0.977 . . . . 61.210000000000001 110.32 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 73' ' ' LYS 0.261 2.6 m-20 -87.23 -20.02 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.938 1.088 . . . . 70.400000000000006 113.938 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.442 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 36.6 t80 -61.97 -33.25 73.96 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.43 -0.35 . . . . 61.32 110.529 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 11.2 pt-20 -66.28 -26.25 67.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 73.510000000000005 111.52 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -70.51 -33.46 71.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.215 -0.902 . . . . 51.240000000000002 109.099 174.471 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.78 -37.01 76.19 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.991 0.901 . . . . 72.409999999999997 108.688 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.19 -157.88 15.56 Favored Glycine 0 N--CA 1.425 -2.089 0 CA-C-N 114.839 -1.073 . . . . 70.109999999999999 111.304 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.79 18.66 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.035 0.445 . . . . 71.0 110.263 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.58 109.81 61.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.963 -0.562 . . . . 71.329999999999998 111.04 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.1 -39.46 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 121.754 1.636 . . . . 63.240000000000002 112.399 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -58.34 -38.94 78.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 116.232 1.938 . . . . 72.129999999999995 116.232 -164.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.65 -37.26 83.38 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.611 0.719 . . . . 72.239999999999995 110.185 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -86.12 -25.02 26.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.785 -0.643 . . . . 63.130000000000003 110.139 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.587 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.7 m -65.67 -33.36 75.7 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.603 -0.726 . . . . 72.540000000000006 109.305 175.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -63.08 -44.27 96.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.420000000000002 109.732 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.23 95.29 Favored Glycine 0 C--O 1.243 0.675 0 C-N-CA 120.855 -0.688 . . . . 55.32 111.798 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.17 -33.03 67.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.327 -0.62 . . . . 42.109999999999999 109.327 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.6 93.47 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.284 -0.416 . . . . 63.130000000000003 110.688 177.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.56 -41.44 94.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.266 0.555 . . . . 74.239999999999995 110.745 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 38.9 t70 -71.24 -36.61 71.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.734 -0.667 . . . . 71.209999999999994 110.551 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.19 -33.84 75.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.015 0.436 . . . . 74.340000000000003 110.187 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.08 79.19 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.284 -0.635 . . . . 55.530000000000001 109.284 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 29.7 t70 -65.45 -46.61 79.21 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.559 -0.746 . . . . 74.040000000000006 109.515 176.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 37.1 m-85 -54.57 -49.85 69.36 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 112.581 0.586 . . . . 72.120000000000005 112.581 176.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.9 pt -67.1 -32.51 58.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 C-N-CA 119.818 -0.753 . . . . 74.049999999999997 111.884 -177.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.53 -42.61 95.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.27 0.557 . . . . 74.519999999999996 109.76 174.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -65.93 -31.89 73.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 74.310000000000002 112.315 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 65.2 mm-40 -84.94 -13.28 51.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.315 0.579 . . . . 73.549999999999997 110.512 176.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.16 35.36 53.42 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.239 -0.891 . . . . 72.030000000000001 113.459 176.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.416 ' CE2' HD11 ' A' ' 48' ' ' ILE . 15.6 m0 -97.96 168.26 10.4 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.18 0.49 . . . . 64.239999999999995 110.401 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.461 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.5 pt20 -130.43 167.42 18.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.423 -0.584 . . . . 64.109999999999999 109.423 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -161.61 177.88 9.57 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.005 -0.739 . . . . 72.120000000000005 109.005 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -119.66 120.73 37.49 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.407 -0.59 . . . . 75.010000000000005 109.407 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -158.42 14.7 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.141 -1.584 . . . . 75.409999999999997 109.141 -175.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.27 151.09 37.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.616 -1.253 . . . . 64.109999999999999 107.616 176.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.69 121.62 18.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 120.949 0.404 . . . . 65.040000000000006 110.453 -177.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.34 120.27 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 121.881 0.848 . . . . 41.539999999999999 110.128 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.0 t -119.13 124.01 72.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.84 -1.541 . . . . 74.230000000000004 106.84 177.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -132.79 136.21 46.17 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.05 0.452 . . . . 72.430000000000007 110.996 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 94.8 m-85 -104.01 141.26 36.5 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.337 -0.847 . . . . 65.439999999999998 108.854 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.85 162.66 34.26 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.562 -0.29 . . . . 71.299999999999997 110.8 176.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -100.66 150.38 22.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.729 -0.669 . . . . 73.439999999999998 110.997 -176.026 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 31.6 t -129.95 129.27 43.6 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.525 -1.287 . . . . 73.239999999999995 107.525 174.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 t -81.45 -27.69 34.53 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.704 -0.851 . . . . 55.100000000000001 108.704 176.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -68.85 -46.34 68.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.015 -0.993 . . . . 70.109999999999999 110.434 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HG ' HE21 ' A' ' 118' ' ' GLN . 6.8 tt -84.41 140.47 31.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.833 -1.076 . . . . 74.140000000000001 110.455 -176.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -120.01 156.91 29.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.111 -0.7 . . . . 74.230000000000004 109.111 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -55.8 119.45 5.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.705 1.202 . . . . 74.040000000000006 110.538 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.66 -27.22 3.74 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 106.589 -2.604 . . . . 32.140000000000001 106.589 -174.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.468 HE21 ' HG ' ' A' ' 114' ' ' LEU . 29.6 tt0 -116.13 146.95 41.84 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 104.806 -2.294 . . . . 70.209999999999994 104.806 172.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -158.37 157.78 33.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.544 -1.28 . . . . 74.420000000000002 107.544 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -130.13 139.35 50.91 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 110.438 -0.208 . . . . 72.319999999999993 110.438 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.03 133.37 29.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.027 -1.472 . . . . 55.43 107.027 177.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -134.72 134.82 41.44 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.607 -0.886 . . . . 71.230000000000004 108.607 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -131.1 125.15 4.38 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.113 -1.195 . . . . 61.210000000000001 110.113 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -142.46 173.0 11.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.899 -0.408 . . . . 71.200000000000003 109.899 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.86 110.37 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.284 -0.636 . . . . 75.109999999999999 109.284 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.4 94.55 40.48 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.828 -0.623 . . . . 73.230000000000004 109.329 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.463 -0.29 0 C-N-CA 122.066 1.844 . . . . 61.420000000000002 110.943 179.448 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.866 1.062 . . . . 62.25 113.866 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.46 -31.57 71.82 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.822 -0.807 . . . . 74.299999999999997 108.822 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.97 -42.08 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.761 -0.654 . . . . 64.049999999999997 109.282 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.48 -43.14 99.4 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.615 -0.513 . . . . 64.329999999999998 109.615 177.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.9 90.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.299 -0.864 . . . . 52.229999999999997 110.97 178.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.85 -44.28 77.52 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.634 -0.427 . . . . 74.239999999999995 110.431 178.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.11 -37.45 87.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.827 0.677 . . . . 71.030000000000001 112.827 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.83 -36.09 82.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 120.036 -0.666 . . . . 75.519999999999996 109.358 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -68.38 -41.89 79.91 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.254 -0.43 . . . . 71.420000000000002 109.955 176.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.27 -45.02 96.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.734 1.213 . . . . 73.239999999999995 110.14 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.21 97.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.441 -0.799 . . . . 71.400000000000006 110.187 177.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.37 71.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.201 0.524 . . . . 65.140000000000001 111.392 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.13 -21.0 43.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.789 -0.641 . . . . 73.239999999999995 110.733 -178.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.56 19.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.975 -0.557 . . . . 53.32 112.139 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.51 134.73 29.72 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-O 121.272 0.558 . . . . 73.530000000000001 111.868 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 5.0 tp-100 -111.6 132.28 54.67 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.36 -1.348 . . . . 74.5 107.36 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -77.06 93.95 3.94 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.796 0.808 . . . . 71.230000000000004 109.883 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.628 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.3 tp -103.08 -165.41 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.119 -1.808 . . . . 72.510000000000005 106.119 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.628 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 2.2 mp0 -42.32 139.01 1.56 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.858 0.863 . . . . 63.340000000000003 111.586 175.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.81 -4.45 14.28 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-N 115.492 -0.777 . . . . 72.200000000000003 114.866 -171.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -72.17 -44.93 62.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.043 -0.354 . . . . 74.140000000000001 110.043 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 32.2 ptt180 -163.73 148.05 10.44 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 111.373 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.12 151.19 21.09 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.017 -0.992 . . . . 74.109999999999999 111.051 -170.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 43.2 tp -86.35 126.6 34.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.443 -0.799 . . . . 64.310000000000002 109.677 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.3 160.38 31.55 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 124.109 0.881 . . . . 72.310000000000002 108.75 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HA ' HG22 ' A' ' 125' ' ' VAL . 78.0 Cg_exo -54.56 153.96 21.66 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.213 2.608 . . . . 64.430000000000007 113.253 176.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 30.5 p-10 -120.09 -34.67 3.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.831 -0.622 . . . . 64.420000000000002 111.133 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -107.64 112.81 25.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.338 -0.616 . . . . 74.439999999999998 109.338 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 53.2 m-85 -109.03 132.0 54.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.671 -0.695 . . . . 65.140000000000001 110.279 -177.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 mm -112.93 117.89 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.582 -0.896 . . . . 65.209999999999994 108.582 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.11 125.83 74.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 -179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -126.89 129.0 47.36 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.427 -0.352 . . . . 72.299999999999997 110.309 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 74' ' ' LEU . 6.2 mp -128.6 178.08 6.57 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.864 -0.607 . . . . 73.420000000000002 109.66 172.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -73.66 168.3 54.06 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.982 -0.847 . . . . 33.43 110.982 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.4 -40.48 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 117.688 0.744 . . . . 70.010000000000005 112.324 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -66.82 -36.01 81.37 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.88 0.848 . . . . 34.130000000000003 109.234 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -65.43 -51.41 60.45 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.498 -1.228 . . . . 75.409999999999997 109.287 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.08 -42.34 98.32 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.251 -1.34 . . . . 74.109999999999999 111.848 -173.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.54 -35.94 78.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.908 0.385 . . . . 64.430000000000007 111.226 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -74.2 -24.98 59.43 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.086 -0.506 . . . . 72.109999999999999 112.208 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 79.1 mt -72.52 -45.2 60.47 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.885 0.374 . . . . 72.409999999999997 111.281 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.13 40.26 56.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 107.912 -2.075 . . . . 43.32 107.912 -168.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.26 5.54 51.44 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.121 1.768 . . . . 60.43 112.09 -172.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -43.05 124.19 3.24 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 124.639 1.212 . . . . 72.400000000000006 110.503 -171.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -38.07 -47.8 2.23 Favored 'Trans proline' 0 C--N 1.373 1.836 1 C-N-CA 125.696 4.264 . . . . 73.439999999999998 116.116 -168.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.51 -17.07 52.68 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.863 -0.735 . . . . 70.230000000000004 112.278 -172.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.98 -56.11 3.63 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.395 0.617 . . . . 75.310000000000002 109.38 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -86.54 -5.5 59.13 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 115.16 1.541 . . . . 71.239999999999995 115.16 -174.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 p -64.97 -62.72 1.39 Allowed 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 119.243 0.929 . . . . 73.329999999999998 111.039 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.9 m -59.02 -40.43 84.94 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.155 0.582 . . . . 62.140000000000001 110.955 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.13 -55.46 9.15 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.907 -0.588 . . . . 40.310000000000002 113.495 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.97 -25.97 56.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.083 0.468 . . . . 73.310000000000002 110.448 -173.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.15 63.48 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.285 -0.566 . . . . 71.310000000000002 109.586 175.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -65.46 -40.74 93.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.133 -1.062 . . . . 60.130000000000003 108.133 175.882 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -59.54 -47.45 85.5 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 116.125 -0.488 . . . . 63.030000000000001 109.927 176.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.26 -37.37 77.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 112.034 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -60.56 -43.09 97.65 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.428 0.633 . . . . 52.109999999999999 109.384 178.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.34 -41.68 97.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.875 -1.057 . . . . 71.010000000000005 109.553 177.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.3 m-85 -61.26 -53.06 61.6 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.918 -0.583 . . . . 63.130000000000003 112.47 175.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 90' ' ' ALA . 37.7 pt -63.91 -31.07 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.742 0.275 . . . . 75.099999999999994 111.742 -176.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 77.3 mm-40 -65.79 -42.93 90.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.45 -0.574 . . . . 71.299999999999997 109.45 174.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.39 -37.33 83.03 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.052 -0.522 . . . . 73.150000000000006 111.202 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 27.3 mm-40 -77.06 -13.51 59.94 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.771 -0.65 . . . . 72.230000000000004 110.603 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 34.05 28.39 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.931 -0.577 . . . . 73.230000000000004 112.629 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -110.77 161.14 16.08 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.577 -0.527 . . . . 75.400000000000006 109.577 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.426 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -130.72 169.55 15.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.461 -0.57 . . . . 71.219999999999999 109.461 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 6.6 t -158.28 170.55 21.99 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.675 -0.491 . . . . 65.010000000000005 109.675 178.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.32 122.49 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.854 0.359 . . . . 71.519999999999996 111.029 -176.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 -150.01 17.06 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.391 -1.084 . . . . 43.520000000000003 110.391 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.1 137.73 46.54 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.667 -0.864 . . . . 60.420000000000002 108.667 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.53 117.68 19.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.09 -1.078 . . . . 72.140000000000001 108.09 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.33 125.76 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-O 121.831 0.824 . . . . 75.439999999999998 112.02 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.0 m -104.87 124.63 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 106.869 -1.53 . . . . 60.039999999999999 106.869 173.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -115.92 130.51 56.86 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.1 -0.704 . . . . 73.239999999999995 109.1 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -104.34 143.9 32.36 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.048 -0.978 . . . . 73.430000000000007 108.859 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.51 168.53 22.47 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.048 -0.524 . . . . 61.409999999999997 110.065 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -114.82 163.52 15.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.287 0.565 . . . . 64.310000000000002 111.051 -176.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.44 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 43.7 t -145.15 133.17 21.37 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.765 -1.198 . . . . 61.399999999999999 107.765 176.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.2 m -80.99 -19.88 43.04 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.43 0.634 . . . . 53.100000000000001 109.498 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -81.01 -32.82 34.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.404 -0.817 . . . . 73.400000000000006 110.854 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.81 148.68 40.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.623 -0.717 . . . . 61.119999999999997 109.79 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -100.48 157.92 16.29 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.859 0.463 . . . . 74.530000000000001 110.229 -171.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.578 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 71.7 m -66.86 120.74 14.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.744 0.783 . . . . 71.019999999999996 112.688 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.1 -5.86 61.53 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.405 -1.27 . . . . 53.329999999999998 111.395 -178.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -107.2 104.73 14.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.026 -1.472 . . . . 63.539999999999999 107.026 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -119.62 157.05 29.24 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.084 -0.507 . . . . 74.209999999999994 111.012 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -134.24 137.45 44.35 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.731 -0.84 . . . . 74.420000000000002 108.731 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.15 125.34 10.77 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.251 -0.648 . . . . 44.100000000000001 109.251 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 -131.18 160.43 34.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 109.646 -0.501 . . . . 73.540000000000006 109.646 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.67 135.73 9.65 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 110.429 -1.068 . . . . 34.43 110.429 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 p -126.04 153.69 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.814 -0.439 . . . . 74.209999999999994 109.814 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.0 t -103.87 107.87 23.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.919 -1.141 . . . . 54.140000000000001 107.919 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -98.45 96.95 4.13 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.201 -1.407 . . . . 53.130000000000003 107.201 173.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 72.0 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 C-N-CA 121.939 1.759 . . . . 64.340000000000003 112.138 -174.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 109.613 -0.514 . . . . 74.030000000000001 109.613 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -69.3 -42.47 75.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.494 -0.928 . . . . 70.310000000000002 108.494 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.31 -46.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.389 -0.967 . . . . 52.340000000000003 108.389 177.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 23.5 mm-40 -52.02 -52.32 51.57 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.436 -0.802 . . . . 73.319999999999993 111.828 175.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.02 -53.96 49.06 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.8 0.688 . . . . 71.019999999999996 111.355 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.05 -42.18 97.12 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.317 0.488 . . . . 65.109999999999999 112.317 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.3 -47.05 77.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.828 0.677 . . . . 72.299999999999997 112.828 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 7.5 ptp180 -70.82 -32.84 70.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 120.428 -0.509 . . . . 73.209999999999994 110.486 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -67.17 -46.58 73.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.905 -0.406 . . . . 60.409999999999997 109.905 176.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 6.2 tp10 -63.03 -37.43 87.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 73.150000000000006 109.694 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -61.57 -41.39 97.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.143 -0.481 . . . . 32.130000000000003 110.943 178.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.07 -34.23 43.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.042 -0.526 . . . . 43.520000000000003 111.566 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.56 -30.82 57.23 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.476 0.655 . . . . 75.5 110.797 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.28 14.0 58.65 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.661 -0.7 . . . . 61.329999999999998 112.607 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.88 131.57 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.306 0.574 . . . . 62.439999999999998 111.106 177.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt-30 -119.45 139.64 51.72 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.251 -0.886 . . . . 62.020000000000003 109.772 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -74.56 126.85 31.67 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.352 -1.295 . . . . 71.540000000000006 108.769 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.574 HD23 ' NE2' ' A' ' 99' ' ' GLN . 14.0 tp -141.31 -165.57 2.0 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.186 -2.153 . . . . 72.430000000000007 105.186 -177.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.525 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 25.2 mt-30 -52.52 145.02 12.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.047 0.385 . . . . 73.430000000000007 110.299 176.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.95 -0.95 7.88 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 114.728 0.651 . . . . 52.109999999999999 114.728 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -64.11 -42.81 96.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.851 -0.796 . . . . 74.129999999999995 108.851 177.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -174.87 157.01 2.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.114 -0.948 . . . . 74.349999999999994 110.877 -179.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.15 151.65 20.89 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.495 0.718 . . . . 71.519999999999996 110.858 -173.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.3 tm? -91.74 128.79 37.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.826 -1.176 . . . . 71.230000000000004 107.826 -176.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.66 162.07 36.45 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 122.739 0.415 . . . . 73.239999999999995 109.954 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.8 Cg_exo -62.43 160.73 30.31 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.244 2.63 . . . . 70.409999999999997 112.941 176.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -132.81 -33.45 1.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.783 -0.644 . . . . 63.119999999999997 112.154 -179.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.04 116.52 32.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 72.200000000000003 108.837 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.516 ' HB2' HG12 ' A' ' 106' ' ' VAL . 35.2 m-85 -118.77 114.81 23.25 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.828 -0.434 . . . . 75.209999999999994 109.828 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.48 110.38 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.68 -0.859 . . . . 53.130000000000003 108.68 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.27 112.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.167 -1.049 . . . . 70.430000000000007 108.167 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -110.79 122.86 48.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.73 -0.668 . . . . 74.409999999999997 109.9 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.65 176.38 5.17 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.385 -0.825 . . . . 74.519999999999996 110.081 177.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.3 165.37 51.77 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.218 -1.553 . . . . 73.209999999999994 109.218 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 3.1 p -59.27 -48.31 87.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 112.673 0.62 . . . . 72.209999999999994 112.673 -178.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -63.94 -36.46 84.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 74.25 110.249 -178.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -69.02 -41.69 77.4 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.465 0.65 . . . . 74.430000000000007 109.563 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -73.87 -22.74 59.63 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 120.415 -0.514 . . . . 72.340000000000003 111.521 -176.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.8 mt-10 -61.77 -28.5 69.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.345 0.593 . . . . 65.129999999999995 109.66 173.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -84.91 -28.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.76 -0.655 . . . . 71.450000000000003 110.55 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 mt -97.02 -14.16 21.81 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 113.01 0.744 . . . . 73.299999999999997 113.01 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.71 22.13 35.24 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 116.077 1.191 . . . . 75.329999999999998 116.077 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.82 -35.13 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.959 0.88 . . . . 74.049999999999997 108.962 176.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -141.73 77.26 19.2 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 115.537 -0.756 . . . . 64.299999999999997 109.203 175.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.32 -50.37 2.03 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.062 1.841 . . . . 42.039999999999999 112.811 -178.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.01 -37.55 82.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.47 0.176 . . . . 74.439999999999998 111.408 -177.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.84 -55.7 29.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.135 0.493 . . . . 52.409999999999997 110.597 177.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 14.3 ptpt -72.86 -22.64 60.75 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.351 0.871 . . . . 75.340000000000003 113.351 -178.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 m -71.48 -36.43 71.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 74.409999999999997 109.131 175.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.3 m -70.89 -40.61 72.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.061 -0.518 . . . . 74.209999999999994 109.765 177.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.664 ' O ' ' HG2' ' A' ' 87' ' ' ARG . . . -57.77 -55.23 31.63 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-N 115.746 -0.661 . . . . 62.350000000000001 112.666 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 106' ' ' VAL . 62.8 m-85 -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.754 -0.85 . . . . 71.510000000000005 112.824 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.85 53.37 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.223 -0.298 . . . . 71.329999999999998 110.993 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 84' ' ' GLY . 35.1 ptt180 -60.68 -41.93 96.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.899 0.857 . . . . 71.129999999999995 110.141 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 87' ' ' ARG . 64.5 m-20 -77.74 -34.66 52.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.137 -0.938 . . . . 51.439999999999998 112.69 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.47 -37.99 89.46 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.094 -1.076 . . . . 71.209999999999994 108.094 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -63.12 -35.55 80.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.877 -0.601 . . . . 65.530000000000001 110.386 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.7 t70 -72.39 -42.09 65.57 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.684 -0.406 . . . . 74.340000000000003 110.027 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 13.8 m-85 -53.73 -48.4 69.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 112.074 175.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.4 pt -66.06 -30.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 119.722 -0.791 . . . . 63.340000000000003 111.104 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 78.7 mm-40 -67.61 -37.94 83.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.083 -0.247 . . . . 75.140000000000001 110.598 175.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.1 mt-10 -61.63 -41.04 96.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.883 0.739 . . . . 63.0 110.884 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 68.2 mm-40 -80.31 -14.22 58.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.191 -0.913 . . . . 63.200000000000003 110.938 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.11 29.11 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.765 -0.652 . . . . 61.43 112.062 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -102.9 174.51 5.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.613 0.72 . . . . 73.25 112.073 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' HD23 ' A' ' 51' ' ' LEU . 25.4 pt20 -137.18 171.91 13.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.412 -0.813 . . . . 72.209999999999994 109.491 179.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -161.15 153.51 20.26 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.738 -0.467 . . . . 44.329999999999998 109.738 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -109.66 120.04 41.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.652 -1.24 . . . . 75.319999999999993 107.652 175.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.85 -150.27 18.28 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 107.951 -2.06 . . . . 71.340000000000003 107.951 -172.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.93 137.83 35.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.187 0.993 . . . . 63.030000000000001 108.842 177.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.49 103.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.316 0.579 . . . . 75.439999999999998 110.094 -175.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.84 127.43 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.25 -0.887 . . . . 74.530000000000001 109.5 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.9 m -105.55 148.73 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 107.244 -1.391 . . . . 72.140000000000001 107.244 176.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -128.21 137.55 52.09 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.732 -0.84 . . . . 71.450000000000003 108.732 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.11 119.73 38.11 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.95 -0.759 . . . . 74.129999999999995 108.95 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.7 175.75 10.38 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.882 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.25 164.37 18.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.031 -176.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -154.17 117.19 4.48 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 124.058 0.943 . . . . 63.219999999999999 108.848 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 p -67.38 -17.73 64.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.603 0.716 . . . . 73.129999999999995 111.099 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -67.26 -28.18 67.82 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.201 1.0 . . . . 72.109999999999999 109.263 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.53 141.3 51.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.998 -1.001 . . . . 75.239999999999995 109.864 -178.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.55 145.96 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.847 -0.615 . . . . 73.450000000000003 110.16 -172.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 m -68.27 121.59 16.55 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.706 -0.679 . . . . 63.119999999999997 109.764 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.67 -11.09 38.65 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 110.471 -1.052 . . . . 63.149999999999999 110.471 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.69 169.09 9.74 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.207 0.527 . . . . 72.420000000000002 110.585 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -164.08 156.63 17.35 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.015 -2.587 . . . . 61.420000000000002 104.015 173.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -146.14 130.57 17.71 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.215 -0.994 . . . . 73.019999999999996 111.791 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.15 118.71 28.28 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.541 -1.281 . . . . 60.399999999999999 107.541 177.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 23.8 tpt180 -121.78 125.85 47.49 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.296 -0.631 . . . . 73.430000000000007 109.296 -177.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.09 130.32 9.1 Favored Glycine 0 C--N 1.289 -2.038 0 N-CA-C 110.581 -1.008 . . . . 72.450000000000003 110.581 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.3 t -138.09 167.26 22.17 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.47 -0.567 . . . . 65.530000000000001 109.47 -177.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 59' ' ' PRO . 50.4 t -92.59 106.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.526 -1.287 . . . . 55.25 107.526 175.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -117.83 102.75 51.12 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.135 -0.691 . . . . 62.409999999999997 109.135 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 C--N 1.323 -0.793 0 C-N-CA 121.84 1.693 . . . . 73.420000000000002 111.13 179.053 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.792 0.329 . . . . 74.430000000000007 110.573 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.87 -32.21 45.84 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.682 -0.488 . . . . 74.430000000000007 109.682 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.7 t -64.47 -49.82 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.781 -0.645 . . . . 60.299999999999997 109.426 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -66.68 -31.4 72.04 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 119.863 -0.735 . . . . 73.409999999999997 110.284 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.93 63.55 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.378 0.424 . . . . 73.140000000000001 110.197 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.68 -40.34 91.77 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 111.191 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 77.8 mt -66.34 -46.78 75.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.554 0.576 . . . . 73.409999999999997 112.554 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.01 -26.89 62.4 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.277 0.561 . . . . 73.439999999999998 110.134 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -45.65 73.35 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.671 -0.695 . . . . 73.510000000000005 109.679 172.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -62.72 -33.91 76.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 122.837 0.455 . . . . 74.409999999999997 111.174 177.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -62.12 -46.07 90.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.012 -0.54 . . . . 73.209999999999994 110.702 177.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.45 53.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.502 0.668 . . . . 65.420000000000002 111.106 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.14 -38.21 61.1 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.717 -0.674 . . . . 43.109999999999999 110.849 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.08 12.81 65.03 Favored Glycine 0 C--N 1.319 -0.396 0 C-N-CA 121.261 -0.495 . . . . 72.540000000000006 113.336 -176.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.72 127.4 19.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.399 0.68 . . . . 74.439999999999998 111.875 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -108.91 146.15 34.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.705 -0.68 . . . . 75.209999999999994 110.039 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.3 m -81.01 103.23 10.69 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.364 -0.834 . . . . 74.329999999999998 109.143 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.7 tp -112.65 -164.21 0.9 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.133 -1.432 . . . . 73.409999999999997 107.133 -177.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.626 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 85.0 mm-40 -49.67 156.99 0.6 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.748 0.819 . . . . 75.019999999999996 112.594 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.72 5.59 22.78 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 114.852 -1.067 . . . . 72.439999999999998 114.086 -172.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.45 -43.37 27.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.388 -0.597 . . . . 53.130000000000003 109.388 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -177.69 165.62 2.1 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.682 0.793 . . . . 72.150000000000006 112.016 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.21 151.3 20.99 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.149 0.98 . . . . 72.310000000000002 111.688 -173.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 51' ' ' LEU . 1.4 tm? -94.46 125.11 38.9 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.099 -1.075 . . . . 54.530000000000001 108.099 -175.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.56 156.98 40.54 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 123.597 0.759 . . . . 72.310000000000002 109.783 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 125' ' ' VAL . 82.1 Cg_exo -51.03 152.15 10.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.983 3.122 . . . . 70.219999999999999 114.307 177.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.6 p-10 -122.69 -33.88 3.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.194 -0.912 . . . . 63.399999999999999 110.605 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.47 100.26 11.27 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.318 0.58 . . . . 64.239999999999995 110.164 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 72.2 m-85 -96.43 114.13 25.77 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.632 0.73 . . . . 74.530000000000001 109.491 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -107.91 117.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.618 -1.174 . . . . 74.340000000000003 109.036 -174.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -118.05 101.74 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.485 -0.932 . . . . 71.439999999999998 108.485 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.5 m -95.82 122.93 39.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 109.311 -176.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.59 162.21 14.95 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.419 0.688 . . . . 73.109999999999999 111.056 176.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.16 163.47 50.63 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.889 -1.685 . . . . 74.430000000000007 108.889 173.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.7 p -63.15 -37.89 80.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 117.387 0.593 . . . . 61.509999999999998 111.357 -177.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -64.11 -38.04 89.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.634 -0.712 . . . . 73.510000000000005 110.393 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.08 -35.56 28.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.867 -0.606 . . . . 71.430000000000007 111.69 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -65.79 -32.36 73.85 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.744 -0.383 . . . . 74.319999999999993 110.994 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.2 mt-10 -59.57 -29.52 67.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.046 0.45 . . . . 74.530000000000001 111.266 177.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -81.5 -26.33 35.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 111.32 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.451 HD11 ' HG ' ' A' ' 66' ' ' LEU . 86.9 mt -70.73 -34.42 71.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.385 -0.598 . . . . 73.109999999999999 109.385 173.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.37 -165.89 21.86 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 110.877 -0.889 . . . . 64.400000000000006 110.877 177.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.89 1.23 55.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 110.52 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -127.82 135.43 27.47 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.125 -0.489 . . . . 71.450000000000003 110.526 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.86 -34.52 1.75 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.057 1.838 . . . . 75.430000000000007 109.286 163.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -48.02 -52.79 18.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 117.376 2.362 . . . . 72.209999999999994 117.376 -165.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.24 -42.71 77.76 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.662 0.665 . . . . 54.140000000000001 110.606 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' H ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -88.84 -17.95 28.65 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.247 -0.888 . . . . 71.099999999999994 112.152 -177.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 59.6 m -71.18 -44.64 65.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.253 -0.647 . . . . 73.409999999999997 109.253 176.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.0 m -65.48 -43.2 90.98 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 115.87 -0.604 . . . . 64.299999999999997 110.006 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.12 -53.84 41.52 Favored Glycine 0 CA--C 1.504 -0.615 0 CA-C-N 115.492 -0.776 . . . . 53.130000000000003 112.373 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -67.37 -31.0 70.95 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 113.002 0.742 . . . . 45.109999999999999 113.002 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.23 82.69 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.062 0.392 . . . . 71.209999999999994 110.45 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -67.17 -48.08 69.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.798 -0.637 . . . . 73.530000000000001 111.505 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.33 -35.87 78.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.078 -0.51 . . . . 73.310000000000002 111.293 -173.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.22 -35.68 63.9 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.368 -0.605 . . . . 74.349999999999994 109.368 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.36 84.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.773 0.797 . . . . 54.350000000000001 109.438 176.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.89 -41.73 99.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.601 -1.181 . . . . 72.140000000000001 109.445 177.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 16.4 m-85 -59.89 -51.17 70.87 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.876 -0.602 . . . . 74.5 112.085 175.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -65.61 -30.78 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.298 -0.561 . . . . 64.120000000000005 112.101 -175.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.32 -44.93 93.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.701 -0.481 . . . . 75.239999999999995 109.701 175.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.17 -30.09 70.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.702 -0.681 . . . . 62.32 112.682 177.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 58.4 mm-40 -82.97 -13.62 55.63 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.918 -0.313 . . . . 73.030000000000001 111.222 178.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 27.08 40.6 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.051 -0.522 . . . . 43.130000000000003 113.125 176.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -98.68 178.38 5.01 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.888 0.344 . . . . 70.310000000000002 110.163 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.7 pt20 -143.03 174.18 10.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.875 -0.787 . . . . 72.129999999999995 108.875 178.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.9 t -157.19 171.74 19.89 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.612 -0.435 . . . . 61.0 109.831 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.1 118.93 37.83 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.069 -1.085 . . . . 72.319999999999993 108.069 176.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.39 -149.93 16.74 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.376 -1.392 . . . . 71.109999999999999 110.985 176.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.04 142.49 46.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.765 -1.198 . . . . 72.209999999999994 107.765 176.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.22 118.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.58 -0.896 . . . . 63.210000000000001 108.58 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.21 137.3 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.643 0.735 . . . . 73.310000000000002 110.443 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 82' ' ' SER . 92.4 t -117.92 142.9 30.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 107.023 -1.473 . . . . 64.120000000000005 107.023 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -146.44 146.79 30.71 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.697 0.284 . . . . 52.030000000000001 111.019 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 84.9 m-85 -121.16 125.07 46.26 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.111 -1.441 . . . . 71.319999999999993 107.111 177.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.39 175.61 8.99 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.504 -0.878 . . . . 65.109999999999999 111.597 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.412 ' OE1' HG23 ' A' ' 68' ' ' VAL . 50.2 mt-30 -105.18 149.43 25.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.837 0.827 . . . . 75.340000000000003 112.154 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 m -143.48 118.13 9.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.59 -1.186 . . . . 63.299999999999997 108.961 172.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 m -72.0 -24.22 61.53 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.813 -0.63 . . . . 65.409999999999997 112.574 -175.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -88.7 -0.25 57.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.457 1.122 . . . . 71.329999999999998 109.26 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -83.7 144.49 29.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 108.282 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.02 149.74 35.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.434 -0.803 . . . . 73.540000000000006 110.83 -171.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -66.5 125.1 24.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.075 -0.713 . . . . 72.450000000000003 109.075 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.5 16.64 73.07 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.744 -0.741 . . . . 75.409999999999997 112.206 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -124.52 123.2 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.199 -1.037 . . . . 71.5 108.199 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -116.23 156.66 26.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.389 -0.967 . . . . 63.399999999999999 108.389 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -126.0 130.72 51.76 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.899 -0.778 . . . . 63.210000000000001 108.899 177.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.04 119.75 29.55 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.813 -1.085 . . . . 53.509999999999998 108.74 -178.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -135.0 126.5 28.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.094 -178.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.22 98.26 2.3 Favored Glycine 0 N--CA 1.424 -2.149 0 N-CA-C 108.502 -1.839 . . . . 55.310000000000002 108.502 176.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.3 m -93.36 138.94 31.22 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 109.939 -175.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 59' ' ' PRO . 92.5 t -98.36 117.43 43.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.878 -0.786 . . . . 71.219999999999999 108.878 175.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -102.83 94.85 5.65 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.472 -1.677 . . . . 34.439999999999998 106.472 170.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.9 Cg_endo . . . . . 0 N--CA 1.451 -0.995 0 C-N-CA 122.225 1.95 . . . . 52.100000000000001 112.067 -175.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.964 0.411 . . . . 74.140000000000001 110.809 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.03 -48.16 77.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.374 -0.973 . . . . 72.310000000000002 108.374 175.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.94 -45.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.826 -0.624 . . . . 73.030000000000001 109.68 178.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.619 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 53.8 mt-10 -53.12 -55.3 25.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.323 -0.399 . . . . 75.209999999999994 111.147 178.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.05 68.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 111.811 -178.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.12 -47.34 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.337 -0.986 . . . . 63.240000000000002 108.337 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 62' ' ' TYR . 3.8 mm? -71.65 -30.7 66.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.852 0.686 . . . . 72.420000000000002 112.852 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtm180 -64.42 -40.09 95.1 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.287 -1.005 . . . . 75.510000000000005 108.287 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -63.9 -44.86 91.7 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 110.333 176.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.59 -39.71 89.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.154 0.502 . . . . 61.219999999999999 110.006 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.22 84.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.786 -0.643 . . . . 60.200000000000003 110.457 177.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.78 64.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 64.200000000000003 111.984 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.52 -37.51 31.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.087 -0.506 . . . . 74.439999999999998 110.267 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 20.56 26.08 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.856 -0.611 . . . . 42.420000000000002 113.03 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -67.12 138.51 22.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 123.28 0.632 . . . . 41.140000000000001 110.657 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -115.87 143.71 45.03 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 176.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 t -76.28 124.67 27.86 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.946 -1.024 . . . . 73.430000000000007 108.705 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.7 tp -140.16 -166.0 2.02 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.073 -2.195 . . . . 73.140000000000001 105.073 -177.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 23.1 mt-30 -51.67 143.53 12.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.674 0.67 . . . . 71.420000000000002 110.259 176.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.88 -18.01 52.41 Favored Glycine 0 C--N 1.322 -0.233 0 CA-C-N 116.087 -0.506 . . . . 71.430000000000007 114.085 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -62.55 -39.1 92.54 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.52 0.328 . . . . 73.209999999999994 111.731 179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -165.8 136.44 3.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.176 -0.465 . . . . 73.450000000000003 111.396 -177.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.87 151.6 21.08 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.934 1.293 . . . . 75.109999999999999 110.353 -176.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -85.71 128.48 34.8 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.446 -0.797 . . . . 73.239999999999995 109.83 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.64 158.57 41.51 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 123.305 0.642 . . . . 73.439999999999998 109.821 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 125' ' ' VAL . 36.0 Cg_exo -61.26 152.59 71.21 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.019 2.479 . . . . 72.439999999999998 112.7 177.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -130.86 -16.34 3.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.647 -0.706 . . . . 63.350000000000001 111.583 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.59 114.97 27.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.76 -1.2 . . . . 61.420000000000002 107.76 178.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.488 ' CD2' HD12 ' A' ' 40' ' ' LEU . 91.7 m-85 -121.18 122.62 40.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.425 -0.352 . . . . 74.040000000000006 110.23 -178.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 63' ' ' ILE . 3.4 mp -106.79 107.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.186 -1.042 . . . . 73.109999999999999 108.186 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 55.9 mt -112.55 103.65 15.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.55 0.691 . . . . 62.030000000000001 109.979 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 109' ' ' GLU . 26.2 m -103.12 120.01 39.91 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.847 -0.615 . . . . 72.109999999999999 109.779 -177.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -99.38 163.5 12.5 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 123.692 0.797 . . . . 71.409999999999997 111.252 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.25 165.1 49.79 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.31 -1.116 . . . . 41.25 110.31 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 112' ' ' SER . 7.4 p -62.67 -47.61 92.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 113.674 0.991 . . . . 72.310000000000002 113.674 -175.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 82.2 t60 -77.35 -24.19 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.477 0.656 . . . . 55.039999999999999 109.857 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.726 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 2.6 m-20 -69.72 -45.79 67.4 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.751 -0.833 . . . . 72.140000000000001 108.751 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 40.8 t80 -71.29 -34.17 70.4 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.564 -0.744 . . . . 74.140000000000001 111.816 -175.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 12.9 pt-20 -65.11 -30.08 70.99 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.103 0.478 . . . . 74.329999999999998 110.936 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 32.1 mmmt -68.94 -35.39 76.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.169 -0.923 . . . . 50.140000000000001 109.703 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.8 -37.33 79.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 110.73 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.49 -167.65 29.72 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 111.525 -0.63 . . . . 51.140000000000001 111.525 -178.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.11 -45.35 7.25 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.089 0.471 . . . . 52.009999999999998 110.475 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 16.1 m-20 -116.43 130.69 24.3 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 75.099999999999994 110.688 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 -20.34 14.48 Favored 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 123.203 2.602 . . . . 65.329999999999998 113.827 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 8.1 pt-20 -58.76 -24.06 61.08 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.323 1.601 . . . . 54.020000000000003 115.323 -171.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.8 tp -78.75 -29.64 45.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.43 0.633 . . . . 73.219999999999999 110.709 175.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.64 -35.17 13.67 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.217 -0.447 . . . . 70.129999999999995 111.773 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -60.78 -41.47 95.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.912 0.387 . . . . 63.439999999999998 110.895 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 m -56.91 -48.16 78.88 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.522 -0.763 . . . . 62.439999999999998 110.99 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.35 -46.33 64.36 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.928 -0.653 . . . . 53.140000000000001 112.006 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.62 -39.46 94.42 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.413 0.285 . . . . 54.109999999999999 110.472 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.23 88.65 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.857 0.361 . . . . 61.549999999999997 110.134 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.44 -37.87 86.12 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.193 -0.458 . . . . 72.030000000000001 110.997 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -71.09 -37.1 72.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 111.1 176.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.03 -43.91 90.87 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.008 -0.738 . . . . 72.0 109.008 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.79 -36.26 80.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.404 0.621 . . . . 65.450000000000003 110.635 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.27 -42.23 79.9 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.153 -0.93 . . . . 72.129999999999995 108.526 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 m-85 -60.72 -56.16 24.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.781 -1.1 . . . . 75.519999999999996 112.403 176.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -59.59 -37.95 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.347 0.499 . . . . 74.140000000000001 112.347 -175.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.88 -37.64 88.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.834 -0.346 . . . . 71.319999999999993 110.733 176.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.5 -21.17 65.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.874 0.694 . . . . 75.439999999999998 112.874 176.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 50.3 mm-40 -92.49 -10.5 37.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.146 0.498 . . . . 71.349999999999994 110.17 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.96 26.55 37.06 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.434 -0.803 . . . . 63.130000000000003 111.851 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -107.22 155.02 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.285 -0.635 . . . . 75.510000000000005 109.285 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -130.87 175.4 9.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.836 -0.431 . . . . 73.409999999999997 109.836 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 t -154.39 158.73 40.47 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 108.264 -1.013 . . . . 52.109999999999999 108.264 175.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.18 120.14 39.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.672 -0.492 . . . . 73.25 109.672 -178.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -149.96 16.94 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.601 -1.8 . . . . 61.509999999999998 108.601 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.02 152.26 41.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.349 -0.982 . . . . 75.019999999999996 108.349 177.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 p -81.42 122.19 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.626 0.727 . . . . 73.310000000000002 110.721 -179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.29 120.28 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.065 -0.97 . . . . 74.340000000000003 109.225 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.85 138.9 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 107.506 -1.294 . . . . 71.400000000000006 107.506 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -116.12 150.23 37.72 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 109.742 -0.466 . . . . 75.420000000000002 109.742 176.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 81.3 m-85 -129.57 125.88 37.23 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.543 -2.021 . . . . 75.099999999999994 105.543 172.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -138.55 174.36 10.62 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.231 -0.655 . . . . 74.319999999999993 109.231 174.608 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.1 pt20 -122.27 150.23 42.62 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.367 -0.605 . . . . 63.399999999999999 109.367 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.564 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 75.4 m -119.19 118.67 31.95 Favored 'General case' 0 C--N 1.264 -3.129 0 N-CA-C 107.733 -1.21 . . . . 61.219999999999999 107.733 173.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' A' ' 68' ' ' VAL . 10.5 m -59.94 -28.22 67.44 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.818 0.847 . . . . 62.149999999999999 112.073 -176.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' A' ' 111' ' ' SER . 23.7 p-10 -83.91 -19.87 33.99 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.904 0.881 . . . . 62.100000000000001 111.301 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 22.1 tp -78.17 135.85 37.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.899 -0.591 . . . . 73.310000000000002 109.915 -175.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -78.78 158.58 28.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.544 -0.753 . . . . 73.25 111.9 -173.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.726 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 30.7 m -70.93 130.72 42.35 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.378 -0.828 . . . . 73.519999999999996 110.082 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 11.42 62.27 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.061 -0.816 . . . . 72.030000000000001 111.061 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -126.49 121.22 31.73 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 108.186 -1.042 . . . . 72.099999999999994 108.186 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 66' ' ' LEU . 31.1 p90 -141.24 154.49 45.81 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.478 -0.564 . . . . 64.129999999999995 109.478 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 3.4 mpt_? -124.17 139.0 54.35 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.183 -0.673 . . . . 74.5 109.183 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.11 118.94 16.19 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.389 -0.967 . . . . 72.200000000000003 108.389 176.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -124.98 119.59 29.16 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.676 -0.41 . . . . 75.0 110.233 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -104.78 124.27 7.94 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.449 -1.06 . . . . 63.100000000000001 110.449 177.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 m -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 108.762 -0.829 . . . . 74.230000000000004 108.762 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.7 t -87.69 119.64 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.84 -1.17 . . . . 64.319999999999993 107.84 175.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -110.93 96.06 27.48 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.317 -1.734 . . . . 73.340000000000003 106.317 171.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.454 -0.845 0 C-N-CA 121.988 1.792 . . . . 52.409999999999997 111.184 -177.68 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 CA--C 1.52 -0.206 0 CA-C-O 121.744 0.783 . . . . 72.409999999999997 110.03 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 37.5 mt-10 -74.8 -5.34 42.93 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.825 -0.625 . . . . 74.319999999999993 112.403 178.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 82.2 t -71.32 -55.51 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.792 -1.188 . . . . 72.349999999999994 107.792 174.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.5 pm0 -62.98 -34.93 78.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.88 0.372 . . . . 70.409999999999997 111.538 176.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . . . -62.19 -50.86 70.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.983 -0.553 . . . . 42.409999999999997 111.269 177.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.01 -30.57 67.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.298 0.57 . . . . 63.329999999999998 110.162 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 16.0 tp -66.1 -41.88 90.01 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.687 -0.688 . . . . 51.130000000000003 110.218 -179.03 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.88 -28.96 66.07 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.154 -0.684 . . . . 73.030000000000001 109.154 178.958 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HE ' ' HB2' ' A' ' 46' ' ' ASP . 6.3 tpt180 -64.62 -52.3 58.14 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-N 115.778 -0.646 . . . . 75.420000000000002 109.614 172.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -60.24 -38.05 82.23 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.856 0.863 . . . . 62.409999999999997 110.998 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.28 -46.68 89.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.998 -0.547 . . . . 70.019999999999996 110.88 177.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.8 -22.84 49.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.879 -0.601 . . . . 75.0 111.179 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' HE ' ' A' ' 42' ' ' ARG . 28.8 t70 -81.13 -37.33 29.03 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.862 -0.608 . . . . 70.25 110.799 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 19.89 29.59 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 116.1 -0.5 . . . . 73.349999999999994 113.538 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -66.11 139.04 21.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 C-N-CA 123.01 0.524 . . . . 70.239999999999995 110.851 178.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -117.85 143.34 46.38 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.173 0.511 . . . . 74.010000000000005 110.166 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -75.44 111.75 11.05 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.6 -1.182 . . . . 64.299999999999997 109.418 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.9 tp -119.13 -176.0 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.044 -1.835 . . . . 73.140000000000001 106.044 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 73.6 mt-30 -47.29 141.28 4.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.579 0.751 . . . . 64.129999999999995 110.058 175.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -10.63 7.77 Favored Glycine 0 CA--C 1.5 -0.857 0 N-CA-C 116.012 1.165 . . . . 74.510000000000005 116.012 -167.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -71.64 -35.72 70.5 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.245 -0.582 . . . . 61.450000000000003 111.844 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -167.26 148.12 5.58 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 112.07 0.396 . . . . 74.230000000000004 112.07 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.99 151.73 20.96 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.821 0.848 . . . . 73.299999999999997 110.508 -174.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.04 127.92 37.69 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.766 -1.198 . . . . 75.109999999999999 107.766 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.03 46.81 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 109.113 -0.699 . . . . 75.420000000000002 109.113 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.68 149.02 83.9 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.111 1.874 . . . . 63.409999999999997 111.153 177.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -113.23 -26.14 8.55 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.734 -0.386 . . . . 71.430000000000007 110.886 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 35.3 tt0 -113.12 125.18 54.08 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.185 0.517 . . . . 74.120000000000005 110.025 -177.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB2' HG12 ' A' ' 106' ' ' VAL . 39.4 m-85 -121.83 124.87 45.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.578 -0.737 . . . . 60.219999999999999 109.87 -177.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 69.2 mt -98.18 114.86 36.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.133 -1.062 . . . . 74.109999999999999 108.133 -179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.75 117.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.562 -0.903 . . . . 74.150000000000006 108.562 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.3 m -116.83 121.42 41.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.038 -0.528 . . . . 74.329999999999998 110.078 -178.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.4 mm? -106.57 163.05 13.2 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.216 -0.902 . . . . 70.200000000000003 109.555 177.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.43 163.64 54.12 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.261 -1.936 . . . . 73.310000000000002 108.261 171.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.25 -40.32 88.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 118.023 0.912 . . . . 63.140000000000001 112.891 -175.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 53.0 t-80 -68.55 -43.24 77.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.254 -1.017 . . . . 74.430000000000007 108.254 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -65.55 -35.43 80.83 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.356 -1.293 . . . . 73.239999999999995 110.699 -177.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.92 -40.48 91.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 70.230000000000004 109.683 178.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.41 -24.83 60.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.188 0.518 . . . . 62.140000000000001 111.193 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 mmmt -77.52 -17.14 58.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.241 -0.436 . . . . 55.329999999999998 111.848 175.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 66' ' ' LEU . 77.5 mt -71.45 -40.44 70.34 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 105.959 -1.867 . . . . 73.209999999999994 105.959 170.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.9 -176.5 18.64 Favored Glycine 0 N--CA 1.414 -2.829 0 CA-C-N 113.776 -1.557 . . . . 72.439999999999998 110.513 176.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -87.12 1.69 52.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.56 0.695 . . . . 72.230000000000004 109.361 178.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 26.6 p-10 -123.05 49.19 2.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 C-N-CA 124.242 1.017 . . . . 63.229999999999997 112.714 -177.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 5.2 Cg_exo -75.19 -17.16 19.37 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.705 1.604 . . . . 53.130000000000003 110.929 -179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -26.31 59.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.376 -0.829 . . . . 63.310000000000002 111.982 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.21 -44.94 62.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.645 -1.243 . . . . 71.150000000000006 107.645 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HE3' ' CZ ' ' A' ' 85' ' ' PHE . 60.2 tptt -61.3 -33.96 74.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.009 0.924 . . . . 61.299999999999997 109.427 176.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 t -63.05 -49.11 75.84 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.886 -1.052 . . . . 65.340000000000003 110.532 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.5 m -62.04 -34.44 76.24 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-O 120.896 0.379 . . . . 75.120000000000005 110.854 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.73 -52.63 44.1 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.62 -0.992 . . . . 60.450000000000003 110.62 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.671 ' CZ ' ' HE3' ' A' ' 81' ' ' LYS . 8.0 m-30 -58.52 -44.23 89.47 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 112.516 0.562 . . . . 75.450000000000003 112.516 178.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.15 74.65 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.756 0.66 . . . . 70.340000000000003 111.061 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -79.67 -40.28 29.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.372 -0.531 . . . . 54.229999999999997 111.066 -176.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 33.9 t70 -63.9 -38.12 89.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.175 0.512 . . . . 70.230000000000004 111.688 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.55 -29.74 52.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.616 -0.434 . . . . 73.409999999999997 110.08 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.31 -37.28 86.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.566 -0.901 . . . . 70.040000000000006 108.566 173.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 21.4 t70 -60.19 -54.94 39.83 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.593 -1.185 . . . . 72.420000000000002 109.327 176.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.4 m-85 -51.71 -49.19 62.94 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 114.005 1.113 . . . . 73.310000000000002 114.005 178.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.9 pt -63.8 -34.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.821 -0.751 . . . . 74.439999999999998 111.12 -177.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 81.1 mm-40 -72.24 -37.37 69.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 121.202 -0.199 . . . . 74.420000000000002 110.697 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 48.3 mm-40 -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.957 -0.565 . . . . 72.129999999999995 110.981 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.4 mm-40 -80.19 -13.3 59.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.727 -0.67 . . . . 74.409999999999997 111.681 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.84 29.81 28.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.756 -0.735 . . . . 60.229999999999997 112.327 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -102.47 162.52 12.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.803 -0.814 . . . . 74.409999999999997 108.803 178.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -133.98 177.17 7.94 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.773 -0.454 . . . . 73.120000000000005 109.773 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -160.83 177.33 10.52 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.74 -1.578 . . . . 74.129999999999995 106.74 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.36 119.11 36.53 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.943 -0.762 . . . . 65.430000000000007 108.943 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -150.92 17.05 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 109.387 -1.485 . . . . 62.299999999999997 109.387 -176.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.65 148.11 48.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.834 -1.543 . . . . 75.430000000000007 106.834 177.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.28 122.37 24.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.144 0.497 . . . . 75.129999999999995 110.814 -177.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 7.3 p -138.93 127.73 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.778 0.799 . . . . 71.219999999999999 109.9 -178.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 62' ' ' TYR . 18.8 m -105.17 148.5 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.556 -0.905 . . . . 74.200000000000003 108.556 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -115.52 125.58 53.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.692 -0.855 . . . . 75.310000000000002 108.692 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -101.11 119.79 39.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.265 -0.643 . . . . 75.25 109.265 173.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.9 pt-20 -139.16 164.8 28.85 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 109.377 178.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.66 159.41 29.39 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.558 0.694 . . . . 61.210000000000001 110.928 -177.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -140.21 109.8 6.31 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 114.937 -1.029 . . . . 63.32 109.188 172.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -64.67 -25.83 68.12 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.462 -0.79 . . . . 74.450000000000003 110.054 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -75.84 -14.72 60.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.16 -0.927 . . . . 70.329999999999998 110.438 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -81.98 161.57 22.97 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.211 -1.033 . . . . 65.349999999999994 108.211 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -83.15 150.84 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.096 0.474 . . . . 63.240000000000002 110.297 -176.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.0 m -76.31 123.53 26.07 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.59 -0.732 . . . . 75.0 110.602 -178.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.48 8.15 62.79 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.634 -0.986 . . . . 74.420000000000002 110.634 -175.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -114.44 122.02 45.33 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.336 -1.357 . . . . 75.200000000000003 107.336 177.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.447 ' HB3' HD13 ' A' ' 66' ' ' LEU . 43.2 p90 -131.28 154.0 48.96 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.204 -1.035 . . . . 73.340000000000003 108.204 -178.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -141.16 148.42 39.98 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 123.142 0.276 . . . . 75.540000000000006 110.367 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -147.32 121.0 9.19 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.711 -0.848 . . . . 64.25 108.711 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -123.54 140.24 53.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.668 -0.493 . . . . 73.120000000000005 109.668 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.1 136.38 13.34 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 111.555 -0.618 . . . . 72.150000000000006 111.555 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -138.71 158.9 43.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.8 -0.815 . . . . 71.129999999999995 108.8 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.86 106.99 19.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.463 -1.31 . . . . 75.230000000000004 107.463 178.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -124.11 96.83 41.54 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 109.799 -0.445 . . . . 65.019999999999996 109.799 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 N--CA 1.451 -1.021 0 C-N-CA 122.056 1.837 . . . . 73.349999999999994 110.96 178.037 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 34.2 tt0 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.753 -0.462 . . . . 65.349999999999994 109.753 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -65.23 -20.79 66.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.141 0.496 . . . . 74.340000000000003 110.681 179.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 78.8 t -72.34 -48.19 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.221 -0.659 . . . . 64.430000000000007 109.221 177.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -71.5 -26.7 62.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.454 0.645 . . . . 74.0 111.054 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.09 79.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.376 -0.829 . . . . 50.130000000000003 109.665 173.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 6.9 tt -76.74 -34.83 58.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.383 -0.969 . . . . 73.230000000000004 108.383 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 96.9 mt -62.28 -47.21 85.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.291 -0.413 . . . . 71.439999999999998 110.851 177.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -66.4 -30.9 71.37 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.454 -0.573 . . . . 72.409999999999997 109.454 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' LEU . 56.7 ttt180 -63.32 -55.25 26.21 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.146 0.978 . . . . 72.400000000000006 109.82 177.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.45 -23.73 58.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.293 -0.412 . . . . 62.219999999999999 111.423 -175.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.49 98.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.286 -0.635 . . . . 63.409999999999997 109.286 172.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.46 63.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.426 -0.807 . . . . 72.230000000000004 110.85 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.02 -42.42 76.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.784 0.326 . . . . 54.119999999999997 110.937 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.45 9.68 40.69 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.894 -0.593 . . . . 75.409999999999997 114.262 -176.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 48' ' ' ILE . 16.0 mm -59.64 135.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.398 0.618 . . . . 75.049999999999997 111.58 177.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 99.5 mt-30 -120.08 150.0 41.29 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.002 -0.999 . . . . 74.430000000000007 110.545 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.1 m -79.78 126.33 30.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.573 -1.194 . . . . 72.450000000000003 109.708 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.5 tp -146.7 -164.07 1.9 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 104.522 -2.399 . . . . 64.530000000000001 104.522 -178.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.608 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 50.7 mt-30 -42.25 133.32 3.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.619 0.768 . . . . 74.019999999999996 110.152 176.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.52 -12.43 46.2 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 114.884 0.714 . . . . 70.409999999999997 114.884 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.55 -34.18 60.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.036 0.384 . . . . 75.120000000000005 112.036 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.416 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 29.0 ptt180 -157.05 135.05 11.01 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.307 0.575 . . . . 74.409999999999997 111.943 -177.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.72 151.64 21.15 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.213 -0.903 . . . . 75.109999999999999 110.737 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 14.7 tp -84.94 125.0 32.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.744 -0.835 . . . . 72.409999999999997 108.744 -176.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.42 158.31 40.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 115.836 -0.62 . . . . 73.140000000000001 109.73 -178.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 39.1 Cg_exo -60.8 148.86 90.75 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.969 2.446 . . . . 75.230000000000004 113.121 177.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.7 p-10 -125.44 -21.63 4.49 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.234 -0.893 . . . . 35.329999999999998 110.626 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 32.5 tt0 -94.23 107.52 19.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.797 -0.816 . . . . 61.25 108.797 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 95.3 m-85 -120.52 114.46 21.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.294 0.569 . . . . 70.219999999999999 109.956 177.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.49 122.06 66.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.16 -1.052 . . . . 71.540000000000006 108.16 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.6 mt -115.6 119.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.376 0.607 . . . . 73.299999999999997 109.521 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 109' ' ' GLU . 15.1 m -117.45 123.71 47.04 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.721 -0.672 . . . . 43.450000000000003 109.261 -177.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 74' ' ' LEU . 6.4 mp -121.8 171.82 8.61 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 109.949 -0.389 . . . . 73.530000000000001 109.949 175.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.79 147.28 43.11 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.484 -1.046 . . . . 61.299999999999997 110.484 175.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.03 -47.76 65.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 123.099 0.56 . . . . 63.039999999999999 110.666 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.592 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 52.7 t-80 -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.506 -0.77 . . . . 65.400000000000006 110.376 -178.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 9.3 t70 -65.2 -43.28 92.11 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.768 0.794 . . . . 73.420000000000002 108.983 -178.337 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.3 -44.43 92.52 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.82 1.648 . . . . 74.430000000000007 109.8 -178.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -67.25 -37.25 83.2 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.087 -0.506 . . . . 73.310000000000002 110.749 177.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 3.1 mmmp? -68.5 -26.28 65.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.462 -0.336 . . . . 61.299999999999997 110.607 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 66' ' ' LEU . 78.8 mt -69.65 -45.68 67.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.804 0.811 . . . . 74.400000000000006 109.792 175.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.6 44.87 7.11 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 105.054 -3.218 . . . . 44.219999999999999 105.054 -165.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -61.53 6.93 0.05 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 128.624 2.77 . . . . 71.129999999999995 116.851 -171.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.4 t70 -43.45 106.85 0.52 Allowed Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.556 1.142 . . . . 71.109999999999999 108.728 -173.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 52.9 Cg_exo -52.65 -52.47 8.79 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.334 3.356 . . . . 74.140000000000001 118.987 -161.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.79 -51.07 7.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.441 1.645 . . . . 72.120000000000005 115.441 -165.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -62.96 -56.48 16.78 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.744 0.646 . . . . 63.409999999999997 112.744 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 85' ' ' PHE 0.286 29.1 mmmt -94.8 -8.61 36.98 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 115.55 1.685 . . . . 64.239999999999995 115.55 -177.352 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -69.46 -45.58 68.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.213 -1.773 . . . . 63.240000000000002 106.213 174.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.4 m -69.92 -36.91 75.73 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.059 -0.973 . . . . 65.340000000000003 108.925 175.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.02 -56.22 26.38 Favored Glycine 0 C--O 1.21 -1.345 0 CA-C-N 115.33 -0.85 . . . . 61.409999999999997 113.109 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 32.1 m-85 -60.2 -35.47 75.48 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.449 0.624 . . . . 70.540000000000006 111.492 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.95 94.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.42 . . . . 52.009999999999998 109.99 177.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -68.88 -41.12 78.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.878 -0.601 . . . . 74.510000000000005 110.085 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.67 -50.97 71.43 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.902 -0.407 . . . . 72.049999999999997 109.902 176.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.8 -31.76 70.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.215 0.82 . . . . 72.109999999999999 113.215 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.43 91.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.332 0.587 . . . . 74.230000000000004 109.661 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.0 -41.99 73.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.638 -0.71 . . . . 61.409999999999997 109.655 177.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -56.48 -52.86 63.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 112.565 0.58 . . . . 72.400000000000006 112.565 176.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.32 -37.8 58.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 120.063 -0.655 . . . . 74.239999999999995 111.699 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.28 -50.89 62.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.379 . . . . 71.510000000000005 111.181 175.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -53.31 -51.03 63.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.942 1.297 . . . . 74.420000000000002 110.784 -178.376 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 1.7 mp0 -74.73 -13.44 60.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.086 1.143 . . . . 72.109999999999999 114.086 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.24 38.21 11.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.028 -1.082 . . . . 72.519999999999996 111.796 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -109.42 158.41 17.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.774 -0.825 . . . . 72.239999999999995 108.774 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 23.6 pt20 -129.11 174.24 9.74 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.923 -0.769 . . . . 73.430000000000007 108.923 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.0 t -162.34 159.29 25.24 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.735 -1.209 . . . . 74.230000000000004 107.735 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.56 118.9 33.11 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.381 -0.97 . . . . 74.25 108.381 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -149.75 16.72 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.567 -1.813 . . . . 54.509999999999998 108.567 -176.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -126.09 164.32 21.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.568 -1.641 . . . . 63.140000000000001 106.568 174.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.37 117.53 28.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.556 -0.905 . . . . 54.399999999999999 108.556 -178.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -118.33 121.03 66.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.607 0.717 . . . . 74.319999999999993 110.643 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 62' ' ' TYR . 79.5 t -111.12 113.18 43.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.387 -0.968 . . . . 72.010000000000005 108.387 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -111.31 134.45 52.89 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.007 -0.542 . . . . 72.530000000000001 109.554 -177.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.4 146.41 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.738 -0.467 . . . . 73.349999999999994 109.738 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 65' ' ' THR . 9.2 pt-20 -151.37 168.31 25.2 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.75 -0.833 . . . . 62.119999999999997 108.75 174.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.42 25.77 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.235 0.541 . . . . 51.109999999999999 111.784 178.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -135.74 136.87 41.15 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.709 -1.132 . . . . 52.049999999999997 109.146 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 t -80.73 -19.27 45.37 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.8 -0.815 . . . . 54.340000000000003 108.8 176.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -72.79 -36.43 67.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.701 -0.681 . . . . 71.129999999999995 110.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.74 155.22 20.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.176 -0.466 . . . . 73.540000000000006 110.707 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -125.27 173.47 8.78 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.2 0.6 . . . . 72.420000000000002 110.645 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 9.8 m -57.79 125.61 23.77 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.474 0.654 . . . . 75.409999999999997 110.933 -179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.87 54.84 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.318 -0.856 . . . . 74.150000000000006 111.058 -176.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -118.18 118.67 32.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.092 0.472 . . . . 73.120000000000005 110.08 -178.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 34.0 p90 -139.03 148.45 43.42 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.564 -1.273 . . . . 74.319999999999993 107.564 177.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -132.12 130.65 41.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.228 -1.027 . . . . 55.43 108.228 175.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . -130.8 129.48 42.47 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.83 -1.174 . . . . 53.119999999999997 107.83 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 39.7 mtp180 -119.61 157.8 27.69 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 123.155 0.285 . . . . 71.519999999999996 111.521 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -137.0 109.85 0.74 Allowed Glycine 0 N--CA 1.424 -2.109 0 O-C-N 124.715 1.26 . . . . 60.310000000000002 110.918 176.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.6 m -114.3 150.43 34.48 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.371 -0.603 . . . . 73.439999999999998 109.371 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.24 106.12 16.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 106.49 -1.67 . . . . 75.310000000000002 106.49 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -110.42 102.28 51.07 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 109.962 -0.384 . . . . 71.239999999999995 109.962 -178.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 121.946 1.764 . . . . 54.5 111.394 178.441 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.445 -0.708 0 N-CA-C 106.271 -1.752 . . . . 74.219999999999999 106.271 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.02 -27.12 33.25 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.443 -1.253 . . . . 72.530000000000001 109.892 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -54.4 33.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.034 0 N-CA-C 107.649 -1.241 . . . . 61.140000000000001 107.649 175.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.78 -46.58 74.45 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.441 1.097 . . . . 71.409999999999997 110.911 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.2 69.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.058 -0.519 . . . . 65.120000000000005 111.655 178.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' CE2' ' A' ' 119' ' ' PHE . 9.6 tt -70.92 -35.4 72.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.849 0.356 . . . . 74.430000000000007 110.576 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 tp -67.12 -38.65 85.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.938 -0.574 . . . . 73.010000000000005 110.522 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -71.86 -29.06 63.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.407 -0.517 . . . . 61.25 111.184 177.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.28 -38.02 68.9 Favored 'General case' 0 C--O 1.203 -1.368 0 C-N-CA 119.037 -1.065 . . . . 61.130000000000003 109.075 173.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -64.34 -33.14 75.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.205 -0.665 . . . . 74.219999999999999 109.205 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.52 73.48 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.345 -0.843 . . . . 74.219999999999999 109.613 174.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -67.98 -30.98 70.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.563 0.697 . . . . 72.239999999999995 111.477 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.6 -29.92 52.2 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.92 -0.582 . . . . 72.25 109.755 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.51 14.1 65.98 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.824 -0.625 . . . . 75.540000000000006 112.41 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 45' ' ' ALA . 8.7 mm -64.0 138.9 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.962 0.905 . . . . 64.439999999999998 111.254 177.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 76.3 mt-30 -119.25 147.47 44.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.952 -0.567 . . . . 72.109999999999999 110.499 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.5 m -82.95 134.55 35.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 115.029 -0.987 . . . . 55.340000000000003 108.807 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.4 tp -150.69 -165.43 2.27 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.008 -2.219 . . . . 64.340000000000003 105.008 -179.371 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.623 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 80.0 mt-30 -42.2 139.33 1.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.727 0.811 . . . . 72.530000000000001 111.649 176.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.47 20.69 0.97 Allowed Glycine 0 CA--C 1.505 -0.543 0 CA-C-N 115.363 -0.835 . . . . 53.210000000000001 115.032 -170.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -86.96 -37.19 17.8 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.316 -1.365 . . . . 53.210000000000001 107.316 175.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -173.92 158.6 3.21 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.195 -0.911 . . . . 63.409999999999997 112.235 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB3' HG23 ' A' ' 48' ' ' ILE . 57.5 mt -91.63 151.76 20.55 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.042 -0.981 . . . . 74.230000000000004 111.36 -174.477 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 22.2 mt -80.88 121.0 25.43 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 115.771 -0.65 . . . . 70.129999999999995 110.978 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.13 151.14 37.61 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.731 -1.211 . . . . 53.329999999999998 107.731 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' HG22 ' A' ' 125' ' ' VAL . 39.3 Cg_exo -59.44 156.09 37.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.42 2.08 . . . . 43.520000000000003 112.882 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -118.86 -29.41 5.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.572 -0.74 . . . . 72.519999999999996 109.568 176.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -96.52 105.28 17.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.822 -0.626 . . . . 75.439999999999998 109.587 179.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 76.0 m-85 -115.8 114.8 25.25 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.802 -0.444 . . . . 74.120000000000005 109.802 178.24 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.8 119.97 61.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.584 -1.265 . . . . 64.200000000000003 107.584 177.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.42 135.69 41.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.664 -1.236 . . . . 63.210000000000001 107.664 -178.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 27.3 m -124.37 113.36 18.09 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 72.310000000000002 109.685 -177.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 3.5 mm? -109.3 -176.89 3.15 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.755 -0.657 . . . . 43.020000000000003 110.26 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.48 173.6 44.17 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.248 -1.141 . . . . 63.340000000000003 110.248 177.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.9 p -65.82 -44.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 117.131 0.466 . . . . 54.520000000000003 111.224 -179.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -56.51 -42.34 78.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.05 0.929 . . . . 74.400000000000006 110.033 177.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 12.6 m-20 -71.94 -37.78 69.93 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.299 -1.318 . . . . 72.019999999999996 110.446 -176.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.7 -37.78 88.77 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.655 -0.498 . . . . 74.329999999999998 109.655 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.5 mt-10 -61.23 -36.96 81.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.693 -0.685 . . . . 65.140000000000001 110.229 177.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.81 -23.88 41.76 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.975 -0.557 . . . . 75.120000000000005 112.362 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 89.5 mt -61.23 -42.29 98.35 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.714 -0.476 . . . . 64.140000000000001 109.714 177.387 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.21 166.65 10.75 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 119.622 -1.275 . . . . 43.439999999999998 113.299 175.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.89 -18.24 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.721 0.408 . . . . 75.299999999999997 111.575 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -115.72 85.4 14.09 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.084 -0.71 . . . . 54.32 109.084 177.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.13 -50.0 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.143 1.895 . . . . 73.129999999999995 112.282 -178.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.27 -49.48 73.89 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.53 0.567 . . . . 74.409999999999997 112.53 -173.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.74 -37.02 82.68 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 112.29 0.478 . . . . 70.030000000000001 112.29 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -77.42 -26.7 51.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.687 -0.405 . . . . 74.310000000000002 111.009 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 60.1 m -65.57 -40.41 92.75 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.876 -0.416 . . . . 52.119999999999997 109.876 175.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 m -59.79 -39.23 84.24 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.389 0.614 . . . . 72.319999999999993 109.964 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.85 55.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.582 -0.736 . . . . 54.439999999999998 111.976 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -68.95 -28.35 66.55 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.117 0.484 . . . . 74.099999999999994 110.03 -178.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -66.9 -38.79 86.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 116.147 -0.479 . . . . 72.530000000000001 109.757 176.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.36 -38.43 89.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 109.564 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -65.31 -42.66 92.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.992 -0.549 . . . . 70.099999999999994 110.344 177.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.15 -33.24 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.373 -0.376 . . . . 74.450000000000003 110.827 178.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.2 98.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.462 -0.569 . . . . 61.009999999999998 109.462 176.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.2 t70 -61.68 -44.18 97.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.304 -0.862 . . . . 73.150000000000006 109.453 177.189 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 m-85 -57.65 -52.96 63.28 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.671 0.619 . . . . 72.510000000000005 112.671 176.047 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.8 pt -64.59 -30.18 49.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.693 -0.403 . . . . 63.25 111.705 -176.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -38.31 85.89 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.123 -0.49 . . . . 72.450000000000003 110.366 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 51.3 mt-10 -65.67 -30.55 71.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.951 -0.568 . . . . 72.129999999999995 111.162 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.0 mm-40 -85.52 -11.43 54.18 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.807 -0.633 . . . . 70.340000000000003 110.941 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.66 33.08 60.92 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.764 -0.653 . . . . 51.100000000000001 113.065 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -97.99 161.34 13.77 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.496 -0.482 . . . . 74.540000000000006 110.122 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.95 161.71 18.43 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.021 -0.733 . . . . 71.540000000000006 109.021 178.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -161.1 172.26 17.12 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.576 -1.638 . . . . 54.340000000000003 106.576 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -123.51 120.14 32.03 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 71.450000000000003 110.235 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.74 13.07 Favored Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 109.751 -1.34 . . . . 53.140000000000001 109.751 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.08 141.32 30.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.542 -0.91 . . . . 64.109999999999999 108.542 174.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.37 138.32 21.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.293 -1.002 . . . . 65.040000000000006 108.293 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.19 124.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 121.152 0.501 . . . . 43.420000000000002 111.125 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 15.3 m -108.87 140.54 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 106.643 -1.614 . . . . 52.210000000000001 106.643 172.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.38 144.92 48.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.512 -0.922 . . . . 74.510000000000005 108.512 177.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -111.77 126.93 55.59 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.413 0.445 . . . . 53.0 110.184 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.5 pt-20 -128.26 168.49 15.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.936 -1.505 . . . . 74.040000000000006 106.936 173.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.35 156.93 34.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 112.004 -177.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 74.5 m -130.48 101.77 5.87 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.171 -1.418 . . . . 61.420000000000002 107.171 169.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -68.14 -9.38 46.17 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 123.948 0.899 . . . . 72.340000000000003 112.941 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.0 -25.66 48.14 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.746 -0.835 . . . . 60.509999999999998 108.746 174.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -104.48 151.45 23.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.66 -1.237 . . . . 72.310000000000002 107.66 -177.235 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -139.65 171.8 13.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 117.563 0.165 . . . . 72.439999999999998 111.307 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 m -36.02 112.87 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.28 2.232 . . . . 53.030000000000001 113.057 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.35 -33.07 3.74 Favored Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 107.848 -2.101 . . . . 74.019999999999996 107.848 -175.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -105.73 139.21 40.65 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.908 -1.516 . . . . 74.329999999999998 106.908 174.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CE2' HD13 ' A' ' 39' ' ' LEU . 32.7 p90 -170.45 154.19 4.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.783 -0.821 . . . . 74.030000000000001 108.783 174.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -128.72 157.97 39.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.963 -0.562 . . . . 72.040000000000006 110.261 -177.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.47 144.15 22.62 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.092 -1.818 . . . . 72.420000000000002 106.092 174.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 33.2 ptt-85 -140.41 145.95 37.69 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.436 -0.579 . . . . 64.439999999999998 109.436 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 110.06 0.93 Allowed Glycine 0 C--N 1.284 -2.326 0 O-C-N 124.206 0.942 . . . . 75.219999999999999 111.81 -176.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.6 m -109.25 137.84 46.51 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.65 -0.5 . . . . 71.340000000000003 109.65 -179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.0 t -89.07 109.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.992 -1.855 . . . . 71.400000000000006 105.992 170.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.16 105.88 31.39 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.437 -0.579 . . . . 44.5 109.437 179.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 C-N-CA 122.165 1.91 . . . . 71.030000000000001 111.689 178.785 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 120.259 0.076 . . . . 60.240000000000002 110.884 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.51 -47.78 69.58 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 123.465 0.706 . . . . 73.219999999999999 109.111 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.36 -44.81 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.272 -0.876 . . . . 74.099999999999994 109.917 -178.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.87 -53.42 56.98 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 116.025 -0.534 . . . . 63.009999999999998 111.352 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.55 86.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.707 -0.679 . . . . 72.329999999999998 111.201 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.36 -41.76 84.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.85 -0.426 . . . . 73.150000000000006 109.85 -178.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.52 -43.4 80.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.581 0.586 . . . . 75.299999999999997 112.581 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -68.65 -29.55 68.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.788 -0.765 . . . . 73.129999999999995 110.78 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -70.06 -38.79 75.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.141 -0.689 . . . . 72.049999999999997 109.141 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.9 -38.15 90.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.962 -0.755 . . . . 74.319999999999993 108.962 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.42 92.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 74.209999999999994 110.421 176.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.91 -31.88 71.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 74.099999999999994 111.468 -178.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.37 -33.55 61.06 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.165 -0.47 . . . . 61.240000000000002 111.217 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.58 15.53 40.74 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.813 -0.631 . . . . 35.109999999999999 112.94 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 48' ' ' ILE . 12.2 mm -67.02 130.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 123.332 0.653 . . . . 72.239999999999995 112.132 179.09 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -116.02 147.41 41.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.353 -0.839 . . . . 74.219999999999999 109.622 176.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.6 m -77.55 102.92 7.19 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.163 0.982 . . . . 64.040000000000006 111.484 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.5 tp -105.2 -165.96 1.18 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.246 -2.131 . . . . 60.130000000000003 105.246 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.5 mt-30 -51.06 138.25 20.12 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.348 -0.982 . . . . 72.030000000000001 108.348 171.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.91 22.47 0.57 Allowed Glycine 0 N--CA 1.471 0.982 0 N-CA-C 114.782 0.673 . . . . 32.32 114.782 -171.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -104.27 -25.23 12.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.266 -1.013 . . . . 64.319999999999993 108.266 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -161.51 134.66 6.31 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.28 -0.873 . . . . 73.129999999999995 110.54 -177.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.0 151.88 19.28 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.783 -0.644 . . . . 75.439999999999998 110.61 -175.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.01 126.6 36.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.159 -1.052 . . . . 74.430000000000007 108.159 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.24 160.41 37.59 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 123.181 0.592 . . . . 53.539999999999999 109.805 -178.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.15 157.99 59.06 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.611 2.208 . . . . 74.510000000000005 111.921 176.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB3' HG21 ' A' ' 100' ' ' THR . 25.3 p-10 -126.38 -25.12 3.53 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.174 0.435 . . . . 63.340000000000003 112.174 -177.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.48 110.38 21.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.551 -0.537 . . . . 72.099999999999994 109.551 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 55.1 m-85 -116.88 119.16 34.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.434 -0.803 . . . . 62.539999999999999 110.076 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.2 118.99 56.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.669 -0.863 . . . . 73.010000000000005 108.669 177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.1 mp -112.48 124.96 69.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.462 -0.94 . . . . 71.209999999999994 108.462 178.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -119.42 133.64 55.61 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.997 -0.742 . . . . 54.439999999999998 108.997 -178.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.58 173.36 7.23 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.209 0.604 . . . . 71.010000000000005 110.226 175.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.51 166.44 45.57 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 108.846 -1.701 . . . . 72.120000000000005 108.846 172.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 95.1 t -59.07 -59.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 117.666 0.733 . . . . 54.439999999999998 110.885 -178.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.499 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 40.8 t-80 -53.44 -49.17 67.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 65.510000000000005 110.809 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.552 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.8 m-20 -58.2 -50.38 73.75 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.62 1.168 . . . . 63.130000000000003 111.134 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.24 -40.08 93.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.354 -0.384 . . . . 71.019999999999996 111.24 -176.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 53.5 mt-10 -65.78 -31.27 72.15 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.856 0.36 . . . . 62.340000000000003 111.074 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.6 mptt -79.32 -27.51 42.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 73.310000000000002 111.266 178.007 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 61.3 mt -75.49 -33.25 60.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.802 . . . . 72.109999999999999 108.833 175.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.01 116.16 1.65 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.833 -1.707 . . . . 72.209999999999994 108.833 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -77.76 1.51 19.89 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.063 0.394 . . . . 61.32 112.063 -176.24 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 25.4 t70 -80.58 101.88 1.07 Allowed Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 124.215 1.006 . . . . 72.109999999999999 109.226 176.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 72.9 Cg_endo -75.92 -33.47 3.7 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.44 2.093 . . . . 72.319999999999993 115.871 -171.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.05 -49.11 71.38 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 112.776 0.658 . . . . 74.150000000000006 112.776 -170.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.96 -15.99 62.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.846 0.355 . . . . 74.450000000000003 111.864 -177.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 75.6 mmtt -81.68 -57.64 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.511 -0.922 . . . . 65.209999999999994 108.511 175.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -53.74 50.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.078 -0.965 . . . . 74.530000000000001 111.308 -173.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.9 m -69.95 -35.5 74.56 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.639 -0.255 . . . . 32.450000000000003 111.195 -177.266 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.09 -51.05 59.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.284 -0.484 . . . . 75.310000000000002 112.01 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 71.7 m-85 -72.65 -36.03 67.88 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 112.493 0.553 . . . . 73.519999999999996 112.493 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.49 96.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.666 -0.414 . . . . 62.409999999999997 110.739 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -63.83 -49.09 74.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.977 -0.556 . . . . 75.310000000000002 110.559 178.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -67.29 -37.31 83.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 64.200000000000003 111.552 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 tp -74.05 -34.93 64.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 63.0 111.005 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.11 89.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.814 -0.81 . . . . 63.229999999999997 108.814 175.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.36 -48.83 74.03 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.968 -1.014 . . . . 74.230000000000004 109.736 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.606 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.9 m-85 -52.08 -53.33 43.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.906 0.706 . . . . 71.430000000000007 112.906 176.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.4 pt -62.09 -36.53 74.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 120.594 -0.443 . . . . 73.299999999999997 111.494 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.56 -41.68 79.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.291 . . . . 64.530000000000001 110.861 177.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -59.27 -41.02 87.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.026 0.441 . . . . 61.43 111.194 177.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 78.6 mm-40 -72.99 -13.37 61.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.009 -0.542 . . . . 63.350000000000001 112.21 -178.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.13 36.07 13.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.37 -0.919 . . . . 63.100000000000001 111.06 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -113.21 170.91 7.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.194 -1.039 . . . . 73.019999999999996 108.194 175.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -151.62 178.19 9.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.691 -0.855 . . . . 72.230000000000004 108.691 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 60' ' ' ASN . 14.6 t -150.52 177.91 9.57 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.518 -0.549 . . . . 74.109999999999999 109.518 -179.314 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.7 m-85 -111.66 121.04 44.05 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 178.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.96 -149.68 17.05 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.222 -1.151 . . . . 64.129999999999995 110.222 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -121.78 147.19 46.26 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.166 -0.679 . . . . 62.509999999999998 109.166 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.9 125.16 39.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 110.844 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.04 120.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 121.789 0.804 . . . . 74.329999999999998 109.984 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.3 t -117.78 112.43 38.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.212 -1.403 . . . . 74.439999999999998 107.212 179.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -115.97 138.87 50.8 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 111.934 0.346 . . . . 75.030000000000001 111.934 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -119.18 134.9 54.94 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.269 -1.011 . . . . 60.310000000000002 108.269 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -156.17 164.16 38.72 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 123.563 0.539 . . . . 64.409999999999997 111.232 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -95.46 164.91 12.61 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.106 -0.497 . . . . 50.100000000000001 111.241 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 p -150.36 150.21 31.12 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 115.444 -0.798 . . . . 71.420000000000002 109.647 177.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -80.78 -22.83 39.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.607 -0.516 . . . . 73.109999999999999 109.607 176.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.93 -28.1 68.67 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.469 0.707 . . . . 71.510000000000005 110.756 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 120' ' ' ARG . 77.3 mt -96.5 135.92 37.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.917 -0.583 . . . . 72.409999999999997 110.716 -178.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -110.66 172.06 7.1 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.638 -1.616 . . . . 74.5 106.638 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 97.4 m -58.91 126.29 27.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.966 1.469 . . . . 62.530000000000001 114.966 -174.129 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.64 -8.79 47.57 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 114.18 -1.373 . . . . 64.120000000000005 111.443 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -104.53 135.68 45.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.75 0.309 . . . . 64.109999999999999 110.865 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.01 151.04 37.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.24 -1.022 . . . . 74.109999999999999 108.24 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 114' ' ' LEU . 53.8 mtm180 -124.67 143.21 50.86 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.855 -1.165 . . . . 75.209999999999994 107.855 177.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.85 118.3 10.3 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.292 -1.744 . . . . 71.230000000000004 106.292 173.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 23.1 tpt180 -120.3 121.67 39.17 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 120.05 -0.66 . . . . 74.129999999999995 110.058 -177.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.09 119.25 6.43 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.607 -1.397 . . . . 42.420000000000002 109.607 176.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.3 p -126.06 156.62 39.68 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 110.081 -0.34 . . . . 73.140000000000001 110.081 -178.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.52 110.74 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 107.199 -1.408 . . . . 62.219999999999999 107.199 175.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -117.4 96.29 49.02 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.408 -0.96 . . . . 74.510000000000005 108.408 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 9.9 Cg_exo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 122.333 2.022 . . . . 71.340000000000003 111.848 -177.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 . . . . . 0 C--O 1.241 0.616 0 CA-C-O 120.691 0.281 . . . . 72.010000000000005 111.491 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.56 -34.48 74.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.011 -0.366 . . . . 74.140000000000001 110.011 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 59.3 t -56.22 -50.5 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 74.450000000000003 110.111 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.82 -43.31 98.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.547 -178.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.14 89.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.666 -0.697 . . . . 54.219999999999999 110.822 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.6 -23.92 58.8 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.832 0.679 . . . . 70.5 112.832 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.6 mt -67.26 -37.43 83.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 65.140000000000001 110.294 175.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -65.26 -42.0 93.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.643 0.735 . . . . 73.040000000000006 109.242 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' ARG . 29.8 mmt180 -71.7 -28.68 63.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.415 -0.811 . . . . 75.209999999999994 111.316 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 29.9 tp10 -68.92 -44.67 72.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.192 -0.67 . . . . 71.349999999999994 109.192 176.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -59.99 -41.58 92.33 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.642 -0.708 . . . . 34.350000000000001 109.728 176.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.62 -36.49 80.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.545 -0.752 . . . . 22.120000000000001 111.147 177.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.96 -39.49 83.36 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 63.420000000000002 111.247 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.92 5.96 80.64 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.747 -0.661 . . . . 62.119999999999997 113.697 -178.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ALA . 10.8 mm -58.91 130.38 22.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.589 0.709 . . . . 73.310000000000002 112.112 178.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -116.19 134.71 54.62 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.356 -0.838 . . . . 70.219999999999999 110.056 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -72.52 106.59 4.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.804 -1.089 . . . . 72.140000000000001 109.694 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.9 tp -109.16 -164.69 0.96 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.796 -1.557 . . . . 61.5 106.796 -177.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.639 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 16.1 mm100 -51.52 162.49 0.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.651 0.781 . . . . 70.310000000000002 112.307 176.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -7.48 38.21 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-N 114.946 -1.024 . . . . 74.530000000000001 113.7 -175.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -68.38 -48.63 64.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 64.319999999999993 108.797 177.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -176.27 167.77 2.84 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.774 1.027 . . . . 73.439999999999998 113.774 -177.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.11 151.26 21.06 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.486 -1.234 . . . . 71.120000000000005 111.153 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.95 126.28 43.28 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.664 -1.236 . . . . 74.239999999999995 107.664 -177.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.82 158.06 35.13 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 123.548 0.739 . . . . 54.219999999999999 109.648 -178.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.9 Cg_exo -61.84 158.27 38.91 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.893 2.396 . . . . 50.439999999999998 113.087 178.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -124.81 -30.16 3.31 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.631 -0.713 . . . . 73.549999999999997 110.448 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.67 107.96 19.62 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.048 0.939 . . . . 64.5 108.596 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -116.22 118.12 31.91 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.885 0.374 . . . . 71.099999999999994 110.353 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.52 114.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.114 -0.698 . . . . 65.040000000000006 109.114 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 2.3 mp -109.27 132.39 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.678 -1.23 . . . . 72.400000000000006 107.678 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.2 m -137.39 135.88 37.36 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.951 -0.389 . . . . 72.329999999999998 109.951 -177.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -130.17 -179.38 5.2 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.303 -0.629 . . . . 74.219999999999999 109.303 175.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -69.77 156.03 53.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.86 -1.296 . . . . 71.400000000000006 109.86 175.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLN . 43.4 t -56.25 -56.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 117.443 0.621 . . . . 45.219999999999999 111.83 -175.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.606 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 50.4 t-80 -59.12 -45.14 91.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.462 0.476 . . . . 74.010000000000005 110.555 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.85 -43.19 99.46 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 70.329999999999998 109.753 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.27 -39.44 82.18 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.382 -0.826 . . . . 73.430000000000007 111.12 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 36.5 mt-10 -65.25 -28.58 69.45 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.648 0.261 . . . . 63.329999999999998 111.607 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 0.4 OUTLIER -78.57 -23.33 46.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 120.017 -0.673 . . . . 73.239999999999995 109.686 178.686 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.22 -36.79 74.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 72.109999999999999 109.916 174.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.21 158.32 8.59 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.821 -0.912 . . . . 51.299999999999997 110.821 177.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.8 -6.92 57.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 111.872 0.323 . . . . 61.420000000000002 111.872 -177.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.72 103.31 46.32 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.691 -0.231 . . . . 74.239999999999995 111.594 -179.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.43 -36.55 8.83 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.62 1.547 . . . . 61.219999999999999 109.86 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.52 -29.19 66.75 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.148 0.796 . . . . 73.319999999999993 113.148 -176.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.84 -42.94 94.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.77 -1.567 . . . . 61.32 106.77 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.69 -38.79 77.12 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.476 -1.238 . . . . 75.420000000000002 109.456 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 106' ' ' VAL . 65.2 m -58.22 -48.36 80.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.353 -0.385 . . . . 54.420000000000002 111.02 177.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -57.8 -49.01 78.04 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 123.391 0.432 . . . . 70.150000000000006 110.69 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.18 -55.73 19.82 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.719 -0.673 . . . . 74.510000000000005 112.904 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -67.41 -37.12 82.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.741 1.015 . . . . 73.040000000000006 113.741 -175.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -66.6 -45.02 80.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.527 . . . . 75.319999999999993 110.697 -179.314 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.36 -40.01 89.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 71.540000000000006 110.3 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.52 -53.32 53.74 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.166 -0.925 . . . . 74.329999999999998 111.064 178.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.11 -30.34 70.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 75.420000000000002 111.334 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.8 78.55 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.178 0.513 . . . . 63.340000000000003 110.033 176.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.69 -39.7 73.34 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.599 -0.889 . . . . 64.239999999999995 108.599 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 22.0 m-85 -56.83 -52.18 66.08 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.532 -0.758 . . . . 63.210000000000001 112.494 175.346 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.1 pt -61.63 -37.27 77.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.357 -0.537 . . . . 73.409999999999997 111.093 -177.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.32 -38.18 84.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.326 -0.397 . . . . 72.109999999999999 110.567 176.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -60.46 -44.0 96.32 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 63.25 111.051 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.5 mm-40 -75.91 -13.7 60.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.455 -0.793 . . . . 65.430000000000007 110.837 -178.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.89 35.68 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.928 -0.578 . . . . 75.400000000000006 112.442 177.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.75 172.56 7.18 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.891 -0.781 . . . . 73.019999999999996 108.891 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.35 173.45 11.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.524 -0.547 . . . . 61.450000000000003 109.524 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 t -157.53 177.84 10.96 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.331 -1.729 . . . . 63.210000000000001 106.331 177.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.07 117.48 34.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.686 -1.227 . . . . 75.340000000000003 107.686 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.82 -149.64 16.75 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.282 -1.927 . . . . 71.420000000000002 108.282 -177.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.68 169.61 15.93 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.387 -1.338 . . . . 74.209999999999994 107.387 171.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.01 120.88 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.825 0.345 . . . . 65.299999999999997 111.287 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -115.5 120.0 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.695 -0.854 . . . . 31.140000000000001 108.695 176.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 86' ' ' ALA . 13.9 p -119.69 129.02 75.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.516 0.674 . . . . 74.219999999999999 110.435 -176.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -115.8 138.07 51.49 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.339 -0.846 . . . . 72.129999999999995 109.983 -178.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -121.41 132.69 54.89 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.189 -1.412 . . . . 64.109999999999999 107.189 179.003 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.94 174.79 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.266 0.555 . . . . 65.25 111.02 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . 17.0 pm0 -110.18 151.94 26.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.063 -0.971 . . . . 73.140000000000001 110.612 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.404 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 37.8 t -141.42 132.28 25.91 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 107.24 -1.392 . . . . 71.340000000000003 107.24 176.063 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -81.6 -22.7 37.53 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.928 -0.767 . . . . 63.109999999999999 108.928 176.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -73.0 -30.21 63.61 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.598 0.714 . . . . 75.209999999999994 109.318 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -81.13 141.7 34.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.68 144.22 28.7 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.894 -0.594 . . . . 61.039999999999999 112.037 -171.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.9 m -64.84 124.54 22.25 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.85 -0.614 . . . . 63.299999999999997 109.567 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.27 -22.89 24.08 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.26 -1.136 . . . . 55.329999999999998 110.26 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -95.04 152.37 18.38 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.254 -1.017 . . . . 74.140000000000001 108.254 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 31.5 p90 -148.37 146.84 28.68 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.017 -1.475 . . . . 62.240000000000002 107.017 174.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 64.9 mtp180 -126.6 144.64 50.83 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.771 -0.455 . . . . 70.349999999999994 109.771 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.71 122.95 19.32 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.298 -1.371 . . . . 74.019999999999996 107.298 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.493 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 26.1 tpt180 -131.39 130.0 42.04 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.946 -0.702 . . . . 74.109999999999999 111.178 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -102.27 126.43 8.87 Favored Glycine 0 N--CA 1.425 -2.077 0 O-C-N 124.072 0.857 . . . . 72.109999999999999 111.059 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.1 m -122.82 146.57 47.43 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.662 -0.866 . . . . 72.230000000000004 108.662 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.1 t -95.66 105.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.184 -1.413 . . . . 74.329999999999998 107.184 174.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.48 100.14 51.15 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 120.871 -0.332 . . . . 63.549999999999997 110.206 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.442 -1.505 0 C-N-CA 121.994 1.796 . . . . 72.510000000000005 110.901 175.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 120.483 0.183 . . . . 72.150000000000006 111.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.09 85.49 0.14 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.774 -0.93 . . . . 71.310000000000002 110.774 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -63.06 127.33 30.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 109.702 -0.481 . . . . 64.010000000000005 109.702 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.5 165.16 13.51 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.166 -0.679 . . . . 62.539999999999999 109.166 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -90.17 149.36 22.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.841 -1.17 . . . . 72.049999999999997 107.841 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' HD2' ' OE1' ' A' ' 130' ' ' GLU . 5.3 tpp180 -72.94 99.46 2.71 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.76 0.791 . . . . 53.130000000000003 110.927 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.8 mt -123.97 112.81 17.64 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.764 -1.199 . . . . 74.129999999999995 107.764 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 m -91.62 -7.08 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.564 0.697 . . . . 54.329999999999998 109.23 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -67.39 93.66 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.768 -1.106 . . . . 71.140000000000001 111.116 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.84 102.55 13.8 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 105.229 -2.138 . . . . 70.340000000000003 105.229 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.5 t -45.12 119.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 124.472 1.107 . . . . 43.240000000000002 111.366 -177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.4 117.17 19.31 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 114.153 1.168 . . . . 72.409999999999997 114.153 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -147.31 143.39 28.03 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 104.348 -2.464 . . . . 70.140000000000001 104.348 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -87.26 81.04 8.05 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.561 -0.855 . . . . 71.420000000000002 111.742 -177.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.78 95.35 2.88 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.079 -0.964 . . . . 74.340000000000003 109.55 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.954 -0.758 . . . . 75.510000000000005 108.954 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.84 87.17 4.22 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 106.686 -1.598 . . . . 74.409999999999997 106.686 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 m -99.31 129.82 45.55 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 114.534 -1.212 . . . . 74.329999999999998 108.0 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 31.4 m -119.11 124.91 73.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.513 0.673 . . . . 61.409999999999997 111.87 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.75 -62.85 0.27 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 111.442 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.94 -4.1 58.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.148 0.499 . . . . 73.420000000000002 110.673 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.69 -36.69 72.3 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-N 115.368 -0.833 . . . . 74.420000000000002 111.619 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -61.86 -43.42 98.87 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.154 -0.475 . . . . 72.109999999999999 111.553 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.99 -46.45 84.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.833 0.349 . . . . 43.350000000000001 111.08 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -71.6 -28.39 63.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.702 -0.681 . . . . 55.32 112.651 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 22' ' ' ALA . 71.1 mt -67.86 -50.32 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 110.334 -0.247 . . . . 72.439999999999998 110.334 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -76.14 -11.69 59.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.869 0.366 . . . . 73.010000000000005 111.76 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.56 29.24 74.62 Favored Glycine 0 CA--C 1.506 -0.498 0 CA-C-N 115.781 -0.645 . . . . 74.340000000000003 112.897 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.15 83.86 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.484 -0.865 . . . . 74.219999999999999 113.542 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 t -60.09 -38.22 82.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.482 1.135 . . . . 55.520000000000003 108.204 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.556 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 23.9 pt -130.89 154.99 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 N-CA-C 104.063 -2.569 . . . . 62.329999999999998 104.063 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.01 94.37 14.69 Favored Pre-proline 0 C--N 1.289 -2.036 0 C-N-CA 120.265 -0.574 . . . . 74.209999999999994 109.582 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 31' ' ' ILE . 23.3 Cg_exo -67.95 -36.54 17.51 Favored 'Trans proline' 0 C--O 1.2 -1.378 0 C-N-CA 122.277 1.984 . . . . 64.329999999999998 110.722 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' CD ' ' A' ' 37' ' ' GLU . 95.1 mt-30 -61.74 -11.93 14.39 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.572 0.953 . . . . 73.349999999999994 113.572 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -71.33 -23.93 62.02 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.244 -1.021 . . . . 71.510000000000005 108.244 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 119' ' ' PHE . 98.4 t -69.12 -54.72 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.352 -0.84 . . . . 54.130000000000003 108.844 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 34' ' ' GLN . 2.7 mp0 -52.64 -43.9 65.75 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.053 0.454 . . . . 71.040000000000006 110.769 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.72 -54.53 43.2 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.087 -0.96 . . . . 74.329999999999998 111.399 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.5 tp -74.53 -25.18 59.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.782 -0.367 . . . . 51.020000000000003 110.857 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.17 -47.83 72.69 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.688 0.795 . . . . 73.340000000000003 109.966 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -71.09 -27.95 63.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.152 0.501 . . . . 62.43 110.182 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.16 -42.38 84.43 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.49 -0.777 . . . . 74.329999999999998 109.035 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.18 -32.6 70.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 72.549999999999997 109.434 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.37 -44.36 95.67 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.923 -0.581 . . . . 74.010000000000005 109.739 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -65.31 -35.17 80.19 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.613 0.721 . . . . 54.140000000000001 110.441 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -16.56 60.5 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.339 -0.846 . . . . 74.120000000000005 110.808 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.06 7.9 41.52 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 116.156 -0.475 . . . . 63.32 112.666 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 45' ' ' ALA . 29.2 mm -65.97 127.51 27.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 120.984 0.421 . . . . 74.230000000000004 110.835 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 10.3 tt0 -105.7 124.43 49.55 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.192 -1.04 . . . . 74.019999999999996 108.192 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -60.9 109.27 1.02 Allowed 'General case' 0 C--N 1.307 -1.24 0 O-C-N 124.124 0.89 . . . . 31.199999999999999 109.961 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.6 tp -122.56 -164.78 1.21 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.138 -1.801 . . . . 75.340000000000003 106.138 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.7 mt-30 -46.35 146.17 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.523 0.729 . . . . 73.329999999999998 110.81 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.65 -11.9 38.13 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 114.519 0.568 . . . . 52.409999999999997 114.519 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -73.34 -47.64 40.74 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.791 0.329 . . . . 73.030000000000001 110.544 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.592 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 24.1 ptt180 -158.88 142.92 15.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.581 0.705 . . . . 75.310000000000002 112.443 -176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.5 mt -91.26 151.63 20.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 125.223 1.409 . . . . 64.439999999999998 109.933 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 100' ' ' THR . 1.1 tt -90.41 118.28 29.77 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.045 -1.094 . . . . 73.439999999999998 108.045 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.37 153.78 39.53 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.716 -0.675 . . . . 74.0 109.714 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 44.8 Cg_exo -60.2 150.07 81.69 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.563 2.175 . . . . 75.310000000000002 112.014 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -114.82 -36.16 4.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.876 -0.602 . . . . 71.340000000000003 110.959 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -104.24 122.92 46.39 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 109.853 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.1 m-85 -118.55 118.53 31.96 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.228 -0.897 . . . . 74.439999999999998 109.53 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.6 109.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.477 -1.305 . . . . 55.340000000000003 107.477 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.3 mt -105.65 107.1 21.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.191 -1.04 . . . . 73.530000000000001 108.191 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 53.2 m -111.08 123.69 50.7 Favored 'General case' 0 N--CA 1.412 -2.357 0 CA-C-N 115.43 -0.805 . . . . 62.119999999999997 110.558 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -116.13 175.62 5.47 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.868 -0.606 . . . . 74.140000000000001 109.952 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -71.97 153.84 50.32 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 109.104 -1.598 . . . . 54.539999999999999 109.104 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.67 -42.17 80.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 110.346 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 5.0 t60 -66.89 -29.9 69.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.272 -0.876 . . . . 71.420000000000002 110.532 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 m-20 -76.27 -46.16 29.28 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 109.634 -0.506 . . . . 73.430000000000007 109.634 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -62.4 -42.53 99.5 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.559 -0.746 . . . . 74.239999999999995 111.877 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HG3' ' HD2' ' A' ' 73' ' ' LYS . 10.1 pt-20 -62.82 -34.33 77.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.929 0.395 . . . . 72.010000000000005 111.581 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 13.8 mptt -75.47 -27.07 58.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.163 -0.471 . . . . 72.040000000000006 111.201 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 66' ' ' LEU . 73.5 mt -72.22 -40.3 67.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.517 -0.92 . . . . 74.140000000000001 108.517 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.16 146.62 6.16 Favored Glycine 0 N--CA 1.416 -2.683 0 N-CA-C 109.771 -1.332 . . . . 62.109999999999999 109.771 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.57 -18.9 62.9 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 114.401 1.26 . . . . 64.25 114.401 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.39 124.04 76.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 119.595 -0.842 . . . . 72.129999999999995 110.472 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -77.39 -35.81 1.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.658 1.572 . . . . 72.420000000000002 110.88 167.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.86 -53.29 33.69 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.432 2.012 . . . . 65.310000000000002 116.432 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.38 -32.25 66.26 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.492 0.663 . . . . 72.420000000000002 110.389 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.14 -39.16 65.93 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.909 -1.041 . . . . 71.430000000000007 108.955 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.7 t -62.17 -44.13 97.28 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.301 -0.863 . . . . 63.039999999999999 109.883 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -59.13 -45.92 89.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.245 -0.434 . . . . 52.130000000000003 110.459 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.93 -48.93 51.6 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.844 -0.616 . . . . 75.219999999999999 112.855 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.25 -39.97 78.14 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.233 0.827 . . . . 74.219999999999999 113.233 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.66 -42.7 95.23 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 121.085 -0.246 . . . . 75.329999999999998 110.625 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -37.56 87.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 72.040000000000006 110.612 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -69.77 -44.69 69.64 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.253 -0.431 . . . . 71.439999999999998 110.523 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.07 -37.96 84.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.127 -0.488 . . . . 71.099999999999994 109.844 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.62 -30.7 71.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.367 0.603 . . . . 61.219999999999999 110.485 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 8.2 t70 -68.29 -43.61 77.33 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.148 -1.056 . . . . 72.329999999999998 108.148 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 34.0 m-85 -57.42 -47.68 81.11 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.323 -0.853 . . . . 74.420000000000002 112.821 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -62.47 -35.42 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.737 -0.785 . . . . 44.439999999999998 111.086 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.76 -45.96 87.46 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.414 -0.587 . . . . 74.409999999999997 109.414 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 32.2 mm-40 -60.44 -31.62 70.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.728 0.811 . . . . 61.350000000000001 113.078 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.2 mm-40 -90.99 -10.95 40.43 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.319 -0.401 . . . . 65.040000000000006 111.395 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 38.15 35.67 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.702 -0.761 . . . . 65.200000000000003 111.424 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 30.3 m0 -104.49 158.8 16.23 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.741 -0.466 . . . . 73.150000000000006 109.741 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.592 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -126.9 167.54 15.7 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.573 -0.528 . . . . 64.030000000000001 109.573 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 11.5 t -158.35 179.27 9.3 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.958 -0.756 . . . . 52.399999999999999 108.958 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -130.81 128.73 41.29 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.588 -0.523 . . . . 70.310000000000002 109.588 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 -149.98 16.9 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 108.313 -1.915 . . . . 15.300000000000001 108.313 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -124.84 141.29 52.22 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.925 -1.139 . . . . 63.130000000000003 107.925 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.75 112.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 O-C-N 123.53 0.518 . . . . 71.409999999999997 110.02 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.74 125.61 67.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.852 0.834 . . . . 70.439999999999998 111.288 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.2 m -105.02 129.82 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 N-CA-C 108.513 -0.921 . . . . 73.109999999999999 108.513 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -106.0 127.17 52.98 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 115.939 -0.573 . . . . 74.120000000000005 109.922 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -109.61 115.43 29.87 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 75.219999999999999 107.877 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.2 pt-20 -145.54 164.02 32.93 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.992 -0.549 . . . . 62.200000000000003 110.218 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -120.11 154.06 35.24 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.236 0.541 . . . . 74.030000000000001 111.124 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.6 m -137.81 143.47 41.04 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.597 -0.89 . . . . 55.119999999999997 108.597 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -72.5 -20.08 61.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.474 0.654 . . . . 73.310000000000002 111.129 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.01 -11.33 59.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.6 -0.727 . . . . 75.450000000000003 111.025 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 67' ' ' GLY . 0.7 OUTLIER -101.39 133.9 45.31 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 105.808 -1.923 . . . . 74.109999999999999 105.808 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -93.27 170.3 9.73 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 112.88 0.696 . . . . 64.239999999999995 112.88 -173.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.5 m -72.59 127.73 33.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.319 -0.855 . . . . 72.329999999999998 111.18 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.02 28.94 24.37 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 110.278 -1.129 . . . . 52.229999999999997 110.278 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -140.64 151.44 44.61 Favored 'General case' 0 N--CA 1.399 -2.993 0 N-CA-C 108.144 -1.058 . . . . 64.439999999999998 108.144 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.514 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 28.3 p90 -152.77 150.91 29.88 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.478 -1.304 . . . . 74.239999999999995 107.478 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -141.96 130.3 22.35 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 109.694 -0.484 . . . . 53.119999999999997 109.694 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.87 121.76 38.78 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.246 -1.39 . . . . 75.430000000000007 107.246 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.419 ' HD3' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -121.59 118.33 28.97 Favored 'General case' 0 N--CA 1.398 -3.068 0 C-N-CA 123.408 0.683 . . . . 75.129999999999995 109.196 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 122' ' ' ARG . . . -111.54 138.12 14.75 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 110.312 -1.115 . . . . 75.319999999999993 110.312 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 t -144.85 163.84 32.88 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.369 -0.974 . . . . 74.120000000000005 108.369 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.9 t -85.57 103.77 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 106.943 -1.503 . . . . 44.539999999999999 106.943 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -118.85 106.41 43.84 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.901 -0.591 . . . . 60.329999999999998 110.065 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -84.13 -11.15 8.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.053 1.835 . . . . 61.229999999999997 110.949 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -83.83 17.32 2.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.782 -0.644 . . . . 73.510000000000005 111.021 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.52 99.88 8.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.464 -1.31 . . . . 74.230000000000004 107.464 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.483 ' OE1' ' HD2' ' A' ' 6' ' ' ARG . 44.6 mt-10 -75.58 118.79 18.81 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 114.621 -1.172 . . . . 51.409999999999997 111.055 -174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.07 86.74 2.58 Favored 'General case' 0 N--CA 1.402 -2.855 0 CA-C-N 114.263 -1.335 . . . . 75.310000000000002 110.215 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 114.628 -1.169 . . . . 75.319999999999993 109.534 -175.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 CA--C 1.501 -0.929 0 N-CA-C 107.595 -1.261 . . . . 71.200000000000003 107.595 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.02 38.54 63.9 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 110.993 -0.843 . . . . 74.439999999999998 110.993 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.7 t -156.93 157.94 35.73 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.91 -0.774 . . . . 50.130000000000003 108.91 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -69.61 138.23 52.94 Favored 'General case' 0 C--O 1.252 1.188 0 C-N-CA 123.141 0.577 . . . . 72.430000000000007 112.014 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -94.27 120.86 35.13 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.156 -1.424 . . . . 74.430000000000007 107.156 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -75.81 107.59 8.1 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.312 -0.625 . . . . 70.409999999999997 109.312 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.17 85.0 6.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.187 0.518 . . . . 74.420000000000002 109.702 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.48 120.92 29.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 115.249 -0.887 . . . . 71.219999999999999 109.347 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -89.29 98.67 11.9 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.311 -0.625 . . . . 75.450000000000003 109.311 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -89.96 96.22 10.58 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 75.340000000000003 106.96 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.5 91.69 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.152 -1.055 . . . . 71.329999999999998 108.152 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.19 117.77 26.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.213 -0.903 . . . . 64.140000000000001 109.304 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -68.31 -32.63 72.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.882 -1.054 . . . . 75.519999999999996 111.958 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -97.14 95.36 7.7 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.392 -0.923 . . . . 74.140000000000001 111.196 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -150.31 99.04 2.75 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 104.135 -2.542 . . . . 71.400000000000006 104.135 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.79 163.36 32.41 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.309 -0.859 . . . . 73.209999999999994 109.811 -172.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -81.25 75.25 8.23 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.174 0.511 . . . . 75.150000000000006 111.972 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.5 m -93.35 101.57 13.81 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 106.13 -1.804 . . . . 51.420000000000002 106.13 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 m -78.91 140.25 17.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 114.509 -1.223 . . . . 72.439999999999998 110.189 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.59 159.32 9.56 Favored Glycine 1 N--CA 1.392 -4.254 0 N-CA-C 109.126 -1.59 . . . . 62.130000000000003 109.126 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 7.4 p-10 -72.95 72.35 1.11 Allowed 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 122.587 1.184 . . . . 70.329999999999998 111.627 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -46.91 88.01 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.7 -1.136 . . . . 74.120000000000005 112.641 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -63.03 -35.18 79.38 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.243 -0.435 . . . . 74.040000000000006 111.284 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.49 -35.96 73.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 70.120000000000005 110.853 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 7.9 mmt180 -77.14 -20.56 55.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 74.030000000000001 110.884 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.2 mt -87.98 -59.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.382 -0.372 . . . . 70.219999999999999 110.85 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 30' ' ' SER . 88.1 m-85 -86.03 -28.31 24.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.289 0.848 . . . . 72.140000000000001 113.289 -173.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.4 -101.83 1.11 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.888 -0.485 . . . . 72.200000000000003 111.888 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.36 31.89 5.81 Favored Glycine 0 C--N 1.294 -1.759 0 N-CA-C 111.476 -0.649 . . . . 71.409999999999997 111.476 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 27' ' ' PHE . 27.4 t -103.14 -150.0 0.41 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.263 -1.755 . . . . 44.539999999999999 106.263 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 31' ' ' ILE 0.267 2.5 pp -55.75 117.97 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.392 1.091 . . . . 72.219999999999999 112.923 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 135.14 19.54 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.525 -1.216 . . . . 62.210000000000001 109.584 -176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 12.4 Cg_endo -55.97 -24.43 48.33 Favored 'Trans proline' 0 C--O 1.21 -0.901 0 C-N-CA 123.624 2.883 . . . . 73.200000000000003 114.82 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.28 -38.99 81.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.464 0.913 . . . . 75.120000000000005 113.464 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.84 -28.87 60.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.225 0.536 . . . . 71.209999999999994 110.296 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.8 t -71.99 -42.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.646 -0.872 . . . . 71.450000000000003 108.646 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 45.2 mt-10 -58.31 -44.27 88.53 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.97 -0.559 . . . . 75.349999999999994 109.856 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -49.84 72.53 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 124.043 0.839 . . . . 55.229999999999997 111.163 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.16 -37.62 75.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.49 0.552 . . . . 55.009999999999998 112.49 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 64' ' ' ILE . 54.7 mt -64.99 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.39 0.515 . . . . 74.120000000000005 112.39 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 26.3 ptt180 -71.08 -28.01 64.03 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.104 -0.638 . . . . 72.420000000000002 109.808 178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -68.9 -40.87 78.92 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 108.526 -0.916 . . . . 73.540000000000006 108.526 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -60.48 -40.69 92.2 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 122.91 0.484 . . . . 35.539999999999999 110.248 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -63.01 -48.3 79.41 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.331 -0.85 . . . . 72.519999999999996 110.777 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.11 76.25 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.41 0.624 . . . . 74.299999999999997 111.112 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -71.57 -44.96 63.57 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.508 -0.769 . . . . 72.329999999999998 110.746 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.57 21.69 20.79 Favored Glycine 0 C--N 1.312 -0.76 0 CA-C-N 115.604 -0.726 . . . . 50.329999999999998 113.523 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 48' ' ' ILE . 11.8 mm -61.97 125.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.255 0.55 . . . . 72.310000000000002 110.346 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -121.17 137.1 54.83 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 114.986 -1.007 . . . . 74.510000000000005 110.841 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -63.24 118.0 7.37 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.39 -1.277 . . . . 74.230000000000004 112.427 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.5 tp -139.03 -165.88 1.92 Allowed 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 104.318 -2.475 . . . . 71.329999999999998 104.318 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.45 140.35 7.98 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 123.186 0.594 . . . . 72.319999999999993 111.287 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.14 -15.87 57.01 Favored Glycine 0 CA--C 1.505 -0.59 0 CA-C-N 115.896 -0.593 . . . . 74.129999999999995 114.408 -171.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -72.63 -35.56 67.82 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 111.815 0.302 . . . . 55.130000000000003 111.815 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 4.4 ptm180 -162.28 131.34 4.31 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.647 0.737 . . . . 65.310000000000002 111.083 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.53 152.33 20.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.369 1.467 . . . . 73.329999999999998 110.719 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 100' ' ' THR . 55.7 tp -78.08 126.01 30.19 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.54 -0.754 . . . . 63.100000000000001 109.909 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.71 158.57 43.28 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 108.316 -0.994 . . . . 73.340000000000003 108.316 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.592 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.5 Cg_exo -60.66 156.7 41.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.135 2.557 . . . . 71.420000000000002 113.674 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -126.66 -27.32 3.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.636 -0.711 . . . . 52.420000000000002 110.118 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.41 109.06 21.2 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.804 -0.813 . . . . 71.099999999999994 108.804 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 94.6 m-85 -115.66 115.45 26.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.595 -0.73 . . . . 75.120000000000005 110.656 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.74 119.51 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.191 -1.04 . . . . 71.530000000000001 108.191 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.462 HD11 HD21 ' A' ' 40' ' ' LEU . 15.2 mm -109.48 115.52 49.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.733 -1.21 . . . . 62.520000000000003 107.733 176.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 m -108.8 129.17 55.38 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.947 -0.57 . . . . 60.329999999999998 110.174 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.1 mm? -124.56 172.72 9.0 Favored 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.939 0.896 . . . . 60.25 109.587 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.33 179.39 53.2 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.057 -0.817 . . . . 41.43 111.057 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.45 -41.01 64.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 112.828 0.677 . . . . 61.439999999999998 112.828 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.556 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 75.4 t60 -73.04 -28.84 62.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.99 0.9 . . . . 73.219999999999999 109.413 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.579 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.5 m-20 -69.21 -44.16 72.67 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.999 -1.001 . . . . 74.230000000000004 108.602 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.89 -30.39 66.74 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.386 -0.825 . . . . 61.310000000000002 111.749 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 13.0 pt-20 -68.55 -29.94 68.61 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 119.95 -0.7 . . . . 74.530000000000001 110.35 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 14.5 mmmm -68.61 -31.51 70.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.039 -0.982 . . . . 74.209999999999994 109.796 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.74 -30.25 59.15 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.613 0.72 . . . . 61.439999999999998 109.107 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.7 -163.67 15.41 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.158 -0.928 . . . . 65.25 111.388 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.9 2.33 51.83 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.63 0.729 . . . . 51.299999999999997 109.5 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -111.76 97.87 39.14 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 113.542 0.941 . . . . 72.230000000000004 113.542 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -78.12 -46.85 0.12 Allowed 'Trans proline' 0 N--CA 1.438 -1.74 0 N-CA-C 109.286 -1.082 . . . . 70.209999999999994 109.286 162.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -43.97 -54.3 5.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 128.558 2.743 . . . . 71.430000000000007 116.994 -167.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tt -69.14 -51.37 39.05 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.387 -0.525 . . . . 74.099999999999994 110.216 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -75.42 -27.06 58.85 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 113.946 1.091 . . . . 64.129999999999995 113.946 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 66.4 p -71.23 -36.25 71.77 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.232 -0.587 . . . . 62.329999999999998 110.544 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -73.76 -37.42 65.04 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.09 -0.505 . . . . 74.150000000000006 109.796 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 87' ' ' ARG . . . -66.08 -41.9 94.82 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.832 -0.907 . . . . 73.129999999999995 110.832 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -69.97 -25.14 63.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.194 0.521 . . . . 73.510000000000005 109.832 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.78 -36.27 78.1 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 75.25 110.251 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 34.6 ttp180 -61.79 -45.57 93.28 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.943 -0.762 . . . . 75.340000000000003 108.943 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 -49.56 76.5 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.066 -0.97 . . . . 74.239999999999995 110.555 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 40' ' ' LEU . 46.4 tp -64.62 -35.35 80.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.568 . . . . 71.340000000000003 111.948 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.9 -36.35 83.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.381 0.61 . . . . 70.219999999999999 109.941 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.66 -39.81 84.51 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.558 -0.746 . . . . 73.299999999999997 109.203 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 21.2 m-85 -57.18 -50.56 72.45 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.548 -0.751 . . . . 72.400000000000006 112.46 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 pt -65.34 -35.14 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.069 -0.652 . . . . 73.209999999999994 111.284 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -67.46 -37.82 83.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.831 0.348 . . . . 55.439999999999998 111.116 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -62.03 -34.77 76.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.217 -0.447 . . . . 64.329999999999998 112.079 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 66.1 mm-40 -81.78 -13.63 57.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.989 -0.55 . . . . 73.019999999999996 110.986 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.87 31.12 18.82 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.693 -0.685 . . . . 70.120000000000005 112.254 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.5 m0 -104.74 177.21 4.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.859 -0.423 . . . . 74.530000000000001 109.859 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.536 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.7 pt20 -147.8 176.58 10.01 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.735 -0.469 . . . . 72.299999999999997 109.735 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.463 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.8 t -156.29 179.11 9.56 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.911 -1.515 . . . . 71.329999999999998 106.911 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.06 122.22 36.58 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 118.15 0.432 . . . . 74.239999999999995 110.567 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.4 17.15 Favored Glycine 0 N--CA 1.416 -2.656 0 N-CA-C 110.131 -1.187 . . . . 75.0 110.131 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -112.52 149.38 32.76 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.825 -1.176 . . . . 72.329999999999998 107.825 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 90' ' ' ALA . 8.0 p -89.39 134.45 28.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 109.651 -0.5 . . . . 73.099999999999994 109.651 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.28 120.75 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 121.754 0.787 . . . . 51.149999999999999 111.173 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' SER . 98.6 t -105.58 132.35 52.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 106.375 -1.713 . . . . 64.120000000000005 106.375 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.71 130.96 54.29 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 110.143 -0.317 . . . . 74.5 110.143 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -100.37 114.39 27.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 105.981 -1.859 . . . . 75.209999999999994 105.981 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -142.93 166.95 23.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 112.113 0.412 . . . . 72.340000000000003 112.113 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.03 164.61 11.62 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.407 1.098 . . . . 65.219999999999999 113.025 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.4 m -151.04 116.17 5.31 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.141 -1.845 . . . . 70.340000000000003 106.885 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.4 m -59.35 -21.84 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.692 0.797 . . . . 54.140000000000001 112.43 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -80.62 -16.11 54.92 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 110.681 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 29.2 tp -97.52 140.96 31.17 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.029 -1.471 . . . . 65.430000000000007 107.029 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -121.69 163.14 19.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.298 -0.961 . . . . 71.150000000000006 111.172 -176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.579 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 44.9 m -45.78 124.32 5.11 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.645 1.978 . . . . 61.530000000000001 115.26 -175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.1 -27.55 16.92 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.583 -1.189 . . . . 62.020000000000003 110.506 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.13 136.74 35.09 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.317 -0.994 . . . . 63.130000000000003 108.317 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -147.78 160.67 42.49 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.733 -1.58 . . . . 74.400000000000006 106.733 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -141.29 150.3 42.37 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.821 0.344 . . . . 65.310000000000002 110.979 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.461 ' HA ' HD13 ' A' ' 64' ' ' ILE . . . -118.51 125.77 50.59 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.098 -1.445 . . . . 61.350000000000001 107.098 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.623 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -123.28 115.24 21.37 Favored 'General case' 0 N--CA 1.395 -3.215 0 N-CA-C 110.138 -0.319 . . . . 73.209999999999994 110.138 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.09 124.34 7.63 Favored Glycine 0 C--N 1.289 -2.078 0 N-CA-C 111.855 -0.498 . . . . 64.209999999999994 111.855 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.5 p -140.64 160.19 40.56 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 122.623 0.369 . . . . 54.149999999999999 111.028 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.592 HG22 ' HA ' ' A' ' 59' ' ' PRO . 61.8 t -105.95 127.85 60.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.783 0.325 . . . . 62.539999999999999 110.164 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -135.48 101.85 10.81 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 108.189 -1.041 . . . . 74.230000000000004 108.189 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -85.52 -2.93 9.25 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.218 1.945 . . . . 71.409999999999997 111.644 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -97.05 66.86 2.17 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-O 121.678 0.751 . . . . 73.120000000000005 109.523 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 34.1 t -135.05 131.52 52.7 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 113.929 -1.487 . . . . 64.329999999999998 107.913 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.72 146.44 53.77 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.851 -0.796 . . . . 74.140000000000001 108.851 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -147.07 144.2 28.9 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.444 -0.902 . . . . 74.420000000000002 112.518 -170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 106.115 -1.809 . . . . 70.319999999999993 106.115 173.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 120.951 0.405 . . . . 72.340000000000003 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.94 145.76 16.18 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 109.596 -1.402 . . . . 52.450000000000003 109.596 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -91.78 85.08 5.52 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 121.717 0.77 . . . . 74.099999999999994 110.129 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -101.26 93.59 5.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.606 -1.257 . . . . 75.230000000000004 107.606 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -82.38 113.92 20.48 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.049 0.452 . . . . 71.530000000000001 110.393 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -134.39 113.15 11.59 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.868 -0.79 . . . . 55.219999999999999 108.868 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 tp -84.73 90.76 7.79 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.282 -1.007 . . . . 74.329999999999998 108.282 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.64 136.57 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 120.851 -0.339 . . . . 73.019999999999996 110.191 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -94.85 116.32 28.57 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.745 -0.382 . . . . 71.5 110.278 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 99' ' ' GLN . 30.4 mtm105 -137.98 72.69 1.42 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.815 -0.629 . . . . 72.549999999999997 110.576 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.42 91.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 122.652 1.215 . . . . 70.239999999999995 109.602 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.84 -173.72 3.45 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.455 -1.248 . . . . 64.049999999999997 108.29 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -89.88 -92.67 0.12 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 114.299 1.222 . . . . 74.219999999999999 114.299 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HD3' ' CG ' ' A' ' 95' ' ' GLU . 23.1 tptm -178.53 141.12 0.21 Allowed 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.325 -0.62 . . . . 71.310000000000002 109.325 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.21 -174.11 2.53 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.838 -0.801 . . . . 74.340000000000003 108.838 173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -102.74 135.22 44.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.559 -2.015 . . . . 65.340000000000003 105.559 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.7 151.75 44.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.745 -0.782 . . . . 74.340000000000003 109.39 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -76.79 98.98 4.98 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.448 0.642 . . . . 70.439999999999998 109.467 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 m -97.6 139.92 18.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 121.871 0.843 . . . . 43.43 111.797 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.4 170.67 32.86 Favored Glycine 1 N--CA 1.382 -4.911 0 N-CA-C 105.497 -3.041 . . . . 71.030000000000001 105.497 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 14.9 m-20 -115.27 19.92 15.24 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 110.04 -0.356 . . . . 72.209999999999994 110.04 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -53.36 -60.62 3.07 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.916 0.71 . . . . 45.439999999999998 112.916 -174.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.97 -31.67 69.5 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.191 0.519 . . . . 75.400000000000006 110.276 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.96 -51.34 64.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.326 -0.852 . . . . 72.129999999999995 111.245 -177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 5.8 ppt_? -71.22 -26.46 62.94 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 113.092 0.775 . . . . 73.219999999999999 113.092 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 22' ' ' ALA . 86.5 mt -68.03 -54.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 110.074 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -79.68 -1.58 38.96 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.637 0.606 . . . . 74.239999999999995 112.637 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.35 16.08 68.8 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-O 121.165 0.314 . . . . 70.420000000000002 112.362 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.03 -1.39 87.77 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 121.439 -0.41 . . . . 70.319999999999993 112.862 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.8 m -69.5 -25.03 63.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.554 0.693 . . . . 71.140000000000001 110.367 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.1 mm -124.18 122.68 64.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.439 -1.689 . . . . 63.100000000000001 106.439 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 34' ' ' GLN . 55.5 t -85.93 122.3 72.82 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.83 -0.804 . . . . 73.329999999999998 108.83 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.45 -24.57 44.42 Favored 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 123.376 2.718 . . . . 72.439999999999998 113.091 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.473 ' H ' HG12 ' A' ' 32' ' ' VAL . 35.1 tt0 -67.99 -11.28 58.56 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.026 0.441 . . . . 63.32 111.625 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.85 -36.93 82.65 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.1 -1.074 . . . . 74.400000000000006 108.1 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -70.22 -44.7 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.11 -0.95 . . . . 75.329999999999998 109.287 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -55.57 -43.12 75.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.962 0.505 . . . . 72.439999999999998 110.614 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.82 87.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.941 -1.027 . . . . 70.530000000000001 111.0 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.92 -37.52 81.78 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.861 0.689 . . . . 74.219999999999999 112.861 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.19 -46.49 90.24 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.987 -0.285 . . . . 73.329999999999998 111.579 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -73.4 -28.87 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.627 -0.429 . . . . 61.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -66.7 -45.86 77.41 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.373 -0.376 . . . . 64.140000000000001 110.706 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -66.12 -35.3 80.13 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.749 0.309 . . . . 73.519999999999996 110.332 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.06 -49.14 77.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.03 -0.532 . . . . 54.329999999999998 110.537 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.99 71.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.647 -0.706 . . . . 73.019999999999996 110.904 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.59 -44.72 73.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.716 -0.674 . . . . 62.009999999999998 110.987 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.84 15.36 37.71 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.99 -0.55 . . . . 52.149999999999999 114.222 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 48' ' ' ILE . 11.4 mm -62.35 123.23 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.388 0.614 . . . . 74.540000000000006 111.504 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 48.5 mt-30 -116.4 145.24 43.39 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 115.092 -0.958 . . . . 62.450000000000003 110.704 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -65.46 125.0 23.79 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.138 -1.392 . . . . 75.109999999999999 110.749 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' OE1' ' A' ' 52' ' ' GLN . 13.9 tp -144.82 -164.34 1.9 Allowed 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 103.65 -2.722 . . . . 71.040000000000006 103.65 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' OE1' ' HG ' ' A' ' 51' ' ' LEU . 27.2 mp0 -44.64 148.21 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 119.065 0.848 . . . . 71.420000000000002 111.737 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.68 -20.37 66.05 Favored Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.615 -0.326 . . . . 74.310000000000002 112.828 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 -9.37 41.91 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 112.079 0.4 . . . . 54.399999999999999 112.079 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.7 ptp180 -157.6 125.3 5.3 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 121.614 0.721 . . . . 72.409999999999997 112.062 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.22 151.54 19.41 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.769 -0.65 . . . . 53.420000000000002 110.063 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 tm? -86.77 127.96 35.01 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 61.119999999999997 107.18 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.68 158.78 44.54 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 123.448 0.468 . . . . 71.109999999999999 110.479 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' HA ' HG22 ' A' ' 125' ' ' VAL . 25.9 Cg_exo -65.68 162.76 33.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.936 2.424 . . . . 72.420000000000002 111.912 175.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.07 -26.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.959 -0.564 . . . . 74.340000000000003 111.692 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -100.88 107.2 18.66 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.82 -0.808 . . . . 73.530000000000001 108.82 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 87.3 m-85 -110.37 114.8 28.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.502 -0.772 . . . . 74.349999999999994 110.507 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.3 mm -105.69 111.33 34.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 107.844 -1.169 . . . . 74.200000000000003 107.844 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.1 mm -105.29 121.24 57.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.193 -1.04 . . . . 53.140000000000001 108.193 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -113.5 124.8 53.25 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.656 -0.418 . . . . 64.430000000000007 110.307 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -108.2 162.83 13.71 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.277 -0.874 . . . . 62.049999999999997 108.905 175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.51 150.17 51.72 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 109.625 -1.39 . . . . 23.539999999999999 109.625 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -58.32 -38.47 69.35 Favored 'Isoleucine or valine' 0 C--O 1.252 1.203 0 CA-C-N 117.575 0.687 . . . . 70.319999999999993 111.741 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 39.0 t60 -73.44 -25.03 60.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.59 -0.522 . . . . 74.120000000000005 109.59 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.581 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 18.0 m-20 -79.3 -31.73 43.35 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 116.483 -0.326 . . . . 75.319999999999993 111.457 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.96 -33.75 72.35 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.376 -0.829 . . . . 75.340000000000003 108.916 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.48 -33.56 68.12 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.636 -0.711 . . . . 54.350000000000001 112.683 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -78.4 -30.02 47.55 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.727 -0.608 . . . . 72.329999999999998 110.498 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 66' ' ' LEU . 75.1 mt -63.16 -36.78 84.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.347 0.594 . . . . 72.310000000000002 110.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.62 -163.09 25.52 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 115.483 -0.78 . . . . 45.210000000000001 111.604 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.42 -30.98 14.8 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.287 0.565 . . . . 71.010000000000005 109.918 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.41 128.77 25.3 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 115.946 -0.57 . . . . 64.200000000000003 109.563 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.14 -27.23 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.213 1.942 . . . . 63.119999999999997 111.287 171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.37 -53.74 33.35 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.022 1.729 . . . . 63.329999999999998 115.1 -167.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.11 -31.25 72.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.249 0.547 . . . . 74.239999999999995 110.724 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -77.09 -34.94 56.84 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.649 -0.705 . . . . 71.109999999999999 109.525 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 42.5 m -65.22 -54.03 35.66 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.403 -0.817 . . . . 75.140000000000001 110.441 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 m -62.01 -38.61 89.27 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.664 -0.698 . . . . 73.439999999999998 111.166 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.78 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 116.024 -0.535 . . . . 71.019999999999996 112.323 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.706 -0.398 . . . . 75.530000000000001 110.03 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.055 -0.52 . . . . 61.119999999999997 110.204 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -56.84 -53.42 58.06 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.186 -0.916 . . . . 72.510000000000005 110.614 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -69.6 -29.59 67.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.018 -0.992 . . . . 74.030000000000001 111.965 -174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.02 -35.51 61.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.097 -0.705 . . . . 72.150000000000006 109.097 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 94' ' ' GLN . . . -62.63 -37.93 88.23 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.741 0.781 . . . . 44.039999999999999 109.58 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.23 -47.6 81.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.728 -1.124 . . . . 63.530000000000001 109.608 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.6 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -54.91 -48.47 73.04 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 112.978 0.733 . . . . 65.120000000000005 112.978 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.9 pt -66.07 -31.64 54.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.098 -0.641 . . . . 74.239999999999995 111.737 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 25.9 mt-30 -64.28 -45.42 88.12 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.837 -0.431 . . . . 65.430000000000007 109.837 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' CG ' ' HD3' ' A' ' 14' ' ' LYS . 2.4 mm-40 -58.04 -41.77 83.95 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.32 1.013 . . . . 70.540000000000006 111.903 177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 75.5 mm-40 -74.74 -14.36 60.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.935 0.346 . . . . 72.299999999999997 111.935 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.95 29.0 48.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.246 -0.502 . . . . 53.130000000000003 112.064 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.0 m0 -104.62 157.31 17.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.201 -0.666 . . . . 63.439999999999998 109.201 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.516 ' HA ' ' NH2' ' A' ' 10' ' ' ARG . 24.1 pt20 -128.33 166.08 19.34 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.006 -0.678 . . . . 72.140000000000001 110.118 177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -155.07 176.57 12.37 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.387 -1.338 . . . . 75.420000000000002 107.387 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 46.2 m-85 -118.37 120.83 38.78 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.538 -0.542 . . . . 72.540000000000006 109.538 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.68 -151.22 17.09 Favored Glycine 0 C--O 1.253 1.321 0 N-CA-C 108.23 -1.948 . . . . 74.519999999999996 108.23 -174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -128.06 162.81 25.99 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 117.986 0.893 . . . . 73.120000000000005 108.646 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.1 t -78.57 121.78 32.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.094 0.473 . . . . 71.329999999999998 111.184 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.46 120.83 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.366 -0.834 . . . . 33.119999999999997 110.047 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 82' ' ' SER . 59.8 t -116.62 127.77 74.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.068 -1.456 . . . . 72.140000000000001 107.068 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 -121.49 152.49 39.08 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.538 -0.465 . . . . 74.519999999999996 109.747 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.31 114.41 22.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.916 -1.142 . . . . 73.450000000000003 107.916 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.14 170.95 10.71 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.342 -0.543 . . . . 73.120000000000005 112.07 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.47 159.19 17.25 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.401 -0.818 . . . . 73.209999999999994 110.722 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 m -152.24 138.83 18.7 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 123.97 0.908 . . . . 72.239999999999995 109.422 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -81.0 -18.34 47.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.207 -1.035 . . . . 72.049999999999997 108.207 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -65.61 -26.69 67.95 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.318 1.447 . . . . 71.409999999999997 110.035 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.0 mt -101.24 128.31 47.43 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.721 -0.672 . . . . 71.219999999999999 109.832 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -88.1 164.05 15.91 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.468 -0.787 . . . . 72.140000000000001 109.975 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.475 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 16.0 m -55.28 123.13 12.8 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.891 0.744 . . . . 72.049999999999997 111.967 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.16 -20.9 30.06 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.293 -0.723 . . . . 44.409999999999997 111.293 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.22 139.71 35.51 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.481 0.657 . . . . 73.310000000000002 111.709 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.663 ' HB3' HD13 ' A' ' 66' ' ' LEU . 29.6 p90 -147.7 160.16 43.01 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.715 -1.217 . . . . 74.430000000000007 107.715 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 146.55 43.77 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.176 -1.046 . . . . 75.409999999999997 108.176 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.52 149.45 34.34 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.548 -0.908 . . . . 72.5 108.548 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 64.5 ttt180 -143.26 124.37 14.48 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 110.263 -0.273 . . . . 74.129999999999995 110.263 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.15 100.25 0.8 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 110.198 -1.161 . . . . 34.140000000000001 110.198 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -111.67 147.88 34.58 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 109.713 -0.477 . . . . 73.239999999999995 109.713 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.2 t -87.29 113.98 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 N-CA-C 108.152 -1.055 . . . . 63.32 108.152 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -126.06 99.69 31.23 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 108.344 -0.984 . . . . 70.129999999999995 108.344 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 57.8 Cg_endo -72.94 -19.34 23.45 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.919 1.746 . . . . 51.340000000000003 111.377 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -94.41 67.17 3.42 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.711 0.767 . . . . 73.430000000000007 110.509 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.81 110.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-N 114.32 -1.309 . . . . 65.219999999999999 108.129 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -93.33 131.61 38.32 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.44 -0.948 . . . . 75.519999999999996 108.44 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -79.82 179.63 7.45 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.211 -0.904 . . . . 72.540000000000006 110.903 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 . . . . . 0 N--CA 1.419 -1.983 0 N-CA-C 109.762 -0.458 . . . . 74.150000000000006 109.762 178.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 108.909 -0.774 . . . . 73.430000000000007 108.909 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.76 147.6 18.74 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 110.608 -0.997 . . . . 73.439999999999998 110.608 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 m -88.84 155.83 19.3 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.866 -0.791 . . . . 53.310000000000002 108.866 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -96.66 -32.1 12.37 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.818 -0.808 . . . . 62.350000000000001 108.818 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -79.6 108.42 13.13 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.792 -1.188 . . . . 62.100000000000001 107.792 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -88.42 107.74 19.01 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.23 0.538 . . . . 73.109999999999999 111.254 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 mp -131.25 118.94 21.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.74 -0.664 . . . . 73.140000000000001 109.408 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.43 131.47 42.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.898 -0.778 . . . . 70.030000000000001 108.898 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -108.6 100.77 9.98 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.202 -0.453 . . . . 73.120000000000005 110.163 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -83.49 124.57 30.85 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.077 -0.511 . . . . 71.230000000000004 109.848 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.79 136.13 35.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.278 -0.569 . . . . 60.25 110.137 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -94.91 116.45 28.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.864 -1.161 . . . . 73.430000000000007 107.864 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -142.48 141.0 32.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.107 -0.701 . . . . 75.409999999999997 109.107 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.21 127.01 45.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.4 -1.333 . . . . 72.030000000000001 107.4 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -93.71 -76.49 0.47 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.633 -0.427 . . . . 54.140000000000001 111.745 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.64 -179.96 6.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 123.127 0.571 . . . . 64.109999999999999 109.926 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.21 99.72 10.73 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.837 -1.542 . . . . 60.140000000000001 106.837 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 m -57.67 124.1 17.92 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.341 -1.3 . . . . 54.409999999999997 113.832 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.0 t -101.67 104.28 16.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.51 -1.663 . . . . 65.530000000000001 106.51 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.4 -75.27 1.15 Allowed Glycine 0 C--N 1.311 -0.852 0 C-N-CA 120.665 -0.779 . . . . 74.239999999999995 114.503 -172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -44.72 -46.43 10.37 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.003 1.483 . . . . 74.349999999999994 115.003 -173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 -59.22 5.25 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 123.965 0.791 . . . . 73.439999999999998 111.636 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.91 -36.72 78.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.832 -0.622 . . . . 71.409999999999997 111.044 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.94 83.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.163 -0.471 . . . . 71.239999999999995 111.609 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -74.63 -36.01 62.9 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.812 0.671 . . . . 54.43 112.812 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.43 -44.25 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.149 0.499 . . . . 71.329999999999998 110.523 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -77.97 -15.57 58.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.564 0.579 . . . . 73.540000000000006 112.564 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 36.13 45.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.853 -0.689 . . . . 25.440000000000001 111.484 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.16 -29.34 6.08 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.696 -0.252 . . . . 62.5 112.994 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 t -91.61 82.49 5.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.612 0.72 . . . . 71.109999999999999 110.075 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.34 109.87 26.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.665 -1.606 . . . . 71.219999999999999 106.665 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 m -119.64 88.18 38.67 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 118.941 -1.103 . . . . 74.340000000000003 113.332 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' OE1' ' A' ' 34' ' ' GLN . 12.2 Cg_exo -76.21 -40.76 0.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.206 1.937 . . . . 52.43 110.5 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' OE1' ' HD2' ' A' ' 33' ' ' PRO . 1.3 mp0 -49.87 -52.23 34.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.444 1.098 . . . . 63.100000000000001 111.302 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -56.69 -47.67 79.35 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.082 -0.963 . . . . 75.439999999999998 110.37 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -68.96 -50.9 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.262 -0.881 . . . . 63.030000000000001 110.405 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 2.9 pp20? -64.4 -38.4 90.91 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.589 0.588 . . . . 72.420000000000002 112.589 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.08 92.48 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.802 0.334 . . . . 32.210000000000001 110.632 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -72.87 -37.58 67.29 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.238 -1.023 . . . . 64.409999999999997 108.238 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.09 -44.79 96.82 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.786 0.834 . . . . 72.450000000000003 110.582 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.0 ptt85 -73.74 -21.86 60.06 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.96 0.409 . . . . 73.310000000000002 111.635 176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 46' ' ' ASP . 43.0 tpt85 -73.09 -31.19 64.2 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.171 -0.677 . . . . 74.430000000000007 109.171 174.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB3' ' HA3' ' A' ' 123' ' ' GLY . 52.0 mm-40 -68.21 -38.7 82.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.517 -0.765 . . . . 72.209999999999994 109.835 173.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.62 -46.52 88.74 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.443 -0.799 . . . . 60.229999999999997 109.734 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.72 -23.29 65.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.788 -0.642 . . . . 62.109999999999999 111.386 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.431 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 31.2 t70 -77.77 -41.19 38.34 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 111.931 0.345 . . . . 71.239999999999995 111.931 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.03 25.89 19.64 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 120.227 -0.987 . . . . 70.239999999999995 113.803 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.77 137.02 25.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.702 0.401 . . . . 52.100000000000001 111.345 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.1 mt-30 -122.91 143.51 49.84 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.823 -0.626 . . . . 61.25 110.397 177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -79.19 92.32 5.07 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.847 -1.07 . . . . 73.219999999999999 111.687 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.572 HD22 HD23 ' A' ' 57' ' ' LEU . 11.9 tp -102.38 -165.48 1.19 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.781 -1.933 . . . . 64.409999999999997 105.781 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.3 mm-40 -48.57 146.89 2.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.888 0.767 . . . . 72.140000000000001 112.214 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.9 32.89 1.25 Allowed Glycine 0 C--N 1.31 -0.886 0 CA-C-N 115.117 -0.947 . . . . 41.399999999999999 113.348 -173.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 52' ' ' GLN . 71.9 m-20 -99.85 -37.01 9.23 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.643 -1.614 . . . . 71.030000000000001 106.643 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -172.97 149.87 1.94 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.491 -1.231 . . . . 71.430000000000007 110.294 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.37 151.79 21.29 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.964 0.506 . . . . 73.349999999999994 110.564 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.572 HD23 HD22 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -87.21 127.7 35.15 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.889 -1.152 . . . . 73.25 107.889 -175.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.11 158.17 46.92 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 123.11 0.564 . . . . 61.009999999999998 111.063 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.621 ' HA ' ' HB ' ' A' ' 125' ' ' VAL . 88.6 Cg_exo -54.86 145.16 63.32 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.948 3.099 . . . . 75.329999999999998 113.997 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -119.96 -22.6 6.67 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.313 -0.858 . . . . 61.130000000000003 110.292 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.69 108.88 20.61 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.412 0.625 . . . . 74.010000000000005 109.684 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 48.9 m-85 -114.06 117.83 32.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.445 -0.798 . . . . 72.519999999999996 109.423 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.6 mt -97.95 116.67 41.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.192 -1.04 . . . . 74.329999999999998 108.192 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 76.1 mt -110.96 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 107.915 -1.143 . . . . 74.030000000000001 107.915 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.7 m -110.33 120.65 43.12 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.866 -0.606 . . . . 74.129999999999995 110.971 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.4 mm? -114.69 163.26 15.71 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.3 -0.864 . . . . 74.239999999999995 108.809 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.17 169.17 51.35 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 109.274 -1.53 . . . . 62.299999999999997 109.274 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.32 -25.7 37.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-O 121.595 0.712 . . . . 64.019999999999996 110.936 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -57.95 -55.69 31.64 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.824 -1.08 . . . . 73.209999999999994 110.001 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.84 -29.49 44.69 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.621 -0.718 . . . . 75.530000000000001 111.718 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -63.7 -32.01 73.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 116.439 -0.346 . . . . 74.200000000000003 110.143 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.17 -35.84 78.2 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 123.25 0.62 . . . . 55.149999999999999 109.954 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.98 -14.64 55.73 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.235 -0.438 . . . . 75.209999999999994 111.22 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.21 -25.04 37.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.652 -0.87 . . . . 54.5 108.652 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.98 -177.26 30.1 Favored Glycine 0 N--CA 1.421 -2.365 0 CA-C-N 114.938 -1.028 . . . . 54.229999999999997 111.867 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.97 1.46 27.38 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.831 0.452 . . . . 54.420000000000002 111.776 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.7 m-20 -110.0 92.57 13.16 Favored Pre-proline 0 C--O 1.251 1.178 0 N-CA-C 112.331 0.493 . . . . 53.409999999999997 112.331 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.84 -37.2 1.72 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.686 1.59 . . . . 64.230000000000004 111.096 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -70.47 -34.33 72.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.26 -0.427 . . . . 55.109999999999999 112.14 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -61.29 -38.06 85.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.194 0.521 . . . . 73.400000000000006 109.837 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 43.4 mmtm -77.28 -35.52 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.837 -0.801 . . . . 71.299999999999997 108.837 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 t -58.31 -54.14 50.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.713 -1.131 . . . . 65.010000000000005 110.023 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.1 m -59.15 -42.33 90.44 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.425 0.69 . . . . 73.319999999999993 111.008 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -61.64 6.21 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.011 -0.54 . . . . 52.450000000000003 111.974 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -63.03 -30.78 71.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.304 0.854 . . . . 63.119999999999997 113.304 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.35 -40.43 89.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.896 -0.322 . . . . 72.409999999999997 110.538 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -73.37 -36.88 66.17 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.466 -0.568 . . . . 72.430000000000007 109.466 -178.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.25 -41.06 94.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.573 -0.285 . . . . 63.32 110.73 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.47 -42.27 87.75 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.447 -0.575 . . . . 75.120000000000005 109.447 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.46 79.67 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 61.439999999999998 109.951 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.554 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.2 t70 -64.24 -43.77 93.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.391 -0.822 . . . . 73.25 109.751 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 27.6 m-85 -58.66 -48.42 81.11 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 112.662 0.615 . . . . 75.409999999999997 112.662 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.99 -29.33 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 119.733 -0.787 . . . . 74.340000000000003 111.247 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.02 -44.24 89.82 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 110.14 -0.318 . . . . 42.219999999999999 110.14 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.6 mt-10 -63.91 -38.38 90.88 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.308 0.575 . . . . 74.420000000000002 110.797 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.2 mm-40 -79.25 -13.9 59.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.971 -0.559 . . . . 64.230000000000004 111.351 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.53 38.37 32.96 Favored Glycine 0 N--CA 1.433 -1.515 0 C-N-CA 120.804 -0.712 . . . . 51.299999999999997 112.2 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.2 m0 -107.11 158.0 17.42 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.765 0.317 . . . . 73.120000000000005 111.093 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD23 ' A' ' 51' ' ' LEU . 23.2 pt20 -123.01 173.03 8.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.816 0.846 . . . . 73.150000000000006 109.087 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.8 t -159.52 177.61 10.76 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.444 -0.502 . . . . 64.519999999999996 110.432 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -124.24 120.99 33.85 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.582 -0.896 . . . . 71.319999999999993 108.582 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.24 -164.17 12.48 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.963 -1.655 . . . . 53.420000000000002 108.963 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -104.71 156.86 17.62 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 106.864 -1.532 . . . . 72.120000000000005 106.864 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -88.67 104.18 14.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 107.985 -1.117 . . . . 63.310000000000002 107.985 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.73 120.38 57.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 122.123 0.963 . . . . 74.409999999999997 111.676 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 62' ' ' TYR . 10.1 m -104.86 120.03 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 N-CA-C 105.804 -1.925 . . . . 75.230000000000004 105.804 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.279 0.0 OUTLIER -117.3 125.4 51.01 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 113.638 0.977 . . . . 72.540000000000006 113.638 -174.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -92.47 139.41 30.61 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.746 -1.57 . . . . 74.329999999999998 108.628 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -156.06 161.1 40.46 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.356 -0.609 . . . . 63.439999999999998 109.356 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.8 pt20 -104.32 157.99 16.76 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 121.582 0.706 . . . . 54.450000000000003 109.493 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 114' ' ' LEU . 62.0 m -144.2 133.1 22.61 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.909 -1.041 . . . . 74.129999999999995 108.974 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.0 m -80.9 -11.74 59.53 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.481 0.658 . . . . 53.229999999999997 110.098 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -87.99 -5.54 58.47 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.478 -0.783 . . . . 71.409999999999997 109.918 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 1.4 tm? -91.07 120.44 32.04 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.938 -1.875 . . . . 65.329999999999998 105.938 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -88.8 153.22 21.24 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.325 -0.398 . . . . 73.25 110.405 -174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 m -64.59 134.16 53.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.51 0.672 . . . . 71.319999999999993 111.234 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.33 -15.46 42.67 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.412 -1.075 . . . . 74.340000000000003 110.412 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -106.08 150.24 25.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.047 -0.723 . . . . 72.439999999999998 109.047 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -149.66 151.25 33.42 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.867 -1.901 . . . . 73.409999999999997 105.867 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -134.99 144.09 47.18 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 112.56 0.578 . . . . 73.420000000000002 112.56 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.79 119.13 10.23 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.701 -1.592 . . . . 64.530000000000001 106.701 172.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.613 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -120.29 120.65 36.67 Favored 'General case' 0 N--CA 1.39 -3.456 0 C-N-CA 123.196 0.598 . . . . 71.349999999999994 109.565 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.53 121.54 7.2 Favored Glycine 0 C--N 1.3 -1.452 0 O-C-N 123.593 0.558 . . . . 64.040000000000006 112.056 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.7 p -142.21 148.61 38.45 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.155 -0.683 . . . . 73.530000000000001 109.155 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 59' ' ' PRO . 5.6 p -95.84 120.54 45.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 119.462 -0.895 . . . . 63.450000000000003 110.006 174.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -125.86 98.62 33.46 Favored Pre-proline 0 C--N 1.278 -2.53 0 CA-C-N 114.819 -1.082 . . . . 64.239999999999995 108.167 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.33 -15.87 15.68 Favored 'Trans proline' 0 CA--C 1.52 -0.221 0 C-N-CA 122.385 2.057 . . . . 75.129999999999995 109.892 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.49 22.48 2.54 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.59 -1.186 . . . . 55.009999999999998 109.629 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.32 110.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-O 121.929 0.871 . . . . 71.230000000000004 109.089 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.86 139.7 30.4 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 114.576 -1.193 . . . . 72.25 109.89 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.7 t -142.89 147.45 35.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.548 -1.279 . . . . 60.140000000000001 107.548 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 t60 . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 109.693 -0.484 . . . . 72.219999999999999 109.693 -174.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.742 0.306 . . . . 70.439999999999998 110.189 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.92 173.36 40.68 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 109.731 -1.348 . . . . 71.430000000000007 109.731 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.6 m -82.26 90.44 6.63 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.597 -1.26 . . . . 70.340000000000003 107.597 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -72.11 103.81 3.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.109 -0.95 . . . . 73.209999999999994 110.234 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -109.2 139.51 44.03 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 110.14 177.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -134.85 133.61 39.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.257 -1.016 . . . . 74.219999999999999 108.257 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.73 101.41 12.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 O-C-N 123.707 0.63 . . . . 63.119999999999997 109.303 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -89.75 87.88 2.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.419 1.104 . . . . 72.120000000000005 109.351 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 10.3 mm-40 -81.78 140.49 34.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.087 -1.415 . . . . 74.439999999999998 110.846 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -136.44 119.88 16.95 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.825 -1.079 . . . . 62.210000000000001 109.987 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -86.41 106.06 15.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.395 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.619 ' HG3' ' H ' ' A' ' 34' ' ' GLN . 35.4 mm-40 -74.91 96.18 3.09 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.699 1.237 . . . . 73.209999999999994 113.15 -174.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -100.0 77.77 2.04 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 113.644 -1.617 . . . . 72.439999999999998 108.07 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -85.99 100.77 12.36 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 105.443 -2.058 . . . . 71.319999999999993 105.443 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.97 95.29 2.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.124 0.488 . . . . 71.530000000000001 109.924 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -162.47 147.76 12.45 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.499 -1.667 . . . . 75.109999999999999 106.499 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.5 84.3 2.01 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.611 -0.885 . . . . 53.32 108.611 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.8 m -101.52 124.59 47.44 Favored 'General case' 0 N--CA 1.407 -2.616 0 CA-C-N 115.145 -0.934 . . . . 73.239999999999995 109.202 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -85.98 88.28 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.499 -1.297 . . . . 71.450000000000003 107.499 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.94 45.44 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 109.988 -1.245 . . . . 72.230000000000004 109.988 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -74.47 -7.01 51.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.256 0.55 . . . . 72.25 110.549 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.57 ' O ' ' HG2' ' A' ' 25' ' ' ARG . . . -63.8 -35.65 81.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.951 0.881 . . . . 55.329999999999998 109.708 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' CE1' ' HD2' ' A' ' 81' ' ' LYS . 98.9 m-85 -73.79 -34.19 64.54 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.394 -0.821 . . . . 70.340000000000003 109.315 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -65.0 -41.79 95.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.987 -0.551 . . . . 52.299999999999997 110.745 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 8.6 ptm180 -67.82 -25.58 65.64 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.705 -0.225 . . . . 75.209999999999994 111.279 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.8 mt -86.82 -50.53 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 120.315 -0.554 . . . . 70.329999999999998 111.493 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.09 -28.12 64.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.94 0.719 . . . . 72.25 112.94 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.77 -73.05 0.27 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.796 -0.716 . . . . 51.200000000000003 112.532 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.19 -35.42 3.4 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.701 -0.761 . . . . 64.239999999999995 111.87 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 36.2 t -79.24 139.17 37.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.276 -0.639 . . . . 60.420000000000002 109.276 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.9 tt -98.84 -33.13 3.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.369 0.604 . . . . 43.399999999999999 110.309 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.52 118.7 8.25 Favored Pre-proline 0 N--CA 1.428 -1.56 0 N-CA-C 108.89 -0.781 . . . . 54.219999999999999 108.89 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.14 95.74 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.261 1.307 . . . . 64.349999999999994 110.102 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.619 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 49.8 tt0 -91.32 -3.66 56.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.743 -0.662 . . . . 53.340000000000003 110.443 -175.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.87 -32.77 73.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.445 -1.317 . . . . 74.129999999999995 107.445 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' HD23 ' A' ' 40' ' ' LEU . 30.7 t -61.3 -49.89 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 114.466 -1.243 . . . . 73.310000000000002 109.619 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 30.6 mt-10 -57.69 -47.11 83.26 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 120.581 -0.448 . . . . 74.530000000000001 110.734 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.88 35.56 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.69 0.619 . . . . 65.319999999999993 111.878 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -69.74 -29.35 66.68 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.216 0.45 . . . . 73.209999999999994 112.216 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 36' ' ' VAL . 4.0 mm? -70.55 -39.55 73.92 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.176 0.436 . . . . 70.430000000000007 112.176 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 58.7 mtp180 -66.13 -33.42 75.74 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.977 -1.12 . . . . 72.25 107.977 176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -49.29 62.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.434 -1.257 . . . . 73.439999999999998 108.948 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.54 -37.8 85.11 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 122.98 0.512 . . . . 72.219999999999999 112.136 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -58.77 -45.82 88.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.998 -0.546 . . . . 41.100000000000001 110.117 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.06 64.66 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.549 0.69 . . . . 75.140000000000001 111.066 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.07 -32.61 73.9 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.483 0.713 . . . . 63.530000000000001 111.043 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.14 6.86 72.61 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.97 -0.633 . . . . 62.240000000000002 113.285 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 98' ' ' TRP . 17.7 mm -64.45 131.31 30.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-O 121.547 0.689 . . . . 54.109999999999999 111.949 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 80.5 mt-30 -119.39 144.82 46.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.272 -0.876 . . . . 74.230000000000004 110.535 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.6 m -80.63 98.28 7.6 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.845 -1.07 . . . . 73.439999999999998 109.992 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.645 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.3 tp -101.91 -165.38 1.18 Allowed 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 106.935 -1.506 . . . . 75.230000000000004 106.935 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.645 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 48.4 mt-30 -56.19 160.77 2.76 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.493 0.717 . . . . 72.140000000000001 111.395 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 4.75 8.17 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.461 -0.79 . . . . 61.509999999999998 114.397 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.32 -46.57 60.33 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.913 -1.143 . . . . 72.530000000000001 107.913 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -179.51 167.21 1.44 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.002 0.921 . . . . 73.040000000000006 110.716 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.56 151.39 21.35 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.059 0.457 . . . . 71.439999999999998 111.698 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.4 tm? -90.63 128.3 36.56 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.366 -0.976 . . . . 44.530000000000001 108.366 -176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.41 158.0 45.98 Favored Pre-proline 0 C--N 1.307 -1.262 0 C-N-CA 123.58 0.752 . . . . 45.530000000000001 109.433 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HA ' HG22 ' A' ' 125' ' ' VAL . 37.8 Cg_exo -61.06 157.93 36.89 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 72.530000000000001 112.628 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -119.8 -33.3 4.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.934 -0.575 . . . . 71.099999999999994 110.695 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -103.66 114.65 29.07 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.651 -0.5 . . . . 74.319999999999993 109.651 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 70.8 m-85 -109.51 119.34 39.12 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.669 -0.696 . . . . 72.530000000000001 109.912 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -109.23 118.5 56.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 CA-C-N 115.284 -0.871 . . . . 75.120000000000005 109.545 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.79 119.98 61.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.934 -1.136 . . . . 71.219999999999999 107.934 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -109.57 128.25 55.07 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.98 -0.555 . . . . 74.099999999999994 109.771 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.6 mm? -115.49 170.58 8.31 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.344 1.058 . . . . 71.200000000000003 109.674 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.99 169.03 54.43 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 109.508 -1.437 . . . . 74.0 109.508 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -57.86 -48.53 83.62 Favored 'Isoleucine or valine' 0 C--O 1.256 1.424 0 CA-C-N 117.472 0.636 . . . . 75.299999999999997 111.681 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -65.03 -40.44 94.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.38 -0.827 . . . . 72.140000000000001 109.477 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.628 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.0 m-20 -69.48 -34.2 73.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.22 -1.355 . . . . 64.439999999999998 110.698 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -63.81 -36.92 85.48 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-O 121.72 0.771 . . . . 75.0 109.104 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.69 -25.22 64.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.757 -0.656 . . . . 73.200000000000003 111.262 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -77.91 -22.08 50.19 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.387 -0.195 . . . . 75.420000000000002 110.482 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.28 -38.36 71.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.157 -0.683 . . . . 71.129999999999995 109.157 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.31 -171.89 29.43 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.056 -1.068 . . . . 64.409999999999997 111.841 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.57 -31.08 18.81 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.939 -0.763 . . . . 62.329999999999998 108.939 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -131.73 81.81 62.43 Favored Pre-proline 0 C--N 1.311 -1.1 0 CA-C-N 115.217 -0.901 . . . . 74.439999999999998 110.548 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.74 -18.7 47.77 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.801 2.334 . . . . 51.149999999999999 112.274 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.01 -22.62 64.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 111.76 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.33 -45.67 92.16 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.88 -0.785 . . . . 55.030000000000001 108.88 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HD2' ' CE1' ' A' ' 23' ' ' PHE . 63.3 tttp -72.13 -31.27 65.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.731 -1.122 . . . . 64.129999999999995 110.437 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.7 m -60.42 -43.53 96.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.42 -0.355 . . . . 73.310000000000002 111.224 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.4 m -65.4 -45.44 83.95 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.761 0.315 . . . . 71.439999999999998 111.165 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.87 93.6 Favored Glycine 0 C--O 1.244 0.733 0 C-N-CA 120.715 -0.755 . . . . 52.25 111.65 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -68.25 -32.59 72.88 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.279 -0.46 . . . . 63.329999999999998 110.247 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.62 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -62.15 -43.1 99.57 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 120.893 0.378 . . . . 73.25 110.514 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.78 -39.02 92.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.539 -0.755 . . . . 74.319999999999993 109.162 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -71.09 -41.32 70.77 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.305 -0.407 . . . . 65.129999999999995 111.183 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.04 -38.06 85.19 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.555 -0.535 . . . . 70.409999999999997 109.555 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.76 87.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.494 0.664 . . . . 75.109999999999999 109.536 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -37.41 84.38 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.95 -1.023 . . . . 62.539999999999999 110.127 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.6 m-85 -60.59 -48.02 83.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 111.903 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 pt -69.69 -31.16 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 119.959 -0.697 . . . . 75.209999999999994 111.544 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.93 -41.14 91.74 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.808 -0.441 . . . . 72.329999999999998 109.808 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 33.2 tt0 -57.29 -36.85 71.56 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 125.329 1.452 . . . . 65.010000000000005 110.331 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -85.62 -9.04 57.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.826 -0.625 . . . . 75.409999999999997 111.052 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.29 29.8 57.85 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 116.025 -0.534 . . . . 75.150000000000006 113.016 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.473 ' CD2' HD11 ' A' ' 48' ' ' ILE . 20.0 m0 -96.19 156.9 16.14 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.594 -0.442 . . . . 64.340000000000003 110.457 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.584 ' NE2' HD23 ' A' ' 51' ' ' LEU . 29.9 pt20 -119.07 169.49 9.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 110.031 -0.359 . . . . 61.520000000000003 110.031 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -159.83 176.31 12.07 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.935 -0.765 . . . . 75.129999999999995 108.935 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -116.77 122.04 43.31 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.105 -1.072 . . . . 64.319999999999993 108.105 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.29 -149.1 17.14 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.863 -1.16 . . . . 75.209999999999994 110.783 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -130.91 151.63 51.12 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.667 -0.864 . . . . 63.420000000000002 108.667 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.51 119.2 18.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.558 0.694 . . . . 71.109999999999999 111.335 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.14 131.63 65.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.024 -0.732 . . . . 64.109999999999999 109.024 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.1 p -137.33 141.85 38.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.514 -1.291 . . . . 74.019999999999996 107.514 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -145.06 155.96 43.65 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.455 -0.498 . . . . 73.510000000000005 110.184 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.36 127.9 53.21 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.005 -1.109 . . . . 74.409999999999997 108.005 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.06 167.83 18.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 116.712 -0.222 . . . . 64.329999999999998 110.46 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -116.47 158.95 22.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.865 0.365 . . . . 63.210000000000001 110.324 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 t -145.01 140.25 28.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.906 -1.146 . . . . 53.329999999999998 107.906 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 -10.38 59.74 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.585 -0.524 . . . . 70.329999999999998 109.585 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -79.38 -27.25 41.88 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.176 -0.465 . . . . 63.299999999999997 110.289 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.24 135.58 33.38 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-N 115.84 -0.618 . . . . 72.109999999999999 109.919 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -99.33 157.07 16.66 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.952 -0.759 . . . . 72.409999999999997 108.952 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.628 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 57.4 m -53.94 126.62 23.1 Favored 'General case' 0 N--CA 1.433 -1.308 0 O-C-N 124.458 1.099 . . . . 73.109999999999999 112.109 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.66 -23.1 28.94 Favored Glycine 0 N--CA 1.423 -2.23 0 CA-C-N 115.092 -0.958 . . . . 73.549999999999997 111.675 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -104.36 139.6 39.09 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.82 -0.437 . . . . 70.010000000000005 109.82 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' HD13 ' A' ' 66' ' ' LEU . 42.9 p90 -143.04 157.89 44.11 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.652 -1.24 . . . . 71.400000000000006 107.652 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 134.81 31.39 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.663 -0.866 . . . . 73.239999999999995 108.663 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.32 139.35 48.92 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.936 -1.505 . . . . 63.240000000000002 106.936 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -139.44 119.13 13.15 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.974 0.416 . . . . 71.129999999999995 110.243 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.4 127.21 8.77 Favored Glycine 0 C--N 1.297 -1.596 0 N-CA-C 110.263 -1.135 . . . . 71.420000000000002 110.263 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.0 p -127.46 145.31 50.88 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.205 0.526 . . . . 72.200000000000003 111.57 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.5 t -98.09 108.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.433 -0.951 . . . . 63.439999999999998 108.433 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -114.48 97.91 47.66 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 109.262 -0.644 . . . . 73.329999999999998 109.262 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.04 -8.76 11.97 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.993 1.796 . . . . 64.030000000000001 111.931 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -98.61 77.02 2.26 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-O 122.775 1.274 . . . . 72.540000000000006 108.621 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.75 139.93 50.34 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.385 0 CA-C-N 112.662 -2.063 . . . . 74.129999999999995 106.891 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -49.71 98.85 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.638 1.208 . . . . 63.100000000000001 110.551 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.0 m -70.83 116.6 11.33 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.17 -1.377 . . . . 72.219999999999999 110.322 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 C--N 1.295 -1.778 0 CA-C-N 115.314 -0.857 . . . . 64.409999999999997 108.933 -179.761 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 CA--C 1.505 -0.752 0 N-CA-C 108.132 -1.062 . . . . 64.109999999999999 108.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.59 7.3 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 109.615 -1.394 . . . . 53.200000000000003 109.615 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -82.18 157.99 23.76 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 108.759 -0.83 . . . . 63.130000000000003 108.759 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -143.33 143.05 31.52 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.524 -1.658 . . . . 74.5 106.524 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -78.71 77.26 5.19 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.335 1.541 . . . . 65.230000000000004 111.015 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -84.04 146.72 27.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.781 -2.009 . . . . 71.329999999999998 107.054 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' O ' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.27 118.21 11.81 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.801 -0.815 . . . . 55.130000000000003 108.801 172.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 99' ' ' GLN . 24.2 m -119.54 145.79 25.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.068 -0.653 . . . . 73.540000000000006 111.206 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -126.44 177.21 6.61 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.694 -1.224 . . . . 75.519999999999996 107.694 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -134.08 96.91 3.73 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.603 -1.629 . . . . 74.209999999999994 106.603 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.7 m -66.34 148.86 11.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.836 -0.62 . . . . 73.5 110.664 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 59.87 76.77 0.35 Allowed 'General case' 0 C--O 1.242 0.689 0 O-C-N 124.496 1.123 . . . . 65.099999999999994 108.887 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -78.5 72.82 5.05 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.887 0.851 . . . . 73.109999999999999 113.225 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.22 95.42 5.95 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.125 -1.065 . . . . 74.319999999999993 108.125 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.9 pt? -112.18 94.4 4.92 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.604 -1.258 . . . . 74.319999999999993 107.604 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.76 122.31 30.48 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.735 -1.12 . . . . 74.010000000000005 109.345 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -49.7 117.21 2.13 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.403 -1.271 . . . . 71.129999999999995 113.895 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.8 m -72.31 123.37 22.87 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.418 -0.956 . . . . 75.400000000000006 108.418 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.2 p -114.58 145.84 19.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.554 -0.906 . . . . 64.340000000000003 108.554 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.42 42.39 1.6 Allowed Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 121.098 -0.572 . . . . 53.340000000000003 112.177 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.44 -38.28 74.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.701 0.763 . . . . 73.340000000000003 110.556 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.54 89.31 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.99 -1.005 . . . . 53.530000000000001 108.472 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' PHE . 7.4 m-85 -62.68 -44.56 95.94 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.762 -1.108 . . . . 75.340000000000003 109.511 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.85 -49.37 71.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.855 -0.611 . . . . 73.140000000000001 111.723 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -76.51 -33.53 58.62 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 112.723 0.638 . . . . 75.519999999999996 112.723 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -71.29 -44.05 73.31 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 121.068 -0.253 . . . . 63.329999999999998 111.608 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' HD2' ' O ' ' A' ' 23' ' ' PHE . 80.6 m-85 -77.02 -29.76 55.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.927 -0.309 . . . . 74.310000000000002 111.19 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.27 -90.13 0.05 OUTLIER Glycine 0 C--O 1.242 0.656 0 O-C-N 123.913 0.758 . . . . 74.25 114.841 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.76 -48.85 32.41 Favored Glycine 0 CA--C 1.495 -1.218 0 CA-C-N 115.344 -0.428 . . . . 63.140000000000001 112.486 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 t -89.39 82.6 6.44 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.43 -1.693 . . . . 74.340000000000003 106.43 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.7 tp -67.58 105.35 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.909 -1.496 . . . . 72.219999999999999 113.216 -173.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 35' ' ' GLU . 58.7 t -126.23 88.79 53.64 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.811 -0.811 . . . . 71.25 108.811 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 34' ' ' GLN . 57.9 Cg_endo -103.57 -34.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.569 0 C-N-CA 122.131 1.887 . . . . 63.399999999999999 115.596 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 25.0 mm-40 -143.02 25.48 1.76 Allowed 'General case' 0 C--O 1.254 1.31 0 CA-C-O 121.682 0.753 . . . . 71.209999999999994 109.185 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' HB2' HG13 ' A' ' 32' ' ' VAL . 13.4 mm-40 -82.05 -37.11 26.94 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.499 -0.773 . . . . 70.109999999999999 110.639 -172.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 40' ' ' LEU . 97.5 t -61.01 -49.8 83.22 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 115.868 -0.605 . . . . 71.219999999999999 109.589 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -58.01 -47.8 81.94 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.528 0.731 . . . . 64.530000000000001 110.887 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.03 -47.61 82.58 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.17 -0.923 . . . . 73.430000000000007 111.856 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.14 -31.54 58.66 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.399 0.518 . . . . 64.140000000000001 112.399 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 36' ' ' VAL . 5.6 mp -62.52 -42.57 99.6 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 111.397 0.147 . . . . 61.219999999999999 111.397 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.75 -28.51 62.67 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.597 -0.841 . . . . 75.420000000000002 110.342 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -63.36 -44.31 95.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.985 -0.552 . . . . 64.239999999999995 109.712 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -71.31 -32.54 68.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 75.010000000000005 111.488 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.15 93.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 63.229999999999997 109.631 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.61 -24.83 61.13 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.689 -0.687 . . . . 73.540000000000006 111.074 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.52 -38.13 74.2 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.155 0.982 . . . . 62.130000000000003 110.208 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.72 42.97 1.78 Allowed Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.568 -0.742 . . . . 70.329999999999998 112.788 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 45' ' ' ALA . 19.6 mm -81.92 138.08 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 C-N-CA 122.958 0.503 . . . . 64.099999999999994 110.696 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 2.0 mp0 -120.3 146.44 46.11 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 123.066 0.547 . . . . 70.439999999999998 109.697 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.0 m -73.46 120.81 19.58 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 124.175 0.922 . . . . 73.329999999999998 109.407 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.7 tp -127.19 -170.66 2.26 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 103.733 -2.692 . . . . 64.349999999999994 103.733 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.479 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 62.0 mt-30 -55.54 148.87 14.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.148 0.885 . . . . 63.039999999999999 110.007 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.33 -5.48 8.36 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 115.08 0.792 . . . . 52.049999999999997 115.08 -171.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -66.35 -38.6 88.0 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.391 -0.596 . . . . 74.209999999999994 109.391 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -171.09 152.65 3.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.901 -0.59 . . . . 74.109999999999999 111.266 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -91.94 151.71 20.38 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.26 0.624 . . . . 74.109999999999999 111.275 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 100' ' ' THR . 41.9 tp -88.98 125.87 35.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.672 -0.695 . . . . 42.100000000000001 109.147 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.05 165.87 12.28 Favored Pre-proline 0 C--N 1.283 -2.288 0 C-N-CA 124.421 1.088 . . . . 65.299999999999997 108.634 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HA ' HG22 ' A' ' 125' ' ' VAL . 28.7 Cg_exo -64.98 159.08 48.13 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.545 2.164 . . . . 73.120000000000005 111.673 176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -115.97 -30.67 5.98 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.71 -0.396 . . . . 74.219999999999999 111.349 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 46.4 tt0 -104.04 127.71 51.62 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.353 -0.98 . . . . 71.510000000000005 108.353 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 106' ' ' VAL . 64.4 m-85 -123.34 114.83 20.71 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.772 -0.455 . . . . 72.0 109.772 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -97.9 110.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.755 -0.832 . . . . 65.510000000000005 108.755 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.8 115.57 48.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.6 -0.727 . . . . 72.219999999999999 109.21 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 m -109.53 123.42 49.38 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.527 -0.306 . . . . 72.219999999999999 110.525 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -117.22 -176.99 3.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.877 1.271 . . . . 71.5 109.183 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.7 -174.09 42.84 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 108.885 -1.686 . . . . 42.310000000000002 108.885 173.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.583 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.4 p -69.54 -58.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 118.321 1.06 . . . . 72.099999999999994 113.652 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.627 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 22.1 t-80 -55.77 -51.56 66.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.866 0.841 . . . . 72.409999999999997 110.068 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -65.19 -31.22 72.29 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.483 -1.235 . . . . 75.129999999999995 113.872 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -68.49 -43.58 76.58 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.409 -0.517 . . . . 71.540000000000006 110.596 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 37.4 mt-10 -62.97 -38.45 91.16 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.837 0.827 . . . . 73.430000000000007 110.092 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 12.4 mptt -80.82 -16.02 54.85 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.059 -0.973 . . . . 73.430000000000007 112.367 -175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 65.9 mt -70.61 -45.42 65.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.636 -1.246 . . . . 54.340000000000003 107.636 170.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.57 121.2 0.8 Allowed Glycine 0 N--CA 1.406 -3.312 0 CA-C-N 114.67 -1.15 . . . . 63.299999999999997 111.648 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.63 -18.73 62.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.995 -1.113 . . . . 74.329999999999998 107.995 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.98 88.89 8.78 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 104.785 -2.302 . . . . 61.310000000000002 104.785 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.2 -33.13 15.5 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.79 2.326 . . . . 74.5 114.007 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.95 -25.84 60.17 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.943 -0.303 . . . . 74.310000000000002 111.455 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.21 -35.25 80.47 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.571 -0.529 . . . . 73.25 109.571 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -74.23 -34.08 63.56 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.58 -0.737 . . . . 74.349999999999994 109.505 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.5 t -58.78 -51.31 70.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.497 -0.556 . . . . 64.239999999999995 109.497 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 28.2 m -62.34 -44.02 97.47 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.294 -0.412 . . . . 73.150000000000006 110.484 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.01 -57.94 17.17 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 116.391 -0.368 . . . . 61.140000000000001 113.051 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -67.87 -28.25 67.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.968 0.729 . . . . 64.150000000000006 112.968 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.1 76.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 74.140000000000001 110.637 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.8 mmt85 -67.75 -43.39 80.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.868 -0.606 . . . . 64.319999999999993 109.883 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.8 t70 -56.69 -56.69 18.2 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.371 -1.286 . . . . 71.140000000000001 109.583 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.81 -31.11 72.19 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 112.589 0.589 . . . . 55.420000000000002 112.589 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.02 98.63 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 121.504 0.669 . . . . 62.530000000000001 111.178 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.31 -27.51 27.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.243 -1.391 . . . . 73.540000000000006 107.243 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 3.3 t80 -65.6 -42.78 91.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.723 -1.581 . . . . 64.319999999999993 110.195 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.95 -30.94 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 120.521 -0.471 . . . . 72.420000000000002 109.787 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -62.71 -42.39 99.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.056 0.455 . . . . 71.439999999999998 109.964 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 92' ' ' TYR . 11.9 mm-40 -57.72 -38.14 74.77 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.807 0.843 . . . . 71.540000000000006 111.098 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.7 mm-40 -83.43 -14.06 53.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 63.409999999999997 111.623 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.59 38.13 25.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.075 -0.584 . . . . 41.340000000000003 112.1 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.0 m0 -117.74 179.7 4.0 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.553 -0.906 . . . . 74.409999999999997 108.553 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.53 ' HB2' HG22 ' A' ' 8' ' ' VAL . 11.0 pt20 -160.09 178.94 9.17 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 110.196 -0.298 . . . . 55.509999999999998 110.196 176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.515 ' HA ' HD12 ' A' ' 57' ' ' LEU . 14.0 t -153.24 171.97 17.71 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 107.298 -1.371 . . . . 72.230000000000004 107.298 177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -89.64 118.92 29.62 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 106.778 -1.564 . . . . 74.329999999999998 106.778 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.83 -149.43 16.59 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 119.277 -1.439 . . . . 63.149999999999999 109.862 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -125.59 152.58 44.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.404 -1.332 . . . . 62.420000000000002 107.404 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 74.3 t -66.93 125.81 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 O-C-N 123.442 0.463 . . . . 72.230000000000004 111.255 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 19.7 m -123.86 120.22 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.519 0.676 . . . . 74.150000000000006 109.75 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 62' ' ' TYR . 15.1 m -116.1 142.78 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 108.707 -0.849 . . . . 65.239999999999995 108.707 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.56 131.01 23.77 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.356 0.598 . . . . 73.519999999999996 112.028 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.19 151.27 19.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.499 -1.228 . . . . 63.439999999999998 108.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -159.51 170.13 22.36 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 123.113 0.565 . . . . 74.109999999999999 109.967 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.16 164.82 12.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.939 0.876 . . . . 63.149999999999999 112.941 -176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 t -142.7 134.91 27.43 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 113.583 -1.644 . . . . 70.129999999999995 106.885 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.43 -12.02 59.06 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.395 0.616 . . . . 74.299999999999997 110.168 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -85.18 -30.49 23.88 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.948 -0.569 . . . . 74.219999999999999 111.187 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 118' ' ' GLN . 57.7 mt -86.94 149.47 24.77 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.733 -0.667 . . . . 52.439999999999998 111.636 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -126.85 168.78 13.99 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.279 -1.008 . . . . 73.329999999999998 108.279 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -57.49 110.55 0.89 Allowed 'General case' 0 C--O 1.251 1.155 0 CA-C-O 121.646 0.736 . . . . 74.129999999999995 110.65 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.14 -24.82 4.18 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 108.698 -1.761 . . . . 72.109999999999999 108.698 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 114' ' ' LEU . 29.0 mm-40 -92.71 156.02 17.32 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.502 -1.296 . . . . 41.329999999999998 107.502 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -176.11 147.7 0.75 Allowed 'General case' 0 C--N 1.278 -2.539 0 O-C-N 125.077 1.486 . . . . 75.299999999999997 107.643 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -143.25 130.87 21.25 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.368 -0.378 . . . . 75.349999999999994 109.991 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.68 135.92 53.69 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.132 -1.062 . . . . 42.399999999999999 108.132 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -125.32 126.48 45.14 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.953 -0.758 . . . . 72.150000000000006 108.953 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.44 125.13 8.39 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 110.461 -1.055 . . . . 54.240000000000002 110.461 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.1 p -121.4 140.49 52.07 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 123.241 0.616 . . . . 71.340000000000003 110.68 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 59' ' ' PRO . 80.1 t -92.35 103.66 14.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 106.719 -1.586 . . . . 62.229999999999997 106.719 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -107.35 104.22 51.6 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 108.23 -1.026 . . . . 71.430000000000007 108.23 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.4 -39.6 6.99 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.936 1.757 . . . . 73.120000000000005 112.924 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.17 69.43 1.15 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.911 1.339 . . . . 62.009999999999998 108.416 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 p -101.59 108.92 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-N 113.082 -1.872 . . . . 75.109999999999999 109.295 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -85.82 122.15 29.49 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.769 -1.105 . . . . 71.5 109.344 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.1 p -70.57 120.09 15.69 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 114.638 -1.165 . . . . 73.129999999999995 111.718 -173.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 107.314 -1.365 . . . . 71.430000000000007 107.314 175.338 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.509 -0.629 0 CA-C-O 121.206 0.527 . . . . 61.539999999999999 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.62 -15.74 13.02 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 109.939 -1.264 . . . . 70.319999999999993 109.939 173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 p -84.56 158.55 20.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 109.551 -0.537 . . . . 72.450000000000003 109.551 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -135.47 108.31 7.56 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.835 0.35 . . . . 71.109999999999999 111.598 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.19 145.63 37.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.929 -0.767 . . . . 70.420000000000002 108.929 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -86.01 8.51 20.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.632 0.729 . . . . 74.439999999999998 111.271 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.6 pp -133.2 96.02 3.66 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-O 122.229 1.014 . . . . 75.099999999999994 110.485 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.66 108.02 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.209 -0.905 . . . . 64.439999999999998 109.008 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.433 -0.803 . . . . 72.329999999999998 109.733 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -124.48 85.2 2.38 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.112 -0.699 . . . . 64.150000000000006 109.112 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.58 124.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.121 -0.945 . . . . 72.329999999999998 110.103 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.2 148.62 44.0 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.451 -0.795 . . . . 63.119999999999997 109.129 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -89.36 113.68 25.02 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.8 -0.444 . . . . 74.140000000000001 109.8 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -88.69 86.36 6.97 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.916 -1.142 . . . . 74.409999999999997 107.916 172.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.08 113.73 18.47 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.741 -1.207 . . . . 64.230000000000004 107.741 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.23 145.75 50.27 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.443 -0.947 . . . . 62.140000000000001 108.443 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -134.11 147.62 50.88 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.253 0.549 . . . . 74.519999999999996 110.6 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -148.56 145.38 27.82 Favored 'General case' 0 N--CA 1.413 -2.312 0 N-CA-C 106.215 -1.772 . . . . 65.120000000000005 106.215 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -102.02 100.69 10.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.304 0.573 . . . . 73.400000000000006 109.84 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.11 69.27 0.55 Allowed Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.335 -0.848 . . . . 51.009999999999998 111.876 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 16.5 t70 -151.62 131.26 13.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.788 -1.19 . . . . 73.420000000000002 107.788 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.351 1.032 . . . . 55.210000000000001 113.163 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -76.94 -34.56 57.63 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.541 -0.3 . . . . 62.219999999999999 111.076 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -58.89 -36.03 73.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.663 -0.495 . . . . 61.210000000000001 109.663 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 12.8 mmm180 -64.55 -42.41 95.71 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.038 -0.528 . . . . 64.430000000000007 109.714 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 22' ' ' ALA . 51.3 mm -60.92 -39.5 82.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 CA-C-N 115.883 -0.599 . . . . 73.329999999999998 111.147 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' SER . 77.9 m-85 -77.61 -17.38 57.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.342 -0.39 . . . . 65.450000000000003 111.855 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.07 39.69 2.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 61.130000000000003 113.358 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.34 22.7 43.2 Favored Glycine 0 C--N 1.313 -0.722 0 N-CA-C 111.52 -0.632 . . . . 54.399999999999999 111.52 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 33.3 t -142.45 147.97 36.99 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.165 -1.42 . . . . 74.140000000000001 107.165 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.32 88.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 122.508 1.147 . . . . 64.400000000000006 109.413 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.2 t -122.62 99.31 42.33 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 114.641 -1.163 . . . . 53.340000000000003 109.476 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -64.37 -24.39 64.53 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.463 2.109 . . . . 61.140000000000001 110.299 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -67.09 -14.17 62.65 Favored 'General case' 0 C--O 1.21 -1.008 0 CA-C-N 114.6 -1.182 . . . . 55.0 111.781 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.96 -44.85 88.03 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.671 0.748 . . . . 64.549999999999997 109.014 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG12 HD23 ' A' ' 40' ' ' LEU . 47.2 t -72.48 -38.22 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.196 -0.911 . . . . 73.329999999999998 108.846 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.37 -42.59 91.98 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.203 -0.453 . . . . 63.130000000000003 110.67 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.19 -45.82 86.9 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.429 0.692 . . . . 55.409999999999997 110.691 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 121' ' ' ALA . 1.6 tm? -66.59 -45.75 78.2 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.854 -0.612 . . . . 54.530000000000001 109.517 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 HG12 ' A' ' 36' ' ' VAL . 4.6 mm? -65.59 -40.15 92.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.09 0.774 . . . . 75.340000000000003 113.09 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -72.21 -29.35 63.88 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 63.039999999999999 110.008 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.74 -44.11 97.07 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.17 -1.048 . . . . 74.349999999999994 108.17 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.94 -48.66 65.29 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.92 -1.036 . . . . 64.549999999999997 110.123 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.84 68.32 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.432 -0.349 . . . . 73.140000000000001 111.814 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.64 -23.24 56.32 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.994 0.368 . . . . 63.329999999999998 111.994 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.02 -34.54 24.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.218 0.533 . . . . 63.229999999999997 110.618 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.75 21.12 15.84 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.54 -0.755 . . . . 73.409999999999997 113.177 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mm -72.57 131.73 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 CA-C-O 121.002 0.43 . . . . 75.129999999999995 110.498 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.7 mt-30 -108.84 133.13 53.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.769 -0.826 . . . . 71.310000000000002 108.769 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -75.32 117.71 17.43 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.949 -1.023 . . . . 71.219999999999999 109.407 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD23 ' NE2' ' A' ' 99' ' ' GLN . 12.9 tp -141.39 -164.34 1.75 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 103.955 -2.609 . . . . 74.140000000000001 103.955 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 97.9 mt-30 -42.68 131.74 3.88 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.702 0.626 . . . . 72.120000000000005 111.662 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.38 -18.47 55.69 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 115.062 0.785 . . . . 74.409999999999997 115.062 -170.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.41 -31.9 54.37 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.627 -0.829 . . . . 73.230000000000004 111.422 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 12.4 ptm180 -151.77 114.42 4.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.497 1.141 . . . . 75.530000000000001 111.029 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -91.1 150.71 21.29 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.969 -1.469 . . . . 74.310000000000002 108.322 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -84.25 120.34 26.1 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.495 -0.558 . . . . 71.420000000000002 109.495 -175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 157.38 38.66 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.676 -0.693 . . . . 74.340000000000003 109.672 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -61.68 147.58 95.01 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.573 2.182 . . . . 71.140000000000001 112.175 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.403 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 28.8 p-10 -120.59 -24.44 5.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.966 -0.561 . . . . 73.420000000000002 110.403 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.11 114.8 29.2 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.455 -0.572 . . . . 71.230000000000004 109.455 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -119.56 114.63 22.53 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.601 -0.727 . . . . 52.229999999999997 109.411 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.4 mt -109.13 120.27 60.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.616 -0.883 . . . . 72.230000000000004 108.616 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.9 126.71 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 108.556 -0.905 . . . . 64.409999999999997 108.556 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.6 m -107.81 130.97 54.94 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.48 -0.782 . . . . 72.340000000000003 109.282 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.35 161.27 22.38 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.68 0.792 . . . . 44.229999999999997 109.244 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.1 157.33 52.55 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.727 -1.349 . . . . 63.509999999999998 109.727 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.4 p -56.76 -39.13 62.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 117.364 0.582 . . . . 64.409999999999997 112.374 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.95 -44.4 82.53 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.481 0.658 . . . . 73.25 110.777 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.57 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 39.8 m-20 -84.76 -21.67 29.92 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 112.784 0.661 . . . . 75.329999999999998 112.784 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 57.0 t80 -69.3 -26.09 64.55 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.162 -0.681 . . . . 70.549999999999997 109.162 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 46.2 mt-10 -58.67 -38.56 78.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.386 -0.37 . . . . 54.329999999999998 110.784 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -76.55 -32.8 58.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.108 0.48 . . . . 73.409999999999997 109.913 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.08 -29.25 70.11 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.988 -0.551 . . . . 63.329999999999998 109.976 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.03 33.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.672 -0.694 . . . . 53.149999999999999 113.904 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.36 0.58 . . . . 72.230000000000004 109.67 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.35 68.34 2.77 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 122.198 0.999 . . . . 64.209999999999994 109.765 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.76 -51.25 0.7 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.199 1.933 . . . . 74.099999999999994 113.685 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.8 -23.16 60.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.439 -0.346 . . . . 73.519999999999996 111.633 -177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -67.5 -43.09 81.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.763 -0.458 . . . . 74.310000000000002 109.763 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -63.33 -34.4 77.62 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.739 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.1 m -66.87 -49.03 66.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.785 -0.643 . . . . 61.32 110.698 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -62.49 -36.27 82.0 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.141 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.15 40.29 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.424 -0.417 . . . . 62.409999999999997 112.122 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -70.85 -28.04 64.29 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.324 0.49 . . . . 64.310000000000002 112.324 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.13 -43.28 87.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.898 -0.408 . . . . 72.040000000000006 109.898 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -59.67 -47.61 84.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.41 -0.813 . . . . 71.239999999999995 109.522 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' HD1' ' A' ' 92' ' ' TYR . 59.7 m-20 -69.52 -45.37 69.01 Favored 'General case' 0 C--O 1.208 -1.1 0 N-CA-C 113.275 0.843 . . . . 61.049999999999997 113.275 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.137 -0.625 . . . . 63.340000000000003 111.812 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.14 -38.34 87.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 109.939 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.93 -44.5 72.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.913 -0.585 . . . . 71.109999999999999 109.734 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.626 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.1 m-85 -58.68 -49.62 76.89 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.485 -0.78 . . . . 65.310000000000002 112.572 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.12 -39.02 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 119.914 -0.715 . . . . 75.319999999999993 111.363 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.63 -41.58 96.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.61 -0.268 . . . . 73.120000000000005 110.491 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.47 -38.95 75.33 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.693 1.197 . . . . 71.329999999999998 110.723 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 52.2 mm-40 -87.44 -13.35 43.5 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.782 -0.645 . . . . 54.539999999999999 111.402 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.61 35.48 28.74 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.976 -0.85 . . . . 72.540000000000006 110.976 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -105.34 158.71 16.44 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.008 -0.738 . . . . 74.400000000000006 109.008 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.5 pt20 -126.33 171.58 10.84 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.197 -0.456 . . . . 62.009999999999998 110.175 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 57' ' ' LEU . 6.3 t -162.52 158.05 23.05 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 107.639 -1.245 . . . . 73.049999999999997 107.639 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.51 120.44 40.3 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.265 -1.013 . . . . 75.409999999999997 108.265 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -152.11 16.99 Favored Glycine 0 N--CA 1.418 -2.526 0 N-CA-C 109.154 -1.579 . . . . 23.329999999999998 109.154 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.95 162.58 20.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.217 -0.66 . . . . 72.230000000000004 109.217 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -81.22 119.83 31.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.58 -0.896 . . . . 75.129999999999995 108.58 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -121.66 133.1 69.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 121.451 0.643 . . . . 64.310000000000002 109.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.03 134.37 61.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.377 -0.972 . . . . 72.299999999999997 108.377 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -130.88 142.99 50.41 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.729 -0.841 . . . . 73.219999999999999 108.729 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -113.98 137.02 52.27 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.765 -0.828 . . . . 63.130000000000003 108.765 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.32 160.8 38.55 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 120.967 0.413 . . . . 73.299999999999997 110.678 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 26.9 pt20 -103.55 153.89 20.08 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.397 -0.82 . . . . 70.349999999999994 109.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.2 t -144.37 132.22 21.38 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 109.025 -0.732 . . . . 65.299999999999997 109.025 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -81.05 -15.73 55.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.08 -1.081 . . . . 53.219999999999999 108.08 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -77.5 -32.89 54.46 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.565 -1.198 . . . . 72.25 109.769 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -84.44 157.66 21.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.423 -0.954 . . . . 63.119999999999997 108.423 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -98.54 164.53 12.22 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.757 0.651 . . . . 74.140000000000001 112.757 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 m -66.13 134.57 53.07 Favored 'General case' 0 C--O 1.25 1.089 0 C-N-CA 123.995 0.918 . . . . 73.510000000000005 110.802 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.1 86.82 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 112.041 -0.424 . . . . 62.340000000000003 112.041 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -138.49 128.38 25.27 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 107.915 -1.143 . . . . 60.210000000000001 107.915 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -122.59 153.94 38.61 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.776 -0.824 . . . . 65.310000000000002 108.776 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -148.61 153.76 38.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.429 -1.323 . . . . 75.030000000000001 107.429 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -145.44 149.35 34.54 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 120.697 -0.401 . . . . 72.200000000000003 110.966 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -134.42 123.0 23.33 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.5 -0.773 . . . . 72.010000000000005 109.476 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.68 126.17 7.57 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 109.715 -1.354 . . . . 74.230000000000004 109.715 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.2 m -135.88 150.59 49.42 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 109.402 -0.592 . . . . 54.520000000000003 109.402 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 59' ' ' PRO . 40.2 t -88.02 110.97 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 107.179 -1.415 . . . . 74.349999999999994 107.179 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -120.06 86.99 38.23 Favored Pre-proline 0 C--N 1.284 -2.264 0 N-CA-C 107.226 -1.398 . . . . 72.230000000000004 107.226 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.27 -13.68 7.4 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.368 2.045 . . . . 70.129999999999995 112.69 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -87.12 29.32 0.84 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.594 -0.73 . . . . 64.239999999999995 112.71 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.16 98.82 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.17 -0.678 . . . . 75.430000000000007 109.17 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -94.8 121.23 36.17 Favored 'General case' 0 N--CA 1.4 -2.969 0 N-CA-C 106.508 -1.664 . . . . 64.5 106.508 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.8 t -123.28 149.39 44.84 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 109.339 -0.615 . . . . 73.409999999999997 109.339 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 106.599 -1.63 . . . . 75.140000000000001 106.599 177.347 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 109.34 -0.615 . . . . 64.140000000000001 109.34 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.27 -175.21 34.02 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 109.869 -1.292 . . . . 71.329999999999998 109.869 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -79.35 92.24 5.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.732 -0.84 . . . . 53.409999999999997 108.732 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -121.94 135.93 54.89 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.588 -0.733 . . . . 71.349999999999994 110.879 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -75.05 83.74 2.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.088 0.947 . . . . 65.129999999999995 108.9 171.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -84.14 139.9 32.12 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.593 -1.185 . . . . 63.219999999999999 110.421 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.65 84.21 7.36 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.205 -1.035 . . . . 61.420000000000002 108.205 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 9' ' ' GLN . 12.2 p -112.35 143.11 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 114.148 -1.387 . . . . 71.209999999999994 109.767 -175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 8' ' ' VAL . 17.8 pt20 -90.8 168.25 11.86 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.214 -1.032 . . . . 71.510000000000005 108.214 174.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -76.03 88.39 2.97 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.976 0.893 . . . . 71.200000000000003 111.146 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 13' ' ' ARG . 48.1 t -70.03 145.83 12.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 113.782 -1.553 . . . . 74.310000000000002 109.229 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -51.61 -45.5 63.25 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.63 0.772 . . . . 71.540000000000006 110.284 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' H ' HG12 ' A' ' 11' ' ' VAL . 22.0 mmt180 -59.43 146.24 40.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.658 -1.155 . . . . 75.239999999999995 110.824 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 117.64 7.69 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.729 -0.841 . . . . 74.010000000000005 108.729 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -91.34 150.37 21.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.263 -0.643 . . . . 65.329999999999998 109.263 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -76.77 110.8 11.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.324 1.231 . . . . 74.510000000000005 114.324 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 11.1 mm-40 -125.38 104.86 8.69 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.103 -1.408 . . . . 63.509999999999998 107.22 171.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.2 m -71.48 112.41 7.58 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.34 -0.846 . . . . 73.329999999999998 110.164 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.65 87.86 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.058 -0.974 . . . . 74.109999999999999 108.601 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.47 50.47 0.03 OUTLIER Glycine 0 C--N 1.287 -2.176 0 N-CA-C 109.099 -1.601 . . . . 61.200000000000003 109.099 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.89 -39.81 66.07 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.388 1.075 . . . . 61.43 111.93 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.503 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.84 -59.24 5.54 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.17 -0.923 . . . . 61.450000000000003 110.139 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -44.73 86.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.15 -0.932 . . . . 72.549999999999997 110.454 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.09 -46.57 82.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.341 -0.845 . . . . 72.439999999999998 111.878 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -78.37 -28.88 47.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.412 -0.515 . . . . 55.020000000000003 111.876 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 22' ' ' ALA . 72.1 mt -66.96 -48.05 80.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 O-C-N 123.317 0.386 . . . . 73.540000000000006 110.385 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.401 ' HB3' ' HB2' ' A' ' 30' ' ' SER . 24.8 m-85 -84.12 -29.73 26.51 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.398 -0.921 . . . . 74.200000000000003 110.626 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.39 -86.42 0.61 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 112.004 -0.439 . . . . 54.539999999999999 112.004 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.34 63.54 0.47 Allowed Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.407 -0.677 . . . . 62.030000000000001 111.407 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 27' ' ' PHE . 23.0 m -147.55 171.4 15.62 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.156 -1.424 . . . . 71.230000000000004 107.156 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.46 147.73 9.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 110.085 -0.339 . . . . 54.409999999999997 110.085 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.11 113.74 55.09 Favored Pre-proline 0 N--CA 1.431 -1.405 0 N-CA-C 107.036 -1.468 . . . . 71.519999999999996 107.036 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -87.49 50.2 1.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 122.484 2.123 . . . . 73.219999999999999 114.406 -173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -71.02 -12.77 61.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 118.232 -1.387 . . . . 74.010000000000005 111.525 177.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.67 -25.3 67.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.357 -0.608 . . . . 73.010000000000005 109.357 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.99 -49.7 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 109.681 -0.488 . . . . 75.109999999999999 109.681 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.97 -35.8 81.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.366 -0.533 . . . . 61.439999999999998 109.822 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.84 -44.33 94.15 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.685 -0.688 . . . . 73.319999999999993 110.773 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -44.45 96.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.774 -0.824 . . . . 74.209999999999994 108.774 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.12 -29.18 68.04 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.035 0.754 . . . . 71.120000000000005 113.035 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 11.4 mtm180 -65.52 -36.97 85.41 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.778 -1.194 . . . . 73.299999999999997 107.778 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.31 -46.87 72.26 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.17 -0.923 . . . . 72.439999999999998 110.07 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.21 -41.08 96.22 Favored 'General case' 0 CA--C 1.5 -0.942 0 O-C-N 123.397 0.435 . . . . 74.519999999999996 111.976 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.49 93.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.095 -0.502 . . . . 63.210000000000001 110.583 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.25 -25.36 42.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.089 -0.505 . . . . 71.329999999999998 111.599 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.19 -40.02 28.04 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.04 0.448 . . . . 64.319999999999993 110.167 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.85 17.96 37.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.472 -0.786 . . . . 64.209999999999994 112.999 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 48' ' ' ILE . 13.8 mm -59.95 127.03 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 CA-C-O 121.325 0.583 . . . . 75.329999999999998 110.814 177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.2 tt0 -109.59 128.27 55.1 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 106.819 -1.549 . . . . 64.219999999999999 106.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -67.61 116.47 8.36 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.419 0.628 . . . . 61.43 110.57 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 18.4 tp -119.62 -165.83 1.21 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.503 -2.036 . . . . 75.530000000000001 105.503 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.577 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 14.1 mm-40 -62.92 166.56 5.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 118.731 0.696 . . . . 71.230000000000004 110.741 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.4 1.7 18.84 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.416 -0.811 . . . . 61.009999999999998 113.472 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.91 -48.64 57.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.621 -0.881 . . . . 71.430000000000007 108.621 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -173.67 159.8 3.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.869 -0.605 . . . . 74.129999999999995 110.649 -176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.87 151.68 20.44 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.653 0.781 . . . . 72.549999999999997 109.993 -176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.4 tm? -98.64 126.27 44.19 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.151 -1.796 . . . . 71.150000000000006 106.151 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.47 157.65 33.43 Favored Pre-proline 0 C--N 1.297 -1.702 0 C-N-CA 122.899 0.48 . . . . 53.43 110.305 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HG2' ' OH ' ' A' ' 62' ' ' TYR . 23.6 Cg_endo -63.73 148.34 92.12 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.334 2.023 . . . . 51.100000000000001 111.698 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 24.5 p-10 -123.37 -16.33 6.89 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.593 -0.73 . . . . 74.129999999999995 112.175 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.92 109.45 18.15 Favored 'General case' 0 N--CA 1.428 -1.549 0 C-N-CA 120.365 -0.534 . . . . 74.349999999999994 110.635 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.451 ' OH ' ' HG2' ' A' ' 59' ' ' PRO . 24.9 m-85 -114.44 127.67 55.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.532 -0.758 . . . . 73.420000000000002 110.7 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 64.8 mt -109.28 115.61 50.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.908 -1.145 . . . . 61.32 107.908 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.99 110.42 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.451 -0.944 . . . . 73.150000000000006 108.451 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -102.27 121.73 42.83 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.189 -0.46 . . . . 70.209999999999994 110.529 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.38 167.89 9.86 Favored 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.698 0.799 . . . . 71.400000000000006 110.168 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.66 162.38 50.56 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 109.39 -1.484 . . . . 73.329999999999998 109.39 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 7.9 p -59.71 -42.01 87.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 117.467 0.633 . . . . 74.430000000000007 112.306 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.476 ' HB3' HG21 ' A' ' 116' ' ' THR . 15.3 t-80 -73.6 -21.95 60.18 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.494 0.664 . . . . 74.310000000000002 110.17 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -79.26 -36.87 39.19 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.766 -0.584 . . . . 73.409999999999997 110.173 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -31.08 71.56 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.766 -0.652 . . . . 64.299999999999997 109.473 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 13.6 mm-40 -59.42 -31.43 69.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.713 -0.676 . . . . 75.420000000000002 112.004 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -84.44 -27.82 27.28 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.085 -0.646 . . . . 62.140000000000001 110.755 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD11 ' HG ' ' A' ' 66' ' ' LEU . 88.2 mt -64.36 -38.97 92.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.395 -0.366 . . . . 63.109999999999999 110.22 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.51 169.28 11.59 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 111.384 -0.686 . . . . 74.349999999999994 111.384 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.14 -31.41 25.23 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.0 0.428 . . . . 64.420000000000002 110.417 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 16.3 m-20 -105.8 105.36 52.85 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.51 -0.768 . . . . 71.310000000000002 109.428 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.16 -18.97 17.96 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.08 1.853 . . . . 71.310000000000002 113.783 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.296 0.0 OUTLIER -62.54 -51.91 65.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.789 1.403 . . . . 71.319999999999993 114.789 -174.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.3 mt -67.35 -36.44 81.41 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 117.86 0.3 . . . . 64.420000000000002 111.314 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 72.4 mmtt -64.61 -45.78 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.231 0.539 . . . . 64.219999999999999 109.904 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.615 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 43.5 m -71.68 -49.71 37.14 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.378 -0.828 . . . . 72.5 111.11 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 56.1 m -65.63 -35.07 79.73 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 120.785 0.326 . . . . 74.239999999999995 111.649 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.73 -46.53 74.54 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.336 -0.705 . . . . 43.43 111.336 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -67.81 -28.28 67.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.274 -0.639 . . . . 73.439999999999998 109.274 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -34.94 79.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.994 -0.548 . . . . 72.140000000000001 110.25 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 83' ' ' THR . 99.9 mtt180 -66.14 -41.9 89.8 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.104 -0.332 . . . . 75.439999999999998 110.104 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.43 -36.66 83.09 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.927 0.394 . . . . 73.5 110.327 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 104' ' ' VAL . 2.7 tm? -73.39 -39.44 65.1 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.948 -0.569 . . . . 51.109999999999999 110.121 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -59.37 -41.44 89.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.65 0.738 . . . . 72.450000000000003 109.026 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 19.2 t70 -58.16 -51.67 68.76 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.265 -1.334 . . . . 73.299999999999997 109.186 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.614 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 10.0 m-85 -55.1 -53.72 52.3 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.27 0.841 . . . . 70.209999999999994 113.27 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.0 pt -61.84 -36.63 74.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 120.774 -0.37 . . . . 75.219999999999999 111.664 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -67.19 -36.63 82.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.067 -0.515 . . . . 65.239999999999995 111.35 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.9 mt-10 -62.93 -38.84 92.63 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.381 0.61 . . . . 65.209999999999994 110.844 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 62.3 mm-40 -79.8 -9.45 59.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.377 -0.828 . . . . 73.450000000000003 110.905 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.81 56.57 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 112.583 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -101.5 159.76 15.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.488 -0.931 . . . . 65.439999999999998 108.488 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -132.94 171.6 13.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.711 -1.218 . . . . 74.129999999999995 107.711 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.1 t -147.86 166.27 28.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.645 -0.502 . . . . 60.409999999999997 109.645 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -106.51 120.76 42.76 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 109.749 -0.463 . . . . 61.219999999999999 109.749 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.85 -149.79 17.03 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.269 -1.132 . . . . 51.329999999999998 110.269 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -108.8 143.0 38.53 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.885 -1.524 . . . . 73.420000000000002 106.885 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 90' ' ' ALA . 14.8 p -81.52 112.99 20.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.128 -1.029 . . . . 61.350000000000001 108.903 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.7 m -120.85 120.15 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 CA-C-O 122.096 0.95 . . . . 73.209999999999994 110.866 -176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 82' ' ' SER . 3.7 m -119.1 139.67 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.106 0 N-CA-C 104.025 -2.583 . . . . 74.200000000000003 104.025 174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -137.81 132.88 33.29 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 118.869 -1.132 . . . . 74.530000000000001 112.119 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -91.35 119.94 31.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.418 -1.265 . . . . 61.210000000000001 108.54 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.89 171.67 9.05 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.81 -0.632 . . . . 74.019999999999996 109.925 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -121.49 157.63 30.22 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.115 -1.069 . . . . 73.549999999999997 108.115 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.7 t -145.76 146.98 31.42 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.093 -0.706 . . . . 60.219999999999999 109.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.3 m -80.89 -22.74 39.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.433 -0.951 . . . . 75.340000000000003 108.433 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -80.46 -29.7 37.51 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.251 -0.886 . . . . 73.519999999999996 109.652 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.02 130.78 37.69 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.113 -1.81 . . . . 72.5 106.113 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 38.1 t-80 -97.74 153.24 18.39 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.499 -0.48 . . . . 73.409999999999997 110.008 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 69' ' ' HIS . 97.9 m -60.51 139.59 57.68 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.635 0.774 . . . . 64.010000000000005 110.768 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.18 3.05 57.88 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.211 -1.155 . . . . 52.43 110.211 -177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 25.3 mt-30 -132.25 154.05 50.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 124.05 0.94 . . . . 64.340000000000003 109.101 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.11 148.22 26.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.434 -1.321 . . . . 61.299999999999997 107.434 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -137.45 135.94 37.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.802 -0.814 . . . . 72.209999999999994 108.802 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -137.28 120.66 16.98 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 123.527 0.517 . . . . 72.040000000000006 109.78 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 1.5 tpm_? -119.73 137.41 53.94 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 107.682 -1.229 . . . . 74.409999999999997 107.682 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -120.4 104.34 0.99 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.189 -0.764 . . . . 62.219999999999999 111.189 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.6 m -105.43 151.22 24.5 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 122.43 -0.453 . . . . 64.519999999999996 109.81 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.0 t -79.35 112.48 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.153 -1.054 . . . . 74.430000000000007 108.153 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -115.5 108.02 48.06 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 109.041 -0.726 . . . . 64.239999999999995 109.041 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.53 -23.98 19.4 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.92 1.747 . . . . 70.109999999999999 112.236 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.07 77.26 1.81 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.507 1.146 . . . . 70.409999999999997 110.471 -175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.88 131.52 32.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.773 0 CA-C-N 113.171 -1.831 . . . . 60.109999999999999 107.546 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -76.97 143.35 39.52 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.119 -0.491 . . . . 74.209999999999994 110.388 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -131.58 140.08 49.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.849 -1.537 . . . . 61.340000000000003 106.849 176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.4 m80 . . . . . 0 C--N 1.295 -1.792 0 CA-C-O 118.755 -0.641 . . . . 74.239999999999995 109.965 -175.788 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 CA--C 1.516 -0.365 0 N-CA-C 110.233 -0.284 . . . . 75.329999999999998 110.233 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.09 110.78 3.15 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.426 -1.47 . . . . 71.420000000000002 109.426 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -72.91 151.01 42.1 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 122.535 0.334 . . . . 62.399999999999999 111.025 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -78.04 24.85 0.23 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.624 0.602 . . . . 73.0 112.624 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -169.43 146.83 3.51 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 123.048 0.539 . . . . 73.310000000000002 109.941 177.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -108.64 153.49 23.34 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.374 -1.343 . . . . 73.400000000000006 107.374 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.71 101.26 8.31 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.917 -0.771 . . . . 73.219999999999999 108.917 177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.1 t -93.73 -79.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.962 -0.563 . . . . 63.109999999999999 109.539 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -154.74 -178.83 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.691 -1.966 . . . . 60.240000000000002 105.691 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -63.85 116.73 6.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.668 0.747 . . . . 72.010000000000005 110.675 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.524 ' HA ' HE21 ' A' ' 17' ' ' GLN . 36.0 t -79.6 81.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 107.423 -1.325 . . . . 63.229999999999997 107.423 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -97.62 113.61 25.37 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.219 -1.355 . . . . 75.409999999999997 113.08 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 57.76 33.24 22.98 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.685 1.194 . . . . 52.43 112.48 169.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.42 140.21 1.38 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.611 -1.996 . . . . 74.439999999999998 105.611 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.82 -9.25 58.03 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.702 1.001 . . . . 72.230000000000004 113.702 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.14 168.81 20.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.846 -1.538 . . . . 74.120000000000005 106.846 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.524 HE21 ' HA ' ' A' ' 11' ' ' VAL . 92.8 mm-40 -106.32 -0.6 24.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.208 1.004 . . . . 75.030000000000001 112.172 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 p -95.93 177.34 5.79 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.179 -1.373 . . . . 74.120000000000005 107.755 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.88 81.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.833 -0.802 . . . . 73.340000000000003 108.833 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.46 9.26 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 110.534 -1.026 . . . . 30.0 110.534 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -42.5 -54.86 3.71 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 114.636 1.347 . . . . 61.210000000000001 114.636 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.521 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -59.3 -59.51 5.35 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 123.972 0.795 . . . . 72.510000000000005 111.753 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -63.25 -38.38 90.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.189 0.44 . . . . 73.409999999999997 112.189 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -60.51 -43.7 96.79 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.284 0.365 . . . . 73.5 111.055 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -78.09 -19.81 53.44 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 120.801 0.334 . . . . 71.120000000000005 111.415 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.4 mt -74.07 -56.47 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.834 -0.432 . . . . 74.340000000000003 109.834 174.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -69.59 -28.32 65.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 120.864 0.364 . . . . 71.530000000000001 111.401 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.59 -49.5 0.94 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 110.988 -0.845 . . . . 51.219999999999999 110.988 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.52 47.06 0.69 Allowed Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.514 -0.85 . . . . 53.140000000000001 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 21.1 t -167.72 136.58 2.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.868 -0.79 . . . . 73.319999999999993 108.868 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 tt -93.3 -43.69 13.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.194 -1.039 . . . . 72.430000000000007 108.194 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.16 123.49 10.38 Favored Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 105.599 -2.001 . . . . 75.010000000000005 105.599 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.46 87.57 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.088 1.859 . . . . 61.32 111.78 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.68 -5.95 59.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 113.326 0.862 . . . . 72.420000000000002 113.326 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.55 -22.65 43.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.847 -0.741 . . . . 74.209999999999994 109.216 172.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.74 -48.79 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.434 -0.803 . . . . 63.119999999999997 109.074 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -65.07 -33.24 75.55 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.8 -0.36 . . . . 63.350000000000001 110.654 178.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.19 81.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.585 0.553 . . . . 21.329999999999998 109.942 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.74 -45.6 93.65 Favored 'General case' 0 C--O 1.205 -1.25 0 N-CA-C 108.765 -0.828 . . . . 71.420000000000002 108.765 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.515 HD21 HD11 ' A' ' 64' ' ' ILE . 11.1 mp -64.75 -42.45 95.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.043 1.127 . . . . 75.0 114.043 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 14.3 ptt180 -71.62 -27.28 63.0 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.205 -0.998 . . . . 70.439999999999998 111.328 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -68.14 -46.26 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.594 -0.521 . . . . 75.0 109.594 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.22 -40.42 93.93 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 124.697 1.199 . . . . 65.219999999999999 109.919 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.33 96.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.729 -0.669 . . . . 74.019999999999996 110.348 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.05 76.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.155 0.502 . . . . 63.219999999999999 111.36 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.91 -28.55 49.81 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.95 0.405 . . . . 72.340000000000003 111.289 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.49 21.6 45.25 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 116.267 -0.424 . . . . 51.130000000000003 113.138 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 56' ' ' LEU . 9.0 mm -62.15 144.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.693 0.797 . . . . 74.319999999999993 111.485 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 9.4 tt0 -120.45 134.66 55.24 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 107.988 -1.116 . . . . 73.25 107.988 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -64.48 128.94 37.93 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.453 0.644 . . . . 40.439999999999998 109.461 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -135.4 -166.25 1.81 Allowed 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 105.57 -2.011 . . . . 45.25 105.57 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.638 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 67.6 mt-30 -59.05 155.68 13.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.611 -0.515 . . . . 64.129999999999995 109.611 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.53 -9.46 37.86 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 116.442 -0.344 . . . . 32.130000000000003 113.494 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -46.73 86.58 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.504 -0.184 . . . . 72.109999999999999 110.504 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 99' ' ' GLN . 6.0 ptm180 -172.16 152.92 2.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.4 -0.364 . . . . 75.420000000000002 110.698 -175.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 48' ' ' ILE . 81.5 mt -91.67 152.38 20.25 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.508 1.123 . . . . 73.530000000000001 111.084 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 1.8 tm? -92.97 133.28 36.28 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 107.092 -1.447 . . . . 70.120000000000005 107.092 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -118.61 159.97 41.96 Favored Pre-proline 0 C--N 1.302 -1.461 0 C-N-CA 123.525 0.73 . . . . 40.350000000000001 109.753 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.427 ' HA ' HG22 ' A' ' 125' ' ' VAL . 32.1 Cg_exo -61.72 162.1 22.72 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.068 2.512 . . . . 72.5 113.418 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 9.8 p30 -134.16 -23.73 1.69 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.96 -0.563 . . . . 53.299999999999997 112.215 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.05 104.49 14.67 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.117 -1.033 . . . . 74.420000000000002 109.515 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -110.28 114.62 28.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.313 -0.858 . . . . 73.329999999999998 109.581 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.6 mt -110.36 118.03 56.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.722 -1.214 . . . . 70.019999999999996 107.722 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 HD21 ' A' ' 40' ' ' LEU . 41.0 mt -113.31 125.79 70.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.011 -1.107 . . . . 72.150000000000006 108.011 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -116.39 123.32 47.28 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.138 -0.69 . . . . 73.420000000000002 109.138 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.1 mm? -102.65 159.62 15.29 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.854 0.862 . . . . 72.109999999999999 109.478 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.82 144.68 48.53 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.683 -2.167 . . . . 62.009999999999998 107.683 169.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 8.3 p -55.59 -36.02 40.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.425 0.898 . . . . 75.239999999999995 113.425 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -69.69 -34.17 73.56 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.762 0.315 . . . . 62.420000000000002 111.227 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 3.3 m-20 -76.69 -25.82 54.06 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.22 0.533 . . . . 71.549999999999997 110.176 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -66.97 -31.18 71.57 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.26 -1.015 . . . . 73.120000000000005 108.26 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 41.6 mt-10 -64.92 -31.7 73.07 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.731 -0.668 . . . . 75.239999999999995 110.532 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -73.23 -27.61 61.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 110.915 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.53 -27.22 66.79 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.167 -0.679 . . . . 73.540000000000006 109.167 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.16 -163.72 12.54 Favored Glycine 0 CA--C 1.483 -1.934 0 CA-C-N 114.81 -1.086 . . . . 44.340000000000003 113.389 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -80.89 -19.35 44.59 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.34 0.59 . . . . 75.409999999999997 109.672 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.23 67.94 36.29 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 115.696 -0.684 . . . . 74.349999999999994 112.54 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 17.1 Cg_exo -72.5 -48.85 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.909 1.739 . . . . 65.230000000000004 110.352 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.599 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 5.4 mm-40 -68.43 -12.84 61.76 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.302 0.853 . . . . 72.230000000000004 113.302 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.22 -38.17 43.69 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.595 -1.261 . . . . 73.219999999999999 107.595 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.54 -25.6 57.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.068 -0.969 . . . . 73.299999999999997 110.407 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.599 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 9.3 m -54.65 -42.35 71.19 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 124.126 0.97 . . . . 74.430000000000007 111.28 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 m -60.85 -44.13 97.42 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.537 0.735 . . . . 72.439999999999998 111.275 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.65 -38.11 67.61 Favored Glycine 0 C--O 1.243 0.686 0 N-CA-C 111.117 -0.793 . . . . 40.340000000000003 111.117 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -67.37 -36.47 81.41 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.363 0.665 . . . . 73.319999999999993 109.652 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.8 96.17 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 110.027 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -67.26 -36.29 81.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.316 -0.402 . . . . 74.140000000000001 110.67 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -43.97 96.74 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.638 -0.875 . . . . 75.549999999999997 108.638 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD22 HD23 ' A' ' 40' ' ' LEU . 53.7 tp -67.62 -36.66 81.25 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.462 -0.79 . . . . 73.25 110.818 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.593 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.36 -38.15 85.9 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.401 0.619 . . . . 72.340000000000003 109.6 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 33.1 t70 -66.21 -42.41 88.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.464 -0.789 . . . . 65.150000000000006 109.329 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.575 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.8 m-85 -54.82 -47.92 73.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.858 -0.61 . . . . 74.400000000000006 111.936 174.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.0 pt -68.49 -33.74 61.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 119.925 -0.71 . . . . 74.450000000000003 111.19 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -61.04 -41.98 97.62 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.295 0.372 . . . . 71.430000000000007 110.275 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 21.7 mm-40 -57.37 -44.15 84.15 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.309 0.644 . . . . 74.340000000000003 111.005 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -79.81 -13.93 59.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.493 -0.776 . . . . 71.010000000000005 110.237 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 90.83 9.6 63.95 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.852 -0.613 . . . . 63.549999999999997 113.543 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -86.83 152.29 22.61 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.993 -0.71 . . . . 73.310000000000002 110.412 -175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 55' ' ' ARG . 7.6 pt20 -122.83 168.62 12.03 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.571 -0.529 . . . . 73.439999999999998 109.571 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 6.0 t -146.78 154.81 41.81 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.355 -0.609 . . . . 71.120000000000005 109.355 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -97.31 120.82 38.36 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.456 -1.313 . . . . 75.040000000000006 107.456 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.87 -163.98 12.59 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 120.264 -0.969 . . . . 72.140000000000001 110.933 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.47 143.65 40.46 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.605 0.24 . . . . 62.299999999999997 110.57 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 90' ' ' ALA . 9.6 p -80.94 123.49 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.822 -0.627 . . . . 63.43 109.799 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.5 129.21 72.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.751 -0.659 . . . . 72.109999999999999 109.939 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' SER . 96.2 t -115.36 119.38 61.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 107.093 -1.447 . . . . 62.100000000000001 107.093 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -110.47 127.12 54.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.228 -0.442 . . . . 75.019999999999996 110.062 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -99.64 119.73 38.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.21 -0.663 . . . . 74.409999999999997 109.21 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.99 166.7 11.87 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 115.146 -0.933 . . . . 75.019999999999996 109.767 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -123.67 156.11 36.52 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.99 -1.115 . . . . 75.409999999999997 107.99 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -144.67 140.13 28.44 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 109.189 -0.671 . . . . 65.230000000000004 109.189 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.6 m -81.02 -20.36 41.92 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.673 -0.862 . . . . 53.530000000000001 108.673 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -72.01 -40.23 68.63 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.066 -0.97 . . . . 63.240000000000002 108.679 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.92 130.47 34.64 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.222 -0.899 . . . . 62.439999999999998 110.178 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -95.77 172.76 7.83 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.278 -0.874 . . . . 72.400000000000006 109.284 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.431 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 12.7 t -56.67 138.1 53.1 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.772 0.796 . . . . 74.420000000000002 111.278 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.76 -30.2 9.74 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 115.065 -0.971 . . . . 74.25 111.655 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -84.92 144.0 28.64 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.227 0.537 . . . . 75.040000000000006 111.47 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HB3' HD13 ' A' ' 66' ' ' LEU . 20.0 p90 -156.75 151.93 26.36 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.91 -1.515 . . . . 73.319999999999993 106.91 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.7 ttp180 -143.72 151.48 40.08 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.183 -1.414 . . . . 72.519999999999996 107.183 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.8 140.12 23.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.089 -0.337 . . . . 75.230000000000004 110.089 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -133.25 137.98 46.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.297 -1.001 . . . . 70.409999999999997 108.297 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.16 117.65 3.97 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.727 -1.349 . . . . 51.219999999999999 109.727 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.7 p -116.49 154.4 30.44 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-O 121.195 0.521 . . . . 73.319999999999993 110.906 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 67.7 t -89.92 103.95 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 N-CA-C 108.102 -1.073 . . . . 53.140000000000001 108.102 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -101.85 95.69 5.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 106.397 -1.705 . . . . 65.450000000000003 106.397 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 71.6 Cg_endo -84.53 -14.46 6.68 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.709 1.606 . . . . 61.109999999999999 112.429 -176.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -95.42 66.42 2.83 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.147 0.975 . . . . 71.200000000000003 109.869 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.4 114.58 47.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 114.221 -1.354 . . . . 71.200000000000003 108.006 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -78.12 146.54 35.09 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.633 -0.712 . . . . 74.0 110.203 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -137.23 165.69 25.53 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 108.809 -0.811 . . . . 74.400000000000006 108.809 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 N--CA 1.42 -1.934 0 N-CA-C 106.468 -1.679 . . . . 42.140000000000001 106.468 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 C--O 1.24 0.571 0 N-CA-C 108.718 -0.845 . . . . 74.040000000000006 108.718 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.5 40.71 0.33 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.508 -1.037 . . . . 52.039999999999999 110.508 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -79.22 95.47 5.64 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.672 -0.862 . . . . 74.349999999999994 108.672 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -150.82 160.98 43.52 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.451 -0.944 . . . . 65.209999999999994 108.451 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 122.22 13.52 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.365 -0.606 . . . . 74.140000000000001 109.365 176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -93.25 118.47 31.3 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.892 -0.781 . . . . 74.239999999999995 108.892 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.09 102.71 8.32 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.542 -0.754 . . . . 64.140000000000001 111.322 -173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.67 110.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.122 -1.436 . . . . 63.350000000000001 107.122 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -77.53 91.68 3.97 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 121.711 0.767 . . . . 71.040000000000006 111.611 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.65 150.85 29.27 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.917 -1.038 . . . . 73.140000000000001 108.262 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 14' ' ' LYS . 16.1 m -119.79 131.26 72.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.192 -0.603 . . . . 74.409999999999997 110.115 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -71.88 -28.49 63.55 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.489 0.661 . . . . 71.120000000000005 109.288 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -94.12 64.87 3.34 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.624 -0.88 . . . . 71.519999999999996 108.624 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HB3' HG23 ' A' ' 11' ' ' VAL . 50.0 pttt -93.36 85.17 4.9 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.909 0.862 . . . . 65.430000000000007 109.167 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -94.48 84.03 4.25 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.246 -0.888 . . . . 71.340000000000003 111.273 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -178.57 94.69 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.851 -1.537 . . . . 74.409999999999997 106.851 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 32' ' ' VAL . 17.1 mp0 -112.82 132.47 55.26 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.135 -0.939 . . . . 75.200000000000003 110.148 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 p -74.14 94.59 2.45 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.921 -0.77 . . . . 51.439999999999998 108.921 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.43 ' HA ' HD11 ' A' ' 31' ' ' ILE . 5.0 p -81.38 94.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.839 0.828 . . . . 62.020000000000003 112.001 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.46 73.16 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.089 -0.96 . . . . 62.409999999999997 112.28 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.21 129.22 12.61 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.42 -0.956 . . . . 45.219999999999999 108.42 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -61.45 -41.08 96.67 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.941 0.719 . . . . 74.140000000000001 112.941 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -80.51 -31.26 37.17 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 116.069 -0.514 . . . . 75.430000000000007 110.486 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 31' ' ' ILE . . . -60.9 -39.06 87.88 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.537 0.684 . . . . 72.439999999999998 109.254 172.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -69.59 -24.14 63.63 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.476 -0.784 . . . . 65.109999999999999 111.404 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 22' ' ' ALA . 47.3 mm -70.01 -34.84 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 109.513 -0.551 . . . . 65.239999999999995 109.513 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -79.2 -29.91 43.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.836 0.35 . . . . 73.129999999999995 111.35 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.35 -90.14 0.65 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 116.087 -0.506 . . . . 70.519999999999996 112.711 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.53 -13.89 39.74 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.616 -0.802 . . . . 71.230000000000004 112.708 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -79.45 97.65 6.48 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 107.006 -1.479 . . . . 73.310000000000002 107.006 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.625 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 19.6 tt -128.54 20.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.088 0.947 . . . . 61.420000000000002 112.055 -169.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' CG2' ' HG3' ' A' ' 17' ' ' GLN . 20.3 t -113.81 88.96 14.95 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.16 -1.052 . . . . 74.219999999999999 108.16 172.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 31' ' ' ILE . 16.4 Cg_exo -73.0 -20.03 22.4 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.361 2.041 . . . . 73.450000000000003 112.266 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -73.04 -8.09 54.17 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 112.888 0.699 . . . . 74.340000000000003 112.888 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -66.79 -33.98 76.81 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.918 -0.771 . . . . 72.409999999999997 108.918 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.59 -54.15 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.142 -0.936 . . . . 73.349999999999994 109.964 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -63.86 -29.54 70.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.815 0.34 . . . . 74.409999999999997 111.348 -178.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' ARG . . . -60.88 -47.99 83.84 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.107 -0.701 . . . . 72.430000000000007 109.107 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 26.7 tp -66.11 -39.55 90.04 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.393 -0.821 . . . . 64.530000000000001 110.419 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.24 -51.11 67.66 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.137 0.273 . . . . 72.530000000000001 111.687 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.1 ptt180 -70.06 -22.91 63.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.076 0.769 . . . . 72.239999999999995 113.076 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 83.9 mtt180 -70.98 -45.37 64.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.827 -0.435 . . . . 65.430000000000007 109.827 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' ALA . 20.2 mm-40 -68.94 -32.61 72.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.047 -0.524 . . . . 75.409999999999997 110.318 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.05 95.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.451 -0.574 . . . . 62.149999999999999 109.451 175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.78 -26.43 66.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.885 -0.598 . . . . 73.120000000000005 111.359 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -78.51 -34.19 47.51 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.316 0.579 . . . . 73.030000000000001 111.172 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.4 9.58 72.67 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.919 -0.658 . . . . 60.119999999999997 112.664 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.8 129.51 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 121.05 0.453 . . . . 74.140000000000001 110.732 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -122.1 141.93 50.9 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.952 -1.022 . . . . 74.239999999999995 110.56 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -75.52 113.44 12.95 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.839 -1.073 . . . . 74.400000000000006 110.782 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.9 tp -116.24 -164.4 0.96 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.428 -2.064 . . . . 51.020000000000003 105.428 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.576 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 42.3 mt-30 -48.3 154.89 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.912 0.485 . . . . 72.329999999999998 111.045 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.05 8.97 4.27 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 116.114 -0.494 . . . . 63.439999999999998 114.157 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -78.16 -47.59 17.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.324 -1.361 . . . . 73.219999999999999 107.324 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -173.61 166.08 4.57 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 112.868 0.692 . . . . 72.150000000000006 112.868 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.0 mt -91.13 151.78 20.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.047 -0.979 . . . . 72.310000000000002 112.298 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -94.47 129.76 41.12 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.824 -1.176 . . . . 60.009999999999998 107.824 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 158.72 39.14 Favored Pre-proline 0 C--N 1.308 -1.209 0 C-N-CA 123.206 0.602 . . . . 63.310000000000002 109.785 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.73 159.5 41.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.593 2.195 . . . . 73.140000000000001 112.536 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.15 -20.61 4.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.765 -0.652 . . . . 63.109999999999999 110.906 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.52 111.09 23.5 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.714 -1.217 . . . . 64.329999999999998 107.714 -174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB2' HG22 ' A' ' 106' ' ' VAL . 91.8 m-85 -124.95 131.03 53.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.246 0.546 . . . . 74.209999999999994 111.669 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' NH2' ' A' ' 122' ' ' ARG . 52.6 mt -127.6 124.41 63.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.513 -0.767 . . . . 62.329999999999998 109.278 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.27 120.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.022 -1.473 . . . . 72.200000000000003 107.022 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 m -108.81 125.96 52.53 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 115.754 -0.657 . . . . 54.140000000000001 109.719 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.67 -176.78 2.98 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 124.662 1.185 . . . . 72.230000000000004 109.135 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.42 172.15 44.61 Favored Glycine 0 N--CA 1.429 -1.831 0 N-CA-C 110.283 -1.127 . . . . 64.319999999999993 110.283 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 70.2 t -59.23 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.66 0.384 . . . . 70.310000000000002 111.362 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 55.9 t-80 -60.65 -40.94 93.86 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.544 0.688 . . . . 73.340000000000003 110.422 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -67.96 -40.34 83.2 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.452 -1.249 . . . . 74.420000000000002 110.454 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.444 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 88.8 t80 -66.81 -31.74 72.56 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.19 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.6 mm-40 -66.49 -26.2 67.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.993 -0.549 . . . . 72.209999999999994 111.178 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER -77.98 -36.12 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.74 -0.837 . . . . 72.319999999999993 108.74 173.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.95 -18.92 65.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.259 -0.882 . . . . 75.400000000000006 110.364 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.45 -5.72 12.88 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.831 -0.622 . . . . 31.309999999999999 113.394 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 -36.77 70.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.701 -0.481 . . . . 75.540000000000006 109.701 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 81' ' ' LYS . 18.4 t70 -155.71 83.74 3.54 Favored Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 108.568 -0.901 . . . . 71.310000000000002 108.568 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.65 -51.51 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.995 1.797 . . . . 60.240000000000002 114.417 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -38.93 20.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.273 1.582 . . . . 70.510000000000005 115.273 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 2.2 tm? -66.2 -52.04 51.82 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.815 -0.439 . . . . 62.219999999999999 109.815 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 30.0 mtpp -58.67 -31.29 68.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.098 0.777 . . . . 63.219999999999999 113.098 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -62.21 -45.09 94.92 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.204 0.526 . . . . 33.25 110.186 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.5 m -72.75 -33.72 66.55 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.098 -0.501 . . . . 61.25 110.332 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.57 -47.05 92.18 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 111.19 -0.764 . . . . 71.299999999999997 111.19 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -69.67 -36.09 75.71 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 111.674 0.25 . . . . 73.239999999999995 111.674 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.39 -46.44 90.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.681 0.277 . . . . 53.420000000000002 110.897 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -66.29 -41.24 90.07 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.342 -0.614 . . . . 73.140000000000001 109.342 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.16 -43.94 81.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.868 -0.605 . . . . 72.430000000000007 110.548 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.48 -36.83 76.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.172 -0.467 . . . . 45.5 110.935 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.32 89.21 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.049 -0.723 . . . . 62.450000000000003 109.049 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -41.92 85.49 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.188 -0.914 . . . . 75.010000000000005 109.788 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.573 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 17.4 m-85 -57.91 -50.3 73.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.44 0.533 . . . . 74.140000000000001 112.44 174.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.9 -31.33 53.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.049 -0.66 . . . . 73.200000000000003 110.965 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -34.59 76.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.420000000000002 111.205 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.56 -43.34 99.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.138 0.971 . . . . 74.109999999999999 109.436 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 63.5 mm-40 -73.81 -12.53 60.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.377 -1.283 . . . . 71.209999999999994 110.899 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.12 30.56 46.08 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.009 -0.541 . . . . 54.450000000000003 112.467 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -97.36 172.1 7.99 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 122.521 -0.399 . . . . 74.310000000000002 110.0 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HD23 ' A' ' 51' ' ' LEU . 27.9 pt20 -138.98 169.43 17.81 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.715 -0.476 . . . . 62.25 109.715 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -159.51 179.3 9.03 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.205 -0.665 . . . . 64.239999999999995 109.205 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.12 120.26 37.79 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.482 -0.562 . . . . 72.409999999999997 109.482 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.37 -149.75 16.71 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.955 -1.117 . . . . 73.019999999999996 110.961 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.3 146.03 45.62 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.222 -1.399 . . . . 64.010000000000005 107.222 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.99 109.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.388 -0.597 . . . . 73.230000000000004 109.388 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.0 m -106.15 122.2 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.578 0.704 . . . . 74.430000000000007 110.364 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' TYR . 78.4 t -118.93 123.51 71.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 74.129999999999995 109.106 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -117.33 147.03 42.97 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.191 -0.67 . . . . 74.209999999999994 109.191 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.36 123.61 45.72 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.25 -1.389 . . . . 74.030000000000001 107.25 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -137.96 176.16 8.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.674 0.273 . . . . 64.340000000000003 110.966 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 25.7 pt20 -113.03 164.72 13.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.918 -0.583 . . . . 64.510000000000005 111.219 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.3 p -151.01 148.81 28.81 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 107.513 -1.292 . . . . 52.420000000000002 107.513 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -81.02 -24.89 37.61 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.257 0.551 . . . . 61.32 109.939 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.66 -21.92 59.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 115.991 -0.549 . . . . 75.450000000000003 112.479 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.36 131.73 41.15 Favored 'General case' 0 N--CA 1.427 -1.625 0 C-N-CA 120.097 -0.641 . . . . 75.530000000000001 109.589 176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -114.04 156.42 24.15 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.537 -0.912 . . . . 71.150000000000006 108.537 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.1 m -51.83 110.68 0.5 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.065 0.853 . . . . 73.099999999999994 111.541 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 134.56 -33.96 2.42 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 109.125 -1.59 . . . . 71.209999999999994 109.125 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.17 144.98 31.21 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.783 -0.708 . . . . 74.109999999999999 109.282 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -157.87 160.3 37.54 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.982 -1.488 . . . . 74.530000000000001 106.982 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -145.43 147.65 32.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.238 -0.653 . . . . 70.519999999999996 109.238 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 43' ' ' GLU . . . -122.79 132.74 54.35 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 104.651 -2.352 . . . . 52.109999999999999 104.651 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.445 ' C ' ' HD2' ' A' ' 122' ' ' ARG . 4.9 tmm_? -136.5 135.55 38.65 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.31 -1.367 . . . . 43.140000000000001 107.31 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.42 155.48 17.53 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.298 -1.121 . . . . 73.400000000000006 110.298 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.7 t -149.77 161.47 42.17 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.916 -0.772 . . . . 73.200000000000003 108.916 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.9 110.57 20.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.955 -1.498 . . . . 52.509999999999998 106.955 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.441 ' ND2' ' HB ' ' A' ' 129' ' ' VAL . 44.8 t30 -125.67 93.56 44.21 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 116.603 -0.271 . . . . 74.420000000000002 110.709 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -89.87 -6.23 4.94 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.31 2.007 . . . . 71.230000000000004 110.376 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -90.96 27.58 1.79 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 124.228 1.011 . . . . 74.140000000000001 109.494 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.441 ' HB ' ' ND2' ' A' ' 126' ' ' ASN . 8.2 p -99.73 126.79 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.577 0 N-CA-C 107.95 -1.13 . . . . 72.049999999999997 107.95 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -69.26 161.35 29.44 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 53.43 111.649 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.7 t -149.86 164.12 36.21 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.258 -1.386 . . . . 71.239999999999995 107.258 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 117.946 -1.026 . . . . 63.310000000000002 108.802 176.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.564 -0.532 . . . . 71.230000000000004 109.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.51 12.22 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 108.318 -1.913 . . . . 75.150000000000006 108.318 -174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -91.38 15.84 11.36 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.449 -0.876 . . . . 63.229999999999997 113.273 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -83.06 71.82 10.12 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.015 0.912 . . . . 71.019999999999996 110.346 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -117.3 97.87 6.13 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-N 114.512 -1.222 . . . . 70.030000000000001 107.849 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -84.87 80.67 9.2 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.04 0.924 . . . . 64.200000000000003 110.084 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.5 tp -150.56 92.13 1.82 Allowed 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.666 -1.606 . . . . 73.099999999999994 109.267 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.13 144.29 19.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.229 -1.397 . . . . 75.409999999999997 107.229 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -78.71 70.66 5.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.445 0.64 . . . . 64.120000000000005 112.4 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -99.52 83.89 2.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 122.21 1.005 . . . . 64.140000000000001 109.616 175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.86 149.25 27.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 106.907 -1.516 . . . . 75.120000000000005 106.907 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -117.7 147.32 43.04 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.801 -0.76 . . . . 62.549999999999997 111.429 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -145.57 126.86 14.85 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 105.74 -1.948 . . . . 63.020000000000003 105.74 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -84.34 122.46 28.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 106.533 -1.654 . . . . 63.399999999999999 106.533 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.79 65.95 7.15 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.164 0.983 . . . . 55.409999999999997 110.616 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -85.08 82.55 8.38 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 107.463 -1.31 . . . . 54.030000000000001 107.463 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 12.2 mm-40 -94.1 105.87 17.85 Favored 'General case' 0 N--CA 1.413 -2.276 0 CA-C-N 114.961 -1.018 . . . . 73.319999999999993 108.77 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -149.78 144.02 25.76 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 115.209 -0.905 . . . . 64.519999999999996 111.235 -174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.56 9.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.552 -1.204 . . . . 65.219999999999999 108.306 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.18 -70.67 0.21 Allowed Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 110.704 -0.958 . . . . 72.450000000000003 110.704 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 5.2 p-10 -83.12 9.27 10.81 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 122.468 -0.43 . . . . 72.540000000000006 111.738 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.55 97.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.831 0.452 . . . . 64.439999999999998 111.893 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' HA ' HG12 ' A' ' 26' ' ' ILE . 81.2 m-85 -68.75 -32.09 71.62 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.479 -0.782 . . . . 74.019999999999996 111.024 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.17 -32.36 71.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.4 0.619 . . . . 75.409999999999997 109.741 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 28.1 mmt180 -71.65 -34.52 69.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.892 -0.595 . . . . 70.409999999999997 110.255 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 23' ' ' PHE . 45.3 pt -87.99 -47.77 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 65.430000000000007 113.656 -176.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -30.19 29.82 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.188 -0.605 . . . . 73.319999999999993 111.405 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.94 -49.96 0.91 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.022 -1.085 . . . . 34.219999999999999 111.502 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.32 -34.03 0.03 OUTLIER Glycine 0 C--N 1.31 -0.864 0 C-N-CA 119.912 -1.137 . . . . 74.109999999999999 114.022 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 144.95 34.49 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.771 0.656 . . . . 64.109999999999999 112.771 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HA ' ' HB2' ' A' ' 23' ' ' PHE . 35.7 pt -95.81 -11.48 8.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 121.881 0.848 . . . . 54.420000000000002 110.375 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 m -117.54 170.01 6.74 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 106.827 -1.545 . . . . 73.319999999999993 106.827 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 16.7 Cg_exo -70.56 30.55 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.355 0 C-N-CA 122.879 2.386 . . . . 65.310000000000002 114.531 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.47 -48.73 79.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.323 0.649 . . . . 74.310000000000002 111.491 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -25.61 66.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.165 0.507 . . . . 73.409999999999997 110.835 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.15 -44.69 49.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.292 -1.003 . . . . 54.240000000000002 108.292 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 45.7 mt-10 -61.59 -34.73 76.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.189 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 42' ' ' ARG . . . -61.61 -57.74 10.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.228 -0.896 . . . . 62.119999999999997 109.638 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.4 tm? -56.94 -44.52 82.6 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.471 -0.566 . . . . 73.409999999999997 109.471 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 HD22 ' A' ' 89' ' ' LEU . 92.5 mt -58.43 -52.51 65.32 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.488 0.551 . . . . 72.349999999999994 112.488 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 17.9 ptp180 -65.29 -30.22 71.06 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.929 0.395 . . . . 71.109999999999999 110.678 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 35.8 mmt180 -76.38 -37.66 56.86 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.067 -0.515 . . . . 71.409999999999997 110.713 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 122' ' ' ARG . 21.6 tt0 -78.15 -27.48 48.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.827 -0.749 . . . . 71.230000000000004 110.416 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.14 91.87 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.148 -0.686 . . . . 65.430000000000007 109.148 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.38 -32.81 68.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.435 0.636 . . . . 64.420000000000002 110.957 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.67 -42.2 78.22 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.782 -0.644 . . . . 72.329999999999998 111.211 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.95 9.55 59.89 Favored Glycine 0 C--N 1.319 -0.414 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 113.157 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 14.1 mm -62.1 130.64 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 121.447 0.641 . . . . 74.140000000000001 111.588 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.7 mt-30 -110.54 134.95 51.91 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 115.517 -0.765 . . . . 71.329999999999998 110.087 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -78.65 91.68 4.66 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.639 -1.164 . . . . 64.329999999999998 108.195 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 24.3 tp -104.4 -165.77 1.18 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.205 -1.405 . . . . 74.420000000000002 107.205 -176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.602 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 54.1 mt-30 -45.15 145.55 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.227 0.611 . . . . 72.099999999999994 110.647 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.35 15.83 1.9 Allowed Glycine 0 C--O 1.218 -0.904 0 CA-C-N 116.003 -0.544 . . . . 73.219999999999999 113.26 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 52' ' ' GLN . 2.4 m-20 -70.17 -44.95 67.71 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 106.654 -1.61 . . . . 74.409999999999997 106.654 175.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 177.35 166.09 0.6 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-N 113.82 -1.536 . . . . 64.430000000000007 109.045 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -90.64 151.09 21.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 110.914 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 36.6 tp -93.62 131.58 38.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.492 -0.776 . . . . 74.409999999999997 108.985 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.49 162.54 33.7 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.128 -0.693 . . . . 75.439999999999998 109.128 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.526 ' HA ' HG22 ' A' ' 125' ' ' VAL . 30.4 Cg_exo -66.16 159.33 50.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.752 2.302 . . . . 73.030000000000001 112.602 176.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 4.8 p-10 -130.23 -19.52 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.328 -0.397 . . . . 71.400000000000006 111.145 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -102.08 112.46 25.13 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.548 -0.908 . . . . 63.030000000000001 108.548 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 75.8 m-85 -118.54 114.24 22.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.067 0.937 . . . . 64.109999999999999 110.865 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.9 mt -104.93 104.21 16.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.322 -1.308 . . . . 71.409999999999997 108.56 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.553 HD13 HG13 ' A' ' 106' ' ' VAL . 3.0 mp -96.49 128.53 47.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.9 -0.778 . . . . 63.310000000000002 108.9 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.3 m -121.1 129.02 53.12 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.74 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.5 mm? -120.81 174.87 6.33 Favored 'General case' 0 C--O 1.255 1.382 0 O-C-N 124.738 1.273 . . . . 71.239999999999995 109.326 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.7 -174.0 41.32 Favored Glycine 0 N--CA 1.42 -2.395 0 N-CA-C 110.265 -1.134 . . . . 31.449999999999999 110.265 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.469 ' HA ' ' NE2' ' A' ' 110' ' ' GLN . 7.6 p -74.68 -51.19 23.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 114.523 1.305 . . . . 63.130000000000003 114.523 -175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -67.4 -42.07 83.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.547 0.689 . . . . 71.439999999999998 110.358 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -72.37 -32.27 66.31 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.851 -1.068 . . . . 74.109999999999999 112.759 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.576 ' HB3' HE21 ' A' ' 110' ' ' GLN . 58.7 t80 -66.26 -31.84 72.9 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 119.86 -0.736 . . . . 70.120000000000005 109.302 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.96 -23.15 67.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.387 0.514 . . . . 74.219999999999999 112.387 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -83.21 -28.65 29.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.8 0.333 . . . . 74.239999999999995 110.198 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.497 HD11 ' HG ' ' A' ' 66' ' ' LEU . 57.8 mt -70.54 -37.94 74.13 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 109.011 -0.737 . . . . 72.530000000000001 109.011 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.29 150.14 8.64 Favored Glycine 0 N--CA 1.411 -2.994 0 CA-C-N 114.816 -1.084 . . . . 75.319999999999993 111.231 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -78.23 1.49 21.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.173 0.511 . . . . 73.430000000000007 110.992 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.14 92.07 4.29 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 121.934 0.874 . . . . 74.219999999999999 109.688 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.8 Cg_exo -75.51 -30.31 6.59 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.418 1.412 . . . . 62.530000000000001 110.03 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -45.65 -53.43 9.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.699 2.0 . . . . 72.129999999999995 113.078 -173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.69 -48.34 72.37 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.612 -0.722 . . . . 53.549999999999997 110.245 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -74.58 -38.61 62.62 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.85 1.056 . . . . 75.409999999999997 113.85 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 p -62.87 -51.69 66.02 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.71 0.633 . . . . 74.040000000000006 112.71 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -65.49 -43.13 91.13 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-N 116.244 -0.434 . . . . 73.329999999999998 111.365 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.27 -47.34 52.78 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 121.049 -0.596 . . . . 73.099999999999994 112.239 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -70.65 -23.66 62.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.832 0.349 . . . . 73.25 110.095 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.48 -45.93 81.73 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.024 0.44 . . . . 74.219999999999999 109.86 175.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.27 -36.72 74.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 109.853 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -62.33 -40.81 97.59 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.275 -0.875 . . . . 73.310000000000002 110.629 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 40' ' ' LEU . 54.7 tp -72.13 -31.88 66.41 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.06 177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.0 85.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.719 0.771 . . . . 63.229999999999997 109.299 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.89 -39.87 91.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.671 -1.15 . . . . 64.129999999999995 109.702 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 12.2 m-85 -57.82 -52.25 66.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.015 -0.539 . . . . 75.140000000000001 112.201 175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 pt -66.9 -33.42 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.221 -0.591 . . . . 73.439999999999998 111.327 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -68.94 -31.09 69.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.57 . . . . 62.32 110.781 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -68.53 -30.32 69.09 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.244 0.545 . . . . 72.329999999999998 111.386 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 54.8 mm-40 -86.74 -10.62 53.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.399 0.618 . . . . 65.200000000000003 109.741 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.57 21.37 58.26 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.709 -0.678 . . . . 73.140000000000001 113.362 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.419 ' CD2' HD11 ' A' ' 48' ' ' ILE . 24.6 m0 -93.67 150.82 20.1 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.085 0.469 . . . . 70.209999999999994 111.488 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -112.47 168.49 9.6 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.541 -0.754 . . . . 73.549999999999997 110.215 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.7 t -162.72 160.61 25.66 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.704 -0.85 . . . . 65.439999999999998 108.704 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -93.52 119.03 32.09 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.457 -1.312 . . . . 74.329999999999998 107.457 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.84 -150.35 16.75 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.78 -1.328 . . . . 61.140000000000001 109.78 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.75 153.82 47.82 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.517 -0.549 . . . . 71.209999999999994 109.517 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.68 123.27 32.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 123.637 0.586 . . . . 63.439999999999998 110.731 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.56 130.48 71.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 115.259 -0.882 . . . . 63.409999999999997 109.128 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 64' ' ' ILE . 54.9 t -123.97 117.17 50.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.07 -1.085 . . . . 54.109999999999999 108.07 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -120.97 148.49 44.02 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.811 -0.756 . . . . 71.239999999999995 109.887 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.75 129.24 56.18 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.381 -1.34 . . . . 73.230000000000004 107.381 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.61 158.97 43.24 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.039 0.447 . . . . 64.400000000000006 110.296 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.576 HE21 ' HB3' ' A' ' 71' ' ' PHE . 35.9 tt0 -102.15 143.31 32.12 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.311 -0.859 . . . . 73.439999999999998 109.092 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.3 m -141.66 133.25 26.95 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 109.572 -0.529 . . . . 41.439999999999998 109.572 174.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.7 m -69.21 -20.43 63.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.142 0.496 . . . . 74.420000000000002 110.559 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -76.6 3.19 12.0 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.481 1.112 . . . . 71.019999999999996 111.408 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD13 ' N ' ' A' ' 115' ' ' HIS . 2.0 tm? -132.83 149.4 52.27 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.383 -2.08 . . . . 75.219999999999999 105.383 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.494 ' N ' HD13 ' A' ' 114' ' ' LEU . 36.7 t-80 -148.2 159.97 43.41 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.566 -0.531 . . . . 71.010000000000005 109.566 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 m -43.97 125.24 4.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.673 1.989 . . . . 71.310000000000002 111.926 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.61 -34.76 4.51 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 108.672 -1.771 . . . . 31.32 108.672 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.94 156.82 18.31 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.177 -1.045 . . . . 71.349999999999994 108.177 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -169.48 151.72 4.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.321 -2.103 . . . . 75.239999999999995 105.321 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -157.11 151.07 24.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.276 -0.969 . . . . 75.510000000000005 109.982 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -118.9 139.29 51.89 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.597 -1.261 . . . . 43.140000000000001 107.597 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 2.4 tpm_? -111.87 117.79 33.74 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.384 -0.969 . . . . 74.140000000000001 108.384 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.57 109.18 3.04 Favored Glycine 0 C--N 1.291 -1.934 0 O-C-N 123.871 0.732 . . . . 75.0 111.629 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 p -123.64 162.0 23.92 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.33 0.652 . . . . 72.209999999999994 111.138 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.1 t -101.4 131.47 49.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 105.069 -2.197 . . . . 73.209999999999994 105.069 173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -112.98 130.8 23.19 Favored Pre-proline 0 C--N 1.295 -1.785 0 C-N-CA 118.542 -1.263 . . . . 74.519999999999996 111.375 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.24 -4.79 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.219 1.946 . . . . 74.230000000000004 110.402 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -97.96 64.77 1.73 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.538 0.685 . . . . 55.329999999999998 111.7 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.79 104.89 17.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 114.824 -1.08 . . . . 63.140000000000001 108.319 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.65 156.1 27.77 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.372 0.606 . . . . 74.010000000000005 111.864 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.2 t -129.32 108.75 10.55 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.227 1.013 . . . . 72.239999999999995 109.258 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.2 m80 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.848 -1.168 . . . . 73.109999999999999 107.848 -179.613 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 121.135 0.493 . . . . 75.099999999999994 110.368 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.9 152.13 52.02 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.819 -0.913 . . . . 64.209999999999994 110.819 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 p -88.5 120.12 29.58 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.147 -0.686 . . . . 72.5 109.147 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.3 109.05 2.96 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.202 -1.036 . . . . 54.130000000000003 108.202 175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -78.02 78.62 4.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.417 -0.957 . . . . 73.340000000000003 108.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.19 94.96 1.61 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 122.26 1.029 . . . . 74.099999999999994 111.095 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -116.38 80.96 1.54 Allowed 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 106.117 -1.808 . . . . 63.549999999999997 106.117 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.4 t -111.32 95.83 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.999 0 CA-C-N 114.384 -1.28 . . . . 64.140000000000001 107.612 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -88.12 110.44 20.67 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.159 -0.928 . . . . 51.420000000000002 110.449 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -118.83 78.93 1.32 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.07 -1.085 . . . . 74.030000000000001 108.07 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.88 87.71 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.78 -1.563 . . . . 75.310000000000002 106.78 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.48 141.95 36.28 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.258 -1.015 . . . . 53.509999999999998 108.258 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -84.97 92.88 8.43 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.768 -0.827 . . . . 73.540000000000006 108.768 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.54 108.0 8.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.679 0.752 . . . . 74.200000000000003 109.865 -179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.1 mt -117.09 77.34 1.11 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.252 -1.018 . . . . 63.25 108.252 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.04 100.68 12.33 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.363 -0.835 . . . . 70.420000000000002 110.421 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -100.27 6.55 44.67 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.135 -0.939 . . . . 63.549999999999997 110.157 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -64.71 125.4 24.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 107.335 -1.357 . . . . 70.409999999999997 107.335 172.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 p -154.38 133.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.335 0.588 . . . . 53.119999999999997 111.512 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 68.94 2.6 Favored Glycine 0 N--CA 1.431 -1.672 0 CA-C-N 115.723 -0.672 . . . . 43.229999999999997 112.537 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -61.96 -23.78 66.6 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 111.68 0.252 . . . . 64.510000000000005 111.68 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.39 73.24 Favored 'General case' 0 C--O 1.213 -0.826 0 O-C-N 123.573 0.545 . . . . 62.100000000000001 110.093 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -60.11 -39.89 87.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.001 -0.545 . . . . 74.420000000000002 110.62 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.67 -38.32 83.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.834 -0.621 . . . . 73.129999999999995 111.262 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -81.74 -20.36 39.48 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.88 -0.512 . . . . 72.439999999999998 112.098 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.6 -49.23 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.343 -0.223 . . . . 70.040000000000006 111.504 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 80.2 m-85 -101.76 -25.45 13.83 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.089 0.403 . . . . 73.450000000000003 112.089 -175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.39 -79.24 1.85 Allowed Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.494 -0.86 . . . . 60.329999999999998 111.493 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.41 65.29 0.27 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 111.673 -0.571 . . . . 50.549999999999997 111.673 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 27' ' ' PHE . 32.6 t -103.97 161.63 13.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.96 -0.755 . . . . 73.219999999999999 108.96 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.6 tt -66.0 138.44 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 109.013 -0.736 . . . . 71.049999999999997 109.013 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.2 113.91 15.99 Favored Pre-proline 0 C--O 1.243 0.76 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 110.205 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.36 -26.49 76.97 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.82 2.347 . . . . 73.219999999999999 111.872 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' CG ' ' A' ' 37' ' ' GLU . 20.9 mp0 -65.17 -28.3 69.31 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 113.188 0.811 . . . . 75.010000000000005 113.188 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -79.33 -31.23 43.07 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.177 -1.046 . . . . 71.450000000000003 108.177 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.53 -53.3 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.089 -0.959 . . . . 61.0 109.533 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.34 -29.9 71.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.599 -0.273 . . . . 71.129999999999995 111.376 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.49 95.65 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.151 -0.477 . . . . 72.329999999999998 110.276 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 39.6 tp -76.12 -37.36 58.17 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 120.705 -0.398 . . . . 63.119999999999997 110.461 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 62' ' ' TYR . 4.1 mm? -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 120.695 -0.402 . . . . 64.140000000000001 112.069 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -69.28 -27.56 65.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.362 -0.607 . . . . 72.030000000000001 109.362 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -70.22 -40.8 74.3 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.209 -0.663 . . . . 71.329999999999998 109.209 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -61.13 -43.39 98.96 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 123.446 0.466 . . . . 74.340000000000003 110.677 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -60.21 -47.22 86.89 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.613 -0.721 . . . . 54.539999999999999 110.381 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.88 -32.46 72.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 63.109999999999999 111.849 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -77.88 -32.15 51.74 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.446 0.641 . . . . 72.129999999999995 110.366 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.05 16.22 61.02 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.548 -0.751 . . . . 74.549999999999997 113.418 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.8 mm -63.04 131.95 28.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.14 0.576 . . . . 72.030000000000001 111.932 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.8 mt-30 -117.16 144.15 45.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.214 -0.903 . . . . 72.129999999999995 109.472 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.2 m -71.49 114.73 9.87 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.053 -0.976 . . . . 64.319999999999993 109.87 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 25.7 tp -122.7 -176.94 3.51 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.068 -1.456 . . . . 74.519999999999996 107.068 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.585 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 78.0 mt-30 -53.69 164.42 0.55 Allowed 'General case' 0 C--O 1.246 0.914 0 C-N-CA 124.601 1.16 . . . . 74.239999999999995 113.525 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.27 -9.46 23.23 Favored Glycine 0 CA--C 1.504 -0.643 0 CA-C-N 114.921 -1.036 . . . . 63.240000000000002 114.734 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -74.7 -43.9 52.76 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.043 -0.663 . . . . 64.430000000000007 111.518 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.4 ptp180 -175.82 167.09 3.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.3 0.482 . . . . 73.019999999999996 112.3 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.82 151.86 20.39 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.438 1.095 . . . . 71.510000000000005 111.403 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.4 tm? -90.73 131.44 36.4 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.07 -1.085 . . . . 62.340000000000003 108.07 -177.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -121.74 162.65 35.56 Favored Pre-proline 0 C--N 1.311 -1.107 0 C-N-CA 123.559 0.744 . . . . 52.420000000000002 110.005 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.642 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.6 Cg_exo -57.42 161.98 10.83 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.38 2.72 . . . . 72.120000000000005 113.958 176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -131.36 -32.71 1.53 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.464 -0.789 . . . . 72.340000000000003 111.719 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.56 106.73 18.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.278 -1.379 . . . . 73.219999999999999 107.278 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.46 ' HB2' HG12 ' A' ' 106' ' ' VAL . 96.7 m-85 -112.16 116.15 30.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.216 0.531 . . . . 75.329999999999998 110.463 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.7 mt -106.12 114.5 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.258 -0.883 . . . . 73.150000000000006 109.574 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.45 125.98 70.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.999 -0.741 . . . . 61.340000000000003 108.999 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -110.9 126.53 54.81 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.69 160.86 20.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.014 -0.736 . . . . 74.219999999999999 109.014 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.49 145.04 49.22 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 108.625 -1.79 . . . . 55.25 108.625 172.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.8 p -52.57 -37.97 25.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 113.01 0.744 . . . . 62.140000000000001 113.01 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -71.17 -22.67 62.01 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.475 0.655 . . . . 74.340000000000003 111.255 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 29.8 m-20 -85.87 -35.25 20.7 Favored 'General case' 0 CA--C 1.484 -1.581 0 O-C-N 121.552 -0.717 . . . . 73.519999999999996 110.279 175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -63.16 -24.86 68.08 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.087 -0.96 . . . . 74.340000000000003 109.444 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 38.2 mt-10 -58.29 -33.6 69.62 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 111.917 0.34 . . . . 65.430000000000007 111.917 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 70' ' ' ASP . 4.2 mppt? -81.08 -34.68 32.5 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 120.327 -0.549 . . . . 71.540000000000006 109.931 177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.4 mt -68.58 -35.36 77.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.52 0.676 . . . . 72.439999999999998 110.224 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 6.32 39.2 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.786 -1.097 . . . . 43.539999999999999 113.973 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.29 97.54 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.613 -1.254 . . . . 73.219999999999999 107.613 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 9.3 m-20 -148.25 82.74 7.49 Favored Pre-proline 0 CA--C 1.508 -0.656 0 N-CA-C 106.175 -1.787 . . . . 73.310000000000002 106.175 173.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.05 -47.64 23.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.511 2.14 . . . . 72.030000000000001 111.694 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.58 -46.66 71.98 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.198 -0.91 . . . . 74.519999999999996 111.046 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.36 -53.7 54.5 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.386 -0.598 . . . . 73.420000000000002 109.386 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 77' ' ' ASP . 14.1 mptt -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.864 -0.607 . . . . 74.030000000000001 111.778 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -67.37 -45.28 76.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.891 -0.324 . . . . 71.040000000000006 110.942 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.4 m -62.42 -44.33 96.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 122.239 0.216 . . . . 74.439999999999998 111.023 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.17 -46.6 90.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.017 -0.611 . . . . 72.200000000000003 112.059 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.71 -35.87 82.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 110.34 -0.244 . . . . 72.420000000000002 110.34 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -63.19 -46.62 86.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.628 0.251 . . . . 74.319999999999993 110.581 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.43 -44.61 90.65 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.129 -0.487 . . . . 65.530000000000001 111.003 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.4 -34.08 75.38 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.559 0.578 . . . . 72.409999999999997 112.559 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.6 tp -73.34 -35.16 65.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.997 0.427 . . . . 55.329999999999998 110.181 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.78 81.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.799 0.809 . . . . 73.5 109.678 176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -66.57 -38.88 88.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.906 -1.043 . . . . 65.540000000000006 109.022 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.5 m-85 -59.36 -49.09 79.15 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.41 -0.814 . . . . 63.329999999999998 111.918 175.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -66.38 -30.5 50.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 120.32 -0.552 . . . . 70.230000000000004 111.006 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -64.02 -43.3 96.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.433 -0.349 . . . . 63.420000000000002 110.537 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.86 -32.77 72.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.074 0.464 . . . . 71.200000000000003 112.072 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 64.8 mm-40 -81.45 -13.21 58.47 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.197 0.522 . . . . 55.299999999999997 111.452 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 84.55 34.42 16.43 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.764 -0.653 . . . . 50.310000000000002 111.669 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -110.71 173.98 6.08 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.88 -0.415 . . . . 64.430000000000007 109.88 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -155.84 174.0 15.96 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.328 -0.99 . . . . 44.109999999999999 108.328 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -147.33 176.4 10.03 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.681 -0.859 . . . . 53.420000000000002 108.681 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -99.06 120.14 38.98 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.277 -1.379 . . . . 72.329999999999998 107.277 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.9 -149.81 16.83 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.999 -1.64 . . . . 61.240000000000002 108.999 -178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -132.47 144.44 50.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.375 -1.343 . . . . 74.319999999999993 107.375 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.05 124.24 20.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.213 0.53 . . . . 74.230000000000004 112.008 -175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.93 120.51 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.408 -0.815 . . . . 64.329999999999998 110.045 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 62' ' ' TYR . 14.8 m -106.65 147.5 11.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.774 -1.195 . . . . 35.229999999999997 107.774 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -137.31 142.12 41.88 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.841 -0.8 . . . . 71.129999999999995 108.841 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -114.19 134.75 54.7 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.03 -0.532 . . . . 62.039999999999999 109.655 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.3 159.81 35.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.122 0.487 . . . . 71.230000000000004 110.001 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -107.56 155.1 20.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.51 -0.768 . . . . 72.510000000000005 109.828 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -138.99 140.12 38.1 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.695 -1.224 . . . . 74.400000000000006 107.695 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.0 m -82.08 -27.43 32.92 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.343 0.592 . . . . 71.109999999999999 110.067 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -80.57 -34.51 35.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.596 -0.729 . . . . 75.219999999999999 109.465 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 tp -77.45 133.37 38.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.168 -1.789 . . . . 73.109999999999999 106.168 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.4 ' CG ' ' H ' ' A' ' 116' ' ' THR . 12.5 t-80 -116.5 172.35 7.27 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.848 -1.541 . . . . 65.239999999999995 112.311 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.612 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 21.9 m -50.59 132.02 25.48 Favored 'General case' 0 C--O 1.256 1.427 0 C-N-CA 125.668 1.587 . . . . 73.319999999999993 113.387 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.62 -6.13 83.29 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.634 -1.166 . . . . 72.439999999999998 112.247 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.36 136.17 54.79 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.893 -1.151 . . . . 75.019999999999996 107.893 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.3 159.96 42.65 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.945 -0.391 . . . . 75.400000000000006 109.945 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.6 mmp_? -133.17 137.31 46.17 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.811 -0.811 . . . . 74.319999999999993 108.811 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.23 44.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.788 -0.819 . . . . 72.439999999999998 108.788 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -139.7 131.87 28.11 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.455 -0.572 . . . . 74.530000000000001 109.455 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.82 128.56 8.5 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.825 -0.91 . . . . 62.409999999999997 110.825 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.4 m -123.33 144.76 49.24 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 109.347 -0.612 . . . . 74.450000000000003 109.347 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 59' ' ' PRO . 89.8 t -93.92 105.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.003 -1.11 . . . . 74.120000000000005 108.003 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.62 110.35 48.68 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.873 -1.158 . . . . 73.409999999999997 107.873 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.77 -20.9 7.45 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.613 1.542 . . . . 73.200000000000003 111.608 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.97 72.42 2.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.473 1.13 . . . . 71.239999999999995 109.275 -176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 99.8 t -110.43 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 113.374 -1.739 . . . . 72.299999999999997 107.156 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.48 116.24 8.0 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.88 -1.896 . . . . 62.210000000000001 105.88 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 t -156.11 165.08 37.49 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.934 -0.765 . . . . 74.400000000000006 108.934 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 N--CA 1.422 -1.827 0 N-CA-C 107.046 -1.465 . . . . 64.540000000000006 107.046 179.866 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.561 -0.533 . . . . 74.219999999999999 109.561 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.74 -128.1 20.21 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.954 -0.641 . . . . 30.5 111.98 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -80.98 0.18 36.7 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.485 0.714 . . . . 74.329999999999998 112.139 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -74.24 75.16 1.82 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.239 0.542 . . . . 74.120000000000005 111.33 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -133.1 160.2 37.89 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.004 -1.11 . . . . 72.430000000000007 108.004 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.37 119.8 33.2 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.075 -0.713 . . . . 72.329999999999998 109.075 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 pp -69.89 138.14 52.23 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.93 -0.577 . . . . 64.310000000000002 110.789 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.39 71.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.843 0.83 . . . . 73.230000000000004 110.413 -174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -174.73 104.13 0.09 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.544 -1.207 . . . . 75.040000000000006 108.003 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -139.58 -159.74 0.99 Allowed 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.065 -1.087 . . . . 71.209999999999994 108.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.85 90.67 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 119.699 -0.8 . . . . 55.329999999999998 110.732 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -77.15 7.2 5.32 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.766 -0.584 . . . . 74.109999999999999 111.197 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.42 -13.48 62.06 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.714 0.635 . . . . 62.439999999999998 112.714 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -112.52 15.89 19.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.483 0.659 . . . . 75.329999999999998 109.918 174.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' HG2' ' A' ' 14' ' ' LYS . 8.7 mp -118.16 108.31 15.02 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.644 -0.707 . . . . 71.319999999999993 110.088 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.01 -5.37 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.617 0.723 . . . . 74.540000000000006 109.31 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -88.57 151.44 22.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.357 -1.292 . . . . 44.420000000000002 108.875 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 m -90.09 134.97 33.94 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.979 -0.748 . . . . 50.229999999999997 108.979 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.15 93.12 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 122.629 1.204 . . . . 73.120000000000005 109.197 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.07 54.02 4.51 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 114.714 -1.13 . . . . 75.239999999999995 113.164 -174.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.5 -42.87 93.16 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 123.135 0.574 . . . . 70.219999999999999 111.413 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -67.51 -52.74 35.5 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.106 -0.952 . . . . 64.519999999999996 109.494 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -54.73 -44.75 73.82 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.356 -0.838 . . . . 75.329999999999998 112.064 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.4 92.63 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 120.757 0.313 . . . . 65.420000000000002 111.019 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -77.17 -30.89 55.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.372 -0.376 . . . . 72.150000000000006 111.767 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.2 mt -65.82 -57.13 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.659 -0.497 . . . . 74.129999999999995 109.659 176.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CB ' ' HB ' ' A' ' 31' ' ' ILE . 35.7 m-85 -68.79 -29.0 67.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 64.25 111.82 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.65 -92.95 1.81 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 111.675 -0.57 . . . . 73.430000000000007 111.675 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 -44.26 0.95 Allowed Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.257 -0.973 . . . . 60.310000000000002 112.863 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -87.77 97.33 10.84 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.968 0.413 . . . . 63.140000000000001 110.721 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.492 ' HB ' ' CB ' ' A' ' 27' ' ' PHE . 6.8 tt -154.98 101.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 121.73 0.776 . . . . 72.239999999999995 112.151 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.71 94.49 47.48 Favored Pre-proline 0 C--N 1.296 -1.727 0 N-CA-C 108.742 -0.836 . . . . 75.420000000000002 108.742 171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.31 -17.79 39.45 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 122.718 2.279 . . . . 75.420000000000002 112.563 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.96 -25.92 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.368 -0.833 . . . . 74.200000000000003 110.494 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.47 -34.46 75.49 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.608 0.595 . . . . 72.019999999999996 112.608 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.42 -51.68 35.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.555 . . . . 74.219999999999999 109.5 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 10.7 pt-20 -66.79 -30.05 70.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.594 -0.275 . . . . 61.450000000000003 111.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.65 -39.19 93.1 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.149 0.5 . . . . 53.109999999999999 109.873 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -71.11 -45.93 62.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.503 -0.925 . . . . 71.409999999999997 108.503 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 40' ' ' LEU 0.268 3.7 mm? -67.69 -33.69 75.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.586 1.328 . . . . 72.109999999999999 114.586 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 2.5 ptm180 -67.48 -32.47 73.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 119.806 -0.758 . . . . 54.43 109.085 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.11 -35.8 69.26 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 109.326 -0.62 . . . . 71.430000000000007 109.326 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -64.9 -43.91 91.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.469 -0.567 . . . . 75.409999999999997 109.469 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.33 -48.08 82.95 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.632 -0.713 . . . . 75.099999999999994 110.47 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.64 -36.98 85.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.019 -0.537 . . . . 71.219999999999999 111.732 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -72.51 -39.91 67.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.137 0.494 . . . . 72.230000000000004 109.753 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.58 31.36 6.17 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.272 -0.876 . . . . 73.099999999999994 113.311 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 56' ' ' LEU . 17.7 mm -71.65 130.35 35.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.185 -0.672 . . . . 55.009999999999998 109.185 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 21.0 tt0 -107.74 136.56 47.27 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.667 -0.864 . . . . 74.430000000000007 108.667 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.4 m -67.59 107.44 2.51 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.764 0.793 . . . . 72.219999999999999 111.093 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.4 tp -118.12 -166.34 1.2 Allowed 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 105.065 -2.198 . . . . 70.019999999999996 105.065 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.605 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 52.6 mt-30 -51.77 152.55 2.84 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 123.245 0.618 . . . . 74.230000000000004 111.631 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.45 -3.28 18.85 Favored Glycine 0 N--CA 1.465 0.618 0 CA-C-N 116.087 -0.506 . . . . 74.219999999999999 113.453 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -65.23 -46.69 79.6 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.868 -1.16 . . . . 74.219999999999999 107.868 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -174.68 154.75 2.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.841 -1.072 . . . . 73.040000000000006 110.901 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.3 mt -90.56 151.79 21.18 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.563 -1.199 . . . . 65.430000000000007 109.878 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 40.6 tp -92.92 128.99 38.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.911 -0.586 . . . . 72.439999999999998 109.458 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.54 154.16 42.49 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 109.203 -0.665 . . . . 64.530000000000001 109.203 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 125' ' ' VAL . 38.8 Cg_exo -62.21 155.78 54.48 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.724 2.283 . . . . 63.100000000000001 112.396 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.431 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -127.49 -24.17 3.37 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.707 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.45 112.54 24.53 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.283 -1.006 . . . . 73.310000000000002 108.283 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.4 m-85 -121.93 122.37 39.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.34 0.59 . . . . 74.310000000000002 110.701 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.3 mt -120.08 116.47 50.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 N-CA-C 109.088 -0.708 . . . . 75.549999999999997 109.088 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.09 126.0 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 108.257 -1.016 . . . . 70.430000000000007 108.257 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -111.81 117.27 32.36 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.64 -0.709 . . . . 71.109999999999999 109.204 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.641 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.5 mm? -100.72 161.69 13.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 122.82 0.448 . . . . 73.430000000000007 109.953 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.02 150.02 51.66 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 108.324 -1.91 . . . . 71.209999999999994 108.324 170.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 p -54.01 -35.01 27.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 117.325 0.562 . . . . 74.120000000000005 112.389 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.57 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 20.6 t60 -73.12 -28.89 62.52 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 116.021 -0.536 . . . . 63.520000000000003 110.576 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -85.72 -24.21 27.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.545 -0.722 . . . . 70.25 110.462 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.54 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 82.4 t80 -64.74 -41.35 95.99 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.277 0.56 . . . . 75.129999999999995 110.089 177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -67.74 -25.54 65.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.032 -0.531 . . . . 73.0 111.008 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 2.1 mptm? -75.22 -22.57 57.84 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.23 -0.895 . . . . 74.510000000000005 111.763 174.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.0 -31.13 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.668 -1.234 . . . . 70.140000000000001 107.668 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.96 -162.73 15.62 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.642 -1.163 . . . . 71.310000000000002 111.69 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.14 -37.37 38.66 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.004 -0.739 . . . . 64.5 109.004 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -115.71 97.06 48.13 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.522 -0.763 . . . . 64.439999999999998 110.385 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -68.49 -33.5 22.54 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 121.962 1.775 . . . . 74.329999999999998 109.525 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.96 -22.29 59.89 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.55 -1.204 . . . . 63.329999999999998 111.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.2 tp -54.48 -45.37 73.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.203 -0.665 . . . . 63.229999999999997 109.203 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -90.54 -26.38 19.76 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 115.698 -0.683 . . . . 61.210000000000001 110.739 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -55.28 -51.14 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.15 0.432 . . . . 52.200000000000003 111.936 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.2 m -56.07 -45.57 79.29 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.127 0.489 . . . . 65.450000000000003 111.047 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.81 -43.25 75.6 Favored Glycine 0 C--O 1.206 -1.626 0 C-N-CA 120.907 -0.663 . . . . 25.300000000000001 111.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -61.17 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.168 0.987 . . . . 74.439999999999998 110.152 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.75 -45.91 92.49 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.546 -0.752 . . . . 63.32 109.837 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -75.34 -24.71 57.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.617 -0.719 . . . . 71.329999999999998 112.212 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.67 -51.47 59.23 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.092 -1.077 . . . . 73.129999999999995 108.092 173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.72 -42.76 99.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.11 -0.95 . . . . 71.549999999999997 109.583 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -60.87 -39.09 87.88 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.192 178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 23.1 t70 -72.83 -36.39 67.48 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.655 -0.498 . . . . 60.140000000000001 109.655 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.9 m-85 -59.26 -44.98 92.39 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.101 -0.5 . . . . 74.409999999999997 111.515 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -70.19 -25.43 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.372 -0.531 . . . . 45.329999999999998 111.293 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 90' ' ' ALA . 79.5 mt-30 -66.69 -42.54 86.31 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.745 -0.835 . . . . 72.129999999999995 108.745 172.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 58.4 mt-10 -63.83 -26.68 68.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.458 -0.792 . . . . 72.129999999999995 111.227 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.5 mm-40 -92.95 -13.73 28.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.041 0.448 . . . . 75.340000000000003 110.794 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.24 28.35 56.1 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.811 -0.632 . . . . 63.520000000000003 113.128 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -97.13 173.45 7.24 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.238 -0.653 . . . . 72.450000000000003 109.238 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.442 ' NE2' HD23 ' A' ' 51' ' ' LEU . 26.6 pt20 -132.32 165.75 23.49 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 122.458 -0.151 . . . . 72.230000000000004 110.822 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.8 t -154.15 158.15 39.94 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.449 -1.315 . . . . 74.25 107.449 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.14 120.7 37.89 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.379 -0.529 . . . . 71.129999999999995 110.989 -176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.04 -169.31 13.81 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 109.825 -1.31 . . . . 73.540000000000006 109.825 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -92.32 143.96 25.86 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.027 -0.731 . . . . 75.420000000000002 109.027 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 90' ' ' ALA . 6.1 p -80.85 115.09 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.923 0.868 . . . . 75.329999999999998 109.953 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.44 128.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 115.237 -0.892 . . . . 64.349999999999994 110.092 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 8.6 p -133.81 141.54 43.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.406 -0.961 . . . . 75.340000000000003 108.406 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -137.45 149.9 47.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 120.129 -0.628 . . . . 62.020000000000003 109.821 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -115.34 114.57 25.3 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.096 -1.446 . . . . 63.109999999999999 107.096 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.09 167.42 11.81 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.644 -0.502 . . . . 33.43 109.644 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.8 pt20 -104.57 160.47 14.92 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.416 0.626 . . . . 53.229999999999997 110.68 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -140.5 130.84 25.17 Favored 'General case' 0 N--CA 1.409 -2.499 0 CA-C-N 115.068 -0.969 . . . . 72.129999999999995 108.885 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -81.19 -5.74 58.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.119 -0.492 . . . . 74.129999999999995 110.501 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -88.87 -20.57 24.43 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.055 0.455 . . . . 75.25 110.758 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.0 mt -94.73 142.96 26.84 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.144 0.497 . . . . 61.039999999999999 110.299 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -98.12 173.07 7.21 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.399 -0.819 . . . . 64.329999999999998 109.787 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 m -53.68 118.38 3.88 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 124.197 0.936 . . . . 73.019999999999996 111.033 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.23 5.3 52.83 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 121.042 -0.599 . . . . 63.210000000000001 113.321 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.04 141.4 48.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.268 0.534 . . . . 71.120000000000005 110.985 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.641 ' HB3' HD13 ' A' ' 66' ' ' LEU . 28.8 p90 -152.06 151.02 30.58 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 109.891 177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.68 144.87 48.52 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.657 -1.238 . . . . 55.43 107.657 176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.44 10.78 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 117.946 0.339 . . . . 64.319999999999993 110.526 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.51 ' HA ' ' NE ' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -125.47 135.23 52.11 Favored 'General case' 0 N--CA 1.39 -3.457 0 N-CA-C 109.906 -0.405 . . . . 75.209999999999994 109.906 178.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.6 143.4 17.83 Favored Glycine 0 N--CA 1.426 -2.013 0 N-CA-C 109.506 -1.438 . . . . 72.040000000000006 109.506 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.6 m -145.35 150.57 36.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.101 -0.703 . . . . 73.349999999999994 109.101 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 59' ' ' PRO . 48.7 t -86.38 105.99 15.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.193 -1.039 . . . . 72.230000000000004 108.193 177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -122.02 100.13 43.2 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 108.772 -0.825 . . . . 72.019999999999996 108.772 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.46 -24.21 31.29 Favored 'Trans proline' 0 C--O 1.245 0.857 0 C-N-CA 122.231 1.954 . . . . 75.450000000000003 112.326 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -95.38 77.08 3.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.211 1.482 . . . . 63.530000000000001 109.431 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 p -127.87 135.96 61.6 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.345 0 CA-C-N 111.737 -2.483 . . . . 61.310000000000002 104.909 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -54.68 128.66 33.56 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.811 0.815 . . . . 73.340000000000003 112.838 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -81.8 137.75 35.24 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.64 -1.244 . . . . 74.329999999999998 107.64 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.7 t60 . . . . . 0 C--N 1.286 -2.155 0 N-CA-C 107.172 -1.418 . . . . 75.010000000000005 107.172 179.669 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 CA--C 1.503 -0.83 0 N-CA-C 108.508 -0.923 . . . . 61.32 108.508 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.94 -133.11 11.33 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.536 -0.84 . . . . 33.409999999999997 111.766 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -120.95 134.16 55.29 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.388 -0.597 . . . . 73.540000000000006 109.388 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -137.55 130.02 29.65 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.398 -0.593 . . . . 74.129999999999995 109.398 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -78.48 94.74 4.99 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.554 -0.536 . . . . 61.109999999999999 109.554 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -88.45 84.85 6.79 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.871 -1.159 . . . . 73.019999999999996 107.871 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.1 87.98 5.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.61 -1.177 . . . . 73.319999999999993 110.795 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.9 m -87.43 110.15 20.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 114.531 -1.213 . . . . 60.200000000000003 109.412 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -90.12 103.5 16.16 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.433 -0.803 . . . . 74.340000000000003 108.851 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -137.74 106.98 6.06 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.901 -1.045 . . . . 71.310000000000002 109.767 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.08 136.32 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.887 -0.783 . . . . 64.209999999999994 108.887 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -87.24 88.44 7.69 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.844 -0.428 . . . . 75.25 109.844 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -85.51 102.27 13.36 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.955 -1.498 . . . . 62.549999999999997 106.955 174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.6 166.73 27.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 112.418 0.525 . . . . 74.430000000000007 112.418 -175.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 pp -162.29 170.22 19.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.808 -1.553 . . . . 72.319999999999993 106.808 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -105.52 149.02 26.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.908 -1.117 . . . . 72.510000000000005 109.594 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -103.52 111.23 23.58 Favored 'General case' 0 N--CA 1.406 -2.629 0 N-CA-C 104.401 -2.444 . . . . 74.030000000000001 104.401 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.8 m -74.42 95.44 2.72 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 122.271 1.034 . . . . 45.450000000000003 110.12 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.0 m -95.13 122.64 46.77 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 113.794 -1.548 . . . . 61.549999999999997 109.701 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.89 42.9 0.56 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.508 -1.037 . . . . 64.030000000000001 110.508 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 6.2 p-10 -77.99 9.82 3.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.529 -0.335 . . . . 72.209999999999994 111.413 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -54.47 -36.97 64.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.923 0.889 . . . . 63.130000000000003 110.456 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HB2' ' HG3' ' A' ' 33' ' ' PRO . 61.6 m-85 -63.48 -40.4 96.99 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.656 -0.702 . . . . 61.140000000000001 110.585 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.31 -30.49 70.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.146 0.498 . . . . 73.310000000000002 109.888 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 27.3 mmm180 -69.05 -32.53 72.08 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.02 -0.733 . . . . 63.5 109.02 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 22' ' ' ALA . 73.4 mt -73.57 -43.21 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.577 -0.738 . . . . 63.340000000000003 110.178 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -65.71 -29.27 69.77 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 111.796 0.295 . . . . 75.409999999999997 111.796 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.32 -91.84 0.21 Allowed Glycine 0 N--CA 1.445 -0.745 0 O-C-N 123.743 0.652 . . . . 40.130000000000003 112.386 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.32 -6.41 41.84 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.934 -0.466 . . . . 73.200000000000003 111.934 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.8 m -82.55 173.41 11.99 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.454 0.169 . . . . 73.409999999999997 110.925 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.98 136.96 19.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 123.998 0.919 . . . . 72.219999999999999 112.476 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.3 m -84.34 152.34 60.93 Favored Pre-proline 0 C--O 1.246 0.899 0 CA-C-N 115.234 -0.894 . . . . 63.109999999999999 112.136 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HG3' ' HB2' ' A' ' 23' ' ' PHE . 33.7 Cg_endo -61.73 -17.17 53.3 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 123.734 2.956 . . . . 65.430000000000007 113.949 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -61.15 -43.61 98.62 Favored 'General case' 0 C--O 1.227 -0.089 0 CA-C-O 120.855 0.36 . . . . 75.230000000000004 110.124 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -72.88 -31.38 64.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 43.100000000000001 109.757 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 99.4 t -60.57 -50.96 78.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.22 -0.446 . . . . 73.340000000000003 110.351 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -67.39 -34.44 77.27 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 120.043 -0.663 . . . . 74.239999999999995 110.661 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.83 80.8 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 110.582 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 9.7 tt -66.32 -42.94 87.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.334 -0.848 . . . . 70.120000000000005 109.931 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 93.9 mt -61.28 -39.21 89.59 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.05 0.452 . . . . 71.099999999999994 111.688 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -67.99 -33.46 74.68 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 123.723 0.809 . . . . 71.239999999999995 110.416 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -75.65 -36.16 60.24 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.063 -1.088 . . . . 74.409999999999997 108.063 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 63.2 mm-40 -63.62 -34.59 78.16 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.409 0.684 . . . . 73.010000000000005 110.351 175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.29 94.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.836 -0.62 . . . . 74.140000000000001 109.727 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.23 -25.23 61.55 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.342 0.591 . . . . 72.140000000000001 110.89 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.69 -46.11 59.81 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.388 0.675 . . . . 75.310000000000002 111.135 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 26.39 10.12 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 120.698 -0.763 . . . . 53.409999999999997 114.093 -175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -69.18 141.61 17.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 122.65 0.38 . . . . 74.109999999999999 110.544 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 78.2 mt-30 -120.31 149.13 42.79 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 120.926 0.393 . . . . 54.240000000000002 110.412 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.5 p -76.56 128.92 35.68 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 114.72 -1.127 . . . . 52.210000000000001 109.446 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 28.4 tp -146.24 -166.35 2.45 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.899 -2.26 . . . . 73.319999999999993 104.899 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.568 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 98.2 mt-30 -43.91 136.52 3.61 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.743 0.652 . . . . 64.150000000000006 110.357 175.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.48 -8.23 31.05 Favored Glycine 0 N--CA 1.464 0.503 0 CA-C-N 116.654 -0.248 . . . . 40.210000000000001 113.487 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -62.61 -38.44 90.21 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.085 0.554 . . . . 73.120000000000005 109.801 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -171.59 147.9 2.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.025 -0.534 . . . . 72.230000000000004 111.213 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -91.08 151.89 20.84 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 123.723 0.809 . . . . 74.420000000000002 111.369 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 34.0 tp -84.81 128.88 34.82 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.74 -0.837 . . . . 65.299999999999997 108.74 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 98' ' ' TRP . . . -112.46 154.31 44.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 122.919 0.487 . . . . 62.299999999999997 111.11 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HB3' ' N ' ' A' ' 124' ' ' THR . 78.3 Cg_exo -58.31 145.91 91.55 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.475 2.783 . . . . 63.310000000000002 112.819 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 125' ' ' VAL . 24.6 p-10 -122.6 -25.37 4.73 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.263 -0.426 . . . . 73.519999999999996 110.137 175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -101.35 113.09 25.85 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.955 -0.758 . . . . 65.439999999999998 108.955 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 93.9 m-85 -112.67 114.94 27.78 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.363 0.602 . . . . 70.230000000000004 109.49 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -106.39 120.91 58.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 71.219999999999999 108.559 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 40' ' ' LEU . 63.6 mt -115.8 125.74 73.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.967 -1.123 . . . . 64.140000000000001 107.967 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.9 m -120.56 120.62 36.35 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 116.4 -0.364 . . . . 72.530000000000001 110.1 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.4 mm? -106.5 170.82 7.7 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 122.905 0.482 . . . . 65.230000000000004 110.736 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.29 167.32 51.96 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.484 -1.446 . . . . 70.430000000000007 109.484 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.97 -40.1 87.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 117.492 0.646 . . . . 74.430000000000007 111.936 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.419 ' CD2' ' HE2' ' A' ' 73' ' ' LYS . 58.3 t60 -75.77 -28.84 58.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.254 -0.647 . . . . 73.510000000000005 109.254 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 61.1 m-20 -76.16 -29.46 57.75 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 120.791 -0.363 . . . . 63.109999999999999 111.13 178.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -69.33 -29.46 67.29 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.313 -0.995 . . . . 75.439999999999998 108.313 174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.11 -26.46 66.71 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.777 -0.647 . . . . 75.140000000000001 111.115 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -70.63 -36.29 73.37 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.199 -0.667 . . . . 71.340000000000003 109.199 173.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.77 -30.11 69.48 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.338 -0.986 . . . . 74.200000000000003 108.338 177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -138.18 16.03 Favored Glycine 0 N--CA 1.418 -2.566 0 CA-C-N 114.13 -1.396 . . . . 23.43 113.325 170.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.88 -2.4 56.85 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.123 -0.538 . . . . 53.43 109.852 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -117.72 100.18 52.36 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 113.27 0.841 . . . . 53.450000000000003 113.27 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.47 -42.57 0.21 Allowed 'Trans proline' 0 CA--C 1.56 1.779 0 C-N-CA 121.656 1.57 . . . . 74.019999999999996 111.589 166.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -84.37 -29.71 26.03 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 118.775 2.88 . . . . 74.329999999999998 118.775 -163.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.74 -44.22 82.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.223 1.374 . . . . 64.439999999999998 108.563 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -65.04 -32.61 74.41 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.099 -0.955 . . . . 74.230000000000004 111.169 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.2 m -63.34 -43.32 98.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.817 -0.438 . . . . 53.130000000000003 109.817 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 64.3 m -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 116.253 -0.43 . . . . 64.439999999999998 110.817 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -52.11 49.89 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.234 -0.507 . . . . 24.399999999999999 112.036 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -63.16 -39.97 96.21 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.507 0.558 . . . . 62.039999999999999 112.507 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.571 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -60.87 -45.28 95.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.82 0.343 . . . . 61.439999999999998 111.151 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -66.5 -42.03 87.99 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.759 -0.655 . . . . 72.109999999999999 110.926 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.43 -42.67 82.8 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.48 -0.782 . . . . 75.400000000000006 110.488 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.47 -34.74 78.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.158 0.429 . . . . 64.400000000000006 112.158 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.09 88.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.509 0.671 . . . . 74.239999999999995 110.334 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 24.6 t70 -69.77 -43.95 71.15 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 109.362 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.543 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 20.3 m-85 -55.44 -56.73 16.8 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 113.126 0.787 . . . . 74.349999999999994 113.126 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.8 pt -57.47 -36.66 54.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 123.26 0.35 . . . . 74.150000000000006 111.548 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.17 -37.66 81.24 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.441 -0.345 . . . . 65.409999999999997 111.856 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.7 mt-10 -63.75 -34.75 78.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.304 0.573 . . . . 71.430000000000007 110.682 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 73.5 mm-40 -76.34 -13.72 60.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.508 -0.769 . . . . 62.310000000000002 111.008 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.01 8.02 67.46 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.943 -0.572 . . . . 75.150000000000006 112.267 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 58' ' ' ALA . 14.8 m0 -81.42 165.01 21.66 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.461 -0.57 . . . . 72.450000000000003 109.461 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -133.8 165.67 24.43 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.257 -0.645 . . . . 75.230000000000004 109.257 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -155.41 170.86 20.94 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 108.157 -1.053 . . . . 65.430000000000007 108.157 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -106.86 119.18 38.65 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.888 -1.152 . . . . 74.530000000000001 107.888 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.14 -149.33 16.59 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 109.168 -1.573 . . . . 71.540000000000006 109.168 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.95 175.76 7.83 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.762 -1.57 . . . . 71.519999999999996 106.762 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -82.41 127.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.066 0.46 . . . . 74.340000000000003 110.511 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 m -127.54 127.33 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 115.548 -0.751 . . . . 71.5 109.083 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -131.62 145.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 107.321 -1.362 . . . . 74.239999999999995 107.321 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.56 139.3 20.75 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.339 0.59 . . . . 73.409999999999997 110.476 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -97.82 131.8 44.0 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.489 -1.232 . . . . 74.010000000000005 109.432 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 65' ' ' THR . 7.2 pt-20 -136.89 176.53 8.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.762 -0.829 . . . . 71.140000000000001 108.762 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -127.0 164.58 21.19 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.732 0.777 . . . . 65.120000000000005 111.406 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 m -142.04 127.03 18.34 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.968 -1.123 . . . . 63.340000000000003 107.968 172.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 t -69.24 -19.16 63.94 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.271 0.628 . . . . 71.329999999999998 110.283 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -65.79 -30.4 71.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.796 -0.638 . . . . 74.030000000000001 109.765 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.9 mt -84.36 131.3 34.71 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.422 0.63 . . . . 74.120000000000005 110.772 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.405 ' HB3' HE21 ' A' ' 118' ' ' GLN . 47.5 t60 -92.29 162.0 14.46 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.635 -1.246 . . . . 72.019999999999996 107.635 177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.9 m -55.93 126.82 27.43 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 123.431 0.692 . . . . 62.329999999999998 110.972 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.37 -14.53 47.26 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.558 -0.746 . . . . 63.509999999999998 111.616 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 115' ' ' HIS . 2.2 mp0 -106.46 131.72 53.32 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 109.565 -0.532 . . . . 63.530000000000001 109.565 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.448 ' HB3' HD13 ' A' ' 66' ' ' LEU . 16.4 p90 -145.45 159.37 43.18 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.093 -0.706 . . . . 73.150000000000006 109.093 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.95 149.81 52.33 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.093 -0.706 . . . . 74.430000000000007 109.093 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.27 134.84 17.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.487 -0.56 . . . . 55.020000000000003 109.487 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.469 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -132.39 145.3 51.13 Favored 'General case' 0 CA--C 1.483 -1.612 0 CA-C-O 121.38 0.609 . . . . 64.129999999999995 111.925 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -125.81 113.4 1.86 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.989 -1.645 . . . . 73.439999999999998 108.989 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.421 ' N ' ' HB3' ' A' ' 59' ' ' PRO . 61.0 m -143.13 145.45 32.84 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 108.951 -0.759 . . . . 75.299999999999997 108.951 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.44 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 6.0 p -86.91 118.15 32.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.993 -1.114 . . . . 71.420000000000002 107.993 174.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' ND2' ' HB ' ' A' ' 129' ' ' VAL . 46.2 t30 -126.21 88.78 53.65 Favored Pre-proline 0 C--N 1.29 -2.018 0 CA-C-N 115.626 -0.715 . . . . 62.420000000000002 110.087 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -83.89 -18.32 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.382 2.055 . . . . 64.140000000000001 111.381 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -98.75 70.32 1.88 Allowed 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.479 1.133 . . . . 72.5 108.126 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.421 ' HB ' ' ND2' ' A' ' 126' ' ' ASN . 6.9 p -125.71 120.99 58.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.133 -1.394 . . . . 73.540000000000006 111.95 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.56 111.08 23.06 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.828 -1.175 . . . . 73.019999999999996 107.828 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -151.79 158.59 43.52 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.595 -1.632 . . . . 64.439999999999998 106.595 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 . . . . . 0 C--N 1.295 -1.798 0 N-CA-C 108.111 -1.07 . . . . 74.129999999999995 108.111 179.389 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 107.986 -1.116 . . . . 62.520000000000003 107.986 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.4 -128.66 24.89 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.821 -0.704 . . . . 42.009999999999998 111.577 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 m 60.95 25.06 15.08 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.074 0.95 . . . . 75.310000000000002 111.445 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 136.75 45.18 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.521 0.676 . . . . 73.329999999999998 112.154 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -97.12 92.01 5.84 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.425 0.631 . . . . 50.100000000000001 109.601 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -88.07 88.34 7.61 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.582 -0.895 . . . . 70.430000000000007 108.582 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 tt -92.45 108.34 19.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.303 -1.369 . . . . 73.329999999999998 107.303 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -109.38 106.16 20.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.171 -1.048 . . . . 62.32 108.171 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -73.13 100.1 2.97 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.89 0.853 . . . . 72.019999999999996 109.794 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -85.84 72.04 10.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.265 1.031 . . . . 74.120000000000005 111.494 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -130.74 92.29 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 113.724 -1.58 . . . . 72.239999999999995 109.593 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.88 -24.54 61.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.945 0.879 . . . . 72.200000000000003 109.272 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -141.75 128.05 19.88 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 102.79 -3.041 . . . . 73.25 102.79 169.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -73.31 -27.3 61.45 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.609 -0.836 . . . . 74.239999999999995 110.647 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 15' ' ' LEU . 3.7 pp -168.35 141.64 3.11 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 108.405 -0.961 . . . . 72.230000000000004 108.405 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -141.9 124.72 16.04 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.3 -0.63 . . . . 75.140000000000001 109.3 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.84 95.45 5.66 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.757 1.265 . . . . 64.310000000000002 111.182 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.512 ' H ' HG21 ' A' ' 32' ' ' VAL . 1.3 m -85.89 96.95 9.95 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.368 -1.287 . . . . 71.030000000000001 108.128 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.1 23.04 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.569 0.699 . . . . 54.039999999999999 111.644 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.99 41.26 2.28 Favored Glycine 0 C--N 1.302 -1.33 0 N-CA-C 110.653 -0.979 . . . . 72.120000000000005 110.653 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 t70 -150.02 136.26 18.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.121 -1.807 . . . . 74.530000000000001 106.121 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.42 -55.69 14.72 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.264 1.026 . . . . 73.310000000000002 113.295 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.06 -29.57 66.61 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 75.040000000000006 111.373 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.95 85.63 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.728 -0.669 . . . . 74.319999999999993 110.38 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 63.6 mtp180 -77.42 -19.93 55.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.859 -0.609 . . . . 61.350000000000001 110.513 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 69.9 mt -69.04 -38.92 79.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.484 -0.932 . . . . 71.109999999999999 108.484 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 73' ' ' LYS . 58.7 m-85 -75.34 -29.3 59.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.857 -0.61 . . . . 73.439999999999998 110.927 175.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.74 -76.61 2.16 Favored Glycine 0 N--CA 1.431 -1.694 0 N-CA-C 110.747 -0.941 . . . . 55.329999999999998 110.747 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -149.3 19.53 1.19 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 121.233 -0.508 . . . . 53.539999999999999 112.469 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -69.46 -74.44 0.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.577 -0.527 . . . . 74.230000000000004 109.577 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.81 159.37 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 N-CA-C 104.839 -2.282 . . . . 74.329999999999998 104.839 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.512 HG21 ' H ' ' A' ' 18' ' ' THR . 29.1 m -125.98 148.73 63.91 Favored Pre-proline 0 C--N 1.292 -1.892 0 C-N-CA 118.888 -1.125 . . . . 73.099999999999994 111.043 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.72 -34.91 76.44 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.067 2.511 . . . . 71.450000000000003 112.121 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -62.82 -33.92 76.23 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.507 -0.769 . . . . 73.200000000000003 110.481 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' H ' HG23 ' A' ' 32' ' ' VAL . 41.4 tt0 -79.82 -38.58 32.62 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.187 -0.915 . . . . 61.450000000000003 108.805 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.53 -53.48 46.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 CA-C-N 115.532 -0.758 . . . . 63.509999999999998 110.028 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -65.53 -32.42 74.01 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 120.642 -0.423 . . . . 72.340000000000003 111.778 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.05 -53.97 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.0 0.429 . . . . 74.349999999999994 110.062 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.2 mm? -71.59 -34.64 70.07 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.044 -0.525 . . . . 74.530000000000001 111.366 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.2 tp -65.85 -41.05 92.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.516 0.198 . . . . 70.099999999999994 111.381 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -73.93 -26.51 60.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.21 -0.596 . . . . 72.120000000000005 109.495 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttt85 -71.18 -35.75 71.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.372 -0.603 . . . . 73.239999999999995 109.372 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 78.0 mm-40 -61.09 -37.36 82.47 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.766 -0.457 . . . . 73.239999999999995 109.766 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.51 -47.68 82.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 73.409999999999997 109.92 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.42 -33.45 73.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.309 0.576 . . . . 45.240000000000002 112.007 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.05 -37.32 39.28 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.469 0.707 . . . . 61.509999999999998 110.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.54 14.49 63.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.483 -0.78 . . . . 41.520000000000003 113.365 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG23 ' HB3' ' A' ' 56' ' ' LEU . 9.0 mm -54.6 141.6 10.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.005 0.922 . . . . 61.450000000000003 110.96 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.36 126.75 55.62 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 107.02 -1.474 . . . . 74.329999999999998 107.02 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -66.71 102.18 0.9 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.331 0.586 . . . . 51.509999999999998 110.125 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.6 tp -104.24 -165.97 1.2 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 105.487 -2.042 . . . . 71.230000000000004 105.487 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.619 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -47.13 144.04 2.85 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.155 -0.683 . . . . 62.219999999999999 109.155 172.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.63 7.49 3.86 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 114.343 0.497 . . . . 51.310000000000002 114.343 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -76.71 -35.6 57.75 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.536 -0.913 . . . . 44.25 108.536 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.488 ' HD3' ' OE1' ' A' ' 99' ' ' GLN . 8.2 ptm180 -168.45 157.54 9.0 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 116.137 -0.483 . . . . 73.219999999999999 110.754 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 98' ' ' TRP . 77.6 mt -91.89 151.37 20.57 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 123.258 0.623 . . . . 70.25 110.408 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 HD22 ' A' ' 51' ' ' LEU . 5.6 tt -101.24 127.29 47.89 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.619 -1.252 . . . . 74.109999999999999 107.619 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.72 158.08 32.45 Favored Pre-proline 0 C--N 1.301 -1.543 0 C-N-CA 122.96 0.504 . . . . 71.430000000000007 110.169 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 125' ' ' VAL . 73.6 Cg_exo -54.25 161.83 4.91 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.073 2.515 . . . . 73.329999999999998 113.363 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -125.94 -25.54 3.59 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.63 -0.713 . . . . 70.340000000000003 110.421 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -101.2 100.52 11.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.917 -1.142 . . . . 53.439999999999998 107.917 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.36 119.24 38.58 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.071 0.462 . . . . 72.030000000000001 109.898 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.0 mt -116.13 114.09 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.527 -0.761 . . . . 71.450000000000003 109.528 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -104.62 134.15 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 106.641 -1.615 . . . . 74.049999999999997 106.641 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.0 m -131.6 125.66 32.79 Favored 'General case' 0 C--N 1.286 -2.164 0 C-N-CA 120.901 -0.32 . . . . 73.140000000000001 111.329 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 110' ' ' GLN . 4.2 mm? -132.44 172.92 11.86 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.341 1.026 . . . . 73.549999999999997 109.543 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.9 51.15 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.675 -0.97 . . . . 72.140000000000001 110.675 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 88.0 t -60.92 -45.73 97.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.993 0.517 . . . . 74.450000000000003 110.87 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -64.65 -31.47 72.7 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.752 1.221 . . . . 73.519999999999996 110.686 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.51 -37.53 19.57 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.584 0.707 . . . . 64.230000000000004 109.252 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 74' ' ' LEU . 40.1 t80 -60.57 -32.02 71.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.168 -0.924 . . . . 75.439999999999998 111.315 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 54.3 mt-10 -55.61 -38.26 69.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.418 0.627 . . . . 74.409999999999997 110.139 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 39.0 mmtm -83.43 -28.64 28.69 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.006 -0.997 . . . . 54.439999999999998 109.842 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 71' ' ' PHE . 67.2 mt -55.78 -45.78 78.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.83 0.707 . . . . 73.540000000000006 109.65 176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.68 158.48 21.31 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.614 -0.995 . . . . 72.109999999999999 110.614 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.9 -18.21 60.45 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.491 0.662 . . . . 75.209999999999994 110.202 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.95 138.22 17.85 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 108.459 -0.941 . . . . 72.150000000000006 108.459 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.4 -51.45 7.41 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.573 2.182 . . . . 73.409999999999997 112.88 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -64.91 -30.12 71.1 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.326 -0.397 . . . . 74.430000000000007 111.486 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.58 -40.91 53.67 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.329 1.018 . . . . 74.230000000000004 109.514 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -95.2 -39.23 10.19 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 74.510000000000005 110.688 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.9 m -58.44 -44.82 89.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.72 0.637 . . . . 75.120000000000005 112.72 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -63.04 -54.49 37.37 Favored 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 120.926 0.393 . . . . 64.129999999999995 111.558 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.83 -37.71 92.47 Favored Glycine 0 C--O 1.245 0.807 0 C-N-CA 121.406 -0.426 . . . . 74.219999999999999 113.1 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -75.47 -30.0 59.79 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.868 -0.195 . . . . 64.319999999999993 110.684 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . . . -65.03 -38.46 90.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.955 -0.387 . . . . 62.310000000000002 109.955 176.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -60.86 -47.74 85.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.403 -0.817 . . . . 71.010000000000005 111.048 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 11.1 t70 -68.15 -32.12 72.17 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.539 0.685 . . . . 74.310000000000002 110.486 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.65 -36.95 70.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 65.519999999999996 109.157 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -63.45 -36.67 84.53 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 109.298 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 30.1 t70 -59.56 -52.2 66.59 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.688 -1.142 . . . . 52.409999999999997 109.06 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -52.96 -50.79 63.36 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.403 0.89 . . . . 75.540000000000006 113.403 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -64.41 -37.26 79.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.193 -0.603 . . . . 71.0 112.225 -176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -70.56 -34.83 72.66 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 120.812 -0.355 . . . . 74.040000000000006 111.281 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 64.7 mm-40 -63.1 -35.26 79.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.156 0.503 . . . . 73.540000000000006 110.636 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 59.6 mm-40 -81.79 -12.96 58.31 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.581 -0.736 . . . . 71.030000000000001 111.204 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . 89.85 23.97 31.42 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.903 -0.59 . . . . 41.530000000000001 112.991 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 18.9 m0 -98.5 149.23 22.94 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.068 0.461 . . . . 75.329999999999998 111.406 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.488 ' OE1' ' HD3' ' A' ' 55' ' ' ARG . 13.8 pt20 -124.47 177.46 5.9 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.367 -0.833 . . . . 74.109999999999999 109.14 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.4 t -162.13 -179.17 6.88 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.744 -0.836 . . . . 60.140000000000001 108.744 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -112.19 120.53 42.1 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.099 -0.704 . . . . 61.109999999999999 109.099 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.06 -150.28 16.73 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 119.713 -1.232 . . . . 63.119999999999997 110.451 175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.68 144.32 38.22 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.371 -1.344 . . . . 73.129999999999995 107.371 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 90' ' ' ALA . 12.0 p -79.51 141.52 15.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.199 -1.037 . . . . 64.519999999999996 108.199 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.61 124.8 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.309 0.576 . . . . 54.439999999999998 109.984 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 72.7 t -108.63 112.59 41.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 105.981 -1.859 . . . . 73.5 105.981 175.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -124.06 140.33 53.08 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.688 -0.687 . . . . 73.209999999999994 111.286 -172.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -109.73 130.77 55.48 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.175 -0.921 . . . . 74.099999999999994 109.972 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.94 166.35 21.86 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.972 0.415 . . . . 72.109999999999999 110.922 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 45.0 mt-30 -106.62 142.8 35.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.233 -0.894 . . . . 71.400000000000006 109.379 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 114' ' ' LEU . 12.5 p -119.88 136.72 54.39 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 112.777 0.658 . . . . 73.140000000000001 112.777 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -82.93 -40.47 20.09 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.582 0.706 . . . . 50.119999999999997 109.7 172.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -79.73 -22.43 43.31 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.135 -0.939 . . . . 72.420000000000002 112.194 -174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.453 ' HB3' ' OG ' ' A' ' 111' ' ' SER . 25.7 tp -114.5 137.37 51.93 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 104.028 -2.582 . . . . 73.140000000000001 104.028 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -139.55 172.61 12.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.325 -1.35 . . . . 65.409999999999997 111.724 -169.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.6 m -35.83 124.64 0.71 Allowed 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.166 2.187 . . . . 74.120000000000005 113.557 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.64 -22.94 27.4 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.217 -1.153 . . . . 75.239999999999995 110.217 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -112.17 128.23 56.17 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.416 -0.587 . . . . 61.140000000000001 109.416 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -124.69 149.66 46.97 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.27 -1.011 . . . . 60.039999999999999 108.27 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -136.74 143.12 43.13 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.237 -1.023 . . . . 73.340000000000003 108.237 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.74 142.03 40.97 Favored 'General case' 0 C--N 1.257 -3.451 0 N-CA-C 104.302 -2.481 . . . . 73.549999999999997 104.302 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -156.9 162.36 39.66 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.28 -0.568 . . . . 74.319999999999993 110.225 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.03 119.2 1.68 Allowed Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 110.67 -0.972 . . . . 73.340000000000003 110.67 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.7 m -110.23 144.01 39.54 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.017 -0.734 . . . . 73.219999999999999 109.017 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 59' ' ' PRO . 63.0 t -99.35 112.96 33.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.566 -1.272 . . . . 71.450000000000003 107.566 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' O ' HG12 ' A' ' 129' ' ' VAL . 54.0 t30 -88.35 107.5 16.98 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 107.051 -1.462 . . . . 75.0 107.051 174.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.27 -36.01 4.52 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.087 1.858 . . . . 63.32 113.273 -174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -98.87 73.12 1.97 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.204 1.002 . . . . 72.140000000000001 110.453 -176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 126' ' ' ASN . 7.1 p -144.71 99.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 114.024 -1.444 . . . . 70.120000000000005 109.673 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.07 147.04 30.31 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.805 -1.088 . . . . 74.200000000000003 109.106 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -86.08 104.6 15.82 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 122.348 1.071 . . . . 70.549999999999997 108.323 175.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.9 p80 . . . . . 0 C--N 1.282 -2.338 0 CA-C-N 114.195 -1.366 . . . . 73.049999999999997 107.657 179.788 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.242 0.669 0 N-CA-C 109.298 -0.63 . . . . 64.140000000000001 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.19 117.08 1.51 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 111.484 -0.646 . . . . 72.109999999999999 111.484 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -68.85 145.21 53.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 122.683 0.393 . . . . 74.430000000000007 110.861 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.38 125.13 30.68 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.128 0.489 . . . . 54.210000000000001 110.795 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.92 145.68 33.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.131 -1.803 . . . . 71.200000000000003 106.131 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -100.7 139.87 35.78 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.138 -0.625 . . . . 73.430000000000007 109.356 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -102.46 85.68 2.65 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.201 -1.037 . . . . 74.200000000000003 108.201 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -171.6 153.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.317 -2.105 . . . . 72.150000000000006 105.317 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -85.89 -168.03 2.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.655 -0.868 . . . . 73.540000000000006 108.655 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -73.68 78.62 1.53 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.744 0.783 . . . . 73.530000000000001 109.262 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -124.78 107.49 18.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.428 -1.323 . . . . 73.400000000000006 107.428 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -95.32 -43.93 7.81 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.243 -0.651 . . . . 63.229999999999997 109.243 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 57.17 66.42 1.16 Allowed 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.331 -0.989 . . . . 75.510000000000005 108.331 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -94.23 80.71 4.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.729 -0.669 . . . . 74.109999999999999 109.428 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.83 -22.96 19.84 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.226 -0.897 . . . . 75.140000000000001 109.637 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.36 97.44 10.43 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.049 -1.463 . . . . 64.329999999999998 107.049 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -134.19 137.29 44.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.888 -0.596 . . . . 73.439999999999998 109.766 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.565 ' HB ' ' OH ' ' A' ' 92' ' ' TYR . 63.2 m -145.5 151.64 38.5 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 105.761 -1.94 . . . . 54.299999999999997 105.761 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -99.69 125.27 53.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.423 -0.911 . . . . 75.5 113.038 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.63 20.06 6.16 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.16 -1.976 . . . . 62.219999999999999 108.16 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 23.6 m-20 -73.0 -2.67 22.03 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 124.743 1.217 . . . . 72.109999999999999 112.519 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.18 -39.39 66.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.604 0.716 . . . . 73.549999999999997 110.294 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -71.29 -26.46 62.88 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.773 -0.648 . . . . 70.510000000000005 112.04 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.63 60.26 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.03 -0.73 . . . . 62.549999999999997 109.03 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 17.1 mmm180 -72.3 -44.19 63.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.578 -0.737 . . . . 73.25 109.145 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 mp -72.55 -49.01 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.949 -0.569 . . . . 73.209999999999994 112.197 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -78.08 -23.7 47.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.61 0.596 . . . . 63.509999999999998 112.61 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.72 -65.93 4.02 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 109.631 -1.388 . . . . 40.32 109.631 -174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.4 27.06 0.15 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 121.106 -0.569 . . . . 64.019999999999996 113.215 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.5 m -62.46 -42.91 99.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.454 0.627 . . . . 73.310000000000002 109.587 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.7 pt -140.95 151.84 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 107.472 -1.307 . . . . 51.25 107.472 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 35' ' ' GLU . 2.7 p -97.76 106.31 32.79 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 109.125 -0.694 . . . . 72.219999999999999 109.125 176.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -47.46 -50.65 10.96 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 124.26 3.307 . . . . 65.430000000000007 114.395 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -65.39 -25.29 67.49 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 114.916 1.45 . . . . 74.530000000000001 114.916 -174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HB2' HG13 ' A' ' 32' ' ' VAL . 43.3 mt-10 -81.11 -27.83 35.42 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.016 -1.074 . . . . 75.040000000000006 109.949 176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.5 -43.23 80.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.026 -1.472 . . . . 74.439999999999998 107.026 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -55.51 -49.37 72.77 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.104 -0.953 . . . . 62.439999999999998 109.824 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -48.94 -52.89 22.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.765 0.826 . . . . 71.430000000000007 111.882 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.65 -42.67 86.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.127 0.417 . . . . 62.439999999999998 112.127 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.1 mt -68.24 -39.96 82.12 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 112.957 0.725 . . . . 72.230000000000004 112.957 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.58 -26.36 62.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.468 0.651 . . . . 75.510000000000005 109.741 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.75 -45.08 60.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.292 -1.003 . . . . 64.040000000000006 108.292 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.047 -0.524 . . . . 72.349999999999994 111.323 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.47 95.33 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.952 -0.567 . . . . 30.129999999999999 111.124 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.69 -22.99 45.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.412 0.625 . . . . 74.340000000000003 111.398 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.28 -40.34 51.98 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.393 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.41 40.8 2.67 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.693 -0.685 . . . . 72.530000000000001 112.559 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.8 mm -79.81 139.41 18.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.21 0.529 . . . . 72.409999999999997 111.616 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.595 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp0 -118.7 144.0 46.51 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.159 0.984 . . . . 73.209999999999994 108.52 176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 m -81.03 100.99 9.27 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.981 0.896 . . . . 53.299999999999997 110.027 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.3 tp -118.67 -163.92 0.99 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 105.596 -2.001 . . . . 74.310000000000002 105.596 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 1.2 mp0 -41.41 126.03 2.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.799 0.687 . . . . 63.399999999999999 109.97 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.28 -22.3 50.08 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 114.656 0.622 . . . . 74.239999999999995 114.656 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.4 -23.86 62.83 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.526 -0.469 . . . . 73.239999999999995 111.805 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 13.9 ptm180 -162.18 128.71 3.67 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.532 0.682 . . . . 72.120000000000005 111.808 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.54 151.81 21.18 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 123.848 0.859 . . . . 60.509999999999998 110.985 -170.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.3 tm? -85.75 118.67 25.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.837 -0.801 . . . . 71.340000000000003 108.837 -174.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.44 165.61 12.33 Favored Pre-proline 0 C--N 1.302 -1.495 0 C-N-CA 124.137 0.975 . . . . 64.200000000000003 110.118 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HA ' HG22 ' A' ' 125' ' ' VAL . 50.8 Cg_exo -57.83 160.8 14.09 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.472 2.782 . . . . 54.130000000000003 113.371 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.9 p-10 -127.28 -31.94 2.51 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.375 -0.829 . . . . 62.240000000000002 111.079 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -109.07 111.5 23.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.026 -0.731 . . . . 74.219999999999999 109.026 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' HB2' HG12 ' A' ' 106' ' ' VAL . 50.0 m-85 -106.68 120.17 41.26 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.682 -0.858 . . . . 75.420000000000002 108.682 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.72 115.31 43.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 109.718 -0.475 . . . . 72.540000000000006 109.718 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.7 mp -112.46 109.94 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 107.194 -1.41 . . . . 72.329999999999998 107.194 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -105.86 122.7 46.64 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.539 -0.541 . . . . 74.510000000000005 109.539 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.3 mm? -110.41 163.64 13.48 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.376 0.67 . . . . 61.520000000000003 109.753 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.13 53.58 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.096 -1.602 . . . . 74.140000000000001 109.096 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 5.8 p -59.73 -37.46 71.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 117.792 0.796 . . . . 72.120000000000005 111.859 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 56.2 t-80 -58.96 -41.93 88.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 75.230000000000004 109.798 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.409 ' O ' HD23 ' A' ' 74' ' ' LEU . 5.8 m-20 -75.28 -39.62 59.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.535 -0.757 . . . . 61.420000000000002 111.739 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -57.94 -28.28 64.16 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.103 0.477 . . . . 72.409999999999997 111.095 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 94.1 mt-10 -62.77 -35.24 79.18 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.144 0.497 . . . . 74.510000000000005 110.215 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 69' ' ' HIS . 45.3 mmtt -85.02 -17.47 37.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.034 -0.728 . . . . 74.120000000000005 109.034 -172.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 4.5 mm? -69.97 -41.49 74.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.882 -1.054 . . . . 63.340000000000003 109.336 172.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.81 168.7 13.02 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.312 -0.946 . . . . 74.230000000000004 112.167 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.96 53.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.897 0.379 . . . . 52.539999999999999 111.762 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -112.14 96.0 32.68 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.305 -0.628 . . . . 54.420000000000002 109.305 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.1 -31.56 4.79 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 122.042 1.828 . . . . 60.210000000000001 111.038 175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -51.72 -53.15 42.51 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 115.508 1.67 . . . . 75.219999999999999 115.508 -172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.51 -15.82 61.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.858 0.754 . . . . 63.439999999999998 111.491 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 74' ' ' LEU . 58.4 mttp -90.79 -44.41 9.45 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.561 -0.745 . . . . 71.340000000000003 109.697 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 p -67.43 -51.22 54.29 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.12 0.568 . . . . 62.100000000000001 110.322 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.4 m -59.69 -41.15 90.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.567 -0.531 . . . . 73.439999999999998 109.567 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.58 52.95 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.563 -0.744 . . . . 62.509999999999998 112.634 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.98 -28.12 65.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.976 0.417 . . . . 61.450000000000003 110.082 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 104' ' ' VAL . . . -64.03 -42.66 97.02 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.997 -0.547 . . . . 50.530000000000001 110.439 176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' THR . 19.0 mmt85 -64.09 -39.59 94.39 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 111.313 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -44.25 87.83 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.332 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.65 -34.98 79.07 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.34 99.05 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.422 0.63 . . . . 72.519999999999996 110.108 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.49 -40.78 80.77 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.107 -0.951 . . . . 54.140000000000001 109.353 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -55.86 -50.75 69.77 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.472 1.109 . . . . 74.230000000000004 111.369 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 34.8 pt -64.45 -35.82 75.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.756 -0.377 . . . . 72.209999999999994 111.142 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.31 -40.93 96.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.196 0.522 . . . . 75.109999999999999 109.76 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -62.67 -29.54 70.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.333 -0.849 . . . . 41.200000000000003 112.338 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 57.7 mm-40 -85.87 1.47 49.72 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.645 -0.707 . . . . 72.340000000000003 111.223 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.35 27.25 52.65 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 121.07 -0.586 . . . . 45.32 112.261 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.83 167.64 10.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.419 -0.46 . . . . 70.140000000000001 110.065 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.504 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 25.4 pt20 -143.34 167.24 22.64 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.287 -1.005 . . . . 71.409999999999997 108.287 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.572 ' HA ' HD22 ' A' ' 57' ' ' LEU . 10.8 t -150.01 -177.33 5.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.718 -0.475 . . . . 73.010000000000005 109.718 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -115.98 120.09 38.0 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.905 -0.406 . . . . 72.439999999999998 109.905 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -155.33 16.35 Favored Glycine 0 N--CA 1.432 -1.625 0 C-N-CA 119.718 -1.23 . . . . 62.310000000000002 111.787 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -103.84 137.1 42.32 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.988 -1.486 . . . . 73.239999999999995 106.988 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.409 ' O ' ' HB1' ' A' ' 86' ' ' ALA . 66.6 t -83.21 124.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 108.776 -0.824 . . . . 60.32 108.776 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p -133.05 130.13 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 CA-C-O 121.642 0.734 . . . . 62.32 110.941 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 62' ' ' TYR . 34.7 m -104.43 127.42 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.356 0 N-CA-C 106.249 -1.76 . . . . 73.319999999999993 106.249 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -105.78 126.61 52.36 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.838 -0.619 . . . . 74.530000000000001 109.95 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -113.59 114.26 26.21 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.243 -1.392 . . . . 74.439999999999998 107.243 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.87 166.79 23.7 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 116.377 -0.374 . . . . 75.420000000000002 111.042 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -99.24 160.87 13.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.091 0.948 . . . . 74.450000000000003 112.171 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -149.48 115.67 5.75 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 113.559 -1.655 . . . . 51.0 107.819 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -81.03 -2.81 49.53 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.881 0.848 . . . . 61.340000000000003 109.559 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.68 -38.47 19.74 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.631 -1.168 . . . . 74.349999999999994 108.364 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.02 161.8 30.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.542 -0.91 . . . . 73.340000000000003 108.542 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -87.55 154.3 20.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.055 0.455 . . . . 63.310000000000002 110.055 -175.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.8 m -62.23 132.48 52.87 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 124.354 1.062 . . . . 71.430000000000007 109.489 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.35 28.96 60.83 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.536 -0.364 . . . . 64.099999999999994 112.417 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -137.07 149.39 47.36 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.024 -1.102 . . . . 71.310000000000002 108.024 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.429 ' HB3' HD13 ' A' ' 66' ' ' LEU . 41.8 p90 -139.37 156.66 46.86 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.668 -0.413 . . . . 72.420000000000002 110.966 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 36.5 mmt180 -123.63 131.16 53.55 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.384 -0.969 . . . . 72.430000000000007 108.384 174.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.58 120.57 24.22 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.41 -0.589 . . . . 54.020000000000003 109.41 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -135.38 138.36 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.362 -0.381 . . . . 74.120000000000005 110.4 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -105.44 109.81 3.31 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.79 -0.924 . . . . 62.43 110.79 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.3 m -109.92 143.16 40.26 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.526 0.679 . . . . 70.540000000000006 110.603 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.9 t -90.54 110.35 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 N-CA-C 106.175 -1.787 . . . . 75.239999999999995 106.175 171.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -102.16 104.42 36.55 Favored Pre-proline 0 C--N 1.281 -2.386 0 N-CA-C 108.087 -1.079 . . . . 74.310000000000002 108.087 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.66 -21.04 13.19 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.295 1.996 . . . . 71.409999999999997 110.447 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.23 42.58 1.09 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.23 -0.896 . . . . 63.130000000000003 109.295 -176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.2 109.94 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 108.268 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.89 123.35 29.31 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.943 0.878 . . . . 73.420000000000002 112.418 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.8 m -80.9 136.46 36.06 Favored 'General case' 0 N--CA 1.407 -2.588 0 CA-C-N 113.965 -1.47 . . . . 75.019999999999996 109.303 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.7 p80 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 108.637 -0.875 . . . . 73.010000000000005 108.637 175.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 109.141 -0.689 . . . . 63.520000000000003 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.0 -67.23 0.41 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 120.619 -0.801 . . . . 43.32 111.58 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 t 62.08 73.99 0.45 Allowed 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.555 -0.906 . . . . 75.040000000000006 108.555 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -86.46 84.75 7.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.405 -0.816 . . . . 74.319999999999993 112.813 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -124.58 155.91 38.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 105.136 -2.172 . . . . 74.0 105.136 171.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -157.36 155.67 30.99 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.568 -0.853 . . . . 54.509999999999998 111.829 -174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.53 85.93 2.86 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 105.855 -1.906 . . . . 52.310000000000002 105.855 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.57 148.55 11.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.745 -0.661 . . . . 75.150000000000006 109.925 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.03 109.99 10.14 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.066 -1.087 . . . . 73.340000000000003 108.066 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.18 115.23 27.48 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.887 -1.051 . . . . 74.400000000000006 109.792 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.8 73.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 123.338 1.542 . . . . 74.040000000000006 110.506 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.93 -166.0 1.16 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.505 -1.68 . . . . 73.099999999999994 107.694 178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -117.08 148.54 41.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.148 -1.021 . . . . 74.129999999999995 110.382 -174.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -74.35 -40.81 61.91 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.451 -2.055 . . . . 73.239999999999995 105.451 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.92 149.23 33.83 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.791 -0.818 . . . . 71.129999999999995 108.791 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -105.28 150.26 25.31 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.166 -1.42 . . . . 62.509999999999998 107.166 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -83.65 69.85 10.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.62 0.724 . . . . 74.219999999999999 109.541 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 m -83.04 95.47 8.05 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-N 115.098 -0.955 . . . . 75.140000000000001 108.743 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.6 t -94.68 98.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 108.121 -1.066 . . . . 52.130000000000003 108.121 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 116.39 0.85 Allowed Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.271 -0.732 . . . . 70.140000000000001 111.271 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 15.6 t70 -171.42 158.16 5.16 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.489 -2.041 . . . . 74.140000000000001 105.489 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.82 -41.4 86.78 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 123.874 0.734 . . . . 64.030000000000001 111.439 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HA ' HG13 ' A' ' 26' ' ' ILE . 82.8 m-85 -70.39 -32.57 70.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.261 -0.427 . . . . 70.349999999999994 110.375 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' SER . . . -65.69 -34.86 79.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.2 -0.667 . . . . 72.230000000000004 109.2 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 24.3 mmt180 -67.57 -52.26 40.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.711 -0.677 . . . . 72.540000000000006 110.21 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.429 HG13 ' HA ' ' A' ' 23' ' ' PHE 0.311 2.7 pp -67.71 -31.69 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 115.25 1.574 . . . . 72.439999999999998 115.25 -176.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 30' ' ' SER . 30.6 m-85 -81.58 -28.15 33.94 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.221 -0.992 . . . . 72.140000000000001 111.109 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.89 59.52 0.74 Allowed Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 120.302 -0.951 . . . . 51.439999999999998 112.993 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.6 20.37 56.48 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 121.359 -0.448 . . . . 75.409999999999997 112.638 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 50.2 m -151.98 153.64 34.46 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 122.248 -0.56 . . . . 62.43 109.707 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 23' ' ' PHE . 4.6 tt -155.05 131.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.645 -0.872 . . . . 72.239999999999995 108.645 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.2 m -125.15 89.4 52.68 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-O 121.328 0.585 . . . . 72.299999999999997 110.747 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 3.8 Cg_exo -80.38 -54.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.307 2.004 . . . . 71.239999999999995 111.573 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -62.18 -24.45 67.21 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.242 -0.89 . . . . 55.219999999999999 112.101 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.34 -55.11 39.17 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.214 -0.661 . . . . 74.219999999999999 109.214 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.67 -42.67 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.113 -0.948 . . . . 71.230000000000004 109.503 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 42.3 mt-10 -56.77 -54.75 42.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 72.5 111.891 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.14 -37.13 81.75 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.335 0.254 . . . . 65.140000000000001 111.558 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 121' ' ' ALA . 2.6 tm? -61.96 -45.73 92.38 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.994 -0.743 . . . . 74.099999999999994 108.994 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -73.93 -29.14 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.043 0.757 . . . . 73.409999999999997 113.043 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 67.2 mtt180 -63.92 -41.53 97.62 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.002 -1.11 . . . . 74.400000000000006 108.002 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.32 -47.65 81.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.93 -1.032 . . . . 72.109999999999999 110.931 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -59.43 -42.55 92.13 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.134 0.574 . . . . 64.420000000000002 110.482 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.17 82.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 72.420000000000002 110.949 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.5 -29.02 63.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 71.450000000000003 111.981 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.49 -36.72 32.97 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.518 -0.31 . . . . 54.32 110.567 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.69 18.92 27.49 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.13 -0.487 . . . . 75.120000000000005 113.652 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -68.83 133.91 31.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 C-N-CA 123.364 0.666 . . . . 74.519999999999996 110.725 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' HD23 ' A' ' 57' ' ' LEU . 94.3 mt-30 -107.03 147.96 29.3 Favored 'General case' 0 CA--C 1.473 -1.994 0 N-CA-C 109.061 -0.718 . . . . 73.200000000000003 109.061 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -86.38 91.62 8.57 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.011 -1.107 . . . . 72.349999999999994 108.011 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 21.9 tp -98.9 -165.55 1.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.825 -1.546 . . . . 73.25 106.825 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.661 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.5 mt-30 -44.6 148.46 0.49 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.685 1.194 . . . . 65.540000000000006 111.449 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.87 -15.95 56.04 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.731 -0.668 . . . . 75.409999999999997 113.185 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -61.6 -48.67 79.88 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.791 -0.448 . . . . 74.329999999999998 109.791 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -168.51 149.27 4.73 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.924 -0.58 . . . . 61.450000000000003 111.242 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.04 151.72 20.92 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.047 0.939 . . . . 63.149999999999999 110.594 -173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD23 ' OE1' ' A' ' 49' ' ' GLN . 15.7 tp -89.9 127.68 36.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.844 -0.616 . . . . 75.549999999999997 109.603 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.68 158.0 40.05 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 123.381 0.672 . . . . 61.240000000000002 109.275 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.573 ' HA ' HG22 ' A' ' 125' ' ' VAL . 34.9 Cg_exo -62.93 148.34 93.57 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.62 2.214 . . . . 60.299999999999997 111.611 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 33.9 p-10 -120.77 -28.41 4.87 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.81 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.68 124.61 50.25 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 108.436 -0.95 . . . . 72.129999999999995 108.436 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 106' ' ' VAL . 45.3 m-85 -121.38 127.69 51.47 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.873 -0.417 . . . . 74.209999999999994 109.873 -178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.37 120.13 63.94 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.943 -0.762 . . . . 71.340000000000003 108.943 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.54 123.67 68.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.928 -0.767 . . . . 74.230000000000004 108.928 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.1 m -104.28 124.89 49.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.579 -0.282 . . . . 72.010000000000005 110.39 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -115.0 165.47 12.85 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.408 0.683 . . . . 61.140000000000001 110.168 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.25 145.23 31.73 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.934 -1.667 . . . . 64.510000000000005 108.934 175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.4 p -50.29 -43.04 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 113.937 1.088 . . . . 75.239999999999995 113.937 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -64.73 -36.61 84.84 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.138 0.494 . . . . 75.510000000000005 111.445 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 116' ' ' THR . 13.0 t70 -86.33 -23.47 26.23 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.639 -0.824 . . . . 64.420000000000002 110.082 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -65.13 -30.87 71.83 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.096 -0.705 . . . . 62.140000000000001 109.096 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.6 mt-10 -57.46 -33.76 68.3 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.036 -0.529 . . . . 75.010000000000005 110.44 175.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -74.57 -39.16 62.44 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.598 -0.89 . . . . 63.329999999999998 108.598 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.481 HD11 ' HG ' ' A' ' 66' ' ' LEU . 89.5 mt -62.41 -37.34 85.43 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.658 0.742 . . . . 72.040000000000006 109.083 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.2 -171.29 13.62 Favored Glycine 0 N--CA 1.414 -2.822 0 CA-C-N 114.615 -1.175 . . . . 55.130000000000003 110.813 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -93.58 -5.81 48.03 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 120.671 0.272 . . . . 55.509999999999998 110.334 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -89.6 111.18 44.35 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 115.702 -0.681 . . . . 71.409999999999997 112.422 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 5.8 Cg_exo -77.94 -51.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.308 2.005 . . . . 73.409999999999997 113.029 172.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 107' ' ' ARG . 48.9 mt-10 -86.54 -39.36 16.29 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 118.476 2.769 . . . . 75.209999999999994 118.476 -169.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -59.98 -52.47 65.24 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.419 1.009 . . . . 70.450000000000003 113.057 -168.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -63.91 -32.13 73.56 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 122.692 1.234 . . . . 65.209999999999994 110.742 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 106' ' ' VAL . 37.9 m -75.8 -17.3 59.91 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.101 -1.409 . . . . 51.219999999999999 112.022 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 m -69.44 -41.87 75.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.372 -0.603 . . . . 71.019999999999996 109.372 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.97 -36.14 61.07 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.9 -0.88 . . . . 42.329999999999998 110.9 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -65.03 -46.51 81.01 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.22 0.533 . . . . 74.329999999999998 109.795 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.85 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.042 -0.526 . . . . 55.100000000000001 111.286 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -59.17 -45.02 92.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.277 0.561 . . . . 75.430000000000007 109.834 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -65.47 -43.72 89.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.982 -1.008 . . . . 62.200000000000003 110.187 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.82 -39.22 90.66 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 115.718 -0.673 . . . . 74.430000000000007 109.828 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -39.1 91.41 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.39 0.614 . . . . 63.100000000000001 110.462 177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -41.03 83.36 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.473 -0.785 . . . . 72.340000000000003 110.009 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 m-85 -56.31 -53.54 56.1 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.622 -0.717 . . . . 71.340000000000003 112.077 175.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.0 pt -62.88 -35.69 72.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 120.797 -0.361 . . . . 74.120000000000005 111.863 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -67.73 -37.19 81.85 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 121.135 -0.226 . . . . 52.25 110.793 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.7 -28.31 69.81 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.41 0.624 . . . . 72.120000000000005 110.483 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 60.2 mm-40 -88.33 -4.68 58.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.985 -0.552 . . . . 60.439999999999998 111.162 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.04 26.94 59.18 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.857 -0.61 . . . . 65.140000000000001 112.416 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -98.44 161.41 13.7 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.929 -0.767 . . . . 75.230000000000004 108.929 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -129.72 174.61 9.54 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 110.068 -0.345 . . . . 75.439999999999998 110.068 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 8.5 t -165.15 170.4 14.99 Favored 'General case' 0 N--CA 1.405 -2.683 0 N-CA-C 105.409 -2.071 . . . . 72.549999999999997 105.409 175.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.08 118.01 33.73 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.092 -1.447 . . . . 64.209999999999994 107.092 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.78 -149.49 16.72 Favored Glycine 0 N--CA 1.414 -2.826 0 C-N-CA 119.218 -1.468 . . . . 75.329999999999998 109.885 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -132.28 163.48 28.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.662 -1.236 . . . . 65.319999999999993 107.662 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.3 t -76.66 131.99 33.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.255 0.55 . . . . 73.329999999999998 112.177 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.95 120.52 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-N 115.233 -0.894 . . . . 64.319999999999993 109.294 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.3 m -112.25 143.36 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 107.071 -1.455 . . . . 75.120000000000005 107.071 178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.3 mtt180 -142.45 150.67 40.87 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.71 0.29 . . . . 74.109999999999999 110.809 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.0 151.14 23.56 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.878 -0.601 . . . . 72.140000000000001 109.503 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -140.71 166.58 24.36 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.94 -1.133 . . . . 53.299999999999997 107.94 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.26 152.57 38.73 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.685 -0.487 . . . . 74.219999999999999 109.685 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.7 m -134.02 138.84 45.64 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 115.902 -0.59 . . . . 62.509999999999998 109.669 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 t -80.53 -23.63 39.9 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.801 -0.814 . . . . 63.439999999999998 108.801 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -82.18 -5.17 58.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.859 -0.61 . . . . 71.299999999999997 111.529 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 30.5 tp -107.3 148.28 29.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.412 -1.329 . . . . 73.120000000000005 107.412 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -119.07 156.7 29.24 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.826 -0.749 . . . . 62.420000000000002 111.055 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 70' ' ' ASP . 4.7 m -49.2 121.14 4.57 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 126.248 1.819 . . . . 60.140000000000001 111.528 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.96 -30.78 6.9 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.832 -0.907 . . . . 70.040000000000006 110.832 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.77 131.1 39.47 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.223 -0.658 . . . . 71.230000000000004 109.223 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 150.75 42.38 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.649 -0.871 . . . . 73.239999999999995 108.649 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -140.65 147.23 38.99 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.24 -0.652 . . . . 72.209999999999994 109.24 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -142.77 139.84 31.17 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 110.003 -0.369 . . . . 73.310000000000002 110.003 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -132.66 149.55 52.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.061 -0.518 . . . . 75.120000000000005 109.762 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.29 123.07 5.53 Favored Glycine 0 C--N 1.282 -2.44 0 N-CA-C 109.656 -1.378 . . . . 73.120000000000005 109.656 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.4 m -121.01 150.85 40.51 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.701 -0.852 . . . . 71.329999999999998 108.701 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 59' ' ' PRO . 46.6 t -98.58 118.09 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.411 -0.959 . . . . 73.299999999999997 108.411 178.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.08 101.97 7.36 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 107.124 -1.436 . . . . 63.310000000000002 107.124 171.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.5 Cg_endo -81.44 -9.31 12.51 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.09 1.86 . . . . 54.439999999999998 112.161 -175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -86.84 26.92 1.05 Allowed 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.772 -0.649 . . . . 63.240000000000002 112.053 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.49 101.01 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.091 -1.448 . . . . 73.219999999999999 107.091 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -88.79 156.36 19.01 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.074 -0.512 . . . . 61.509999999999998 109.982 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -80.37 123.36 27.95 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.492 0.663 . . . . 75.219999999999999 109.54 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.9 m80 . . . . . 0 C--N 1.292 -1.91 0 N-CA-C 107.566 -1.272 . . . . 74.540000000000006 107.566 -179.665 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm . . . . . 0 CA--C 1.5 -0.979 0 N-CA-C 108.923 -0.769 . . . . 54.329999999999998 108.923 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.0 -104.25 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 119.952 -1.118 . . . . 65.239999999999995 111.719 177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -118.26 106.43 12.79 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 109.54 -0.541 . . . . 52.210000000000001 109.54 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -139.08 107.33 5.77 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.048 -1.093 . . . . 64.010000000000005 108.048 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 -162.19 0.8 Allowed 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.793 -1.188 . . . . 73.319999999999993 107.793 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 23.2 mmt180 -77.28 91.89 3.84 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.342 -0.614 . . . . 74.200000000000003 109.342 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.99 106.84 2.9 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.387 -1.338 . . . . 72.540000000000006 107.387 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -73.83 144.2 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 108.281 -1.007 . . . . 73.239999999999995 108.281 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -42.75 111.62 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.426 1.491 . . . . 75.319999999999993 112.402 -174.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -95.21 177.32 5.9 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.522 -0.763 . . . . 72.409999999999997 111.978 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.55 144.97 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.468 -0.787 . . . . 72.129999999999995 110.702 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.23 114.55 8.48 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.028 -0.73 . . . . 73.540000000000006 109.028 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.7 mmt-85 -137.7 155.62 48.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.727 -0.842 . . . . 74.420000000000002 108.727 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.07 134.37 40.51 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.914 -1.143 . . . . 63.439999999999998 107.914 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -74.61 156.61 36.57 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.386 0.429 . . . . 74.230000000000004 110.436 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.75 124.93 24.65 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.433 0.635 . . . . 72.340000000000003 110.627 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -101.32 142.18 33.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.43 -0.805 . . . . 74.209999999999994 109.356 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.6 m -64.9 147.14 53.9 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 107.575 -1.268 . . . . 75.129999999999995 107.575 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 m -76.05 84.59 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 122.823 1.297 . . . . 74.409999999999997 111.153 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 67.67 2.07 Favored Glycine 0 N--CA 1.42 -2.371 0 CA-C-N 114.648 -1.16 . . . . 75.150000000000006 112.081 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.69 -40.35 83.36 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.115 0.483 . . . . 61.399999999999999 110.151 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.23 -51.21 68.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.107 -0.952 . . . . 25.219999999999999 110.102 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -56.54 -48.48 77.19 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.33 -0.85 . . . . 53.43 110.682 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.22 -49.41 74.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.592 -0.731 . . . . 74.319999999999993 111.576 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -72.24 -28.08 62.92 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.439 0.533 . . . . 72.230000000000004 112.439 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.8 mt -77.24 -55.89 9.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.899 0.38 . . . . 72.450000000000003 111.523 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -84.89 -13.55 50.54 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.623 0.601 . . . . 75.310000000000002 112.623 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.4 51.79 3.79 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.041 -0.823 . . . . 42.520000000000003 111.041 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.01 -73.61 0.46 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 110.955 -0.858 . . . . 65.409999999999997 110.955 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 t 57.38 32.19 21.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.16 0.984 . . . . 74.310000000000002 110.44 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.45 -44.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.646 -1.242 . . . . 74.5 107.646 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 p -140.24 119.86 8.81 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 114.63 -1.168 . . . . 41.210000000000001 108.923 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.34 74.23 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.783 1.655 . . . . 74.450000000000003 110.544 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -71.31 -42.0 69.19 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.84 -1.073 . . . . 73.409999999999997 110.53 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -58.53 -34.74 71.31 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.917 0.389 . . . . 53.009999999999998 111.043 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.57 -56.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.697 -0.683 . . . . 44.310000000000002 110.034 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.45 -25.47 64.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.18 -0.608 . . . . 63.439999999999998 111.901 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.02 94.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.202 0.525 . . . . 65.150000000000006 109.713 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.15 -37.92 66.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 120.045 -0.662 . . . . 62.509999999999998 109.938 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.28 0.474 . . . . 64.299999999999997 112.28 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -63.68 -29.96 71.13 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.961 0.41 . . . . 75.120000000000005 110.341 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 -69.13 -51.76 35.08 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 116.446 -0.343 . . . . 73.230000000000004 110.512 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -64.76 -30.87 71.89 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.344 0.403 . . . . 71.219999999999999 110.679 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.74 88.32 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.131 -0.486 . . . . 41.450000000000003 109.887 175.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -72.27 -25.9 61.78 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.818 0.818 . . . . 71.219999999999999 110.787 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -77.93 -24.91 48.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.268 -0.878 . . . . 70.150000000000006 110.791 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.65 17.01 54.2 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 115.87 -0.605 . . . . 34.240000000000002 112.826 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 45' ' ' ALA . 22.2 mm -67.5 131.55 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-O 121.059 0.457 . . . . 74.349999999999994 110.943 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 HE21 HD23 ' A' ' 57' ' ' LEU . 26.3 mt-30 -127.91 144.34 51.1 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 115.654 -0.703 . . . . 64.209999999999994 110.342 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 m -66.76 130.11 42.08 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 114.512 -1.222 . . . . 74.439999999999998 110.906 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.8 tp -149.12 -166.21 2.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 104.027 -2.583 . . . . 63.149999999999999 104.027 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 84.6 mm-40 -60.26 155.83 16.83 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.586 0.958 . . . . 64.409999999999997 113.586 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.71 -5.31 44.61 Favored Glycine 0 CA--C 1.507 -0.407 0 CA-C-N 114.991 -1.004 . . . . 64.049999999999997 114.678 -170.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -42.79 51.38 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.29 -0.633 . . . . 74.420000000000002 109.29 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.492 ' HD3' ' HB3' ' A' ' 99' ' ' GLN . 13.2 ptp180 -165.06 140.69 5.41 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.636 -0.711 . . . . 73.219999999999999 112.501 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.89 152.48 20.72 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.117 1.367 . . . . 74.530000000000001 110.282 -172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 100' ' ' THR . 44.9 tp -79.07 127.45 32.02 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.447 -0.575 . . . . 71.530000000000001 109.447 -176.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -122.26 164.46 25.77 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 123.575 0.75 . . . . 73.519999999999996 109.419 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HA ' HG22 ' A' ' 125' ' ' VAL . 44.9 Cg_exo -62.04 156.96 46.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.178 2.585 . . . . 71.510000000000005 113.525 176.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 29.7 p-10 -128.02 -30.12 2.49 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.342 -0.844 . . . . 63.149999999999999 110.739 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.06 117.55 32.68 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.165 -1.05 . . . . 71.030000000000001 108.165 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.82 114.14 22.19 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.46 0.648 . . . . 73.239999999999995 110.231 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.5 mt -108.11 111.9 37.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.97 -1.014 . . . . 64.420000000000002 108.944 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 3.0 mp -102.97 119.52 51.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.728 -0.842 . . . . 74.219999999999999 108.728 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 126.58 53.27 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 109.582 -0.525 . . . . 72.200000000000003 109.582 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.45 165.82 16.43 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 122.915 0.486 . . . . 64.019999999999996 110.642 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.08 146.68 50.44 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.734 -1.747 . . . . 43.439999999999998 108.734 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -46.2 -54.96 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 113.606 0.965 . . . . 75.519999999999996 113.606 -173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -69.06 -29.94 68.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.436 0.532 . . . . 72.25 112.436 -175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.25 -40.84 62.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.513 -1.291 . . . . 70.209999999999994 107.513 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -63.03 -34.27 77.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.216 -1.356 . . . . 63.420000000000002 111.891 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -53.79 -37.75 63.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.22 0.533 . . . . 62.310000000000002 111.134 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -85.41 -29.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.664 -0.698 . . . . 73.049999999999997 110.413 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 mt -71.91 -36.79 70.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.367 0.603 . . . . 63.240000000000002 109.962 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.49 12.54 26.74 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.256 -0.884 . . . . 62.140000000000001 112.557 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.32 -10.36 54.61 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.327 -0.62 . . . . 73.319999999999993 109.327 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -139.48 72.48 37.21 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.074 -0.512 . . . . 61.25 111.739 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.69 -28.03 31.37 Favored 'Trans proline' 0 C--O 1.236 0.419 0 N-CA-C 108.383 -1.429 . . . . 75.129999999999995 108.383 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.38 -53.67 54.88 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.28 -1.782 . . . . 74.310000000000002 111.343 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.95 -42.88 12.81 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.087 0.773 . . . . 63.109999999999999 113.087 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -76.56 -58.86 3.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.109 0.781 . . . . 72.120000000000005 113.109 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.8 m -63.29 -48.52 77.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.854 0.359 . . . . 72.400000000000006 110.998 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -64.87 -44.46 89.62 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 111.256 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.02 -56.49 20.41 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 115.773 -0.649 . . . . 63.030000000000001 112.625 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -61.27 -32.42 72.24 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 112.301 0.482 . . . . 72.099999999999994 112.301 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.27 86.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 71.209999999999994 111.229 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -82.1 -25.73 34.22 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.204 0.446 . . . . 75.319999999999993 112.204 -178.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.64 -43.85 65.39 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.486 -0.931 . . . . 65.420000000000002 108.486 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 92' ' ' TYR . 1.2 tm? -67.7 -31.79 71.99 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.769 -0.826 . . . . 73.310000000000002 108.769 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.93 -40.08 94.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 72.120000000000005 110.779 176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 29.1 t70 -74.33 -32.87 62.98 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.303 -0.629 . . . . 62.43 109.303 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -56.39 -57.6 11.61 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.438 -0.801 . . . . 73.230000000000004 110.191 173.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 45.3 pt -56.5 -30.08 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 120.995 -0.282 . . . . 64.420000000000002 111.198 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mm-40 -64.75 -45.43 86.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.842 -0.343 . . . . 72.230000000000004 110.926 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 50.3 mt-10 -59.79 -42.55 93.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.711 0.804 . . . . 63.420000000000002 111.895 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -80.64 -13.27 59.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 113.885 1.068 . . . . 74.349999999999994 113.885 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.71 39.41 9.6 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.597 -1.287 . . . . 50.329999999999998 112.52 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -112.12 174.45 5.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 122.519 -0.401 . . . . 73.430000000000007 110.272 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' A' ' 55' ' ' ARG . 26.7 pt20 -149.07 171.23 16.74 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.191 0.596 . . . . 72.519999999999996 109.611 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 57' ' ' LEU . 13.4 t -159.49 178.36 9.97 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.338 -0.986 . . . . 44.420000000000002 108.338 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -101.45 118.62 37.33 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.392 -0.966 . . . . 74.439999999999998 108.392 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.79 -149.46 16.6 Favored Glycine 0 N--CA 1.432 -1.591 0 C-N-CA 119.296 -1.431 . . . . 75.310000000000002 111.055 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -118.99 150.57 39.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.878 -1.527 . . . . 74.129999999999995 106.878 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.6 128.1 38.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 109.478 -0.564 . . . . 54.409999999999997 109.478 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.73 149.65 26.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 O-C-N 123.627 0.579 . . . . 74.549999999999997 110.039 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.96 113.98 25.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.252 0.549 . . . . 50.299999999999997 110.181 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -119.97 139.66 52.12 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.9 -0.591 . . . . 72.230000000000004 110.285 -176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.25 143.82 42.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.356 -0.609 . . . . 72.340000000000003 109.356 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -145.28 171.49 14.5 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.886 0.374 . . . . 70.25 111.653 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.88 159.54 15.56 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.785 -0.643 . . . . 61.340000000000003 110.875 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.2 p -143.74 141.78 30.63 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.496 -0.775 . . . . 54.130000000000003 109.229 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 p -81.36 -26.77 35.26 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.272 0.558 . . . . 71.439999999999998 110.809 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -77.86 -30.39 50.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.655 -0.702 . . . . 72.129999999999995 111.991 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.4 mt -82.72 150.7 26.57 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.904 -0.718 . . . . 61.130000000000003 111.518 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 118' ' ' GLN . 84.8 m-70 -97.1 173.54 7.2 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.939 -1.028 . . . . 73.019999999999996 110.606 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -70.71 130.58 42.12 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.239 -1.393 . . . . 75.430000000000007 107.239 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.87 -3.87 82.04 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.805 -0.712 . . . . 51.020000000000003 111.903 -174.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 115' ' ' HIS . 5.2 tp-100 -101.54 119.8 39.32 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.088 -1.449 . . . . 74.510000000000005 107.088 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -139.9 157.15 46.16 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.69 -0.804 . . . . 75.010000000000005 112.106 -174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -145.38 143.31 30.04 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.439 -1.255 . . . . 75.349999999999994 107.81 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . . . -134.56 139.12 45.15 Favored 'General case' 0 C--N 1.271 -2.847 0 N-CA-C 105.511 -2.033 . . . . 75.129999999999995 105.511 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -129.25 127.49 41.33 Favored 'General case' 0 C--N 1.278 -2.529 0 C-N-CA 119.99 -0.684 . . . . 70.140000000000001 109.999 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.33 117.47 5.87 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.297 -1.521 . . . . 61.43 109.297 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 90.4 m -121.16 145.82 47.42 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 122.767 0.427 . . . . 52.32 110.019 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 59' ' ' PRO . 47.1 t -93.52 110.07 22.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -108.45 104.12 53.12 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 109.693 -0.484 . . . . 73.230000000000004 109.693 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -89.51 3.43 5.35 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.38 2.054 . . . . 73.430000000000007 110.893 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -96.59 71.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.398 1.094 . . . . 74.019999999999996 109.834 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.99 121.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.482 -1.69 . . . . 73.519999999999996 106.548 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -73.31 143.88 46.79 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.242 -0.651 . . . . 75.430000000000007 109.242 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -88.46 116.3 26.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.976 -1.12 . . . . 73.510000000000005 107.976 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 107.19 -1.411 . . . . 64.329999999999998 107.19 -177.023 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.634 0.254 . . . . 72.319999999999993 110.651 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.19 166.38 40.38 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.872 -1.291 . . . . 63.530000000000001 109.872 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -79.93 -68.52 0.66 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.936 -0.705 . . . . 74.239999999999995 109.183 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 61.81 -0.74 0.4 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.046 1.339 . . . . 72.510000000000005 114.204 175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -71.84 129.97 39.93 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.448 0.642 . . . . 71.439999999999998 110.991 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -84.7 88.64 7.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.529 -0.759 . . . . 73.340000000000003 110.537 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.76 92.87 9.38 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.334 -0.987 . . . . 74.25 108.334 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.3 m -80.73 81.63 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 122.425 1.107 . . . . 74.519999999999996 110.434 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -110.88 140.58 45.23 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.815 -1.084 . . . . 75.109999999999999 110.165 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -84.15 89.63 7.34 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.72 -0.844 . . . . 62.329999999999998 108.72 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 p -130.93 117.02 36.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.356 -0.838 . . . . 30.039999999999999 109.084 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.27 146.27 24.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.938 -0.574 . . . . 73.319999999999993 112.229 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -159.38 173.19 16.63 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.742 -0.836 . . . . 35.32 108.742 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.12 174.72 10.26 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.323 -0.991 . . . . 74.319999999999993 108.323 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 tp -86.13 -43.25 13.2 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.147 -1.797 . . . . 75.209999999999994 106.147 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 81.03 2.27 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.142 -1.39 . . . . 71.519999999999996 109.493 177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -89.78 -32.02 17.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.134 -0.626 . . . . 74.140000000000001 109.98 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.6 m -86.2 123.68 31.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.248 -0.887 . . . . 74.239999999999995 109.286 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.63 101.11 12.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 116.186 -0.461 . . . . 63.119999999999997 109.878 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.79 97.37 0.18 Allowed Glycine 0 C--N 1.316 -0.574 0 CA-C-N 115.653 -0.703 . . . . 54.130000000000003 111.983 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -162.38 151.95 15.92 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.298 -1.371 . . . . 62.240000000000002 107.298 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -58.72 -59.86 4.75 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 124.107 0.879 . . . . 70.519999999999996 111.581 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -68.41 -35.8 78.17 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.644 -0.253 . . . . 74.420000000000002 111.345 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.41 79.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.129999999999995 111.643 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 22' ' ' ALA . 10.4 ptp180 -81.1 -28.41 35.22 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 121.001 -0.28 . . . . 74.310000000000002 111.064 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 22' ' ' ALA . 80.1 mt -63.23 -50.21 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 110.013 -0.366 . . . . 73.150000000000006 110.013 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -81.3 -28.24 34.71 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.125 0.488 . . . . 73.319999999999993 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.86 -48.94 3.3 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 111.184 -0.767 . . . . 75.420000000000002 111.184 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.22 24.35 3.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 115.042 0.777 . . . . 70.209999999999994 115.042 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t 67.58 27.36 7.81 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 117.47 0.635 . . . . 52.439999999999998 111.418 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.16 121.06 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.553 -0.906 . . . . 72.519999999999996 108.553 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 m -125.64 162.26 45.91 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 109.051 -0.722 . . . . 70.230000000000004 109.051 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.3 -21.51 52.94 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.003 2.468 . . . . 63.020000000000003 112.02 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -62.84 -34.34 77.13 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.606 -0.725 . . . . 75.340000000000003 111.071 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -60.02 -44.1 94.83 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.98 0.895 . . . . 62.43 109.198 176.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 48.5 t -63.18 -55.87 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.772 -1.558 . . . . 43.539999999999999 110.74 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 pt-20 -64.44 -34.01 77.2 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.391 -0.523 . . . . 75.219999999999999 111.735 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.77 -46.3 91.01 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.919 -0.401 . . . . 62.520000000000003 109.919 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.96 -38.46 72.8 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.304 -0.407 . . . . 72.340000000000003 110.444 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.9 mt -60.34 -47.65 85.15 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.908 0.336 . . . . 74.549999999999997 111.908 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 15.2 ptm180 -71.58 -30.62 66.04 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 120.552 -0.459 . . . . 75.230000000000004 111.034 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -68.13 -41.43 81.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 72.540000000000006 109.269 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 122' ' ' ARG . 4.9 tp10 -64.51 -43.94 92.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.081 -0.963 . . . . 73.129999999999995 109.024 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.75 76.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 65.340000000000003 110.654 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.41 -30.42 71.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 60.219999999999999 112.64 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.39 -13.54 24.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 118.969 -1.092 . . . . 74.439999999999998 110.661 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.16 3.42 76.49 Favored Glycine 0 CA--C 1.502 -0.749 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.86 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.479 HG23 ' HB3' ' A' ' 56' ' ' LEU . 20.4 mm -55.55 127.67 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 C-N-CA 124.39 1.076 . . . . 73.230000000000004 111.028 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 35.2 tt0 -105.45 135.89 46.01 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.449 -1.315 . . . . 65.049999999999997 107.449 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -70.19 122.25 19.12 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 107.318 -1.364 . . . . 60.450000000000003 107.318 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 14.1 tp -127.02 -165.59 1.48 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 105.98 -1.859 . . . . 71.329999999999998 105.98 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.582 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 92.1 mt-30 -53.29 160.37 1.14 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.056 0.543 . . . . 70.349999999999994 111.733 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.77 -10.91 47.65 Favored Glycine 0 C--O 1.238 0.378 0 CA-C-N 116.124 -0.489 . . . . 60.409999999999997 113.233 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -68.45 -44.58 74.58 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.498 -0.186 . . . . 55.240000000000002 110.498 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -171.89 166.59 6.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 113.066 0.765 . . . . 71.409999999999997 113.066 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB3' HG23 ' A' ' 48' ' ' ILE . 76.8 mt -93.94 151.92 19.21 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 125.17 1.388 . . . . 73.409999999999997 111.401 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 31.0 tp -98.94 130.96 45.34 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 108.554 -0.906 . . . . 74.5 108.554 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.38 156.28 44.67 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 123.539 0.525 . . . . 74.030000000000001 110.424 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.3 Cg_exo -62.47 154.87 61.42 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.95 2.434 . . . . 72.420000000000002 112.229 176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 104' ' ' VAL . 29.0 p-10 -128.34 -28.09 2.6 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.04 -0.527 . . . . 62.020000000000003 112.131 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.7 119.15 35.76 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 120.067 -0.653 . . . . 73.209999999999994 109.703 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' HB2' HG22 ' A' ' 106' ' ' VAL . 68.7 m-85 -120.14 114.26 21.69 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.406 0.622 . . . . 71.019999999999996 109.792 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.2 mt -102.2 107.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.985 -1.117 . . . . 73.049999999999997 107.985 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.3 mt -102.02 115.28 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.054 -1.091 . . . . 72.150000000000006 108.054 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 16.9 m -109.06 121.83 45.99 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 115.927 -0.579 . . . . 75.219999999999999 110.152 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 4.6 mm? -110.03 174.75 5.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.851 1.26 . . . . 72.109999999999999 109.986 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.67 164.9 50.92 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 108.762 -1.735 . . . . 71.219999999999999 108.762 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.26 -33.12 61.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 118.316 1.058 . . . . 63.219999999999999 111.483 -176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.562 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 41.9 t60 -75.85 -28.5 58.23 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 120.449 -0.501 . . . . 73.239999999999995 109.729 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 33.0 m-20 -75.29 -31.96 60.86 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.145 -0.687 . . . . 74.219999999999999 109.145 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 78' ' ' PRO . 73.2 t80 -62.25 -44.49 96.43 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.338 -0.846 . . . . 74.230000000000004 110.734 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.57 -30.58 69.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.316 0.579 . . . . 73.25 110.771 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 74.3 mmtt -73.14 -24.27 60.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.408 -0.814 . . . . 73.530000000000001 110.647 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 98.4 mt -68.26 -31.62 71.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.056 -1.09 . . . . 71.400000000000006 108.056 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.56 179.76 19.65 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.231 -0.895 . . . . 52.149999999999999 111.621 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.32 -17.27 46.35 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.274 -1.009 . . . . 44.450000000000003 108.274 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -128.98 75.16 80.64 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.902 -1.045 . . . . 75.120000000000005 108.399 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 23.4 Cg_exo -69.15 -36.37 12.55 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.263 1.975 . . . . 73.530000000000001 111.836 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.52 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 2.8 tp10 -69.35 -12.16 61.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.649 -0.705 . . . . 73.230000000000004 110.631 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -70.56 -36.66 73.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 116.016 -0.538 . . . . 63.219999999999999 109.839 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -84.89 -13.18 51.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.912 -0.315 . . . . 72.109999999999999 111.824 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 19.9 m -61.1 -40.96 95.72 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 64.010000000000005 110.453 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -67.86 -29.09 68.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.785 -0.643 . . . . 73.239999999999995 110.007 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -45.3 91.89 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.425 -1.07 . . . . 44.25 110.425 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -68.65 -32.43 72.27 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 111.688 0.255 . . . . 70.129999999999995 111.688 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.69 -44.78 96.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 110.333 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -67.79 -44.15 78.07 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.528 -0.76 . . . . 64.329999999999998 110.625 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.77 -38.07 89.75 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.302 -0.408 . . . . 64.420000000000002 111.237 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.3 -41.79 72.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.439 -0.578 . . . . 74.430000000000007 109.439 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.63 90.68 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.439 0.638 . . . . 71.5 109.468 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -60.86 -53.62 55.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.481 -1.236 . . . . 74.219999999999999 108.779 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.632 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.5 m-85 -51.06 -55.37 17.89 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.924 0.713 . . . . 72.150000000000006 112.924 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 pt -62.16 -37.22 77.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 112.618 0.599 . . . . 72.450000000000003 112.618 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -71.74 -35.25 70.08 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.904 -0.319 . . . . 74.409999999999997 111.024 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.87 -31.98 73.46 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.261 0.553 . . . . 74.329999999999998 111.235 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.0 mm-40 -79.45 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.024 -0.534 . . . . 70.239999999999995 110.969 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.46 21.28 32.4 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.218 -0.515 . . . . 72.25 112.033 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -102.99 172.1 7.01 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.747 -0.834 . . . . 75.019999999999996 108.747 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -140.74 173.91 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.143 -0.688 . . . . 70.439999999999998 109.143 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.3 t -148.98 171.28 16.62 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.609 -0.886 . . . . 64.109999999999999 108.609 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 73.8 m-85 -114.43 121.05 42.37 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 109.476 -0.565 . . . . 62.130000000000003 109.476 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.83 -150.06 17.05 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 109.516 -1.434 . . . . 73.230000000000004 109.516 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -119.42 143.48 47.46 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.915 -1.143 . . . . 62.210000000000001 107.915 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 60' ' ' ASN . 69.9 t -74.66 118.12 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.173 -0.677 . . . . 75.510000000000005 109.173 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.8 120.23 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-O 122.131 0.967 . . . . 64.219999999999999 110.305 -178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.9 t -115.33 137.47 48.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 N-CA-C 106.297 -1.742 . . . . 73.420000000000002 106.297 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -141.18 139.31 33.84 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.47 0.481 . . . . 74.5 111.859 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -108.72 114.23 27.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.588 -0.893 . . . . 64.200000000000003 108.588 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.1 pt-20 -135.61 165.5 25.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.743 -0.208 . . . . 71.120000000000005 110.793 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.18 165.59 10.93 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 114.612 1.338 . . . . 62.329999999999998 114.612 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -134.22 141.69 47.12 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 106.541 -1.651 . . . . 42.130000000000003 106.541 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.0 p -80.7 -16.66 53.36 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.516 0.674 . . . . 74.430000000000007 110.295 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -83.49 -30.44 27.17 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 53.100000000000001 110.554 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.22 133.06 37.78 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.915 -0.584 . . . . 71.209999999999994 110.948 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -97.52 159.52 14.87 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.452 -0.794 . . . . 32.219999999999999 109.012 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.48 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 8.1 m -52.4 117.85 3.14 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 124.409 1.068 . . . . 74.150000000000006 111.863 -176.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.75 -1.84 28.93 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 120.938 -0.649 . . . . 64.209999999999994 112.842 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.21 123.87 50.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 120.925 0.393 . . . . 73.049999999999997 111.29 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' HB3' HD13 ' A' ' 66' ' ' LEU . 21.0 p90 -131.18 150.75 52.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.861 -0.792 . . . . 70.510000000000005 108.861 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -142.22 132.74 25.22 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.754 -0.832 . . . . 73.340000000000003 108.754 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.04 122.72 41.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.709 -0.848 . . . . 73.219999999999999 108.709 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.453 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.8 tpm_? -111.93 121.54 45.3 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.886 -0.783 . . . . 61.210000000000001 108.886 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -110.74 130.01 9.59 Favored Glycine 0 C--N 1.29 -2.008 0 N-CA-C 110.98 -0.848 . . . . 45.310000000000002 110.98 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.9 t -135.9 163.29 30.58 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.601 -0.518 . . . . 64.349999999999994 109.601 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 59' ' ' PRO . 45.1 t -99.15 107.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.773 -0.825 . . . . 63.140000000000001 108.773 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -116.39 99.68 52.91 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 109.649 -0.501 . . . . 64.519999999999996 109.649 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 6.8 Cg_exo -73.61 -23.97 16.47 Favored 'Trans proline' 0 C--O 1.246 0.92 0 C-N-CA 122.699 2.266 . . . . 63.130000000000003 112.429 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -86.73 66.85 9.65 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.123 0.963 . . . . 73.219999999999999 112.479 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.83 98.0 6.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 105.586 -2.005 . . . . 74.430000000000007 105.586 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.31 96.49 2.83 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.009 -0.996 . . . . 61.200000000000003 110.512 -175.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -91.15 163.05 14.41 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.582 -1.19 . . . . 44.240000000000002 110.033 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.8 t60 . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 106.955 -1.498 . . . . 72.310000000000002 106.955 176.183 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.674 -0.491 . . . . 75.439999999999998 109.674 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.52 54.96 0.19 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.794 -0.923 . . . . 52.329999999999998 110.794 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 m -108.51 82.75 1.66 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.602 0.715 . . . . 54.520000000000003 110.534 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -108.69 103.01 12.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.13 -0.941 . . . . 74.439999999999998 108.757 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 147.12 48.65 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.164 -0.615 . . . . 70.299999999999997 110.422 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -125.45 96.13 4.7 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.084 -1.821 . . . . 72.239999999999995 106.084 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.24 97.27 2.41 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.195 0.521 . . . . 74.239999999999995 111.965 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.26 127.24 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 107.103 -1.443 . . . . 70.109999999999999 107.103 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -92.98 -2.68 55.54 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.229 0.538 . . . . 73.209999999999994 111.498 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -95.84 138.41 33.52 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.196 -1.409 . . . . 73.519999999999996 107.196 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 p -82.63 89.69 2.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.47 -1.307 . . . . 74.420000000000002 107.47 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -50.62 110.42 0.41 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.116 -1.402 . . . . 53.439999999999998 111.94 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.19 118.82 4.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.395 -1.275 . . . . 71.510000000000005 110.665 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -88.65 109.29 19.99 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.749 -0.834 . . . . 62.009999999999998 108.749 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.9 tp -72.63 121.61 20.03 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.358 -0.837 . . . . 62.119999999999997 109.091 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.68 101.56 1.69 Allowed 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.748 -1.575 . . . . 74.430000000000007 106.748 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -67.72 166.19 15.73 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.336 -0.847 . . . . 74.219999999999999 110.696 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -56.3 107.26 0.35 Allowed 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.73 0.644 . . . . 75.420000000000002 110.407 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -72.81 106.81 3.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.78 -0.822 . . . . 75.329999999999998 108.78 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 45.87 1.83 Allowed Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.475 -1.05 . . . . 62.25 110.475 -177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.566 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 11.2 t70 -135.36 120.87 19.28 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.861 -1.163 . . . . 72.109999999999999 107.861 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.06 -40.13 92.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.079 0.862 . . . . 61.25 112.844 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -65.65 -42.64 91.16 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.325 -0.398 . . . . 62.329999999999998 110.184 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.07 72.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.603 -0.726 . . . . 62.130000000000003 111.018 177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 25.2 mmm180 -71.65 -47.61 53.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.367 0.603 . . . . 74.349999999999994 109.596 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -53.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.877 -1.056 . . . . 72.219999999999999 112.111 -176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -78.01 -28.98 49.32 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.909 -0.716 . . . . 55.32 111.68 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.04 -14.19 28.15 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.412 -0.675 . . . . 74.239999999999995 111.412 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.77 99.5 0.19 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 108.033 -2.027 . . . . 71.530000000000001 108.033 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.9 m -43.37 125.81 3.99 Favored 'General case' 0 C--O 1.251 1.145 0 C-N-CA 125.689 1.595 . . . . 43.229999999999997 114.108 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.13 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.395 -1.335 . . . . 70.219999999999999 107.395 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -111.35 155.21 43.15 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 116.031 -0.531 . . . . 72.409999999999997 110.587 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.97 -18.41 9.43 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.974 3.116 . . . . 52.030000000000001 113.705 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 37' ' ' GLU . 27.2 mt-30 -65.85 -30.93 71.62 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 116.551 -0.295 . . . . 73.209999999999994 111.18 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.24 -34.13 74.32 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.457 -0.942 . . . . 62.310000000000002 108.457 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.8 t -68.06 -48.05 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.623 -1.171 . . . . 22.420000000000002 109.96 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -66.33 -33.79 76.52 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.375 -0.53 . . . . 75.549999999999997 110.934 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.73 82.46 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.566 -0.531 . . . . 53.140000000000001 109.566 175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.8 mt -66.16 -32.94 74.68 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 115.31 -0.859 . . . . 74.099999999999994 111.844 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 80.9 mt -69.74 -38.44 76.83 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 123.06 0.225 . . . . 64.450000000000003 111.19 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 74.9 mtm180 -62.68 -43.23 99.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.538 -0.912 . . . . 72.540000000000006 108.538 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -40.66 90.62 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.0 -1.0 . . . . 75.409999999999997 111.698 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -60.47 -46.47 89.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.425 0.69 . . . . 61.229999999999997 109.845 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.36 92.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.482 -0.781 . . . . 52.450000000000003 110.83 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.68 -31.35 68.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 62.219999999999999 111.888 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.03 -35.87 31.32 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 122.11 -0.369 . . . . 73.219999999999999 111.121 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.99 13.73 52.69 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.814 -0.63 . . . . 62.149999999999999 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 48' ' ' ILE . 15.6 mm -55.88 137.03 17.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 123.43 0.692 . . . . 75.099999999999994 111.978 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 23.0 tt0 -119.56 132.97 55.86 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.25 -1.389 . . . . 64.310000000000002 107.25 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -66.51 134.89 53.34 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 121.684 0.754 . . . . 65.0 109.992 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 17.2 tp -149.7 -165.53 2.3 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 103.096 -2.928 . . . . 75.319999999999993 103.096 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.509 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 76.5 mt-30 -54.52 146.36 16.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.083 0.856 . . . . 72.040000000000006 109.506 172.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.87 -12.92 58.41 Favored Glycine 0 C--O 1.237 0.333 0 CA-C-N 116.773 -0.194 . . . . 72.319999999999993 113.114 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -61.85 -40.02 93.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.208 -0.664 . . . . 71.430000000000007 109.208 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -167.94 132.83 1.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.416 -0.811 . . . . 73.310000000000002 110.885 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.4 mt -90.76 152.17 20.91 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 124.692 1.197 . . . . 73.109999999999999 109.641 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -88.84 122.14 31.93 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.482 -1.303 . . . . 73.530000000000001 107.482 -174.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.3 160.16 26.98 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.33 -0.619 . . . . 64.439999999999998 109.33 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.66 151.08 72.62 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 111.049 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 5.3 p-10 -123.24 -27.59 4.12 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.415 -0.514 . . . . 54.240000000000002 111.46 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -106.03 110.91 23.33 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.098 -1.075 . . . . 74.349999999999994 108.098 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.91 131.73 54.8 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 109.892 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.4 mt -121.84 111.73 32.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 109.613 -0.514 . . . . 63.210000000000001 109.613 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.17 109.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.978 -1.489 . . . . 64.209999999999994 106.978 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.425 ' HB ' ' HG2' ' A' ' 120' ' ' ARG . 8.7 m -112.94 126.48 55.53 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.088 -0.708 . . . . 64.140000000000001 109.088 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.2 mm? -105.22 156.14 18.39 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.377 -0.972 . . . . 74.5 108.377 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.64 146.73 50.53 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 109.323 -1.511 . . . . 74.230000000000004 109.323 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.477 HG23 ' NE2' ' A' ' 110' ' ' GLN . 3.3 p -53.83 -40.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 112.516 0.562 . . . . 52.509999999999998 112.516 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 23.9 t60 -62.17 -33.37 74.38 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 123.336 0.654 . . . . 70.450000000000003 111.004 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.51 -44.33 12.79 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.619 0.247 . . . . 73.439999999999998 111.011 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CB ' ' HB3' ' A' ' 110' ' ' GLN . 35.6 t80 -66.28 -34.89 79.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 111.957 0.355 . . . . 73.140000000000001 111.957 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 68' ' ' VAL . 14.9 pt-20 -63.45 -31.87 73.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.187 0.518 . . . . 74.239999999999995 110.671 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 46.3 mmtm -73.52 -28.1 61.72 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.603 -0.726 . . . . 74.010000000000005 109.869 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -71.43 -39.11 71.25 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.996 -0.742 . . . . 54.43 108.996 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.85 175.02 15.59 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 111.217 -0.753 . . . . 75.219999999999999 111.217 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.625 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -94.62 1.25 55.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.712 0.291 . . . . 71.329999999999998 111.236 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -103.9 95.65 8.07 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.852 1.056 . . . . 64.140000000000001 113.852 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 6.3 Cg_exo -76.8 -43.78 0.25 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.886 2.391 . . . . 64.140000000000001 112.116 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.699 ' HA ' ' OG ' ' A' ' 82' ' ' SER . 44.5 tt0 -63.88 -29.98 71.12 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.016 0.747 . . . . 74.340000000000003 113.016 -172.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.8 tp -62.65 -24.23 67.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.974 -0.557 . . . . 73.0 110.456 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -99.88 -36.75 9.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 111.411 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.699 ' OG ' ' HA ' ' A' ' 79' ' ' GLU . 23.2 p -66.32 -45.39 80.44 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.375 0.509 . . . . 75.030000000000001 112.375 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.9 m -67.31 -39.85 85.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 120.522 -0.471 . . . . 53.149999999999999 110.925 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.0 -51.29 52.49 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.956 -0.566 . . . . 61.420000000000002 111.774 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.92 -30.66 70.87 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.635 0.605 . . . . 73.200000000000003 112.635 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -65.47 -48.05 73.98 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 120.907 0.384 . . . . 64.510000000000005 110.151 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -67.54 -38.02 83.56 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.56 -0.746 . . . . 72.420000000000002 109.822 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.57 -47.07 80.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.498 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.1 tp -72.37 -31.84 65.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.895 -0.593 . . . . 65.510000000000005 110.832 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.19 93.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.108 -0.701 . . . . 44.130000000000003 109.108 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 36.3 t70 -62.59 -44.46 96.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.167 -0.924 . . . . 72.209999999999994 109.636 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 18.0 m-85 -55.23 -54.25 45.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.786 0.679 . . . . 52.32 112.42 175.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.7 pt -62.35 -32.95 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.163 0.506 . . . . 70.409999999999997 111.213 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -64.93 -41.89 95.14 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.699 -0.682 . . . . 75.010000000000005 110.723 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 49.0 mt-10 -62.99 -39.19 94.0 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.293 0.568 . . . . 71.150000000000006 111.032 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 76.9 mm-40 -73.57 -14.24 61.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.321 -0.854 . . . . 65.420000000000002 112.336 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 38.21 13.48 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.217 -0.992 . . . . 64.209999999999994 110.972 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -115.18 -178.95 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.271 -0.641 . . . . 73.439999999999998 109.271 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -157.21 178.34 10.45 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.771 -0.825 . . . . 73.120000000000005 108.771 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 11.2 t -156.7 173.57 16.76 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.538 -0.912 . . . . 71.530000000000001 108.538 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.0 m-85 -115.93 124.02 49.54 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 109.306 -0.628 . . . . 74.200000000000003 109.306 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.0 -149.45 18.18 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.115 -1.194 . . . . 71.219999999999999 110.115 -177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -112.32 142.74 44.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.749 -0.834 . . . . 44.130000000000003 108.749 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.04 104.0 11.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.296 -1.372 . . . . 74.340000000000003 107.296 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 p -125.84 120.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 CA-C-O 121.733 0.778 . . . . 65.209999999999994 110.434 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 86' ' ' ALA . 7.3 p -110.91 127.87 67.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 108.108 -1.071 . . . . 64.109999999999999 108.108 178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -106.22 132.74 51.92 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.361 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -115.26 114.29 25.0 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.265 -2.124 . . . . 70.25 105.265 171.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.02 173.24 12.63 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.239 0.542 . . . . 62.229999999999997 111.893 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.477 ' NE2' HG23 ' A' ' 68' ' ' VAL . 16.1 pt20 -119.86 164.84 15.42 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 114.903 -1.044 . . . . 72.439999999999998 109.762 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.7 t -143.88 141.42 30.28 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.804 -1.554 . . . . 71.340000000000003 106.804 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -81.01 -16.61 52.91 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.049 -1.093 . . . . 53.030000000000001 108.049 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -82.57 -4.34 57.48 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.049 -0.978 . . . . 74.409999999999997 110.793 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.73 131.05 56.33 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.112 -1.07 . . . . 72.310000000000002 108.112 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 118' ' ' GLN . 40.2 m80 -100.72 172.35 7.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.587 -0.279 . . . . 64.450000000000003 111.388 -175.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.7 t -68.3 145.31 54.34 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.171 0.51 . . . . 71.150000000000006 110.635 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.65 -4.89 76.56 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.097 -1.201 . . . . 72.400000000000006 110.097 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 115' ' ' HIS . 52.4 mt-30 -119.74 133.22 55.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.987 0.915 . . . . 64.25 109.335 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.472 ' HB3' HD13 ' A' ' 66' ' ' LEU . 50.5 p90 -159.9 157.0 28.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.136 -1.431 . . . . 74.409999999999997 107.136 177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 9.1 ptp85 -135.84 153.92 51.34 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.581 -0.525 . . . . 62.32 109.581 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.08 118.03 11.15 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 105.264 -2.124 . . . . 51.219999999999999 105.264 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.99 137.41 21.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.402 -0.962 . . . . 73.439999999999998 108.402 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -117.65 142.56 17.3 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.501 -1.04 . . . . 65.530000000000001 110.501 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.8 t -136.05 156.7 48.34 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.275 -0.639 . . . . 73.340000000000003 109.275 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.33 110.11 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.564 -0.902 . . . . 72.420000000000002 108.564 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -130.91 91.93 35.32 Favored Pre-proline 0 C--N 1.292 -1.895 0 N-CA-C 108.043 -1.095 . . . . 74.120000000000005 108.043 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 51.2 Cg_endo -72.18 -15.13 28.79 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.031 1.82 . . . . 61.039999999999999 111.334 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.62 65.16 9.02 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.599 1.19 . . . . 72.239999999999995 111.533 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 p -136.29 127.58 43.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-N 113.11 -1.859 . . . . 74.420000000000002 106.288 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -68.73 118.17 11.38 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.282 0.563 . . . . 74.129999999999995 110.268 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.0 t -122.4 88.4 2.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.882 1.325 . . . . 65.200000000000003 111.992 -173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 106.935 -1.505 . . . . 71.299999999999997 106.935 176.926 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.503 -0.861 0 N-CA-C 110.224 -0.287 . . . . 75.109999999999999 110.224 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.97 149.02 5.47 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.994 -1.642 . . . . 64.239999999999995 108.994 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.414 ' HB3' ' HE2' ' A' ' 5' ' ' LYS . 63.6 m -85.06 89.5 7.63 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.812 0.815 . . . . 75.310000000000002 110.1 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -103.24 123.6 47.05 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.191 -0.913 . . . . 73.439999999999998 109.598 -178.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -171.59 159.07 5.32 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.976 -1.49 . . . . 54.299999999999997 106.976 175.724 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -101.44 109.75 21.63 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.92 -1.141 . . . . 65.439999999999998 107.92 176.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -81.76 87.86 6.31 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.791 -2.3 . . . . 70.340000000000003 104.791 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 10' ' ' ARG . 10.7 p -92.53 129.45 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 114.74 -1.118 . . . . 54.109999999999999 109.954 -174.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -110.49 24.96 12.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.748 -0.66 . . . . 72.239999999999995 112.277 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HD3' ' O ' ' A' ' 10' ' ' ARG 0.321 0.0 OUTLIER -83.63 105.31 14.44 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 118.616 -1.233 . . . . 71.510000000000005 111.076 173.61 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.61 127.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.445 -0.798 . . . . 64.430000000000007 110.14 -178.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.39 150.31 29.87 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 109.018 -0.734 . . . . 73.120000000000005 109.018 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 150.25 50.0 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.12 -0.491 . . . . 73.349999999999994 109.996 -178.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -166.22 152.59 9.12 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 106.244 -1.761 . . . . 72.430000000000007 106.244 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.85 74.94 8.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.349 -1.352 . . . . 74.319999999999993 107.349 171.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.522 ' OE1' ' HG2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -105.59 163.03 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.15 -1.387 . . . . 74.010000000000005 109.163 -174.273 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.522 ' HG2' ' OE1' ' A' ' 16' ' ' GLU . 12.7 pt20 -79.72 147.12 32.05 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.031 -0.531 . . . . 72.340000000000003 110.562 -178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -77.79 106.07 9.38 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.754 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t -85.34 123.9 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 107.041 -1.466 . . . . 53.229999999999997 107.041 178.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 33' ' ' PRO . . . 83.35 36.31 14.93 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 108.5 -1.84 . . . . 51.25 108.5 -172.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.611 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 18.5 t70 -54.64 -37.67 65.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.059 0.944 . . . . 64.420000000000002 111.76 -176.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -60.58 -44.87 95.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 110.395 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -65.83 -41.2 92.07 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.751 -0.659 . . . . 62.109999999999999 110.293 178.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -48.13 77.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 75.239999999999995 111.195 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 20.6 ptt85 -74.03 -26.03 60.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.177 0.806 . . . . 54.119999999999997 113.177 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.7 mt -71.36 -37.69 66.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 109.305 -0.628 . . . . 72.420000000000002 109.305 173.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -75.47 -28.62 59.31 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.053 -0.522 . . . . 64.200000000000003 109.82 178.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.18 -86.14 0.77 Allowed Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 121.132 -0.556 . . . . 72.209999999999994 112.472 175.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.17 -21.76 40.6 Favored Glycine 0 C--N 1.315 -0.622 0 C-N-CA 121.126 -0.559 . . . . 61.130000000000003 113.511 -176.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 m -74.44 107.86 6.85 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.345 0.593 . . . . 63.32 110.48 -179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.1 pt -84.16 -25.92 7.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 114.914 1.45 . . . . 62.539999999999999 114.914 -173.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.46 96.39 49.81 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 120.062 -0.655 . . . . 62.030000000000001 111.827 -177.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' HG2' ' O ' ' A' ' 20' ' ' GLY . 5.3 Cg_exo -87.08 -23.3 1.56 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.762 2.308 . . . . 64.310000000000002 111.708 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.4 -17.41 64.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.728 -0.669 . . . . 63.210000000000001 112.359 -176.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -63.14 -25.58 68.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.296 -0.411 . . . . 64.219999999999999 110.501 -178.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.2 t -63.16 -47.47 92.24 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 116.282 -0.417 . . . . 60.5 110.438 178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 48.5 mt-10 -63.47 -48.24 78.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.794 0.331 . . . . 72.099999999999994 110.534 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.17 86.32 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.402 -0.817 . . . . 74.109999999999999 111.865 -178.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.54 -33.68 62.79 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.379 -0.373 . . . . 65.129999999999995 110.539 -178.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -73.57 -36.67 65.62 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.457 -0.497 . . . . 44.119999999999997 111.03 -177.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -71.76 -25.21 61.95 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.377 -0.929 . . . . 74.510000000000005 110.368 175.587 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -68.78 -37.33 79.23 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 107.981 -1.118 . . . . 73.109999999999999 107.981 175.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -68.49 -40.07 81.04 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 115.37 -0.832 . . . . 73.239999999999995 109.49 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.01 93.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.047 -0.524 . . . . 72.239999999999995 110.834 177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.76 -33.28 58.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.974 -0.557 . . . . 42.530000000000001 111.189 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.8 -33.69 57.99 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.488 0.661 . . . . 72.430000000000007 109.715 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.33 8.13 59.08 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.202 -0.908 . . . . 74.430000000000007 113.59 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.48 HG21 HD13 ' A' ' 56' ' ' LEU . 9.5 mm -56.44 135.08 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 C-N-CA 123.434 0.693 . . . . 73.540000000000006 111.537 177.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 19.0 tt0 -124.52 142.86 51.02 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 108.216 -1.031 . . . . 73.239999999999995 108.216 -177.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 m -76.48 131.8 39.23 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.698 -0.683 . . . . 54.409999999999997 110.995 -177.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.2 tp -148.06 -168.99 3.23 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 105.174 -2.158 . . . . 71.450000000000003 105.174 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.637 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 49.2 mt-30 -48.43 140.43 7.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.439 1.096 . . . . 65.5 110.542 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.2 24.76 0.87 Allowed Glycine 0 C--N 1.316 -0.551 0 C-N-CA 123.457 0.551 . . . . 52.200000000000003 114.465 -173.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -85.16 -38.75 18.67 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.638 -1.616 . . . . 72.519999999999996 106.638 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 3.1 ptp180 -174.22 160.24 3.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.407 -1.27 . . . . 74.299999999999997 110.173 179.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD13 HG21 ' A' ' 48' ' ' ILE . 65.3 mt -90.51 152.38 20.95 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 123.826 0.851 . . . . 74.209999999999994 111.131 -173.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD23 HD22 ' A' ' 51' ' ' LEU . 2.0 tm? -92.89 121.79 34.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.608 -1.627 . . . . 74.340000000000003 106.608 -176.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.78 158.24 32.82 Favored Pre-proline 0 C--N 1.296 -1.757 0 N-CA-C 109.629 -0.508 . . . . 54.420000000000002 109.629 -177.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.35 156.78 58.07 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.427 2.085 . . . . 71.430000000000007 112.266 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -125.18 -22.58 4.37 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.922 -0.581 . . . . 23.309999999999999 110.563 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 11.4 tp10 -94.02 106.36 18.33 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.644 -1.243 . . . . 72.109999999999999 107.644 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -122.43 114.54 20.86 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.468 0.651 . . . . 75.450000000000003 111.011 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.52 122.55 69.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.55 -0.907 . . . . 61.340000000000003 108.55 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -116.25 117.3 55.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.761 -0.829 . . . . 71.140000000000001 108.761 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.3 m -103.47 116.78 33.05 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.775 -0.648 . . . . 75.450000000000003 109.39 -178.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.07 175.04 5.61 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.963 -0.562 . . . . 70.109999999999999 110.027 178.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.18 145.05 32.86 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 111.11 -0.796 . . . . 75.349999999999994 111.11 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -64.52 -24.62 36.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.381 0.61 . . . . 73.319999999999993 110.044 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.495 ' O ' ' HG2' ' A' ' 72' ' ' GLU . 52.8 t-80 -55.28 -51.86 65.31 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.051 -0.977 . . . . 61.210000000000001 110.32 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 73' ' ' LYS 0.261 2.6 m-20 -87.23 -20.02 27.52 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 113.938 1.088 . . . . 70.400000000000006 113.938 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.442 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 36.6 t80 -61.97 -33.25 73.96 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.43 -0.35 . . . . 61.32 110.529 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 11.2 pt-20 -66.28 -26.25 67.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.398 -0.521 . . . . 73.510000000000005 111.52 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -70.51 -33.46 71.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.215 -0.902 . . . . 51.240000000000002 109.099 174.471 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.78 -37.01 76.19 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.991 0.901 . . . . 72.409999999999997 108.688 176.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.19 -157.88 15.56 Favored Glycine 0 N--CA 1.425 -2.089 0 CA-C-N 114.839 -1.073 . . . . 70.109999999999999 111.304 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.01 -25.79 18.66 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.035 0.445 . . . . 71.0 110.263 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -108.58 109.81 61.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.963 -0.562 . . . . 71.329999999999998 111.04 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.1 -39.46 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 121.754 1.636 . . . . 63.240000000000002 112.399 170.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -58.34 -38.94 78.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 116.232 1.938 . . . . 72.129999999999995 116.232 -164.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.65 -37.26 83.38 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.611 0.719 . . . . 72.239999999999995 110.185 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -86.12 -25.02 26.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.785 -0.643 . . . . 63.130000000000003 110.139 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.587 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 24.7 m -65.67 -33.36 75.7 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.603 -0.726 . . . . 72.540000000000006 109.305 175.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -63.08 -44.27 96.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.420000000000002 109.732 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.23 95.29 Favored Glycine 0 C--O 1.243 0.675 0 C-N-CA 120.855 -0.688 . . . . 55.32 111.798 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -72.17 -33.03 67.4 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.327 -0.62 . . . . 42.109999999999999 109.327 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.6 93.47 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.284 -0.416 . . . . 63.130000000000003 110.688 177.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -60.56 -41.44 94.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.266 0.555 . . . . 74.239999999999995 110.745 177.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 38.9 t70 -71.24 -36.61 71.87 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.734 -0.667 . . . . 71.209999999999994 110.551 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 tp -68.19 -33.84 75.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.015 0.436 . . . . 74.340000000000003 110.187 175.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.08 79.19 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.284 -0.635 . . . . 55.530000000000001 109.284 175.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 29.7 t70 -65.45 -46.61 79.21 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.559 -0.746 . . . . 74.040000000000006 109.515 176.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 37.1 m-85 -54.57 -49.85 69.36 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 112.581 0.586 . . . . 72.120000000000005 112.581 176.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.9 pt -67.1 -32.51 58.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 C-N-CA 119.818 -0.753 . . . . 74.049999999999997 111.884 -177.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.53 -42.61 95.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.27 0.557 . . . . 74.519999999999996 109.76 174.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -65.93 -31.89 73.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.374 -0.83 . . . . 74.310000000000002 112.315 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 65.2 mm-40 -84.94 -13.28 51.23 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.315 0.579 . . . . 73.549999999999997 110.512 176.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.16 35.36 53.42 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.239 -0.891 . . . . 72.030000000000001 113.459 176.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.416 ' CE2' HD11 ' A' ' 48' ' ' ILE . 15.6 m0 -97.96 168.26 10.4 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.18 0.49 . . . . 64.239999999999995 110.401 178.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.461 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.5 pt20 -130.43 167.42 18.62 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.423 -0.584 . . . . 64.109999999999999 109.423 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -161.61 177.88 9.57 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.005 -0.739 . . . . 72.120000000000005 109.005 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -119.66 120.73 37.49 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 109.407 -0.59 . . . . 75.010000000000005 109.407 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.66 -158.42 14.7 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 109.141 -1.584 . . . . 75.409999999999997 109.141 -175.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -117.27 151.09 37.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.616 -1.253 . . . . 64.109999999999999 107.616 176.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.69 121.62 18.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 120.949 0.404 . . . . 65.040000000000006 110.453 -177.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.34 120.27 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-O 121.881 0.848 . . . . 41.539999999999999 110.128 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 82' ' ' SER . 93.0 t -119.13 124.01 72.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 106.84 -1.541 . . . . 74.230000000000004 106.84 177.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -132.79 136.21 46.17 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.05 0.452 . . . . 72.430000000000007 110.996 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 94.8 m-85 -104.01 141.26 36.5 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.337 -0.847 . . . . 65.439999999999998 108.854 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -138.85 162.66 34.26 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.562 -0.29 . . . . 71.299999999999997 110.8 176.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -100.66 150.38 22.8 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.729 -0.669 . . . . 73.439999999999998 110.997 -176.026 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 31.6 t -129.95 129.27 43.6 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 107.525 -1.287 . . . . 73.239999999999995 107.525 174.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 t -81.45 -27.69 34.53 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.704 -0.851 . . . . 55.100000000000001 108.704 176.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -68.85 -46.34 68.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.015 -0.993 . . . . 70.109999999999999 110.434 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HG ' HE21 ' A' ' 118' ' ' GLN . 6.8 tt -84.41 140.47 31.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.833 -1.076 . . . . 74.140000000000001 110.455 -176.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -120.01 156.91 29.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.111 -0.7 . . . . 74.230000000000004 109.111 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.3 m -55.8 119.45 5.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.705 1.202 . . . . 74.040000000000006 110.538 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.66 -27.22 3.74 Favored Glycine 0 C--N 1.295 -1.724 0 N-CA-C 106.589 -2.604 . . . . 32.140000000000001 106.589 -174.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.468 HE21 ' HG ' ' A' ' 114' ' ' LEU . 29.6 tt0 -116.13 146.95 41.84 Favored 'General case' 0 N--CA 1.406 -2.634 0 N-CA-C 104.806 -2.294 . . . . 70.209999999999994 104.806 172.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -158.37 157.78 33.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.544 -1.28 . . . . 74.420000000000002 107.544 175.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 3.1 mmp_? -130.13 139.35 50.91 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 110.438 -0.208 . . . . 72.319999999999993 110.438 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.03 133.37 29.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.027 -1.472 . . . . 55.43 107.027 177.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -134.72 134.82 41.44 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.607 -0.886 . . . . 71.230000000000004 108.607 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -131.1 125.15 4.38 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.113 -1.195 . . . . 61.210000000000001 110.113 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.3 t -142.46 173.0 11.92 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.899 -0.408 . . . . 71.200000000000003 109.899 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.86 110.37 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.284 -0.636 . . . . 75.109999999999999 109.284 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -126.4 94.55 40.48 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.828 -0.623 . . . . 73.230000000000004 109.329 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.57 -19.27 16.85 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.066 1.844 . . . . 61.420000000000002 110.943 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.18 20.37 2.36 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.319 -0.855 . . . . 72.019999999999996 110.662 -176.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.96 108.88 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-O 122.265 1.031 . . . . 73.340000000000003 110.44 -179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -77.91 143.51 37.65 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 114.614 -1.176 . . . . 74.299999999999997 109.05 177.261 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.4 t -126.23 149.35 49.12 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.826 0.346 . . . . 72.349999999999994 111.227 -174.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 . . . . . 0 C--N 1.304 -1.407 0 N-CA-C 106.273 -1.751 . . . . 72.040000000000006 106.273 172.649 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.501 -0.909 0 N-CA-C 108.859 -0.793 . . . . 72.310000000000002 108.859 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.91 55.24 0.55 Allowed Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 108.938 -1.665 . . . . 70.319999999999993 108.938 178.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -59.94 -44.42 94.39 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.775 0.83 . . . . 65.25 112.138 -175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -87.84 110.23 20.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.536 -0.542 . . . . 70.340000000000003 109.536 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -106.3 125.77 51.41 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.122 -0.696 . . . . 73.209999999999994 109.122 178.442 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -94.97 157.16 16.02 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.888 -0.597 . . . . 63.439999999999998 109.916 -174.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 mp 61.56 72.32 0.52 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.996 0.81 . . . . 65.310000000000002 110.907 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.26 83.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.595 -0.73 . . . . 72.400000000000006 110.24 -176.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.0 126.16 9.23 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.295 -0.866 . . . . 65.310000000000002 108.747 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -92.31 88.1 6.31 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.502 -0.925 . . . . 71.519999999999996 108.502 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -84.65 95.87 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.983 0.897 . . . . 74.409999999999997 111.611 -177.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.93 90.23 3.25 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.513 -1.662 . . . . 73.129999999999995 106.513 175.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -88.73 150.04 23.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.202 -1.363 . . . . 73.030000000000001 111.99 -169.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -110.97 115.86 30.2 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 72.230000000000004 111.213 176.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.44 65.02 0.88 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.345 -1.724 . . . . 74.140000000000001 106.345 173.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.93 145.99 27.94 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.311 -1.313 . . . . 75.420000000000002 110.065 -174.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -122.0 115.63 22.87 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.652 -0.704 . . . . 72.310000000000002 109.514 179.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.6 m -111.86 128.78 56.23 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.462 -0.94 . . . . 71.430000000000007 108.462 177.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.74 162.94 7.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.06 0.457 . . . . 64.209999999999994 110.902 -178.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.77 29.86 2.32 Favored Glycine 0 C--N 1.299 -1.474 0 N-CA-C 109.285 -1.526 . . . . 52.340000000000003 109.285 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 4.6 p-10 -62.6 -29.65 70.76 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.889 -0.655 . . . . 73.010000000000005 111.141 -176.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.32 93.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.088 0.47 . . . . 74.450000000000003 110.122 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -65.4 -43.12 91.6 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.463 -0.79 . . . . 71.25 109.332 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.71 -47.07 87.11 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.46 -0.791 . . . . 71.510000000000005 111.469 178.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 37.4 mmt180 -66.66 -37.85 85.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 73.439999999999998 111.643 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.5 mt -76.37 -49.82 23.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 111.946 0.35 . . . . 54.240000000000002 111.946 -178.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' O ' ' HA3' ' A' ' 117' ' ' GLY . 98.9 m-85 -91.73 -28.58 17.33 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.236 0.828 . . . . 55.43 113.236 -172.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.59 -69.3 3.04 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 120.395 -0.907 . . . . 43.229999999999997 112.172 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.72 -49.23 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.675 -0.57 . . . . 60.219999999999999 111.675 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 m -79.05 88.95 4.78 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 109.596 -0.52 . . . . 74.430000000000007 109.596 178.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -85.19 -27.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.84 -0.618 . . . . 70.329999999999998 111.237 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.27 136.46 24.53 Favored Pre-proline 0 N--CA 1.443 -0.786 0 CA-C-N 116.235 -0.439 . . . . 62.420000000000002 110.188 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.26 -36.47 46.92 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.528 2.818 . . . . 71.230000000000004 112.21 175.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.32 -9.91 14.01 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.866 1.062 . . . . 62.25 113.866 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.46 -31.57 71.82 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.822 -0.807 . . . . 74.299999999999997 108.822 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.97 -42.08 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.761 -0.654 . . . . 64.049999999999997 109.282 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -61.48 -43.14 99.4 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.615 -0.513 . . . . 64.329999999999998 109.615 177.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.9 90.94 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.299 -0.864 . . . . 52.229999999999997 110.97 178.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.85 -44.28 77.52 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.634 -0.427 . . . . 74.239999999999995 110.431 178.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.11 -37.45 87.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.827 0.677 . . . . 71.030000000000001 112.827 -178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.83 -36.09 82.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 120.036 -0.666 . . . . 75.519999999999996 109.358 177.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -68.38 -41.89 79.91 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.254 -0.43 . . . . 71.420000000000002 109.955 176.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.27 -45.02 96.24 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.734 1.213 . . . . 73.239999999999995 110.14 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.32 -44.21 97.04 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.441 -0.799 . . . . 71.400000000000006 110.187 177.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.37 71.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.201 0.524 . . . . 65.140000000000001 111.392 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.13 -21.0 43.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.789 -0.641 . . . . 73.239999999999995 110.733 -178.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.56 19.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.975 -0.557 . . . . 53.32 112.139 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.51 134.73 29.72 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-O 121.272 0.558 . . . . 73.530000000000001 111.868 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.603 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . 5.0 tp-100 -111.6 132.28 54.67 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.36 -1.348 . . . . 74.5 107.36 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -77.06 93.95 3.94 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.796 0.808 . . . . 71.230000000000004 109.883 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.628 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 22.3 tp -103.08 -165.41 1.17 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.119 -1.808 . . . . 72.510000000000005 106.119 179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.628 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 2.2 mp0 -42.32 139.01 1.56 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.858 0.863 . . . . 63.340000000000003 111.586 175.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.81 -4.45 14.28 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-N 115.492 -0.777 . . . . 72.200000000000003 114.866 -171.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -72.17 -44.93 62.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.043 -0.354 . . . . 74.140000000000001 110.043 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 32.2 ptt180 -163.73 148.05 10.44 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 111.373 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.12 151.19 21.09 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.017 -0.992 . . . . 74.109999999999999 111.051 -170.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 49' ' ' GLN . 43.2 tp -86.35 126.6 34.46 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.443 -0.799 . . . . 64.310000000000002 109.677 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.3 160.38 31.55 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 124.109 0.881 . . . . 72.310000000000002 108.75 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.554 ' HA ' HG22 ' A' ' 125' ' ' VAL . 78.0 Cg_exo -54.56 153.96 21.66 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.213 2.608 . . . . 64.430000000000007 113.253 176.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 30.5 p-10 -120.09 -34.67 3.64 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.831 -0.622 . . . . 64.420000000000002 111.133 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -107.64 112.81 25.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.338 -0.616 . . . . 74.439999999999998 109.338 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 53.2 m-85 -109.03 132.0 54.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.671 -0.695 . . . . 65.140000000000001 110.279 -177.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 mm -112.93 117.89 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.582 -0.896 . . . . 65.209999999999994 108.582 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.11 125.83 74.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.962 -0.755 . . . . 73.310000000000002 108.962 -179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -126.89 129.0 47.36 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.427 -0.352 . . . . 72.299999999999997 110.309 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 74' ' ' LEU . 6.2 mp -128.6 178.08 6.57 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.864 -0.607 . . . . 73.420000000000002 109.66 172.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -73.66 168.3 54.06 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.982 -0.847 . . . . 33.43 110.982 177.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.4 -40.48 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-N 117.688 0.744 . . . . 70.010000000000005 112.324 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -66.82 -36.01 81.37 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.88 0.848 . . . . 34.130000000000003 109.234 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.578 ' OD2' ' HA ' ' A' ' 116' ' ' THR . 1.8 m-20 -65.43 -51.41 60.45 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.498 -1.228 . . . . 75.409999999999997 109.287 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.08 -42.34 98.32 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.251 -1.34 . . . . 74.109999999999999 111.848 -173.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.54 -35.94 78.13 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.908 0.385 . . . . 64.430000000000007 111.226 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -74.2 -24.98 59.43 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.086 -0.506 . . . . 72.109999999999999 112.208 178.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 79.1 mt -72.52 -45.2 60.47 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.885 0.374 . . . . 72.409999999999997 111.281 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.13 40.26 56.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 107.912 -2.075 . . . . 43.32 107.912 -168.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.26 5.54 51.44 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.121 1.768 . . . . 60.43 112.09 -172.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -43.05 124.19 3.24 Favored Pre-proline 0 N--CA 1.474 0.761 0 O-C-N 124.639 1.212 . . . . 72.400000000000006 110.503 -171.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -38.07 -47.8 2.23 Favored 'Trans proline' 0 C--N 1.373 1.836 1 C-N-CA 125.696 4.264 . . . . 73.439999999999998 116.116 -168.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -80.51 -17.07 52.68 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 119.863 -0.735 . . . . 70.230000000000004 112.278 -172.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.98 -56.11 3.63 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.395 0.617 . . . . 75.310000000000002 109.38 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -86.54 -5.5 59.13 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 115.16 1.541 . . . . 71.239999999999995 115.16 -174.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.7 p -64.97 -62.72 1.39 Allowed 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 119.243 0.929 . . . . 73.329999999999998 111.039 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.9 m -59.02 -40.43 84.94 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 123.155 0.582 . . . . 62.140000000000001 110.955 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.13 -55.46 9.15 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.907 -0.588 . . . . 40.310000000000002 113.495 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.97 -25.97 56.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.083 0.468 . . . . 73.310000000000002 110.448 -173.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -29.15 63.48 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 120.285 -0.566 . . . . 71.310000000000002 109.586 175.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' C ' ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -65.46 -40.74 93.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.133 -1.062 . . . . 60.130000000000003 108.133 175.882 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -59.54 -47.45 85.5 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 116.125 -0.488 . . . . 63.030000000000001 109.927 176.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.26 -37.37 77.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 112.034 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -60.56 -43.09 97.65 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.428 0.633 . . . . 52.109999999999999 109.384 178.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.34 -41.68 97.44 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.875 -1.057 . . . . 71.010000000000005 109.553 177.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.589 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 11.3 m-85 -61.26 -53.06 61.6 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.918 -0.583 . . . . 63.130000000000003 112.47 175.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 90' ' ' ALA . 37.7 pt -63.91 -31.07 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.742 0.275 . . . . 75.099999999999994 111.742 -176.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 77.3 mm-40 -65.79 -42.93 90.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.45 -0.574 . . . . 71.299999999999997 109.45 174.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -61.39 -37.33 83.03 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.052 -0.522 . . . . 73.150000000000006 111.202 176.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 27.3 mm-40 -77.06 -13.51 59.94 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.771 -0.65 . . . . 72.230000000000004 110.603 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.88 34.05 28.39 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.931 -0.577 . . . . 73.230000000000004 112.629 178.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.8 m0 -110.77 161.14 16.08 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.577 -0.527 . . . . 75.400000000000006 109.577 178.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.426 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 27.3 pt20 -130.72 169.55 15.53 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.461 -0.57 . . . . 71.219999999999999 109.461 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 57' ' ' LEU . 6.6 t -158.28 170.55 21.99 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.675 -0.491 . . . . 65.010000000000005 109.675 178.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.32 122.49 47.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.854 0.359 . . . . 71.519999999999996 111.029 -176.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.91 -150.01 17.06 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.391 -1.084 . . . . 43.520000000000003 110.391 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.1 137.73 46.54 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.667 -0.864 . . . . 60.420000000000002 108.667 176.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.53 117.68 19.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.09 -1.078 . . . . 72.140000000000001 108.09 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.33 125.76 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-O 121.831 0.824 . . . . 75.439999999999998 112.02 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 62' ' ' TYR . 35.0 m -104.87 124.63 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 106.869 -1.53 . . . . 60.039999999999999 106.869 173.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -115.92 130.51 56.86 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 109.1 -0.704 . . . . 73.239999999999995 109.1 -177.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -104.34 143.9 32.36 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 115.048 -0.978 . . . . 73.430000000000007 108.859 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.51 168.53 22.47 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.048 -0.524 . . . . 61.409999999999997 110.065 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -114.82 163.52 15.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.287 0.565 . . . . 64.310000000000002 111.051 -176.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.44 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 43.7 t -145.15 133.17 21.37 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.765 -1.198 . . . . 61.399999999999999 107.765 176.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.2 m -80.99 -19.88 43.04 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.43 0.634 . . . . 53.100000000000001 109.498 177.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -81.01 -32.82 34.04 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.404 -0.817 . . . . 73.400000000000006 110.854 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -74.81 148.68 40.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.623 -0.717 . . . . 61.119999999999997 109.79 -176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -100.48 157.92 16.29 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.859 0.463 . . . . 74.530000000000001 110.229 -171.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.578 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 71.7 m -66.86 120.74 14.08 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.744 0.783 . . . . 71.019999999999996 112.688 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 27' ' ' PHE . . . 98.1 -5.86 61.53 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.405 -1.27 . . . . 53.329999999999998 111.395 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -107.2 104.73 14.43 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 107.026 -1.472 . . . . 63.539999999999999 107.026 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -119.62 157.05 29.24 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 116.084 -0.507 . . . . 74.209999999999994 111.012 -174.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.2 mmt-85 -134.24 137.45 44.35 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.731 -0.84 . . . . 74.420000000000002 108.731 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.15 125.34 10.77 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.251 -0.648 . . . . 44.100000000000001 109.251 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 -131.18 160.43 34.83 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 109.646 -0.501 . . . . 73.540000000000006 109.646 177.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.67 135.73 9.65 Favored Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 110.429 -1.068 . . . . 34.43 110.429 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 p -126.04 153.69 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.814 -0.439 . . . . 74.209999999999994 109.814 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 59' ' ' PRO . 93.0 t -103.87 107.87 23.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.919 -1.141 . . . . 54.140000000000001 107.919 177.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -98.45 96.95 4.13 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 107.201 -1.407 . . . . 53.130000000000003 107.201 173.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 72.0 Cg_endo -82.43 -21.66 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.939 1.759 . . . . 64.340000000000003 112.138 -174.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -100.28 70.58 1.53 Allowed 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 122.778 1.275 . . . . 64.200000000000003 107.853 -176.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 p -118.36 129.06 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.84 0 CA-C-N 113.11 -1.859 . . . . 72.329999999999998 107.137 179.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -64.16 142.69 58.32 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.345 -0.843 . . . . 72.329999999999998 111.238 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -121.39 164.92 16.32 Favored 'General case' 0 N--CA 1.417 -2.125 0 N-CA-C 109.041 -0.725 . . . . 72.319999999999993 109.041 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 106.965 -1.495 . . . . 64.510000000000005 106.965 179.876 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 109.121 -0.696 . . . . 72.230000000000004 109.121 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.89 63.29 0.5 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.709 -1.356 . . . . 71.049999999999997 109.709 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 m -78.69 82.69 4.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.319 0.581 . . . . 30.239999999999998 112.479 -175.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -102.96 91.6 4.2 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.244 -2.132 . . . . 72.409999999999997 105.244 171.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.1 169.59 18.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.545 0.943 . . . . 72.329999999999998 113.545 -169.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 177.44 171.1 0.59 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.028 -2.212 . . . . 75.030000000000001 105.028 173.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.31 126.29 30.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.226 -1.398 . . . . 73.540000000000006 107.226 172.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.37 -24.0 12.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 120.793 0.33 . . . . 62.240000000000002 110.747 -177.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -77.24 132.68 38.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.74 -0.664 . . . . 70.099999999999994 109.575 178.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 10' ' ' ARG . 19.5 mtp180 -89.97 129.91 36.24 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.33 -2.1 . . . . 64.329999999999998 105.33 174.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.73 109.54 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.037 0.922 . . . . 63.420000000000002 111.826 -174.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -119.34 90.58 3.36 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.065 -0.971 . . . . 73.230000000000004 109.924 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 13' ' ' ARG . 5.3 ppt_? -97.04 105.05 17.13 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 105.426 -2.064 . . . . 64.430000000000007 105.426 168.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -109.42 116.14 31.26 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.984 -1.007 . . . . 73.409999999999997 112.927 -165.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.5 mt 65.22 20.04 11.84 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.778 1.299 . . . . 74.129999999999995 110.78 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -94.84 126.81 40.42 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.111 -0.95 . . . . 74.109999999999999 110.792 -175.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -154.9 110.99 3.19 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.59 -1.263 . . . . 73.150000000000006 107.59 174.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 5.0 t -101.53 140.85 35.26 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.33 -1.359 . . . . 64.349999999999994 107.33 176.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 18' ' ' THR . 13.6 p 172.15 169.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 105.318 -2.105 . . . . 71.530000000000001 105.318 -177.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.5 51.65 2.61 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.522 0.601 . . . . 74.450000000000003 112.612 177.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 24.7 t70 -67.17 -35.17 79.11 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 123.419 0.687 . . . . 44.100000000000001 109.395 -178.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -57.44 -46.29 83.76 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.813 -1.085 . . . . 51.310000000000002 110.272 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -67.25 -35.11 78.85 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 110.636 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 -33.73 76.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.791 0.329 . . . . 73.010000000000005 110.456 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 21' ' ' ASP . 31.9 mtm-85 -74.44 -32.52 62.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.253 -0.431 . . . . 74.430000000000007 110.382 178.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 22' ' ' ALA . 79.4 mt -73.37 -54.73 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.107 -0.497 . . . . 65.219999999999999 110.71 178.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.59 -27.78 62.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.966 0.728 . . . . 75.049999999999997 112.966 -175.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.61 -96.35 0.18 Allowed Glycine 0 N--CA 1.441 -1.027 0 O-C-N 123.785 0.678 . . . . 63.140000000000001 112.814 177.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.45 9.22 5.31 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 115.116 -0.542 . . . . 63.229999999999997 112.449 -178.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.6 t -80.32 -86.13 0.08 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.484 0.642 . . . . 64.239999999999995 109.398 179.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.93 93.28 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 106.224 -1.769 . . . . 71.040000000000006 106.224 175.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 34' ' ' GLN . 21.3 t -76.37 121.67 85.33 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 116.188 -0.46 . . . . 64.049999999999997 111.228 -173.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 -2.48 8.51 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.216 2.61 . . . . 61.240000000000002 114.082 -176.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.462 ' H ' HG12 ' A' ' 32' ' ' VAL . 9.4 pt20 -67.61 -23.25 65.35 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.613 -0.514 . . . . 74.030000000000001 109.613 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -69.3 -42.47 75.41 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.494 -0.928 . . . . 70.310000000000002 108.494 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.7 t -64.31 -46.87 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.389 -0.967 . . . . 52.340000000000003 108.389 177.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 23.5 mm-40 -52.02 -52.32 51.57 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.436 -0.802 . . . . 73.319999999999993 111.828 175.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.02 -53.96 49.06 Favored 'General case' 0 C--O 1.22 -0.471 0 O-C-N 123.8 0.688 . . . . 71.019999999999996 111.355 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.05 -42.18 97.12 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.317 0.488 . . . . 65.109999999999999 112.317 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.3 -47.05 77.96 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.828 0.677 . . . . 72.299999999999997 112.828 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 7.5 ptp180 -70.82 -32.84 70.03 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 120.428 -0.509 . . . . 73.209999999999994 110.486 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -67.17 -46.58 73.54 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.905 -0.406 . . . . 60.409999999999997 109.905 176.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 6.2 tp10 -63.03 -37.43 87.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.935 -0.575 . . . . 73.150000000000006 109.694 -179.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -61.57 -41.39 97.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.143 -0.481 . . . . 32.130000000000003 110.943 178.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.07 -34.23 43.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.042 -0.526 . . . . 43.520000000000003 111.566 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.56 -30.82 57.23 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.476 0.655 . . . . 75.5 110.797 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.28 14.0 58.65 Favored Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.661 -0.7 . . . . 61.329999999999998 112.607 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.88 131.57 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.306 0.574 . . . . 62.439999999999998 111.106 177.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt-30 -119.45 139.64 51.72 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.251 -0.886 . . . . 62.020000000000003 109.772 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -74.56 126.85 31.67 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.352 -1.295 . . . . 71.540000000000006 108.769 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.574 HD23 ' NE2' ' A' ' 99' ' ' GLN . 14.0 tp -141.31 -165.57 2.0 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.186 -2.153 . . . . 72.430000000000007 105.186 -177.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.525 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 25.2 mt-30 -52.52 145.02 12.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.047 0.385 . . . . 73.430000000000007 110.299 176.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.95 -0.95 7.88 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 114.728 0.651 . . . . 52.109999999999999 114.728 -173.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -64.11 -42.81 96.73 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.851 -0.796 . . . . 74.129999999999995 108.851 177.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -174.87 157.01 2.35 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.114 -0.948 . . . . 74.349999999999994 110.877 -179.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -91.15 151.65 20.89 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.495 0.718 . . . . 71.519999999999996 110.858 -173.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 1.3 tm? -91.74 128.79 37.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.826 -1.176 . . . . 71.230000000000004 107.826 -176.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -120.66 162.07 36.45 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 122.739 0.415 . . . . 73.239999999999995 109.954 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.8 Cg_exo -62.43 160.73 30.31 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.244 2.63 . . . . 70.409999999999997 112.941 176.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -132.81 -33.45 1.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.783 -0.644 . . . . 63.119999999999997 112.154 -179.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.04 116.52 32.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.837 -0.801 . . . . 72.200000000000003 108.837 -178.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.516 ' HB2' HG12 ' A' ' 106' ' ' VAL . 35.2 m-85 -118.77 114.81 23.25 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.828 -0.434 . . . . 75.209999999999994 109.828 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.48 110.38 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.68 -0.859 . . . . 53.130000000000003 108.68 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.27 112.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.167 -1.049 . . . . 70.430000000000007 108.167 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.9 m -110.79 122.86 48.88 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.73 -0.668 . . . . 74.409999999999997 109.9 -178.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.65 176.38 5.17 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.385 -0.825 . . . . 74.519999999999996 110.081 177.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.3 165.37 51.77 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.218 -1.553 . . . . 73.209999999999994 109.218 175.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 3.1 p -59.27 -48.31 87.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 112.673 0.62 . . . . 72.209999999999994 112.673 -178.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -63.94 -36.46 84.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 74.25 110.249 -178.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -69.02 -41.69 77.4 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.465 0.65 . . . . 74.430000000000007 109.563 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -73.87 -22.74 59.63 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 120.415 -0.514 . . . . 72.340000000000003 111.521 -176.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.8 mt-10 -61.77 -28.5 69.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.345 0.593 . . . . 65.129999999999995 109.66 173.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -84.91 -28.79 25.69 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.76 -0.655 . . . . 71.450000000000003 110.55 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.0 mt -97.02 -14.16 21.81 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 113.01 0.744 . . . . 73.299999999999997 113.01 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.71 22.13 35.24 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 116.077 1.191 . . . . 75.329999999999998 116.077 -169.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.82 -35.13 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.959 0.88 . . . . 74.049999999999997 108.962 176.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -141.73 77.26 19.2 Favored Pre-proline 0 C--O 1.242 0.693 0 CA-C-N 115.537 -0.756 . . . . 64.299999999999997 109.203 175.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -65.32 -50.37 2.03 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.062 1.841 . . . . 42.039999999999999 112.811 -178.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.01 -37.55 82.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.47 0.176 . . . . 74.439999999999998 111.408 -177.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.5 tp -55.84 -55.7 29.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.135 0.493 . . . . 52.409999999999997 110.597 177.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 14.3 ptpt -72.86 -22.64 60.75 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.351 0.871 . . . . 75.340000000000003 113.351 -178.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 m -71.48 -36.43 71.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 74.409999999999997 109.131 175.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.3 m -70.89 -40.61 72.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.061 -0.518 . . . . 74.209999999999994 109.765 177.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.664 ' O ' ' HG2' ' A' ' 87' ' ' ARG . . . -57.77 -55.23 31.63 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-N 115.746 -0.661 . . . . 62.350000000000001 112.666 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 106' ' ' VAL . 62.8 m-85 -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.754 -0.85 . . . . 71.510000000000005 112.824 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.85 53.37 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.223 -0.298 . . . . 71.329999999999998 110.993 178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 84' ' ' GLY . 35.1 ptt180 -60.68 -41.93 96.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.899 0.857 . . . . 71.129999999999995 110.141 -179.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 87' ' ' ARG . 64.5 m-20 -77.74 -34.66 52.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.137 -0.938 . . . . 51.439999999999998 112.69 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.47 -37.99 89.46 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.094 -1.076 . . . . 71.209999999999994 108.094 176.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -63.12 -35.55 80.63 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.877 -0.601 . . . . 65.530000000000001 110.386 177.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.7 t70 -72.39 -42.09 65.57 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.684 -0.406 . . . . 74.340000000000003 110.027 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 13.8 m-85 -53.73 -48.4 69.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 112.074 175.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.4 pt -66.06 -30.73 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 119.722 -0.791 . . . . 63.340000000000003 111.104 -179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 78.7 mm-40 -67.61 -37.94 83.23 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.083 -0.247 . . . . 75.140000000000001 110.598 175.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 44.1 mt-10 -61.63 -41.04 96.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.883 0.739 . . . . 63.0 110.884 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 68.2 mm-40 -80.31 -14.22 58.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.191 -0.913 . . . . 63.200000000000003 110.938 -178.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.11 29.11 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.765 -0.652 . . . . 61.43 112.062 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -102.9 174.51 5.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.613 0.72 . . . . 73.25 112.073 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.574 ' NE2' HD23 ' A' ' 51' ' ' LEU . 25.4 pt20 -137.18 171.91 13.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.412 -0.813 . . . . 72.209999999999994 109.491 179.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.7 t -161.15 153.51 20.26 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.738 -0.467 . . . . 44.329999999999998 109.738 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -109.66 120.04 41.24 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.652 -1.24 . . . . 75.319999999999993 107.652 175.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.85 -150.27 18.28 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 107.951 -2.06 . . . . 71.340000000000003 107.951 -172.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.93 137.83 35.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 118.187 0.993 . . . . 63.030000000000001 108.842 177.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.49 103.59 3.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.316 0.579 . . . . 75.439999999999998 110.094 -175.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.84 127.43 29.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.25 -0.887 . . . . 74.530000000000001 109.5 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 62' ' ' TYR . 4.9 m -105.55 148.73 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 N-CA-C 107.244 -1.391 . . . . 72.140000000000001 107.244 176.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -128.21 137.55 52.09 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.732 -0.84 . . . . 71.450000000000003 108.732 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -114.11 119.73 38.11 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.95 -0.759 . . . . 74.129999999999995 108.95 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.7 175.75 10.38 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.882 -178.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -123.25 164.37 18.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.031 -176.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -154.17 117.19 4.48 Favored 'General case' 0 N--CA 1.421 -1.875 0 C-N-CA 124.058 0.943 . . . . 63.219999999999999 108.848 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 p -67.38 -17.73 64.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.603 0.716 . . . . 73.129999999999995 111.099 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -67.26 -28.18 67.82 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.201 1.0 . . . . 72.109999999999999 109.263 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.53 141.3 51.91 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.998 -1.001 . . . . 75.239999999999995 109.864 -178.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.55 145.96 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.847 -0.615 . . . . 73.450000000000003 110.16 -172.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.0 m -68.27 121.59 16.55 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.706 -0.679 . . . . 63.119999999999997 109.764 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 107.67 -11.09 38.65 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 110.471 -1.052 . . . . 63.149999999999999 110.471 -177.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -98.69 169.09 9.74 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.207 0.527 . . . . 72.420000000000002 110.585 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -164.08 156.63 17.35 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.015 -2.587 . . . . 61.420000000000002 104.015 173.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -146.14 130.57 17.71 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.215 -0.994 . . . . 73.019999999999996 111.791 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.15 118.71 28.28 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.541 -1.281 . . . . 60.399999999999999 107.541 177.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 23.8 tpt180 -121.78 125.85 47.49 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.296 -0.631 . . . . 73.430000000000007 109.296 -177.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.09 130.32 9.1 Favored Glycine 0 C--N 1.289 -2.038 0 N-CA-C 110.581 -1.008 . . . . 72.450000000000003 110.581 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.3 t -138.09 167.26 22.17 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.47 -0.567 . . . . 65.530000000000001 109.47 -177.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 59' ' ' PRO . 50.4 t -92.59 106.73 18.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.526 -1.287 . . . . 55.25 107.526 175.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.581 ' O ' HG23 ' A' ' 129' ' ' VAL . 43.6 t30 -117.83 102.75 51.12 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.135 -0.691 . . . . 62.409999999999997 109.135 178.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.4 -25.01 15.84 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.84 1.693 . . . . 73.420000000000002 111.13 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -91.24 32.08 1.07 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.297 -0.865 . . . . 54.329999999999998 111.492 -174.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 126' ' ' ASN . 79.2 t -66.92 117.12 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.14 -1.059 . . . . 72.219999999999999 108.14 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -63.92 138.95 58.7 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.567 -1.197 . . . . 73.310000000000002 109.8 177.531 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.7 t -133.03 162.17 32.4 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.274 -1.01 . . . . 73.439999999999998 108.274 -174.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 C--N 1.297 -1.686 0 N-CA-C 108.772 -0.825 . . . . 75.349999999999994 108.772 -179.615 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.568 -0.531 . . . . 74.530000000000001 109.568 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.17 116.23 0.62 Allowed Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.802 -0.919 . . . . 71.430000000000007 110.802 178.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 m -73.96 134.52 43.13 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.893 -0.41 . . . . 44.43 109.893 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -74.67 146.33 42.44 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.519 -0.919 . . . . 62.43 108.519 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -72.03 82.81 0.96 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.514 0.673 . . . . 75.319999999999993 111.33 -177.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -152.46 172.96 15.72 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.272 1.429 . . . . 74.540000000000006 107.481 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.28 138.89 29.89 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.662 -0.866 . . . . 71.439999999999998 108.662 175.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.14 82.98 2.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.378 1.085 . . . . 75.239999999999995 110.146 176.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -79.62 77.43 6.22 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.533 -1.212 . . . . 73.439999999999998 110.677 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 59.51 61.7 1.94 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 113.392 -1.731 . . . . 73.219999999999999 111.599 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.7 t -131.74 90.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.823 -1.177 . . . . 74.530000000000001 107.823 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -79.89 98.11 6.98 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.463 0.649 . . . . 62.219999999999999 109.347 178.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -57.6 -42.01 82.36 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.521 -1.218 . . . . 63.130000000000003 112.808 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -94.3 73.41 3.91 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.65 -0.82 . . . . 63.399999999999999 109.395 177.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -114.29 104.55 12.19 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.842 -1.17 . . . . 75.439999999999998 107.842 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.68 -161.74 1.3 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.486 -0.779 . . . . 54.549999999999997 109.253 -178.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -50.67 118.1 2.88 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.094 0.957 . . . . 65.230000000000004 112.826 -176.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -178.37 145.07 0.32 Allowed 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.361 -1.718 . . . . 72.329999999999998 106.361 175.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.93 107.84 23.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.321 -0.551 . . . . 50.0 111.256 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.93 22.21 12.79 Favored Glycine 0 C--N 1.308 -1.017 0 N-CA-C 109.058 -1.617 . . . . 74.230000000000004 109.058 176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 22.8 t70 -64.39 -41.42 96.68 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.391 -0.905 . . . . 75.400000000000006 111.674 -174.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.96 -37.99 87.43 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.86 -0.609 . . . . 62.149999999999999 110.597 -178.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -64.64 -40.24 95.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.576 -0.738 . . . . 74.329999999999998 109.654 177.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.01 -33.4 75.49 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.669 -0.696 . . . . 72.219999999999999 110.415 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 15.5 mmm180 -72.61 -28.07 62.55 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.176 0.512 . . . . 74.0 110.918 177.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -86.56 -50.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 112.251 0.463 . . . . 42.340000000000003 112.251 -178.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.25 -28.52 12.23 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 113.006 0.743 . . . . 73.219999999999999 113.006 -175.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.0 -104.5 0.68 Allowed Glycine 0 CA--C 1.496 -1.155 0 O-C-N 123.429 0.456 . . . . 71.439999999999998 112.01 -178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.16 12.88 8.49 Favored Glycine 0 C--N 1.286 -2.203 0 CA-C-N 114.516 -0.842 . . . . 71.430000000000007 111.583 -178.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -72.56 -33.64 66.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.525 -0.917 . . . . 73.019999999999996 108.525 178.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 tp -163.7 133.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.404 -1.702 . . . . 72.219999999999999 106.404 176.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.48 153.29 53.85 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 110.511 -0.181 . . . . 71.340000000000003 110.511 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.76 -26.5 66.42 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 123.351 2.701 . . . . 73.519999999999996 111.915 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -62.6 -33.74 75.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.282 -0.872 . . . . 74.430000000000007 110.573 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.87 -32.21 45.84 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.682 -0.488 . . . . 74.430000000000007 109.682 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 47.7 t -64.47 -49.82 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.781 -0.645 . . . . 60.299999999999997 109.426 179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -66.68 -31.4 72.04 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 119.863 -0.735 . . . . 73.409999999999997 110.284 178.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.93 63.55 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 123.378 0.424 . . . . 73.140000000000001 110.197 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.68 -40.34 91.77 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.239 -0.437 . . . . 75.019999999999996 111.191 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 77.8 mt -66.34 -46.78 75.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.554 0.576 . . . . 73.409999999999997 112.554 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.01 -26.89 62.4 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.277 0.561 . . . . 73.439999999999998 110.134 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -45.65 73.35 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.671 -0.695 . . . . 73.510000000000005 109.679 172.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -62.72 -33.91 76.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 122.837 0.455 . . . . 74.409999999999997 111.174 177.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . . . -62.12 -46.07 90.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.012 -0.54 . . . . 73.209999999999994 110.702 177.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.45 53.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.502 0.668 . . . . 65.420000000000002 111.106 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.14 -38.21 61.1 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.717 -0.674 . . . . 43.109999999999999 110.849 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.08 12.81 65.03 Favored Glycine 0 C--N 1.319 -0.396 0 C-N-CA 121.261 -0.495 . . . . 72.540000000000006 113.336 -176.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.8 mm -59.72 127.4 19.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.399 0.68 . . . . 74.439999999999998 111.875 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -108.91 146.15 34.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.705 -0.68 . . . . 75.209999999999994 110.039 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.3 m -81.01 103.23 10.69 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.364 -0.834 . . . . 74.329999999999998 109.143 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 12.7 tp -112.65 -164.21 0.9 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.133 -1.432 . . . . 73.409999999999997 107.133 -177.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.626 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 85.0 mm-40 -49.67 156.99 0.6 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.748 0.819 . . . . 75.019999999999996 112.594 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.72 5.59 22.78 Favored Glycine 0 C--N 1.309 -0.931 0 CA-C-N 114.852 -1.067 . . . . 72.439999999999998 114.086 -172.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.45 -43.37 27.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.388 -0.597 . . . . 53.130000000000003 109.388 175.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -177.69 165.62 2.1 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.682 0.793 . . . . 72.150000000000006 112.016 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.21 151.3 20.99 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.149 0.98 . . . . 72.310000000000002 111.688 -173.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.463 HD23 HD22 ' A' ' 51' ' ' LEU . 1.4 tm? -94.46 125.11 38.9 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.099 -1.075 . . . . 54.530000000000001 108.099 -175.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -111.56 156.98 40.54 Favored Pre-proline 0 C--N 1.306 -1.284 0 C-N-CA 123.597 0.759 . . . . 72.310000000000002 109.783 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.637 ' HA ' HG22 ' A' ' 125' ' ' VAL . 82.1 Cg_exo -51.03 152.15 10.77 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.983 3.122 . . . . 70.219999999999999 114.307 177.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.6 p-10 -122.69 -33.88 3.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.194 -0.912 . . . . 63.399999999999999 110.605 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.47 100.26 11.27 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.318 0.58 . . . . 64.239999999999995 110.164 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 59' ' ' PRO . 72.2 m-85 -96.43 114.13 25.77 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.632 0.73 . . . . 74.530000000000001 109.491 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.0 mt -107.91 117.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.618 -1.174 . . . . 74.340000000000003 109.036 -174.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 3.5 mp -118.05 101.74 12.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.485 -0.932 . . . . 71.439999999999998 108.485 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.5 m -95.82 122.93 39.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 109.311 -176.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.6 mm? -110.59 162.21 14.95 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.419 0.688 . . . . 73.109999999999999 111.056 176.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.16 163.47 50.63 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.889 -1.685 . . . . 74.430000000000007 108.889 173.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.7 p -63.15 -37.89 80.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 117.387 0.593 . . . . 61.509999999999998 111.357 -177.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -64.11 -38.04 89.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.634 -0.712 . . . . 73.510000000000005 110.393 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.08 -35.56 28.51 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.867 -0.606 . . . . 71.430000000000007 111.69 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -65.79 -32.36 73.85 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.744 -0.383 . . . . 74.319999999999993 110.994 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 49.2 mt-10 -59.57 -29.52 67.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.046 0.45 . . . . 74.530000000000001 111.266 177.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -81.5 -26.33 35.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 111.32 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.451 HD11 ' HG ' ' A' ' 66' ' ' LEU . 86.9 mt -70.73 -34.42 71.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.385 -0.598 . . . . 73.109999999999999 109.385 173.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.37 -165.89 21.86 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 110.877 -0.889 . . . . 64.400000000000006 110.877 177.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.89 1.23 55.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.017 0.437 . . . . 71.430000000000007 110.52 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -127.82 135.43 27.47 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.125 -0.489 . . . . 71.450000000000003 110.526 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -77.86 -34.52 1.75 Allowed 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 122.057 1.838 . . . . 75.430000000000007 109.286 163.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -48.02 -52.79 18.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 117.376 2.362 . . . . 72.209999999999994 117.376 -165.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.24 -42.71 77.76 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.662 0.665 . . . . 54.140000000000001 110.606 -173.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' H ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -88.84 -17.95 28.65 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.247 -0.888 . . . . 71.099999999999994 112.152 -177.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 59.6 m -71.18 -44.64 65.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.253 -0.647 . . . . 73.409999999999997 109.253 176.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.0 m -65.48 -43.2 90.98 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 115.87 -0.604 . . . . 64.299999999999997 110.006 178.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.12 -53.84 41.52 Favored Glycine 0 CA--C 1.504 -0.615 0 CA-C-N 115.492 -0.776 . . . . 53.130000000000003 112.373 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -67.37 -31.0 70.95 Favored 'General case' 0 C--O 1.211 -0.935 0 N-CA-C 113.002 0.742 . . . . 45.109999999999999 113.002 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.23 82.69 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.062 0.392 . . . . 71.209999999999994 110.45 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -67.17 -48.08 69.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.798 -0.637 . . . . 73.530000000000001 111.505 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.33 -35.87 78.42 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.078 -0.51 . . . . 73.310000000000002 111.293 -173.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.22 -35.68 63.9 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.368 -0.605 . . . . 74.349999999999994 109.368 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.36 84.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.773 0.797 . . . . 54.350000000000001 109.438 176.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.89 -41.73 99.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.601 -1.181 . . . . 72.140000000000001 109.445 177.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.574 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 16.4 m-85 -59.89 -51.17 70.87 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.876 -0.602 . . . . 74.5 112.085 175.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.1 pt -65.61 -30.78 51.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.298 -0.561 . . . . 64.120000000000005 112.101 -175.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -63.32 -44.93 93.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.701 -0.481 . . . . 75.239999999999995 109.701 175.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -66.17 -30.09 70.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.702 -0.681 . . . . 62.32 112.682 177.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 58.4 mm-40 -82.97 -13.62 55.63 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.918 -0.313 . . . . 73.030000000000001 111.222 178.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.46 27.08 40.6 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 116.051 -0.522 . . . . 43.130000000000003 113.125 176.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.9 m0 -98.68 178.38 5.01 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.888 0.344 . . . . 70.310000000000002 110.163 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.401 ' NE2' HD23 ' A' ' 51' ' ' LEU . 28.7 pt20 -143.03 174.18 10.9 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.875 -0.787 . . . . 72.129999999999995 108.875 178.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 10.9 t -157.19 171.74 19.89 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.612 -0.435 . . . . 61.0 109.831 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.1 118.93 37.83 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 108.069 -1.085 . . . . 72.319999999999993 108.069 176.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.39 -149.93 16.74 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.376 -1.392 . . . . 71.109999999999999 110.985 176.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.04 142.49 46.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.765 -1.198 . . . . 72.209999999999994 107.765 176.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.22 118.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.58 -0.896 . . . . 63.210000000000001 108.58 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.21 137.3 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 121.643 0.735 . . . . 73.310000000000002 110.443 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 82' ' ' SER . 92.4 t -117.92 142.9 30.21 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 107.023 -1.473 . . . . 64.120000000000005 107.023 178.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -146.44 146.79 30.71 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.697 0.284 . . . . 52.030000000000001 111.019 176.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 84.9 m-85 -121.16 125.07 46.26 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.111 -1.441 . . . . 71.319999999999993 107.111 177.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.39 175.61 8.99 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.504 -0.878 . . . . 65.109999999999999 111.597 178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' OE1' HG23 ' A' ' 68' ' ' VAL . 50.2 mt-30 -105.18 149.43 25.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.837 0.827 . . . . 75.340000000000003 112.154 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 m -143.48 118.13 9.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.59 -1.186 . . . . 63.299999999999997 108.961 172.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 m -72.0 -24.22 61.53 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.813 -0.63 . . . . 65.409999999999997 112.574 -175.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -88.7 -0.25 57.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.457 1.122 . . . . 71.329999999999998 109.26 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.4 tp -83.7 144.49 29.34 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.902 -1.045 . . . . 74.200000000000003 108.282 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.02 149.74 35.84 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.434 -0.803 . . . . 73.540000000000006 110.83 -171.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.3 m -66.5 125.1 24.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.075 -0.713 . . . . 72.450000000000003 109.075 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.5 16.64 73.07 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.744 -0.741 . . . . 75.409999999999997 112.206 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -124.52 123.2 39.59 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.199 -1.037 . . . . 71.5 108.199 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -116.23 156.66 26.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.389 -0.967 . . . . 63.399999999999999 108.389 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -126.0 130.72 51.76 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.899 -0.778 . . . . 63.210000000000001 108.899 177.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.04 119.75 29.55 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.813 -1.085 . . . . 53.509999999999998 108.74 -178.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -135.0 126.5 28.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.094 -178.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -94.22 98.26 2.3 Favored Glycine 0 N--CA 1.424 -2.149 0 N-CA-C 108.502 -1.839 . . . . 55.310000000000002 108.502 176.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.3 m -93.36 138.94 31.22 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 121.198 0.523 . . . . 74.239999999999995 109.939 -175.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.637 HG22 ' HA ' ' A' ' 59' ' ' PRO . 92.5 t -98.36 117.43 43.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.878 -0.786 . . . . 71.219999999999999 108.878 175.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -102.83 94.85 5.65 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.472 -1.677 . . . . 34.439999999999998 106.472 170.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 125' ' ' VAL . 91.9 Cg_endo -88.73 -3.56 6.43 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.225 1.95 . . . . 52.100000000000001 112.067 -175.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -91.34 33.14 1.0 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.494 -0.775 . . . . 61.130000000000003 110.716 -175.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -75.76 97.57 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 108.113 -1.069 . . . . 71.319999999999993 108.113 177.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.79 91.69 8.72 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.7 1.238 . . . . 75.140000000000001 110.466 -176.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -81.8 90.54 6.4 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 123.628 1.68 . . . . 64.420000000000002 110.215 -178.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 . . . . . 0 C--N 1.284 -2.28 0 CA-C-N 112.963 -1.926 . . . . 65.150000000000006 108.063 179.808 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tmm? . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 106.884 -1.524 . . . . 72.319999999999993 106.884 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.73 83.24 0.13 Allowed Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 119.709 -1.234 . . . . 72.310000000000002 112.417 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 p -65.13 -57.31 8.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.561 -0.533 . . . . 74.409999999999997 109.561 175.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 67.93 -43.54 0.47 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.358 1.463 . . . . 42.100000000000001 114.467 170.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -66.04 122.4 17.32 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 123.884 0.874 . . . . 75.120000000000005 110.532 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -107.8 115.75 30.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.419 -0.956 . . . . 74.409999999999997 108.419 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -92.6 104.13 16.45 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.591 -0.522 . . . . 32.119999999999997 109.591 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.28 98.95 6.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.034 -1.098 . . . . 75.120000000000005 108.034 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -88.93 113.63 24.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.814 -0.63 . . . . 70.340000000000003 109.587 -176.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -119.31 122.07 41.04 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.253 0.549 . . . . 75.219999999999999 109.825 178.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 m -80.09 79.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 122.391 1.091 . . . . 65.439999999999998 110.872 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.94 -31.17 71.94 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.22 -1.355 . . . . 63.32 110.273 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -72.11 97.09 1.86 Allowed 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.139 -0.937 . . . . 52.030000000000001 108.829 174.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' ' 15' ' ' LEU . 79.8 tttt -91.96 -69.75 0.72 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.919 -0.582 . . . . 61.32 110.311 -176.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD12 ' HG2' ' A' ' 14' ' ' LYS . 6.9 mp -104.55 85.58 2.36 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.017 -0.673 . . . . 75.120000000000005 111.095 178.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.77 129.24 50.75 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.228 -1.026 . . . . 64.0 108.228 179.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -89.87 132.99 34.99 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 120.947 0.403 . . . . 75.420000000000002 110.505 -177.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.8 p -91.84 97.07 10.76 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 106.335 -1.728 . . . . 70.239999999999995 106.335 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 21' ' ' ASP . 17.9 t -76.89 117.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 115.187 -0.915 . . . . 45.329999999999998 110.704 -171.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.94 29.7 11.94 Favored Glycine 0 C--N 1.308 -1.021 0 N-CA-C 111.163 -0.775 . . . . 71.140000000000001 111.163 179.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' H ' HG12 ' A' ' 19' ' ' VAL . 19.5 t70 -68.53 -34.63 76.21 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.231 0.538 . . . . 74.319999999999993 110.549 -177.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -59.68 -45.52 91.84 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.157 -0.929 . . . . 65.109999999999999 109.639 176.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -67.48 -27.95 67.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.147 -0.933 . . . . 63.530000000000001 111.497 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.75 87.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.915 -0.402 . . . . 70.319999999999993 109.915 177.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -80.41 -19.92 45.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.975 -0.557 . . . . 70.239999999999995 110.054 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 22' ' ' ALA . 41.1 mm -67.47 -57.13 10.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.656 -0.498 . . . . 71.109999999999999 109.656 175.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.82 -30.17 56.27 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.657 0.614 . . . . 74.329999999999998 112.657 -176.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.94 -67.39 1.72 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.373 0.509 . . . . 54.219999999999999 114.373 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.39 -61.7 0.92 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.462 -0.399 . . . . 72.219999999999999 112.705 -176.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.4 m -96.59 89.55 5.02 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.46 -0.57 . . . . 73.319999999999993 109.46 -179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.85 88.19 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 120.439 -0.504 . . . . 71.109999999999999 110.145 -177.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.488 ' HB ' ' CB ' ' A' ' 35' ' ' GLU . 6.2 m -128.45 86.46 57.7 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-O 121.784 0.802 . . . . 74.430000000000007 111.802 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -88.8 -46.34 0.03 OUTLIER 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.938 2.425 . . . . 64.109999999999999 111.447 174.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -71.47 -16.52 62.37 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.751 -0.658 . . . . 74.140000000000001 110.809 -178.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' CB ' ' HB ' ' A' ' 32' ' ' VAL . 8.8 tp10 -64.03 -48.16 77.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.374 -0.973 . . . . 72.310000000000002 108.374 175.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -64.94 -45.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.826 -0.624 . . . . 73.030000000000001 109.68 178.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.619 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 53.8 mt-10 -53.12 -55.3 25.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.323 -0.399 . . . . 75.209999999999994 111.147 178.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.83 -27.05 68.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 111.811 -178.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -69.12 -47.34 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.337 -0.986 . . . . 63.240000000000002 108.337 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 62' ' ' TYR . 3.8 mm? -71.65 -30.7 66.02 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.852 0.686 . . . . 72.420000000000002 112.852 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 32.2 mtm180 -64.42 -40.09 95.1 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.287 -1.005 . . . . 75.510000000000005 108.287 175.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -63.9 -44.86 91.7 Favored 'General case' 0 C--O 1.203 -1.39 0 CA-C-N 115.554 -0.748 . . . . 74.219999999999999 110.333 176.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.59 -39.71 89.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.154 0.502 . . . . 61.219999999999999 110.006 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.22 84.79 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.786 -0.643 . . . . 60.200000000000003 110.457 177.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.78 64.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 64.200000000000003 111.984 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.52 -37.51 31.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.087 -0.506 . . . . 74.439999999999998 110.267 -179.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 20.56 26.08 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.856 -0.611 . . . . 42.420000000000002 113.03 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.4 mm -67.12 138.51 22.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 C-N-CA 123.28 0.632 . . . . 41.140000000000001 110.657 177.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 76.6 mt-30 -115.87 143.71 45.03 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 176.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.5 t -76.28 124.67 27.86 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.946 -1.024 . . . . 73.430000000000007 108.705 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.7 tp -140.16 -166.0 2.02 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 105.073 -2.195 . . . . 73.140000000000001 105.073 -177.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 23.1 mt-30 -51.67 143.53 12.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.674 0.67 . . . . 71.420000000000002 110.259 176.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.88 -18.01 52.41 Favored Glycine 0 C--N 1.322 -0.233 0 CA-C-N 116.087 -0.506 . . . . 71.430000000000007 114.085 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -62.55 -39.1 92.54 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.52 0.328 . . . . 73.209999999999994 111.731 179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -165.8 136.44 3.63 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.176 -0.465 . . . . 73.450000000000003 111.396 -177.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.8 mt -90.87 151.6 21.08 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 124.934 1.293 . . . . 75.109999999999999 110.353 -176.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 46.1 tp -85.71 128.48 34.8 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.446 -0.797 . . . . 73.239999999999995 109.83 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -115.64 158.57 41.51 Favored Pre-proline 0 C--N 1.306 -1.308 0 C-N-CA 123.305 0.642 . . . . 73.439999999999998 109.821 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 125' ' ' VAL . 36.0 Cg_exo -61.26 152.59 71.21 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.019 2.479 . . . . 72.439999999999998 112.7 177.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 26.4 p-10 -130.86 -16.34 3.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.647 -0.706 . . . . 63.350000000000001 111.583 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.59 114.97 27.87 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.76 -1.2 . . . . 61.420000000000002 107.76 178.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.488 ' CD2' HD12 ' A' ' 40' ' ' LEU . 91.7 m-85 -121.18 122.62 40.37 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.425 -0.352 . . . . 74.040000000000006 110.23 -178.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 63' ' ' ILE . 3.4 mp -106.79 107.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.186 -1.042 . . . . 73.109999999999999 108.186 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 55.9 mt -112.55 103.65 15.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.55 0.691 . . . . 62.030000000000001 109.979 -178.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 109' ' ' GLU . 26.2 m -103.12 120.01 39.91 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.847 -0.615 . . . . 72.109999999999999 109.779 -177.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 119' ' ' PHE . 4.0 mm? -99.38 163.5 12.5 Favored 'General case' 0 C--O 1.257 1.466 0 C-N-CA 123.692 0.797 . . . . 71.409999999999997 111.252 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.25 165.1 49.79 Favored Glycine 0 N--CA 1.426 -1.974 0 N-CA-C 110.31 -1.116 . . . . 41.25 110.31 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 112' ' ' SER . 7.4 p -62.67 -47.61 92.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 113.674 0.991 . . . . 72.310000000000002 113.674 -175.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.554 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 82.2 t60 -77.35 -24.19 50.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.477 0.656 . . . . 55.039999999999999 109.857 -178.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.726 ' OD1' ' HA ' ' A' ' 116' ' ' THR . 2.6 m-20 -69.72 -45.79 67.4 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.751 -0.833 . . . . 72.140000000000001 108.751 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' CG ' ' HB3' ' A' ' 110' ' ' GLN . 40.8 t80 -71.29 -34.17 70.4 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 115.564 -0.744 . . . . 74.140000000000001 111.816 -175.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 12.9 pt-20 -65.11 -30.08 70.99 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.103 0.478 . . . . 74.329999999999998 110.936 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 32.1 mmmt -68.94 -35.39 76.73 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.169 -0.923 . . . . 50.140000000000001 109.703 174.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.8 -37.33 79.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 73.239999999999995 110.73 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.49 -167.65 29.72 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 111.525 -0.63 . . . . 51.140000000000001 111.525 -178.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -95.11 -45.35 7.25 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.089 0.471 . . . . 52.009999999999998 110.475 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 16.1 m-20 -116.43 130.69 24.3 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 75.099999999999994 110.688 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 -20.34 14.48 Favored 'Trans proline' 0 C--N 1.333 -0.28 0 C-N-CA 123.203 2.602 . . . . 65.329999999999998 113.827 -177.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 77' ' ' ASP . 8.1 pt-20 -58.76 -24.06 61.08 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.323 1.601 . . . . 54.020000000000003 115.323 -171.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.8 tp -78.75 -29.64 45.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.43 0.633 . . . . 73.219999999999999 110.709 175.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.64 -35.17 13.67 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.217 -0.447 . . . . 70.129999999999995 111.773 -175.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -60.78 -41.47 95.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.912 0.387 . . . . 63.439999999999998 110.895 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 m -56.91 -48.16 78.88 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.522 -0.763 . . . . 62.439999999999998 110.99 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.35 -46.33 64.36 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.928 -0.653 . . . . 53.140000000000001 112.006 -179.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.62 -39.46 94.42 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.413 0.285 . . . . 54.109999999999999 110.472 -177.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.23 88.65 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.857 0.361 . . . . 61.549999999999997 110.134 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.44 -37.87 86.12 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.193 -0.458 . . . . 72.030000000000001 110.997 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -71.09 -37.1 72.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 111.1 176.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.03 -43.91 90.87 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.008 -0.738 . . . . 72.0 109.008 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HB2' HG11 ' A' ' 104' ' ' VAL . . . -61.79 -36.26 80.57 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.404 0.621 . . . . 65.450000000000003 110.635 177.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.27 -42.23 79.9 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.153 -0.93 . . . . 72.129999999999995 108.526 -178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.568 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 m-85 -60.72 -56.16 24.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.781 -1.1 . . . . 75.519999999999996 112.403 176.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.7 pt -59.59 -37.95 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.347 0.499 . . . . 74.140000000000001 112.347 -175.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.88 -37.64 88.32 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.834 -0.346 . . . . 71.319999999999993 110.733 176.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -67.5 -21.17 65.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.874 0.694 . . . . 75.439999999999998 112.874 176.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 50.3 mm-40 -92.49 -10.5 37.58 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.146 0.498 . . . . 71.349999999999994 110.17 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.96 26.55 37.06 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.434 -0.803 . . . . 63.130000000000003 111.851 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -107.22 155.02 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.285 -0.635 . . . . 75.510000000000005 109.285 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -130.87 175.4 9.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.836 -0.431 . . . . 73.409999999999997 109.836 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 t -154.39 158.73 40.47 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 108.264 -1.013 . . . . 52.109999999999999 108.264 175.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.18 120.14 39.97 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.672 -0.492 . . . . 73.25 109.672 -178.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.32 -149.96 16.94 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.601 -1.8 . . . . 61.509999999999998 108.601 -175.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.02 152.26 41.11 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.349 -0.982 . . . . 75.019999999999996 108.349 177.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 90' ' ' ALA . 7.1 p -81.42 122.19 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.626 0.727 . . . . 73.310000000000002 110.721 -179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.29 120.28 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.065 -0.97 . . . . 74.340000000000003 109.225 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.2 m -112.85 138.9 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 107.506 -1.294 . . . . 71.400000000000006 107.506 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -116.12 150.23 37.72 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 109.742 -0.466 . . . . 75.420000000000002 109.742 176.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 81.3 m-85 -129.57 125.88 37.23 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.543 -2.021 . . . . 75.099999999999994 105.543 172.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -138.55 174.36 10.62 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 109.231 -0.655 . . . . 74.319999999999993 109.231 174.608 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.457 ' HB3' ' CG ' ' A' ' 71' ' ' PHE . 11.1 pt20 -122.27 150.23 42.62 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.367 -0.605 . . . . 63.399999999999999 109.367 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.564 ' HB3' ' OD1' ' A' ' 113' ' ' ASN . 75.4 m -119.19 118.67 31.95 Favored 'General case' 0 C--N 1.264 -3.129 0 N-CA-C 107.733 -1.21 . . . . 61.219999999999999 107.733 173.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' A' ' 68' ' ' VAL . 10.5 m -59.94 -28.22 67.44 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.818 0.847 . . . . 62.149999999999999 112.073 -176.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' A' ' 111' ' ' SER . 23.7 p-10 -83.91 -19.87 33.99 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.904 0.881 . . . . 62.100000000000001 111.301 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 111' ' ' SER . 22.1 tp -78.17 135.85 37.72 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.899 -0.591 . . . . 73.310000000000002 109.915 -175.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -78.78 158.58 28.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.544 -0.753 . . . . 73.25 111.9 -173.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.726 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 30.7 m -70.93 130.72 42.35 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.378 -0.828 . . . . 73.519999999999996 110.082 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 11.42 62.27 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.061 -0.816 . . . . 72.030000000000001 111.061 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -126.49 121.22 31.73 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 108.186 -1.042 . . . . 72.099999999999994 108.186 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 66' ' ' LEU . 31.1 p90 -141.24 154.49 45.81 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.478 -0.564 . . . . 64.129999999999995 109.478 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 3.4 mpt_? -124.17 139.0 54.35 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.183 -0.673 . . . . 74.5 109.183 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.11 118.94 16.19 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.389 -0.967 . . . . 72.200000000000003 108.389 176.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -124.98 119.59 29.16 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.676 -0.41 . . . . 75.0 110.233 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -104.78 124.27 7.94 Favored Glycine 0 N--CA 1.422 -2.274 0 N-CA-C 110.449 -1.06 . . . . 63.100000000000001 110.449 177.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.9 m -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.403 -2.804 0 N-CA-C 108.762 -0.829 . . . . 74.230000000000004 108.762 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.7 t -87.69 119.64 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.84 -1.17 . . . . 64.319999999999993 107.84 175.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -110.93 96.06 27.48 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.317 -1.734 . . . . 73.340000000000003 106.317 171.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.36 -25.92 17.84 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.988 1.792 . . . . 52.409999999999997 111.184 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -95.52 70.7 3.1 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.99 1.376 . . . . 53.439999999999998 111.035 -177.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.76 127.19 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 N-CA-C 103.559 -2.756 . . . . 74.540000000000006 103.559 171.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -69.47 95.0 0.79 Allowed 'General case' 0 C--N 1.278 -2.535 0 CA-C-O 121.938 0.875 . . . . 74.109999999999999 110.089 -178.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.1 t -76.91 120.47 22.09 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.047 -1.433 . . . . 73.299999999999997 108.33 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 C--N 1.293 -1.86 0 CA-C-N 114.656 -1.157 . . . . 73.140000000000001 108.528 -171.096 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.555 0.217 . . . . 60.509999999999998 110.938 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.71 33.16 22.56 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 108.305 -1.918 . . . . 52.109999999999999 108.305 -172.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -109.16 135.86 49.6 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.084 -1.058 . . . . 70.239999999999995 110.611 -176.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.85 -178.37 4.49 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 122.662 0.385 . . . . 73.409999999999997 110.668 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.72 112.9 22.88 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.504 -0.924 . . . . 70.549999999999997 108.504 176.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -89.01 93.86 9.75 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.421 -0.912 . . . . 72.439999999999998 110.875 179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.53 95.66 10.32 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.261 -1.385 . . . . 74.030000000000001 107.261 176.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -156.35 109.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.73 0.776 . . . . 72.450000000000003 112.125 -176.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -116.72 119.86 36.79 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.402 -1.703 . . . . 73.099999999999994 106.402 171.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -79.03 100.83 7.51 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.269 -1.011 . . . . 73.109999999999999 108.269 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -74.27 95.9 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.285 -1.006 . . . . 71.409999999999997 108.285 179.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.134 -0.939 . . . . 74.519999999999996 109.782 -176.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -87.09 76.96 9.22 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.99 -1.856 . . . . 73.319999999999993 105.99 172.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.51 94.04 1.25 Allowed 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.054 -0.975 . . . . 71.319999999999993 112.058 -171.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.7 mt -128.79 151.48 49.54 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.384 -1.71 . . . . 65.150000000000006 106.384 177.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.56 97.6 11.18 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.927 -1.508 . . . . 73.120000000000005 106.927 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.83 102.36 11.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.98 0.895 . . . . 61.32 112.509 -176.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -131.89 90.49 2.83 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.508 -1.664 . . . . 64.450000000000003 106.508 172.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 p -95.21 112.86 28.4 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.754 0 CA-C-N 114.497 -1.229 . . . . 73.530000000000001 110.662 -177.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.9 133.71 5.95 Favored Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.72 -0.952 . . . . 64.310000000000002 110.72 -179.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -90.45 105.36 17.76 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.414 -1.328 . . . . 73.25 107.414 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 26' ' ' ILE . . . -43.95 -56.55 3.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.477 -1.238 . . . . 74.140000000000001 112.932 -177.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -65.81 -29.76 70.29 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.0 0.741 . . . . 74.129999999999995 113.0 -177.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.4 79.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.835 -0.802 . . . . 55.399999999999999 108.835 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -67.6 -21.83 65.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.739 -0.664 . . . . 71.439999999999998 111.753 178.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 22' ' ' ALA . 73.5 mt -78.28 -59.32 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.046 0.451 . . . . 72.329999999999998 110.261 177.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -83.98 -17.02 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.121 1.156 . . . . 74.439999999999998 114.121 -173.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.4 38.46 3.49 Favored Glycine 0 C--N 1.308 -1.009 0 C-N-CA 119.918 -1.134 . . . . 74.239999999999995 112.088 179.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.5 45.63 95.91 Favored Glycine 0 CA--C 1.509 -0.3 0 CA-C-N 115.548 -0.326 . . . . 63.329999999999998 112.585 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -165.87 164.8 18.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 106.889 -1.523 . . . . 70.450000000000003 106.889 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 pt 42.63 37.66 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 125.952 1.701 . . . . 75.120000000000005 114.705 176.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 27.1 m -73.75 128.76 86.31 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.064 -0.516 . . . . 74.120000000000005 110.906 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 3.4 Cg_exo -75.31 71.64 5.12 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.736 2.291 . . . . 34.329999999999998 111.536 177.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -89.15 -2.65 58.61 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.744 0.783 . . . . 72.409999999999997 110.03 -178.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 37.5 mt-10 -74.8 -5.34 42.93 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.825 -0.625 . . . . 74.319999999999993 112.403 178.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 82.2 t -71.32 -55.51 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.792 -1.188 . . . . 72.349999999999994 107.792 174.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.5 pm0 -62.98 -34.93 78.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.88 0.372 . . . . 70.409999999999997 111.538 176.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . . . -62.19 -50.86 70.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.983 -0.553 . . . . 42.409999999999997 111.269 177.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.5 tp -70.01 -30.57 67.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.298 0.57 . . . . 63.329999999999998 110.162 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 16.0 tp -66.1 -41.88 90.01 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.687 -0.688 . . . . 51.130000000000003 110.218 -179.03 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.88 -28.96 66.07 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.154 -0.684 . . . . 73.030000000000001 109.154 178.958 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HE ' ' HB2' ' A' ' 46' ' ' ASP . 6.3 tpt180 -64.62 -52.3 58.14 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-N 115.778 -0.646 . . . . 75.420000000000002 109.614 172.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -60.24 -38.05 82.23 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.856 0.863 . . . . 62.409999999999997 110.998 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.28 -46.68 89.0 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.998 -0.547 . . . . 70.019999999999996 110.88 177.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.8 -22.84 49.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.879 -0.601 . . . . 75.0 111.179 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' HE ' ' A' ' 42' ' ' ARG . 28.8 t70 -81.13 -37.33 29.03 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.862 -0.608 . . . . 70.25 110.799 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.41 19.89 29.59 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 116.1 -0.5 . . . . 73.349999999999994 113.538 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.0 mm -66.11 139.04 21.88 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 C-N-CA 123.01 0.524 . . . . 70.239999999999995 110.851 178.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -117.85 143.34 46.38 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.173 0.511 . . . . 74.010000000000005 110.166 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -75.44 111.75 11.05 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.6 -1.182 . . . . 64.299999999999997 109.418 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 20.9 tp -119.13 -176.0 3.03 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.044 -1.835 . . . . 73.140000000000001 106.044 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 73.6 mt-30 -47.29 141.28 4.78 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.579 0.751 . . . . 64.129999999999995 110.058 175.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -10.63 7.77 Favored Glycine 0 CA--C 1.5 -0.857 0 N-CA-C 116.012 1.165 . . . . 74.510000000000005 116.012 -167.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -71.64 -35.72 70.5 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.245 -0.582 . . . . 61.450000000000003 111.844 178.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -167.26 148.12 5.58 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 112.07 0.396 . . . . 74.230000000000004 112.07 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.99 151.73 20.96 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.821 0.848 . . . . 73.299999999999997 110.508 -174.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.04 127.92 37.69 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.766 -1.198 . . . . 75.109999999999999 107.766 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.03 46.81 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 109.113 -0.699 . . . . 75.420000000000002 109.113 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.68 149.02 83.9 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.111 1.874 . . . . 63.409999999999997 111.153 177.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -113.23 -26.14 8.55 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.734 -0.386 . . . . 71.430000000000007 110.886 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 35.3 tt0 -113.12 125.18 54.08 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.185 0.517 . . . . 74.120000000000005 110.025 -177.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB2' HG12 ' A' ' 106' ' ' VAL . 39.4 m-85 -121.83 124.87 45.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.578 -0.737 . . . . 60.219999999999999 109.87 -177.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 69.2 mt -98.18 114.86 36.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.133 -1.062 . . . . 74.109999999999999 108.133 -179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.3 mt -112.75 117.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 108.562 -0.903 . . . . 74.150000000000006 108.562 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 21.3 m -116.83 121.42 41.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.038 -0.528 . . . . 74.329999999999998 110.078 -178.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.471 ' HG ' HD11 ' A' ' 74' ' ' LEU . 4.4 mm? -106.57 163.05 13.2 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.216 -0.902 . . . . 70.200000000000003 109.555 177.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.43 163.64 54.12 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.261 -1.936 . . . . 73.310000000000002 108.261 171.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.25 -40.32 88.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 118.023 0.912 . . . . 63.140000000000001 112.891 -175.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 53.0 t-80 -68.55 -43.24 77.06 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.254 -1.017 . . . . 74.430000000000007 108.254 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -65.55 -35.43 80.83 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.356 -1.293 . . . . 73.239999999999995 110.699 -177.283 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.92 -40.48 91.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.146 0.498 . . . . 70.230000000000004 109.683 178.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.41 -24.83 60.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.188 0.518 . . . . 62.140000000000001 111.193 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 28.7 mmmt -77.52 -17.14 58.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.241 -0.436 . . . . 55.329999999999998 111.848 175.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD11 ' HG ' ' A' ' 66' ' ' LEU . 77.5 mt -71.45 -40.44 70.34 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 105.959 -1.867 . . . . 73.209999999999994 105.959 170.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.9 -176.5 18.64 Favored Glycine 0 N--CA 1.414 -2.829 0 CA-C-N 113.776 -1.557 . . . . 72.439999999999998 110.513 176.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' C ' ' HD3' ' A' ' 78' ' ' PRO . . . -87.12 1.69 52.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.56 0.695 . . . . 72.230000000000004 109.361 178.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 26.6 p-10 -123.05 49.19 2.29 Favored Pre-proline 0 CA--C 1.572 1.811 0 C-N-CA 124.242 1.017 . . . . 63.229999999999997 112.714 -177.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' ALA . 5.2 Cg_exo -75.19 -17.16 19.37 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 121.705 1.604 . . . . 53.130000000000003 110.929 -179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -26.31 59.65 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.376 -0.829 . . . . 63.310000000000002 111.982 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -72.21 -44.94 62.2 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.645 -1.243 . . . . 71.150000000000006 107.645 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HE3' ' CZ ' ' A' ' 85' ' ' PHE . 60.2 tptt -61.3 -33.96 74.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.009 0.924 . . . . 61.299999999999997 109.427 176.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 t -63.05 -49.11 75.84 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.886 -1.052 . . . . 65.340000000000003 110.532 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.5 m -62.04 -34.44 76.24 Favored 'General case' 0 C--O 1.253 1.273 0 CA-C-O 120.896 0.379 . . . . 75.120000000000005 110.854 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.73 -52.63 44.1 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.62 -0.992 . . . . 60.450000000000003 110.62 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.671 ' CZ ' ' HE3' ' A' ' 81' ' ' LYS . 8.0 m-30 -58.52 -44.23 89.47 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 112.516 0.562 . . . . 75.450000000000003 112.516 178.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.15 74.65 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.756 0.66 . . . . 70.340000000000003 111.061 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -79.67 -40.28 29.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.372 -0.531 . . . . 54.229999999999997 111.066 -176.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 91' ' ' ASP . 33.9 t70 -63.9 -38.12 89.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.175 0.512 . . . . 70.230000000000004 111.688 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.55 -29.74 52.4 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.616 -0.434 . . . . 73.409999999999997 110.08 -179.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 94' ' ' GLN . . . -64.31 -37.28 86.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.566 -0.901 . . . . 70.040000000000006 108.566 173.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 88' ' ' ASP . 21.4 t70 -60.19 -54.94 39.83 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.593 -1.185 . . . . 72.420000000000002 109.327 176.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.4 m-85 -51.71 -49.19 62.94 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 114.005 1.113 . . . . 73.310000000000002 114.005 178.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.9 pt -63.8 -34.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.821 -0.751 . . . . 74.439999999999998 111.12 -177.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 81.1 mm-40 -72.24 -37.37 69.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 121.202 -0.199 . . . . 74.420000000000002 110.697 178.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 48.3 mm-40 -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.957 -0.565 . . . . 72.129999999999995 110.981 178.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 70.4 mm-40 -80.19 -13.3 59.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.727 -0.67 . . . . 74.409999999999997 111.681 179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.84 29.81 28.02 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.756 -0.735 . . . . 60.229999999999997 112.327 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -102.47 162.52 12.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.803 -0.814 . . . . 74.409999999999997 108.803 178.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -133.98 177.17 7.94 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.773 -0.454 . . . . 73.120000000000005 109.773 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -160.83 177.33 10.52 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.74 -1.578 . . . . 74.129999999999995 106.74 178.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.36 119.11 36.53 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.943 -0.762 . . . . 65.430000000000007 108.943 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 -150.92 17.05 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 109.387 -1.485 . . . . 62.299999999999997 109.387 -176.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.65 148.11 48.14 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.834 -1.543 . . . . 75.430000000000007 106.834 177.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 65.0 t -72.28 122.37 24.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.144 0.497 . . . . 75.129999999999995 110.814 -177.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' GLU . 7.3 p -138.93 127.73 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.778 0.799 . . . . 71.219999999999999 109.9 -178.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 62' ' ' TYR . 18.8 m -105.17 148.5 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.556 -0.905 . . . . 74.200000000000003 108.556 178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -115.52 125.58 53.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.692 -0.855 . . . . 75.310000000000002 108.692 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -101.11 119.79 39.26 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.265 -0.643 . . . . 75.25 109.265 173.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 65' ' ' THR . 9.9 pt-20 -139.16 164.8 28.85 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.844 -0.616 . . . . 74.310000000000002 109.377 178.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.66 159.41 29.39 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.558 0.694 . . . . 61.210000000000001 110.928 -177.007 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 65.6 m -140.21 109.8 6.31 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 114.937 -1.029 . . . . 63.32 109.188 172.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -64.67 -25.83 68.12 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.462 -0.79 . . . . 74.450000000000003 110.054 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -75.84 -14.72 60.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.16 -0.927 . . . . 70.329999999999998 110.438 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.7 tp -81.98 161.57 22.97 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.211 -1.033 . . . . 65.349999999999994 108.211 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -83.15 150.84 26.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.096 0.474 . . . . 63.240000000000002 110.297 -176.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.0 m -76.31 123.53 26.07 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.59 -0.732 . . . . 75.0 110.602 -178.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.48 8.15 62.79 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.634 -0.986 . . . . 74.420000000000002 110.634 -175.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -114.44 122.02 45.33 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.336 -1.357 . . . . 75.200000000000003 107.336 177.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.447 ' HB3' HD13 ' A' ' 66' ' ' LEU . 43.2 p90 -131.28 154.0 48.96 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.204 -1.035 . . . . 73.340000000000003 108.204 -178.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -141.16 148.42 39.98 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 123.142 0.276 . . . . 75.540000000000006 110.367 -179.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' ILE . . . -147.32 121.0 9.19 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 108.711 -0.848 . . . . 64.25 108.711 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -123.54 140.24 53.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.668 -0.493 . . . . 73.120000000000005 109.668 179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -107.1 136.38 13.34 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 111.555 -0.618 . . . . 72.150000000000006 111.555 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.5 t -138.71 158.9 43.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 108.8 -0.815 . . . . 71.129999999999995 108.8 179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.86 106.99 19.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.463 -1.31 . . . . 75.230000000000004 107.463 178.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -124.11 96.83 41.54 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 109.799 -0.445 . . . . 65.019999999999996 109.799 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.76 -6.86 12.48 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.056 1.837 . . . . 73.349999999999994 110.96 178.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.25 73.9 3.36 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.604 1.193 . . . . 50.450000000000003 108.981 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.88 114.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 113.122 -1.854 . . . . 72.340000000000003 108.422 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.22 125.56 42.61 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.417 0.627 . . . . 72.420000000000002 111.094 -179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.7 m -81.64 133.06 35.32 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.801 -1.555 . . . . 74.510000000000005 106.801 176.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.8 m170 . . . . . 0 C--O 1.263 1.767 0 CA-C-O 118.15 -0.929 . . . . 72.040000000000006 109.038 -178.692 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtm . . . . . 0 C--O 1.249 1.038 0 N-CA-C 108.732 -0.84 . . . . 73.140000000000001 108.732 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.46 -118.23 9.78 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.991 -0.843 . . . . 51.409999999999997 110.991 -178.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -154.43 144.13 21.6 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 122.614 0.366 . . . . 62.020000000000003 110.626 176.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -88.69 93.84 9.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 105.741 -1.948 . . . . 64.019999999999996 105.741 170.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 1.2 pptp? -54.77 121.23 8.1 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 114.667 1.358 . . . . 72.230000000000004 114.667 -172.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.47 122.11 37.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.134 -1.432 . . . . 75.340000000000003 107.134 175.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.56 121.29 23.71 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.148 0.499 . . . . 74.439999999999998 110.525 -176.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -111.77 23.87 4.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 122.906 1.336 . . . . 72.409999999999997 107.465 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -77.75 -45.49 24.5 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.682 -1.144 . . . . 75.340000000000003 111.676 -177.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -87.01 71.97 10.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.209 1.004 . . . . 72.239999999999995 111.125 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.4 73.02 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 104.938 -2.245 . . . . 74.329999999999998 104.938 170.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.41 30.4 0.71 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.257 -1.792 . . . . 73.439999999999998 110.246 -174.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 70.16 13.19 7.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.221 1.01 . . . . 74.430000000000007 111.002 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -120.12 92.8 3.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 114.384 -1.28 . . . . 75.109999999999999 107.923 173.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 tp -152.07 -66.68 0.17 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.544 -1.28 . . . . 72.409999999999997 107.544 179.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 94.74 9.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.232 -1.766 . . . . 75.099999999999994 106.232 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -102.02 -20.12 14.92 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.214 -0.903 . . . . 63.340000000000003 109.908 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -145.55 118.47 8.75 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.771 -1.196 . . . . 74.209999999999994 107.771 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.87 86.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-O 122.385 1.088 . . . . 34.329999999999998 111.652 -178.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.13 175.11 15.9 Favored Glycine 1 N--CA 1.379 -5.117 0 N-CA-C 110.532 -1.027 . . . . 74.230000000000004 110.532 178.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 9.0 m-20 56.25 31.29 18.19 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 125.83 1.652 . . . . 74.129999999999995 112.647 177.052 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.51 -60.2 4.22 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 123.271 0.629 . . . . 70.209999999999994 112.326 -176.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -70.14 -28.93 65.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.649 -0.705 . . . . 75.219999999999999 109.733 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.07 65.99 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.075 -0.966 . . . . 60.020000000000003 110.926 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 21' ' ' ASP . 10.4 ptp180 -74.88 -33.2 62.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.164 0.431 . . . . 72.140000000000001 112.164 -178.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.8 mt -78.88 -55.01 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.751 0.31 . . . . 75.25 111.767 -177.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 94.9 m-85 -93.48 -11.27 32.42 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.899 0.703 . . . . 74.530000000000001 112.899 -173.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.35 -1.6 80.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 120.217 -0.992 . . . . 75.239999999999995 113.804 176.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.59 13.09 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 119.888 -1.148 . . . . 71.239999999999995 112.978 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -75.45 -63.57 1.26 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.996 0.427 . . . . 74.140000000000001 110.73 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.435 ' HB ' ' CG ' ' A' ' 27' ' ' PHE . 47.2 mm -91.47 79.26 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.955 0.883 . . . . 73.0 108.72 176.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.9 t -134.0 120.23 15.09 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.589 -1.263 . . . . 63.200000000000003 107.589 177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.26 58.03 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.136 2.557 . . . . 75.299999999999997 112.718 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 34.2 tt0 -71.8 -33.84 68.89 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.753 -0.462 . . . . 65.349999999999994 109.753 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -65.23 -20.79 66.59 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.141 0.496 . . . . 74.340000000000003 110.681 179.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 78.8 t -72.34 -48.19 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 109.221 -0.659 . . . . 64.430000000000007 109.221 177.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -71.5 -26.7 62.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.454 0.645 . . . . 74.0 111.054 179.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.09 79.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.376 -0.829 . . . . 50.130000000000003 109.665 173.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' ARG . 6.9 tt -76.74 -34.83 58.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.383 -0.969 . . . . 73.230000000000004 108.383 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 96.9 mt -62.28 -47.21 85.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.291 -0.413 . . . . 71.439999999999998 110.851 177.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -66.4 -30.9 71.37 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.454 -0.573 . . . . 72.409999999999997 109.454 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 39' ' ' LEU . 56.7 ttt180 -63.32 -55.25 26.21 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.146 0.978 . . . . 72.400000000000006 109.82 177.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.45 -23.73 58.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.293 -0.412 . . . . 62.219999999999999 111.423 -175.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.49 98.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.286 -0.635 . . . . 63.409999999999997 109.286 172.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.46 63.07 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.426 -0.807 . . . . 72.230000000000004 110.85 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.02 -42.42 76.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.784 0.326 . . . . 54.119999999999997 110.937 178.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.45 9.68 40.69 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.894 -0.593 . . . . 75.409999999999997 114.262 -176.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 48' ' ' ILE . 16.0 mm -59.64 135.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.398 0.618 . . . . 75.049999999999997 111.58 177.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 99.5 mt-30 -120.08 150.0 41.29 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.002 -0.999 . . . . 74.430000000000007 110.545 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.1 m -79.78 126.33 30.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.573 -1.194 . . . . 72.450000000000003 109.708 177.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 19.5 tp -146.7 -164.07 1.9 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 104.522 -2.399 . . . . 64.530000000000001 104.522 -178.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.608 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 50.7 mt-30 -42.25 133.32 3.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.619 0.768 . . . . 74.019999999999996 110.152 176.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.52 -12.43 46.2 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 114.884 0.714 . . . . 70.409999999999997 114.884 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.55 -34.18 60.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.036 0.384 . . . . 75.120000000000005 112.036 177.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.416 ' HG3' ' NE2' ' A' ' 99' ' ' GLN . 29.0 ptt180 -157.05 135.05 11.01 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.307 0.575 . . . . 74.409999999999997 111.943 -177.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.9 mt -90.72 151.64 21.15 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.213 -0.903 . . . . 75.109999999999999 110.737 -173.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 14.7 tp -84.94 125.0 32.3 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.744 -0.835 . . . . 72.409999999999997 108.744 -176.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.42 158.31 40.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 115.836 -0.62 . . . . 73.140000000000001 109.73 -178.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 39.1 Cg_exo -60.8 148.86 90.75 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.969 2.446 . . . . 75.230000000000004 113.121 177.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 100' ' ' THR . 25.7 p-10 -125.44 -21.63 4.49 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.234 -0.893 . . . . 35.329999999999998 110.626 179.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 32.5 tt0 -94.23 107.52 19.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.797 -0.816 . . . . 61.25 108.797 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.554 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 95.3 m-85 -120.52 114.46 21.8 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.294 0.569 . . . . 70.219999999999999 109.956 177.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.49 122.06 66.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.16 -1.052 . . . . 71.540000000000006 108.16 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.6 mt -115.6 119.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 121.376 0.607 . . . . 73.299999999999997 109.521 -178.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 109' ' ' GLU . 15.1 m -117.45 123.71 47.04 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.721 -0.672 . . . . 43.450000000000003 109.261 -177.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 74' ' ' LEU . 6.4 mp -121.8 171.82 8.61 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 109.949 -0.389 . . . . 73.530000000000001 109.949 175.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.79 147.28 43.11 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.484 -1.046 . . . . 61.299999999999997 110.484 175.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.03 -47.76 65.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 123.099 0.56 . . . . 63.039999999999999 110.666 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.592 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 52.7 t-80 -64.0 -40.72 97.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.506 -0.77 . . . . 65.400000000000006 110.376 -178.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 9.3 t70 -65.2 -43.28 92.11 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.768 0.794 . . . . 73.420000000000002 108.983 -178.337 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -59.3 -44.43 92.52 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 125.82 1.648 . . . . 74.430000000000007 109.8 -178.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -67.25 -37.25 83.2 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.087 -0.506 . . . . 73.310000000000002 110.749 177.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 3.1 mmmp? -68.5 -26.28 65.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.462 -0.336 . . . . 61.299999999999997 110.607 179.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 66' ' ' LEU . 78.8 mt -69.65 -45.68 67.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.804 0.811 . . . . 74.400000000000006 109.792 175.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.6 44.87 7.11 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 105.054 -3.218 . . . . 44.219999999999999 105.054 -165.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -61.53 6.93 0.05 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 128.624 2.77 . . . . 71.129999999999995 116.851 -171.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.4 t70 -43.45 106.85 0.52 Allowed Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.556 1.142 . . . . 71.109999999999999 108.728 -173.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 52.9 Cg_exo -52.65 -52.47 8.79 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 124.334 3.356 . . . . 74.140000000000001 118.987 -161.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.79 -51.07 7.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.441 1.645 . . . . 72.120000000000005 115.441 -165.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -62.96 -56.48 16.78 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 112.744 0.646 . . . . 63.409999999999997 112.744 -176.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 85' ' ' PHE 0.286 29.1 mmmt -94.8 -8.61 36.98 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 115.55 1.685 . . . . 64.239999999999995 115.55 -177.352 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -69.46 -45.58 68.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 106.213 -1.773 . . . . 63.240000000000002 106.213 174.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.4 m -69.92 -36.91 75.73 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.059 -0.973 . . . . 65.340000000000003 108.925 175.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.02 -56.22 26.38 Favored Glycine 0 C--O 1.21 -1.345 0 CA-C-N 115.33 -0.85 . . . . 61.409999999999997 113.109 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 32.1 m-85 -60.2 -35.47 75.48 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.449 0.624 . . . . 70.540000000000006 111.492 179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.95 94.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.277 -0.42 . . . . 52.009999999999998 109.99 177.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -68.88 -41.12 78.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.878 -0.601 . . . . 74.510000000000005 110.085 178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.67 -50.97 71.43 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.902 -0.407 . . . . 72.049999999999997 109.902 176.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.5 mt -68.8 -31.76 70.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.215 0.82 . . . . 72.109999999999999 113.215 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.43 91.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.332 0.587 . . . . 74.230000000000004 109.661 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.0 -41.99 73.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.638 -0.71 . . . . 61.409999999999997 109.655 177.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -56.48 -52.86 63.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 112.565 0.58 . . . . 72.400000000000006 112.565 176.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.32 -37.8 58.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 C-N-CA 120.063 -0.655 . . . . 74.239999999999995 111.699 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -66.28 -50.89 62.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.365 -0.379 . . . . 71.510000000000005 111.181 175.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HB3' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -53.31 -51.03 63.65 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.942 1.297 . . . . 74.420000000000002 110.784 -178.376 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 1.7 mp0 -74.73 -13.44 60.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.086 1.143 . . . . 72.109999999999999 114.086 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.24 38.21 11.39 Favored Glycine 0 C--N 1.313 -0.714 0 C-N-CA 120.028 -1.082 . . . . 72.519999999999996 111.796 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -109.42 158.41 17.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.774 -0.825 . . . . 72.239999999999995 108.774 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' A' ' 55' ' ' ARG . 23.6 pt20 -129.11 174.24 9.74 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.923 -0.769 . . . . 73.430000000000007 108.923 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 60' ' ' ASN . 9.0 t -162.34 159.29 25.24 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.735 -1.209 . . . . 74.230000000000004 107.735 177.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.56 118.9 33.11 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.381 -0.97 . . . . 74.25 108.381 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.42 -149.75 16.72 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 108.567 -1.813 . . . . 54.509999999999998 108.567 -176.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -126.09 164.32 21.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.568 -1.641 . . . . 63.140000000000001 106.568 174.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.37 117.53 28.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.556 -0.905 . . . . 54.399999999999999 108.556 -178.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -118.33 121.03 66.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.607 0.717 . . . . 74.319999999999993 110.643 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 62' ' ' TYR . 79.5 t -111.12 113.18 43.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.387 -0.968 . . . . 72.010000000000005 108.387 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -111.31 134.45 52.89 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.007 -0.542 . . . . 72.530000000000001 109.554 -177.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -105.4 146.41 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.738 -0.467 . . . . 73.349999999999994 109.738 177.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 65' ' ' THR . 9.2 pt-20 -151.37 168.31 25.2 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.75 -0.833 . . . . 62.119999999999997 108.75 174.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.42 25.77 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.235 0.541 . . . . 51.109999999999999 111.784 178.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.1 t -135.74 136.87 41.15 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.709 -1.132 . . . . 52.049999999999997 109.146 -175.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 t -80.73 -19.27 45.37 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.8 -0.815 . . . . 54.340000000000003 108.8 176.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -72.79 -36.43 67.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.701 -0.681 . . . . 71.129999999999995 110.103 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.74 155.22 20.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.176 -0.466 . . . . 73.540000000000006 110.707 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -125.27 173.47 8.78 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 123.2 0.6 . . . . 72.420000000000002 110.645 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 9.8 m -57.79 125.61 23.77 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.474 0.654 . . . . 75.409999999999997 110.933 -179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.27 -3.87 54.84 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.318 -0.856 . . . . 74.150000000000006 111.058 -176.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -118.18 118.67 32.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.092 0.472 . . . . 73.120000000000005 110.08 -178.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 34.0 p90 -139.03 148.45 43.42 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.564 -1.273 . . . . 74.319999999999993 107.564 177.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -132.12 130.65 41.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.228 -1.027 . . . . 55.43 108.228 175.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . -130.8 129.48 42.47 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.83 -1.174 . . . . 53.119999999999997 107.83 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 39.7 mtp180 -119.61 157.8 27.69 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 123.155 0.285 . . . . 71.519999999999996 111.521 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 61' ' ' GLU . . . -137.0 109.85 0.74 Allowed Glycine 0 N--CA 1.424 -2.109 0 O-C-N 124.715 1.26 . . . . 60.310000000000002 110.918 176.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.6 m -114.3 150.43 34.48 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.371 -0.603 . . . . 73.439999999999998 109.371 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.24 106.12 16.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 106.49 -1.67 . . . . 75.310000000000002 106.49 170.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -110.42 102.28 51.07 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 109.962 -0.384 . . . . 71.239999999999995 109.962 -178.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.9 -14.17 12.55 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.946 1.764 . . . . 54.5 111.394 178.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -95.12 70.53 3.27 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 123.2 1.476 . . . . 42.409999999999997 109.111 179.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.76 131.36 64.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 CA-C-N 112.479 -2.146 . . . . 72.420000000000002 107.451 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -76.62 124.52 27.75 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.166 -1.049 . . . . 74.209999999999994 108.166 178.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 t -130.77 157.63 42.31 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.391 -0.822 . . . . 74.040000000000006 109.362 -177.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--N 1.291 -1.977 0 CA-C-O 118.366 -0.826 . . . . 72.200000000000003 109.028 -178.453 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 108.597 -0.89 . . . . 61.219999999999999 108.597 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.39 8.63 68.01 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.819 -0.705 . . . . 71.319999999999993 112.899 177.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -102.54 23.71 11.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.213 0.53 . . . . 71.450000000000003 109.666 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -102.18 164.1 11.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.997 -0.547 . . . . 75.200000000000003 110.293 -177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -126.03 103.98 8.03 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.536 -1.283 . . . . 65.209999999999994 107.536 170.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -83.67 104.31 13.69 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.223 0.535 . . . . 62.32 110.151 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.2 149.6 52.35 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.057 -0.974 . . . . 64.120000000000005 109.104 177.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.16 125.48 33.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.201 -0.666 . . . . 75.420000000000002 109.201 178.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -117.75 130.61 56.42 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.691 -0.485 . . . . 70.439999999999998 109.691 -178.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -94.48 102.41 14.36 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 109.034 -0.728 . . . . 75.400000000000006 109.034 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.75 -5.43 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.519 1.152 . . . . 74.540000000000006 108.272 177.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -68.59 141.77 55.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 113.994 -1.457 . . . . 64.230000000000004 109.833 176.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 68.4 21.14 8.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.797 1.239 . . . . 73.409999999999997 112.729 173.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -76.77 -35.11 57.93 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 106.135 -1.802 . . . . 75.099999999999994 106.135 168.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.92 98.09 8.36 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 104.982 -2.229 . . . . 64.140000000000001 104.982 171.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.15 88.01 6.34 Favored 'General case' 0 CA--C 1.489 -1.398 0 C-N-CA 120.235 -0.586 . . . . 75.430000000000007 110.983 -179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -73.28 129.75 38.71 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.278 -1.749 . . . . 75.450000000000003 106.278 172.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -79.56 159.65 26.77 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.062 -0.517 . . . . 72.519999999999996 111.223 -176.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.01 91.63 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.932 -1.136 . . . . 53.43 107.932 177.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.8 -68.58 0.14 Allowed Glycine 0 C--N 1.3 -1.471 0 N-CA-C 110.074 -1.21 . . . . 73.109999999999999 110.074 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -103.28 15.26 29.62 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.57 0.7 . . . . 75.120000000000005 109.946 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.479 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -59.7 -44.86 93.52 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.622 -1.172 . . . . 44.399999999999999 111.857 -177.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' HA ' HG12 ' A' ' 26' ' ' ILE . 63.3 m-85 -63.93 -34.54 78.2 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 123.36 0.412 . . . . 71.439999999999998 111.87 -177.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.09 82.06 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.438 0.637 . . . . 74.340000000000003 109.86 177.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -71.84 -30.86 65.91 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.367 -0.833 . . . . 73.340000000000003 112.248 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG12 ' HA ' ' A' ' 23' ' ' PHE . 24.0 pt -85.23 -16.24 10.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 112.766 0.654 . . . . 71.400000000000006 112.766 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -92.4 -29.45 16.3 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.282 -0.567 . . . . 60.200000000000003 111.204 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.79 -94.62 0.03 OUTLIER Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.928 0.767 . . . . 51.200000000000003 114.522 174.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.02 71.43 Favored Glycine 0 C--N 1.307 -1.066 0 CA-C-N 115.164 -0.518 . . . . 73.420000000000002 112.443 -177.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 m -91.37 172.94 8.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.847 -0.427 . . . . 71.349999999999994 109.847 174.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.77 121.66 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.722 -1.584 . . . . 74.230000000000004 106.722 176.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 21.6 m -85.01 142.02 38.27 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.28 -0.418 . . . . 72.510000000000005 111.951 -173.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -53.56 115.46 2.33 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 122.965 2.443 . . . . 65.430000000000007 112.171 175.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 32' ' ' VAL . 13.1 pt20 176.46 -41.67 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 127.036 2.134 . . . . 74.219999999999999 106.271 -178.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.02 -27.12 33.25 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.443 -1.253 . . . . 72.530000000000001 109.892 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -54.4 33.66 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.034 0 N-CA-C 107.649 -1.241 . . . . 61.140000000000001 107.649 175.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.78 -46.58 74.45 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.441 1.097 . . . . 71.409999999999997 110.911 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.2 69.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.058 -0.519 . . . . 65.120000000000005 111.655 178.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD13 ' CE2' ' A' ' 119' ' ' PHE . 9.6 tt -70.92 -35.4 72.24 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.849 0.356 . . . . 74.430000000000007 110.576 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 tp -67.12 -38.65 85.97 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.938 -0.574 . . . . 73.010000000000005 110.522 -178.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -71.86 -29.06 63.98 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.407 -0.517 . . . . 61.25 111.184 177.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -72.28 -38.02 68.9 Favored 'General case' 0 C--O 1.203 -1.368 0 C-N-CA 119.037 -1.065 . . . . 61.130000000000003 109.075 173.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -64.34 -33.14 75.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.205 -0.665 . . . . 74.219999999999999 109.205 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.52 73.48 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.345 -0.843 . . . . 74.219999999999999 109.613 174.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' A' ' 48' ' ' ILE . . . -67.98 -30.98 70.38 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.563 0.697 . . . . 72.239999999999995 111.477 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.6 -29.92 52.2 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.92 -0.582 . . . . 72.25 109.755 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.51 14.1 65.98 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.824 -0.625 . . . . 75.540000000000006 112.41 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 45' ' ' ALA . 8.7 mm -64.0 138.9 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 123.962 0.905 . . . . 64.439999999999998 111.254 177.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 76.3 mt-30 -119.25 147.47 44.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.952 -0.567 . . . . 72.109999999999999 110.499 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.5 m -82.95 134.55 35.06 Favored 'General case' 0 N--CA 1.415 -2.222 0 CA-C-N 115.029 -0.987 . . . . 55.340000000000003 108.807 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.4 tp -150.69 -165.43 2.27 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.008 -2.219 . . . . 64.340000000000003 105.008 -179.371 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.623 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 80.0 mt-30 -42.2 139.33 1.42 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.727 0.811 . . . . 72.530000000000001 111.649 176.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.47 20.69 0.97 Allowed Glycine 0 CA--C 1.505 -0.543 0 CA-C-N 115.363 -0.835 . . . . 53.210000000000001 115.032 -170.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -86.96 -37.19 17.8 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.316 -1.365 . . . . 53.210000000000001 107.316 175.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -173.92 158.6 3.21 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 115.195 -0.911 . . . . 63.409999999999997 112.235 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB3' HG23 ' A' ' 48' ' ' ILE . 57.5 mt -91.63 151.76 20.55 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.042 -0.981 . . . . 74.230000000000004 111.36 -174.477 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 22.2 mt -80.88 121.0 25.43 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 115.771 -0.65 . . . . 70.129999999999995 110.978 178.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.13 151.14 37.61 Favored Pre-proline 0 C--N 1.285 -2.206 0 N-CA-C 107.731 -1.211 . . . . 53.329999999999998 107.731 175.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HA ' HG22 ' A' ' 125' ' ' VAL . 39.3 Cg_exo -59.44 156.09 37.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.42 2.08 . . . . 43.520000000000003 112.882 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -118.86 -29.41 5.33 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.572 -0.74 . . . . 72.519999999999996 109.568 176.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -96.52 105.28 17.35 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.822 -0.626 . . . . 75.439999999999998 109.587 179.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 76.0 m-85 -115.8 114.8 25.25 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.802 -0.444 . . . . 74.120000000000005 109.802 178.24 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 25.0 mm -112.8 119.97 61.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.584 -1.265 . . . . 64.200000000000003 107.584 177.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.42 135.69 41.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.664 -1.236 . . . . 63.210000000000001 107.664 -178.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 27.3 m -124.37 113.36 18.09 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.685 -0.487 . . . . 72.310000000000002 109.685 -177.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 3.5 mm? -109.3 -176.89 3.15 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.755 -0.657 . . . . 43.020000000000003 110.26 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.48 173.6 44.17 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.248 -1.141 . . . . 63.340000000000003 110.248 177.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 7.9 p -65.82 -44.31 92.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 117.131 0.466 . . . . 54.520000000000003 111.224 -179.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -56.51 -42.34 78.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.05 0.929 . . . . 74.400000000000006 110.033 177.468 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 12.6 m-20 -71.94 -37.78 69.93 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.299 -1.318 . . . . 72.019999999999996 110.446 -176.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -64.7 -37.78 88.77 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.655 -0.498 . . . . 74.329999999999998 109.655 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 47.5 mt-10 -61.23 -36.96 81.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.693 -0.685 . . . . 65.140000000000001 110.229 177.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -79.81 -23.88 41.76 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.975 -0.557 . . . . 75.120000000000005 112.362 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 89.5 mt -61.23 -42.29 98.35 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.714 -0.476 . . . . 64.140000000000001 109.714 177.387 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.21 166.65 10.75 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 119.622 -1.275 . . . . 43.439999999999998 113.299 175.252 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.89 -18.24 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.721 0.408 . . . . 75.299999999999997 111.575 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -115.72 85.4 14.09 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.084 -0.71 . . . . 54.32 109.084 177.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.13 -50.0 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.143 1.895 . . . . 73.129999999999995 112.282 -178.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.27 -49.48 73.89 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.53 0.567 . . . . 74.409999999999997 112.53 -173.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.74 -37.02 82.68 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 112.29 0.478 . . . . 70.030000000000001 112.29 -179.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -77.42 -26.7 51.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.687 -0.405 . . . . 74.310000000000002 111.009 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' VAL . 60.1 m -65.57 -40.41 92.75 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.876 -0.416 . . . . 52.119999999999997 109.876 175.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 m -59.79 -39.23 84.24 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.389 0.614 . . . . 72.319999999999993 109.964 178.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.89 -45.85 55.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.582 -0.736 . . . . 54.439999999999998 111.976 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -68.95 -28.35 66.55 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.117 0.484 . . . . 74.099999999999994 110.03 -178.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 106' ' ' VAL . . . -66.9 -38.79 86.91 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 116.147 -0.479 . . . . 72.530000000000001 109.757 176.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.36 -38.43 89.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 109.564 178.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -65.31 -42.66 92.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.992 -0.549 . . . . 70.099999999999994 110.344 177.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.15 -33.24 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.373 -0.376 . . . . 74.450000000000003 110.827 178.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.2 98.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.462 -0.569 . . . . 61.009999999999998 109.462 176.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 27.2 t70 -61.68 -44.18 97.45 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.304 -0.862 . . . . 73.150000000000006 109.453 177.189 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 m-85 -57.65 -52.96 63.28 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.671 0.619 . . . . 72.510000000000005 112.671 176.047 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 32.8 pt -64.59 -30.18 49.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 120.693 -0.403 . . . . 63.25 111.705 -176.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -66.95 -38.31 85.89 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.123 -0.49 . . . . 72.450000000000003 110.366 174.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 51.3 mt-10 -65.67 -30.55 71.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.951 -0.568 . . . . 72.129999999999995 111.162 177.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 56.0 mm-40 -85.52 -11.43 54.18 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.807 -0.633 . . . . 70.340000000000003 110.941 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.66 33.08 60.92 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.764 -0.653 . . . . 51.100000000000001 113.065 178.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -97.99 161.34 13.77 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.496 -0.482 . . . . 74.540000000000006 110.122 178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.95 161.71 18.43 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.021 -0.733 . . . . 71.540000000000006 109.021 178.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -161.1 172.26 17.12 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.576 -1.638 . . . . 54.340000000000003 106.576 177.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -123.51 120.14 32.03 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 71.450000000000003 110.235 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.74 13.07 Favored Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 109.751 -1.34 . . . . 53.140000000000001 109.751 -179.667 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.08 141.32 30.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.542 -0.91 . . . . 64.109999999999999 108.542 174.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.37 138.32 21.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.293 -1.002 . . . . 65.040000000000006 108.293 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.19 124.6 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-O 121.152 0.501 . . . . 43.420000000000002 111.125 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 15.3 m -108.87 140.54 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 106.643 -1.614 . . . . 52.210000000000001 106.643 172.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.38 144.92 48.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.512 -0.922 . . . . 74.510000000000005 108.512 177.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -111.77 126.93 55.59 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.413 0.445 . . . . 53.0 110.184 178.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.5 pt-20 -128.26 168.49 15.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.936 -1.505 . . . . 74.040000000000006 106.936 173.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.35 156.93 34.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.805 0.812 . . . . 73.319999999999993 112.004 -177.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 74.5 m -130.48 101.77 5.87 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.171 -1.418 . . . . 61.420000000000002 107.171 169.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -68.14 -9.38 46.17 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 123.948 0.899 . . . . 72.340000000000003 112.941 -175.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.0 -25.66 48.14 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.746 -0.835 . . . . 60.509999999999998 108.746 174.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -104.48 151.45 23.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.66 -1.237 . . . . 72.310000000000002 107.66 -177.235 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -139.65 171.8 13.71 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 117.563 0.165 . . . . 72.439999999999998 111.307 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 m -36.02 112.87 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.28 2.232 . . . . 53.030000000000001 113.057 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.35 -33.07 3.74 Favored Glycine 0 CA--C 1.494 -1.253 0 N-CA-C 107.848 -2.101 . . . . 74.019999999999996 107.848 -175.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -105.73 139.21 40.65 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.908 -1.516 . . . . 74.329999999999998 106.908 174.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CE2' HD13 ' A' ' 39' ' ' LEU . 32.7 p90 -170.45 154.19 4.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.783 -0.821 . . . . 74.030000000000001 108.783 174.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -128.72 157.97 39.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.963 -0.562 . . . . 72.040000000000006 110.261 -177.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.47 144.15 22.62 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 106.092 -1.818 . . . . 72.420000000000002 106.092 174.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 33.2 ptt-85 -140.41 145.95 37.69 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.436 -0.579 . . . . 64.439999999999998 109.436 178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 110.06 0.93 Allowed Glycine 0 C--N 1.284 -2.326 0 O-C-N 124.206 0.942 . . . . 75.219999999999999 111.81 -176.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 15.6 m -109.25 137.84 46.51 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.65 -0.5 . . . . 71.340000000000003 109.65 -179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 59' ' ' PRO . 59.0 t -89.07 109.12 19.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 105.992 -1.855 . . . . 71.400000000000006 105.992 170.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -98.16 105.88 31.39 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 109.437 -0.579 . . . . 44.5 109.437 179.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.5 -11.37 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.165 1.91 . . . . 71.030000000000001 111.689 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -93.72 72.19 4.23 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-O 123.297 1.522 . . . . 74.310000000000002 109.057 178.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.9 p -142.21 143.79 25.91 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 104.614 -2.365 . . . . 62.210000000000001 104.614 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 130' ' ' GLU . 0.8 OUTLIER -73.21 134.95 44.51 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.694 0.759 . . . . 70.420000000000002 111.109 -179.102 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.9 t -147.12 136.61 22.8 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 114.527 -1.215 . . . . 75.129999999999995 108.002 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.7 t60 . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 108.023 -1.103 . . . . 75.219999999999999 108.023 -178.633 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 73.140000000000001 109.14 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.37 9.78 10.11 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.667 -0.778 . . . . 50.219999999999999 111.437 -178.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -79.2 84.67 5.14 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.536 0.684 . . . . 41.130000000000003 109.722 178.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -113.39 163.69 14.54 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.078 -0.965 . . . . 44.32 110.976 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.2 150.21 24.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.197 -0.91 . . . . 64.040000000000006 108.903 -178.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -93.09 93.96 8.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 105.408 -2.071 . . . . 75.510000000000005 105.408 170.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.82 -40.32 94.85 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.691 -0.686 . . . . 74.530000000000001 112.247 -173.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t 65.44 91.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 124.18 0.925 . . . . 71.150000000000006 110.263 -176.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -156.9 123.55 5.06 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.444 -1.317 . . . . 65.510000000000005 107.444 178.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -83.79 134.49 34.72 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.213 -1.032 . . . . 65.519999999999996 108.213 178.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.81 98.38 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.397 -0.964 . . . . 63.310000000000002 108.397 178.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.12 152.76 43.13 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.366 -1.288 . . . . 54.340000000000003 112.104 -176.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -119.66 79.15 1.39 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.477 -0.783 . . . . 55.43 109.129 172.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 14' ' ' LYS . 3.9 ttpm? -109.17 84.67 1.96 Allowed 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.891 -1.151 . . . . 63.240000000000002 107.891 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -77.72 -40.62 40.62 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.333 -1.358 . . . . 65.430000000000007 107.333 179.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -138.92 154.62 48.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.525 -1.287 . . . . 74.310000000000002 107.525 175.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.64 152.16 24.93 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 123.322 0.389 . . . . 73.340000000000003 110.092 -178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 m -69.07 109.53 4.05 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.319 -0.993 . . . . 64.25 108.319 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.44 145.43 22.43 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 109.105 -0.702 . . . . 75.329999999999998 109.105 -175.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.06 22.98 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 109.762 -1.335 . . . . 70.230000000000004 109.762 -175.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -135.85 111.77 9.52 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.482 -1.303 . . . . 71.140000000000001 107.482 -178.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.49 -56.92 9.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.652 0.982 . . . . 63.210000000000001 113.652 -174.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.06 -42.61 96.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 112.69 0.626 . . . . 63.240000000000002 112.69 -175.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' HG21 ' A' ' 31' ' ' ILE . . . -63.44 -40.27 96.7 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.801 0.334 . . . . 75.310000000000002 111.193 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -69.59 -41.57 75.58 Favored 'General case' 0 N--CA 1.393 -3.306 0 C-N-CA 124.275 1.03 . . . . 73.109999999999999 111.464 -178.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -79.54 -55.93 8.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 112.024 0.379 . . . . 73.140000000000001 112.024 -177.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.52 -29.79 17.67 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.939 1.089 . . . . 75.239999999999995 113.939 -170.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.95 -67.74 1.36 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.759 -0.734 . . . . 70.430000000000007 113.588 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.55 -79.44 1.2 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.711 -0.28 . . . . 71.450000000000003 112.87 -177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -81.3 91.72 6.27 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.027 -0.731 . . . . 65.129999999999995 109.027 -179.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.499 HG21 ' HA ' ' A' ' 24' ' ' ALA . 36.3 pt -108.41 19.42 5.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.32 -0.855 . . . . 73.519999999999996 110.728 -175.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.17 123.73 47.74 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 113.222 0.823 . . . . 71.200000000000003 113.222 -173.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.67 -12.63 22.26 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.261 1.974 . . . . 74.409999999999997 109.388 174.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -61.9 -20.84 64.19 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 113.43 -1.714 . . . . 60.240000000000002 110.884 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.51 -47.78 69.58 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 123.465 0.706 . . . . 73.219999999999999 109.111 177.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.36 -44.81 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.272 -0.876 . . . . 74.099999999999994 109.917 -178.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.87 -53.42 56.98 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-N 116.025 -0.534 . . . . 63.009999999999998 111.352 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.55 86.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.707 -0.679 . . . . 72.329999999999998 111.201 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.36 -41.76 84.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.85 -0.426 . . . . 73.150000000000006 109.85 -178.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.52 -43.4 80.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.581 0.586 . . . . 75.299999999999997 112.581 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -68.65 -29.55 68.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.788 -0.765 . . . . 73.129999999999995 110.78 178.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -70.06 -38.79 75.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.141 -0.689 . . . . 72.049999999999997 109.141 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.9 -38.15 90.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.962 -0.755 . . . . 74.319999999999993 108.962 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.42 92.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.471 -0.786 . . . . 74.209999999999994 110.421 176.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.91 -31.88 71.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.667 -0.697 . . . . 74.099999999999994 111.468 -178.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.37 -33.55 61.06 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.165 -0.47 . . . . 61.240000000000002 111.217 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.58 15.53 40.74 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.813 -0.631 . . . . 35.109999999999999 112.94 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 48' ' ' ILE . 12.2 mm -67.02 130.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 123.332 0.653 . . . . 72.239999999999995 112.132 179.09 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -116.02 147.41 41.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.353 -0.839 . . . . 74.219999999999999 109.622 176.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.6 m -77.55 102.92 7.19 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.163 0.982 . . . . 64.040000000000006 111.484 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 16.5 tp -105.2 -165.96 1.18 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.246 -2.131 . . . . 60.130000000000003 105.246 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.485 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 79.5 mt-30 -51.06 138.25 20.12 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.348 -0.982 . . . . 72.030000000000001 108.348 171.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.91 22.47 0.57 Allowed Glycine 0 N--CA 1.471 0.982 0 N-CA-C 114.782 0.673 . . . . 32.32 114.782 -171.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -104.27 -25.23 12.97 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.266 -1.013 . . . . 64.319999999999993 108.266 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -161.51 134.66 6.31 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.28 -0.873 . . . . 73.129999999999995 110.54 -177.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -97.0 151.88 19.28 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.783 -0.644 . . . . 75.439999999999998 110.61 -175.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -91.01 126.6 36.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.159 -1.052 . . . . 74.430000000000007 108.159 -177.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.24 160.41 37.59 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 123.181 0.592 . . . . 53.539999999999999 109.805 -178.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.15 157.99 59.06 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.611 2.208 . . . . 74.510000000000005 111.921 176.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB3' HG21 ' A' ' 100' ' ' THR . 25.3 p-10 -126.38 -25.12 3.53 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.174 0.435 . . . . 63.340000000000003 112.174 -177.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.48 110.38 21.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.551 -0.537 . . . . 72.099999999999994 109.551 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' ARG . 55.1 m-85 -116.88 119.16 34.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.434 -0.803 . . . . 62.539999999999999 110.076 -177.138 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.0 mt -108.2 118.99 56.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 108.669 -0.863 . . . . 73.010000000000005 108.669 177.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 3.1 mp -112.48 124.96 69.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.462 -0.94 . . . . 71.209999999999994 108.462 178.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -119.42 133.64 55.61 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.997 -0.742 . . . . 54.439999999999998 108.997 -178.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.58 173.36 7.23 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.209 0.604 . . . . 71.010000000000005 110.226 175.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.51 166.44 45.57 Favored Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 108.846 -1.701 . . . . 72.120000000000005 108.846 172.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 95.1 t -59.07 -59.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 117.666 0.733 . . . . 54.439999999999998 110.885 -178.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.499 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 40.8 t-80 -53.44 -49.17 67.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 65.510000000000005 110.809 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.552 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.8 m-20 -58.2 -50.38 73.75 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 124.62 1.168 . . . . 63.130000000000003 111.134 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.24 -40.08 93.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.354 -0.384 . . . . 71.019999999999996 111.24 -176.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 53.5 mt-10 -65.78 -31.27 72.15 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.856 0.36 . . . . 62.340000000000003 111.074 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 69' ' ' HIS . 13.6 mptt -79.32 -27.51 42.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 73.310000000000002 111.266 178.007 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 61.3 mt -75.49 -33.25 60.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.833 -0.802 . . . . 72.109999999999999 108.833 175.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.01 116.16 1.65 Allowed Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 108.833 -1.707 . . . . 72.209999999999994 108.833 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 78' ' ' PRO . . . -77.76 1.51 19.89 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.063 0.394 . . . . 61.32 112.063 -176.24 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 25.4 t70 -80.58 101.88 1.07 Allowed Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 124.215 1.006 . . . . 72.109999999999999 109.226 176.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 76' ' ' ALA . 72.9 Cg_endo -75.92 -33.47 3.7 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.44 2.093 . . . . 72.319999999999993 115.871 -171.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -65.05 -49.11 71.38 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 112.776 0.658 . . . . 74.150000000000006 112.776 -170.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.96 -15.99 62.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.846 0.355 . . . . 74.450000000000003 111.864 -177.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 75.6 mmtt -81.68 -57.64 3.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.511 -0.922 . . . . 65.209999999999994 108.511 175.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -62.22 -53.74 50.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.078 -0.965 . . . . 74.530000000000001 111.308 -173.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.9 m -69.95 -35.5 74.56 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.639 -0.255 . . . . 32.450000000000003 111.195 -177.266 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.09 -51.05 59.54 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.284 -0.484 . . . . 75.310000000000002 112.01 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 81' ' ' LYS . 71.7 m-85 -72.65 -36.03 67.88 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 112.493 0.553 . . . . 73.519999999999996 112.493 -179.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.49 96.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.666 -0.414 . . . . 62.409999999999997 110.739 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -63.83 -49.09 74.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.977 -0.556 . . . . 75.310000000000002 110.559 178.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -67.29 -37.31 83.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 64.200000000000003 111.552 -176.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 tp -74.05 -34.93 64.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 63.0 111.005 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.11 89.87 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.814 -0.81 . . . . 63.229999999999997 108.814 175.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.36 -48.83 74.03 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.968 -1.014 . . . . 74.230000000000004 109.736 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.606 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 14.9 m-85 -52.08 -53.33 43.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.906 0.706 . . . . 71.430000000000007 112.906 176.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.4 pt -62.09 -36.53 74.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 120.594 -0.443 . . . . 73.299999999999997 111.494 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.56 -41.68 79.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.973 -0.291 . . . . 64.530000000000001 110.861 177.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -59.27 -41.02 87.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.026 0.441 . . . . 61.43 111.194 177.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 78.6 mm-40 -72.99 -13.37 61.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.009 -0.542 . . . . 63.350000000000001 112.21 -178.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.13 36.07 13.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.37 -0.919 . . . . 63.100000000000001 111.06 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -113.21 170.91 7.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.194 -1.039 . . . . 73.019999999999996 108.194 175.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -151.62 178.19 9.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.691 -0.855 . . . . 72.230000000000004 108.691 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 60' ' ' ASN . 14.6 t -150.52 177.91 9.57 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.518 -0.549 . . . . 74.109999999999999 109.518 -179.314 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' PRO . 68.7 m-85 -111.66 121.04 44.05 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 178.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.96 -149.68 17.05 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 110.222 -1.151 . . . . 64.129999999999995 110.222 -178.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.481 ' H ' ' HB ' ' A' ' 129' ' ' VAL . 32.2 t70 -121.78 147.19 46.26 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.166 -0.679 . . . . 62.509999999999998 109.166 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.9 125.16 39.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 110.844 -177.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.04 120.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 121.789 0.804 . . . . 74.329999999999998 109.984 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.3 t -117.78 112.43 38.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.212 -1.403 . . . . 74.439999999999998 107.212 179.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ttp85 -115.97 138.87 50.8 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 111.934 0.346 . . . . 75.030000000000001 111.934 -175.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -119.18 134.9 54.94 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.269 -1.011 . . . . 60.310000000000002 108.269 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -156.17 164.16 38.72 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 123.563 0.539 . . . . 64.409999999999997 111.232 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -95.46 164.91 12.61 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.106 -0.497 . . . . 50.100000000000001 111.241 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.7 p -150.36 150.21 31.12 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 115.444 -0.798 . . . . 71.420000000000002 109.647 177.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -80.78 -22.83 39.76 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.607 -0.516 . . . . 73.109999999999999 109.607 176.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -65.93 -28.1 68.67 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.469 0.707 . . . . 71.510000000000005 110.756 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD11 ' HG3' ' A' ' 120' ' ' ARG . 77.3 mt -96.5 135.92 37.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.917 -0.583 . . . . 72.409999999999997 110.716 -178.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -110.66 172.06 7.1 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.638 -1.616 . . . . 74.5 106.638 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.534 ' HA ' ' OD1' ' A' ' 70' ' ' ASP . 97.4 m -58.91 126.29 27.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.966 1.469 . . . . 62.530000000000001 114.966 -174.129 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.64 -8.79 47.57 Favored Glycine 0 N--CA 1.433 -1.565 0 CA-C-N 114.18 -1.373 . . . . 64.120000000000005 111.443 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -104.53 135.68 45.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.75 0.309 . . . . 64.109999999999999 110.865 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.01 151.04 37.95 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.24 -1.022 . . . . 74.109999999999999 108.24 174.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HG3' HD11 ' A' ' 114' ' ' LEU . 53.8 mtm180 -124.67 143.21 50.86 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.855 -1.165 . . . . 75.209999999999994 107.855 177.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.85 118.3 10.3 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.292 -1.744 . . . . 71.230000000000004 106.292 173.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 62' ' ' TYR . 23.1 tpt180 -120.3 121.67 39.17 Favored 'General case' 0 C--N 1.283 -2.295 0 C-N-CA 120.05 -0.66 . . . . 74.129999999999995 110.058 -177.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.09 119.25 6.43 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.607 -1.397 . . . . 42.420000000000002 109.607 176.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.3 p -126.06 156.62 39.68 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 110.081 -0.34 . . . . 73.140000000000001 110.081 -178.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.52 110.74 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 N-CA-C 107.199 -1.408 . . . . 62.219999999999999 107.199 175.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -117.4 96.29 49.02 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.408 -0.96 . . . . 74.510000000000005 108.408 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 101' ' ' TYR . 9.9 Cg_exo -69.28 -23.75 32.64 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.333 2.022 . . . . 71.340000000000003 111.848 -177.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.37 69.95 4.31 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.404 1.097 . . . . 72.430000000000007 111.223 -176.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.481 ' HB ' ' H ' ' A' ' 103' ' ' ASP . 44.0 t -123.85 97.81 4.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 105.469 -2.048 . . . . 73.140000000000001 105.469 171.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.08 98.9 10.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.816 -0.629 . . . . 63.140000000000001 111.161 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.0 t -103.77 123.65 47.45 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 107.621 -1.252 . . . . 61.439999999999998 107.621 177.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--N 1.311 -1.084 0 N-CA-C 108.53 -0.915 . . . . 74.129999999999995 108.53 -176.345 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.489 0 N-CA-C 108.707 -0.849 . . . . 71.129999999999995 108.707 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.95 89.19 0.51 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 110.004 -1.238 . . . . 62.350000000000001 110.004 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -150.85 119.35 6.46 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 108.91 -0.774 . . . . 74.120000000000005 108.91 -176.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -169.6 131.19 1.1 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.34 -0.615 . . . . 71.0 109.34 177.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 162.53 35.25 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.778 -0.823 . . . . 53.420000000000002 108.778 178.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -148.24 79.19 1.45 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.905 0.859 . . . . 74.310000000000002 110.308 178.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -114.62 96.14 5.6 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 104.756 -2.312 . . . . 74.420000000000002 104.756 175.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.0 111.77 37.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.622 -0.717 . . . . 75.299999999999997 109.797 -175.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -80.31 105.05 11.27 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 106.501 -1.666 . . . . 72.25 106.501 174.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -75.87 81.49 2.78 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.031 0.919 . . . . 71.450000000000003 111.687 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.2 126.35 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 113.851 -1.522 . . . . 71.200000000000003 107.86 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -65.86 136.0 55.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.47 -0.786 . . . . 74.439999999999998 110.934 -178.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.24 143.8 40.76 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.272 -1.01 . . . . 73.219999999999999 108.272 178.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -80.6 87.76 5.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.497 -1.297 . . . . 75.439999999999998 107.497 175.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.43 140.77 58.07 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.168 -1.378 . . . . 62.509999999999998 109.758 -177.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -98.42 136.61 38.32 Favored 'General case' 0 N--CA 1.402 -2.842 0 C-N-CA 119.408 -0.917 . . . . 75.310000000000002 110.298 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -83.92 86.99 7.1 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 105.981 -1.859 . . . . 71.030000000000001 105.981 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -72.3 92.14 1.38 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.051 -0.977 . . . . 74.420000000000002 112.514 -174.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -73.8 128.38 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 CA-C-N 114.866 -1.061 . . . . 60.240000000000002 108.906 178.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.91 -4.48 61.14 Favored Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.62 -0.8 . . . . 73.109999999999999 111.654 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.56 86.18 6.4 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.682 0.754 . . . . 74.019999999999996 110.3 177.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.52 -59.13 4.67 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.013 -1.449 . . . . 72.129999999999995 110.838 -176.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -51.78 -49.71 62.16 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.426 0.691 . . . . 75.230000000000004 112.12 -176.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.21 -43.11 87.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 111.027 178.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -81.77 -19.47 41.23 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.496 1.295 . . . . 72.140000000000001 114.496 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 73' ' ' LYS . 1.4 mp -64.87 -41.74 92.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.89 -0.781 . . . . 62.399999999999999 108.89 171.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.523 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 50.9 m-85 -84.62 -17.16 39.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.842 -0.617 . . . . 74.409999999999997 110.439 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -65.37 4.08 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.596 -0.602 . . . . 52.43 111.596 178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 25.79 2.61 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.143 0.417 . . . . 72.439999999999998 114.143 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.1 p 51.78 75.39 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.161 1.385 . . . . 74.329999999999998 113.876 178.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.523 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 68.6 mt -94.9 100.7 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 107.323 -1.362 . . . . 75.409999999999997 107.323 175.629 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 40.1 t -80.79 132.25 58.13 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 108.416 -0.957 . . . . 65.5 108.416 -177.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 36.6 Cg_exo -65.65 29.21 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.916 3.077 . . . . 71.349999999999994 114.731 -178.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.46 -21.11 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.719 -0.613 . . . . 72.010000000000005 111.491 -177.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -69.56 -34.48 74.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.011 -0.366 . . . . 74.140000000000001 110.011 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 59.3 t -56.22 -50.5 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.778 -0.646 . . . . 74.450000000000003 110.111 176.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.82 -43.31 98.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.547 -178.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.66 -46.14 89.92 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.666 -0.697 . . . . 54.219999999999999 110.822 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.6 -23.92 58.8 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.832 0.679 . . . . 70.5 112.832 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 36' ' ' VAL . 74.6 mt -67.26 -37.43 83.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.886 0.374 . . . . 65.140000000000001 110.294 175.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -65.26 -42.0 93.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.643 0.735 . . . . 73.040000000000006 109.242 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 42' ' ' ARG . 29.8 mmt180 -71.7 -28.68 63.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.415 -0.811 . . . . 75.209999999999994 111.316 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' OE2' ' HD2' ' A' ' 122' ' ' ARG . 29.9 tp10 -68.92 -44.67 72.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.192 -0.67 . . . . 71.349999999999994 109.192 176.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -59.99 -41.58 92.33 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.642 -0.708 . . . . 34.350000000000001 109.728 176.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.62 -36.49 80.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.545 -0.752 . . . . 22.120000000000001 111.147 177.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.96 -39.49 83.36 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.12 0.486 . . . . 63.420000000000002 111.247 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.92 5.96 80.64 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.747 -0.661 . . . . 62.119999999999997 113.697 -178.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ALA . 10.8 mm -58.91 130.38 22.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.589 0.709 . . . . 73.310000000000002 112.112 178.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -116.19 134.71 54.62 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.356 -0.838 . . . . 70.219999999999999 110.056 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -72.52 106.59 4.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.804 -1.089 . . . . 72.140000000000001 109.694 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 52' ' ' GLN . 15.9 tp -109.16 -164.69 0.96 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.796 -1.557 . . . . 61.5 106.796 -177.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.639 ' H ' ' HG ' ' A' ' 51' ' ' LEU . 16.1 mm100 -51.52 162.49 0.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.651 0.781 . . . . 70.310000000000002 112.307 176.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.15 -7.48 38.21 Favored Glycine 0 C--N 1.312 -0.751 0 CA-C-N 114.946 -1.024 . . . . 74.530000000000001 113.7 -175.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -68.38 -48.63 64.24 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.797 -0.816 . . . . 64.319999999999993 108.797 177.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -176.27 167.77 2.84 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.774 1.027 . . . . 73.439999999999998 113.774 -177.42 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.11 151.26 21.06 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.486 -1.234 . . . . 71.120000000000005 111.153 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.95 126.28 43.28 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.664 -1.236 . . . . 74.239999999999995 107.664 -177.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.82 158.06 35.13 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 123.548 0.739 . . . . 54.219999999999999 109.648 -178.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 125' ' ' VAL . 31.9 Cg_exo -61.84 158.27 38.91 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.893 2.396 . . . . 50.439999999999998 113.087 178.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -124.81 -30.16 3.31 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.631 -0.713 . . . . 73.549999999999997 110.448 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -92.67 107.96 19.62 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.048 0.939 . . . . 64.5 108.596 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -116.22 118.12 31.91 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 120.885 0.374 . . . . 71.099999999999994 110.353 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.52 114.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.114 -0.698 . . . . 65.040000000000006 109.114 -178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' ARG . 2.3 mp -109.27 132.39 57.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.678 -1.23 . . . . 72.400000000000006 107.678 177.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.2 m -137.39 135.88 37.36 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.951 -0.389 . . . . 72.329999999999998 109.951 -177.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' HG ' ' CB ' ' A' ' 119' ' ' PHE . 6.4 mp -130.17 -179.38 5.2 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.303 -0.629 . . . . 74.219999999999999 109.303 175.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 111' ' ' SER . . . -69.77 156.03 53.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.86 -1.296 . . . . 71.400000000000006 109.86 175.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.635 ' HA ' ' HB2' ' A' ' 110' ' ' GLN . 43.4 t -56.25 -56.53 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 117.443 0.621 . . . . 45.219999999999999 111.83 -175.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.606 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 50.4 t-80 -59.12 -45.14 91.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.462 0.476 . . . . 74.010000000000005 110.555 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.85 -43.19 99.46 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 70.329999999999998 109.753 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -68.27 -39.44 82.18 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.382 -0.826 . . . . 73.430000000000007 111.12 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 68' ' ' VAL . 36.5 mt-10 -65.25 -28.58 69.45 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.648 0.261 . . . . 63.329999999999998 111.607 179.057 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 69' ' ' HIS . 0.4 OUTLIER -78.57 -23.33 46.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 120.017 -0.673 . . . . 73.239999999999995 109.686 178.686 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.22 -36.79 74.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 72.109999999999999 109.916 174.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.21 158.32 8.59 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.821 -0.912 . . . . 51.299999999999997 110.821 177.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.8 -6.92 57.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 111.872 0.323 . . . . 61.420000000000002 111.872 -177.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.72 103.31 46.32 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 116.691 -0.231 . . . . 74.239999999999995 111.594 -179.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.43 -36.55 8.83 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.62 1.547 . . . . 61.219999999999999 109.86 175.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.52 -29.19 66.75 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.148 0.796 . . . . 73.319999999999993 113.148 -176.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.84 -42.94 94.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.77 -1.567 . . . . 61.32 106.77 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -69.69 -38.79 77.12 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.476 -1.238 . . . . 75.420000000000002 109.456 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 106' ' ' VAL . 65.2 m -58.22 -48.36 80.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.353 -0.385 . . . . 54.420000000000002 111.02 177.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -57.8 -49.01 78.04 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 123.391 0.432 . . . . 70.150000000000006 110.69 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.18 -55.73 19.82 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.719 -0.673 . . . . 74.510000000000005 112.904 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -67.41 -37.12 82.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.741 1.015 . . . . 73.040000000000006 113.741 -175.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.541 ' HB2' HG12 ' A' ' 106' ' ' VAL . . . -66.6 -45.02 80.56 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 120.381 -0.527 . . . . 75.319999999999993 110.697 -179.314 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.36 -40.01 89.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 71.540000000000006 110.3 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.52 -53.32 53.74 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.166 -0.925 . . . . 74.329999999999998 111.064 178.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -67.11 -30.34 70.32 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 75.420000000000002 111.334 -178.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.8 78.55 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.178 0.513 . . . . 63.340000000000003 110.033 176.516 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.69 -39.7 73.34 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.599 -0.889 . . . . 64.239999999999995 108.599 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 22.0 m-85 -56.83 -52.18 66.08 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.532 -0.758 . . . . 63.210000000000001 112.494 175.346 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.1 pt -61.63 -37.27 77.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.357 -0.537 . . . . 73.409999999999997 111.093 -177.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -67.32 -38.18 84.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.326 -0.397 . . . . 72.109999999999999 110.567 176.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -60.46 -44.0 96.32 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 63.25 111.051 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 92' ' ' TYR . 72.5 mm-40 -75.91 -13.7 60.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.455 -0.793 . . . . 65.430000000000007 110.837 -178.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.15 25.89 35.68 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.928 -0.578 . . . . 75.400000000000006 112.442 177.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -99.75 172.56 7.18 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.891 -0.781 . . . . 73.019999999999996 108.891 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -145.35 173.45 11.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.524 -0.547 . . . . 61.450000000000003 109.524 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 t -157.53 177.84 10.96 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.331 -1.729 . . . . 63.210000000000001 106.331 177.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -102.07 117.48 34.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.686 -1.227 . . . . 75.340000000000003 107.686 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.82 -149.64 16.75 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.282 -1.927 . . . . 71.420000000000002 108.282 -177.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.68 169.61 15.93 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.387 -1.338 . . . . 74.209999999999994 107.387 171.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.01 120.88 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.825 0.345 . . . . 65.299999999999997 111.287 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -115.5 120.0 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 N-CA-C 108.695 -0.854 . . . . 31.140000000000001 108.695 176.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 86' ' ' ALA . 13.9 p -119.69 129.02 75.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.516 0.674 . . . . 74.219999999999999 110.435 -176.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -115.8 138.07 51.49 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.339 -0.846 . . . . 72.129999999999995 109.983 -178.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -121.41 132.69 54.89 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.189 -1.412 . . . . 64.109999999999999 107.189 179.003 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.94 174.79 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.266 0.555 . . . . 65.25 111.02 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . 17.0 pm0 -110.18 151.94 26.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.063 -0.971 . . . . 73.140000000000001 110.612 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.404 ' O ' ' HA2' ' A' ' 67' ' ' GLY . 37.8 t -141.42 132.28 25.91 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 107.24 -1.392 . . . . 71.340000000000003 107.24 176.063 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.7 t -81.6 -22.7 37.53 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.928 -0.767 . . . . 63.109999999999999 108.928 176.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -73.0 -30.21 63.61 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.598 0.714 . . . . 75.209999999999994 109.318 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -81.13 141.7 34.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.68 144.22 28.7 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.894 -0.594 . . . . 61.039999999999999 112.037 -171.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.9 m -64.84 124.54 22.25 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.85 -0.614 . . . . 63.299999999999997 109.567 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.27 -22.89 24.08 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.26 -1.136 . . . . 55.329999999999998 110.26 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -95.04 152.37 18.38 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 108.254 -1.017 . . . . 74.140000000000001 108.254 176.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . 31.5 p90 -148.37 146.84 28.68 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.017 -1.475 . . . . 62.240000000000002 107.017 174.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 64.9 mtp180 -126.6 144.64 50.83 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.771 -0.455 . . . . 70.349999999999994 109.771 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.71 122.95 19.32 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.298 -1.371 . . . . 74.019999999999996 107.298 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.493 ' HD2' ' OE2' ' A' ' 43' ' ' GLU . 26.1 tpt180 -131.39 130.0 42.04 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.946 -0.702 . . . . 74.109999999999999 111.178 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -102.27 126.43 8.87 Favored Glycine 0 N--CA 1.425 -2.077 0 O-C-N 124.072 0.857 . . . . 72.109999999999999 111.059 177.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.1 m -122.82 146.57 47.43 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.662 -0.866 . . . . 72.230000000000004 108.662 179.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 59' ' ' PRO . 62.1 t -95.66 105.16 16.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.184 -1.413 . . . . 74.329999999999998 107.184 174.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.48 100.14 51.15 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 120.871 -0.332 . . . . 63.549999999999997 110.206 -179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.21 -3.71 4.49 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 C-N-CA 121.994 1.796 . . . . 72.510000000000005 110.901 175.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -92.59 29.14 1.81 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.789 -0.641 . . . . 64.129999999999995 109.708 -175.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.4 123.81 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 CA-C-O 121.702 0.763 . . . . 61.509999999999998 110.621 -178.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -96.81 147.02 24.36 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.626 -1.99 . . . . 74.049999999999997 105.626 168.448 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.9 m -30.41 115.51 0.13 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 126.112 1.765 . . . . 75.319999999999993 114.446 -174.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 107.188 -1.412 . . . . 74.409999999999997 107.188 177.56 . . . . . . . . 0 0 . 1 stop_ save_